PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Barrios, B; Baez, NS; Reynolds, D; Iribarren, P; Cejas, H; Young, HA; Rodriguez-Galan, MC				Barrios, Bibiana; Baez, Natalia S.; Reynolds, Della; Iribarren, Pablo; Cejas, Hugo; Young, Howard A.; Cecilia Rodriguez-Galan, Maria			Abrogation of TNF alpha Production during Cancer Immunotherapy Is Crucial for Suppressing Side Effects Due to the Systemic Expression of IL-12	PLOS ONE			English	Article							PHASE-I TRIAL; RECOMBINANT HUMAN INTERLEUKIN-12; TUMOR-NECROSIS-FACTOR; RENAL-CELL CANCER; IFN-GAMMA; GENE-THERAPY; INTERFERON-GAMMA; NITRIC-OXIDE; TOXICITY; MICE	For more than a decade, the cytokine interleukin-12 (IL-12) has been utilized, either alone or in combination with other drugs, as a treatment for cancer. The numerous anti-tumor properties of IL-12 still generate interest in the clinical use of this cytokine, even though it has demonstrated toxicity when administrated systemically. As an approach to overcome this toxicity, numerous laboratories have attempted to induce IL-12 expression at the site of the tumor. However for tumors that are difficult to remove surgically or for the treatment of disseminated metastases, systemic expression of this cytokine still remains as the most efficient method of administration. Nevertheless, finding alternative approaches for the use of IL-12 in the treatment of cancer and unraveling the basis of IL-12-side effects remain a challenge. In the present work we demonstrate that systemic expression of IL-12 through hydrodynamic injection of IL-12 cDNA is able to induce different types of liver lesions associated with a toxic pathology. However we report here that hepatic toxicity is diminished and survival of mice enhanced in the absence of tumor necrosis factor alpha (TNF alpha). This observation is in contrast to several murine models and clinical trials that postulate interferon gamma (IFN gamma) as the main cytokine responsible for IL-12 toxicity. Moreover, our work demonstrates that when IL-12 cDNA is co-injected with IL-18 cDNA or when mice are pre-treated with a low dose of IL-12 cDNA prior to receiving a high dose of IL-12 cDNA, systemic levels of TNF alpha are almost completely abrogated, resulting in improved survival and less hepatic damage. Importantly, abrogation of TNF alpha signaling does not affect the strong anti-tumor activity of IL-12. Thus, neutralizing TNF alpha with antagonists already approved for human use offers a promising approach to abrogate IL-12 side effects during the use of this cytokine for the treatment of cancer.	[Barrios, Bibiana; Baez, Natalia S.; Iribarren, Pablo; Cejas, Hugo; Cecilia Rodriguez-Galan, Maria] Univ Nacl Cordoba, CIBICI CONICET, Fac Ciencias Quim, RA-5000 Cordoba, Argentina; [Reynolds, Della; Young, Howard A.] NCI, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res,NIH, Frederick, MD 21701 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rodriguez-Galan, MC (corresponding author), Univ Nacl Cordoba, CIBICI CONICET, Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	crodri@bioclin.fcq.unc.edu.ar	Young, Howard/R-5140-2019; Young, Howard/A-6350-2008	Young, Howard/0000-0002-3118-5111	Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba (SeCyT-UNC, Argentina)	Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba (SeCyT-UNC, Argentina)(Secretaria de Ciencia y Tecnologia (SECYT))	This project has been funded in part with federal funds from the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, and also by Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) and Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba (SeCyT-UNC, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell SM, 2002, BLOOD, V99, P67, DOI 10.1182/blood.V99.1.67; Atkins MB, 1997, CLIN CANCER RES, V3, P409; Bastos KRB, 2007, J INTERF CYTOK RES, V27, P399, DOI 10.1089/jir.2007.0128; Bekaii-Saab TS, 2009, MOL CANCER THER, V8, P2983, DOI 10.1158/1535-7163.MCT-09-0820; CAR BD, 1995, AM J PATHOL, V147, P1693; Carson WE, 2000, BLOOD, V96, P1465, DOI 10.1182/blood.V96.4.1465.h8001465_1465_1473; Rodriguez-Galan MC, 2009, J IMMUNOL, V183, P740, DOI 10.4049/jimmunol.0804166; Chiang CLL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-198; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Egilmez Nejat K., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P266, DOI 10.2174/187153007782794335; ERRICOGRIGIONI A, 2008, LIVER TRANSPLANT, V14, P313, DOI DOI 10.1002/LT.21375.PUBMED:18306349; Gollob JA, 2000, CLIN CANCER RES, V6, P1678; Hallaj-Nezhadi S, 2010, J PHARM PHARM SCI, V13, P472, DOI 10.18433/J3630V; Hamid O, 2007, CLIN CANCER RES, V13, P215, DOI 10.1158/1078-0432.CCR-06-1450; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Ito H, 2006, LAB INVEST, V86, P254, DOI 10.1038/labinvest.3700388; Lange M, 2009, FRONT BIOSCI-LANDMRK, V14, P1979, DOI 10.2741/3357; Lenzi R, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-66; Lopez MV, 2005, J IMMUNOL, V175, P5885, DOI 10.4049/jimmunol.175.9.5885; Lui VWY, 2001, J GENE MED, V3, P384; MAYORAL JL, 1990, ARCH SURG-CHICAGO, V125, P24; Mazzolini G, 2001, GENE THER, V8, P259, DOI 10.1038/sj.gt.3301387; Mazzolini G, 2003, CURR PHARM DESIGN, V9, P1981, DOI 10.2174/1381612033454261; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Motzer RJ, 1998, CLIN CANCER RES, V4, P1183; Nakamura S, 2000, J IMMUNOL, V164, P3330, DOI 10.4049/jimmunol.164.6.3330; Portielje JEA, 1999, CLIN CANCER RES, V5, P3983; Portielje JEA, 2003, CLIN CANCER RES, V9, P76; Rakhmilevich AL, 1999, J IMMUNOTHER, V22, P135, DOI 10.1097/00002371-199903000-00005; Rodriguez-Galan MC, 2005, J IMMUNOL, V174, P2796, DOI 10.4049/jimmunol.174.5.2796; Rook AH, 2001, ANN NY ACAD SCI, V941, P177; Santos SS, 2012, SHOCK, V38, P18, DOI 10.1097/SHK.0b013e318257114e; Sgadari C, 1996, BLOOD, V87, P3877, DOI 10.1182/blood.V87.9.3877.bloodjournal8793877; Suzuki A, 2012, CLIN GASTROENTEROL H, V10, P786, DOI 10.1016/j.cgh.2012.01.020; Taniguchi Hideaki, 2012, Nihon Shokakibyo Gakkai Zasshi, V109, P630; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tsuji H, 1999, J IMMUNOL, V162, P1049; Yarchoan R, 2007, CRIT REV IMMUNOL, V27, P401, DOI 10.1615/CritRevImmunol.v27.i5.10	39	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90116	10.1371/journal.pone.0090116	http://dx.doi.org/10.1371/journal.pone.0090116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587231	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200130
J	Dossou-Yovo, F; Mamadou, G; Soudy, ID; Limas-Nzouzi, N; Miantezila, J; Desjeux, JF; Eto, B				Dossou-Yovo, Flore; Mamadou, Godefroy; Soudy, Imar Djibrine; Limas-Nzouzi, Nicolas; Miantezila, Joe; Desjeux, Jehan-Francois; Eto, Bruno			Metronidazole or Cotrimoxazole Therapy Is Associated with a Decrease in Intestinal Bioavailability of Common Antiretroviral Drugs	PLOS ONE			English	Article							MUCOUS GEL LAYER; P-GLYCOPROTEIN; MUCIN DYNAMICS; MUCUS; PERMEABILITY; TRANSPORT; LOPINAVIR/RITONAVIR; EXPRESSION; PARAMETERS; RESISTANCE	Metronidazole (MTZ) and Cotrimoxazole (CTX) are used in HIV/AIDS patients eligible for antiretroviral treatment. The objective of this animal study was to determine whether pre-treatment with antibiotics affects the intestinal bioavailability of Atazanavir (ATV) and Ritonavir (RTV). After oral administration of 1 mg MTZ and CTX for 7 days, the rat colonic mucosa were analyzed for mucus thickness or placed in Ussing chambers to measure ATV and RTV net transepithelial fluxes (J(net)). 1. In control rats, the mucus thickness was 43.3 +/- 7.6 mu m and 40.7 +/- 6.9 mu m, in proximal and distal colon, respectively. In proximal colon, the thickness was 57.2 +/- 8.8 and 58.2 +/- 6.9 mu m after MTZ and CTX, respectively whereas in distal colon, the thickness was 121.1 +/- 38.4 and 170.5 +/- 35.0 mu m (P<0.05) respectively. 2. Transepithelial conductance was reduced after MTZ or CTX in the proximal and distal colon. 3. In control, net ATV secretion was observed both in proximal (2 0.36 +/- 0.02 mu g.hr(-1) cm(-2)) and distal colon (-0.30 +/- 0.08 mu g.hr(-1) cm(-2)). After MTZ and CTX, it was increased in the proximal colon by two 2 fold and 4 fold, respectively and in the distal colon by 3 fold and 5 fold, respectively. 4. In control, there was no net active RTV transport either in proximal (+0.01 +/- 0.01 mu g.hr(-1) cm(-2)) or distal colon (+0.04 +/- 0.01 mu g.hr(-1) cm(-2)). After MTZ and CTX, secretion was increased 5 fold and 10 fold, respectively, in the proximal colon and two fold and 5 fold, respectively in the distal colon (p<0.001). In conclusion, after MTZ and CTX therapy, the mucus layer was enlarged, passive permeability was decreased and ATV and RTV were actively secreted by the colonic epithelium suggesting that, in rat, the intestinal bioavailability of ATV and RTV is impaired after antibiotic therapy.	[Dossou-Yovo, Flore] CNAM, Biol Lab, Paris, France; [Mamadou, Godefroy; Soudy, Imar Djibrine; Limas-Nzouzi, Nicolas; Miantezila, Joe; Eto, Bruno] Univ Paris 07, Fac Med Xavier Bichat, Lab TBC TransCell Lab, Paris, France; [Soudy, Imar Djibrine] Inst Univ Sci & Tech Abeche, Ndjamena, Chad; [Desjeux, Jehan-Francois] Acad Natl Med, Paris, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Eto, B (corresponding author), Univ Paris 07, Fac Med Xavier Bichat, Lab TBC TransCell Lab, Paris, France.	bruno.eto@paris7.jussieu.fr		ETO, Bruno/0000-0001-9397-2690	budget of training of the laboratory TBC-Transcell-lab, faculty of medicine Xavier Bichat. University of Paris Diderot - paris7, France	budget of training of the laboratory TBC-Transcell-lab, faculty of medicine Xavier Bichat. University of Paris Diderot - paris7, France	The study was support by the budget of training of the laboratory TBC-Transcell-lab, faculty of medicine Xavier Bichat. University of Paris Diderot - paris7, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 2013, SCIENCE, V342, P432, DOI 10.1126/science.1246252; Chiou WL, 1996, J PHARMACOKINET BIOP, V24, P433, DOI 10.1007/BF02353521; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; COOK HC, 1973, MED LAB TECHNOL, V30, P217; Crommentuyn KML, 2004, CLIN INFECT DIS, V38, pE73, DOI 10.1086/382675; DARMON N, 1993, J NUTR, V123, P1068; DAWSON DC, 1978, AM J PHYSIOL, V235, pE7, DOI 10.1152/ajpendo.1978.235.1.E7; DESAI MA, 1991, J PHARM PHARMACOL, V43, P124, DOI 10.1111/j.2042-7158.1991.tb06647.x; HEYMAN M, 1980, AM J PHYSIOL, V238, pG326, DOI 10.1152/ajpgi.1980.238.4.G326; Heyman M, 2000, ANN NY ACAD SCI, V915, P304; IIBOSHI Y, 1994, JPEN-PARENTER ENTER, V18, P346, DOI 10.1177/0148607194018004346; Iiboshi Y, 1996, JPEN-PARENTER ENTER, V20, P98, DOI 10.1177/014860719602000298; Iiboshi Y, 1996, JPEN-PARENTER ENTER, V20, P406, DOI 10.1177/0148607196020006406; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kageyama M, 2005, BIOL PHARM BULL, V28, P130, DOI 10.1248/bpb.28.130; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Korjamo T, 2009, J PHARM SCI-US, V98, P4469, DOI 10.1002/jps.21762; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Mathieu J, 2008, METHOD FIND EXP CLIN, V30, P591, DOI 10.1358/mf.2008.30.8.1271096; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; McIsaac Warren J, 2008, Can J Infect Dis Med Microbiol, V19, P287; OTA H, 1992, HISTOCHEM J, V24, P86, DOI 10.1007/BF01082444; Pelissier MA, 2006, STEROIDS, V71, P240, DOI 10.1016/j.steroids.2005.10.009; Pelissier MA, 2010, FEMS MICROBIOL ECOL, V73, P601, DOI 10.1111/j.1574-6941.2010.00916.x; Perloff MD, 2001, J PHARM SCI-US, V90, P1829, DOI 10.1002/jps.1133.abs; Rebiere H, 2007, J CHROMATOGR B, V850, P376, DOI 10.1016/j.jchromb.2006.12.007; Rodriguez-Novoa S, 2006, PHARMACOGENOMICS J, V6, P234, DOI 10.1038/sj.tpj.6500374; SHARMA R, 1995, GUT, V36, P209, DOI 10.1136/gut.36.2.209; Sharma R, 1995, DIGEST DIS SCI, V40, P2532, DOI 10.1007/BF02220438; TAI YH, 1981, J MEMBRANE BIOL, V59, P173, DOI 10.1007/BF01875423; THOMSON ABR, 1980, AM J PHYSIOL, V239, pG372, DOI 10.1152/ajpgi.1980.239.5.G372; USSING HH, 1949, ACTA PHYSIOL SCAND, V17, P1, DOI 10.1111/j.1748-1716.1949.tb00550.x; Varum FJO, 2012, J PHARM PHARMACOL, V64, P218, DOI 10.1111/j.2042-7158.2011.01399.x; Vertzoni M, 2011, INT J PHARMACEUT, V413, P81, DOI 10.1016/j.ijpharm.2011.04.028; Vogel M, 2004, LIVER TRANSPLANT, V10, P939, DOI 10.1002/lt.20165; Zembruski NCL, 2011, J ANTIMICROB CHEMOTH, V66, P802, DOI 10.1093/jac/dkq501	37	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89943	10.1371/journal.pone.0089943	http://dx.doi.org/10.1371/journal.pone.0089943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587140	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000115
J	Gu, W; Wan, DW; Qian, QY; Yi, B; He, ZL; Gu, YL; Wang, L; He, SB				Gu, Wen; Wan, Daiwei; Qian, Qinyi; Yi, Bin; He, Zhilong; Gu, Yilin; Wang, Liang; He, Songbing			Ambra1 Is an Essential Regulator of Autophagy and Apoptosis in SW620 Cells: Pro-Survival Role of Ambra1	PLOS ONE			English	Article							CALPAIN-MEDIATED CLEAVAGE; COLORECTAL-CANCER CELLS; MOLECULAR-MECHANISMS; MONITORING AUTOPHAGY; BECLIN-1; INHIBITION; EXPRESSION; THERAPY; PROTEIN	Recent research has revealed a role for Ambra1, an autophagy-related gene-related (ATG) protein, in the autophagic pro-survival response, and Ambra1 has been shown to regulate Beclin1 and Beclin1-dependent autophagy in embryonic stem cells. However, whether Ambra1 plays an important role in the autophagy pathway in colorectal cancer cells is unknown. In this study, we hypothesized that Ambra1 is an important regulator of autophagy and apoptosis in CRC cell lines. To test this hypothesis, we confirmed autophagic activity in serum-starved SW620 CRC cells by assessing endogenous microtubule-associated protein 1 light chain 3 (LC3) localization, the presence of autophagosomes (transmission electron microscopy) and LC3 protein levels (Western blotting). Ambra1 expression was detected by Western blot in SW620 cells treated with staurosporine or etoposide. Calpain and caspase inhibitors were employed to verify whether calpains and caspases were responsible for Ambra1 cleavage. To examine the role of Ambra1 in apoptosis, Ambra1 knockdown cells were treated with staurosporine and etoposide. Cell apoptosis and viability were measured by annexin-V and PI staining and MTT assays. We determined that serum deprivation-induced autophagy was associated with Ambra1 upregulation in colorectal cancer cell lines. Ambra1 expression decreased during staurosporine- or etoposide-induced apoptosis. Calpains and caspases may be responsible for Ambra1 degradation. When Ambra1 expression was reduced by siRNA, SW620 cells were more sensitive to staurosporine-or etoposide-induced apoptosis. In addition, starvation-induced autophagy decreased. Finally, Co-immunoprecipitation of Ambra1 and Beclin1 demonstrated that Ambra1 and Beclin1 interact in serum-starved or rapamycin-treated SW620 cells, suggesting that Ambra1 regulates autophagy in CRC cells by interacting with Beclin1. In conclusion, Ambra1 is a crucial regulator of autophagy and apoptosis in CRC cells that maintains the balance between autophagy and apoptosis.	[Gu, Wen; Yi, Bin; Wang, Liang; He, Songbing] Soochow Univ, Affiliated Hosp 1, Dept Gen Surg, Suzhou, Peoples R China; [Wan, Daiwei] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [He, Songbing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [He, Songbing] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Immunol, Shanghai, Peoples R China; [He, Songbing] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Qian, Qinyi] Changshu 2 Peoples Hosp, Dept Ultrasonog, Changshu, Peoples R China; [Gu, Yilin] Soochow Univ, Affiliated Hosp 1, Dept Operating Rooms, Suzhou, Peoples R China; [He, Zhilong] Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou, Peoples R China; [He, Songbing] Washington Univ, Sch Med, St Louis, MO USA	Soochow University - China; Sun Yat Sen University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Soochow University - China; Soochow University - China; Washington University (WUSTL)	Wang, L (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Gen Surg, Suzhou, Peoples R China.	wangliangsuda@163.com; hesongbing1979@163.com			Nature Science Foundation of P.R. China [81201905]; China Postdoctoral Science Foundation [2013M540374]; Shanghai Postdoctoral Scientific Program of P.R. China [13R21415200]; Nature Science Research Grants of the University of Jiangsu Province of P.R. China [12KJB320009]; Research Project of the Science and Technology Bureau of Suzhou City of P.R. China [SYS201220]; Government Overseas Scholarship from the Department of Education of Jiangsu Province	Nature Science Foundation of P.R. China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Scientific Program of P.R. China; Nature Science Research Grants of the University of Jiangsu Province of P.R. China; Research Project of the Science and Technology Bureau of Suzhou City of P.R. China; Government Overseas Scholarship from the Department of Education of Jiangsu Province	This work was supported by the Project of the Nature Science Foundation of P.R. China (81201905), the China Postdoctoral Science Foundation (2013M540374), the Shanghai Postdoctoral Scientific Program of P.R. China (13R21415200), Nature Science Research Grants of the University of Jiangsu Province of P.R. China (12KJB320009), and the Research Project of the Science and Technology Bureau of Suzhou City of P.R. China (SYS201220), and sponsored by a Government Overseas Scholarship from the Department of Education of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Cecconi F, 2008, CELL DEATH DIFFER, V15, P1170, DOI 10.1038/cdd.2008.64; Cui JZ, 2013, BBA-REV CANCER, V1836, P15, DOI 10.1016/j.bbcan.2013.02.003; Fan YJ, 2013, CHIN J CANCER, V32, P121, DOI 10.5732/cjc.012.10106; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fimia GM, 2011, AUTOPHAGY, V7, P115, DOI 10.4161/auto.7.1.14071; Grothey A, 2005, J CLIN ONCOL, V23, P9441, DOI 10.1200/JCO.2005.04.4792; Holt SV, 2011, TOXICOL PATHOL, V39, P516, DOI 10.1177/0192623310396903; Jaboin JJ, 2009, METHOD ENZYMOL, V453, P287, DOI 10.1016/S0076-6879(08)04014-7; Jain K, 2013, AM J CANCER RES, V3, P251; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lotze MT, 2013, CANCER J, V19, P341, DOI 10.1097/PPO.0b013e31829da0d6; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pagliarini V, 2012, CELL DEATH DIFFER, V19, P1495, DOI 10.1038/cdd.2012.27; Pandey S, 2012, ASIAN PAC J CANCER P, V13, P4867, DOI 10.7314/APJCP.2012.13.10.4867; Rohn TT, 2011, NEUROBIOL DIS, V43, P68, DOI 10.1016/j.nbd.2010.11.003; Russo R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.29; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Strappazzon F, 2011, EMBO J, V30, P1195, DOI 10.1038/emboj.2011.49; Troiani T, 2013, CURR MED CHEM; Wang S, 1999, MOL BRAIN RES, V70, P167, DOI 10.1016/S0169-328X(99)00145-X; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wu SB, 2013, BIOCHEM BIOPH RES CO, V434, P898, DOI 10.1016/j.bbrc.2013.04.053; Xu HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063232; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zheng Hai-yang, 2012, Cancer Biology Medicine, V9, P105, DOI 10.3969/j.issn.2095-3941.2012.02.004	33	28	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90151	10.1371/journal.pone.0090151	http://dx.doi.org/10.1371/journal.pone.0090151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587252	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000136
J	Kim, DR; Ali, M; Thiem, VD; Wierzba, TF				Kim, Deok Ryun; Ali, Mohammad; Vu Dinh Thiem; Wierzba, Thomas F.			Socio-Ecological Risk Factors for Prime-Age Adult Death in Two Coastal Areas of Vietnam	PLOS ONE			English	Article							MORTALITY; SUICIDE; HEALTH; PATTERNS; ALCOHOL	Background: Hierarchical spatial models enable the geographic and ecological analysis of health data thereby providing useful information for designing effective health interventions. In this study, we used a Bayesian hierarchical spatial model to evaluate mortality data in Vietnam. The model enabled identification of socio-ecological risk factors and generation of risk maps to better understand the causes and geographic implications of prime-age (15 to less than 45 years) adult death. Methods and Findings: The study was conducted in two sites: Nha Trang and Hue in Vietnam. The study areas were split into 500x500 meter cells to define neighborhoods. We first extracted socio-demographic data from population databases of the two sites, and then aggregated the data by neighborhood. We used spatial hierarchical model that borrows strength from neighbors for evaluating risk factors and for creating spatially smoothed risk map after adjusting for neighborhood level covariates. The Markov chain Monte Carlo procedure was used to estimate the parameters. Male mortality was more than twice the female mortality. The rates also varied by age and sex. The most frequent cause of mortality was traffic accidents and drowning for men and traffic accidents and suicide for women. Lower education of household heads in the neighborhood was an important risk factor for increased mortality. The mortality was highly variable in space and the socio-ecological risk factors are sensitive to study site and sex. Conclusion: Our study suggests that lower education of the household head is an important predictor for prime age adult mortality. Variability in socio-ecological risk factors and in risk areas by sex make it challenging to design appropriate intervention strategies aimed at decreasing prime-age adult deaths in Vietnam.	[Kim, Deok Ryun; Ali, Mohammad; Wierzba, Thomas F.] SNU Res Pk, Int Vaccine Inst, Seoul, South Korea; [Ali, Mohammad] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Vu Dinh Thiem] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam	International Vaccine Institute; Seoul National University (SNU); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institute of Hygiene & Epidemiology (NIHE)	Kim, DR (corresponding author), SNU Res Pk, Int Vaccine Inst, Nakseongdae Dong, Seoul, South Korea.	drkim@ivi.int	Ali, Mohammad/E-2365-2017	Ali, Mohammad/0000-0003-1410-388X; Vu, Thiem/0000-0001-6168-4555	Diseases of the Most Impoverished (DOMI) grant; Bill and Melinda Gates Foundation	Diseases of the Most Impoverished (DOMI) grant; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was supported by the Diseases of the Most Impoverished (DOMI) grant awarded to IVI by the Bill and Melinda Gates Foundation. IVI receives core support from the Swedish International Development Cooperation Agency (Sida) and the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-31; Anselin L., 2003, GEODA 0 9 USERS GUID; AUSTER R, 1969, J HUM RESOUR, V4, P411, DOI 10.2307/145166; Avramov D, 2010, ANNU REV FINANC ECON, V2, P25, DOI 10.1146/annurev-financial-120209-133947; Banerjee S, 2003, HIERARCHICAL MODELIN; BLUMENTHAL SJ, 1990, PSYCHIAT CLIN N AM, V13, P511; Browne W., 2009, MCMC ESTIMATION MLWI; Browne WJ, 2001, STAT MODEL, V1, P103, DOI 10.1177/1471082X0100100202; Byass P, 2003, SCAND J PUBLIC HEALT, V31, P8, DOI 10.1080/14034950310015040; Chaix B, 2005, AM J EPIDEMIOL, V162, P171, DOI 10.1093/aje/kwi175; CHRISTENSON BA, 1995, DEMOGRAPHY, V32, P215, DOI 10.2307/2061741; Cliff A. D., 1981, SPATIAL PROCESSES MO; Collings S. C., 2005, SUICIDE PREVENTION N; Diekmann KA, 2003, J PERS SOC PSYCHOL, V85, P672, DOI 10.1037/0022-3514.85.4.672; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Diggle P, 2002, J R STAT SOC C-APPL, V51, P493, DOI 10.1111/1467-9876.00283; Fawell J, 2003, BRIT MED BULL, V68, P199, DOI 10.1093/bmb/ldg027; General Statistical Office, 2011, 2009 VIETN POP HOUS; Grossman M, 1997, SOCIAL BENEFITS ED; Harriden K, 2013, J WATER SANIT HYG DE, V3, P70, DOI 10.2166/washdev.2013.015; HOWLAND J, 1988, ACCIDENT ANAL PREV, V20, P19, DOI 10.1016/0001-4575(88)90011-5; HunterL TwineW, 2008, WB20050004 U COL BOU; Huy TQ, 2007, THESIS; Janis IB, 2008, J CLIN PSYCHOL, V64, P1164, DOI 10.1002/jclp.20509; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Jones AQ, 2007, SCI TOTAL ENVIRON, V388, P54, DOI 10.1016/j.scitotenv.2007.08.028; Kaljee LM, 2005, HEALTH EDUC RES, V20, P71, DOI 10.1093/her/cyg096; Kim DR, 2008, HEALTH PLACE, V14, P755, DOI 10.1016/j.healthplace.2007.12.003; Kitagawa EM, 1973, DIFFERENTIAL MORTALI; Lewinsohn PM, 2001, J AM ACAD CHILD PSY, V40, P427, DOI 10.1097/00004583-200104000-00011; Lleras-Muney A, 2002, NBER WORKING PAPERS; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Minh HV, 2006, UMEA U MED DISSERTAT, V1018; MURRAY CJL, 1992, HLTH ADULTS DEV WORL, P23; Ngo Anh D, 2010, BMC Res Notes, V3, P78, DOI 10.1186/1756-0500-3-78; Quan L, 2003, INJURY PREV, V9, P163, DOI 10.1136/ip.9.2.163; Nguyen QN, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/560397; Rahman MO, 1999, INT J EPIDEMIOL, V28, P485, DOI 10.1093/ije/28.3.485; Roux AVD, 2004, EPIDEMIOL REV, V26, P104, DOI 10.1093/epirev/mxh006; Sankoh OA, 2002, 032002 U HEID; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steele D, 2012, EXPERT REV VACCINES, V11, P407, DOI [10.1586/erv.12.9, 10.1586/ERV.12.9]; U.S. Department of Health and Human Services, 2003, CARD RISK VIETN COMM; UNFPA, 1999, NEW GEN FAM SOC; WHO, 2010, TRENDS MAT MORT 1990; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2; Wu KCC, 2012, INT J ENV RES PUB HE, V9, P1135, DOI 10.3390/ijerph9041135	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89780	10.1371/journal.pone.0089780	http://dx.doi.org/10.1371/journal.pone.0089780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24587031	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000092
J	Silva, B; Goles, NI; Varas, R; Campusano, JM				Silva, Bryon; Goles, Nicolas I.; Varas, Rodrigo; Campusano, Jorge M.			Serotonin Receptors Expressed in Drosophila Mushroom Bodies Differentially Modulate Larval Locomotion	PLOS ONE			English	Article							CENTRAL COMPLEX; DOPA DECARBOXYLASE; BEHAVIOR; NEURONS; BODY; OCTOPAMINE; MELANOGASTER; TYRAMINE; BRAIN; RELEASE	Drosophila melanogaster has been successfully used as a simple model to study the cellular and molecular mechanisms underlying behaviors, including the generation of motor programs. Thus, it has been shown that, as in vertebrates, CNS biogenic amines (BA) including serotonin (5HT) participate in motor control in Drosophila. Several evidence show that BA systems innervate an important association area in the insect brain previously associated to the planning and/or execution of motor programs, the Mushroom Bodies (MB). The main objective of this work is to evaluate the contribution of 5HT and its receptors expressed in MB to motor behavior in fly larva. Locomotion was evaluated using an automated tracking system, in Drosophila larvae (3rd-instar) exposed to drugs that affect the serotonergic neuronal transmission: alpha-methyl-L-dopa, MDMA and fluoxetine. In addition, animals expressing mutations in the 5HT biosynthetic enzymes or in any of the previously identified receptors for this amine (5HT(1A)R, 5HT(1B)R, 5HT(2)R and 5HT(7)R) were evaluated in their locomotion. Finally, RNAi directed to the Drosophila 5HT receptor transcripts were expressed in MB and the effect of this manipulation on motor behavior was assessed. Data obtained in the mutants and in animals exposed to the serotonergic drugs, suggest that 5HT systems are important regulators of motor programs in fly larvae. Studies carried out in animals pan-neuronally expressing the RNAi for each of the serotonergic receptors, support this idea and further suggest that CNS 5HT pathways play a role in motor control. Moreover, animals expressing an RNAi for 5HT(1B)R, 5HT(2)R and 5HT(7)R in MB show increased motor behavior, while no effect is observed when the RNAi for 5HT(1A)R is expressed in this region. Thus, our data suggest that CNS 5HT systems are involved in motor control, and that 5HT receptors expressed in MB differentially modulate motor programs in fly larvae.	[Silva, Bryon; Goles, Nicolas I.; Varas, Rodrigo; Campusano, Jorge M.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Varas, Rodrigo] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Pontificia Universidad Catolica de Chile; Universidad Autonoma de Chile	Campusano, JM (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Alameda 340, Santiago, Chile.	jcampusano@bio.puc.cl	Campusano, Jorge M/A-1592-2014; Campusano, Jorge M/CAF-8833-2022	Campusano, Jorge M/0000-0001-5254-8340; Campusano, Jorge M/0000-0001-5254-8340; Silva, Bryon/0000-0001-5871-8099	Grant Fondo Nacional de Desarrollo Cientifico y Tecnologico [1100965]; Millennium Science Initiative [10/063-F, P-10/035-F]	Grant Fondo Nacional de Desarrollo Cientifico y Tecnologico; Millennium Science Initiative	Funded by Grant Fondo Nacional de Desarrollo Cientifico y Tecnologico 1100965 (JMC) and Millennium Science Initiative 10/063-F (JMC & RV) and P-10/035-F (RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Becnel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020800; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Berni J, 2012, CURR BIOL, V22, P1861, DOI 10.1016/j.cub.2012.07.048; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; Borue X, 2009, J NEUROSCI METH, V179, P300, DOI 10.1016/j.jneumeth.2009.02.013; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bustos G, 2004, BRAIN RES REV, V47, P126, DOI 10.1016/j.brainresrev.2004.05.002; Campusano JM, 2005, NEUROCHEM RES, V30, P567, DOI 10.1007/s11064-005-2691-3; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Dasari S, 2004, NEUROSCI RES, V48, P221, DOI 10.1016/j.neures.2003.10.005; Dasari S, 2007, EUR J NEUROSCI, V26, P424, DOI 10.1111/j.1460-9568.2007.05655.x; Dunbar MJ, 2010, J PHYSIOL-LONDON, V588, P139, DOI 10.1113/jphysiol.2009.177378; Farooqui T, 2007, NEUROCHEM RES, V32, P1511, DOI 10.1007/s11064-007-9344-7; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Hardie SL, 2007, DEV NEUROBIOL, V67, P1396, DOI 10.1002/dneu.20459; Heiman RG, 1996, P NATL ACAD SCI USA, V93, P2420, DOI 10.1073/pnas.93.6.2420; Helfrich-Forster C, 2002, J NEUROGENET, V16, P73, DOI 10.1080/01677060290024592; Howarth CJ, 2002, J INSECT PHYSIOL, V48, P43, DOI 10.1016/S0022-1910(01)00142-1; Huser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047518; Huston SJ, 2011, CURR OPIN NEUROBIOL, V21, P527, DOI 10.1016/j.conb.2011.05.030; Jordan KW, 2006, GENETICS, V174, P271, DOI 10.1534/genetics.106.058099; KAMYSHEV NG, 1983, PHARMACOL BIOCHEM BE, V18, P677, DOI 10.1016/0091-3057(83)90005-9; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; MARSH JL, 1986, GENETICS, V112, P249; Martin JR, 1998, LEARN MEMORY, V5, P179; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Nichols CD, 2007, DEV NEUROBIOL, V67, P752, DOI 10.1002/dneu.20370; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pauls D, 2010, J NEUROSCI, V30, P10655, DOI 10.1523/JNEUROSCI.1281-10.2010; Pendleton RG, 2002, J PHARMACOL EXP THER, V300, P91, DOI 10.1124/jpet.300.1.91; Pfluger HJ, 2000, ACTA BIOL HUNG, V51, P343; Pizzo AB, 2013, MOL PSYCHIATR, V18, P824, DOI 10.1038/mp.2012.82; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Ritzmann RE, 2007, CURR OPIN NEUROBIOL, V17, P629, DOI 10.1016/j.conb.2008.01.001; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Scantlebury N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010652; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Shpargel KB, 2009, MOL BIOL CELL, V20, P90, DOI 10.1091/mbc.E08-01-0024; Simon AF, 2009, GENETICS, V181, P525, DOI 10.1534/genetics.108.094110; Sinadinos C, 2012, J NEUROSCI METH, V203, P325, DOI 10.1016/j.jneumeth.2011.08.037; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Varnam CJ, 1996, J NEUROGENET, V11, P99, DOI 10.3109/01677069609107065; Wang JW, 1997, J NEUROGENET, V11, P231, DOI 10.3109/01677069709115098; WRIGHT TRF, 1981, CHROMOSOMA, V83, P45, DOI 10.1007/BF00286015; Xiong Y, 2010, FLY, V4, P194, DOI 10.4161/fly.12668; YANG MY, 1995, NEURON, V15, P45; Zhang W, 2007, EUR J NEUROSCI, V26, P2405, DOI 10.1111/j.1460-9568.2007.05862.x; Zill S, 2010, CURR BIOL, V20, pR438, DOI 10.1016/j.cub.2010.03.049	62	28	29	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89641	10.1371/journal.pone.0089641	http://dx.doi.org/10.1371/journal.pone.0089641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586928	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900062
J	Van Dyck, E; Vansteenkiste, P; Lenoir, M; Lesaffre, M; Leman, M				Van Dyck, Edith; Vansteenkiste, Pieter; Lenoir, Matthieu; Lesaffre, Micheline; Leman, Marc			Recognizing Induced Emotions of Happiness and Sadness from Dance Movement	PLOS ONE			English	Article							POINT-LIGHT DISPLAYS; SEX-DIFFERENCES; FACIAL EXPRESSIONS; BODY MOVEMENT; PERCEPTION; RECOGNITION; ADOLESCENTS; GESTURES; CHILDREN; FACES	Recent research revealed that emotional content can be successfully decoded from human dance movement. Most previous studies made use of videos of actors or dancers portraying emotions through choreography. The current study applies emotion induction techniques and free movement in order to examine the recognition of emotional content from dance. Observers (N = 30) watched a set of silent videos showing depersonalized avatars of dancers moving to an emotionally neutral musical stimulus after emotions of either sadness or happiness had been induced. Each of the video clips consisted of two dance performances which were presented side-by-side and were played simultaneously; one of a dancer in the happy condition and one of the same individual in the sad condition. After every film clip, the observers were asked to make forced-choices concerning the emotional state of the dancer. Results revealed that observers were able to identify the emotional state of the dancers with a high degree of accuracy. Moreover, emotions were more often recognized for female dancers than for their male counterparts. In addition, the results of eye tracking measurements unveiled that observers primarily focus on movements of the chest when decoding emotional information from dance movement. The findings of our study show that not merely portrayed emotions, but also induced emotions can be successfully recognized from free dance movement.	[Van Dyck, Edith; Lesaffre, Micheline; Leman, Marc] Univ Ghent, IPEM, Dept Arts Mus & Theater Sci, Fac Arts & Philosophy, B-9000 Ghent, Belgium; [Vansteenkiste, Pieter; Lenoir, Matthieu] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sports Sci Motor Control & Learni, B-9000 Ghent, Belgium	Ghent University; Ghent University	Van Dyck, E (corresponding author), Univ Ghent, IPEM, Dept Arts Mus & Theater Sci, Fac Arts & Philosophy, B-9000 Ghent, Belgium.	edith.vandyck@ugent.be	Van Dyck, Edith/ABE-4913-2020; vansteenkiste, pieter/ABE-7819-2021	vansteenkiste, pieter/0000-0001-5053-6864; Van Dyck, Edith/0000-0001-7239-1918	Ghent University EmcoMetecca project	Ghent University EmcoMetecca project	Edith Van Dyck acknowledges the Ghent University EmcoMetecca project (http://www.ipem.ugent.be/EmcoMetecca) for a doctoral grant. This long-term project aims at closing the gap between musical experience and the digital/electronic environments that provide this experience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, BIOMECHANICAL ANAL F; Atkinson AP, 2007, COGNITION, V104, P59, DOI 10.1016/j.cognition.2006.05.005; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Boone RT, 1998, DEV PSYCHOL, V34, P1007, DOI 10.1037/0012-1649.34.5.1007; Brownlow S, 1997, PSYCHOL REC, V47, P411, DOI 10.1007/BF03395235; Camurri A, 2003, INT J HUM-COMPUT ST, V59, P213, DOI 10.1016/S1071-5819(03)00050-8; Charness N, 2001, MEM COGNITION, V29, P1146, DOI 10.3758/BF03206384; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DEMEIJER M, 1989, J NONVERBAL BEHAV, V13, P247, DOI 10.1007/BF00990296; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Donges US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041745; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 1972, NEBRASKA S MOTIVATIO, P207, DOI DOI 10.1037/0022-3514.53.4.712; Gegenfurtner A, 2011, EDUC PSYCHOL REV, V23, P523, DOI 10.1007/s10648-011-9174-7; Gobl C, 2003, SPEECH COMMUN, V40, P189, DOI 10.1016/S0167-6393(02)00082-1; Gross MM, 2010, J NONVERBAL BEHAV, V34, P223, DOI 10.1007/s10919-010-0094-x; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Herba CM, 2006, J CHILD PSYCHOL PSYC, V47, P1098, DOI 10.1111/j.1469-7610.2006.01652.x; Inouye KS, 1998, FEATURE BASED UNPUB; Johnson KL, 2011, COGNITION, V119, P265, DOI 10.1016/j.cognition.2011.01.016; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; Lagerlof I, 2000, INT J PSYCHOL, V35, P225; Larcom MJ, 2009, J GERONTOL B-PSYCHOL, V64, P733, DOI 10.1093/geronb/gbp077; Laukkanen A.-M., 1997, LOGOP PHONIATR VOCO, V22, P157, DOI DOI 10.3109/14015439709075330; Leman Marc, 2010, MUSICAL GESTURES SOU, P103; Levy, 1988, DANCE MOVEMENT THERA; Likowski KU, 2011, J NONVERBAL BEHAV, V35, P101, DOI 10.1007/s10919-011-0107-4; Luck G, 2010, J RES PERS, V44, P714, DOI 10.1016/j.jrp.2010.10.001; LUNDQVIST LO, 1995, J PSYCHOPHYSIOL, V9, P203; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Montepare J, 1999, J NONVERBAL BEHAV, V23, P133, DOI 10.1023/A:1021435526134; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Nelson NL, 2011, COGNITIVE DEV, V26, P248, DOI 10.1016/j.cogdev.2011.06.001; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Passmore A, 2001, ADOLESCENCE, V36, P67; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Risner D., 2009, MEN DANCE CHOREOGRAP; Ross PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044815; Sachs Curt, 1937, WORLD HIST DANCE; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; SCHOUWSTRA SJ, 1995, PERCEPT MOTOR SKILL, V81, P673, DOI 10.1177/003151259508100262; Shikanai N, 2013, J NONVERBAL BEHAV, V37, P107, DOI 10.1007/s10919-013-0148-y; Sroufe L.A, 1996, EMOTIONAL DEV; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Van Dyck E, 2013, J NONVERBAL BEHAV, V37, P175, DOI 10.1007/s10919-013-0153-1; Van Meel J, 1993, EMPIR STUD ARTS, V11, P117, DOI DOI 10.2190/V69N-VB0T-A9Q3-TJ04; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W	50	9	9	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89773	10.1371/journal.pone.0089773	http://dx.doi.org/10.1371/journal.pone.0089773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB6EP	24587026	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700089
J	Moghaddassi, S; Eyestone, W; Bishop, CE				Moghaddassi, Shaida; Eyestone, Will; Bishop, Colin E.			TALEN-Mediated Modification of the Bovine Genome for Large-Scale Production of Human Serum Albumin	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; GENE DISRUPTION; SOMATIC-CELLS; GENERATION; KNOCKOUT; CATTLE; SHEEP	As an initial step towards creating genetically modified cattle as a biopharming source of recombinant human serum albumin (rHSA), we report modification of the bovine albumin (bA) locus by transcription activator-like effector nuclease (TALEN)-stimulated homology-directed repair (HDR). Pedigreed bovine fibroblasts were co-transfected with TALENs and an 11.5-kb human serum albumin (HSA) minigene donor construct, designed to simultaneously disrupt and replace bovine serum albumin (BSA) expression with controlled rHSA expression in both the liver and the milk. Targeted integration of the HSA minigene was confirmed in transfected fibroblasts at a frequency of approximately 11% and transgenic bovine embryos were produced from targeted fibroblasts using somatic cell nuclear transfer (SCNT). The research delineated here lays the foundation for the future generation of transgenic rHSA cattle with the potential to provide a large-scale, reliable, and quality-controlled source of rHSA.	[Moghaddassi, Shaida; Bishop, Colin E.] Wake Forest Inst Regenerat Med, Winston Salem, NC 27103 USA; [Eyestone, Will] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA	Wake Forest University; Virginia Polytechnic Institute & State University	Moghaddassi, S (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC 27103 USA.	shaidamoghaddassi@gmail.com	Eyestone, Willard/C-6284-2013		VA-MD College of Veterinary Medicine	VA-MD College of Veterinary Medicine	Funding Source: Internal Competitive Research Grant from the VA-MD College of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Carter DC, 2005, HUMAN SERUM ALBUMIN; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Chen Z, 2013, BBA-GEN SUBJECTS, V1830, P5515, DOI 10.1016/j.bbagen.2013.04.037; Cooper J, 1996, ALPHA LACTALBUMIN GE; DEFRANCESCO L, 2011, NAT BIOTECHNOL, V29, P681, DOI DOI 10.1038/NBT.1935.PUBMED:21822235; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Echelard Y, 2009, TRANSGENIC RES, V18, P361, DOI 10.1007/s11248-008-9229-9; GARDNER DK, 1994, BIOL REPROD, V50, P390, DOI 10.1095/biolreprod50.2.390; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Monks J, 2004, J PHYSIOL-LONDON, V560, P267, DOI 10.1113/jphysiol.2004.068403; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; REMIS RS, 1990, CAN MED ASSOC J, V142, P1247; RIBADEAUDUMAS B, 1989, LAIT, V69, P357; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; VILOTTE JL, 1989, EUR J BIOCHEM, V186, P43, DOI 10.1111/j.1432-1033.1989.tb15175.x; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153	19	20	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89631	10.1371/journal.pone.0089631	http://dx.doi.org/10.1371/journal.pone.0089631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586924	gold, Green Submitted, Green Published			2022-12-27	WOS:000331717900134
J	Yoshihisa, Y; Norisugi, O; Matsunaga, K; Nishihira, J; Shimizu, T				Yoshihisa, Yoko; Norisugi, Osamu; Matsunaga, Kenji; Nishihira, Jun; Shimizu, Tadamichi			Involvement of MIF in Basement Membrane Damage in Chronically UVB-Exposed Skin in Mice	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; MATRIX METALLOPROTEINASE-1 EXPRESSION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN DERMAL FIBROBLASTS; NECROSIS-FACTOR-ALPHA; TUMOR-CELL GROWTH; BREAST-CANCER; TNF-ALPHA; IN-VIVO; INTERLEUKIN-1-BETA	Solar ultraviolet (UV) B radiation is known to induce matrix metalloproteinases (MMPs) that degrade collagen in the basement membrane. Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that plays an essential role in the pathophysiology of skin inflammation induced by UV irradiation. This study examined the effects of MIF on basement membrane damage following chronic UVB irradiation in mice. The back skin of MIF transgenic (Tg) and wild-type (WT) mice was exposed to UVB three times a week for 10 weeks. There was a decrease in intact protein levels of type IV collagen and increased basement membrane damage in the exposed skin of the MIF Tg mice compared to that observed in the WT mice. Moreover, the skin of the MIF Tg mice exhibited higher MIF, MMP-2 and MMP-9 expression and protein levels than those observed in the WT mice. We also found that chronic UVB exposure in MIF Tg mice resulted in higher levels of neutrophil infiltration in the dermis compared with that observed in the WT mice. In vitro experiments revealed that MIF induced increases in the MMPs expression, including that of MMP-9 in keratinocytes and MMP-2 in fibroblasts. Cultured neutrophils also secreted MMP-9 stimulated by MIF. Therefore, MIF-mediated basement membrane damage occurs primarily through MMPs activation and neutrophil influx in murine skin following chronic UVB irradiation.	[Yoshihisa, Yoko; Norisugi, Osamu; Matsunaga, Kenji; Shimizu, Tadamichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Dermatol, Toyama 930, Japan; [Nishihira, Jun] Hokkaido Informat Univ, Dept Med Informat, Ebetsu, Hokkaido, Japan	University of Toyama	Shimizu, T (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Dermatol, Toyama 930, Japan.	shimizut@med.u-toyama.ac.jp		Shimizu, Tadamichi/0000-0002-3231-0279	Japan Society for the Promotion of Science [20591337, 25860938]; 5th Rohto Award	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 5th Rohto Award	This research was supported by a Grant-in-Aid for Scientific Research (No. 20591337 and No. 25860938) from the Japan Society for the Promotion of Science, and by grants from the 5th Rohto Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; Alexander JP, 2001, INVEST OPHTH VIS SCI, V42, P2831; Bacher M, 1997, AM J PATHOL, V150, P235; Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Brenneisen P, 1996, PHOTOCHEM PHOTOBIOL, V64, P877, DOI 10.1111/j.1751-1097.1996.tb01851.x; Bucala R, 1996, FASEB J, V7, P19; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Coligan JE., 1994, CURRENT PROTOCOLS IM; Contet-Audonneau JL, 1999, BRIT J DERMATOL, V140, P1038; Cui ZG, 2004, FREE RADICAL RES, V38, P363, DOI 10.1080/1071576042000191754; Daryadel A, 2006, J BIOL CHEM, V281, P27653, DOI 10.1074/jbc.M604051200; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; De Arcangelis A, 1996, J CELL BIOL, V133, P417, DOI 10.1083/jcb.133.2.417; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fisher GJ, 2001, J INVEST DERMATOL, V117, P219, DOI 10.1046/j.0022-202x.2001.01432.x; Foote A, 2004, J RHEUMATOL, V31, P268; Goffin L, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2991; Hernandez-Pigeon H, 2007, J BIOL CHEM, V282, P8157, DOI 10.1074/jbc.M607436200; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hoi AY, 2003, IMMUNOL CELL BIOL, V81, P367, DOI 10.1046/j.1440-1711.2003.01183.x; Honda A, 2008, J DERMATOL SCI, V49, P63, DOI 10.1016/j.jdermsci.2007.09.007; Inomata S, 2003, J INVEST DERMATOL, V120, P128, DOI 10.1046/j.1523-1747.2003.12021.x; INOUE S, 1989, INT REV CYTOL, V117, P57; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Lee JS, 2010, EXP DERMATOL, V19, P1060, DOI 10.1111/j.1600-0625.2010.01129.x; Meephansan J, 2012, CLIN EXP DERMATOL, V37, P889, DOI 10.1111/j.1365-2230.2012.04381.x; MeyerSiegler K, 1996, UROLOGY, V48, P448, DOI 10.1016/S0090-4295(96)00207-5; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; NISHIHIRA J, 1993, BIOCHEM MOL BIOL INT, V31, P841; Nishihira J, 1998, INT J MOL MED, V2, P17; Obayashi K, 2005, J COSMET SCI, V56, P17; Ohnishi Y, 2000, ARCH DERMATOL RES, V292, P27, DOI 10.1007/PL00007457; Pakozdi A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2021; Park CH, 2011, J DERMATOL SCI, V64, P134, DOI 10.1016/j.jdermsci.2011.07.002; Park HM, 2011, J MED FOOD, V14, P899, DOI 10.1089/jmf.2010.1363; Rutter JL, 1997, J CELL BIOCHEM, V66, P322, DOI 10.1002/(SICI)1097-4644(19970901)66:3<322::AID-JCB5>3.3.CO;2-D; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; Sasaki S, 2004, KIDNEY INT, V65, P469, DOI 10.1111/j.1523-1755.2004.00394.x; Segrelles C, 2011, BMC DERMATOL, V11, DOI 10.1186/1471-5945-11-9; SELTZER JL, 1989, J BIOL CHEM, V264, P19583; Shimizu T, 1999, J INVEST DERMATOL, V112, P210, DOI 10.1046/j.1523-1747.1999.00486.x; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Shimizu T, 1996, FEBS LETT, V381, P199, DOI 10.1016/0014-5793(96)00120-2; Takahashi N, 1998, MOL MED, V4, P707, DOI 10.1007/BF03401765; Wang HJ, 2005, FREE RADICAL BIO MED, V38, P890, DOI 10.1016/j.freeradbiomed.2004.12.005; Watanabe H, 2004, J BIOL CHEM, V279, P1676, DOI 10.1074/jbc.M303650200; Wisithphrom K, 2006, J ENDODONT, V32, P853, DOI 10.1016/j.joen.2006.03.017; WISTOW GJ, 1993, P NATL ACAD SCI USA, V90, P1272, DOI 10.1073/pnas.90.4.1272; WLASCHEK M, 1994, PHOTOCHEM PHOTOBIOL, V59, P550, DOI 10.1111/j.1751-1097.1994.tb02982.x; Yao YQ, 2009, INFLAMMATION, V32, P233, DOI 10.1007/s10753-009-9125-3; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418; Yu XY, 2007, J INTERF CYTOK RES, V27, P103, DOI 10.1089/jir.2006.0054; Zhao YN, 2005, AM J PATHOL, V167, P1519, DOI 10.1016/S0002-9440(10)61238-2	57	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89569	10.1371/journal.pone.0089569	http://dx.doi.org/10.1371/journal.pone.0089569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586879	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900121
J	Han, G; Liu, D; Gan, H; Denniston, KA; Li, SC; Tan, WY; Hu, DS; Zhen, WN; Wang, ZH				Han, Guang; Liu, Dong; Gan, Hua; Denniston, Kyle A.; Li, Sicong; Tan, Wenyong; Hu, Desheng; Zhen, Weining; Wang, Zhaohua			Evaluation of the Dosimetric Feasibility of Hippocampal Sparing Intensity-Modulated Radiotherapy in Patients with Locally Advanced Nasopharyngeal Carcinoma	PLOS ONE			English	Article							WHOLE-BRAIN RADIOTHERAPY; COGNITIVE DYSFUNCTION; RADIATION-THERAPY; IRRADIATION; NEUROGENESIS; CANCER; TRIAL	Purpose: The objective of this study was to evaluate the dosimetric feasibility of using hippocampus (HPC) sparing intensity-modulated radiotherapy (IMRT) in patients with locally advanced nasopharyngeal carcinoma (NPC). Materials/Methods: Eight cases of either T3 or T4 NPC were selected for this study. Standard IMRT treatment plans were constructed using the volume and dose constraints for the targets and organs at risk (OAR) per Radiation Therapy Oncology Group (RTOG) 0615 protocol. Experimental plans were constructed using the same criteria, with the addition of the HPC as an OAR. The two dose-volume histograms for each case were compared for the targets and OARs. Results: All plans achieved the protocol dose criteria. The homogeneity index, conformity index, and coverage index for the planning target volumes (PTVs) were not significantly compromised by the avoidance of the HPC. The doses to all OARs, excluding the HPC, were similar. Both the dose (D-max, D-2%, D-40%, D-mean, D-median, D-98% and D-min) and volume (V-5, V-10, V-15, V-20, V-30, V-40 and V-50) parameters for the HPC were significantly lower in the HPC sparing plans (p<0.05), except for D-min (P = 0.06) and V-5 (P = 0.12). Conclusions: IMRT for patients with locally advanced NPC exposes the HPC to a significant radiation dose. HPC sparing IMRT planning significantly decreases this dose, with minimal impact on the therapeutic targets and other OARs.	[Han, Guang; Liu, Dong; Tan, Wenyong; Hu, Desheng; Wang, Zhaohua] Hubei Canc Hosp, Dept Radiat Oncol, Wuhan, Peoples R China; [Gan, Hua; Denniston, Kyle A.; Li, Sicong; Zhen, Weining] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Wang, ZH (corresponding author), Hubei Canc Hosp, Dept Radiat Oncol, Wuhan, Peoples R China.	hg7913@hotmail.com		Tan, Wenyong/0000-0002-2706-4149	Youth Science & Technology foundation from Hubei Provincial Health Department [QJX2012-29]	Youth Science & Technology foundation from Hubei Provincial Health Department	This study was financially supported by the Youth Science & Technology foundation from Hubei Provincial Health Department (QJX2012-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Brown PD, 2013, NEURO-ONCOLOGY, V15, P1429, DOI 10.1093/neuonc/not114; Feuvret L, 2006, INT J RADIAT ONCOL, V64, P333, DOI 10.1016/j.ijrobp.2005.09.028; Gondi V, 2013, INT J RADIAT ONCOL, V87, P1186, DOI DOI 10.1016/J.IJR0BP.2013.10.005; Gondi V, 2013, INT J RADIAT ONCOL, V85, P348, DOI 10.1016/j.ijrobp.2012.11.031; Gondi V, 2010, RADIOTHER ONCOL, V97, P370, DOI 10.1016/j.radonc.2010.09.013; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Gondi V, 2010, RADIOTHER ONCOL, V95, P327, DOI 10.1016/j.radonc.2010.02.030; Gutierrez AN, 2007, INT J RADIAT ONCOL, V69, P589, DOI 10.1016/j.ijrobp.2007.05.038; Hsiao KY, 2010, INT J RADIAT ONCOL, V77, P722, DOI 10.1016/j.ijrobp.2009.06.080; Khodayari B, 2011, INT J RADIAT ONCOL, V81, pS508, DOI 10.1016/j.ijrobp.2011.06.1037; Lam LCW, 2003, J NEUROPSYCH CLIN N, V15, P90, DOI 10.1176/appi.neuropsych.15.1.90; Lee NY, 2012, LANCET ONCOL, V13, P172, DOI 10.1016/S1470-2045(11)70303-5; LEE PWH, 1989, J NEUROL NEUROSUR PS, V52, P488, DOI 10.1136/jnnp.52.4.488; LEUNG SF, 1992, BRIT J RADIOL, V65, P710, DOI 10.1259/0007-1285-65-776-710; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; Marsh JC, 2010, INT J RADIAT ONCOL, V78, P946, DOI 10.1016/j.ijrobp.2009.12.012; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Shaw EG, 2006, J CLIN ONCOL, V24, P1415, DOI 10.1200/JCO.2005.03.3001; Taheri-Kadkhoda Z, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-4; The International Commission on Radiation Units and Measurements Prescribing recording and reporting photon beam therapy, 1999, 62 ICRU; Van Esch A, 2006, MED PHYS, V33, P4130, DOI 10.1118/1.2358333; van Kesteren Z, 2012, RADIOTHER ONCOL, V102, P225, DOI 10.1016/j.radonc.2011.09.023; [吴晨彬 Wu Chenbin], 2012, [中华放射医学与防护杂志, Chinese Journal of Radiological Medicine and Protection], V32, P297	27	10	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90007	10.1371/journal.pone.0090007	http://dx.doi.org/10.1371/journal.pone.0090007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587184	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200110
J	Jin, J; Ryu, HS; Lee, KB; Jang, JJ				Jin, Jing; Ryu, Han Suk; Lee, Kyoung Bun; Jang, Ja-June			High Expression of Protein Tyrosine Kinase 7 Significantly Associates with Invasiveness and Poor Prognosis in Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							JNK ACTIVATION; CELL POLARITY; RHO-GTPASES; CANCERS; PATHWAYS; INVASION	Background: The incidence, prevalence, and mortality of intrahepatic cholangiocarcinoma (ICC) are increasing worldwide. Protein tyrosine kinase-7 (PTK7) is upregulated in many common human cancers. However, its expression in ICC has not been studied. The present study aimed to explore the underlying mechanism of PTK7 in ICC. Materials and Methods: The role of PTK7 was studied in vitro by suppressing PTK7 expression in ICC cell lines. The in vivo effect of PTK7 was evaluated using a nude mouse model inoculated with a human ICC cell line. We also examined the role of PTK7 in human ICC samples. Results: Cells with high PTK7 expression exhibited higher proliferation, DNA synthesis, invasion, and migration abilities than did cells with low PTK7 expression. The knockdown of PTK7 with small interfering RNA (siRNA) in high PTK7 expressing cells resulted in impairment of invasion, migration, and DNA synthesis through the regulation of several cell-cycle-related proteins. It also induced cell apoptosis and decreased phospho-RhoA expression. In a xenograft nude mouse model, PTK7 siRNA resulted in a reduction of the tumor size, compared with scrambled siRNA injection. PTK7 expression was higher in human ICC than in the normal bile duct. Patients with low expression of PTK7 had a longer disease-free survival and overall survival than those with high expression. Conclusions: PTK7 expression plays an important role in the invasiveness of ICC cells and leads to a poor prognosis in ICC patients. Thus, PTK7 can be used as a prognostic indicator, and the inhibition of PTK7 expression could be a new therapeutic target for ICC.	[Jin, Jing; Ryu, Han Suk; Lee, Kyoung Bun; Jang, Ja-June] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU)	Jang, JJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea.	tripj@snu.ac.kr	Lee, Kyoungbun/J-2571-2016	Lee, Kyoungbun/0000-0001-8427-3003	Seoul National University hospital Research Fund [0320130290]; Bio & Medical Technology Development Program of National Research Foundation of Korea [NRF-2012M3A9B6055346]	Seoul National University hospital Research Fund; Bio & Medical Technology Development Program of National Research Foundation of Korea	This study was supported by the Seoul National University hospital Research Fund (#0320130290) and a grant from Bio & Medical Technology Development Program of National Research Foundation of Korea (NRF-2012M3A9B6055346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2001, ARTERIOSCL THROM VAS, V21, P300, DOI 10.1161/01.ATV.21.3.300; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fava G, 2007, CANCER LETT, V250, P155, DOI 10.1016/j.canlet.2006.09.011; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Jin J, 2011, VIRCHOWS ARCH, V458, P689, DOI 10.1007/s00428-011-1071-4; Kim DG, 2001, GENE CHROMOSOME CANC, V30, P48, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1053>3.0.CO;2-P; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Meng L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014018; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Nakanuma Y, 2010, WORLD J HEPATOL, V2, P419, DOI 10.4254/wjh.v2.i12.419; Palmer WC, 2012, J HEPATOL, V57, P69, DOI 10.1016/j.jhep.2012.02.022; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Rapisarda A, 2009, MOL CANCER THER, V8, P1867, DOI 10.1158/1535-7163.MCT-09-0274; Rubin JS, 2006, FRONT BIOSCI, V11, P2093, DOI 10.2741/1952; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Yao C, 2013, ACTA PHARMACOL SIN, V34, P289, DOI 10.1038/aps.2012.134	25	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90247	10.1371/journal.pone.0090247	http://dx.doi.org/10.1371/journal.pone.0090247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587299	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200153
J	Liu, D; Lu, YC; Hu, ZL; Wu, N; Nie, XM; Xia, Y; Han, YP; Li, Q; Zhu, GS; Bai, C				Liu, Dan; Lu, Yachao; Hu, Zhenli; Wu, Ning; Nie, Xiaomeng; Xia, Yang; Han, Yiping; Li, Qiang; Zhu, Guanshan; Bai, Chong			Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma	PLOS ONE			English	Article							FACTOR-RECEPTOR MUTATIONS; SMALL-CELL; CANCER; HETEROGENEITY; FLUID	Background: Though the possibility of using malignant pleural effusions (MPEs) as alternatives for metastatic pleural tumor tissues (MPTTs) in epidermal growth factor receptor (EGFR) mutation test has been examined, due to the lack of studies comparing the results in matching MPEs and MPTTs, the clinical value of MPEs for advanced adenocarcinoma patients with pleural effusions is not confirmed. Methods: EGFR mutation statuses in matching MPTTs, MPE supernatants and cell blocks, of 41 patients with advanced lung adenocarcinoma as diagnosed by thoracoscopy were analyzed using amplification refractory mutation system (ARMS). Results: EGFR mutations were detected in 46.3% (19/41) of MPTTs, 43.9% (18/41) of MPE supernatants and 56.3% (18/32) of MPE cell blocks by ARMS analysis. Generally, the same EGFR statuses were identified in both MPTTs and matching MPE cell blocks of 81.3% patients (26/32), whereas MPTTs and matching MPE supernatants of 87.8% (36/41) patients shared the same EGFR status. Compared with EGFR mutation detection in MPTTs, the sensitivity of EGFR mutation detection in MPE-cell blocks was 87.5% (14/16), specificity was 75.0% (12/16), while the sensitivity of EGFR mutation detection in MPE-supernatants was 84.2% (16/19), specificity was 90.9% (20/22). Conclusions: The high concordance of EGFR mutation statuses between MPEs and MPTTs in lung adenocarcinoma patients with pleural metastasis as determined by ARMS analysis suggests that MPEs, particularly MPE supernatants, may be substitutes for MPTTs in EGFR mutation test.	[Liu, Dan; Hu, Zhenli; Wu, Ning; Nie, Xiaomeng; Xia, Yang; Han, Yiping; Li, Qiang; Bai, Chong] Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China; [Lu, Yachao; Zhu, Guanshan] AstraZeneca Global R&D, Innovat Ctr China, Shanghai, Peoples R China	Naval Medical University; AstraZeneca	Bai, C (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China.	bc7878@sohu.com			Wu Jie-Ping Research Fund	Wu Jie-Ping Research Fund	Chong Bai was supported by Wu Jie-Ping Research Fund. Guanshan Zhu and Yachao Lu received honoraria from AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANTO A, 1985, CHEST, V87, P649, DOI 10.1378/chest.87.5.649; Do H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-142; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo JA, 2010, J CANCER RES CLIN, V136, P1341, DOI 10.1007/s00432-010-0785-z; Hung Ming-Szu, 2006, Chang Gung Med J, V29, P373; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang SX, 2008, INT J CANCER, V123, P2480, DOI 10.1002/ijc.23868; Kawada I, 2008, J THORAC ONCOL, V3, P1096, DOI 10.1097/JTO.0b013e318186fadd; Kimura H, 2006, BRIT J CANCER, V95, P1390, DOI 10.1038/sj.bjc.6603428; Kimura H, 2006, CANCER SCI, V97, P642, DOI 10.1111/j.1349-7006.2006.00216.x; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Nakano H, 2008, LUNG CANCER, V60, P136, DOI 10.1016/j.lungcan.2007.08.021; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P3, DOI 10.1159/000055386; Sekine I, 2008, ONCOLOGIST, V13, P21, DOI 10.1634/theoncologist.13-S1-21; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Soh J, 2006, INT J CANCER, V119, P2353, DOI 10.1002/ijc.22190; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Viera AJ, 2005, FAM MED, V37, P360; Wu SG, 2008, EUR RESPIR J, V32, P924, DOI 10.1183/09031936.00167407; Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Zhang XZ, 2008, LUNG CANCER, V60, P175, DOI 10.1016/j.lungcan.2007.10.011	22	25	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89946	10.1371/journal.pone.0089946	http://dx.doi.org/10.1371/journal.pone.0089946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587142	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200096
J	Sheffer, E; Canham, CD; Kigel, J; Perevolotsky, A				Sheffer, Efrat; Canham, Charles D.; Kigel, Jaime; Perevolotsky, Avi			An Integrative Analysis of the Dynamics of Landscape- and Local-Scale Colonization of Mediterranean Woodlands by Pinus halepensis	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SEED DISPERSAL; ECOLOGICAL-SYSTEMS; PATTERNS; INVASION; RECRUITMENT; MECHANISMS; FORESTS; ESTABLISHMENT; CONSEQUENCES	Afforestation efforts have resulted in extensive plantations of either native or non-native conifers, which in many regions has led to the spread of those conifers into surrounding natural vegetation. This process of species colonization can trigger profound changes in both community dynamics and ecosystem processes. Our study disentangled the complexity of a process of colonization in a heterogeneous landscape into a simple set of rules. We analyzed the factors that control the colonization of natural woodland ecosystems by Pinus halepensis dispersing from plantations in the Mediterranean region of Israel. We developed maximum-likelihood models to explain the densities of P. halepensis colonizing natural woodlands. Our models unravel how P. halepensis colonization is controlled by factors that determine colonization pressure by dispersing seeds and by factors that control resistance to colonization of the natural ecosystems. Our models show that the combination of different seed arrival processes from local, landscape, and regional scales determine pine establishment potential, but the relative importance of each component varied according to seed source distribution. Habitat resistance, determined by abiotic and biotic conditions, was as important as propagule input in determining the density of pine colonization. Thus, despite the fact that pine propagules disperse throughout the landscape, habitat heterogeneity within the natural ecosystems generates significant variation in the actual densities of colonized pine. Our approach provides quantitative measures of how processes at different spatial scales affect the distribution and densities of colonizing species, and a basis for projection of expected distributions. Variation in colonization rates, due to landscape-scale heterogeneity in both colonization pressure and resistance to colonization, can be expected to produce a diversity of new ecosystems. This work provides a template for understanding species colonization processes, especially in light of anthropogenic impacts, and predicting future transformation of natural ecosystems by species invasion.	[Sheffer, Efrat] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Canham, Charles D.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Kigel, Jaime] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Perevolotsky, Avi] Agr Res Org, Volcani Ctr, Dept Agron & Nat Resources, IL-50250 Bet Dagan, Israel	Princeton University; Cary Institute of Ecosystem Studies; Hebrew University of Jerusalem; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Sheffer, E (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	eshefer@princeton.edu	Canham, Charles D/F-6161-2011	Canham, Charles D/0000-0001-8361-9148	Nekudat Hen; Israeli Science Foundation [514/10]; Israeli Forest Authority (KKL) [277-0198-08]	Nekudat Hen; Israeli Science Foundation(Israel Science Foundation); Israeli Forest Authority (KKL)	This work was funded by Nekudat Hen, the Israeli Science Foundation grant #514/10, and by the Israeli Forest Authority (KKL) grant #277-0198-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelet S, 2010, ENVIRON ECOL STAT, V17, P347, DOI 10.1007/s10651-009-0111-6; Barbero Marcel, 1998, P153; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Bonneh O, 2000, ECOLOGY, BIOGEOGRAPHY AND MANAGEMENT OF PINUS HALEPENSIS AND P BRUTIA FOREST ECOSYSTEMS IN THE MEDITERRANEAN BASIN, P377; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bustamante RO, 2005, BIOL INVASIONS, V7, P243, DOI 10.1007/s10530-004-0740-5; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Castro-Diez P, 2012, PLANT SOIL, V350, P179, DOI 10.1007/s11104-011-0893-9; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chapin FSIII, 2002, PRINCIPLES TERRESTRI; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Edwards AWF, 1992, LIKELIHOOD EXPANDED; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Emer C, 2011, BIOL INVASIONS, V13, P189, DOI 10.1007/s10530-010-9801-0; Environmental Systems Research Institute Inc. ESRI, 1999, ARCVIEW GIS 8 3; Goldreich Y., 2012, CLIMATE ISRAEL OBSER; Gomez-Aparicio L, 2008, ECOL MONOGR, V78, P69, DOI 10.1890/06-2036.1; Greene DF, 2004, J ECOL, V92, P758, DOI 10.1111/j.0022-0477.2004.00921.x; Gribben PE, 2013, OIKOS, V122, P816, DOI 10.1111/j.1600-0706.2012.20868.x; Halfon N, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/025001; HILL JD, 1995, ECOL APPL, V5, P459, DOI 10.2307/1942036; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Jutila HM, 2002, J ECOL, V90, P291, DOI 10.1046/j.1365-2745.2001.00665.x; Lavi A, 2005, APPL VEG SCI, V8, P85, DOI 10.1658/1402-2001(2005)008[0085:IOPHFP]2.0.CO;2; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2004, FOREST ECOL MANAG, V198, P303, DOI 10.1016/j.foreco.2004.05.040; Moore KA, 2006, ECOL LETT, V9, P797, DOI 10.1111/j.1461-0248.2006.00923.x; Murphy L., 2008, LIKELIHOOD METHODS M; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2001, ECOLOGY, V82, P374, DOI 10.1890/0012-9658(2001)082[0374:FVASAO]2.0.CO;2; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2000, ECOLOGY, V81, P2156, DOI 10.1890/0012-9658(2000)081[2156:SVISDA]2.0.CO;2; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Osem Y, 2011, BIOL INVASIONS, V13, P485, DOI 10.1007/s10530-010-9843-3; Osem Y, 2009, FOREST ECOL MANAG, V259, P14, DOI 10.1016/j.foreco.2009.09.034; Pausas J., 1999, REMOTE SENSING LARGE, P3, DOI [10.1007/978-3-642-60164-4, DOI 10.1007/978-3-642-60164-4, 10.1007/978-3-642-60164-4_2, DOI 10.1007/978-3-642-60164-4_2]; Pena E, 2008, FOREST ECOL MANAG, V256, P1049, DOI 10.1016/j.foreco.2008.06.020; Perevolotsky A, 2011, ISR J ECOL EVOL, V57, P111, DOI 10.1560/IJEE.57.1-2.111; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; R Development Core Team, 2008, LANG ENV STAT COMP; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Ruiz-Benito P, 2012, DIVERS DISTRIB, V18, P1092, DOI 10.1111/j.1472-4642.2012.00901.x; Sambaraju KR, 2012, ECOGRAPHY, V35, P211, DOI 10.1111/j.1600-0587.2011.06847.x; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; SCHILLER G, 1982, FOREST ECOL MANAG, V4, P213, DOI 10.1016/0378-1127(82)90001-9; Schiller G, 2000, ECOLOGY, BIOGEOGRAPHY AND MANAGEMENT OF PINUS HALEPENSIS AND P BRUTIA FOREST ECOSYSTEMS IN THE MEDITERRANEAN BASIN, P13; SCHILLER G, 1989, FOREST ECOL MANAG, V28, P141, DOI 10.1016/0378-1127(89)90066-2; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Sheffer E, 2013, ECOLOGY, V94, P1718, DOI 10.1890/12-2121.1; Sheffer E, 2012, ANN FOREST SCI, V69, P429, DOI 10.1007/s13595-011-0181-0; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; Sternberg M, 2001, FOREST ECOL MANAG, V148, P179, DOI 10.1016/S0378-1127(00)00528-4; Tapias R, 2001, J ECOL, V89, P629, DOI 10.1046/j.1365-2745.2001.00575.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; TOMASELLI R, 1977, AMBIO, V6, P356; Urli M, 2014, J VEG SCI, V25, P147, DOI 10.1111/jvs.12079; Van Couwenberghe R, 2013, ECOGRAPHY, V36, P665, DOI 10.1111/j.1600-0587.2012.07362.x; Western D, 2001, P NATL ACAD SCI USA, V98, P5458, DOI 10.1073/pnas.101093598; Zavala MA, 2000, BOT REV, V66, P119, DOI 10.1007/BF02857785; Zavala MA, 2011, CAN J FOREST RES, V41, P1432, DOI [10.1139/X11-050, 10.1139/x11-050]; Zavaleta ES, 2006, J ARID ENVIRON, V66, P290, DOI 10.1016/j.jaridenv.2005.11.008; Zenni RD, 2013, BIOL INVASIONS, V15, P1623, DOI 10.1007/s10530-012-0397-4; Zohary M, 1973, GEOBOTANICAL FDN MID	72	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90178	10.1371/journal.pone.0090178	http://dx.doi.org/10.1371/journal.pone.0090178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587263	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200143
J	Wu, SK; Yang, MT; Kang, KH; Liou, HC; Lu, DH; Fu, WM; Lin, WL				Wu, Sheng-Kai; Yang, Ming-Tao; Kang, Kai-Hsiang; Liou, Houng-Chi; Lu, Dai-Hua; Fu, Wen-Mei; Lin, Win-Li			Targeted Delivery of Erythropoietin by Transcranial Focused Ultrasound for Neuroprotection against Ischemia/Reperfusion-Induced Neuronal Injury: A Long-Term and Short-Term Study	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MIDDLE CEREBRAL-ARTERY; CORTICAL INFARCTION; DRUG-DELIVERY; DISRUPTION; ISCHEMIA; RAT; STROKE; MODEL; OCCLUSION	Erythropoietin (EPO) is a neuroprotective agent against cerebral ischemia/reperfusion (I/R)-induced brain injury. However, its crossing of blood-brain barrier is limited. Focused ultrasound (FUS) sonication with microbubbles (MBs) can effectively open blood-brain barrier to boost the vascular permeability. In this study, we investigated the effects of MBs/FUS on extending the therapeutic time window of EPO and its neuroprotective effects in both acute and chronic phases. Male Wistar rats were firstly subjected to two common carotid arteries and right middle cerebral artery occlusion (three vessels occlusion, 3VO) for 50 min, and then the rats were treated with hEPO (human recombinant EPO, 5000 IU/kg) with or without MBs/FUS at 5 h after occlusion/reperfusion. Acute phase investigation (I/R, I/R+MBs/FUS, I/R+hEPO, and I/R+hEPO+MBs/FUS) was performed 24 h after I/R; chronic tests including cylinder test and gait analysis were performed one month after I/R. The experimental results showed that MBs/FUS significantly increased the cerebral content of EPO by bettering vascular permeability. In acute phase, both significant improvement of neurological score and reduction of infarct volume were found in the I/R+hEPO+MBs/FUS group, as compared with I/R and I/R+hEPO groups. In chronic phase, long-term behavioral recovery and neuronal loss in brain cortex after I/R injury was significantly improved in the I/R+hEPO+MBs/FUS group. This study indicates that hEPO administration with MBs/FUS sonication even at 5 h after occlusion/reperfusion can produce a significant neuroprotection.	[Wu, Sheng-Kai; Lin, Win-Li] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Wu, Sheng-Kai; Lin, Win-Li] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Yang, Ming-Tao; Kang, Kai-Hsiang; Liou, Houng-Chi; Lu, Dai-Hua; Fu, Wen-Mei] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Lin, Win-Li] Natl Hlth Res Inst, Div Med Engn Res, Miaoli, Taiwan; [Yang, Ming-Tao] Far Eastern Mem Hosp, Dept Pediat, New Taipei City, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Health Research Institutes - Taiwan; Far Eastern Memorial Hospital	Fu, WM (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	wenmei@ntu.edu.tw; winli@ntu.edu.tw	Wu, Sheng-Kai/GRF-1332-2022; Yang, Ming-Tao/K-2837-2019	Yang, Ming-Tao/0000-0001-5235-6912; FU, WEN-MEI/0000-0003-4157-8987; Kang, Kai-Hsiang/0000-0002-6529-4543	National Science Council of Taiwan [NSC 99-2221-E-002-005-MY3]; National Health Research Institutes of Taiwan [NHRI ME-100-PP-13]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by research grants from the National Science Council of Taiwan (NSC 99-2221-E-002-005-MY3) and National Health Research Institutes of Taiwan (NHRI ME-100-PP-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Gan Y, 2012, STROKE, V43, P3071, DOI 10.1161/STROKEAHA.112.663120; Hamby AM, 2007, STROKE, V38, P632, DOI 10.1161/01.STR.0000250742.61241.79; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2006, J NEUROSURG, V105, P445, DOI 10.3171/jns.2006.105.3.445; Hynynen K, 2006, EUR J RADIOL, V59, P149, DOI 10.1016/j.ejrad.2006.04.007; Ishii T, 2010, BRAIN RES, V1321, P164, DOI 10.1016/j.brainres.2010.01.039; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022598; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; MENZIES SA, 1993, J NEUROSURG, V78, P257, DOI 10.3171/jns.1993.78.2.0257; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; MORIOKA T, 1991, J CEREBR BLOOD F MET, V11, P966, DOI 10.1038/jcbfm.1991.162; NAGAO M, 1992, BIOCHIM BIOPHYS ACTA, V1171, P99, DOI 10.1016/0167-4781(92)90146-Q; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Park EJ, 2012, J CONTROL RELEASE, V163, P277, DOI 10.1016/j.jconrel.2012.09.007; Raymond SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002175; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sadamoto Y, 1998, BIOCHEM BIOPH RES CO, V253, P26, DOI 10.1006/bbrc.1998.9748; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Villa P, 2007, J CEREBR BLOOD F MET, V27, P552, DOI 10.1038/sj.jcbfm.9600370; Vykhodtseva N, 2008, ULTRASONICS, V48, P279, DOI 10.1016/j.ultras.2008.04.004; Wang YG, 2008, J CEREBR BLOOD F MET, V28, P1936, DOI 10.1038/jcbfm.2008.82; WEN D, 1993, BLOOD, V82, P1507; Weng JC, 2011, MAGN RESON MED, V65, P802, DOI 10.1002/mrm.22643; Yamamoto H, 2003, EXP NEUROL, V182, P261, DOI 10.1016/S0014-4886(03)00116-X; Yang FY, 2012, J CONTROL RELEASE, V160, P652, DOI 10.1016/j.jconrel.2012.02.023; Zhang F, 2010, TRANSL STROKE RES, V1, P113, DOI 10.1007/s12975-010-0019-3	40	96	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90107	10.1371/journal.pone.0090107	http://dx.doi.org/10.1371/journal.pone.0090107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587228	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200127
J	Arvanitis, M; Anagnostou, T; Kourkoumpetis, TK; Ziakas, PD; Desalermos, A; Mylonakis, E				Arvanitis, Marios; Anagnostou, Theodora; Kourkoumpetis, Themistoklis K.; Ziakas, Panayiotis D.; Desalermos, Athanasios; Mylonakis, Eleftherios			The Impact of Antimicrobial Resistance and Aging in VAP Outcomes: Experience from a Large Tertiary Care Center	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; HOSPITAL-ACQUIRED PNEUMONIA; PSEUDOMONAS-AERUGINOSA; CANDIDA COLONIZATION; RESPIRATORY-TRACT; SURVEILLANCE; INFECTION; EPIDEMIOLOGY; PREVALENCE; MORTALITY	Background: Ventilator associated pneumonia (VAP) is a serious infection among patients in the intensive care unit (ICU). Methods: We reviewed the medical charts of all patients admitted to the adult intensive care units of the Massachusetts General Hospital that went on to develop VAP during a five year period. Results: 200 patients were included in the study of which 50 (25%) were infected with a multidrug resistant pathogen. Increased age, dialysis and late onset (>= 5 days from admission) VAP were associated with increased incidence of resistance. Multidrug resistant bacteria (MDRB) isolation was associated with a significant increase in median length of ICU stay (19 vs. 16 days, p = 0.02) and prolonged duration of mechanical ventilation (18 vs. 14 days, p = 0.03), but did not impact overall mortality (HR 1.12, 95% CI 0.51-2.46, p = 0.77). However, age (HR 1.04 95% CI 1.01-1.07, p = 0.003) was an independent risk factor for mortality and age >= 65 years was associated with increased incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections (OR 2.83, 95% CI 1.27-6.32, p = 0.01). Conclusions: MDRB-related VAP is associated with prolonged ICU stay and mechanical ventilation. Interestingly, age >= 65 years is associated with MRSA VAP.	[Arvanitis, Marios; Anagnostou, Theodora; Ziakas, Panayiotis D.; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis,Dept Med, Providence, RI 02903 USA; [Arvanitis, Marios; Anagnostou, Theodora; Kourkoumpetis, Themistoklis K.; Desalermos, Athanasios; Mylonakis, Eleftherios] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis,Dept Med, Boston, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Mylonakis, E (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis,Dept Med, Providence, RI 02903 USA.	emylonakis@lifespan.org		Ziakas, Panayiotis/0000-0002-5943-8635	Astellas, Inc.	Astellas, Inc.(Astellas Pharmaceuticals)	Part of this work was supported through a grant from Astellas, Inc. No additional funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Azoulay E, 2006, CHEST, V129, P110, DOI 10.1378/chest.129.1.110; Barbier F, 2013, CURR OPIN PULM MED, V19, P216, DOI 10.1097/MCP.0b013e32835f27be; Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12; Bird D, 2010, ARCH SURG-CHICAGO, V145, P465, DOI 10.1001/archsurg.2010.69; Bouza E, 2012, J HOSP INFECT, V80, P150, DOI 10.1016/j.jhin.2011.11.013; Chung DR, 2011, AM J RESP CRIT CARE, V184, P1409, DOI 10.1164/rccm.201102-0349OC; Combes A, 2004, AM J RESP CRIT CARE, V170, P786, DOI 10.1164/rccm.200403-346OC; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Delisle MS, 2011, CAN RESPIR J, V18, P131, DOI 10.1155/2011/827692; Deliste MS, 2008, J CRIT CARE, V23, P11, DOI 10.1016/j.jcrc.2008.01.005; Depuydt PO, 2008, CRIT CARE, V12, DOI 10.1186/cc7119; Di Pasquale M, 2014, CRIT CARE MED, V42, P303, DOI 10.1097/CCM.0b013e3182a272a2; Hamet M, 2012, INTENS CARE MED, V38, P1272, DOI 10.1007/s00134-012-2584-2; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hunter JD, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3325; Janssens JP, 2004, LANCET INFECT DIS, V4, P112, DOI 10.1016/S1473-3099(04)00931-4; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Kaminski C, 2011, CRIT CARE, V15, DOI 10.1186/cc10136; Kanaan AO, 2013, J AM GERIATR SOC, V61, P1894, DOI 10.1111/jgs.12504; Kollef MH, 2008, CLIN INFECT DIS, V47, pS3, DOI 10.1086/590061; Kourkoumpetis T, 2010, VIRULENCE, V1, P359, DOI 10.4161/viru.1.5.12795; Lanspa MJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11308; Lee MS, 2013, INFECT CONT HOSP EP, V34, P657, DOI 10.1086/670991; Magill SS, 2013, CRIT CARE MED, V41, P2467, DOI 10.1097/CCM.0b013e3182a262db; Martin-Loeches I, 2013, INTENS CARE MED, V39, P672, DOI 10.1007/s00134-012-2808-5; Michetti CP, 2012, J TRAUMA ACUTE CARE, V72, P1165, DOI 10.1097/TA.0b013e31824d10fa; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Parker CM, 2008, J CRIT CARE, V23, P18, DOI 10.1016/j.jcrc.2008.02.001; Pena C, 2013, EUR J CLIN MICROBIOL, V32, P413, DOI 10.1007/s10096-012-1758-8; Planquette B, 2013, AM J RESP CRIT CARE, V188, P69, DOI 10.1164/rccm.201210-1897OC; Price J, 2009, CLIN INFECT DIS, V48, P997, DOI 10.1086/597359; Sandiumenge A, 2011, CHEST, V140, P643, DOI 10.1378/chest.11-0462; Sinuff T, 2013, CRIT CARE MED, V41, P15, DOI 10.1097/CCM.0b013e318265e874; Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093; Suka M, 2007, INFECT CONT HOSP EP, V28, P307, DOI 10.1086/511997; Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064; Tseng CC, 2012, AM J INFECT CONTROL, V40, P648, DOI 10.1016/j.ajic.2011.08.017; Williamson DR, 2011, CAN J ANESTH, V58, P275, DOI 10.1007/s12630-010-9439-5; Zimlichman E, 2013, JAMA INTERN MED, DOI [10.1001/jamainternmed.2013.9763, DOI 10.1001/JAMAIN-TERNMED.2013.9763]	40	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89984	10.1371/journal.pone.0089984	http://dx.doi.org/10.1371/journal.pone.0089984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587166	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800063
J	Sattler, VA; Mohnl, M; Klose, V				Sattler, Verity Ann; Mohnl, Michaela; Klose, Viviana			Development of a Strain-Specific Real-Time PCR Assay for Enumeration of a Probiotic Lactobacillus reuteri in Chicken Feed and Intestine	PLOS ONE			English	Article							HUMAN FECES; SUBTRACTIVE HYBRIDIZATION; LACTOCOCCUS-LACTIS; FECAL SAMPLES; IDENTIFICATION; QUANTIFICATION; PRIMERS; BACTERIA; RHAMNOSUS; POULTRY	A strain-specific real-time PCR assay was developed for quantification of a probiotic Lactobacillus reuteri (DSM 16350) in poultry feed and intestine. The specific primers were designed based on a genomic sequence of the strain derived from suppression subtractive hybridization with the type strain L. reuteri DSM 20016. Specificity was tested using a set of nontarget strains from several sources. Applicability of the real-time PCR assay was evaluated in a controlled broiler feeding trial by using standard curves specific for feed and intestinal matrices. The amount of the probiotic L. reuteri was determined in feed from three feeding phases and in intestinal samples of the jejunum, ileum, and caecum of three, 14, and 39 day old birds. L. reuteri DSM 16350 cells were enumerated in all feeds supplemented with the probiotic close to the inclusion rate of 7.0610 3 cfu/g, however, were not detected in L. reuteri DSM 16350 free feed. In three day old birds L. reuteri DSM 16350 was only detected in intestinal samples from probiotic fed animals ranging from 8.2 +/- 7.8x10(5) cfu/g in the jejunum, 1.0 +/- 1.1x10(7) cfu/g in the ileum, and 2.5 +/- 5.7x10(5) cfu/g in the caecum. Similar results were obtained for intestinal samples of older birds (14 and 39 days). With increasing age of the animals the amount of L. reuteri signals in the control animals, however, also increased, indicating the appearance of highly similar bacterial genomes in the gut microbiota. The L. reuteri DSM 16350 qPCR assay could be used in future for feeding trials to assure the accurate inclusion of the supplement to the feed and to monitor it's uptake into the GIT of young chicken.	[Sattler, Verity Ann; Klose, Viviana] Univ Nat Resources & Appl Life Sci, Dept Agrobiotechnol, Tulln, Austria; [Mohnl, Michaela] BIOMIN Res Ctr, Tulln, Austria	University of Natural Resources & Life Sciences, Vienna	Sattler, VA (corresponding author), Univ Nat Resources & Appl Life Sci, Dept Agrobiotechnol, Tulln, Austria.	verityann.sattler@boku.ac.at			FFG (Austrian Research Promotion Agency) [820117]	FFG (Austrian Research Promotion Agency)	This work was part of a FFG (Austrian Research Promotion Agency) funded project (Gut function Project No. 820117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agron PG, 2002, FEMS MICROBIOL LETT, V211, P175, DOI 10.1016/S0378-1097(02)00650-X; Ahlroos T, 2009, J APPL MICROBIOL, V106, P506, DOI 10.1111/j.1365-2672.2008.04018.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093; [Anonymous], 2002, GUIDELINES EVALUATIO; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Brandt K, 2003, INT J FOOD MICROBIOL, V84, P189, DOI 10.1016/S0168-1605(02)00419-1; CASON JA, 1994, AVIAN DIS, V38, P583, DOI 10.2307/1592082; Chan RK, 2003, J MICROBIOL METH, V55, P565, DOI 10.1016/S0167-7012(03)00186-6; COX NA, 1983, POULTRY SCI, V62, P2169, DOI 10.3382/ps.0622169; Dong BX, 2007, J RAPID METH AUT MIC, V15, P244, DOI 10.1111/j.1745-4581.2007.00094.x; Drouault S, 1999, APPL ENVIRON MICROB, V65, P4881; Fujimoto J, 2011, J APPL MICROBIOL, V110, P209, DOI 10.1111/j.1365-2672.2010.04873.x; Fujimoto J, 2008, INT J FOOD MICROBIOL, V126, P210, DOI 10.1016/j.ijfoodmicro.2008.05.022; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Geoffroy MC, 2000, APPL ENVIRON MICROB, V66, P383, DOI 10.1128/AEM.66.1.383-391.2000; Guan LL, 2003, APPL ENVIRON MICROB, V69, P6750, DOI 10.1128/AEM.69.11.6750-6757.2003; Hilmi HTA, 2007, APPL ENVIRON MICROB, V73, P7867, DOI 10.1128/AEM.01128-07; Huang XW, 2007, APPL MICROBIOL BIOT, V76, P753, DOI 10.1007/s00253-007-1076-8; Karjalainen H, 2012, INT DAIRY J, V27, P58, DOI 10.1016/j.idairyj.2012.07.006; Klose V, 2006, MOL NUTR FOOD RES, V50, P563, DOI 10.1002/mnfr.200500166; Konstantinov SR, 2005, APPL ENVIRON MICROB, V71, P7578, DOI 10.1128/AEM.71.11.7578-7581.2005; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Maciorowski KG, 2007, ANIM FEED SCI TECH, V133, P109, DOI 10.1016/j.anifeedsci.2006.08.006; Makarova KS, 2007, J BACTERIOL, V189, P1199, DOI 10.1128/JB.01351-06; Malinen E, 2001, FOOD MICROBIOL, V18, P309, DOI 10.1006/fmic.2001.0402; Maruo T, 2006, INT J FOOD MICROBIOL, V110, P69, DOI 10.1016/j.ijfoodmicro.2006.01.037; Mountzouris KC, 2010, POULTRY SCI, V89, P58, DOI 10.3382/ps.2009-00308; Peng M, 2011, APPL ENVIRON MICROB, V77, P3898, DOI 10.1128/AEM.02586-10; De Martinis ECP, 2007, J FOOD PROTECT, V70, P1650, DOI 10.4315/0362-028X-70.7.1650; Rebrikov DV, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e90; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; RODTONG S, 1993, APPL ENVIRON MICROB, V59, P3480, DOI 10.1128/AEM.59.10.3480-3484.1993; Saxena D, 2005, J CLIN MICROBIOL, V43, P3508, DOI 10.1128/JCM.43.7.3508-3511.2005; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tilsala-Timisjarvi A, 1998, APPL ENVIRON MICROB, V64, P4816; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Yeung PSM, 2004, J APPL MICROBIOL, V97, P1095, DOI 10.1111/j.1365-2672.2004.02400.x; Yeung PSM, 2002, J DAIRY SCI, V85, P1039, DOI 10.3168/jds.S0022-0302(02)74164-7; Zoetendal EG, 2001, SYST APPL MICROBIOL, V24, P405, DOI 10.1078/0723-2020-00060	40	30	30	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90208	10.1371/journal.pone.0090208	http://dx.doi.org/10.1371/journal.pone.0090208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587284	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800091
J	van Spijker, BAJ; van Straten, A; Kerkhof, AJFM				van Spijker, Bregje A. J.; van Straten, Annemieke; Kerkhof, Ad J. F. M.			Effectiveness of Online Self-Help for Suicidal Thoughts: Results of a Randomised Controlled Trial	PLOS ONE			English	Article							DIALECTICAL BEHAVIOR-THERAPY; COGNITIVE THERAPY; ADULT DEPRESSION; CURRENT STATE; RISK-FACTORS; HOPELESSNESS; PREVENTION; PSYCHOTHERAPY; EFFICACY; IDEATION	Background: Many people with suicidal thoughts do not receive treatment. The Internet can be used to reach more people in need of support. Objective: To test the effectiveness of unguided online self-help to reduce suicidal thoughts. Method: 236 adults with mild to moderate suicidal thoughts were randomised to the intervention (n = 116) or a waitlist control group (n = 120). Assessments took place at baseline, and 2, 4 and 6 weeks later. Primary outcome was suicidal thoughts. Secondary outcomes were depressive symptoms, anxiety, hopelessness, worry, and health status. Results: The intervention group showed a small significant effect in reducing suicidal thoughts (d = 0.28). Effects were more pronounced for those with a history of repeated suicide attempts. There was also a significant reduction in worry (d = 0.33). All other secondary outcomes showed small but non-significant improvements. Conclusions: Although effect sizes were small, the reach of the internet could enable this intervention to help many people reduce their suicidal thoughts.	[van Spijker, Bregje A. J.] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [van Spijker, Bregje A. J.; van Straten, Annemieke; Kerkhof, Ad J. F. M.] Vrije Univ Amsterdam, Fac Psychol & Educ, Dept Clin Psychol, Amsterdam, Netherlands; [van Spijker, Bregje A. J.; van Straten, Annemieke; Kerkhof, Ad J. F. M.] Vrije Univ Amsterdam, Fac Psychol & Educ, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Australian National University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Spijker, BAJ (corresponding author), Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia.	baj.van.spijker@gmail.com	van Straten, Annemieke/P-8495-2019	van Straten, Annemieke/0000-0001-6875-2215; van Spijker, Bregje/0000-0002-8124-2559	Netherlands Organisation for Health Research and Development (ZonMw), the Hague [120510003]	Netherlands Organisation for Health Research and Development (ZonMw), the Hague(Netherlands Organization for Health Research and Development)	This study was funded by the Netherlands Organisation for Health Research and Development (ZonMw), the Hague, project number 120510003. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Barak A, 2007, COMPUT HUM BEHAV, V23, P971, DOI 10.1016/j.chb.2005.08.001; Barnard J, 1999, BIOMETRIKA, V86, P948, DOI 10.1093/biomet/86.4.948; Beck A.T., 1991, MANUAL BECK SCALE SU; Beck A.T., 1988, MANUAL BECK HOPELESS; Beck AT, 2005, ARCH GEN PSYCHIAT, V62, P953, DOI 10.1001/archpsyc.62.9.953; BECK AT, 1990, AM J PSYCHIAT, V147, P190; Beck AT, 1996, PSYCHOL ASSESS; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Bruffaerts R, 2011, BRIT J PSYCHIAT, V199, P64, DOI 10.1192/bjp.bp.110.084129; Burgess P, 2000, PSYCHIATR SERV, V51, P1555, DOI 10.1176/appi.ps.51.12.1555; Christensen H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002886; Cuijpers P, 2013, J AFFECT DISORDERS, V144, P183, DOI 10.1016/j.jad.2012.06.025; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Evans MO, 1999, BRIT J PSYCHIAT, V175, P23, DOI 10.1192/bjp.175.1.23; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Hawton K, 1999, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001764, 10.1002/14651858.CD001764]; Kerkhof AJFM, 2011, INT HDB SUICIDE PREV, P199; Linehan M. M., 1993, DBT SKILLS TRAINING; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Linehan MM, 2006, ARCH GEN PSYCHIAT, V63, P757, DOI 10.1001/archpsyc.63.7.757; Mokkenstorm J K, 2012, Tijdschr Psychiatr, V54, P341; Mokkenstorm JK, 2010, MGV, V65, P488; Morrison R, 2008, SUICIDE LIFE-THREAT, V38, P523, DOI 10.1521/suli.2008.38.5.523; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Rickwood D, 2005, ADV MENT HEALTH, V4, P218, DOI 10.5172/jamh.4.3.218; Riper H, 2008, ADDICTION, V103, P218, DOI 10.1111/j.1360-0443.2007.02063.x; Segal Z. V., 2002, MINDFULNESS BASED CO; Stober J, 1998, BEHAV RES THER, V36, P645, DOI 10.1016/S0005-7967(98)00031-X; Tarrier N, 2008, BEHAV MODIF, V32, P77, DOI 10.1177/0145445507304728; Townsend E, 2001, PSYCHOL MED, V31, P979, DOI 10.1017/S0033291701004238; van den Bosch LMC, 2005, BEHAV RES THER, V43, P1231, DOI 10.1016/j.brat.2004.09.008; Van der Does A. J. W., 2002, DUTCH VERSION BECK D; van Spijker BAJ, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-25; van Spijker BAJ, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1966; Verheul R, 2003, BRIT J PSYCHIAT, V182, P135, DOI 10.1192/bjp.182.2.135; Watts S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001558; Williams J Mark G, 2004, Arch Suicide Res, V8, P315; Williams JMG, 2006, J CLIN PSYCHOL, V62, P201, DOI 10.1002/jclp.20223; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	87	88	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90118	10.1371/journal.pone.0090118	http://dx.doi.org/10.1371/journal.pone.0090118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24587233	Green Published, gold			2022-12-27	WOS:000332390800077
J	Turunen, MP; Husso, T; Musthafa, H; Laidinen, S; Dragneva, G; Laham-Karam, N; Honkanen, S; Paakinaho, A; Laakkonen, JP; Gao, E; Vihinen-Ranta, M; Liimatainen, T; Yla-Herttuala, S				Turunen, Mikko P.; Husso, Tiia; Musthafa, Haja; Laidinen, Svetlana; Dragneva, Galina; Laham-Karam, Nihay; Honkanen, Sanna; Paakinaho, Anne; Laakkonen, Johanna P.; Gao, Erhe; Vihinen-Ranta, Maija; Liimatainen, Timo; Yla-Herttuala, Seppo			Epigenetic Upregulation of Endogenous VEGF-A Reduces Myocardial Infarct Size in Mice	PLOS ONE			English	Article							INDUCE TRANSCRIPTIONAL ACTIVATION; MAMMALIAN-CELLS; GENE; PROMOTER; MOUSE; EXPRESSION; MICRORNAS; SEQUENCES; PROTEIN	"Epigenetherapy" alters epigenetic status of the targeted chromatin and modifies expression of the endogenous therapeutic gene. In this study we used lentiviral in vivo delivery of small hairpin RNA (shRNA) into hearts in a murine infarction model. shRNA complementary to the promoter of vascular endothelial growth factor (VEGF-A) was able to upregulate endogenous VEGF-A expression. Histological and multiphoton microscope analysis confirmed the therapeutic effect in the transduced hearts. Magnetic resonance imaging (MRI) showed in vivo that the infarct size was significantly reduced in the treatment group 14 days after the epigenetherapy. Importantly, we show that promoter-targeted shRNA upregulates all isoforms of endogenous VEGF-A and that an intact hairpin structure is required for the shRNA activity. In conclusion, regulation of gene expression at the promoter level is a promising new treatment strategy for myocardial infarction and also potentially useful for the upregulation of other endogenous genes.	[Turunen, Mikko P.; Husso, Tiia; Musthafa, Haja; Laidinen, Svetlana; Dragneva, Galina; Laham-Karam, Nihay; Honkanen, Sanna; Paakinaho, Anne; Laakkonen, Johanna P.; Liimatainen, Timo; Yla-Herttuala, Seppo] Univ Eastern Finland, AI Virtanen Inst, Dept Biotechnol & Mol Med, Kuopio, Finland; [Gao, Erhe] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Vihinen-Ranta, Maija] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Gene Therapy Unit, SF-70210 Kuopio, Finland	University of Eastern Finland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Jyvaskyla; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Yla-Herttuala, S (corresponding author), Univ Eastern Finland, AI Virtanen Inst, Dept Biotechnol & Mol Med, Kuopio, Finland.	seppo.ylaherttuala@uef.fi	Turunen, Tiia/AAQ-2086-2021; Turunen, Mikko P./H-5339-2019; Liimatainen, Timo/F-9235-2019	Turunen, Tiia/0000-0001-7536-451X; Liimatainen, Timo/0000-0001-7472-9900; Yla-Herttuala, Seppo/0000-0001-7593-2708; Vihinen-Ranta, Maija/0000-0003-0959-1153; Laakkonen, Johanna/0000-0002-8556-9727; Laham-Karam, Nihay/0000-0001-8718-4612	Finnish Academy; ERC; Kuopio University Hospital; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Jenny and Antti Wihuri Foundation; Eye and Tissue bank Foundation; Orion-Farmos Research Foundation; Instrumentarium Science Foundation	Finnish Academy(Academy of Finland); ERC(European Research Council (ERC)European Commission); Kuopio University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Jenny and Antti Wihuri Foundation; Eye and Tissue bank Foundation; Orion-Farmos Research Foundation; Instrumentarium Science Foundation	This study was supported by grants from Finnish Academy, ERC, Kuopio University Hospital, Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular Research, Jenny and Antti Wihuri Foundation, Eye and Tissue bank Foundation, Orion-Farmos Research Foundation and Instrumentarium Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Hu J, 2012, BIOCHEM J, V447, P407, DOI 10.1042/BJ20120256; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Makinen PI, 2006, J GENE MED, V8, P433, DOI 10.1002/jgm.860; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Ng Y, 2001, DEV DYNAM, V121, P112; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Turunen MP, 2009, CIRC RES, V105, P604, DOI 10.1161/CIRCRESAHA.109.200774; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; van Nierop BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055424; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wech T, 2011, J MAGN RESON IMAGING, V34, P1072, DOI 10.1002/jmri.22718; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	22	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89979	10.1371/journal.pone.0089979	http://dx.doi.org/10.1371/journal.pone.0089979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587164	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000125
J	Gerrits, EG; Alkhalaf, A; Landman, GWD; van Hateren, KJJ; Groenier, KH; Struck, J; Schulte, J; Gans, ROB; Bakker, SJL; Kleefstra, N; Bilo, HJG				Gerrits, Esther G.; Alkhalaf, Alaa; Landman, Gijs W. D.; van Hateren, Kornelis J. J.; Groenier, Klaas H.; Struck, Joachim; Schulte, Janin; Gans, Reinold O. B.; Bakker, Stephan J. L.; Kleefstra, Nanne; Bilo, Henk J. G.			Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASES; STREPTOZOTOCIN; MECHANISM; COMPLICATIONS; PROTECTS; MELLITUS; IV	Background: Oxidative stress plays an underlying pathophysiologic role in the development of diabetes complications. The aim of this study was to investigate peroxiredoxin 4 (Prx4), a proposed novel biomarker of oxidative stress, and its association with and capability as a biomarker in predicting (cardiovascular) mortality in type 2 diabetes mellitus. Methods: Prx4 was assessed in baseline serum samples of 1161 type 2 diabetes patients. Cox proportional hazard models were used to evaluate the relationschip between Prx4 and (cardiovascular) mortality. Risk prediction capabilities of Prx4 for (cardiovascular) mortality were assessed with Harrell's C statistic, the integrated discrimination improvement and net reclassification improvement. Results: Mean age was 67 and the median diabetes duration was 4.0 years. After a median follow-up period of 5.8 years, 327 patients died; 137 cardiovascular deaths. Prx4 was associated with (cardiovascular) mortality. The Cox proportional hazard models added the variables: Prx4 (model 1); age and gender (model 2), and BMI, creatinine, smoking, diabetes duration, systolic blood pressure, cholesterol-HDL ratio, history of macrovascular complications, and albuminuria (model 3). Hazard ratios (HR) (95% CI) for cardiovascular mortality were 1.93 (1.57 - 2.38), 1.75 (1.39 - 2.20), and 1.63 (1.28 - 2.09) for models 1, 2 and 3, respectively. HR for all-cause mortality were 1.73 (1.50 - 1.99), 1.50 (1.29 - 1.75), and 1.44 (1.23 - 1.67) for models 1, 2 and 3, respectively. Addition of Prx4 to the traditional risk factors slightly improved risk prediction of (cardiovascular) mortality. Conclusions: Prx4 is independently associated with (cardiovascular) mortality in type 2 diabetes patients. After addition of Prx4 to the traditional risk factors, there was a slightly improvement in risk prediction of (cardiovascular) mortality in this patient group.	[Gerrits, Esther G.] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands; [Gerrits, Esther G.; Alkhalaf, Alaa; Landman, Gijs W. D.; van Hateren, Kornelis J. J.; Groenier, Klaas H.; Kleefstra, Nanne; Bilo, Henk J. G.] Isala Clin, Ctr Diabet, Zwolle, Netherlands; [Alkhalaf, Alaa] Isala Clin, Dept Gastroenterol, Zwolle, Netherlands; [van Hateren, Kornelis J. J.; Kleefstra, Nanne] Langerhans Med Res Grp, Zwolle, Netherlands; [Groenier, Klaas H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9713 AV Groningen, Netherlands; [Struck, Joachim; Schulte, Janin] BRAHMS Biomarkers, Thermo Fisher Sci, Res Dept, Hennigsdorf, Germany; [Gans, Reinold O. B.; Bakker, Stephan J. L.; Kleefstra, Nanne; Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Bilo, Henk J. G.] Isala Clin, Dept Internal Med, Zwolle, Netherlands	Maastricht University; Isala Clinics; Isala Clinics; Langerhans Medical Research Group; University of Groningen; Thermo Fisher Scientific; Brahms AG; University of Groningen; Isala Clinics	Gerrits, EG (corresponding author), Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands.	esther.gerrits@mumc.nl	Bakker, Stephan J. L./J-4023-2015; Landman, Gijs/AAJ-5540-2021	Bakker, Stephan J. L./0000-0003-3356-6791; Landman, Gijs/0000-0002-6852-6450; Kleefstra, Nanne/0000-0003-1473-8519; Gans, Reinold/0000-0001-5481-2387	Center of Excellence for Diabetes of the Isala Clinics, Zwolle, The Netherlands; Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Center for Translational Molecular Medicine (CTMM) project PREDICCt [01C-104-07]	Center of Excellence for Diabetes of the Isala Clinics, Zwolle, The Netherlands; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Center for Translational Molecular Medicine (CTMM) project PREDICCt	This study was supported by grants of the Center of Excellence for Diabetes of the Isala Clinics, Zwolle, The Netherlands. S.J.L. Bakker received support from the Netherlands Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation, together participating in the framework of the Center for Translational Molecular Medicine (CTMM) (www.ctmm.nl) project PREDICCt (grant 01C-104-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002956; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Chang XT, 2009, J RHEUMATOL, V36, P872, DOI 10.3899/jrheum.080939; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; Dreja T, 2010, DIABETOLOGIA, V53, P309, DOI 10.1007/s00125-009-1576-4; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Jiang YL, 2011, INT J MOL MED, V28, P153, DOI 10.3892/ijmm.2011.696; May S, 1998, LIFETIME DATA ANAL, V4, P109, DOI 10.1023/A:1009612305785; Nickel CH, 2011, ACAD EMERG MED, V18, P851, DOI 10.1111/j.1553-2712.2011.01126.x; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Schulte J, 2011, SHOCK, V35, P460, DOI 10.1097/SHK.0b013e3182115f40; Schulte J, 2010, CLIN CHIM ACTA, V411, P1258, DOI 10.1016/j.cca.2010.05.016; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Ubink-Veltmaat LJ, 2003, EUR J EPIDEMIOL, V18, P793, DOI 10.1023/A:1025369623365; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xie XL, 2008, BBA-PROTEINS PROTEOM, V1784, P276, DOI 10.1016/j.bbapap.2007.11.008; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217	26	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89719	10.1371/journal.pone.0089719	http://dx.doi.org/10.1371/journal.pone.0089719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586984	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900071
J	Qiu, Y; Wang, ZW; Liu, YX; Han, YJ; Miao, M; Qi, N; Yang, J; Xia, HJ; Li, XF; Qin, CF; Hu, YY; Zhou, X				Qiu, Yang; Wang, Zhaowei; Liu, Yongxiang; Han, Yajuan; Miao, Meng; Qi, Nan; Yang, Jie; Xia, Hongjie; Li, Xiaofeng; Qin, Cheng-Feng; Hu, Yuanyang; Zhou, Xi			The Self-Interaction of a Nodavirus Replicase Is Enhanced by Mitochondrial Membrane Lipids	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; FLOCK-HOUSE-VIRUS; PROTEIN-A; DROSOPHILA-CELLS; ANIMAL VIRUS; ASSOCIATION; OLIGOMERIZATION; POLYPROTEIN; POLIOVIRUS; BINDING	RNA replication of positive-strand (+) RNA viruses requires the protein-protein interactions among viral replicases and the association of viral replicases with intracellular membranes. Protein A from Wuhan nodavirus (WhNV), which closely associate with mitochondrial membranes, is the sole replicase required for viral RNA replication. Here, we studied the direct effects of mitochondrial membrane lipids (MMLs) on WhNV protein A activity in vitro. Our investigations revealed the self-interaction of WhNV protein A is accomplished via two different patterns (i.e., homotypic and heterotypic self-interactions via different interfaces). MMLs stimulated the protein A self-interaction, and this stimulation exhibited selectivity for specific phospholipids. Moreover, we found that specific phospholipids differently favor the two self-interaction patterns. Furthermore, manipulating specific phospholipid metabolism affected protein A self-interaction and the activity of protein A to replicate RNA in cells. Taken together, our findings reveal the direct effects of membrane lipids on a nodaviral RNA replicase.	[Qiu, Yang; Wang, Zhaowei; Liu, Yongxiang; Han, Yajuan; Miao, Meng; Qi, Nan; Yang, Jie; Xia, Hongjie; Hu, Yuanyang; Zhou, Xi] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Qiu, Yang; Li, Xiaofeng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Wuhan University; Beijing Institute of Microbiology & Epidemiology	Hu, YY (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	yyhu@whu.edu.cn; zhouxi@whu.edu.cn	Qiu, Yang/AAQ-4435-2020; Xia, Hongjie/M-9241-2019; Qin, Cheng-Feng/I-6839-2019	Xia, Hongjie/0000-0002-2520-7038; Qin, Cheng-Feng/0000-0002-0632-2807	National Basic Research Program of China (973 Program) [2014CB542603]; National Natural Science Foundation of China [31270190, 81201292, 31270189]; Chinese 111 Project [B06018]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (973 Program, 2014CB542603), the National Natural Science Foundation of China grants No. 31270190 (to XZ), No. 81201292 (to XZ) and No. 31270189 (to YH), and the Chinese 111 Project grant No. B06018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Ahlquist P, 1992, CURR OPIN GENET DEV, V2, P71, DOI 10.1016/S0959-437X(05)80325-9; Ahola T, 1999, EMBO J, V18, P3164, DOI 10.1093/emboj/18.11.3164; Beckman MTL, 1998, J BIOL CHEM, V273, P6724, DOI 10.1074/jbc.273.12.6724; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Castorena K.M., 2011, BMC GENOMICS, V11, P183; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Dye BT, 2005, J VIROL, V79, P8909, DOI 10.1128/JVI.79.14.8909-8919.2005; GALLAGHER TM, 1983, J VIROL, V46, P481, DOI 10.1128/JVI.46.2.481-489.1983; Goregaoker SP, 2003, J VIROL, V77, P3549, DOI 10.1128/JVI.77.6.3549-3556.2003; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0303s04, 10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0304s04]; Graham J M, 1993, Methods Mol Biol, V19, P19; Han Xue, 2012, Virologica Sinica, V27, P254, DOI 10.1007/s12250-012-3256-7; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hojjati MR, 2006, J LIPID RES, V47, P673, DOI 10.1194/jlr.D500040-JLR200; Kopek BG, 2010, J VIROL, V84, P12492, DOI 10.1128/JVI.01495-10; Kovalev N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002537; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; Miller DJ, 2002, J VIROL, V76, P9856, DOI 10.1128/JVI.76.19.9856-9867.2002; Miller DJ, 2001, J VIROL, V75, P11664, DOI 10.1128/JVI.75.23.11664-11676.2001; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; Panaviene Z, 2003, VIROLOGY, V308, P191, DOI 10.1016/S0042-6822(02)00132-0; PATA JD, 1995, RNA, V1, P466; Qi N, 2012, J VIROL, V86, P5763, DOI 10.1128/JVI.07229-11; Qi N, 2011, J VIROL, V85, P9543, DOI 10.1128/JVI.00785-11; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Qiu Y, 2013, SCI CHINA LIFE SCI, V56, P711, DOI 10.1007/s11427-013-4520-2; Qiu Y, 2013, VIROLOGY, V439, P140, DOI 10.1016/j.virol.2013.02.010; Qiu Y, 2011, J VIROL, V85, P4440, DOI 10.1128/JVI.02410-10; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; RUSSO M, 1994, ADV VIRUS RES, V44, P381, DOI 10.1016/S0065-3527(08)60334-6; Sasvari Z, 2010, VIRUSES-BASEL, V2, P2436, DOI 10.3390/v2112436; SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Stapleford KA, 2009, J VIROL, V83, P4498, DOI 10.1128/JVI.00040-09; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Van Wynsberghe PA, 2007, J VIROL, V81, P4633, DOI 10.1128/JVI.02267-06; Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Wang Z, 2013, J BIOL CHEM; Weeks SA, 2008, J VIROL, V82, P2004, DOI 10.1128/JVI.02017-07; Weng LY, 2010, J VIROL, V84, P11761, DOI 10.1128/JVI.00638-10; WU SX, 1992, P NATL ACAD SCI USA, V89, P11136, DOI 10.1073/pnas.89.23.11136; WU SX, 1991, VIROLOGY, V183, P392, DOI 10.1016/0042-6822(91)90153-3	53	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89628	10.1371/journal.pone.0089628	http://dx.doi.org/10.1371/journal.pone.0089628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586921	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900061
J	Sun, MZ; Sun, XL; Zhao, Y; Zhao, CY; DuanMu, HZ; Yu, Y; Ji, W; Zhu, YM				Sun, Mingzhe; Sun, Xiaoli; Zhao, Yang; Zhao, Chaoyue; DuanMu, Huizi; Yu, Yang; Ji, Wei; Zhu, Yanming			Ectopic Expression of GsPPCK3 and SCMRP in Medicago sativa Enhances Plant Alkaline Stress Tolerance and Methionine Content	PLOS ONE			English	Article							CYSTATHIONINE GAMMA-SYNTHASE; CARBOXYLASE-KINASE-ACTIVITY; PHOSPHOENOLPYRUVATE CARBOXYLASE; SALT STRESS; GENE-EXPRESSION; REGULATORY PHOSPHORYLATION; PUCCINELLIA-TENUIFLORA; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; PEP-CARBOXYLASE	So far, it has been suggested that phosphoenolpyruvate carboxylases (PEPCs) and PEPC kinases (PPCKs) fulfill several important non-photosynthetic functions. However, the biological functions of soybean PPCKs, especially in alkali stress response, are not yet well known. In previous studies, we constructed a Glycine soja transcriptional profile, and identified three PPCK genes (GsPPCK1, GsPPCK2 and GsPPCK3) as potential alkali stress responsive genes. In this study, we confirmed the induced expression of GsPPCK3 under alkali stress and investigated its tissue expression specificity by using quantitative real-time PCR analysis. Then we ectopically expressed GsPPCK3 in Medicago sativa and found that GsPPCK3 overexpression improved plant alkali tolerance, as evidenced by lower levels of relative ion leakage and MDA content and higher levels of chlorophyll content and root activity. In this respect, we further co-transformed the GsPPCK3 and SCMRP genes into alfalfa, and demonstrated the increased alkali tolerance of GsPPCK3-SCMRP transgenic lines. Further investigation revealed that GsPPCK3-SCMRP co-overexpression promoted the PEPC activity, net photosynthetic rate and citric acid content of transgenic alfalfa under alkali stress. Moreover, we also observed the up-regulated expression of PEPC, CS (citrate synthase), H+-ATPase and NADP-ME genes in GsPPCK3-SCMRP transgenic alfalfa under alkali stress. As expected, we demonstrated that GsPPCK3-SCMRP transgenic lines displayed higher methionine content than wild type alfalfa. Taken together, results presented in this study supported the positive role of GsPPCK3 in plant response to alkali stress, and provided an effective way to simultaneously improve plant alkaline tolerance and methionine content, at least in legume crops.	[Sun, Mingzhe; Sun, Xiaoli; Zhao, Yang; Zhao, Chaoyue; DuanMu, Huizi; Yu, Yang; Ji, Wei; Zhu, Yanming] Northeast Agr Univ, Key Lab Agr Biol Funct Gene, Harbin, Peoples R China	Northeast Agricultural University - China	Zhu, YM (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Gene, Harbin, Peoples R China.	ymzhu2001@neau.edu.cn		Sun, Xiaoli/0000-0003-1134-3976; Sun, Mingzhe/0000-0001-7557-623X	Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National Natural Science Foundation of China [31171578]; National Major Project for Cultivation of Transgenic Crops [2011ZX08004-002]; Scientific Research Foundation of Graduate School of Heilongjiang Province [YJSCX2012-047HLJ]; National Science Foundation for Fostering Talents in Basic Research of China [J1210069]	Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Cultivation of Transgenic Crops; Scientific Research Foundation of Graduate School of Heilongjiang Province; National Science Foundation for Fostering Talents in Basic Research of China	This work was supported by Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (2011TD005); National Natural Science Foundation of China (31171578); National Major Project for Cultivation of Transgenic Crops (2011ZX08004-002); Scientific Research Foundation of Graduate School of Heilongjiang Province (YJSCX2012-047HLJ) and National Science Foundation for Fostering Talents in Basic Research of China (J1210069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Avraham T, 2005, PLANT BIOTECHNOL J, V3, P71, DOI 10.1111/j.1467-7652.2004.00102.x; Bagavathiannan MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039440; BAKRIM N, 1993, PLANT PHYSIOL, V101, P891, DOI 10.1104/pp.101.3.891; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050544; Charkazi F, 2010, PLANT OMICS, V3, P194; Chen ZH, 2008, PLANT CELL ENVIRON, V31, P1844, DOI 10.1111/j.1365-3040.2008.01885.x; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Fukayama H, 2006, PLANT J, V47, P258, DOI 10.1111/j.1365-313X.2006.02779.x; Garcia-Maurino S, 2003, PLANTA, V216, P648, DOI 10.1007/s00425-002-0893-3; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; Ge Ying, 2009, Pratacultural Science, V26, P47; GONZALEZ DH, 1984, J PLANT PHYSIOL, V116, P425, DOI 10.1016/S0176-1617(84)80134-0; Guillet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036795; Hacham Y, 2008, PLANT J, V54, P260, DOI 10.1111/j.1365-313X.2008.03415.x; Hanafy MS, 2013, J PLANT PHYSIOL, V170, P338, DOI 10.1016/j.jplph.2012.10.018; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Hughes JA, 2000, J DENT, V28, P147, DOI 10.1016/S0300-5712(99)00060-3; Nguyen HC, 2012, J EXP BOT, V63, P5991, DOI 10.1093/jxb/ers253; Ibraheem O, 2011, PLANT OMICS, V4, P68; Ishitani M, 1998, PLANT CELL, V10, P1151, DOI 10.1105/tpc.10.7.1151; Jemaa E., 2011, Australian Journal of Agricultural Engineering, V2, P18; Jin H, 2006, PLANT SCI, V170, P1081, DOI 10.1016/j.plantsci.2006.01.002; Kawanabe S., 1991, Nippon Sochi Gakkaishi = Journal of Japanese Society of Grassland Science, V37, P91; KIRIHARA JA, 1988, GENE, V71, P359, DOI 10.1016/0378-1119(88)90053-4; KNIEVEL DP, 1973, CROP SCI, V13, P124, DOI 10.2135/cropsci1973.0011183X001300010043x; KURTZ I, 1987, J CLIN INVEST, V80, P928, DOI 10.1172/JCI113184; Lee MS, 2008, PLANT J, V54, P310, DOI 10.1111/j.1365-313X.2008.03419.x; Lee TTT, 2003, BIOSCI BIOTECH BIOCH, V67, P1699, DOI 10.1271/bbb.67.1699; Li L, 2001, CHINESE SCI BULL, V46, P482, DOI 10.1007/BF03187262; Li R, 2010, S AFR J BOT, V76, P380, DOI 10.1016/j.sajb.2010.01.004; Li R, 2010, ENVIRON EXP BOT, V68, P66, DOI 10.1016/j.envexpbot.2009.10.004; Liu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057531; Long YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057153; MARTINOIA E, 1994, ANNU REV PLANT PHYS, V45, P447, DOI 10.1146/annurev.pp.45.060194.002311; MELACK JM, 1974, LIMNOL OCEANOGR, V19, P743, DOI 10.4319/lo.1974.19.5.0743; Monreal JA, 2013, PLANTA, V237, P1401, DOI 10.1007/s00425-013-1855-7; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Oh DH, 2010, J EXP BOT, V61, P1205, DOI 10.1093/jxb/erp391; PEEVER TL, 1989, PLANT PHYSIOL, V90, P867, DOI 10.1104/pp.90.3.867; Penagaricano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072302; Peng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051159; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Shi DC, 2005, PLANT SOIL, V271, P15, DOI 10.1007/s11104-004-1307-z; Shi DC, 2002, ACTA BOT SIN, V44, P537; SIMON EW, 1974, NEW PHYTOL, V73, P377, DOI 10.1111/j.1469-8137.1974.tb02118.x; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Sullivan S, 2004, PLANT PHYSIOL, V135, P2078, DOI 10.1104/pp.104.042762; Tabe L, 2010, J EXP BOT, V61, P721, DOI 10.1093/jxb/erp338; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Vestin JLK, 2006, GEODERMA, V135, P97, DOI 10.1016/j.geoderma.2005.11.013; Vidal J, 1997, TRENDS PLANT SCI, V2, P230, DOI 10.1016/S1360-1385(97)01046-7; Wang HM, 2013, PHOTOSYNTHETICA, V51, P115, DOI 10.1007/s11099-013-0008-3; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037817; Wang YC, 2008, PLANT MOL BIOL REP, V26, P241, DOI 10.1007/s11105-008-0037-4; Wei ZhengWei, 2013, Acta Agronomica Sinica, V39, P68, DOI 10.3724/SP.J.1006.2013.00068; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Xu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037438; Xu WF, 2012, J EXP BOT, V63, P6105, DOI 10.1093/jxb/ers259; Xu WX, 2007, PLANT J, V49, P910, DOI 10.1111/j.1365-313X.2006.03006.x; Yang TB, 2004, J BIOL CHEM, V279, P42552, DOI 10.1074/jbc.M402830200; [翟红 ZHAI Hong], 2009, [东北农业大学学报, Journal of Northeast Agricultural University], V40, P60; Zhang X, 2013, J INTEGR PLANT BIOL, V55, P262, DOI 10.1111/jipb.12013; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; [朱军利 Zhu Junli], 2012, [分析试验室, Chinese Journal of Analysis Laboratory], V31, P115	68	16	18	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89578	10.1371/journal.pone.0089578	http://dx.doi.org/10.1371/journal.pone.0089578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586886	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900055
J	Virdis, B; Millo, D; Donose, BC; Batstone, DJ				Virdis, Bernardino; Millo, Diego; Donose, Bogdan C.; Batstone, Damien J.			Real-Time Measurements of the Redox States of c-Type Cytochromes in Electroactive Biofilms: A Confocal Resonance Raman Microscopy Study	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; GEOBACTER-SULFURREDUCENS; CYCLIC VOLTAMMETRY; SPECTROSCOPY; SPECTRA; SURFACE; CONDUCTIVITY; ACCUMULATION; GRAPHITE	Confocal Resonance Raman Microscopy (CRRM) was used to probe variations of redox state of c-type cytochromes embedded in living mixed-culture electroactive biofilms exposed to different electrode polarizations, under potentiostatic and potentiodynamic conditions. In the absence of the metabolic substrate acetate, the redox state of cytochromes followed the application of reducing and oxidizing electrode potentials. Real-time monitoring of the redox state of cytochromes during cyclic voltammetry (CV) in a potential window where cytochromes reduction occurs, evidenced a measurable time delay between the oxidation of redox cofactors probed by CV at the electrode interface, and oxidation of distal cytochromes probed by CRRM. This delay was used to tentatively estimate the diffusivity of electrons through the biofilm. In the presence of acetate, the resonance Raman spectra of young (10 days, j = 208 +/- 49 mu A cm(-2)) and mature (57 days, j = 267 +/- 73 mu A cm(-2)) biofilms show that cytochromes remained oxidized homogeneously even at layers as far as 70 mu m from the electrode, implying the existence of slow metabolic kinetics that do not result in the formation of a redox gradient inside the biofilm during anode respiration. However, old biofilms (80 days, j = 190 +/- 37 mu A cm(-2)) with thickness above 100 mu m were characterized by reduced catalytic activity compared to the previous developing stages. The cytochromes in these biofilm were mainly in the reduced redox state, showing that only aged mixed-culture biofilms accumulate electrons during anode respiration. These results differ substantially from recent observations in pure Geobacter sulfurreducens electroactive biofilms, in which accumulation of reduced cytochromes is already observed in thinner biofilms, thus suggesting different bottlenecks in current production for mixed-culture and G. sulfurreducens biofilms.	[Virdis, Bernardino; Donose, Bogdan C.] Univ Queensland, Ctr Microbial Electrosynth CEMES, Brisbane, Qld, Australia; [Virdis, Bernardino; Donose, Bogdan C.; Batstone, Damien J.] Univ Queensland, Adv Water Management Ctr AWMC, Brisbane, Qld, Australia; [Millo, Diego] Vrije Univ Amsterdam, Biomol Spectroscopy LaserLaB Amsterdam, Amsterdam, Netherlands	University of Queensland; University of Queensland; Vrije Universiteit Amsterdam	Virdis, B (corresponding author), Univ Queensland, Ctr Microbial Electrosynth CEMES, Brisbane, Qld, Australia.	b.virdis@uq.edu.au	Batstone, Damien J/N-1896-2014; Virdis, Bernardino/B-2665-2014; Donose, Bogdan/C-5657-2009	Batstone, Damien J/0000-0002-4294-3942; Virdis, Bernardino/0000-0001-8036-8937; Donose, Bogdan/0000-0003-1935-9489	Centre for Microbial Electrosynthesis (UQ); Netherlands Organisation for Scientific Research (NWO) [722.011.003]; Australian Research Council [DP0985000]; Australian Research Fellowship	Centre for Microbial Electrosynthesis (UQ); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Australian Research Council(Australian Research Council); Australian Research Fellowship(Australian Research Council)	BV is supported by strategic funding for the Centre for Microbial Electrosynthesis (UQ). BV wishes to thank the UQ Early Career Researcher Scheme. DM acknowledges the Netherlands Organisation for Scientific Research (NWO) grant 722.011.003. DJB wishes to thank the Australian Research Council (Grant DP0985000). DJB is holder of an Australian Research Fellowship under this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1978, J CHEM PHYS, V69, P4526, DOI 10.1063/1.436450; ADAR F, 1978, J PHYS CHEM-US, V82, P230, DOI 10.1021/j100491a019; Bhosale P, 2004, APPL MICROBIOL BIOT, V63, P351, DOI 10.1007/s00253-003-1441-1; Bonanni PS, 2013, CHEMSUSCHEM; Brazhe NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041990; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; Fricke K, 2008, ENERG ENVIRON SCI, V1, P144, DOI 10.1039/b802363h; Harnisch F, 2012, CHEM-ASIAN J, V7, P466, DOI 10.1002/asia.201100740; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; Inoue K, 2011, ENV MICROBIOL REP, V3, P211, DOI 10.1111/j.1758-2229.2010.00210.x; Liu Y, 2012, CHEMSUSCHEM, V5, P1047, DOI 10.1002/cssc.201100734; Liu Y, 2010, BIOSENS BIOELECTRON, V25, P2167, DOI 10.1016/j.bios.2010.01.016; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lovley DR, 2012, ANNU REV MICROBIOL, V66, P391, DOI 10.1146/annurev-micro-092611-150104; Lu HB, 2006, WATER RES, V40, P3838, DOI 10.1016/j.watres.2006.09.004; Ly HK, 2013, CHEMSUSCHEM, V6, P487, DOI 10.1002/cssc.201200626; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Millo D, 2012, BIOCHEM SOC T, V40, P1284, DOI 10.1042/BST20120115; Millo D, 2011, ANGEW CHEM INT EDIT, V50, P2625, DOI 10.1002/anie.201006046; Oellerich S, 2002, J PHYS CHEM B, V106, P6566, DOI 10.1021/jp013841g; Reich S, 2004, PHILOS T R SOC A, V362, P2271, DOI 10.1098/rsta.2004.1454; Robuschi L, 2013, ANGEW CHEM INT EDIT, V52, P925, DOI 10.1002/anie.201205440; Scholz F, 2010, ELECTROANALYTICAL METHODS: GUIDE TO EXPERIMENTS AND APPLICATIONS, SECOND EDITION, P1, DOI 10.1007/978-3-642-02915-8; Snider RM, 2012, P NATL ACAD SCI USA, V109, P15467, DOI 10.1073/pnas.1209829109; Srikanth S, 2008, BIOTECHNOL BIOENG, V99, P1065, DOI 10.1002/bit.21671; Strycharz SM, 2011, ENERG ENVIRON SCI, V4, P896, DOI 10.1039/c0ee00260g; Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e; Virdis B, 2012, ENERG ENVIRON SCI, V5, P7017, DOI 10.1039/c2ee03374g; Yeo BS, 2008, J PHYS CHEM C, V112, P4867, DOI 10.1021/jp709799m; Zheng YT, 2013, ANAL CHEM, V85, P7295, DOI 10.1021/ac401188f	32	48	48	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89918	10.1371/journal.pone.0089918	http://dx.doi.org/10.1371/journal.pone.0089918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587123	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900096
J	Werner, HMJ; Trovik, J; Halle, MK; Wik, E; Akslen, LA; Birkeland, E; Bredholt, T; Tangen, IL; Krakstad, C; Salvesen, HB				Werner, Henrica M. J.; Trovik, Jone; Halle, Mari K.; Wik, Elisabeth; Akslen, Lars A.; Birkeland, Even; Bredholt, Therese; Tangen, Ingvild L.; Krakstad, Camilla; Salvesen, Helga B.			Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer	PLOS ONE			English	Article							TISSUE CONFIRMATION; CELL-DEATH; EXPRESSION; CARCINOMA; OVEREXPRESSION; SENSITIVITY; PACLITAXEL; THERAPY; GENE; PHOSPHORYLATION	Stathmin is a prognostic marker in many cancers, including endometrial cancer. Preclinical studies, predominantly in breast cancer, have suggested that stathmin may additionally be a predictive marker for response to paclitaxel. We first evaluated the response to paclitaxel in endometrial cancer cell lines before and after stathmin knock-down. Subsequently we investigated the clinical response to paclitaxel containing chemotherapy in metastatic endometrial cancer in relation to stathmin protein level in tumors. Stathmin level was also determined in metastatic lesions, analyzing changes in biomarker status on disease progression. Knock-down of stathmin improved sensitivity to paclitaxel in endometrial carcinoma cell lines with both naturally higher and lower sensitivity to paclitaxel. In clinical samples, high stathmin level was demonstrated to be associated with poor response to paclitaxel containing chemotherapy and to reduced disease specific survival only in patients treated with such combination. Stathmin level increased significantly from primary to metastatic lesions. This study suggests, supported by both preclinical and clinical data, that stathmin could be a predictive biomarker for response to paclitaxel treatment in endometrial cancer. Re-assessment of stathmin level in metastatic lesions prior to treatment start may be relevant. Also, validation in a randomized clinical trial will be important.	[Werner, Henrica M. J.; Trovik, Jone; Halle, Mari K.; Wik, Elisabeth; Birkeland, Even; Bredholt, Therese; Tangen, Ingvild L.; Krakstad, Camilla; Salvesen, Helga B.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway; [Werner, Henrica M. J.; Trovik, Jone; Tangen, Ingvild L.; Salvesen, Helga B.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Akslen, Lars A.] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers, Bergen, Norway; [Wik, Elisabeth; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Werner, HMJ (corresponding author), Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway.	Henrica.Werner@k2.uib.no	Wik, E./AAA-9105-2020; Krakstad, Camilla/AAB-5138-2020; Werner, henrica/ABG-1235-2021; Akslen, Lars A./AAG-6097-2021; Akslen, Lars A/C-1202-2017; Halle, Mari K/AAT-4856-2020; salvesen, Helga B/C-1187-2017; Bredholt, Therese/AAA-1456-2020	Krakstad, Camilla/0000-0002-0174-8139; Werner, henrica/0000-0001-5186-8369; Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543; salvesen, Helga B/0000-0002-4438-8831; Halle, Mari K/0000-0002-2660-8271	Helse Vest, Research Council of Norway [803100, 805797]; Norwegian Cancer Society	Helse Vest, Research Council of Norway; Norwegian Cancer Society(Norwegian Cancer Society)	Helse Vest, Research Council of Norway (803100, 805797) and The Norwegian Cancer Society (Harald Andersens legat) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli E, 2002, CANCER RES, V62, P6864; Alli E, 2007, MOL PHARMACOL, V71, P1233, DOI 10.1124/mol.106.029702; Amant F, 2012, INT J GYNECOL OBSTET, V119, pS110, DOI 10.1016/S0020-7292(12)60024-1; Amir E, 2012, CANCER TREAT REV, V38, P708, DOI 10.1016/j.ctrv.2011.11.006; Amir E, 2012, J CLIN ONCOL, V30, P587, DOI 10.1200/JCO.2010.33.5232; Arslan C, 2011, EXPERT OPIN THER TAR, V15, P21, DOI 10.1517/14656566.2011.537260; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baquero MT, 2012, CANCER-AM CANCER SOC, V118, P4660, DOI 10.1002/cncr.27453; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Bieche I, 1998, BRIT J CANCER, V78, P701, DOI 10.1038/bjc.1998.565; Birkeland E, 2012, BRIT J CANCER, V107, P1997, DOI 10.1038/bjc.2012.477; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Engelsen IB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.043; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Halle MK, 2012, HISTOPATHOLOGY, V60, P516, DOI 10.1111/j.1365-2559.2011.04057.x; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hiramatsu HP, 2000, ANTI-CANCER DRUG, V11, P573, DOI 10.1097/00001813-200008000-00009; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Khasraw M, 2011, CURR ONCOL REP, V13, P17, DOI 10.1007/s11912-010-0137-9; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; Krakstad C, 2012, BRIT J CANCER, V106, P1682, DOI 10.1038/bjc.2012.91; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Liu P, 2013, ONCOL REP, V29, P419, DOI 10.3892/or.2012.2157; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Mistry SJ, 1998, BIOCHEM J, V334, P23, DOI 10.1042/bj3340023; Mistry SJ, 2006, MOL CANCER THER, V5, P3248, DOI 10.1158/1535-7163.MCT-06-0227; Mitra M, 2011, INVEST OPHTH VIS SCI, V52, P5441, DOI 10.1167/iovs.10-6973; Ong FS, 2012, EXPERT REV MOL DIAGN, V12, P593, DOI [10.1586/ERM.12.59, 10.1586/erm.12.59]; Paik D, 2010, GYNECOL ONCOL, V119, P140, DOI 10.1016/j.ygyno.2010.06.024; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Salvesen HB, 2000, CLIN CANCER RES, V6, P153; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Shankaran V, 2010, ONCOLOGIST, V15, P157, DOI 10.1634/theoncologist.2009-0221; Simmons C, 2009, ANN ONCOL, V20, P1499, DOI 10.1093/annonc/mdp028; Su D, 2009, CANCER-AM CANCER SOC, V115, P2453, DOI 10.1002/cncr.24282; Taatjes DJ, 2008, HISTOCHEM CELL BIOL, V129, P33, DOI 10.1007/s00418-007-0356-9; Trovik J, 2012, GYNECOL ONCOL, V125, P381, DOI 10.1016/j.ygyno.2012.01.050; Trovik J, 2011, CLIN CANCER RES, V17, P3368, DOI 10.1158/1078-0432.CCR-10-2412; Vandenput I, 2011, INT J GYNECOL CANCER, V21, P316, DOI 10.1097/IGC.0b013e31820575f5; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103	52	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90141	10.1371/journal.pone.0090141	http://dx.doi.org/10.1371/journal.pone.0090141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587245	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900119
J	Chow, EPF; Tucker, JD; Wong, FY; Nehl, EJ; Wang, YJ; Zhuang, X; Zhang, L				Chow, Eric P. F.; Tucker, Joseph D.; Wong, Frank Y.; Nehl, Eric J.; Wang, Yanjie; Zhuang, Xun; Zhang, Lei			Disparities and Risks of Sexually Transmissible Infections among Men Who Have Sex with Men in China: A Meta-Analysis and Data Synthesis	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; HEPATITIS-C VIRUS; ANAL HUMAN-PAPILLOMAVIRUS; MAINTENANCE TREATMENT CLINICS; TRANSMITTED-DISEASES; PUBLIC-HEALTH; B-VIRUS; VIRAL-HEPATITIS; HIV PREVALENCE; HPV INFECTION	Background: Sexually transmitted infections (STIs), including Hepatitis B and C virus, are emerging public health risks in China, especially among men who have sex with men (MSM). This study aims to assess the magnitude and risks of STIs among Chinese MSM. Methods: Chinese and English peer-reviewed articles were searched in five electronic databases from January 2000 to February 2013. Pooled prevalence estimates for each STI infection were calculated using meta-analysis. Infection risks of STIs in MSM, HIV-positive MSM and male sex workers (MSW) were obtained. This review followed the PRISMA guidelines and was registered in PROSPERO. Results: Eighty-eight articles (11 in English and 77 in Chinese) investigating 35,203 MSM in 28 provinces were included in this review. The prevalence levels of STIs among MSM were 6.3% (95% CI: 3.5-11.0%) for chlamydia, 1.5% (0.7-2.9%) for genital wart, 1.9% (1.3-2.7%) for gonorrhoea, 8.9% (7.8-10.2%) for hepatitis B (HBV), 1.2% (1.0-1.6%) for hepatitis C (HCV), 66.3% (57.4-74.1%) for human papillomavirus (HPV), 10.6% (6.2-17.6%) for herpes simplex virus (HSV-2) and 4.3% (3.2-5.8%) for Ureaplasma urealyticum. HIV-positive MSM have consistently higher odds of all these infections than the broader MSM population. As a subgroup of MSM, MSW were 2.5 (1.4-4.7), 5.7 (2.7-12.3), and 2.2 (1.4-3.7) times more likely to be infected with chlamydia, gonorrhoea and HCV than the broader MSM population, respectively. Conclusion: Prevalence levels of STIs among MSW were significantly higher than the broader MSM population. Co-infection of HIV and STIs were prevalent among Chinese MSM. Integration of HIV and STIs healthcare and surveillance systems is essential in providing effective HIV/STIs preventive measures and treatments.	[Chow, Eric P. F.; Wang, Yanjie; Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Chow, Eric P. F.] Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Chow, Eric P. F.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Chow, Eric P. F.; Zhang, Lei] Tsinghua Univ, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China; [Tucker, Joseph D.] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Tucker, Joseph D.] London Sch Hyg & Trop Med, London WC1, England; [Wong, Frank Y.; Nehl, Eric J.] Emory Univ, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Zhuang, Xun] Nantong Univ, Sch Publ Hlth, Nantong, Jiangsu, Peoples R China	University of New South Wales Sydney; Kirby Institute; Monash University; Florey Institute of Neuroscience & Mental Health; Tsinghua University; University of London; London School of Hygiene & Tropical Medicine; Emory University; Nantong University	Chow, EPF (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	echow@mshc.org.au; lzhang@kirby.unsw.edu.au	Zhang, Lei/D-4039-2011; Chow, Eric Pui Fung/H-3196-2013; Chow, Eric P.F./W-6684-2019	Zhang, Lei/0000-0003-2343-084X; Chow, Eric Pui Fung/0000-0003-1766-0657; Chow, Eric P.F./0000-0003-1766-0657; Tucker, Joseph/0000-0003-2804-1181; Wong, Frank Y./0000-0001-5835-9938	Australian Government Department of Health and Ageing; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was funded by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; Bai Yu, 2009, China Tropical Medicine, V9, P2275; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Borenstein M., 2009, INTRO METAANALYSIS; Boukli Nawal M, 2012, Clin Proteomics, V9, P11, DOI 10.1186/1559-0275-9-11; Bradshaw D, 2013, CURR OPIN INFECT DIS, V26, P66, DOI 10.1097/QCO.0b013e32835c2120; Buffington J, 2007, PUBLIC HEALTH REP, V122, P1; CAI GF, 2008, CHINA PREVENTIVE MED, V9, P482; CAI WD, 2005, MOD PREV MED, V32, P328; CAI X, 2007, PREV MED TRIB, V13, P888; Chen G, 2010, STRAIT J PREV MED, V16, P13; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056444; CHEN S, 2007, PREV MED TRIB, V13, P772; Chen SH, 2010, OCCUPATION HLTH, V26, P56; Chen SH, 2010, CHIN J DIS CONTROL P, V14, P130; Chen XS, 2012, SEX TRANSM DIS, V39, P226, DOI 10.1097/OLQ.0b013e31823d2cd3; Chen XM, 2011, ACTA U MED ANHUI, V46, P569; Chen XS, 2005, AIDS PATIENT CARE ST, V19, P853, DOI 10.1089/apc.2005.19.853; Chen XX, 2011, INT J VIROLOGY, V18, P101; Chen Z, 2011, SOFT SCI HLTH, V25, P719; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Choi KH, 2005, SEX TRANSM DIS, V32, P44, DOI 10.1097/01.olq.0000148296.93945.53; Chow EPF, 2013, BURDEN SEXUALLY TRAN; Chow EPF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048025; Chow EPF, 2012, AIDS BEHAV, V16, P653, DOI 10.1007/s10461-011-9935-9; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Cohen Myron S, 2004, Top HIV Med, V12, P104; COX DR, 1970, BIOMETRIKA, V57, P217, DOI 10.1093/biomet/57.1.217; Cunningham Anthony L, 2004, J HIV Ther, V9, P9; Dai SY, 2012, J MED VIROL, V84, P1, DOI 10.1002/jmv.22214; Danta M., 2008, HIV VIRAL HEPATITIS, P9; Deng LP, 2009, WORLD J GASTROENTERO, V15, P996, DOI 10.3748/wjg.15.996; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diamond C, 2003, SEX TRANSM DIS, V30, P425, DOI 10.1097/00007435-200305000-00009; Ding Xianbin F., 2010, CHIN J DIS CONTROL P, V14, P227; Donlin MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009032; Feng F, 2009, MODERN PREVENTIVE ME, V36, P2902; FENG JF, 2008, SHANGHAI J PREVENTIV, V20, P531; Feng JF, 2008, CHINESE J HLTH LAB T, V18, P1885; FENG JF, 2008, SHANGHAI J PREVENTIV, V20, P541; Feng LG, 2010, J TROPICAL MED, V10, P78; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Gao LM, 2010, SOFT SCI HLTH, V24, P553; Gao LM, 2010, SOFT SCI HLTH, V24, P547; Gong CangTao, 2010, China Tropical Medicine, V10, P1496; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; GU Y, 2004, CHINESE J PUBLIC HLT, V20, P573; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Han X, 2012, NINGXIA MED J, V34, P69; Harris JL, 2007, PUBLIC HEALTH REP, V122, P42, DOI 10.1177/00333549071220S208; He H, 2011, PRACTICAL PREVENTIVE, V18, P1151; He N, 2005, SEX TRANSM DIS, V32, P286, DOI 10.1097/01.olq.0000152219.58592.9b; He Q, 2009, SEX TRANSM INFECT, V85, P383, DOI 10.1136/sti.2009.035808; HE Q, 2005, CHINESE J DIS CONTRO, V9, P106; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; Hesketh T, 2005, INT J STD AIDS, V16, P262, DOI 10.1258/0956462053420257; Hesketh T, 2008, EMERG HLTH THREATS J, V1, P1, DOI DOI 10.3134/EHTJ.08.006; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Hong Y, 2011, J WOMENS HEALTH, V20, P129, DOI 10.1089/jwh.2010.2139; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Hu JF, 2011, WORLD HLTH DIGEST, V8, P68; Hu Q, 2006, CHINESE J HLTH ED, V22, P647; Hu YL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-221; Huan Xi-ping, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P975; Huang HongYan, 2011, Modern Preventive Medicine, V38, P1933; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Jin F, 2007, SEX TRANSM INFECT, V83, P113, DOI 10.1136/sti.2006.021915; Jin Fengyi, 2004, Sex Health, V1, P227, DOI 10.1071/SH04022; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kippax S, 1997, AIDS, V11, P191, DOI 10.1097/00002030-199702000-00009; Klein H, 2011, AM J MENS HEALTH, V5, P466, DOI 10.1177/1557988311398472; Lama JR, 2010, AM J TROP MED HYG, V83, P194, DOI 10.4269/ajtmh.2010.10-0003; LAN GH, 2009, APPL PREV MED, V15, P168; Lan Ya-jia, 2004, Sichuan Da Xue Xue Bao Yi Xue Ban, V35, P372; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2013, J SEX MED, V10, P642, DOI 10.1111/j.1743-6109.2012.02956.x; Li Yang, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P142; LIANG L, 2009, HEBEI MED J, V31, P1991; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; LIAO MZ, 2006, CHIN J AIDS STD, V12, P530; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin HJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-69; Liu PL, 2010, CHINESE J DIS CONTRO, V14, P917; Liu SS, 2012, AIDS BEHAV, V16, P835, DOI 10.1007/s10461-011-9978-y; Liu Ying-jie, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P971; Liu YY, 2010, PRACTICAL PREVENTIVE, V17, P788; LU CG, 2006, GUIZHOU MED J, V30, P202; LU CG, 2006, CHIN J PUBLIC HLTH, V2, P1320; LU HY, 2008, CHINESE J AIDS STD, V14, P467; Lu L, 2011, J PUBLIC HLTH PREVEN, V22, P45; Luo ZB, 2011, EUR J GASTROEN HEPAT, V23, P695, DOI 10.1097/MEG.0b013e328347322b; Ma GL, 2010, CHIN J DIS CONTROL P, V14, P726; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; MacLachlan JH, 2013, AUST NZ J PUBL HEAL, V37, P416, DOI 10.1111/1753-6405.12049; Mao FY, 2010, WORLD HLTH DIGEST, V7, P246; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; Mei Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P649; Meng Xia, 2010, Journal of Tropical Medicine (Guangzhou), V10, P884; Miao XiaoLan, 2011, Occupation and Health, V27, P2599; MIAO ZF, 2009, J NINGXIA MED U, V31, P761; Milosevic M, 2010, CENT EUR J MED, V5, P698, DOI 10.2478/s11536-010-0019-4; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Nie ZQ, 2011, J TROP MED, V11, P29; Nie ZQ, 2011, J TROP MED, V11, P45; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Peters Marion G, 2007, Top HIV Med, V15, P163; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Qi SZ, 2006, 3 NAT PREV CONTR SEX, P176; Qi SZ, 2006, CHINA J LEPROSY SKIN, V22, P819; Quinn R, 2012, AIDS RES HUM RETROV, V28, P1734, DOI [10.1089/aid.2011.0307, 10.1089/AID.2011.0307]; Reiter PL, 2011, SEX TRANSM DIS, V38, P235, DOI 10.1097/OLQ.0b013e3181f422bb; Remis RS, 2000, AM J PUBLIC HEALTH, V90, P1570, DOI 10.2105/AJPH.90.10.1570; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Saxton Peter J W, 2002, N Z Med J, V115, pU106; Seage GR, 1997, PUBLIC HEALTH REP, V112, P158; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; Shi JC, 2010, HENAN J PREV MED, V21, P405; SHI WD, 2009, MED SOC, V22, P42; Shi XD, 2010, S CHINA J PREVENTIVE, V36, P22; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; Singer MC, 2006, SOC SCI MED, V63, P2010, DOI 10.1016/j.socscimed.2006.05.012; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Soriano V, 2002, AIDS, V16, P813, DOI 10.1097/00002030-200204120-00001; Standing Committee of the National People's Congress, 2004, LAW PEOPL REP CHIN P; Stanley MA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-398; State Council AIDS Working Committee Office (SCAWCO), 2012, 2012 CHIN AIDS RESP; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Sun DY, 2010, CHINESE J PRACTICAL, V37, P10; SUN ML, 2009, PREVENTIVE MED TRIBU, V15, P1074; Sun ZX, 2007, MODERN PREVENTIVE ME, V34, P4130; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Tucker JD, 2012, SEX TRANSM INFECT, V88, P116, DOI 10.1136/sextrans-2011-050135; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; van de Laar TJW, 2011, SEX TRANSM DIS, V38, P102, DOI 10.1097/OLQ.0b013e3181ec9de5; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Wang C, 2007, CHINESE J HLTH LAB T, V17, P2291; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048219; Wang HL, 2008, CHIN J PUBL HLTH, V24, P995; WANG J, 2004, CHIN J PUBLIC HLTH, V20, P1377; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; [王鸣 WANG Ming], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P1317; Wang T, 2010, PRACT PREV MED, V17, P1261; Wang W, 2010, INT J STD AIDS, V21, P410, DOI 10.1258/ijsa.2009.008518; Wang X, 2011, J DERMATOLOGY VENERE, V33, P104; Wang Y, 2011, PRACTICAL PREVENTIVE, V18, P2072; WANG Y, 2009, PRACTICAL PREVENTIVE, V16, P375; Wang ZJ, 2010, JIANGSU J PREVENTIVE, V21, P4; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; WENG YQ, 2009, J APPL PREV MED, V15, P152; Wu J, 2011, SHANGHAI J PREVENTIV, V23, P373; Wu Jiang, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P555; Wu S, 2004, CHINESE J AIDS STD, V10, P328; Wu S, 2004, CHIN J STD AIDS, V10, P332; Xi LF, 1991, CHIN J VIROL S, V7, P21; Xiao HW, 2007, CHINESE MED SCI HLTH, V6, P7; XU H, 2009, CHIN J HLTH LAB TECH, V19, P658; XU H, 2009, CHINESE J HLTH LAB T, V19, P713; Xu X, 2011, J DIS MONITOR CONTRO, V5, P393; Xu XY, 2011, J DIS MONITOR CONTRO, V5, P390; Xue FangHui, 2010, Disease Surveillance, V25, P54; Yang C, 2010, SEX TRANSM INFECT, V86, P559, DOI 10.1136/sti.2009.041731; Yao JL, 1996, GUT, V38, pS37, DOI 10.1136/gut.38.Suppl_2.S37; Yin YP, 2012, SEX TRANSM DIS, V39, P354, DOI 10.1097/OLQ.0b013e318244aef0; Yu QL, 2007, STRAIT J PREVENTIVE, V13, P45; Yuan F, 2009, PREVENTIVE MED TRIBU, V15, P791; Zhang B, 2008, CHINJ HUM SEX, V17, P6; ZHANG B, 2008, CHINESE J AIDS STD, V14, P541; Zhang BC, 2004, CHINESE J AIDS STD, V10, P329; Zhang BC, 2001, J CHINA AIDS STD PRE, V7, P102; [张北川 Zhang Beichuan], 2002, [中华皮肤科杂志, Chinese Journa of Dermatology], V35, P214; Zhang BY, 2001, J MATER SCI TECHNOL, V17, P17; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang DD, 2010, ZHEJIANG PREVENTIVE, V22, P1; Zhang GF, 2004, CHINESE J DIS CONTRO, V8, P433; Zhang Hong, 2011, Occupation and Health, V27, P2406; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-546; Zhang Lei, 2012, Open AIDS J, V6, P163, DOI 10.2174/1874613601206010163; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076; ZHANG M, 2009, CHIN J PUBLIC HLTH, V25, P1075; Zhang R, 2011, CHINESE J HLTH LAB T, V21, P732; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c; Zhang XY, 2006, CHIN J AIDS STD, V12, P294; Zhang XY, 2006, CHINESE J AIDS STD, V12, P320; Zhang Yi, 2008, Endemic Diseases Bulletin / Di Fang Bing Tong Bao, V23, P26; Zhang ZhenKai, 2010, Disease Surveillance, V25, P213; Zhao XH, 2010, J PREV MED INF, V26, P876; Zheng M, 2011, GUIZHOU MED J, V35, P830; Zhou Chao, 2011, Modern Preventive Medicine, V38, P815; Zhou CX, 2011, JIANGSU J PREVENTIVE, V22, P11; Zhou CX, 2010, ANHUI J PREVENTATIVE, V16, P211; Zhou J, 2008, CHINESE J AIDS STD, V14, P51; ZHOU J, 2008, CHINESE J AIDS STD, V14, P47; Zhou ZhenHai, 2010, China Tropical Medicine, V10, P10; Zhu X, 2000, CHIN J VAC IMMUN CHI, V6, P193; Zhuang X, 2012, DRUG ALCOHOL DEPEN, V126, P286, DOI 10.1016/j.drugalcdep.2012.05.028; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130; Zou HC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-341; 王万海, 2011, [中国公共卫生, China Public Health], V27, P624; 王存明, 2008, [中国中医基础医学杂志, Chinese Journal of Basic Medicine in Traditional Chinese Medicine], V14, P552	222	44	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89959	10.1371/journal.pone.0089959	http://dx.doi.org/10.1371/journal.pone.0089959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587152	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700122
J	Jez, M; Ambady, S; Kashpur, O; Grella, A; Malcuit, C; Vilner, L; Rozman, P; Dominko, T				Jez, Mojca; Ambady, Sakthikumar; Kashpur, Olga; Grella, Alexandra; Malcuit, Christopher; Vilner, Lucy; Rozman, Primoz; Dominko, Tanja			Expression and Differentiation between OCT4A and Its Pseudogenes in Human ESCs and Differentiated Adult Somatic Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; OCT-4 EXPRESSION; SELF-RENEWAL; MESSENGER-RNA; BONE-MARROW; PROTEIN; POU5F1; GENES; ISOFORMS; MARKER	The POU5F1 gene codes for the OCT4 transcription factor, which is one of the key regulators of pluripotency. Its transcription, alternative splicing, and alternative translation leading to the synthesis of the active, nuclear localized OCT4A has been described in detail. Much less, however, is known about actively transcribed OCT4 pseudogenes, several of which display high homology to OCT4A and can be expressed and translated into proteins. Using RT-PCR followed by pseudogene-specific restriction digestion, cloning, and sequencing we discriminate between OCT4A and transcripts for pseudogenes 1, 3 and 4. We show that expression of OCT4 and its pseudogenes follows a developmentally-regulated pattern in differentiating hESCs, indicating a tight regulatory relationship between them. We further demonstrate that differentiated human cells from a variety of tissues express exclusively pseudogenes. Expression of OCT4A can, however be triggered in adult differentiated cells by oxygen and FGF2-dependent mechanisms.	[Jez, Mojca; Rozman, Primoz] Blood Transfus Ctr Slovenia, Ljubljana, Slovenia; [Ambady, Sakthikumar] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Kashpur, Olga; Grella, Alexandra; Dominko, Tanja] Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA; [Malcuit, Christopher; Dominko, Tanja] Worcester Polytech Inst, Bioengn Inst, Worcester, MA 01609 USA; [Malcuit, Christopher; Vilner, Lucy; Dominko, Tanja] CellThera Inc, Worcester, MA USA	Worcester Polytechnic Institute; Worcester Polytechnic Institute; Worcester Polytechnic Institute	Dominko, T (corresponding author), Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA.	tdominko@wpi.edu	Rozman, Primoz/ABD-4051-2020		National Institutes of Health (NIH) [R01GM085456]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085456] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by the National Institutes of Health (NIH) R01GM085456 to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlasi Y, 2007, INT J CANCER, V120, P1598, DOI 10.1002/ijc.22508; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Berg JS, 2007, CELL STEM CELL, V1, P359, DOI 10.1016/j.stem.2007.09.007; Bhartiya D, 2011, STEM CELLS DEV; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Cauffman G, 2005, MOL HUM REPROD, V11, P173, DOI 10.1093/molehr/gah155; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; Cheng L, 2007, J PATHOL, V211, P1, DOI 10.1002/path.2105; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; de Jong Jeroen, 2006, Critical Reviews in Oncogenesis, V12, P171; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Hansis C, 2000, MOL HUM REPROD, V6, P999, DOI 10.1093/molehr/6.11.999; Hansis C, 2001, MOL HUM REPROD, V7, P155, DOI 10.1093/molehr/7.2.155; Kaltz N, 2008, STEM CELLS, V26, P2419, DOI 10.1634/stemcells.2008-0304; Kashpur O, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-656; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Korneev SA, 1999, J NEUROSCI, V19, P7711; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kucia MJ, 2008, STEM CELLS, V26, P2083, DOI 10.1634/stemcells.2007-0922; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Mitalipov SM, 2003, BIOL REPROD, V69, P1785, DOI 10.1095/biolreprod.103.019455; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pacini S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009861; Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]; Page RL, 2009, CLONING STEM CELLS, V11, P417, DOI 10.1089/clo.2009.0015; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Palumbo C, 2002, J PATHOL, V196, P467, DOI 10.1002/path.1064; Panagopoulos I, 2008, ONCOL REP, V20, P1029, DOI 10.3892/or_00000105; Panagopoulos I, 2008, GENE CHROMOSOME CANC, V47, P521, DOI 10.1002/gcc.20555; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Ratajczak MZ, 2007, LEUKEMIA, V21, P860, DOI 10.1038/sj.leu.2404630; Redshaw Z, 2010, J NEGAT RESULTS BIOM, V9, DOI 10.1186/1477-5751-9-2; Roche S, 2007, J CELL BIOCHEM, V101, P271, DOI 10.1002/jcb.21185; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Sovalat H, 2011, EXP HEMATOL, V39, P495, DOI 10.1016/j.exphem.2011.01.003; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; Wang X, 2009, STEM CELLS, V27, P1265, DOI 10.1002/stem.58; Yano Y, 2004, J MOL MED, V82, P414, DOI 10.1007/s00109-004-0550-3; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zangrossi S, 2007, STEM CELLS, V25, P1675, DOI 10.1634/stemcells.2006-0611; Zhao SD, 2011, J PATHOL, V223, P672, DOI 10.1002/path.2827	60	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89546	10.1371/journal.pone.0089546	http://dx.doi.org/10.1371/journal.pone.0089546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586860	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700060
J	N'Diaye, DS; Yazdanpanah, Y; Krivine, A; Andrieu, T; Rozenberg, F; Picone, O; Tsatsaris, V; Goffinet, F; Launay, O				N'Diaye, Dieynaba S.; Yazdanpanah, Yazdan; Krivine, Anne; Andrieu, Thibaut; Rozenberg, Flore; Picone, Olivier; Tsatsaris, Vassilis; Goffinet, Francois; Launay, Odile			Predictive Factors of Cytomegalovirus Seropositivity among Pregnant Women in Paris, France	PLOS ONE			English	Article							CMV INFECTION; RISK-FACTORS; HEARING-LOSS; SEROPREVALENCE; EPIDEMIOLOGY; DIAGNOSIS; AWARENESS; CHILDREN; VIRUS; FETUS	Background: Cytomegalovirus (CMV) is the most frequent cause of congenital infection. The objective of this study was to evaluate predictive factors for CMV seronegativity in a cohort of pregnant women in Paris, France. Methods: Pregnant women enrolled in a prospective cohort during the 2009 A/H1N1 pandemic were tested for CMV IgG antibodies. Variables collected were age, geographic origin, lifestyle, work characteristics, socioeconomic status, gravidity, parity and number of children at home. A multivariate logistic regression model was used to identify independent predictive factors for CMV seropositivity. Results: Among the 826 women enrolled, 389 (47.1%) were primiparous, and 552 (67.1%) had Metropolitan France as a geographic origin. Out of these, 355 (i.e. 57.0%, 95% confidence interval (CI): [53.6%-60.4%]) were CMV seropositive: 43.7% (95% CI:[39.5%-47.9%]) in those whose geographic origin was Metropolitan France and 84.1% in those with other origins (95% CI:[79.2%-88.3%]). Determinants associated with CMV seropositivity in a multivariate logistic regression model were: (i) geographic origin (p = 0.001(compared with Metropolitan France, geographic origins of Africa adjusted odds ratio (aOR) 21.2, 95% CI:[9.7-46.5], French overseas departments and territories and other origin, aOR 7.5, 95% CI:[3.9-14.6], and Europe or Asia, aOR 2.2, 95% CI: [1.3-3.7]); and (ii) gravidity (p = 0.019), (compared with gravidity = 1, if gravidity >= 3, aOR = 1.5, 95% CI: [1.1-2.2]; if gravidity = 2, aOR = 1.0, 95% CI: [0.7-1.4]). Work characteristics and socioeconomic status were not independently associated with CMV seropositivity. Conclusions: In this cohort of pregnant women, a geographic origin of Metropolitan France and a low gravidity were predictive factors for CMV low seropositivity. Such women are therefore the likely target population for prevention of CMV infection during pregnancy in France.	[N'Diaye, Dieynaba S.; Yazdanpanah, Yazdan] Univ Univ Paris Diderot, UMR 1137, INSERM, Sorbonne Paris Cite, Paris, France; [N'Diaye, Dieynaba S.] Univ Paris 06, ED 393, Paris, France; [Yazdanpanah, Yazdan] Univ Paris Diderot, Grp Hosp Bichat Claude Bernard, AP HP, HUPNVS,Serv Malad Infect, Paris, France; [Krivine, Anne; Rozenberg, Flore] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Dept Virol, Paris, France; [Andrieu, Thibaut; Goffinet, Francois] Univ Paris 06, INSERM, U953, Paris, France; [Rozenberg, Flore; Tsatsaris, Vassilis; Goffinet, Francois; Launay, Odile] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Picone, Olivier] Hop Foch, Suresnes, France; [Tsatsaris, Vassilis; Goffinet, Francois] Hop Cochin, AP HP, F-75674 Paris, France; [Goffinet, Francois] CIC P0901, INSERM, Paris, France; [Launay, Odile] CIC BT505, INSERM, Paris, France; [Launay, Odile] Hop Cochin, AP HP, CIC Vaccinol Cochin Pasteur, F-75674 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	N'Diaye, DS (corresponding author), Univ Univ Paris Diderot, UMR 1137, INSERM, Sorbonne Paris Cite, Paris, France.	dieynaba.ndiaye@inserm.fr	Rozenberg, Flore/O-8854-2017; PICONE, Olivier/ABF-7916-2020	PICONE, Olivier/0000-0001-8421-9971; N'Diaye, Dieynaba/0000-0002-7801-0458; GOFFINET, Francois/0000-0001-9643-0299	graduate school: ED 393 "Public health: epidemiology and biomedical information science''	graduate school: ED 393 "Public health: epidemiology and biomedical information science''	The study was founded by a three-years doctoral contract funded by the graduate school: ED 393 "Public health: epidemiology and biomedical information science''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanen A, 2005, BJOG-INT J OBSTET GY, V112, P50, DOI 10.1111/j.1471-0528.2004.00320.x; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cordier AG, 2012, J CLIN VIROL, V55, P158, DOI 10.1016/j.jcv.2012.06.022; Cordier AG, 2012, J CLIN VIROL, V53, P332, DOI 10.1016/j.jcv.2011.12.031; de Ory F, 2004, EUR J EPIDEMIOL, V19, P85, DOI 10.1023/B:EJEP.0000013253.56343.6f; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Fowler KB, 2006, PEDIATRICS, V118, pE286, DOI 10.1542/peds.2005-1142; Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016; Fowler KB, 1999, J PEDIATR-US, V135, P60, DOI 10.1016/S0022-3476(99)70328-8; Freund R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020900; Gaytant MA, 2005, J MED VIROL, V76, P71, DOI 10.1002/jmv.20325; Gouarin S, 2001, J CLIN VIROL, V21, P47, DOI 10.1016/S1386-6532(00)00184-0; Gratacap-Cavallier B, 1998, EUR J EPIDEMIOL, V14, P147, DOI 10.1023/A:1007450729633; Grosse SD, 2008, J CLIN VIROL, V41, P57, DOI 10.1016/j.jcv.2007.09.004; Hyde TB, 2010, REV MED VIROL, V20, P311, DOI 10.1002/rmv.659; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Khare M, 2004, J VIROL METHODS, V119, P31, DOI 10.1016/j.jviromet.2004.02.013; Launay O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052303; Lubeck PR, 2010, MED MICROBIOL IMMUN, V199, P53, DOI 10.1007/s00430-009-0136-3; Munro SC, 2005, J CLIN MICROBIOL, V43, P4713, DOI 10.1128/JCM.43.9.4713-4718.2005; Naessens A, 2005, J PEDIATR-US, V146, P194, DOI 10.1016/j.jpeds.2004.09.025; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Picone O, 2009, BJOG-INT J OBSTET GY, V116, P818, DOI 10.1111/j.1471-0528.2009.02139.x; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Schleiss MR, 2006, CURR OPIN PEDIATR, V18, P48; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; The French High Autority for Health (HAS) official website, 2004, EV INT DEP INF CYT C; Vauloup-Fellous C, 2009, J CLIN VIROL, V46, pS49, DOI 10.1016/j.jcv.2009.09.003	30	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89857	10.1371/journal.pone.0089857	http://dx.doi.org/10.1371/journal.pone.0089857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587077	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700103
J	Yang, Y; Zhang, YG; Lin, GA; Xie, HQ; Pan, HT; Huang, BQ; Liu, JD; Liu, H; Zhang, N; Li, L; Chen, JH				Yang, Yang; Zhang, Yong-Gang; Lin, Guo-An; Xie, He-Qiu; Pan, Hai-Tao; Huang, Ben-Qing; Liu, Ji-Dong; Liu, Hui; Zhang, Nan; Li, Li; Chen, Jian-Hua			Spinal Changes of a Newly Isolated Neuropeptide Endomorphin-2 Concomitant with Vincristine-Induced Allodynia	PLOS ONE			English	Article							PAINFUL PERIPHERAL NEUROPATHY; DORSAL-HORN; NEURONAL RESPONSES; OPIOID RECEPTORS; SUBSTANCE-P; MU; CORD; EXPRESSION; RATS; INHIBITION	Chemotherapy-induced neuropathic pain (CNP) is the major dose-limiting factor in cancer chemotherapy. However, the neural mechanisms underlying CNP remain unclear. There is increasing evidence implicating the involvement of spinal endomorphin-2 (EM2) in neuropathic pain. In this study, we used a vincristine-evoked rat CNP model displaying mechanical allodynia and central sensitization, and observed a significant decrease in the expression of spinal EM2 in CNP. Also, while intrathecal administration of exogenous EM2 attenuated allodynia and central sensitization, the mu-opioid receptor antagonist beta-funaltrexamine facilitated these events. We found that the reduction in spinal EM2 was mediated by increased activity of dipeptidylpeptidase IV, possibly as a consequence of chemotherapy-induced oxidative stress. Taken together, our findings suggest that a decrease in spinal EM2 expression causes the loss of endogenous analgesia and leads to enhanced pain sensation in CNP.	[Yang, Yang; Liu, Ji-Dong; Liu, Hui; Li, Li; Chen, Jian-Hua] Zhumadian City Ctr Hosp, Dept Neurosurg, Zhumadian, Peoples R China; [Zhang, Yong-Gang] Zhumadian City Ctr Hosp, Dept ICU, Zhumadian, Peoples R China; [Lin, Guo-An] PLA, Hosp 159, Dept Burn, Zhumadian, Peoples R China; [Xie, He-Qiu] Zhumadian City Ctr Hosp, Dept Pain, Zhumadian, Peoples R China; [Pan, Hai-Tao] Xian Univ Finance & Econ, Sch Stat, Xian, Peoples R China; [Huang, Ben-Qing] PLA, Hosp 159, Dept Oncol, Zhumadian, Peoples R China; [Zhang, Nan] Xinxiang Med Univ, Dept Student Affairs, Xinxiang, Peoples R China	Xi'an University of Finance & Economics; Xinxiang Medical University	Li, L (corresponding author), Zhumadian City Ctr Hosp, Dept Neurosurg, Zhumadian, Peoples R China.	LLiZhumadian@163.com; JHChenZhumadian@163.com	Pan, Haitao/N-2529-2018	Pan, Haitao/0000-0003-4457-7349	Natural Science Foundation of Zhumadian City [2013m5218]; National Natural Science Foundation of China [81172095, 81171135, 81200324]	Natural Science Foundation of Zhumadian City; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of Zhumadian City (2013m5218) and the National Natural Science Foundation of China (Nos. 81172095, 81171135, 81200324). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher SA, 2003, BRAIN RES, V977, P190, DOI 10.1016/S0006-8993(03)02678-7; Ami N, 2012, BRAIN RES, V1461, P24, DOI 10.1016/j.brainres.2012.04.044; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BESSE D, 1990, PROG CLIN BIOL RES, V328, P183; Bosnjak S, 2002, J CHEMOTHERAPY, V14, P214, DOI 10.1179/joc.2002.14.2.214; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; Dahl JL, 2002, J PAIN SYMPTOM MANAG, V24, P136, DOI 10.1016/S0885-3924(02)00472-4; Delander GE, 1997, ACTA PHYSIOL SCAND, V161, P509, DOI 10.1046/j.1365-201X.1997.00259.x; DRAISCI G, 1991, BRAIN RES, V560, P186, DOI 10.1016/0006-8993(91)91231-O; Farquhar-Smith Paul, 2011, Curr Opin Support Palliat Care, V5, P1, DOI 10.1097/SPC.0b013e328342f9cc; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Fujita T, 2006, NEUROSCIENCE, V139, P1095, DOI 10.1016/j.neuroscience.2006.01.010; Grass S, 2002, NEUROSCI LETT, V324, P197, DOI 10.1016/S0304-3940(02)00201-X; Grass S, 2000, NEUROSCIENCE, V98, P339, DOI 10.1016/S0306-4522(00)00116-0; Hao JX, 1999, ACTA ANAESTH SCAND, V43, P1027, DOI 10.1034/j.1399-6576.1999.431010.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hempenstall Kathleen, 2002, Curr Opin Investig Drugs, V3, P441; HEPPELMANN B, 1994, CELL TISSUE RES, V275, P493, DOI 10.1007/BF00318818; Janecka A, 2008, PEPTIDES, V29, P2066, DOI 10.1016/j.peptides.2008.07.015; Ji RR, 1995, J NEUROSCI, V15, P8156; KAJANDER KC, 1990, PEPTIDES, V11, P719, DOI 10.1016/0196-9781(90)90187-A; Kautio AL, 2011, SUPPORT CARE CANCER, V19, P1991, DOI 10.1007/s00520-010-1043-2; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; Li KC, 2004, NEUROSCIENCE, V126, P753, DOI 10.1016/j.neuroscience.2004.03.050; Liao YH, 2011, BRAIN RES, V1368, P324, DOI 10.1016/j.brainres.2010.10.044; Lynch JJ, 2004, PAIN, V110, P56, DOI 10.1016/j.pain.2004.03.010; Maekawa K, 1996, PAIN, V64, P365, DOI 10.1016/0304-3959(95)00132-8; Malan TP, 2000, PAIN, V86, P185, DOI 10.1016/S0304-3959(00)00243-8; Martin-Schild S, 1999, J COMP NEUROL, V405, P450, DOI 10.1002/(SICI)1096-9861(19990322)405:4<450::AID-CNE2>3.0.CO;2-#; Meng XZ, 2011, BRAIN RES, V1414, P58, DOI 10.1016/j.brainres.2011.08.004; Meuser T, 2001, PAIN, V93, P247, DOI 10.1016/S0304-3959(01)00324-4; Nadeson R, 2002, BRIT J ANAESTH, V88, P685, DOI 10.1093/bja/88.5.685; Nozaki-Taguchi N, 2001, PAIN, V93, P69, DOI 10.1016/S0304-3959(01)00294-9; Nydahl KS, 2004, EUR J NEUROSCI, V19, P1789, DOI 10.1111/j.1460.9568.2004.03284.x; Pierce TL, 2000, J CHEM NEUROANAT, V18, P181, DOI 10.1016/S0891-0618(00)00042-9; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Przewlocka B, 1999, EUR J PHARMACOL, V367, P189, DOI 10.1016/S0014-2999(98)00956-X; Przewlocki R, 1999, ANN NY ACAD SCI, V897, P154, DOI 10.1111/j.1749-6632.1999.tb07887.x; Schwartz ES, 2008, PAIN, V138, P514, DOI 10.1016/j.pain.2008.01.029; Shane R, 1999, BRAIN RES, V815, P278, DOI 10.1016/S0006-8993(98)01121-4; Smith RR, 2001, NEUROSCIENCE, V105, P773, DOI 10.1016/S0306-4522(01)00228-7; STANFA LC, 1993, BRIT J PHARMACOL, V108, P967, DOI 10.1111/j.1476-5381.1993.tb13493.x; Stone LS, 1997, NEUROREPORT, V8, P3131, DOI 10.1097/00001756-199709290-00025; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Sun YY, 2005, BRAIN RES, V1043, P231, DOI 10.1016/j.brainres.2005.02.048; Tanner KD, 2003, NEUROSCIENCE, V118, P809, DOI 10.1016/S0306-4522(03)00023-X; Topp KS, 2000, J COMP NEUROL, V424, P563; Tseng LF, 2000, J PHARMACOL EXP THER, V292, P576; Uhm, 1999, Curr Treat Options Neurol, V1, P428, DOI 10.1007/s11940-996-0006-x; Virmani A, 2005, ANN NY ACAD SCI, V1053, P183, DOI 10.1196/annals.1344.016; Wang CH, 2008, AM J PHYSIOL-REG I, V294, pR811, DOI 10.1152/ajpregu.00543.2007; Weng HR, 2003, PAIN, V103, P131, DOI 10.1016/S0304-3959(02)00445-1; Wolfe D, 2007, PAIN, V133, P29, DOI 10.1016/j.pain.2007.02.003; Yamamoto J, 2008, NEUROSCIENCE, V151, P843, DOI 10.1016/j.neuroscience.2007.11.025; Yang SF, 2008, NEUROCHEM RES, V33, P2044, DOI 10.1007/s11064-008-9675-z; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0; Zadina JE, 1999, ANN NY ACAD SCI, V897, P136, DOI 10.1111/j.1749-6632.1999.tb07885.x; Zadina JE, 2002, JPN J PHARMACOL, V89, P203, DOI 10.1254/jjp.89.203; Zhao M, 2007, NEUROSCIENCE, V144, P1486, DOI 10.1016/j.neuroscience.2006.11.009; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	62	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89583	10.1371/journal.pone.0089583	http://dx.doi.org/10.1371/journal.pone.0089583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586889	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700062
J	Ye, J; Lou, LX; He, JJ; Xu, YF				Ye, Juan; Lou, Li-Xia; He, Jin-Jing; Xu, Yu-Feng			Body Mass Index and Risk of Age-Related Cataract: A Meta-Analysis of Prospective Cohort Studies	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; NUCLEAR CATARACT; FAT DISTRIBUTION; LENS OPACITIES; POPULATION; OBESITY; ASSOCIATION; EXTRACTION; SURGERY	Background: Age-related cataract (ARC) is the leading cause of blindness in the world. The relationship between body mass index (BMI) and risk of ARC is controversial across observational studies. We therefore performed this meta-analysis to evaluate the association between BMI and risk of ARC. Methods: Eligible studies were identified through an electronic search of PubMed, Embase and the Cochrane Library. We pooled study-specific relative risks (RRs) and 95% confidence intervals (CIs) to determine the risk of ARC associated with BMI categories and per 1 kg/m(2) increase in BMI. Results: A total of 17 prospective cohort studies were included in the meta-analysis. The pooled RRs of ARC were 1.08 (95% CI, 1.01-1.16) for overweight and 1.19 (95% CI, 1.10-1.28) for obesity compared with normal weight. These findings were robust when stratified by sex, sample source, outcome types and confounders, while significantly differed by assessment of BMI and ARC, and duration of follow-up. The summary RR suggested that per 1 kg/m(2) increase in BMI was associated with a 2% increased risk of ARC (RR 1.02, 95% CI 1.01-1.03). Pooled estimates of RRs consistently indicated a trend for subjects with a high BMI to develop posterior subcapsular cataracts (RR 1.19, 95% CI 1.06-1.35, for overweight; RR 1.50, 95% CI 1.24-1.81, for obesity; RR 1.04, 95% CI 1.01-1.06, per 1 kg/m(2) increase in BMI) other than nuclear or cortical cataracts. Conclusions: The overall findings suggest that elevated BMI may increase the risk of ARC, especially posterior subcapsular cataracts. Further trials are needed to investigate the effect of weight reduction in obese populations on the risk of ARC.	[Ye, Juan; Lou, Li-Xia; He, Jin-Jing; Xu, Yu-Feng] Zhejiang Univ, Dept Ophthalmol, Coll Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Ye, J (corresponding author), Zhejiang Univ, Dept Ophthalmol, Coll Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	yejuan@zju.edu.cn			Natural Science Foundation of China [81070756]; National "Twelfth Five-Year'' Plan for Science & Technology Support of China [2012BAI08B01]; Program for New Century Excellent Talents in University, China [NCET-11-0161]; Zhejiang Provincial Program for Cultivation of High-Level Innovative Health Talents; Specialized Key Science & Technology Foundation of Zhejiang Provincial S T Department [2012C13023-2]; Zhejiang Provincial Key Project of Medical and Health [2011ZDA014]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year'' Plan for Science & Technology Support of China; Program for New Century Excellent Talents in University, China(Program for New Century Excellent Talents in University (NCET)); Zhejiang Provincial Program for Cultivation of High-Level Innovative Health Talents; Specialized Key Science & Technology Foundation of Zhejiang Provincial S T Department; Zhejiang Provincial Key Project of Medical and Health	This study was funded by: 1. Natural Science Foundation of China (No. 81070756); 2. National "Twelfth Five-Year'' Plan for Science & Technology Support of China (No. 2012BAI08B01); 3. Program for New Century Excellent Talents in University, China (No. NCET-11-0161); 4. Zhejiang Provincial Program for Cultivation of High-Level Innovative Health Talents; 5. The Specialized Key Science & Technology Foundation of Zhejiang Provincial S & T Department (No. 2012C13023-2); 6. Zhejiang Provincial Key Project of Medical and Health (No. 2011ZDA014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Appleby PN, 2011, AM J CLIN NUTR, V93, P1128, DOI 10.3945/ajcn.110.004028; Asbell PA, 2005, LANCET, V365, P599; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Chang JR, 2011, OPHTHALMOLOGY, V118, P2113, DOI 10.1016/j.ophtha.2011.03.032; Chodick G, 2008, AM J EPIDEMIOL, V168, P620, DOI 10.1093/aje/kwn171; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Friedemann C, 2012, BMJ-BRIT MED J, V345, P4759; Glynn RJ, 2009, OPHTHAL EPIDEMIOL, V16, P98, DOI 10.1080/09286580902737532; Haidar Yarah M, 2011, Clin Colon Rectal Surg, V24, P205, DOI 10.1055/s-0031-1295684; Hattori A, 2013, OBESITY, V21, P856, DOI 10.1002/oby.20313; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hiller R, 1998, OPHTHALMOLOGY, V105, P1244, DOI 10.1016/S0161-6420(98)97029-4; Janghorbani M, 2004, OPHTHAL EPIDEMIOL, V11, P347, DOI 10.1080/09286580490888753; Janghorbani M B, 2000, Ophthalmic Epidemiol, V7, P13; Kanthan GL, 2010, AM J OPHTHALMOL, V150, P434, DOI 10.1016/j.ajo.2010.04.020; Karppi J, 2012, BRIT J NUTR, V108, P148, DOI 10.1017/S0007114511005332; Klein BEK, 2006, AM J OPHTHALMOL, V141, P116, DOI 10.1016/j.ajo.2005.08.021; Klein BEK, 2003, OPHTHALMIC EPIDEMIOL, V10, P97, DOI 10.1076/opep.10.2.97.13896; Leske MC, 1999, OPHTHALMOLOGY, V106, P35, DOI 10.1016/S0161-6420(99)90003-9; Leske MC, 2002, OPHTHALMOLOGY, V109, P1303, DOI 10.1016/S0161-6420(02)01094-1; Lindblad BE, 2008, OPHTHALMOLOGY, V115, P1687, DOI 10.1016/j.ophtha.2008.04.004; Mares JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P738, DOI 10.1001/archophthalmol.2010.84; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nirmalan PK, 2004, BRIT J OPHTHALMOL, V88, P989, DOI 10.1136/bjo.2003.038380; Ono K, 2010, AM J PUBLIC HEALTH, V100, P1784, DOI 10.2105/AJPH.2009.187930; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pastor-Valero Maria, 2007, BMC Ophthalmol, V7, P18, DOI 10.1186/1471-2415-7-18; Radzeviciene L, 2013, PUBLIC HEALTH, V127, P241, DOI 10.1016/j.puhe.2012.12.001; Richter GM, 2012, OPHTHALMOLOGY, V119, P2040, DOI 10.1016/j.ophtha.2012.05.001; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Schaumberg DA, 2000, AM J CLIN NUTR, V72, P1495; Schaumberg DA, 1999, ANN EPIDEMIOL, V9, P166, DOI 10.1016/S1047-2797(98)00049-0; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; SPIEGELMAN D, 1992, AM J CLIN NUTR, V55, P1033, DOI 10.1093/ajcn/55.6.1033; Tan JSL, 2008, OPHTHAL EPIDEMIOL, V15, P317, DOI 10.1080/09286580802105806; TAUBER WB, 1992, HEALTH PHYS, V63, P13, DOI 10.1097/00004032-199207000-00002; Weintraub JM, 2002, INT J OBESITY, V26, P1588, DOI 10.1038/sj.ijo.0802158; Wells G., 2013, NEWCASTLE OTTAWA SCA; Williams PT, 2009, INVEST OPHTH VIS SCI, V50, P95, DOI 10.1167/iovs.08-1797; Yamagishi SI, 2003, MICROVASC RES, V65, P186, DOI 10.1016/S0026-2862(03)00005-0; Yoshida Masao, 2010, Environmental Health and Preventive Medicine, V15, P367, DOI 10.1007/s12199-010-0153-2; Younan C, 2003, OPHTHALMIC EPIDEMIOL, V10, P227, DOI 10.1076/opep.10.4.227.15905; Zhang JS, 2011, OPHTHALMOLOGY, V118, P711, DOI 10.1016/j.ophtha.2010.08.021	48	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89923	10.1371/journal.pone.0089923	http://dx.doi.org/10.1371/journal.pone.0089923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587127	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700117
J	Chang, YC; Hsu, YC; Liu, CL; Huang, SY; Hu, MC; Cheng, SP				Chang, Yuan-Ching; Hsu, Yi-Chiung; Liu, Chien-Liang; Huang, Shih-Yuan; Hu, Meng-Chun; Cheng, Shih-Ping			Local Anesthetics Induce Apoptosis in Human Thyroid Cancer Cells through the Mitogen-Activated Protein Kinase Pathway	PLOS ONE			English	Article							PERCUTANEOUS ETHANOL INJECTION; GROWTH-FACTOR RECEPTOR; IN-VITRO; RADIOFREQUENCY ABLATION; INDUCED NEUROTOXICITY; SIGNALING PATHWAYS; LIDOCAINE; INHIBITION; PAPILLARY; EXPRESSION	Local anesthetics are frequently used in fine-needle aspiration of thyroid lesions and locoregional control of persistent or recurrent thyroid cancer. Recent evidence suggests that local anesthetics have a broad spectrum of effects including inhibition of cell proliferation and induction of apoptosis in neuronal and other types of cells. In this study, we demonstrated that treatment with lidocaine and bupivacaine resulted in decreased cell viability and colony formation of both 8505C and K1 cells in a dose-dependent manner. Lidocaine and bupivacaine induced apoptosis, and necrosis in high concentrations, as determined by flow cytometry. Lidocaine and bupivacaine caused disruption of mitochondrial membrane potential and release of cytochrome c, accompanied by activation of caspase 3 and 7, PARP cleavage, and induction of a higher ratio of Bax/Bcl-2. Based on microarray and pathway analysis, apoptosis is the prominent transcriptional change common to lidocaine and bupivacaine treatment. Furthermore, lidocaine and bupivacaine attenuated extracellular signal-regulated kinase 1/2 (ERK1/2) activity and induced activation of p38 mitogen-activated protein kinase (MAPK) and c-jun N-terminal kinase. Pharmacological inhibitors of MAPK/ERK kinase and p38 MAPK suppressed caspase 3 activation and PARP cleavage. Taken together, our results for the first time demonstrate the cytotoxic effects of local anesthetics on thyroid cancer cells and implicate the MAPK pathways as an important mechanism. Our findings have potential clinical relevance in that the use of local anesthetics may confer previously unrecognized benefits in the management of patients with thyroid cancer.	[Chang, Yuan-Ching; Hu, Meng-Chun] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10764, Taiwan; [Chang, Yuan-Ching; Liu, Chien-Liang; Huang, Shih-Yuan; Cheng, Shih-Ping] Mackay Mem Hosp, Dept Surg, Taipei, Taiwan; [Chang, Yuan-Ching; Liu, Chien-Liang; Huang, Shih-Yuan; Cheng, Shih-Ping] Mackay Med Coll, Taipei, Taiwan; [Hsu, Yi-Chiung] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Chang, Yuan-Ching; Liu, Chien-Liang; Cheng, Shih-Ping] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Cheng, Shih-Ping] Taipei Med Univ, Dept Pharmacol, Grad Inst Med Sci, Taipei, Taiwan	National Taiwan University; Mackay Memorial Hospital; Mackay Medical College; Academia Sinica - Taiwan; Mackay Junior College of Medicine, Nursing & Management; Taipei Medical University	Hu, MC (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10764, Taiwan.	mengchun@ntu.edu.tw; surg.mmh@gmail.com	Cheng, Shih-Ping/Q-3014-2018	Cheng, Shih-Ping/0000-0002-6301-5096; HU, MENG-CHUN/0000-0002-2783-5687	National Science Council of Taiwan [NSC 100-2314-B-195-001-MY3]; Mackay Memorial Hospital [MMH-10206, MMH-E-101-10]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This study was supported by grants from National Science Council of Taiwan (NSC 100-2314-B-195-001-MY3), and from Mackay Memorial Hospital (MMH-10206 and MMH-E-101-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2011, AM J ROENTGENOL, V197, pW331, DOI 10.2214/AJR.10.5345; Borgeat A, 2010, CURR OPIN ANESTHESIO, V23, P466, DOI 10.1097/ACO.0b013e328339eef2; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cela O, 2010, MITOCHONDRION, V10, P487, DOI 10.1016/j.mito.2010.05.005; Chang YC, 2014, ANESTH ANALG, V118, P116, DOI 10.1213/ANE.0b013e3182a94479; Cheng SP, 2013, CELL BIOCHEM BIOPHYS, V65, P203, DOI 10.1007/s12013-012-9419-1; Cheng SP, 2011, ONCOL REP, V26, P1265, DOI 10.3892/or.2011.1388; Cheng SP, 2010, ONCOL REP, V23, P1721, DOI 10.3892/or_00000817; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Drasner K, 1997, ANESTHESIOLOGY, V87, P469, DOI 10.1097/00000542-199709000-00002; Eguchi Y, 1997, CANCER RES, V57, P1835; Friederich P, 2002, EUR J ANAESTH, V19, P564, DOI 10.1017/S0265021502000911; GROUSELLE M, 1990, BIOCHEM J, V271, P269, DOI 10.1042/bj2710269; Harato M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-149; Hirata M, 2004, ANESTHESIOLOGY, V100, P1206, DOI 10.1097/00000542-200405000-00024; Irwin W, 2002, J BIOL CHEM, V277, P12221, DOI 10.1074/jbc.M108938200; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Joo JD, 2011, EUR J ANAESTH, V28, P106, DOI 10.1097/EJA.0b013e32834050fb; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kamiya Y, 2005, BIOMED RES-TOKYO, V26, P231, DOI 10.2220/biomedres.26.231; Karniel M, 2000, MOL GENET METAB, V69, P40, DOI 10.1006/mgme.1999.2954; Kawasaki C, 2010, J TRAUMA, V68, P401, DOI 10.1097/TA.0b013e3181af6e56; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Leboeuf R, 2008, J CLIN ENDOCR METAB, V93, P2194, DOI 10.1210/jc.2007-2825; Lee HT, 2003, AM J NEPHROL, V23, P129, DOI 10.1159/000069304; Lewis BD, 2002, AM J ROENTGENOL, V178, P699, DOI 10.2214/ajr.178.3.1780699; Lirk P, 2008, ANESTH ANALG, V106, P1456, DOI 10.1213/ane.0b013e318168514b; Lirk P, 2007, ANESTH ANALG, V105, P1657, DOI 10.1213/01.ane.0000286171.78182.e2; Lu J, 2011, EUR J PHARMACOL, V657, P51, DOI 10.1016/j.ejphar.2011.01.055; Lucchinetti E, 2012, ANESTHESIOLOGY, V116, P841, DOI 10.1097/ALN.0b013e31824babfe; Mammoto T, 2002, J CELL PHYSIOL, V192, P351, DOI 10.1002/jcp.10145; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Monchik JM, 2006, ANN SURG, V244, P296, DOI 10.1097/01.sla.0000217685.85467.2d; Nouette-Gaulain K, 2011, INT J BIOCHEM CELL B, V43, P14, DOI 10.1016/j.biocel.2010.10.005; Perez-Castro R, 2009, ANESTH ANALG, V108, P997, DOI 10.1213/ane.0b013e31819385e1; Piegeler T, 2012, ANESTHESIOLOGY, V117, P548, DOI 10.1097/ALN.0b013e3182661977; Piper SL, 2011, AM J SPORT MED, V39, P2245, DOI 10.1177/0363546511402780; Pomerance M, 2006, J PATHOL, V209, P298, DOI 10.1002/path.1975; Sakaguchi M, 2006, ANESTH ANALG, V102, P1103, DOI 10.1213/01.ane.0000198330.84341.35; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shin JE, 2013, CURR OPIN ONCOL, V25, P14, DOI 10.1097/CCO.0b013e32835a583d; Unami Akira, 2003, J Toxicol Sci, V28, P77, DOI 10.2131/jts.28.77; Villar-Garea A, 2003, CANCER RES, V63, P4984; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang Z, 2012, NEUROSCIENCE, V206, P190, DOI 10.1016/j.neuroscience.2011.12.043; Werdehausen R, 2007, ANESTHESIOLOGY, V107, P136, DOI 10.1097/01.anes.0000268389.39436.66; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431	49	79	83	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89563	10.1371/journal.pone.0089563	http://dx.doi.org/10.1371/journal.pone.0089563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586874	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900119
J	Andrew, KN; Hoshooley, J; Joanisse, MF				Andrew, Kathy N.; Hoshooley, Jennifer; Joanisse, Marc F.			Sign Language Ability in Young Deaf Signers Predicts Comprehension of Written Sentences in English	PLOS ONE			English	Article							PASSIVE VOICE; CHILDREN; ACQUISITION; READERS	We investigated the robust correlation between American Sign Language (ASL) and English reading ability in 51 young deaf signers ages 7; 3 to 19; 0. Signers were divided into 'skilled' and 'less-skilled' signer groups based on their performance on three measures of ASL. We next assessed reading comprehension of four English sentence structures (actives, passives, pronouns, reflexive pronouns) using a sentence-to-picture-matching task. Of interest was the extent to which ASL proficiency provided a foundation for lexical and syntactic processes of English. Skilled signers outperformed less-skilled signers overall. Error analyses further indicated greater single-word recognition difficulties in less-skilled signers marked by a higher rate of errors reflecting an inability to identify the actors and actions described in the sentence. Our findings provide evidence that increased ASL ability supports English sentence comprehension both at the levels of individual words and syntax. This is consistent with the theory that first language learning promotes second language through transference of linguistic elements irrespective of the transparency of mapping of grammatical structures between the two languages.	[Joanisse, Marc F.] Univ Western Ontario, Dept Psychol, London, ON, Canada; Univ Western Ontario, Brain & Mind Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Joanisse, MF (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	marcj@uwo.ca	Joanisse, Marc/B-5772-2015	Joanisse, Marc/0000-0002-6352-291X	NSERC Canada Graduate Scholarship; NSERC	NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by an NSERC Canada Graduate Scholarship to KNM and an NSERC operating grant to MFJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standards Institute, 2004, S3212004 ANSI; BALDIE BJ, 1976, J CHILD LANG, V3, P331, DOI 10.1017/S0305000900007224; Beech J. R., 1997, J RES READ, V20, P105, DOI DOI 10.1111/1467-9817.00024; Brown L., 1997, TEST NONVERBAL INTEL; Chamberlain C, 2008, APPL PSYCHOLINGUIST, V29, P367, DOI 10.1017/S014271640808017X; Chomsky N., 1981, LECT GOVT BINDING PI; CUMMINS J, 1979, REV EDUC RES, V49, P222, DOI 10.3102/00346543049002222; DEUTSCH W, 1986, LINGUISTICS, V24, P203, DOI 10.1515/ling.1986.24.1.203; Friesen DC, 2012, READ WRIT, V25, P375, DOI 10.1007/s11145-010-9275-6; Goldin-Meadow S., 2001, LEARN DISABIL RES PR, V16, P222, DOI [DOI 10.1111/0938-8982.00022, 10.1111/0938-8982.00022]; HANSON VL, 1987, MEM COGNITION, V15, P199, DOI 10.3758/BF03197717; Hoffmeister R. J., 1999, AM SIGN LANGUAGE ASS; Hoffmeister RJ, 2000, LANGUAGE ACQUISITION BY EYE, P143; Isenhath JO, 1990, LINGUISTICS AM SIGN; Janzen T., 2001, SIGN LANG STUD, V1, P281, DOI [DOI 10.1353/SLS.2001.0009, 10.1353/sls.2001.0009]; Klima E., 1979, SIGNS LANGUAGE; MacWhinney B., 1989, CROSSLINGUISTIC STUD; MacWhinney B, 2005, NATURE NURTURE MAHWA, P79; Mayberry RI, 2011, J DEAF STUD DEAF EDU, V16, P164, DOI 10.1093/deafed/enq049; Mayberry RI, 2003, BRAIN LANG, V87, P369, DOI 10.1016/S0093-934X(03)00137-8; Mayberry RI, 2002, NATURE, V417, P38, DOI 10.1038/417038a; Morford JP, 2011, COGNITION, V118, P286, DOI 10.1016/j.cognition.2010.11.006; Nielsen DC, 2002, AM ANN DEAF, V147, P11, DOI 10.1353/aad.2012.0213; Padden C, 1998, TOP LANG DISORD, V18, P30, DOI 10.1097/00011363-199808000-00005; Pichler D. C., 2001, THESIS U CONNECTICUT; POWER DJ, 1973, J SPEECH HEAR RES, V16, P5, DOI 10.1044/jshr.1601.05; Semel E., 2006, CLIN EVALUATION LANG; Strong M, 1997, J Deaf Stud Deaf Educ, V2, P37; Transler C, 1999, J Deaf Stud Deaf Educ, V4, P124, DOI 10.1093/deafed/4.2.124; Traxler MJ, 2014, MEM COGNITION, V42, P97, DOI 10.3758/s13421-013-0346-1; vanderLely HKJ, 1997, COGNITION, V62, P245, DOI 10.1016/S0010-0277(96)00783-4; Vasilyeva M, 2006, DEV PSYCHOL, V42, P164, DOI 10.1037/0012-1649.42.1.164; Wexler Kenneth, 1990, LANG ACQUIS, V1, P225, DOI DOI 10.1207/S15327817LA0103_2; Wiederholt J.L., 2001, GRAY ORAL READING TE	34	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89994	10.1371/journal.pone.0089994	http://dx.doi.org/10.1371/journal.pone.0089994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587174	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200104
J	Rao, F; Yang, RQ; Chen, XS; Xu, JS; Fu, HM; Su, H; Wang, L				Rao, Fang; Yang, Ren-Qiang; Chen, Xiao-Shu; Xu, Jin-Song; Fu, Hui-Min; Su, Hai; Wang, Ling			PPAR gamma Ligands Decrease Hydrostatic Pressure-Induced Platelet Aggregation and Proinflammatory Activity	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CD40 LIGAND; DEPENDENT MECHANISM; PROTHROMBOTIC STATE; ENDOTHELIAL-CELLS; HYPERTENSION; MICROPARTICLES; CD40-CD40L; TISSUE; RISK	Hypertension is known to be associated with platelet overactivity, but the direct effects of hydrostatic pressure on platelet function remain unclear. The present study sought to investigate whether elevated hydrostatic pressure is responsible for platelet activation and to address the potential role of peroxisome proliferator-activated receptor-gamma (PPAR gamma). We observed that hypertensive patients had significantly higher platelet volume and rate of ADP-induced platelets aggregation compared to the controls. In vitro, Primary human platelets were cultured under standard (0 mmHg) or increased (120, 180, 240 mmHg) hydrostatic pressure for 18 h. Exposure to elevated pressure was associated with morphological changes in platelets. Platelet aggregation and PAC-1 (the active confirmation of GPIIb/IIIa) binding were increased, CD40L was translocated from cytoplasm to the surface of platelet and soluble CD40L (sCD40L) was released into the medium in response to elevated hydrostatic pressure (180 and 240 mmHg). The PPAR gamma activity was up-regulated as the pressure was increased from 120 mmHg to 180 mmHg. Pressure-induced platelet aggregation, PAC-1 binding, and translocation and release of CD40L were all attenuated by the PPAR gamma agonist Thiazolidinediones (TZDs). These results demonstrate that platelet activation and aggregation are increased by exposure to elevated pressure and that PPAR gamma may modulate platelet activation induced by high hydrostatic pressure.	[Rao, Fang] Guangdong Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Rao, Fang] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Yang, Ren-Qiang; Chen, Xiao-Shu; Xu, Jin-Song; Su, Hai; Wang, Ling] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Peoples R China; [Fu, Hui-Min] Jiangxi Prov Blood Ctr, Nanchang, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Nanchang University	Su, H (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Peoples R China.	suyihappy@sohu.com; prettywangling@gmail.com			National Natural Science Foundation of China [81060069, 81160027, 81370295]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by National Natural Science Foundation of China (www.nsfc.gov.cn) (Project number. 81060069, 81160027, 81370295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Aamer, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P124; Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Barbe-Tuana FM, 2006, DIABETES, V55, P2437, DOI 10.2337/db05-1673; Cols M, 2012, J IMMUNOL, V188, P6071, DOI 10.4049/jimmunol.1102066; Davi G, 1997, CIRCULATION, V96, P69; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Engel D, 2009, SEMIN IMMUNOL, V21, P308, DOI 10.1016/j.smim.2009.06.004; Freedman JE, 2003, CIRC RES, V92, P944, DOI 10.1161/01.RES.0000074030.98009.FF; Freedman JE, 2003, NEW ENGL J MED, V348, P1163, DOI 10.1056/NEJMe030012; Gavins FNE, 2011, J THROMB HAEMOST, V9, P574, DOI 10.1111/j.1538-7836.2010.04176.x; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kawai M, 2008, ARTHRITIS RHEUM-US, V58, P3562, DOI 10.1002/art.23994; Kayrak M, 2011, HEART VESSELS, V26, P131, DOI 10.1007/s00380-010-0036-x; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; Lip GYH, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003186.pub3; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Merten M, 1999, CIRCULATION, V99, P2577, DOI 10.1161/01.CIR.99.19.2577; Michalik L, 1999, CURR OPIN BIOTECH, V10, P564, DOI 10.1016/S0958-1669(99)00030-0; Nadar S, 2004, ANN MED, V36, P552, DOI 10.1080/07853890410017386; Nadar S, 2003, CURR PHARM DESIGN, V9, P1715, DOI 10.2174/1381612033454559; Naimushin YA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P782, DOI 10.1007/s10541-005-0184-2; Ray DM, 2008, THROMB HAEMOSTASIS, V99, P86, DOI 10.1160/TH07-05-0328; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schmieder RE, 2000, J HUM HYPERTENS, V14, P597, DOI 10.1038/sj.jhh.1001044; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Seijkens T, 2013, DIABETES VASC DIS RE, V10, P115, DOI 10.1177/1479164112455817; Varughese GI, 2005, CURR HYPERTENS REP, V7, P168, DOI 10.1007/s11906-005-0005-4	30	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89654	10.1371/journal.pone.0089654	http://dx.doi.org/10.1371/journal.pone.0089654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586940	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200068
J	Rinaldi, C; Penhale, WJ; Stumbles, PA; Tay, G; Berry, CM				Rinaldi, Catherine; Penhale, William J.; Stumbles, Philip A.; Tay, Guan; Berry, Cassandra M.			Modulation of Innate Immune Responses by Influenza-Specific Ovine Polyclonal Antibodies Used for Prophylaxis	PLOS ONE			English	Article							A VIRUS PNEUMONIA; MONOCLONAL-ANTIBODY; H5N1; NEURAMINIDASE; INFECTION; VACCINE; HEMAGGLUTININ; IMMUNIZATION; INTERFERON; MICE	In the event of a novel influenza A virus pandemic, prophylaxis mediated by antibodies provides an adjunct control option to vaccines and antivirals. This strategy is particularly pertinent to unvaccinated populations at risk during the lag time to produce and distribute an effective vaccine. Therefore, development of effective prophylactic therapies is of high importance. Although previous approaches have used systemic delivery of monoclonal antibodies or convalescent sera, available supply is a serious limitation. Here, we have investigated intranasal delivery of influenza-specific ovine polyclonal IgG antibodies for their efficacy against homologous influenza virus challenge in a mouse model. Both influenza-specific IgG and F(ab')(2) reduced clinical scores, body weight loss and lung viral loads in mice treated 1 hour before virus exposure. Full protection from disease was also observed when antibody was delivered up to 3 days prior to virus infection. Furthermore, effective prophylaxis was independent of a strong innate immune response. This strategy presents a further option for prophylactic intervention against influenza A virus using ruminants to generate a bulk supply that could potentially be used in a pandemic setting, to slow virus transmission and reduce morbidity associated with a high cytokine phenotype.	[Rinaldi, Catherine; Tay, Guan] Univ Western Australia, Ctr Forens Sci, Nedlands, WA 6009, Australia; [Penhale, William J.; Stumbles, Philip A.; Berry, Cassandra M.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia	University of Western Australia; Murdoch University	Berry, CM (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia.	c.berry@murdoch.edu.au	Berry, Cassandra/AAX-7145-2020	Tay, Guan/0000-0001-6639-3298; Berry, Cassandra/0000-0003-0768-0857	AB-Health; Murdoch University	AB-Health; Murdoch University	This study was supported in part by AB-Health, and funding from Murdoch University was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; AKERFELDT S, 1972, BIOCHEM PHARMACOL, V21, P503, DOI 10.1016/0006-2952(72)90323-1; Alisky J, 2009, MED HYPOTHESES, V72, P74, DOI 10.1016/j.mehy.2008.08.016; AYMARDHENRY M, 1973, B WORLD HEALTH ORGAN, V48, P199; Berry CM, 2012, BIOMARK MED, V6, P159, DOI 10.2217/BMM.12.10; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Brett IC, 2005, VIROLOGY, V339, P273, DOI 10.1016/j.virol.2005.06.006; Cull VS, 2002, IMMUNOLOGY, V106, P428, DOI 10.1046/j.1365-2567.2002.01423.x; Dreffier C, 2003, INT J PHARMACEUT, V254, P43, DOI 10.1016/S0378-5173(02)00680-4; Fritz R, 2012, J INFECT DIS, V205, P28, DOI 10.1093/infdis/jir711; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Gefen T, 2010, VACCINE, V28, P8197, DOI 10.1016/j.vaccine.2010.09.032; Girard MP, 2005, VACCINE, V23, P5708, DOI 10.1016/j.vaccine.2005.07.046; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hernandez E, 2003, MIL MED, V168, P246; Hovden AO, 2005, SCAND J IMMUNOL, V62, P36, DOI 10.1111/j.1365-3083.2005.01633.x; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; James CM, 2007, VACCINE, V25, P1856, DOI 10.1016/j.vaccine.2006.10.038; James CM, 2007, VACCINE, V25, P5892, DOI 10.1016/j.vaccine.2007.05.023; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; KILBOURNE ED, 1987, INFLUENZA; Koudstaal W, 2009, J INFECT DIS, V200, P1870, DOI 10.1086/648378; KRIS RM, 1988, IMMUNOLOGY, V63, P349; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Luke TC, 2010, CRITICAL CARE MED, V38, pS1; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Mancini N, 2011, ANTIVIR RES, V92, P15, DOI 10.1016/j.antiviral.2011.07.013; Meng WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066276; Ng WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013622; Nguyen AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064198; Oxford JS, 2006, INT J ANTIMICROB AG, V27, P271, DOI 10.1016/j.ijantimicag.2006.02.007; Papenburg J, 2011, CLIN VACCINE IMMUNOL, V18, P520, DOI 10.1128/CVI.00449-10; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Ramisse F, 1998, CLIN EXP IMMUNOL, V111, P583; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rockman S, 2012, CRIT CARE MED, V40, P973, DOI 10.1097/CCM.0b013e318236f486; Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304; Snelgrove RJ, 2011, TRENDS IMMUNOL, V32, P328, DOI 10.1016/j.it.2011.04.006; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Tang JW, 2008, J MED VIROL, V80, P1992, DOI 10.1002/jmv.21321; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; VANDEUSEN RA, 1983, AVIAN DIS, V27, P745, DOI 10.2307/1590317; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574; WONG JP, 1994, IMMUNOLOGY, V81, P280; World Organization for Animal Health, 2004, MANUAL DIAGNOSTIC TE; Ye JQ, 2012, IMMUNOTHERAPY-UK, V4, P175, DOI [10.2217/IMT.11.167, 10.2217/imt.11.167]; Ye JQ, 2010, CLIN VACCINE IMMUNOL, V17, P1363, DOI 10.1128/CVI.00002-10; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	56	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89674	10.1371/journal.pone.0089674	http://dx.doi.org/10.1371/journal.pone.0089674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586955	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200071
J	Robles, H; Martin, K				Robles, Hugo; Martin, Kathy			Habitat-Mediated Variation in the Importance of Ecosystem Engineers for Secondary Cavity Nesters in a Nest Web	PLOS ONE			English	Article							EXPERIMENTAL REDUCTION; NICHE-CONSTRUCTION; CRITICAL RESOURCE; BRITISH-COLUMBIA; TREE-HOLES; COMMUNITIES; CANADA; HETEROGENEITY; CONSERVATION; ORGANISMS	Through physical state changes in biotic or abiotic materials, ecosystem engineers modulate resource availability to other organisms and are major drivers of evolutionary and ecological dynamics. Understanding whether and how ecosystem engineers are interchangeable for resource users in different habitats is a largely neglected topic in ecosystem engineering research that can improve our understanding of the structure of communities. We addressed this issue in a cavity-nest web (1999-2011). In aspen groves, the presence of mountain bluebird (Sialia currucoides) and tree swallow (Tachycineta bicolour) nests was positively related to the density of cavities supplied by northern flickers (Colaptes auratus), which provided the most abundant cavities (1.61 cavities/ha). Flickers in aspen groves provided numerous nesting cavities to bluebirds (66%) and swallows (46%), despite previous research showing that flicker cavities are avoided by swallows. In continuous mixed forests, however, the presence of nesting swallows was mainly related to cavity density of red-naped sapsuckers (Sphyrapicus nuchalis), which provided the most abundant cavities (0.52 cavities/ha), and to cavity density of hairy woodpeckers (Picoides villosus), which provided few (0.14 cavities/ha) but high-quality cavities. Overall, sapsuckers and hairy woodpeckers provided 86% of nesting cavities to swallows in continuous forests. In contrast, the presence of nesting bluebirds in continuous forests was associated with the density of cavities supplied by all the ecosystem engineers. These results suggest that (i) habitat type may mediate the associations between ecosystem engineers and resource users, and (ii) different ecosystem engineers may be interchangeable for resource users depending on the quantity and quality of resources that each engineer supplies in each habitat type. We, therefore, urge the incorporation of the variation in the quantity and quality of resources provided by ecosystem engineers across habitats into models that assess community dynamics to improve our understanding of the importance of ecosystem engineers in shaping ecological communities.	[Robles, Hugo; Martin, Kathy] Univ British Columbia, Dept Forest & Conservat Sci, Ctr Appl Conservat Res, Vancouver, BC V5Z 1M9, Canada; [Martin, Kathy] Environm Canada, Pacific Wildlife Res Ctr, Delta, BC, Canada	University of British Columbia; Environment & Climate Change Canada; Canadian Wildlife Service; Pacific Wildlife Research Centre	Robles, H (corresponding author), Univ A Coruna, Fac Sci, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain.	hugo.roblesdiez@uantwerpen.be	Robles, Hugo/AAH-6795-2021; Robles, Hugo/GLT-7003-2022	Robles, Hugo/0000-0003-0289-0687; 	Natural Sciences and Engineering Research Council of Canada (NSERC); Environment Canada; Sustainable Forest Management Network; Forest Renewal B.C. Tolko Industries Limited (Cariboo Woodlands)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Sustainable Forest Management Network; Forest Renewal B.C. Tolko Industries Limited (Cariboo Woodlands)	This research was funded by The Natural Sciences and Engineering Research Council of Canada (NSERC Special Strategic Grant to KM), Environment Canada, Sustainable Forest Management Network and Forest Renewal B.C. Tolko Industries Limited (Cariboo Woodlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KEH, 2007, J ORNITHOL, V148, pS425, DOI 10.1007/s10336-007-0166-9; Aitken KEH, 2008, ECOLOGY, V89, P971, DOI 10.1890/07-0711.1; Baker BW, 2012, ECOGRAPHY, V35, P1; Blakely TJ, 2008, AUSTRAL ECOL, V33, P963, DOI 10.1111/j.1442-9993.2008.01867.x; Blanc LA, 2008, CONDOR, V110, P80, DOI 10.1525/cond.2008.110.1.80; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calderon-Cortes N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019083; Cardinale BJ, 2004, FUNCT ECOL, V18, P381, DOI 10.1111/j.0269-8463.2004.00865.x; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Cully JF, 2010, ECOGRAPHY, V33, P667, DOI 10.1111/j.1600-0587.2009.05746.x; Davidson AD, 2007, ECOGRAPHY, V30, P515, DOI 10.1111/j.0906-7590.2007.05032.x; Day RL, 2003, PERSPECT BIOL MED, V46, P80, DOI 10.1353/pbm.2003.0003; Edworthy AB, 2012, ECOL APPL, V22, P1733, DOI 10.1890/11-1594.1; Galvez-Bravo L, 2011, J ARID ENVIRON, V75, P779, DOI 10.1016/j.jaridenv.2011.03.015; Gutierrez JL, 2006, BIOSCIENCE, V56, P227, DOI 10.1641/0006-3568(2006)056[0227:PEEAAO]2.0.CO;2; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Joseph GS, 2011, LANDSCAPE ECOL, V26, P439, DOI 10.1007/s10980-011-9572-8; Koch AJ, 2012, IBIS, V154, P590, DOI 10.1111/j.1474-919X.2012.01242.x; Machicote M, 2004, OIKOS, V106, P527, DOI 10.1111/j.0030-1299.2004.13139.x; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; Odling-Smee F. J., 2003, NICHE CONSTRUCTION N, P468; Pinheiro J, 2001, MIXED EFFECTS MODELS; Power H. W., 1996, BIRDS N AM ONLINE; Pringle RM, 2008, ECOLOGY, V89, P26, DOI 10.1890/07-0776.1; Prugh LR, 2012, J ANIM ECOL, V81, P667, DOI 10.1111/j.1365-2656.2011.01930.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raphael M. G., 1984, WILDLIFE MONOGR, V86, P3; Robles H, 2007, FOREST ECOL MANAG, V242, P343, DOI 10.1016/j.foreco.2007.01.052; Robles H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074694; Robles H, 2012, FOREST ECOL MANAG, V277, P46, DOI 10.1016/j.foreco.2012.04.017; Robles H, 2011, FOREST ECOL MANAG, V261, P1428, DOI 10.1016/j.foreco.2011.01.029; SAUER JR, 2011, N AM BREEDING BIRD S; STAUFFER D F, 1982, Wilson Bulletin, V94, P329; Waters JR, 1988, THESIS HUMBOLDT STAT; Wiebe K. L., 2008, BIRDS N AM ONLINE; Winkler DW, 2011, BIRDS N AM; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2	40	21	21	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90071	10.1371/journal.pone.0090071	http://dx.doi.org/10.1371/journal.pone.0090071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587211	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200120
J	Chaput-Bardy, A; Ducatez, S; Legrand, D; Baguette, M				Chaput-Bardy, Audrey; Ducatez, Simon; Legrand, Delphine; Baguette, Michel			Fitness Costs of Thermal Reaction Norms for Wing Melanisation in the Large White Butterfly (Pieris brassicae)	PLOS ONE			English	Article							ADAPTIVE PHENOTYPIC PLASTICITY; LIFE-HISTORY TRAITS; COLIAS BUTTERFLIES; EVOLUTION; LEPIDOPTERA; TEMPERATURE; BEHAVIOR; LIMITS; MELANIZATION; HERITABILITY	The large white butterfly, Pieris brassicae, shows a seasonal polyphenism of wing melanisation, spring individuals being darker than summer individuals. This phenotypic plasticity is supposed to be an adaptive response for thermoregulation in natural populations. However, the variation in individuals' response, the cause of this variation (genetic, non genetic but inheritable or environmental) and its relationship with fitness remain poorly known. We tested the relationships between thermal reaction norm of wing melanisation and adult lifespan as well as female fecundity. Butterflies were reared in cold (18 degrees C), moderate (22 degrees C), and hot (26 degrees C) temperatures over three generations to investigate variation in adult pigmentation and the effects of maternal thermal environment on offspring reaction norms. We found a low heritability in wing melanisation (h(2) = 0.18). Rearing families had contrasted thermal reaction norms. Adult lifespan of males and females from highly plastic families was shorter in individuals exposed to hot developmental temperature. Also, females from plastic families exhibited lower fecundity. We did not find any effect of maternal or grand-maternal developmental temperature on fitness. This study provides new evidence on the influence of phenotypic plasticity on life history-traits' evolution, a crucial issue in the context of global change.	[Chaput-Bardy, Audrey; Ducatez, Simon; Legrand, Delphine; Baguette, Michel] Museum Natl Hist Nat, Inst Systemat Evolut Biodiversite, UMR 7205, F-75231 Paris, France; [Chaput-Bardy, Audrey] INRA, Equipe Ecotoxicol & Qualite Milieux Aquat, UMR Ecol & Sante Ecosyst 985, INRA Agrocampus, F-35042 Rennes, France; [Ducatez, Simon] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Legrand, Delphine; Baguette, Michel] CNRS, Stn Ecol Expt CNRS Moulis, USR 2936, Moulis, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; INRAE; Institut Agro; Agrocampus Ouest; McGill University; Centre National de la Recherche Scientifique (CNRS)	Chaput-Bardy, A (corresponding author), Museum Natl Hist Nat, Inst Systemat Evolut Biodiversite, UMR 7205, F-75231 Paris, France.	chaput_bardy_audrey@hotmail.com	Ducatez, Simon/AAA-5378-2020; Legrand, Delphine/N-4575-2014; Baguette, Michel/HHZ-3609-2022	Ducatez, Simon/0000-0003-2865-4674; Legrand, Delphine/0000-0002-5186-2909; 	Agence Nationale de la Recherche; Fondation Fyssen	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Fyssen	MB and DL are funded by the Agence Nationale de la Recherche, via the programs (1) open call DIAME, (2) 6th extinction MOBIGEN, and (3) open call INDHET. MB and DL are part of the Laboratoire d'Excellence TULIP (ANR-10-LABX-41). SD was funded by a post-doctoral fellowship from the Fondation Fyssen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Crill WD, 1996, EVOLUTION, V50, P1205, DOI [10.2307/2410661, 10.1111/j.1558-5646.1996.tb02361.x]; Danchin E, 2010, OIKOS, V119, P210, DOI 10.1111/j.1600-0706.2009.17640.x; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Ducatez S, 2012, EVOLUTION, V66, P3558, DOI 10.1111/j.1558-5646.2012.01704.x; Ellers J, 2002, EVOLUTION, V56, P836, DOI 10.1111/j.0014-3820.2002.tb01394.x; Feltwell J., 1982, LARGE WHITE BUTTERFL; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Gilchrist GW, 2001, EVOLUTION, V55, P209, DOI 10.1111/j.0014-3820.2001.tb01287.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Kingsolver JG, 2007, J EVOLUTION BIOL, V20, P892, DOI 10.1111/j.1420-9101.2007.01318.x; KINGSOLVER JG, 1985, OECOLOGIA, V66, P540, DOI 10.1007/BF00379347; KINGSOLVER JG, 1985, OECOLOGIA, V66, P546, DOI 10.1007/BF00379348; KINGSOLVER JG, 1987, EVOLUTION, V41, P472, DOI 10.1111/j.1558-5646.1987.tb05819.x; KINGSOLVER JG, 1983, ECOLOGY, V64, P534, DOI 10.2307/1939973; KINGSOLVER JG, 1991, AM NAT, V137, P816, DOI 10.1086/285195; Lee KP, 2008, FUNCT ECOL, V22, P1052, DOI 10.1111/j.1365-2435.2008.01459.x; Ma WH, 2008, ECOL ENTOMOL, V33, P37, DOI 10.1111/j.1365-2311.2007.00932.x; MAERCKS HANS, 1934, ZEIT SCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V28, P692, DOI 10.1007/BF00412834; Moczek AP, 2011, NATURE, V473, P34, DOI 10.1038/473034a; Moczek AP, 2010, PHILOS T R SOC B, V365, P593, DOI 10.1098/rstb.2009.0263; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Murren CJ, 2005, EVOL ECOL, V19, P583, DOI 10.1007/s10682-005-2005-x; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Obara Y, 2000, ZOOL SCI, V17, P725, DOI 10.2108/zsj.17.725; Obara Y, 2008, J EXP BIOL, V211, P3698, DOI 10.1242/jeb.021980; PARTRIDGE L, 1988, SCIENCE, V241, P1449, DOI 10.1126/science.241.4872.1449; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pigliucci M., 2001, SYN ECO EVO; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Roff Derek, 2002, pi; Schlichting C.D., 2004, PHENOTYPIC PLASTICIT, P191, DOI DOI 10.1002/AJHB.20088; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stoehr AM, 2006, FUNCT ECOL, V20, P276, DOI 10.1111/j.1365-2435.2006.01090.x; Stoehr AM, 2008, ECOL ENTOMOL, V33, P137, DOI 10.1111/j.1365-2311.2007.00931.x; Stoehr AM, 2010, EVOL ECOL, V24, P287, DOI 10.1007/s10682-009-9306-4; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Talloen W, 2004, EVOLUTION, V58, P360, DOI 10.1111/j.0014-3820.2004.tb01651.x; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; Van Dyck H, 1998, OECOLOGIA, V114, P326, DOI 10.1007/s004420050454; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; West-Eberhard Mary Jane, 2003, pi; Western D, 2001, P NATL ACAD SCI USA, V98, P5458, DOI 10.1073/pnas.101093598; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Zuur Alain F., 2009, P1	60	10	10	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90026	10.1371/journal.pone.0090026	http://dx.doi.org/10.1371/journal.pone.0090026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587196	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800068
J	Cronqvist, T; Salje, K; Familari, M; Guller, S; Schneider, H; Gardiner, C; Sargent, IL; Redman, CW; Morgelin, M; Akerstrom, B; Gram, M; Hansson, SR				Cronqvist, Tina; Salje, Karen; Familari, Mary; Guller, Seth; Schneider, Henning; Gardiner, Chris; Sargent, Ian L.; Redman, Christopher W.; Morgelin, Matthias; Akerstrom, Bo; Gram, Magnus; Hansson, Stefan R.			Syncytiotrophoblast Vesicles Show Altered micro-RNA and Haemoglobin Content after Ex-vivo Perfusion of Placentas with Haemoglobin to Mimic Preeclampsia	PLOS ONE			English	Article							MICROVILLOUS MEMBRANES; MATERNAL CIRCULATION; EXPRESSION PROFILES; NORMAL-PREGNANCY; MICROPARTICLES; CELLS; MECHANISM; APOPTOSIS; EXOSOMES; RELEASE	Background: Cell-free foetal haemoglobin (HbF) has been shown to play a role in the pathology of preeclampsia (PE). In the present study, we aimed to further characterize the harmful effects of extracellular free haemoglobin (Hb) on the placenta. In particular, we investigated whether cell-free Hb affects the release of placental syncytiotrophoblast vesicles (STBMs) and their micro-RNA content. Methods: The dual ex-vivo perfusion system was used to perfuse isolated cotyledons from human placenta, with medium alone (control) or supplemented with cell-free Hb. Perfusion medium from the maternal side of the placenta was collected at the end of all perfusion phases. The STBMs were isolated using ultra-centrifugation, at 10,000xg and 150,000xg (referred to as 10K and 150K STBMs). The STBMs were characterized using the nanoparticle tracking analysis, identification of surface markers and transmission electron microscopy. RNA was extracted and nine different micro-RNAs, related to hypoxia, PE and Hb synthesis, were selected for analysis by quantitative PCR. Results: All micro-RNAs investigated were present in the STBMs. Mir-517a, mir-141 and mir-517b were down regulated after Hb perfusion in the 10K STBMs. Furthermore, Hb was shown to be carried by the STBMs. Conclusion: This study showed that Hb perfusion can alter the micro-RNA content of released STBMs. Of particular interest is the alteration of two placenta specific micro-RNAs; mir-517a and mir-517b. We have also seen that STBMs may function as carriers of Hb into the maternal circulation.	[Cronqvist, Tina; Hansson, Stefan R.] Lund Univ, Univ Lund Hosp, Dept Clin Sci, Div Obstet & Gynecol, Lund, Sweden; [Salje, Karen] Ernst Moritz Arndt Univ Greifswald, Dept Clin Pharmacol, Greifswald, Germany; [Familari, Mary] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Guller, Seth] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Schneider, Henning] Univ Bern, Inselspital, Dept Obstet & Gynecol, CH-3010 Bern, Switzerland; [Gardiner, Chris; Sargent, Ian L.; Redman, Christopher W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Morgelin, Matthias; Akerstrom, Bo; Gram, Magnus] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden	Lund University; Skane University Hospital; Ernst Moritz Arndt Universitat Greifswald; University of Melbourne; Yale University; University of Bern; University Hospital of Bern; University of Oxford; Lund University	Cronqvist, T (corresponding author), Lund Univ, Univ Lund Hosp, Dept Clin Sci, Div Obstet & Gynecol, Lund, Sweden.	tina.cronqvist@med.lu.se	Gram, Magnus/AAM-4825-2021; Gardiner, Chris/F-1178-2011; Cronqvist, Tina/C-1585-2015	Gram, Magnus/0000-0002-5880-2925; Gardiner, Chris/0000-0002-2318-0062; Cronqvist, Tina/0000-0002-7401-1939; Familari, Mary/0000-0002-2275-9582	Swedish Research council; Marianne & Marcus Wallenberg foundation; Torsten Soderbergsfoundation; Maggie Stephens foundation; Wellcome Trust [GR087730]; Medical Research Council [MR/J003360/1] Funding Source: researchfish; MRC [MR/J003360/1] Funding Source: UKRI	Swedish Research council(Swedish Research CouncilEuropean Commission); Marianne & Marcus Wallenberg foundation; Torsten Soderbergsfoundation; Maggie Stephens foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Swedish Research council (TC); the Marianne & Marcus Wallenberg foundation (TC); the Torsten Soderbergsfoundation (TC); the Maggie Stephens foundation (TC); and the Wellcome Trust Technology Development Grant Ref GR087730 (CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon A, 2011, THROMB RES, V127, pS67, DOI 10.1016/S0049-3848(11)70019-6; Alijotas-Reig J, 2013, FERTIL STERIL, V99, P441, DOI 10.1016/j.fertnstert.2012.10.009; Aly AS, 2004, AM J OBSTET GYNECOL, V190, P252, DOI 10.1016/j.ajog.2003.07.003; Anderson UD, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.058; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Centlow M, 2008, FERTIL STERIL, V90, P1834, DOI 10.1016/j.fertnstert.2007.09.030; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dechend R, 2012, HYPERTENSION, V59, P191, DOI 10.1161/HYPERTENSIONAHA.111.184861; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; Enquobahrie Daniel A, 2011, Am J Obstet Gynecol, V204, DOI 10.1016/j.ajog.2010.09.004; Faivre B, 1998, ARTIF CELL BLOOD SUB, V26, P17, DOI 10.3109/10731199809118943; Gabbianelli M, 2010, HAEMATOL-HEMATOL J, V95, P1253, DOI 10.3324/haematol.2009.018259; Gardiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026313; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Guller S, 2011, PLACENTA, V32, P63, DOI 10.1016/j.placenta.2010.10.011; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x; Longtine MS, 2012, PLACENTA, V33, P352, DOI 10.1016/j.placenta.2012.01.017; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; May K, 2011, PLACENTA, V32, P323, DOI 10.1016/j.placenta.2011.01.017; Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Mouillet JF, 2011, BIRTH DEFECTS RES A, V91, P737, DOI 10.1002/bdra.20782; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Oehmcke S, 2012, CELL MICROBIOL, V14, P107, DOI 10.1111/j.1462-5822.2011.01705.x; Olsson MG, 2010, FREE RADICAL BIO MED, V48, P284, DOI 10.1016/j.freeradbiomed.2009.10.052; Orozco AF, 2009, PLACENTA, V30, P891, DOI 10.1016/j.placenta.2009.06.012; Orozco AF, 2010, CYTOM PART A, V77A, P502, DOI 10.1002/cyto.a.20886; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Reddy A, 2008, PLACENTA, V29, P942, DOI 10.1016/j.placenta.2008.08.018; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roos MA, 2010, CELL BIOCHEM FUNCT, V28, P539, DOI 10.1002/cbf.1695; Sankaran VG, 2011, HEMATOL-AM SOC HEMAT, P459, DOI 10.1182/asheducation-2011.1.459; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; von Dadelszen P, 1999, HUM REPROD, V14, P919, DOI 10.1093/humrep/14.4.919; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	56	35	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90020	10.1371/journal.pone.0090020	http://dx.doi.org/10.1371/journal.pone.0090020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587192	Green Published, gold			2022-12-27	WOS:000332390800067
J	Limmer, K; Pippig, DA; Aschenbrenner, D; Gaub, HE				Limmer, Katja; Pippig, Diana A.; Aschenbrenner, Daniela; Gaub, Hermann E.			A Force-Based, Parallel Assay for the Quantification of Protein-DNA Interactions	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; TRANSCRIPTION FACTORS; BINDING SPECIFICITIES; PHOSPHOPANTETHEINYL TRANSFERASE; MICROARRAYS; SITES; SPECTROSCOPY; RECOGNITION; SEQUENCE; LIGANDS	Analysis of transcription factor binding to DNA sequences is of utmost importance to understand the intricate regulatory mechanisms that underlie gene expression. Several techniques exist that quantify DNA-protein affinity, but they are either very time-consuming or suffer from possible misinterpretation due to complicated algorithms or approximations like many high-throughput techniques. We present a more direct method to quantify DNA-protein interaction in a force-based assay. In contrast to single-molecule force spectroscopy, our technique, the Molecular Force Assay (MFA), parallelizes force measurements so that it can test one or multiple proteins against several DNA sequences in a single experiment. The interaction strength is quantified by comparison to the well-defined rupture stability of different DNA duplexes. As a proof-of-principle, we measured the interaction of the zinc finger construct Zif268/NRE against six different DNA constructs. We could show the specificity of our approach and quantify the strength of the protein-DNA interaction.	[Limmer, Katja; Pippig, Diana A.; Aschenbrenner, Daniela; Gaub, Hermann E.] Univ Munich, Lehrstuhl Angew Phys, Munich, Germany; [Limmer, Katja; Pippig, Diana A.; Aschenbrenner, Daniela; Gaub, Hermann E.] Univ Munich, Ctr Nanosci CeNS, Munich, Germany; [Limmer, Katja] Munich Ctr Integrated Prot Sci CIPSM, Munich, Germany	University of Munich; University of Munich; University of Munich	Gaub, HE (corresponding author), Univ Munich, Lehrstuhl Angew Phys, Munich, Germany.	Gaub@lmu.de			German Science Foundation [SFB 1032-A01]; European Research Council	German Science Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	Funding provided by German Science Foundation SFB 1032-A01 and a European Research Council Advanced Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2003, SCIENCE, V301, P367, DOI 10.1126/science.1084713; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bartels FW, 2003, J STRUCT BIOL, V143, P145, DOI 10.1016/S1047-8477(03)00127-8; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bizzarri AR, 2010, CHEM SOC REV, V39, P734, DOI 10.1039/b811426a; Blank K, 2003, P NATL ACAD SCI USA, V100, P11356, DOI 10.1073/pnas.1934928100; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Ho D, 2009, ANAL CHEM, V81, P3159, DOI 10.1021/ac802766j; Ho D, 2009, BIOPHYS J, V96, P4661, DOI 10.1016/j.bpj.2009.02.059; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kim JS, 1998, P NATL ACAD SCI USA, V95, P2812, DOI 10.1073/pnas.95.6.2812; Koch SJ, 2002, BIOPHYS J, V83, P1098, DOI 10.1016/S0006-3495(02)75233-8; Kuhner F, 2004, BIOPHYS J, V87, P2683, DOI 10.1529/biophysj.104.048968; Limmer K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1455; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Otten M, 2013, LAB CHIP, V13, P4198, DOI 10.1039/c3lc50830g; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Severin PMD, 2011, LAB CHIP, V11, P856, DOI [10.1039/c0lc00302f, 10.1039/c01c00302f]; Severin PMD, 2012, SMALL; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Wiegand G, 1998, APPL OPTICS, V37, P6892, DOI 10.1364/AO.37.006892; Wong LS, 2008, J AM CHEM SOC, V130, P12456, DOI 10.1021/ja8030278; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43	35	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89626	10.1371/journal.pone.0089626	http://dx.doi.org/10.1371/journal.pone.0089626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586920	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800031
J	Silva, LA; Andrade, RO; Carneiro, ACAV; Vitor, RWA				Silva, Leticia A.; Andrade, Renata O.; Carneiro, Ana Carolina A. V.; Vitor, Ricardo W. A.			Overlapping Toxoplasma gondii Genotypes Circulating in Domestic Animals and Humans in Southeastern Brazil	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; SAO-PAULO; VIRULENCE; CHICKENS; DIVERSITY; LINEAGES; STRAINS; STATE	Although several Toxoplasma gondii genotyping studies have been performed in Brazil, studies of isolates from animals in the state of Minas Gerais are rare. The objective of this study was to conduct a genotypic characterization of T. gondii isolates obtained from dogs, free-range chickens, and humans in Minas Gerais and to verify whether the T. gondii genotypes circulating in domestic animals correspond to the genotypes detected in humans. Genetic variability was assessed by restricted fragment length polymorphism at 11 loci (SAG1, 5'+3'SAG2, SAG2 alt, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, and Apico). Twelve different genotypes were identified among the 24 isolates studied, including 8 previously identified genotypes and 4 new genotypes. The genetic relationship of the 24 T. gondii isolates, together with the genotypes previously described from 24 human newborns with congenital toxoplasmosis, revealed a high degree of similarity among the genotypes circulating in humans and animals in Minas Gerais. The most common genotypes among these species were BrII, BrIII, ToxoDB #108, and ToxoDB #206. Restricted fragment length polymorphism at the CS3 locus of these 48 isolates showed that the majority of isolates presented alleles I (50%) or II (27%). Isolates harboring allele III at the CS3 locus presented low virulence for mice, whereas those harboring alleles I or II presented higher virulence. These results confirm the utility of marker CS3 for predicting the virulence of Brazilian isolates of T. gondii in mice. No association was found between the allele type and clinical manifestations of human congenital toxoplasmosis. This is the first report of T. gondii genotyping that verifies the overlapping genotypes of T. gondii from humans and animals in the same geographic region of Brazil. Our results suggest that there is a common source of infection to the species studied, most likely oocysts contaminating the environment.	[Silva, Leticia A.; Andrade, Renata O.; Carneiro, Ana Carolina A. V.; Vitor, Ricardo W. A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Vitor, RWA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil.	ricardovitor@icb.ufmg.br	Vitor, Ricardo/B-8924-2013; De Almeida Vitor, Ricardo Wagner/ABH-1666-2020	De Almeida Vitor, Ricardo Wagner/0000-0002-8599-0474	Conselho Nacional de Desenvolvimento e Pesquisa - CNPq [301110/2009-3, 471486/2010-8]; Fundacao de Amparo a Pesquisa de Minas Gerais [00129-09]; Pro-Reitoria de Pesquisa-Universidade Federal de Minas Gerais	Conselho Nacional de Desenvolvimento e Pesquisa - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa-Universidade Federal de Minas Gerais	This work was supported by Conselho Nacional de Desenvolvimento e Pesquisa - CNPq (Grants 301110/2009-3 and 471486/2010-8), Fundacao de Amparo a Pesquisa de Minas Gerais (Grant 00129-09) and Pro-Reitoria de Pesquisa-Universidade Federal de Minas Gerais. RWAV is a CNPq Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12; Brandao GP, 2006, PARASITE, V13, P143, DOI 10.1051/parasite/2006132143; Cabral AD, 2013, VET PARASITOL, V193, P100, DOI 10.1016/j.vetpar.2012.11.015; Castro FC, 2001, REV BRAS GINECOL OBS, V23, P277; da Silva RC, 2011, VET PARASITOL, V175, P173, DOI 10.1016/j.vetpar.2010.09.021; Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673; Dubey JP, 2011, J PARASITOL, V97, P842, DOI 10.1645/GE-2728.1; Dubey JP, 2010, J PARASITOL, V96, P709, DOI 10.1645/GE-2425.1; Dubey JP, 2002, INT J PARASITOL, V32, P99, DOI 10.1016/S0020-7519(01)00364-2; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Ferreira AD, 2006, INFECT GENET EVOL, V6, P22, DOI 10.1016/j.meegid.2004.12.004; Frazao-Teixeira E, 2011, VET PARASITOL, V175, P33, DOI 10.1016/j.vetpar.2010.09.030; Germano P. M. L., 1985, Revista da Faculdade de Medicina Veterinaria e Zootecnia da Universidade de Sao Paulo, V22, P53; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025; Khan A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000404; Lindsay DS, 1997, VET PARASITOL, V73, P27, DOI 10.1016/S0304-4017(97)00048-4; LITERAK I, 1993, AVIAN PATHOL, V22, P275, DOI 10.1080/03079459308418920; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Pena HFJ, 2013, VET PARASITOL, V192, P111, DOI 10.1016/j.vetpar.2012.10.004; Ragozo AMA, 2010, VET PARASITOL, V170, P307, DOI 10.1016/j.vetpar.2010.02.024; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Ferreira IMR, 2011, EXP PARASITOL, V129, P190, DOI 10.1016/j.exppara.2011.06.002; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Soares RM, 2011, VET PARASITOL, V178, P29, DOI 10.1016/j.vetpar.2010.12.037; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Vidigal Paula Vieira Teixeira, 2002, Rev. Soc. Bras. Med. Trop., V35, P1, DOI 10.1590/S0037-86822002000100001; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053483; Yai LEO, 2009, VET PARASITOL, V162, P332, DOI 10.1016/j.vetpar.2009.03.007	34	57	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90237	10.1371/journal.pone.0090237	http://dx.doi.org/10.1371/journal.pone.0090237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587295	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800094
J	Stegmaier, J; Otte, JC; Kobitski, A; Bartschat, A; Garcia, A; Nienhaus, GU; Strahle, U; Mikut, R				Stegmaier, Johannes; Otte, Jens C.; Kobitski, Andrei; Bartschat, Andreas; Garcia, Ariel; Nienhaus, G. Ulrich; Straehle, Uwe; Mikut, Ralf			Fast Segmentation of Stained Nuclei in Terabyte-Scale, Time Resolved 3D Microscopy Image Stacks	PLOS ONE			English	Article							CELL-NUCLEI; EMBRYOS; RECONSTRUCTION; GENERATION; SOFTWARE	Automated analysis of multi-dimensional microscopy images has become an integral part of modern research in life science. Most available algorithms that provide sufficient segmentation quality, however, are infeasible for a large amount of data due to their high complexity. In this contribution we present a fast parallelized segmentation method that is especially suited for the extraction of stained nuclei from microscopy images, e. g., of developing zebrafish embryos. The idea is to transform the input image based on gradient and normal directions in the proximity of detected seed points such that it can be handled by straightforward global thresholding like Otsu's method. We evaluate the quality of the obtained segmentation results on a set of real and simulated benchmark images in 2D and 3D and show the algorithm's superior performance compared to other state-of-the-art algorithms. We achieve an up to ten-fold decrease in processing times, allowing us to process large data sets while still providing reasonable segmentation results.	[Stegmaier, Johannes; Bartschat, Andreas; Mikut, Ralf] Karlsruhe Inst Technol, Inst Appl Comp Sci IAI, D-76021 Karlsruhe, Germany; [Otte, Jens C.; Kobitski, Andrei; Nienhaus, G. Ulrich; Straehle, Uwe] Karlsruhe Inst Technol, ITG, D-76021 Karlsruhe, Germany; [Garcia, Ariel] Karlsruhe Inst Technol, SCC, D-76021 Karlsruhe, Germany; [Kobitski, Andrei; Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Inst Appl Phys APH, D-76021 Karlsruhe, Germany; [Kobitski, Andrei; Nienhaus, G. Ulrich] Karlsruhe Inst Technol, CFN, D-76021 Karlsruhe, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL USA	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign	Stegmaier, J (corresponding author), Karlsruhe Inst Technol, Inst Appl Comp Sci IAI, D-76021 Karlsruhe, Germany.	johannes.stegmaier@kit.edu	Stegmaier, Johannes/ABA-4230-2021; Mikut, Ralf/A-5949-2013; Nienhaus, Gerd Ulrich/G-8698-2012; Straehle, Uwe/K-7054-2013	Stegmaier, Johannes/0000-0003-4072-3759; Mikut, Ralf/0000-0001-9100-5496; Nienhaus, Gerd Ulrich/0000-0002-5027-3192; 	EU IP ZF-Health [FP7-HEALTH-2007-B2]; Interreg network for synthetic biology in the Upper Rhine valley (NSB-Upper Rhine); BMBF; Helmholtz Association; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Karlsruhe Institute of Technology	EU IP ZF-Health; Interreg network for synthetic biology in the Upper Rhine valley (NSB-Upper Rhine); BMBF(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	The authors are grateful for support by the EU IP ZF-Health, FP7-HEALTH-2007-B2, NeuroXsys, the Interreg network for synthetic biology in the Upper Rhine valley (NSB-Upper Rhine), the BMBF funded network EraSysBio, and the Helmholtz Association. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Bamford P, 2003, INT C IM PROC 2003 I, V2; Beare R, 2006, INSIGHT J; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Cheng JR, 2009, IEEE T BIO-MED ENG, V56, P741, DOI 10.1109/TBME.2008.2008635; Coelho LP, 2009, I S BIOMED IMAGING, P518, DOI 10.1109/ISBI.2009.5193098; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Garcia A, 2011, P 6 INT C DIG INF MA; Hale D, 2006, RECURSIVE GAUSSIAN F; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kayser K, 2009, DIAGN PATHOL, V4; Keller P, 2011, COLD SPRING HARBOR P, V2011; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Khairy K, 2011, GENESIS, V49, P488, DOI 10.1002/dvg.20698; Korzynska A, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-48; Li CM, 2010, IEEE T IMAGE PROCESS, V19, P3243, DOI 10.1109/TIP.2010.2069690; Li G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-40; Lindeberg T, 1998, INT J COMPUT VISION, V30, P79, DOI 10.1023/A:1008045108935; Liu TM, 2008, BIOINFORMATICS, V24, P438, DOI 10.1093/bioinformatics/btm615; Lou XH, 2012, PROC CVPR IEEE, P1012; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Meijering E, 2009, SEMIN CELL DEV BIOL, V20, P894, DOI 10.1016/j.semcdb.2009.07.004; Mikula K, 2011, SPRINGER PROC MATH, V4, P693, DOI 10.1007/978-3-642-20671-9_73; Mikut R, 2013, ZEBRAFISH, V10, P401, DOI 10.1089/zeb.2013.0886; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Romo D, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S22; Schmid B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3207; Sharma H, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-134; Soubies E, 2012, HAL00733187 INR; Stegmaier J, 2012, BIOMED ENG-BIOMED TE, V57, P458, DOI 10.1515/bmt-2012-4073; Stegmaier J, 2012, P 22 WORKSH COMP INT, P55; Svoboda D, 2012, LECT NOTES COMPUT SC, V7325, P473, DOI 10.1007/978-3-642-31298-4_56; Svoboda D, 2009, CYTOM PART A, V75A, P494, DOI 10.1002/cyto.a.20714; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Wienert S, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-34; Yoo TS, 2002, STUD HEALTH TECHNOL, V85, P586; Zanella C, 2010, IEEE T IMAGE PROCESS, V19, P770, DOI 10.1109/TIP.2009.2033629	39	62	62	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90036	10.1371/journal.pone.0090036	http://dx.doi.org/10.1371/journal.pone.0090036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587204	Green Published, gold			2022-12-27	WOS:000332390800071
J	Felice, RN; O'Connor, PM				Felice, Ryan N.; O'Connor, Patrick M.			Ecology and Caudal Skeletal Morphology in Birds: The Convergent Evolution of Pygostyle Shape in Underwater Foraging Taxa	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SEXUAL-DIMORPHISM; FLIGHT BEHAVIOR; BODY-SIZE; TAILS; PATTERNS; LOCOMOTION; SELECTION; PROCELLARIIFORMES; DIVERSIFICATION	Birds exhibit a specialized tail that serves as an integral part of the flight apparatus, supplementing the role of the wings in facilitating high performance aerial locomotion. The evolution of this function for the tail contributed to the diversification of birds by allowing them to utilize a wider range of flight behaviors and thus exploit a greater range of ecological niches. The shape of the wings and the tail feathers influence the aerodynamic properties of a bird. Accordingly, taxa that habitually utilize different flight behaviors are characterized by different flight apparatus morphologies. This study explores whether differences in flight behavior are also associated with variation in caudal vertebra and pygostyle morphology. Details of the tail skeleton were characterized in 51 Aequornithes and Charadriiformes species. Free caudal vertebral morphology was measured using linear metrics. Variation in pygostyle morphology was characterized using Elliptical Fourier Analysis, a geometric morphometric method for the analysis of outline shapes. Each taxon was categorized based on flight style (flap, flap-glide, dynamic soar, etc.) and foraging style (aerial, terrestrial, plunge dive, etc.). Phylogenetic MANOVAs and Flexible Discriminant Analyses were used to test whether caudal skeletal morphology can be used to predict flight behavior. Foraging style groups differ significantly in pygostyle shape, and pygostyle shape predicts foraging style with less than 4% misclassification error. Four distinct lineages of underwater foraging birds exhibit an elongate, straight pygostyle, whereas aerial and terrestrial birds are characterized by a short, dorsally deflected pygostyle. Convergent evolution of a common pygostyle phenotype in diving birds suggests that this morphology is related to the mechanical demands of using the tail as a rudder during underwater foraging. Thus, distinct locomotor behaviors influence not only feather attributes but also the underlying caudal skeleton, reinforcing the importance of the entire caudal locomotor module in avian ecological diversification.	[Felice, Ryan N.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Felice, Ryan N.; O'Connor, Patrick M.] Ohio Univ, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [O'Connor, Patrick M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Felice, RN (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	rf273509@ohio.edu	OConnor, Patrick M/I-9383-2012; Felice, Ryan/ABG-9737-2021	OConnor, Patrick M/0000-0002-6762-3806; 	Sigma Xi [G20130315163195]; Ohio University Graduate Student Senate Original Work Grant; Ohio University Student Enhancement Award; Department of Biological Sciences; Department of Biomedical Sciences; Heritage College of Osteopathic Medicine at Ohio University	Sigma Xi; Ohio University Graduate Student Senate Original Work Grant; Ohio University Student Enhancement Award; Department of Biological Sciences; Department of Biomedical Sciences; Heritage College of Osteopathic Medicine at Ohio University	Funding was provided by the Sigma Xi Grant-in-Aid of Research, ID number G20130315163195, Ohio University Graduate Student Senate Original Work Grant, and Ohio University Student Enhancement Award. RNF is supported by the Department of Biological Sciences, and RNF and PMO are supported by the Department of Biomedical Sciences and the Heritage College of Osteopathic Medicine at Ohio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Adams DC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-216; ANDERSON JGT, 1991, COLON WATERBIRD, V14, P166, DOI 10.2307/1521506; Andersson S, 1992, ANIMAL BEHAV; BALMFORD A, 1993, NATURE, V361, P628, DOI 10.1038/361628a0; BALMFORD A, 1994, EVOLUTION, V48, P1062, DOI 10.1111/j.1558-5646.1994.tb05293.x; BANCROFT GT, 1984, CONDOR, V86, P423, DOI 10.2307/1366822; Barr JF, 1996, HYDROBIOLOGIA, V321, P119, DOI 10.1007/BF00023169; Baumel J. J, 1988, FUNCTIONAL MORPHOLOG; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Bell A, 2011, J SYST PALAEONTOL, V9, P119, DOI 10.1080/14772019.2010.525536; Benson RBJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1780; Berner D, 2008, J EVOLUTION BIOL, V21, P1653, DOI 10.1111/j.1420-9101.2008.01583.x; Bleiweiss R, 2009, BIOL J LINN SOC, V97, P467, DOI 10.1111/j.1095-8312.2009.01240.x; Bonhomme V, 2013, J STAT SOFT IN PRESS; Brewer ML, 2007, J MORPHOL, V268, P866, DOI 10.1002/jmor.10555; BROWN DE, 1980, J WILDLIFE MANAGE, V44, P198, DOI 10.2307/3808366; Burt WH, 1930, U CALIFORNIA PUBLICA; CLARK BD, 1979, J ZOOL, V188, P411; Claude J, 2008, MORPHOMETRICS R; Close RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036664; Coulson John C., 2002, P87; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; del Hoyo J., 1992, P1; Dial KP, 2006, ACTA ZOOL SINICA, V52, P502; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; EVANS MR, 1992, ANIM BEHAV, V43, P337, DOI 10.1016/S0003-3472(05)80229-5; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; FISHER HI, 1946, AM MIDL NAT, V35, P545, DOI 10.2307/2421553; Fitzpatrick J.W., 1985, ORNITHOLOGICAL MONOG, V36, P447, DOI [10.2307/40168298, DOI 10.2307/40168298]; Fitzpatrick S, 1999, J EVOLUTION BIOL, V12, P49; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; FREDERICK PC, 1992, WILSON BULL, V104, P1; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Gatesy SM, 1996, EVOLUTION, V50, P2037, DOI 10.1111/j.1558-5646.1996.tb03590.x; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Habib MB, 2008, ZOOL J LINN SOC-LOND, V153, P601, DOI 10.1111/j.1096-3642.2008.00402.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hamilton J. L., 2006, ALCID SWIMMING KINEM; Hand DJ, 1987, MULTIVARIATE ANAL VA, DOI [10.1007/978-94-009-3143-5, DOI 10.1007/978-94-009-3143-5]; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hinic-Frlog S, 2010, J EVOLUTION BIOL, V23, P372, DOI 10.1111/j.1420-9101.2009.01909.x; Hobson KA, 1992, OBSERVATIONS FORAGIN; HUI CA, 1985, CAN J ZOOL, V63, P2165, DOI 10.1139/z85-318; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P31, DOI 10.1016/S0169-5347(97)01273-1; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; KAHL MP, 1987, COLON WATERBIRD, V10, P131, DOI 10.2307/1521251; Kelly JF, 2003, WILSON BULL, V115, P105, DOI 10.1676/02-053; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; LeCorre M, 1997, CONDOR, V99, P1004; Lovvorn JR, 2002, FUNCT ECOL, V16, P106, DOI 10.1046/j.0269-8463.2001.00604.x; LOVVORN JR, 1991, J EXP BIOL, V159, P89; Mallarino R, 2012, ANNU REV CELL DEV BI, V28, P743, DOI 10.1146/annurev-cellbio-101011-155732; Manegold A, 2013, J ZOOL SYST EVOL RES, V51, P72, DOI 10.1111/jzs.12000; Martin L.D., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P35; Maybury WJ, 2001, P ROY SOC B-BIOL SCI, V268, P1443, DOI 10.1098/rspb.2001.1666; Mayr G, 2011, J ZOOL SYST EVOL RES, V49, P58, DOI 10.1111/j.1439-0469.2010.00586.x; McCracken KG, 1999, SYST BIOL, V48, P683, DOI 10.1080/106351599259979; MCMAHON BF, 1992, BEHAVIOUR, V120, P69, DOI 10.1163/156853992X00219; Monteiro LR, 2010, EVOLUTION, V64, P724, DOI 10.1111/j.1558-5646.2009.00857.x; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; MOSIMANN JE, 1979, EVOLUTION, V33, P444, DOI 10.1111/j.1558-5646.1979.tb04697.x; Motani R, 2011, EVOLUTION, V65, P2245, DOI 10.1111/j.1558-5646.2011.01271.x; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; Owens IPF, 1999, P ROY SOC B-BIOL SCI, V266, P933, DOI 10.1098/rspb.1999.0726; Owre OT, 1967, ADAPTATIONS LOCOMOTI; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; PENNYCUICK CJ, 1987, J EXP BIOL, V128, P335; Pennycuick CJ, 1997, J EXP BIOL, V200, P2355; Pryke SR, 2005, BIOL J LINN SOC, V86, P35, DOI 10.1111/j.1095-8312.2005.00522.x; Raikow RJ, 1970, U CALIFORNIA PUBLICA; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; RICHARDSON F, 1972, CONDOR, V74, P350, DOI 10.2307/1366597; Richardson F, 1942, ADAPTIVE MODIFICATIO; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; ROSS RK, 1976, WILSON BULL, V88, P143; Sachs G, 2007, J THEOR BIOL, V249, P464, DOI 10.1016/j.jtbi.2007.07.014; Sanger TJ, 2012, EVOLUTION, V66, P1525, DOI 10.1111/j.1558-5646.2011.01519.x; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D, 1996, AM NAT, V148, pS40, DOI 10.1086/285901; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Sheets H. David, 2006, Frontiers in Zoology, V3, pUnpaginated, DOI 10.1186/1742-9994-3-15; Simons ELR, 2011, J MORPHOL, V272, P958, DOI 10.1002/jmor.10963; Simons ELR, 2010, ZOOLOGY, V113, P39, DOI 10.1016/j.zool.2009.05.002; Smith ND, 2012, EVOLUTION, V66, P1059, DOI 10.1111/j.1558-5646.2011.01494.x; Smith ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013354; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Thomas ALR, 1996, J THEOR BIOL, V183, P247, DOI 10.1006/jtbi.1996.0218; THOMAS ALR, 1993, PHILOS T ROY SOC B, V340, P361, DOI 10.1098/rstb.1993.0079; Thomas ALR, 1995, AM NAT, V146, P848, DOI 10.1086/285828; Thomas ALR, 1997, BIOSCIENCE, V47, P215, DOI 10.2307/1313075; Van Bocxlaer B, 2010, PALEOBIOLOGY, V36, P497, DOI 10.1666/08068.1; Van Oort ED, 1904, BEITRAG OSTEOLOGIE V; Veit AC, 2003, AUK, V120, P1033, DOI 10.1642/0004-8038(2003)120[1033:FOTSOR]2.0.CO;2; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Wang Xia, 2011, PLoS ONE, V6, P1, DOI 10.1371/journal.pone.0028672; Ward AB, 2010, INTEGR COMP BIOL, V50, P1106, DOI 10.1093/icb/icq029; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; Zeffer A, 2003, BIOL J LINN SOC, V79, P461, DOI 10.1046/j.1095-8312.2003.00200.x	107	28	29	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89737	10.1371/journal.pone.0089737	http://dx.doi.org/10.1371/journal.pone.0089737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586998	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000087
J	Ross, LL; Horton, J; Hasan, S; Brown, JR; Murphy, D; DeJesus, E; Potter, M; LaMarca, A; Melendez-Rivera, I; Ward, D; Uy, J; Shaefer, MS				Ross, Lisa L.; Horton, Joseph; Hasan, Samiul; Brown, James R.; Murphy, Daniel; DeJesus, Edwin; Potter, Martin; LaMarca, Anthony; Melendez-Rivera, Ivan; Ward, Douglas; Uy, Jonathon; Shaefer, Mark S.			HIV-1 Transmission Patterns in Antiretroviral Therapy-Naive, HIV-Infected North Americans Based on Phylogenetic Analysis by Population Level and Ultra-Deep DNA Sequencing	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; RITONAVIR-BOOSTED ATAZANAVIR; SUBTYPE B; NETWORKS; EPIDEMIC; CLUSTERS; SEX; MEN; ABACAVIR/LAMIVUDINE; SUPPRESSION	Factors that contribute to the transmission of human immunodeficiency virus type 1 (HIV-1), especially drug-resistant HIV-1 variants remain a significant public health concern. In-depth phylogenetic analyses of viral sequences obtained in the screening phase from antiretroviral-naive HIV-infected patients seeking enrollment in EPZ108859, a large open-label study in the USA, Canada and Puerto Rico (ClinicalTrials.gov NCT00440947) were examined for insights into the roles of drug resistance and epidemiological factors that could impact disease dissemination. Viral transmission clusters (VTCs) were initially predicted from a phylogenetic analysis of population level HIV-1 pol sequences obtained from 690 antiretroviral-naive subjects in 2007. Subsequently, the predicted VTCs were tested for robustness by ultra deep sequencing (UDS) using pyrosequencing technology and further phylogenetic analyses. The demographic characteristics of clustered and non-clustered subjects were then compared. From 690 subjects, 69 were assigned to 1 of 30 VTCs, each containing 2 to 5 subjects. Race composition of VTCs were significantly more likely to be white (72% vs. 60%; p = 0.04). VTCs had fewer reverse transcriptase and major PI resistance mutations (9% vs. 24%; p = 0.002) than non-clustered sequences. Both men-who-have-sex-with-men (MSM) (68% vs. 48%; p = 0.001) and Canadians (29% vs. 14%; p = 0.03) were significantly more frequent in VTCs than non-clustered sequences. Of the 515 subjects who initiated antiretroviral therapy, 33 experienced confirmed virologic failure through 144 weeks while only 3/33 were from VTCs. Fewer VTCs subjects (as compared to those with non-clustering virus) had HIV-1 with resistance-associated mutations or experienced virologic failure during the course of the study. Our analysis shows specific geographical and drug resistance trends that correlate well with transmission clusters defined by HIV sequences of similarity. Furthermore, our study demonstrates the utility of molecular and epidemiological analysis of VTCs for identifying population-specific risks associated with HIV-1 transmission and developing effective local healthcare strategies.	[Ross, Lisa L.; Shaefer, Mark S.] ViiV HealthCare, Res Triangle Pk, NC 27709 USA; [Horton, Joseph; Brown, James R.] GlaxoSmithKline, Res Triangle Pk, NC USA; [Hasan, Samiul] GlaxoSmithKline, Stevenage, Herts, England; [Murphy, Daniel] Clin Med Lactuel, Montreal, PQ, Canada; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Potter, Martin] McGill Univ Hlth Ctr, Montreal, PQ, Canada; [LaMarca, Anthony] Therafirst Med Ctr, Ft Lauderdale, FL USA; [Melendez-Rivera, Ivan] Ctr Ararat, Ponce, PR USA; [Ward, Douglas] Dupont Circle Physicians Grp, Washington, DC USA; [Uy, Jonathon] Amicus Therapeut, Cranbury, NJ USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Orlando Immunology Center; McGill University	Ross, LL (corresponding author), ViiV HealthCare, Res Triangle Pk, NC 27709 USA.	Lisa.L.Ross@viivhealthcare.com		Shaefer, Mark/0000-0002-0545-7304; Brown, James/0000-0002-9368-627X	ViiV Healthcare, RTP, NC, USA	ViiV Healthcare, RTP, NC, USA	This ad hoc phylogenetic analysis used study data from EPZ108859, which was sponsored by ViiV Healthcare, RTP, NC, USA (http://www.viivhealthcare.com/). BristolMyers-Squibb supplied the atazanavir used by eligible participants in EPZ108859. L.L.R. and M.S.S. are employed by ViiV Healthcare and they had roles in the original study design, collection of data and analysis, as well as roles in the ad hoc phylogenetic analysis design and analysis as well as the decision to publish and the preparation of the manuscript; J.U. played a role in ad hoc analysis, the decision to publish and the preparation of the manuscript and was employed by BristolMyers-Squibb during the initial data collection. J.H., S.H. and J.B., employed by GlaxoSmithKline, were involved in the ad hoc phylogenetic analysis design and analysis and manuscript writing. D.M., E.D., M.P., A.L., I.M-R., and D.W. were involved with the clinical data collection and manuscript writing.	Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Cachay Edward R, 2007, Open AIDS J, V1, P5, DOI 10.2174/1874613600701010005; Callegaro A, 2011, INFECT GENET EVOL, V11, P624, DOI 10.1016/j.meegid.2011.01.019; Castro E, 2010, AIDS RES HUM RETROV, V26, P1233, DOI 10.1089/aid.2010.0083; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Chan PA, 2011, AIDS RES HUM RETROV, V27, P275, DOI 10.1089/aid.2010.0198; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Felsentein J, 2000, PHYLIP PHYLOGENETIC; Fisher M, 2010, AIDS, V24, P1739, DOI 10.1097/QAD.0b013e32833ac9e6; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jafa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005416; Lai A, 2012, AIDS RES HUM RETROV, V28, P857, DOI [10.1089/aid.2011.0245, 10.1089/AID.2011.0245]; Lambert G, 2011, AIDS BEHAV, V15, P584, DOI 10.1007/s10461-009-9605-3; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Martinez-Picado J, 2000, VIROLOGY, V275, P318, DOI 10.1006/viro.2000.0527; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Paredes R, 2012, J INT AIDS SOC, V15, P7, DOI 10.7448/IAS.15.6.18309; Rumyantseva OA, 2009, AIDS RES HUM RETROV, V25, P931, DOI 10.1089/aid.2009.0075; Skoura L, 2011, J ANTIMICROB CHEMOTH, V66, P2831, DOI 10.1093/jac/dkr386; Smith DA, 2009, AIDS, V23, P225, DOI 10.1097/QAD.0b013e32831d2a81; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Squires KE, 2012, HIV CLIN TRIALS, V13, P233, DOI 10.1310/hct1305-233; Squires KE, 2010, AIDS, V24, P2019, DOI 10.1097/QAD.0b013e32833bee1b; Squires KE, 2010, HIV CLIN TRIALS, V11, P69, DOI 10.1310/hct1102-69; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89611	10.1371/journal.pone.0089611	http://dx.doi.org/10.1371/journal.pone.0089611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586911	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000067
J	Bretman, A; Lize, A; Walling, CA; Price, TAR				Bretman, Amanda; Lize, Anne; Walling, Craig A.; Price, Tom A. R.			The Heritability of Mating Behaviour in a Fly and Its Plasticity in Response to the Threat of Sperm Competition	PLOS ONE			English	Article							BY-ENVIRONMENT INTERACTIONS; SEX-RATIO POLYMORPHISM; DROSOPHILA-MELANOGASTER; PHENOTYPIC PLASTICITY; REACTION NORMS; NATURAL-POPULATIONS; COPULATION DURATION; GENETIC-VARIATION; SELECTION; EVOLUTION	Phenotypic plasticity is a key mechanism by which animals can cope with rapidly changeable environments, but the evolutionary lability of such plasticity remains unclear. The socio-sexual environment can fluctuate very rapidly, affecting both the frequency of mating opportunities and the level of competition males may face. Males of many species show plastic behavioural responses to changes in social environment, in particular the presence of rival males. For example, Drosophila pseudoobscura males respond to rivals by extending mating duration and increasing ejaculate size. Whilst such responses are predicted to be adaptive, the extent to which the magnitude of response is heritable, and hence selectable, is unknown. We investigated this using isofemale lines of the fruit fly D. pseudoobscura, estimating heritability of mating duration in males exposed or not to a rival, and any genetic basis to the change in this trait between these environments (i.e. degree of plasticity). The two populations differed in population sex ratio, and the presence of a sex ratio distorting selfish chromosome. We find that mating duration is heritable, but no evidence of population differences. We find no significant heritability of plasticity in mating duration in one population, but borderline significant heritability of plasticity in the second. This difference between populations might be related to the presence of the sex ratio distorting selfish gene in the latter population, but this will require investigation in additional populations to draw any conclusions. We suggest that there is scope for selection to produce an evolutionary response in the plasticity of mating duration in response to rivals in D. pseudoobscura, at least in some populations.	[Bretman, Amanda] Univ Leeds, Sch Biol Sci, Leeds, W Yorkshire, England; [Lize, Anne; Price, Tom A. R.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Walling, Craig A.] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Leeds; University of Liverpool; University of Edinburgh	Price, TAR (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	Tom.Price@liverpool.ac.uk	Walling, Craig/HGT-8539-2022; Lizé, Anne/B-9897-2011	Lizé, Anne/0000-0002-7289-4205; Price, Thomas/0000-0002-4394-6301; Bretman, Amanda/0000-0002-4421-3337	BBSRC [BB/H002499/1]; Marie Curie fellowship [FP7PEOPLE-IEF 2008/235645]; NERC [NE/I020245/1, NE/H015604/1]; Biotechnology and Biological Sciences Research Council [BB/H002499/1] Funding Source: researchfish; Natural Environment Research Council [NE/I020245/1, NE/H015604/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie fellowship(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AB was supported by a BBSRC grant (BB/H002499/1) to Tracey Chapman, Matt Gage and AB. AL is supported by a Marie Curie fellowship (FP7PEOPLE-IEF 2008/235645). CW is supported by NERC grant NE/I020245/1. TP is supported by NERC grant NE/H015604/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer JA, 2013, ANIM PROD SCI, V53, P1083, DOI 10.1071/AN12305; Barron AB, 2000, J INSECT PHYSIOL, V46, P439, DOI 10.1016/S0022-1910(99)00129-8; Beckenbach AT, 1996, EVOLUTION, V50, P787, DOI 10.1111/j.1558-5646.1996.tb03888.x; BECKENBACH AT, 1978, AM NAT, V112, P97, DOI 10.1086/283255; Bretman A, 2011, CURR BIOL, V21, P1, DOI DOI 10.1016/J.CUB.2010.11.056; Bretman A, 2012, P ROY SOC B-BIOL SCI, V279, P2868, DOI 10.1098/rspb.2012.0235; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Bretman A, 2010, BEHAV ECOL, V21, P317, DOI 10.1093/beheco/arp189; Bretman A, 2009, P ROY SOC B-BIOL SCI, V276, P1705, DOI 10.1098/rspb.2008.1878; Brommer JE, 2005, EVOLUTION, V59, P1362; Brommer JE, 2008, P ROY SOC B-BIOL SCI, V275, P687, DOI 10.1098/rspb.2007.0951; Brown EA, 2009, HEREDITY, V103, P340, DOI 10.1038/hdy.2009.80; BRYANT SH, 1982, EVOLUTION, V36, P27, DOI 10.1111/j.1558-5646.1982.tb05006.x; CARROLL SP, 1995, BEHAV ECOL, V6, P46, DOI 10.1093/beheco/6.1.46; Charney E, 2012, BEHAV BRAIN SCI, V35, P331, DOI 10.1017/S0140525X11002226; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; Dingemanse NJ, 2012, J EVOLUTION BIOL, V25, P485, DOI 10.1111/j.1420-9101.2011.02439.x; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; DOBZHANSKY T, 1958, EVOLUTION, V12, P385, DOI 10.1111/j.1558-5646.1958.tb02968.x; Dobzhansky T., 1944, CONTRIBUTIONS GENETI; Fisher, 1958, GENETICAL THEORY NAT; Fisher DN, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-157; Ghalambor Cameron K., 2010, P90; Gilmour AR, 2009, ASREML USER GUIDE RE; GROMKO MH, 1989, HEREDITY, V62, P251, DOI 10.1038/hdy.1989.35; GROMKO MH, 1991, EVOLUTION, V45, P69, DOI 10.1111/j.1558-5646.1991.tb05267.x; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Holman L, 2008, CURR BIOL, V18, P292, DOI 10.1016/j.cub.2008.01.048; Ingleby FC, 2013, J EVOLUTION BIOL, V26, P94, DOI 10.1111/jeb.12030; Jia FY, 2000, EVOLUTION, V54, P953; Kasumovic MM, 2008, EVOLUTION, V62, P2316, DOI 10.1111/j.1558-5646.2008.00446.x; Lize A, 2007, GENETICS, V175, P1735, DOI 10.1534/genetics.106.070045; Lize A, 2012, PHYSIOL ENTOMOL, V37, P227, DOI 10.1111/j.1365-3032.2012.00836.x; Lize A, 2012, BIOL LETTERS, V8, P35, DOI 10.1098/rsbl.2011.0544; Lynch M., 1998, GENETICS ANAL QUANTI; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Mazzi D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-132; Morrow EH, 2001, HEREDITY, V87, P356, DOI 10.1046/j.1365-2540.2001.00921.x; Muhlhauser C, 1996, ANIM BEHAV, V51, P1401, DOI 10.1006/anbe.1996.0143; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Parker G.A., 1982, P173; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P1291, DOI 10.1098/rspb.1996.0189; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; POLICANSKY D, 1979, AM NAT, V114, P672, DOI 10.1086/283515; Price TAR, 2011, ANIM BEHAV, V82, P1381, DOI 10.1016/j.anbehav.2011.09.022; Price TAR, 2012, J INSECT PHYSIOL, V58, P1669, DOI 10.1016/j.jinsphys.2012.10.008; Qvarnstrom A, 1999, EVOLUTION, V53, P1564, DOI 10.1111/j.1558-5646.1999.tb05419.x; Renn SCP, 2013, ANIM BEHAV, V85, P1012, DOI 10.1016/j.anbehav.2013.02.012; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Scheiner SM, 2002, J EVOLUTION BIOL, V15, P889, DOI 10.1046/j.1420-9101.2002.00468.x; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; Snook RR, 2000, J INSECT PHYSIOL, V46, P1489, DOI 10.1016/S0022-1910(00)00074-3; Stirling G, 2000, ANIM BEHAV, V59, P929, DOI 10.1006/anbe.1999.1386; Taylor ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077347; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Visscher PM, 2006, TWIN RES HUM GENET, V9, P490, DOI 10.1375/183242706778024928; Wedell N, 1999, EVOLUTION, V53, P620, DOI 10.1111/j.1558-5646.1999.tb03797.x; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; West-Eberhard Mary Jane, 2003, pi; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036	63	8	8	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90236	10.1371/journal.pone.0090236	http://dx.doi.org/10.1371/journal.pone.0090236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587294	gold, Green Published			2022-12-27	WOS:000332385900130
J	Liu, P; Wu, XP; Liao, CS; Liu, XL; Du, J; Shi, HN; Wang, XL; Bai, X; Peng, P; Yu, L; Wang, F; Zhao, Y; Liu, MY				Liu, Pan; Wu, Xiuping; Liao, Chengshui; Liu, Xiaolei; Du, Jing; Shi, Haining; Wang, Xuelin; Bai, Xue; Peng, Peng; Yu, Lu; Wang, Feng; Zhao, Ying; Liu, Mingyuan			Escherichia coli and Candida albicans Induced Macrophage Extracellular Trap-Like Structures with Limited Microbicidal Activity	PLOS ONE			English	Article							MANNHEIMIA-HAEMOLYTICA; ANTIMICROBIAL ACTIVITY; BOVINE NEUTROPHILS; MITOCHONDRIAL-DNA; NADPH OXIDASE; NITRIC-OXIDE; MAST-CELLS; RELEASE; INHIBITOR; MECHANISM	The formation of extracellular traps (ETs) has recently been recognized as a novel defense mechanism in several types of innate immune cells. It has been suggested that these structures are toxic to microbes and contribute significantly to killing several pathogens. However, the role of ETs formed by macrophages (METs) in defense against microbes remains little known. In this study, we demonstrated that a subset of murine J774A. 1 macrophage cell line (8% to 17%) and peritoneal macrophages (8.5% to 15%) form METs-like structures (METs-LS) in response to Escherichia coli and Candida albicans challenge. We found only a portion of murine METs-LS, which are released by dying macrophages, showed detectable killing effects on trapped E. coli but not C. albicans. Fluorescence and scanning electron microscopy analyses revealed that, in vitro, both microorganisms were entrapped in J774A. 1 METs-LS composed of DNA and microbicidal proteins such as histone, myeloperoxidase and lysozyme. DNA components of both nucleus and mitochondrion origins were detectable in these structures. Additionally, METs-LS formation occurred independently of ROS produced by NADPH oxidase, and this process did not result in cell lysis. In summary, our results emphasized that microbes induced METs-LS in murine macrophage cells and that the microbicidal activity of these METs-LS differs greatly. We propose the function of METs-LS is to contain invading microbes at the infection site, thereby preventing the systemic diffusion of them, rather than significantly killing them.	[Liu, Pan; Wu, Xiuping; Liao, Chengshui; Liu, Xiaolei; Du, Jing; Wang, Xuelin; Bai, Xue; Peng, Peng; Yu, Lu; Wang, Feng; Zhao, Ying; Liu, Mingyuan] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China; [Shi, Haining] Massachusetts Gen Hosp E, Mucosal Immunol Lab, Pediat Gastroenterol Unit, Charlestown, MA USA; [Liu, Mingyuan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China	Jilin University	Liu, MY (corresponding author), Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China.	liumy@jlu.edu.cn			Ministry of Science and Technology of China [MOST 2011AA10A215]; National Natural Science Foundation of China [NSFC 31030064, 30972177, 81070311, 31072124]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China (MOST 2011AA10A215) and the National Natural Science Foundation of China (NSFC 31030064, 30972177, 81070311, 31072124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; Alby K, 2010, EUKARYOT CELL, V9, P1690, DOI 10.1128/EC.00155-10; Alghamdi AS, 2005, BIOL REPROD, V73, P1174, DOI 10.1095/biolreprod.105.045666; Aulik NA, 2012, INFECT IMMUN, V80, P1923, DOI 10.1128/IAI.06120-11; Aulik NA, 2010, INFECT IMMUN, V78, P4454, DOI 10.1128/IAI.00840-10; Banning N, 2002, J APPL MICROBIOL, V93, P69, DOI 10.1046/j.1365-2672.2002.01670.x; Behrendt JH, 2010, VET IMMUNOL IMMUNOP, V133, P1, DOI 10.1016/j.vetimm.2009.06.012; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Byrd AS, 2013, J IMMUNOL, V190, P4136, DOI 10.4049/jimmunol.1202671; Charles A., 2001, IMMUNOBIOLOGY IMMUNE; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; CUTLER JE, 1991, ANNU REV MICROBIOL, V45, P187, DOI 10.1146/annurev.mi.45.100191.001155; DoddO JM, 1997, BRIT J PHARMACOL, V120, P857, DOI 10.1038/sj.bjp.0701014; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gabriel C, 2010, J IMMUNOL, V185, P4319, DOI 10.4049/jimmunol.1000893; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hellenbrand KM, 2013, MICROB PATHOGENESIS, V54, P67, DOI 10.1016/j.micpath.2012.09.007; Hosseinzadeh A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00391; Jann NJ, 2009, J LEUKOCYTE BIOL, V86, P1159, DOI 10.1189/jlb.0209053; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lippolis JD, 2006, VET IMMUNOL IMMUNOP, V113, P248, DOI 10.1016/j.vetimm.2006.05.004; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; McCormick A, 2010, MICROBES INFECT, V12, P928, DOI 10.1016/j.micinf.2010.06.009; Mege JL, 2011, CURR OPIN INFECT DIS, V24, P230, DOI 10.1097/QCO.0b013e328344b73e; Menegazzi R, 2012, BLOOD, V119, P1214, DOI 10.1182/blood-2011-07-364604; Mohanan S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00067; Palic D, 2007, DEV COMP IMMUNOL, V31, P805, DOI 10.1016/j.dci.2006.11.010; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Radic M, 2013, SEMIN IMMUNOPATHOL, V35, P465, DOI 10.1007/s00281-013-0376-6; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rose FRAJ, 1998, INFECT IMMUN, V66, P3255, DOI 10.1128/IAI.66.7.3255-3263.1998; Tazzeo T, 2009, BRIT J PHARMACOL, V158, P790, DOI 10.1111/j.1476-5381.2009.00394.x; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wong KW, 2013, J INFECT DIS, V208, P109, DOI 10.1093/infdis/jit097; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	53	68	74	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90042	10.1371/journal.pone.0090042	http://dx.doi.org/10.1371/journal.pone.0090042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587206	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900113
J	Sheu, MJ; Teng, YN; Chen, YY; Hung, CC				Sheu, Ming-Jyh; Teng, Yu-Ning; Chen, Ying-Yi; Hung, Chin-Chuan			The Functional Influences of Common ABCB1 Genetic Variants on the Inhibition of P-glycoprotein by Antrodia cinnamomea Extracts	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; MULTIDRUG-RESISTANCE; FRUITING BODIES; CANCER; PHARMACOKINETICS; CELLS; LEUKEMIA; POLYMORPHISMS; DIGOXIN; TRANSPORTERS	Antrodia cinnamomea is a traditional healthy food that has been demonstrated to possess anti-inflammatory, antioxidative, and anticacer effects. The purpose of this study was to evaluate whether the ethanolic extract of A. cinnamomea (EEAC) can affect the efflux function of P-glycoprotein (P-gp) and the effect of ABCB1 genetic variants on the interaction between EEAC and P-gp. To investigate the mechanism of this interaction, Flp-In (TM)-293 cells stably transfected with various genotypes of human P-gp were established and the expression of P-gp was confirmed by Western blot. The results of the rhodamine 123 efflux assay demonstrated that EEAC efficiently inhibited wild-type P-gp function at an IC50 concentration of 1.51+/-0.08 mu g/mL through non-competitive inhibition. The IC50 concentrations for variant-type 1236T-2677T-3435T P-gp and variant-type 1236T-2677A-3435T P-gp were 5.56+/-0.49 mu g/mL and 3.33+/-0.67 mu g/mL, respectively. In addition, the inhibition kinetics of EEAC also changed to uncompetitive inhibition in variant-type 1236T-2677A-3435T P-gp. The ATPase assay revealed that EEAC was an ATPase stimulator and was capable of reducing verapamil-induced ATPase levels. These results indicate that EEAC may be a potent P-gp inhibitor and higher dosages may be required in subjects carrying variant-types P-gp. Further studies are required to translate this basic knowledge into clinical applications.	[Sheu, Ming-Jyh; Teng, Yu-Ning; Chen, Ying-Yi; Hung, Chin-Chuan] China Med Univ, Dept Pharm, Coll Pharm, Taichung, Taiwan; [Hung, Chin-Chuan] China Med Univ Hosp, Dept Pharm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hung, CC (corresponding author), China Med Univ, Dept Pharm, Coll Pharm, Taichung, Taiwan.	cc0206hung@gmail.com	Yu-Ning, Teng/AAS-8002-2021		National Science Council in Taiwan [NSC 102-2320-B-039-016]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]; National Health Research Institutes in Taiwan [NHRI-102A1-PDCO-1312141]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from the National Science Council in Taiwan (NSC 102-2320-B-039-016), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004), and the National Health Research Institutes in Taiwan (NHRI-102A1-PDCO-1312141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CY, 2008, J ETHNOPHARMACOL, V118, P387, DOI 10.1016/j.jep.2008.05.001; Chen YY, 2012, PHYTOMEDICINE, V19, P768, DOI 10.1016/j.phymed.2012.02.016; Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744; Eid SY, 2013, PHYTOMEDICINE, V21, P47, DOI 10.1016/j.phymed.2013.07.019; Falasca M, 2012, EXPERT OPIN INV DRUG, V21, P657, DOI 10.1517/13543784.2012.679339; Fenner KS, 2009, CLIN PHARMACOL THER, V85, P173, DOI 10.1038/clpt.2008.195; Gillet JP, 2011, CURR PHARM BIOTECHNO, V12, P686, DOI 10.2174/138920111795163931; Green H, 2008, J PHARM SCI-US, V97, P2045, DOI 10.1002/jps.21169; Hseu YC, 2004, NUTR CANCER, V48, P189, DOI 10.1207/s15327914nc4802_9; Hsu YL, 2007, FOOD CHEM TOXICOL, V45, P1249, DOI 10.1016/j.fct.2007.01.005; Hung CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059419; Hung CC, 2011, INVEST NEW DRUG, V29, P1337, DOI 10.1007/s10637-010-9496-1; Isla D, 2004, ANN ONCOL, V15, P1194, DOI 10.1093/annonc/mdh319; Jabir RS, 2012, PHARMACOGENOMICS, V13, P1979, DOI [10.2217/PGS.12.165, 10.2217/pgs.12.165]; Kafka A, 2003, INT J ONCOL, V22, P1117; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kishimoto W, 2014, DRUG METAB DISPOS, V42, P257, DOI 10.1124/dmd.113.053769; Liu FC, 2013, PHYTOMEDICINE, V20, P874, DOI 10.1016/j.phymed.2013.03.008; Liu YM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/569737; Lu MC, 2013, PHARMACOL THERAPEUT, V139, P124, DOI 10.1016/j.pharmthera.2013.04.001; Mathijssen RHJ, 2003, CLIN CANCER RES, V9, P3246; Neuhoff S, 2013, J PHARM SCI-US, V102, P3145, DOI 10.1002/jps.23594; Neuhoff S, 2013, J PHARM SCI-US, V102, P3161, DOI 10.1002/jps.23607; Sissung TM, 2008, CLIN CANCER RES, V14, P4543, DOI 10.1158/1078-0432.CCR-07-4230; Tateishi T, 2008, BRIT J CLIN PHARMACO, V65, P693, DOI 10.1111/j.1365-2125.2008.03116.x; Ueda K, 2011, BIOSCI BIOTECH BIOCH, V75, P401, DOI 10.1271/bbb.100816; Wang HC, 2013, J AGR FOOD CHEM, V61, P8556, DOI 10.1021/jf402849b; Yasui-Furukori N, 2005, CLIN PHARMACOL THER, V77, P17, DOI 10.1016/j.clpt.2004.08.026; Yu M, 2013, CANCER METAST REV, V32, P211, DOI 10.1007/s10555-012-9402-8; Zhao Y, 2013, BRIT J PHARMACOL, V171, P1043	30	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89622	10.1371/journal.pone.0089622	http://dx.doi.org/10.1371/journal.pone.0089622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586917	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900059
J	Wang, Y; Jackson, KJL; Davies, J; Chen, ZL; Gaeta, BA; Rimmer, J; Sewell, WA; Collins, AM				Wang, Yan; Jackson, Katherine J. L.; Davies, Janet; Chen, Zhiliang; Gaeta, Bruno A.; Rimmer, Janet; Sewell, William A.; Collins, Andrew M.			IgE-Associated IGHV Genes from Venom and Peanut Allergic Individuals Lack Mutational Evidence of Antigen Selection	PLOS ONE			English	Article							HUMAN-IMMUNOGLOBULIN HEAVY; SOMATIC HYPERMUTATION; RHINITIS PATIENTS; TRANSCRIPTS; DISEASE; REPERTOIRES; MATURATION; SEQUENCE; PATIENT; DRIVEN	Antigen selection of B cells within the germinal center reaction generally leads to the accumulation of replacement mutations in the complementarity-determining regions (CDRs) of immunoglobulin genes. Studies of mutations in IgE-associated VDJ gene sequences have cast doubt on the role of antigen selection in the evolution of the human IgE response, and it may be that selection for high affinity antibodies is a feature of some but not all allergic diseases. The severity of IgE-mediated anaphylaxis is such that it could result from higher affinity IgE antibodies. We therefore investigated IGHV mutations in IgE-associated sequences derived from ten individuals with a history of anaphylactic reactions to bee or wasp venom or peanut allergens. IgG sequences, which more certainly experience antigen selection, served as a control dataset. A total of 6025 unique IgE and 5396 unique IgG sequences were generated using high throughput 454 pyrosequencing. The proportion of replacement mutations seen in the CDRs of the IgG dataset was significantly higher than that of the IgE dataset, and the IgE sequences showed little evidence of antigen selection. To exclude the possibility that 454 errors had compromised analysis, rigorous filtering of the datasets led to datasets of 90 core IgE sequences and 411 IgG sequences. These sequences were present as both forward and reverse reads, and so were most unlikely to include sequencing errors. The filtered datasets confirmed that antigen selection plays a greater role in the evolution of IgG sequences than of IgE sequences derived from the study participants.	[Wang, Yan; Jackson, Katherine J. L.; Collins, Andrew M.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Davies, Janet] Univ Queensland, Lung & Allergy Res Ctr, Sch Med, Woolloongabba, Qld, Australia; [Chen, Zhiliang; Gaeta, Bruno A.] Univ New S Wales, Sch Comp Sci & Engn, Sydney, NSW, Australia; [Rimmer, Janet] St Vincents Clin, Darlinghurst, NSW 2010, Australia; [Sewell, William A.] St Vincents Hosp, Inst Lab Med, Darlinghurst, NSW 2010, Australia; [Sewell, William A.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW, Australia	University of New South Wales Sydney; University of Queensland; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Collins, AM (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	a.collins@unsw.edu.au	Jackson, Katherine/AAE-4326-2019; Davies, Janet/C-7989-2009; Gaeta, Bruno/K-2849-2012	Gaeta, Bruno/0000-0003-4723-4982; Jackson, Katherine/0000-0002-9952-7069; Davies, Janet/0000-0002-6378-4119	National Health and Medical Research Council [455440]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council, Grant number 455440. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests	[Anonymous], 2013, SCI TRANSL MED; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Briney BS, 2012, GENES IMMUN, V13, P469, DOI 10.1038/gene.2012.20; Chan TD, 2012, IMMUNOL REV, V247, P11, DOI 10.1111/j.1600-065X.2012.01118.x; Chen Zhiliang, 2010, Immunome Res, V6 Suppl 1, pS4, DOI 10.1186/1745-7580-6-S1-S4; Coker HA, 2003, J IMMUNOL, V171, P5602, DOI 10.4049/jimmunol.171.10.5602; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; Dahlke I, 2006, J ALLERGY CLIN IMMUN, V117, P1477, DOI 10.1016/j.jaci.2005.12.1359; Davies JM, 2008, CLIN EXP ALLERGY, V38, P566, DOI 10.1111/j.1365-2222.2008.02941.x; Davies JM, 2013, J ALLERGY CLIN IMMUN, V131, P972, DOI 10.1016/j.jaci.2012.12.1569; Davies JM, 2004, CLIN EXP ALLERGY, V34, P429, DOI 10.1111/j.1365-2222.2004.01900.x; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Dullaers M, 2012, J ALLERGY CLIN IMMUN, V129, P635, DOI 10.1016/j.jaci.2011.10.029; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Gaeta BA, 2007, BIOINFORMATICS, V23, P1580, DOI 10.1093/bioinformatics/btm147; Janezic A, 1998, J ALLERGY CLIN IMMUN, V101, P391, DOI 10.1016/S0091-6749(98)70253-2; Kabat EA, 1991, SEQUENCES PROTEINS I; Kerzel S, 2010, J IMMUNOL, V185, P2253, DOI 10.4049/jimmunol.0902942; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Levin M, 2013, INT ARCH ALLERGY IMM, V161, P122, DOI 10.1159/000345421; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Pallares N, 1999, EXP CLIN IMMUNOGENET, V16, P36, DOI 10.1159/000019095; Sicherer SH, 2005, J ALLERGY CLIN IMMUN, V116, P153, DOI 10.1016/j.jaci.2005.03.017; Snow RE, 1997, EUR J IMMUNOL, V27, P162, DOI 10.1002/eji.1830270124; Snow RE, 1999, IMMUNOLOGY, V98, P646, DOI 10.1046/j.1365-2567.1999.00910.x; Tomlinson IM, 1996, V BASE SEQUENCE DIRE; VANDERSTOEP N, 1993, J EXP MED, V177, P99, DOI 10.1084/jem.177.1.99; Wang Y, 2008, IMMUNOL CELL BIOL, V86, P111, DOI 10.1038/sj.icb.7100144; Wang Y, 2011, IMMUNOGENETICS, V63, P259, DOI 10.1007/s00251-010-0510-8; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941; Zheng NY, 2005, J EXP MED, V201, P1467, DOI 10.1084/jem.20042483	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89730	10.1371/journal.pone.0089730	http://dx.doi.org/10.1371/journal.pone.0089730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586993	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900073
J	Yamada, E; Bastie, CC				Yamada, Eijiro; Bastie, Claire C.			Disruption of Fyn SH3 Domain Interaction with a Proline-Rich Motif in Liver Kinase B1 Results in Activation of AMP-Activated Protein Kinase	PLOS ONE			English	Article							TYROSINE KINASE; CELLULAR-LOCALIZATION; MUSCLE-CELLS; IN-VITRO; SRC; UPSTREAM; PATHWAY; BETA; LKB1; PHOSPHORYLATION	Fyn-deficient mice display increased AMP-activated Protein Kinase (AMPK) activity as a result of Fyn-dependent regulation of Liver Kinase B1 (LKB1) in skeletal muscle. Mutation of Fyn-specific tyrosine sites in LKB1 results in LKB1 export into the cytoplasm and increased AMPK activation site phosphorylation. This study characterizes the structural elements responsible for the physical interaction between Fyn and LKB1. Effects of point mutations in the Fyn SH2/SH3 domains and in the LKB1 proline-rich motif on 1) Fyn and LKB1 binding, 2) LKB1 subcellular localization and 3) AMPK phosphorylation were investigated in C2C12 muscle cells. Additionally, novel LKB1 proline-rich motif mimicking cell permeable peptides were generated to disrupt Fyn/LKB1 binding and investigate the consequences on AMPK activity in both C2C12 cells and mouse skeletal muscle. Mutation of either Fyn SH3 domain or the proline-rich motif of LKB1 resulted in the disruption of Fyn/LKB1 binding, re-localization of 70% of LKB1 signal in the cytoplasm and a 2-fold increase in AMPK phosphorylation. In vivo disruption of the Fyn/LKB1 interaction using LKB1 proline-rich motif mimicking cell permeable peptides recapitulated Fyn pharmacological inhibition. We have pinpointed the structural elements within Fyn and LKB1 that are responsible for their binding, demonstrating the functionality of this interaction in regulating AMPK activity.	[Yamada, Eijiro; Bastie, Claire C.] Albert Einstein Coll Med, Diabet Res & Training Ctr, Dept Med, Bronx, NY 10467 USA; [Yamada, Eijiro] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Bastie, Claire C.] Univ Warwick, Warwick Med Sch, Div Metab & Vasc Hlth, Coventry CV4 7AL, W Midlands, England; [Yamada, Eijiro] Gunma Univ, Dept Med & Mol Sci, Grad Sch Med, Gunma, Japan	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Warwick; Gunma University	Bastie, CC (corresponding author), Albert Einstein Coll Med, Diabet Res & Training Ctr, Dept Med, Bronx, NY 10467 USA.	claire.bastie@einstein.yu.edu		Bastie, Claire/0000-0001-8178-4748	NIH [DK81412]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081412] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH DK81412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Feng DR, 2011, DIABETES, V60, P2134, DOI 10.2337/db10-1411; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; MUSACCHIO A, 1994, PROG BIOPHYS MOL BIO, V61, P283, DOI 10.1016/0079-6107(94)90003-5; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Solheim SA, 2008, FEBS J, V275, P4863, DOI 10.1111/j.1742-4658.2008.06626.x; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamada E, 2010, FUTURE MED CHEM, V2, P1785, DOI 10.4155/FMC.10.264; Yamada E, 2010, CELL METAB, V11, P113, DOI 10.1016/j.cmet.2009.12.010; YANG WY, 1995, J BIOL CHEM, V270, P20832, DOI 10.1074/jbc.270.35.20832; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89604	10.1371/journal.pone.0089604	http://dx.doi.org/10.1371/journal.pone.0089604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586906	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900057
J	Zhao, GM; Shi, QM; Han, Y; Li, SH; Wang, CH				Zhao Gengmao; Shi Quanmei; Han Yu; Li Shihui; Wang Changhai			The Physiological and Biochemical Responses of a Medicinal Plant (Salvia miltiorrhiza L.) to Stress Caused by Various Concentrations of NaCl	PLOS ONE			English	Article							SALT STRESS; OXIDATIVE STRESS; SALINITY STRESS; GROWTH; TOLERANCE; CULTIVARS; PROLINE; IONS	Salvia miltiorrhiza, which is commonly known as Danshen, is a traditional Chinese herbal medicine. To illustrate its physiological and biochemical responses to salt stress and to evaluate the feasibility of cultivating this plant in saline coastal soils, a factorial experiment under hydroponic conditions was arranged on the basis of a completely randomised design with three replications. Five salinity treatments (0, 25, 50, 75 and 100 mM NaCl) were employed in this experiment. The results showed that salinity treatments of,100 mM NaCl did not affect the growth of Salvia miltiorrhiza in a morphological sense, but significantly inhibit the accumulation of dry matter. Salinity treatments significantly decreased the Chl-b content but caused a negligible change in the Chl-a content, leading to a conspicuous overall decrease in the T-Chl content. The Na+ content significantly increased with increasing hydroponic salinity but the K+ and Ca2+ contents were reversed, indicating that a high level of external Na+ resulted in a decrease in both K+ and Ca2+ concentrations in the organs of Salvia miltiorrhiza. Salt stress significantly decreased the superoxide dismutase (SOD) activity of Salvia miltiorrhiza leaves in comparison with that of the control. On the contrary, the catalase (CAT) activity in the leaves markedly increased with the increasing salinity of the hydroponic solution. Moreover, the soluble sugar and protein contents in Salvia miltiorrhiza leaves dramatically increased with the increasing salinity of the hydroponic solution. These results suggested that antioxidant enzymes and osmolytes are partially involved in the adaptive response to salt stress in Salvia miltiorrhiza, thereby maintaining better plant growth under saline conditions.	[Zhao Gengmao; Shi Quanmei; Han Yu; Li Shihui; Wang Changhai] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhao, GM (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	seawater@njau.edu.cn			National Natural Science Foundation of China [31370422]; National Key 948 Project from The Ministry of Agriculture [2013-Z22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key 948 Project from The Ministry of Agriculture	This work was supported by National Natural Science Foundation of China (No. 31370422) and National Key 948 Project from The Ministry of Agriculture (No. 2013-Z22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour H., 2012, Journal of Medicinal Plants Research, V6, P2468; Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; ADLY AAM, 2010, RES J IMMUNOLOGY, V3, P129, DOI DOI 10.3923/RJI.2010.129.145; Aghaei Keyvan, 2013, Front Plant Sci, V4, P8, DOI 10.3389/fpls.2013.00008; Ahmad P., 2011, OXIDATIVE STRESS ROL, P19; AHMAD P., 2008, PLANT SOIL ENV PRAHA, V54, P89; Ahmad Parvaiz, 2005, Archives of Agronomy and Soil Science, V51, P665, DOI 10.1080/03650340500274151; Ahmad Parvaiz, 2006, Physiology and Molecular Biology of Plants, V12, P59; Ahmad Parvaiz, 2010, Archives of Agronomy and Soil Science, V56, P575, DOI 10.1080/03650340903164231; Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; Akhzari D., 2012, World Applied Sciences Journal, V16, P998; Alam S.M., 1999, HDB PLANT CROP STRES, P285, DOI DOI 10.1201/9780824746728.CH12; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; AWANG YB, 1995, SCI HORTIC-AMSTERDAM, V62, P25, DOI 10.1016/0304-4238(95)00770-T; Bergmeyer H.U., 1970, METHODS ENZYMATIC AN, P636; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY CJ, 1984, PLANT CELL ENVIRON, V7, P571, DOI 10.1111/1365-3040.ep11591840; D'Anna F, 2003, ACTA HORTIC, P355, DOI 10.17660/ActaHortic.2003.609.53; Datta J. K., 2009, Journal of Applied Sciences and Environmental Management, V13, P93; Dolatabadian A., 2011, Notulae Scientia Biologicae, V3, P41; El-Tayeb MA, 2005, PLANT GROWTH REGUL, V45, P215, DOI 10.1007/s10725-005-4928-1; Esfandiari E., 2007, Notulae Botanicae, Horti Agrobotanici, Cluj-Napoca, V35, P48; Fisarakis I, 2001, AGR WATER MANAGE, V51, P13, DOI 10.1016/S0378-3774(01)00115-9; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; Guo YQ, 2009, LIFE SCI J, V6, P67; Hajiboland R, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P283, DOI 10.1007/978-1-4614-0634-1_16; Hasanuzzaman M., 2009, International Journal of Integrative Biology, V6, P85; HAWKINS HJ, 1993, NEW PHYTOL, V124, P171, DOI 10.1111/j.1469-8137.1993.tb03807.x; Hou Jie, 2009, Acta Pedologica Sinica, V46, P173; HUANG CYL, 1985, COMMUN SOIL SCI PLAN, V16, P943, DOI 10.1080/00103628509367657; Jalali-e-Emam S. M. S., 2011, Middle East Journal of Scientific Research, V7, P07; Keutgen AJ, 2009, ENVIRON EXP BOT, V65, P170, DOI 10.1016/j.envexpbot.2008.08.002; KWAK SS, 1995, PHYTOCHEMISTRY, V39, P981, DOI 10.1016/0031-9422(95)00098-R; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu Ling, 2010, Acta Pedologica Sinica, V47, P1237; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu R, 1999, METHODS SOIL AGR CHE; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Mittal S, 2012, PLANT PHYSIOL BIOCH, V54, P17, DOI 10.1016/j.plaphy.2012.02.003; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Nieves-Cordones M., 2012, ENV ADAPTATIONS STRE, P85, DOI [10.1007/978-1-4614-0815-4_4, DOI 10.1007/978-1-4614-0815-4_4]; Ozturk L, 2012, ROM BIOTECH LETT, V17, P7227; Panda S. K., 2003, Physiology and Molecular Biology of Plants, V9, P273; Patil N. M., 2012, Asian Journal of Crop Science, V4, P50, DOI 10.3923/ajcs.2012.50.62; Perveen S, 2011, PAK J BOT, V43, P2463; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Raza SH, 2006, PAK J BOT, V38, P341; Rehm S, 1991, CULTIVATED PLANTS TR, P558; ROGERS ME, 1992, PLANT SOIL, V146, P131, DOI 10.1007/BF00012005; Taffouo Victor Desire, 2009, International Journal of Botany, V5, P135, DOI 10.3923/ijb.2009.135.143; Taiz L., 2018, FUNDAMENTALS PLANT P; TANG QZ, 2005, CHIN J PLANT ECOL, V29, P1000; Tuncturk M, 2011, AFR J BIOTECHNOL, V10, P1827; Zhao GM, 2010, AGR WATER MANAGE, V97, P1987, DOI 10.1016/j.agwat.2009.04.013	55	45	48	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89624	10.1371/journal.pone.0089624	http://dx.doi.org/10.1371/journal.pone.0089624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586918	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900060
J	Dahlsten, E; Isokallio, M; Somervuo, P; Lindstrom, M; Korkeala, H				Dahlsten, Elias; Isokallio, Marita; Somervuo, Panu; Lindstrom, Miia; Korkeala, Hannu			Transcriptomic Analysis of (Group I) Clostridium botulinum ATCC 3502 Cold Shock Response	PLOS ONE			English	Article							GENERAL STRESS GENES; CODY-BINDING SITES; BOX RNA HELICASES; BACILLUS-SUBTILIS; LISTERIA-MONOCYTOGENES; FATTY-ACIDS; STATIONARY-PHASE; HALL-A; IDENTIFICATION; GROWTH	Profound understanding of the mechanisms foodborne pathogenic bacteria utilize in adaptation to the environmental stress they encounter during food processing and storage is of paramount importance in design of control measures. Chill temperature is a central control measure applied in minimally processed foods; however, data on the mechanisms the foodborne pathogen Clostridium botulinum activates upon cold stress are scarce. Transcriptomic analysis on the C. botulinum ATCC 3502 strain upon temperature downshift from 37 degrees C to 15 degrees C was performed to identify the cold-responsive gene set of this organism. Significant up-or down-regulation of 16 and 11 genes, respectively, was observed 1 h after the cold shock. At 5 h after the temperature downshift, 199 and 210 genes were up-or down-regulated, respectively. Thus, the relatively small gene set affected initially indicated a targeted acute response to cold shock, whereas extensive metabolic remodeling appeared to take place after prolonged exposure to cold. Genes related to fatty acid biosynthesis, oxidative stress response, and iron uptake and storage were induced, in addition to mechanisms previously characterized as cold-tolerance related in bacteria. Furthermore, several uncharacterized DNA-binding transcriptional regulator-encoding genes were induced, suggesting involvement of novel regulatory mechanisms in the cold shock response of C. botulinum. The role of such regulators, CBO0477 and CBO0558A, in cold tolerance of C. botulinum ATCC 3502 was demonstrated by deteriorated growth of related mutants at 17 degrees C.	[Dahlsten, Elias; Isokallio, Marita; Somervuo, Panu; Lindstrom, Miia; Korkeala, Hannu] Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland	University of Helsinki	Dahlsten, E (corresponding author), Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland.	elias.dahlsten@helsinki.fi		Korkeala, Hannu/0000-0003-0699-1290	Academy of Finland [118602, 1115133, 1120180]; ABS Graduate School; Walter Ehrstrom Foundation; Finnish Foundation of Veterinary Research	Academy of Finland(Academy of Finland); ABS Graduate School; Walter Ehrstrom Foundation; Finnish Foundation of Veterinary Research	This research was performed in the Finnish Centre of Excellence in Microbial Food Safety Research (http://www.vetmed.helsinki.fi/mifosa/) and was funded by the Academy of Finland (http://www.aka.fi/en-GB/A/)(grants 118602, 1115133, and 1120180), the ABS Graduate School (http://www.vetmed.helsinki.fi/abs/index.htm), the Walter Ehrstrom Foundation (http://www.maitohygienialiitto.fi/walter-ehrstromin-saatio), and the Finnish Foundation of Veterinary Research (http://www.sels.fi/index_eng.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 1998, J BACTERIOL, V180, P2194, DOI 10.1128/JB.180.8.2194-2200.1998; Alsaker KV, 2005, J BACTERIOL, V187, P7103, DOI 10.1128/JB.187.20.7103-7118.2005; Angelidis AS, 2002, APPL ENVIRON MICROB, V68, P2644, DOI 10.1128/AEM.68.6.2644-2650.2002; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Beckering CL, 2002, J BACTERIOL, V184, P6395, DOI 10.1128/JB.184.22.6395-6402.2002; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Belitsky BR, 2013, P NATL ACAD SCI USA, V110, P7026, DOI 10.1073/pnas.1300428110; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bergholz PW, 2009, J BACTERIOL, V191, P2340, DOI 10.1128/JB.01377-08; Chan YC, 2007, APPL ENVIRON MICROB, V73, P6484, DOI 10.1128/AEM.00897-07; Charollais J, 2004, NUCLEIC ACIDS RES, V32, P2751, DOI 10.1093/nar/gkh603; Chen Y, 2008, APPL ENVIRON MICROB, V74, P6132, DOI 10.1128/AEM.00469-08; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Cybulski LE, 2002, MOL MICROBIOL, V45, P1379, DOI 10.1046/j.1365-2958.2002.03103.x; Dahlsten E, 2014, APPL ENVIRON MICROB, V80, P306, DOI 10.1128/AEM.03173-13; Dahlsten E, 2013, APPL ENVIRON MICROB, V79, P3867, DOI 10.1128/AEM.04036-12; den Besten HMW, 2013, APPL ENVIRON MICROB, V79, P57, DOI 10.1128/AEM.02282-12; den Besten HMW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013746; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; Derman Y, 2013, INT J FOOD MICROBIOL, V167, P87, DOI 10.1016/j.ijfoodmicro.2013.06.004; Dineen SS, 2010, J BACTERIOL, V192, P5350, DOI 10.1128/JB.00341-10; ELSDEN SR, 1980, J GEN MICROBIOL, V118, P115; ELSDEN SR, 1978, ARCH MICROBIOL, V117, P165, DOI 10.1007/BF00402304; Fonknechten N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-555; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Heap JT, 2010, METHODS MOL BIOL, V646, P165, DOI 10.1007/978-1-60327-365-7_11; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hillmann F, 2009, J BACTERIOL, V191, P6082, DOI 10.1128/JB.00351-09; Hinderink K, 2009, J FOOD PROTECT, V72, P375, DOI 10.4315/0362-028X-72.2.375; Hoffmann T, 2011, J BACTERIOL, V193, P1552, DOI 10.1128/JB.01319-10; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; Hunger K, 2006, J BACTERIOL, V188, P240, DOI 10.1128/JB.188.1.240-248.2006; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; JONES PG, 1992, J BACTERIOL, V174, P3903, DOI 10.1128/jb.174.12.3903-3914.1992; Kaan T, 2002, MICROBIOL-SGM, V148, P3441, DOI 10.1099/00221287-148-11-3441; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KIMBLE CE, 1969, APPL MICROBIOL, V18, P883, DOI 10.1128/AEM.18.5.883-888.1969; Klein W, 1999, J BACTERIOL, V181, P5341, DOI 10.1128/JB.181.17.5341-5349.1999; KO R, 1994, J BACTERIOL, V176, P426, DOI 10.1128/JB.176.2.426-431.1994; Kuehne SA, 2011, METHODS MOL BIOL, V765, P389, DOI 10.1007/978-1-61779-197-0_23; Lindstrom M, 2006, INT J FOOD MICROBIOL, V108, P92, DOI 10.1016/j.ijfoodmicro.2005.11.003; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Lindstrom M, 2012, APPL ENVIRON MICROB, V78, P5466, DOI 10.1128/AEM.00555-12; Liu SQ, 2002, APPL ENVIRON MICROB, V68, P1697, DOI 10.1128/AEM.68.4.1697-1705.2002; Lobel L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002887; Lovenklev M, 2004, APPL ENVIRON MICROB, V70, P2919, DOI 10.1128/AEM.70.5.2919-2927.2004; Lovett ST, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P205; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Mansilla MC, 2003, PROSTAG LEUKOTR ESS, V68, P187, DOI 10.1016/S0952-3278(02)00269-7; Markkula A, 2012, ENVIRON MICROBIOL, V14, P2223, DOI 10.1111/j.1462-2920.2012.02761.x; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; MOSS CW, 1967, APPL MICROBIOL, V15, P390, DOI 10.1128/AEM.15.2.390-397.1967; Palonen E, 2012, APPL ENVIRON MICROB, V78, P1298, DOI 10.1128/AEM.07278-11; Pandiani F, 2010, APPL ENVIRON MICROB, V76, P6692, DOI 10.1128/AEM.00782-10; PATTERSONCURTIS SI, 1989, APPL ENVIRON MICROB, V55, P1544, DOI 10.1128/AEM.55.6.1544-1548.1989; Peck MW, 1997, TRENDS FOOD SCI TECH, V8, P186, DOI 10.1016/S0924-2244(97)01027-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Reder A, 2012, J BACTERIOL, V194, P3601, DOI 10.1128/JB.00528-12; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Singh AK, 2009, FEMS MICROBIOL LETT, V301, P188, DOI 10.1111/j.1574-6968.2009.01814.x; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soderholm H, 2011, INT J FOOD MICROBIOL, V146, P23, DOI 10.1016/j.ijfoodmicro.2011.01.033; Soderholm H, 2013, BOTULINUM J, V2, P189, DOI DOI 10.1504/TBJ.2013.055662; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Stickland LH, 1934, BIOCHEM J, V28, P1746, DOI 10.1042/bj0281746; SUUTARI M, 1994, CRIT REV MICROBIOL, V20, P285, DOI 10.3109/10408419409113560; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WHITMER ME, 1988, APPL ENVIRON MICROB, V54, P753, DOI 10.1128/AEM.54.3.753-759.1988; Wolz C, 2010, INT J MED MICROBIOL, V300, P142, DOI 10.1016/j.ijmm.2009.08.017; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003252	79	16	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89958	10.1371/journal.pone.0089958	http://dx.doi.org/10.1371/journal.pone.0089958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587151	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700121
J	Bhullar, GS; Edwards, PJ; Venterink, HO				Bhullar, Gurbir S.; Edwards, Peter J.; Venterink, Harry Olde			Influence of Different Plant Species on Methane Emissions from Soil in a Restored Swiss Wetland	PLOS ONE			English	Article							VASCULAR PLANTS; WATER-TABLE; FLUX; TRANSPORT; ATMOSPHERE; VEGETATION; PEATLANDS; DYNAMICS; CO2	Plants are a major factor influencing methane emissions from wetlands, along with environmental parameters such as water table, temperature, pH, nutrients and soil carbon substrate. We conducted a field experiment to study how different plant species influence methane emissions from a wetland in Switzerland. The top 0.5 m of soil at this site had been removed five years earlier, leaving a substrate with very low methanogenic activity. We found a sixfold difference among plant species in their effect on methane emission rates: Molinia caerulea and Lysimachia vulgaris caused low emission rates, whereas Senecio paludosus, Carex flava, Juncus effusus and Typha latifolia caused relatively high rates. Centaurea jacea, Iris sibirica, and Carex davalliana caused intermediate rates. However, we found no effect of either plant biomass or plant functional groups based on life form or productivity of the habitat - upon methane emission. Emissions were much lower than those usually reported in temperate wetlands, which we attribute to reduced concentrations of labile carbon following topsoil removal. Thus, unlike most wetland sites, methane production in this site was probably fuelled chiefly by root exudation from living plants and from root decay. We conclude that in most wetlands, where concentrations of labile carbon are much higher, these sources account for only a small proportion of the methane emitted. Our study confirms that plant species composition does influence methane emission from wetlands, and should be considered when developing measures to mitigate the greenhouse gas emissions.	[Bhullar, Gurbir S.; Edwards, Peter J.; Venterink, Harry Olde] ETH, Inst Integrat Biol, Zurich, Switzerland; [Bhullar, Gurbir S.] Res Inst Organ Agr FiBL, Frick, Switzerland; [Venterink, Harry Olde] Vrije Univ Brussel, Brussels, Belgium	Swiss Federal Institutes of Technology Domain; ETH Zurich; Vrije Universiteit Brussel	Bhullar, GS (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	gurbir.bhullar@fibl.org	olde Venterink, Harry/K-9547-2015	olde Venterink, Harry/0000-0002-8963-1153; Bhullar, Gurbir S./0000-0001-7311-2562	ETH Zurich [TH-07 07-3]	ETH Zurich(ETH Zurich)	This work was supported by ETH Zurich [TH-07 07-3]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; Bakkenes MD, 2002, MOVE NATL MODEL VEGE, P1; Bhullar GS, 2011, THESIS SWISS FEDERAL; Bhullar GS, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-32; Bhullar GS, 2013, J PLANT ECOL, V6, P298, DOI 10.1093/jpe/rts045; Bouchard V, 2007, ECOLOGY, V88, P2903, DOI 10.1890/06-1144.1; BUBIER JL, 1995, J ECOL, V83, P403, DOI 10.2307/2261594; BUBIER JL, 1995, GLOBAL BIOGEOCHEM CY, V9, P455, DOI 10.1029/95GB02379; Cao MK, 1998, ATMOS ENVIRON, V32, P3293, DOI 10.1016/S1352-2310(98)00105-8; CHANTON JP, 1995, GEOCHIM COSMOCHIM AC, V59, P3663, DOI 10.1016/0016-7037(95)00240-Z; Chanton JP, 1997, GLOBAL BIOGEOCHEM CY, V11, P15, DOI 10.1029/96GB03761; Christensen TR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016848; Dias ATC, 2010, ECOSYSTEMS, V13, P526, DOI 10.1007/s10021-010-9338-1; Ding WX, 2005, ATMOS ENVIRON, V39, P3199, DOI 10.1016/j.atmosenv.2005.02.022; Ding WX, 2003, CHEMOSPHERE, V51, P167, DOI 10.1016/S0045-6535(02)00804-4; Dinsmore KJ, 2009, PLANT SOIL, V318, P229, DOI 10.1007/s11104-008-9832-9; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Hirota M, 2004, SOIL BIOL BIOCHEM, V36, P737, DOI 10.1016/j.soilbio.2003.12.009; Inubushi K, 2005, NUTR CYCL AGROECOSYS, V71, P93, DOI 10.1007/s10705-004-5283-8; Joabsson A, 1999, POLAR RES, V18, P215, DOI 10.1111/j.1751-8369.1999.tb00296.x; Joabsson A, 2001, GLOBAL CHANGE BIOL, V7, P919, DOI 10.1046/j.1354-1013.2001.00044.x; Koelbener A, 2010, PLANT SOIL, V326, P147, DOI 10.1007/s11104-009-9989-x; Lai DYF, 2009, PEDOSPHERE, V19, P409, DOI 10.1016/S1002-0160(09)00003-4; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Long KD, 2010, GLOBAL CHANGE BIOL, V16, P2420, DOI 10.1111/j.1365-2486.2009.02083.x; Maynard D.G., 2008, SOIL SAMPLING METHOD, P71; Moore T, 1990, GLOBAL BIOGEOCHEM CY, V4, P29, DOI 10.1029/GB004i001p00029; MOORE TR, 1990, BIOGEOCHEMISTRY, V11, P45; MORRISSEY LA, 1992, J GEOPHYS RES-ATMOS, V97, P16661, DOI 10.1029/92JD00063; R Core Team, 2018, R LANG ENV STAT COMP; Rice AL, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041565; Rothman E, 2007, WETLANDS, V27, P1134, DOI 10.1672/0277-5212(2007)27[1134:ROCPBM]2.0.CO;2; Saarnio S, 2004, PLANT SOIL, V267, P343, DOI 10.1007/s11104-005-0140-3; SCHIMEL JP, 1995, BIOGEOCHEMISTRY, V28, P183, DOI 10.1007/BF02186458; SCHUTZ H, 1989, J GEOPHYS RES-ATMOS, V94, P16405, DOI 10.1029/JD094iD13p16405; SEBACHER DI, 1985, J ENVIRON QUAL, V14, P40, DOI 10.2134/jeq1985.00472425001400010008x; Solomon S., 2007, PHYS SCI BASIS WORKI; Stanley EH, 2010, WETLANDS, V30, P889, DOI 10.1007/s13157-010-0087-x; Strom L, 2005, BIOGEOCHEMISTRY, V75, P65, DOI 10.1007/s10533-004-6124-1; TORN MS, 1993, CHEMOSPHERE, V26, P357, DOI 10.1016/0045-6535(93)90431-4; Waddington JM, 1996, GLOBAL BIOGEOCHEM CY, V10, P233, DOI 10.1029/95GB03871; Ward SE, 2009, FUNCT ECOL, V23, P454, DOI 10.1111/j.1365-2435.2008.01521.x; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0	43	43	45	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89588	10.1371/journal.pone.0089588	http://dx.doi.org/10.1371/journal.pone.0089588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586894	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900125
J	Verma, SK; Ranjan, R; Kumar, V; Siddiqi, MI; Ahmed, S				Verma, Sumit Kumar; Ranjan, Rajeev; Kumar, Vikash; Siddiqi, Mohammad Imran; Ahmed, Shakil			Wat1/pop3, a Conserved WD Repeat Containing Protein Acts Synergistically with Checkpoint Kinase Chk1 to Maintain Genome Ploidy in Fission Yeast S. pombe	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; SCHIZOSACCHAROMYCES-POMBE; SPINDLE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; TERMINAL DOMAIN; TOR COMPLEXES; REPLICATION; PATHWAY; MUTANT; ATR	Aberrant chromosome segregation defects can lead to aneuploidy, a common characteristic of human solid tumors. Aneuploidy is generated due to defects in the mitotic spindle or due to inefficient mitotic checkpoint response. We have isolated a novel mutant allele of wat1, a WD repeat containing protein that exhibits conditional synthetic lethality with chk1 knock out. We observed only a marginal decrease in the level of a tubulin protein level in wat1-17 mutants after prolong exposure at semi permissive temperature. Interestingly the protein level of a-tubulin was reduced in the chk1 Delta wat1-17 double mutant at 18 degrees C with defective microtubule structure. Consistent with loss of microtubule structure in the chk1 deletion background, the double mutant of wat1-17 chk1 Delta was hypersensitive to the microtubule destabilizing agent TBZ suggesting severe defects in microtubule integrity in wat1-17 mutant in the absence of Chk1. Combination of wat1-17 with the chk1 deletion also aggravates the defects in the maintenance of genome ploidy. The mutation in wat1-17 was mapped to Cys 233 that was changed to tyrosine. Based on the molecular modeling studies, we hypothesize that the substitution of the bulky Tyr residue at Cys233 position in wat1-17 mutant results in conformational changes. This in turn can affect its intercations with other interacting partners and perturb the overall functions of the Wat1 protein.	[Verma, Sumit Kumar; Ranjan, Rajeev; Kumar, Vikash; Siddiqi, Mohammad Imran; Ahmed, Shakil] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ahmed, S (corresponding author), CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Sect 10, Lucknow, Uttar Pradesh, India.	shakil_ahmed@cdri.res.in			Council of Scientific and Industrial Research (Genesis), India [BSC0121]; Department of Biotechnology, India [GAP0027]	Council of Scientific and Industrial Research (Genesis), India; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by grant from Council of Scientific and Industrial Research (Genesis, BSC0121), India and Department of Biotechnology, India (GAP0027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Ahmed S, 2007, GENETICS, V177, P1487, DOI 10.1534/genetics.107.078691; Alfa C., 1993, EXPT FISSION YEAST; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; CHAN CSM, 1993, GENETICS, V135, P677; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Collura A, 2005, MOL CELL BIOL, V25, P7889, DOI 10.1128/MCB.25.17.7889-7899.2005; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAGAN IM, 1988, J CELL SCI, V89, P343; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Heichman KA, 1996, CELL, V85, P39, DOI 10.1016/S0092-8674(00)81080-6; Kemp JT, 1997, MOL GEN GENET, V254, P127, DOI 10.1007/s004380050400; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Liu QH, 2000, GENE DEV, V14, P1448; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ochotorena IL, 2001, J CELL SCI, V114, P2911; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto I, 2000, EMBO J, V19, P1598, DOI 10.1093/emboj/19.7.1598; POTASHKIN J, 1993, SCIENCE, V262, P573, DOI 10.1126/science.8211184; Ren Q, 2005, J CELL PHYSIOL, V203, P273, DOI 10.1002/jcp.20222; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Roberg KJ, 1997, GENETICS, V147, P1569; Royou A, 2005, CURR BIOL, V15, P334, DOI 10.1016/j.cub.2005.02.026; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAZER S, 1990, J CELL SCI, V97, P509; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singer JD, 1996, MOL CELL BIOL, V16, P1356; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; VALLEN EA, 1992, CELL, V69, P505, DOI 10.1016/0092-8674(92)90451-H; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; WISE D, 1991, CELL MOTIL CYTOSKEL, V18, P131, DOI 10.1002/cm.970180208; Yadav S, 2011, GENET RES, V93, P275, DOI 10.1017/S0016672311000188; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZHAI Y, 1994, J CELL SCI, V107, P881; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	49	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89587	10.1371/journal.pone.0089587	http://dx.doi.org/10.1371/journal.pone.0089587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586893	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900124
J	Antonopoulos, CG; Bianco-Martinez, E; Baptista, MS				Antonopoulos, Chris G.; Bianco-Martinez, Ezequiel; Baptista, Murilo S.			Production and Transfer of Energy and Information in Hamiltonian Systems	PLOS ONE			English	Article							CHARACTERISTIC EXPONENTS; LYAPUNOV EXPONENTS; ENTROPY; CHAOS	We present novel results that relate energy and information transfer with sensitivity to initial conditions in chaotic multi-dimensional Hamiltonian systems. We show the relation among Kolmogorov-Sinai entropy, Lyapunov exponents, and upper bounds for the Mutual Information Rate calculated in the Hamiltonian phase space and on bi-dimensional subspaces. Our main result is that the net amount of transfer from kinetic to potential energy per unit of time is a power-law of the upper bound for the Mutual Information Rate between kinetic and potential energies, and also a power-law of the Kolmogorov-Sinai entropy. Therefore, transfer of energy is related with both transfer and production of information. However, the power-law nature of this relation means that a small increment of energy transferred leads to a relatively much larger increase of the information exchanged. Then, we propose an "experimental" implementation of a 1-dimensional communication channel based on a Hamiltonian system, and calculate the actual rate with which information is exchanged between the first and last particle of the channel. Finally, a relation between our results and important quantities of thermodynamics is presented.	[Antonopoulos, Chris G.; Bianco-Martinez, Ezequiel; Baptista, Murilo S.] Univ Aberdeen, Dept Phys ICSMB, Aberdeen, Scotland	University of Aberdeen	Antonopoulos, CG (corresponding author), Univ Aberdeen, Dept Phys ICSMB, Aberdeen, Scotland.	chris.antonopoulos@abdn.ac.uk	baptista, murilo s/B-7277-2008; Antonopoulos, Chris G./A-2354-2015	Antonopoulos, Chris G./0000-0001-7195-6892	 [EPSRC EP/I032606/1]; EPSRC [EP/I032606/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I032606/1] Funding Source: researchfish	; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors were supported by the "EPSRC EP/I032606/1" grant.	Abramowitz M., 1965, HDB MATH FUNCTIONS; Antonopoulos C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056206; Antonopoulos C, 2006, INT J BIFURCAT CHAOS, V16, P1777, DOI 10.1142/S0218127406015672; Baptista MS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026205; Baptista MS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.045202; Baptista MS, 2012, PLOS ONE, V7; Baptista MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003479; BENETTIN G, 1984, PHYSICA D, V13, P211, DOI 10.1016/0167-2789(84)90278-1; Benettin G., 1980, MECCANICA, V15, P21, DOI [10.1007/BF02128237, DOI 10.1007/BF02128237]; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; Bountis T., 2012, COMPLEX HAMILTONIAN, DOI [10.1007/978-3-642-27305-6, DOI 10.1007/978-3-642-27305-6]; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; Fermi E, 1955, LA1940, V27, P379; Giorgilli A., 1980, MECCANICA, V15, P9, DOI 10.1007/BF02128236; LANDAUER R, 1961, IBM J RES DEV, V5, P183, DOI 10.1147/rd.53.0183; LIVI R, 1986, J PHYS A-MATH GEN, V19, P2033, DOI 10.1088/0305-4470/19/11/012; Mandal D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.030602; Mandal D, 2012, P NATL ACAD SCI USA, V109, P11641, DOI 10.1073/pnas.1204263109; Marchiori MA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041119; Mohammad Fouladgar A, 2013, IEEE WIRELESS COMMUN; Muller I, 2008, ENTROPY-SWITZ, V10, P462, DOI 10.3390/e10040462; Park J, 2013, ABS13031693 CORR, P1693; Pesin J. B., 1976, IZV AKAD NAUK SSSR M, V40, P1332; Pesin YB, 1977, USP MAT NAUK, V32, P196; Pettini M, 2005, CHAOS, V15, DOI 10.1063/1.1849131; PETTINI M, 1990, PHYS REV A, V41, P768, DOI 10.1103/PhysRevA.41.768; PETTINI M, 1991, PHYS REV A, V44, P975, DOI 10.1103/PhysRevA.44.975; Popovski P, 2013, IEEE T COMMUNICATION, V61; RECHESTER AB, 1979, PHYS REV LETT, V42, P1247, DOI 10.1103/PhysRevLett.42.1247; Ruelle D., 1978, BOL SOC BRAS MAT, V9, P83, DOI DOI 10.1007/BF02584795; Rugh HH, 1997, PHYS REV LETT, V78, P772, DOI 10.1103/PhysRevLett.78.772; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Skokos C, 2010, LECT NOTES PHYS, V790, P63, DOI 10.1007/978-3-642-04458-8_2; Szilard L, 1929, Z PHYS, V53, P840, DOI 10.1007/BF01341281; Toyabe S, 2010, NAT PHYS, V6, P988, DOI 10.1038/NPHYS1821; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9	36	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89585	10.1371/journal.pone.0089585	http://dx.doi.org/10.1371/journal.pone.0089585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586891	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000332396200063
J	Means, AR; Weaver, MR; Burnett, SM; Mbonye, MK; Naikoba, S; McClelland, RS				Means, Arianna Rubin; Weaver, Marcia R.; Burnett, Sarah M.; Mbonye, Martin K.; Naikoba, Sarah; McClelland, R. Scott			Correlates of Inappropriate Prescribing of Antibiotics to Patients with Malaria in Uganda	PLOS ONE			English	Article							INTEGRATED MANAGEMENT; CHILDHOOD ILLNESS; FEBRILE ILLNESS; CHILDREN; BACTEREMIA; FACILITIES; QUALITY; PRESCRIPTION; PREVALENCE; PNEUMONIA	Background: In many rural areas of Uganda, febrile patients presenting to health facilities are prescribed both antimalarials and antibiotics, contributing to the overuse of antibiotics. We identified the prevalence and correlates of inappropriate antibiotic management of patients with confirmed malaria. Methods: We utilized individual outpatient data from 36 health centers from January to September 2011. We identified patients who were prescribed antibiotics without an appropriate clinical indication, as well as patients who were not prescribed antibiotics when treatment was clinically indicated. Multivariate logistic regression models were used to identify clinical and operational factors associated with inappropriate case management. Findings: Of the 45,591 patients with parasitological diagnosis of malaria, 40,870 (90%) did not have a clinical indication for antibiotic treatment. Within this group, 17,152 (42%) were inappropriately prescribed antibiotics. The odds of inappropriate prescribing were higher if the patient was less than five years old (aOR 1.96, 95% CI 1.75-2.19) and if the health provider had the fewest years of training (aOR 1.86, 95% CI 1.05-3.29). The odds of inappropriate prescribing were lower if patients had emergency triage status (aOR 0.75, 95% CI 0.59-0.96) or were HIV positive (aOR 0.31, 95% CI 0.20-0.45). Of the 4,721 (10%) patients with clinical indications for antibiotic treatment, 521 (11%) were inappropriately not prescribed antibiotics. Clinical officers were less likely than medical officers to inappropriately withhold antibiotics (aOR 0.54, 95% CI 0.29-0.98). Conclusion: Over 40% of the antibiotic treatment in malaria positive patients is prescribed despite a lack of documented clinical indication. In addition, over 10% of patients with malaria and a clinical indication for antibiotics do not receive them. These findings should inform facility-level trainings and interventions to optimize patient care and slow trends of rising antibiotic resistance.	[Means, Arianna Rubin; Weaver, Marcia R.; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Means, Arianna Rubin; McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Burnett, Sarah M.] Accordia Global Hlth Fdn, Washington, DC USA; [Mbonye, Martin K.; Naikoba, Sarah] Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Burnett, Sarah M.; Mbonye, Martin K.; Naikoba, Sarah] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Antwerp; University of Washington; University of Washington Seattle	Means, AR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	aerubin@u.washington.edu			Bill & Melinda Gates Foundation [94298]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported through grant number 94298 to Accordia Global Health Foundation from the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funder did not have any role in study design; data collection, analysis or interpretation; paper writing; or the decision to submit the paper for publication.	[Anonymous], 2003, IMPR DAT QUAL GUID D; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; Batwala V, 2011, MALARIA J, V10, DOI [10.1186/1475-2875-10-377, 10.1186/1475-2875-10-373]; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Franco Beatriz Espinosa, 2009, Infect Drug Resist, V2, P1; Gouws E, 2004, B WORLD HEALTH ORGAN, V82, P509; Gwimile JJ, 2012, PAN AFR MED J, V12; Holloway KA, 2013, TROP MED INT HEALTH, V18, P656, DOI 10.1111/tmi.12123; Kajungu DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-311; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Koura KG, 2013, ACTA TROP, V127, P87, DOI 10.1016/j.actatropica.2013.04.004; Mbonye MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084945; Miceli A, 2012, INT J INFECT DIS, V16, pE708, DOI 10.1016/j.ijid.2012.07.003; MOH, 2010, NAT GUID MAN COMM CO; Opondo C, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-109; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Peabody JW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1293; PMI, 2011, MAL OP PLAN FY 2012; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; WHO, 2011, IMAI DISTR CLIN MAN; WHO, 2001, IMCI MULT EV MAIN FI; WHO, 2005, INT MAN CHILDH ILLN; WHO, 2010, RAT US MED; World Health Organization, 2010, MARK FOOD NONALC BEV; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633	35	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90179	10.1371/journal.pone.0090179	http://dx.doi.org/10.1371/journal.pone.0090179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587264	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200144
J	Rai, R; Sharma, KL; Sharma, S; Misra, S; Kumar, A; Mittal, B				Rai, Rajani; Sharma, Kiran L.; Sharma, Surbhi; Misra, Sanjeev; Kumar, Ashok; Mittal, Balraj			Death Receptor (DR4) Haplotypes Are Associated with Increased Susceptibility of Gallbladder Carcinoma in North Indian Population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FAS PROMOTER POLYMORPHISMS; ACUTE MYELOID-LEUKEMIA; PATHWAY GENES FAS; LUNG-CANCER; BREAST-CANCER; BLADDER-CANCER; INCREASED RISK; OVARIAN-CANCER; LIGAND	Background and Aim: Defective apoptosis is a hallmark of cancer development and progression. Death receptors (DR4, FAS) and their ligands (TRAIL, FASL) are thought to mediate the major extrinsic apoptotic pathway in the cell. SNPs in these genes may lead to defective apoptosis. Hence, the present study aimed to investigate the association of functional SNPs of DR4 (rs20575, rs20576 and rs6557634), FAS (rs2234767) and FASL (rs763110) with gallbladder cancer (GBC) risk. Methods: This case-control study included 400 GBC and 246 healthy controls (HC). Genotyping was carried out by Taqman genotyping assays. Statistical analysis was performed by using SPSS ver16. Meta-analysis was performed using Comprehensive Meta-analysis software (Version 2.0, BIOSTAT, Englewood, NJ) to systematically summarize the possible association of SNP with cancer risk. Functional prediction of these variants was carried out using Bioinformatics tools (FAST-SNP, F-SNP). False discovery rate (FDR test) was used in multiple comparisons. Results: The DR4 C(rs20575)A(rs20576)A(rs6557634), G(rs20575)A(rs20576)G(rs6557634) and G(rs20575)C(rs20576)G(rs6557634) haplotypes conferred two-fold increased risk for GBC. Among these, the DR4 Crs20575Ars20576Ars6557634 haplotype emerged as main factor influencing GBC susceptibility as the risk was not modulated by gender or gallstone stratification. Our meta-analysis results showed significant association of DR4 rs6557634 with overall cancer risk, GI cancers as well as in Caucasians. We didn't find any association of FAS and FASL SNPs with GBC susceptibility. Conclusions: The DR4 haplotype C(rs20575)A(rs20576)A(rs6557634) represents an important factor accounting the patients susceptibility to GBC probably due to decreased apoptosis. However, additional well-designed studies with larger sample size focusing on different ethnicities are required to further validate the results.	[Rai, Rajani; Sharma, Kiran L.; Sharma, Surbhi; Mittal, Balraj] SGPGIMS, Dept Genet, Lucknow, Uttar Pradesh, India; [Misra, Sanjeev] KGMU, Dept Surg Oncol, Lucknow, Uttar Pradesh, India; [Kumar, Ashok] SGPGIMS, Dept Surg Gastroenterol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; King George's Medical University; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Mittal, B (corresponding author), SGPGIMS, Dept Genet, Lucknow, Uttar Pradesh, India.	balraj@sgpgi.ac.in	Sharma, Kiran Lata/F-7960-2017; Sharma, Kiran/GZL-1834-2022	Sharma, Kiran Lata/0000-0002-1988-389X; 	DBT; ICMR Govt of India	DBT(Department of Biotechnology (DBT) India); ICMR Govt of India(Indian Council of Medical Research (ICMR))	The authors are thankful to DBT and ICMR Govt of India for providing financial support to carry out the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson JM, 2009, MSRTR20095337 MICR; Chatterjee Koushik, 2009, BMC Res Notes, V2, P238, DOI 10.1186/1756-0500-2-238; Chen B, 2009, EUR J CANCER, V45, P2598, DOI 10.1016/j.ejca.2009.06.023; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Das SN, 2011, INDIAN J MED RES, V134, P54; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fernandez V, 2004, HAEMATOLOGICA, V89, P1322; Fisher MJ, 2001, CLIN CANCER RES, V7, P1688; Frank B, 2005, CARCINOGENESIS, V26, P1975, DOI 10.1093/carcin/bgi164; Frank B, 2006, CANCER EPIDEM BIOMAR, V15, P2002, DOI 10.1158/1055-9965.EPI-06-0053; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; George GP, 2012, UROL ONCOL-SEMIN ORI, V30, P781, DOI 10.1016/j.urolonc.2010.08.027; Ghosh M, 2013, SAUDI J GASTROENTERO, V19, P34, DOI 10.4103/1319-3767.105922; Gormus U, 2007, IN VIVO, V21, P663; Gormus U, 2007, ANTICANCER RES, V27, P991; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Guo Lu, 2007, Wuhan Daxue Xuebao (Yixue Ban), V28, P93; Hamdani NH, 2012, ASIAN PAC J CANCER P, V13, P5613, DOI 10.7314/APJCP.2012.13.11.5613; Hashemi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053075; Hazra A, 2003, CANCER RES, V63, P1157; Horak P, 2005, GYNECOL ONCOL, V97, P514, DOI 10.1016/j.ygyno.2005.01.021; Hsu PI, 2008, ANTICANCER RES, V28, P97; Jin KT, 2011, CLIN TRANSL ONCOL, V13, P25, DOI 10.1007/s12094-011-0613-1; Kalita D, 2013, ASIAN PAC J CANCER P, V14, P3315, DOI 10.7314/APJCP.2013.14.5.3315; Kang S, 2008, CANCER GENET CYTOGEN, V180, P1, DOI 10.1016/j.cancergencyto.2007.09.002; Kim HJ, 2010, DNA CELL BIOL, V29, P619, DOI 10.1089/dna.2010.1032; Korner C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-85; Kuraoka K, 2005, ONCOL REP, V14, P465; Lee SH, 1999, CANCER RES, V59, P3068; MacPherson G, 2004, JNCI-J NATL CANCER I, V96, P1866, DOI 10.1093/jnci/dji001; Martinez-Ferrandis Jose I., 2007, Cancer Biomarkers, V3, P89; Miao XY, 2013, INT J CLIN EXP PATHO, V6, P179; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mittal RD, 2011, EJSO-EUR J SURG ONC, V37, P727, DOI 10.1016/j.ejso.2011.05.013; Murthy NS, 2011, GASTROINTESTINAL CAN, V1, P1; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Park JB, 2008, INT ORTHOP, V32, P835, DOI 10.1007/s00264-007-0410-1; Rai R, 2013, GENE, V518, P303, DOI 10.1016/j.gene.2013.01.019; Shao PF, 2011, PROSTATE, V71, P1122, DOI 10.1002/pros.21328; Shirley S, 2011, RECENT PAT ANTI-CANC, V6, P311, DOI 10.2174/157489211796957757; Sibley K, 2003, CANCER RES, V63, P4327; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Tastemir-Korkmaz D, 2013, PATHOL ONCOL RES, V19, P779, DOI 10.1007/s12253-013-9643-z; Ter-Minassian M, 2008, CARCINOGENESIS, V29, P2147, DOI 10.1093/carcin/bgn205; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Ulybina YM, 2011, TUMORI, V97, P248, DOI 10.1700/667.7794; Ulybina YM, 2009, CANCER LETT, V278, P183, DOI 10.1016/j.canlet.2009.01.012; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wang ML, 2009, BIOCHEM GENET, V47, P559, DOI 10.1007/s10528-009-9264-0; Wolf S, 2006, INT J CANCER, V118, P1831, DOI 10.1002/ijc.21502; Wu JM, 2003, J IMMUNOL, V170, P132, DOI 10.4049/jimmunol.170.1.132; Xu LN, 2005, WORLD J GASTROENTERO, V11, P3719, DOI 10.3748/wjg.v11.i24.3719; Zhang HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069366; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang Z, 2006, CLIN CANCER RES, V12, P5596, DOI 10.1158/1078-0432.CCR-05-1739; Zhang ZZ, 2009, EUR J HUM GENET, V17, P1294, DOI 10.1038/ejhg.2009.45; Zhang ZZ, 2009, CARCINOGENESIS, V30, P487, DOI 10.1093/carcin/bgp016; Zhou RM, 2010, J GASTROEN HEPATOL, V25, P555, DOI 10.1111/j.1440-1746.2009.06116.x; Zornig M, 2001, BBA-REV CANCER, V1551, pF1, DOI 10.1016/S0304-419X(01)00031-2	61	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90264	10.1371/journal.pone.0090264	http://dx.doi.org/10.1371/journal.pone.0090264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587306	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200157
J	Roos, AB; Mori, M; Gronneberg, R; Osterlund, C; Claesson, HE; Wahlstrom, J; Grunewald, J; Eklund, A; Erjefalt, JS; Lundberg, JO; Nord, M				Roos, Abraham B.; Mori, Michiko; Gronneberg, Reidar; Osterlund, Christina; Claesson, Hans-Erik; Wahlstrom, Jan; Grunewald, Johan; Eklund, Anders; Erjefalt, Jonas S.; Lundberg, Jon O.; Nord, Magnus			Elevated Exhaled Nitric Oxide in Allergen-Provoked Asthma Is Associated with Airway Epithelial iNOS	PLOS ONE			English	Article							SYNTHASE; NO; CHALLENGE; ACIDIFICATION; EXPRESSION; INCREASES	Background: Fractional exhaled nitric oxide is elevated in allergen-provoked asthma. The cellular and molecular source of the elevated fractional exhaled nitric oxide is, however, uncertain. Objective: To investigate whether fractional exhaled nitric oxide is associated with increased airway epithelial inducible nitric oxide synthase (iNOS) in allergen-provoked asthma. Methods: Fractional exhaled nitric oxide was measured in healthy controls (n = 14) and allergic asthmatics (n = 12), before and after bronchial provocation to birch pollen out of season. Bronchoscopy was performed before and 24 hours after allergen provocation. Bronchial biopsies and brush biopsies were processed for nitric oxide synthase activity staining with nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d), iNOS immunostaining, or gene expression analysis of iNOS by real-time PCR. NADPH-d and iNOS staining were quantified using automated morphometric analysis. Results: Fractional exhaled nitric oxide and expression of iNOS mRNA were significantly higher in un-provoked asthmatics, compared to healthy controls. Allergic asthmatics exhibited a significant elevation of fractional exhaled nitric oxide after allergen provocation, as well as an accumulation of airway eosinophils. Moreover, nitric oxide synthase activity and expression of iNOS was significantly increased in the bronchial epithelium of asthmatics following allergen provocation. Fractional exhaled nitric oxide correlated with eosinophils and iNOS expression. Conclusion: Higher fractional exhaled nitric oxide concentration among asthmatics is associated with elevated iNOS mRNA in the bronchial epithelium. Furthermore, our data demonstrates for the first time increased expression and activity of iNOS in the bronchial epithelium after allergen provocation, and thus provide a mechanistic explanation for elevated fractional exhaled nitric oxide in allergen-provoked asthma.	[Roos, Abraham B.; Gronneberg, Reidar; Wahlstrom, Jan; Grunewald, Johan; Eklund, Anders; Nord, Magnus] Karolinska Inst, Dept Med, Resp Med Unit, Stockholm, Sweden; [Roos, Abraham B.; Mori, Michiko; Erjefalt, Jonas S.] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Osterlund, Christina; Claesson, Hans-Erik] Karolinska Inst, Dept Med, Div Hematol, Stockholm, Sweden; [Lundberg, Jon O.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Pharmacol Nitr Oxide Res, Stockholm, Sweden; [Nord, Magnus] AstraZeneca Global Med Dev, Safety Sci Global Regulatory Affairs & Patient Sa, Molndal, Sweden	Karolinska Institutet; Lund University; Karolinska Institutet; Karolinska Institutet; AstraZeneca	Roos, AB (corresponding author), Karolinska Inst, Dept Med, Resp Med Unit, Stockholm, Sweden.	abraham.roos@ki.se	Grunewald, Johan/GQZ-8122-2022	Lundberg, Jon/0000-0002-0174-5210; Grunewald, Johan/0000-0003-0473-3984; Erjefalt, Jonas/0000-0002-6716-3010; Claesson, Hans-Erik/0000-0002-1960-6542	Swedish Research Council; Stockholm County Council; Swedish Cancer- and Allergy Foundation; Swedish Asthma- and Allergy Foundation; Swedish Heart-Lung Foundation; King Gustaf V 80th Birthday Foundation; Karolinska Institutet; Centre for Allergy Research at Karolinska Instituet; Vinnova (CIDaT); Hesselman Foundation; Konsul Th C Bergh Foundation; Lars Hierta; Tornspiran Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Cancer- and Allergy Foundation; Swedish Asthma- and Allergy Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V 80th Birthday Foundation; Karolinska Institutet(Karolinska Institutet); Centre for Allergy Research at Karolinska Instituet(Karolinska Institutet); Vinnova (CIDaT)(Vinnova); Hesselman Foundation; Konsul Th C Bergh Foundation; Lars Hierta; Tornspiran Foundation	This work was supported by grants from the Swedish Research Council, the Stockholm County Council, the Swedish Cancer- and Allergy Foundation, the Swedish Asthma- and Allergy Foundation, the Swedish Heart-Lung Foundation, the King Gustaf V 80th Birthday Foundation, Karolinska Institutet, Centre for Allergy Research at Karolinska Instituet, Vinnova (CIDaT), Hesselman's, Konsul Th C Bergh's, Lars Hierta's and Tornspiran's Foundations. AstraZeneca R&D provided financial support in the form of travel grants and salaried employment. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2011, FREE RADICAL BIO MED, V50, P1679, DOI 10.1016/j.freeradbiomed.2011.03.015; BELVISI MG, 1995, ARCH INT PHARMACOD T, V329, P97; Brindicci C, 2009, CHEST, V135, P353, DOI 10.1378/chest.08-0964; Chibana K, 2008, CLIN EXP ALLERGY, V38, P936, DOI 10.1111/j.1365-2222.2008.02969.x; DAHLEN B, 1994, EUR RESPIR J, V7, P324, DOI 10.1183/09031936.94.07020324; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; EKLUND A, 1986, THORAX, V41, P629, DOI 10.1136/thx.41.8.629; ERJEFALT JS, 1994, AM J RESP CRIT CARE, V150, P227, DOI 10.1164/ajrccm.150.1.8025753; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; HAMID Q, 1993, LANCET, V342, P1510, DOI 10.1016/S0140-6736(05)80083-2; Heijkenskjold-Rentzhog C, 2012, PEDIATR PULM, V47, P941, DOI 10.1002/ppul.22556; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8; Ko FW, 2012, EUR RESP J; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Levanen B, 2011, RESP MED, V105, P282, DOI 10.1016/j.rmed.2010.11.018; Muller M, 2006, EUR RESPIR J, V28, P513, DOI 10.1183/09031936.06.00118505; Paredes PT, 2012, ALLERGY, V67, P911, DOI 10.1111/j.1398-9995.2012.02835.x; Pedrosa M, 2012, LUNG, V190, P209, DOI 10.1007/s00408-011-9358-4; Puckett JL, 2008, RESP PHYSIOL NEUROBI, V163, P166, DOI 10.1016/j.resp.2008.07.020; Ricciardolo FLM, 2012, INT J IMMUNOPATH PH, V25, P175, DOI 10.1177/039463201202500120; Rolla G, 2011, EUR J CLIN INVEST, V41, P411, DOI 10.1111/j.1365-2362.2010.02423.x; Rouhos A, 2008, CLIN RESPIR J, V2, P141, DOI 10.1111/j.1752-699X.2007.00045.x; Schneider A, RESP MED; See KC, 2012, CHEST; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Thunberg S, 2010, ALLERGY, V65, P311, DOI 10.1111/j.1398-9995.2009.02218.x; van der Valk RJP, 2012, ALLERGY, V67, P265, DOI 10.1111/j.1398-9995.2011.02734.x; Van Muylem A, 2013, RESP PHYSIOL NEUROBI, V185, P313, DOI 10.1016/j.resp.2012.09.011; Watkins DN, 1997, AM J RESP CELL MOL, V16, P629, DOI 10.1165/ajrcmb.16.6.9191464; World Health Organization, 2007, GLOB SURV PREV CONTR; Yamamoto M, 2012, CLIN EXP ALLERGY, V42, P760, DOI 10.1111/j.1365-2222.2011.03860.x	33	46	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90018	10.1371/journal.pone.0090018	http://dx.doi.org/10.1371/journal.pone.0090018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587191	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200113
J	Catry, B; Latour, K; Jans, B; Vandendriessche, S; Preal, R; Mertens, K; Denis, O				Catry, Boudewijn; Latour, Katrien; Jans, Beatrice; Vandendriessche, Stien; Preal, Ragna; Mertens, Karl; Denis, Olivier			Risk Factors for Methicillin Resistant Staphylococcus aureus: A Multi-Laboratory Study	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ANTIBIOTIC USE; METAANALYSIS; BACTEREMIA; HOSPITALS; MORTALITY; CARRIAGE; EXPOSURE; CARE	Background: The present study aimed to investigate the dose response relationship between the prescriptions of antimicrobial agents and infection/colonization with methicillin resistant Staphylococcus aureus (MRSA) taking additional factors like stay in a health care facility into account. Methods: Multi-centre retrospective study on a cohort of patients that underwent microbiological diagnostics in Belgium during 2005. The bacteriological results retrieved from 17 voluntary participating clinical laboratories were coupled with the individual antimicrobial consumption patterns (July 2004-December 2005) and other variables as provided by pooled data of health insurance funds. Multivariate analysis was used to identify risk factors for MRSA colonization/infection. Results: A total of 6844 patients of which 17.5% died in the year 2005, were included in a logistic regression model. More than 97% of MRSA was associated with infection (clinical samples), and only a minority with screening/colonization (1.59%). Factors (95% CI) significantly (p <=< 0.01) associated with MRSA in the final multivariate model were: admission to a long term care settings (2.79-4.46); prescription of antibiotics via a hospital pharmacy (1.30-2.01); age 55+ years (3.32-5.63); age 15-54 years (1.23-2.16); and consumption of antimicrobial agent per DDD (defined daily dose) (1.25-1.40). Conclusions: The data demonstrated a direct dose-response relationship between MRSA and consumption of antimicrobial agents at the individual patient level of 25-40% increased risk per every single day. In addition the study indicated an involvement of specific healthcare settings and age in MRSA status.	[Catry, Boudewijn; Latour, Katrien; Jans, Beatrice; Mertens, Karl] Sci Inst Publ Hlth Brussels WIV ISP, Brussels, Belgium; [Vandendriessche, Stien; Denis, Olivier] ULB, Hop Erasme, Dept Microbiol, Lab Reference MRSA Staphylocoques, Brussels, Belgium; [Preal, Ragna] IMA AIM, Intermutualist Agcy, Brussels, Belgium	Universite Libre de Bruxelles	Catry, B (corresponding author), Sci Inst Publ Hlth Brussels WIV ISP, Brussels, Belgium.	Boudewijn.Catry@wiv-isp.be		Catry, Boudewijn/0000-0002-8700-7138	Belgian National Council for the Promotion of Quality (Nationale Raad voor Kwaliteitspromotie)	Belgian National Council for the Promotion of Quality (Nationale Raad voor Kwaliteitspromotie)	This study was supported by the Belgian National Council for the Promotion of Quality (Nationale Raad voor Kwaliteitspromotie; URL: http://www.riziv.fgov.be/care/nl/doctors/promotion-quality/cnpqnrkp/index.htm). The funders had an advisory role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Costelloe C, 2012, INT J ANTIMICROB AG, V39, P135, DOI 10.1016/j.ijantimicag.2011.09.022; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grundmann H, 2011, LANCET INFECT DIS, V11, P344, DOI 10.1016/S1473-3099(11)70107-4; Jans B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064908; Kuster SP, 2008, INFECTION, V36, P549, DOI 10.1007/s15010-008-7462-z; Monnet DL, 1998, INFECT CONT HOSP EP, V19, P552; Rahal K, 1997, CLIN INFECT DIS, V24, pS169, DOI 10.1093/clinids/24.Supplement_1.S169; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Tacconelli E, 2008, J ANTIMICROB CHEMOTH, V61, P26, DOI 10.1093/jac/dkm416; Talon D, 2002, Eur J Intern Med, V13, P31, DOI 10.1016/S0953-6205(01)00189-3; Vandendriessche S, 2012, EUR J CLIN MICROBIOL, V31, P2283, DOI 10.1007/s10096-012-1567-0; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	14	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89579	10.1371/journal.pone.0089579	http://dx.doi.org/10.1371/journal.pone.0089579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586887	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000064
J	Grosen, K; Vase, L; Pilegaard, HK; Pfeiffer-Jensen, M; Drewes, AM				Grosen, Kasper; Vase, Lene; Pilegaard, Hans K.; Pfeiffer-Jensen, Mogens; Drewes, Asbjorn M.			Conditioned Pain Modulation and Situational Pain Catastrophizing as Preoperative Predictors of Pain following Chest Wall Surgery: A Prospective Observational Cohort Study	PLOS ONE			English	Article							ACUTE POSTOPERATIVE PAIN; ENDOGENOUS PAIN; INDIVIDUAL-DIFFERENCES; CLINICAL-TRIALS; RISK-FACTOR; ANALGESIA; RESPONSES; ASSOCIATION; SENSITIVITY; PREVALENCE	Background: Variability in patients' postoperative pain experience and response to treatment challenges effective pain management. Variability in pain reflects individual differences in inhibitory pain modulation and psychological sensitivity, which in turn may be clinically relevant for the disposition to acquire pain. The aim of this study was to investigate the effects of conditioned pain modulation and situational pain catastrophizing on postoperative pain and pain persistency. Methods: Preoperatively, 42 healthy males undergoing funnel chest surgery completed the Spielberger's State-Trait Anxiety Inventory and Beck's Depression Inventory before undergoing a sequential conditioned pain modulation paradigm. Subsequently, the Pain Catastrophizing Scale was introduced and patients were instructed to reference the conditioning pain while answering. Ratings of movement-evoked pain and consumption of morphine equivalents were obtained during postoperative days 2-5. Pain was reevaluated at six months postoperatively. Results: Patients reporting persistent pain at six months follow-up (n = 15) were not significantly different from pain-free patients (n = 16) concerning preoperative conditioned pain modulation response (Z = 1.0, P = 0.3) or level of catastrophizing (Z = 0.4, P = 1.0). In the acute postoperative phase, situational pain catastrophizing predicted movement-evoked pain, independently of anxiety and depression (beta = 1.0, P = 0.007) whereas conditioned pain modulation predicted morphine consumption (beta = -0.005, P = 0.001). Conclusions: Preoperative conditioned pain modulation and situational pain catastrophizing were not associated with the development of persistent postoperative pain following funnel chest repair. Secondary outcome analyses indicated that conditioned pain modulation predicted morphine consumption and situational pain catastrophizing predicted movement-evoked pain intensity in the acute postoperative phase. These findings may have important implications for developing strategies to treat or prevent acute postoperative pain in selected patients. Pain may be predicted and the malfunctioning pain inhibition mechanism as tested with CPM may be treated with suitable drugs augmenting descending inhibition.	[Grosen, Kasper; Pilegaard, Hans K.] Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-8000 Aarhus, Denmark; [Vase, Lene] Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark; [Vase, Lene] Aarhus Univ, Danish Pain Res Ctr, Aarhus, Denmark; [Pfeiffer-Jensen, Mogens] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; [Drewes, Asbjorn M.] Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Aalborg, Denmark; [Drewes, Asbjorn M.] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Aalborg University	Grosen, K (corresponding author), Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-8000 Aarhus, Denmark.	kasper.grosen@ki.au.dk	Grosen, Kasper/C-3538-2016; Drewes, Asbjørn/AAR-7479-2021; Pfeiffer-Jensen, Mogens/E-2251-2016	Drewes, Asbjørn/0000-0001-7465-964X; Pfeiffer-Jensen, Mogens/0000-0001-7013-8281; Vase, Lene/0000-0002-0379-2256; Grosen, Kasper/0000-0002-2147-899X	M.L. Jorgensen and Gunnar Hansen's Foundation, Copenhagen, Denmark; Danish Council for Strategic Research; Danish Agency for Science, Technology and Innovation, Copenhagen, Denmark; Aarhus University, Aarhus, Denmark	M.L. Jorgensen and Gunnar Hansen's Foundation, Copenhagen, Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Agency for Science, Technology and Innovation, Copenhagen, Denmark; Aarhus University, Aarhus, Denmark	This study received financial support from the M.L. Jorgensen and Gunnar Hansen's Foundation, Copenhagen, Denmark and the Danish Council for Strategic Research, the Danish Agency for Science, Technology and Innovation, Copenhagen, Denmark. Kasper Grosen has received a Ph.D. scholarship from Aarhus University, Aarhus, Denmark. There are no other conditions, relationships or circumstances that present potential conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasvang EK, 2010, ANESTHESIOLOGY, V112, P957, DOI 10.1097/ALN.0b013e3181d31ff8; Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Arendt-Nielsen L, 2012, CLIN J PAIN, V28, P623, DOI 10.1097/AJP.0b013e31823e15cb; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Campbell CM, 2010, J PAIN, V11, P443, DOI 10.1016/j.jpain.2009.08.009; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Dai F, 2013, J PAIN, V14, P767, DOI 10.1016/j.jpain.2013.04.004; Dolin SJ, 2002, BRIT J ANAESTH, V89, P409, DOI 10.1093/bja/aef207; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Edwards RR, 2006, CLIN J PAIN, V22, P730, DOI 10.1097/01.ajp.0000210914.72794.bc; Edwards RR, 2005, NEUROLOGY, V65, P437, DOI 10.1212/01.wnl.0000171862.17301.84; Edwards RR, 2005, J PAIN, V6, P338, DOI 10.1016/j.jpain.2005.02.013; Edwards RR, 2003, PAIN, V106, P427, DOI 10.1016/j.pain.2003.09.005; Fillingim RB, 2005, BIOL PSYCHOL, V69, P97, DOI 10.1016/j.biopsycho.2004.11.008; Gjeilo KH, 2007, J PAIN SYMPTOM MANAG, V34, P648, DOI 10.1016/j.jpainsymman.2007.01.010; Goodin BR, 2009, J PAIN, V10, P180, DOI 10.1016/j.jpain.2008.08.012; Granot M, 2005, CLIN J PAIN, V21, P439, DOI 10.1097/01.ajp.0000135236.12705.2d; Granot M, 2008, PAIN, V136, P142, DOI 10.1016/j.pain.2007.06.029; Grosen K, 2013, EUR J PAIN, V17, P1267, DOI 10.1002/j.1532-2149.2013.00330.x; Grosen K, 2013, EUR J CARDIO-THORAC, V43, P95, DOI 10.1093/ejcts/ezs159; Haythornthwaite JA, 2003, PAIN, V106, P453, DOI 10.1016/j.pain.2003.09.009; Holen JC, 2008, CLIN J PAIN, V24, P219, DOI 10.1097/AJP.0b013e31815ec22a; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Jacobsen PB, 1996, J BEHAV MED, V19, P17, DOI 10.1007/BF01858172; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; Khan RS, 2012, PAIN MED, V13, P820, DOI 10.1111/j.1526-4637.2012.01386.x; Lautenbacher S, 2010, PAIN, V151, P722, DOI 10.1016/j.pain.2010.08.041; Lautenbacher S, 2009, CLIN J PAIN, V25, P92, DOI 10.1097/AJP.0b013e3181850dce; Lewis GN, 2012, J PAIN, V13, P936, DOI 10.1016/j.jpain.2012.07.005; Logan DE, 2005, J PEDIATR PSYCHOL, V30, P187, DOI 10.1093/jpepsy/jsi006; Martel MO, 2013, PAIN MED, V14, P1757, DOI 10.1111/pme.12220; McQuay HJ, 2012, PAIN, V153, P1364, DOI 10.1016/j.pain.2012.01.024; Miro J, 2009, EUR J PAIN, V13, P1089, DOI 10.1016/j.ejpain.2009.07.002; Moore RA, 2005, PAIN, V116, P322, DOI 10.1016/j.pain.2005.05.001; Nielsen CS, 2009, J PAIN, V10, P231, DOI 10.1016/j.jpain.2008.09.010; Niesters M, 2013, BRIT J ANAESTH, V110, P1010, DOI 10.1093/bja/aes578; Ochroch EA, 2005, CHEST, V128, P2664, DOI 10.1378/chest.128.4.2664; Ochroch EA, 2006, CLIN J PAIN, V22, P491, DOI 10.1097/01.ajp.0000208246.18251.f2; Olesen SS, 2010, CLIN GASTROENTEROL H, V8, P724, DOI 10.1016/j.cgh.2010.03.005; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Page M Gabrielle, 2012, J Pain Res, V5, P547, DOI 10.2147/JPR.S36614; Page MG, 2012, J PAIN, V13, P359, DOI 10.1016/j.jpain.2011.12.010; Papaioannou M, 2009, PAIN MED, V10, P1452, DOI 10.1111/j.1526-4637.2009.00730.x; Patanwala AE, 2007, ANN PHARMACOTHER, V41, P255, DOI 10.1345/aph.1H421; Pavlin DJ, 2005, CLIN J PAIN, V21, P83, DOI 10.1097/00002508-200501000-00010; Peters ML, 2010, BRIT J SURG, V97, P1518, DOI 10.1002/bjs.7152; Peters ML, 2007, ANN SURG, V245, P487, DOI 10.1097/01.sla.0000245495.79781.65; Piche M, 2011, NEUROSCIENCE, V195, P166, DOI 10.1016/j.neuroscience.2011.08.040; Pilegaard HK, 2008, ANN THORAC SURG, V86, P952, DOI 10.1016/j.athoracsur.2008.04.078; Pinto PR, 2013, EUR J PAIN, V17, P423, DOI 10.1002/j.1532-2149.2012.00205.x; Pinto PR, 2012, PAIN, V153, P218, DOI 10.1016/j.pain.2011.10.020; Price DD, 2008, PAIN, V140, P158, DOI 10.1016/j.pain.2008.07.028; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Schug SA, 2006, WALL MELZACKS TXB PA, P443; Seminowicz DA, 2006, PAIN, V120, P297, DOI 10.1016/j.pain.2005.11.008; SILVERMAN DG, 1993, ANESTH ANALG, V77, P168, DOI 10.1213/00000539-199307000-00032; Sommer M, 2008, EUR J ANAESTH, V25, P267, DOI 10.1017/S0265021507003031; Sommer M, 2010, CLIN J PAIN, V26, P87, DOI 10.1097/AJP.0b013e3181b43d68; Sommer M, 2009, ARCH OTOLARYNGOL, V135, P124, DOI 10.1001/archoto.2009.3; Spielberger C.D., 1997, MANUAL STATE TRAIT A; Srikandarajah S, 2011, PAIN, V152, P1734, DOI 10.1016/j.pain.2011.02.008; Strulov L, 2007, J PAIN, V8, P273, DOI 10.1016/j.jpain.2006.09.004; Stubhaug A, 1997, ACTA ANAESTH SCAND, V41, P1124, DOI 10.1111/j.1399-6576.1997.tb04854.x; Sullivan MJ., 2008, CONT HYPNOSIS, V25, P129, DOI DOI 10.1002/CH.365; SULLIVAN MJL, 1990, J ABNORM PSYCHOL, V99, P260, DOI 10.1037/0021-843X.99.3.260; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sullivan MJL, 2001, PAIN, V91, P147, DOI 10.1016/S0304-3959(00)00430-9; Theunissen M, 2012, CLIN J PAIN, V28, P819, DOI 10.1097/AJP.0b013e31824549d6; van Wijk G, 2010, J PAIN, V11, P408, DOI 10.1016/j.jpain.2009.10.009; Vase L, 2011, PAIN, V152, P157, DOI 10.1016/j.pain.2010.10.013; Weissman-Fogel I, 2008, EXP BRAIN RES, V186, P79, DOI 10.1007/s00221-007-1206-7; Weissman-Fogel I, 2009, J PAIN, V10, P628, DOI 10.1016/j.jpain.2008.12.009; White PF, 2008, CURR OPIN INVEST DR, V9, P76; White PF, 2010, ANESTHESIOLOGY, V112, P220, DOI 10.1097/ALN.0b013e3181c6316e; Wilder-Smith Oliver Hamilton, 2010, J Pain Palliat Care Pharmacother, V24, P119, DOI 10.3109/15360281003706069; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004; Zachariae R, 2001, AM HEART J, V142, P63, DOI 10.1067/mhj.2001.115794	82	55	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90185	10.1371/journal.pone.0090185	http://dx.doi.org/10.1371/journal.pone.0090185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24587268	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000140
J	Ifkovits, JL; Addis, RC; Epstein, JA; Gearhart, JD				Ifkovits, Jamie L.; Addis, Russell C.; Epstein, Jonathan A.; Gearhart, John D.			Inhibition of TGF beta Signaling Increases Direct Conversion of Fibroblasts to Induced Cardiomyocytes	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SMALL-MOLECULE INHIBITORS; HEART REPAIR; EMBRYONIC FIBROBLASTS; CARDIAC FIBROBLASTS; DEFINED FACTORS; DIFFERENTIATION; INDUCTION; REGENERATION; PROMISE	Recent studies have been successful at utilizing ectopic expression of transcription factors to generate induced cardiomyocytes (iCMs) from fibroblasts, albeit at a low frequency in vitro. This work investigates the influence of small molecules that have been previously reported to improve differentiation to cardiomyocytes as well as reprogramming to iPSCs in conjunction with ectopic expression of the transcription factors Hand2, Nkx2.5, Gata4, Mef2C, and Tbx5 on the conversion to functional iCMs. We utilized a reporter system in which the calcium indicator GCaMP is driven by the cardiac Troponin T promoter to quantify iCM yield. The TGF beta inhibitor, SB431542 (SB), was identified as a small molecule capable of increasing the conversion of both mouse embryonic fibroblasts and adult cardiac fibroblasts to iCMs up to similar to 5 fold. Further characterization revealed that inhibition of TGF beta by SB early in the reprogramming process led to the greatest increase in conversion of fibroblasts to iCMs in a dose-responsive manner. Global transcriptional analysis at Day 3 post-induction of the transcription factors revealed an increased expression of genes associated with the development of cardiac muscle in the presence of SB compared to the vehicle control. Incorporation of SB in the reprogramming process increases the efficiency of iCM generation, one of the major goals necessary to enable the use of iCMs for discovery-based applications and for the clinic.	[Ifkovits, Jamie L.; Addis, Russell C.; Epstein, Jonathan A.; Gearhart, John D.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Ifkovits, JL (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	Ifkovits@mail.med.upenn.edu; gearhart@upenn.edu		Epstein, Jonathan/0000-0001-8637-4465	NIH [U01 HL100405]; American Heart Association Jon Holden DeHaan Myogenesis Center; Pennsylvania Health Research Formula Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405, U01HL100395] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Jon Holden DeHaan Myogenesis Center(American Heart Association); Pennsylvania Health Research Formula Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from NIH U01 HL100405, the American Heart Association Jon Holden DeHaan Myogenesis Center, and Pennsylvania Health Research Formula Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis RC, 2013, NAT MED, V19, P829, DOI 10.1038/nm.3225; Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Aguirre A, 2013, CELL STEM CELL, V12, P275, DOI 10.1016/j.stem.2013.02.008; Ao A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041627; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Cai WQ, 2012, CIRC RES, V111, P876, DOI 10.1161/CIRCRESAHA.112.270272; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Hansson EM, 2012, CELL STEM CELL, V11, P3, DOI 10.1016/j.stem.2012.06.014; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; Mathison M, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005652; McCombs JE, 2008, METHODS, V46, P152, DOI 10.1016/j.ymeth.2008.09.015; Mezentseva NV, 2013, STEM CELLS DEV, V22, P654, DOI 10.1089/scd.2012.0181; Nam YJ, 2013, NAT MED, V19, P413, DOI 10.1038/nm.3147; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Palpant NJ, 2012, NATURE, V485, P585, DOI 10.1038/485585a; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Sy JC, 2010, J CARDIOVASC TRANSL, V3, P461, DOI 10.1007/s12265-010-9210-x; Trokovic R, 2013, STEM CELLS DEV, V22, P114, DOI 10.1089/scd.2012.0157; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Willems E, 2011, CIRC RES, V109, P360, DOI 10.1161/CIRCRESAHA.111.249540; Zhu JG, 2012, CELL REPROGRAM, V14, P99, DOI 10.1089/cell.2011.0074	42	123	130	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89678	10.1371/journal.pone.0089678	http://dx.doi.org/10.1371/journal.pone.0089678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586958	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000075
J	Cai, HJ; Wu, MZ; Luo, YLL; Yang, J				Cai, Huajian; Wu, Mingzheng; Luo, Yu L. L.; Yang, Jing			Implicit Self-Esteem Decreases in Adolescence: A Cross-Sectional Study	PLOS ONE			English	Article							ASSOCIATION TEST; NAME; EXPLICIT	Implicit self-esteem has remained an active research topic in both the areas of implicit social cognition and self-esteem in recent decades. The purpose of this study is to explore the development of implicit self-esteem in adolescents. A total of 599 adolescents from junior and senior high schools in East China participated in the study. They ranged in age from 11 to 18 years with a mean age of 14.10 (SD = 2.16). The degree of implicit self-esteem was assessed using the Implicit Association Test (IAT) with the improved D score as the index. Participants also completed the Rosenberg Self-Esteem Scale (alpha = 0.77). For all surveyed ages, implicit self-esteem was positively biased, all ts > 8.59, all ps < 0.001. The simple correlation between implicit self-esteem and age was significant, r = -.25, p = 1.0 x 10(-10). A regression with implicit self-esteem as the criterion variable, and age, gender, and age 6 gender interaction as predictors further revealed the significant negative linear relationship between age and implicit self-esteem, beta = -0.19, t = -3.20, p = 0.001. However, explicit self-esteem manifested a reverse "U'' shape throughout adolescence. Implicit self-esteem in adolescence manifests a declining trend with increasing age, suggesting that it is sensitive to developmental or age-related changes. This finding enriches our understanding of the development of implicit social cognition.	[Cai, Huajian; Luo, Yu L. L.; Yang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Wu, Mingzheng] Zhejiang Univ, Dept Psychol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Zhejiang University	Cai, HJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	caihj@psych.ac.cn			Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]; National Natural Science Foundation of China [31070919]; Hundred Talents Program [Y1CX153003]; Key Laboratory of Behavioral Science, Institute of Psychology, Chinese Academy of Sciences [112000S001]; Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences [Y1CX273005]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program(Chinese Academy of Sciences); Key Laboratory of Behavioral Science, Institute of Psychology, Chinese Academy of Sciences; Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences	The present study is supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-8), National Natural Science Foundation of China (31070919), Hundred Talents Program (Y1CX153003), the Open Project of Key Laboratory of Behavioral Science, Institute of Psychology, Chinese Academy of Sciences (112000S001), and the Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences (Y1CX273005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Arnett JJ, 1999, AM PSYCHOL, V54, P317, DOI 10.1037/0003-066X.54.5.317; Baccus JR, 2004, PSYCHOL SCI, V15, P498, DOI 10.1111/j.0956-7976.2004.00708.x; Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Bowlby J., 1969, ATTACHMENT AND LOSS; Brown JD, 2010, SOC PERSONAL PSYCHOL, V4, P318, DOI 10.1111/j.1751-9004.2010.00267.x; Brown JD, 2010, COGNITION EMOTION, V24, P1389, DOI 10.1080/02699930903504405; BUCHANAN CM, 1992, PSYCHOL BULL, V111, P62, DOI 10.1037/0033-2909.111.1.62; Buhrmester MD, 2011, J PERS SOC PSYCHOL, V100, P365, DOI 10.1037/a0021341; Cai HJ, 2004, SOC COGNITION, V22, P673, DOI 10.1521/soco.22.6.673.54821; Cai HJ, 2009, ASIAN J SOC PSYCHOL, V12, P104, DOI 10.1111/j.1467-839X.2009.01278.x; Cvencek D, 2011, J EXP CHILD PSYCHOL, V109, P187, DOI 10.1016/j.jecp.2010.11.002; DeHart T, 2006, J EXP SOC PSYCHOL, V42, P1, DOI 10.1016/j.jesp.2004.12.005; DeHart T, 2007, J EXP SOC PSYCHOL, V43, P157, DOI 10.1016/j.jesp.2006.01.002; Dunham Y, 2007, SELF IDENTITY, V6, P238, DOI 10.1080/15298860601115344; EPSTEIN S, 1995, EFFICACY AGENCY SELF, P9, DOI DOI 10.1007/978-1-4899-1280-0_2; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Gregg AP, 2010, SELF IDENTITY, V9, P142, DOI 10.1080/15298860902815451; Hall G.S., 1904, ADOLESCENCE ITS PSYC, VI; Hall G. S., 1904, ADOLESCENCE ITS PSYC, VII; Harter S, 2003, J PERS, V71, P1027, DOI 10.1111/1467-6494.7106006; Harter S., 1999, CONSTRUCTION SELF; Heine SJ, 2002, J PERS SOC PSYCHOL, V82, P903, DOI 10.1037//0022-3514.82.6.903; Hetts JJ, 1999, J EXP SOC PSYCHOL, V35, P512, DOI 10.1006/jesp.1999.1391; HOORENS V, 1990, EUR J SOC PSYCHOL, V20, P181; Hummert ML, 2002, PSYCHOL AGING, V17, P482, DOI 10.1037//0882-7974.17.3.482; Jones JT, 2002, J EXP SOC PSYCHOL, V38, P170, DOI 10.1006/jesp.2001.1497; Kitayama S, 1997, PERS SOC PSYCHOL B, V23, P736, DOI 10.1177/0146167297237006; Koole SL, 2007, FRONT SOC PSYCHOL, P21; Koole SL, 2001, J PERS SOC PSYCHOL, V80, P669, DOI 10.1037//0022-3514.80.4.669; Lane K. A., 2007, IMPLICIT MEASURES AT, P59, DOI DOI 10.1016/J.BRAT.2008.02.003; Laursen B, 1998, CHILD DEV, V69, P817, DOI 10.2307/1132206; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; McFarland SG, 2002, SOC COGNITION, V20, P483, DOI 10.1521/soco.20.6.483.22977; Orth U, 2012, J PERS SOC PSYCHOL, V102, P1271, DOI 10.1037/a0025558; PAIKOFF RL, 1991, PSYCHOL BULL, V110, P47, DOI 10.1037/0033-2909.110.1.47; Rosenberg M., 1965, SOC ADOLESCENT SELF, V11; Rudman LA, 2004, CURR DIR PSYCHOL SCI, V13, P79, DOI 10.1111/j.0963-7214.2004.00279.x; SMETANA JG, 1989, CHILD DEV, V60, P1052, DOI 10.2307/1130779; Trzesniewski K. H., 2011, HDB SELF ENHANCEMENT, P341; Verkuyten M, 2005, SELF IDENTITY, V4, P177, DOI 10.1080/13576500444000290; Wilson TD, 2000, PSYCHOL REV, V107, P101, DOI 10.1037/0033-295X.107.1.101; Yamaguchi S, 2007, PSYCHOL SCI, V18, P498, DOI 10.1111/j.1467-9280.2007.01928.x	47	7	7	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89988	10.1371/journal.pone.0089988	http://dx.doi.org/10.1371/journal.pone.0089988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24587169	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900106
J	Yip, KW; Zhang, Z; Sakemura-Nakatsugawa, N; Huang, JW; Vu, NM; Chiang, YK; Lin, CL; Kwan, JYY; Yue, SJ; Jitkova, Y; To, T; Zahedi, P; Pai, EF; Schimmer, AD; Lovell, JF; Sessler, JL; Liu, FF				Yip, Kenneth W.; Zhang, Zhan; Sakemura-Nakatsugawa, Noriko; Huang, Jui-Wen; Nhu Mai Vu; Chiang, Yi-Kun; Lin, Chih-Lung; Kwan, Jennifer Y. Y.; Yue, Shijun; Jitkova, Yulia; To, Terence; Zahedi, Payam; Pai, Emil F.; Schimmer, Aaron D.; Lovell, Jonathan F.; Sessler, Jonathan L.; Liu, Fei-Fei			A Porphodimethene Chemical Inhibitor of Uroporphyrinogen Decarboxylase	PLOS ONE			English	Article							PORPHOMETHENE INHIBITOR; MOTEXAFIN GADOLINIUM; ACCURATE DOCKING; DRUG; GLIDE; RADIOTHERAPY; THERAPY; HEAD	Uroporphyrinogen decarboxylase (UROD) catalyzes the conversion of uroporphyrinogen to coproporphyrinogen during heme biosynthesis. This enzyme was recently identified as a potential anticancer target; its inhibition leads to an increase in reactive oxygen species, likely mediated by the Fenton reaction, thereby decreasing cancer cell viability and working in cooperation with radiation and/or cisplatin. Because there is no known chemical UROD inhibitor suitable for use in translational studies, we aimed to design, synthesize, and characterize such a compound. Initial in silico-based design and docking analyses identified a potential porphyrin analogue that was subsequently synthesized. This species, a porphodimethene (named PI-16), was found to inhibit UROD in an enzymatic assay (IC50 = 9.9 mu M), but did not affect porphobilinogen deaminase (at 62.5 mu M), thereby exhibiting specificity. In cellular assays, PI-16 reduced the viability of FaDu and ME-180 cancer cells with half maximal effective concentrations of 22.7 mu M and 26.9 mu M, respectively, and only minimally affected normal oral epithelial (NOE) cells. PI-16 also combined effectively with radiation and cisplatin, with potent synergy being observed in the case of cisplatin in FaDu cells (Chou-Talalay combination index <1). This work presents the first known synthetic UROD inhibitor, and sets the foundation for the design, synthesis, and characterization of higher affinity and more effective UROD inhibitors.	[Yip, Kenneth W.; Sakemura-Nakatsugawa, Noriko; Kwan, Jennifer Y. Y.; Yue, Shijun; Jitkova, Yulia; To, Terence; Zahedi, Payam; Pai, Emil F.; Schimmer, Aaron D.; Liu, Fei-Fei] Ontario Canc Inst, Campbell Family Canc Res Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Zhang, Zhan; Nhu Mai Vu; Sessler, Jonathan L.] Univ Texas Austin, Dept Chem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Huang, Jui-Wen; Chiang, Yi-Kun; Lin, Chih-Lung] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Pai, Emil F.; Schimmer, Aaron D.; Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Lovell, Jonathan F.] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Liu, Fei-Fei] Princess Margaret Canc Ctr, Dept Radiat Oncol, UHN, Toronto, ON, Canada; [Liu, Fei-Fei] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Texas System; University of Texas Austin; Industrial Technology Research Institute - Taiwan; University of Toronto; University of Toronto; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Liu, FF (corresponding author), Ontario Canc Inst, Campbell Family Canc Res Inst, Univ Hlth Network, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca	Pai, Emil/R-8908-2019; Kwan, Jennifer/E-7537-2017; Sessler, Jonathan/AAY-7091-2021; Kwan, Jennifer/AAE-8836-2019	Pai, Emil/0000-0002-1162-7242; Kwan, Jennifer/0000-0003-2651-2402; Kwan, Jennifer/0000-0003-2651-2402; Lovell, Jonathan/0000-0002-9052-884X; Spence, Tara/0000-0001-7098-4103; Schimmer, Aaron/0000-0003-4023-3899; Liu, Fei-Fei/0000-0003-4344-6486	Canadian Institutes of Health Research Proof of Principle and Operating [PPP-102202, MOP-102497]; Cancer Prevention and Research Institute of Texas [CP RP101501]	Canadian Institutes of Health Research Proof of Principle and Operating(Canadian Institutes of Health Research (CIHR)); Cancer Prevention and Research Institute of Texas	This work was funded by Canadian Institutes of Health Research Proof of Principle and Operating Grants [Grants PPP-102202, MOP-102497]. Support from the Cancer Prevention and Research Institute of Texas [Grant CP RP101501] is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Danton M, 2007, BIOMED CHROMATOGR, V21, P661, DOI 10.1002/bmc.860; ELDER GH, 1990, SEMIN DERMATOL, V9, P63; ELDER GH, 1995, J BIOENERG BIOMEMBR, V27, P207, DOI 10.1007/BF02110035; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fury MG, 2011, J NATL COMPR CANC NE, V9, P681, DOI 10.6004/jnccn.2011.0056; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hower V, 2009, MOL BIOSYST, V5, P422, DOI 10.1039/b816714c; Hwang IT, 2007, BIOCHEM BIOPH RES CO, V359, P304, DOI 10.1016/j.bbrc.2007.05.088; Ito E, 2011, FUTURE ONCOL, V7, P595, DOI [10.2217/fon.11.27, 10.2217/FON.11.27]; Ito E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001922; JORDAN PM, 1988, BIOCHEM J, V254, P427, DOI 10.1042/bj2540427; Kral V, 2000, ANGEW CHEM INT EDIT, V39, P1055, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1055::AID-ANIE1055>3.3.CO;2-F; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lewis CA, 2008, P NATL ACAD SCI USA, V105, P17328, DOI 10.1073/pnas.0809838105; LOH CS, 1993, BRIT J CANCER, V68, P41, DOI 10.1038/bjc.1993.284; Lovell JF, 2011, NAT MATER, V10, P324, DOI [10.1038/NMAT2986, 10.1038/nmat2986]; Magda D, 2006, SEMIN CANCER BIOL, V16, P466, DOI 10.1016/j.semcancer.2006.09.002; Mehta MP, 2009, INT J RADIAT ONCOL, V73, P1069, DOI 10.1016/j.ijrobp.2008.05.068; MOAN J, 1987, PHOTOCHEM PHOTOBIOL, V46, P713, DOI 10.1111/j.1751-1097.1987.tb04837.x; PANTELIDES ML, 1989, PHOTOCHEM PHOTOBIOL, V49, P67, DOI 10.1111/j.1751-1097.1989.tb04079.x; Phillips JD, 2003, EMBO J, V22, P6225, DOI 10.1093/emboj/cdg606; Phillips JD, 2001, CURR PROTOC TOXICOL, V8; Phillips JD, 2007, P NATL ACAD SCI USA, V104, P5079, DOI 10.1073/pnas.0700547104; Phillips JD, 2007, TRANSL RES, V149, P85, DOI 10.1016/j.trsl.2006.08.006; Phillips JD, 2009, J MOL BIOL, V389, P306, DOI 10.1016/j.jmb.2009.04.013; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; SMITH KM, 1986, J ORG CHEM, V51, P666, DOI 10.1021/jo00355a016; Whitby FG, 1998, EMBO J, V17, P2463, DOI 10.1093/emboj/17.9.2463	37	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89889	10.1371/journal.pone.0089889	http://dx.doi.org/10.1371/journal.pone.0089889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587102	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900092
J	Farkas, D; Kraskauskas, D; Drake, JI; Alhussaini, AA; Kraskauskiene, V; Bogaard, HJ; Cool, CD; Voelkel, NF; Farkas, L				Farkas, Daniela; Kraskauskas, Donatas; Drake, Jennifer I.; Alhussaini, Aysar A.; Kraskauskiene, Vita; Bogaard, Harm J.; Cool, Carlyne D.; Voelkel, Norbert F.; Farkas, Laszlo			CXCR4 Inhibition Ameliorates Severe Obliterative Pulmonary Hypertension and Accumulation of C-Kit(+) Cells in Rats	PLOS ONE			English	Article							CIRCULATING FIBROCYTES; PROGENITOR CELLS; C-KIT; PLEXIFORM LESIONS; STEM-CELLS; RECRUITMENT; APOPTOSIS; TRANSDIFFERENTIATION; PROLIFERATION; MOBILIZATION	Successful curative treatment of severe pulmonary arterial hypertension with luminal obliteration will require a thorough understanding of the mechanism underlying the development and progression of pulmonary vascular lesions. But the cells that obliterate the pulmonary arterial lumen in severe pulmonary arterial hypertension are incompletely characterized. The goal of our study was to evaluate whether inhibition of CXC chemokine receptor 4 will prevent the accumulation of c-kit(+) cells and severe pulmonary arterial hypertension. We detected c-kit(+-)cells expressing endothelial (von Willebrand Factor) or smooth muscle cell/myofibroblast (alpha-smooth muscle actin) markers in pulmonary arterial lesions of SU5416/chronic hypoxia rats. We found increased expression of CXC chemokine ligand 12 in the lung tissue of SU5416/chronic hypoxia rats. In our prevention study, AMD3100, an inhibitor of the CXC chemokine ligand 12 receptor, CXC chemokine receptor 4, only moderately decreased pulmonary arterial obliteration and pulmonary hypertension in SU5416/chronic hypoxia animals. AMD3100 treatment reduced the number of proliferating c-kit(+) alpha-smooth muscle actin(+) cells and pulmonary arterial muscularization and did not affect c-kit(+) von Willebrand Factor(+) cell numbers. Both c-kit(+) cell types expressed CXC chemokine receptor 4. In conclusion, our data demonstrate that in the SU5416/chronic hypoxia model of severe pulmonary hypertension, the CXC chemokine receptor 4-expressing c-kit(+) alpha-smooth muscle actin(+) cells contribute to pulmonary arterial muscularization. In contrast, vascular lumen obliteration by c-kit(+) von Willebrand Factor(+) cells is largely independent of CXC chemokine receptor 4.	[Farkas, Daniela; Kraskauskas, Donatas; Drake, Jennifer I.; Alhussaini, Aysar A.; Kraskauskiene, Vita; Voelkel, Norbert F.; Farkas, Laszlo] Virginia Commonwealth Univ, Victoria Johnson Ctr Obstruct Lung Res, Dept Internal Med, Div Resp Dis & Crit Care Med, Richmond, VA 23284 USA; [Bogaard, Harm J.] Vrije Univ Amsterdam Med Ctr, Dept Pulm Med, Amsterdam, Netherlands; [Cool, Carlyne D.] Univ Colorado, Dept Pathol, Denver, CO 80202 USA; [Cool, Carlyne D.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA	Virginia Commonwealth University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Farkas, L (corresponding author), Virginia Commonwealth Univ, Victoria Johnson Ctr Obstruct Lung Res, Dept Internal Med, Div Resp Dis & Crit Care Med, Richmond, VA 23284 USA.	lfarkas@vcu.edu		Drake, Jennifer/0000-0002-2808-4475; Bogaard, Harm Jan/0000-0001-5371-0346	NIH/NHLBI [HL109918]; Victoria Johnson Center for Obstructive Lung Disease Funds (VCU); NIH-National Institute of Neurological Disorders and Stroke Center core [5P30NS047463-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Victoria Johnson Center for Obstructive Lung Disease Funds (VCU); NIH-National Institute of Neurological Disorders and Stroke Center core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by the NIH/NHLBI grant HL109918 and the Victoria Johnson Center for Obstructive Lung Disease Funds (VCU). Confocal microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscope Facility, supported, in part, with funding from NIH-National Institute of Neurological Disorders and Stroke Center core grant (5P30NS047463-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Al Husseini A, 2013, EUR RESPIR J, V41, P104, DOI 10.1183/09031936.00196511; Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Asosingh K, 2012, BLOOD, V120, P1218, DOI 10.1182/blood-2012-03-419275; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Burke DL, 2009, AM J PHYSIOL-LUNG C, V297, pL238, DOI 10.1152/ajplung.90591.2008; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cheng M, 2010, CIRC RES, V107, P1083, DOI 10.1161/CIRCRESAHA.110.220970; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Erzurum S, 2010, AM J RESP CRIT CARE, V182, P1554, DOI 10.1164/rccm.201006-0869WS; Fang ST, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001407; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; Gambaryan N, 2011, EUR RESPIR J, V37, P1392, DOI 10.1183/09031936.00045710; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Makino H, 2013, J MED INVESTIG, V60, P127, DOI 10.2152/jmi.60.127; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Nicolls Mark R, 2012, Pulm Circ, V2, P434, DOI 10.4103/2045-8932.105031; Nikam VS, 2010, EUR RESPIR J, V36, P1302, DOI 10.1183/09031936.00028009; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Ray P, 2008, CELL CYCLE, V7, P2826, DOI 10.4161/cc.7.18.6752; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje; Sakao S, 2007, FASEB J, V21, P3640, DOI 10.1096/fj.07-8432com; Sakao S, 2010, AM J RESP CELL MOL, V43, P629, DOI 10.1165/rcmb.2009-0389TR; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Song JS, 2010, EXP MOL MED, V42, P465, DOI 10.3858/emm.2010.42.6.048; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Toshner M, 2009, AM J RESP CRIT CARE, V180, P780, DOI 10.1164/rccm.200810-1662OC; TUDER RM, 1994, AM J PATHOL, V144, P275; Weiss Daniel J, 2011, Proc Am Thorac Soc, V8, P223, DOI 10.1513/pats.201012-071DW; Yoder MC, 2009, BBA-REV CANCER, V1796, P50, DOI 10.1016/j.bbcan.2009.04.002; Yu LY, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-21; Yu XL, 2012, J NEUROL SCI, V316, P141, DOI 10.1016/j.jns.2012.01.001; Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38	48	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89810	10.1371/journal.pone.0089810	http://dx.doi.org/10.1371/journal.pone.0089810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587052	Green Submitted, gold, Green Published			2022-12-27	WOS:000331880700093
J	Monfardini, E; Hadj-Bouziane, F; Meunier, M				Monfardini, Elisabetta; Hadj-Bouziane, Fadila; Meunier, Martine			Model-Observer Similarity, Error Modeling and Social Learning in Rhesus Macaques	PLOS ONE			English	Article							OTHERS MISTAKES; FACILITATION; METAANALYSIS; PREFERENCES; PERFORMANCE; ATTRACTION; BEHAVIOR; REWARDS	Monkeys readily learn to discriminate between rewarded and unrewarded items or actions by observing their conspecifics. However, they do not systematically learn from humans. Understanding what makes human-to-monkey transmission of knowledge work or fail could help identify mediators and moderators of social learning that operate regardless of language or culture, and transcend inter-species differences. Do monkeys fail to learn when human models show a behavior too dissimilar from the animals' own, or when they show a faultless performance devoid of error? To address this question, six rhesus macaques trained to find which object within a pair concealed a food reward were successively tested with three models: a familiar conspecific, a 'stimulus-enhancing' human actively drawing the animal's attention to one object of the pair without actually performing the task, and a 'monkey-like' human performing the task in the same way as the monkey model did. Reward was manipulated to ensure that all models showed equal proportions of errors and successes. The 'monkey-like' human model improved the animals' subsequent object discrimination learning as much as a conspecific did, whereas the 'stimulus-enhancing' human model tended on the contrary to retard learning. Modeling errors rather than successes optimized learning from the monkey and 'monkey-like' models, while exacerbating the adverse effect of the 'stimulus-enhancing' model. These findings identify error modeling as a moderator of social learning in monkeys that amplifies the models' influence, whether beneficial or detrimental. By contrast, model-observer similarity in behavior emerged as a mediator of social learning, that is, a prerequisite for a model to work in the first place. The latter finding suggests that, as preverbal infants, macaques need to perceive the model as 'like-me' and that, once this condition is fulfilled, any agent can become an effective model.	[Monfardini, Elisabetta; Hadj-Bouziane, Fadila; Meunier, Martine] INSERM, U1028, Lyon Neurosci Res Ctr, ImpAct Team, F-69008 Lyon, France; [Monfardini, Elisabetta; Hadj-Bouziane, Fadila; Meunier, Martine] CNRS, UMR5292, Lyon Neurosci Res Ctr, ImpAct Team, Lyon, France; [Monfardini, Elisabetta; Hadj-Bouziane, Fadila; Meunier, Martine] Univ Lyon, Lyon, France; [Monfardini, Elisabetta] Inst Environm Med, Paris, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Monfardini, E (corresponding author), INSERM, U1028, Lyon Neurosci Res Ctr, ImpAct Team, F-69008 Lyon, France.	elisabetta.monfardini@inserm.fr	Monfardini, Elisabetta/E-8544-2016; MEUNIER, Martine/C-2611-2015; Hadj-Bouziane, Fadila/A-1180-2013; Hadj-Bouziane, Fadila/AAC-7147-2020; Hadj-Bouziane, Fadila/F-6309-2016	Monfardini, Elisabetta/0000-0002-0783-0926; MEUNIER, Martine/0000-0002-9380-9372; Hadj-Bouziane, Fadila/0000-0002-5415-7949	Institut de Medecine Environnementale; NEURODIS Foundation; CNRS; INSERM; ANR [RPV08085CSA, ANR-O8-BLAN-0068-1]; AVENIR [R05265CS]; James S. McDonnell Foundation	Institut de Medecine Environnementale; NEURODIS Foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); AVENIR; James S. McDonnell Foundation	Elisabetta Monfardini is supported by the Institut de Medecine Environnementale and the NEURODIS Foundation; Fadila Hadj-Bouziane by the NEURODIS Foundation; Martine Meunier by CNRS, INSERM, the ANR (grants no. RPV08085CSA and ANR-O8-BLAN-0068-1), the AVENIR (grant no. R05265CS), and a scholar award from the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addessi Elsa, 2001, Animal Cognition, V4, P297, DOI 10.1007/s100710100113; Bandura A., 1986, SOCIAL FDN THOUGHT A; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bevacqua S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059961; Boer D, 2011, PERS SOC PSYCHOL B, V37, P1159, DOI 10.1177/0146167211407521; BOND CF, 1983, PSYCHOL BULL, V94, P265, DOI 10.1037/0033-2909.94.2.265; Bonnie KE, 2006, PRIMATES, V47, P27, DOI 10.1007/s10329-005-0141-0; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; Bonnie KE, 2007, ANIM COGN, V10, P283, DOI 10.1007/s10071-006-0069-9; Braaksma MAH, 2002, J EDUC PSYCHOL, V94, P405, DOI 10.1037//0022-0663.94.2.405; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; BYRNE D, 1961, J ABNORM SOC PSYCH, V62, P713, DOI 10.1037/h0044721; Chang SWC, 2013, NAT NEUROSCI, V16, P243, DOI 10.1038/nn.3287; Chang SWC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00027; Claidiere N, 2013, CURR BIOL, V23, P1251, DOI 10.1016/j.cub.2013.05.036; Cook R, 2009, P NATL ACAD SCI USA, V106, P9530, DOI 10.1073/pnas.0903378106; Dahlander L, 2013, ADMIN SCI QUART, V58, P69, DOI 10.1177/0001839212474272; DARBY CL, 1959, J COMP PHYSIOL PSYCH, V52, P94, DOI 10.1037/h0046068; de Waal FBM, 2001, APE SUSHI MASTER; DEWAAL FBM, 1986, FOLIA PRIMATOL, V46, P215, DOI 10.1159/000156255; Dindo M, 2009, AM J PRIMATOL, V71, P419, DOI 10.1002/ajp.20669; Egan LC, 2007, PSYCHOL SCI, V18, P978, DOI 10.1111/j.1467-9280.2007.02012.x; Egan LC, 2010, J EXP SOC PSYCHOL, V46, P204, DOI 10.1016/j.jesp.2009.08.014; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040283; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032209; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hadj-Bouziane F, 2003, J PHYSIOL-PARIS, V97, P567, DOI 10.1016/j.jphysparis.2004.01.014; Hilmert CJ, 2006, J PERS SOC PSYCHOL, V90, P440, DOI 10.1037/0022-3514.90.3.440; Itoh K, 2001, BEHAV NEUROSCI, V115, P259, DOI 10.1037/0735-7044.115.2.259; Izuma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00041; Johnson SC, 2001, COGNITIVE DEV, V16, P637, DOI 10.1016/S0885-2014(01)00043-0; Kuroshima H, 2008, ANIM COGN, V11, P599, DOI 10.1007/s10071-008-0150-7; Laland KN, 2004, LEARN BEHAV, V32, P4; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Maestripieri D, 2008, MACACHIAVELLIAN INTE; Meltzoff AN, 2007, ACTA PSYCHOL, V124, P26, DOI 10.1016/j.actpsy.2006.09.005; Meltzoff AN, 2010, NEURAL NETWORKS, V23, P966, DOI 10.1016/j.neunet.2010.09.005; Meunier M, 2007, NEUROBIOL LEARN MEM, V88, P243, DOI 10.1016/j.nlm.2007.04.015; Monfardini E, 2008, NEUROIMAGE, V42, P1207, DOI 10.1016/j.neuroimage.2008.05.043; Monfardini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073879; Monfardini E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00127; Montoya RM, 2008, J SOC PERS RELAT, V25, P889, DOI 10.1177/0265407508096700; MYERS WA, 1970, J EXP ANAL BEHAV, V14, P225, DOI 10.1901/jeab.1970.14-225; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; Rieucau G, 2011, PHILOS T R SOC B, V366, P949, DOI 10.1098/rstb.2010.0325; RIOPELLE AJ, 1960, J COMP PHYSIOL PSYCH, V53, P426, DOI 10.1037/h0046480; RIOPELLE AJ, 1954, J COMP PHYSIOL PSYCH, V47, P293, DOI 10.1037/h0054078; Rizzolatti Giacomo, 2008, MIRRORS BRAIN OUR MI; SCHUNK DH, 1987, REV EDUC RES, V57, P149, DOI 10.3102/00346543057002149; Schwab C, 2008, ANIM BEHAV, V75, P501, DOI 10.1016/j.anbehav.2007.06.006; Shane MS, 2008, NEUROIMAGE, V42, P450, DOI 10.1016/j.neuroimage.2007.12.067; Spence KW, 1937, PSYCHOL REV, V44, P430, DOI 10.1037/h0062885; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Templeton JJ, 1998, ANIM BEHAV, V55, P79, DOI 10.1006/anbe.1997.0587; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Want SC, 2001, CHILD DEV, V72, P431, DOI 10.1111/1467-8624.00288; WARREN JM, 1959, J COMP PHYSIOL PSYCH, V52, P99, DOI 10.1037/h0040911; Weinstein TAR, 2012, J COMP PSYCHOL, V126, P97, DOI 10.1037/a0025607; West S, 2010, J COMP PSYCHOL, V124, P425, DOI 10.1037/a0019932; Whiten A, 2012, EVOLUTION PRIMATE SO, P681; Yoshida K, 2012, NAT NEUROSCI, P1; Yu RJ, 2006, NEUROREPORT, V17, P1747, DOI 10.1097/01.wnr.0000239960.98813.50; Zentall TR, 2012, J COMP PSYCHOL, V126, P114, DOI 10.1037/a0025381	67	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89825	10.1371/journal.pone.0089825	http://dx.doi.org/10.1371/journal.pone.0089825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587063	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700098
J	Nyasembe, VO; Tchouassi, DP; Kirwa, HK; Foster, WA; Teal, PEA; Borgemeister, C; Torto, B				Nyasembe, Vincent O.; Tchouassi, David P.; Kirwa, Hillary K.; Foster, Woodbridge A.; Teal, Peter E. A.; Borgemeister, Christian; Torto, Baldwyn			Development and Assessment of Plant-Based Synthetic Odor Baits for Surveillance and Control of Malaria Vectors	PLOS ONE			English	Article							ANOPHELES-GAMBIAE COMPLEX; CARBON-DIOXIDE; FIELD-EVALUATION; MATING-BEHAVIOR; AEDES-AEGYPTI; MOSQUITO; DIPTERA; RESPONSES; TRAPS; POPULATIONS	Background: Recent malaria vector control measures have considerably reduced indoor biting mosquito populations. However, reducing the outdoor biting populations remains a challenge because of the unavailability of appropriate lures to achieve this. This study sought to test the efficacy of plant-based synthetic odor baits in trapping outdoor populations of malaria vectors. Methodology and Principal Finding: Three plant-based lures ((E)-linalool oxide [LO], (E)-linalool oxide and (E)-beta-ocimene [LO + OC], and a six-component blend comprising (E)-linalool oxide, (E)-beta-ocimene, hexanal, beta-pinene, limonene, and (E)-beta-farnesene [Blend C]), were tested alongside an animal/human-based synthetic lure (comprising heptanal, octanal, nonanal, and decanal [Blend F]) and worn socks in a malaria endemic zone in the western part of Kenya. Mosquito Magnet-X (MM-X) and lightless Centre for Disease Control (CDC) light traps were used. Odor-baited traps were compared with traps baited with either solvent alone or solvent + carbon dioxide (controls) for 18 days in a series of randomized incomplete-block designs of days x sites x treatments. The interactive effect of plant and animal/human odor was also tested by combining LO with either Blend F or worn socks. Our results show that irrespective of trap type, traps baited with synthetic plant odors compared favorably to the same traps baited with synthetic animal odors and worn socks in trapping malaria vectors, relative to the controls. Combining LO and worn socks enhanced trap captures of Anopheles species while LO + Blend F recorded reduced trap capture. Carbon dioxide enhanced total trap capture of both plant- and animal/human-derived odors. However, significantly higher proportions of male and engorged female Anopheles gambiae s.l. were caught when the odor treatments did not include carbon dioxide. Conclusion and Significance: The results highlight the potential of plant-based odors and specifically linalool oxide, with or without carbon dioxide, for surveillance and mass trapping of malaria vectors.	[Nyasembe, Vincent O.; Tchouassi, David P.; Kirwa, Hillary K.; Borgemeister, Christian; Torto, Baldwyn] Int Ctr Insect Physiol & Ecol, Behav & Chem Ecol Dept, Nairobi, Kenya; [Foster, Woodbridge A.] Ohio State Univ, Dept Ecol & Organismal Biol, Columbus, OH 43210 USA; [Teal, Peter E. A.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA; [Borgemeister, Christian] Univ Bonn, Res Dev Ctr, Bonn, Germany	International Centre of Insect Physiology & Ecology (ICIPE); University System of Ohio; Ohio State University; United States Department of Agriculture (USDA); University of Bonn	Torto, B (corresponding author), Int Ctr Insect Physiol & Ecol, Behav & Chem Ecol Dept, POB 30772, Nairobi, Kenya.	btorto@icipe.org		Kirwa, Hillary/0000-0003-2912-0762	Center for Medical, Agricultural, and Veterinary Entomology, U.S. Department of Agriculture; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01A1077722]	Center for Medical, Agricultural, and Veterinary Entomology, U.S. Department of Agriculture; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by the Center for Medical, Agricultural, and Veterinary Entomology, U.S. Department of Agriculture and by the U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases, grant R01A1077722 to WAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos N, 1999, PESTIC SCI, V55, P225, DOI 10.1002/(SICI)1096-9063(199903)55:3&lt;225::AID-PS887&gt;3.0.CO;2-7; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000404; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000402; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; [Anonymous], 1968, ANOPHELINAE AFR S SA; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; Charlwood JD, 2002, J VECTOR ECOL, V27, P178; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Edwards F.W., 1941, MOSQUITOES ETHIOPIAN; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Foster WA, 2008, J AM MOSQUITO CONTR, V24, P138, DOI 10.2987/8756-971X(2008)24[138:PAPSL]2.0.CO;2; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Geier M, 1999, J EXP BIOL, V202, P1639; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Golding JB, 1998, POSTHARVEST BIOL TEC, V14, P87, DOI 10.1016/S0925-5214(98)00032-5; Govella NJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00199; Grant AJ, 1996, CIBA F SYMP, V200, P233; Gravitz L, 2012, NATURE, V484, pS26, DOI 10.1038/484S26a; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Hiscox A, 2012, MALARIA J, V11, pO45; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kennedy JS, 1940, P ZOOL SOC LOND A-GE, V109, P221, DOI 10.1111/j.1096-3642.1940.tb00831.x; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; Kline DL, 1999, J AM MOSQUITO CONTR, V15, P276; Kline DL, 2002, J VECTOR ECOL, V27, P1; Knols BGJ, 2007, AM J TROP MED HYG, V77, P232, DOI 10.4269/ajtmh.2007.77.232; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; malERA Consultative Group on Vector Control, 2011, PLoS Med, V8, pe1000401, DOI 10.1371/journal.pmed.1000401; Matowo NS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-137; MAYER MS, 1969, B ENTOMOL RES, V58, P629, DOI 10.1017/S0007485300057357; Mboera LEG, 2000, J MED ENTOMOL, V37, P172, DOI 10.1603/0022-2585-37.1.172; Misharina TA, 2001, APPL BIOCHEM MICRO+, V37, P622, DOI 10.1023/A:1012315403828; Muller GC, 2011, ACTA TROP, V118, P45, DOI 10.1016/j.actatropica.2011.01.009; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-262; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Nyasembe VO, 2014, PHYTOCHEM LETT, V8, P196, DOI 10.1016/j.phytol.2013.10.003; Nyasembe VO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-234; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; OMER SM, 1971, ENTOMOL EXP APPL, V14, P251, DOI 10.1111/j.1570-7458.1971.tb00162.x; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; R Development Core Team, 2010, R LANG ENV STAT COMP; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Richards PW, 1952, TROPICAL RAIN FOREST; Riehle MA, 2003, J EXP BIOL, V206, P3809, DOI 10.1242/jeb.00609; Riehle MM, 2011, SCIENCE, V331, P596, DOI 10.1126/science.1196759; Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Takken W, 2009, TRENDS PARASITOL, V25, P101, DOI 10.1016/j.pt.2008.12.002; Tchouassi DP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002007; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; VALE GA, 1993, J MED ENTOMOL, V30, P831, DOI 10.1093/jmedent/30.5.831; VERHOEK BA, 1994, ENTOMOL EXP APPL, V72, P167, DOI 10.1007/BF02383551; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2; World Health Organisation, 2002, MAL ENT VECT CONTR, P41; World Health Organisation, 2013, MAL WHO; Zhou GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020318	83	39	41	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89818	10.1371/journal.pone.0089818	http://dx.doi.org/10.1371/journal.pone.0089818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587059	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700097
J	Garcia-Ramirez, DL; Calvo, JR; Hochman, S; Quevedo, JN				Garcia-Ramirez, David L.; Calvo, Jorge R.; Hochman, Shawn; Quevedo, Jorge N.			Serotonin, Dopamine and Noradrenaline Adjust Actions of Myelinated Afferents via Modulation of Presynaptic Inhibition in the Mouse Spinal Cord	PLOS ONE			English	Article							II MUSCLE AFFERENTS; DORSAL-HORN NEURONS; SUBSTANTIA-GELATINOSA NEURONS; IN-VITRO; ROOT POTENTIALS; NOCICEPTIVE RESPONSES; SYNAPTIC-TRANSMISSION; RAPHE MAGNUS; NEONATE RAT; RECEPTOR	Gain control of primary afferent neurotransmission at their intraspinal terminals occurs by several mechanisms including primary afferent depolarization (PAD). PAD produces presynaptic inhibition via a reduction in transmitter release. While it is known that descending monoaminergic pathways complexly regulate sensory processing, the extent these actions include modulation of afferent-evoked PAD remains uncertain. We investigated the effects of serotonin (5HT), dopamine (DA) and noradrenaline (NA) on afferent transmission and PAD. Responses were evoked by stimulation of myelinated hindlimb cutaneous and muscle afferents in the isolated neonatal mouse spinal cord. Monosynaptic responses were examined in the deep dorsal horn either as population excitatory synaptic responses (recorded as extracellular field potentials; EFPs) or intracellular excitatory postsynaptic currents (EPSCs). The magnitude of PAD generated intraspinally was estimated from electrotonically back-propagating dorsal root potentials (DRPs) recorded on lumbar dorsal roots. 5HT depressed the DRP by 76%. Monosynaptic actions were similarly depressed by 5HT (EFPs 54%; EPSCs 75%) but with a slower time course. This suggests that depression of monosynaptic EFPs and DRPs occurs by independent mechanisms. DA and NA had similar depressant actions on DRPs but weaker effects on EFPs. IC50 values for DRP depression were 0.6, 0.8 and 1.0 mu M for 5HT, DA and NA, respectively. Depression of DRPs by monoamines was nearly-identical in both muscle and cutaneous afferent-evoked responses, supporting a global modulation of the multimodal afferents stimulated. 5HT, DA and NA produced no change in the compound antidromic potentials evoked by intraspinal microstimulation indicating that depression of the DRP is unrelated to direct changes in the excitability of intraspinal afferent fibers, but due to metabotropic receptor activation. In summary, both myelinated afferent-evoked DRPs and monosynaptic transmission in the dorsal horn are broadly reduced by descending monoamine transmitters. These actions likely integrate with modulatory actions elsewhere to reconfigure spinal circuits during motor behaviors.	[Garcia-Ramirez, David L.; Calvo, Jorge R.; Quevedo, Jorge N.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico; [Hochman, Shawn] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Emory University	Quevedo, JN (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico.	jquevedo@fisio.cinvestav.mx	Hochman, Shawn/ABG-3875-2020		CONACyT, Mexico [59873]; National Institutes of Health (NIH), USA [NS-065949]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065949] Funding Source: NIH RePORTER	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following grants: CONACyT 59873 (J.Q), Mexico (http://www.conacyt.gob.mx) and National Institutes of Health (NIH) NS-065949 (S.H), USA (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos R, 2013, P NATL ACAD SCI USA, V110, P348, DOI 10.1073/pnas.1213680110; Bramley JR, 2005, J NEUROPHYSIOL, V93, P3157, DOI 10.1152/jn.00770.2004; BRAS H, 1989, EXP BRAIN RES, V76, P27; BRAS H, 1990, EUR J NEUROSCI, V2, P1029, DOI 10.1111/j.1460-9568.1990.tb00015.x; Calvo JR, 2008, SOC NEUR ABST, V575; Calvo JR, 2006, SOC NEUR ABST, V146; CARP JS, 1982, BRAIN RES, V242, P247, DOI 10.1016/0006-8993(82)90307-9; Clemens S, 2004, J NEUROSCI, V24, P11337, DOI 10.1523/JNEUROSCI.3698-04.2004; Conte D, 2005, NEUROSCIENCE, V134, P165, DOI 10.1016/j.neuroscience.2005.02.013; CRICK H, 1991, BRIT J PHARMACOL, V103, P1769, DOI 10.1111/j.1476-5381.1991.tb09861.x; CURTIS DR, 1983, BRAIN RES, V258, P328, DOI 10.1016/0006-8993(83)91160-5; Dougherty KJ, 2005, J NEUROSCI, V25, P584, DOI 10.1523/JNEUROSCI.3797-04.2005; ECCLES JC, 1962, J PHYSIOL-LONDON, V160, P62, DOI 10.1113/jphysiol.1962.sp006835; ELYASSIR N, 1990, BRAIN RES, V523, P92, DOI 10.1016/0006-8993(90)91639-X; ENGBERG I, 1966, J PHYSIOL-LONDON, V185, P298, DOI 10.1113/jphysiol.1966.sp007988; FLEETWOODWALKER SM, 1985, BRAIN RES, V334, P243, DOI 10.1016/0006-8993(85)90216-1; Flores-Hernandez J, 2000, J NEUROPHYSIOL, V83, P2996, DOI 10.1152/jn.2000.83.5.2996; Garraway SM, 2001, J NEUROPHYSIOL, V86, P2183, DOI 10.1152/jn.2001.86.5.2183; HEADLEY PM, 1978, BRAIN RES, V145, P185, DOI 10.1016/0006-8993(78)90809-0; Hochman S, 2001, METH NE FRO NEUROSCI, P47; Hochman S, 2012, FRONT BIOSCI-LANDMRK, V17, P2158, DOI 10.2741/4043; Jankowska E, 1997, EUR J NEUROSCI, V9, P1375, DOI 10.1111/j.1460-9568.1997.tb01492.x; Jankowska E, 2000, EUR J NEUROSCI, V12, P701, DOI 10.1046/j.1460-9568.2000.00955.x; Khasabov SG, 1999, BRIT J PHARMACOL, V127, P843, DOI 10.1038/sj.bjp.0702592; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; LEVTOV A, 1992, J PHYSIOL-LONDON, V447, P149, DOI 10.1113/jphysiol.1992.sp018996; MCLENNAN H, 1961, J PHYSIOL-LONDON, V158, P411, DOI 10.1113/jphysiol.1961.sp006777; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Miller BA, 1996, J NEUROPHYSIOL, V76, P1465, DOI 10.1152/jn.1996.76.3.1465; MURASE K, 1990, BRAIN RES, V525, P84, DOI 10.1016/0006-8993(90)91323-9; Nicholson R, 2005, NEUROSCI LETT, V380, P316, DOI 10.1016/j.neulet.2005.01.079; NUSSBAUMER JC, 1989, BRIT J PHARMACOL, V98, P373, DOI 10.1111/j.1476-5381.1989.tb12607.x; OKSAMITNYI V N, 1987, Neirofiziologiya, V19, P741; Olave MJ, 2002, NEUROSCIENCE, V115, P31, DOI 10.1016/S0306-4522(02)00407-4; PRESTON PR, 1980, GEN PHARMACOL, V11, P527, DOI 10.1016/0306-3623(80)90085-3; PROUDFIT HK, 1974, BRAIN RES, V65, P542, DOI 10.1016/0006-8993(74)90246-7; PROUDFIT HK, 1980, BRAIN RES, V195, P149, DOI 10.1016/0006-8993(80)90873-2; QUEVEDO J, 1995, J PHYSIOL-LONDON, V482, P623, DOI 10.1113/jphysiol.1995.sp020545; RIDDELL JS, 1993, J PHYSIOL-LONDON, V461, P723, DOI 10.1113/jphysiol.1993.sp019538; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Shreckengost J, 2010, J NEUROSCI, V30, P5283, DOI 10.1523/JNEUROSCI.3873-09.2010; SKOOG B, 1995, EXP BRAIN RES, V105, P39; Sonohata M, 2004, J PHYSIOL-LONDON, V555, P515, DOI 10.1113/jphysiol.2003.054932; Stanford IM, 1996, J NEUROSCI, V16, P7566; SYPERT GW, 1980, J NEUROPHYSIOL, V44, P792, DOI 10.1152/jn.1980.44.4.792; Tamae A, 2005, J PHYSIOL-LONDON, V568, P243, DOI 10.1113/jphysiol.2005.091843; VEJSADA R, 1985, INT J DEV NEUROSCI, V3, P583, DOI 10.1016/0736-5748(85)90048-6; WALL PD, 1958, J PHYSIOL-LONDON, V142, P1; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Zimmerman AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047213	51	39	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89999	10.1371/journal.pone.0089999	http://dx.doi.org/10.1371/journal.pone.0089999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587177	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200107
J	Huang, R; Ho, SY; Lo, WS; Lam, TH				Huang, Rong; Ho, Sai-Yin; Lo, Wing-Sze; Lam, Tai-Hing			Physical Activity and Constipation in Hong Kong Adolescents	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; CHILDHOOD CONSTIPATION; IDIOPATHIC CONSTIPATION; FUNCTIONAL CONSTIPATION; OLDER-ADULTS; PREVALENCE; CHILDREN; POPULATION; HEALTH; PATTERNS	Objective: To examine the association of constipation with exercise, non-exercise physical activity, and sedentary behaviours in Hong Kong adolescents. Methods: In 2006-2007, 42 secondary schools were randomly selected to participate in the Hong Kong Student Obesity Surveillance (HKSOS) project. A total of 33692 Form 1-7 students (44.9% boys; mean age 14.8, SD 1.9 years) completed an anonymous questionnaire on lifestyle behaviours. Constipation was defined as a frequency of evacuation of less than once every two days. Exercise (moderate-to-vigorous levels) and non-exercise physical activity (NEPA) were each considered insufficient when less than 1 hour per day, and sedentary behaviours were considered excessive when over 4 hours per day. Logistic regression was used to calculate adjusted odds ratio (AOR) for constipation in relation to exercise, NEPA, and sedentary behaviours, adjusting for potential confounders. Results: Constipation was identified in 15.6% (95% CI 15.2% - 16.0%) of adolescents overall, 14.0% in those with sufficient exercise and 19.6% in those without. Constipation was associated with insufficient exercise (AOR 1.26, 95% CI 1.16 - 1.36), insufficient NEPA 1.21 (1.10 - 1.33) and excessive sedentary behaviours (1.25, 1.17 - 1.34). Compared with having none of the above 3 inactive behaviours, increasing AORs of constipation were observed for having 1 (AOR 1.23), 2 (AOR 1.57) and 3 (AOR 1.88) inactive behaviours (p for trend <0.001). Conclusions: Constipation was associated with insufficient physical activity and excessive sedentary behaviours among Chinese adolescents with a dose-response relation. If the association is causal, constipation could be prevented by promotion of physical activity.	[Huang, Rong; Ho, Sai-Yin; Lo, Wing-Sze; Lam, Tai-Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Ho, SY (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	syho@hku.hk	Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Lam, Tai Hing/0000-0002-2033-9971; Ho, Daniel Sai Yin/0000-0001-9485-0273	University Research Committee, University of Hong Kong	University Research Committee, University of Hong Kong(University of Hong Kong)	This work was supported by the Strategic Research Theme in Public Health of the University Research Committee, University of Hong Kong. There is no grant number, and the URL is: http://www.rss.hku.hk/sras/com-public-health.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AR THES SPEC REC YOU; Anti M, 1998, HEPATO-GASTROENTEROL, V45, P727; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Bassotti G, 2001, DIGEST LIVER DIS, V33, P36, DOI 10.1016/S1590-8658(01)80133-X; Biddle SJH, 2004, J SPORT SCI, V22, P679, DOI 10.1080/02640410410001712412; Blundell JE, 2003, P NUTR SOC, V62, P651, DOI 10.1079/PNS2003286; CAMPBELL AJ, 1993, J EPIDEMIOL COMMUN H, V47, P23, DOI 10.1136/jech.47.1.23; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; Chan MF, 2007, CANCER EPIDEM BIOMAR, V16, P900, DOI 10.1158/1055-9965.EPI-06-0745; Cheng C, 2003, ALIMENT PHARM THERAP, V18, P319, DOI 10.1046/j.1365-2036.2003.01663.x; Chiarelli P, 2000, INT UROGYNECOL J PEL, V11, P71, DOI 10.1007/s001920050073; Chien LY, 2011, J PAEDIATR CHILD H, V47, P381, DOI 10.1111/j.1440-1754.2010.01990.x; De Schryver AM, 2005, SCAND J GASTROENTERO, V40, P422, DOI 10.1080/00365520510011641; DONALD IP, 1985, GERONTOLOGY, V31, P112, DOI 10.1159/000212689; Driessen LM, 2013, J PEDIATR GASTR NUTR, V57, P768, DOI 10.1097/MPG.0b013e3182a313fc; DROSSMAN DA, 1982, GASTROENTEROLOGY, V83, P529; Dukas L, 2003, AM J GASTROENTEROL, V98, P1790, DOI 10.1111/j.1572-0241.2003.07591.x; EVERHART JE, 1989, DIGEST DIS SCI, V34, P1153, DOI 10.1007/BF01537261; Eves FF, 2008, MED SCI SPORT EXER, V40, P965, DOI 10.1249/MSS.0b013e3181659c68; Eves FF, 2006, INT J EPIDEMIOL, V35, P1286, DOI 10.1093/ije/dyl141; Garrigues V, 2004, AM J EPIDEMIOL, V159, P520, DOI 10.1093/aje/kwh072; Hsieh C, 2005, AM FAM PHYSICIAN, V72, P2277; Inan M, 2007, J PAEDIATR CHILD H, V43, P700, DOI 10.1111/j.1440-1754.2007.01165.x; Khan S, 2007, DIGEST DIS SCI, V52, P64, DOI 10.1007/s10620-006-9308-9; Kim HS, 2005, AM J GASTROENTEROL, V100, P1964, DOI 10.1111/j.1572-0241.2005.40373.x; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Kinnunen O, 1991, Aging (Milano), V3, P161; Lee WTK, 2008, J PAEDIATR CHILD H, V44, P170, DOI 10.1111/j.1440-1754.2007.01212.x; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; Lo WS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-271; Mak KK, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-3; Mak KK, 2010, SLEEP MED, V11, P268, DOI 10.1016/j.sleep.2009.07.017; Mugie SM, 2011, NAT REV GASTRO HEPAT, V8, P502, DOI 10.1038/nrgastro.2011.130; Mugie SM, 2011, BEST PRACT RES CL GA, V25, P3, DOI 10.1016/j.bpg.2010.12.010; Muller-Lissner SA, 2005, AM J GASTROENTEROL, V100, P232, DOI 10.1111/j.1572-0241.2005.40885.x; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Sodergren M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-551; Suares NC, 2011, AM J GASTROENTEROL, V106, P1582, DOI 10.1038/ajg.2011.164; Tam YH, 2012, J PEDIATR GASTR NUTR, V55, P56, DOI 10.1097/MPG.0b013e31824741ce; Wald A, 2008, ALIMENT PHARM THER, V28, P917, DOI 10.1111/j.1365-2036.2008.03806.x; WHITEHEAD WE, 1989, J AM GERIATR SOC, V37, P423, DOI 10.1111/j.1532-5415.1989.tb02638.x; Youssef NN, 2005, J PEDIATR GASTR NUTR, V41, P56, DOI 10.1097/01.mpg.0000167500.34236.6a	43	17	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90193	10.1371/journal.pone.0090193	http://dx.doi.org/10.1371/journal.pone.0090193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587274	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200145
J	Lee, EJ; Kim, TW; Kim, M; Choi, YJ				Lee, Eun Ji; Kim, Tae-Woo; Kim, Mijin; Choi, Yun Jeong			Peripapillary Retinoschisis in Glaucomatous Eyes	PLOS ONE			English	Article							POSTERIOR VITREOUS DETACHMENT; OPTICAL COHERENCE TOMOGRAPHY; MACULAR RETINOSCHISIS; NERVE HEAD; RISK-FACTORS; DISC PIT; SCHISIS; VITRECTOMY; PREVALENCE; OUTCOMES	Purpose: To investigate the structural and clinical characteristics of peripapillary retinoschisis observed in glaucomatous eyes using spectral-domain optical coherence tomography (SD-OCT). Methods: Circumpapillary retinal nerve fiber layer (cpRNFL) and macular cross-hair SD-OCT scans and infrared fundus images of the glaucoma patients from the Investigating Glaucoma Progression Study (IGPS) and healthy volunteers were reviewed. Optic disc images obtained using enhanced depth imaging (EDI) SD-OCT were also evaluated. The structural characteristics and clinical course of the retinoschisis associated with glaucoma were investigated. Results: Twenty-five retinoschisis areas were found in 22 of the 372 patients (5.9%) included in the IGPS, and in 1 area in 1 of 187 healthy control subjects (0.5%). In the 22 glaucomatous eyes with retinoschisis, the schisis was attached to the optic disc and overlapped with the retinal nerve fiber layer (RNFL) defect. The RNFL was the layer most commonly affected by the retinoschisis, either alone or together with other deeper layers. Acquired optic disc pit was identified in 8 eyes on disc photography and/or B-scan images obtained by EDI SD-OCT. Spontaneous resolution of this condition was observed in nine eyes. No retinal detachment or macular involvement of the retinoschisis was observed in any of the eyes. Multivariate analysis showed a significant influence of a higher intraocular pressure at SD-OCT scanning on the presence of retinoschisis (Odds ratio = 1.418, P = 0.001). Conclusions: The present study investigated 22 cases of peripapillary retinoschisis in glaucomatous eyes. The retinoschisis was attached to the optic nerve and topographically correlated with RNFL defect. It often resolved spontaneously without causing severe visual disturbance. Care should be taken not to overestimate the RNFL thickness in eyes with retinoschisis, and also not to misinterpret the resolution of retinoschisis as a rapid glaucomatous RNFL deterioration.	[Lee, Eun Ji; Kim, Tae-Woo; Kim, Mijin; Choi, Yun Jeong] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea	Seoul National University (SNU)	Kim, TW (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.	twkim7@snu.ac.kr		Kim, Tae-Woo/0000-0002-5180-0978	National Research Foundation of Korea; Korean Government [800-20130242]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This study was supported by a National Research Foundation of Korea Grant funded by the Korean Government (800-20130242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIBA J, 1993, OPHTHALMOLOGY, V100, P1384; Akimoto M, 2012, CASE REP OPHTHALM, V3, P169, DOI 10.1159/000339292; BROCKHURST R J, 1970, Archives of Ophthalmology, V84, P158; BROWN GC, 1979, ARCH OPHTHALMOL-CHIC, V97, P1341, DOI 10.1001/archopht.1979.01020020083020; Chuo JY, 2006, AM J OPHTHALMOL, V142, P931, DOI 10.1016/j.ajo.2006.08.002; Eriksson U, 2004, ACTA OPHTHALMOL SCAN, V82, P218, DOI 10.1111/j.1600-0420.2004.00227.x; Farjad H, 2010, OPTOM VIS SCI; Georgalas I, 2011, GRAEF ARCH CLIN EXP, V249, P1113, DOI 10.1007/s00417-011-1698-5; George NDL, 1996, ARCH OPHTHALMOL-CHIC, V114, P274, DOI 10.1001/archopht.1996.01100130270007; Hayreh SS, 2004, OPHTHALMOLOGICA, V218, P333, DOI 10.1159/000079476; Hirakata A, 2005, JPN J OPHTHALMOL, V49, P414, DOI 10.1007/s10384-004-0227-z; Hiraoka T, 2010, CLIN EXP OPHTHALMOL, V38, P669, DOI 10.1111/j.1442-9071.2010.02311.x; Hollander DA, 2005, ARCH OPHTHALMOL-CHIC, V123, P270, DOI 10.1001/archopht.123.2.270; Hwang JU, 2013, BRIT J OPHTHALMOL, V97, P879, DOI 10.1136/bjophthalmol-2012-302906; Imamura Y, 2010, RETINA-J RET VIT DIS, V30, P1104, DOI 10.1097/IAE.0b013e3181d87ecb; Kahook MY, 2007, AM J OPHTHALMOL, V143, P697, DOI 10.1016/j.ajo.2006.10.054; Kicova N, 2012, ACTA OPHTHALMOL, V90, pE264, DOI 10.1111/j.1755-3768.2011.02330.x; Krivoy D, 1996, ARCH OPHTHALMOL-CHIC, V114, P165, DOI 10.1001/archopht.1996.01100130159008; Kuhn F, 2006, GRAEF ARCH CLIN EXP, V244, P1360, DOI 10.1007/s00417-006-0267-9; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Moreno-Lopez M, 2012, CLIN OPHTHALMOL, V6, P433, DOI 10.2147/OPTH.S29857; MORITA H, 1995, RETINA-J RET VIT DIS, V15, P117, DOI 10.1097/00006982-199515020-00005; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Rosenfeld PJ, 1998, OPHTHALMIC SURG LAS, V29, P190; Rutledge BK, 1996, OPHTHALMOLOGY, V103, P1047, DOI 10.1016/S0161-6420(96)30568-X; Scott IU, 2006, ARCH OPHTHALMOL-CHIC, V124, P1197, DOI 10.1001/archopht.124.8.1197; Shao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058498; Shen ZJ, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-33; Shimada N, 2013, AM J OPHTHALMOL, V156, P948, DOI 10.1016/j.ajo.2013.06.031; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Sun CB, 2010, EYE, V24, P1787, DOI 10.1038/eye.2010.123; Tang J, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/175613; Tawara A, 2013, JPN J OPHTHALMOL, V57, P263, DOI 10.1007/s10384-012-0225-5; YONEMOTO J, 1994, GRAEF ARCH CLIN EXP, V232, P67, DOI 10.1007/BF00171665; Yoshikawa T, 2013, INT OPHTHALMOL, V33, P425, DOI 10.1007/s10792-012-9673-7; Yu HH, 2012, AM J OPHTHALMOL, V154, P394, DOI 10.1016/j.ajo.2012.02.005; Zhao M, 2011, GRAEF ARCH CLIN EXP, V249, P1255, DOI 10.1007/s00417-011-1668-y; Zumbro DS, 2007, AM J OPHTHALMOL, V144, P70, DOI 10.1016/j.ajo.2007.03.027	38	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90129	10.1371/journal.pone.0090129	http://dx.doi.org/10.1371/journal.pone.0090129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587238	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200133
J	Ramaekers, CHMA; van den Beucken, T; Bristow, RG; Chiu, RK; Durocher, D; Wouters, BG				Ramaekers, Chantal H. M. A.; van den Beucken, Twan; Bristow, Robert G.; Chiu, Roland K.; Durocher, Daniel; Wouters, Bradly G.			RNF8-Independent Lys63 Poly-Ubiquitylation Prevents Genomic Instability in Response to Replication-Associated DNA Damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; GAMMA-H2AX FOCI; TOPOISOMERASE-I; REPAIR PATHWAY; UBIQUITIN; PROTEIN; POLY(ADP-RIBOSE); RAD18	The cellular response to DNA double strand breaks (DSBs) involves the ordered assembly of repair proteins at or near sites of damage. This process is mediated through post-translational protein modifications that include both phosphorylation and ubiquitylation. Recent data have demonstrated that recruitment of the repair proteins BRCA1, 53BP1, and RAD18 to ionizing irradiation (IR) induced DSBs is dependent on formation of non-canonical K63-linked polyubiquitin chains by the RNF8 and RNF168 ubiquitin ligases. Here we report a novel role for K63-ubiquitylation in response to replication-associated DSBs that contributes to both cell survival and maintenance of genome stability. Suppression of K63-ubiquitylation markedly increases large-scale mutations and chromosomal aberrations in response to endogenous or exogenous replication-associated DSBs. These effects are associated with an S-phase specific defect in DNA repair as revealed by an increase in residual 53BP1 foci. Use of both knockdown and knockout cell lines indicates that unlike the case for IR-induced DSBs, the requirement for K63-ubiquitylation for the repair of replication associated DSBs was found to be RNF8-independent. Our findings reveal the existence of a novel K63-ubiquitylation dependent repair pathway that contributes to the maintenance of genome integrity in response to replication-associated DSBs.	[Ramaekers, Chantal H. M. A.; van den Beucken, Twan; Bristow, Robert G.; Wouters, Bradly G.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON, Canada; [Ramaekers, Chantal H. M. A.; van den Beucken, Twan; Bristow, Robert G.; Wouters, Bradly G.] Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Canc Res, Toronto, ON, Canada; [Ramaekers, Chantal H. M. A.; van den Beucken, Twan; Wouters, Bradly G.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht Radiat Oncol MaastRO Lab, Maastricht, Netherlands; [Bristow, Robert G.; Wouters, Bradly G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Bristow, Robert G.; Wouters, Bradly G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Chiu, Roland K.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands; [Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Maastricht University; University of Toronto; University of Toronto; University of Groningen; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Wouters, BG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON, Canada.	bwouters@uhnresearch.ca	van den Beucken, Jeroen J. J. P./N-2910-2013; Wouters, Bradly/T-1525-2017; Durocher, Daniel/A-7733-2010	van den Beucken, Jeroen J. J. P./0000-0002-0301-1966; Wouters, Bradly/0000-0002-8187-592X; Durocher, Daniel/0000-0003-3863-8635; Bristow, Robert/0000-0002-8553-9544; van den Beucken, Twan/0000-0002-2233-7558	Transnational University Limburg [30943045T]; Dutch Cancer Society; Ontario Ministry of Health and Long Term Care (OMOHLTC); Ontario Institute for Cancer Research; Terry Fox Research Institute	Transnational University Limburg; Dutch Cancer Society(KWF Kankerbestrijding); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Ontario Institute for Cancer Research; Terry Fox Research Institute	This work was financially supported by the Transnational University Limburg (30943045T to BW), the Dutch Cancer Society, the Ontario Ministry of Health and Long Term Care (OMOHLTC), the Ontario Institute for Cancer Research, and the Terry Fox Research Institute (Selective therapies program to BW). The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 2006, CARCINOGENESIS, V27, P883, DOI 10.1093/carcin/bgi319; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Banath JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-4; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Brun Jan, 2010, BMC Res Notes, V3, P85, DOI 10.1186/1756-0500-3-85; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Bryant HE, 2006, NUCLEIC ACIDS RES, V34, P1685, DOI 10.1093/nar/gkl108; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; CHENG KC, 1992, J BIOL CHEM, V267, P166; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Groth P, 2012, NUCL ACIDS RES; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; HSIANG YH, 1988, CANCER RES, V48, P1722; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kato TA, 2006, RADIAT RES, V166, P443, DOI 10.1667/RR3604.1; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; LEPAGE F, 1995, CARCINOGENESIS, V16, P2779; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Li ZQ, 2002, P NATL ACAD SCI USA, V99, P4459, DOI 10.1073/pnas.062047799; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Lobrich M, 2000, GENE CHROMOSOME CANC, V27, P59; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; RYAN AJ, 1991, NUCLEIC ACIDS RES, V19, P3295, DOI 10.1093/nar/19.12.3295; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Tsirigotis M, 2001, J BIOL CHEM, V276, P46073, DOI 10.1074/jbc.M109023200; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	56	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89997	10.1371/journal.pone.0089997	http://dx.doi.org/10.1371/journal.pone.0089997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587176	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200106
J	Sun, JJ; Zhou, Y; Cai, HF; Lan, XY; Lei, CZ; Zhao, X; Zhang, CL; Chen, H				Sun, Jiajie; Zhou, Yang; Cai, Hanfang; Lan, Xianyong; Lei, Chuzhao; Zhao, Xin; Zhang, Chunlei; Chen, Hong			Discovery of Novel and Differentially Expressed MicroRNAs between Fetal and Adult Backfat in Cattle	PLOS ONE			English	Article							ADIPOSE-TISSUE; GENES; IDENTIFICATION; MECHANISM; BIOGENESIS; MIR-122; MIR-27; MOUSE; FAT; PCR	The posttranscriptional gene regulation mediated by microRNAs (miRNAs) plays an important role in various species. Recently, a large number of miRNAs and their expression patterns have been identified. However, to date, limited miRNAs have been reported to modulate adipogenesis and lipid deposition in beef cattle. Total RNAs from Chinese Qinchuan bovine backfat at fetal and adult stages were used to construct small RNA libraries for Illumina next-generation sequencing. A total of 13,915,411 clean reads were obtained from a fetal library and 14,244,946 clean reads from an adult library. In total, 475 known and 36 novel miRNA candidates from backfat were identified. The nucleotide bias, base editing, and family of the known miRNAs were also analyzed. Based on stem-loop qPCR, 15 specific miRNAs were detected, and the results showed that bta-miRNAn25 and miRNAn26 were highly expressed in backfat tissue, suggesting these small RNAs play a role in the development and maintenance of bovine subcutaneous fat tissue. Putative targets for miRNAn25 and miRNAn26 were predicted, and the 61 most significant target transcripts were related to lipid and fatty acid metabolism. Of interest, the canonical pathway and gene networks analyses revealed that PPAR alpha/RXR alpha activation and LXR/RXR activation were important components of the gene interaction hierarchy results. In the present study, we explored the backfat miRNAome differences between cattle of different developmental stages, expanding the expression repertoire of bovine miRNAs that could contribute to further studies on the fat development of cattle. Predication of target genes analysis of miRNA25 and miRNA26 also showed potential gene networks that affect lipid and fatty acid metabolism. These results may help in the design of new intervention strategies to improve beef quality.	[Sun, Jiajie; Zhou, Yang; Cai, Hanfang; Lan, Xianyong; Lei, Chuzhao; Zhao, Xin; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Sun, Jiajie; Zhang, Chunlei] Jiangsu Normal Univ, Inst Cellular & Mol Biol, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; Jiangsu Normal University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332	National Natural Science Foundation of China [31272408]; National 863 Program of China [2013AA102505]; Agricultural Science and Technology Innovation Projects of Shaanxi Province [2012NKC01-13]; Program of National Beef Cattle Industrial Technology System [CARS-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); Agricultural Science and Technology Innovation Projects of Shaanxi Province; Program of National Beef Cattle Industrial Technology System	This study was supported by the National Natural Science Foundation of China (Grant Nos. 31272408), National 863 Program of China (Grant No. 2013AA102505), Agricultural Science and Technology Innovation Projects of Shaanxi Province (No. 2012NKC01-13), and Program of National Beef Cattle Industrial Technology System (CARS-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; Gibs R, 2006, BOVINE GENOMIC SEQUE, P1; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Hishikawa D, 2005, PHYSIOL GENOMICS, V21, P343, DOI 10.1152/physiolgenomics.00184.2004; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Lingenfelter BM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-40; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; POWELL WE, 1973, J ANIM SCI, V36, P1069, DOI 10.2527/jas1973.3661069x; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RICHARDSON C, 1990, VET REC, V126, P279; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sang YK, 2010, BIOCH BIOPHYSICAL RE, V392, P323; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shifang Z, 2013, PLOS ONE, V8; Sun JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-42; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tripurani SK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-25; Tripurani SK, 2010, ANIM REPROD SCI, V120, P16, DOI 10.1016/j.anireprosci.2010.03.001; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang XW, 2009, RNA, V15, P716, DOI 10.1261/rna.1460509; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xuechun Y, 2012, PLOS ONE, V7; Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163; Zhibin J, 2012, PLOS ONE, V7	67	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90244	10.1371/journal.pone.0090244	http://dx.doi.org/10.1371/journal.pone.0090244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587298	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200152
J	Komarova, TV; Petrunia, IV; Shindyapina, AV; Silachev, DN; Sheshukova, EV; Kiryanov, GI; Dorokhov, YL				Komarova, Tatiana V.; Petrunia, Igor V.; Shindyapina, Anastasia V.; Silachev, Denis N.; Sheshukova, Ekaterina V.; Kiryanov, Gleb I.; Dorokhov, Yuri L.			Endogenous Methanol Regulates Mammalian Gene Activity	PLOS ONE			English	Article							DEHYDROGENASE; ETHANOL; 4-METHYLPYRAZOLE; FORMALDEHYDE; METABOLISM; TOXICITY; FRUIT	We recently showed that methanol emitted by wounded plants might function as a signaling molecule for plant-to-plant and plant-to-animal communications. In mammals, methanol is considered a poison because the enzyme alcohol dehydrogenase (ADH) converts methanol into toxic formaldehyde. However, the detection of methanol in the blood and exhaled air of healthy volunteers suggests that methanol may be a chemical with specific functions rather than a metabolic waste product. Using a genome-wide analysis of the mouse brain, we demonstrated that an increase in blood methanol concentration led to a change in the accumulation of mRNAs from genes primarily involved in detoxification processes and regulation of the alcohol/aldehyde dehydrogenases gene cluster. To test the role of ADH in the maintenance of low methanol concentration in the plasma, we used the specific ADH inhibitor 4-methylpyrazole (4-MP) and showed that intraperitoneal administration of 4-MP resulted in a significant increase in the plasma methanol, ethanol and formaldehyde concentrations. Removal of the intestine significantly decreased the rate of methanol addition to the plasma and suggested that the gut flora may be involved in the endogenous production of methanol. ADH in the liver was identified as the main enzyme for metabolizing methanol because an increase in the methanol and ethanol contents in the liver homogenate was observed after 4-MP administration into the portal vein. Liver mRNA quantification showed changes in the accumulation of mRNAs from genes involved in cell signalling and detoxification processes. We hypothesized that endogenous methanol acts as a regulator of homeostasis by controlling the mRNA synthesis.	[Komarova, Tatiana V.; Silachev, Denis N.; Kiryanov, Gleb I.; Dorokhov, Yuri L.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Komarova, Tatiana V.; Petrunia, Igor V.; Shindyapina, Anastasia V.; Sheshukova, Ekaterina V.; Dorokhov, Yuri L.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Vavilov Institute of General Genetics	Dorokhov, YL (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	dorokhov@genebee.msu.su	Dorokhov, Yuri L/D-3565-2012; Silachev, Denis/ABE-8515-2020; Komarova, Tatiana V./D-5824-2012; Sheshukova, Ekaterina V./O-1365-2013; Silachev, Denis N/C-9464-2012	Dorokhov, Yuri L/0000-0002-4066-8940; Komarova, Tatiana V./0000-0001-6558-8755; Sheshukova, Ekaterina V./0000-0002-0934-3902; Shindyapina, Anastasia/0000-0002-7336-3086; Silachev, Denis/0000-0003-0581-9755	Russian Foundation for Basic Research [11-04-01152, 12-04-33016]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grants (#11-04-01152 and 12-04-33016) from the Russian Foundation for Basic Research (to T. V. K.) and Moscow Government (to Y.L.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; BAUD FJ, 1986, J TOXICOL-CLIN TOXIC, V24, P463, DOI 10.3109/15563658608995388; DILIBERT.EJ, 1974, P NATL ACAD SCI USA, V71, P1701, DOI 10.1073/pnas.71.5.1701; Dorokhov YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036122; Dorokhov YL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002640; Dragsted LO, 2006, P NUTR SOC, V65, P61, DOI 10.1079/PNS2005480; ERIKSEN SP, 1963, SCIENCE, V141, P639, DOI 10.1126/science.141.3581.639; Fisher JW, 2000, TOXICOL SCI, V53, P185, DOI 10.1093/toxsci/53.2.185; Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110; Jones GR, 2007, J FORENSIC SCI, V52, P1376, DOI 10.1111/j.1556-4029.2007.00554.x; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939; Magnuson BA, 2007, CRIT REV TOXICOL, V37, P629, DOI 10.1080/10408440701516184; Matsumoto M, 2011, ALCOHOL CLIN EXP RES, V35, P28, DOI 10.1111/j.1530-0277.2010.01319.x; RESTANI P, 1991, CRIT REV TOXICOL, V21, P315, DOI 10.3109/10408449109019569; Sarkola T, 2001, ALCOHOL CLIN EXP RES, V25, P513, DOI 10.1111/j.1530-0277.2001.tb02244.x; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; TEPHLY TR, 1991, LIFE SCI, V48, P1031, DOI 10.1016/0024-3205(91)90504-5; Thompson CM, 2010, TOXICOL LETT, V193, P1, DOI 10.1016/j.toxlet.2009.11.023; Tong ZQ, 2011, NEUROBIOL AGING, V32, P31, DOI 10.1016/j.neurobiolaging.2009.07.013; Turner C, 2006, PHYSIOL MEAS, V27, P637, DOI 10.1088/0967-3334/27/7/007; von Dahl CC, 2006, PLANT J, V46, P948, DOI 10.1111/j.1365-313X.2006.02760.x; VONBURG R, 1994, J APPL TOXICOL, V14, P309, DOI 10.1002/jat.2550140412	23	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90239	10.1371/journal.pone.0090239	http://dx.doi.org/10.1371/journal.pone.0090239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587296	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800095
J	Cai, TL; Huettmann, F; Guo, YM				Cai, Tianlong; Huettmann, Falk; Guo, Yumin			Using Stochastic Gradient Boosting to Infer Stopover Habitat Selection and Distribution of Hooded Cranes Grus monacha during Spring Migration in Lindian, Northeast China	PLOS ONE			English	Article							SITES; CONSERVATION; MODELS; WINTER; BIRDS	The Hooded Crane (Grus monacha) is a globally vulnerable species, and habitat loss is the primary cause of its decline. To date, little is known regarding the specific habitat needs, and stopover habitat selection in particular, of the Hooded Crane. In this study we used stochastic gradient boosting (TreeNet) to develop three specific habitat selection models for roosting, daytime resting, and feeding site selection. In addition, we used a geographic information system (GIS) combined with TreeNet to develop a species distribution model. We also generated a digital map of the relative occurrence index (ROI) of this species at daytime resting sites in the study area. Our study indicated that the water depth, distance to village, coverage of deciduous leaves, open water area, and density of plants were the major predictors of roosting site selection. For daytime resting site selection, the distance to wetland, distance to farmland, and distance to road were the primary predictors. For feeding site selection, the distance to road, quantity of food, plant coverage, distance to village, plant density, distance to wetland, and distance to river were contributing factors, and the distance to road and quantity of food were the most important predictors. The predictive map showed that there were two consistent multi-year daytime resting sites in our study area. Our field work in 2013 using systematic ground-truthing confirmed that this prediction was accurate. Based on this study, we suggest that Lindian plays an important role for migratory birds and that cultivation practices should be adjusted locally. Furthermore, public education programs to promote the concept of the harmonious coexistence of humans and cranes can help successfully protect this species in the long term and eventually lead to its delisting by the IUCN.	[Cai, Tianlong; Guo, Yumin] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Huettmann, Falk] Univ Alaska Fairbanks, Inst Arct Biol, Dept Biol & Wildlife, Ecol Wildlife & Habitat Anal Land & Seascape Lab, Fairbanks, AK USA	Beijing Forestry University; University of Alaska System; University of Alaska Fairbanks	Guo, YM (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	guoyumin@bjfu.edu.cn			National Natural Science Foundation of China [30770287]; Whitley Foundation for Nature (WFN); State Forestry Administration of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Whitley Foundation for Nature (WFN); State Forestry Administration of China	This study was supported by the National Natural Science Foundation of China (Project NO. 30770287), Whitley Foundation for Nature (WFN), and State Forestry Administration of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHOLD P, 1991, ANNU REV ECOL SYST, V22, P357, DOI 10.1146/annurev.es.22.110191.002041; Berthold P., 2001, BIRD MIGRATION GEN S; Beyer HL, 2008, HAWTHS ANAL TOOLS AR; Booms TL, 2010, POLAR BIOL, V33, P347, DOI 10.1007/s00300-009-0711-5; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnham K. P., 1998, MODEL SELECTION INFE; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Chamberlain MJ, 2000, J WILDLIFE MANAGE, V64, P1025, DOI 10.2307/3803213; Cody M.L., 1985, P3; Collar N.J., 2001, THREATENED BIRDS ASI; Cumming GS, 2000, J BIOGEOGR, V27, P441, DOI 10.1046/j.1365-2699.2000.00408.x; Diaz M, 1996, BIOL CONSERV, V75, P119, DOI 10.1016/0006-3207(95)00064-X; DUPLESSIS MA, 1994, AUK, V111, P292; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Hegel TM, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P273, DOI 10.1007/978-4-431-87771-4_16; Higuchi H., 1991, International Council for Bird Preservation Technical Publication, P189; Higuchi H, 1998, ECOL RES, V13, P273, DOI 10.1046/j.1440-1703.1998.00271.x; Higuchi Hiroyoshi, 1992, Strix, V11, P1; Higuchi Hiroyoshi, 2005, Landscape and Ecological Engineering, V1, P33, DOI 10.1007/s11355-005-0002-4; IUCN (International Union for Conservation of Nature), 2012, 2012 IUCN RED LIST T; Iwatsuki K, 2009, HARMONIOUS COEXISTEN; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kanai Y, 2002, BIOL CONSERV, V106, P339, DOI 10.1016/S0006-3207(01)00259-2; [康明江 KANG MingJiang], 2007, [生态学报, Acta Ecologica Sinica], V27, P2929; Kong DJ, 2011, ORYX, V45, P258, DOI 10.1017/S0030605310000888; Li L, 1995, CHINESE WILDLIFE, P14; LINDSTROM A, 1992, AM NAT, V140, P477, DOI 10.1086/285422; Liu YB, 2003, ENVIRON MANAGE, V31, P365, DOI 10.1007/s00267-002-2785-5; Luo Jinming, 2012, Chinese Birds, V3, P206; Ma ZJ, 1999, IBIS, V141, P135, DOI 10.1111/j.1474-919X.1999.tb04272.x; Ma ZJ, 2003, ECOL RES, V18, P321, DOI 10.1046/j.1440-1703.2003.00557.x; Manly BF, 1992, RESOURCE SELECTION A; MARSH RL, 1983, AUK, V100, P170, DOI 10.1093/auk/100.1.170; MECH LD, 1966, J MAMMAL, V47, P450, DOI 10.2307/1377686; Mehlman DW, 2005, AUK, V122, P1281, DOI 10.1642/0004-8038(2005)122[1281:CSSFFM]2.0.CO;2; Meine C.D., 1996, CRANES STATUS SURVEY; Miller J, 2010, GEOGR COMPASS, V4, P490, DOI 10.1111/j.1749-8198.2010.00351.x; Moisen GG, 2006, ECOL MODEL, V199, P176, DOI 10.1016/j.ecolmodel.2006.05.021; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Piersma T, 1987, HOP SKIP JUMP CONSTR; Pomeroy AC, 2008, AVIAN CONSERV ECOL, V3; Popp J., 2007, J MED BIOL SCI, V1; Rayner J.M.V., 1990, P283; Schaub M, 2001, ECOLOGY, V82, P852, DOI 10.2307/2680203; Shimazaki Hiroto, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P162; Sodeikat G., 2007, Wildlife Biology in Practice, V3, P28, DOI 10.2461/wbp.2007.3.4; Taborsky B, 1995, AUK, V112, P680; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thorne LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043167; Vegvari Z, 2002, FOLIA ZOOL, V51, P221; WALSBERG GE, 1986, AUK, V103, P1; Wickert Claudia, 2010, Open Ornithology Journal, V3, P1; Yarrow G, 2009, HABITAT REQUIREMENTS	58	15	18	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89913	10.1371/journal.pone.0089913	http://dx.doi.org/10.1371/journal.pone.0089913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587118	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000110
J	Chen, M; Glenn, JV; Dasari, S; McVicar, C; Ward, M; Colhoun, L; Quinn, M; Bierhaus, A; Xu, HP; Stitt, AW				Chen, Mei; Glenn, Josephine V.; Dasari, Shilpa; McVicar, Carmel; Ward, Michael; Colhoun, Liza; Quinn, Michael; Bierhaus, Angelika; Xu, Heping; Stitt, Alan W.			RAGE Regulates Immune Cell Infiltration and Angiogenesis in Choroidal Neovascularization	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; BRUCHS MEMBRANE; ENDOTHELIAL-CELLS; RECEPTOR RAGE; RD8 MUTATION; CRB1 GENE; AGE; MACROPHAGES; MOUSE; ACCUMULATION	Purpose: RAGE regulates pro-inflammatory responses in diverse cells and tissues. This study has investigated if RAGE plays a role in immune cell mobilization and choroidal neovascular pathology that is associated with the neovascular form of age-related macular degeneration (nvAMD). Methods: RAGE null (RAGE-/-) mice and age-matched wild type (WT) control mice underwent laser photocoagulation to generate choroidal neovascularization (CNV) lesions which were then analyzed for morphology, S100B immunoreactivity and inflammatory cell infiltration. The chemotactic ability of bone marrow derived macrophages (BMDMs) towards S100B was investigated. Results: RAGE expression was significantly increased in the retina during CNV of WT mice (p<0.001). RAGE-/- mice exhibited significantly reduced CNV lesion size when compared to WT controls (p<0.05). S100B mRNA was upregulated in the lasered WT retina but not RAGE-/- retina and S100B immunoreactivity was present within CNV lesions although levels were less when RAGE-/- mice were compared to WT controls. Activated microglia in lesions were considerably less abundant in RAGE-/- mice when compared to WT counterparts (p<0.001). A dose dependent chemotactic migration was observed in BMDMs from WT mice (p<0.05-0.01) but this was not apparent in cells isolated from RAGE-/- mice. Conclusions: RAGE-S100B interactions appear to play an important role in CNV lesion formation by regulating pro-inflammatory and angiogenic responses. This study highlights the role of RAGE in inflammation-mediated outer retinal pathology.	[Chen, Mei; Glenn, Josephine V.; Dasari, Shilpa; McVicar, Carmel; Ward, Michael; Colhoun, Liza; Quinn, Michael; Xu, Heping; Stitt, Alan W.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland; [Bierhaus, Angelika] Heidelberg Univ, Dept Med & Clin Chem, Heidelberg, Germany	Queens University Belfast; Ruprecht Karls University Heidelberg	Stitt, AW (corresponding author), Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland.	a.stitt@qub.ac.uk	Xu, Heping/A-4430-2008; Stitt, Alan/A-9842-2009; Ward, Micheal/G-1379-2012	Xu, Heping/0000-0003-4000-931X; Stitt, Alan/0000-0002-8647-9918; Ward, Micheal/0000-0001-8988-5797	Fight for Sight, Action Medical Research; Wolfson Royal Society; Medical Research Council [G0801962] Funding Source: researchfish; Fight for Sight [1871/72] Funding Source: researchfish; MRC [G0801962] Funding Source: UKRI	Fight for Sight, Action Medical Research; Wolfson Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge generous grant support from Fight for Sight, Action Medical Research. AWS holds a Wolfson Royal Society Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Barile GR, 2005, INVEST OPHTH VIS SCI, V46, P2916, DOI 10.1167/iovs.04-1409; Beattie JR, 2010, FASEB J, V24, P4816, DOI 10.1096/fj.10-166090; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985; Boulanger E, 2007, KIDNEY INT, V71, P126, DOI 10.1038/sj.ki.5002016; Caicedo A, 2005, EXP EYE RES, V81, P38, DOI 10.1016/j.exer.2005.01.013; Chang B, 2013, INVEST OPHTH VIS SCI, V54, P4974, DOI 10.1167/iovs.13-12289; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022818; Chen XT, 2013, J NEUROPATH EXP NEUR, V72, P782, DOI 10.1097/NEN.0b013e31829e8375; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Cruz-Guilloty F, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/503725; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Frommhold D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-56; Fujimoto T, 2010, INVEST OPHTH VIS SCI, V51, P4694, DOI 10.1167/iovs.09-4464; Fujiya A, 2013, OBESITY; Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772, DOI 10.1152/ajpcell.2000.279.6.C1772; Glenn JV, 2007, FASEB J, V21, P3542, DOI 10.1096/fj.06-7896com; Glenn JV, 2009, INVEST OPHTH VIS SCI, V50, P441, DOI 10.1167/iovs.08-1724; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Grote K, 2011, THESCIENTIFICWORLDJO, V11, P981, DOI 10.1100/tsw.2011.92; Hammes HP, 1999, INVEST OPHTH VIS SCI, V40, P1855; Handa JT, 1999, INVEST OPHTH VIS SCI, V40, P775; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Howes KA, 2004, INVEST OPHTH VIS SCI, V45, P3713, DOI 10.1167/iovs.04-0404; Ishibashi T, 1998, ARCH OPHTHALMOL-CHIC, V116, P1629, DOI 10.1001/archopht.116.12.1629; Jin P, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2447; Kalea AZ, 2010, CANCER RES, V70, P5628, DOI 10.1158/0008-5472.CAN-10-0595; Kettenmann H, 2006, NAT NEUROSCI, V9, P1463, DOI 10.1038/nn1206-1463; Luhmann UFO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035551; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma WC, 2007, INVEST OPHTH VIS SCI, V48, P1355, DOI 10.1167/iovs.06-0738; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Muther PS, 2010, INVEST OPHTH VIS SCI, V51, P4831, DOI 10.1167/iovs.09-4923; Perrone L, 2009, J CELL PHYSIOL, V221, P262, DOI 10.1002/jcp.21852; Rambotti MG, 1999, NEUROSCIENCE, V92, P1089, DOI 10.1016/S0306-4522(99)00074-3; Robinson AB, 2012, AM J PHYSIOL-LUNG C, V302, pL1192, DOI 10.1152/ajplung.00099.2012; Roychoudhury J, 2010, INVEST OPHTH VIS SCI, V51, P3560, DOI 10.1167/iovs.09-3890; Slevin M, 2010, J VASC RES, V47, P323, DOI 10.1159/000265566; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102; Tsuji A, 2008, CLIN CANCER RES, V14, P5368, DOI 10.1158/1078-0432.CCR-08-0198; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Yamada Y, 2006, EXP EYE RES, V82, P840, DOI 10.1016/j.exer.2005.10.005; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	59	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89548	10.1371/journal.pone.0089548	http://dx.doi.org/10.1371/journal.pone.0089548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586862	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000058
J	Cho, KJ; Hong, KW; Kim, SH; Seok, JH; Kim, S; Lee, JH; Saelens, X; Kim, KH				Cho, Ki Joon; Hong, Kwang W.; Kim, Se-Ho; Seok, Jong Hyeon; Kim, Sella; Lee, Ji-Hye; Saelens, Xavier; Kim, Kyung Hyun			Insight into Highly Conserved H1 Subtype-Specific Epitopes in Influenza Virus Hemagglutinin	PLOS ONE			English	Article							RECEPTOR-BINDING; NEUTRALIZING EPITOPE; MEMBRANE-FUSION; MORTALITY; PATHOGENICITY; ANTIBODY	Influenza viruses continuously undergo antigenic changes with gradual accumulation of mutations in hemagglutinin (HA) that is a major determinant in subtype specificity. The identification of conserved epitopes within specific HA subtypes gives an important clue for developing new vaccines and diagnostics. We produced and characterized nine monoclonal antibodies that showed significant neutralizing activities against H1 subtype influenza viruses, and determined the complex structure of HA derived from a 2009 pandemic virus A/Korea/01/2009 (KR01) and the Fab fragment from H1-specific monoclonal antibody GC0587. The overall structure of the complex was essentially identical to the previously determined KR01 HA-Fab0757 complex structure. Both Fab0587 and Fab0757 recognize readily accessible head regions of HA, revealing broadly shared and conserved antigenic determinants among H1 subtypes. The beta-strands constituted by Ser110-Glu115 and Lys169-Lys170 form H1 epitopes with distinct conformations from those of H1 and H3 HA sites. In particular, Glu112, Glu115, Lys169, and Lys171 that are highly conserved among H1 subtype HAs have close contacts with HCDR3 and LCDR3. The differences between Fab0587 and Fab0757 complexes reside mainly in HCDR3 and LCDR3, providing distinct antigenic determinants specific for 1918 pdm influenza strain. Our results demonstrate a potential key neutralizing epitope important for H1 subtype specificity in influenza virus.	[Cho, Ki Joon; Seok, Jong Hyeon; Kim, Sella; Lee, Ji-Hye; Kim, Kyung Hyun] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea; [Hong, Kwang W.; Kim, Se-Ho] Green Cross Co, Cent Res Ctr, Antibody Engn Lab, Yongin, Kyunggi, South Korea; [Saelens, Xavier] VIB Inflammat Res Ctr, Ghent, Belgium; [Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Korea University; Green Cross Corporation; Flanders Institute for Biotechnology (VIB); Ghent University	Cho, KJ (corresponding author), Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea.	c-azna@korea.ac.kr; khkim@korea.ac.kr	Saelens, Xavier/N-5728-2015		NRF [2010-0029242, 2012-044524]; ME; Transgovernmental Enterprise for Pandemic Influenza in Korea [2011-A103001]; Korea University; ME, Korea	NRF; ME; Transgovernmental Enterprise for Pandemic Influenza in Korea; Korea University; ME, Korea	The authors wish to acknowledge the technical support from the staffs at beamlines of Pohang Light Source (5C) and PF (BL-17A) synchrotrons. This work was supported by grants from the Mid-career Researcher (KHK 2010-0029242) and Basic Research (KJC 2012-044524) Programs through NRF funded by the ME, the Transgovernmental Enterprise for Pandemic Influenza in Korea (KHK 2011-A103001), Korea University (KJC), and the BK21 plus program of the ME, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhardwaj A, 2008, PROTEIN SCI, V17, P1475, DOI 10.1110/ps.036111.108; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cho KJ, 2013, J GEN VIROL, V94, P1712, DOI 10.1099/vir.0.051136-0; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; GETHING MJ, 1986, J CELL BIOL, V102, P11, DOI 10.1083/jcb.102.1.11; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mueller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009097; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pielak RM, 2011, BBA-BIOMEMBRANES, V1808, P522, DOI 10.1016/j.bbamem.2010.04.015; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Vareckova E, 2002, J CLIN MICROBIOL, V40, P2220, DOI 10.1128/JCM.40.6.2220-2223.2002; Volpe Joseph M, 2008, Immunome Res, V4, P3, DOI 10.1186/1745-7580-4-3; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023374; Zhu XY, 2013, P NATL ACAD SCI USA, V110, P1458, DOI 10.1073/pnas.1218509110; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	40	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89803	10.1371/journal.pone.0089803	http://dx.doi.org/10.1371/journal.pone.0089803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587046	Green Published, gold			2022-12-27	WOS:000332389000096
J	Singh, M; Brahma, B; Maharana, J; Patra, MC; Kumar, S; Mishra, P; Saini, M; De, BC; Mahanty, S; Datta, TK; De, S				Singh, Manvender; Brahma, Biswajit; Maharana, Jitendra; Patra, Mahesh Chandra; Kumar, Sushil; Mishra, Purusottam; Saini, Megha; De, Bidhan Chandra; Mahanty, Sourav; Datta, Tirtha Kumar; De, Sachinandan			Insight into Buffalo (Bubalus bubalis) RIG1 and MDA5 Receptors: A Comparative Study on dsRNA Recognition and In-Vitro Antiviral Response	PLOS ONE			English	Article							IMMUNE GENE REPERTOIRE; DOUBLE-STRANDED-RNA; STRUCTURAL BASIS; PATTERN-RECOGNITION; HELICASE; ACTIVATION; EXPRESSION; LGP2; DOMAIN; INDUCTION	RIG1 and MDA5 have emerged as important intracellular innate pattern recognition receptors that recognize viral RNA and mediate cellular signals controlling Type I interferon (IFN-I) response. Buffalo RIG1 and MDA5 genes were investigated to understand the mechanism of receptor induced antiviral response. Sequence analysis revealed that RIG1 and MDA5 maintain a domain arrangement that is common in mammals. Critical binding site residues of the receptors are evolutionary conserved among mammals. Molecular dynamics simulations suggested that RIG1 and MDA5 follow a similar, if not identical, dsRNA binding pattern that has been previously reported in human. Moreover, binding free energy calculation revealed that MDA5 had a greater affinity towards dsRNA compared to RIG1. Constitutive expressions of RLR genes were ubiquitous in different tissues without being specific to immune organs. Poly I: C stimulation induced elevated expressions of IFN-beta and IFN-stimulated genes (ISGs) through interferon regulatory factors (IRFs) mediated pathway in buffalo foetal fibroblast cells. The present study provides crucial insights into the structure and function of RIG1 and MDA5 receptors in buffalo.	[Singh, Manvender; Brahma, Biswajit; Maharana, Jitendra; Patra, Mahesh Chandra; Kumar, Sushil; Mishra, Purusottam; Saini, Megha; De, Bidhan Chandra; Mahanty, Sourav; Datta, Tirtha Kumar; De, Sachinandan] Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal 132001, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	De, S (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal 132001, Haryana, India.	sachinandan@ndri.res.in	DE, BIDHAN CHANDRA/P-1606-2015; Maharana, Jitendra/B-5210-2014; Patra, Mahesh/I-9746-2014	DE, BIDHAN CHANDRA/0000-0002-9379-8909; Maharana, Jitendra/0000-0003-4628-5956; De, Sachinandan/0000-0002-3182-0904; Patra, Mahesh/0000-0003-0471-6236; Brahma, Biswajit/0000-0003-0052-5029	Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India [BT/PR3111/AAQ/1/474/2011]	Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India(Department of Biotechnology (DBT) India)	The study was supported by a grant (BT/PR3111/AAQ/1/474/2011) received from Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartenschlager R, 2005, P NATL ACAD SCI USA, V102, P9739, DOI 10.1073/pnas.0504296102; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Biacchesi S, 2009, J VIROL, V83, P7815, DOI 10.1128/JVI.00404-09; Borriello G, 2006, INFECT IMMUN, V74, P2115, DOI 10.1128/IAI.74.4.2115-2120.2006; Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Eisenacher K, 2012, EUR J CELL BIOL, V91, P36, DOI 10.1016/j.ejcb.2011.01.011; FAO, 2000, WAT BUFF ASS UND, P1; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Ohtani M, 2011, DEV COMP IMMUNOL, V35, P554, DOI 10.1016/j.dci.2010.12.013; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sweeney SE, 2010, J IMMUNOL, V184, P7162, DOI 10.4049/jimmunol.0903944; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Triantafilou K, 2012, J CELL SCI, V125, P4761, DOI 10.1242/jcs.103887; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xing F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045136; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	52	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89788	10.1371/journal.pone.0089788	http://dx.doi.org/10.1371/journal.pone.0089788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587036	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000094
J	Carrizzo, A; Di Pardo, A; Maglione, V; Damato, A; Amico, E; Formisano, L; Vecchione, C; Squitieri, F				Carrizzo, Albino; Di Pardo, Alba; Maglione, Vittorio; Damato, Antonio; Amico, Enrico; Formisano, Luigi; Vecchione, Carmine; Squitieri, Ferdinando			Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease	PLOS ONE			English	Article							PROTEIN EXPRESSION; TRANSGENIC MICE; SYNTHASE; BLOOD; AGE; DYSFUNCTION; MUTATION	Nitric oxide (NO) is a biologically active inorganic molecule involved in the regulation of many physiological processes, such as control of blood flow, platelet adhesion, endocrine function, neurotransmission and neuromodulation. In the present study, for the first time, we investigated the modulation of NO signaling in platelets of HD patients. We recruited 55 patients with manifest HD and 28 gender-and age-matched healthy controls. Our data demonstrated that NO-mediated vasorelaxation, when evoked by supernatant from insulin-stimulated HD platelets, gradually worsens along disease course. The defective vasorelaxation seems to stem from a faulty release of NO from platelets of HD patients and, it is associated with impairment of eNOS phosphorylation (Ser(1177)) and activity. This study provides important insights about NO metabolism in HD and raises the hypothesis that the decrease of NO in platelets of HD individuals could be a good tool for monitoring advanced stages of the disease.	[Carrizzo, Albino; Di Pardo, Alba; Maglione, Vittorio; Damato, Antonio; Amico, Enrico; Vecchione, Carmine; Squitieri, Ferdinando] IRCCS Neuromed, Pozzilli, IS, Italy; [Formisano, Luigi] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Vecchione, Carmine] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy	IRCCS Neuromed; University of Sannio; University of Salerno	Vecchione, C (corresponding author), IRCCS Neuromed, Pozzilli, IS, Italy.	cvecchione@unisa.it; ferdinando.squitieri@lirh.it	Di Pardo, Alba/AAC-9393-2020; Carrizzo, Albino/K-5177-2016; amico, enrico/AAA-8797-2019; Maglione, Vittorio/AAA-5455-2019; Vecchione, Carmine/K-2175-2018; Squitieri, Ferdinando/N-1852-2019; Damato, Antonio/K-5307-2016	Di Pardo, Alba/0000-0002-9514-0086; Carrizzo, Albino/0000-0003-2689-0008; amico, enrico/0000-0002-0160-3634; Maglione, Vittorio/0000-0002-6906-7372; Squitieri, Ferdinando/0000-0002-7397-1727; Vecchione, Carmine/0000-0002-2473-4565; Damato, Antonio/0000-0003-0258-5324; Formisano, Luigi/0000-0001-7294-8595	Marie Curie International Incoming Fellowship (IIF) within the 7th European Community Framework Programme [300197]	Marie Curie International Incoming Fellowship (IIF) within the 7th European Community Framework Programme	We are grateful to all patients for contributing to our work and to Lega Italiana Ricerca Huntington e malattie correlate (LIRH) onlus. Also, we thank Mariateresa Ambrosio and all the laboratory assistants for technical support and fruitful discussion. Vittorio Maglione is supported by a Marie Curie International Incoming Fellowship (IIF, grant no 300197) within the 7th European Community Framework Programme.	Barton M, 1997, HYPERTENSION, V30, P817, DOI 10.1161/01.HYP.30.4.817; Calabrese V, 2000, NEUROCHEM RES, V25, P1315, DOI 10.1023/A:1007604414773; Carrizzo A, 2013, HYPERTENSION, V62, P359, DOI 10.1161/HYPERTENSIONAHA.111.01009; Deckel AW, 2002, BRAIN RES, V939, P76, DOI 10.1016/S0006-8993(02)02550-7; Deckel AW, 2001, J NEUROSCI RES, V64, P99, DOI 10.1002/jnr.1057; Deckel AW, 2001, BRAIN RES, V919, P70, DOI 10.1016/S0006-8993(01)03000-1; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gentile MT, 2008, DIABETES, V57, P577, DOI 10.2337/db07-0557; Kiriazis H, 2012, J PHYSIOL-LONDON, V590, P5845, DOI 10.1113/jphysiol.2012.238113; Ku CJ, 2007, ANAL CHEM, V79, P2421, DOI 10.1021/ac061572q; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Maglione V, 2006, NEUROSCI LETT, V393, P27, DOI 10.1016/j.neulet.2005.09.037; Maglione V, 2005, AM J MED GENET B, V139B, P101, DOI 10.1002/ajmg.b.30223; Marder K, 2002, NEUROLOGY, V59, P1622, DOI 10.1212/01.WNL.0000035627.16789.23; Markianos M, 2004, J NEURAL TRANSM, V111, P475, DOI 10.1007/s00702-003-0103-x; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; MURAMATSU Y, 1982, ARCH PSYCHIAT NERVEN, V232, P191, DOI 10.1007/BF02141780; Perez-Severiano F, 2002, BRAIN RES, V951, P36, DOI 10.1016/S0006-8993(02)03102-5; Puca AA, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-26; RADOMSKI M, 1983, THROMB RES, V30, P383, DOI 10.1016/0049-3848(83)90230-X; Reynolds NC, 2002, NUCL MED COMMUN, V23, P13, DOI 10.1097/00006231-200201000-00004; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Runne H, 2007, P NATL ACAD SCI USA, V104, P14424, DOI 10.1073/pnas.0703652104; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Schulz JB, 1995, CURR OPIN NEUROL, V8, P480, DOI 10.1097/00019052-199512000-00016; Squitieri F, 2011, J NEURAL TRANSM, V118, P1599, DOI 10.1007/s00702-011-0646-1; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Vecchione C, 2002, CIRC RES, V91, P173, DOI 10.1161/01.RES.0000028004.76218.B8; World Medical Association, 1991, Law Med Health Care, V19, P264; 1996, MOV DISORD, V11, P136	34	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89745	10.1371/journal.pone.0089745	http://dx.doi.org/10.1371/journal.pone.0089745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587005	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900075
J	Chaterji, S; Lam, CH; Ho, DS; Proske, DC; Baker, AB				Chaterji, Somali; Lam, Christoffer H.; Ho, Derek S.; Proske, Daniel C.; Baker, Aaron B.			Syndecan-1 Regulates Vascular Smooth Muscle Cell Phenotype	PLOS ONE			English	Article							KINASE-B AKT; EXTRACELLULAR-MATRIX; TISSUE FACTOR; TNF-ALPHA; SIGNAL-TRANSDUCTION; TYROSINE KINASE; SRC KINASE; TGF-BETA; IN-VITRO; KAPPA-B	Objective: We examined the role of syndecan-1 in modulating the phenotype of vascular smooth muscle cells in the context of endogenous inflammatory factors and altered microenvironments that occur in disease or injury-induced vascular remodeling. Methods and Results: Vascular smooth muscle cells (vSMCs) display a continuum of phenotypes that can be altered during vascular remodeling. While the syndecans have emerged as powerful and complex regulators of cell function, their role in controlling vSMC phenotype is unknown. Here, we isolated vSMCs from wild type (WT) and syndecan-1 knockout (S1KO) mice. Gene expression and western blotting studies indicated decreased levels of alpha-smooth muscle actin (alpha-SMA), calponin, and other vSMC-specific differentiation markers in S1KO relative to WT cells. The spread area of the S1KO cells was found to be greater than WT cells, with a corresponding increase in focal adhesion formation, Src phosphorylation, and alterations in actin cytoskeletal arrangement. In addition, S1KO led to increased S6RP phosphorylation and decreased AKT and PKC-alpha phosphorylation. To examine whether these changes were present in vivo, isolated aortae from aged WT and S1KO mice were stained for calponin. Consistent with our in-vitro findings, the WT mice aortae stained higher for calponin relative to S1KO. When exposed to the inflammatory cytokine TNF-alpha, WT vSMCs had an 80% reduction in syndecan-1 expression. Further, with TNF-alpha, S1KO vSMCs produced increased pro-inflammatory cytokines relative to WT. Finally, inhibition of interactions between syndecan-1 and integrins alpha v beta 3 and alpha v beta 5 using the inhibitory peptide synstatin appeared to have similar effects on vSMCs as knocking out syndecan-1, with decreased expression of vSMC differentiation markers and increased expression of inflammatory cytokines, receptors, and osteopontin. Conclusions: Taken together, our results support that syndecan-1 promotes vSMC differentiation and quiescence. Thus, the presence of syndecan-1 would have a protective effect against vSMC dedifferentiation and this activity is linked to interactions with integrins alpha v beta 3 and alpha v beta 5.	[Chaterji, Somali; Lam, Christoffer H.; Ho, Derek S.; Proske, Daniel C.; Baker, Aaron B.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Chaterji, S (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	somalichaterji@gmail.com; abbaker1@gmail.com	Baker, Aaron/AAT-4635-2020	Ho, Derek/0000-0001-8367-8666	American Heart Association [10SDG2630139]; National Institutes of Health [1DP2OD008716-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008716] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the American Heart Association (10SDG2630139) and the National Institutes of Health (1DP2OD008716-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Baars T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-12; BACH RR, 1988, CRC CR REV BIOCH MOL, V23, P339, DOI 10.3109/10409238809082548; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Baker AB, 2012, J AM COLL CARDIOL, V59, P1551, DOI 10.1016/j.jacc.2011.11.057; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bose D, 2007, AM J PHYSIOL-HEART C, V292, pH2295, DOI 10.1152/ajpheart.01116.2006; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Carey DJ, 1997, BIOCHEM J, V327, P1; Chaterji S, 2014, TISSUE EN A IN PRESS; Chaterji S, 2010, TISSUE ENG PT A, V16, P1901, DOI [10.1089/ten.tea.2009.0271, 10.1089/ten.TEA.2009.0271]; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Clunn GF, 2010, INT J CARDIOL, V139, P2, DOI 10.1016/j.ijcard.2009.05.019; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Das S, 2014, BIOMATERIALS, V35, P196, DOI 10.1016/j.biomaterials.2013.09.105; Der P, 2006, J MOL CELL CARDIOL, V40, P313, DOI 10.1016/j.yjmcc.2005.10.005; Dykes AC, 2007, CAN J PHYSIOL PHARM, V85, P225, DOI 10.1139/Y07-005; Fears CY, 2006, MATRIX BIOL, V25, P443, DOI 10.1016/j.matbio.2006.07.003; FOX JC, 1993, IN VITRO CELL DEV-AN, V29A, P228; FOX JC, 1994, MOL CELL BIOL, V14, P4244, DOI 10.1128/MCB.14.6.4244; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; FRID MG, 1992, DEV BIOL, V153, P185, DOI 10.1016/0012-1606(92)90104-O; Fukai N, 2009, ARTERIOSCL THROM VAS, V29, P1356, DOI 10.1161/ATVBAHA.109.190132; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; GRAINGER DJ, 1993, CARDIOVASC RES, V27, P2238; Hautmann MB, 1999, ARTERIOSCL THROM VAS, V19, P2049, DOI 10.1161/01.ATV.19.9.2049; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Hedner U, 2008, ANNU REV MED, V59, P29, DOI 10.1146/annurev.med.59.061606.095605; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; Hoshi S, 2000, J BIOL CHEM, V275, P883, DOI 10.1074/jbc.275.2.883; Ishida T, 1999, J CLIN INVEST, V103, P789, DOI 10.1172/JCI4189; Jang E, 2012, P NATL ACAD SCI USA, V109, P1679, DOI 10.1073/pnas.1117885109; Jin N, 1996, AM J PHYSIOL-HEART C, V271, pH1348, DOI 10.1152/ajpheart.1996.271.4.H1348; Joshi Sachindra R, 2012, Mol Cell Pharmacol, V4, P1; Ju R, 2013, CELL SIGNAL, V25, P101, DOI 10.1016/j.cellsig.2012.09.007; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kato S, 1998, IN VITRO CELL DEV-AN, V34, P341; Kawahara S, 2005, J CARDIOVASC PHARM, V45, P367, DOI 10.1097/01.fjc.0000157454.60939.43; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Lee J, 2013, LAB CHIP, V13, P4573, DOI 10.1039/c3lc50894c; Matthew JD, 2000, J PHYSIOL-LONDON, V529, P811, DOI 10.1111/j.1469-7793.2000.00811.x; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mourani PM, 2004, CIRCULATION, V109, P1299, DOI 10.1161/01.CIR.0000118462.22970.BE; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; NIKKARI ST, 1994, AM J PATHOL, V144, P1348; NORTH AJ, 1994, J CELL SCI, V107, P437; O'Callaghan CJ, 2002, J HYPERTENS, V20, P287, DOI 10.1097/00004872-200202000-00019; ORLANDI A, 1994, EXP CELL RES, V214, P528, DOI 10.1006/excr.1994.1290; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Pawlinski R, 2004, THROMB HAEMOSTASIS, V92, P444, DOI 10.1160/TH04-05-0309; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Qiu ZB, 2012, PHARMAZIE, V67, P553, DOI 10.1691/ph.2012.1123; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; Reddy MA, 2009, ARTERIOSCL THROM VAS, V29, P387, DOI 10.1161/ATVBAHA.108.179150; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; ROSS R, 1971, J CELL BIOL, V50, P159, DOI 10.1083/jcb.50.1.159; RUS HG, 1991, ATHEROSCLEROSIS, V89, P247; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stewart MD, 2013, MATRIX BIOL; Szymanski PT, 2004, J MUSCLE RES CELL M, V25, P7, DOI 10.1023/B:JURE.0000021349.47697.bf; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Vanhoutte D, 2007, CIRCULATION, V115, P475, DOI 10.1161/CIRCULATIONAHA.106.644609; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wang ZB, 2001, FEBS LETT, V508, P360, DOI 10.1016/S0014-5793(01)03109-X; Williams C, 2011, BIOMATERIALS, V32, P410, DOI 10.1016/j.biomaterials.2010.08.105; Xiao YG, 2013, ARTERIOSCL THROM VAS, V33, P2733, DOI 10.1161/ATVBAHA.113.302062; Yang XS, 2014, INT J SWARM INTELL R, V5, P1, DOI 10.4018/ijsir.2014040101	82	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89824	10.1371/journal.pone.0089824	http://dx.doi.org/10.1371/journal.pone.0089824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587062	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900089
J	Liu, DJ; Wu, J; Ouyang, L; Wang, JY				Liu, Duojian; Wu, Jing; Ouyang, Li; Wang, Jingyu			Variations in Lead Isotopic Abundances in Sprague-Dawley Rat Tissues: Possible Reason of Formation	PLOS ONE			English	Article							STABLE CARBON; FRACTIONATION; EXPOSURE; PB	It has been reported in previous research that the lead isotopic composition of blood, urine and feces samples statistically differed from the given lead sources in Sprague-Dawley (SD) rats. However, the reason for this phenomenon is still unclear. An animal experiment was performed to investigate the lead isotope fractionation in diverse biological samples (i.e., lungs, liver, kidneys, bone) and to explore the possible reasons. SD rats were intratracheally instilled with lead acetate at the concentrations of 0, 0.02, 0.2, and 2 mg/kg body weight. Biological samples were collected for lead isotope analysis using an inductively coupled plasma mass spectrometry (ICP-MS). Significant differences are observed in lead isotope abundances among the diverse biological samples. The lead isotope abundances (Pb-206, Pb-207 and Pb-208) in diverse biological samples show different degrees and directions of departure from the given lead source. The results suggest that differences in enrichment or depletion capacity for each lead isotope in the various tissues might lead to the variation in lead isotopic abundances in tissues. Moreover, a nonlinear relationship between the blood lead level and the lead isotope abundances in liver and bone is observed. When the whole-blood level is higher than 50 ng/mL, the lead isotopic compositions of biological samples tend to be the same. Thus, the data support the speculation of a fractionation functional threshold.	[Liu, Duojian; Wu, Jing; Ouyang, Li; Wang, Jingyu] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Ouyang, Li; Wang, Jingyu] Peking Univ, Ctr Med & Hlth Anal, Beijing 100871, Peoples R China	Peking University; Peking University	Wang, JY (corresponding author), Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China.	wjy@bjmu.edu.cn			Natural Science Foundation of China (NSFC) [30972434]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funding for this work was provided by the Natural Science Foundation of China (NSFC. No. 30972434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bollhofer A, 2012, APPL GEOCHEM, V27, P171, DOI 10.1016/j.apgeochem.2011.10.002; Carlson AK, 1996, J ARCHAEOL SCI, V23, P557, DOI 10.1006/jasc.1996.0052; Doe B.R, 1970, LEAD ISOTOPES; Epov VN, 2008, ANAL CHEM, V80, P3530, DOI 10.1021/ac800384b; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Gould E., 2009, Environmental Health Perspectives, V117, P1162, DOI 10.1289/ehp.0800408; Hsu SC, 2006, ATMOS ENVIRON, V40, P5393, DOI 10.1016/j.atmosenv.2006.05.003; Hu X, 2011, CHEMOSPHERE, V82, P1351, DOI 10.1016/j.chemosphere.2010.11.079; Johnson CM, 2004, REV MINERAL GEOCHEM, V55, P1, DOI 10.2138/gsrmg.55.1.1; Komarek M, 2008, ENVIRON INT, V34, P562, DOI 10.1016/j.envint.2007.10.005; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; Li FL, 2012, SCI TOTAL ENVIRON, V431, P339, DOI 10.1016/j.scitotenv.2012.05.040; Meyer PA, 2008, MUTAT RES-REV MUTAT, V659, P166, DOI 10.1016/j.mrrev.2008.03.003; Miller JR, 2005, SCI TOTAL ENVIRON, V350, P204, DOI 10.1016/j.scitotenv.2005.01.030; RABINOWITZ MB, 1976, J CLIN INVEST, V58, P260, DOI 10.1172/JCI108467; RABINOWITZ MB, 1972, ENVIRON SCI TECHNOL, V6, P705, DOI 10.1021/es60067a003; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Scheuhammer AM, 1998, ECOTOXICOLOGY, V7, P37, DOI 10.1023/A:1008855617453; Smith DR, 1996, ENVIRON HEALTH PERSP, V104, P60, DOI 10.2307/3432761; Stenberg A, 2004, ANAL CHEM, V76, P3971, DOI 10.1021/ac049698f; Stokes PE, 1982, J CLIN PSYCHOPHARM, V2, P430; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tomasevic M, 2013, ECOL INDIC, V24, P504, DOI 10.1016/j.ecolind.2012.08.007; Veron AJ, 1998, ENVIRON RES, V78, P104, DOI 10.1006/enrs.1998.3856; Walczyk T, 2002, SCIENCE, V295, P2065, DOI 10.1126/science.1069389; Wu J, 2011, The enrichment and separation of trace lead in complex matrix, Patent No. 201110001498; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052462; Wu L, 2011, SILICON AGR, V207; [张建平 ZHANG Jianping], 2008, [分析测试学报, Journal of Instrumental Analysis], V27, P835	29	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89805	10.1371/journal.pone.0089805	http://dx.doi.org/10.1371/journal.pone.0089805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587048	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900086
J	Zhang, XM; Pagel, MD; Baker, AF; Gillies, RJ				Zhang, Xiaomeng; Pagel, Mark D.; Baker, Amanda F.; Gillies, Robert J.			Reproducibility of Magnetic Resonance Perfusion Imaging	PLOS ONE			English	Article							INTRACLASS CORRELATION-COEFFICIENT; CONTRAST-ENHANCED MRI; BLOOD-POOL AGENT; TUMOR VASCULATURE; NORMALIZATION; BIOMARKERS; P792	Dynamic MR biomarkers (T2*-weighted or susceptibility-based and T1-weighted or relaxivity-enhanced) have been applied to assess tumor perfusion and its response to therapies. A significant challenge in the development of reliable biomarkers is a rigorous assessment and optimization of reproducibility. The purpose of this study was to determine the measurement reproducibility of T1-weighted dynamic contrast-enhanced (DCE)-MRI and T2*-weighted dynamic susceptibility contrast (DSC)-MRI with two contrast agents (CA) of different molecular weight (MW): gadopentetate (Gd-DTPA, 0.5 kDa) and Gadomelitol (P792, 6.5 kDa). Each contrast agent was tested with eight mice that had subcutaneous MDA-MB-231 breast xenograft tumors. Each mouse was imaged with a combined DSC-DCE protocol three times within one week to achieve measures of reproducibility. DSC-MRI results were evaluated with a contrast to noise ratio (CNR) efficiency threshold. There was a clear signal drop (>95% probability threshold) in the DSC of normal tissue, while signal changes were minimal or nonexistent (, >95% probability threshold) in tumors. Mean within-subject coefficient of variation (wCV) of relative blood volume (rBV) in normal tissue was 11.78% for Gd-DTPA and 6.64% for P792. The intra-class correlation coefficient (ICC) of rBV in normal tissue was 0.940 for Gd-DTPA and 0.978 for P792. The inter-subject correlation coefficient was 0.092. Calculated K-trans from DCE-MRI showed comparable reproducibility (mean wCV, 5.13% for Gd-DTPA, 8.06% for P792). ICC of K-trans showed high intra-subject reproducibility (ICC = 0.999/0.995) and inter-subject heterogeneity (ICC = 0.774). Histograms of K-trans distributions for three measurements had high degrees of overlap (sum of difference of the normalized histograms, <0.01). These results represent homogeneous intra-subject measurement and heterogeneous inter-subject character of biological population, suggesting that perfusion MRI could be an imaging biomarker to monitor or predict response of disease.	[Zhang, Xiaomeng; Pagel, Mark D.] Univ Arizona, Biomed Engn Grad Interdisciplinary Program, Tucson, AZ 85721 USA; [Pagel, Mark D.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Pagel, Mark D.; Baker, Amanda F.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Baker, Amanda F.] Univ Arizona, Coll Med, Hematol Oncol Sect, Tucson, AZ USA; [Zhang, Xiaomeng; Gillies, Robert J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Zhang, XM (corresponding author), Univ Arizona, Biomed Engn Grad Interdisciplinary Program, Tucson, AZ 85721 USA.	zhang@pet.mgh.harvard.edu	Baker, Amanda/I-4119-2014	Baker, Amanda/0000-0002-0663-8369; Gillies, Robert/0000-0002-8888-7747	National Cancer Institute [R01 CA 077575, R01 CA 125627, P50 CA95060, P01 CA017094]; NATIONAL CANCER INSTITUTE [P01CA017094, R01CA125627, P50CA095060, R01CA077575] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the National Cancer Institute under grants R01 CA 077575, R01 CA 125627, P50 CA95060, and P01 CA017094. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Abo-Ramadan U, 2009, EXP NEUROL, V219, P328, DOI 10.1016/j.expneurol.2009.06.002; ALLISON DB, 1993, NUTRITION, V9, P559; Barrett T, 2006, EUR J RADIOL, V60, P353, DOI 10.1016/j.ejrad.2006.06.025; Cha Soonmee, 2003, Magn Reson Imaging Clin N Am, V11, P403, DOI 10.1016/S1064-9689(03)00066-7; Cutajar M, 2010, EUR J RADIOL, V74, pE155, DOI 10.1016/j.ejrad.2009.05.041; Daldrup H, 1998, PEDIATR RADIOL, V28, P67, DOI 10.1007/s002470050296; Ferrier MC, 2007, NEOPLASIA, V9, P546, DOI 10.1593/neo.07289; Galbraith SM, 2002, NMR BIOMED, V15, P132, DOI 10.1002/nbm.731; Haacke E. M., 1999, MAGNETIC RESONANCE I; Hormigo A, 2007, CANCER CELL, V11, P6, DOI 10.1016/j.ccr.2006.12.008; Jackson A, 2003, BRIT J RADIOL, V76, P153, DOI 10.1259/bjr/70653746; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jennings D, 2008, CANCER METAST REV, V27, P589, DOI 10.1007/s10555-008-9157-4; Jordan BF, 2005, NEOPLASIA, V7, P475, DOI 10.1593/neo.04628; KNAPP WH, 1985, INT J RADIAT ONCOL, V11, P1357, DOI 10.1016/0360-3016(85)90252-4; Laking GR, 2006, CRIT REV ONCOL HEMAT, V58, P95, DOI 10.1016/j.critrevonc.2005.10.006; Marcus CD, 2009, CRIT REV ONCOL HEMAT, V72, P217, DOI 10.1016/j.critrevonc.2008.07.012; MARTINEZ GV, 2011, NMR BIOMED; Myers AL, 2010, J PEDIATR SURG, V45, P1080, DOI 10.1016/j.jpedsurg.2010.02.068; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Pellis L, 2003, PHYSIOL GENOMICS, V16, P99, DOI 10.1152/physiolgenomics.00111.2003; Persigehl T, 2010, RADIOLOGY, V255, P781, DOI 10.1148/radiol.10090832; Port M, 2001, INVEST RADIOL, V36, P445, DOI 10.1097/00004424-200108000-00002; Port M, 2001, MAGN RESON MATER PHY, V12, P121, DOI 10.1007/BF02668093; Smith JJ, 2003, RADIOLOGY, V227, P633, DOI 10.1148/radiol.2273020518; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Watanabe H, 2003, CANCER SCI, V94, P1015, DOI 10.1111/j.1349-7006.2003.tb01394.x; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Yankeelov TE, 2007, CURR MED IMAGING REV, V3, P91, DOI 10.2174/157340507780619179	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89797	10.1371/journal.pone.0089797	http://dx.doi.org/10.1371/journal.pone.0089797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587040	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900084
J	Bansal, R; Prakash, J; De Ruiter, M; Poelstra, K				Bansal, Ruchi; Prakash, Jai; De Ruiter, Marieke; Poelstra, Klaas			Targeted Recombinant Fusion Proteins of IFN gamma and Mimetic IFN gamma with PDGF beta R Bicyclic Peptide Inhibits Liver Fibrogenesis In Vivo	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; GROWTH-FACTOR RECEPTOR; INTERFERON-GAMMA; FIBROSIS; ACTIVATION; EXPRESSION; CIRRHOSIS; EFFICACY; INJURY	Hepatic stellate cells (HSCs), following transdifferentiation to myofibroblasts plays a key role in liver fibrosis. Therefore, attempts to attenuate this myofibroblastic phenotype would be a promising therapeutic approach. Interferon gamma (IFN gamma) is a potent anti-fibrotic cytokine, but its pleiotropic receptor expression leading to severe adverse effects has limited its clinical application. Since, activated HSC express high-level of platelet derived growth factor beta receptor (PDGF beta R), we investigated the potential of PDGFbR-specific targeting of IFN gamma and its signaling peptide that lacks IFN gamma R binding site (mimetic IFN gamma or mimIFNc) in liver fibrosis. We prepared DNA constructs expressing IFN gamma, mimIFN gamma or BiPPB (PDGF beta R-specific bicyclic peptide)-IFN gamma, BiPPB-mimIFN gamma fusion proteins. Both chimeric proteins alongwith IFN gamma and mimIFN gamma were produced in E. coli. The expressed proteins were purified and analyzed for PDGF beta R-specific binding and in vitro effects. Subsequently, these recombinant proteins were investigated for the liver uptake (pSTAT1 alpha signaling pathway), for antifibrotic effects and adverse effects (platelet counts) in CCl4-induced liver fibrogenesis in mice. The purified HSC-targeted IFN gamma and mimIFN gamma fusion proteins showed PDGF beta R-specific binding and significantly reduced TGF beta-induced collagen-I expression in human HSC (LX2 cells), while mouse IFN gamma and mimIFN gamma did not show any effect. Conversely, mouse IFN gamma and BiPPB-IFN gamma induced activation and dose-dependent nitric oxide release in mouse macrophages (express IFN gamma R while lack PDGF beta R), which was not observed with mimIFNc and BiPPB-mimIFN gamma, due to the lack of IFN gamma R binding sites. In vivo, targeted BiPPB-IFN gamma and BiPPB-mimIFN gamma significantly activated intrahepatic IFNc-signaling pathway compared to IFN gamma and mimIFN gamma suggesting increased liver accumulation. Furthermore, the targeted fusion proteins ameliorated liver fibrogenesis in mice by significantly reducing collagen and alpha-SMA expression and potentiating collagen degradation. IFN gamma also induced reduction in fibrogenesis but showed significant decrease in platelet counts, which was restored with targeted proteins. These results suggest that these rationally designed proteins can be further developed as novel anti-fibrotic therapeutics.	[Bansal, Ruchi; Prakash, Jai] Univ Twente, Dept Controlled Drug Delivery Targeted Therapeut, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [Bansal, Ruchi; Prakash, Jai; De Ruiter, Marieke; Poelstra, Klaas] Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands	University of Twente; University of Groningen	Bansal, R (corresponding author), Univ Twente, Dept Controlled Drug Delivery Targeted Therapeut, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	R.Bansal@utwente.nl	Bansal, Ruchi/F-4649-2014; Prakash, Jai/C-8015-2014; Bansal, Ruchi/D-4796-2016	Prakash, Jai/0000-0003-1050-650X; Bansal, Ruchi/0000-0003-2470-5876	Netherlands Organization for Scientific Research (NWO); Technical foundation (STW)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Technical foundation (STW)(Technologiestichting STW)	Work was supported by VICI grant-in-aid from Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/) and the Technical foundation (STW; http://www.stw.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed CML, 2003, J CELL SCI, V116, P3089, DOI 10.1242/jcs.00528; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bansal R, 2011, J CONTROL RELEASE, V154, P233, DOI 10.1016/j.jconrel.2011.05.027; Bansal R, 2011, HEPATOLOGY, V54, P586, DOI 10.1002/hep.24395; Barisal R, 2011, MOL PHARMACEUT, V8, P1899, DOI 10.1021/mp200263q; Baroni GS, 1996, HEPATOLOGY, V23, P1189; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beljaars L, 2000, J BIOL CHEM, V275, P12743, DOI 10.1074/jbc.275.17.12743; Beljaars L, 2003, BIOCHEM PHARMACOL, V66, P1307, DOI 10.1016/S0006-2952(03)00445-3; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; BONNEM EM, 1987, J BIOL RESP MODIF, V6, P275; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Borkham-Kamphorst E, 2008, LAB INVEST, V88, P1090, DOI 10.1038/labinvest.2008.71; Bouros D, 2006, EXPERT OPIN BIOL TH, V6, P1051, DOI 10.1517/14712598.6.10.1051; Cleland JL, 1996, PHARMACEUT RES, V13, P1464, DOI 10.1023/A:1016063109373; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Friedman SL, 2004, HEPATOLOGY, V40, P1041, DOI 10.1002/hep.20476; Ghosh AK, 2006, J CELL PHYSIOL, V207, P251, DOI 10.1002/jcp.20559; Gressner Olav A, 2007, Comp Hepatol, V6, P7, DOI 10.1186/1476-5926-6-7; Gu F, 2005, J CONTROL RELEASE, V102, P607, DOI 10.1016/j.jconrel.2004.10.020; Guo JS, 2007, SEMIN LIVER DIS, V27, P413, DOI 10.1055/s-2007-991517; Johnson HM, 2006, CELL MOL BIOL, V52, P71, DOI 10.1170/T700; Kim YM, 1996, J IMMUNOL METHODS, V198, P203, DOI 10.1016/S0022-1759(96)00162-7; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Knight B, 2007, J HEPATOL, V47, P826, DOI 10.1016/j.jhep.2007.06.022; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Oldroyd SD, 1999, KIDNEY INT, V56, P2116, DOI 10.1046/j.1523-1755.1999.00775.x; Pockros PJ, 2007, HEPATOLOGY, V45, P569, DOI 10.1002/hep.21561; Poelstra K, 2011, J HEPATOL, V55, P726, DOI 10.1016/j.jhep.2011.04.008; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Schafer A, 2010, J HEPATOL, V52, P10, DOI 10.1016/j.jhep.2009.10.007; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Subramaniam PS, 2004, BIOCHEMISTRY-US, V43, P5445, DOI 10.1021/bi036213t; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	37	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89878	10.1371/journal.pone.0089878	http://dx.doi.org/10.1371/journal.pone.0089878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587093	Green Published, gold			2022-12-27	WOS:000331880700108
J	De Filippis, F; La Storia, A; Stellato, G; Gatti, M; Ercolini, D				De Filippis, Francesca; La Storia, Antonietta; Stellato, Giuseppina; Gatti, Monica; Ercolini, Danilo			A Selected Core Microbiome Drives the Early Stages of Three Popular Italian Cheese Manufactures	PLOS ONE			English	Article							STREPTOCOCCUS-THERMOPHILUS STRAINS; GRANA-PADANO CHEESE; NATURAL WHEY CULTURES; RAW-MILK; GENETIC DIVERSITY; PCR; BIODIVERSITY; STARTER; HETEROGENEITY; ENVIRONMENT	Mozzarella (M), Grana Padano (GP) and Parmigiano Reggiano (PR) are three of the most important traditional Italian cheeses. In the three cheese manufactures the initial fermentation is carried out by adding natural whey cultures (NWCs) according to a back-slopping procedure. In this study, NWCs and the corresponding curds from M, GP and PR manufactures were analyzed by culture-independent pyrosequencing of the amplified V1-V3 regions of the 16S rRNA gene, in order to provide insights into the microbiota involved in the curd acidification. Moreover, culture-independent high-throughput sequencing of lacS gene amplicons was carried out to evaluate the biodiversity occurring within the S. thermophilus species. Beta diversity analysis showed a species-based differentiation between GP-PR and M manufactures indicating differences between the preparations. Nevertheless, all the samples shared a naturally-selected core microbiome, that is involved in the curd acidification. Type-level variability within S. thermophilus species was also found and twenty-eight lacS gene sequence types were identified. Although lacS gene did not prove variable enough within S. thermophilus species to be used for quantitative biotype monitoring, the possibility of using non rRNA targets for quantitative biotype identification in food was highlighted.	[De Filippis, Francesca; La Storia, Antonietta; Stellato, Giuseppina; Ercolini, Danilo] Univ Naples Federico II, Dept Agr Sci, Div Microbiol, Portici, Italy; [Gatti, Monica] Univ Parma, Dept Food Sci, I-43100 Parma, Italy; [Gatti, Monica] Univ Parma, Multidisciplinary Interdept Dairy Ctr MILC, I-43100 Parma, Italy	University of Naples Federico II; University of Parma; University of Parma	Ercolini, D (corresponding author), Univ Naples Federico II, Dept Agr Sci, Div Microbiol, Portici, Italy.	ercolini@unina.it	De Filippis, Francesca/K-3816-2016; Ercolini, Danilo/B-2431-2009; La Storia, Antonietta/K-8570-2016	De Filippis, Francesca/0000-0002-3474-2884; Ercolini, Danilo/0000-0003-3061-9560; La Storia, Antonietta/0000-0002-8318-9376	Ministero dell'Istruzione, dell'Universita e della Ricerca [PON01_02863]; Campania Region within the program "POR CAMPANIA FSE'' - project CARINA (Safety sustainability and competitiveness of the agro-food production in Campania)	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Campania Region within the program "POR CAMPANIA FSE'' - project CARINA (Safety sustainability and competitiveness of the agro-food production in Campania)	This work was supported by a grant from the "Ministero dell'Istruzione, dell'Universita e della Ricerca" within the program PON01_02863 Research and Competitiveness 2007-2013. Project title: "Encapsulation of active ingredients for improving the quality and food safety''. Francesca De Filippis was supported by a grant from Campania Region within the program "POR CAMPANIA FSE 2007/2013'' - project CARINA (Safety sustainability and competitiveness of the agro-food production in Campania). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria A, 2012, APPL ENVIRON MICROB, V78, P1890, DOI 10.1128/AEM.06081-11; Andrighetto C, 2002, INT DAIRY J, V12, P141, DOI 10.1016/S0958-6946(01)00134-0; Bottari B, 2010, J APPL MICROBIOL, V108, P1676, DOI 10.1111/j.1365-2672.2009.04564.x; Broadbent JR, 2005, ASM NEWS, V71, P121; BROOK I, 1991, REV INFECT DIS, V13, P819; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Coppola R, 2000, LAIT, V80, P479, DOI 10.1051/lait:2000139; Coppola S, 2001, J APPL MICROBIOL, V90, P414, DOI 10.1046/j.1365-2672.2001.01262.x; Coppola S, 2006, J DAIRY RES, V73, P264, DOI 10.1017/S0022029906001804; Daigle D., 2011, CURR PROT MOL BIOL, V96, P7; De Filippis F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070222; de Vin F, 2005, APPL ENVIRON MICROB, V71, P3659, DOI 10.1128/AEM.71.7.3659-3667.2005; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El-Sharoud WM, 2012, J APPL MICROBIOL, V112, P329, DOI 10.1111/j.1365-2672.2011.05212.x; Ercolini D, 2005, RES MICROBIOL, V156, P161, DOI 10.1016/j.resmic.2004.09.005; Ercolini D, 2004, J APPL MICROBIOL, V96, P263, DOI 10.1046/j.1365-2672.2003.02146.x; Ercolini D, 2001, SYST APPL MICROBIOL, V24, P610, DOI 10.1078/0723-2020-00076; Ercolini D, 2008, INT J FOOD MICROBIOL, V124, P164, DOI 10.1016/j.ijfoodmicro.2008.03.007; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Ercolini D, 2012, APPL ENVIRON MICROB, V78, P8142, DOI 10.1128/AEM.02218-12; Fornasari ME, 2006, FEMS MICROBIOL LETT, V257, P139, DOI 10.1111/j.1574-6968.2006.00155.x; Gatti M, 2004, APPL ENVIRON MICROB, V70, P182, DOI 10.1128/AEM.70.1.182-190.2004; Gatti M, 2003, J APPL MICROBIOL, V95, P463, DOI 10.1046/j.1365-2672.2003.01997.x; Gatti M, 2014, J DAIRY SCI, V97, P573, DOI 10.3168/jds.2013-7187; Gelsomino R, 2001, INT J FOOD MICROBIOL, V71, P177, DOI 10.1016/S0168-1605(01)00620-1; Giraffa G, 1996, J APPL BACTERIOL, V80, P199, DOI 10.1111/j.1365-2672.1996.tb03210.x; Giraffa G, 2001, J APPL MICROBIOL, V91, P937, DOI 10.1046/j.1365-2672.2001.01464.x; Goh YJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S22; Groenewald WH, 2008, EXTREMOPHILES, V12, P159, DOI 10.1007/s00792-007-0112-z; Lazzi C, 2004, J APPL MICROBIOL, V96, P481, DOI 10.1111/j.1365-2672.2004.02180.x; Lazzi C, 2009, J MICROBIOL METH, V79, P48, DOI 10.1016/j.mimet.2009.07.021; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Masoud W, 2011, INT DAIRY J, V21, P142, DOI 10.1016/j.idairyj.2010.10.007; Mauriello G, 2003, J DAIRY SCI, V86, P486, DOI 10.3168/jds.S0022-0302(03)73627-3; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miller DM, 2012, J DAIRY SCI, V95, P4868, DOI 10.3168/jds.2012-5445; Mora D, 2003, MICROBIOL-SGM, V149, P807, DOI 10.1099/mic.0.25925-0; Mora D, 2002, J APPL MICROBIOL, V93, P278, DOI 10.1046/j.1365-2672.2002.01696.x; Morales P, 2005, J FOOD PROTECT, V68, P1399, DOI 10.4315/0362-028X-68.7.1399; Moschetti G, 1998, J APPL MICROBIOL, V85, P25, DOI 10.1046/j.1365-2672.1998.00461.x; NEVIANI E, 1995, J DAIRY SCI, V78, P1248, DOI 10.3168/jds.S0022-0302(95)76744-3; Neviani E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00036; Neviani E, 2009, FOOD MICROBIOL, V26, P240, DOI 10.1016/j.fm.2009.01.004; Pitzskchke A, 2013, PLANT SCI, V4, P1; Pogacic T, 2013, FOOD MICROBIOL, V36, P207, DOI 10.1016/j.fm.2013.05.009; Quigley L, 2012, J APPL MICROBIOL, V113, P96, DOI 10.1111/j.1365-2672.2012.05294.x; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rossetti L, 2008, INT J FOOD MICROBIOL, V127, P168, DOI 10.1016/j.ijfoodmicro.2008.06.005; Santarelli M, 2008, J DAIRY SCI, V91, P883, DOI 10.3168/jds.2007-0296; Sesena S, 2005, INT J FOOD MICROBIOL, V104, P325, DOI 10.1016/j.ijfoodmicro.2005.03.013; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Bogaard PTC, 2000, J BACTERIOL, V182, P5982, DOI 10.1128/JB.182.21.5982-5989.2000; van den Bogaard PTC, 2004, SYST APPL MICROBIOL, V27, P10, DOI 10.1078/0723-2020-00258; Vaningelgem F, 2004, APPL ENVIRON MICROB, V70, P900, DOI 10.1128/AEM.70.2.900-912.2004; Vaughan EE, 2001, J BACTERIOL, V183, P1184, DOI 10.1128/JB.183.4.1184-1194.2001; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zotta T, 2008, FOOD MICROBIOL, V25, P113, DOI 10.1016/j.fm.2007.07.001	61	78	78	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89680	10.1371/journal.pone.0089680	http://dx.doi.org/10.1371/journal.pone.0089680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586960	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700072
J	Renard, M; Trachet, B; Casteleyn, C; Campens, L; Cornillie, P; Callewaert, B; Deleye, S; Vandeghinste, B; van Heijningen, PM; Dietz, H; De Vos, F; Essers, J; Staelens, S; Segers, P; Loeys, B; Coucke, P; De Paepe, A; De Backer, J				Renard, Marjolijn; Trachet, Bram; Casteleyn, Christophe; Campens, Laurence; Cornillie, Pieter; Callewaert, Bert; Deleye, Steven; Vandeghinste, Bert; van Heijningen, Paula M.; Dietz, Harry; De Vos, Filip; Essers, Jeroen; Staelens, Steven; Segers, Patrick; Loeys, Bart; Coucke, Paul; De Paepe, Anne; De Backer, Julie			Absence of Cardiovascular Manifestations in a Haploinsufficient Tgfbr1 Mouse Model	PLOS ONE			English	Article							LOEYS-DIETZ-SYNDROME; MARFAN-SYNDROME; AORTIC-ANEURYSMS; BETA RECEPTOR; MUTATIONS; MICE; FIBRILLIN; DIFFERENTIATION; ANGIOGENESIS; PATHOGENESIS	Loeys-Dietz syndrome (LDS) is an autosomal dominant arterial aneurysm disease belonging to the spectrum of transforming growth factor beta (TGF beta)-associated vasculopathies. In its most typical form it is characterized by the presence of hypertelorism, bifid uvula/cleft palate and aortic aneurysm and/or arterial tortuosity. LDS is caused by heterozygous loss of function mutations in the genes encoding TGF beta receptor 1 and 2 (TGFBR1 and -2), which lead to a paradoxical increase in TGF beta signaling. To address this apparent paradox and to gain more insight into the pathophysiology of aneurysmal disease, we characterized a new Tgfbr1 mouse model carrying a p.Y378* nonsense mutation. Study of the natural history in this model showed that homozygous mutant mice die during embryonic development due to defective vascularization. Heterozygous mutant mice aged 6 and 12 months were morphologically and (immuno) histochemically indistinguishable from wild-type mice. We show that the mutant allele is degraded by nonsense mediated mRNA decay, expected to result in haploinsufficiency of the mutant allele. Since this haploinsufficiency model does not result in cardiovascular malformations, it does not allow further study of the process of aneurysm formation. In addition to providing a comprehensive method for cardiovascular phenotyping in mice, the results of this study confirm that haploinsuffciency is not the underlying genetic mechanism in human LDS.	[Renard, Marjolijn; Campens, Laurence; Callewaert, Bert; Loeys, Bart; Coucke, Paul; De Paepe, Anne; De Backer, Julie] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Trachet, Bram; Segers, Patrick] Univ Ghent, Inst Biomed Technol Biofluid Tissue & Solid Mech, B-9000 Ghent, Belgium; [Casteleyn, Christophe; Cornillie, Pieter] Univ Ghent, Fac Vet Med, Dept Morphol, Merelbeke, Belgium; [Casteleyn, Christophe] Univ Antwerp, Fac Pharmaceut Biochem & Vet Sci, Dept Vet Sci, Antwerp, Belgium; [Deleye, Steven; Vandeghinste, Bert; Staelens, Steven] Univ Ghent, Inst Biomed Technol, Med Image & Signal Proc Unit, B-9000 Ghent, Belgium; [Deleye, Steven; Staelens, Steven] Univ Antwerp, Mol Imaging Ctr, Antwerp, Belgium; [van Heijningen, Paula M.; Essers, Jeroen] Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands; [van Heijningen, Paula M.; Essers, Jeroen] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands; [van Heijningen, Paula M.; Essers, Jeroen] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands; [Dietz, Harry] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Dietz, Harry] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [De Vos, Filip] Univ Ghent, Fac Pharmaceut Sci, Lab Radiopharm, B-9000 Ghent, Belgium; [Loeys, Bart] Univ Antwerp Hosp, Ctr Med Genet, Edegem, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; University of Antwerp; Ghent University; University of Antwerp; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Ghent University; University of Antwerp	Renard, M (corresponding author), Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium.	Marjolijn.Renard@UGent.be	Staelens, Steven/D-8385-2017; Trachet, Bram/R-4272-2017; Segers, Patrick/AAA-7844-2020; Campens, Laurence/I-2038-2012; Coucke, Paul J/AAO-2954-2020; Callewaert, Bert/J-6357-2014; Loeys, Bart/B-3236-2017; De Backer, Julie/B-2897-2014	Staelens, Steven/0000-0003-3376-0519; Trachet, Bram/0000-0003-4863-8399; Segers, Patrick/0000-0003-3870-3409; Coucke, Paul J/0000-0001-7119-586X; Callewaert, Bert/0000-0002-9743-4205; Loeys, Bart/0000-0003-3703-9518; De Backer, Julie/0000-0001-8878-1507	Fund for Scientific Research, Flanders (Belgium) [G.0094.06]; Fighting Aneurysmal Disease [EC-FP7]; Special Research Fund of the Ghent University [BOF10/GOA/005]; Methusalem grant from the Flemish government and the Ghent University [08/01M01108]; Fund for Scientific Research, Flanders (Belgium)	Fund for Scientific Research, Flanders (Belgium)(FWO); Fighting Aneurysmal Disease [EC-FP7]; Special Research Fund of the Ghent University; Methusalem grant from the Flemish government and the Ghent University; Fund for Scientific Research, Flanders (Belgium)(FWO)	This study was partly supported by the Fund for Scientific Research, Flanders (Belgium) [G.0094.06]; Fighting Aneurysmal Disease [EC-FP7]; the Special Research Fund of the Ghent University [BOF10/GOA/005]; and a Methusalem grant from the Flemish government and the Ghent University to A. De Paepe [08/01M01108]. B. Loeys, J. De Backer, B. Callewaert, and M. Renard are/were, respectively, senior clinical investigators (BL and JDB), postdoctoral fellow (BC), and PhD fellow (MR) supported by the Fund for Scientific Research, Flanders (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias D, 2009, CIRCULATION, V120, P2541, DOI 10.1161/CIRCULATIONAHA.109.887042; Augustin M, 2005, MAMM GENOME, V16, P405, DOI 10.1007/s00335-004-3028-2; Bartram U, 2001, CIRCULATION, V103, P2745; Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Callewaert BL, 2008, GENESIS, V46, P385, DOI 10.1002/dvg.20409; Cardoso S, 2012, J RECEPT SIG TRANSD, V32, P150, DOI 10.3109/10799893.2012.664553; Carvalho RLC, 2007, J CELL SCI, V120, P4269, DOI 10.1242/jcs.013169; Choudhary B, 2006, DEV BIOL, V289, P420, DOI 10.1016/j.ydbio.2005.11.008; Choudhary B, 2009, GENESIS, V47, P115, DOI 10.1002/dvg.20466; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Goudie DR, 2011, NAT GENET, V43, P365, DOI 10.1038/ng.780; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Kaijzel EL, 2010, CIRC-CARDIOVASC IMAG, V3, P567, DOI 10.1161/CIRCIMAGING.109.933093; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lindsay M.E., 2012, NAT GENET; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Ramirez F, 1996, CURR OPIN GENET DEV, V6, P309, DOI 10.1016/S0959-437X(96)80007-4; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Redon R, 2006, EUR J HUM GENET, V14, P759, DOI 10.1038/sj.ejhg.5201613; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Singh KK, 2006, HUM MUTAT, V27, P770, DOI 10.1002/humu.20354; Tang Y, 2003, HUM MOL GENET, V12, P1579, DOI 10.1093/hmg/ddg164; Tanga Y, 2005, GENOMICS, V85, P60, DOI 10.1016/j.ygeno.2004.09.003; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Van Hemelrijk CR, 2010, CURR OPIN CARDIOL, V25, P6; Wang JK, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-51; Yuan SM, 2011, VASA, V40, P369, DOI 10.1024/0301-1526/a000133	37	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89749	10.1371/journal.pone.0089749	http://dx.doi.org/10.1371/journal.pone.0089749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587008	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700084
J	de Gannes, V; Eudoxie, G; Hickey, WJ				de Gannes, Vidya; Eudoxie, Gaius; Hickey, William J.			Impacts of Edaphic Factors on Communities of Ammonia-Oxidizing Archaea, Ammonia-Oxidizing Bacteria and Nitrification in Tropical Soils	PLOS ONE			English	Article							RED SOIL; OXIDATION; ABUNDANCE; NITROGEN; DIVERSITY; RELEASE; RATHER; GENES; LINKS; PH	Nitrification is a key process in soil nitrogen (N) dynamics, but relatively little is known about it in tropical soils. In this study, we examined soils from Trinidad to determine the edaphic drivers affecting nitrification levels and community structure of ammonia-oxidizing bacteria (AOB) and ammonia-oxidizing archaea (AOA) in non-managed soils. The soils were naturally vegetated, ranged in texture from sands to clays and spanned pH 4 to 8. The AOA were detected by qPCR in all soils (ca. 10(5) to 10(6) copies archaeal amoA g(-1) soil), but AOB levels were low and bacterial amoA was infrequently detected. AOA abundance showed a significant negative correlation (p<0.001) with levels of soil organic carbon, clay and ammonium, but was not correlated to pH. Structures of AOA and AOB communities, as determined by amoA terminal restriction fragment (TRF) analysis, differed significantly between soils (p<0.001). Variation in AOA TRF profiles was best explained by ammonium-N and either Kjeldahl N or total N (p<0.001) while variation in AOB TRF profiles was best explained by phosphorus, bulk density and iron (p<0.01). In clone libraries, phylotypes of archaeal amoA (predominantly Nitrososphaera) and bacterial amoA (predominanatly Nitrosospira) differed between soils, but variation was not correlated with pH. Nitrification potential was positively correlated with clay content and pH (p<0.001), but not to AOA or AOB abundance or community structure. Collectively, the study showed that AOA and AOB communities were affected by differing sets of edaphic factors, notably that soil N characteristics were significant for AOA, but not AOB, and that pH was not a major driver for either community. Thus, the effect of pH on nitrification appeared to mainly reflect impacts on AOA or AOB activity, rather than selection for AOA or AOB phylotypes differing in nitrifying capacity.	[de Gannes, Vidya; Eudoxie, Gaius] Univ W Indies, Fac Food & Agr, Dept Food Prod, St Augustine, Trinidad Tobago; [Hickey, William J.] Univ Wisconsin, Dept Soil Sci, ON Allen Lab Soil Microbiol, Madison, WI 53706 USA	University West Indies Mona Jamaica; University West Indies Saint Augustine; University of Wisconsin System; University of Wisconsin Madison	Hickey, WJ (corresponding author), Univ Wisconsin, Dept Soil Sci, ON Allen Lab Soil Microbiol, Madison, WI 53706 USA.	wjhickey@wisc.edu	Hickey, William/HGC-5490-2022		Postgraduate Research Fund; Department of Food Production, Faculty of Food and Agriculture University of the West Indies, St. Augustine Campus, Trinidad and Tobago	Postgraduate Research Fund; Department of Food Production, Faculty of Food and Agriculture University of the West Indies, St. Augustine Campus, Trinidad and Tobago	These studies were supported by a grant (to Vidya de Gannes) from the Postgraduate Research Fund and the Department of Food Production, Faculty of Food and Agriculture University of the West Indies, St. Augustine Campus, Trinidad and Tobago, and an endowment from the O.N. Allen Professorship in Soil Microbiology (to William Hickey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrahami S, 2002, APPL ENVIRON MICROB, V68, P5685, DOI 10.1128/AEM.68.11.5685-5692.2002; Boyle-Yarwood SA, 2008, ENVIRON MICROBIOL, V10, P2956, DOI 10.1111/j.1462-2920.2008.01600.x; de Boer W, 2001, SOIL BIOL BIOCHEM, V28, P203; de Gannes V, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00244; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Fierer N, 2009, MICROB ECOL, V58, P435, DOI 10.1007/s00248-009-9517-9; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Glass JB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00061; Godfrey LV, 2011, METHOD ENZYMOL, V486, P483, DOI [10.1016/S0076-6879(11)86022-2, 10.1016/B978-0-12-381294-0.00022-5]; GREEN CJ, 1994, SOIL SCI SOC AM J, V58, P1411, DOI 10.2136/sssaj1994.03615995005800050019x; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Hart S.C., 1994, SSSA BOOK SERRIES, P98, DOI [10.2136/sssabookser5.2.frontmatter, DOI 10.2136/SSSABOOKSER5.2.FRONTMATTER]; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hofferle S, 2010, FEMS MICROBIOL ECOL, V74, P302, DOI 10.1111/j.1574-6941.2010.00961.x; Horz HP, 2000, J MICROBIOL METH, V39, P197, DOI 10.1016/S0167-7012(99)00119-0; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jiang X, 2011, SOIL BIOL BIOCHEM, V43, P2215, DOI 10.1016/j.soilbio.2011.07.014; Karlsson AE, 2012, FEMS MICROBIOL ECOL, V80, P305, DOI 10.1111/j.1574-6941.2012.01298.x; KUNC F, 1980, FOLIA MICROBIOL, V25, P106, DOI 10.1007/BF02933010; Kyveryga PM, 2004, SOIL SCI SOC AM J, V68, P545, DOI 10.2136/sssaj2004.0545; Le Roux X, 2008, ISME J, V2, P221, DOI 10.1038/ismej.2007.109; Levicnik-Hofferle S, 2012, FEMS MICROBIOL ECOL, V80, P114, DOI 10.1111/j.1574-6941.2011.01275.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; O'Sullivan CA, 2013, SOIL RES, V51, P240, DOI 10.1071/SR13039; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pett-Ridge J, 2013, FEMS MICROBIOL ECOL, V85, P179, DOI 10.1111/1574-6941.12111; POWELL SJ, 1991, J GEN MICROBIOL, V137, P1923, DOI 10.1099/00221287-137-8-1923; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; Rees GN, 2004, ANTON LEEUW INT J G, V86, P339, DOI 10.1007/s10482-004-0498-x; Sahrawat KL, 2008, COMMUN SOIL SCI PLAN, V39, P1436, DOI 10.1080/00103620802004235; SAHRAWAT KL, 1982, PLANT SOIL, V65, P281, DOI 10.1007/BF02374659; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shand CA, 2008, TALANTA, V74, P648, DOI 10.1016/j.talanta.2007.06.039; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Stopnisek N, 2010, APPL ENVIRON MICROB, V76, P7626, DOI 10.1128/AEM.00595-10; Taylor AE, 2010, APPL ENVIRON MICROB, V76, P7691, DOI 10.1128/AEM.01324-10; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Webster G, 2005, ENVIRON MICROBIOL, V7, P676, DOI 10.1111/j.1462-2920.2005.00740.x; Wessen E, 2011, ISME J, V5, P1213, DOI 10.1038/ismej.2010.206; Wessen E, 2010, SOIL BIOL BIOCHEM, V42, P1759, DOI 10.1016/j.soilbio.2010.06.013; Yao HY, 2013, ENVIRON MICROBIOL, V15, P2545, DOI 10.1111/1462-2920.12141; Yao H, 2011, APPL ENVIRON MICROB, V77, P4618, DOI 10.1128/AEM.00136-11; Ying JY, 2010, ENV MICROBIOL REP, V2, P304, DOI 10.1111/j.1758-2229.2009.00130.x; Zeglin LH, 2011, ENV MICROBIOL REP, V3, P717, DOI 10.1111/j.1758-2229.2011.00290.x; Zhang LM, 2010, P NATL ACAD SCI USA, V107, P17240, DOI 10.1073/pnas.1004947107	53	23	24	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89568	10.1371/journal.pone.0089568	http://dx.doi.org/10.1371/journal.pone.0089568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586878	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200061
J	Miozzi, L; Napoli, C; Sardo, L; Accotto, GP				Miozzi, Laura; Napoli, Chiara; Sardo, Luca; Accotto, Gian Paolo			Transcriptomics of the Interaction between the Monopartite Phloem-Limited Geminivirus Tomato Yellow Leaf Curl Sardinia Virus and Solanum lycopersicum Highlights a Role for Plant Hormones, Autophagy and Plant Immune System Fine Tuning during Infection	PLOS ONE			English	Article							MOSAIC-VIRUS; DIFFERENTIAL EXPRESSION; CELL-CYCLE; SMALL RNAS; MICRORNAS; DEFENSE; GENES; REPLICATION; METHYLATION; RESISTANCE	Tomato yellow leaf curl Sardinia virus (TYLCSV), a DNA virus belonging to the genus Begomovirus, causes severe losses in tomato crops. It infects only a limited number of cells in the vascular tissues, making difficult to detect changes in host gene expression linked to its presence. Here we present the first microarray study of transcriptional changes induced by the phloem-limited geminivirus TYLCSV infecting tomato, its natural host. The analysis was performed on the midrib of mature leaves, a material naturally enriched in vascular tissues. A total of 2206 genes were up-regulated and 1398 were down-regulated in infected plants, with an overrepresentation of genes involved in hormone metabolism and responses, nucleic acid metabolism, regulation of transcription, ubiquitin-proteasome pathway and autophagy among those up-regulated, and in primary and secondary metabolism, phosphorylation, transcription and methylation-dependent chromatin silencing among those down-regulated. Our analysis showed a series of responses, such as the induction of GA- and ABA-responsive genes, the activation of the autophagic process and the fine tuning of the plant immune system, observed only in TYLCSV-tomato compatible interaction so far. On the other hand, comparisons with transcriptional changes observed in other geminivirus-plant interactions highlighted common host responses consisting in the deregulation of biotic stress responsive genes, key enzymes in the ethylene biosynthesis and methylation cycle, components of the ubiquitin proteasome system and DNA polymerases II. The involvement of conserved miRNAs and of solanaceous-and tomato-specific miRNAs in geminivirus infection, investigated by integrating differential gene expression data with miRNA targeting data, is discussed.	[Miozzi, Laura; Napoli, Chiara; Sardo, Luca; Accotto, Gian Paolo] Natl Res Council CNR, Ist Virol Vegetale, Turin, Italy; [Sardo, Luca] NCI, Viral Recombinat Sect, HIV Drug Resistance Program, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Accotto, GP (corresponding author), Natl Res Council CNR, Ist Virol Vegetale, Turin, Italy.	g.accotto@ivv.cnr.it	Miozzi, Laura/AAW-9296-2021; Sardo, Luca/AAH-5478-2019; Accotto, Gian Paolo/B-8111-2015; Miozzi, Laura/AAY-2139-2020	Miozzi, Laura/0000-0003-0410-8230; Sardo, Luca/0000-0002-6491-5088; Accotto, Gian Paolo/0000-0002-3825-1097; Miozzi, Laura/0000-0003-0410-8230	CISIA Project (CNR, Italy); "GenoPom" Project (MIUR, Italy); Fondazione CRT-Progetto Lagrange (Torino, Italy)	CISIA Project (CNR, Italy); "GenoPom" Project (MIUR, Italy)(Ministry of Education, Universities and Research (MIUR)); Fondazione CRT-Progetto Lagrange (Torino, Italy)	This work was supported by the CISIA Project (CNR, Italy), the "GenoPom" Project (MIUR, Italy) to GPA and LM, and the Fondazione CRT-Progetto Lagrange (Torino, Italy) with a fellowship to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Amin I, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-143; Diaz-Pendon JA, 2010, MOL PLANT PATHOL, V11, P441, DOI [10.1111/j.1364-3703.2010.00618.x, 10.1111/J.1364-3703.2010.00618.X]; Arguello-Astorga G, 2004, J VIROL, V78, P4817, DOI 10.1128/JVI.78.9.4817-4826.2004; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barker CL, 2006, PLANT J, V46, P369, DOI 10.1111/j.1365-313X.2006.02698.x; Bluthgen N, 2005, NUCLEIC ACIDS RES, V33, P272, DOI 10.1093/nar/gki167; Brommonschenkel SH, 2000, MOL PLANT MICROBE IN, V13, P1130, DOI 10.1094/MPMI.2000.13.10.1130; BROUGH CL, 1992, PLANT MOL BIOL, V18, P703, DOI 10.1007/BF00020012; Brown JK, 2012, VIRUS TAXONOMY, P351; Buchmann RC, 2009, J VIROL, V83, P5005, DOI 10.1128/JVI.01771-08; Buxdorf K, 2010, PLANTA, V232, P1009, DOI 10.1007/s00425-010-1231-9; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Chen L, 2012, PLANT SCI, V184, P14, DOI 10.1016/j.plantsci.2011.11.007; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Cho HJ, 2012, FEBS LETT, V586, P2332, DOI 10.1016/j.febslet.2012.05.035; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; Derksen H, 2013, PLANT SCI, V207, P79, DOI 10.1016/j.plantsci.2013.03.004; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; ERMAK G, 1993, NUCLEIC ACIDS RES, V21, P3445, DOI 10.1093/nar/21.15.3445; Fondong VN, 2013, MOL PLANT PATHOL, V14, P635, DOI 10.1111/mpp.12032; FRASER RSS, 1982, J GEN VIROL, V58, P305, DOI 10.1099/0022-1317-58-2-305; Gandia M, 2007, VIROLOGY, V367, P298, DOI 10.1016/j.virol.2007.05.025; Golldack D, 2013, PLANT J, V49, P683; Gongora-Castillo E, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-295; Gronenborn Bruno, 2007, P67, DOI 10.1007/978-1-4020-4769-5_5; Gutierrez C, 2004, VET MICROBIOL, V98, P111, DOI 10.1016/j.vetmic.2003.10.012; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Hayward AP, 2011, ANNU REV PHYTOPATHOL, V49, P557, DOI 10.1146/annurev-phyto-072910-095333; Hou XL, 2013, PLANT CELL REP, V32, P1067, DOI 10.1007/s00299-013-1423-4; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KHEYRPOUR A, 1991, NUCLEIC ACIDS RES, V19, P6763, DOI 10.1093/nar/19.24.6763; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Krochko JE, 1998, PLANT PHYSIOL, V118, P849, DOI 10.1104/pp.118.3.849; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Li FQ, 2012, TRENDS PLANT SCI, V17, P526, DOI 10.1016/j.tplants.2012.05.006; Li F, 2012, PLANT J, V70, P891, DOI 10.1111/j.1365-313X.2012.04922.x; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lozano-Duran R, 2011, PLANT CELL, V23, P1014, DOI 10.1105/tpc.110.080267; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Miozzi L, 2011, MOL PLANT MICROBE IN, V24, P1562, DOI 10.1094/MPMI-05-11-0116; Moffatt BA, 2002, PLANT PHYSIOL, V128, P812, DOI 10.1104/pp.010880; Morilla G, 2004, J VIROL, V78, P10715, DOI [10.1128/JVI.78.19.10715-10723.2004, 10.1128/jvi.78.19.10715-10723.2004]; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Naqvi AR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-281; Naqvi AR, 2011, VIRUS RES, V160, P395, DOI 10.1016/j.virusres.2011.05.002; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020054; Parniske M, 1999, P NATL ACAD SCI USA, V96, P5850, DOI 10.1073/pnas.96.10.5850; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Pierce EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067534; Postnikova OA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-101; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Sanchez-Hernandez C, 2006, PLANT CELL ENVIRON, V29, P546, DOI 10.1111/j.1365-3040.2005.01431.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sponsel VM, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P63; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Szittya G, 2013, CURR TOP MICROBIOL, V371, P153, DOI 10.1007/978-3-642-37765-5_6; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wang H, 2005, J VIROL, V79, P7410, DOI 10.1128/JVI.79.12.7410-7418.2005; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; WHENHAM RJ, 1986, PLANTA, V168, P592, DOI 10.1007/BF00392281; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7; Zvereva AS, 2012, VIRUSES-BASEL, V4, P2578, DOI 10.3390/v4112578	83	55	56	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89951	10.1371/journal.pone.0089951	http://dx.doi.org/10.1371/journal.pone.0089951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587146	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200099
J	Vijver, MG; van den Brink, PJ				Vijver, Martina G.; van den Brink, Paul J.			Macro-Invertebrate Decline in Surface Water Polluted with Imidacloprid: A Rebuttal and Some New Analyses	PLOS ONE			English	Article							COMMUNITIES	Imidacloprid, the largest selling insecticide in the world, has received particular attention from scientists, policymakers and industries due to its potential toxicity to bees and aquatic organisms. The decline of aquatic macro-invertebrates due to imidacloprid concentrations in the Dutch surface waters was hypothesised in a recent paper by Van Dijk, Van Staalduinen and Van der Sluijs (PLOS ONE, May 2013). Although we do not disagree with imidacloprid's inherent toxicity to aquatic organisms, we have fundamental concerns regarding the way the data were analysed and interpreted. Here, we demonstrate that the underlying toxicity of imidacloprid in the field situation cannot be understood except in the context of other co-occurring pesticides. Although we agree with Van Dijk and co-workers that effects of imidacloprid can emerge between 13 and 67 ng/L we use a different line of evidence. We present an alternative approach to link imidacloprid concentrations and biological data. We analysed the national set of chemical monitoring data of the year 2009 to estimate the relative contribution of imidacloprid compared to other pesticides in relation to environmental quality target and chronic ecotoxicity threshold exceedances. Moreover, we assessed the relative impact of imidacloprid on the pesticide-induced potential affected fractions of the aquatic communities. We conclude that by choosing to test a starting hypothesis using insufficient data on chemistry and biology that are difficult to link, and by ignoring potential collinear effects of other pesticides present in Dutch surface waters Van Dijk and co-workers do not provide direct evidence that reduced taxon richness and abundance of macroinvertebrates can be attributed to the presence of imidacloprid only. Using a different line of evidence we expect ecological effects of imidacloprid at some of the exposure profiles measured in 2009 in the surface waters of the Netherlands.	[Vijver, Martina G.] Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands; [van den Brink, Paul J.] Univ Wageningen & Res Ctr, Alterra, Wageningen, Netherlands; [van den Brink, Paul J.] Wageningen Univ, Univ Wageningen & Res Ctr, NL-6700 AP Wageningen, Netherlands	Leiden University; Leiden University - Excl LUMC; Wageningen University & Research; Wageningen University & Research	Vijver, MG (corresponding author), Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands.	vijver@cml.leidenuniv.nl	van den Brink, Paul J/E-8315-2013; van den brink, Paul/AAT-7144-2020	van den brink, Paul/0000-0002-7241-4347; Vijver, Martina/0000-0003-2999-1605				De Snoo G. R., 2012, BESTRIJDINGSMIDDELEN; de Zwart D, 2005, INTEGR ENVIRON ASSES, V1, P123, DOI 10.1897/IEAM_2004-015.1; HEWLETT PS, 1959, BIOMETRICS, V15, P591, DOI 10.2307/2527657; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; McDonald-Gibson C., 2013, INDEPENDENT; Mineau P., 2013, AM BIRD CONSERV; Posthuma L., 2002, SPECIES SENSITIVITY; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Van Vliet J, 2013, 8252013 CLM; VANWIJNGAARDEN RPA, 1995, ECOTOXICOLOGY, V4, P61, DOI 10.1007/BF00350650; Vijver MG, 2008, J ENVIRON SCI HEAL B, V43, P665, DOI 10.1080/03601230802388728; Vijver MG, 2012, IMPACT PESTICIDES; Yamamoto Izuru, 1999, NICOTINOID INSECTICI, P3, DOI DOI 10.1007/978-4-431-67933-2_1; Zafar MI, 2012, ECOTOXICOLOGY, V21, P1024, DOI 10.1007/s10646-012-0856-9	16	49	51	4	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89837	10.1371/journal.pone.0089837	http://dx.doi.org/10.1371/journal.pone.0089837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587069	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200086
J	Zeng, YB; Li, DZ; Wang, W; Su, MK; Lin, JP; Chen, HJ; Jiang, L; Chen, J; Yang, B; Ou, QS				Zeng, Yongbin; Li, Dezhong; Wang, Wei; Su, Mingkuan; Lin, Jinpiao; Chen, Huijuan; Jiang, Ling; Chen, Jing; Yang, Bin; Ou, Qishui			Establishment of Real Time Allele Specific Locked Nucleic Acid Quantitative PCR for Detection of HBV YIDD (ATT) Mutation and Evaluation of Its Application	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; LAMIVUDINE; QUANTIFICATION; RESISTANCE; VARIANTS; ADEFOVIR; POLYMERASE; MANAGEMENT; INFECTION; MUTANTS	Background: Long-term use of nucleos(t)ide analogues can increase risk of HBV drug-resistance mutations. The rtM204I (ATT coding for isoleucine) is one of the most important resistance mutation sites. Establishing a simple, rapid, reliable and highly sensitive assay to detect the resistant mutants as early as possible is of great clinical significance. Methods: Recombinant plasmids for HBV YMDD (tyrosine-methionine-aspartate-aspartate) and YIDD (tyrosine-isoleucine-aspartate-aspartate) were constructed by TA cloning. Real time allele specific locked nucleic acid quantitative PCR (RT-AS-LNA-qPCR) with SYBR Green I was established by LNA-modified primers and evaluated with standard recombinant plasmids, clinical templates (the clinical wild type and mutant HBV DNA mixture) and 102 serum samples from nucleos(t) ide analogues-experienced patients. The serum samples from a chronic hepatitis B (CHB) patient firstly received LMV mono therapy and then switched to LMV + ADV combined therapy were also dynamically analyzed for 10 times. Results: The linear range of the assay was between 1x10(9) copies/mu l and 1x10(2) copies/mu l. The low detection limit was 1x10(1) copies/mu l. Sensitivity of the assay were 10(-6), 10(-4) and 10(-2) in the wild-type background of 1x10(9) copies/mu l, 1x10(7) copies/ml and 1x10(5) copies/mu l, respectively. The sensitivity of the assay in detection of clinical samples was 0.03%. The complete coincidence rate between RT-AS-LNA-qPCR and direct sequencing was 91.2% (93/102), partial coincidence rate was 8.8% (9/102), and no complete discordance was observed. The two assays showed a high concordance (Kappa = 0.676, P = 0.000). Minor variants can be detected 18 weeks earlier than the rebound of HBV DNA load and alanine aminotransferase level. Conclusions: A rapid, cost-effective, high sensitive, specific and reliable method of RT-AS-LNA-qPCR with SYBR Green I for early and absolute quantification of HBV YIDD (ATT coding for isoleucine) variants was established, which can provide valuable information for clinical antiretroviral regimens.	[Zeng, Yongbin; Wang, Wei; Su, Mingkuan; Lin, Jinpiao; Chen, Huijuan; Jiang, Ling; Chen, Jing; Yang, Bin; Ou, Qishui] Fujian Med Univ, Clin Coll 1, Fuzhou, Peoples R China; [Zeng, Yongbin; Wang, Wei; Su, Mingkuan; Lin, Jinpiao; Chen, Huijuan; Jiang, Ling; Yang, Bin; Ou, Qishui] Fujian Med Univ, Affiliated Hosp 1, Dept Lab Med, Fuzhou, Peoples R China; [Li, Dezhong] Armed Police Hosp Fujian, Dept Lab Med, Fuzhou, Peoples R China; [Chen, Jing] Fujian Med Univ, Affiliated Hosp 1, Ctr Liver Dis, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University	Ou, QS (corresponding author), Fujian Med Univ, Clin Coll 1, Fuzhou, Peoples R China.	ouqishui@163.com			Key Project of Industry-university Cooperation of Fujian province [2013Y4002]; Social Key Project of Fujian Technology Department [2011Y0023]; National Natural Science Foundation of China [81371888]	Key Project of Industry-university Cooperation of Fujian province; Social Key Project of Fujian Technology Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the grants from Key Project of Industry-university Cooperation of Fujian province (2013Y4002), Social Key Project of Fujian Technology Department (2011Y0023; http://www.fjkjt.gov.cn/) and National Natural Science Foundation of China (81371888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2013, J VIROL METHODS, V190, P34, DOI 10.1016/j.jviromet.2013.02.009; Chevaliez S, 2012, GASTROENTEROLOGY, V142, P1303, DOI 10.1053/j.gastro.2012.02.027; Degertekin B, 2009, J HEPATOL, V50, P42, DOI 10.1016/j.jhep.2008.08.020; Di Giusto DA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh036; Fang J, 2009, ANTIMICROB AGENTS CH, V53, P2762, DOI 10.1128/AAC.00130-09; Hong SP, 2004, J HEPATOL, V40, P837, DOI 10.1016/j.jhep.2004.01.006; Kim SS, 2013, J MED VIROL, V85, P55, DOI 10.1002/jmv.23440; Kirishima T, 2002, J HEPATOL, V37, P259, DOI 10.1016/S0168-8278(02)00145-9; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Liu HY, 2011, J VIROL METHODS, V175, P1, DOI 10.1016/j.jviromet.2011.04.005; Lupo J, 2009, J VIROL METHODS, V156, P52, DOI 10.1016/j.jviromet.2008.10.028; Morandi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036084; Ntziora F, 2009, J CLIN MICROBIOL, V47, P2544, DOI 10.1128/JCM.00045-09; Pallier C, 2006, J VIROL, V80, P643, DOI 10.1128/JVI.80.2.643-653.2006; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Punia P, 2004, J HEPATOL, V40, P986, DOI [10.1016/j.jhep.2004.02.009, 10.1016/S0168-8278(04)00062-5]; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Strand H, 2008, CLIN CHIM ACTA, V390, P126, DOI 10.1016/j.cca.2008.01.010; [孙余婕 SUN Yujie], 2007, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V30, P533; Umeoka F, 2006, J GASTROENTEROL, V41, P693, DOI 10.1007/s00535-006-1834-x; Wightman F, 2004, J CLIN MICROBIOL, V42, P3809, DOI 10.1128/JCM.42.8.3809-3812.2004	22	6	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90029	10.1371/journal.pone.0090029	http://dx.doi.org/10.1371/journal.pone.0090029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587198	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200116
J	DeFraine, WC; Williams, WM; Ceci, SJ				DeFraine, William C.; Williams, Wendy M.; Ceci, Stephen J.			Attracting STEM Talent: Do STEM Students Prefer Traditional or Work/Life-Interaction Labs?	PLOS ONE			English	Article								The demand for employees trained in science, technology, engineering, and mathematics (STEM) fields continues to increase, yet the number of Millennial students pursuing STEM is not keeping pace. We evaluated whether this shortfall is associated with Millennials' preference for flexibility and work/life-interaction in their careers-a preference that may be inconsistent with the traditional idea of a science career endorsed by many lab directors. Two contrasting approaches to running STEM labs and training students were explored, and we created a lab recruitment video depicting each. The work-focused video emphasized the traditional notions of a science lab, characterized by long work hours and a focus on individual achievement and conducting research above all else. In contrast, the work/life-interaction-focused video emphasized a more progressive view - lack of demarcation between work and non-work lives, flexible hours, and group achievement. In Study 1, 40 professors rated the videos, and the results confirmed that the two lab types reflected meaningful real-world differences in training approaches. In Study 2, we recruited 53 current and prospective graduate students in STEM fields who displayed high math-identification and a commitment to science careers. In a between-subjects design, they watched one of the two lab-recruitment videos, and then reported their anticipated sense of belonging to and desire to participate in the lab depicted in the video. Very large effects were observed on both primary measures: Participants who watched the work/life-interaction-focused video reported a greater sense of belonging to (d = 1.49) and desire to participate in (d = 1.33) the lab, relative to participants who watched the work-focused video. These results suggest Millennials possess a strong desire for work/life-interaction, which runs counter to the traditional lab-training model endorsed by many lab directors. We discuss implications of these findings for STEM recruitment.	[DeFraine, William C.; Williams, Wendy M.; Ceci, Stephen J.] Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA	Cornell University	DeFraine, WC (corresponding author), Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA.	wcd42@cornell.edu			National Institutes of Health [1 R01 NS069792-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a grant to the second author from the National Institutes of Health, 1 R01 NS069792-01. Data are archived and available at ciws.cornell.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CLASS DEGR FIELD OCC; Atkinson RD, 2012, ISSUES SCI TECHNOL, V28, P29; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Committee on STEM Workforce Needs for the U.S. Department of Defense and the U.S. Defense Industrial Base, 2012, ASS US DEP DEF STRON; Darley JM, 2003, COMPLEAT ACAD; Deal JJ, 2010, J BUS PSYCHOL, V25, P191, DOI 10.1007/s10869-010-9177-2; Galinsky E., 2009, TIMES CHANGING GENDE; Halpern DF, 2005, FROM WORK-FAMILY BALANCE TO WORK-FAMILY INTERACTION: CHANGING THE METAPHOR, P3; Halpern DF, 2005, STRESS HEALTH, V21, P157, DOI 10.1002/smi.1049; Howell LP, 2012, AM J MED, V125, P719, DOI 10.1016/j.amjmed.2012.03.013; Mason Mary Ann, 2009, ACADEME, P11; Miller C. C., 2011, NY TIMES; Murphy MC, 2007, PSYCHOL SCI, V18, P879, DOI 10.1111/j.1467-9280.2007.01995.x; Sommers CH, 2008, AMERICAN, V2; Twenge JM, 2010, J BUS PSYCHOL, V25, P201, DOI 10.1007/s10869-010-9165-6; Williams WM, 2012, AM SCI, V100, P138	16	2	2	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89801	10.1371/journal.pone.0089801	http://dx.doi.org/10.1371/journal.pone.0089801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24587044	Green Submitted, gold, Green Published			2022-12-27	WOS:000332390800041
J	Kaiser, T; Kinny-Koster, B; Bartels, M; Parthaune, T; Schmidt, M; Thiery, J				Kaiser, Thorsten; Kinny-Koester, Benedict; Bartels, Michael; Parthaune, Tanja; Schmidt, Michael; Thiery, Joachim			Impact of Different Creatinine Measurement Methods on Liver Transplant Allocation	PLOS ONE			English	Article							DISEASE MELD; CLINICAL-CHEMISTRY; MODEL; END; SURVIVAL; SCORES; ASSAYS	Introduction: The model for end-stage liver disease (MELD) score is used in many countries to prioritize organ allocation for the majority of patients who require orthotopic liver transplantation. This score is calculated based on the following laboratory parameters: creatinine, bilirubin and the international normalized ratio (INR). Consequently, high measurement accuracy is essential for equitable and fair organ allocation. For serum creatinine measurements, the Jaffe method and enzymatic detection are well-established routine diagnostic tests. Methods: A total of 1,013 samples from 445 patients on the waiting list or in evaluation for liver transplantation were measured using both creatinine methods from November 2012 to September 2013 at the university hospital Leipzig, Germany. The measurements were performed in parallel according to the manufacturer's instructions after the samples arrived at the institute of laboratory medicine. Patients who had required renal replacement therapy twice in the previous week were excluded from analyses. Results: Despite the good correlation between the results of both creatinine quantification methods, relevant differences were observed, which led to different MELD scores. The Jaffe measurement led to greater MELD score in 163/1,013 (16.1%) samples with differences of up to 4 points in one patient, whereas differences of up to 2 points were identified in 15/1,013 (1.5%) samples using the enzymatic assay. Overall, 50/152 (32.9%) patients with MELD scores >20 had higher scores when the Jaffe method was used. Discussion: Using the Jaffe method to measure creatinine levels in samples from patients who require liver transplantation may lead to a systematic preference in organ allocation. In this study, the differences were particularly pronounced in samples with MELD scores >20, which has clinical relevance in the context of urgency of transplantation. These data suggest that official recommendations are needed to determine which laboratory diagnostic methods should be used when calculating MELD scores.	[Kaiser, Thorsten; Kinny-Koester, Benedict; Parthaune, Tanja; Thiery, Joachim] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Bartels, Michael] Univ Hosp Leipzig, Dept Visceral Vasc Thorac & Transplant Surg, Leipzig, Germany; [Schmidt, Michael] Reference Inst Bioanalyt, Bonn, Germany	Leipzig University; Leipzig University	Kaiser, T (corresponding author), Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany.	thorsten.kaiser@medizin.uni-leipzig.de			University Hospital Leipzig	University Hospital Leipzig	No funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current funding sources for this study were used. Evaluation of the creatinin assays was nessasary for clinical routine diagnostics and was therefore paid by the University Hospital Leipzig.	Asrani SK, 2011, CLIN LIVER DIS, V15, P685, DOI 10.1016/j.cld.2011.08.009; Badiou S, 2003, J CLIN LAB ANAL, V17, P235, DOI 10.1002/jcla.10103; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOWERS LD, 1980, CLIN CHEM, V26, P555; Breuer J, 1996, EUR J CLIN CHEM CLIN, V34, P385; Cholongitas E, 2007, LIVER TRANSPLANT, V13, P523, DOI 10.1002/lt.20994; Cholongitas E, 2010, NAT REV GASTRO HEPAT, V7, P659, DOI 10.1038/nrgastro.2010.169; German Medical Association, 2013, DTSCH ARZTEBL, V110; GLICK MR, 1986, CLIN CHEM, V32, P470; Greenberg N, 2012, CLIN CHEM, V58, P391, DOI 10.1373/clinchem.2011.172288; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kuster N, 2012, CLIN BIOCHEM, V45, P320, DOI 10.1016/j.clinbiochem.2011.11.008; Londono MC, 2007, GUT, V56, P1283, DOI 10.1136/gut.2006.102764; Mazzachi BC, 1998, CLIN BIOCHEM REV, V19, P82; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Schouten JN, 2012, CLIN TRANSPLANT, V26, pE62, DOI 10.1111/j.1399-0012.2011.01538.x; Sonntag O, 2001, ANN CLIN BIOCHEM, V38, P376, DOI 10.1258/0004563011900696; Trotter JF, 2007, AM J TRANSPLANT, V7, P1624, DOI 10.1111/j.1600-6143.2007.01822.x; Trotter JE, 2004, LIVER TRANSPLANT, V10, P995, DOI 10.1002/lt.20195; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879	21	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90015	10.1371/journal.pone.0090015	http://dx.doi.org/10.1371/journal.pone.0090015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587188	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800066
J	Galuschka, K; Ise, E; Krick, K; Schulte-Korne, G				Galuschka, Katharina; Ise, Elena; Krick, Kathrin; Schulte-Koerne, Gerd			Effectiveness of Treatment Approaches for Children and Adolescents with Reading Disabilities: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PUBLICATION BIAS; COLORED FILTERS; DEVELOPMENTAL DYSLEXIA; LEARNING-DISABILITIES; STRUGGLING READERS; PHONEMIC AWARENESS; DISABLED-CHILDREN; IRLEN-SYNDROME; INTERVENTIONS; INSTRUCTION	Children and adolescents with reading disabilities experience a significant impairment in the acquisition of reading and spelling skills. Given the emotional and academic consequences for children with persistent reading disorders, evidence-based interventions are critically needed. The present meta-analysis extracts the results of all available randomized controlled trials. The aims were to determine the effectiveness of different treatment approaches and the impact of various factors on the efficacy of interventions. The literature search for published randomized-controlled trials comprised an electronic search in the databases ERIC, PsycINFO, PubMed, and Cochrane, and an examination of bibliographical references. To check for unpublished trials, we searched the websites clinicaltrials.com and ProQuest, and contacted experts in the field. Twenty-two randomized controlled trials with a total of 49 comparisons of experimental and control groups could be included. The comparisons evaluated five reading fluency trainings, three phonemic awareness instructions, three reading comprehension trainings, 29 phonics instructions, three auditory trainings, two medical treatments, and four interventions with coloured overlays or lenses. One trial evaluated the effectiveness of sunflower therapy and another investigated the effectiveness of motor exercises. The results revealed that phonics instruction is not only the most frequently investigated treatment approach, but also the only approach whose efficacy on reading and spelling performance in children and adolescents with reading disabilities is statistically confirmed. The mean effect sizes of the remaining treatment approaches did not reach statistical significance. The present meta-analysis demonstrates that severe reading and spelling difficulties can be ameliorated with appropriate treatment. In order to be better able to provide evidence-based interventions to children and adolescent with reading disabilities, research should intensify the application of blinded randomized controlled trials.	[Galuschka, Katharina; Krick, Kathrin; Schulte-Koerne, Gerd] Univ Munich, Dept Child & Adolescent Psychiat & Psychotherapy, Munich, Germany; [Ise, Elena] Univ Cologne, Dept Child & Adolescent Psychiat & Psychotherapy, D-50931 Cologne, Germany	University of Munich; University of Cologne	Schulte-Korne, G (corresponding author), Univ Munich, Dept Child & Adolescent Psychiat & Psychotherapy, Munich, Germany.	Gerd.Schulte-Koerne@med.uni-muenchen.de	von Wirth, Elena/AAG-1372-2020; Schulte-Körne, Gerd/AAI-4828-2021	von Wirth, Elena/0000-0003-2461-4966; Schulte-Körne, Gerd/0000-0002-9960-1572	Bundesverband fur Legasthenie und Dyskalkulie e.V. (BVL); Deutsche Gesellschaft fur Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP)	Bundesverband fur Legasthenie und Dyskalkulie e.V. (BVL); Deutsche Gesellschaft fur Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP)	This research was supported by grants from the Bundesverband fur Legasthenie und Dyskalkulie e.V. (BVL) and Deutsche Gesellschaft fur Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Berwanger D, 2004, Z KINDER JUG-PSYCH, V32, P77, DOI 10.1024/1422-4917.32.2.77; Bhattacharya A, 2004, J LEARN DISABIL-US, V37, P331, DOI 10.1177/00222194040370040501; Borenstein M., 2005, COMPREHENSIVE META A; Bull Leona, 2007, Complement Ther Clin Pract, V13, P15, DOI 10.1016/j.ctcp.2006.07.003; Bus AG, 1999, J EDUC PSYCHOL, V91, P403, DOI 10.1037/0022-0663.91.3.403; Carroll JM, 2005, J CHILD PSYCHOL PSYC, V46, P524, DOI 10.1111/j.1469-7610.2004.00366.x; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; DIIANNI M, 1985, J CLIN PSYCHOPHARM, V5, P272, DOI 10.1097/00004714-198510000-00004; Dohnert M, 2003, Z KINDER JUG-PSYCH, V31, P305, DOI 10.1024/1422-4917.31.4.305; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ehri LC, 2001, REV EDUC RES, V71, P393, DOI 10.3102/00346543071003393; Ehri LC, 2001, READ RES QUART, V36, P250, DOI 10.1598/RRQ.36.3.2; Elbaum B, 2000, J EDUC PSYCHOL, V92, P605, DOI 10.1037/0022-0663.92.4.605; Erickson K, 2010, AUGMENT ALTERN COMM, V26, P177, DOI 10.3109/07434618.2010.505606; EVANS BJW, 1991, OPHTHAL PHYSL OPT, V11, P206, DOI 10.1016/0275-5408(91)90092-W; Gonzalez MDO, 2002, J LEARN DISABIL-US, V35, P334, DOI 10.1177/00222194020350040401; Goodwin AP, 2010, ANN DYSLEXIA, V60, P183, DOI 10.1007/s11881-010-0041-x; Goswami U, 2011, DEVELOPMENTAL SCI, V14, P34, DOI 10.1111/j.1467-7687.2010.00955.x; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Heikkila R, 2013, SCI STUD READ, V17, P398, DOI 10.1080/10888438.2012.753452; Ise E, 2012, KINDH ENTWICKL, V21, P122, DOI 10.1026/0942-5403/a000077; Jimenez JE, 2007, SPAN J PSYCHOL, V10, P52, DOI 10.1017/S1138741600006314; Kirk C, 2009, LANG SPEECH HEAR SER, V40, P341, DOI 10.1044/0161-1461(2008/08-0009); Landerl K, 2013, J CHILD PSYCHOL PSYC, V54, P686, DOI 10.1111/jcpp.12029; Loo JHY, 2010, DEV MED CHILD NEUROL, V52, P708, DOI 10.1111/j.1469-8749.2010.03654.x; Lovett MW, 1996, BRAIN LANG, V54, P447, DOI 10.1006/brln.1996.0085; LOVETT MW, 1990, J EDUC PSYCHOL, V82, P769, DOI 10.1037/0022-0663.82.4.769; LOVETT MW, 1989, BRAIN LANG, V37, P90, DOI 10.1016/0093-934X(89)90103-X; Lovett MW, 2000, J EDUC PSYCHOL, V92, P263, DOI 10.1037/0022-0663.92.2.263; Lovett MW, 1997, LEARN DISABILITY Q, V20, P189, DOI 10.2307/1511308; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; McArthur G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009115.pub2; McPhillips M, 2000, LANCET, V355, P537, DOI 10.1016/S0140-6736(99)02179-0; Mitchell C, 2008, PERCEPT MOTOR SKILL, V106, P517, DOI 10.2466/PMS.106.2.517-532; Murphy CFB, 2011, FOLIA PHONIATR LOGO, V63, P147, DOI 10.1159/000316327; National Institute of Child Health and Human Development, 2000, NIH PUBL; O'Shaughnessy TE, 2000, J LEARN DISABIL-US, V33, P257, DOI 10.1177/002221940003300304; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Robinson GL, 1999, PERCEPT MOTOR SKILL, V88, P35, DOI 10.2466/PMS.88.1.35-52; Ryder JF, 2008, READ WRIT, V21, P349, DOI 10.1007/s11145-007-9080-z; SANCHEZ E, 1991, READ WRIT, V3, P11, DOI 10.1007/BF00554561; Scammacca N., 2007, INTERVENTIONS ADOLES; Scerri TS, 2010, EUR CHILD ADOLES PSY, V19, P179, DOI 10.1007/s00787-009-0081-0; Schulte-Korne G, 2010, CLIN NEUROPHYSIOL, V121, P1794, DOI 10.1016/j.clinph.2010.04.028; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Suggate SP, 2010, DEV PSYCHOL, V46, P1556, DOI 10.1037/a0020612; Swanson HL, 1999, J LEARN DISABIL-US, V32, P504, DOI 10.1177/002221949903200605; Swanson HL, 2001, ELEM SCHOOL J, V101, P331, DOI 10.1086/499671; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Tormanen MRK, 2009, SCAND J PSYCHOL, V50, P277, DOI 10.1111/j.1467-9450.2009.00708.x; Tressoldi PE, 2000, J LEARN DISABIL-US, V33, P278, DOI 10.1177/002221940003300305; Wanzek J, 2013, REV EDUC RES, V83, P163, DOI 10.3102/0034654313477212; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368; Wilsher Colin R, 1994, Eur Child Adolesc Psychiatry, V3, P59, DOI 10.1007/BF01977668; WILSHER CR, 1987, J CLIN PSYCHOPHARM, V7, P230; Ziegler JC, 2010, DEVELOPMENTAL SCI, V13, pF8, DOI 10.1111/j.1467-7687.2010.00983.x; Ziegler JC, 2010, PSYCHOL SCI, V21, P551, DOI 10.1177/0956797610363406	60	156	156	4	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89900	10.1371/journal.pone.0089900	http://dx.doi.org/10.1371/journal.pone.0089900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24587110	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000107
J	Ingley, SJ; Billman, EJ; Belk, MC; Johnson, JB				Ingley, Spencer J.; Billman, Eric J.; Belk, Mark C.; Johnson, Jerald B.			Morphological Divergence Driven by Predation Environment within and between Species of Brachyrhaphis Fishes	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; GUPPIES POECILIA-RETICULATA; ECOLOGICAL SPECIATION; EPISCOPI POECILIIDAE; SWIMMING PERFORMANCE; NATURAL-POPULATIONS; MITOCHONDRIAL-DNA; UNIQUE FEATURES; GENETIC-BASIS; BODY-SIZE	Natural selection often results in profound differences in body shape among populations from divergent selective environments. Predation is a well-studied driver of divergence, with predators having a strong effect on the evolution of prey body shape, especially for traits related to escape behavior. Comparative studies, both at the population level and between species, show that the presence or absence of predators can alter prey morphology. Although this pattern is well documented in various species or population pairs, few studies have tested for similar patterns of body shape evolution at multiple stages of divergence within a taxonomic group. Here, we examine morphological divergence associated with predation environment in the livebearing fish genus Brachyrhaphis. We compare differences in body shape between populations of B. rhabdophora from different predation environments to differences in body shape between B. roseni and B. terrabensis (sister species) from predator and predator free habitats, respectively. We found that in each lineage, shape differed between predation environments, consistent with the hypothesis that locomotor function is optimized for either steady swimming (predator free) or escape behavior (predator). Although differences in body shape were greatest between B. roseni and B. terrabensis, we found that much of the total morphological diversification between these species had already been achieved within B. rhabdophora (29% in females and 47% in males). Interestingly, at both levels of divergence we found that early in ontogenetic development, females differed in shape between predation environments; however, as females matured, their body shapes converged on a similar phenotype, likely due to the constraints of pregnancy. Finally, we found that body shape varies with body size in a similar way, regardless of predation environment, in each lineage. Our findings are important because they provide evidence that the same source of selection can drive similar phenotypic divergence independently at multiple divergence levels.	[Ingley, Spencer J.; Billman, Eric J.; Belk, Mark C.; Johnson, Jerald B.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Johnson, Jerald B.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Ingley, SJ (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	sjingley@byu.edu	Johnson, Jerald/AAN-5574-2020	Billman, Eric/0000-0001-6013-7867; Ingley, Spencer/0000-0002-2414-9892	U.S. National Science Foundation PIRE program [OISE 0539267]; Monte L. Bean Life Science Museum at Brigham Young University	U.S. National Science Foundation PIRE program(National Science Foundation (NSF)); Monte L. Bean Life Science Museum at Brigham Young University	This work was funded by a grant to Jerald B. Johnson from the U.S. National Science Foundation PIRE program (OISE 0539267) and museum collecting funds from the Monte L. Bean Life Science Museum at Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2007, EVOLUTION, V61, P510, DOI 10.1111/j.1558-5646.2007.00063.x; Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; Archard GA, 2011, J FISH BIOL, V78, P593, DOI 10.1111/j.1095-8649.2010.02880.x; Arendt JD, 2005, P ROY SOC B-BIOL SCI, V272, P333, DOI 10.1098/rspb.2004.2899; Barros M, 2008, REV NEUROSCIENCE, V19, P157; Basolo AL, 2004, ANIM BEHAV, V68, P75, DOI 10.1016/j.anbehav.2003.07.019; Berner D, 2010, MOL ECOL, V19, P4963, DOI 10.1111/j.1365-294X.2010.04858.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Biro PA, 2009, HYDROBIOLOGIA, V635, P395, DOI 10.1007/s10750-009-9902-x; BISAZZA A, 1993, MAR BEHAV PHYSIOL, V23, P257, DOI 10.1080/10236249309378869; Blake RW, 2006, J FISH BIOL, V69, P1824, DOI 10.1111/j.1095-8649.2006.01251.x; Blake R.W., 1983, FISH LOCOMOTION; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; Brown C, 2007, J FISH BIOL, V71, P1590, DOI 10.1111/j.1095-8649.2007.01627.x; Brown C, 2005, BEHAV ECOL, V16, P482, DOI 10.1093/beheco/ari016; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burns JG, 2009, J FISH BIOL, V75, P1144, DOI 10.1111/j.1095-8649.2009.02314.x; Bussing WA, 1998, PECES AGUAS CONTINEN; Butler D, 2007, FISHERIES; Collyer ML, 2007, ECOLOGY, V88, P683, DOI 10.1890/06-0727; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C., 1859, ORIGINS SPECIES MEAN; DODSON S, 1989, BIOSCIENCE, V39, P447, DOI 10.2307/1311136; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; ENDLER JA, 1987, ANIM BEHAV, V35, P1376, DOI 10.1016/S0003-3472(87)80010-6; Garza-Mourino G, 2005, HYDROBIOLOGIA, V546, P169, DOI 10.1007/s10750-005-4114-5; Ge DY, 2011, P ROY SOC B-BIOL SCI, V278, P2133, DOI 10.1098/rspb.2010.1500; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; GODIN JGJ, 1995, OECOLOGIA, V103, P224, DOI 10.1007/BF00329084; Hendry AP, 2009, J FISH BIOL, V75, P2000, DOI 10.1111/j.1095-8649.2009.02419.x; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Hossie TJ, 2010, ECOSCIENCE, V17, P100, DOI 10.2980/17-1-3312; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Husak JF, 2006, HERPETOLOGICA, V62, P156, DOI 10.1655/05-62.1; Jennions MD, 2002, OECOLOGIA, V132, P44, DOI 10.1007/s00442-002-0942-4; Jennions MD, 2002, OIKOS, V97, P79, DOI 10.1034/j.1600-0706.2002.970108.x; Jennions MD, 2006, ENVIRON BIOL FISH, V76, P211, DOI 10.1007/s10641-006-9022-7; Johnson JB, 2002, OIKOS, V96, P82, DOI 10.1034/j.1600-0706.2002.960109.x; Johnson JB, 2001, BIOL J LINN SOC, V72, P519, DOI 10.1006/bijl.2000.0513; Johnson JB, 2001, EVOLUTION, V55, P1486; Johnson JB, 2001, OECOLOGIA, V126, P142, DOI 10.1007/s004420000504; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Johnson JB, 2011, ECOLOGY EVOLUTION PO; Johnson JB, 2009, ECOLOGY, V90, P2243, DOI 10.1890/07-1672.1; Jones CP, 2009, MOL ECOL, V18, P1640, DOI 10.1111/j.1365-294X.2009.04129.x; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KORPIMAKI E, 1994, EVOL ECOL, V8, P357, DOI 10.1007/BF01238188; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P2231, DOI 10.1111/j.1420-9101.2009.01839.x; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Lee JB, 2009, MOL ECOL, V18, P4088, DOI 10.1111/j.1365-294X.2009.04339.x; Maddison W., 2018, MESQUITE MODULAR SYS; MAGURRAN AE, 1991, P ROY SOC B-BIOL SCI, V246, P31, DOI 10.1098/rspb.1991.0121; Magurran AE, 1990, RISK SENSITIVE COURT, P194; Mateos M, 2005, J BIOGEOGR, V32, P775, DOI 10.1111/j.1365-2699.2005.01236.x; Mikolajewski DJ, 2010, EVOLUTION, V64, P3327, DOI 10.1111/j.1558-5646.2010.01078.x; Mojica CL, 1997, COPEIA, P298, DOI 10.2307/1447750; Nosil P, 2007, GENETICA, V129, P309, DOI 10.1007/s10709-006-0013-6; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Nosil P, 2009, EVOLUTION, V63, P1902, DOI 10.1111/j.1558-5646.2009.00671.x; Plaut I, 2002, FUNCT ECOL, V16, P290, DOI 10.1046/j.1365-2435.2002.00638.x; Relyea RA, 2002, ECOLOGY, V83, P1953, DOI 10.2307/3071778; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; REZNICK DN, 1987, EVOLUTION, V41, P1370, DOI 10.1111/j.1558-5646.1987.tb02474.x; REZNICK DN, 1989, EVOLUTION, V43, P1285, DOI 10.1111/j.1558-5646.1989.tb02575.x; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RODD FH, 1991, OIKOS, V62, P13, DOI 10.2307/3545440; Rohlf F, 2011, TPSREGR MULTIVARIATE; Rohlf F. J., 2005, TPSDIG DIGITIZE LAND; Rohlf F. J., 2003, TPSRELW RELATIVE WAR; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; RYAN MJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P231; Schmidt TR, 1998, COPEIA, P14, DOI 10.2307/1447697; Scott LE, 2010, BIOL J LINN SOC, V100, P608, DOI 10.1111/j.1095-8312.2010.01452.x; Taborsky M, 1997, BEHAV ECOL SOCIOBIOL, V41, P361, DOI 10.1007/s002650050396; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Unmack PJ, 2009, BIOL J LINN SOC, V97, P876, DOI 10.1111/j.1095-8312.2009.01224.x; Urban MC, 2007, P NATL ACAD SCI USA, V104, P14377, DOI 10.1073/pnas.0704645104; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; WEBB PW, 1984, AM ZOOL, V24, P107; Wesner JS, 2011, BIOL J LINN SOC, V104, P386, DOI 10.1111/j.1095-8312.2011.01715.x; Wirsing AJ, 2003, EVOL ECOL RES, V5, P315; ZIMMERER EJ, 1989, EVOLUTION, V43, P1298, DOI 10.1111/j.1558-5646.1989.tb02576.x	91	40	43	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90274	10.1371/journal.pone.0090274	http://dx.doi.org/10.1371/journal.pone.0090274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587309	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000147
J	Poncet, N; Mitchell, FE; Ibrahim, AFM; McGuire, VA; English, G; Arthur, JSC; Shi, YB; Taylor, PM				Poncet, Nadege; Mitchell, Fiona E.; Ibrahim, Adel F. M.; McGuire, Victoria A.; English, Grant; Arthur, J. Simon C.; Shi, Yun-Bo; Taylor, Peter M.			The Catalytic Subunit of the System L1 Amino Acid Transporter (Slc7a5) Facilitates Nutrient Signalling in Mouse Skeletal Muscle	PLOS ONE			English	Article							PROTEIN; LEUCINE; ACTIVATION; IMPROVES; GLUCOSE; MTORC1; MICE; AVAILABILITY; DISRUPTION; EXPRESSION	The System L1-type amino acid transporter mediates transport of large neutral amino acids (LNAA) in many mammalian cell-types. LNAA such as leucine are required for full activation of the mTOR-S6K signalling pathway promoting protein synthesis and cell growth. The SLC7A5 (LAT1) catalytic subunit of high-affinity System L1 functions as a glycoprotein-associated heterodimer with the multifunctional protein SLC3A2 (CD98). We generated a floxed Slc7a5 mouse strain which, when crossed with mice expressing Cre driven by a global promoter, produced Slc7a5 heterozygous knockout (Slc7a5(+/-)) animals with no overt phenotype, although homozygous global knockout of Slc7a5 was embryonically lethal. Musclespecific (MCK Cre-mediated) Slc7a5 knockout (MS-Slc7a5-KO) mice were used to study the role of intracellular LNAA delivery by the SLC7A5 transporter for mTOR-S6K pathway activation in skeletal muscle. Activation of muscle mTOR-S6K (Thr389 phosphorylation) in vivo by intraperitoneal leucine injection was blunted in homozygous MS-Slc7a5-KO mice relative to wild-type animals. Dietary intake and growth rate were similar for MS-Slc7a5-KO mice and wild-type littermates fed for 10 weeks (to age 120 days) with diets containing 10%, 20% or 30% of protein. In MS-Slc7a5-KO mice, Leu and Ile concentrations in gastrocnemius muscle were reduced by similar to 40% as dietary protein content was reduced from 30 to 10%. These changes were associated with >50% decrease in S6K Thr389 phosphorylation in muscles from MS-Slc7a5-KO mice, indicating reduced mTOR-S6K pathway activation, despite no significant differences in lean tissue mass between groups on the same diet. MS-Slc7a5-KO mice on 30% protein diet exhibited mild insulin resistance (e. g. reduced glucose clearance, larger gonadal adipose depots) relative to control animals. Thus, SLC7A5 modulates LNAA-dependent muscle mTOR-S6K signalling in mice, although it appears non-essential (or is sufficiently compensated by e. g. SLC7A8 (LAT2)) for maintenance of normal muscle mass.	[Poncet, Nadege; Mitchell, Fiona E.; McGuire, Victoria A.; Arthur, J. Simon C.; Taylor, Peter M.] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland; [Ibrahim, Adel F. M.] Univ Dundee, Coll Life Sci, Med Res Council, Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland; [English, Grant] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee, Scotland; [Mitchell, Fiona E.; Shi, Yun-Bo] NICHD, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD 20814 USA	University of Dundee; University of Dundee; University of Dundee; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shi, YB (corresponding author), NICHD, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD 20814 USA.	shiyu@mail.nih.gov; p.m.taylor@dundee.ac.uk	Ibrahim, Adel FM/E-5273-2012; McGuire, Victoria/AAG-1953-2019	McGuire, Victoria/0000-0002-7808-3278; Shi, Yun-Bo/0000-0002-6330-0639; Arthur, Simon/0000-0002-8135-1958; Poncet, Nadege/0000-0002-0199-994X	Wellcome Trust [WT094226]; Intramural Research Program of NICHD/National Institutes of Health (NIH); Diabetes UK [10/0004089]; UK Biotechnology and Biological Sciences Research Council; Physiological Society; Nuffield Foundation; Carnegie Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I007261/1] Funding Source: researchfish; BBSRC [BB/I007261/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Intramural Research Program of NICHD/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes UK(Diabetes UK); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Physiological Society; Nuffield Foundation; Carnegie Trust(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Wellcome Trust (WT094226) (http://www.wellcome.ac.uk); The Intramural Research Program of NICHD/National Institutes of Health (NIH) (http://www.nichd.nih.gov); Diabetes UK (10/0004089) (http://www.diabetes.org.uk); UK Biotechnology and Biological Sciences Research Council (http://bbsrc.ac.uk); The Physiological Society (http://www.physoc.org); the Nuffield Foundation (http://www.nuffieldfoundation.org/); and Carnegie Trust (http://www.carnegie-trust.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva MM, 2012, AMINO ACIDS, V43, P171, DOI 10.1007/s00726-011-1088-7; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Binder E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074705; Blouet C, 2006, J NUTR, V136, P1849, DOI 10.1093/jn/136.7.1849; Braun D, 2011, BIOCHEM J, V439, P249, DOI 10.1042/BJ20110759; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Drummond MJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1011, DOI 10.1152/ajpendo.00690.2009; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Gannon MC, 2003, AM J CLIN NUTR, V78, P734, DOI 10.1093/ajcn/78.4.734; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; He YJ, 2010, J BIOL CHEM, V285, P9516, DOI 10.1074/jbc.M109.092429; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Kawaguchi T, 2008, INT J MOL MED, V22, P105; Kelleher AR, 2013, AM J PHYSIOL-ENDOC M, V304, pE229, DOI 10.1152/ajpendo.00409.2012; Kim S, 2013, MOL CELLS, P1; Le Plenier S, 2012, AMINO ACIDS, V43, P1171, DOI 10.1007/s00726-011-1172-z; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Luo JQ, 2013, NUTRITION, V29, P284, DOI 10.1016/j.nut.2012.05.008; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Mercan F, 2013, MOL CELL BIOL, V33, P293, DOI 10.1128/MCB.01285-12; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Ritchie JWA, 2001, BIOCHEM J, V356, P719, DOI 10.1042/0264-6021:3560719; Sato Y, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-7; Schriever SC, 2012, J NUTR BIOCH; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Simon J, 2009, Methods Mol Biol, V561, P127, DOI 10.1007/978-1-60327-019-9_9; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Strauss KA, 2010, MOL GENET METAB, V99, P333, DOI 10.1016/j.ymgme.2009.12.007; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Tsumura H, 2003, BIOCHEM BIOPH RES CO, V308, P847, DOI 10.1016/S0006-291X(03)01473-6; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wilson GJ, 2011, AM J PHYSIOL-ENDOC M, V301, pE1236, DOI 10.1152/ajpendo.00242.2011; Wolfe RR, 2002, J NUTR, V132, p3219S, DOI 10.1093/jn/131.10.3219S; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	45	60	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89547	10.1371/journal.pone.0089547	http://dx.doi.org/10.1371/journal.pone.0089547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586861	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000057
J	Ritzmann, R; Kramer, A; Bernhardt, S; Gollhofer, A				Ritzmann, Ramona; Kramer, Andreas; Bernhardt, Sascha; Gollhofer, Albert			Whole Body Vibration Training - Improving Balance Control and Muscle Endurance	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INCREASES VERTICAL JUMP; POSTURAL CONTROL; MULTIPLE-SCLEROSIS; KNEE EXTENSORS; OXYGEN-UPTAKE; STRENGTH; EXERCISE; PERFORMANCE; FREQUENCY	Exercise combined with whole body vibration (WBV) is becoming increasingly popular, although additional effects of WBV in comparison to conventional exercises are still discussed controversially in literature. Heterogeneous findings are attributed to large differences in the training designs between WBV and "control" groups in regard to training volume, load and type. In order to separate the additional effects of WBV from the overall adaptations due to the intervention, in this study, a four-week WBV training setup was compared to a matched intervention program with identical training parameters in both training settings except for the exposure to WBV. In a repeated-measures matched-subject design, 38 participants were assigned to either the WBV group (VIB) or the equivalent training group (CON). Training duration, number of sets, rest periods and task-specific instructions were matched between the groups. Balance, jump height and local static muscle endurance were assessed before and after the training period. The statistical analysis revealed significant interaction effects of group x time for balance and local static muscle endurance (p<0.05). Hence, WBV caused an additional effect on balance control (pre vs. post VIB +13%, p<0.05 and CON +6%, p = 0.33) and local static muscle endurance (pre vs. post VIB +36%, p<0.05 and CON +11%, p = 0.49). The effect on jump height remained insignificant (pre vs. post VIB +3%, p = 0.25 and CON +/- 0%, p = 0.82). This study provides evidence for the additional effects of WBV above conventional exercise alone. As far as balance and muscle endurance of the lower leg are concerned, a training program that includes WBV can provide supplementary benefits in young and well-trained adults compared to an equivalent program that does not include WBV.	[Ritzmann, Ramona; Bernhardt, Sascha; Gollhofer, Albert] Univ Freiburg, Inst Sport & Sport Sci, D-79106 Freiburg, Germany; [Kramer, Andreas] Univ Konstanz, Dept Sports Sci, Constance, Germany	University of Freiburg; University of Konstanz	Ritzmann, R (corresponding author), Univ Freiburg, Inst Sport & Sport Sci, Hugstetter Str 55, D-79106 Freiburg, Germany.	ramona.ritzmann@sport.uni-freiburg.de	Albert, Gollhofer/V-3291-2019; Gollhofer, Albert/ABF-5766-2020; Kramer, Andreas/AAJ-1837-2020	Kramer, Andreas/0000-0002-2586-5508	German Space Agency (DLR)	German Space Agency (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR))	The study has been funded by the German Space Agency (DLR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1794, DOI 10.1249/mss.0b013e3181238a0f; Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1642, DOI 10.1249/mss.0b013e318093f551; Adams JB, 2009, J STRENGTH COND RES, V23, P237, DOI 10.1519/JSC.0b013e3181876830; Adsuar JC, 2012, J SPORT MED PHYS FIT, V52, P85; Amano H., 2011, BRIT J SPORT MED, V45, P334; Armstrong WJ, 2008, J STRENGTH COND RES, V22, P471, DOI 10.1519/JSC.0b013e3181660605; Artero EG, 2011, INT J SPORTS MED, V32, P159, DOI 10.1055/s-0030-1268488; Bazett-Jones D, 2008, J SPORT SCI MED, V1, P44; Bogaerts A, 2007, GAIT POSTURE, V26, P309, DOI 10.1016/j.gaitpost.2006.09.078; Cloak R, 2010, INT J SPORTS MED, V31, P894, DOI 10.1055/s-0030-1265151; Cochrane DJ, 2005, BRIT J SPORT MED, V39, P860, DOI 10.1136/bjsm.2005.019950; Cochrane DJ, 2011, SCAND J MED SCI SPOR; Da Silva ME, 2007, J STRENGTH COND RES, V21, P470, DOI 10.1519/R-19025.1; de Ruiter CJ, 2003, EUR J APPL PHYSIOL, V90, P595, DOI 10.1007/s00421-003-0931-2; Delecluse C, 2003, MED SCI SPORT EXER, V35, P1033, DOI 10.1249/01.MSS.0000069752.96438.B0; Di Giminiani R, 2009, J SPORT SCI, V27, P169, DOI 10.1080/02640410802495344; Ebersbach G, 2008, ARCH PHYS MED REHAB, V89, P399, DOI 10.1016/j.apmr.2007.09.031; Fagnani F, 2006, AM J PHYS MED REHAB, V85, P956, DOI 10.1097/01.phm.0000247652.94486.92; Games KE, 2011, SCAND J MED SCI SPOR; JOHNSON SC, 1995, MED SCI SPORT EXER, V27, P323; Kawanabe Kazuhiro, 2007, Keio Journal of Medicine, V56, P28, DOI 10.2302/kjm.56.28; Keller M, 2011, SCAND J MED SCI SPOR, DOI 10.1111/j.1600-0838.2010.01268.x; Kerschan-Schindl K, 2001, CLIN PHYSIOL, V21, P377, DOI 10.1046/j.1365-2281.2001.00335.x; Kinser AM, 2008, MED SCI SPORT EXER, V40, P133, DOI 10.1249/mss.0b013e3181586b13; Koceja DM, 2000, INT J NEUROSCI, V103, P1, DOI 10.3109/00207450009035005; Kvorning T, 2006, EUR J APPL PHYSIOL, V96, P615, DOI 10.1007/s00421-006-0139-3; Mahieu NN, 2006, J ATHL TRAINING, V41, P286; Maloney-Hinds C, 2008, MED SCI MONITOR, V14, pCR112; Marin PJ, 2009, J STRENGTH COND RES, V23, P2311, DOI 10.1519/JSC.0b013e3181b8d637; Mason RR, 2012, DISABIL REHABIL, V34, P647, DOI 10.3109/09638288.2011.615370; Mazina NK, 2006, B EXP BIOL MED+, V142, P327, DOI 10.1007/s10517-006-0358-y; Meinyk M, 2008, INT J SPORTS MED, V29, P839, DOI 10.1055/s-2008-1038405; Melnyk M, 2009, INT J SPORTS MED, V30, P461, DOI 10.1055/s-0028-1112141; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P371, DOI 10.1113/jphysiol.1973.sp010193; Moezy A, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038554; Noe F, 2009, J ELECTROMYOGR KINES, V19, P341, DOI 10.1016/j.jelekin.2007.09.003; Nordlund MM, 2007, SCAND J MED SCI SPOR, V17, P12, DOI 10.1111/j.1600-0838.2006.00586.x; Obuchi Shuichi, 2004, Nihon Ronen Igakkai Zasshi, V41, P321; Osawa Y, 2013, J MUSCULOSKEL NEURON, V13, P380; Oullier O, 2009, EUR J APPL PHYSIOL, V105, P235, DOI 10.1007/s00421-008-0894-4; Pel JJM, 2009, MED ENG PHYS, V31, P937, DOI 10.1016/j.medengphy.2009.05.005; Petit PD, 2010, J ELECTROMYOGR KINES, V20, P1186, DOI 10.1016/j.jelekin.2010.08.002; Pollock RD, 2010, CLIN BIOMECH, V25, P840, DOI 10.1016/j.clinbiomech.2010.05.004; Rees SS, 2008, PHYS THER, V88, P462, DOI 10.2522/ptj.20070027; Rittweger J, 2000, CLIN PHYSIOL, V20, P134; Rittweger J, 2002, INT J SPORTS MED, V23, P428, DOI 10.1055/s-2002-33739; Rittweger J, 2001, EUR J APPL PHYSIOL, V86, P169, DOI 10.1007/s004210100511; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Ritzmann R, 2012, EUR J APPL PHYSL; Ritzmann R, 2011, SCAND J MED SCI SPOR; Roelants M, 2004, J AM GERIATR SOC, V52, P901, DOI 10.1111/j.1532-5415.2004.52256.x; ROLL JP, 1980, AVIAT SPACE ENVIR MD, V51, P1227; Ronnestad BR, 2004, J STRENGTH COND RES, V18, P839; Russo CR, 2003, ARCH PHYS MED REHAB, V84, P1854, DOI 10.1016/S0003-9993(03)00357-5; Sanudo B, 2011, J STRENGTH COND RES; Savelberg HHCM, 2007, J STRENGTH COND RES, V21, P589; Sayenko DG, 2010, NEUROSCI LETT, V482, P66, DOI 10.1016/j.neulet.2010.07.009; Schuhfried O, 2005, CLIN REHABIL, V19, P834, DOI 10.1191/0269215505cr919oa; Siu PM, 2010, ARCH PHYS MED REHAB, V91, P1608, DOI 10.1016/j.apmr.2010.07.214; Solopova I. A., 2002, Fiziologiya Cheloveka, V28, P73; Stewart JA, 2009, J SCI MED SPORT, V12, P50, DOI 10.1016/j.jsams.2007.09.005; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; Taube W, 2007, INT J SPORTS MED, V28, P999, DOI 10.1055/s-2007-964996; Taube W, 2008, EXP BRAIN RES, V188, P353, DOI 10.1007/s00221-008-1370-4; Taube W, 2008, J NEUROPHYSIOL, V99, P1243, DOI 10.1152/jn.01118.2007; Tihanyi TK, 2007, CLIN REHABIL, V21, P782, DOI 10.1177/0269215507077814; Torvinen S, 2003, J BONE MINER RES, V18, P876, DOI 10.1359/jbmr.2003.18.5.876; van Nes IJW, 2006, STROKE, V37, P2331, DOI 10.1161/01.STR.0000236494.62957.f3; Wyon M, 2010, J STRENGTH COND RES, V24, P866, DOI 10.1519/JSC.0b013e3181c7c640	70	41	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89905	10.1371/journal.pone.0089905	http://dx.doi.org/10.1371/journal.pone.0089905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587114	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000109
J	De Craene, JO; Courte, F; Rinaldi, B; Fitterer, C; Herranz, MC; Schmitt-Keichinger, C; Ritzenthaler, C; Friant, S				De Craene, Johan-Owen; Courte, Fanny; Rinaldi, Bruno; Fitterer, Chantal; Herranz, Mari Carmen; Schmitt-Keichinger, Corinne; Ritzenthaler, Christophe; Friant, Sylvie			Study of the Plant COPII Vesicle Coat Subunits by Functional Complementation of Yeast Saccharomyces cerevisiae Mutants	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM EXIT; PLASMA-MEMBRANE ATPASE; TRANSPORT VESICLES; SECRETORY PATHWAY; GOLGI-APPARATUS; ARABIDOPSIS-THALIANA; PROTEIN-TRANSPORT; SELECTIVE EXPORT; GENE FAMILY; SNARE SNC1P	The formation and budding of endoplasmic reticulum ER-derived vesicles depends on the COPII coat protein complex that was first identified in yeast Saccharomyces cerevisiae. The ER-associated Sec12 and the Sar1 GTPase initiate the COPII coat formation by recruiting the Sec23-Sec24 heterodimer following the subsequent recruitment of the Sec13-Sec31 heterotetramer. In yeast, there is usually one gene encoding each COPII protein and these proteins are essential for yeast viability, whereas the plant genome encodes multiple isoforms of all COPII subunits. Here, we used a systematic yeast complementation assay to assess the functionality of Arabidopsis thaliana COPII proteins. In this study, the different plant COPII subunits were expressed in their corresponding temperature-sensitive yeast mutant strain to complement their thermosensitivity and secretion phenotypes. Secretion was assessed using two different yeast cargos: the soluble alpha-factor pheromone and the membranous v-SNARE (3vesicle-soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein receptor) Snc1 involved in the fusion of the secretory vesicles with the plasma membrane. This complementation study allowed the identification of functional A. thaliana COPII proteins for the Sec12, Sar1, Sec24 and Sec13 subunits that could represent an active COPII complex in plant cells. Moreover, we found that AtSec12 and AtSec23 were co-immunoprecipitated with AtSar1 in total cell extract of 15 day-old seedlings of A. thaliana. This demonstrates that AtSar1, AtSec12 and AtSec23 can form a protein complex that might represent an active COPII complex in plant cells.	[De Craene, Johan-Owen; Courte, Fanny; Rinaldi, Bruno; Friant, Sylvie] Univ Strasbourg, Dept Mol & Cellular Genet, UMR7156, Strasbourg, France; [De Craene, Johan-Owen; Courte, Fanny; Rinaldi, Bruno; Friant, Sylvie] CNRS, Strasbourg, France; [Courte, Fanny; Fitterer, Chantal; Herranz, Mari Carmen; Schmitt-Keichinger, Corinne; Ritzenthaler, Christophe] Univ Strasbourg, IBMP, UPR2357, CNRS, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Friant, S (corresponding author), Univ Strasbourg, Dept Mol & Cellular Genet, UMR7156, Strasbourg, France.	s.friant@unistra.fr	herranz, mari carmen/AAN-7064-2020; Friant, Sylvie/L-9244-2019; De Craene, Johan-Owen/J-6461-2019; Friant, Sylvie/F-5409-2019	herranz, mari carmen/0000-0002-6812-5753; Friant, Sylvie/0000-0002-5412-6288; De Craene, Johan-Owen/0000-0001-9654-2143; Friant, Sylvie/0000-0002-5412-6288; SCHMITT-KEICHINGER, Corinne/0000-0003-1642-0221; Ritzenthaler, Christophe/0000-0001-7121-2359	CNRS [ATIP-CNRS 05-00932, ATIP-Plus 2008-3098]; Fondation Recherche Medicale [FRM INE20051105238, FRM-Comite Alsace 2006CX67-1]; Association pour la Recherche sur le Cancer [ARC JR/MLD/MDV-CR306/7901]; Region Alsace; Ministerio De Educacion y Ciencia Spain	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation Recherche Medicale; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Region Alsace(Region Grand-Est); Ministerio De Educacion y Ciencia Spain(Spanish Government)	This work was supported by the CNRS (ATIP-CNRS 05-00932 and ATIP-Plus 2008-3098 to SF), the Fondation Recherche Medicale (FRM INE20051105238 and FRM-Comite Alsace 2006CX67-1 to SF and FRM Postdoctoral fellowship to JODC), the Association pour la Recherche sur le Cancer (ARC JR/MLD/MDV-CR306/7901 to SF), the Region Alsace (PhD fellowship to FC), Ministerio De Educacion y Ciencia Spain (Postdoctoral fellowship to MCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BarPeled M, 1997, PLANT PHYSIOL, V114, P315, DOI 10.1104/pp.114.1.315; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; CIEJEK E, 1979, CELL, V18, P623, DOI 10.1016/0092-8674(79)90117-X; DENFERT C, 1992, EMBO J, V11, P4205, DOI 10.1002/j.1460-2075.1992.tb05514.x; dEnfert C, 1995, METHOD CELL BIOL, V49, P417, DOI 10.1016/S0091-679X(08)61470-3; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Faso C, 2009, PLANT CELL, V21, P3655, DOI 10.1105/tpc.109.068262; FIELD C, 1980, J CELL BIOL, V86, P123, DOI 10.1083/jcb.86.1.123; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GERST JE, 1992, P NATL ACAD SCI USA, V89, P4338, DOI 10.1073/pnas.89.10.4338; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hanton SL, 2008, PLANT MOL BIOL, V67, P283, DOI 10.1007/s11103-008-9317-5; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Kim WY, 1997, PLANT MOL BIOL, V33, P1025, DOI 10.1023/A:1005731209124; Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983; LEE HI, 1993, P NATL ACAD SCI USA, V90, P11433, DOI 10.1073/pnas.90.23.11433; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; MANNEY TR, 1983, J BACTERIOL, V155, P291, DOI 10.1128/JB.155.1.291-301.1983; Marti L, 2010, TRENDS PLANT SCI, V15, P522, DOI 10.1016/j.tplants.2010.05.010; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Movafeghi A, 1999, PLANT PHYSIOL, V119, P1437, DOI 10.1104/pp.119.4.1437; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Nakano RT, 2009, PLANT CELL, V21, P3672, DOI 10.1105/tpc.109.068270; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; Phillipson BA, 2001, PLANT CELL, V13, P2005, DOI 10.1105/tpc.13.9.2005; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; Robinson DG, 2007, CRIT REV PLANT SCI, V26, P199, DOI 10.1080/07352680701495820; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; SPRAGUE GF, 1981, J MOL BIOL, V153, P305, DOI 10.1016/0022-2836(81)90280-1; Takeuchi M, 1998, PLANT CELL PHYSIOL, V39, P590, DOI 10.1093/oxfordjournals.pcp.a029409; Van Mullem V, 2003, YEAST, V20, P739, DOI 10.1002/yea.999; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Wuestehube LJ, 1996, GENETICS, V142, P393; Yamanushi T, 1996, J BIOCHEM-TOKYO, V120, P452; Yang YD, 2005, PLANT CELL, V17, P1513, DOI 10.1105/tpc.104.026757; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644	48	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90072	10.1371/journal.pone.0090072	http://dx.doi.org/10.1371/journal.pone.0090072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587212	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900115
J	Egyir, B; Guardabassi, L; Sorum, M; Nielsen, SS; Kolekang, A; Frimpong, E; Addo, KK; Newman, MJ; Larsen, AR				Egyir, Beverly; Guardabassi, Luca; Sorum, Marit; Nielsen, Soren Saxmose; Kolekang, Augusta; Frimpong, Enoch; Addo, Kennedy Kwasi; Newman, Mercy Jemima; Larsen, Anders Rhod			Molecular Epidemiology and Antimicrobial Susceptibility of Clinical Staphylococcus aureus from Healthcare Institutions in Ghana	PLOS ONE			English	Article							METHICILLIN-RESISTANT; POPULATION-STRUCTURE; HIGH PREVALENCE; EVOLUTION; DIVERSITY; COMBINATION; EMERGENCE; LINEAGES; CLONES; SPREAD	The objective of this study was to determine the antimicrobial susceptibility patterns and clonal diversity of clinical Staphylococcus aureus isolates from Ghana. A total of 308 S. aureus isolates from six healthcare institutions located across Northern, Central and Southern Ghana were characterized by antibiotyping, spa typing and PCR detection of Panton Valentine leukocin (PVL) genes. Methicillin-resistant S. aureus (MRSA) were confirmed by PCR detection of mecA gene and further characterized by SCCmec and multi-locus sequence typing (MLST). The prevalence of antimicrobial resistance was below 5% for all agents tested except for penicillin (97%), tetracycline (42%) and erythromycin (6%). Ninety-one spa types were found, with t355 (ST152, 19%), t084 (ST15, 12%) and t314 (ST121, 6%) being the most frequent types. Based on established associations between spa and MLST types, isolates were assigned to 16 clonal complexes (CCs): CC152 (n = 78), CC15 (n = 57), CC121 (n = 39), CC8 (n = 36), CC5 (n = 33), CC1 (n = 29), CC45 (n = 9), CC88 (n = 8), CC30 (n = 4), CC9 (n = 3), CC25 (n = 2), CC97 (n = 2) CC20 (n = 2), CC707 (n = 2), CC7 (n = 3) and CC522 (n = 1). Most isolates (60%) were PVL-positive, especially those belonging to ST152, ST121, ST5, ST15, ST1, ST8, and ST88. Nine (3%) isolates were MRSA belonging to seven distinct clones: ST88-IV (n = 2), ST250-I (n = 2), ST8-IV (n = 1), ST72-V (n = 1), ST789-IV (n = 1), ST2021-V (n = 1), and ST239-III (n = 1). The study confirmed a high frequency of PVL-positive S. aureus in Africa, low prevalence of antimicrobial resistance and high diversity of MRSA lineages in Ghana compared to developed countries and other African countries. The detection of known pandemic MRSA clones in the absence of routine MRSA identification in most Ghanaian clinical microbiology laboratories calls for capacity building to strengthen surveillance and prevent spread of these clones.	[Egyir, Beverly; Sorum, Marit; Larsen, Anders Rhod] Statens Serum Insitut, Dept Microbiol & Infect Control, Copenhagen, Denmark; [Egyir, Beverly; Guardabassi, Luca] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark; [Egyir, Beverly; Addo, Kennedy Kwasi] Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana; [Newman, Mercy Jemima] Univ Ghana, Dept Microbiol, Sch Med, Accra, Ghana; [Nielsen, Soren Saxmose] Univ Copenhagen, Dept Large Anim Sci, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark; [Kolekang, Augusta; Frimpong, Enoch] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Clin Microbiol, Kumasi, Ghana	University of Copenhagen; University of Ghana; University of Ghana; University of Copenhagen; Kwame Nkrumah University Science & Technology	Egyir, B (corresponding author), Statens Serum Insitut, Dept Microbiol & Infect Control, Copenhagen, Denmark.	begyir@sund.ku.dk		Egyir, Beverly/0000-0002-5032-8739; Larsen, Anders Rhod/0000-0002-1713-8765; Guardabassi, Luca/0000-0002-2389-5084; Nielsen, Soren/0000-0003-2417-0787	Antibiotic Drug use, Monitoring and Evaluation of Resistance (ADMER) project; Danish International Development Agency (DANIDA)	Antibiotic Drug use, Monitoring and Evaluation of Resistance (ADMER) project; Danish International Development Agency (DANIDA)	This study was supported by Antibiotic Drug use, Monitoring and Evaluation of Resistance (ADMER) project funded by the Danish International Development Agency (DANIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P3790, DOI 10.1128/JCM.01192-06; Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P633, DOI 10.1111/j.1469-0691.2010.03320.x; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; David MZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018217; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Egyir B, 2013, J GLOB ANTIMICROB RE, V1, P189, DOI 10.1016/j.jgar.2013.05.006; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068024; Fang H, 2008, CLIN MICROBIOL INFEC, V14, P370, DOI 10.1111/j.1469-0691.2007.01941.x; Fitzgibbon MM, 2007, J CLIN MICROBIOL, V45, P3263, DOI 10.1128/JCM.00836-07; Francois P, 2008, EMERG INFECT DIS, V14, P304, DOI 10.3201/eid1402.070229; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Graffunder EM, 2002, J ANTIMICROB CHEMOTH, V49, P999, DOI 10.1093/jac/dkf009; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larsen AR, 2008, CLIN MICROBIOL INFEC, V14, P611, DOI 10.1111/j.1469-0691.2008.01995.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mine Y, 2013, J DERMATOL, V40, P34, DOI 10.1111/j.1346-8138.2012.01569.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Monnet DL, 2004, EMERG INFECT DIS, V10, P8; Moodley A, 2010, J CLIN MICROBIOL, V48, P4608, DOI 10.1128/JCM.01704-10; Muller AA, 2003, CLIN INFECT DIS, V36, P971, DOI 10.1086/374221; Newman Mercy J, 2011, Infect Drug Resist, V4, P215, DOI 10.2147/IDR.S21769; Ngoa UA, 2012, ACTA TROP, V124, P42, DOI 10.1016/j.actatropica.2012.06.005; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Song Y, 2013, J MED MICROBIOL, V62, P274, DOI 10.1099/jmm.0.050971-0	37	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89716	10.1371/journal.pone.0089716	http://dx.doi.org/10.1371/journal.pone.0089716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586981	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900070
J	Jusiak, B; Karandikar, UC; Kwak, SJ; Wang, F; Wang, H; Chen, R; Mardon, G				Jusiak, Barbara; Karandikar, Umesh C.; Kwak, Su-Jin; Wang, Feng; Wang, Hui; Chen, Rui; Mardon, Graeme			Regulation of Drosophila Eye Development by the Transcription Factor Sine oculis	PLOS ONE			English	Article							GENE DISRUPTION PROJECT; MORPHOGENETIC FURROW; EGF RECEPTOR; ECDYSONE RECEPTOR; VISUAL-SYSTEM; ECTOPIC EYES; FACTOR DREF; CELL FATE; PROTEIN; ENCODES	Homeodomain transcription factors of the Sine oculis (SIX) family direct multiple regulatory processes throughout the metazoans. Sine oculis (So) was first characterized in the fruit fly Drosophila melanogaster, where it is both necessary and sufficient for eye development, regulating cell survival, proliferation, and differentiation. Despite its key role in development, only a few direct targets of So have been described previously. In the current study, we aim to expand our knowledge of So-mediated transcriptional regulation in the developing Drosophila eye using ChIP-seq to map So binding regions throughout the genome. We find 7,566 So enriched regions (peaks), estimated to map to 5,952 genes. Using overlap between the So ChIP-seq peak set and genes that are differentially regulated in response to loss or gain of so, we identify putative direct targets of So. We find So binding enrichment in genes not previously known to be regulated by So, including genes that encode cell junction proteins and signaling pathway components. In addition, we analyze a subset of So-bound novel genes in the eye, and find eight genes that have previously uncharacterized eye phenotypes and may be novel direct targets of So. Our study presents a greatly expanded list of candidate So targets and serves as basis for future studies of So-mediated gene regulation in the eye.	[Jusiak, Barbara; Chen, Rui; Mardon, Graeme] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Karandikar, Umesh C.; Kwak, Su-Jin; Mardon, Graeme] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Wang, Feng; Wang, Hui; Chen, Rui; Mardon, Graeme] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wang, Feng; Wang, Hui; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Program Cell & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Mardon, G (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	gmardon@bcm.edu	Wang, Feng/G-4847-2015	Karandikar, Umesh/0000-0003-2659-9675; /0000-0001-6439-0456	Retina Research Foundation; National Eye Institute [R01 EY011232]; NEI/NIH Core Grant for Vision Research [EY-002520]; NATIONAL EYE INSTITUTE [R01EY011232, P30EY002520] Funding Source: NIH RePORTER	Retina Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI/NIH Core Grant for Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Retina Research Foundation (http://retinaresearchfnd.org/), the National Eye Institute (www.nei.nih.gov) grant R01 EY011232 and the NEI/NIH Core Grant for Vision Research EY-002520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; Anderson AE, 2011, DEVELOPMENT, V138, P1957, DOI 10.1242/dev.058461; Araujo H, 2003, MECH DEVELOP, V120, P537, DOI 10.1016/S0925-4773(03)00040-6; Atkins M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003731; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Brennan CA, 1998, DEVELOPMENT, V125, P2653; Brennan CA, 2001, DEVELOPMENT, V128, P1; Brown KE, 2006, DEV BIOL, V300, P710, DOI 10.1016/j.ydbio.2006.08.003; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Cai C, 2006, DROS RES C, V47, p466C; Cavodeassi F, 1999, DEVELOPMENT, V126, P4933; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Curtiss J, 1997, DEV BIOL, V190, P129, DOI 10.1006/dbio.1997.8659; Curtiss J, 2007, DEV BIOL, V306, P685, DOI 10.1016/j.ydbio.2007.04.006; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Ezzeddine N, 2011, MOL CELL BIOL, V31, P328, DOI 10.1128/MCB.00943-10; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Ghbeish N, 2002, MECH DEVELOP, V111, P89, DOI 10.1016/S0925-4773(01)00610-4; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Halder G, 1998, DEVELOPMENT, V125, P2181; Hart CM, 1999, CHROMOSOMA, V108, P375, DOI 10.1007/s004120050389; Hayashi T, 2008, DEVELOPMENT, V135, P2787, DOI 10.1242/dev.006189; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Hirose F, 1996, J BIOL CHEM, V271, P3930; Hirose F, 2001, MOL CELL BIOL, V21, P7231, DOI 10.1128/MCB.21.21.7231-7242.2001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Johnson K, 1999, DEV BIOL, V212, P440, DOI 10.1006/dbio.1999.9351; Lim J, 2004, GENESIS, V39, P26, DOI 10.1002/gene.20022; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; MARDON G, 1994, DEVELOPMENT, V120, P3473; McNeill H, 1997, GENE DEV, V11, P1073, DOI 10.1101/gad.11.8.1073; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Nagaraj R, 2009, EMBO J, V28, P337, DOI 10.1038/emboj.2008.286; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Newsome TP, 2000, DEVELOPMENT, V127, P851; Niimi T, 1999, DEVELOPMENT, V126, P2253; Ohno K, 1996, NUCLEIC ACIDS RES, V24, P3942, DOI 10.1093/nar/24.20.3942; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Pignoni F, 1997, DEVELOPMENT, V124, P271; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RIDDIFORD LM, 1993, RECEPTOR, V3, P203; Rogers EM, 2005, DEVELOPMENT, V132, P4833, DOI 10.1242/dev.02061; Rutkowski RJ, 2009, DEV DYNAM, V238, P1131, DOI 10.1002/dvdy.21922; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Seimiya M, 2000, DEVELOPMENT, V127, P1879; SERIKAKU MA, 1994, GENETICS, V138, P1137; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; SIMON MA, 1989, P NATL ACAD SCI USA, V86, P8333, DOI 10.1073/pnas.86.21.8333; Sousa-Nunes R, 2009, GENE DEV, V23, P359, DOI 10.1101/gad.1723609; Spradling AC, 1999, GENETICS, V153, P135; Thomas-Chollier M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1104; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Wasserman JD, 2000, GENE DEV, V14, P1651; Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; Yan HJ, 2003, DEV BIOL, V263, P323, DOI 10.1016/j.ydbio.2003.08.003; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zelhof AC, 1997, DEVELOPMENT, V124, P2499; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng L, 2008, MECH DEVELOP, V125, P18, DOI 10.1016/j.mod.2007.10.007	85	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89695	10.1371/journal.pone.0089695	http://dx.doi.org/10.1371/journal.pone.0089695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586968	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900068
J	Zhang, XB; Li, Q; Eskine, KJ; Zuo, B				Zhang, Xiaobin; Li, Qiong; Eskine, Kendall J.; Zuo, Bin			Perceptual Simulation in Gender Categorization: Associations between Gender, Vertical Height, and Spatial Size	PLOS ONE			English	Article							WOMEN SCALE; ATTITUDES; TIME; ATTENTION; SPACE; POWER; STEREOTYPES; PERSONALITY; RELIABILITY; METAPHORS	The current studies extend perceptual symbol systems theory to the processing of gender categorization by revealing that gender categorization recruits perceptual simulations of spatial height and size dimensions. In study 1, categorization of male faces were faster when the faces were in the "up'' (i.e., higher on the vertical axis) rather than the "down'' (i.e., lower on the vertical axis) position and vice versa for female face categorization. Study 2 found that responses to male names depicted in larger font were faster than male names depicted in smaller font, whereas opposite response patterns were given for female names. Study 3 confirmed that the effect in Study 2 was not due to metaphoric relationships between gender and social power. Together, these findings suggest that representation of gender (social categorization) also involves processes of perceptual simulation.	[Zhang, Xiaobin; Li, Qiong] Northwest Normal Univ, Sch Psychol, Lanzhou, Peoples R China; [Eskine, Kendall J.] Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA; [Zuo, Bin] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China	Northwest Normal University - China; Central China Normal University	Zuo, B (corresponding author), Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China.	zxbnwnu@163.com	Zuo, Bin/Q-1118-2019	Zuo, Bin/0000-0002-9633-7067	Projects of Enhancing Research Ability of Youth Teachers of Northwest Normal University	Projects of Enhancing Research Ability of Youth Teachers of Northwest Normal University	This research was supported by Projects of Enhancing Research Ability of Youth Teachers of Northwest Normal University (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou LW, 2008, CURR DIR PSYCHOL SCI, V17, P91, DOI 10.1111/j.1467-8721.2008.00555.x; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Borghi AM, 2004, MEM COGNITION, V32, P863, DOI 10.3758/BF03196865; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Bruner JS, 1948, J SOC PSYCHOL, V27, P203, DOI 10.1080/00224545.1948.9918925; BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484; Byrne ZS, 2011, MEAS EVAL COUNS DEV, V44, P248, DOI 10.1177/0748175611418982; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Chia RC, 1997, PSYCHOL WOMEN QUART, V21, P137, DOI 10.1111/j.1471-6402.1997.tb00105.x; Cloutier J, 2005, J PERS SOC PSYCHOL, V88, P885, DOI 10.1037/0022-3514.88.6.885; Crawford LE, 2006, COGNITION EMOTION, V20, P1153, DOI 10.1080/02699930500347794; DAUGHERTY CG, 1986, EDUC PSYCHOL MEAS, V46, P449, DOI 10.1177/001316448604600221; ECCLES JS, 1990, J SOC ISSUES, V46, P183, DOI 10.1111/j.1540-4560.1990.tb01929.x; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; FENNEMA E, 1977, AM EDUC RES J, V14, P51, DOI 10.3102/00028312014001051; Gentner D, 2002, LANG COGNITIVE PROC, V17, P537, DOI 10.1080/01690960143000317; Giessner SR, 2007, ORGAN BEHAV HUM DEC, V104, P30, DOI 10.1016/j.obhdp.2006.10.001; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; Institute of Women The All China Women's Federation, 2011, BRIEFING INFORM RES, V3, P1; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Meier BP, 2006, J RES PERS, V40, P451, DOI 10.1016/j.jrp.2005.03.001; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Moeller SK, 2008, PSYCHOL SCI, V19, P355, DOI 10.1111/j.1467-9280.2008.02093.x; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Rauscher FH, 1996, PSYCHOL SCI, V7, P226, DOI 10.1111/j.1467-9280.1996.tb00364.x; Robinson MD, 2008, J RES PERS, V42, P933, DOI 10.1016/j.jrp.2007.12.002; Schnall S., 2013, METAPHORICAL THOUGHT; Schubert TW, 2009, SOC COGNITION, V27, P1, DOI 10.1521/soco.2009.27.1.1; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Slepian ML, 2011, PSYCHOL SCI, V22, P26, DOI 10.1177/0956797610390388; SMITH RL, 1980, PSYCHOL REP, V47, P511, DOI 10.2466/pr0.1980.47.2.511; Spence J.T., 1972, JSAS CATALOG SELECTE, V2, P66, DOI DOI 10.1111/J.1471-6402.1997.TB00098.X; SPENCE JT, 1973, B PSYCHONOMIC SOC, V2, P219; SWIM JK, 1994, J PERS SOC PSYCHOL, V66, P21, DOI 10.1037/0022-3514.66.1.21; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; WAPNER S, 1957, J PERS, V25, P752, DOI 10.1111/j.1467-6494.1957.tb01563.x; Zwaan RA, 2003, PSYCHON B REV, V10, P954, DOI 10.3758/BF03196557	40	5	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89768	10.1371/journal.pone.0089768	http://dx.doi.org/10.1371/journal.pone.0089768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24587022	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900079
J	Garcia-Calzon, S; Moleres, A; Marcos, A; Campoy, C; Moreno, LA; Azcona-Sanjulian, MC; Martinez-Gonzalez, MA; Martinez, JA; Zalba, G; Marti, A				Garcia-Calzon, Sonia; Moleres, Adriana; Marcos, Ascension; Campoy, Cristina; Moreno, Luis A.; Cristina Azcona-Sanjulian, M.; Martinez-Gonzalez, Miguel A.; Alfredo Martinez, J.; Zalba, Guillermo; Marti, Amelia		EVASYON Study Grp	Telomere Length as a Biomarker for Adiposity Changes after a Multidisciplinary Intervention in Overweight/Obese Adolescents: The EVASYON Study	PLOS ONE			English	Article							SPANISH ADOLESCENTS; INSULIN-RESISTANCE; OXIDATIVE STRESS; OBESITY; INFLAMMATION; DESIGN	Context: Telomeres are biomarkers of biological aging. Shorter telomeres have been associated with increased adiposity in adults. However, this relationship remains unclear in children and adolescents. Objective: To evaluate the association between telomere length (TL) and adiposity markers in overweight/obese adolescents after an intensive program. We hypothesize that greater TL at baseline would predict a better response to a weight loss treatment. Design, Setting, Patients and Intervention: The EVASYON is a multidisciplinary treatment program for adolescents with overweight and obesity that is aimed at applying the intervention to all possibly involved areas of the individual, such as dietary habits, physical activity and cognitive and psychological profiles. Seventy-four participants (36 males, 38 females, 12-16 yr) were enrolled in the intervention program: 2 months of an energy-restricted diet and a follow-up period (6 months). Main Outcome: TL was measured by quantitative real-time polymerase chain reaction at baseline and after 2 months; meanwhile, anthropometric variables were also assessed after 6 months of follow-up. Results: TL lengthened in participants during the intensive period (+ 1.9 +/- 1.0, p<0.001) being greater in overweight/obese adolescents with the shortest telomeres at baseline (r = -0.962, p<0.001). Multivariable linear regression analysis showed that higher baseline TL significantly predicted a higher decrease in body weight ( B = -1.53, p = 0.005; B = -2.25, p = 0.047) and in standard deviation score for body mass index (BMI-SDS) (B = -0.22, p = 0.010; B = -0.47, p = 0.005) after the intensive and extensive period treatment respectively, in boys. Conclusion: Our study shows that a weight loss intervention is accompanied by a significant increase in TL in overweight/obese adolescents. Moreover, we suggest that initial longer TL could be a potential predictor for a better weight loss response.	[Garcia-Calzon, Sonia; Moleres, Adriana; Alfredo Martinez, J.; Marti, Amelia] Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain; [Marcos, Ascension] Spanish Natl Res Council, Inst Frio, Inst Food Sci Technol & Nutr, Immunonutr Res Grp,Dept Metab & Nutr, Madrid, Spain; [Campoy, Cristina] Univ Granada, Sch Med, Dept Pediat, Granada, Spain; [Moreno, Luis A.] Univ Zaragoza, Fac Ciencias Salud, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Cristina Azcona-Sanjulian, M.] Univ Navarra Hosp, Dept Pediat, Pediat Endocrinol Unit, Pamplona, Spain; [Martinez-Gonzalez, Miguel A.] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Martinez-Gonzalez, Miguel A.; Alfredo Martinez, J.; Marti, Amelia] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Zalba, Guillermo] Univ Navarra, Dept Biochem & Genet, E-31080 Pamplona, Spain	University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); University of Granada; University of Zaragoza; University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra	Marti, A (corresponding author), Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain.	amarti@unav.es	San Julián, María Cristina Azcona/A-1160-2015; Calzón, Sonia García/AAA-6385-2020; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Moreno, Luis/S-1780-2019; Marti, Amelia/M-2709-2019; martinez, david/GQI-0849-2022; Campoy, Cristina/F-4946-2017; Martí, Amelia/H-1192-2017; Sanchez, Ascension Marcos/K-4965-2014; Vaquero, M Pilar/K-9866-2014; Navas-Carretero, Santiago/L-2918-2015; ZALBA, GUILLERMO/AAB-6231-2019	San Julián, María Cristina Azcona/0000-0001-5534-8758; Moreno, Luis/0000-0003-0454-653X; Marti, Amelia/0000-0001-9832-7981; Campoy, Cristina/0000-0002-9860-6785; Martí, Amelia/0000-0001-9832-7981; Sanchez, Ascension Marcos/0000-0002-8022-9563; Vaquero, M Pilar/0000-0001-8828-5423; Navas-Carretero, Santiago/0000-0002-5163-2230; ZALBA, GUILLERMO/0000-0003-4616-1523; Garcia-Calzon, Sonia/0000-0002-1249-4795; Martin-Bautista, Elena/0000-0002-7651-8100; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Agil, Ahmad/0000-0003-0164-9648	Carlos III Health Institute; Ministry of Health and Consumption, Fondo de Investigacion Sanitaria (FIS) [PI051579, PI051080]; Spanish Ministry of Science and Innovation (MICINN) [SAF2010-20367]; Carlos III Health Institute [Centro de Investigacion Biomedica en Red (CIBER)] [CB06/03/1017]; Spanish Ministry	Carlos III Health Institute(Instituto de Salud Carlos III); Ministry of Health and Consumption, Fondo de Investigacion Sanitaria (FIS); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute [Centro de Investigacion Biomedica en Red (CIBER)]; Spanish Ministry(Spanish Government)	Research relating to this work was funded by grants from the Health Research Fund from the Carlos III Health Institute from Ministry of Health and Consumption, Fondo de Investigacion Sanitaria (FIS; PI051579, PI051080) for the EVASYON project; Linea Especial, Nutricion y Obesidad (University of Navarra); Spanish Ministry of Science and Innovation (MICINN) [SAF2010-20367]; Carlos III Health Institute [Centro de Investigacion Biomedica en Red (CIBER) project, CB06/03/1017], and RETICS network. The scholarship to S. Garcia-Calzon from the FPU 'Formacion de Profesorado Universitario' from the Spanish Ministry is fully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attas OS, 2010, ACTA PAEDIATR, V99, P896, DOI 10.1111/j.1651-2227.2010.01720.x; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Crocker MK, 2011, PEDIATR CLIN N AM, V58, P1217, DOI 10.1016/j.pcl.2011.07.004; Cui Y, 2013, OBESITY SILVER SPRIN, P1, DOI [DOI 10.1002/0BY.20321, 10.1002/oby.20321]; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Diaz VA, 2010, INT J OBESITY, V34, P261, DOI 10.1038/ijo.2009.198; Epel E, 2012, CANCER PREV RES, V5, P1163, DOI 10.1158/1940-6207.CAPR-12-0370; GARCIACALZON S, 2013, INT J OBES LOND, DOI DOI 10.1038/IJ0.2013.68; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Hovatta I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034948; Kiecolt-Glaser JK, 2013, BRAIN BEHAV IMMUN, V28, P16, DOI 10.1016/j.bbi.2012.09.004; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Marin C, 2012, AGE, V34, P1309, DOI 10.1007/s11357-011-9305-6; Marques M, 2012, NUTR HOSP, V27, P165, DOI [10.1590/S0212-16112012000100020, 10.3305/nh.2012.27.1.5452]; Martinez-Gomez D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-414; Moreno LA, 2007, INT J OBESITY, V31, P1798, DOI 10.1038/sj.ijo.0803670; *NAT RES COUNC FOO, 2005, DIET REF INT EN CARB; Njajou OT, 2012, INT J OBESITY, V36, P1176, DOI 10.1038/ijo.2011.196; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; O'Callaghan NJ, 2009, REJUV RES, V12, P169, DOI 10.1089/rej.2008.0819; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Rankin JW, 2008, DIABETES OBES METAB, V10, P1086, DOI 10.1111/j.1463-1326.2008.00867.x; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Shalev C, 2013, PSYCHONEUROENDOCRINO, V38, P1835, DOI 10.1016/j.psyneuen.2013.03.010; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Steenstrup T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt370; Suzuki Koji, 2003, Asian Pac J Cancer Prev, V4, P259; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Zannolli R, 2008, ACTA PAEDIATR, V97, P952, DOI 10.1111/j.1651-2227.2008.00783.x; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	36	64	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89828	10.1371/journal.pone.0089828	http://dx.doi.org/10.1371/journal.pone.0089828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587065	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700100
J	Yang, XY; Gao, S; Ding, J; Chen, Y; Zhou, XS; Wang, JE				Yang, Xiao-ying; Gao, Shan; Ding, Jie; Chen, Yan; Zhou, Xing-sheng; Wang, Jing-E			Plasma D-Dimer Predicts Short-Term Poor Outcome after Acute Ischemic Stroke	PLOS ONE			English	Article							SERUM D-DIMER; HEMOSTATIC BIOMARKERS; CARDIOVASCULAR EVENTS; CLASSIFICATION; FIBRINOGEN; RISK; CARE	Objective: Haemostatic biomarkers associated with poor outcome in acute ischemic stroke (AIS). The objective of the study was to evaluate the predictive value of plasma D-dimer (D-D) on functional outcome at 90-day follow-up from stroke onset. Methods: We conducted a prospective, observational cohort study in the emergency department and enrolled 220 patients with AIS. Plasma D-D concentrations, determined by a particle-enhanced, immunoturbidimetric assay, were measured. Each patient's medical record was reviewed, and demographic, clinical, laboratory and neuroimaging information was abstracted. Results: There was a positive correlation between levels of D-D and the NIHSS (r = 0.361, p<0.001), and the infarct volume (r = 0.449, p<0.001). In the 69 patients with an unfavorable functional outcome, D-D levels were higher compared with those in patients with a favorable outcome [3.24(IQR, 2.18-4.60) mg/L vs 0.88(IQR, 0.35-1.77) mg/L; p<0.001]. After adjusting for all other significant outcome predictors, D-D level remained an independent predictor for unfavorable functional outcome and mortality with an odds ratio of 2.18 (95% CI, 1.55-2.83), 3.22 (95% CI, 2.05-6.43); respectively. Conclusions: D-D levels are a useful tool to predict outcome and mortality 90-day after acute ischemic stroke and have a potential to assist clinicians.	[Yang, Xiao-ying] Shanghai Jiao Tong Univ, People Hosp 6, Fengxian Branch, Dept Clin Lab, Shanghai 200030, Peoples R China; [Gao, Shan; Chen, Yan; Zhou, Xing-sheng; Wang, Jing-E] Shanghai Jiao Tong Univ, People Hosp 6, Fengxian Branch, Dept Neurol, Shanghai 200030, Peoples R China; [Ding, Jie] Tianjin Union Med Ctr, Dept Neurol, Tianjin, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, S (corresponding author), Shanghai Jiao Tong Univ, People Hosp 6, Fengxian Branch, Dept Neurol, Shanghai 200030, Peoples R China.	cams024@163.com			Shanghai health bureau scientific research plan fund [2011350]	Shanghai health bureau scientific research plan fund	This study was supported by Shanghai health bureau scientific research plan fund (2011350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ageno W, 2002, ARCH INTERN MED, V162, P2589, DOI 10.1001/archinte.162.22.2589; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barber M, 2006, STROKE, V37, P1113, DOI 10.1161/01.STR.0000209240.63821.1a; Barber M, 2004, STROKE, V35, P1421, DOI 10.1161/01.STR.0000126890.63512.41; Berge E, 2001, THROMB RES, V101, P13, DOI 10.1016/S0049-3848(00)00380-7; Bonita R., 1988, STROKE; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chiu CC, 2012, J CLIN NEUROSCI, V19, P810, DOI 10.1016/j.jocn.2011.08.032; Csala M, 1998, SCAND J IMMUNOL, V48, P269; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; Di Napoli M, 2002, STROKE, V33, P1763, DOI 10.1161/01.STR.0000019124.54361.08; Goldenberg NA, 2013, J PEDIATR-US, V162, P1041, DOI 10.1016/j.jpeds.2012.11.035; Haapaniemi E, 2009, ACTA NEUROL SCAND, V119, P141, DOI 10.1111/j.1600-0404.2008.01081.x; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Juvela S, 2006, STROKE, V37, P1451, DOI 10.1161/01.STR.0000221710.55467.33; Kang DW, 2009, STROKE, V40, P1653, DOI 10.1161/STROKEAHA.108.539429; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Koch Horst J, 2005, J Stroke Cerebrovasc Dis, V14, P75, DOI 10.1016/j.jstrokecerebrovasdis.2004.12.002; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Lowe GDO, 1999, THROMB HAEMOSTASIS, V82, P667; Mahe I, 2012, THROMB RES, V129, P693, DOI 10.1016/j.thromres.2011.08.014; Meng R, 2013, INT J STROKE, DOI [10.1111/ijs.12034, DOI 10.1111/IJS.12034.[]; Park YW, 2011, J KOREAN NEUROSURG S, V50, P89, DOI 10.3340/jkns.2011.50.2.89; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Tu WJ, 2013, J NEUROENDOCRINOL, V25, P771, DOI 10.1111/jne.12052; Tu WJ, 2014, CLIN SCI, V126, P339, DOI 10.1042/CS20130284; Urbach H, 2002, NEURORADIOLOGY, V44, P695, DOI 10.1007/s00234-002-0762-6; Welsh P, 2009, CEREBROVASC DIS, V27, P247, DOI 10.1159/000196823; Whiteley W, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000145; Yuan W, 2014, J NEURAL TRANSM, V121, P409, DOI 10.1007/s00702-013-1113-y	31	39	41	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89756	10.1371/journal.pone.0089756	http://dx.doi.org/10.1371/journal.pone.0089756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587013	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700086
J	Bradley, BD; Howie, SRC; Chan, TCY; Cheng, YL				Bradley, Beverly D.; Howie, Stephen R. C.; Chan, Timothy C. Y.; Cheng, Yu-Ling			Estimating Oxygen Needs for Childhood Pneumonia in Developing Country Health Systems: A New Model for Expecting the Unexpected	PLOS ONE			English	Article							DISCRETE-EVENT SIMULATION; NASAL PRONGS; RESPIRATORY-INFECTIONS; SEASONAL INFLUENZA; CHILDREN; HYPOXEMIA; DELIVERY; EPIDEMIOLOGY; STRATEGIES; SETTINGS	Background: Planning for the reliable and cost-effective supply of a health service commodity such as medical oxygen requires an understanding of the dynamic need or 'demand' for the commodity over time. In developing country health systems, however, collecting longitudinal clinical data for forecasting purposes is very difficult. Furthermore, approaches to estimating demand for supplies based on annual averages can underestimate demand some of the time by missing temporal variability. Methods: A discrete event simulation model was developed to estimate variable demand for a health service commodity using the important example of medical oxygen for childhood pneumonia. The model is based on five key factors affecting oxygen demand: annual pneumonia admission rate, hypoxaemia prevalence, degree of seasonality, treatment duration, and oxygen flow rate. These parameters were varied over a wide range of values to generate simulation results for different settings. Total oxygen volume, peak patient load, and hours spent above average-based demand estimates were computed for both low and high seasons. Findings: Oxygen demand estimates based on annual average values of demand factors can often severely underestimate actual demand. For scenarios with high hypoxaemia prevalence and degree of seasonality, demand can exceed average levels up to 68% of the time. Even for typical scenarios, demand may exceed three times the average level for several hours per day. Peak patient load is sensitive to hypoxaemia prevalence, whereas time spent at such peak loads is strongly influenced by degree of seasonality. Conclusion: A theoretical study is presented whereby a simulation approach to estimating oxygen demand is used to better capture temporal variability compared to standard average-based approaches. This approach provides better grounds for health service planning, including decision-making around technologies for oxygen delivery. Beyond oxygen, this approach is widely applicable to other areas of resource and technology planning in developing country health systems.	[Bradley, Beverly D.; Chan, Timothy C. Y.; Cheng, Yu-Ling] Univ Toronto, Ctr Global Engn, Toronto, ON, Canada; [Bradley, Beverly D.; Cheng, Yu-Ling] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Howie, Stephen R. C.] MRC Unit, Banjul, Gambia; [Chan, Timothy C. Y.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada	University of Toronto; University of Toronto; University of London; London School of Hygiene & Tropical Medicine; University of Toronto	Bradley, BD (corresponding author), Univ Toronto, Ctr Global Engn, Toronto, ON, Canada.	bev.bradley@mail.utoronto.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; MRC [MC_UP_A900_1116, MC_U190081957] Funding Source: UKRI; Medical Research Council [MC_U190081957, MC_UP_A900_1116] Funding Source: researchfish	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	B. Bradley is supported by a graduate scholarship from the Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed JA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-7; Alexopoulos C, 2008, OMEGA-INT J MANAGE S, V36, P33, DOI 10.1016/j.omega.2005.07.013; Assi TM, 2013, VACCINE, V31, P2828, DOI 10.1016/j.vaccine.2013.04.011; Assi TM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-425; Belle J, 2010, J INFECT DEV COUNTR, V4, P419, DOI 10.3855/jidc.859; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blumenfeld S, 1985, OPERATIONS RES METHO; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Deo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035479; Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639; Duke T, 2010, INT J TUBERC LUNG D, V14, P1362; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Duke T, 2002, ARCH DIS CHILD, V86, P108, DOI 10.1136/adc.86.2.108; Duke T, 2009, CLIN USE OXYGEN HOSP; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Evans HGT, 2012, PNEUMONIA, V1, P3, DOI 10.15172/pneu.2012.1/208; Fone D, 2003, J PUBLIC HEALTH MED, V25, P325, DOI 10.1093/pubmed/fdg075; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Ginsburg AS, 2012, J TROP PEDIATRICS, V58, P389, DOI 10.1093/tropej/fmr103; Hill SE, 2009, INT J TUBERC LUNG D, V13, P587; Hoffmann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043666; Howie SRC, 2009, B WORLD HEALTH ORGAN, V87, P763, DOI 10.2471/BLT.08.058370; Jacobson SH, 2006, INT SER OPER RES MAN, V91, P211, DOI 10.1007/978-0-387-33636-7_8; Jun JB, 1999, J OPER RES SOC, V50, P109, DOI 10.1057/palgrave.jors.2600669; Junge S, 2006, TROP MED INT HEALTH, V11, P367, DOI 10.1111/j.1365-3156.2006.01570.x; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kwofie TB, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-78; La Vincente SF, 2011, INT J TUBERC LUNG D, V15, P693, DOI 10.5588/ijtld.10.0544; Langley I, 2012, HEALTH CARE MANAG SC, V15, P239, DOI 10.1007/s10729-012-9201-3; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; Marazzi A, 1998, MED CARE, V36, P915, DOI 10.1097/00005650-199806000-00014; Matai S, 2008, ANN TROP PAEDIATR, V28, P71, DOI 10.1179/146532808X270716; Muhe L, 1998, J TROP PEDIATRICS, V44, P365, DOI 10.1093/tropej/44.6.365; Muhe L, 1997, ANN TROP PAEDIATR, V17, P273, DOI 10.1080/02724936.1997.11747898; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Rauner MS, 2005, J OPER RES SOC, V56, P222, DOI 10.1057/palgrave.jors.2601884; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; RUFFIEUX C, 1993, SOZ PRAVENTIV MED, V38, P77, DOI 10.1007/BF01318464; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Swartzman G, 1970, Health Serv Res, V5, P320; Tchidjou HK, 2010, J TROP PEDIATRICS, V56, P317, DOI 10.1093/tropej/fmp127; Turner C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050100; WEBER MW, 1995, J PEDIATR-US, V127, P378, DOI 10.1016/S0022-3476(95)70067-6; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; Weber MW, 1998, PEDIATR INFECT DIS J, V17, P224, DOI 10.1097/00006454-199803000-00010; WHO, 2012, CHILDR RED MORT; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Williams P, 2010, ANN OPER RES, V178, P263, DOI 10.1007/s10479-009-0580-x; World Health Organization, 2013, POCK BOOK HOSP CAR C	52	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89872	10.1371/journal.pone.0089872	http://dx.doi.org/10.1371/journal.pone.0089872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24587089	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700135
J	Majorin, F; Freeman, MC; Barnard, S; Routray, P; Boisson, S; Clasen, T				Majorin, Fiona; Freeman, Matthew C.; Barnard, Sharmani; Routray, Parimita; Boisson, Sophie; Clasen, Thomas			Child Feces Disposal Practices in Rural Orissa: A Cross Sectional Study	PLOS ONE			English	Article							EVENTS; DIARRHEA; BEHAVIOR	Background: An estimated 2.5 billion people worldwide lack access to improved sanitation facilities. While large-scale programs in some countries have increased latrine coverage, they sometimes fail to ensure optimal latrine use, including the safe disposal of child feces, a significant source of exposure to fecal pathogens. We undertook a cross-sectional study to explore fecal disposal practices among children in rural Orissa, India in villages where the Government of India's Total Sanitation Campaign had been implemented at least three years prior to the study. Methods and Findings: We conducted surveys with heads of 136 households with 145 children under 5 years of age in 20 villages. We describe defecation and feces disposal practices and explore associations between safe disposal and risk factors. Respondents reported that children commonly defecated on the ground, either inside the household (57.5%) for pre-ambulatory children or around the compound (55.2%) for ambulatory children. Twenty percent of pre-ambulatory children used potties and nappies; the same percentage of ambulatory children defecated in a latrine. While 78.6% of study children came from 106 households with a latrine, less than a quarter (22.8%) reported using them for disposal of child feces. Most child feces were deposited with other household waste, both for pre-ambulatory (67.5%) and ambulatory (58.1%) children. After restricting the analysis to households owning a latrine, the use of a nappy or potty was associated with safe disposal of feces (OR 6.72, 95% CI 1.02-44.38) though due to small sample size the regression could not adjust for confounders. Conclusions: In the area surveyed, the Total Sanitation Campaign has not led to high levels of safe disposal of child feces. Further research is needed to identify the actual scope of this potential gap in programming, the health risk presented and interventions to minimize any adverse effect.	[Majorin, Fiona; Barnard, Sharmani; Routray, Parimita; Boisson, Sophie; Clasen, Thomas] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Freeman, Matthew C.; Clasen, Thomas] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of London; London School of Hygiene & Tropical Medicine; Emory University; Rollins School Public Health	Clasen, T (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	thomas.clasen@lshtm.ac.uk	Freeman, Matthew/ABE-6245-2020; Kuang, Jinyi/L-8488-2017	Freeman, Matthew/0000-0002-1517-2572; Kuang, Jinyi/0000-0003-4173-3246; Majorin, Fiona/0000-0002-4697-2679	Bill AMP; Melinda Gates Foundation	Bill AMP; Melinda Gates Foundation	This work was supported by the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, BMCCOMPLEMENTALTERNM; Arnold BF, 2010, P NATL ACAD SCI USA, V107, P22605, DOI 10.1073/pnas.1008944107; Barnard S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071438; Bostoen K, 2006, INT J EPIDEMIOL, V35, P751, DOI 10.1093/ije/dyl019; Clasen T, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-7; Cohen Hubal EA, 2000, ENV HLTH PERSPECTIVE, V108; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; CURTIS V, 1995, SOC SCI MED, V41, P383, DOI 10.1016/0277-9536(94)00341-P; Gil A, 2004, ENV HLTH PROJECT; HUTTLY SRA, 1994, J DIARRHOEAL DIS RES, V12, P14; International Institute for Population Sciences and Macro International, 2007, NAT FAM HLTH SURV NF, V1; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; Lanata CF, 1998, PEDIATR INFECT DIS J, V17, P7, DOI 10.1097/00006454-199801000-00003; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; Ministry of Drinking Water and Sanitation, 2012, MIN DRINK WAT SAN GU; Moya J, 2004, PEDIATRICS, V113, P996; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Roy E, 2011, S AFR J CHILD HEALTH, V5, P78; Spears D, 2012, POLICY LESSONS IMPLE; TARU/UNICEF, 2008, IMP ASS NIRM GRAM PU; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; WaterAid India, 2008, FEEL PULS STUD TOT S; WHO/UNICEF, 2006, COR QUEST DRINK WAT; WHO/UNICEF, 2013, JOINT MON PROGR WAT	28	54	54	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89551	10.1371/journal.pone.0089551	http://dx.doi.org/10.1371/journal.pone.0089551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586864	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000331714700125
J	Ballard, KJ; Savage, S; Leyton, CE; Vogel, AP; Hornberger, M; Hodges, JR				Ballard, Kirrie J.; Savage, Sharon; Leyton, Cristian E.; Vogel, Adam P.; Hornberger, Michael; Hodges, John R.			Logopenic and Nonfluent Variants of Primary Progressive Aphasia Are Differentiated by Acoustic Measures of Speech Production	PLOS ONE			English	Article							MINI-MENTAL-STATE; SYLLABLE FREQUENCY; CHILDHOOD APRAXIA; A-BETA; RECOGNITION; HYPOTHESIS; ALZHEIMER; SPEAKERS; SUBTYPES; HEALTHY	Differentiation of logopenic (lvPPA) and nonfluent/agrammatic (nfvPPA) variants of Primary Progressive Aphasia is important yet remains challenging since it hinges on expert based evaluation of speech and language production. In this study acoustic measures of speech in conjunction with voxel-based morphometry were used to determine the success of the measures as an adjunct to diagnosis and to explore the neural basis of apraxia of speech in nfvPPA. Forty-one patients (21 lvPPA, 20 nfvPPA) were recruited from a consecutive sample with suspected frontotemporal dementia. Patients were diagnosed using the current gold-standard of expert perceptual judgment, based on presence/absence of particular speech features during speaking tasks. Seventeen healthy age-matched adults served as controls. MRI scans were available for 11 control and 37 PPA cases; 23 of the PPA cases underwent amyloid ligand PET imaging. Measures, corresponding to perceptual features of apraxia of speech, were periods of silence during reading and relative vowel duration and intensity in polysyllable word repetition. Discriminant function analyses revealed that a measure of relative vowel duration differentiated nfvPPA cases from both control and lvPPA cases (r(2) = 0.47) with 88% agreement with expert judgment of presence of apraxia of speech in nfvPPA cases. VBM analysis showed that relative vowel duration covaried with grey matter intensity in areas critical for speech motor planning and programming: precentral gyrus, supplementary motor area and inferior frontal gyrus bilaterally, only affected in the nfvPPA group. This bilateral involvement of frontal speech networks in nfvPPA potentially affects access to compensatory mechanisms involving right hemisphere homologues. Measures of silences during reading also discriminated the PPA and control groups, but did not increase predictive accuracy. Findings suggest that a measure of relative vowel duration from of a polysyllable word repetition task may be sufficient for detecting most cases of apraxia of speech and distinguishing between nfvPPA and lvPPA.	[Ballard, Kirrie J.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Ballard, Kirrie J.; Savage, Sharon; Leyton, Cristian E.; Hornberger, Michael; Hodges, John R.] Neurosci Res Australia, Randwick, NSW, Australia; [Savage, Sharon; Hornberger, Michael; Hodges, John R.] Univ New S Wales, Sydney, NSW, Australia; [Vogel, Adam P.] Univ Melbourne, Melbourne, Vic, Australia	University of Sydney; Neuroscience Research Australia; University of New South Wales Sydney; University of Melbourne	Ballard, KJ (corresponding author), Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia.	Kirrie.ballard@sydney.edu.au	Hornberger, Michael/C-9610-2011; Vogel, Adam/ABD-7685-2020; Savage, Sharon/A-9459-2013	Hornberger, Michael/0000-0002-2214-3788; Vogel, Adam/0000-0002-3505-2631; Savage, Sharon/0000-0002-6477-5222; Ballard, Kirrie/0000-0002-9917-5390; Leyton, Cristian E./0000-0002-8236-6561	National Health and Medical Research Council (NHMRC) of Australia [630489]; Australian Research Council (ARC) [FF120100355]; ARC Federation Fellowship [FF0776229]; NHMRC Postdoctoral Fellowship [1012302]; ARC Research Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ARC Federation Fellowship(Australian Research Council); NHMRC Postdoctoral Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ARC Research Fellowship(Australian Research Council)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Project Grant (No. 630489, in part, to JRH and KJB); Australian Research Council (ARC) Future Fellowship (FF120100355 to KJB); ARC Federation Fellowship (FF0776229 to JRH); NHMRC Postdoctoral Fellowship 1012302 to APV; ARC Research Fellowship to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichert I, 2004, BRAIN LANG, V88, P148, DOI 10.1016/S0093-934X(03)00296-7; Allen P., 2008, SPSS HLTH BEHAV SCI; Amici S, 2006, BEHAV NEUROL, V17, P77, DOI 10.1155/2006/260734; Ash S, 2010, BRAIN LANG, V113, P13, DOI 10.1016/j.bandl.2009.12.001; Ballard KJ, 2007, J MOTOR BEHAV, V39, P19, DOI 10.3200/JMBR.39.1.19-28; Ballard KJ, 2012, J SPEECH LANG HEAR R, V55, P1822, DOI 10.1044/1092-4388(2012/11-0257); Ballard KJ, 2010, J SPEECH LANG HEAR R, V53, P1227, DOI 10.1044/1092-4388(2010/09-0130); Ballard KJ, 2001, APHASIOLOGY, V15, P50; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Boersma Paul, 2002, GLOT INT, V5, P341; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Courson MEA, 2012, J MED SPEECH-LANG PA, V20, P47; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Croot K, 2012, J SPEECH LANG HEAR R, V55, pS1562, DOI 10.1044/1092-4388(2012/11-0323); CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Duffy JR, 2006, APHASIOLOGY, V20, P511, DOI 10.1080/02687030600597358; Fletcher J., 2010, HDB PHONETIC SCI; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRY DB, 1955, J ACOUST SOC AM, V27, P765, DOI 10.1121/1.1908022; Gorno-Tempini ML, 2008, NEUROLOGY, V71, P1227, DOI 10.1212/01.wnl.0000320506.79811.da; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Hosom JP, 2004, J MED SPEECH-LANG PA, V12, P167; Irish M, 2013, HUM BRAIN M IN PRESS; JONAS S, 1987, FRONTAL LOBES REVISI, P241; Josephs K, 2012, NEUROLOGY, V78; Josephs KA, 2013, NEUROLOGY, V81, P337, DOI 10.1212/WNL.0b013e31829c5ed5; Josephs KA, 2012, BRAIN, V135, P1522, DOI 10.1093/brain/aws032; Josephs KA, 2006, BRAIN, V129, P1385, DOI 10.1093/brain/awl078; Kent R. D., 1996, AM J SPEECH-LANG PAT, V5, P7, DOI [DOI 10.1044/1058-0360.0503.07, 10.1044/1058-0360.0503.0, DOI 10.1044/1058-0360.0503.0]; Kent RD, 2003, CLIN LINGUIST PHONET, V17, P427, DOI 10.1080/0269920031000086248; Knopman DS, 2008, BRAIN, V131, P2957, DOI 10.1093/brain/awn234; Kochanski G, 2005, J ACOUST SOC AM, V118, P1038, DOI 10.1121/1.1923349; Kotani Y, 2009, NEUROSCI LETT, V450, P75, DOI 10.1016/j.neulet.2008.11.032; Laganaro M, 2008, APHASIOLOGY, V22, P1191, DOI 10.1080/02687030701820469; Laganaro M, 2012, CORTEX, V48, P963, DOI 10.1016/j.cortex.2011.03.010; Lavidor M, 2012, HDB NEUROPSYCHOLOGY, P41; Leyton CE, 2011, BRAIN, V134, P3030, DOI 10.1093/brain/awr216; Ling LE, 2000, LANG SPEECH, V43, P377, DOI 10.1177/00238309000430040301; Maas E, 2008, BRAIN LANG, V106, P107, DOI 10.1016/j.bandl.2008.03.004; McNeil M.R., 2009, CLIN MANAGEMENT SENS; Mesulam M, 2008, ANN NEUROL, V63, P709, DOI 10.1002/ana.21388; Mohanan K.P., 1986, THEORY LEXICAL PHONO; Nestor PJ, 2003, BRAIN, V126, P2406, DOI 10.1093/brain/awg240; Ogar JM, 2007, ALZ DIS ASSOC DIS, V21, pS23, DOI 10.1097/WAD.0b013e31815d19fe; Rabinovici GD, 2008, ANN NEUROL, V64, P388, DOI 10.1002/ana.21451; Robin D. A., 2008, NEUROIMAGING COMMUNI, P129; Rogers MA, 1999, APHASIOLOGY, V13, P793, DOI 10.1080/026870399401885; Rohrer JD, 2010, NEUROLOGY, V75, P603, DOI 10.1212/WNL.0b013e3181ed9c6b; Rohrer JD, 2010, NEUROIMAGE, V49, P984, DOI 10.1016/j.neuroimage.2009.08.002; Rohrer JD, 2010, J NEUROL, V257, P569, DOI 10.1007/s00415-009-5371-4; Rosen K, 2010, CLIN LINGUIST PHONET, V24, P141, DOI 10.3109/02699200903440983; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Sajjadi SA, 2012, NEUROLOGY, V78, P1670, DOI 10.1212/WNL.0b013e3182574f79; Savage S, 2013, DEMENT GERIATR COGN, V35, P208, DOI 10.1159/000346389; Shahin MA, 2012, IEEE W SP LANG TECH, P388, DOI 10.1109/SLT.2012.6424255; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Staiger A, 2008, APHASIOLOGY, V22, P1201, DOI 10.1080/02687030701820584; Stockmal V, 2005, LANG SPEECH, V48, P55, DOI 10.1177/00238309050480010301; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Van Riper C., 1963, SPEECH CORRECTION, V4th; Varley R, 2001, APHASIOLOGY, V15, P39; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Vogel AP, 2012, NEUROPSYCHOLOGIA, V50, P3273, DOI 10.1016/j.neuropsychologia.2012.09.011; Vogel AP, 2010, J ACOUST SOC AM, V128, P3747, DOI 10.1121/1.3506349; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; Young V, 2010, ASSIST TECHNOL, V22, P99, DOI 10.1080/10400435.2010.483646; Ziegler W, 1997, NEUROPSYCHOLOGIA, V35, P1197, DOI 10.1016/S0028-3932(97)00040-7; ZYSKI BJ, 1987, J COMMUN DISORD, V20, P367, DOI 10.1016/0021-9924(87)90025-6	69	63	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89864	10.1371/journal.pone.0089864	http://dx.doi.org/10.1371/journal.pone.0089864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587083	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000332396200090
J	Peng, ZY; Li, HL; Zhang, C; Qian, X; Feng, ZY; Zhu, SM				Peng, Zhiyou; Li, Huiling; Zhang, Chong; Qian, Xiang; Feng, Zhiying; Zhu, Shengmei			A Retrospective Study of Chronic Post-Surgical Pain following Thoracic Surgery: Prevalence, Risk Factors, Incidence of Neuropathic Component, and Impact on Qualify of Life	PLOS ONE			English	Article							CHRONIC POSTTHORACOTOMY PAIN; POSTOPERATIVE PAIN; PERSISTENT PAIN; LUNG-CANCER; ID PAIN; OF-LIFE; THORACOTOMY; PREVENTION; QUESTIONNAIRE; ANALGESIA	Background: Thoracic surgeries including thoracotomy and VATS are some of the highest risk procedures that often lead to CPSP, with or without a neuropathic component. This retrospective study aims to determine retrospectively the prevalence of CPSP following thoracic surgery, its predicting risk factors, the incidence of neuropathic component, and its impact on quality of life. Methods: Patients who underwent thoracic surgeries including thoracotomy and VATS between 01/2010 and 12/2011 at the First Affiliated Hospital, School of Medicine, Zhejiang University were first contacted and screened for CPSP following thoracic surgery via phone interview. Patients who developed CPSP were then mailed with a battery of questionnaires, including a questionnaire referenced to Maguire's research, a validated Chinese version of the ID pain questionnaire, and a SF-36 Health Survey. Logistic regression analyses were subsequently performed to identify risk factors for CPSP following thoracic surgery and its neuropathic component. Results: The point prevalence of CPSP following thoracic surgery was 24.9% (320/1284 patients), and the point prevalence of neuropathic component of CPSP was 32.5% (86/265 patients). CPSP following thoracic surgery did not improve significantly with time. Multiple predictive factors were identified for CPSP following thoracic surgery, including age, 60 years old, female gender, prolonged duration of post-operative chest tube drainage (>= 4 days), options of post-operative pain management, and pre-existing hypertension. Furthermore, patients who experienced CPSP following thoracic surgery were found to have significantly decreased physical function and worse quality of life, especially those with neuropathic component. Conclusions: Our study demonstrated that nearly 1 out of 4 patients underwent thoracic surgery might develop CPSP, and one third of them accompanied with a neuropathic component. Early prevention as well as aggressive treatment is important for patients with CPSP following thoracic surgery to achieve a high quality of life.	[Peng, Zhiyou; Li, Huiling; Feng, Zhiying; Zhu, Shengmei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Chong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Qian, Xiang] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA	Zhejiang University; Zhejiang University; Stanford University	Feng, ZY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China.	fzy1972@zju.edu.cn		QIAN, XIANG/0000-0003-0697-2540	Zhejiang Provincial Natural Science Foundation of China [Y12H030053]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by the grants from the Zhejiang Provincial Natural Science Foundation of China (Grant No. Y12H030053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn MA, 2012, ANESTHESIOLOGY, V116, P248, DOI 10.1097/ALN.0b013e31823c1030; Brunelli A, 2007, ANN THORAC SURG, V84, P410, DOI 10.1016/j.athoracsur.2007.04.019; Buchheit T, 2012, SURG CLIN N AM, V92, P393, DOI 10.1016/j.suc.2012.01.005; Deumens R, 2013, PROG NEUROBIOL, V104, P1, DOI 10.1016/j.pneurobio.2013.01.002; Enck RE, 2010, AM J HOSP PALLIAT ME, V27, P301, DOI 10.1177/1049909110369530; Forcella D, 2009, J THORAC CARDIOV SUR, V137, pE48, DOI 10.1016/j.jtcvs.2008.03.062; Gotoda Y, 2001, EUR J PAIN-LONDON, V5, P89, DOI 10.1053/eujp.2001.0225; Guastella V, 2011, PAIN, V152, P74, DOI 10.1016/j.pain.2010.09.004; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Haroutiunian S, 2013, PAIN, V154, P95, DOI 10.1016/j.pain.2012.09.010; International Association for the Study of Pain Committee, ASP TAX PAIN TERMS C; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; KALSO E, 1992, ACTA ANAESTH SCAND, V36, P96, DOI 10.1111/j.1399-6576.1992.tb03430.x; Katz J, 1996, CLIN J PAIN, V12, P50, DOI 10.1097/00002508-199603000-00009; Katz J, 2009, EXPERT REV NEUROTHER, V9, P723, DOI 10.1586/ERN.09.20; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Khan IH, 2000, EUR J CARDIO-THORAC, V18, P656, DOI 10.1016/S1010-7940(00)00591-1; Kinney MAO, 2012, ANN THORAC SURG, V93, P1242, DOI 10.1016/j.athoracsur.2012.01.031; Lavand'homme P, 2011, CURR OPIN ANESTHESIO, V24, P545, DOI 10.1097/ACO.0b013e32834a4f74; Li J, 2012, PAIN PHYSICIAN, V15, P179; Macrae WA, 2001, BRIT J ANAESTH, V87, P88, DOI 10.1093/bja/87.1.88; Maguire MF, 2006, EUR J CARDIO-THORAC, V29, P800, DOI 10.1016/j.ejcts.2006.02.002; Miyazaki T, 2013, GEN THORAC CARDIOVAS; Mogil JS, 2010, PROG BRAIN RES, V186, P141, DOI 10.1016/B978-0-444-53630-3.00009-9; Mongardon N, 2011, CLIN J PAIN, V27, P677, DOI 10.1097/AJP.0b013e31821981a3; Nakamura Hiroshige, 2009, Interact Cardiovasc Thorac Surg, V8, P58, DOI 10.1510/icvts.2008.188086; Ochroch EA, 2006, CLIN J PAIN, V22, P491, DOI 10.1097/01.ajp.0000208246.18251.f2; Perttunen K, 1999, ACTA ANAESTH SCAND, V43, P563; Pluijms WA, 2006, ACTA ANAESTH SCAND, V50, P804, DOI 10.1111/j.1399-6576.2006.01065.x; Portenoy R, 2006, CURR MED RES OPIN, V22, P1555, DOI 10.1185/030079906X115702; Puolakka PAE, 2010, EUR J ANAESTH, V27, P455, DOI 10.1097/EJA.0b013e328335b31c; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Reyes-Gibby C, 2010, J PAIN SYMPTOM MANAG, V39, P882, DOI 10.1016/j.jpainsymman.2009.09.020; Salati Michele, 2009, Interact Cardiovasc Thorac Surg, V8, P79, DOI 10.1510/icvts.2008.184986; Searle Robert D, 2009, Interact Cardiovasc Thorac Surg, V9, P999, DOI 10.1510/icvts.2009.216887; Song JG, 2012, EUR J CARDIO-THORAC, V41, P1078, DOI 10.1093/ejcts/ezr133; Steegers MAH, 2008, J PAIN, V9, P955, DOI 10.1016/j.jpain.2008.05.009; Tiippana E, 2003, ACTA ANAESTH SCAND, V47, P433, DOI 10.1034/j.1399-6576.2003.00056.x; Van de Ven TJ, 2012, CURR OPIN CRIT CARE, V18, P366, DOI 10.1097/MCC.0b013e3283557a7f; VanDenKerkhof EG, 2013, CLIN J PAIN, V29, P2, DOI 10.1097/AJP.0b013e31824730c2; Wang HT, 2012, CHINESE MED J-PEKING, V125, P3033, DOI 10.3760/cma.j.issn.0366-6999.2012.17.012; Wildgaard K, 2013, ACTA ANAESTH SCAND, V57, P776, DOI 10.1111/aas.12077; Wildgaard K, 2011, ACTA ANAESTH SCAND, V55, P60, DOI 10.1111/j.1399-6576.2010.02357.x; Wildgaard K, 2011, PERSISTENT POSTSURGI, V15, P83; Wildgaard K, 2009, EUR J CARDIO-THORAC, V36, P170, DOI 10.1016/j.ejcts.2009.02.005; Wu CL, 2011, LANCET, V377, P2215, DOI 10.1016/S0140-6736(11)60245-6	46	87	94	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90014	10.1371/journal.pone.0090014	http://dx.doi.org/10.1371/journal.pone.0090014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587187	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200112
J	Hill, MP; Terblanche, JS				Hill, Matthew P.; Terblanche, John S.			Niche Overlap of Congeneric Invaders Supports a Single-Species Hypothesis and Provides Insight into Future Invasion Risk: Implications for Global Management of the Bactrocera dorsalis Complex	PLOS ONE			English	Article							ECOLOGICAL-NICHE; FRUIT-FLY; DIPTERA TEPHRITIDAE; DISTRIBUTION MODELS; POTENTIAL DISTRIBUTION; GEOGRAPHIC DISTRIBUTIONS; SHIFTS; RANGE; SPACE; AREA	Background: The invasive fruit fly, Bactrocera invadens, has expanded its range rapidly over the past 10 years. Here we aimed to determine if the recent range expansion of Bactrocera invadens into southern Africa can be better understood through niche exploration tools, ecological niche models (ENMs), and through incorporating information about Bactrocera dorsalis s.s., a putative conspecific species from Asia. We test for niche overlap of environmental variables between Bactrocera invadens and Bactrocera dorsalis s.s. as well as two other putative conspecific species, Bactrocera philippinensis and B. papayae. We examine overlap and similarity in the geographical expression of each species' realised niche through reciprocal distribution models between Africa and Asia. We explore different geographical backgrounds, environmental variables and model complexity with multiple and single Bactrocera species hypotheses in an attempt to predict the recent range expansion of B. invadens into northern parts of South Africa. Principal Findings: Bactrocera invadens has a high degree of niche overlap with B. dorsalis s.s. (and B. philippinensis and B. papayae). Ecological niche models built for Bactrocera dorsalis s.s. have high transferability to describe the range of B. invadens, and B. invadens is able to project to the core range of B. dorsalis s.s. The ENMs of both Bactrocera dorsalis and B. dorsalis combined with B. philipenesis and B. papayae have significantly higher predictive ability to capture the distribution points in South Africa than for B. invadens alone. Conclusions/Significance: Consistent with other studies proposing these Bactrocera species as conspecific, niche similarity and overlap between these species is high. Considering these other Bactrocera dorsalis complex species simultaneously better describes the range expansion and invasion potential of B. invadens in South Africa. We suggest that these species should be considered the same-at least functionally-and global quarantine and management strategies applied equally to these Bactrocera species.	[Hill, Matthew P.; Terblanche, John S.] Univ Stellenbosch, Fac AgriSci, Conservat Ecol & Entomol Dept, Western Cape, South Africa; [Terblanche, John S.] Univ Stellenbosch, Fac AgriSci, Conservat Ecol & Entomol Dept, Ctr Invas Biol, Western Cape, South Africa	Stellenbosch University; Stellenbosch University	Hill, MP (corresponding author), Univ Stellenbosch, Fac AgriSci, Conservat Ecol & Entomol Dept, Western Cape, South Africa.	hillmp@sun.ac.za	Terblanche, John/AAB-4457-2020	Hill, Matthew/0000-0002-7762-5258; Terblanche, John/0000-0001-9665-9405	CIB Core Team Member funding; NRF Incentive Funding for Rated researchers	CIB Core Team Member funding; NRF Incentive Funding for Rated researchers	JST was supported by CIB Core Team Member funding and NRF Incentive Funding for Rated researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; [Anonymous], P 21 INT C MACH LEAR; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; De Meyer M, 2008, J BIOGEOGR, V35, P270, DOI 10.1111/j.1365-2699.2007.01769.x; De Meyer M, 2010, B ENTOMOL RES, V100, P35, DOI 10.1017/S0007485309006713; de Villiers M, 2013, B ENTOMOL RES, V103, P60, DOI 10.1017/S0007485312000454; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Drew RAI, 2005, AFR ENTOMOL, V13, P149; Ekesi S, 2009, J ECON ENTOMOL, V102, P981, DOI 10.1603/029.102.0317; Elith J, 2013, AUSTRALAS PLANT PATH, V42, P43, DOI 10.1007/s13313-012-0178-7; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Herborg LM, 2007, ECOL APPL, V17, P663, DOI 10.1890/06-0239; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MP, 2013, GLOBAL ECOL BIOGEOGR, V22, P942, DOI 10.1111/geb.12059; Hill MP, 2012, AGR FOREST ENTOMOL, V14, P127, DOI 10.1111/j.1461-9563.2011.00544.x; Hill MP, 2012, DIVERS DISTRIB, V18, P191, DOI 10.1111/j.1472-4642.2011.00844.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Karsten M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054281; Khamis FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044862; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Krosch MN, 2013, SYST ENTOMOL, V38, P2, DOI 10.1111/j.1365-3113.2012.00643.x; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Manrakhan A, 2011, AFR ENTOMOL, V19, P650, DOI 10.4001/003.019.0307; Manrakhan A, 2013, 17 C ENT SOC SO AFR; Martinez-Gordillo D, 2010, J EVOLUTION BIOL, V23, P259, DOI 10.1111/j.1420-9101.2009.01897.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Metzger MJ, 2013, GLOBAL ECOL BIOGEOGR, V22, P630, DOI 10.1111/geb.12022; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nyamukondiwa C, 2010, ECOL ENTOMOL, V35, P565, DOI 10.1111/j.1365-2311.2010.01215.x; Ohno S, 2009, APPL ENTOMOL ZOOL, V44, P643, DOI 10.1303/aez.2009.643; Pearman PB, 2010, ECOGRAPHY, V33, P990, DOI 10.1111/j.1600-0587.2010.06443.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; R Core Team, 2021, R LANGUAGE ENV STAT; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Sanchez-Fernandez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048163; Satarkar V. R., 2009, International Journal of Tropical Insect Science, V29, P195, DOI 10.1017/S174275840999035X; Schutze MK, 2013, J ECON ENTOMOL, V106, P695, DOI 10.1603/EC12409; Schutze MK, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-130; Shi W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037083; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2011, REV MEX BIODIVERS, V82, P1348; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Strubbe D, 2009, BIOL INVASIONS, V11, P497, DOI 10.1007/s10530-008-9266-6; Tan KH, 2011, CHEMOECOLOGY, V21, P25, DOI 10.1007/s00049-010-0063-1; Thompson GD, 2011, DIVERS DISTRIB, V17, P1001, DOI 10.1111/j.1472-4642.2011.00820.x; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Venter JH (, 2013, DETECTION BACTROCERA; Wan XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036176; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wellenreuther M, 2012, ECOLOGY, V93, P1353; Wu Zhong-Zheng, 2011, Acta Entomologica Sinica, V54, P149; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	75	44	46	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90121	10.1371/journal.pone.0090121	http://dx.doi.org/10.1371/journal.pone.0090121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587234	gold, Green Published			2022-12-27	WOS:000332390800078
J	Horowitz, G; Ben-Ari, O; Wasserzug, O; Weizman, N; Yehuda, M; Fliss, DM				Horowitz, Gilad; Ben-Ari, Oded; Wasserzug, Oshri; Weizman, Noam; Yehuda, Moshe; Fliss, Dan M.			The Transcervical Approach for Parapharyngeal Space Pleomorphic Adenomas: Indications and Technique	PLOS ONE			English	Article							SURGICAL-MANAGEMENT; TUMORS; SURGERY	Background: Head and Neck Parapharyngeal space tumors are rare. Pleomorphic Adenomas are the most common Parapharyngeal space tumors. The purpose of this study was to define preoperative criteria for enabling full extirpation of parapharyngeal space pleomorphic adenomas via the transcervical approach while minimizing functional and cosmetic morbidity. Methods: The surgical records and medical charts of 19 females and 10 males with parapharyngeal space pleomorphic adenomas operated between 1993 and 2012 were reviewed. Results: Fifteen patients were operated by a simple transcervical approach, 13 by a transparotid transcervical approach, and one by a transmandibular transcervical approach. Complications included facial nerve paralysis, infection, hemorrhage and first bite syndrome. There were three recurrences, but neither recurrence nor complications were associated with the type of surgical approach. Conclusion: A simple transcervical approach is preferred for parapharyngeal space pleomorphic adenomas with narrow attachments to the deep lobe of the parotid gland and for pleomorphic adenomas originating in a minor salivary gland within the parapharyngeal space.	[Horowitz, Gilad; Ben-Ari, Oded; Wasserzug, Oshri; Weizman, Noam; Yehuda, Moshe; Fliss, Dan M.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Otolaryngol Head & Neck & Maxillofacial Surg, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Fliss, DM (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Otolaryngol Head & Neck & Maxillofacial Surg, IL-69978 Tel Aviv, Israel.	danf@tasmc.health.gov.il	Ben-Ari, Oded/AAX-9712-2020					Albergotti WG, 2012, LARYNGOSCOPE, V122, P1954, DOI 10.1002/lary.23396; BASS RM, 1982, HEAD NECK SURG, V4, P281, DOI 10.1002/hed.2890040404; BATSAKIS JG, 1989, ANN OTO RHINOL LARYN, V98, P320, DOI 10.1177/000348948909800416; CARRAU RL, 1990, LARYNGOSCOPE, V100, P583; Cohen SM, 2005, HEAD NECK-J SCI SPEC, V27, P669, DOI 10.1002/hed.20199; Dimitrijevic MV, 2010, INT J ORAL MAX SURG, V39, P983, DOI 10.1016/j.ijom.2010.06.005; FLISS D M, 1992, Ear Nose and Throat Journal, V71, P254; GAUGHRAN G R, 1959, Ann Otol Rhinol Laryngol, V68, P1082; HUGHES KV, 1995, HEAD NECK-J SCI SPEC, V17, P124, DOI 10.1002/hed.2880170209; Infante-Cossio P, 2011, ORAL MAXILLOFAC SURG, V15, P211, DOI 10.1007/s10006-011-0289-2; Khafif A, 2005, OTOLARYNG HEAD NECK, V132, P401, DOI 10.1016/j.otohns.2004.09.062; Malone JP, 2001, ANN OTO RHINOL LARYN, V110, P1093, DOI 10.1177/000348940111001202; Mendelsohn AH, 2009, LARYNGOSCOPE, V119, P2170, DOI 10.1002/lary.20496; O'Malley BW, 2010, ORL-J OTO-RHIN-LARYN, V72, P332, DOI 10.1159/000320596; OLSEN KD, 1994, LARYNGOSCOPE, V104, P1, DOI 10.1288/00005537-199405000-00001; Roh JL, 2008, J SURG ONCOL, V98, P42, DOI 10.1002/jso.21082; SHOSS SM, 1985, ARCH OTOLARYNGOL, V111, P753; Yang TL, 2012, EUR ARCH OTO-RHINO-L, V269, P2097, DOI 10.1007/s00405-011-1855-9; Zhi KQ, 2009, J ORAL MAXIL SURG, V67, P1239, DOI 10.1016/j.joms.2008.09.003	19	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90210	10.1371/journal.pone.0090210	http://dx.doi.org/10.1371/journal.pone.0090210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587286	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800092
J	Whitemarsh, RCM; Tepp, WH; Johnson, EA; Pellett, S				Whitemarsh, Regina Clare Meyer; Tepp, William Howard; Johnson, Eric Arthur; Pellett, Sabine			Persistence of Botulinum Neurotoxin A Subtypes 1-5 in Primary Rat Spinal Cord Cells	PLOS ONE			English	Article							CLOSTRIDIUM-BOTULINUM; GENETIC DIVERSITY; LIGHT-CHAIN; TOXIN; PURIFICATION; SEROTYPES; NEURONS; STRAIN; LOCALIZATION; RECOVERY	Botulinum neurotoxins (BoNTs) are the most poisonous substances known and cause the severe disease botulism. BoNTs have also been remarkably effective as therapeutics in treating many neuronal and neuromuscular disorders. One of the hallmarks of BoNTs, particularly serotype A, is its long persistence of 2-6 months in patients at concentrations as low as fM or pM. The mechanisms for this persistence are currently unclear. In this study we determined the persistence of the BoNT/A subtypes 1 through 5 in primary rat spinal neurons. Remarkably, the duration of intracellular enzymatic activity of BoNT/A1, /A2, /A4 and /A5 was shown to be at least 10 months. Conversely, the effects of BoNT/A3 were observed for up to,5 months. An intermittent dosing with BoNT/E showed intracellular activity of the shorter acting BoNT/E for 2-3 weeks, followed by reoccurrence and persistence of BoNT/A-induced SNAP-25 cleavage products.	[Whitemarsh, Regina Clare Meyer; Tepp, William Howard; Johnson, Eric Arthur; Pellett, Sabine] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pellett, S (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	sludwig@wisc.edu			University of Wisconsin-Madison; National Institute of Allergy and Infectious Diseases [R01AI095274, R01AI093504]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093504, R01AI095274] Funding Source: NIH RePORTER	University of Wisconsin-Madison; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the University of Wisconsin-Madison and the National Institute of Allergy and Infectious Diseases (R01AI095274 and R01AI093504). (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2001, TOXICON, V39, P233, DOI 10.1016/S0041-0101(00)00120-3; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Bradshaw M, 2010, APPL ENVIRON MICROB, V76, P387, DOI 10.1128/AEM.02005-09; Chakraborty S, 2010, NEUROCHEM INT, V56, P727, DOI 10.1016/j.neuint.2010.02.016; DasGupta BR, 2006, J GEN APPL MICROBIOL, V52, P1, DOI 10.2323/jgam.52.1; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; Dineen SS, 2003, CURR MICROBIOL, V46, P345, DOI 10.1007/s00284-002-3851-1; Dolly JO, 2002, SCI THERAPEUTIC ASPE, P91; Dover N, 2014, J INFECT DIS, V209, P192, DOI 10.1093/infdis/jit450; Dover N, 2009, J CLIN MICROBIOL, V47, P2349, DOI 10.1128/JCM.00799-09; Dressler D, 2012, CURR OPIN MICROBIOL, V15, P325, DOI 10.1016/j.mib.2012.05.012; Eleopra R, 1998, NEUROSCI LETT, V256, P135, DOI 10.1016/S0304-3940(98)00775-7; Fernandez-Salas E, 2004, MOVEMENT DISORD, V19, pS23, DOI 10.1002/mds.20006; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; GIMENEZ DF, 1995, INT J FOOD MICROBIOL, V27, P1, DOI 10.1016/0168-1605(94)00144-U; HASSAN SM, 1994, MUSCLE NERVE, V17, P623, DOI 10.1002/mus.880170609; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Jacobson MJ, 2011, APPL ENVIRON MICROB, V77, P4217, DOI 10.1128/AEM.00201-11; Jankovic J, 1997, MUSCLE NERVE, pS129; Keller JE, 2006, NEUROSCIENCE, V139, P629, DOI 10.1016/j.neuroscience.2005.12.029; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Lin GY, 2010, APPL ENVIRON MICROB, V76, P40, DOI 10.1128/AEM.01882-09; Luquez C, 2009, APPL ENVIRON MICROB, V75, P6094, DOI 10.1128/AEM.01009-09; Malizio CJ, 2000, METH MOL B, V145, P27; Meunier FA, 2003, MOL CELL NEUROSCI, V22, P454, DOI 10.1016/S1044-7431(02)00016-7; PATTERSONCURTIS SI, 1989, APPL ENVIRON MICROB, V55, P1544, DOI 10.1128/AEM.55.6.1544-1548.1989; Pellett S, 2007, FEBS LETT, V581, P4803, DOI 10.1016/j.febslet.2007.08.078; Pier CL, 2011, FEBS LETT, V585, P199, DOI 10.1016/j.febslet.2010.11.045; SCHANTZ EJ, 1978, J ASSOC OFF ANA CHEM, V61, P96; SCHANTZ EJ, 1992, MICROBIOL REV, V56, P80, DOI 10.1128/MMBR.56.1.80-99.1992; Smith L. D. S., 1988, BOTULISM ORGANISM IT; Tepp WH, 2012, APPL ENVIRON MICROB, V78, P3108, DOI 10.1128/AEM.07967-11; TIAN WH, 1995, SYNAPSE, V20, P24, DOI 10.1002/syn.890200105; Tsai YC, 2010, P NATL ACAD SCI USA, V107, P16554, DOI 10.1073/pnas.1008302107; Whelchel DD, 2004, MOVEMENT DISORD, V19, pS7, DOI 10.1002/mds.20004; Whitemarsh RCM, 2013, INFECT IMMUN, V81, P3894, DOI 10.1128/IAI.00536-13; Whitemarsh RCM, 2012, TOXICOL SCI, V126, P426, DOI 10.1093/toxsci/kfr354; WILLEMS A, 1993, RES MICROBIOL, V144, P547, DOI 10.1016/0923-2508(93)90004-L	41	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90252	10.1371/journal.pone.0090252	http://dx.doi.org/10.1371/journal.pone.0090252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587301	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800096
J	Markus, MA; Dullin, C; Mitkovski, M; Prieschl-Grassauer, E; Epstein, MM; Alves, F				Markus, M. Andrea; Dullin, Christian; Mitkovski, Miso; Prieschl-Grassauer, Eva; Epstein, Michelle M.; Alves, Frauke			Non-Invasive Optical Imaging of Eosinophilia during the Course of an Experimental Allergic Airways Disease Model and in Response to Therapy	PLOS ONE			English	Article							SIGLEC-F; MURINE MODEL; MOUSE MODEL; MAST-CELLS; ASTHMA; FLUORESCENCE; INFLAMMATION; EXPRESSION; APOPTOSIS; CYTOKINE	Background: Molecular imaging of lung diseases, including asthma, is limited and either invasive or non-specific. Central to the inflammatory process in asthma is the recruitment of eosinophils to the airways, which release proteases and proinflammatory factors and contribute to airway remodeling. The aim of this study was to establish a new approach to non-invasively assess lung eosinophilia during the course of experimental asthma by combining non-invasive near-infrared fluorescence (NIRF) imaging with the specific detection of Siglec-F, a lectin found predominantly on eosinophils. Methodology/Principal Findings: An ovalbumin (OVA)-based model was used to induce asthma-like experimental allergic airway disease (EAAD) in BALB/c mice. By means of a NIRF imager, we demonstrate that 48 h-72 h after intravenous (i.v.) application of a NIRF-labeled anti-Siglec-F antibody, mice with EAAD exhibited up to 2 times higher fluorescence intensities compared to lungs of control mice. Furthermore, average lung intensities of dexamethasone-treated as well as beta-escin-treated mice were 1.8 and 2 times lower than those of untreated, EAAD mice, respectively and correlated with the reduction of cell infiltration in the lung. Average fluorescence intensities measured in explanted lungs confirmed the in vivo findings of significantly higher values in inflamed lungs as compared to controls. Fluorescence microscopy of lung cryosections localized the i.v. applied NIRF-labeled anti-Siglec-F antibody predominantly to eosinophils in the peribronchial areas of EAAD lungs as opposed to control lungs. Conclusion/Significance: We show that monitoring the occurrence of eosinophils, a prominent feature of allergic asthma, by means of a NIRF-labeled antibody directed against Siglec-F is a novel and powerful non-invasive optical imaging approach to assess EAAD and therapeutic response in mice over time.	[Markus, M. Andrea; Alves, Frauke] Univ Med Ctr Gottingen, Dept Haematol & Oncol, Gottingen, Germany; [Dullin, Christian] Univ Med Ctr Gottingen, Dept Diagnost & Intervent Radiol, Gottingen, Germany; [Mitkovski, Miso] Max Planck Inst Expt Med, Light Microscopy Facil, D-37075 Gottingen, Germany; [Prieschl-Grassauer, Eva] Marinomed Biotechnol GmbH, Vienna, Austria; [Epstein, Michelle M.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Alves, Frauke] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany	University of Gottingen; University of Gottingen; Max Planck Society; Medical University of Vienna; Max Planck Society	Markus, MA (corresponding author), Univ Med Ctr Gottingen, Dept Haematol & Oncol, Gottingen, Germany.	andrea.markus@med.uni-goettingen.de		Markus, Andrea/0000-0003-2305-3394; Epstein, Michelle/0000-0002-4755-0224; Mitkovski, Miso/0000-0001-9195-2434; Dullin, Christian/0000-0003-4297-8077	European Commission [GA 230739]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The presented data is part of the P3AGI project (public private partnership for asthma imaging and genomics) funded by the European Commission through an FP7-IAPP Marie Curie Action (GA 230739). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN SJ, 1983, J EXP MED, V158, P946, DOI 10.1084/jem.158.3.946; Al-Hajjaj MS, 2011, ANN THORAC MED, V6, P1, DOI 10.4103/1817-1737.74268; Aysola R, 2010, J MAGN RESON IMAGING, V32, P1379, DOI 10.1002/jmri.22388; Bates JHT, 2009, AM J PHYSIOL-LUNG C, V297, pL401, DOI 10.1152/ajplung.00027.2009; Berlier JE, 2003, J HISTOCHEM CYTOCHEM, V51, P1699, DOI 10.1177/002215540305101214; Biffi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057150; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; Bochner BS, 2009, CLIN EXP ALLERGY, V39, P317, DOI 10.1111/j.1365-2222.2008.03173.x; Bosnjak B, 2014, PULM PHARMACOL THER, V27, P44, DOI 10.1016/j.pupt.2013.09.004; Cortez-Retamozo V, 2008, J CLIN INVEST, V118, P4058, DOI 10.1172/JCI36335; Druilhe A, 2003, APOPTOSIS, V8, P481, DOI 10.1023/A:1025590308147; Dullin C, 2009, MOL IMAGING, V8, P2, DOI 10.2310/7290.2009.00001; Dyer KD, 2011, J IMMUNOL METHODS, V369, P91, DOI 10.1016/j.jim.2011.04.009; Farid SS, 2012, IMMUNOPHARM IMMUNOT, V34, P721, DOI 10.3109/08923973.2011.589453; Feng YH, 2012, J ZHEJIANG UNIV-SC B, V13, P386, DOI 10.1631/jzus.B1100218; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P603, DOI 10.1016/j.jaci.2008.01.008; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Haller J, 2008, J APPL PHYSIOL, V104, P795, DOI 10.1152/japplphysiol.00959.2007; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Jannasch K., 2009, DRUG DISCOV TODAY, V6, P129, DOI DOI 10.1016/J.DDMOD.2009.12.003; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Korideck H, 2009, J PHARMACOL EXP THER, V329, P882, DOI 10.1124/jpet.108.147579; Lindner I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-24; Mao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068143; Mojtabavi N, 2002, J IMMUNOL, V169, P4788, DOI 10.4049/jimmunol.169.9.4788; Napp J, 2011, PEDIATR RADIOL, V41, P161, DOI 10.1007/s00247-010-1907-0; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Ohkawara Y, 1997, AM J RESP CELL MOL, V16, P510, DOI 10.1165/ajrcmb.16.5.9160833; Pappas K, 2013, CYTOKINE, V64, P613, DOI 10.1016/j.cyto.2013.09.010; Rubinstein E, 2011, J PEDIATR GASTR NUTR, V53, P409, DOI 10.1097/MPG.0b013e3182182ff8; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Song DJ, 2009, J IMMUNOL, V183, P5333, DOI 10.4049/jimmunol.0801421; Uller L, 2006, TRENDS PHARMACOL SCI, V27, P461, DOI 10.1016/j.tips.2006.07.006; Wegmann M, 2011, AM J RESP CELL MOL, V45, P667, DOI 10.1165/rcmb.2011-0013TR; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x	39	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90017	10.1371/journal.pone.0090017	http://dx.doi.org/10.1371/journal.pone.0090017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587190	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900109
J	Wang, Y; Zhao, GX; Xu, LH; Liu, KP; Pan, H; He, J; Cai, JY; Ouyang, DY; He, XH				Wang, Yao; Zhao, Gao-Xiang; Xu, Li-Hui; Liu, Kun-Peng; Pan, Hao; He, Jian; Cai, Ji-Ye; Ouyang, Dong-Yun; He, Xian-Hui			Cucurbitacin IIb Exhibits Anti-Inflammatory Activity through Modulating Multiple Cellular Behaviors of Mouse Lymphocytes	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; RELA/P65 NUCLEAR TRANSLOCATION; INFLAMMATORY-BOWEL-DISEASE; ENDOTHELIAL-CELLS; ACTIN AGGREGATION; CAYAPONIA-TAYUYA; FACTOR-ALPHA; MAP KINASES; IN-VIVO	Cucurbitacin IIb (CuIIb) is one of the major active compounds in Hemsleyadine tablets which have been used for clinical treatment of bacillary dysentery, enteritis and acute tonsilitis. However, its action mechanism has not been completely understood. This study aimed to explore the anti-inflammatory activity of CuIIb and its underlying mechanism in mitogen-activated lymphocytes isolated from mouse mesenteric lymph nodes. The results showed that CuIIb inhibited the proliferation of concanavalin A (Con A)-activated lymphocytes in a time-and dose-dependent manner. CuIIb treatment arrested their cell cycle in S and G(2)/M phases probably due to the disruption of the actin cytoskeleton and the modulation of p27(Kip1) and cyclin levels. Moreover, the surface expression of activation markers CD69 and CD25 on Con A-activated CD3(+) T lymphocytes was suppressed by CuIIb treatment. Both Con A-and phorbol ester plus ionomycin-induced expression of TNF-alpha, IFN-gamma and IL-6 proteins was attenuated upon exposure to CuIIb. Mechanistically, CuIIb treatment suppressed the phosphorylation of JNK and Erk1/2 but not p38 in Con A-activated lymphocytes. Although CuIIb unexpectedly enhanced the phosphorylation of I kappa B and NF-kappa B (p65), it blocked the nuclear translocation of NF-kappa B (p65). In support of this, CuIIb significantly decreased the mRNA levels of I kappa B alpha and TNF-alpha, two target genes of NF-kappa B, in Con A-activated lymphocytes. In addition, CuIIb downregulated Con A-induced STAT3 phosphorylation and increased cell apoptosis. Collectively, these results suggest that CuIIb exhibits its anti-inflammatory activity through modulating multiple cellular behaviors and signaling pathways, leading to the suppression of the adaptive immune response.	[Wang, Yao; Zhao, Gao-Xiang; Liu, Kun-Peng; Pan, Hao; He, Jian; Ouyang, Dong-Yun; He, Xian-Hui] Jinan Univ, Dept Immunobiol, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China; [Xu, Li-Hui] Jinan Univ, Dept Cell Biol, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China; [Cai, Ji-Ye] Jinan Univ, Dept Chem, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Ouyang, DY (corresponding author), Jinan Univ, Dept Immunobiol, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China.	dongyun1967@aliyun.com; thexh@jnu.edu.cn	Ouyang, dong-yun/GSD-5233-2022; Ouyang, Dong-Yun/P-7305-2019; Liu, Kunpeng/AAR-7582-2021; He, Xian-Hui/H-3153-2019; 潘, 浩/AAZ-6693-2020; Wang, Yao/AAG-5876-2021	Ouyang, Dong-Yun/0000-0002-4743-942X; Liu, Kunpeng/0000-0003-3452-880X; He, Xian-Hui/0000-0001-7433-7392; 潘, 浩/0000-0002-2049-1842; Cai, Jiye/0000-0002-4791-3320; Xu, Li-hui/0000-0002-2633-9999	Specialized Research Program of 'Twelfth Five-Year Plan' of China [2011ZX09307-303-03]; National Natural Science Foundation of China [81373423, 81173604]; Major State Basic Research Development Program of China ('973' Program) [2010CB833603]	Specialized Research Program of 'Twelfth Five-Year Plan' of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China ('973' Program)(National Basic Research Program of China)	This study was supported by grants from the Specialized Research Program of 'Twelfth Five-Year Plan' of China (2011ZX09307-303-03), the National Natural Science Foundation of China (81373423 and 81173604), and the Major State Basic Research Development Program of China ('973' Program) (No. 2010CB833603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boykin C, 2011, BRIT J CANCER, V104, P781, DOI 10.1038/bjc.2011.10; Chen W.H., 1975, ACTA CHIM SINICA, V33, P49; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Coskun M, 2011, CLIN CHIM ACTA, V412, P513, DOI 10.1016/j.cca.2010.12.020; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Escandell JM, 2010, BRIT J PHARMACOL, V160, P1844, DOI 10.1111/j.1476-5381.2010.00856.x; Escandell JM, 2006, EUR J PHARMACOL, V532, P145, DOI 10.1016/j.ejphar.2005.12.028; Escandell JM, 2007, J PHARMACOL EXP THER, V320, P581, DOI 10.1124/jpet.106.107003; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Gerard C, 2009, P NATL ACAD SCI USA, V106, P21643, DOI 10.1073/pnas.0903827106; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; He J, 2013, INT IMMUNOPHARMACOL, V16, P27, DOI 10.1016/j.intimp.2013.03.013; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Jayaprakasam B, 2003, CANCER LETT, V189, P11, DOI 10.1016/S0304-3835(02)00497-4; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kleindienst P, 2005, IMMUNOLOGY, V115, P556, DOI 10.1111/j.1365-2567.2005.02196.x; Koike T, 2003, J BIOL CHEM, V278, P15685, DOI 10.1074/jbc.M210829200; Korsholm KS, 2010, IMMUNOLOGY, V129, P75, DOI 10.1111/j.1365-2567.2009.03164.x; Larsson BM, 1999, INFLAMMATION, V23, P217; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Ouyang DY, 2013, AUTOPHAGY, V9, P20, DOI 10.4161/auto.22397; Ouyang DY, 2011, ACTA BIOCH BIOPH SIN, V43, P487, DOI 10.1093/abbs/gmr032; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qiao J, 2013, INFLAMM RES, V62, P461, DOI 10.1007/s00011-013-0598-z; Rea IM, 1999, EXP GERONTOL, V34, P79, DOI 10.1016/S0531-5565(98)00058-8; Recio MC, 2004, PLANTA MED, V70, P414, DOI 10.1055/s-2004-818968; Ren S, 2012, CANCER CHEMOTH PHARM, V70, P415, DOI 10.1007/s00280-012-1921-z; Rios JL, 2010, J ETHNOPHARMACOL, V128, P1, DOI 10.1016/j.jep.2009.12.045; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; SAITO S, 1992, IMMUNOLOGY, V75, P710; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shrum CK, 2009, P NATL ACAD SCI USA, V106, P2647, DOI 10.1073/pnas.0806677106; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Yang S.J., 2004, J MED PHARM CHIN MIN, P234, DOI [10.16041/j.cnki.cn15-1175.2004.s1.164, DOI 10.16041/J.CNKI.CN15-1175.2004.S1.164]; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Zhang YT, 2013, J CELL BIOCHEM, V114, P2415, DOI 10.1002/jcb.24587; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757	46	16	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89751	10.1371/journal.pone.0089751	http://dx.doi.org/10.1371/journal.pone.0089751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587010	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900078
J	Breier, M; Wahl, S; Prehn, C; Fugmann, M; Ferrari, U; Weise, M; Banning, F; Seissler, J; Grallert, H; Adamski, J; Lechner, A				Breier, Michaela; Wahl, Simone; Prehn, Cornelia; Fugmann, Marina; Ferrari, Uta; Weise, Michaela; Banning, Friederike; Seissler, Jochen; Grallert, Harald; Adamski, Jerzy; Lechner, Andreas			Targeted Metabolomics Identifies Reliable and Stable Metabolites in Human Serum and Plasma Samples	PLOS ONE			English	Article							WHOLE-BLOOD; STABILITY; SEPARATION; ACID	Background: Information regarding the variability of metabolite levels over time in an individual is required to estimate the reproducibility of metabolite measurements. In intervention studies, it is critical to appropriately judge changes that are elicited by any kind of intervention. The pre-analytic phase (collection, transport and sample processing) is a particularly important component of data quality in multi-center studies. Methods: Reliability of metabolites (within-and between-person variance, intraclass correlation coefficient) and stability (shipment simulation at different temperatures, use of gel-barrier collection tubes, freeze-thaw cycles) were analyzed in fasting serum and plasma samples of 22 healthy human subjects using a targeted LC-MS approach. Results: Reliability of metabolite measurements was higher in serum compared to plasma samples and was good in most saturated short-and medium-chain acylcarnitines, amino acids, biogenic amines, glycerophospholipids, sphingolipids and hexose. The majority of metabolites were stable for 24 h on cool packs and at room temperature in non-centrifuged tubes. Plasma and serum metabolite stability showed good coherence. Serum metabolite concentrations were mostly unaffected by tube type and one or two freeze-thaw cycles. Conclusion: A single time point measurement is assumed to be sufficient for a targeted metabolomics analysis of most metabolites. For shipment, samples should ideally be separated and frozen immediately after collection, as some amino acids and biogenic amines become unstable within 3 h on cool packs. Serum gel-barrier tubes can be used safely for this process as they have no effect on concentration in most metabolites. Shipment of non-centrifuged samples on cool packs is a cost-efficient alternative for most metabolites.	[Breier, Michaela; Wahl, Simone; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Breier, Michaela; Wahl, Simone; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Epidemiol 2, Neuherberg, Germany; [Breier, Michaela; Wahl, Simone; Fugmann, Marina; Ferrari, Uta; Weise, Michaela; Banning, Friederike; Grallert, Harald; Adamski, Jerzy; Lechner, Andreas] German Ctr Diabet Res, Neuherberg, Germany; [Breier, Michaela; Fugmann, Marina; Ferrari, Uta; Weise, Michaela; Banning, Friederike; Seissler, Jochen; Grallert, Harald; Lechner, Andreas] Univ Munich, Clin Cooperat Grp Subclassificat Type Diabet 2, Munich, Germany; [Breier, Michaela; Fugmann, Marina; Ferrari, Uta; Weise, Michaela; Banning, Friederike; Seissler, Jochen; Grallert, Harald; Lechner, Andreas] Helmholtz Zentrum Muenchen, Munich, Germany; [Prehn, Cornelia; Adamski, Jerzy] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany; [Fugmann, Marina; Ferrari, Uta; Weise, Michaela; Banning, Friederike; Seissler, Jochen; Lechner, Andreas] Klinikum Univ Munchen, Diabet Res Grp, Med Klin & Poliklin 4, Munich, Germany; [Adamski, Jerzy] Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich	Breier, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, Neuherberg, Germany.	Michaela.Breier@helmholtz-muenchen.de	Grallert, Harald/B-3424-2013	Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715	German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.) [01GI0925]; Innovative Medicines Initiative Joint Undertaking [115317 (DIRECT)]; Helmholtz association; European Union; EFPIA companies	German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.); Innovative Medicines Initiative Joint Undertaking; Helmholtz association(Helmholtz Association); European Union(European Commission); EFPIA companies	This study was supported in part by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) (URL:http://www.bmbf.de/en/) to the German Center for Diabetes Research (DZD e.V.). The work leading to this publication has received support from the Innovative Medicines Initiative Joint Undertaking (URL:http://www.imi.europa.eu/) under grant agreement no115317 (DIRECT), resources of which are composed of financial contribution from the Helmholtz association (URL:http://www.helmholtz.de/en/), the European Union's Seventh Framework Programme (URL:http://cordis.europa.eu/fp7/home_en.html) (FP7/2007-2013) and EFPIA companies' (URL:http://www.efpia.eu/about-us/membership) in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmaier E, 2011, EUR J EPIDEMIOL, V26, P145, DOI 10.1007/s10654-010-9524-7; Boslem E, 2012, ISLETS, V4, P177, DOI 10.4161/isl.20102; Bruns DE, 2009, CLIN CHEM, V55, P850, DOI 10.1373/clinchem.2009.126037; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Cannan RK, 1928, BIOCHEM J, V22, P920, DOI 10.1042/bj0220920; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Clark S, 2003, INT J EPIDEMIOL, V32, P125, DOI 10.1093/ije/dyg023; Cuhadar S, 2013, BIOCHEM MEDICA, V23, P70, DOI 10.11613/BM.2013.009; Development Core Team R, 2011, R LANG ENV STAT COMP; Floegel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021103; Giltay EJ, 2003, CLIN CHEM, V49, P652, DOI 10.1373/49.4.652; Hollander M, 1973, WILEY SERIES PROBABI, P139; Kaplan LA, 2003, RENAL FUNCTION; Key T, 1996, CANCER EPIDEM BIOMAR, V5, P811; LADENSON JH, 1974, AM J CLIN PATHOL, V62, P545; MA J, 1995, AM J CLIN NUTR, V62, P572, DOI 10.1093/ajcn/62.3.572; Mancinelli A, 2007, CLIN CHIM ACTA, V375, P169, DOI 10.1016/j.cca.2006.06.014; Menni C, 2013, METABOLOMICS, V9, P506, DOI 10.1007/s11306-012-0469-6; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Prajapati B., 2010, OPTOMETRY TODAY, V16; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Rosenling T, 2009, J PROTEOME RES, V8, P5511, DOI 10.1021/pr9005876; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; U.S. Department of Health and Human Services FaDA. USFDA, 2001, GUID IND BIOAN METH; van Eijsden M, 2005, CLIN CHEM, V51, P230; Widjaja A, 1999, CLIN CHEM, V45, P561; Yang W, 2013, ANAL CHEM, V85, P2606, DOI 10.1021/ac303576b; Yin PY, 2013, CLIN CHEM, V59, P833, DOI 10.1373/clinchem.2012.199257; Yu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021230; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2; Zukunft S, 2013, CHROMATOGRAPHIA, V76, P1295, DOI 10.1007/s10337-013-2429-3	31	155	157	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89728	10.1371/journal.pone.0089728	http://dx.doi.org/10.1371/journal.pone.0089728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586991	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700078
J	Chang, WC; Ko, KH; Lin, CS; Hsu, HH; Tsai, SH; Fan, HL; Tung, HJ; Huang, GS; Chen, RC				Chang, Wei-Chou; Ko, Kai-Hsiung; Lin, Chun-Shu; Hsu, Hsian-He; Tsai, Shih-Hung; Fan, Hsiu-Lung; Tung, Ho-Jui; Huang, Guo-Shu; Chen, Ran-Chou			Features on MDCT That Predict Surgery in Patients with Adhesive-Related Small Bowel Obstruction	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; FECES SIGN; INTESTINAL-OBSTRUCTION; CT; DIAGNOSIS; NEED; MANAGEMENT; ISCHEMIA; MODEL	Purpose: The purpose of this study was to determine the contribution of multidetector-row computed tomography (MDCT) in the management of adhesion-related small bowel obstruction (SBO) and to identify its predictive value for surgery. Methods: We conducted a retrospective review of 151 patients over a 5-year period with the diagnosis of SBO caused by adhesion. These patients were divided into two groups: surgery (n = 63) and observation group (n = 88). Two radiologists blinded to the outcome of the patients evaluated MDCT images retrospectively, recording the bowel diameter, bowel wall thickness, degree of obstruction, air-fluid level, mesenteric fatty stranding, transitional zone, intraperitoneal fluid, close loop, whirl sign, and faeces sign. Statistical analyses were performed using univariate and multivariable analyses. Results: Multivariable analysis showed that MDCT demonstrated presence of intraperitoneal fluid (Odds ratio, OR, 4.38), high-grade or complete obstruction (OR, 3.19) and mesenteric fatty stranding (OR, 2.81), and absence of faeces sign (OR, 2.11) were the most significant predictors. When all of the four criteria were used in combination, high sensitivity of 98.4% and specificity of 90.9% were achieved for the prediction for surgery. Conclusion: MDCT is useful to evaluate adhesion-related SBO and to predict accurately patients who require surgery. Use of the four MDCT features in combination is highly suggestive of the need for early surgical intervention.	[Chang, Wei-Chou; Ko, Kai-Hsiung; Hsu, Hsian-He; Huang, Guo-Shu] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chang, Wei-Chou; Chen, Ran-Chou] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lin, Chun-Shu] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Tsai, Shih-Hung] Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Fan, Hsiu-Lung] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Taipei, Taiwan; [Tung, Ho-Jui] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chen, Ran-Chou] Taipei City Hosp, Dept Radiol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Asia University Taiwan; Taipei City Hospital	Chen, RC (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	chenranchou@yahoo.com.tw		Tsai, Shih-Hung/0000-0003-0215-3193	National Science Council [NSC 100-2314-B-016-012]; Tri-Service General Hospital [TSGH-C100-044]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	The study is granted by the National Science Council (NSC 100-2314-B-016-012) and Tri-Service General Hospital (TSGH-C100-044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALTHAZAR EJ, 1992, RADIOLOGY, V185, P769, DOI 10.1148/radiology.185.3.1438761; Delabrousse E, 2005, J RADIOL, V86, P393; Delabrousse E, 2009, AM J ROENTGENOL, V192, P693, DOI 10.2214/AJR.08.1550; Deshmukh SD, 2011, EUR RADIOL, V21, P982, DOI 10.1007/s00330-010-1983-4; Drasin TE, 2008, AM J ROENTGENOL, V191, P1821, DOI 10.2214/AJR.07.3347; Duda JB, 2008, AM J ROENTGENOL, V191, P743, DOI 10.2214/AJR.07.3386; Foster NM, 2006, J AM COLL SURGEONS, V203, P170, DOI 10.1016/j.jamcollsurg.2006.04.020; Furukawa A, 2001, RADIOGRAPHICS, V21, P341, DOI 10.1148/radiographics.21.2.g01mr05341; Hwang JY, 2009, EUR RADIOL, V19, P2425, DOI 10.1007/s00330-009-1424-4; Idris M, 2012, JPN J RADIOL, V30, P235, DOI 10.1007/s11604-011-0038-3; Jacobs SL, 2007, CLIN RADIOL, V62, P353, DOI 10.1016/j.crad.2006.11.007; Jones K, 2007, AM J SURG, V194, P780, DOI 10.1016/j.amjsurg.2007.09.020; Kim JH, 2004, WORLD J SURG, V28, P63, DOI 10.1007/s00268-003-6899-6; Lazarus DE, 2004, AM J ROENTGENOL, V183, P1361, DOI 10.2214/ajr.183.5.1831361; Lujan Henry J, 2006, JSLS, V10, P466; Mallo RD, 2005, J GASTROINTEST SURG, V9, P690, DOI 10.1016/j.gassur.2004.10.006; Petrovic B, 2006, EMERG RADIOL, V12, P88, DOI 10.1007/s10140-005-0450-z; Sheedy SP, 2006, RADIOLOGY, V241, P729, DOI 10.1148/radiol.2413050965; Silva AC, 2009, RADIOGRAPHICS, V29, P423, DOI 10.1148/rg.292085514; Suri S, 1999, ACTA RADIOL, V40, P422, DOI 10.3109/02841859909177758; TAOUREL PG, 1995, AM J ROENTGENOL, V165, P1187, DOI 10.2214/ajr.165.5.7572500; Zielinski MD, 2011, J AM COLL SURGEONS, V212, P1068, DOI 10.1016/j.jamcollsurg.2011.02.023; Zielinski MD, 2010, WORLD J SURG, V34, P910, DOI 10.1007/s00268-010-0479-3	23	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89804	10.1371/journal.pone.0089804	http://dx.doi.org/10.1371/journal.pone.0089804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587047	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700091
J	Huang, WK; Sun, JH; Cui, JK; Wang, GF; Kong, LA; Peng, H; Chen, SL; Peng, DL				Huang, Wen-Kun; Sun, Jian-Hua; Cui, Jiang-Kuan; Wang, Gang-Feng; Kong, Ling-An; Peng, Huan; Chen, Shu-Long; Peng, De-Liang			Efficacy Evaluation of Fungus Syncephalastrum racemosum and Nematicide Avermectin against the Root-Knot Nematode Meloidogyne incognita on Cucumber	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; MANAGEMENT; CROPS	The root-knot nematode (RKN) is one of the most damaging agricultural pests. Effective biological control is need for controlling this destructive pathogen in organic farming system. During October 2010 to 2011, the nematicidal effects of the Syncephalastrum racemosum fungus and the nematicide, avermectin, alone or combined were tested against the RKN (Meloidogyne incognita) on cucumber under pot and field condition in China. Under pot conditions, the application of S. racemosum alone or combined with avermectin significantly increased the plant vigor index by 31.4% and 10.9%, respectively compared to the M. incognita-inoculated control. However, treatment with avermectin alone did not significantly affect the plant vigor index. All treatments reduced the number of root galls and juvenile nematodes compared to the untreated control. Under greenhouse conditions, all treatments reduced the disease severity and enhanced fruit yield compared to the untreated control. Fewer nematodes infecting plant roots were observed after treatment with avermectin alone, S. racemosum alone or their combination compared to the M. incognita-inoculated control. Among all the treatments, application of avermectin or S. racemosum combined with avermectin was more effective than the S. racemosum treatment. Our results showed that application of S. racemosum combined with avermectin not only reduced the nematode number and plant disease severity but also enhanced plant vigor and yield. The results indicated that the combination of S. racemosum with avermectin could be an effective biological component in integrated management of RKN on cucumber.	[Huang, Wen-Kun; Cui, Jiang-Kuan; Wang, Gang-Feng; Kong, Ling-An; Peng, Huan; Peng, De-Liang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Sun, Jian-Hua] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Animals & Plants Resistance, Tianjin, Peoples R China; [Chen, Shu-Long] Hebei Acad Agr & Forestry, Inst Plant Protect, Baoding, Hebei Province, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Tianjin Normal University; Hebei Academy of Agricultural & Forestry Sciences	Peng, DL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	dlpeng@ippcaas.cn			Special Project for Public Agriculture Research and Development of Ministry of Agriculture [201103018]; National Basic Research Program of China (973 Program) [2013CB127502]; National Science Foundation Project [31272022, 31272019]	Special Project for Public Agriculture Research and Development of Ministry of Agriculture; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation Project(National Science Foundation (NSF))	This research work were supported by the Special Project for Public Agriculture Research and Development of Ministry of Agriculture (Project No. 201103018), the National Basic Research Program of China (973 Program, Project No. 2013CB127502) and the National Science Foundation Project (Projects No. 31272022 and No. 31272019). The funders had no role in study design, data collection and analysis, decision to publish of the manuscript.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; ABDULBAK.AA, 1973, CROP SCI, V13, P630, DOI 10.2135/cropsci1973.0011183X001300060013x; Atkins SD, 2003, PEST MANAG SCI, V59, P183, DOI 10.1002/ps.603; BYBD DW, 1983, J NEMATOL, V15, P142; Collange B, 2011, CROP PROT, V30, P1251, DOI 10.1016/j.cropro.2011.04.016; Dong LL, 2012, CROP PROT, V33, P34, DOI 10.1016/j.cropro.2011.11.012; Eisenback J. D., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P95; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; GraeffTeixeira C, 1997, MEM I OSWALDO CRUZ, V92, P399, DOI 10.1590/S0074-02761997000300017; Hallmann J, 2010, ROOT-KNOT NEMATODES, P380, DOI 10.1079/9781845934927.0380; Hashem M, 2011, CROP PROT, V30, P285, DOI 10.1016/j.cropro.2010.12.009; [黄文坤 Huang Wenkun], 2010, [植物保护, Plant Protection], V36, P139; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Kiewnick S, 2006, BIOL CONTROL, V38, P179, DOI 10.1016/j.biocontrol.2005.12.006; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; [李平 Li Ping], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P238; Li XQ, 2008, BIOL CONTROL, V47, P97, DOI 10.1016/j.biocontrol.2008.06.007; Moens M, 2010, ROOT-KNOT NEMATODES, P1; PUTTER I, 1981, EXPERIENTIA, V37, P963, DOI 10.1007/BF01971780; Qiao K, 2012, CROP PROT, V38, P30, DOI 10.1016/j.cropro.2012.03.007; Qiao K, 2011, SCI HORTIC-AMSTERDAM, V130, P570, DOI 10.1016/j.scienta.2011.08.007; Riga E, 2008, BIOL CONTROL, V45, P380, DOI 10.1016/j.biocontrol.2008.01.002; Sahebani N, 2008, SOIL BIOL BIOCHEM, V40, P2016, DOI 10.1016/j.soilbio.2008.03.011; Sikora RA, 2007, AUSTRALAS PLANT PATH, V36, P124, DOI 10.1071/AP07008; Stirling G.R., 1991, BIOL CONTROL PLANT P; Sun J. H., 1999, J YUNNAN AGR U, V14, P122; Sun JH, 2002, HUA BEI NONG XUE BAO, V17, P119; Sun JH, 2008, ANN MICROBIOL, V58, P369, DOI 10.1007/BF03175530; Sun JianHua, 2005, Acta Agriculturae Boreali-Sinica, V20, P74; Tobin JD, 2008, BIOL CONTROL, V46, P194, DOI 10.1016/j.biocontrol.2008.03.014; TOWNSHEND J. L., 1963, NEMATOLOGICA, V9, P106; Wesemael WML, 2011, NEMATOLOGY, V13, P3, DOI 10.1163/138855410X526831; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Zuckerman BM., 1994, JAPANESE J NEMATOLOG, V24, P1, DOI [10.3725/jjn1993.24.1_1, DOI 10.3725/JJN1993.24.1_1]	34	51	59	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89717	10.1371/journal.pone.0089717	http://dx.doi.org/10.1371/journal.pone.0089717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586982	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700076
J	Kuster, TM; Dobbertin, M; Gunthardt-Goerg, MS; Schaub, M; Arend, M				Kuster, Thomas M.; Dobbertin, Matthias; Guenthardt-Goerg, Madeleine S.; Schaub, Marcus; Arend, Matthias			A Phenological Timetable of Oak Growth under Experimental Drought and Air Warming	PLOS ONE			English	Article							DECIDUOUS FOREST TREES; QUERCUS-ROBUR; SHOOT ELONGATION; EUROPEAN OAKS; RESPONSES; TEMPERATURE; SOIL; MODEL; WATER; SEEDLINGS	Climate change is expected to increase temperature and decrease summer precipitation in Central Europe. Little is known about how warming and drought will affect phenological patterns of oaks, which are considered to possess excellent adaptability to these climatic changes. Here, we investigated bud burst and intra-annual shoot growth of Quercus robur, Q. petraea and Q. pubescens grown on two different forest soils and exposed to air warming and drought. Phenological development was assessed over the course of three growing seasons. Warming advanced bud burst by 1-3 days degrees C-1 and led to an earlier start of intra-annual shoot growth. Despite this phenological shift, total time span of annual growth and shoot biomass were not affected. Drought changed the frequency and intensity of intra-annual shoot growth and advanced bud burst in the subsequent spring of a severe summer drought by 1-2 days. After re-wetting, shoot growth recovered within a few days, demonstrating the superior drought tolerance of this tree genus. Our findings show that phenological patterns of oaks are modified by warming and drought but also suggest that ontogenetic factors and/or limitations of water and nutrients counteract warming effects on the biomass and the entire span of annual shoot growth.	[Kuster, Thomas M.; Dobbertin, Matthias; Guenthardt-Goerg, Madeleine S.; Schaub, Marcus; Arend, Matthias] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Kuster, Thomas M.] Swiss Fed Inst Technol, Inst Terr Ecosyst ITES, Zurich, Switzerland; [Kuster, Thomas M.] Univ Manchester, Soil & Ecosyst Ecol Grp, Manchester, Lancs, England	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Manchester	Kuster, TM (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	thomaskuster@gmx.ch	Günthardt-Goerg, Madeleine Silvia/S-2562-2019; Schaub, Marcus/E-4874-2012; Arend, Matthias/L-7795-2013	Günthardt-Goerg, Madeleine Silvia/0000-0003-0468-5302; Schaub, Marcus/0000-0002-0158-8892; Arend, Matthias/0000-0003-4514-0667	Velux foundation [489]	Velux foundation(Velux Fonden)	For funding, the authors are gratefully indebted to the Velux foundation (project number: 489, www.veluxstiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1990, TREE PHYSIOL, V7, P227, DOI 10.1093/treephys/7.1-2-3-4.227; Arend M, 2013, PLANT BIOLOGY, V15, P169, DOI 10.1111/j.1438-8677.2012.00625.x; Arend M, 2011, TREE PHYSIOL, V31, P287, DOI 10.1093/treephys/tpr004; Bergmann W., 1983, ERNAHRUNGSSTORUNGEN, V1st; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bucher-Wallin IK, 2000, PHYTON-ANN REI BOT A, V40, P49; CH2011, 2011, TECHNICAL REPORT, DOI [10.3929/ethz-a-006720559, DOI 10.3929/ETHZ-A-006720559]; Chaar H, 1997, FOREST ECOL MANAG, V97, P119, DOI 10.1016/S0378-1127(97)00093-5; Collet C, 1996, CAN J FOREST RES, V26, P1934, DOI 10.1139/x26-218; Collet C, 1997, ANN SCI FOREST, V54, P65, DOI 10.1051/forest:19970106; Dobbertin M, 2005, EUR J FOREST RES, V124, P319, DOI 10.1007/s10342-005-0085-3; Ehrenberger W, 2012, FUNCT PLANT BIOL, V39, P297, DOI 10.1071/FP11206; Fontaine F, 1999, CAN J BOT, V77, P1623, DOI 10.1139/cjb-77-11-1623; Fonti P, 2013, PLANT BIOLOGY, V15, P210, DOI 10.1111/j.1438-8677.2012.00599.x; Fonti P, 2007, NEW PHYTOL, V173, P562, DOI 10.1111/j.1469-8137.2006.01945.x; Fritts H. C., 1962, Tree-Ring Bulletin, V25, P2; Fu YSH, 2012, ECOL MODEL, V230, P92, DOI 10.1016/j.ecolmodel.2012.01.010; Fu YH, 2012, INT J BIOMETEOROL, V56, P153, DOI 10.1007/s00484-011-0408-7; Gunthardt-Goerg MS, 2013, PLANT BIOLOGY, V15, P1, DOI 10.1111/j.1438-8677.2012.00698.x; Gunthardt-Goerg MS, 2013, PLANT BIOLOGY, V15, P185, DOI 10.1111/j.1438-8677.2012.00665.x; Hanninen H, 2011, TRENDS PLANT SCI, V16, P412, DOI 10.1016/j.tplants.2011.05.001; Hanson PJ, 2001, TREE PHYSIOL, V21, P345, DOI 10.1093/treephys/21.6.345; HARMER R, 1989, FORESTRY, V62, P383, DOI 10.1093/forestry/62.4.383; Hlasny T, 2011, CLIM RES, V47, P219, DOI 10.3354/cr01024; Jayawickrama KJS, 1998, NEW FOREST, V16, P11, DOI 10.1023/A:1016527317326; Johnsen KH, 1996, TREE PHYSIOL, V16, P375; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Kuster TM, 2013, PLANT BIOLOGY, V15, P220, DOI 10.1111/j.1438-8677.2012.00686.x; Kuster TM, 2013, PLANT BIOLOGY, V15, P138, DOI 10.1111/j.1438-8677.2011.00552.x; Kuster TM, 2013, PLANT SOIL, V369, P61, DOI 10.1007/s11104-012-1541-8; Leuzinger S, 2005, TREE PHYSIOL, V25, P641, DOI 10.1093/treephys/25.6.641; Leuzinger S, 2007, GLOBAL CHANGE BIOL, V13, P2498, DOI 10.1111/j.1365-2486.2007.01467.x; Limousin JM, 2012, OECOLOGIA, V169, P565, DOI 10.1007/s00442-011-2221-8; Lof M, 2000, CAN J FOREST RES, V30, P468, DOI 10.1139/cjfr-30-3-468; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Misson L, 2011, GLOBAL CHANGE BIOL, V17, P1036, DOI 10.1111/j.1365-2486.2010.02348.x; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; Myking T, 2007, SCAND J FOREST RES, V22, P369, DOI 10.1080/02827580701672121; NIZINSKI JJ, 1988, J APPL ECOL, V25, P643, DOI 10.2307/2403851; Norby RJ, 2003, GLOBAL CHANGE BIOL, V9, P1792, DOI 10.1111/j.1365-2486.2003.00714.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Renaud V, 2009, AGR FOREST METEOROL, V149, P873, DOI 10.1016/j.agrformet.2008.11.006; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Rohde A, 2011, TREE PHYSIOL, V31, P472, DOI 10.1093/treephys/tpr038; Sanz-Perez V, 2010, TREES-STRUCT FUNCT, V24, P89, DOI 10.1007/s00468-009-0381-5; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soolanayakanahally RY, 2013, PLANT CELL ENVIRON, V36, P116, DOI 10.1111/j.1365-3040.2012.02560.x; Spiess N, 2012, ENVIRON EXP BOT, V77, P117, DOI 10.1016/j.envexpbot.2011.11.010; Thomas FM, 1998, J APPL BOT-ANGEW BOT, V72, P28; Vitasse Y, 2010, FUNCT ECOL, V24, P1211, DOI 10.1111/j.1365-2435.2010.01748.x; Vitasse Y, 2009, OECOLOGIA, V161, P187, DOI 10.1007/s00442-009-1363-4; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Zidia N., 2008, SOIL SAMPLING METHOD, V2, P81	56	48	48	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89724	10.1371/journal.pone.0089724	http://dx.doi.org/10.1371/journal.pone.0089724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586988	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700077
J	Satcher, RL; Pan, TH; Cheng, CJ; Lee, YC; Lin, SC; Yu, GY; Li, XX; Hoang, AG; Tamboli, P; Jonasch, E; Gallick, GE; Lin, SH				Satcher, Robert L.; Pan, Tianhong; Cheng, Chien-Jui; Lee, Yu-Chen; Lin, Song-Chang; Yu, Guoyu; Li, Xiaoxia; Hoang, Anh G.; Tamboli, Pheroze; Jonasch, Eric; Gallick, Gary E.; Lin, Sue-Hwa			Cadherin-11 in Renal Cell Carcinoma Bone Metastasis	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; EXPRESSION; HYPOXIA; GROWTH; CXCR4; COMPLICATIONS; PATHWAY; MOUSE; MET	Bone is one of the common sites of metastases from renal cell carcinoma (RCC), however the mechanism by which RCC preferentially metastasize to bone is poorly understood. Homing/retention of RCC cells to bone and subsequent proliferation are necessary steps for RCC cells to colonize bone. To explore possible mechanisms by which these processes occur, we used an in vivo metastasis model in which 786-O RCC cells were injected into SCID mice intracardially, and organotropic cell lines from bone, liver, and lymph node were selected. The expression of molecules affecting cell adhesion, angiogenesis, and osteolysis were then examined in these selected cells. Cadherin-11, a mesenchymal cadherin mainly expressed in osteoblasts, was significantly increased on the cell surface in bone metastasis-derived 786-O cells (Bo-786-O) compared to parental, liver, or lymph node-derived cells. In contrast, the homing receptor CXCR4 was equivalently expressed in cells derived from all organs. No significant difference was observed in the expression of angiogenic factors, including HIF-1 alpha, VEGF, angiopoeitin-1, Tie2, c-MET, and osteolytic factors, including PTHrP, IL-6 and RANKL. While the parental and Bo-786-O cells have similar proliferation rates, Bo-786-O cells showed an increase in migration compared to the parental 786-O cells. Knockdown of Cadherin-11 using shRNA reduced the rate of migration in Bo-786-O cells, suggesting that Cadherin-11 contributes to the increased migration observed in bone-derived cells. Immunohistochemical analysis of cadherin-11 expression in a human renal carcinoma tissue array showed that the number of human specimens with positive cadherin-11 activity was significantly higher in tumors that metastasized to bone than that in primary tumors. Together, these results suggest that Cadherin-11 may play a role in RCC bone metastasis.	[Satcher, Robert L.; Pan, Tianhong; Lee, Yu-Chen; Lin, Song-Chang; Yu, Guoyu; Li, Xiaoxia; Hoang, Anh G.; Tamboli, Pheroze; Jonasch, Eric; Gallick, Gary E.; Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Cheng, Chien-Jui] Taipei Med Univ, Dept Pathol, Sch Med, Coll Med, Taipei, Taiwan; [Cheng, Chien-Jui] Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan	University of Texas System; UTMD Anderson Cancer Center; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lin, SH (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	slin@mdanderson.org			MDACC Institutional Start-up fund; NIH [CA174798, P50 CA140388, CA16672]; Cancer Prevention and Research Institute of Texas [CPRIT RP110327]; National Natural Science Foundation of China [81101596]; NATIONAL CANCER INSTITUTE [R01CA174798, P50CA140388, P30CA016672] Funding Source: NIH RePORTER	MDACC Institutional Start-up fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from MDACC Institutional Start-up fund, the NIH CA174798, P50 CA140388, CA16672, Cancer Prevention and Research Institute of Texas (CPRIT RP110327), and National Natural Science Foundation of China (Grant No. 81101596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnet S, 2004, ANTICANCER RES, V24, P1705; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; D'Alterio C, 2010, CURR CANCER DRUG TAR, V10, P772, DOI 10.2174/156800910793605839; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fizazi K, 2003, CLIN CANCER RES, V9, P2587; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; Guise TA, 2002, BONE, V30, P670, DOI 10.1016/S8756-3282(02)00685-3; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Harshman LC, 2013, CANCER J, V19, P316, DOI 10.1097/PPO.0b013e31829e3c9a; Haviv YS, 2004, MOL CANCER THER, V3, P687; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Kakonen SM, 2003, CANCER-AM CANCER SOC, V97, P834, DOI 10.1002/cncr.11132; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim M, 2004, BIOCHEM BIOPH RES CO, V320, P945, DOI 10.1016/j.bbrc.2004.06.042; Lee YC, 2013, MOL CANC RES; Lee YC, 2010, J PATHOL, V221, P68, DOI 10.1002/path.2687; Mikami S, 2009, J PATHOL, V218, P530, DOI 10.1002/path.2567; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Murakami T, 2002, CANCER RES, V62, P7328; OKAZAKI M, 1994, J BIOL CHEM, V269, P12092; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Pan TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045183; Sahi Chakshu, 2010, Ther Adv Med Oncol, V2, P75, DOI 10.1177/1758834009358417; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Shiirevnyamba A, 2011, BRIT J CANCER, V104, P505, DOI 10.1038/sj.bjc.6606070; Sottnik JL, 2013, CURR MOL MED, V13, P626; STREWLER GJ, 1983, J CLIN INVEST, V71, P769, DOI 10.1172/JCI110825; Strube A, 2010, CLIN EXP METASTAS, V27, P319, DOI 10.1007/s10585-010-9329-9; Taichman RS, 2002, CANCER RES, V62, P1832; Tamura D, 2008, INT J ONCOL, V33, P17; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Weber K, 2007, CANCER METAST REV, V26, P691, DOI 10.1007/s10555-007-9090-y; Wehler TC, 2008, J ONCOL, V2008, DOI 10.1155/2008/626340; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wood SL, 2012, CANCER TREAT REV, V38, P284, DOI 10.1016/j.ctrv.2011.06.011; Woodward E, 2011, BONE, V48, P160, DOI 10.1016/j.bone.2010.09.008; Xie C, 2012, J ORTHOP RES, V30, P325, DOI 10.1002/jor.21500; Yamakawa M, 2004, AM J PHYSIOL-RENAL, V287, pF649, DOI 10.1152/ajprenal.00028.2004; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zekri J, 2001, INT J ONCOL, V19, P379; Zimmer M, 2004, MOL CANCER RES, V2, P89	48	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89880	10.1371/journal.pone.0089880	http://dx.doi.org/10.1371/journal.pone.0089880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587095	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700109
J	Isoda, K; Takeuchi, T; Kotani, T; Hata, K; Shoda, T; Ishida, T; Yoshida, S; Kimura, Y; Makino, S; Hanafusa, T				Isoda, Kentaro; Takeuchi, Tohru; Kotani, Takuya; Hata, Kenichiro; Shoda, Takeshi; Ishida, Takaaki; Yoshida, Shuzo; Kimura, Yuko; Makino, Shigeki; Hanafusa, Toshiaki			Pre-Treatment Ferritin Level and Alveolar-Arterial Oxygen Gradient Can Predict Mortality Rate Due to Acute/Subacufte Interstitial Pneumonia in Dermatomyositis Treated by Cyclosporine A/Glucocorticosteroid Combination Therapy: A Case Control Study	PLOS ONE			English	Article							LUNG-DISEASE; CYCLOPHOSPHAMIDE; POLYMYOSITIS; PROGNOSIS; CORTICOSTEROIDS; COMPLICATION; MYOSITIS; ANTIBODY; KL-6	Background: Acute/subacute interstitial pneumonia in dermatomyositis (DM-A/SIP) is a disease associated with a poor prognosis that resists treatment with glucocorticosteroids (GC) and progresses rapidly in a period of weeks to months to death. We retrospectively studied outcomes, prognostic factors, and their relations with survival rate in patients with DM-A/SIP treated with early cyclosporine A (CSA)/GC combination therapy and 2-hour postdose blood concentration monitoring. Methods: This study comprised 32 DM-A/SIP patients who were simultaneously treated with CSA and prednisolone. Clinical and laboratory findings were compared between those who died due to DM-A/SIP and those surviving 24 weeks after beginning of therapy. Prognostic factors were extracted, and their relations with the survival rate were evaluated. Results: Of the 32 DM-A/SIP patients, 25 survived, 5 died of DM-A/SIP, and 2 died of infections. In those who died due to DM-A/SIP, ferritin level and the alveolar-arterial oxygen gradient were significantly increased compared with the survivors (P<0.001 and P = 0.002, respectively). Multivariate analyses showed that ferritin and alveolar-arterial oxygen gradient were independent prognostic factors of poor outcome. The survival rate 24 weeks after beginning of treatment was significantly lower in those with a ferritin level of $ 600 ng/ml and alveolar-arterial oxygen gradient of >= 45 Torr (P<0.001 and P<0.001, respectively). All patients with both prognostic factors died, and the outcome was significantly poorer in these patients than in those with one or neither of the prognostic factors (P<0.001). Conclusions: We identified pre-treatment high serum ferritin level and high alveolar-arterial oxygen gradient as poor prognostic factors in DM-A/SIP patients undergoing early CSA/GC combination therapy and showed that the outcomes were poor in patients with both factors.	[Isoda, Kentaro; Takeuchi, Tohru; Kotani, Takuya; Hata, Kenichiro; Shoda, Takeshi; Ishida, Takaaki; Yoshida, Shuzo; Kimura, Yuko; Makino, Shigeki; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 569, Japan	Osaka Medical College	Takeuchi, T (corresponding author), Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 569, Japan.	t-takeuchi@poh.osaka-med.ac.jp						Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Ando M, 2010, CLIN RHEUMATOL, V29, P443, DOI 10.1007/s10067-009-1358-x; Arai S, 2013, MOD RHEUMATOL, V23, P872, DOI [10.3109/s10165-012-0756-0, 10.1007/s10165-012-0756-0]; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Chen F, 2012, RHEUMATOL INT, V32, P3909, DOI 10.1007/s00296-011-2323-y; Gerami P, 2006, J AM ACAD DERMATOL, V54, P597, DOI 10.1016/j.jaad.2005.10.041; Gono T, 2012, RHEUMATOLOGY, V51, P1563, DOI 10.1093/rheumatology/kes102; Gono T, 2010, RHEUMATOLOGY, V49, P1713, DOI 10.1093/rheumatology/keq149; Gono T, 2010, RHEUMATOLOGY, V49, P1354, DOI 10.1093/rheumatology/keq073; Hayashi S, 2008, J RHEUMATOL, V35, P260; Heikkila HP, 2011, J VET INTERN MED, V25, P433, DOI 10.1111/j.1939-1676.2011.0694.x; Ichiyasu H, 2012, MOD RHEUMAT IN PRESS; Kakugawa T, 2008, INTERNAL MED, V47, P785, DOI 10.2169/internalmedicine.47.0639; Kameda H, 2005, J RHEUMATOL, V32, P1719; Koreeda Y, 2010, INTERNAL MED, V49, P361, DOI 10.2169/internalmedicine.49.2889; Kotani T, 2008, J RHEUMATOL, V35, P254; Levy G, 2002, TRANSPLANTATION, V73, pS12, DOI 10.1097/00007890-200205151-00003; Mimori T, 2012, CURR RHEUMATOL REP, V14, P264, DOI 10.1007/s11926-012-0246-6; Miyazaki E, 2007, CLIN RHEUMATOL, V26, P436, DOI 10.1007/s10067-005-0147-4; Morganroth PA, 2010, ARTHRIT CARE RES, V62, P1496, DOI 10.1002/acr.20212; Nagai K, 2011, MOD RHEUMATOL, V21, P32, DOI 10.1007/s10165-010-0342-2; Satoh H, 2006, J INTERN MED, V260, P429, DOI 10.1111/j.1365-2796.2006.01704.x; Sontheimer RD, 2002, DERMATOL CLIN, V20, P387, DOI 10.1016/S0733-8635(02)00021-9; TAZELAAR HD, 1990, AM REV RESPIR DIS, V141, P727, DOI 10.1164/ajrccm/141.3.727; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; Yamasaki Y, 2007, RHEUMATOLOGY, V46, P124, DOI 10.1093/rheumatology/kel112	27	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89610	10.1371/journal.pone.0089610	http://dx.doi.org/10.1371/journal.pone.0089610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586910	Green Published, gold			2022-12-27	WOS:000331717900129
J	Krane-Gartiser, K; Henriksen, TEG; Morken, G; Vaaler, A; Fasmer, OB				Krane-Gartiser, Karoline; Henriksen, Tone Elise Gjotterud; Morken, Gunnar; Vaaler, Arne; Fasmer, Ole Bernt			Actigraphic Assessment of Motor Activity in Acutely Admitted Inpatients with Bipolar Disorder	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CARDIAC AUTONOMIC MODULATION; MAJOR DEPRESSIVE DISORDER; PSYCHOMOTOR ACTIVITY; SLEEP; COMPLEXITY; DISEASE; POLYSOMNOGRAPHY; SCHIZOPHRENIA; DYNAMICS	Introduction: Manla is associated with increased activity, whereas psychomotor retardation is often found in bipolar depression. Actigraphy is a promising tool for monitoring phase shifts and changes following treatment in bipolar disorder. The aim of this study was to compare recordings of motor activity in mania, bipolar depression and healthy controls, using linear and nonlinear analytical methods. Materials and Methods: Recordings from 18 acutely hospitalized inpatients with mania were compared to 12 recordings from bipolar depression inpatients and 28 healthy controls. 24-hour actigraphy recordings and 64-minute periods of continuous motor activity in the morning and evening were analyzed. Mean activity and several measures of variability and complexity were calculated. Results: Patients with depression had a lower mean activity level compared to controls, but higher variability shown by increased standard deviation (SD) and root mean square successive difference (RMSSD) over 24 hours and in the active morning period. The patients with mania had lower first lag autocorrelation compared to controls, and Fourier analysis showed higher variance in the high frequency part of the spectrum corresponding to the period from 2-8 minutes. Both patient groups had a higher RMSSD/SD ratio compared to controls. In patients with mania we found an increased complexity of time series in the active morning period, compared to patients with depression. The findings in the patients with mania are similar to previous findings in patients with schizophrenia and healthy individuals treated with a glutamatergic antagonist. Conclusion: We have found distinctly different activity patterns in hospitalized patients with bipolar disorder in episodes of mania and depression, assessed by actigraphy and analyzed with linear and nonlinear mathematical methods, as well as clear differences between the patients and healthy comparison subjects.	[Krane-Gartiser, Karoline; Morken, Gunnar; Vaaler, Arne] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Krane-Gartiser, Karoline; Morken, Gunnar; Vaaler, Arne] St Olavs Univ Hosp, Dept Psychiat, Trondheim, Norway; [Henriksen, Tone Elise Gjotterud; Fasmer, Ole Bernt] Univ Bergen, Fac Med & Dent, Sect Psychiat, Dept Clin Med, Bergen, Norway; [Henriksen, Tone Elise Gjotterud; Fasmer, Ole Bernt] Valen Hosp, Fonna Reg Hlth Author, Div Mental Hlth Care, Sunnhordland, Norway; [Henriksen, Tone Elise Gjotterud; Fasmer, Ole Bernt] Haukeland Hosp, Div Psychiat, MoodNet Res Grp, N-5021 Bergen, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bergen; University of Bergen; Haukeland University Hospital	Krane-Gartiser, K (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway.	karoline.krane-gartiser@ntnu.no	Henriksen, Tone Elise Gjotterud/AAD-5310-2019; Morken, Gunnar/AAX-3373-2020	Morken, Gunnar/0000-0003-1972-5901	Department of Neuroscience, the Norwegian University of Science and Technology (NTNU), Trondheim, Norway; St. Olav's University Hospital, Trondheim, Norway; Fonna Regional Health Authority; Western Norway Regional Health Authority; MoodNet, a regional research network on mood disorders located at Haukeland University Hospital, Bergen, Norway	Department of Neuroscience, the Norwegian University of Science and Technology (NTNU), Trondheim, Norway; St. Olav's University Hospital, Trondheim, Norway; Fonna Regional Health Authority; Western Norway Regional Health Authority; MoodNet, a regional research network on mood disorders located at Haukeland University Hospital, Bergen, Norway	The patient study was supported by the Department of Neuroscience, the Norwegian University of Science and Technology (NTNU), Trondheim, Norway and St. Olav's University Hospital, Trondheim, Norway. The healthy control study was supported by Fonna Regional Health Authority, the Western Norway Regional Health Authority and MoodNet, a regional research network on mood disorders located at Haukeland University Hospital, Bergen, Norway, also funded by the Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Bahrami B, 2005, NEUROREPORT, V16, P187, DOI 10.1097/00001756-200502080-00025; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; Burton C, 2013, J AFFECT DISORDERS, V145, P21, DOI 10.1016/j.jad.2012.07.001; Buyukdura JS, 2011, PROG NEURO-PSYCHOPH, V35, P395, DOI 10.1016/j.pnpbp.2010.10.019; Chitty KM, 2013, EUR NEUROPSYCHOPHARM, V23, P1348, DOI 10.1016/j.euroneuro.2013.07.007; Faedda Gianni L, 2005, Essent Psychopharmacol, V6, P239; Faurholt-Jepsen M, 2012, J AFFECT DISORDERS, V141, P457, DOI 10.1016/j.jad.2012.02.020; FOSTER FG, 1975, AM J PSYCHIAT, V132, P928; Friedman A, 2007, J MOL NEUROSCI, V32, P72, DOI 10.1007/s12031-007-0016-5; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldberger AL, 1997, PERSPECT BIOL MED, V40, P543; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; Hauge ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016291; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Johnsen E, 2013, ACTA NEUROPSYCHIATR, V25, P105, DOI 10.1111/j.1601-5215.2012.00674.x; Judd LL, 2012, J AFFECT DISORDERS, V138, P440, DOI 10.1016/j.jad.2011.12.046; Kaplan KA, 2012, BIPOLAR DISORD, V14, P870, DOI 10.1111/bdi.12021; KLEIN E, 1991, J NERV MENT DIS, V179, P499, DOI 10.1097/00005053-199108000-00009; Littner M, 2003, SLEEP, V26, P754, DOI 10.1093/sleep/26.6.754; Minassian A, 2010, J AFFECT DISORDERS, V120, P200, DOI 10.1016/j.jad.2009.04.018; Mitchell PB, 2011, BRIT J PSYCHIAT, V199, P303, DOI 10.1192/bjp.bp.110.088823; Mujica-Parodi LR, 2005, NEUROPSYCHOBIOLOGY, V51, P10, DOI 10.1159/000082850; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Park DH, 2007, CHRONOBIOL INT, V24, P905, DOI 10.1080/07420520701669677; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phillips ML, 2013, LANCET, V381, P1663, DOI 10.1016/S0140-6736(13)60989-7; Porta A, 2007, AM J PHYSIOL-HEART C, V293, pH702, DOI 10.1152/ajpheart.00006.2007; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Salvatore P, 2008, BIPOLAR DISORD, V10, P256, DOI 10.1111/j.1399-5618.2007.00505.x; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; TEICHER MH, 1995, HARVARD REV PSYCHIAT, V3, P18, DOI 10.3109/10673229509017161; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; VANHILTEN JJ, 1993, ELECTROEN CLIN NEURO, V89, P359, DOI 10.1016/0168-5597(93)90076-2; Volkers AC, 2003, J AFFECT DISORDERS, V76, P23, DOI 10.1016/S0165-0327(02)00066-6; Wey D, 2012, PHYSIOL BEHAV, V105, P613, DOI 10.1016/j.physbeh.2011.10.006; WOLFF EA, 1985, ARCH GEN PSYCHIAT, V42, P288; Wood AC, 2009, J AM ACAD CHILD PSY, V48, P1023, DOI 10.1097/CHI.0b013e3181b54612	40	72	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89574	10.1371/journal.pone.0089574	http://dx.doi.org/10.1371/journal.pone.0089574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586883	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700129
J	Songstad, NT; Johansen, D; How, OJ; Kaaresen, PI; Ytrehus, K; Acharya, G				Songstad, Nils Thomas; Johansen, David; How, Ole-Jacob; Kaaresen, Per Ivar; Ytrehus, Kirsti; Acharya, Ganesh			Effect of Transverse Aortic Constriction on Cardiac Structure, Function and Gene Expression in Pregnant Rats	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; MYOSIN HEAVY-CHAIN; PRESSURE-OVERLOAD; LEFT-VENTRICLE; HYPERTROPHY; MYOCYTES; FAILURE; WOMEN	Background: There is an increased risk of heart failure and pulmonary edema in pregnancies complicated by hypertensive disorders. However, in a previous study we found that pregnancy protects against fibrosis and preserves angiogenesis in a rat model of angiotensin II induced cardiac hypertrophy. In this study we test the hypothesis that pregnancy protects against negative effects of increased afterload. Methods: Pregnant (gestational day 5.5-8.5) and non-pregnant Wistar rats were randomized to transverse aortic constriction (TAC) or sham surgery. After 14.2 +/- 0.14 days echocardiography was performed. Aortic blood pressure and left ventricular (LV) pressure-volume loops were obtained using a conductance catheter. LV collagen content and cardiomyocyte circumference were measured. Myocardial gene expression was assessed by real-time polymerase chain reaction. Results: Heart weight was increased by TAC (p<0.001) but not by pregnancy. Cardiac myocyte circumference was larger in pregnant compared to non-pregnant rats independent of TAC (p = 0.01), however TAC per se did not affect this parameter. Collagen content in LV myocardium was not affected by pregnancy or TAC. TAC increased stroke work more in pregnant rats (34.1 +/- 2.4 vs 17.5 +/- 2.4 mmHg/mL, p<0.001) than in non-pregnant (28.2 +/- 1.7 vs 20.9 +/- 1.5 mmHg/mL, p = 0.06). However, it did not lead to overt heart failure in any group. In pregnant rats, alpha-MHC gene expression was reduced by TAC. Increased in the expression of beta-MHC gene was higher in pregnant (5-fold) compared to non-pregnant rats (2-fold) after TAC (p = 0.001). Nine out of the 19 genes related to cardiac remodeling were affected by pregnancy independent of TAC. Conclusions: This study did not support the hypothesis that pregnancy is cardioprotective against the negative effects of increased afterload. Some differences in cardiac structure, function and gene expression between pregnant and nonpregnant rats following TAC indicated that afterload increase is less tolerated in pregnancy.	[Songstad, Nils Thomas; Acharya, Ganesh] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Womens Hlth & Perinatol Res Grp, Tromso, Norway; [Songstad, Nils Thomas; Kaaresen, Per Ivar] Univ Hosp Northern Norway, Dept Pediat, Tromso, Norway; [Johansen, David; How, Ole-Jacob; Ytrehus, Kirsti] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Cardiovasc Res Grp, Tromso, Norway; [Kaaresen, Per Ivar] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Pediat Res Grp, Tromso, Norway; [Acharya, Ganesh] Univ Hosp Northern Norway, Dept Obstet & Gynecol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Songstad, NT (corresponding author), Univ Tromso, Fac Hlth Sci, Dept Clin Med, Womens Hlth & Perinatol Res Grp, Tromso, Norway.	nils.songstad@unn.no			Northern Norway Regional Health Authority [1411, 1668, 2038]	Northern Norway Regional Health Authority	This work was supported by research grants from the Northern Norway Regional Health Authority, grant numbers 1411, 1668 and 2038 (http://www.helse-nord.no/about-helse-nord/category5770.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljabri MB, 2011, ACTA PHYSIOL, V201, P445, DOI 10.1111/j.1748-1716.2010.02234.x; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bassien-Capsa V, 2011, CAN J CARDIOL, V27, P834, DOI 10.1016/j.cjca.2011.05.009; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; Conrad KP, 2011, AM J PHYSIOL-REG I, V301, pR267, DOI 10.1152/ajpregu.00156.2011; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Drenthen W, 2007, J AM COLL CARDIOL, V49, P2303, DOI 10.1016/j.jacc.2007.03.027; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Eghbali M, 2006, TRENDS CARDIOVAS MED, V16, P285, DOI 10.1016/j.tcm.2006.07.001; GERDES AM, 1995, J MOL CELL CARDIOL, V27, P849, DOI 10.1016/0022-2828(95)90000-4; GERDES AM, 1986, ANAT RECORD, V215, P420, DOI 10.1002/ar.1092150414; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Gonzalez AMD, 2007, AM J PHYSIOL-HEART C, V293, pH3008, DOI 10.1152/ajpheart.00401.2007; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Iacono A, 2009, AM J HYPERTENS, V22, P777, DOI 10.1038/ajh.2009.68; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Jankowski M, 2005, J ENDOCRINOL, V184, P209, DOI 10.1677/joe.1.05702; Karamlou T, 2011, ANN THORAC SURG, V92, P2193, DOI 10.1016/j.athoracsur.2011.05.088; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Qu P, 2000, HYPERTENS RES, V23, P613, DOI 10.1291/hypres.23.613; Rasband WS, 1997, QUANTIFYING STAINED; Rimbaud S, 2009, J MOL CELL CARDIOL, V46, P952, DOI 10.1016/j.yjmcc.2009.01.013; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; Sciscione AC, 2003, OBSTET GYNECOL, V101, P511, DOI 10.1016/S0029-7844(02)02733-3; Simmons LA, 2002, AM J PHYSIOL-HEART C, V283, pH1627, DOI 10.1152/ajpheart.00966.2001; Slangen BFM, 1996, AM J PHYSIOL-HEART C, V270, pH1779, DOI 10.1152/ajpheart.1996.270.5.H1779; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tournoux F, 2011, J AM SOC ECHOCARDIOG, V24, P465, DOI 10.1016/j.echo.2010.12.019; Virgen-Ortiz A, 2009, J PHYSIOL SCI, V59, P391, DOI 10.1007/s12576-009-0047-5; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941	37	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89559	10.1371/journal.pone.0089559	http://dx.doi.org/10.1371/journal.pone.0089559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586871	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700127
J	Pinho, BR; Sousa, C; Valentao, P; Oliveira, JMA; Andrade, PB				Pinho, Brigida R.; Sousa, Carla; Valentao, Patricia; Oliveira, Jorge M. A.; Andrade, Paula B.			Modulation of Basophils' Degranulation and Allergy-Related Enzymes by Monomeric and Dimeric Naphthoquinones	PLOS ONE			English	Article							RBL-2H3 CELLS; MAST-CELLS; INHIBITORS; HYALURONIDASE; MENADIONE; INFLAMMATION; RELEASE; 15-LIPOXYGENASE; 5-LIPOXYGENASE; METABOLISM	Allergic disorders are characterized by an abnormal immune response towards non-infectious substances, being associated with life quality reduction and potential life-threatening reactions. The increasing prevalence of allergic disorders demands for new and effective anti-allergic treatments. Here we test the anti-allergic potential of monomeric (juglone, menadione, naphthazarin, plumbagin) and dimeric (diospyrin and diosquinone) naphthoquinones. Inhibition of RBL-2H3 rat basophils' degranulation by naphthoquinones was assessed using two complementary stimuli: IgE/antigen and calcium ionophore A23187. Additionally, we tested for the inhibition of leukotrienes production in IgE/antigen-stimulated cells, and studied hyaluronidase and lipoxidase inhibition by naphthoquinones in cell-free assays. Naphthazarin (0.1 mu M) decreased degranulation induced by IgE/antigen but not A23187, suggesting a mechanism upstream of the calcium increase, unlike diospyrin (10 mu M) that reduced degranulation in A23187-stimulated cells. Naphthoquinones were weak hyaluronidase inhibitors, but all inhibited soybean lipoxidase with the most lipophilic diospyrin, diosquinone and menadione being the most potent, thus suggesting a mechanism of competition with natural lipophilic substrates. Menadione was the only naphthoquinone reducing leukotriene C-4 production, with a maximal effect at 5 mu M. This work expands the current knowledge on the biological properties of naphthoquinones, highlighting naphthazarin, diospyrin and menadione as potential lead compounds for structural modification in the process of improving and developing novel anti-allergic drugs.	[Pinho, Brigida R.; Sousa, Carla; Valentao, Patricia; Andrade, Paula B.] Univ Porto, Fac Farm, Dept Quim, REQUIMTE,Lab Farmacognosia, P-4100 Oporto, Portugal; [Oliveira, Jorge M. A.] Univ Porto, Fac Farm, Dept Ciencias Medicamento, REQUIMTE,Lab Farmacol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Andrade, PB (corresponding author), Univ Porto, Fac Farm, Dept Quim, REQUIMTE,Lab Farmacognosia, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	pandrade@ff.up.pt	Andrade, Paula B/A-5900-2008; Pinho, Brígida/L-1504-2016; Valentão, Patrícia/D-4818-2013; Sousa, Carla/D-4989-2013; Oliveira, Jorge M. A./D-4787-2013	Andrade, Paula B/0000-0002-9764-3920; Pinho, Brígida/0000-0002-1627-6795; Valentão, Patrícia/0000-0002-0740-4396; Sousa, Carla/0000-0003-2734-7461; Oliveira, Jorge M. A./0000-0002-6040-5355	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-C/EQB/LA0006/2011]; FCT [SFRH/BD/63852/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) for grant PEst-C/EQB/LA0006/2011. Brigida R. Pinho is grateful to FCT for her PhD fellowship (SFRH/BD/63852/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka R, 1996, INFLAMM RES, V45, P583, DOI 10.1007/BF02312039; Akula US, 2008, J MED PLANTS RES, V2, P207; Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; Anand P, 2012, N-S ARCH PHARMACOL, V385, P657, DOI 10.1007/s00210-012-0757-8; Babula P, 2009, CURR PHARM ANAL, V5, P47, DOI 10.2174/157341209787314936; BARCHOWSKY A, 1989, J CLIN INVEST, V83, P1153, DOI 10.1172/JCI113995; BOTTJER J, 1994, AGENTS ACTIONS, V41, pC28, DOI 10.1007/BF02007752; Broide DH, 2009, ANNU REV MED, V60, P279, DOI 10.1146/annurev.med.60.041807.123524; Burnett BP, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/385780; Calogiuri G, 2010, IMMUNOPHARM IMMUNOT, V32, P700, DOI 10.3109/08923971003685942; Chen BH, 2012, FOOD CHEM, V132, P968, DOI 10.1016/j.foodchem.2011.11.079; Choi Y, 2012, INFLAMMATION, V35, P1904, DOI 10.1007/s10753-012-9513-y; Costa MAC, 1998, PLANTA MED, V64, P391, DOI 10.1055/s-2006-957464; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Ferreres F, 2012, MAR DRUGS, V10, P2766, DOI 10.3390/md10122766; Fujitani N, 2001, J APPL PHYCOL, V13, P489, DOI 10.1023/A:1012592620347; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Gundersen LL, 2003, BIOORGAN MED CHEM, V11, P5409, DOI 10.1016/j.bmc.2003.09.033; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Hsu MF, 2009, EUR J PHARMACOL, V607, P234, DOI 10.1016/j.ejphar.2009.02.005; Huang FH, 2010, ACTA PHARMACOL SIN, V31, P849, DOI 10.1038/aps.2010.63; Hussein Z, 1997, CLIN PHARMACOL THER, V61, P518, DOI 10.1016/S0009-9236(97)90132-6; IGARASHI Y, 1993, IMMUNOPHARMACOLOGY, V25, P131, DOI 10.1016/0162-3109(93)90016-J; Itoh T, 2011, FOOD CHEM, V126, P289, DOI 10.1016/j.foodchem.2010.10.058; Jovanovic DL, 2009, J DERMATOL, V36, P63, DOI 10.1111/j.1346-8138.2008.00588.x; Kawamura F, 2010, BIOL PHARM BULL, V33, P881, DOI 10.1248/bpb.33.881; Kimata M, 2000, PLANTA MED, V66, P25, DOI 10.1055/s-2000-11107; Kohli V, 2011, INT IMMUNOPHARMACOL, V11, P233, DOI 10.1016/j.intimp.2010.11.027; Lien JC, 1997, BIOORGAN MED CHEM, V5, P2111, DOI 10.1016/S0968-0896(97)00133-8; Malterud KE, 2000, J AGR FOOD CHEM, V48, P5576, DOI 10.1021/jf000613v; Passante E, 2009, INFLAMM RES, V58, P611, DOI [10.1007/s00011-009-0028-4, 10.1007/s00011-009-0644-z]; Pinho BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024098; Prigge ST, 1996, PROTEINS, V24, P275; Sakunphueak A, 2012, NAT PROD RES, V26, P1119, DOI 10.1080/14786419.2010.551297; Sarkhel S, 2004, PROTEINS, V54, P247, DOI 10.1002/prot.10567; Singh RK, 2010, PHARMACOLOGY, V85, P336, DOI 10.1159/000312669; Subramaniya BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018695; Takahashi T, 2003, ANAL BIOCHEM, V322, P257, DOI 10.1016/j.ab.2003.08.005; Takano-Ohmuro H, 2008, INFLAMM RES, V57, P484, DOI 10.1007/s00011-008-8067-9; Tewtrakul S, 2006, BIOORGAN MED CHEM, V14, P8707, DOI 10.1016/j.bmc.2006.08.012; Tewtrakul S, 2009, PHYTOMEDICINE, V16, P929, DOI 10.1016/j.phymed.2009.03.010; Umetsu DT, 2006, IMMUNOL REV, V212, P238, DOI 10.1111/j.0105-2896.2006.00413.x; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; Westcott JY, 1996, BBA-LIPID LIPID MET, V1303, P74, DOI 10.1016/0005-2760(96)00074-4; Yingprasertchai S, 2003, TOXICON, V42, P635, DOI 10.1016/j.toxicon.2003.09.001	46	18	20	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90122	10.1371/journal.pone.0090122	http://dx.doi.org/10.1371/journal.pone.0090122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587235	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200132
J	Huber, M; Su, YH; Kruger, M; Faschian, K; Glasauer, S; Hermsdorfer, J				Huber, Markus; Su, Yi-Huang; Krueger, Melanie; Faschian, Katrin; Glasauer, Stefan; Hermsdoerfer, Joachim			Adjustments of Speed and Path when Avoiding Collisions with Another Pedestrian	PLOS ONE			English	Article							GOAL-ORIENTED LOCOMOTION; BEHAVIORAL DYNAMICS; OBSTACLE AVOIDANCE; TRAJECTORIES; COMPLEX; HUMANS; MODEL	When walking in open space, collision avoidance with other pedestrians is a process that successfully takes place many times. To pass another pedestrian (an interferer) walking direction, walking speed or both can be adjusted. Currently, the literature is not yet conclusive of how humans adjust these two parameters in the presence of an interferer. This impedes the development of models predicting general obstacle avoidance strategies in humans' walking behavior. The aim of this study was to investigate the adjustments of path and speed when a pedestrian is crossing a non-reactive human interferer at different angles and speeds, and to compare the results to general model predictions. To do so, we designed an experiment where a pedestrian walked a 12 m distance to reach a goal position. The task was designed in such a way that collision with an interferer would always occur if the pedestrian would not apply a correction of movement path or speed. Results revealed a strong dependence of path and speed adjustments on crossing angle and walking speed, suggesting local planning of the collision avoidance strategy. Crossing at acute angles (i.e. 45 degrees and 90 degrees) seems to require more complex collision avoidance strategies involving both path and speed adjustments than crossing at obtuse angles, where only path adjustments were observed. Overall, the results were incompatible with predictions from existing models of locomotor collision avoidance. The observed initiations of both adjustments suggest a collision avoidance strategy that is temporally controlled. The present study provides a comprehensive picture of human collision avoidance strategies in walking, which can be used to evaluate and adjust existing pedestrian dynamics models, or serve as an empirical basis to develop new models.	[Huber, Markus; Glasauer, Stefan] Univ Munich, Ctr Sensorimotor Res, Inst Clin Neurosci, Munich, Germany; [Su, Yi-Huang; Krueger, Melanie; Faschian, Katrin; Hermsdoerfer, Joachim] Tech Univ Munich, Inst Movement Sci, D-80290 Munich, Germany; [Krueger, Melanie] Univ Munich, Munich Ctr Neurosci Brain & Mind, Munich, Germany; [Glasauer, Stefan] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Glasauer, Stefan] Bernstein Ctr Computat Neurosci Munich, Munich, Germany	University of Munich; Technical University of Munich; University of Munich; University of Munich	Glasauer, S (corresponding author), Univ Munich, Ctr Sensorimotor Res, Inst Clin Neurosci, Munich, Germany.	s.glasauer@lrz.uni-muenchen.de	Krüger, Melanie/AAS-9139-2021; Glasauer, Stefan/A-5898-2008	Krüger, Melanie/0000-0001-5344-5060; Glasauer, Stefan/0000-0002-4313-6210; Su, Yi-Huang/0000-0003-2660-9183	German Research Foundation; German Center for Vertigo and Balance Disorders [BMBF IFB 01EO0901]; Munich Center for Neurosciences - Brain and Mind	German Research Foundation(German Research Foundation (DFG)); German Center for Vertigo and Balance Disorders; Munich Center for Neurosciences - Brain and Mind	This research was financially supported by the Cluster of Excellence "Cognition for Technical Systems" of the German Research Foundation (www.cotesys.org/), the German Center for Vertigo and Balance Disorders (BMBF IFB 01EO0901) and the Munich Center for Neurosciences - Brain and Mind (www.mcn.uni-muenchen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basili P, 2013, GAIT POSTURE, V37, P385, DOI 10.1016/j.gaitpost.2012.08.003; Cinelli M, 2012, EXP BRAIN RES, V219, P175, DOI 10.1007/s00221-012-3077-9; Cinelli ME, 2008, GAIT POSTURE, V28, P596, DOI 10.1016/j.gaitpost.2008.04.006; Cinelli ME, 2007, GAIT POSTURE, V26, P186, DOI 10.1016/j.gaitpost.2006.08.012; Cinelli ME, 2008, HUM MOVEMENT SCI, V27, P513, DOI 10.1016/j.humov.2007.10.001; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Fajen BR, 2007, EXP BRAIN RES, V180, P303, DOI 10.1007/s00221-007-0859-6; Fajen BR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00085; Fox D, 1997, IEEE ROBOT AUTOM MAG, V4, P23, DOI 10.1109/100.580977; Gerin-Lajoie M, 2008, GAIT POSTURE, V27, P239, DOI 10.1016/j.gaitpost.2007.03.015; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; Jansen SEM, 2011, EXP BRAIN RES, V212, P449, DOI 10.1007/s00221-011-2757-1; Karamouzas I, 2009, LECT NOTES COMPUT SC, V5884, P41, DOI 10.1007/978-3-642-10347-6_4; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Moussaid M, 2009, P ROY SOC B-BIOL SCI, V276, P2755, DOI 10.1098/rspb.2009.0405; Olivier AH, 2013, GAIT POSTURE, V38, P751, DOI 10.1016/j.gaitpost.2013.03.017; Olivier AH, 2012, GAIT POSTURE, V36, P399, DOI 10.1016/j.gaitpost.2012.03.021; Ossen S, 2007, TRANSPORT RES REC, P95, DOI 10.3141/1999-11; Paris S, 2007, COMPUT GRAPH FORUM, V26, P665, DOI 10.1111/j.1467-8659.2007.01090.x; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Pham QC, 2007, EUR J NEUROSCI, V26, P2391, DOI 10.1111/j.1460-9568.2007.05835.x; Pham QC, 2009, J NEUROPHYSIOL, V102, P2800, DOI 10.1152/jn.00284.2009; Reynolds CW., 1999, GAM DEV C, P763; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2	27	53	53	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89589	10.1371/journal.pone.0089589	http://dx.doi.org/10.1371/journal.pone.0089589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586895	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000065
J	Tien, KJ; Chou, CW; Lee, SY; Yeh, NC; Yang, CY; Yen, FC; Wang, JJ; Weng, SF				Tien, Kai-Jen; Chou, Chien-Wen; Lee, Shang-Yu; Yeh, Nai-Cheng; Yang, Chwen-Yi; Yen, Feng-Chieh; Wang, Jhi-Joung; Weng, Shih-Feng			Obstructive Sleep Apnea and the Risk of Atopic Dermatitis: A Population-Based Case Control Study	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; DIABETES-MELLITUS; ALLERGIC RHINITIS; OXIDATIVE STRESS; ADIPOSE-TISSUE; ASSOCIATION; PSORIASIS; DISEASES; CONSEQUENCES; EPIDEMIOLOGY	Background: Obstructive sleep apnea (OSA) is associated with systemic inflammation and induces various comorbid medical diseases. To date, no study has explored the relationship between OSA and atopic dermatitis (AD), an inflammatory and autoimmune skin disorder. This study investigated the longitudinal risk for AD in patients with OSA. Methods: A random sample of 1,000,000 individuals from Taiwan's National Health Insurance database was collected. From this sample, 1222 patients with newly-diagnosed OSA between 2000 and 2005 were identified and compared with a matched cohort of 18330 patients without OSA. All patients were tracked for 5.5 years from the index date in order to identify which patients subsequently developed AD. Results: During the 5.5-year follow-up period, the incidence rates of AD in the OSA cohort and comparison groups were 9.81 and 6.21 per 1000 person-years, respectively. After adjustment for age, gender, diabetes, hypertension, coronary heart disease, obesity, allergy, allergic rhinitis, asthma, monthly income, and geographic location, patients with OSA were 1.5-times more likely to develop AD than patients without OSA (95% CI = 1.15-1.95, p = 0.0025). The hazard risk for AD was greater in male OSA patients and young OSA patients (0-18 and 19-34 years), adjusted HRs being 1.53 (95% CI = 1.14-2.06, p = 0.005), 4.01(95% CI = 1.57-10.26, p = 0.0038) and 1.75(95% CI = 1.00-3.04, p = 0.0483), respectively. The log-rank test indicated that OSA patients <35-years-old had significantly higher cumulative incidence rates of AD than those patient of the same age in the comparison group (p = 0.0001). Conclusion: Patients with OSA, especially male patients and younger patients, are at an increased risk for AD later in life.	[Tien, Kai-Jen; Chou, Chien-Wen; Lee, Shang-Yu; Yeh, Nai-Cheng; Yang, Chwen-Yi; Yen, Feng-Chieh] Chi Mei Med Ctr, Div Endocrinol & Metab, Dept Internal Med, Tainan, Taiwan; [Tien, Kai-Jen] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Wang, Jhi-Joung; Weng, Shih-Feng] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Weng, Shih-Feng] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Weng, SF (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	cacmmc@gmail.com		Weng, Shih-Feng/0000-0001-8684-3487				Akmal M. K., 2013, MIDDLE E CURR PSYCHI, V20, P30, DOI DOI 10.1097/01.XME.0000422808.09000.59; Al Lawati NM, 2009, PROG CARDIOVASC DIS, V51, P285, DOI 10.1016/j.pcad.2008.08.001; [Anonymous], 2011, Adv Cardiol, V46, P43, DOI 10.1159/000325105; Attal P, 2010, J CLIN ENDOCR METAB, V95, P483, DOI 10.1210/jc.2009-1912; Beattie PE, 2006, BRIT J DERMATOL, V155, P145, DOI 10.1111/j.1365-2133.2006.07185.x; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Bullo M, 2003, OBES RES, V11, P525, DOI 10.1038/oby.2003.74; Buske-Kirschbaum A, 2002, J CLIN ENDOCR METAB, V87, P4245, DOI 10.1210/jc.2001-010872; Buslau M, 1999, ACTA DERM-VENEREOL, V79, P234; Canguven O, 2013, J SEX MED, V10, P618, DOI 10.1111/j.1743-6109.2012.02786.x; Chan Lawrence S., 2008, V10, P76, DOI 10.1159/000131450; Chen GY, 2008, J FORMOS MED ASSOC, V107, P21, DOI 10.1016/S0929-6646(08)60004-2; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; Chng SY, 2004, PEDIATR PULM, V38, P210, DOI 10.1002/ppul.20075; Cho S, 2010, ANN DERMATOL, V22, P180, DOI 10.5021/ad.2010.22.2.180; Chung SD, 2012, J SEX MED, V9, P679, DOI 10.1111/j.1743-6109.2011.02587.x; Dalamaga M, 2013, SLEEP BREATH, V17, P449, DOI 10.1007/s11325-012-0749-4; Das U N, 2005, J Assoc Physicians India, V53, P472; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Ioja S, 2012, POSTGRAD MED, V124, P119, DOI 10.3810/pgm.2012.07.2573; Karaca S, 2013, SLEEP BREATH, V17, P275, DOI 10.1007/s11325-012-0686-2; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kumar MK, 2012, J CLIN DIAGN RES, V6, P1162; Lin WC, 2012, CURR PSYCHIAT REP, V14, P503, DOI 10.1007/s11920-012-0307-6; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Manigrasso MR, 2005, J CLIN ENDOCR METAB, V90, P5876, DOI 10.1210/jc.2005-0281; Mannarino MR, 2012, EUR J INTERN MED, V23, P586, DOI 10.1016/j.ejim.2012.05.013; Marshall NS, 2007, PEDIATR PULM, V42, P584, DOI 10.1002/ppul.20606; Matin A, 2002, SOUTH MED J, V95, P253; Monahan K, 2011, CURR OPIN CARDIOL, V26, P541, DOI 10.1097/HCO.0b013e32834b806a; Montezano AC, 2012, ANN MED, V44, pS2, DOI 10.3109/07853890.2011.653393; Montnemery Peter, 2003, BMC Dermatol, V3, P4, DOI 10.1186/1471-5945-3-4; MORREN MA, 1994, J AM ACAD DERMATOL, V31, P467, DOI 10.1016/S0190-9622(94)70213-6; Okayama Yoshimichi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P517, DOI 10.2174/1568010054526386; Papadavid E, 2013, J EUR ACAD DERMATOL, V27, P820, DOI 10.1111/j.1468-3083.2012.04580.x; Pratt-Ubunama MN, 2007, CHEST, V131, P453, DOI 10.1378/chest.06-1442; Rosario Inell C, 2011, Minn Med, V94, P44; Schut C, 2013, ACTA DERM-VENEREOL, V93, P57, DOI 10.2340/00015555-1415; Shochat T, 2003, DRUG AGING, V20, P551, DOI 10.2165/00002512-200320080-00001; Silverberg JI, 2012, CURR DERMATOL REP, V1, P168, DOI 10.1007/s13671-012-0021-y; Vieira VJ, 2005, AM J CLIN NUTR, V82, P504, DOI 10.1093/ajcn/82.3.504; Yang YW, 2012, SLEEP MED, V13, P285, DOI 10.1016/j.sleep.2011.07.018; Young Terry, 2009, WMJ, V108, P246; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67	50	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89656	10.1371/journal.pone.0089656	http://dx.doi.org/10.1371/journal.pone.0089656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586942	gold, Green Submitted, Green Published			2022-12-27	WOS:000332385900064
J	Dealtry, S; Ding, GC; Weichelt, V; Dunon, V; Schluter, A; Martini, MC; Del Papa, MF; Lagares, A; Amos, GCA; Wellington, EMH; Gaze, WH; Sipkema, D; Sjoling, S; Springael, D; Heuer, H; van Elsas, JD; Thomas, C; Smalla, K				Dealtry, Simone; Ding, Guo-Chun; Weichelt, Viola; Dunon, Vincent; Schlueter, Andreas; Carla Martini, Maria; Florencia Del Papa, Maria; Lagares, Antonio; Amos, Gregory Charles Auton; Wellington, Elizabeth Margaret Helen; Gaze, William Hugo; Sipkema, Detmer; Sjoling, Sara; Springael, Dirk; Heuer, Holger; van Elsas, Jan Dirk; Thomas, Christopher; Smalla, Kornelia			Cultivation-Independent Screening Revealed Hot Spots of IncP-1, IncP-7 and IncP-9 Plasmid Occurrence in Different Environmental Habitats	PLOS ONE			English	Article							RESISTANCE GENES; NAPHTHALENE; PSEUDOMONAS; ADAPTATION; PREVALENCE; TRANSPOSON; DIVERSITY; SEDIMENT; BIOBEDS	IncP-1, IncP-7 and IncP-9 plasmids often carry genes encoding enzymes involved in the degradation of man-made and natural contaminants, thus contributing to bacterial survival in polluted environments. However, the lack of suitable molecular tools often limits the detection of these plasmids in the environment. In this study, PCR followed by Southern blot hybridization detected the presence of plasmid-specific sequences in total community (TC-) DNA or fosmid DNA from samples originating from different environments and geographic regions. A novel primer system targeting IncP-9 plasmids was developed and applied along with established primers for IncP-1 and IncP-7. Screening TC- DNA from biopurification systems (BPS) which are used on farms for the purification of pesticide-contaminated water revealed high abundances of IncP-1 plasmids belonging to different subgroups as well as IncP-7 and IncP-9. The novel IncP-9 primer-system targeting the rep gene of nine IncP-9 subgroups allowed the detection of a high diversity of IncP-9 plasmid specific sequences in environments with different sources of pollution. Thus polluted sites are "hot spots'' of plasmids potentially carrying catabolic genes.	[Dealtry, Simone; Ding, Guo-Chun; Weichelt, Viola; Heuer, Holger; Smalla, Kornelia] Inst Epidemiol & Pathogen Diagnost, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI, Braunschweig, Germany; [Dunon, Vincent; Springael, Dirk] Katholieke Univ Leuven, Div Soil & Water Management, Heverlee, Belgium; [Schlueter, Andreas] Univ Bielefeld, Ctr Biotechnol CeBiTec, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Carla Martini, Maria; Florencia Del Papa, Maria; Lagares, Antonio] Univ Nacl La Plata, IBBM, CCT CONICET La Plata, Dept Ciencias Biol,Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina; [Amos, Gregory Charles Auton; Wellington, Elizabeth Margaret Helen; Gaze, William Hugo] Univ Warwick, Sch Life Sci, Warwick, England; [Sipkema, Detmer] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Sjoling, Sara] Sodertorns Hogskola Sodertorn Univ, Miljo Medietekn Sch Nat Sci Environm Studies & Me, Inst Nat Vetenskap, Huddinge, Sweden; [van Elsas, Jan Dirk] Univ Groningen, Groningen, Netherlands; [Thomas, Christopher] Univ Birmingham, Sch Biosci, Warwick, England	Julius Kuhn-Institut; KU Leuven; University of Bielefeld; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Warwick; Wageningen University & Research; Sodertorn University; University of Groningen; University of Birmingham	Smalla, K (corresponding author), Inst Epidemiol & Pathogen Diagnost, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI, Braunschweig, Germany.	kornelia.smalla@jki.bund.de	Dunon, Vincent/O-7296-2019; Amos, Gregory/C-8790-2014; Del Papa, María Florencia/AAQ-3046-2021; Smalla, Kornelia/H-4002-2011; Gaze, William/HCH-3571-2022; Thomas, Christopher M/J-8258-2017; Springael, Dirk/D-4085-2014	Dunon, Vincent/0000-0002-6009-2061; Amos, Gregory/0000-0001-9748-1813; Del Papa, María Florencia/0000-0003-0088-6756; Thomas, Christopher M/0000-0002-2810-0455; Wellington, ELizabeth/0000-0002-4329-0699; Gaze, William/0000-0002-9345-6204; ding, guo-chun/0000-0002-5468-5979; Heuer, Holger/0000-0001-6044-8171; Schluter, Andreas/0000-0003-4830-310X; Springael, Dirk/0000-0002-1100-7414	EU [222625]; Inter-University Attraction Pole (IUAP) "mu-manager'' of the Belgian Science Policy (BELSPO) [P7/25]; BBSRC [BB/H531578/1] Funding Source: UKRI; NERC [NE/E004482/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H531578/1] Funding Source: researchfish; Natural Environment Research Council [NE/E004482/1] Funding Source: researchfish	EU(European Commission); Inter-University Attraction Pole (IUAP) "mu-manager'' of the Belgian Science Policy (BELSPO); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by the EU 7th Framework Programme (MetaExplore 222625) and the Inter-University Attraction Pole (IUAP) "mu-manager'' of the Belgian Science Policy (BELSPO, P7/25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl MI, 2009, PLASMID, V62, P134, DOI 10.1016/j.plasmid.2009.05.004; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Castillo MDP, 2008, J AGR FOOD CHEM, V56, P6206, DOI 10.1021/jf800844x; Dunon VSK, 2013, FEMS MICROBIOLOGY EC; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; FETZNER S, 1994, MICROBIOL REV, V58, P641, DOI 10.1128/MMBR.58.4.641-685.1994; Gaze WH, 2011, ISME J, V5, P1253, DOI 10.1038/ismej.2011.15; Gomes NCM, 2010, FEMS MICROBIOL ECOL, V74, P276, DOI 10.1111/j.1574-6941.2010.00962.x; Greated A, 2002, ENVIRON MICROBIOL, V4, P856, DOI 10.1046/j.1462-2920.2002.00305.x; Hardeman F, 2007, FEMS MICROBIOL ECOL, V59, P524, DOI 10.1111/j.1574-6941.2006.00206.x; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Izmalkova TY, 2006, PLASMID, V56, P1, DOI 10.1016/j.plasmid.2005.12.004; Izmalkova TY, 2005, MICROBIOLOGY+, V74, P290, DOI 10.1007/s11021-005-0065-0; Jechalke S, 2013, APPL ENVIRON MICROB, V79, P1410, DOI 10.1128/AEM.03728-12; Jutkina J, 2011, GENES-BASEL, V2, P853, DOI 10.3390/genes2040853; Krol JE, 2012, APPL ENVIRON MICROB, V78, P828, DOI 10.1128/AEM.07480-11; Oliveira CS, 2012, PLASMID, V67, P252, DOI 10.1016/j.plasmid.2011.11.002; Omirou M, 2012, ENVIRON POLLUT, V166, P31, DOI 10.1016/j.envpol.2012.03.001; Schauss K, 2009, TRAC-TREND ANAL CHEM, V28, P612, DOI 10.1016/j.trac.2009.02.009; Sen DY, 2013, MOL BIOL EVOL, V30, P154, DOI 10.1093/molbev/mss210; Sevastsyanovich YR, 2008, MICROBIOL-SGM, V154, P2929, DOI 10.1099/mic.0.2008/017939-0; Sipkema D, 2010, MAR BIOL, V157, P627, DOI 10.1007/s00227-009-1347-2; Smalla K, 2006, APPL ENVIRON MICROB, V72, P7253, DOI 10.1128/AEM.00922-06; Sota M, 2006, J BACTERIOL, V188, P4057, DOI 10.1128/JB.00185-06; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Top EM, 2003, CURR OPIN BIOTECH, V14, P262, DOI 10.1016/S0958-1669(03)00066-1; Trefault N, 2004, ENVIRON MICROBIOL, V6, P655, DOI 10.1111/j.1462-2920.2004.00596.x; Zhou Y, 1996, HUANJING KEXUE, V17, P13	28	28	29	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89922	10.1371/journal.pone.0089922	http://dx.doi.org/10.1371/journal.pone.0089922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587126	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700116
J	Koshimizu, H; Takao, K; Matozaki, T; Ohnishi, H; Miyakawa, T				Koshimizu, Hisatsugu; Takao, Keizo; Matozaki, Takashi; Ohnishi, Hiroshi; Miyakawa, Tsuyoshi			Comprehensive Behavioral Analysis of Cluster of Differentiation 47 Knockout Mice	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; EXPRESSION; CD47; LIGAND; SHP2; ACTIVATION; IAP/CD47; SURVIVAL; ALPHA; CELLS	Cluster of differentiation 47 (CD47) is a member of the immunoglobulin superfamily which functions as a ligand for the extracellular region of signal regulatory protein alpha (SIRP alpha), a protein which is abundantly expressed in the brain. Previous studies, including ours, have demonstrated that both CD47 and SIRP alpha fulfill various functions in the central nervous system (CNS), such as the modulation of synaptic transmission and neuronal cell survival. We previously reported that CD47 is involved in the regulation of depression-like behavior of mice in the forced swim test through its modulation of tyrosine phosphorylation of SIRP alpha. However, other potential behavioral functions of CD47 remain largely unknown. In this study, in an effort to further investigate functional roles of CD47 in the CNS, CD47 knockout (KO) mice and their wild-type littermates were subjected to a battery of behavioral tests. CD47 KO mice displayed decreased prepulse inhibition, while the startle response did not differ between genotypes. The mutants exhibited slightly but significantly decreased sociability and social novelty preference in Crawley's three-chamber social approach test, whereas in social interaction tests in which experimental and stimulus mice have direct contact with each other in a freely moving setting in a novel environment or home cage, there were no significant differences between the genotypes. While previous studies suggested that CD47 regulates fear memory in the inhibitory avoidance test in rodents, our CD47 KO mice exhibited normal fear and spatial memory in the fear conditioning and the Barnes maze tests, respectively. These findings suggest that CD47 is potentially involved in the regulation of sensorimotor gating and social behavior in mice.	[Koshimizu, Hisatsugu; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi, Japan; [Koshimizu, Hisatsugu; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Patterns, Okazaki, Aichi 444, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Genet Engn & Funct Genom Grp, Kyoto, Japan; [Matozaki, Takashi; Ohnishi, Hiroshi] Gunma Univ, Inst Mol & Cellular Regulat, Lab Biosignal Sci, Maebashi, Gunma 371, Japan; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan; [Ohnishi, Hiroshi] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma 371, Japan	Fujita Health University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kyoto University; Gunma University; Kobe University; Gunma University	Ohnishi, H (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Biosignal Sci, Maebashi, Gunma 371, Japan.	ohnishih@gunma-u.ac.jp; miyakawa@fujita-hu.ac.jp	Takao, Keizo/B-9527-2008; Miyakawa, Tsuyoshi/A-7741-2008; Koshimizu, Hisatsugu/AAD-2428-2019	Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Koshimizu, Hisatsugu/0000-0002-8619-6678	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [200163013, 19653081, 21300121, 23500437, 24111546, 24111508]; Core Research for Evolutional Science and Technology (CREST); Institute for Bioinformatics Research and Development (BIRD) of the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [25430077] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Institute for Bioinformatics Research and Development (BIRD) of the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Scientific Research on Priority Areas (200163013), Grant-in-Aid for Exploratory Research (19653081), Grant-in-Aid for Scientific Research (B) (21300121), Grant-in-Aid for Scientific Research (C) (23500437), Scientific Research on Innovative Areas ("Brain Environment'', 24111546 and 24111508), Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network), and Integrative Brain Research (IBR- shien) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and grants from Core Research for Evolutional Science and Technology (CREST) and the Institute for Bioinformatics Research and Development (BIRD) of the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckarsater H, 2006, AM J PSYCHIAT, V163, P1239, DOI 10.1176/appi.ajp.163.7.1239; Araki T, 2000, J NEUROCHEM, V75, P1502, DOI 10.1046/j.1471-4159.2000.0751502.x; Babic I, 2000, J IMMUNOL, V164, P3652, DOI 10.4049/jimmunol.164.7.3652; Bainbridge NK, 2008, BEHAV BRAIN RES, V190, P50, DOI 10.1016/j.bbr.2008.02.001; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chang HP, 1999, LEARN MEMORY, V6, P448, DOI 10.1101/lm.6.5.448; Chen TT, 2004, CANCER RES, V64, P117, DOI 10.1158/0008-5472.CAN-3455-2; Chong ZZ, 2003, CELL MOL NEUROBIOL, V23, P561, DOI 10.1023/A:1025158314016; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Hampton TG, 2004, PHYSIOL BEHAV, V82, P381, DOI 10.1016/j.physbeh.2004.04.006; Hatherley D, 2009, J BIOL CHEM, V284, P26613, DOI 10.1074/jbc.M109.017566; Huang AM, 1998, J NEUROSCI, V18, P4305; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kaidanovich-Beilin O, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-35; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Koshimizu H, 2002, J NEUROCHEM, V82, P249, DOI 10.1046/j.1471-4159.2002.00965.x; Koshimizu H, 2011, CELL MOL NEUROBIOL, V31, P1027, DOI 10.1007/s10571-011-9700-7; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Mi ZP, 2000, J COMP NEUROL, V416, P335; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mulligan SJ, 2002, BIOMED SCI INSTRUM, V38, P77; Narayan S, 2009, J NEUROSCI RES, V87, P278, DOI 10.1002/jnr.21822; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Numakawa T, 2004, J BIOL CHEM, V279, P43245, DOI 10.1074/jbc.M406733200; Ohnishi H, 2005, J NEUROSCI, V25, P2702, DOI 10.1523/JNEUROSCI.5173-04.2005; Ohnishi H, 2010, J NEUROSCI, V30, P10472, DOI 10.1523/JNEUROSCI.0257-10.2010; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Powell E, 1999, PHYSIOL BEHAV, V67, P819, DOI 10.1016/S0031-9384(99)00127-4; REINHOLD MI, 1995, J CELL SCI, V108, P3419; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Takai S, 2002, J NEUROCHEM, V82, P353, DOI 10.1046/j.1471-4159.2002.00960.x; Takao K, 2006, ANN NY ACAD SCI, V1086, P144, DOI 10.1196/annals.1377.008; Takao Keizo, 2006, J Vis Exp, P104, DOI 10.3791/104; Tinsley MR, 2004, LEARN MEMORY, V11, P35, DOI 10.1101/lm.70204; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48	43	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89584	10.1371/journal.pone.0089584	http://dx.doi.org/10.1371/journal.pone.0089584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586890	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700063
J	Martins, KAO; Steffens, JT; van Tongeren, SA; Wells, JB; Bergeron, AA; Dickson, SP; Dye, JM; Salazar, AM; Bavari, S				Martins, Karen A. O.; Steffens, Jesse T.; van Tongeren, Sean A.; Wells, Jay B.; Bergeron, Alison A.; Dickson, Samuel P.; Dye, John M.; Salazar, Andres M.; Bavari, Sina			Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation	PLOS ONE			English	Article							POLYRIBOINOSINIC-POLYRIBOCYTIDYLIC ACID; T-CELL RESPONSES; POLYINOSINIC-POLYCYTIDYLIC ACID; PHASE-II TRIAL; NONHUMAN-PRIMATES; FILOVIRUS VACCINE; NEURO-BLASTOMA; ACUTE-LEUKEMIA; POLY-ICLC; MARBURG	Identifying safe and effective adjuvants is critical for the advanced development of protein-based vaccines. Pattern recognition receptor (PRR) agonists are increasingly being explored as potential adjuvants, but there is concern that the efficacy of these molecules may be dependent on potentially dangerous levels of non-specific immune activation. The filovirus virus-like particle (VLP) vaccine protects mice, guinea pigs, and nonhuman primates from viral challenge. In this study, we explored the impact of a stabilized dsRNA mimic, polyICLC, on VLP vaccination of C57BL/6 mice and Hartley guinea pigs. We show that at dose levels as low as 100 ng, the adjuvant increased the efficacy of the vaccine in mice. Antigen-specific, polyfunctional CD4 and CD8 T cell responses and antibody responses increased significantly upon inclusion of adjuvant. To determine whether the efficacy of polyICLC correlated with systemic immune activation, we examined serum cytokine levels and cellular activation in the draining lymph node. PolyICLC administration was associated with increases in TNF alpha, IL6, MCP1, MIP1 alpha, KC, and MIP1 beta levels in the periphery and with the activation of dendritic cells (DCs), NK cells, and B cells. However, this activation resolved within 24 to 72 hours at efficacious adjuvant dose levels. These studies are the first to examine the polyICLC-induced enhancement of antigen-specific immune responses in the context of non-specific immune activation, and they provide a framework from which to consider adjuvant dose levels.	[Martins, Karen A. O.; Steffens, Jesse T.; van Tongeren, Sean A.; Wells, Jay B.; Bergeron, Alison A.; Bavari, Sina] US Army Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Dye, John M.] US Army Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD USA; [Dickson, Samuel P.] US Army Med Res Inst Infect Dis, Off Regulated Studies, Ft Detrick, MD USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Bavari, S (corresponding author), US Army Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.	sina.bavari@us.army.mil	Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635; Dye, John/0000-0002-0883-5016	Chemical-Biological Medical System-Joint Vaccine Acquisition Program (CBMS-JVAP); Defense Threat Reduction Agency (DTRA) [921159]	Chemical-Biological Medical System-Joint Vaccine Acquisition Program (CBMS-JVAP); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	Chemical-Biological Medical System-Joint Vaccine Acquisition Program (CBMS-JVAP) and Defense Threat Reduction Agency (DTRA) (Project 921159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500; Blaney JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003389; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Brunner R, 2010, IMMUNOL LETT, V128, P29, DOI 10.1016/j.imlet.2009.10.005; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; CHAMPNEY KJ, 1979, INFECT IMMUN, V25, P831, DOI 10.1128/IAI.25.3.831-837.1979; Cho HI, 2009, CANCER RES, V69, P9012, DOI 10.1158/0008-5472.CAN-09-2019; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Falzarano D, 2011, EXPERT REV VACCINES, V10, P63, DOI [10.1586/erv.10.152, 10.1586/ERV.10.152]; Fausther-Bovendo H, 2012, CURR OPIN VIROL, V2, P324, DOI 10.1016/j.coviro.2012.04.003; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; HOUSTON WE, 1976, INFECT IMMUN, V14, P318, DOI 10.1128/IAI.14.1.318-319.1976; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kastenmuller K, 2012, INFECT IMMUN; KROWN SE, 1985, J BIOL RESP MODIF, V4, P640; LAMPKIN BC, 1985, J BIOL RESP MODIF, V4, P531; LAMPKIN BC, 1985, CANCER RES, V45, P5904; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; LEVINE AS, 1978, CANCER TREAT REP, V62, P1907; LEVY HB, 1975, J INFECT DIS, V132, P434, DOI 10.1093/infdis/132.4.434; Li Y, 2011, J GENE MED, V13, P60, DOI 10.1002/jgm.1536; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Martins Karen A. O., 2013, Virologica Sinica, V28, P65, DOI 10.1007/s12250-013-3306-9; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; NORDLUND JJ, 1970, P SOC EXP BIOL MED, V133, P439, DOI 10.3181/00379727-133-34492; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005; Park H, 2013, J IMMUNOL, V190, P4103, DOI 10.4049/jimmunol.1202958; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Puri SK, 1996, J INTERF CYTOK RES, V16, P49, DOI 10.1089/jir.1996.16.49; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Rosenfeld MR, 2010, NEURO-ONCOLOGY, V12, P1071, DOI 10.1093/neuonc/noq071; Salazar AM, 1996, NEUROSURGERY, V38, P1096, DOI 10.1097/00006123-199606000-00006; SAMMONS ML, 1977, ANTIMICROB AGENTS CH, V11, P80, DOI 10.1128/AAC.11.1.80; Shedlock DJ, 2013, MOL THER, V21, P1432, DOI 10.1038/mt.2013.61; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; STEVENSON HC, 1985, J BIOL RESP MODIF, V4, P650; Swenson DL, 2008, CLIN VACCINE IMMUNOL, V15, P460, DOI 10.1128/CVI.00431-07; Swenson DL, 2005, VACCINE, V23, P3033, DOI 10.1016/j.vaccine.2004.11.070; Swenson DL, 2004, FEMS IMMUNOL MED MIC, V40, P27, DOI 10.1016/S0928-8244(03)00273-6; Tarrant JM, 2010, TOXICOL SCI, V117, P4, DOI 10.1093/toxsci/kfq134; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098; Thakur A, 2012, VACCINE, V30, P4907, DOI 10.1016/j.vaccine.2012.05.049; Wahl-Jensen V, 2005, J VIROL, V79, P2413, DOI 10.1128/JVI.79.4.2413-2419.2005; Wang YM, 2010, J IMMUNOL, V184, P2751, DOI 10.4049/jimmunol.0903201; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Warfield KL, 2004, VACCINE, V22, P3495, DOI 10.1016/j.vaccine.2004.01.063; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; WONG G, 2012, SCI TRANSL MED, V4	59	40	43	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89735	10.1371/journal.pone.0089735	http://dx.doi.org/10.1371/journal.pone.0089735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586996	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700079
J	Ren, B; Shen, HF; Lu, ZJ; Liu, HM; Xu, YQ				Ren, Bin; Shen, Huifeng; Lu, Zhi John; Liu, Haiming; Xu, Yuquan			The phzA2-G2 Transcript Exhibits Direct RsmA-Mediated Activation in Pseudomonas aeruginosa M18	PLOS ONE			English	Article							QUORUM-SENSING RESPONSE; MESSENGER-RNA; FUNCTIONAL-ANALYSIS; ANTIBIOTIC BIOSYNTHESIS; POSITIVE REGULATION; ESCHERICHIA-COLI; FLHDC EXPRESSION; PYOCYANIN; CSRA; BINDING	In bacteria, RNA-binding proteins of the RsmA/CsrA family act as post-transcriptional regulators that modulate translation initiation at target transcripts. The Pseudomonas aeruginosa genome contains two phenazine biosynthetic (phz) gene clusters, phzA1-G1 (phz1) and phzA2-G2 (phz2), each of which is responsible for phenazine-1-carboxylic acid (PCA) biosynthesis. In the present study, we show that RsmA exhibits differential gene regulation on two phz clusters in P. aeruginosa M18 at the post-transcriptional level. Based on the sequence analysis, four GGA motifs, the potential RsmA binding sites, are found on the 5'-untranslated region (UTR) of the phz2 transcript. Studies with a series of lacZ reporter fusions, and gel mobility shift assays suggest that the third GGA motif (S3), located 21 nucleotides upstream of the Shine-Dalgarno (SD) sequence, is involved in direct RsmA-mediated activation of phz2 expression. We therefore propose a novel model in which the binding of RsmA to the target S3 results in the destabilization of the stem-loop structure and the enhancement of ribosome access. This model could be fully supported by RNA structure prediction, free energy calculations, and nucleotide replacement studies. In contrast, various RsmA-mediated translation repression mechanisms have been identified in which RsmA binds near the SD sequence of target transcripts, thereby blocking ribosome access. Similarly, RsmA is shown to negatively regulate phz1 expression. Our new findings suggest that the differential regulation exerted by RsmA on the two phz clusters may confer an advantage to P. aeruginosa over other pseudomonads containing only a single phz cluster in their genomes.	[Ren, Bin; Shen, Huifeng; Liu, Haiming; Xu, Yuquan] Shanghai Jiao Tong Univ, SKLMM Life Sci & Biotechnol Sch, Shanghai 200030, Peoples R China; [Lu, Zhi John] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	Shanghai Jiao Tong University; Tsinghua University	Xu, YQ (corresponding author), Shanghai Jiao Tong Univ, SKLMM Life Sci & Biotechnol Sch, Shanghai 200030, Peoples R China.	xuyq@sjtu.edu.cn			National Key Basic Research Programme (973 Programme) [2009CB118906]; Shanghai Science Technology Programme [08391911900]	National Key Basic Research Programme (973 Programme); Shanghai Science Technology Programme	This work was supported by the research grant of the National Key Basic Research Programme (973 Programme, No. 2009CB118906) and the Shanghai Science Technology Programme (No. 08391911900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; Bardill JP, 2011, MOL MICROBIOL, V80, P1381, DOI 10.1111/j.1365-2958.2011.07655.x; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Fitzpatrick DA, 2009, J MOL EVOL, V68, P171, DOI 10.1007/s00239-009-9198-5; Ge YH, 2004, FEMS MICROBIOL LETT, V237, P41, DOI [10.1016/j.femsle.2004.06.028, 10.1111/j.1574-6968.2004.tb09676.x]; Gonzalez N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-167; Greenhagen BT, 2008, BIOCHEMISTRY-US, V47, P5281, DOI 10.1021/bi702480t; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Heeb S, 2006, J MOL BIOL, V355, P1026, DOI 10.1016/j.jmb.2005.11.045; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huang JF, 2009, APPL ENVIRON MICROB, V75, P6568, DOI 10.1128/AEM.01148-09; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; KING EO, 1954, J LAB CLIN MED, V44, P301; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lapouge K, 2007, MOL MICROBIOL, V66, P341, DOI 10.1111/j.1365-2958.2007.05909.x; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; LEVITCH ME, 1964, ARCH BIOCHEM BIOPHYS, V106, P194, DOI 10.1016/0003-9861(64)90175-4; Li YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019413; Liang HH, 2008, J BACTERIOL, V190, P6217, DOI 10.1128/JB.00428-08; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Liu Y, 1998, MOL MICROBIOL, V29, P219, DOI 10.1046/j.1365-2958.1998.00924.x; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Marden JN, 2013, P NATL ACAD SCI USA, V110, P15055, DOI 10.1073/pnas.1307217110; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MAZZOLA M, 1992, APPL ENVIRON MICROB, V58, P2616, DOI 10.1128/AEM.58.8.2616-2624.1992; Mentel M, 2009, CHEMBIOCHEM, V10, P2295, DOI 10.1002/cbic.200900323; Mercante J, 2009, J MOL BIOL, V392, P511, DOI 10.1016/j.jmb.2009.07.034; Morris ER, 2013, STRUCTURE, V21, P1659, DOI 10.1016/j.str.2013.07.007; Parsons JF, 2007, BIOCHEMISTRY-US, V46, P1821, DOI 10.1021/bi6024403; Patterson-Fortin LM, 2013, J MOL BIOL, V425, P3662, DOI 10.1016/j.jmb.2012.12.010; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Sambrook J., 2001, MOL CLONING LAB MANU; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Wang GH, 2012, J BACTERIOL, V194, P2443, DOI 10.1128/JB.00029-12; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Yakhnin AV, 2013, MOL MICROBIOL, V87, P851, DOI 10.1111/mmi.12136; Zhang XH, 2005, WORLD J MICROB BIOT, V21, P883, DOI 10.1007/s11274-004-6358-z; Zuckerkandl E, 2001, J MOL EVOL, V53, P539, DOI 10.1007/s002390010244; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	31	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89653	10.1371/journal.pone.0089653	http://dx.doi.org/10.1371/journal.pone.0089653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586939	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700070
J	Sterken, MG; Snoek, LB; Bosman, KJ; Daamen, J; Riksen, JAG; Bakker, J; Pijlman, GP; Kammenga, JE				Sterken, Mark G.; Snoek, L. Basten; Bosman, Kobus J.; Daamen, Jikke; Riksen, Joost A. G.; Bakker, Jaap; Pijlman, Gorben P.; Kammenga, Jan E.			A Heritable Antiviral RNAi Response Limits Orsay Virus Infection in Caenorhabditis elegans N2	PLOS ONE			English	Article							GENE-EXPRESSION; C. ELEGANS; INTERFERENCE; REQUIREMENTS; INHERITANCE; ENVIRONMENT; GENOTYPE; RDE-4	Orsay virus (OrV) is the first virus known to be able to complete a full infection cycle in the model nematode species Caenorhabditis elegans. OrV is transmitted horizontally and its infection is limited by antiviral RNA interference (RNAi). However, we have no insight into the kinetics of OrV replication in C. elegans. We developed an assay that infects worms in liquid, allowing precise monitoring of the infection. The assay revealed a dual role for the RNAi response in limiting Orsay virus infection in C. elegans. Firstly, it limits the progression of the initial infection at the step of recognition of dsRNA. Secondly, it provides an inherited protection against infection in the offspring. This establishes the heritable RNAi response as anti-viral mechanism during OrV infections in C. elegans. Our results further illustrate that the inheritance of the anti-viral response is important in controlling the infection in the canonical wild type Bristol N2. The OrV replication kinetics were established throughout the worm life-cycle, setting a standard for further quantitative assays with the OrV-C. elegans infection model.	[Sterken, Mark G.; Snoek, L. Basten; Bosman, Kobus J.; Daamen, Jikke; Riksen, Joost A. G.; Bakker, Jaap; Kammenga, Jan E.] Wageningen Univ, Nematol Lab, NL-6700 AP Wageningen, Netherlands; [Sterken, Mark G.; Pijlman, Gorben P.] Wageningen Univ, Virol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Kammenga, JE (corresponding author), Wageningen Univ, Nematol Lab, NL-6700 AP Wageningen, Netherlands.	jan.kammenga@wur.nl	Snoek, Basten L/E-4713-2014	Snoek, Basten L/0000-0001-5321-2996; Sterken, Mark/0000-0001-7119-6213; Pijlman, Gorben/0000-0001-9301-0408	Graduate School Production Ecology & Resource Conservation (PERC); ERASysbio-plus ZonMW [90201066]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Graduate School Production Ecology & Resource Conservation (PERC); ERASysbio-plus ZonMW; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MGS was funded by the Graduate School Production Ecology & Resource Conservation (PE&RC). LBS was funded by ERASysbio-plus ZonMW project 90201066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun ZF, 2009, ALIMENTARY SYSTEM IN; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Ashe A, 2013, ELIFE, V2, DOI 10.7554/eLife.00994; Bates D.M., 1992, STAT MODELS S; Blanchard D, 2011, RNA BIOL, V8, P458, DOI 10.4161/rna.8.3.14657; BRENNER S, 1974, GENETICS, V77, P71; Elvin M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-510; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Franz CJ, 2014, VIROLOGY, V448, P255, DOI 10.1016/j.virol.2013.09.024; Franz CJ, 2012, J VIROL, V86, P11940, DOI 10.1128/JVI.02025-12; Grishkevich V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.19; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Guo XY, 2013, P NATL ACAD SCI USA, V110, P16085, DOI 10.1073/pnas.1307453110; Jager T, 2005, FUNCT ECOL, V19, P136, DOI 10.1111/j.0269-8463.2005.00941.x; Kammenga JE, 2008, TRENDS GENET, V24, P178, DOI 10.1016/j.tig.2008.01.001; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kirienko NV, 2010, DEV DYNAM, V239, P1413, DOI 10.1002/dvdy.22247; Le Novere N, 2001, BIOINFORMATICS, V17, P1226, DOI 10.1093/bioinformatics/17.12.1226; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Marsh EK, 2012, APPL ENVIRON MICROB, V78, P2075, DOI 10.1128/AEM.07486-11; Parrish S, 2001, RNA, V7, P1397; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Sarkies P, 2013, GENOME RES, V23, P1258, DOI 10.1101/gr.153296.112; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Snoek LB, 2014, SCI REP-UK, V4, DOI 10.1038/srep03912; Sundaram P, 2008, GENETICS, V178, P801, DOI 10.1534/genetics.107.081588; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Volkers RJM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-93; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957	37	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89760	10.1371/journal.pone.0089760	http://dx.doi.org/10.1371/journal.pone.0089760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587016	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700088
J	Tanvig, M; Vinter, CA; Jorgensen, JS; Wehberg, S; Ovesen, PG; Lamont, RF; Beck-Nielsen, H; Christesen, HT; Jensen, DM				Tanvig, Mette; Vinter, Christina A.; Jorgensen, Jan S.; Wehberg, Sonja; Ovesen, Per G.; Lamont, Ronald F.; Beck-Nielsen, Henning; Christesen, Henrik T.; Jensen, Dorte M.			Anthropometrics and Body Composition by Dual Energy X-Ray in Children of Obese Women: A Follow-Up of a Randomized Controlled Trial (the Lifestyle in Pregnancy and Offspring [LiPO] Study)	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; MASS INDEX; CHILDHOOD OBESITY; MATERNAL OBESITY; RISK-FACTORS; OVERWEIGHT; ADULTHOOD; INTERVENTION; ASSOCIATION; PREVALENCE	Objective: In obese women, 1) to assess whether lower gestational weight gain (GWG) during pregnancy in the lifestyle intervention group of a randomized controlled trial (RCT) resulted in differences in offspring anthropometrics and body composition, and 2) to compare offspring outcomes to a reference group of children born to women with a normal Body Mass Index (BMI). Research design and methods: The LiPO (Lifestyle in Pregnancy and Offspring) study was an offspring follow-up of a RCT with 360 obese pregnant women with a lifestyle intervention during pregnancy including dietary advice, coaching and exercise. The trial was completed by 301 women who were eligible for follow-up. In addition, to the children from the RCT, a group of children born to women with a normal BMI were included as a reference group. At 2.8 (range 2.5-3.2) years, anthropometrics were measured in 157 children of the RCT mothers and in 97 reference group children with Body Mass Index (BMI) Z-score as a primary outcome. Body composition was estimated by Dual Energy X-ray (DEXA) in 123 successful scans out of 147 (84%). Results: No differences between randomized groups were seen in mean (95% C. I.) BMI Z-score (intervention group 0.06 [-0.17; 0.29] vs. controls -0.18 [-0.43; 0.05]), in the percentage of overweight or obese children (10.9% vs. 6.7%), in other anthropometrics, or in body composition values by DEXA. Outcomes between children from the RCT and the reference group children were not significantly different. Conclusions: The RCT with lifestyle intervention in obese pregnant women did not result in any detectable effect on offspring anthropometrics or body composition by DEXA at 2.8 years of age. This may reflect the limited difference in GWG between intervention and control groups. Offspring of obese mothers from the RCT were comparable to offspring of mothers with a normal BMI.	[Tanvig, Mette; Beck-Nielsen, Henning; Jensen, Dorte M.] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Tanvig, Mette; Vinter, Christina A.; Jorgensen, Jan S.; Lamont, Ronald F.] Odense Univ Hosp, Dept Gynecol & Obstet, DK-5000 Odense, Denmark; [Tanvig, Mette; Vinter, Christina A.; Jorgensen, Jan S.; Wehberg, Sonja; Beck-Nielsen, Henning; Christesen, Henrik T.; Jensen, Dorte M.] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Wehberg, Sonja] Odense Univ Hosp, Ctr Clin Epidemiol, DK-5000 Odense, Denmark; [Ovesen, Per G.] Aarhus Univ Hosp, Dept Gynecol & Obstet, Skejby, Denmark; [Lamont, Ronald F.] UCL, Div Surg, London, England; [Christesen, Henrik T.] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Aarhus University; University of London; University College London; University of Southern Denmark; Odense University Hospital	Tanvig, M (corresponding author), Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark.	mette.tanvig@rsyd.dk	Jensen, Dorte Møller/T-6656-2019; Christesen, Henrik/AAR-9023-2021	Jensen, Dorte Møller/0000-0002-3298-9824; Christesen, Henrik/0000-0001-5330-6853; Wehberg, Sonja/0000-0003-1503-2649; jorgensen, jan stener/0000-0001-5222-2535; Vinter, Christina/0000-0001-5084-6053	Odense University Hospital; Hede Nielsen Family foundation; A.P. Moller Foundation; Region of Southern Denmark	Odense University Hospital; Hede Nielsen Family foundation; A.P. Moller Foundation; Region of Southern Denmark	Funding for this study was obtained from Odense University Hospital, The Hede Nielsen Family foundation, The A.P. Moller Foundation for the Advancement of Medical Science and Sister lodge No. 3 Freja I.O.O.F. MT is a recipient of PhD scholarships from The Region of Southern Denmark, The faculty of Health sciences, University of Southern Denmark and The Danish PhD school of Molecular Metabolism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo KB, 2013, CONTEMP CLIN TRIALS, V35, P87, DOI 10.1016/j.cct.2013.02.010; Andersen CS, 2011, INT J PEDIATR OBES, V6, pE179, DOI 10.3109/17477166.2010.521560; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Euser AM, 2008, HORM RES, V70, P319, DOI 10.1159/000161862; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Gillman MW, 2010, DIABETES CARE, V33, P964, DOI 10.2337/dc09-1810; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hinkle SN, 2012, J NUTR, V142, P1851, DOI 10.3945/jn.112.161158; Jensen SM, 2015, MATERN CHILD NUTR, V11, P398, DOI 10.1111/mcn.12013; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Larsen LM, 2012, ACTA PAEDIATR, V101, P201, DOI 10.1111/j.1651-2227.2011.02551.x; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; Mustila T, 2012, J NEGAT RESULTS BIOM, V11, DOI 10.1186/1477-5751-11-11; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Plagemann A, 2005, PHYSIOL BEHAV, V86, P661, DOI 10.1016/j.physbeh.2005.08.065; Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1; Rowan JA, 2011, DIABETES CARE, V34, P2279, DOI 10.2337/dc11-0660; Tanvig M, 2013, BJOG-INT J OBSTET GY, V120, P320, DOI 10.1111/1471-0528.12062; Thangaratinam S, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16310; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150; Weng SF, 2012, ARCH DIS CHILD, V97, P1019, DOI 10.1136/archdischild-2012-302263; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Wolff S, 2008, INT J OBESITY, V32, P495, DOI 10.1038/sj.ijo.0803710	31	37	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89590	10.1371/journal.pone.0089590	http://dx.doi.org/10.1371/journal.pone.0089590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586896	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700064
J	Leone, FA; Bezerra, TMS; Garcon, DP; Lucena, MN; Pinto, MR; Fontes, CFL; McNamara, JC				Leone, Francisco A.; Bezerra, Thais M. S.; Garcon, Daniela P.; Lucena, Malson N.; Pinto, Marcelo R.; Fontes, Carlos F. L.; McNamara, John C.			Modulation By K+ Plus NH4+ of Microsomal (Na+, K+)ATPase Activity in Selected Ontogenetic Stages of the Diadromous River Shrimp Macrobrachium amazonicum (Decapoda, Palaemonidae)	PLOS ONE			English	Article							FRESH-WATER SHRIMP; DILOCARCINUS-PAGEI BRACHYURA; CRAB CARCINUS-MAENAS; HIGH SALINITY ACCLIMATION; NA/K-ATPASE ACTIVITY; GILL (NA+; LARVAL DEVELOPMENT; AMMONIA EXCRETION; ALPHA-SUBUNIT; CALLINECTES DANAE	We investigate the synergistic stimulation by K+ plus NH4+ of (Na+, K+)-ATPase activity in microsomal preparations of whole zoea I and decapodid III, and in juvenile and adult river shrimp gills. Modulation of (Na+, K+)-ATPase activity is ontogenetic stage-specific, and particularly distinct between juveniles and adults. Although both gill enzymes exhibit two different sites for K+ and NH4+ binding, in the juvenile enzyme, these two sites are equivalent: binding by both ions results in slightly stimulated activity compared to that of a single ionic species. In the adult enzyme, the sites are not equivalent: when one ion occupies its specific binding site, (Na+, K+)-ATPase activity is stimulated synergistically by approximate to 50% on binding of the complementary ion. Immunolocalization reveals the enzyme to be distributed predominantly throughout the intralamellar septum in the gill lamellae of juveniles and adults. Western blot analyses demonstrate a single immunoreactive band, suggesting a single (Na+, K+)-ATPase alpha-subunit isoform that is distributed into different density membrane fractions, independently of ontogenetic stage. We propose a model for the modulation by K+ and NH4+ of gill (Na+, K+)-ATPase activity. These findings suggest that the gill enzyme may be regulated by NH4+ during ontogenetic development in M. amazonicum.	[Leone, Francisco A.; Bezerra, Thais M. S.; Pinto, Marcelo R.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil; [McNamara, John C.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, SP, Brazil; [Garcon, Daniela P.] Univ Fed Paraiba, Ctr Ciencias Exatas & Natureza, Dept Biol Mol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Lucena, Malson N.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049 Ribeirao Preto, SP, Brazil; [Fontes, Carlos F. L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal da Paraiba; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Leone, FA (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil.	fdaleone@ffclrp.usp.br	Garçon, Daniela Pereira/Y-9725-2019; Leone, Francisco/O-7944-2016; Pinto, Marcelo Rodrigues/P-5898-2019; Fontes, C.F.L. or Fontes/G-2343-2014; McNamara, John Campbell/B-9823-2012; Pinto, Marcelo M. R./L-2068-2013; Bezerra, Thais/C-3933-2015	Leone, Francisco/0000-0003-4515-4057; Pinto, Marcelo Rodrigues/0000-0003-4545-1369; Fontes, C.F.L. or Fontes/0000-0002-9384-0898; McNamara, John Campbell/0000-0002-6530-8706; Pinto, Marcelo M. R./0000-0003-4545-1369; Lucena, Malson/0000-0003-2566-5642; Bezerra, Thais/0000-0001-5385-1157	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/17534-0]; Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto Nacional de Ciencia e Tecnologia (INCT); Adapta/Fundacao de Amparo a Pesquisa do Estado do Amazonas [FAPEAM 573976/2008-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia (INCT); Adapta/Fundacao de Amparo a Pesquisa do Estado do Amazonas	This investigation was supported by research grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2010/17534-0) (www.fapesp.br); Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq) (wwww.cnpq.br); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (www.capes.gov.br) and Instituto Nacional de Ciencia e Tecnologia (INCT) Adapta/Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM 573976/2008-2) (adapta@inpa.gov.br). TMBS and MNL received undergraduate scholarships from CNPq (566167/2008-5) and FAPESP (2010/16115-3), respectively. DPG and MRP received post-doctoral scholarships from FAPESP (2010/06395-9) and CNPq (560501/2010-2), respectively. FAL (302776/2012-7), JCM (300662/20092) and CFLF (307559/2011-4) received research scholarships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger K, 2003, INVERTEBR REPROD DEV, V43, P29, DOI 10.1080/07924259.2003.9652520; Anger K, 2001, CRUSTACEAN ISS, V14; Anger K, 2013, J CRUSTACEAN BIOL, V33, P151, DOI 10.1163/1937240X-00002124; Anger K, 2009, AQUACULTURE, V287, P341, DOI 10.1016/j.aquaculture.2008.10.042; ARMSTRONG DA, 1978, BIOL BULL, V154, P15, DOI 10.2307/1540771; ARMSTRONG DA, 1981, BIOL BULL, V160, P349, DOI 10.2307/1540844; Arruda Hayd Arruda, 2008, Nauplius, V16, P55; Augusto A, 2007, J CRUSTACEAN BIOL, V27, P626, DOI 10.1651/S-2796.1; Belli NM, 2009, COMP BIOCHEM PHYS A, V152, P431, DOI 10.1016/j.cbpa.2008.11.017; Boudour-Boucheker N, 2013, CELL TISSUE RES, V353, P87, DOI 10.1007/s00441-013-1622-x; Charmantier G, 1998, INVERTEBR REPROD DEV, V33, P177, DOI 10.1080/07924259.1998.9652630; Charmantier G, 2011, J EXP MAR BIOL ECOL, V396, P89, DOI 10.1016/j.jembe.2010.10.013; Cieluch U, 2000, THESIS TIERARZTLICHE; Collart OO, 1996, J CRUSTACEAN BIOL, V16, P684, DOI 10.2307/1549189; CONTE FP, 1977, J EXP ZOOL, V202, P339, DOI 10.1002/jez.1402020306; Cortes VF, 2006, INT J BIOCHEM CELL B, V38, P1901, DOI 10.1016/j.biocel.2006.05.002; de Araujo MC, 2007, AQUACULTURE, V265, P187, DOI 10.1016/j.aquaculture.2007.01.016; ESCALANTE R, 1995, J HISTOCHEM CYTOCHEM, V43, P391, DOI 10.1177/43.4.7897181; Faleiros RO, 2010, J EXP BIOL, V213, P3894, DOI 10.1242/jeb.046870; Franca JL, 2013, J MEMBRANE BIOL, V246, P529, DOI 10.1007/s00232-013-9565-4; Freire CA, 2003, COMP BIOCHEM PHYS A, V136, P771, DOI 10.1016/j.cbpb.2003.08.007; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Furriel RPM, 2004, J EXP ZOOL PART A, V301A, P63, DOI 10.1002/jez.a.20008; Garcon DP, 2007, COMP BIOCHEM PHYS A, V147, P145, DOI 10.1016/j.cbpa.2006.12.020; Garcon DP, 2009, COMP BIOCHEM PHYS A, V154, P44, DOI 10.1016/j.cbpa.2009.04.624; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Goncalves RR, 2006, COMP BIOCHEM PHYS A, V145, P346, DOI 10.1016/j.cbpa.2006.07.007; GUEST WC, 1979, PROG FISH CULT, V41, P14, DOI 10.1577/1548-8659(1979)41[14:PSMA]2.0.CO;2; GUEST WC, 1979, CRUSTACEANA, V37, P141, DOI 10.1163/156854079X00979; Haond C, 1999, PHYSIOL BIOCHEM ZOOL, V72, P534, DOI 10.1086/316692; Henry RP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00431; HERRERA FD, 1993, REV BIOL TROP, V41, P239; Hu YK, 2000, J BIOL CHEM, V275, P30734, DOI 10.1074/jbc.M003737200; Huong DTT, 2004, FISHERIES SCI, V70, P518, DOI 10.1111/j.1444-2906.2004.00833.x; Ituarte RB, 2008, AQUAT BIOL, V3, P283, DOI 10.3354/ab00089; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Jorgensen PL, 1998, BBA-BIOENERGETICS, V1365, P65, DOI 10.1016/S0005-2728(98)00043-7; Jorgensen PL, 2001, BBA-BIOENERGETICS, V1505, P57, DOI 10.1016/S0005-2728(00)00277-2; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Khodabandeh S, 2006, J CRUSTACEAN BIOL, V26, P515, DOI 10.1651/S-2669.1; Kirschner LB, 2004, J EXP BIOL, V207, P1439, DOI 10.1242/jeb.00907; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KJ, 1994, PHYSIOL ZOOL, V67, P910, DOI 10.1086/physzool.67.4.30163871; Leone FA, 2005, BIOCHEM MOL BIOL EDU, V33, P399, DOI 10.1002/bmb.2005.49403306399; Leone FA, 2012, J MEMBRANE BIOL, V245, P201, DOI 10.1007/s00232-012-9431-9; Lucena MN, 2012, COMP BIOCHEM PHYS B, V161, P380, DOI 10.1016/j.cbpb.2012.01.003; Lucu C, 2003, COMP BIOCHEM PHYS A, V135, P195; LUCU C, 1989, J EXP ZOOL, V249, P1, DOI 10.1002/jez.1402490102; Maciel CR., 2009, NAUPLIUS, V17, P61; MAGALHAES C, 1985, AMAZONIANA, V9, P247; MANGUM C, 1977, AM SCI, V65, P67; Martin DW, 2005, SEMIN NEPHROL, V25, P282, DOI 10.1016/j.semnephrol.2005.03.003; Masui DC, 2005, INT J BIOCHEM CELL B, V37, P2521, DOI 10.1016/j.biocel.2005.06.004; Masui DC, 2002, COMP BIOCHEM PHYS C, V132, P471, DOI 10.1016/S1532-0456(02)00110-2; Masui DC, 2009, COMP BIOCHEM PHYS A, V153, P141, DOI 10.1016/j.cbpa.2009.01.020; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; McNamara JC, 1997, BIOL BULL, V192, P321, DOI 10.2307/1542725; McNamara JC, 1999, J EXP ZOOL, V284, P617, DOI 10.1002/(SICI)1097-010X(19991101)284:6<617::AID-JEZ3>3.0.CO;2-V; MCNAMARA JC, 1983, HYDROBIOLOGIA, V101, P239, DOI 10.1007/BF00009880; MCNAMARA JC, 1986, COMP BIOCHEM PHYS A, V83, P359, DOI 10.1016/0300-9629(86)90590-6; McNamara JC, 2012, J COMP PHYSIOL B, V182, P997, DOI 10.1007/s00360-012-0665-8; Furriel RPM, 2010, J EXP ZOOL PART A, V313A, P508, DOI 10.1002/jez.622; MOREIRA GS, 1986, CRUSTACEANA, V50, P231, DOI 10.1163/156854086X00250; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Onken H, 1998, COMP BIOCHEM PHYS A, V119, P883, DOI 10.1016/S1095-6433(98)00020-8; ONKEN H, 1995, HELGOLANDER MEERESUN, V49, P715, DOI 10.1007/BF02368395; Onken H, 2002, J EXP BIOL, V205, P167; Onken H, 2002, J EXP BIOL, V205, P523; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; Pettovello AD, 1996, CRUSTACEANA, V69, P113, DOI 10.1163/156854096X00141; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; Ramos-Porto M., 1998, CATALOGUE CRASTACEA, P325; READ GHL, 1984, COMP BIOCHEM PHYS A, V78, P501, DOI 10.1016/0300-9629(84)90585-1; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; Rebelo MF, 1999, COMP BIOCHEM PHYS A, V122, P429, DOI 10.1016/S1095-6433(99)00026-4; Riestenpatt S, 1996, J EXP BIOL, V199, P1545; Romano N, 2013, REV FISH SCI, V21, P1, DOI 10.1080/10641262.2012.753404; Rudolph F B, 1979, Methods Enzymol, V63, P22; Saez AG, 2009, GENETICA, V136, P479, DOI 10.1007/s10709-009-9356-0; SANDIFER PA, 1975, AQUACULTURE, V6, P103, DOI 10.1016/0044-8486(75)90063-0; Santos LCF, 2007, COMP BIOCHEM PHYS A, V148, P178, DOI 10.1016/j.cbpa.2007.04.008; Short JW, 2004, HYDROBIOLOGIA, V525, P1, DOI 10.1023/B:HYDR.0000038871.50730.95; Silva ECC, 2012, BBA-BIOMEMBRANES, V1818, P2588, DOI 10.1016/j.bbamem.2012.05.009; Firmino KCS, 2011, COMP BIOCHEM PHYS B, V160, P24, DOI 10.1016/j.cbpb.2011.05.002; SUN DY, 1991, J HISTOCHEM CYTOCHEM, V39, P1455, DOI 10.1177/39.11.1655875; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Torres A. H., 2003, 18 REUN AN FED SOC B; Torres G, 2007, COMP BIOCHEM PHYS A, V147, P460, DOI 10.1016/j.cbpa.2007.01.020; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOWLE DW, 1987, AM J PHYSIOL, V252, pR479, DOI 10.1152/ajpregu.1987.252.3.R479; Towle DW, 2001, AM ZOOL, V41, P770, DOI 10.1668/0003-1569(2001)041[0770:OBGOEC]2.0.CO;2; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; Weihrauch D, 2004, J EXP BIOL, V207, P4491, DOI 10.1242/jeb.01308; Weihrauch D, 2002, J EXP BIOL, V205, P2765; Weihrauch D, 1999, J COMP PHYSIOL B, V169, P25, DOI 10.1007/s003600050190; Weihrauch D, 2001, J EXP BIOL, V204, P25; Weihrauch D, 1998, J COMP PHYSIOL B, V168, P364, DOI 10.1007/s003600050156; Weihrauch D, 2012, J INSECT PHYSIOL, V58, P473, DOI 10.1016/j.jinsphys.2011.11.005; Weihrauch D, 2009, J EXP BIOL, V212, P1716, DOI 10.1242/jeb.024851; Wilder MN, 2001, FISHERIES SCI, V67, P182, DOI 10.1046/j.1444-2906.2001.00219.x; ZANDERS IP, 1992, COMP BIOCHEM PHYS A, V101, P505, DOI 10.1016/0300-9629(92)90502-H; Zare S, 1998, COMP BIOCHEM PHYS A, V119, P739, DOI 10.1016/S1095-6433(98)01029-0	108	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89625	10.1371/journal.pone.0089625	http://dx.doi.org/10.1371/journal.pone.0089625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586919	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900131
J	Loh, SH; Lee, CY; Tsai, YT; Shih, SJ; Chen, LW; Cheng, TH; Chang, CY; Tsai, CS				Loh, Shih-Hurng; Lee, Chung-Yi; Tsai, Yi-Ting; Shih, Shou-Jou; Chen, Li-Wei; Cheng, Tzu-Hurng; Chang, Chung-Yi; Tsai, Chein-Sung			Intracellular Acid-Extruding Regulators and the Effect of Lipopolysaccharide in Cultured Human Renal Artery Smooth Muscle Cells	PLOS ONE			English	Article							NA+-H+ EXCHANGE; CARDIOVASCULAR OUTCOMES; FUNCTIONAL EVIDENCE; PH REGULATION; SLC4 FAMILY; EXPRESSION; INHIBITOR; BICARBONATE; AMILORIDE; STENOSIS	Homeostasis of the intracellular pH (pHi) in mammalian cells plays a pivotal role in maintaining cell function. Thus far, the housekeeping Na+-H+ exchanger (NHE) and the Na+-HCO3- co-transporter (NBC) have been confirmed in many mammalian cells as major acid extruders. However, the role of acid-extruding regulators in human renal artery smooth muscle cells (HRASMCs) remains unclear. It has been demonstrated that lipopolysaccharide (LPS)-induced vascular occlusion is associated with the apoptosis, activating calpain and increased [Ca2+] i that are related to NHE1 activity in endothelia cells. This study determines the acid-extruding mechanisms and the effect of LPS on the resting pHi and active acid extruders in cultured HRASMCs. The mechanism of pHi recovery from intracellular acidosis (induced by NH4Cl-prepulse) is determined using BCECF-fluorescence in cultured HRASMCs. It is seen that (a) the resting pHi is 7.19 +/- 0.03 and 7.10 +/- 0.02 for HEPES-and CO2/HCO3--buffered solution, respectively; (b) apart from the housekeeping NHE1, another Na+-coupled HCO3- transporter i. e. NBC, functionally co-exists to achieve acid-equivalent extrusion; (c) three different isoforms of NBC: NBCn1 (SLC4A7; electroneutral), NBCe1 (SLC(4)A(4); electrogenic) and NBCe2 (SLC(4)A(5)), are detected in protein/mRNA level; and (d) pHi and NHE protein expression/activity are significantly increased by LPS, in both a dose-and time-dependent manner, but NBCs protein expression is not. In conclusion, it is demonstrated, for the first time, that four pHi acid-extruding regulators: NHE1, NBCn1, NBCe1 and NBCe2, co-exist in cultured HRASMCs. LPS also increases cellular growth, pHi and NHE in a doseand time-dependent manner.	[Loh, Shih-Hurng; Shih, Shou-Jou; Chen, Li-Wei] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Lee, Chung-Yi; Tsai, Yi-Ting; Tsai, Chein-Sung] Tri Serv Gen Hosp, Dept Cardiovasc Surg, Taipei, Taiwan; [Cheng, Tzu-Hurng] China Med Univ, Coll Life Sci, Dept Biol Sci & Technol, Taichung, Taiwan; [Chang, Chung-Yi] Cheng Hsieng Gen Hosp, Dept Gen Surg, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan	Loh, SH (corresponding author), Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan.	shloh@ndmctsgh.edu.tw		Loh, Shih-hurng/0000-0001-9269-5580	National Science Council [NSC 96-2320-B-016-015-MY3, 97-2321-B-016-001-MY3]; National Defense Medical Bureau [DOD100-I-30; DOD 101-15-6]; Tri-Service General Hospital [TSGH-C100-088]; Teh-Tzer Study Group for Human Medical Research Foundation, Taipei, Taiwan, Republic of China	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Bureau; Tri-Service General Hospital; Teh-Tzer Study Group for Human Medical Research Foundation, Taipei, Taiwan, Republic of China	This study was supported by the grants from the National Science Council (NSC 96-2320-B-016-015-MY3; 97-2321-B-016-001-MY3), National Defense Medical Bureau (DOD100-I-30; DOD 101-15-6), Tri-Service General Hospital (TSGH-C100-088), and Teh-Tzer Study Group for Human Medical Research Foundation, Taipei, Taiwan, Republic of China to SH Loh, YT Tsai and CY Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; Bobulescu IA, 2005, CURR OPIN NEPHROL HY, V14, P485, DOI 10.1097/01.mnh.0000174146.52915.5d; Boedtkjer E, 2006, CIRC RES, V98, P515, DOI 10.1161/01.RES.0000204750.04971.76; Boedtkjer E, 2013, TRENDS CARDIOVAS MED, V23, P59, DOI 10.1016/j.tcm.2012.09.001; Boedtkjer E, 2012, J VASC RES, V49, P479, DOI 10.1159/000341235; Boedtkjer E, 2012, J PHYSIOL-LONDON, V590, P1895, DOI 10.1113/jphysiol.2011.227132; Boedtkjer E, 2011, CIRCULATION, V124, P1819, DOI 10.1161/CIRCULATIONAHA.110.015974; BOND JM, 1991, BIOCHEM BIOPH RES CO, V179, P798, DOI 10.1016/0006-291X(91)91887-I; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Cingolani HE, 1998, CIRC RES, V83, P775, DOI 10.1161/01.RES.83.8.775; Conlon PJ, 2001, KIDNEY INT, V60, P1490, DOI 10.1046/j.1523-1755.2001.00953.x; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; De Giusti VC, 2011, BRIT J PHARMACOL, V164, P1976, DOI 10.1111/j.1476-5381.2011.01496.x; DELVAUX M, 1990, AM J PHYSIOL, V259, pG842, DOI 10.1152/ajpgi.1990.259.5.G842; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; FLIEGEL L, 1991, FEBS LETT, V279, P25, DOI 10.1016/0014-5793(91)80241-T; Garciarena CD, 2009, J APPL PHYSIOL, V106, P1325, DOI 10.1152/japplphysiol.91300.2008; Goossens JF, 2000, EUR J PHARM SCI, V10, P125, DOI 10.1016/S0928-0987(99)00091-3; Goyal S, 2003, AM J PHYSIOL-RENAL, V284, pF467, DOI 10.1152/ajprenal.00352.2002; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; GRINSTEIN S, 1992, J BIOL CHEM, V267, P23823; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Hotta Y, 2001, J CARDIOVASC PHARM, V37, P143, DOI 10.1097/00005344-200102000-00002; JACOBSON HR, 1988, KIDNEY INT, V34, P729, DOI 10.1038/ki.1988.240; JEREMY RW, 1992, CIRC RES, V70, P1180, DOI 10.1161/01.RES.70.6.1180; Kalaria RN, 1998, MOL BRAIN RES, V58, P178, DOI 10.1016/S0169-328X(98)00108-9; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Kiss L, 1999, J NEUROPHYSIOL, V81, P1839, DOI 10.1152/jn.1999.81.4.1839; LAGADICGOSSMANN D, 1992, J PHYSIOL-LONDON, V458, P361, DOI 10.1113/jphysiol.1992.sp019422; Lam TI, 2009, AM J PHYSIOL-CELL PH, V297, pC278, DOI 10.1152/ajpcell.00093.2009; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; Li HL, 2007, CELL BIOL INT, V31, P831, DOI 10.1016/j.cellbi.2007.01.034; Li HL, 2012, MOL MED REP, V6, P774, DOI 10.3892/mmr.2012.1010; Liu TZ, 2008, AM J PHYSIOL-CELL PH, V295, pC819, DOI 10.1152/ajpcell.00366.2007; Loh SH, 2002, J BIOMED SCI, V9, P198; Loh SH, 2002, JPN J PHYSIOL, V52, P277, DOI 10.2170/jjphysiol.52.277; Loh SH, 1996, BRIT J PHARMACOL, V118, P1905, DOI 10.1111/j.1476-5381.1996.tb15623.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Orlowski A, 2012, AM J PHYSIOL-CELL PH, V303, pC69, DOI 10.1152/ajpcell.00431.2011; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Pillay WR, 2002, BRIT J SURG, V89, P737, DOI 10.1046/j.1365-2168.2002.02144.x; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Schelling JR, 2008, AM J PHYSIOL-RENAL, V295, pF625, DOI 10.1152/ajprenal.90212.2008; SCHOLZ W, 1993, BRIT J PHARMACOL, V109, P562, DOI 10.1111/j.1476-5381.1993.tb13607.x; Son Seok Man, 2004, Curr Diab Rep, V4, P247; Sun HY, 2004, EUR J PHARMACOL, V486, P121, DOI 10.1016/j.ejphar.2003.12.016; Teshima Y, 2003, CIRCULATION, V108, P2275, DOI 10.1161/01.CIR.0000093277.20968.C7; Thomsen ABK, 2014, J CEREBR BLOOD F MET, V34, P161, DOI 10.1038/jcbfm.2013.192; Vashist A, 2002, AM HEART J, V143, P559, DOI 10.1067/mhj.2002.120769; Wang HL, 2007, J IMMUNOL, V179, P1834, DOI 10.4049/jimmunol.179.3.1834; Zhao YX, 2012, BIOCHEM BIOPH RES CO, V427, P125, DOI 10.1016/j.bbrc.2012.09.023; Zoccali C, 2002, J AM SOC NEPHROL, V13, pS179, DOI 10.1097/01.ASN.0000032548.18973.0F	60	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e90273	10.1371/journal.pone.0090273	http://dx.doi.org/10.1371/journal.pone.0090273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24587308	gold, Green Submitted, Green Published			2022-12-27	WOS:000331717900152
J	Cieniewicz, B; Carpino, N; Krug, LT				Cieniewicz, Brandon; Carpino, Nicholas; Krug, Laurie T.			Enhanced Response of T Cells from Murine Gammaherpesvirus 68-Infected Mice Lacking the Suppressor of T Cell Receptor Signaling Molecules Sts-1 and Sts-2	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; GAMMA-HERPESVIRUS INFECTION; LYMPHOPROLIFERATIVE DISEASE; KAPOSIS-SARCOMA; B-CELLS; VIRAL INTERLEUKIN-10; ADOPTIVE TRANSFER; MEDIATED CONTROL; DEFICIENT MICE; IMMUNE CONTROL	The human gammaherpesviruses establish life-long infections that are associated with the development of lymphomas and neoplasms, especially in immunocompromised individuals. T cells play a crucial role in the control of gammaherpesvirus infection through multiple functions, including the direct killing of infected cells, production of cytokines such as interferon-gamma (IFN-gamma), and costimulation of B cells. Impaired T cell function in mice infected with murine gammaherpesvirus 68 (MHV68) leads to increased reactivation and pathologies, including a higher incidence of lymphoid hyperplasia. Here we report that the absence of Suppressor of TCR signaling -1 and -2 (Sts-1(-/-)/2(-/-)) during MHV68 infection leads to the generation of T cells with significantly heightened responses. Transient differences in the T and B cell response of infected Sts-1(-/-)/2(-/-) (Sts dKO) mice were also observed when compared to WT mice. However, these alterations in the immune response and the overall absence of Sts-1 and Sts-2 did not impact viral pathogenesis or lead to pathology. Acute lytic replication in the lungs, establishment of latency in the spleen and reactivation from latency in the spleen in the Sts dKO mice were comparable to WT mice. Our studies indicate that Sts-1 and Sts-2 are not required for the immune control of MHV68 in a normal course of gammaherpesvirus infection, but suggest that interference with negative regulators of T cell responses might be further explored as a safe and efficacious strategy to improve adoptive T cell therapy.	[Krug, Laurie T.] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Krug, LT (corresponding author), SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA.	laurie.krug@stonybrook.edu	Krug, Laurie T/H-5315-2019	Krug, Laurie T/0000-0002-9648-522X	National Institute of Allergy And Infectious Diseases [T32AI007539]; American Cancer Society [RSG-11-160-01-MPC]; NIH [R01AI080892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080892, T32AI007539] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	BC was supported by Award Number T32AI007539 from the National Institute of Allergy And Infectious Diseases. LTK was supported by an American Cancer Society research scholar grant, RSG-11-160-01-MPC. NC was supported by NIH R01AI080892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Agrawal R, 2008, J CELL BIOCHEM, V104, P953, DOI 10.1002/jcb.21678; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Bax HI, 2013, J CLIN IMMUNOL, V33, P1062, DOI 10.1007/s10875-013-9907-0; Belz GT, 2001, J VIROL, V75, P4435, DOI 10.1128/JVI.75.9.4435-4438.2001; Bollard CM, 2012, NAT REV CLIN ONCOL, V9, P510, DOI 10.1038/nrclinonc.2012.111; BOSHOFF C, 1995, NAT MED, V1, P1274, DOI 10.1038/nm1295-1274; Braaten DC, 2005, J VIROL, V79, P2573, DOI 10.1128/JVI.79.4.2573-2583.2005; Carbone A, 2008, BRIT J HAEMATOL, V140, P13, DOI 10.1111/j.1365-2141.2007.06879.x; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Carpino N, 2009, MOL IMMUNOL, V46, P3224, DOI 10.1016/j.molimm.2009.08.015; Casiraghi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002715; Catalina MD, 2001, J IMMUNOL, V167, P4450, DOI 10.4049/jimmunol.167.8.4450; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Dutia BM, 1997, J VIROL, V71, P4278, DOI 10.1128/JVI.71.6.4278-4283.1997; Ebrahimi B, 2001, AM J PATHOL, V158, P2117, DOI 10.1016/S0002-9440(10)64683-4; EHTISHAM S, 1993, J VIROL, V67, P5247, DOI 10.1128/JVI.67.9.5247-5252.1993; El-Bietar J, 2011, PEDIATR HEMAT ONCOL, V28, P627, DOI 10.3109/08880018.2011.628367; Evans AG, 2008, J EXP MED, V205, P669, DOI 10.1084/jem.20071135; Fallarino F, 2000, J IMMUNOL, V165, P5495, DOI 10.4049/jimmunol.165.10.5495; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Forrest JC, 2008, DNA TUMOR VIRUSES; Freeman ML, 2011, J IMMUNOL, V187, P6180, DOI 10.4049/jimmunol.1102745; Freeman ML, 2010, J VIROL, V84, P2881, DOI 10.1128/JVI.02229-09; Fuse S, 2007, J IMMUNOL, V178, P5227, DOI 10.4049/jimmunol.178.8.5227; Fuse S, 2006, J VIROL, V80, P9159, DOI 10.1128/JVI.00422-06; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Heslop Helen E, 2005, Hematology Am Soc Hematol Educ Program, P260; Heslop HE, 2010, BLOOD, V115, P925, DOI 10.1182/blood-2009-08-239186; Hinrichs C, 2011, TRANSPL INT, V24, P892, DOI 10.1111/j.1432-2277.2011.01282.x; Hislop AD, 2008, SEMIN CANCER BIOL, V18, P416, DOI 10.1016/j.semcancer.2008.10.005; Kanakry JA, 2013, CURR TREAT OPTION ON, V14, P224, DOI 10.1007/s11864-013-0231-y; Kim IJ, 2002, J IMMUNOL, V168, P3958, DOI 10.4049/jimmunol.168.8.3958; Kim IJ, 2007, J IMMUNOL, V178, P1692, DOI 10.4049/jimmunol.178.3.1692; Liang XZ, 2013, J VIROL, V87, P6051, DOI 10.1128/JVI.00375-13; Liu LZ, 1999, J VIROL, V73, P9849, DOI 10.1128/JVI.73.12.9849-9857.1999; Liu ZQ, 2008, J IMMUNOL, V181, P4363, DOI 10.4049/jimmunol.181.6.4363; Louis CU, 2010, J IMMUNOTHER, V33, P983, DOI 10.1097/CJI.0b013e3181f3cbf4; Lyon AB, 2006, VIROLOGY, V356, P50, DOI 10.1016/j.virol.2006.06.039; Malnati Mauro S, 2003, Rev Clin Exp Hematol, V7, P375; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Molloy MJ, 2011, J IMMUNOL, V186, P6218, DOI 10.4049/jimmunol.1003812; Myoung J, 2011, J CLIN INVEST, V121, P1130, DOI 10.1172/JCI43755; Nagy N, 2011, PNAS, V109, P1512; NIIRO H, 1992, LYMPHOKINE CYTOK RES, V11, P209; OHSHIMA K, 1995, INT J CANCER, V62, P5, DOI 10.1002/ijc.2910620103; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Robertson KA, 2001, J VIROL, V75, P3480, DOI 10.1128/JVI.75.7.3480-3482.2001; ROWE M, 1992, J VIROL, V66, P122, DOI 10.1128/JVI.66.1.122-131.1992; San Luis B., 2011, J BIOL CHEM, V286, P15943; Sehrawat S, 2012, CELL REPORTS, V1, P461, DOI 10.1016/j.celrep.2012.03.009; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Sparks-Thissen RL, 2005, VIROLOGY, V338, P201, DOI 10.1016/j.virol.2005.05.011; Steed AL, 2006, J VIROL, V80, P192, DOI 10.1128/JVI.80.1.192-200.2006; Steed A, 2007, J VIROL, V81, P6134, DOI 10.1128/JVI.00108-07; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stevenson PG, 2009, J GEN VIROL, V90, P2317, DOI 10.1099/vir.0.013300-0; Stevenson PG, 2005, VIRAL IMMUNOL, V18, P445, DOI 10.1089/vim.2005.18.445; Stevenson PG, 1998, J VIROL, V72, P943, DOI 10.1128/JVI.72.2.943-949.1998; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Tibbetts SA, 2003, J VIROL, V77, P2522, DOI 10.1128/JVI.77.4.2522-2529.2003; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Tripp RA, 1997, J EXP MED, V185, P1641, DOI 10.1084/jem.185.9.1641; Tsai CY, 2011, VIRAL IMMUNOL, V24, P273, DOI 10.1089/vim.2011.0004; Usherwood EJ, 2000, J EXP MED, V192, P943, DOI 10.1084/jem.192.7.943; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang LX, 2007, BLOOD, V109, P4865, DOI 10.1182/blood-2006-09-045245; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Yin L, 2003, J MED VIROL, V71, P446, DOI 10.1002/jmv.10504; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556	76	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90196	10.1371/journal.pone.0090196	http://dx.doi.org/10.1371/journal.pone.0090196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587276	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200146
J	Heermann, R; Zigann, K; Gayer, S; Rodriguez-Fernandez, M; Banga, JR; Kremling, A; Jung, K				Heermann, Ralf; Zigann, Katja; Gayer, Stefan; Rodriguez-Fernandez, Maria; Banga, Julio R.; Kremling, Andreas; Jung, Kirsten			Dynamics of an Interactive Network Composed of a Bacterial Two-Component System, a Transporter and K+ as Mediator	PLOS ONE			English	Article							SENSOR KINASE KDPD; ESCHERICHIA-COLI K-12; SALMONELLA-TYPHIMURIUM; OPERON EXPRESSION; CATION-TRANSPORT; TURGOR SENSOR; POTASSIUM; PROTEIN; KDPD/KDPE; ATPASE	KdpD and KdpE form a histidine kinase/response regulator system that senses K+ limitation and induces the kdpFABC operon, which encodes a high-affinity K+ uptake complex. To define the primary stimulus perceived by KdpD we focused in this study on the dynamics of the Kdp response. Escherichia coli cells were subjected to severe K+ limitation, and all relevant parameters of the Kdp response, i.e., levels of kdpFABC transcripts and KdpFABC proteins, as well as extra-and intracellular K+ concentrations, were quantitatively analysed over time (0 to 180 min). Unexpectedly, induction of kdpFABC was found to follow a non-monotonic time-course. To interpret this unusual behaviour, a mathematical model that adequately captures the dynamics of the Kdp system was established and used for simulations. We found a strong correlation between KdpD/KdpE activation and the intracellular K+ concentration, which is influenced by the uptake of K+ via the KdpFABC complex. Based on these results a model is proposed in which KdpD/KdpE phosphorylation is inversely correlated with the intracellular K+ concentration. To corroborate this hypothesis an isogenic mutant that produces a defective KdpFABC complex, and the trans-complemented mutant that expresses the KtrAB high-affinity K+ uptake system of Vibrio alginolyticus were quantitatively analysed. Experimental data and simulations for the mutants consistently support the tight correlation between KdpD/KdpE activation and the intracellular K+ concentration. This study presents a striking example of the non-intuitive dynamics of a functional unit comprising signalling proteins and a transporter with K+ as mediator.	[Heermann, Ralf; Zigann, Katja; Jung, Kirsten] Univ Munich, CiPSM, Dept Biol 1, Martinsried, Germany; [Gayer, Stefan; Kremling, Andreas] Tech Univ Munich, Fachgebiet Syst Biotechnol, Garching, Germany; [Rodriguez-Fernandez, Maria; Banga, Julio R.] Spanish Council Sci Res, BioProc Engn Grp, IIM CSIC, Vigo, Spain	University of Munich; Technical University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Jung, K (corresponding author), Univ Munich, CiPSM, Dept Biol 1, Martinsried, Germany.	jung@lmu.de	Heermann, Ralf/CAF-8609-2022; Banga, Julio R./A-8388-2008; Rodriguez-Fernandez, Maria/I-7193-2016; Rodriguez-Fernandez, Maria/AAF-7049-2021; Banga, Julio R./ABD-8629-2020; Heermann, Ralf/E-1793-2013	Banga, Julio R./0000-0002-4245-0320; Rodriguez-Fernandez, Maria/0000-0003-1966-2920; Rodriguez-Fernandez, Maria/0000-0003-1966-2920; Banga, Julio R./0000-0002-4245-0320; Heermann, Ralf/0000-0003-0631-6156	Deutsche Forschungsgemeinschaft [Exc114/1+2, JU270/15-1]; BMBF (SysMO); EU ERASysBio programme; Spanish MICINN; MINECO (SYSMO grant KOSMOBAC) [GEN2006-27747-E/SYS, DPI2011-28112-C04-03]; European Regional Development Fund	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF (SysMO)(Federal Ministry of Education & Research (BMBF)); EU ERASysBio programme; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO (SYSMO grant KOSMOBAC); European Regional Development Fund(European Commission)	This work was financially supported by the Deutsche Forschungsgemeinschaft (Exc114/1+2 and JU270/15-1) and the BMBF (SysMO, project 4). MRF and JRB acknowledge financial support from the EU ERASysBio programme and the Spanish MICINN and MINECO (SYSMO grant KOSMOBAC, ref. GEN2006-27747-E/SYS and project MultiScales ref. DPI2011-28112-C04-03; both with partial support from the European Regional Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1981, J BIOL CHEM, V256, P1905; ALTENDORF K, 1992, ANN NY ACAD SCI, V671, P228, DOI 10.1111/j.1749-6632.1992.tb43799.x; ASHA H, 1993, J BACTERIOL, V175, P4528, DOI 10.1128/JB.175.14.4528-4537.1993; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; Bertrand J, 2004, J BACTERIOL, V186, P5519, DOI 10.1128/JB.186.16.5519-5522.2004; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; BOSSEMEYER D, 1989, J BIOL CHEM, V264, P16403; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Epstein W, 1970, J BACTERIOL, V101, P836, DOI 10.1128/JB.101.3.836-843.1970; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; Frymier JS, 1997, J BACTERIOL, V179, P3061, DOI 10.1128/jb.179.9.3061-3063.1997; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; Heermann R, 2000, J BIOL CHEM, V275, P17080, DOI 10.1074/jbc.M000093200; HEERMANN R, 2012, 2 COMPONENT SYSTEMS, P181; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Heermann R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-133; Heermann R, 2009, J MOL BIOL, V386, P134, DOI 10.1016/j.jmb.2008.12.007; Heermann R, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-14; Jung K, 1997, J BIOL CHEM, V272, P10847; Jung K, 2001, J BACTERIOL, V183, P3800, DOI 10.1128/JB.183.12.3800-3803.2001; Jung K, 2000, J BIOL CHEM, V275, P40142, DOI 10.1074/jbc.M008917200; Jung K, 1998, J BIOL CHEM, V273, P26415, DOI 10.1074/jbc.273.41.26415; Kremling A, 2004, BIOSYSTEMS, V78, P23, DOI 10.1016/j.biosystems.2004.06.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laermann V, 2013, MOL MICROBIOL, V88, P1194, DOI 10.1111/mmi.12251; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; LEE SB, 1984, BIOTECHNOL BIOENG, V26, P1372, DOI 10.1002/bit.260261115; Lee SJ, 2004, MOL CELL, V14, P153, DOI 10.1016/S1097-2765(04)00202-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; Malli R, 1998, J BACTERIOL, V180, P5102, DOI 10.1128/JB.180.19.5102-5108.1998; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; NELDER JA, 1961, BIOMETRICS, V17, P89, DOI 10.2307/2527498; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; RHOADS DB, 1978, J GEN PHYSIOL, V72, P283, DOI 10.1085/jgp.72.3.283; Rodriguez-Fernandez M, 2010, BIOINFORMATICS, V26, P1675, DOI 10.1093/bioinformatics/btq242; Roe AJ, 2000, MOL MICROBIOL, V35, P1235, DOI 10.1046/j.1365-2958.2000.01793.x; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; SCHLOSSER A, 1995, J BACTERIOL, V177, P1908, DOI 10.1128/jb.177.7.1908-1910.1995; STOCK JB, 1977, J BIOL CHEM, V252, P7850; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; SUGIURA A, 1992, MOL MICROBIOL, V6, P1769, DOI 10.1111/j.1365-2958.1992.tb01349.x; SUTHERLAND L, 1986, J BACTERIOL, V168, P805, DOI 10.1128/jb.168.2.805-814.1986; Trchounian A, 1999, FEBS LETT, V447, P144, DOI 10.1016/S0014-5793(99)00288-4; VOELKNER P, 1993, EUR J BIOCHEM, V217, P1019, DOI 10.1111/j.1432-1033.1993.tb18333.x; WALDERHAUG MO, 1992, J BACTERIOL, V174, P2152, DOI 10.1128/JB.174.7.2152-2159.1992; Yan H, 2011, BIOL PHARM BULL, V34, P426, DOI 10.1248/bpb.34.426	56	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89671	10.1371/journal.pone.0089671	http://dx.doi.org/10.1371/journal.pone.0089671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586952	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200069
J	Piro, S; Mascali, LG; Urbano, F; Filippello, A; Malaguarnera, R; Calanna, S; Rabuazzo, AM; Purrello, F				Piro, Salvatore; Mascali, Loriana G.; Urbano, Francesca; Filippello, Agnese; Malaguarnera, Roberta; Calanna, Salvatore; Rabuazzo, Agata M.; Purrello, Francesco			Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (alpha-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELLS; INSULIN-SECRETION; PROTEIN-KINASE; RECEPTOR ACTIVATION; ANALOG LIRAGLUTIDE; DIABETES-MELLITUS; MOUSE PANCREAS; RAT PANCREAS; FATTY-ACIDS	Aims/Hypothesis: Incretin therapies, which are used to treat diabetic patients, cause a chronic supra-physiological increase in GLP-1 circulating levels. It is still unclear how the resulting high hormone concentrations may affect pancreatic alpha cells. The present study was designed to investigate the effects of chronic exposure to high GLP-1 levels on a cultured pancreatic alpha cell line. Methods: alpha-TC1-6 cell line was cultured in the presence or absence of GLP-1 (100 nmol/l) for up to 72 h. In our model GLP-1 receptor (GLP-1R) was measured. After the cells were exposed to GLP-1 the levels of glucagon secretion were measured. Because GLP-1 acts on intracellular cAMP production, the function of GLP-1R was studied. We also investigated the effects of chronic GLP-1 exposure on the cAMP/MAPK pathway, Pax6 levels, the expression of prohormone convertases (PCs), glucagon gene (Gcg) and protein expression, glucagon and GLP-1 production. Results: In our model, we were able to detect GLP-1R. After GLP-1 exposure we found a reduction in glucagon secretion. During further investigation of the function of GLP-1R, we found an activation of the cAMP/MAPK/Pax6 pathway and an increase of Gcg gene and protein expression. Furthermore we observed a significant increase in PC1/3 protein expression, GLP-1 intracellular content and GLP-1 secretion. Conclusions/Interpretation: Our data indicate that the chronic exposure of pancreatic alpha cells to GLP-1 increases the ability of these cells to produce and release GLP-1. This phenomenon occurs through the stimulation of the transcription factor Pax6 and the increased expression of the protein convertase PC1/3.	[Piro, Salvatore; Mascali, Loriana G.; Urbano, Francesca; Filippello, Agnese; Calanna, Salvatore; Rabuazzo, Agata M.; Purrello, Francesco] Univ Catania, Garibaldi Nesima Hosp, Dept Clin & Mol BioMed, Catania, Italy; [Malaguarnera, Roberta] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	Presidio Ospedaliero Garibaldi-Nesima; University of Catania; Magna Graecia University of Catanzaro	Purrello, F (corresponding author), Univ Catania, Garibaldi Nesima Hosp, Dept Clin & Mol BioMed, Catania, Italy.	fpurrell@unict.it	Purrello, Francesco/K-9721-2016; Filippello, Agnese/AAB-5147-2022; Piro, Salvatore/H-9353-2012	Purrello, Francesco/0000-0003-3313-8543; Piro, Salvatore/0000-0002-1781-0902; URBANO, Francesca/0000-0001-5948-8782; FILIPPELLO, Agnese Rita/0000-0001-6593-8823				Agerso H, 2002, DIABETOLOGIA, V45, P195, DOI 10.1007/s00125-001-0719-z; Ahren Bo, 2007, Curr Diab Rep, V7, P340, DOI 10.1007/s11892-007-0056-9; Anello M, 2004, AM J PHYSIOL-ENDOC M, V287, pE602, DOI 10.1152/ajpendo.00320.2003; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BAROVSKY K, 1984, MOL PHARMACOL, V25, P256; Butler PC, 2013, DIABETES CARE; Calanna S, 2013, OBESITY, V21, P320, DOI 10.1002/oby.20017; Calanna S, 2012, EUR J ENDOCRINOL, V166, P917, DOI 10.1530/EJE-11-0765; Chen L, 2005, FEBS J, V272, P2746, DOI 10.1111/j.1742-4658.2005.04694.x; de Heer J, 2008, DIABETOLOGIA, V51, P2263, DOI 10.1007/s00125-008-1149-y; De Marinis YZ, 2010, CELL METAB, V11, P543, DOI 10.1016/j.cmet.2010.04.007; Ding WG, 1997, DIABETES, V46, P792, DOI 10.2337/diabetes.46.5.792; Drucker DJ, 2010, DIABETES CARE, V33, P428, DOI 10.2337/dc09-1499; DRUCKER DJ, 1991, ENDOCRINOLOGY, V128, P394, DOI 10.1210/endo-128-1-394; Dunning BE, 2005, DIABETOLOGIA, V48, P1700, DOI 10.1007/s00125-005-1878-0; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; FEHMANN HC, 1995, ACTA DIABETOL, V32, P176, DOI 10.1007/BF00838488; FEHMANN HC, 1991, FEBS LETT, V279, P335, DOI 10.1016/0014-5793(91)80182-3; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Hamaguchi K, 2003, EXP BIOL MED, V228, P1227, DOI 10.1177/153537020322801020; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Heller RS, 1995, AM J PHYSIOL-GASTR L, V269, pG852, DOI 10.1152/ajpgi.1995.269.6.G852; Jacobsen LV, 2009, BRIT J CLIN PHARMACO, V68, P898, DOI 10.1111/j.1365-2125.2009.03536.x; Kedees MH, 2009, MOL CELL ENDOCRINOL, V311, P69, DOI 10.1016/j.mce.2009.07.024; Kim SJ, 2012, CELL DEATH DIFFER, V19, P333, DOI 10.1038/cdd.2011.102; KREYMANN B, 1991, ENDOCRINOLOGY, V129, P1001, DOI 10.1210/endo-129-2-1001; Larsson LI, 1998, MECH DEVELOP, V79, P153, DOI 10.1016/S0925-4773(98)00182-8; Leibiger B, 2012, P NATL ACAD SCI USA, V109, P20925, DOI 10.1073/pnas.1212870110; Malaguarnera R, 2005, ENDOCR-RELAT CANCER, V12, P953, DOI 10.1677/erc.1.00968; Malm-Erjefalt M, 2010, DRUG METAB DISPOS, V38, P1944, DOI 10.1124/dmd.110.034066; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; Masur K, 2005, MOL ENDOCRINOL, V19, P1373, DOI 10.1210/me.2004-0350; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; MOJSOV S, 1990, J BIOL CHEM, V265, P8001; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Piro S, 2008, NUTR METAB CARDIOVAS, V18, P96, DOI 10.1016/j.numecd.2007.01.009; Piro S, 2010, ENDOCRINOLOGY, V151, P4197, DOI 10.1210/en.2009-1472; Prasadan K, 2002, DIABETES, V51, P3229, DOI 10.2337/diabetes.51.11.3229; Pyke C, 2013, ENDOCRINOLOGY, V154, P4, DOI 10.1210/en.2012-2124; Rabuazzo AM, 1997, DIABETES, V46, P1148, DOI 10.2337/diabetes.46.7.1148; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Reimann F, 2002, DIABETES, V51, P2757, DOI 10.2337/diabetes.51.9.2757; Rouille Y, 1997, J BIOL CHEM, V272, P32810, DOI 10.1074/jbc.272.52.32810; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Sengupta R, 2011, TRENDS PHARMACOL SCI, V32, P337, DOI 10.1016/j.tips.2011.02.015; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Tamagawa T, 2009, HUM CELL, V22, P55, DOI 10.1111/j.1749-0774.2009.00069.x; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; UMEZAWA H, 1984, J ANTIBIOT, V37, P422, DOI 10.7164/antibiotics.37.422; UNGER RH, 1975, LANCET, V1, P14; Wang LN, 2011, PEPTIDES, V32, P1313, DOI 10.1016/j.peptides.2011.03.018; Webb GC, 2004, J BIOL CHEM, V279, P31068, DOI 10.1074/jbc.M404110200; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563; Wideman RD, 2006, P NATL ACAD SCI USA, V103, P13468, DOI 10.1073/pnas.0600655103; Wideman RD, 2009, MOL THER, V17, P191, DOI 10.1038/mt.2008.219; Xiao JZ, 2001, ENDOCRINOLOGY, V142, P4777, DOI 10.1210/en.142.11.4777	65	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90093	10.1371/journal.pone.0090093	http://dx.doi.org/10.1371/journal.pone.0090093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587221	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200123
J	Yu, F; Wang, DX; Yi, XF; Shi, XX; Huang, YK; Zhang, HW; Zhang, XP				Yu, Fei; Wang, Dexiang; Yi, Xianfeng; Shi, Xiaoxiao; Huang, Yakun; Zhang, Hongwu; Zhang, XinPing			Does Animal-Mediated Seed Dispersal Facilitate the Formation of Pinus armandii-Quercus aliena var. acuteserrata Forests?	PLOS ONE			English	Article							TEMPERATE FOREST; CACHING BEHAVIOR; SMALL RODENTS; REGENERATION; PREDATION; ACORNS; ABUNDANCE; GROWTH; LIAOTUNGENSIS; RECRUITMENT	The Pinus armandii and Quercus aliena var. acuteserrata mixed forest is one of the major forest types in the Qinling Mountains, China. P. armandii is considered to be a pioneer species during succession and it is usually invaded by late successional Q. aliena var. acuteserrata. However, the mechanism that underlies its invasion remains unclear. In the present study, we tracked seed dispersal of P. armandii and Q. aliena var. acuteserrata using coded plastic tags in the western, middle and eastern Qinling Mountains to elucidate the invasion process in the mixed forests. Our results indicated that the seeds of both P. armandii and Q. aliena var. acuteserrata were removed rapidly in the Qinling Mountains, and there were no differences in the seed removal rates between the two species. There were significant differences in rodent seed-eating and caching strategies between the two tree species. For P. armandii, seeds were more likely to be eaten in situ than those of Q. aliena var. acuteserrata in all plots. By contrast, the acorns of Q. aliena var. acuteserrata were less frequently eaten in situ, but more likely to be removed and cached. Q. aliena var. acuteserrata acorns had significantly longer dispersal distances than P. armandii seeds in all plots. Although P. armandii seeds were less likely to be dispersed into the Q. aliena var. acuteserrata stands, over 30% of the released acorns were transported into the P. armandii stands where they established five seedlings. Based on the coupled recruitment patterns of P. armandii and Q. aliena var. acuteserrata, we suggest that the animal-mediated seed dispersal contributes to the formation of Pinus armandii-Quercus aliena var. acuteserrata forests.	[Yu, Fei; Wang, Dexiang; Huang, Yakun; Zhang, Hongwu; Zhang, XinPing] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Yi, Xianfeng] Jiangxi Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China; [Shi, Xiaoxiao] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Jiangxi Normal University; Northwest A&F University - China	Wang, DX (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	wangdx66@126.com			National Natural Science Funds [31070570]; Special Research Program for Public-Welfare Forestry of State Forestry Administration of China [20100400206]; CFERN & GENE Award Funds on Ecological Paper	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Special Research Program for Public-Welfare Forestry of State Forestry Administration of China; CFERN & GENE Award Funds on Ecological Paper	Funds were provided by National Natural Science Funds (No. 31070570), the Special Research Program for Public-Welfare Forestry of State Forestry Administration of China (No. 20100400206), and CFERN & GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGSPURGER CK, 1984, J ECOL, V72, P777, DOI 10.2307/2259531; Barbero Marcel, 1998, P153; Barcelos AR, 2013, INTEGR ZOOL, V8, P63, DOI 10.1111/1749-4877.12003; BROKAW NVL, 1985, ECOLOGY, V66, P682, DOI 10.2307/1940529; Caccia FD, 2006, OIKOS, V113, P469, DOI 10.1111/j.2006.0030-1299.14390.x; Capece PI, 2013, INTEGR ZOOL, V8, P57, DOI 10.1111/j.1749-4877.2012.00313.x; Caves EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065618; Chang G, 2012, PLANT ECOL, V213, P1633, DOI 10.1007/s11258-012-0118-1; [常罡 Chang Gang], 2012, [生态学报, Acta Ecologica Sinica], V32, P3177; Dang HS, 2007, FOREST ECOL MANAG, V240, P143, DOI 10.1016/j.foreco.2006.12.021; DaSilva JMC, 1996, CONSERV BIOL, V10, P491, DOI 10.1046/j.1523-1739.1996.10020491.x; DeMattia EA, 2004, ECOLOGY, V85, P2161, DOI 10.1890/03-0254; Galindo-Jaimes L, 2002, PLANT ECOL, V162, P259, DOI 10.1023/A:1020309004233; Gomez JM, 2003, ECOGRAPHY, V26, P573, DOI 10.1034/j.1600-0587.2003.03586.x; Gracia M, 2002, ACTA OECOL, V23, P405, DOI 10.1016/S1146-609X(02)01169-4; GREENE DF, 1993, OIKOS, V67, P69, DOI 10.2307/3545096; Hollander JL, 2004, OECOLOGIA, V138, P57, DOI 10.1007/s00442-003-1393-2; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jansen PA, 2001, MONOG BIOL, V80, P275; Jansen Patrick A., 2002, P209, DOI 10.1079/9780851995250.0209; JENSEN TS, 1986, OECOLOGIA, V70, P214, DOI 10.1007/BF00379242; Kang Bing, 2011, Yingyong Shengtai Xuebao, V22, P3123; Li HJ, 2003, FOREST ECOL MANAG, V176, P387, DOI 10.1016/S0378-1127(02)00286-4; Li HJ, 2007, FOREST ECOL MANAG, V242, P511, DOI 10.1016/j.foreco.2007.01.063; Liu GuangQuan, 2001, Scientia Silvae Sinicae, V37, P28; Liu HY, 2002, PLANT ECOL, V158, P139, DOI 10.1023/A:1015515332254; Lookingbill TR, 2000, J VEG SCI, V11, P607, DOI 10.2307/3246590; Mendoza I, 2009, J VEG SCI, V20, P367, DOI 10.1111/j.1654-1103.2009.05705.x; Meng LZ, 2012, INTEGR ZOOL, V7, P30, DOI [10.1111/j.1749-4877.2012.00273.x, 10.1111/j.1749-4877.2011.00275.x]; Mosandl R, 1998, FOREST ECOL MANAG, V106, P35, DOI 10.1016/S0378-1127(97)00237-5; Nepstad DC, 1996, OIKOS, V76, P25, DOI 10.2307/3545745; Perea R, 2012, EUR J FOREST RES, V131, P623, DOI 10.1007/s10342-011-0536-y; Pons J, 2006, FOREST ECOL MANAG, V231, P196, DOI 10.1016/j.foreco.2006.05.049; Price M.V., 1986, P191; SCHUPP EW, 1989, ECOLOGY, V70, P562, DOI 10.2307/1940206; Steele MA, 2001, OAK FOREST ECOSYSTEMS, P182; STEELE MA, 1993, AM MIDL NAT, V130, P229, DOI 10.2307/2426123; Urbieta IR, 2011, J VEG SCI, V22, P18, DOI 10.1111/j.1654-1103.2010.01222.x; Vander Wall SB, 2003, OIKOS, V100, P25, DOI 10.1034/j.1600-0706.2003.11973.x; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; VANDERWALL SB, 1993, OECOLOGIA, V96, P246, DOI 10.1007/BF00317738; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; WHITMORE T C, 1978, P639; Xiao ZS, 2013, J ECOL, V101, P1256, DOI 10.1111/1365-2745.12113; Xiao ZS, 2006, FOREST ECOL MANAG, V223, P18, DOI 10.1016/j.foreco.2005.10.054; Xiao ZS, 2005, PLANT ECOL, V177, P249, DOI 10.1007/s11258-005-2321-9; Xu HC, 1993, CHINESE PINE PINUS T, P113; Yi XF, 2008, ECOL RES, V23, P379, DOI 10.1007/s11284-007-0392-x; Yu F, 2013, ACTA BOT BOREAL OCCI, V33, P0592; Yu Fei, 2013, Yingyong Shengtai Xuebao, V24, P1531; Zhang HM, 2008, FOREST ECOL MANAG, V255, P1243, DOI 10.1016/j.foreco.2007.10.028; Zhang YQ, 1989, SHAANXI FOREST, P242; Zhang ZB., 2001, ACTA ECOLOGICA SINIC, V21, P839, DOI DOI 10.1007/BF02863045	54	16	19	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89886	10.1371/journal.pone.0089886	http://dx.doi.org/10.1371/journal.pone.0089886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587099	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200093
J	Chanda, D; Lee, JH; Sawant, A; Hensel, JA; Isayeva, T; Reilly, SD; Siegal, GP; Smith, C; Grizzle, W; Singh, R; Ponnazhagan, S				Chanda, Diptiman; Lee, Joo Hyoung; Sawant, Anandi; Hensel, Jonathan A.; Isayeva, Tatyana; Reilly, Stephanie D.; Siegal, Gene P.; Smith, Claire; Grizzle, William; Singh, Raj; Ponnazhagan, Selvarangan			Anterior Gradient Protein-2 Is a Regulator of Cellular Adhesion in Prostate Cancer	PLOS ONE			English	Article							BONE METASTASIS; TUMOR-CELL; AGR2; EXPRESSION; GENE; IDENTIFICATION; PROMOTES; PATHWAY; ANTIGEN; GROWTH	Anterior Gradient Protein (AGR-2) is reported to be over-expressed in many epithelial cancers and promotes metastasis. A clear-cut mechanism for its observed function(s) has not been previously identified. We found significant upregulation of AGR-2 expression in a bone metastatic prostate cancer cell line, PC3, following culturing in bone marrow-conditioned medium. Substantial AGR-2 expression was also confirmed in prostate cancer tissue specimens in patients with bone lesions. By developing stable clones of PC3 cells with varying levels of AGR-2 expression, we identified that abrogation of AGR-2 significantly reduced cellular attachment to fibronectin, collagen I, collagen IV, laminin I and fibrinogen. Loss of cellular adhesion was associated with sharp decrease in the expression of alpha 4, alpha 5, alpha V, beta 3 and beta 4 integrins. Failure to undergo apoptosis following detachment is a hallmark of epithelial cancer metastasis. The AGR-2-silenced PC3 cells showed higher resistance to Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis in vitro. This observation was also supported by significantly reduced Caspase-3 expression in AGR-2-silenced PC3 cells, which is a key effector of both extrinsic and intrinsic death signaling pathways. These data suggest that AGR-2 influence prostate cancer metastasis by regulation of cellular adhesion and apoptosis.	[Chanda, Diptiman; Lee, Joo Hyoung; Sawant, Anandi; Hensel, Jonathan A.; Isayeva, Tatyana; Reilly, Stephanie D.; Siegal, Gene P.; Grizzle, William; Ponnazhagan, Selvarangan] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Smith, Claire] Univ Alabama Hosp & Clin, Hosp Labs, Birmingham, AL USA; [Singh, Raj] Vivo Biosci Inc, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ponnazhagan, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	pons@uab.edu	Lee, Joo Hyoung/A-7713-2017	Lee, Joo Hyoung/0000-0003-4450-3067; Singh, Raj/0000-0002-6331-9196	National Institutes of Health [R01 AR560948, R01 CA133737, P30 AR046031]; NATIONAL CANCER INSTITUTE [R01CA133737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The financial support of the National Institutes of Health grants R01 AR560948, R01 CA133737 and P30 AR046031 is gratefully appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Barraclough DL, 2009, AM J PATHOL, V175, P1848, DOI 10.2353/ajpath.2009.090246; Barthel SR, 2013, CANCER RES, V73, P942, DOI 10.1158/0008-5472.CAN-12-3264; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin JK, 2011, INT J CANCER, V128, P2545, DOI 10.1002/ijc.26024; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Koci L, 2011, CYTOKINE, V55, P34, DOI 10.1016/j.cyto.2011.03.013; Lee DH, 2011, MOL CELLS, V31, P563, DOI 10.1007/s10059-011-1053-z; Lee HJ, 2012, EXP MOL MED, V44, P60, DOI 10.3858/emm.2012.44.1.006; Liapis H, 1996, DIAGN MOL PATHOL, V5, P127, DOI 10.1097/00019606-199606000-00008; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Maresh EL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-680; Marin-Aguilera M, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.09.006; Maslon MM, 2010, J MOL BIOL, V404, P418, DOI 10.1016/j.jmb.2010.09.035; McCabe NP, 2007, ONCOGENE, V26, P6238, DOI 10.1038/sj.onc.1210429; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Nancarrow DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022513; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Paoli P, 2013, BIOCH BIOPHYS ACTA; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Patel P, 2013, J MOL BIOL, V425, P929, DOI 10.1016/j.jmb.2012.12.009; Pizzi M, 2012, APPL IMMUNOHISTO M M, V20, P31, DOI 10.1097/PAI.0b013e3182233f9f; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Schneider JG, 2011, BONE, V48, P54, DOI 10.1016/j.bone.2010.09.016; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; van der Pluijm G, 1997, LAB INVEST, V77, P665; VanderVeldeZimmermann D, 1997, EXP CELL RES, V230, P111, DOI 10.1006/excr.1996.3405; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhang Y, 2007, PROSTATE CANCER P D, V10, P293, DOI 10.1038/sj.pcan.4500960	38	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89940	10.1371/journal.pone.0089940	http://dx.doi.org/10.1371/journal.pone.0089940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587138	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800059
J	Gruninger, RJ; Sensen, CW; McAllister, TA; Forster, RJ				Gruninger, Robert J.; Sensen, Christoph W.; McAllister, Timothy A.; Forster, Robert J.			Diversity of Rumen Bacteria in Canadian Cervids	PLOS ONE			English	Article							HERBIVORE GASTROINTESTINAL-TRACT; GEN. NOV.; MICROBIOME; RECOVERY; ECOLOGY; BIOMASS	Interest in the bacteria responsible for the breakdown of lignocellulosic feedstuffs within the rumen has increased due to their potential utility in industrial applications. To date, most studies have focused on bacteria from domesticated ruminants. We have expanded the knowledge of the microbial ecology of ruminants by examining the bacterial populations found in the rumen of non-domesticated ruminants found in Canada. Next-generation sequencing of 16S rDNA was employed to characterize the liquid and solid-associated bacterial communities in the rumen of elk (Cervus canadensis), and white tailed deer (Odocoileus virginianus). Despite variability in the microbial populations between animals, principle component and weighted UniFrac analysis indicated that bacterial communities in the rumen of elk and white tail deer are distinct. Populations clustered according to individual host animal and not the association with liquid or solid phase of the rumen contents. In all instances, Bacteroidetes and Firmicutes were the dominant bacterial phyla, although the relative abundance of these differed among ruminant species and between phases of rumen digesta, respectively. In the elk samples Bacteroidetes were more predominant in the liquid phase whereas Firmicutes was the most prevalent phyla in the solid digesta (P = 1x10(-5)). There were also statistically significant differences in the abundance of OTUs classified as Fibrobacteres (P = 5x10(-3)) and Spirochaetes (P = 3x10(-4)) in the solid digesta of the elk samples. We identified a number of OTUs that were classified as phylotypes not previously observed in the rumen environment. Our results suggest that although the bacterial diversity in wild North American ruminants shows overall similarities to domesticated ruminants, we observed a number of OTUs not previously described. Previous studies primarily focusing on domesticated ruminants do not fully represent the microbial diversity of the rumen and studies focusing on non-domesticated ruminants should be expanded.	[Gruninger, Robert J.; McAllister, Timothy A.; Forster, Robert J.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Sensen, Christoph W.] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB, Canada	Agriculture & Agri Food Canada; University of Calgary	Forster, RJ (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	Robert.Forster@agr.gc.ca	Sensen, Christoph W./C-1798-2013; McAllister, Tim A./R-9201-2017	Sensen, Christoph W./0000-0001-9604-8962; McAllister, Tim A./0000-0002-8266-6513	Genome Alberta; Agriculture and Agri-Food Canada Genomics Research and Development Initiative	Genome Alberta; Agriculture and Agri-Food Canada Genomics Research and Development Initiative	This study was supported through funding from Genome Alberta and the Agriculture and Agri-Food Canada Genomics Research and Development Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hook SE, 2011, FEMS MICROBIOL ECOL, V78, P275, DOI 10.1111/j.1574-6941.2011.01154.x; Ishaq SL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-212; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Klouche N, 2007, INT J SYST EVOL MICR, V57, P1757, DOI 10.1099/ijs.0.64642-0; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; LEE SF, 1992, J BACTERIOL, V174, P5275, DOI 10.1128/JB.174.16.5275-5283.1992; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; Ouwerkerk D, 2005, LETT APPL MICROBIOL, V41, P327, DOI 10.1111/j.1472-765X.2005.01774.x; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Pope PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038571; Qi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020521; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stewart CS., 1997, RUMEN MICROBIAL ECOS, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2]; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Sundset M, 2009, MICROB ECOL, V57, P335, DOI 10.1007/s00248-008-9414-7; TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zoetendal EG, 2003, INT J SYST EVOL MICR, V53, P211, DOI 10.1099/ijs.0.02362-0	31	45	53	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89682	10.1371/journal.pone.0089682	http://dx.doi.org/10.1371/journal.pone.0089682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586961	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800034
J	Zasada, IA; Peetz, A; Howe, DK; Wilhelm, LJ; Cheam, D; Denver, DR; Smythe, AB				Zasada, Inga A.; Peetz, Amy; Howe, Dana K.; Wilhelm, Larry J.; Cheam, Daravuth; Denver, Dee R.; Smythe, Ashleigh B.			Using Mitogenomic and Nuclear Ribosomal Sequence Data to Investigate the Phylogeny of the Xiphinema americanum Species Complex	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; DNA-SEQUENCES; NEMATODA; LONGIDORIDAE; TRANSMISSION; DELIMITATION; NEPOVIRUSES; DIVERSITY; EVOLUTION; LENGTH	Nematodes within the Xiphinema americanum species complex are economically important because they vector nepoviruses which cause considerable damage to a variety of agricultural crops. The taxonomy of X. americanum species complex is controversial, with the number of putative species being the subject of debate. Accurate phylogenetic knowledge of this group is highly desirable as it may ultimately reveal genetic differences between species. For this study, nematodes belonging to the X. americanum species complex, including potentially mixed species populations, were collected from 12 geographically disparate locations across the U. S. from different crops and in varying association with nepoviruses. At least four individuals from each population were analyzed. A portion of the 18S nuclear ribosomal DNA (rDNA) gene was sequenced for all individuals while the internal transcribed spacer region 1 (ITS1) of rDNA was cloned and 2 to 6 clones per individual were sequenced. Mitochondrial genomes for numerous individuals were sequenced in parallel using high-throughput DNA sequencing (HTS) technology. Phylogenetic analysis of the 18S rDNA revealed virtually identical sequences across all populations. Analysis of ITS1 rDNA sequences revealed several well-supported clades, with some degree of congruence with geographic location and viral transmission, but also numerous presumably paralogous sequences that failed to form clades with other sequences from the same population. Analysis of mitochondrial DNA (mtDNA) indicated the presence of three distinct monophyletic clades of X. americanum species complex nematodes. Two clades contained nematodes found in association with nepovirus and the third contained divergent mtDNA sequences from three nematode populations from the western U. S. where nepovirus was absent. The inherent heterogeneity in ITS1 rDNA sequence data and lack of informative sites in 18S rDNA analysis suggests that mtDNA may be more useful in sorting out the taxonomic confusion of the X. americanum species complex.	[Zasada, Inga A.; Peetz, Amy] USDA ARS Hort Crops Res Lab, Corvallis, OR USA; [Howe, Dana K.; Wilhelm, Larry J.; Cheam, Daravuth; Denver, Dee R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Smythe, Ashleigh B.] Hamilton Coll, Dept Biol, Clinton, NY 13323 USA	Oregon State University; Hamilton College	Zasada, IA (corresponding author), USDA ARS Hort Crops Res Lab, Corvallis, OR USA.	inga.zasada@ars.usda.gov			USDA-NIFA Specialty Crops Research Initiative [2009-51181-06022]; Oregon State University Agricultural Research Foundation	USDA-NIFA Specialty Crops Research Initiative; Oregon State University Agricultural Research Foundation	This work was partially funded by USDA-NIFA Specialty Crops Research Initiative grant 2009-51181-06022 and the Oregon State University Agricultural Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN DJF, 1994, PHYTOPATHOLOGY, V84, P646, DOI 10.1094/Phyto-84-646; BROWN DJF, 1993, J NEMATOL, V25, P349; Cardoso JMS, 2012, GENET MOL RES, V11, P4508, DOI 10.4238/2012.October.15.1; Cherry T, 1997, J NEMATOL, V29, P23; CHO MR, 1991, J NEMATOL, V23, P134; Cobb N. A., 1913, J Acad Sci, V3; Converse R.H., 1991, COMPENDIUM RASPBERRY, P47; Coomans A, 2001, ANN SC ZOOL MUS AFR, V1913; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; GEORGI LL, 1988, J NEMATOL, V20, P304; Gozel U, 2006, NEMATOLOGY, V8, P521, DOI 10.1163/156854106778613958; Gutierrez-Gutierrez C, 2012, EUR J PLANT PATHOL, V134, P561, DOI 10.1007/s10658-012-0039-9; He Y, 2005, J MOL EVOL, V61, P819, DOI 10.1007/s00239-005-0102-7; Howe DK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-62; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hugall A, 1999, MOL BIOL EVOL, V16, P157, DOI 10.1093/oxfordjournals.molbev.a026098; INGHAM R., 1994, METHODS SOIL ANAL 2, P459; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lamberti F., 2004, Nematologia Mediterranea, V32, P53; Lamberti F., 1987, P321; Lamberti F, 2002, RUSS J NEMATOL, V10, P99; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazarova SS, 2006, J NEMATOL, V38, P404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luc M, 1998, FUND APPL NEMATOL, V21, P475; Macfarlane SA, 2003, MOL PLANT PATHOL, V4, P211, DOI 10.1046/j.1364-3703.2003.00164.x; MacFarlane SA, 2002, ADV BOT RES, V36, P169, DOI 10.1016/S0065-2296(02)36063-4; Mes THM, 2004, PARASITOLOGY, V129, P213, DOI 10.1017/S0031182004005499; Nei M., 1987, MOL EVOLUTIONARY GEN; Neilson R, 2004, HELMINTHOLOGIA, V41, P209; Oliveira CMG, 2004, J NEMATOL, V36, P153; Pinkerton JN, 2005, INT J FRUIT SCI, V5, P55, DOI 10.1300/J492v05n03_06; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Raboin MJ, 2010, MOL BIOL EVOL, V27, P1087, DOI 10.1093/molbev/msp318; ROBBINS RT, 1991, NEMATOLOGICA, V37, P395, DOI 10.1163/187529291X00402; ROBBINS RT, 1993, J NEMATOL, V25, P344; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor C.E., 1997, NEMATODE VECTORS PLA; VRAIN TC, 1993, J NEMATOL, V25, P361; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; WILLIAMS BD, 1992, GENETICS, V131, P609; Ye WM, 2004, J NEMATOL, V36, P14; Zasada IA, 2010, ANNU REV PHYTOPATHOL, V48, P311, DOI 10.1146/annurev-phyto-073009-114425; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	19	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90035	10.1371/journal.pone.0090035	http://dx.doi.org/10.1371/journal.pone.0090035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587203	Green Published, gold			2022-12-27	WOS:000332390800070
J	Zhao, ZT; Jin, QJ; Xu, JR; Liu, HQ				Zhao, Zhongtao; Jin, Qiaojun; Xu, Jin-Rong; Liu, Huiquan			Identification of a Fungi-Specific Lineage of Protein Kinases Closely Related to Tyrosine Kinases	PLOS ONE			English	Article							SEQUENCE CONSERVATION; SUPERFAMILY; EVOLUTION; REVEALS; YEAST	Tyrosine kinases (TKs) specifically catalyze the phosphorylation of tyrosine residues in proteins and play essential roles in many cellular processes. Although TKs mainly exist in animals, recent studies revealed that some organisms outside the Opisthokont clade also contain TKs. The fungi, as the sister group to animals, are thought to lack TKs. To better understand the origin and evolution of TKs, it is important to investigate if fungi have TK or TK-related genes. We therefore systematically identified possible TKs across the fungal kingdom by using the profile hidden Markov Models searches and phylogenetic analyses. Our results confirmed that fungi lack the orthologs of animal TKs. We identified a fungi-specific lineage of protein kinases (FslK) that appears to be a sister group closely related to TKs. Sequence analysis revealed that members of the FslK clade contain all the conserved protein kinase sub-domains and thus are likely enzymatically active. However, they lack key amino acid residues that determine TK-specific activities, indicating that they are not true TKs. Phylogenetic analysis indicated that the last common ancestor of fungi may have possessed numerous members of FslK. The ancestral FslK genes were lost in Ascomycota and Ustilaginomycotina and Pucciniomycotina of Basidiomycota during evolution. Most of these ancestral genes, however, were retained and expanded in Agaricomycetes. The discovery of the fungi-specific lineage of protein kinases closely related to TKs helps shed light on the origin and evolution of TKs and also has potential implications for the importance of these kinases in mushroom fungi.	[Zhao, Zhongtao; Jin, Qiaojun; Liu, Huiquan] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liu, HQ (corresponding author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	liuhuiquan@nwsuaf.edu.cn	Liu, Huiquan/M-1587-2013	Liu, Huiquan/0000-0002-4723-845X	National Basic Research Program of China (973 program) [2013CB127702]; State Key Laboratory of Crop Stress Biology for Arid Areas	National Basic Research Program of China (973 program)(National Basic Research Program of China); State Key Laboratory of Crop Stress Biology for Arid Areas	This work was supported by grant 2013CB127702 from the National Basic Research Program of China (973 program) and State Key Laboratory of Crop Stress Biology for Arid Areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; Cowan-Jacob SW, 2006, CELL MOL LIFE SCI, V63, P2608, DOI 10.1007/s00018-006-6202-8; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; Kosti I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-133; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD85, DOI 10.2741/mustelin; Popovici C, 1999, GENOME RES, V9, P1026, DOI 10.1101/gr.9.11.1026; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Shiu SH, 2004, MOL BIOL EVOL, V21, P828, DOI 10.1093/molbev/msh077; Suga H, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002733; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; Wheeler GL, 2008, GENETICS, V179, P193, DOI 10.1534/genetics.107.085936	30	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89813	10.1371/journal.pone.0089813	http://dx.doi.org/10.1371/journal.pone.0089813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587055	Green Submitted, gold, Green Published			2022-12-27	WOS:000332390800043
J	Shao, C; Bai, LP; Qi, ZY; Hui, GZ; Wang, Z				Shao, Chuan; Bai, Li-Ping; Qi, Zhen-Yu; Hui, Guo-Zhen; Wang, Zhong			Overweight, Obesity and Meningioma Risk: A Meta-Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; SEX-STEROID-HORMONES; CANCER-RISK; INTRACRANIAL MENINGIOMA; LINKING OBESITY; BREAST-CANCER; UNITED-STATES; MILLION WOMEN; ASSOCIATION; GROWTH	Background and Objectives: Studies of the association between excess body weight and risk of meningioma have produced inconsistent results. Therefore, a meta-analysis of published studies was performed to better assess the association between meningioma and excess body weight. Methods: A literature search was conducted in the PubMed and EMBASE databases without any limitations. The reference lists of identified articles were also screened for additional studies. The summary relative risks (RRs) and 95% confidence intervals (CI) were calculated using fixed-or random-effects models. Results: A total of 6 studies provided risk estimates for overweight or obesity. Overall, the combined RRs were 1.12 (95% CI = 0.98-1.28) for overweight and 1.45 (95% CI = 1.26-1.67) for obesity. After stratification by gender, no significant association was observed for obese men (RR = 1.30, 95% CI = 0.64-2.62), while significant association was detected for obese women (RR = 1.46, 95% CI = 1.26-1.69). No substantial differences emerged across strata of study design and geographic areas. Conclusion: The results of this meta-analysis suggest that obesity but not overweight is associated with an increased risk of meningioma. Due to the limited number of studies, further research is needed to confirm the association.	[Shao, Chuan; Qi, Zhen-Yu; Hui, Guo-Zhen; Wang, Zhong] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China; [Bai, Li-Ping] Max Planck Inst Terr Microbiol, Dept Biochem, D-35043 Marburg, Hessen, Germany	Soochow University - China; Max Planck Society	Qi, ZY (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.	qizhenyu@suda.edu.cn		Shao, Chuan/0000-0001-8260-4761				ALBANES D, 1990, NUTR CANCER, V14, P69, DOI 10.1080/01635589009514078; Attner B, 2012, CANCER CAUSE CONTROL, V23, P769, DOI 10.1007/s10552-012-9946-5; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; BELLUR SN, 1983, ANN NEUROL, V13, P346, DOI 10.1002/ana.410130329; Benson VS, 2008, BRIT J CANCER, V99, P185, DOI 10.1038/sj.bjc.6604445; Bezemer ID, 2005, CANCER CAUSE CONTROL, V16, P561, DOI 10.1007/s10552-004-7472-9; Cabaniols C, 2011, J NEURO-ONCOL, V103, P307, DOI 10.1007/s11060-010-0388-1; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Claus EB, 2005, NEUROSURGERY, V57, P1088, DOI 10.1227/01.NEU.0000188281.91351.B9; Claus EB, 2013, J NEUROSURG, V118, P649, DOI 10.3171/2012.9.JNS12811; Cowppli-Bony A, 2011, CANCER CAUSE CONTROL, V22, P697, DOI 10.1007/s10552-011-9742-7; Custer B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-152; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Derby CA, 2006, CLIN ENDOCRINOL, V65, P125, DOI 10.1111/j.1365-2265.2006.02560.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan ZX, 2013, CANCER CAUSE CONTROL, V24, P1517, DOI 10.1007/s10552-013-0228-7; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hatiboglu MA, 2008, SURG NEUROL, V69, P356, DOI 10.1016/j.surneu.2007.03.013; HELSETH A, 1989, NEUROEPIDEMIOLOGY, V8, P277, DOI 10.1159/000110195; Hemminki K, 2011, EUR J CANCER PREV, V20, P438, DOI 10.1097/CEJ.0b013e32834761c0; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsu DW, 1997, J NEUROSURG, V86, P113, DOI 10.3171/jns.1997.86.1.0113; JACOBS DH, 1986, ANN NEUROL, V20, P376, DOI 10.1002/ana.410200326; JAY JR, 1985, J NEUROSURG, V62, P757, DOI 10.3171/jns.1985.62.5.0757; Jhawar BS, 2003, J NEUROSURG, V99, P848, DOI 10.3171/jns.2003.99.5.0848; Johnson DR, 2011, NEURO-ONCOLOGY, V13, P1011, DOI 10.1093/neuonc/nor081; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Lee E, 2006, INT J CANCER, V119, P1152, DOI 10.1002/ijc.21950; Maor G, 1999, ENDOCRINOLOGY, V140, P1901, DOI 10.1210/en.140.4.1901; Michaud DS, 2011, CANCER PREV RES, V4, P1385, DOI 10.1158/1940-6207.CAPR-11-0014; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55; Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Osorio-Costa F, 2009, ARQ BRAS ENDOCRINOL, V53, P213, DOI 10.1590/S0004-27302009000200013; Pan SY, 2004, AM J EPIDEMIOL, V159, P259, DOI 10.1093/aje/kwh041; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Qi ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083261; Qi ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068695; Ragel Brian T, 2005, Neurosurg Focus, V19, pE9; Rao G, 2009, NEUROSURGERY, V65, P483, DOI 10.1227/01.NEU.0000350876.91495.E0; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; RUBINSTEIN AB, 1994, J NEUROSURG, V81, P184, DOI 10.3171/jns.1994.81.2.0184; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Samanic C, 2004, CANCER CAUSE CONTROL, V15, P35, DOI 10.1023/B:CACO.0000016573.79453.ba; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Schneider B, 2005, CANCER DETECT PREV, V29, P440, DOI 10.1016/j.cdp.2005.07.002; SMALLEY KJ, 1990, AM J CLIN NUTR, V52, P405, DOI 10.1093/ajcn/52.3.405; Tulinius H, 1997, CANCER EPIDEM BIOMAR, V6, P863; Wellens RI, 1996, OBES RES, V4, P35, DOI 10.1002/j.1550-8528.1996.tb00510.x; Wells G.A., 2000, VIS COMMUN Q; Wiedmann M, 2013, BRIT J CANCER, V109, P289, DOI 10.1038/bjc.2013.304; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278	64	33	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90167	10.1371/journal.pone.0090167	http://dx.doi.org/10.1371/journal.pone.0090167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587258	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000138
J	Arbuthnott, D; Agrawal, AF; Rundle, HD				Arbuthnott, Devin; Agrawal, Aneil F.; Rundle, Howard D.			Remating and Sperm Competition in Replicate Populations of Drosophila melanogaster Adapted to Alternative Environments	PLOS ONE			English	Article							SEXUAL CONFLICT; FEMALE RESISTANCE; NATURAL-SELECTION; EVOLUTION; DIVERGENCE; FITNESS; SPECIATION; GENITALIA; TRAITS; MALES	The prevalence of sexual conflict in nature, as well as the supposedly arbitrary direction of the resulting coevolutionary trajectories, suggests that it may be an important driver of phenotypic divergence even in a constant environment. However, natural selection has long been central to the operation of sexual conflict within populations and may therefore constrain or otherwise direct divergence among populations. Ecological context may therefore matter with respect to the diversification of traits involved in sexual conflict, and if natural selection is sufficiently strong, such traits may evolve in correlation with environment, generating a pattern of ecologically-dependent parallel evolution. In this study we assess among-population divergence both within and between environments for several traits involved in sexual conflict. Using eight replicate populations of Drosophila melanogaster from a long-term evolution experiment, we measured remating rates and subsequent offspring production of females when housed with two separate males in sequence. We found no evidence of any variation in male reproductive traits (offense or defense). However, the propensity of females to remate diverged significantly among the eight populations with no evidence of any environmental effect, consistent with sexual conflict promoting diversification even in the absence of ecological differences. On the other hand, females adapted to one environment (ethanol) tended to produce a higher proportion of offspring sired by their first mate as compared to those adapted to the other (cadmium) environment, suggesting ecologically-based divergence of this conflict phenotype. Because we find evidence for both stochastic population divergence operating outside of an ecological context and environment-dependent divergence of traits under sexual conflict, the interaction of these two processes is an important topic for future work.	[Arbuthnott, Devin; Rundle, Howard D.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Agrawal, Aneil F.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Ottawa; University of Toronto	Arbuthnott, D (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	devin.arbuthnott@uottawa.ca		Rundle, Howard/0000-0002-8288-8888	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by NSERC grants to DA (PGS-D), AFA (Discovery), and HDR (Discovery). (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuthnott D, 2014, ECOL LETT, V17, P221, DOI 10.1111/ele.12222; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist Goran, 2005, pUnpaginated; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bjork A, 2007, P ROY SOC B-BIOL SCI, V274, P1779, DOI 10.1098/rspb.2007.0293; Bonduriansky R, 2011, AM NAT, V178, P729, DOI 10.1086/662665; BOORMAN E, 1976, ECOL ENTOMOL, V1, P145, DOI 10.1111/j.1365-2311.1976.tb01217.x; Cayetano L, 2011, EVOLUTION, V65, P2171, DOI 10.1111/j.1558-5646.2011.01309.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Civetta A, 1995, J MOL EVOL, V41, P1085, DOI 10.1007/BF00173190; Clark AG, 1998, GENETICS, V149, P1487; Clark AG, 2000, EVOLUTION, V54, P1030, DOI 10.1111/j.0014-3820.2000.tb00102.x; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; Coyne J.A., 2004, SPECIATION; Edward DA, 2011, EVOLUTION, V65, P564, DOI 10.1111/j.1558-5646.2010.01151.x; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fricke C, 2010, J EVOLUTION BIOL, V23, P1857, DOI 10.1111/j.1420-9101.2010.02050.x; Fricke C, 2009, BIOL LETTERS, V5, P671, DOI 10.1098/rsbl.2009.0433; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Gromko M.H., 1984, P371; Heinen-Kay JL, 2013, J EVOLUTION BIOL, V26, DOI 10.1111/jeb.12229; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Karlsson K, 2010, J EVOLUTION BIOL, V23, P2540, DOI 10.1111/j.1420-9101.2010.02102.x; Linder JE, 2005, J EVOLUTION BIOL, V18, P568, DOI 10.1111/j.1420-9101.2004.00872.x; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; Long TAF, 2006, PHILOS T R SOC B, V361, P363, DOI 10.1098/rstb.2005.1786; Long TAF, 2012, CURR BIOL, V22, P204, DOI 10.1016/j.cub.2011.12.020; Maklakov AA, 2010, EVOLUTION, V64, P1273, DOI 10.1111/j.1558-5646.2009.00904.x; Martin OY, 2004, CURR BIOL, V14, P906, DOI 10.1016/j.cub.2004.04.043; Parker G.A., 1979, SEXUAL SELECTION REP, P123, DOI DOI 10.1016/B978-0-12-108750-0.50010-0; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Perry JC, 2012, EVOLUTION, V66, P544, DOI 10.1111/j.1558-5646.2011.01464.x; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rowe L, 2006, PHILOS T R SOC B, V361, P277, DOI 10.1098/rstb.2005.1788; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Rowe L, 2012, EVOLUTION, V66, P40, DOI 10.1111/j.1558-5646.2011.01411.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Stewart AD, 2008, J EVOLUTION BIOL, V21, P1808, DOI 10.1111/j.1420-9101.2008.01593.x; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	45	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90207	10.1371/journal.pone.0090207	http://dx.doi.org/10.1371/journal.pone.0090207			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587283	gold, Green Published			2022-12-27	WOS:000332385900128
J	Heimesaat, MM; Lugert, R; Fischer, A; Alutis, M; Kuhl, AA; Zautner, AE; Tareen, AM; Gobel, UB; Bereswill, S				Heimesaat, Markus M.; Lugert, Raimond; Fischer, Andre; Alutis, Marie; Kuehl, Anja A.; Zautner, Andreas E.; Tareen, A. Malik; Goebel, Ulf B.; Bereswill, Stefan			Impact of Campylobacter jejuni cj0268c Knockout Mutation on Intestinal Colonization, Translocation, and Induction of Immunopathology in Gnotobiotic IL-10 Deficient Mice	PLOS ONE			English	Article							EXTRAINTESTINAL IMMUNE-RESPONSES; EPITHELIAL-CELL INVASION; CAMPYLOBACTER-JEJUNI; INTEGRIN BETA1; FIBRONECTIN; ACTIVATION; PROTEIN; JLPA	Background: Although Campylobacter jejuni infections have a high prevalence worldwide and represent a significant socioeconomic burden, the underlying molecular mechanisms of induced intestinal immunopathology are still not well understood. We have recently generated a C. jejuni mutant strain NCTC11168::cj0268c, which has been shown to be involved in cellular adhesion and invasion. The immunopathological impact of this gene, however, has not been investigated in vivo so far. Methodology/Principal Findings: Gnotobiotic IL-10 deficient mice were generated by quintuple antibiotic treatment and perorally infected with C. jejuni mutant strain NCTC11168:: cj0268c, its complemented version (NCTC11168::cj0268c-comp-cj0268c), or the parental strain NCTC11168. Kinetic analyses of fecal pathogen loads until day 6 post infection (p.i.) revealed that knockout of cj0268c did not compromise intestinal C. jejuni colonization capacities. Whereas animals irrespective of the analysed C. jejuni strain developed similar clinical symptoms of campylobacteriosis (i.e. enteritis), mice infected with the NCTC11168::cj0268c mutant strain displayed significant longer small as well as large intestinal lengths indicative for less distinct C. jejuni induced pathology when compared to infected control groups at day 6 p.i. This was further supported by significantly lower apoptotic and T cell numbers in the colonic mucosa and lamina propria, which were paralleled by lower intestinal IFN-gamma and IL-6 concentrations at day 6 following knockout mutant NCTC11168::cj0268c as compared to parental strain infection. Remarkably, less intestinal immunopathology was accompanied by lower IFN-gamma secretion in ex vivo biopsies taken from mesenteric lymphnodes of NCTC11168::cj0268c infected mice versus controls. Conclusion/Significance: We here for the first time show that the cj0268c gene is involved in mediating C. jejuni induced immunopathogenesis in vivo. Future studies will provide further deep insights into the immunological and molecular interplays between C. jejuni and innate immunity in human campylobacteriosis.	[Heimesaat, Markus M.; Fischer, Andre; Alutis, Marie; Goebel, Ulf B.; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Lugert, Raimond; Zautner, Andreas E.; Tareen, A. Malik] Univ Med Ctr Gottingen, Dept Med Microbiol, Gottingen, Germany; [Kuehl, Anja A.] Charite, Dept Pathol, Res Ctr ImmunoSci RCIS, D-13353 Berlin, Germany; [Zautner, Andreas E.] Univ Med Ctr Gottingen, Dept Clin Chem, UMG Lab, Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen	Heimesaat, MM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de	Zautner, Andreas Erich/ABA-9655-2020; Zautner, Andreas Erich/AAE-7425-2019	Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X; Kuhl, Anja/0000-0003-2293-5387; Heimesaat, Markus/0000-0001-6399-651X	German Research Foundation (DFG) (CampyGerm) [GR906/13-1, GO363/12-1, SFB633, TP A7, TP Z1, TP B6]; Deutsche Akademische Austauschdienst (DAAD); German Federal Ministry of Education and Research (BMBF)	German Research Foundation (DFG) (CampyGerm); Deutsche Akademische Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to RL (GR906/13-1, CampyGerm), UBG (GO363/12-1, CampyGerm; SFB633, TP A7), SB and AF (SFB633, TP A7), AAK (SFB633, TP Z1), MMH (SFB633, TP B6), MA (SFB633, Immuco), the Deutsche Akademische Austauschdienst (DAAD) to AMT, and from the German Federal Ministry of Education and Research (BMBF) to SB (TP1.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; Backert S, 2013, J MICROBIOL METH, V95, P8, DOI 10.1016/j.mimet.2013.06.031; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Boehm M, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00017; Croinin TO, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00025; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Haag LM, 2012, EUR J MICROBIOL IMMU, V2, P2, DOI 10.1556/EuJMI.2.2012.1.2; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Havelaar AH, 2009, CRIT REV MICROBIOL, V35, P1, DOI 10.1080/10408410802636017; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2013, EUR J MICROBIOL IMMU, V3, P174, DOI 10.1556/EuJMI.3.2013.3.4; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Holden KM, 2012, MICROB PATHOGENESIS, V52, P344, DOI 10.1016/j.micpath.2012.03.004; Jin SM, 2003, CELL MICROBIOL, V5, P165, DOI 10.1046/j.1462-5822.2003.00265.x; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Krause-Gruszczynska M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-32; Masanta WO, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/526860; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Novik V, 2010, INFECT IMMUN, V78, P3540, DOI 10.1128/IAI.00109-10; Oakland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020084; Otto B, 2012, EUR J MICROBIOL IMMU, V2, P210, DOI 10.1556/EuJMI.2.2012.3.7; Pei ZH, 1998, INFECT IMMUN, V66, P938, DOI 10.1128/IAI.66.3.938-943.1998; Tareen AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081069; Tareen AM, 2011, MICROBIOL-SGM, V157, P1776, DOI 10.1099/mic.0.045567-0; Tareen AM, 2010, MICROBIOL-SGM, V156, P3123, DOI 10.1099/mic.0.039438-0	30	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90148	10.1371/journal.pone.0090148	http://dx.doi.org/10.1371/journal.pone.0090148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587249	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900120
J	Titov, N; Dear, BF; Johnston, L; McEvoy, PM; Wootton, B; Terides, MD; Gandy, M; Fogliati, V; Kayrouz, R; Rapee, RM				Titov, Nickolai; Dear, Blake F.; Johnston, Luke; McEvoy, Peter M.; Wootton, Bethany; Terides, Matthew D.; Gandy, Milena; Fogliati, Vincent; Kayrouz, Rony; Rapee, Ronald M.			Improving Adherence and Clinical Outcomes in Self-Guided Internet Treatment for Anxiety and Depression: A 12-Month Follow-Up of a Randomised Controlled Trial	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; SOCIAL PHOBIA; MEASURING RESPONSE; DISORDER; HEALTH; QUESTIONNAIRE; RELAPSE; PHQ-9; CARE	Background: A recent paper reported the outcomes of a study examining a new self-guided internet-delivered treatment, the Wellbeing Course, for symptoms of anxiety or depression. This study found the intervention resulted in significant symptom reductions. It also found that automated emails increased treatment completion and clinical improvements in a subsample with elevated anxiety and depression. Aims: To examine the clinical outcomes and the effect of automated emails at 12 months post-treatment. Method: Participants, who were randomly allocated to a Treatment Plus Automated Emails Group (TEG; n = 100), a standard Treatment Group (TG; n = 106) or delayed-treatment Waitlist Control Group (Control; n = 51), were followed up at 12 months post-treatment. Eighty-one percent, 78% and 87% of participants in the TEG, TG and treated Waitlist Control Group provided symptom data at 12-month follow-up, respectively. The primary outcome measures were the Patient Health Questionnaire-9 Item Scale (PHQ-9) and the Generalized Anxiety Disorder-7 Item Scale (GAD-7). Results: Significant improvements in symptoms of anxiety and depression were observed over time in both the TEG and TG (Fs > 69, ps < .001) these were sustained from post-treatment to 12-month follow-up (ps > .05), and were associated with large effect sizes. No statistically significant differences in symptoms were found between the TEG and TG at post-treatment, 3-month or 12-month follow-up. Previously reported symptom differences between TEG and TG participants with comorbid symptoms were no longer present at 12-month follow-up (ps > .70). Conclusions: The overall benefits of the Wellbeing Course were sustained at 12-month follow-up. Although automated emails facilitated Course completion and reductions in symptoms for participants with comorbid anxiety and depression from pre-post treatment, these differences were no longer observed at 12-month follow-up. The results indicate that automated emails promote more rapid treatment response for people with elevated and comorbid symptoms, but may not improve longer term outcomes.	[Titov, Nickolai; Dear, Blake F.; Johnston, Luke; Wootton, Bethany; Terides, Matthew D.; Gandy, Milena; Fogliati, Vincent; Kayrouz, Rony; Rapee, Ronald M.] Macquarie Univ, Ctr Emot Hlth, Dept Psychol, Sydney, NSW 2109, Australia; [McEvoy, Peter M.] UWA, Ctr Clin Intervent, Perth, WA, Australia; [McEvoy, Peter M.] UWA, Sch Psychol, Perth, WA, Australia	Macquarie University; University of Western Australia; University of Western Australia	Titov, N (corresponding author), Macquarie Univ, Ctr Emot Hlth, Dept Psychol, Sydney, NSW 2109, Australia.	nick.titov@mq.edu.au	Gandy, Milena/AAV-3617-2020	Gandy, Milena/0000-0003-2161-3298; Titov, Nickolai/0000-0002-7268-729X; Woottonb, Bethany/0000-0002-0751-8529; Wootton, Bethany/0000-0001-9036-0699; Rapee, Ronald/0000-0002-1724-1076; Dear, Blake/0000-0001-9324-3092; McEvoy, Peter/0000-0003-2924-6760	Australian National Health and Medical Research Council (NHMRC) Project [630560]; National Health and Medical Research Council (NHMRC) Australian Public Health Fellowship	Australian National Health and Medical Research Council (NHMRC) Project(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) Australian Public Health Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The authors gratefully acknowledge the participants for their involvement and helpful comments. This research was enabled by funding from the Australian National Health and Medical Research Council (NHMRC) Project Grant No. 630560. BFD is supported by a National Health and Medical Research Council (NHMRC) Australian Public Health Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P55, DOI 10.1080/16506070902916400; Berger Thomas, 2011, Cognitive Behaviour Therapy, V40, P251, DOI 10.1080/16506073.2011.616531; Carlbring P, 2009, BEHAV RES THER, V47, P848, DOI 10.1016/j.brat.2009.06.012; Christensen H, 2006, PSYCHOL MED, V36, P1737, DOI 10.1017/S0033291706008695; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Clarke G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.3.e14; Dear BF, 2011, BEHAV RES THER, V49, P830, DOI 10.1016/j.brat.2011.09.007; Dear Blake F., 2011, Cognitive Behaviour Therapy, V40, P216, DOI 10.1080/16506073.2011.582138; Farvolden P, 2009, J TECHNOL HUMAN SERV, V27, P5, DOI 10.1080/15228830802458889; Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Johnston L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028079; Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Mackinnon A, 2008, BRIT J PSYCHIAT, V192, P130, DOI 10.1192/bjp.bp.106.032078; McEvoy PM, 2009, J COGN PSYCHOTHER, V23, P20, DOI 10.1891/0889-8391.23.1.20; Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151; Richards DA, 2009, BRIT J CLIN PSYCHOL, V48, P377, DOI 10.1348/014466509X405178; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Spek V, 2008, PSYCHOL MED, V38, P635, DOI 10.1017/S0033291707002590; Titov N, 2012, SPANISH J CLIN PSYCH, V17, P237, DOI DOI 10.5944/RPPC.V0L.17.NUM.3.2012; Titov N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062873; Titov Nickolai, 2011, Cognitive Behaviour Therapy, V40, P126, DOI 10.1080/16506073.2010.550059; Titov N, 2011, BEHAV RES THER, V49, P441, DOI 10.1016/j.brat.2011.03.007; Titov N, 2010, AUST NZ J PSYCHIAT, V44, P938, DOI 10.3109/00048674.2010.493859; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010885; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P913, DOI 10.1080/00048670903179160; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P1030, DOI 10.1080/00048670802512107; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P36, DOI 10.1080/00048670802534424; Vittengl JR, 2007, J CONSULT CLIN PSYCH, V75, P475, DOI 10.1037/0022-006X.75.3.475; Yonkers KA, 2003, DEPRESS ANXIETY, V17, P173, DOI 10.1002/da.10106	33	45	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89591	10.1371/journal.pone.0089591	http://dx.doi.org/10.1371/journal.pone.0089591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24586897	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900056
J	Zucco, LN; Zhang, QW; Kuliszewski, MA; Kandic, I; Faughnan, ME; Stewart, DJ; Kutryk, MJ				Zucco, Liana; Zhang, Qiuwang; Kuliszewski, Michael A.; Kandic, Ivana; Faughnan, Marie E.; Stewart, Duncan J.; Kutryk, Michael J.			Circulating Angiogenic Cell Dysfunction in Patients with Hereditary Hemorrhagic Telangiectasia	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ENDOGLIN; BLOOD; GENE; PROTEIN; DIFFERENTIATION; MUTATIONS; MONOCYTES; COLONIES; NUMBER	Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder. Circulating angiogenic cells (CACs) play an important role in vascular repair and regeneration. This study was designed to examine the function of CACs derived from patients with HHT. Peripheral blood mononuclear cells (PBMNCs) isolated from patients with HHT and age-and gender-matched healthy volunteers were assessed for expression of CD34, CD133 and VEGF receptor 2 by flow cytometry. PBMNCs were cultured to procure early outgrowth CACs. Development of endothelial cell (EC) phenotype in CACs was analyzed by fluorescence microscopy. CAC apoptosis was assayed with Annexin V staining, and CAC migration assessed by a modified Boyden chamber assay. mRNA expression of endoglin (ENG), activin receptor-like kinase-1 (ACVLR1 or ALK1) and endothelial nitric oxide synthase (eNOS) in CACs was measured by real time RT-PCR. The percentage of CD34+ cells in PBMNCs from HHT patients was significantly higher than in PBMNCs of healthy controls. CACs derived from patients with HHT not only showed a significant reduction in EC-selective surface markers following 7-day culture, but also a significant increase in the rate of basal apoptosis and blunted migration in response to vascular endothelial growth factor and stromal cell-derived factor-1. CACs from HHT patients expressed significantly lower levels of ENG, ALK1 and eNOS mRNAs. In conclusion, CACs from patients with HHT exhibited various functional impairments, suggesting a reduced regenerative capacity of CACs to repair the vascular lesions seen in HHT patients.	[Zucco, Liana; Zhang, Qiuwang; Kuliszewski, Michael A.; Kandic, Ivana; Kutryk, Michael J.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiol,Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Faughnan, Marie E.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Respirol,Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Stewart, Duncan J.] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Zucco, Liana] St Georges Hosp Trust, South Thames Fdn Sch, London, England	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; Ottawa Hospital Research Institute	Kutryk, MJ (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiol,Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.	kutrykm@smh.ca	Qiuwang Zhang, Research Associate/AAE-6707-2020		Heart and Stroke Foundation of Ontario, Toronto, ON [NA-5114]; Canadian Institute of Health Research, Ottawa, ON, Canada [FRN-80031]	Heart and Stroke Foundation of Ontario, Toronto, ON(Heart & Stroke Foundation of Ontario); Canadian Institute of Health Research, Ottawa, ON, Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Heart and Stroke Foundation of Ontario (Grant No. NA-5114), Toronto, ON, and the Canadian Institute of Health Research (Grant No. FRN-80031), Ottawa, ON, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BIDEAU A, 1992, ANN HUM BIOL, V19, P233, DOI 10.1080/03014469200002112; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; Fernandez-Lopez A, 2007, HUM MOL GENET, V16, P1515, DOI 10.1093/hmg/ddm069; Gallione CJ, 2006, J MED GENET, V43, P793, DOI 10.1136/jmg.2006.041517; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; Guven H, 2006, J AM COLL CARDIOL, V48, P1579, DOI 10.1016/j.jacc.2006.04.101; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lopez-Holgado N, 2007, CYTOTHERAPY, V9, P14, DOI 10.1080/14653240601047726; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Quirici N, 2001, BRIT J HAEMATOL, V115, P186, DOI 10.1046/j.1365-2141.2001.03077.x; Rehman J, 2004, J AM COLL CARDIOL, V43, P2314, DOI 10.1016/j.jacc.2004.02.049; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; van Laake LW, 2006, CIRCULATION, V114, P2288, DOI 10.1161/CIRCULATIONAHA.106.639161; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Ward MR, 2011, MOL THER, V19, P1323, DOI 10.1038/mt.2011.52; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Zhang QW, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/859643	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89927	10.1371/journal.pone.0089927	http://dx.doi.org/10.1371/journal.pone.0089927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587130	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900099
J	Yang, H; Gao, Y; Feng, T; Jin, TB; Kang, LL; Chen, C				Yang, Hua; Gao, Ya; Feng, Tian; Jin, Tian-Bo; Kang, Long-Li; Chen, Chao			Meta-Analysis of the rs4779584 Polymorphism and Colorectal Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TGF-BETA; HETEROGENEITY	Purpose: Several researchers have suggested that the rs4779584 (15q13.3) polymorphism is associated with an increased risk of developing colorectal cancer (CRC). However, past results remain inconclusive. We addressed this controversy by performing a meta-analysis of the relationship between rs4779584 of GREM1-SCG5 and colorectal cancer. Methods: We selected 12 case-control studies involving 11,769 cases of CRC and 14,328 healthy controls. The association between the rs4779584 polymorphism and CRC was examined by the overall odds ratio (OR) with a 95% confidence interval (CI). We used different genetic model analyses, sensitivity analyses, and assessments of bias in our meta-analysis. Results: GREM1-SCG5 rs4779584 polymorphisms were associated with CRC in all of the genetic models that were examined in this meta-analysis of 12 case-control studies. Conclusion: GREM1-SCG5 rs4779584 polymorphisms may increase the risk of developing colorectal cancer.	[Yang, Hua; Jin, Tian-Bo; Chen, Chao] NW Univ Xian, Sch Life Sci, Xian, Shaanxi, Peoples R China; [Gao, Ya] Xi An Jiao Tong Univ, Sch Med, Xian 710049, Peoples R China; [Feng, Tian; Jin, Tian-Bo; Chen, Chao] Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Shaanxi, Peoples R China; [Jin, Tian-Bo; Kang, Long-Li] Tibet Univ Nationalities, Sch Med, Key Lab High Altitude Environm & Genes Related Di, Xianyang, Shaanxi, Peoples R China	Northwest University Xi'an; Xi'an Jiaotong University; Xizang Minzu University	Kang, LL (corresponding author), Tibet Univ Nationalities, Sch Med, Key Lab High Altitude Environm & Genes Related Di, Xianyang, Shaanxi, Peoples R China.	klongli@163.com; cchen898@nwu.edu.cn			National 863 High-Technology Research and Development Program [2012AA02A519]	National 863 High-Technology Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by the National 863 High-Technology Research and Development Program (No. 2012AA02A519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dunlop MG, 2013, GUT, V62, P871, DOI 10.1136/gutjnl-2011-300537; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Hahn SA, 1995, CANCER RES, V55, P6; He J, 2010, CANCER EPIDEM BIOMAR, V20, P70; Hemminki K, 2004, CANCER EPIDEM BIOMAR, V13, P1253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Houlston RS, NATURE GENETICS, V40, P1426; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Le Marchand L, 2009, SURG ONCOL CLIN N AM, V18, P663, DOI 10.1016/j.soc.2009.07.004; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Middeldorp A, 2009, CANCER EPIDEM BIOMAR, V18, P3062, DOI 10.1158/1055-9965.EPI-09-0601; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Stewart B.W., 2003, WORLD CANC REPORT; Talseth-Palmer BA, 2011, J MED GENET, V48, P279, DOI 10.1136/jmg.2010.079962; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Topol LZ, 2000, CYTOGENET CELL GENET, V89; Vlodrop IJHv, 2010, AM J PATHOLOGY, V176; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Wordinger RJ, 2008, EXP EYE RES, V87, P78, DOI 10.1016/j.exer.2007.11.016; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89736	10.1371/journal.pone.0089736	http://dx.doi.org/10.1371/journal.pone.0089736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586997	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700080
J	Krishnakumar, M; Atheeshwar, S; Chandrasekar, MD				Krishnakumar, Mathangi; Atheeshwar, Shweta; Chandrasekar, Mathangi D.			Myopia and Digit Ratio in Medical College Students	PLOS ONE			English	Article							GROWTH-FACTOR-I; CEREBRAL LATERALIZATION; REFRACTIVE ERROR; SEX; CHILDREN; HORMONE; TESTOSTERONE; INTELLIGENCE; PREVALENCE; HYPOTHESIS	Myopia is amongst the most common refractive errors in the world. Both environmental and genetic factors are attributed to its causation, however all factors contributing to the development of myopia is yet to be found. Recent studies show presence of sex hormone receptor in the eyes. This has been shown to have a role in the development of various ocular pathologies. The second to fourth finger length ratio (2D: 4D) has been hypothesised to be determined by exposure to sex steroids prenatally and thus considered a crude measure for prenatal androgen exposure. Hence this study was initiated to assess the association between myopia and 2D: 4D ratio (a proxy marker to prenatal sex steroid exposure) among 100 medical college students of either sex and explore the possibility of role of prenatal sex steroids in causation of myopia. This study showed significant negative associations between myopia and digit ratio favouring a probable causal role of sex steroids on eye growth and development of myopia.	[Krishnakumar, Mathangi; Atheeshwar, Shweta] Chettinad Hosp & Res Inst, Dept Ophthalmol, Kelambakkam, Tamil Nadu, India; [Chandrasekar, Mathangi D.] Chettinad Hosp & Res Inst, Dept Physiol, Kelambakkam, Tamil Nadu, India		Chandrasekar, MD (corresponding author), Chettinad Hosp & Res Inst, Dept Physiol, Kelambakkam, Tamil Nadu, India.	mathz89@gmail.com	Krishnakumar, Mathangi/AAM-8343-2020; Chandrasekar, Mathangi Damal/Y-5442-2018	Chandrasekar, Mathangi Damal/0000-0002-3148-3792; krishnakumar, Mathangi/0000-0002-9225-3165				Allaway HC, 2009, AM J HUM BIOL, V21, P365, DOI 10.1002/ajhb.20892; Barlow HD, 2001, CASEBOOK ABNORMAL PS; BENBOW CP, 1986, NEUROPSYCHOLOGIA, V24, P719, DOI 10.1016/0028-3932(86)90011-4; Cardwell M, 2003, COMPLETE A Z PSYCHOL; Chen ZTY, 2011, MOL VIS, V17, P2297; CHOW Y C, 1990, SMJ Singapore Medical Journal, V31, P472; Cohen-Bendahan CCC, 2004, PSYCHONEUROENDOCRINO, V29, P911, DOI 10.1016/j.psyneuen.2003.07.001; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P521, DOI 10.1001/archneur.1985.04060060019009; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; Gupta PD, 2005, SURV OPHTHALMOL, V50, P274, DOI 10.1016/j.survophthal.2005.02.005; Kemper CJ, 2009, AM J HUM BIOL, V21, P188, DOI 10.1002/ajhb.20843; Laron Z, 1998, EUR J ENDOCRINOL, V138, P176, DOI 10.1530/eje.0.1380176; Lin LLK, 1996, OPTOMETRY VISION SCI, V73, P495, DOI 10.1097/00006324-199607000-00007; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; Manning JT, 2003, ANN HUM BIOL, V30, P579, DOI 10.1080/0301446032000112689; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT., 2002, DIGIT RATIO POINTER; Mathangi K, 2012, J CLIN RES LETT, V3, P24; McIntyre MH, 2005, P ROY SOC B-BIOL SCI, V272, P1473, DOI 10.1098/rspb.2005.3100; MIDELFART A, 1992, ACTA OPHTHALMOL, V70, P317; MILLER EM, 1995, OPTOMETRY VISION SCI, V72, P34, DOI 10.1097/00006324-199501000-00007; Mohan M, 1988, Acta Ophthalmol Suppl, V185, P19; Needlam R, 2001, LEFT HANDED THINKING; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Storfer M, 1999, INT J NEUROSCI, V98, P153, DOI 10.3109/00207459908997465; Sudhakar H H, 2013, Indian J Physiol Pharmacol, V57, P72; TEASDALE TW, 1988, LANCET, V2, P1351; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	30	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89800	10.1371/journal.pone.0089800	http://dx.doi.org/10.1371/journal.pone.0089800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24587043	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900150
J	Matsunaka, R; Hiraki, K				Matsunaka, Reiko; Hiraki, Kazuo			Fearful Gaze Cueing: Gaze Direction and Facial Expression Independently Influence Overt Orienting Responses in 12-Month-Olds	PLOS ONE			English	Article							EYE GAZE; ATTENTION; INFANTS; FACE; PERCEPTION; LOOKING; ADULTS; MODULATION; EMOTION; SYSTEM	Gaze direction cues and facial expressions have been shown to influence object processing in infants. For example, infants around 12 months of age utilize others' gaze directions and facial expressions to regulate their own behaviour toward an ambiguous target (i.e., social referencing). However, the mechanism by which social signals influence overt orienting in infants is unclear. The present study examined the effects of static gaze direction cues and facial expressions (neutral vs. fearful) on overt orienting using a gaze-cueing paradigm in 6- and 12-month-old infants. Two experiments were conducted: in Experiment 1, a face with a leftward or rightward gaze direction was used as a cue, and a face with a forward gaze direction was added in Experiment 2. In both experiments, an effect of facial expression was found in 12-month-olds; no effect was found in 6-month-olds. Twelve-month-old infants exhibited more rapid overt orienting in response to fearful expressions than neutral expressions, irrespective of gaze direction. These findings suggest that gaze direction information and facial expressions independently influence overt orienting in infants, and the effect of facial expression emerges earlier than that of static gaze direction. Implications for the development of gaze direction and facial expression processing systems are discussed.	[Matsunaka, Reiko; Hiraki, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan; [Matsunaka, Reiko; Hiraki, Kazuo] Japan Sci & Technol Agcy, CREST, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Hiraki, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan.	khiraki@idea.c.u-tokyo.ac.jp	Matsunaka, Reiko/R-7638-2019	Matsunaka, Reiko/0000-0001-5833-9830	JSPS [22240026]; JST CREST; Grants-in-Aid for Scientific Research [21118001] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (A) from JSPS (22240026) and grants from JST CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; BRONSTEIN AM, 1987, VISION RES, V27, P517, DOI 10.1016/0042-6989(87)90037-X; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; Csibra G, 2000, NEUROREPORT, V11, P1069, DOI 10.1097/00001756-200004070-00033; de Gelder BC, 2003, P NATL ACAD SCI USA, V100, P13105, DOI 10.1073/pnas.1735530100; De Groote I, 2007, INFANT BEHAV DEV, V30, P492, DOI 10.1016/j.infbeh.2006.12.009; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI [10.1093/acprof:oso/9780195134971.003.0029, DOI 10.1093/ACPROF:OSO/9780195134971.003.0029, /10.1093/acprof:oso/9780195134971.003.0029]; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Duchowski A., 2007, EYE TRACKING METHODO; Engell AD, 2007, NEUROPSYCHOLOGIA, V45, P3234, DOI 10.1016/j.neuropsychologia.2007.06.022; Farroni T, 2004, INFANCY, V5, P39, DOI 10.1207/s15327078in0501_2; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2000, VIS COGN, V7, P705, DOI 10.1080/13506280050144399; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Flom R, 2005, INFANCY, V7, P207, DOI 10.1207/s15327078in0702_5; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Friesen CK, 2003, NEUROREPORT, V14, P489, DOI 10.1097/01.wnr.0000058776.36017.5d; Graham R, 2010, VIS COGN, V18, P331, DOI 10.1080/13506280802689281; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Hoehl S, 2008, DEVELOPMENTAL SCI, V11, P10, DOI 10.1111/j.1467-7687.2007.00643.x; Hoehl S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002389; Hood BM, 1998, PSYCHOL SCI, V9, P131, DOI 10.1111/1467-9280.00024; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Karatekin C, 2007, DEV REV, V27, P283, DOI 10.1016/j.dr.2007.06.006; Klucharev V, 2004, NEUROREPORT, V15, P621, DOI 10.1097/00001756-200403220-00010; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Mansfield EM, 2003, VIS COGN, V10, P7, DOI [10.1080/713756671, 10.1080/13506280143000647]; Mathews A, 2003, VIS COGN, V10, P823, DOI 10.1080/13506280344000095; Mumme DL, 2003, CHILD DEV, V74, P221, DOI 10.1111/1467-8624.00532; Mundy P, 2000, DEV PSYCHOBIOL, V36, P325, DOI 10.1002/(SICI)1098-2302(200005)36:4<325::AID-DEV7>3.3.CO;2-6; Nakagawa A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-40; NELSON CA, 1985, CHILD DEV, V56, P58, DOI 10.2307/1130173; Peltola MJ, 2008, DEVELOPMENTAL SCI, V11, P60, DOI 10.1111/j.1467-7687.2007.00659.x; Peltola MJ, 2009, SOC COGN AFFECT NEUR, V4, P134, DOI 10.1093/scan/nsn046; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pourtois G, 2006, PROG BRAIN RES, V156, P67, DOI 10.1016/S0079-6123(06)56004-2; Rigato S, 2013, INT J BEHAV DEV, V37, P154, DOI 10.1177/0165025412472410; Rigato S, 2013, BRIT J DEV PSYCHOL, V31, P15, DOI 10.1111/j.2044-835X.2011.02069.x; Rigato S, 2010, SOC COGN AFFECT NEUR, V5, P88, DOI 10.1093/scan/nsp037; Senju A, 2005, VIS COGN, V12, P127, DOI 10.1080/13506280444000157; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; SORCE JF, 1985, DEV PSYCHOL, V21, P195, DOI 10.1037/0012-1649.21.1.195; Tipples J, 2006, COGNITION EMOTION, V20, P309, DOI 10.1080/02699930500405550; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Vecera SP, 2006, NEUROPSYCHOLOGIA, V44, P150, DOI 10.1016/j.neuropsychologia.2005.04.010; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2007, PHILOS T R SOC B, V362, P837, DOI 10.1098/rstb.2007.2092; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Woodward AL, 2003, DEVELOPMENTAL SCI, V6, P297, DOI 10.1111/1467-7687.00286	52	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89567	10.1371/journal.pone.0089567	http://dx.doi.org/10.1371/journal.pone.0089567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586877	gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700128
J	Khanal, V; Gavidia, T; Adhikari, M; Mishra, SR; Karkee, R				Khanal, Vishnu; Gavidia, Tania; Adhikari, Mandira; Mishra, Shiva Raj; Karkee, Rajendra			Poor Thermal Care Practices among Home Births in Nepal: Further Analysis of Nepal Demographic and Health Survey 2011	PLOS ONE			English	Article							LOW-RESOURCE SETTINGS; NEONATAL HYPOTHERMIA; SOUTHERN NEPAL; NEWBORN SURVIVAL; MORTALITY; DETERMINANTS; INDONESIA; RISK; INFANTS; LIFE	Introduction: Hypothermia is a major factor associated with neonatal mortality in low and middle income countries. Thermal care protection of newborn through a series of measures taken at birth and during the initial days of life is recommended to reduce the hypothermia and associated neonatal mortality. This study aimed to identify the prevalence of and the factors associated with receiving 'optimum thermal care' among home born newborns of Nepal. Methods: Data from the Nepal Demographic and Health Surveys (NDHS) 2011 were used for this study. Women who reported a home birth for their most recent childbirth was included in the study. Factors associated with optimum thermal care were examined using Chi-square test followed by logistic regression. Results: A total of 2464 newborns were included in the study. A total of 57.6 % were dried before the placenta was delivered; 60.3% were wrapped; 24.5% had not bathing during the first 24 hours, and 63.9% were breastfed within one hour of birth. Overall, only 248 (10.7%; 95% CI (8.8 %, 12.9%)) newborns received optimum thermal care. Newborns whose mothers had achieved higher education (OR 2.810; 95% CI (1.132, 6.976)), attended four or more antenatal care visits (OR 2.563; 95% CI (1.309, 5.017)), and those whose birth were attended by skilled attendants (OR 2.178; 95% CI (1.428, 3.323)) were likely to receive optimum thermal care. Conclusion: The current study showed that only one in ten newborns in Nepal received optimum thermal care. Future newborn survival programs should focus on those mothers who are uneducated; who do not attend the recommended four or more attend antenatal care visits; and those who deliver without the assistance of skilled birth attendants to reduce the risk of neonatal hypothermia in Nepal.	[Khanal, Vishnu; Karkee, Rajendra] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Gavidia, Tania] Curtin Univ, Ctr Int Hlth, Perth, WA 6845, Australia; [Adhikari, Mandira] Publ Hlth Worker, Kathmandu, Nepal; [Mishra, Shiva Raj] Inst Med, Kathmandu, Nepal; [Karkee, Rajendra] BP Koirala Inst Hlth Sci, Sch Publ Hlth & Community Med, Dharan, Nepal	Curtin University; Curtin University; B.P. Koirala Institute of Health Sciences	Khanal, V (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia.	khanal.vishnu@gmail.com	Khanal, Vishnu/AAE-5948-2020; Mishra, Shiva Raj/C-4172-2014	Mishra, Shiva Raj/0000-0002-2993-3504; Karkee, Rajendra/0000-0003-1510-5457; Khanal, Vishnu/0000-0002-3863-9913				Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS18, DOI 10.1038/sj.jp.7211271; Darmstadt GL, 2006, J PERINATOL, V26, P597, DOI 10.1038/sj.jp.7211569; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Darmstadt GL, 2013, JAMA-J AM MED ASSOC, V310, P969, DOI 10.1001/jama.2013.277269; Government of Nepal & The United Nations Country Team Nepal, 2013, NEP MILL DEV GOALS P; Karas DJ, 2012, J TROP PEDIATRICS, V58, P200, DOI 10.1093/tropej/fmr057; Kc A, 2011, J Nepal Health Res Counc, V9, P92; Kc A, 2011, J Nepal Health Res Counc, V9, P107; Khanal S, 2011, J HEALTH POPUL NUTR, V29, P255, DOI 10.3329/jhpn.v29i3.7873; Khanal V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-958; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Lunze K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-24; Macro International Inc, 2012, MEAS DHS DEM HLTH SU; McCall EM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004210.pub3; Mekonnen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-483; Ministry of Health and Population, 2010, COMM BAS NEWB CAR PR; Ministry of Health & Population NE ICF Macro USAID, 2012, NEP DEM HLTH SURV 20; Mullany LC, 2010, SEMIN PERINATOL, V34, P426, DOI 10.1053/j.semperi.2010.09.007; Mullany LC, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-43; Mullany LC, 2010, ARCH PEDIAT ADOL MED, V164, P650, DOI 10.1001/archpediatrics.2010.103; Mullany LC, 2010, ARCH PEDIAT ADOL MED, V164, P71, DOI 10.1001/archpediatrics.2009.239; Neupane S, 2013, MATERN CHILD HLTH J, P1; Neupane S, 2012, J COMMUN HEALTH, V37, P865, DOI 10.1007/s10900-011-9521-0; Osrin D, 2002, BMJ-BRIT MED J, V325, P1063, DOI 10.1136/bmj.325.7372.1063; Pradhan Y V, 2011, J Nepal Health Res Counc, V9, P119; Pradhan YV, 2012, HEALTH POLICY PLANN, V27, P57, DOI 10.1093/heapol/czs052; Rutstein O, 2012, GUIDE DHS STAT; Sodemann M, 2008, TROP MED INT HEALTH, V13, P980, DOI 10.1111/j.1365-3156.2008.02113.x; Sreeramareddy Chandrashekhar T, 2006, BMC Pregnancy Childbirth, V6, P27, DOI 10.1186/1471-2393-6-27; Thairu L, 2008, MATERN CHILD NUTR, V4, P194, DOI 10.1111/j.1740-8709.2008.00135.x; Titaley CR, 2012, HEALTH POLICY PLANN, V27, P405, DOI 10.1093/heapol/czr053; Titaley CR, 2010, B WORLD HEALTH ORGAN, V88, P500, DOI 10.2471/BLT.09.065813; Titaley CR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-232; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE; Waiswa P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-9; West BT, 2008, J TRAUMA STRESS, V21, P440, DOI 10.1002/jts.20356; Witter S, 2011, HEALTH POLICY PLANN, V26, pII84, DOI 10.1093/heapol/czr066; World Health Organization. Maternal and Newborn Health/Safe Motherhood, 1997, THERM PROT NEWB PRAC	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89950	10.1371/journal.pone.0089950	http://dx.doi.org/10.1371/journal.pone.0089950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587145	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200098
J	Kim, JT; Heo, SH; Park, MS; Chang, J; Choi, KH; Cho, KH				Kim, Joon-Tae; Heo, Suk-Hee; Park, Man-Seok; Chang, Jane; Choi, Kang-Ho; Cho, Ki-Hyun			Use of Antithrombotics after Hemorrhagic Transformation in Acute Ischemic Stroke	PLOS ONE			English	Article							ASSOCIATION; REPERFUSION; GUIDELINES; INFARCTION	Backgrounds: There have been neither appropriate guidelines nor clinical studies about the use of antithrombotics after hemorrhagic transformation (HT). We sought to find whether the use of antithrombotics after hemorrhagic infarction might be associated with aggravation of HT and neurological deterioration. Methods: This retrospective study included prospectively registered consecutive patients with acute ischemic stroke and HT in our tertiary stroke center. We focused on the hemorrhagic infarction. Aggravation of HT was defined as either enlargement of the original HT or newly developed HT within the infarcted area by visual analysis. We analyzed relationships between antithrombotics and HT, and neurological deterioration after HT in patients with hemorrhagic infarction. In addition, we assessed composite outcomes including neurological deterioration, vascular events, and death at 1month after HT. We analyzed relationships between antithrombotics after discharge and composite outcomes within 1month after HT. Results: 222 patients were finally analyzed. Of the 150 patients with hemorrhagic infarction, 75 (50.0%) were type 1. The use of warfarin after detection of hemorrhagic infarction more frequently increased aggravation of HT than did the use of antiplatelets (4 of 24 vs 3 of 69; p = 0.094), but neither warfarin nor antiplatelets caused more HT than no medication. In addition, the use of antithrombotics after hemorrhagic infarction was not significantly associated with neurological deterioration after HT. The frequency of composite events at 1months was significantly lower in patients treated with antithrombotics than those treated without (p = 0.041). Conclusion: In conclusion, the results of this study suggest that antithrombotics can safely be used after hemorrhagic infarction and may not be associated with neurological deterioration and aggravation of HT. Further studies are needed to confirm our results.	[Kim, Joon-Tae; Park, Man-Seok; Chang, Jane; Choi, Kang-Ho; Cho, Ki-Hyun] Chonnam Natl Univ Hosp, Cerebrovasc Ctr, Dept Neurol, Kwangju, South Korea; [Kim, Joon-Tae] Chonnam Natl Univ Hosp, Biomed Res Inst, Kwangju, South Korea; [Heo, Suk-Hee] Chonnam Natl Univ, Hwasun Hosp, Dept Radiol, Hwasun, Jeonnam, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University Hospital; Chonnam National University	Kim, JT (corresponding author), Chonnam Natl Univ Hosp, Cerebrovasc Ctr, Dept Neurol, Kwangju, South Korea.	alldelight2@hanmail.net; mspark@jnu.ac.kr			Chonnam National University Hospital Research Institute of Clinical Medicine [CRI 12008-1]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Chonnam National University Hospital Research Institute of Clinical Medicine; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant (CRI 12008-1) from Chonnam National University Hospital Research Institute of Clinical Medicine and a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Berger C, 2001, STROKE, V32, P1330, DOI 10.1161/01.STR.32.6.1330; Fiehler J, 2005, CEREBROVASC DIS, V19, P117, DOI 10.1159/000083180; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Kablau M, 2011, CEREBROVASC DIS, V32, P334, DOI 10.1159/000331702; Kent DM, 2004, STROKE, V35, P1141, DOI 10.1161/01.STR.0000125712.02090.6e; Molina CA, 2002, STROKE, V33, P1551, DOI 10.1161/01.STR.0000016323.13456.E5; Park JH, 2012, NEUROLOGY, V78, P421, DOI 10.1212/WNL.0b013e318245d22c; PESSIN MS, 1993, NEUROLOGY, V43, P1298, DOI 10.1212/WNL.43.7.1298	10	12	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89798	10.1371/journal.pone.0089798	http://dx.doi.org/10.1371/journal.pone.0089798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587041	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200084
J	Logie, CH; Daniel, C; Newman, PA; Weaver, J; Loutfy, MR				Logie, Carmen H.; Daniel, CarolAnn; Newman, Peter A.; Weaver, James; Loutfy, Mona R.			A Psycho-Educational HIV/STI Prevention Intervention for Internally Displaced Women in Leogane, Haiti: Results from a Non-Randomized Cohort Pilot Study	PLOS ONE			English	Article							PSYCHOMETRIC EVALUATION; HIV PREVENTION; RURAL HAITI; POWER; RISK; POPULATIONS; DEPRESSION; INFECTION; ADULTS; MODEL	Background: Little evidence exists regarding efficacious HIV and sexually transmitted infections (STI) prevention interventions with internally displaced populations. Internally displaced women are at elevated risk for HIV/STI due to limited access to health services, heightened poverty and social network breakdown. The FASY (Famn an Aksyon Pou Sante' Yo) (Women Taking Action For Their Health) study examined the effectiveness of a peer health worker (PHW) delivered psycho-educational HIV/STI pilot study with internally displaced women in Leogane, Haiti. Method: This was a non-randomized cohort pilot study. Participants completed a computer-assisted pre-test programmed on Android tablet PCs followed by an HIV/STI educational video-based session and a 6-week psycho-educational group program of weekly meetings. Participants completed a post-test upon completion of group sessions. The primary outcome was HIV knowledge; our pre-specified index of clinically significant change was an effect size of 0.30. Secondary outcomes included: STI knowledge, condom use, social support, resilient coping, depression and relationship control. We used mixed-effects regression to calculate mean outcome pre-post score change. This study was registered (clinicaltrials.gov, NCT01492829). Results: Between January 1-April 30, 2012 we assigned 200 participants to the study. The majority of participants (n = 176, 88%) completed the study and were followed up at 8 weeks, finishing April 30, 2012. Adjusted for socio-demographic characteristics, HIV knowledge (beta = 4.81; 95% CI 4.36-5.26), STI knowledge (beta = 0.84; 95% CI 0.70-0.99), condom use (AOR = 4.05, 95% CI 1.86-8.83), and depression (beta = -0.63, 95% CI -0.88--0.39) scores showed statistically significant change post-intervention (p < 0.05). Conclusions: This pilot study evaluated a PHW psycho-educational HIV/STI prevention intervention among internally displaced women in post-earthquake Haiti. Pilot studies are an important approach to understand feasibility and scientific impacts of HIV prevention strategies in disaster contexts. Study results may inform HIV prevention interventions among internally displaced women in Haiti and can be tested for applicability with internally displaced women globally. ClinicalTrials.gov: Identifier NCT01492829, URL: http://clinicaltrials.gov/ct2/show/NCT01492829?term=logie&rank=1	[Logie, Carmen H.; Newman, Peter A.; Weaver, James] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Logie, Carmen H.; Loutfy, Mona R.] Univ Toronto, Res Inst, Womens Coll, Toronto, ON, Canada; [Daniel, CarolAnn] Adelphi Univ, Fac Social Work, New York, NY USA	University of Toronto; University of Toronto; Women's College Research Institute; Adelphi University	Logie, CH (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.	carmen.logie@utoronto.ca	Newman, Peter A/P-7056-2019	Newman, Peter A/0000-0003-0444-5915; Weaver, James/0000-0003-0755-5191	Grand Challenges Canada Rising Star in Global Health grant [0016-01-04-01-01]	Grand Challenges Canada Rising Star in Global Health grant	This trial was funded by a Grand Challenges Canada Rising Star in Global Health grant (grant number 0016-01-04-01-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Bruwer B, 2008, COMPR PSYCHIAT, V49, P195, DOI 10.1016/j.comppsych.2007.09.002; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Celletti F, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000366082.68321.d6; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; CIA (Central Intelligence Agency), 2013, WORLD FACTB HAIT; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dorjgochoo T, 2009, JAIDS-J ACQ IMM DEF, V52, P498, DOI 10.1097/QAI.0b013e3181ac12a8; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fawzi MCS, 2006, SEX TRANSM INFECT, V82, P175, DOI 10.1136/sti.2005.016733; Hampton T, 2008, JAMA-J AM MED ASSOC, V300, P493, DOI 10.1001/jama.300.5.493; Harrison A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-102; Holstad Marcia McDonnell, 2012, Afr J Reprod Health, V16, P14; Internal Displacement Monitoring Centre, 2011, INT DISPL GLOB OV TR; International Organization for Migration, 2013, DISPL TRACK MATR V2; Jaworski BC, 2007, AIDS BEHAV, V11, P557, DOI 10.1007/s10461-006-9168-5; Jerome G, 2010, AIDS, V24, pS67, DOI 10.1097/01.aids.0000366084.75945.c9; Julmy S, 2011, HUMANITARIAN EXC FEB, V49; Kaponda CPN, 2011, HEALTH EDUC BEHAV, V38, P159, DOI 10.1177/1090198110378588; Khaw AJ, 2000, DISASTERS, V24, P181, DOI 10.1111/1467-7717.00141; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; LAIRD NM, 1988, STAT MED, V7, P305, DOI 10.1002/sim.4780070131; Logie CH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001634; Logie CH, 2012, SOC SCI MED, V74, P1261, DOI 10.1016/j.socscimed.2012.01.008; MADRE, 2011, ON YEAR UPD OUR BOD; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Population Council, 2009, ITS ALL ON CURR GUID; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Spiegel PB, 2004, DISASTERS, V28, P322, DOI 10.1111/j.0361-3666.2004.00261.x; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Tiffany JS, 2006, J URBAN HEALTH, V83, pI113, DOI 10.1007/s11524-006-9107-9; UNAIDS, 2011, 2010 REP GLOB AIDS E; UNAIDS, 2011, AIDS INF HAIT; United Nations Programme on HIV and AIDS (UNAIDS), 2011, PROGR REST ACC HIV S; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	41	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89836	10.1371/journal.pone.0089836	http://dx.doi.org/10.1371/journal.pone.0089836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587068	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200085
J	Brinkley-Rubinstein, L; Craven, K				Brinkley-Rubinstein, Lauren; Craven, Krista			A Latent Class Analysis of Stigmatizing Attitudes and Knowledge of HIV Risk among Youth in South Africa	PLOS ONE			English	Article							AIDS STIGMA; PATTERNS; CAPE	Background: The current study aims to investigate how the ability to accurately gauge risk factors associated with contracting HIV while taking into consideration various individual and community level socio-demographic characteristics (e.g., race and poverty) predicts the nature of stigmatizing attitudes toward persons with HIV. Methods: Data from a sample of 1,347 Cape Town area youth who participated in the Cape Area Panel Study (CAPS) Wave 2a were used. Latent Class Analysis was conducted to ascertain whether response patterns regarding knowledge of HIV contraction suggest the presence of subgroups within the sample. Results: Findings indicate that there are four latent classes representing unique response pattern profiles regarding knowledge of HIV contraction. Additionally, our results suggest that those in South Africa who are classified as "white," live in more affluent communities, and have more phobic perceptions of HIV risk are also more likely to have the most stigmatizing attitudes toward those who are HIV positive. Conclusion: Implications of these findings include extending HIV knowledge, education, and awareness programs to those who are not traditionally targeted in an attempt to increase levels of knowledge about HIV and, consequently, decrease stigma.	[Brinkley-Rubinstein, Lauren; Craven, Krista] Vanderbilt Univ, Dept Human & Org Dev, Nashville, TN 37235 USA	Vanderbilt University	Brinkley-Rubinstein, L (corresponding author), Vanderbilt Univ, Dept Human & Org Dev, 221 Kirkland Hall, Nashville, TN 37235 USA.	lauren.brinkley@gmail.com						Allport G. W., 1954, NATURE PREJUDICE; Ankomah A, 2011, HIV AIDS-RES PALLIAT, V3, P93, DOI 10.2147/HIV.S23081; Campbell C, 2005, AM J PUBLIC HEALTH, V95, P808, DOI 10.2105/AJPH.2003.037499; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Hadzi-Pavlovic D, 2009, ACTA NEUROPSYCHIATR, V21, P312, DOI 10.1111/j.1601-5215.2009.00429.x; Herek GM, 1997, J APPL SOC PSYCHOL, V27, P1, DOI 10.1111/j.1559-1816.1997.tb00621.x; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Lam D, 2008, CAPE AREA PANEL STUD; Letamo G, 2003, J HEALTH POPUL NUTR, V21, P347; Mall S, 2013, AIDS CARE, V25, P194, DOI 10.1080/09540121.2012.689810; Maughan-Brown B, 2010, SOC SCI MED, V70, P368, DOI 10.1016/j.socscimed.2009.09.041; Nel JA, 2013, AIDS BEHAV, V17, pS51, DOI 10.1007/s10461-012-0329-4; NYBLADE L, 2000, COMMUNITY INVOLVEMEN; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; SHISANA O, 2005, S AFRICAN NATL HIV P; Stephenson R, 2009, AIDS CARE, V21, P403, DOI 10.1080/09540120802290365	17	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89915	10.1371/journal.pone.0089915	http://dx.doi.org/10.1371/journal.pone.0089915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24587120	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800056
J	Hansson, B; Ljungqvist, M; Illera, JC; Kvist, L				Hansson, Bengt; Ljungqvist, Marcus; Illera, Juan-Carlos; Kvist, Laura			Pronounced Fixation, Strong Population Differentiation and Complex Population History in the Canary Islands Blue Tit Subspecies Complex	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; EVOLUTIONARY HISTORY; TENERIFFAE-GROUP; DNA-SEQUENCE; COLONIZATION; SPECIATION; AVES; DIVERSIFICATION; PHYLOGEOGRAPHY; INFERENCE	Evolutionary molecular studies of island radiations may lead to insights in the role of vicariance, founder events, population size and drift in the processes of population differentiation. We evaluate the degree of population genetic differentiation and fixation of the Canary Islands blue tit subspecies complex using microsatellite markers and aim to get insights in the population history using coalescence based methods. The Canary Island populations were strongly genetically differentiated and had reduced diversity with pronounced fixation including many private alleles. In population structure models, the relationship between the central island populations (La Gomera, Tenerife and Gran Canaria) and El Hierro was difficult to disentangle whereas the two European populations showed consistent clustering, the two eastern islands (Fuerteventura and Lanzarote) and Morocco weak clustering, and La Palma a consistent unique lineage. Coalescence based models suggested that the European mainland forms an outgroup to the Afrocanarian population, a split between the western island group (La Palma and El Hierro) and the central island group, and recent splits between the three central islands, and between the two eastern islands and Morocco, respectively. It is clear that strong genetic drift and low level of concurrent gene flow among populations have shaped complex allelic patterns of fixation and skewed frequencies over the archipelago. However, understanding the population history remains challenging; in particular, the pattern of extreme divergence with low genetic diversity and yet unique genetic material in the Canary Island system requires an explanation. A potential scenario is population contractions of a historically large and genetically variable Afrocanarian population, with vicariance and drift following in the wake. The suggestion from sequence-based analyses of a Pleistocene extinction of a substantial part of North Africa and a Pleistocene/Holocene eastward re-colonisation of western North Africa from the Canaries remains possible.	[Hansson, Bengt; Ljungqvist, Marcus] Lund Univ, Dept Biol, Lund, Sweden; [Illera, Juan-Carlos] Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Spain; [Illera, Juan-Carlos] Univ Oviedo, Res Unit Biodivers, Oviedo, Spain; [Kvist, Laura] Univ Oulu, Dept Biol, Oulu, Finland	Lund University; University of Oviedo; University of Oulu	Hansson, B (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	bengt.hansson@biol.lu.se	Illera, Juan Carlos/C-6583-2014; Hansson, Bengt/L-8874-2013	Illera, Juan Carlos/0000-0002-4389-0264; Hansson, Bengt/0000-0001-6694-8169	Swedish Research Council [621-2007-5381, 621-2009-4945]; Oscar and Lili Lamm Foundation; Crafoord Foundation; Spanish postdoctoral fellowship (subprogram Ramon y Cajal)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Oscar and Lili Lamm Foundation; Crafoord Foundation; Spanish postdoctoral fellowship (subprogram Ramon y Cajal)	This study was supported by the Swedish Research Council (621-2007-5381; 621-2009-4945), the Oscar and Lili Lamm Foundation, the Crafoord Foundation; and a Spanish postdoctoral fellowship (subprogram Ramon y Cajal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGUITA F, 1986, J VOLCANOL GEOTH RES, V30, P155, DOI 10.1016/0377-0273(86)90072-7; Bellemain E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-240; Illera JC, 2012, QUATERNARY SCI REV, V50, P14, DOI 10.1016/j.quascirev.2012.07.013; Illera JC, 2011, MOL ECOL, V20, P4123, DOI 10.1111/j.1365-294X.2011.05259.x; Chaves JA, 2012, J EVOLUTION BIOL, V25, P509, DOI 10.1111/j.1420-9101.2011.02447.x; Clegg S, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P293; COELLO J, 1992, J VOLCANOL GEOTH RES, V53, P251, DOI 10.1016/0377-0273(92)90085-R; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Darwin C, 1859, ORIGIN SPECIES MEANS; del Hoyo J, 2007, HDB BIRDS WORLD HBW, P38; Dietzen C, 2008, J ORNITHOL, V149, P1, DOI 10.1007/s10336-007-0192-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; GRANT PR, 1979, BIOL J LINN SOC, V11, P103, DOI 10.1111/j.1095-8312.1979.tb00029.x; Hansson B, 2010, HEREDITY, V104, P67, DOI 10.1038/hdy.2009.107; Harrap S., 1996, TITS NUTHATCHES TREE; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Illera JC, 2007, MOL ECOL, V16, P4599, DOI 10.1111/j.1365-294X.2007.03543.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson NK, 2004, EVOLUTION, V58, P1122; Jonsson KA, 2011, P NATL ACAD SCI USA, V108, P2328, DOI 10.1073/pnas.1018956108; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kvist L, 2006, MOL PHYLOGENET EVOL, V38, P290, DOI 10.1016/j.ympev.2005.10.012; Kvist L, 2005, MOL PHYLOGENET EVOL, V34, P501, DOI 10.1016/j.ympev.2004.11.017; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Mila B, 2007, MOL ECOL, V16, P159, DOI 10.1111/j.1365-294X.2006.03119.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Olano-Marin J, 2010, MOL ECOL RESOUR, V10, P516, DOI 10.1111/j.1755-0998.2009.02777.x; Packert M, 2013, MOL PHYLOGENET EVOL, V67, P458, DOI 10.1016/j.ympev.2013.02.010; Price T, 2008, SPECIATION BIRDS; Pritchard JK, 2000, GENETICS, V155, P945; Salzburger W, 2002, MOL PHYLOGENET EVOL, V24, P19, DOI 10.1016/S1055-7903(02)00265-8; Schottler B, 1993, B MUS MUN FUNCHAL S, V2, P273; Schottler Brigitte, 1995, Bioacoustics, V6, P135; Sheldon FH, 2009, J BIOGEOGR, V36, P1070, DOI 10.1111/j.1365-2699.2009.02087.x; Suarez NM, 2009, MOL PHYLOGENET EVOL, V53, P556, DOI 10.1016/j.ympev.2009.07.018; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590	48	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90186	10.1371/journal.pone.0090186	http://dx.doi.org/10.1371/journal.pone.0090186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587269	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800088
J	Sierra-Garcia, IN; Alvarez, JC; de Vasconcellos, SP; de Souza, AP; dos Santos, EV; de Oliveira, VM				Sierra-Garcia, Isabel Natalia; Alvarez, Javier Correa; de Vasconcellos, Suzan Pantaroto; de Souza, Anete Pereira; dos Santos Neto, Eugenio Vaz; de Oliveira, Valeria Maia			New Hydrocarbon Degradation Pathways in the Microbial Metagenome from Brazilian Petroleum Reservoirs	PLOS ONE			English	Article							ANAEROBIC BENZOATE DEGRADATION; AROMATIC-COMPOUNDS; DENITRIFYING BACTERIUM; GENE-CLUSTER; PHYLOGENETIC CLASSIFICATION; ALKANE HYDROXYLASES; BIODEGRADATION; METABOLISM; OXIDATION; BENZENE	Current knowledge of the microbial diversity and metabolic pathways involved in hydrocarbon degradation in petroleum reservoirs is still limited, mostly due to the difficulty in recovering the complex community from such an extreme environment. Metagenomics is a valuable tool to investigate the genetic and functional diversity of previously uncultured microorganisms in natural environments. Using a function-driven metagenomic approach, we investigated the metabolic abilities of microbial communities in oil reservoirs. Here, we describe novel functional metabolic pathways involved in the biodegradation of aromatic compounds in a metagenomic library obtained from an oil reservoir. Although many of the deduced proteins shared homology with known enzymes of different well-described aerobic and anaerobic catabolic pathways, the metagenomic fragments did not contain the complete clusters known to be involved in hydrocarbon degradation. Instead, the metagenomic fragments comprised genes belonging to different pathways, showing novel gene arrangements. These results reinforce the potential of the metagenomic approach for the identification and elucidation of new genes and pathways in poorly studied environments and contribute to a broader perspective on the hydrocarbon degradation processes in petroleum reservoirs.	[Sierra-Garcia, Isabel Natalia; de Oliveira, Valeria Maia] Univ Campinas UNICAMP, Res Ctr Chem Biol & Agr CPQBA, Microbial Resources Div, Campinas, Brazil; [Alvarez, Javier Correa] Univ Campinas UNICAMP, Lab Genom & Express, Campinas, Brazil; [de Vasconcellos, Suzan Pantaroto] Univ Fed Sao Paulo UNIFESP, Sao Paulo, Brazil; [de Souza, Anete Pereira] Univ Estadual Campinas, CBMEG, Ctr Mol Biol & Genet Engn, Rio De Janeiro, Brazil; [dos Santos Neto, Eugenio Vaz] PETROBRAS R&D Ctr, Rio De Janeiro, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual de Campinas; Petrobras	Sierra-Garcia, IN (corresponding author), Univ Campinas UNICAMP, Res Ctr Chem Biol & Agr CPQBA, Microbial Resources Div, Campinas, Brazil.	inatalia.sierra@gmail.com	DE SOUZA, ANETE PEREIRA/B-8663-2012; Vasconcellos, Suzan P/E-3954-2013; Oliveira, Valéria Maia/L-2422-2014; Alvarez, Javier Correa/AAB-4773-2021; Garcia, Isabel Natalia Sierra/Y-7477-2018; Vasconcellos, Suzan Pantaroto/H-7079-2012	DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Oliveira, Valéria Maia/0000-0001-8817-4758; Alvarez, Javier Correa/0000-0001-9009-823X; Garcia, Isabel Natalia Sierra/0000-0001-6373-2901; 	PETROBRAS [0050.0043275.08.4]	PETROBRAS(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras)	This work was financially supported by PETROBRAS (cooperation agreement number 0050.0043275.08.4). The authors thank PETROBRAS for the authorization to publish this work and critical revision of the manuscript. The funders had no role in study design, data collection and analysis.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Valderrama JA, 2012, J BIOL CHEM, V287, P10494, DOI 10.1074/jbc.M111.309005; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bains J, 2011, PROTEIN SCI, V20, P1048, DOI 10.1002/pro.639; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; Boll M, 2000, J BIOL CHEM, V275, P21889, DOI 10.1074/jbc.M001833200; Boll M, 2002, CURR OPIN CHEM BIOL, V6, P604, DOI 10.1016/S1367-5931(02)00375-7; Breinig S, 2000, J BACTERIOL, V182, P5849, DOI 10.1128/JB.182.20.5849-5863.2000; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chakraborty R, 2005, APPL ENVIRON MICROB, V71, P8649, DOI 10.1128/AEM.71.12.8649-8655.2005; Chakraborty R, 2004, APPL MICROBIOL BIOT, V64, P437, DOI 10.1007/s00253-003-1526-x; Coleman NV, 2002, APPL ENVIRON MICROB, V68, P2726, DOI 10.1128/AEM.68.6.2726-2730.2002; de Vasconcellos SP, 2010, ORG GEOCHEM, V41, P675, DOI 10.1016/j.orggeochem.2010.03.014; de Vasconcellos SP, 2009, ORG GEOCHEM, V40, P574, DOI 10.1016/j.orggeochem.2009.02.006; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; DiDonato RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014072; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; Eyers L, 2004, APPL MICROBIOL BIOT, V66, P123, DOI 10.1007/s00253-004-1703-6; Fahy A, 2006, FEMS MICROBIOL ECOL, V58, P260, DOI 10.1111/j.1574-6941.2006.00162.x; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Fulthorpe RR, 2010, EVOLUTION NEW CATABO, P1219; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Haft DH, 2005, PLOS COMPUTATIONAL B, pe60; HAIGLER BE, 1992, APPL ENVIRON MICROB, V58, P2237, DOI 10.1128/AEM.58.7.2237-2244.1992; HAIGLER BE, 1994, APPL ENVIRON MICROB, V60, P3466, DOI 10.1128/AEM.60.9.3466-3469.1994; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Head IM, 2010, HDB HYDROCARBON LIPI, P3097, DOI DOI 10.1007/978-3-540-77587-4_232; Ian Head NG, 2010, GEOPH RES ABSTR; Ismail W, 2012, APPL ENVIRON MICROB, V78, P5043, DOI 10.1128/AEM.00633-12; Ivanova N, 2010, ENVIRON MICROBIOL, V12, P1803, DOI 10.1111/j.1462-2920.2010.02270.x; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Kellenberger E, 2001, EMBO REP, V2, P5, DOI 10.1093/embo-reports/kve014; KIMBARA K, 1989, J BACTERIOL, V171, P2740, DOI 10.1128/jb.171.5.2740-2747.1989; Krieger CJ, 1999, J BACTERIOL, V181, P6403, DOI 10.1128/JB.181.20.6403-6410.1999; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kube M, 2005, SYST APPL MICROBIOL, V28, P287, DOI 10.1016/j.syapm.2005.02.006; Kunze M, 2009, MICROBIOL-SGM, V155, P4069, DOI 10.1099/mic.0.032110-0; Laurie AD, 1999, J BACTERIOL, V181, P531, DOI 10.1128/JB.181.2.531-540.1999; Liu XQ, 2009, MICROBIOL-SGM, V155, P2078, DOI 10.1099/mic.0.027201-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marin M, 2009, BIOCHEM BIOPH RES CO, V390, P1345, DOI 10.1016/j.bbrc.2009.10.151; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Oppermann UCT, 2000, TOXICOLOGY, V144, P71, DOI 10.1016/S0300-483X(99)00192-4; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pieper DH, 2005, APPL MICROBIOL BIOT, V67, P170, DOI 10.1007/s00253-004-1810-4; Pieper DH, 2004, CURR OPIN BIOTECH, V15, P215, DOI 10.1016/j.copbio.2004.03.008; Rabus R, 2005, ARCH MICROBIOL, V183, P27, DOI 10.1007/s00203-004-0742-9; Rojo F, 2010, ENZYMES AEROBIC DEGR, P781; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salinero KK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-351; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Shinoda Y, 2004, APPL ENVIRON MICROB, V70, P1385, DOI 10.1128/AEM.70.3.1385-1392.2004; Sierra-Garcia IN, 2013, MICROBIAL HYDROCARBO, P47; Silva TR, 2013, INT BIODETER BIODEGR, V81, P57, DOI 10.1016/j.ibiod.2012.05.005; Suenaga H, 2007, ENVIRON MICROBIOL, V9, P2289, DOI 10.1111/j.1462-2920.2007.01342.x; Suenaga H, 2009, ISME J, V3, P1335, DOI 10.1038/ismej.2009.76; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis KN., 2010, HDB HYDROCARBON LIPI, DOI [10.1007/978-3-540-77587-4_121, DOI 10.1007/978-3-540-77587-4_121]; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Torsvik V, 1998, J BIOTECHNOL, V64, P53, DOI 10.1016/S0168-1656(98)00103-5; Uchiyama T, 2009, CURR OPIN BIOTECH, V20, P616, DOI 10.1016/j.copbio.2009.09.010; van Beilen JB, 2007, APPL MICROBIOL BIOT, V74, P13, DOI 10.1007/s00253-006-0748-0; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006; Verde L.C.L., 2013, J PET ENV BIOTECHNOL, V4, P138, DOI [DOI 10.4172/2157-7463.1000138, 10.4172/2157-7463.1000138]; Von Der Weid I, 2008, J MICROBIOL BIOTECHN, V18, P5; Widdel F., 2010, HDB HYDROCARBON LIPI; Wischgoll S, 2005, MOL MICROBIOL, V58, P1238, DOI 10.1111/j.1365-2958.2005.04909.x; Yuste L, 2000, FEMS MICROBIOL ECOL, V32, P69, DOI 10.1111/j.1574-6941.2000.tb00700.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang J., 2012, PLOS ONE, V7; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275; ZINDER SH, 1984, APPL ENVIRON MICROB, V47, P796, DOI 10.1128/AEM.47.4.796-807.1984	86	59	60	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90087	10.1371/journal.pone.0090087	http://dx.doi.org/10.1371/journal.pone.0090087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587220	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000133
J	Shmelkov, E; Krachmarov, C; Grigoryan, AV; Pinter, A; Statnikov, A; Cardozo, T				Shmelkov, Evgeny; Krachmarov, Chavdar; Grigoryan, Arsen V.; Pinter, Abraham; Statnikov, Alexander; Cardozo, Timothy			Computational Prediction of Neutralization Epitopes Targeted by Human Anti-V3 HIV Monoclonal Antibodies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROAD NEUTRALIZATION; CROSS-REACTIVITY; STRUCTURAL BASIS; BINDING MODE; VACCINE; GP120; COMPLEX; DESIGN; CONFORMATION	The extreme diversity of HIV-1 strains presents a formidable challenge for HIV-1 vaccine design. Although antibodies (Abs) can neutralize HIV-1 and potentially protect against infection, antibodies that target the immunogenic viral surface protein gp120 have widely variable and poorly predictable cross-strain reactivity. Here, we developed a novel computational approach, the Method of Dynamic Epitopes, for identification of neutralization epitopes targeted by anti-HIV-1 monoclonal antibodies (mAbs). Our data demonstrate that this approach, based purely on calculated energetics and 3D structural information, accurately predicts the presence of neutralization epitopes targeted by V3-specific mAbs 2219 and 447-52D in any HIV-1 strain. The method was used to calculate the range of conservation of these specific epitopes across all circulating HIV-1 viruses. Accurately identifying an Ab-targeted neutralization epitope in a virus by computational means enables easy prediction of the breadth of reactivity of specific mAbs across the diversity of thousands of different circulating HIV-1 variants and facilitates rational design and selection of immunogens mimicking specific mAb-targeted epitopes in a multivalent HIV-1 vaccine. The defined epitopes can also be used for the purpose of epitope-specific analyses of breakthrough sequences recorded in vaccine clinical trials. Thus, our study is a prototype for a valuable tool for rational HIV-1 vaccine design.	[Shmelkov, Evgeny; Grigoryan, Arsen V.; Cardozo, Timothy] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA; [Krachmarov, Chavdar; Pinter, Abraham] Rutgers New Jersey Med Sch, Publ Hlth Res Inst Ctr, Newark, NJ USA; [Statnikov, Alexander] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA	New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University	Shmelkov, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA.	evs234@nyu.edu		Krachmarov, Chavdar/0000-0003-1100-5096	Bill and Melinda Gates Foundation [38631]; National Institutes of Health [R01A1084119, AI078410]; National Center for Research Resources, National Institutes of Health [1UL1RR029893]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078410, R01AI102718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA036478] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Bill and Melinda Gates Foundation 38631 to Dr. Susan Zolla-Pazner; the National Institutes of Health R01A1084119 to TC, AI078410 to AP; and the National Center for Research Resources, National Institutes of Health 1UL1RR029893 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Agarwal A, 2011, VACCINE, V29, P6736, DOI 10.1016/j.vaccine.2010.12.052; Almond D, 2010, AIDS RES HUM RETROV, V26, P717, DOI 10.1089/aid.2009.0254; [Anonymous], SCIENCE; [Anonymous], 2003, HP INVEN; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Berger EA, 1998, NAT STRUCT BIOL, V5, P671, DOI 10.1038/1362; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; Cardozo T, 2009, AIDS RES HUM RETROV, V25, P441, DOI 10.1089/aid.2008.0188; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Dhillon AK, 2008, ACTA CRYSTALLOGR D, V64, P792, DOI 10.1107/S0907444908013978; Edlefsen PT, 2013, CURR OPIN HIV AIDS, V8, P432, DOI 10.1097/COH.0b013e328362db2b; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Krachmarov CP, 2001, AIDS RES HUM RETROV, V17, P1737, DOI 10.1089/08892220152741432; Lee A.J., 1990, U STAT THEORY PRACTI; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Shmelkov E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027279; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Swetnam J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015994; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weiss SM, 1991, COMPUTER SYSTEMS LEA, Vxii; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2011, J VIROL, V85, P9887, DOI 10.1128/JVI.05086-11; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89987	10.1371/journal.pone.0089987	http://dx.doi.org/10.1371/journal.pone.0089987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587168	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900105
J	Zong, ZY				Zong, Zhiyong			The Complex Genetic Context of bla(PER-1) Flanked by Miniature Inverted-Repeat Transposable Elements in Acinetobacter johnsonii	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; BAUMANNII STRAIN; PER-1; RESISTANCE; INTEGRON	On a large plasmid of Acinetobacter johnsonii strain XBB1 from hospital sewage, bla(PER-1) and ISCR1 were found in a complex Tn402-like integron carrying an arr3-aacA4 cassette array. The integron was truncated by the same 439-bp miniature inverted-repeat transposable element (MITE) at both ends. bla(PER-1) and its complex surroundings might have been mobilized by the MITEst into an orf of unknown function, evidenced by the presence of the characteristic 5-bp direct target repeats. The same 439-bp MITEs have also been found flanking class 1 integrons carrying metallo-beta-lactamases genes bla(IMP-1), bla(IMP-5) and bla(VIM-2) before but without ISCR1. Although the cassette arrays are different, integrons have always been truncated by the 439-bp MITEs at the exact same locations. The results suggested that MITEs might be able to mobilize class 1 integrons via transposition or homologous recombination and therefore represent a possible common mechanism for mobilizing antimicrobial resistance determinants.	[Zong, Zhiyong] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu 610064, Sichuan Provinc, Peoples R China; [Zong, Zhiyong] Sichuan Univ, Div Infect Dis, State Key Lab Biotherapy, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Zong, ZY (corresponding author), Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu 610064, Sichuan Provinc, Peoples R China.	zongzhiy@scu.edu.cn		ZONG, ZHIYONG/0000-0002-7675-260X	National Natural Science Foundation of China [81222025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (project no. 81222025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bae IK, 2011, ANTIMICROB AGENTS CH, V55, P1305, DOI 10.1128/AAC.00994-10; Casin I, 2003, ANTIMICROB AGENTS CH, V47, P697, DOI 10.1128/AAC.47.2.697-703.2003; Claeys G, 2000, J ANTIMICROB CHEMOTH, V45, P924, DOI 10.1093/jac/45.6.924; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; Domingues S, 2011, J ANTIMICROB CHEMOTH, V66, P2667, DOI 10.1093/jac/dkr327; Erac B, 2013, JPN J INFECT DIS, V66, P146, DOI 10.7883/yoken.66.146; Gillings MR, 2009, APPL ENVIRON MICROB, V75, P6002, DOI 10.1128/AEM.01033-09; Guardabassi L, 1999, J APPL MICROBIOL, V87, P659, DOI 10.1046/j.1365-2672.1999.00905.x; Llanes C, 2006, CLIN MICROBIOL INFEC, V12, P270, DOI 10.1111/j.1469-0691.2005.01333.x; Mantengoli E, 2005, ANTIMICROB AGENTS CH, V49, P3289, DOI 10.1128/AAC.49.8.3289-3296.2005; Naas T, 2006, J ANTIMICROB CHEMOTH, V58, P178, DOI 10.1093/jac/dkl178; NORDMANN P, 1993, ANTIMICROB AGENTS CH, V37, P962, DOI 10.1128/AAC.37.5.962; Park JY, 2011, J BACTERIOL, V193, P6393, DOI 10.1128/JB.06109-11; Partridge S, 2012, 22 EUR C CLIN MICR I; Partridge SR, 2003, ANTIMICROB AGENTS CH, V47, P342, DOI 10.1128/AAC.47.1.342-349.2003; Penzak SR, 2000, INFECT CONT HOSP EP, V21, P597, DOI 10.1086/501810; Picao RC, 2008, ANTIMICROB AGENTS CH, V52, P3461, DOI 10.1128/AAC.00770-08; Poirel L, 1999, J ANTIMICROB CHEMOTH, V43, P157, DOI 10.1093/jac/43.1.157; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P1708, DOI 10.1128/AAC.49.5.1708-1713.2005; Ranellou K, 2012, J ANTIMICROB CHEMOTH, V67, P357, DOI 10.1093/jac/dkr471; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Wang FP, 2012, INT J ANTIMICROB AG, V40, P404, DOI 10.1016/j.ijantimicag.2012.06.016; Zong ZY, 2013, J ANTIMICROB CHEMOTH, V68, P1007, DOI 10.1093/jac/dks505	23	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90046	10.1371/journal.pone.0090046	http://dx.doi.org/10.1371/journal.pone.0090046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587208	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900114
J	Kalnak, N; Peyrard-Janvid, M; Forssberg, H; Sahlen, B				Kalnak, Nelli; Peyrard-Janvid, Myriam; Forssberg, Hans; Sahlen, Birgitta			Nonword Repetition - A Clinical Marker for Specific Language Impairment in Swedish Associated with Parents' Language-Related Problems	PLOS ONE			English	Article							NON-WORD REPETITION; SCHOOL-AGE-CHILDREN; SHORT-TERM-MEMORY; GRAMMATICAL MORPHOLOGY; HEARING IMPAIRMENT; SPEAKING CHILDREN; SPEECH; EDUCATION; HERITABILITY; PERFORMANCE	First, we explore the performance of nonword repetition (NWR) in children with specific language impairment (SLI) and typically developing children (TD) in order to investigate the accuracy of NWR as a clinical marker for SLI in Swedishspeaking school-age children. Second, we examine the relationship between NWR, family aggregation, and parental level of education in children with SLI. A sample of 61 children with SLI, and 86 children with TD, aged 8-12 years, were administered an NWR test. Family aggregation, measured as the prevalence of language and/or literacy problems (LLP) in parents of the children with SLI, was based on family history interviews. The sensitivity and specificity of nonword repetition was analyzed in a binary logistic regression, cut-off values were established with ROC curves, and positive and negative likelihood ratios reported. Results from the present study show that NWR distinguishes well between Swedish-speaking school-children with and without SLI. We found 90.2% sensitivity and 97.7% specificity at a cut-off level of -2 standard deviations for binary scoring of nonwords. Differences between the SLI and TD groups showed large effect sizes for the two scoring measures binary (d = 2.11) and percent correct consonants (PCC) (d = 1.79). The children with SLI were split into two subgroups: those with no parents affected with LLP (n = 12), and those with one or both parents affected (n = 49). The subgroup consisting of affected parents had a significantly lower score on NWR binary (p =.037), and there was a great difference between the subgroups (d = 0.7). When compared to the TD group, the difference from the subgroup with affected parents was almost one standard deviation larger (d = 2.47) than the difference from the TD to the subgroup consisting of non-affected parents (d = 1.57). Our study calls for further exploration of the complex interaction between family aggregation, language input, and phenotypes of SLI.	[Kalnak, Nelli; Forssberg, Hans] Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Peyrard-Janvid, Myriam] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Sahlen, Birgitta] Lund Univ, Dept Logoped Phoniatr & Audiol, Lund, Sweden	Karolinska Institutet; Karolinska Institutet; Lund University	Kalnak, N (corresponding author), Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Nelli.Kalnak@karolinska.se	Kalnak, Nelli/AAW-6396-2021; Sahlén, Birgitta/O-1245-2014; Forssberg, Hans/A-2944-2009	Sahlén, Birgitta/0000-0002-8468-0546; Forssberg, Hans/0000-0003-2069-6618	Olle Engkvist Byggmastare; Frimurarna Barnhuset; Sunnerdahls Handikappfond; Clas Groschinskys Minnesfond; Promobilia and Sallskapet Barnavard; Swedish Research Council; Swedish Foundation for Strategic Research; VINNOVA; Strategic Neuroscience Program at Karolinska Institutet	Olle Engkvist Byggmastare; Frimurarna Barnhuset; Sunnerdahls Handikappfond; Clas Groschinskys Minnesfond; Promobilia and Sallskapet Barnavard; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); VINNOVA(Vinnova); Strategic Neuroscience Program at Karolinska Institutet	This work was supported by grants from the foundations Olle Engkvist Byggmastare, Frimurarna Barnhuset, Sunnerdahls Handikappfond, Clas Groschinskys Minnesfond, Promobilia and Sallskapet Barnavard, the Swedish Research Council, the Swedish Foundation for Strategic Research, VINNOVA, and the Strategic Neuroscience Program at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald LMD, 2006, J SPEECH LANG HEAR R, V49, P970, DOI 10.1044/1092-4388(2006/070); Archibald LMD, 2008, CAN J SPEECH-LANG PA, V32, P21; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Barry JG, 2007, GENES BRAIN BEHAV, V6, P66, DOI 10.1111/j.1601-183X.2006.00232.x; Bishop DVM, 2008, GENES BRAIN BEHAV, V7, P365, DOI 10.1111/j.1601-183X.2007.00360.x; Bishop DVM, 2006, CURR DIR PSYCHOL SCI, V15, P217, DOI 10.1111/j.1467-8721.2006.00439.x; Bishop DVM, 2009, INT J LANG COMM DIS, V44, P600, DOI 10.1080/13682820802259662; Bishop DV, 2006, J CHILD PSYCHOL PSYC, V37, P391; Bishop DVM, 2006, BEHAV GENET, V36, P173, DOI 10.1007/s10519-005-9020-0; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; BISHOP DVM, 1997, UNCOMMON UNDERSTANDI; Botting N, 2001, INT J LANG COMM DIS, V36, P421, DOI 10.1080/13682820110074971; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Catts HW, 2005, J SPEECH LANG HEAR R, V48, P1378, DOI 10.1044/1092-4388(2005/096); Christian K, 1998, EARLY CHILD RES Q, V13, P501, DOI 10.1016/S0885-2006(99)80054-4; Coady JA, 2008, INT J LANG COMM DIS, V43, P1, DOI 10.1080/13682820601116485; Conti-Ramsden G, 2006, J SPEECH LANG HEAR R, V49, P88, DOI 10.1044/1092-4388(2006/007); Conti-Ramsden G, 2003, J SPEECH LANG HEAR R, V46, P1029, DOI 10.1044/1092-4388(2003/082); Conti-Ramsden G, 1999, J SPEECH LANG HEAR R, V42, P1195, DOI 10.1044/jslhr.4205.1195; Conti-Ramsden G, 2001, INT J LANG COMM DIS, V36, P207, DOI 10.1080/13682820010019883; CONTIRAMSDEN G, 1995, J SPEECH HEAR RES, V38, P1290, DOI 10.1044/jshr.3806.1290; CONTIRAMSDEN G, 1984, J COMMUN DISORD, V17, P19, DOI 10.1016/0021-9924(84)90023-6; Corrigan R., 2008, COMMUNICATION DISORD, V29, P109, DOI DOI 10.1177/1525740108315880; Costanzo F, 2013, RES DEV DISABIL, V34, P1770, DOI 10.1016/j.ridd.2013.01.024; Craig L, 2006, BRIT J SOCIOL, V57, P553, DOI 10.1111/j.1468-4446.2006.00125.x; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; De Bree E, 2007, CLIN LINGUIST PHONET, V21, P935, DOI 10.1080/02699200701576892; Dethorne LS, 2006, CLIN LINGUIST PHONET, V20, P641, DOI 10.1080/02699200500074313; Dispaldro M, 2012, J SPEECH LANG HEAR R; Dollaghan C, 1998, J SPEECH LANG HEAR R, V41, P1136, DOI 10.1044/jslhr.4105.1136; Ebbels SH, 2012, INT J LANG COMM DIS, V47, P257, DOI 10.1111/j.1460-6984.2011.00099.x; Estes KG, 2007, J SPEECH LANG HEAR R, V50, P177, DOI 10.1044/1092-4388(2007/015); Falcaro M, 2008, GENES BRAIN BEHAV, V7, P393, DOI 10.1111/j.1601-183X.2007.00364.x; Fidler LJ, 2011, AM J SPEECH-LANG PAT, V20, P2, DOI 10.1044/1058-0360(2010/09-0096); Flax JF, 2003, J SPEECH LANG HEAR R, V46, P530, DOI 10.1044/1092-4388(2003/043); Friend A, 2008, PSYCHOL SCI, V19, P1124, DOI 10.1111/j.1467-9280.2008.02213.x; Fujiki M, 2001, LANG SPEECH HEAR SER, V32, P101, DOI 10.1044/0161-1461(2001/008); Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Girbau D, 2007, INT J LANG COMM DIS, V42, P59, DOI 10.1080/13682820600783210; Hansson K, 2004, INT J LANG COMM DIS, V39, P401, DOI 10.1080/13682820410001669887; Hansson K, 2007, INT J LANG COMM DIS, V42, P307, DOI 10.1080/13682820600933526; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; Hesketh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056314; Ibertsson T, 2008, LOGOP PHONIATR VOCO, V33, P168, DOI 10.1080/14015430801945299; Kalnak N, 2012, GENES BRAIN BEHAV, V11, P921, DOI 10.1111/j.1601-183X.2012.00841.x; KAMHI AG, 1988, J SPEECH HEAR DISORD, V53, P316, DOI 10.1044/jshd.5303.316; Kapalkova S, 2013, INT J LANG COMM DIS, V48, P78, DOI 10.1111/j.1460-6984.2012.00189.x; Keegstra AL, 2007, INT J PEDIATR OTORHI, V71, P815, DOI 10.1016/j.ijporl.2007.02.001; Kjelgaard MM, 2001, LANG COGNITIVE PROC, V16, P287, DOI 10.1080/01690960042000058; Kluever RC, 1995, WISC 3 RAVEN COLOURE; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; LASKY EZ, 1982, J SPEECH HEAR DISORD, V47, P7, DOI 10.1044/jshd.4701.07; Law J, 2000, INT J LANG COMM DIS, V35, P165, DOI 10.1080/136828200247133; Leonard L.B., 2000, CHILDREN SPECIFIC LA; Lewis BA, 2006, J SPEECH LANG HEAR R, V49, P1294, DOI 10.1044/1092-4388(2006/093); Montgomery JW, 2007, J SPEECH LANG HEAR R, V50, P778, DOI 10.1044/1092-4388(2007/054); Moyle MJ, 2011, LANG SPEECH HEAR SER, V42, P550, DOI 10.1044/0161-1461(2011/10-0029); Nation K, 2004, J SPEECH LANG HEAR R, V47, P199, DOI 10.1044/1092-4388(2004/017); Nettelbladt U, 2007, SPRAKSTRONING HOS BA, VI; Newbury DF, 2010, NEURON, V68, P309, DOI 10.1016/j.neuron.2010.10.001; Peterson RL, 2009, J SPEECH LANG HEAR R, V52, P1175, DOI 10.1044/1092-4388(2009/08-0024); Plante E, 1996, J SPEECH HEAR RES, V39, P661, DOI 10.1044/jshr.3903.661; Plante E., 1994, LANG SPEECH HEAR SER, V25, P15, DOI [10.1044/0161-1461.2501.15, DOI 10.1044/0161-1461.2501.15]; Poll GH, 2010, J SPEECH LANG HEAR R, V53, P414, DOI 10.1044/1092-4388(2009/08-0016); Radeborg K, 2006, SCAND J PSYCHOL, V47, P187, DOI 10.1111/j.1467-9450.2006.00506.x; Ramus F, 2013, BRAIN, V136, P630, DOI 10.1093/brain/aws356; Raven J. C., 1986, RAVENS PROGR MATRICE; Reuterskiold-Wagner C, 2005, CLIN LINGUIST PHONET, V19, P681, DOI 10.1080/02699200400000343; Sahlen B, 1999, INT J LANG COMM DIS, V34, P337, DOI 10.1080/136828299247441; Sahlen B, 1999, CLIN LINGUIST PHONET, V13, P369; Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; Skibbe LE, 2008, EARLY EDUC DEV, V19, P68, DOI 10.1080/10409280701839015; Snowling MJ, 2006, J CHILD PSYCHOL PSYC, V47, P759, DOI 10.1111/j.1469-7610.2006.01631.x; Stromswold K, 1998, HUM BIOL, V70, P297; Taylor LC, 2004, REV GEN PSYCHOL, V8, P163, DOI 10.1037/1089-2680.8.3.163; Thordardottir E, 2011, J SPEECH LANG HEAR R, V54, P580, DOI 10.1044/1092-4388(2010/09-0196); Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Viding E, 2004, J CHILD PSYCHOL PSYC, V45, P315, DOI 10.1111/j.1469-7610.2004.00223.x; Wass M, 2008, SCAND J PSYCHOL, V49, P559, DOI 10.1111/j.1467-9450.2008.00680.x; Weismer SE, 2000, J SPEECH LANG HEAR R, V43, P865, DOI 10.1044/jslhr.4304.865; Weschler D., 1991, WECHSLER INTELLIGENC; Whitehouse AJO, 2010, J SPEECH LANG HEAR R, V53, P1015, DOI 10.1044/1092-4388(2009/09-0078); Zhang XY, 2000, AM J SPEECH-LANG PAT, V9, P345, DOI 10.1044/1058-0360.0904.345	87	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89544	10.1371/journal.pone.0089544	http://dx.doi.org/10.1371/journal.pone.0089544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB6EP	24586859	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700059
J	Kumar, R; Clerc, AC; Gori, I; Russell, R; Pellegrini, C; Govender, L; Wyss, JC; Golshayan, D; Canny, GO				Kumar, Rajesh; Clerc, Anne-Catherine; Gori, Ilaria; Russell, Ronan; Pellegrini, Chiara; Govender, Lerisa; Wyss, Jean-Christophe; Golshayan, Dela; Canny, Geraldine O.			Lipoxin A(4) Prevents the Progression of De Novo and Established Endometriosis in a Mouse Model by Attenuating Prostaglandin E-2 Production and Estrogen Signaling	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STROMAL CELLS; C-MYC; PERITONEAL ENDOMETRIOSIS; ANTI-INFLAMMATION; EPITHELIAL-CELLS; LIPID MEDIATORS; GENE-EXPRESSION; BREAST-CANCER; FACTOR-BETA	Endometriosis, a leading cause of pelvic pain and infertility, is characterized by ectopic growth of endometrial-like tissue and affects approximately 176 million women worldwide. The pathophysiology involves inflammatory and angiogenic mediators as well as estrogen-mediated signaling and novel, improved therapeutics targeting these pathways are necessary. The aim of this study was to investigate mechanisms leading to the establishment and progression of endometriosis as well as the effect of local treatment with Lipoxin A(4) (LXA(4)), an anti-inflammatory and pro-resolving lipid mediator that we have recently characterized as an estrogen receptor agonist. LXA(4) treatment significantly reduced endometriotic lesion size and downregulated the pro-inflammatory cytokines IL-1 beta and IL-6, as well as the angiogenic factor VEGF. LXA(4) also inhibited COX-2 expression in both endometriotic lesions and peritoneal fluid cells, resulting in attenuated peritoneal fluid Prostaglandin E-2 (PGE(2)) levels. Besides its anti-inflammatory effects, LXA(4) differentially regulated the expression and activity of the matrix remodeling enzyme matrix metalloproteinase (MMP)-9 as well as modulating transforming growth factor (TGF)-beta isoform expression within endometriotic lesions and in peritoneal fluid cells. We also report for first time that LXA(4) attenuated aromatase expression, estrogen signaling and estrogen-regulated genes implicated in cellular proliferation in a mouse model of disease. These effects were observed both when LXA(4) was administered prior to disease induction and during established disease. Collectively, our findings highlight potential targets for the treatment of endometriosis and suggest a pleotropic effect of LXA(4) on disease progression, by attenuating proinflammatory and angiogenic mediators, matrix remodeling enzymes, estrogen metabolism and signaling, as well as downstream proliferative pathways.	[Kumar, Rajesh; Clerc, Anne-Catherine; Gori, Ilaria; Russell, Ronan; Pellegrini, Chiara; Canny, Geraldine O.] Univ Lausanne Hosp, Dept Gynecol Obstet & Med Genet, Mucosal Immun Lab, Lausanne, Switzerland; [Kumar, Rajesh; Clerc, Anne-Catherine; Gori, Ilaria; Russell, Ronan; Pellegrini, Chiara; Govender, Lerisa; Wyss, Jean-Christophe; Golshayan, Dela; Canny, Geraldine O.] Univ Lausanne, Lausanne, Switzerland; [Kumar, Rajesh; Govender, Lerisa; Wyss, Jean-Christophe; Golshayan, Dela] Univ Lausanne Hosp, Transplantat Ctr, Lausanne, Switzerland; [Kumar, Rajesh; Govender, Lerisa; Wyss, Jean-Christophe; Golshayan, Dela] Univ Lausanne Hosp, Dept Med, Transplantat Immunopathol Lab, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Golshayan, D (corresponding author), Univ Lausanne Hosp, Transplantat Ctr, Lausanne, Switzerland.	Dela.Golshayan@chuv.ch; Geraldine.Canny@gmail.com	Kumar, Rajesh/F-6579-2014; Kumar, Rajesh/I-5668-2019; Russell, Ronan/AAD-8418-2019	Golshayan, Dela/0000-0001-5631-6096; Canny, Geraldine/0000-0003-0632-7365; Kumar, Rajesh/0000-0002-0211-7195	Swiss National Science Foundation [310030-120761]; European Society of Clinical Microbiology and Infectious Diseases; Novartis Foundation for Medical-Biological Research; Roche Research Foundation; Department of Gynecology and Obstetrics; Swiss National Science Foundation (SCORE) [32323B-111370, 32003B-111371]; Faculty of Biology and Medicine of the University of Lausanne; Fondation Medi-CAL Futur; Fondation Pierre Mercier pour la Science; Institute of Pathology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Society of Clinical Microbiology and Infectious Diseases; Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Roche Research Foundation; Department of Gynecology and Obstetrics; Swiss National Science Foundation (SCORE)(Swiss National Science Foundation (SNSF)); Faculty of Biology and Medicine of the University of Lausanne; Fondation Medi-CAL Futur; Fondation Pierre Mercier pour la Science; Institute of Pathology	This study was funded by the Swiss National Science Foundation (grant number 310030-120761), as well as grants from the European Society of Clinical Microbiology and Infectious Diseases, the Novartis Foundation for Medical-Biological Research, the Roche Research Foundation and the Department of Gynecology and Obstetrics (GOC). DG is supported by the Swiss National Science Foundation (SCORE 32323B-111370 and 32003B-111371), the Faculty of Biology and Medicine of the University of Lausanne, Fondation Medi-CAL Futur, Fondation Pierre Mercier pour la Science and the Institute of Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker CM, 2008, AM J PATHOL, V172, P534, DOI 10.2353/ajpath.2008.061244; Becker CM, 2007, MICROVASC RES, V74, P121, DOI 10.1016/j.mvr.2007.04.008; Beliard A, 2004, FERTIL STERIL, V82, P80, DOI 10.1016/j.fertnstert.2003.11.048; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bourlev V, 2010, FERTIL STERIL, V94, P52, DOI 10.1016/j.fertnstert.2009.02.019; Bulun SE, 2000, J MOL ENDOCRINOL, V25, P35, DOI 10.1677/jme.0.0250035; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burns KA, 2012, ENDOCRINOLOGY, V153, P3960, DOI 10.1210/en.2012-1294; Chen QH, 2010, FERTIL STERIL, V93, P1440, DOI 10.1016/j.fertnstert.2009.01.107; Chen QH, 2009, EUR J OBSTET GYN R B, V145, P200, DOI 10.1016/j.ejogrb.2009.05.015; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; CLARK JH, 1984, J STEROID BIOCHEM, V20, P1005, DOI 10.1016/0022-4731(84)90011-6; CUMMINGS AM, 1995, REPROD TOXICOL, V9, P233, DOI 10.1016/0890-6238(95)00004-T; Dmowski WP, 2001, HUM REPROD, V16, P1802, DOI 10.1093/humrep/16.9.1802; DUNSELMAN GAJ, 1988, J REPROD FERTIL, V82, P707; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; FIORE S, 1993, BLOOD, V81, P3395; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Fu L, 2008, FERTIL STERIL, V89, P1344, DOI 10.1016/j.fertnstert.2007.03.042; Ricci AG, 2011, REPROD SCI, V18, P614, DOI 10.1177/1933719110395406; Ghosh MG, 2000, CANCER RES, V60, P6367; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Gori I, 2013, FERTIL STERIL, V99, P1965, DOI 10.1016/j.fertnstert.2013.01.146; Gronert K, 1998, J EXP MED, V187, P1285, DOI 10.1084/jem.187.8.1285; Grummer R, 2006, HUM REPROD UPDATE, V12, P641, DOI 10.1093/humupd/dml026; HAINING REB, 1991, HUM REPROD, V6, P1200, DOI 10.1093/oxfordjournals.humrep.a137512; Harada T, 2001, FERTIL STERIL, V76, P1, DOI 10.1016/S0015-0282(01)01816-7; Hashimoto A, 2007, J RHEUMATOL, V34, P2144; Huhtinen K, 2012, MOL CELL ENDOCRINOL, V358, P146, DOI 10.1016/j.mce.2011.08.022; Johnson MC, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-45; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kupker W, 1998, HUM REPROD UPDATE, V4, P719, DOI 10.1093/humupd/4.5.719; Laschke MW, 2006, HUM REPROD, V21, P262, DOI 10.1093/humrep/dei308; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahnke JL, 2000, FERTIL STERIL, V73, P166, DOI 10.1016/S0015-0282(99)00466-5; Melamed M, 1997, MOL ENDOCRINOL, V11, P1868, DOI 10.1210/me.11.12.1868; Meola J, 2010, FERTIL STERIL, V93, P1750, DOI 10.1016/j.fertnstert.2008.12.058; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Nyholt DR, 2012, NAT GENET, V44, P1355, DOI 10.1038/ng.2445; OOSTERLYNCK DJ, 1994, OBSTET GYNECOL, V83, P287; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Ota H, 2001, HUM REPROD, V16, P561, DOI 10.1093/humrep/16.3.561; Parazzini F, 2001, HUM REPROD, V16, P2668; Pelch KE, 2010, FERTIL STERIL, V93, P1615, DOI 10.1016/j.fertnstert.2009.03.086; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pellegrini C, 2012, FERTIL STERIL, V98, P1200, DOI 10.1016/j.fertnstert.2012.06.056; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Polli V, 1996, GYNECOL ENDOCRINOL, V10, P297, DOI 10.3109/09513599609012815; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Russell R, 2011, FASEB J, V25, P4326, DOI 10.1096/fj.11-187658; Schaldach CM, 1999, BIOCHEMISTRY-US, V38, P7594, DOI 10.1021/bi982861e; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Shimizu Y, 2009, MOL HUM REPROD, V15, P693, DOI 10.1093/molehr/gap042; Sillem M, 2001, EUR J OBSTET GYN R B, V95, P167, DOI 10.1016/S0301-2115(00)00415-2; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Sivridis E, 2002, CANCER-AM CANCER SOC, V95, P1055, DOI 10.1002/cncr.10774; Sotnikova NY, 2010, FERTIL STERIL, V93, P2701, DOI 10.1016/j.fertnstert.2009.11.024; Streuli I, 2013, EXPERT OPIN PHARMACO, V14, P291, DOI 10.1517/14656566.2013.767334; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tamura M, 2002, J BIOL CHEM, V277, P26208, DOI 10.1074/jbc.M201347200; Velarde MC, 2009, ENDOCRINOLOGY, V150, P4701, DOI 10.1210/en.2009-0389; Vercellini P, 2011, HUM REPROD, V26, P3, DOI 10.1093/humrep/deq302; VERNON MW, 1985, FERTIL STERIL, V44, P684; WALLER KG, 1993, FERTIL STERIL, V59, P511; Wu MH, 2005, AM J PATHOL, V167, P1061, DOI 10.1016/S0002-9440(10)61195-9; Xu ZY, 2012, AM J REPROD IMMUNOL, V67, P491, DOI 10.1111/j.1600-0897.2011.01101.x	75	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89742	10.1371/journal.pone.0089742	http://dx.doi.org/10.1371/journal.pone.0089742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587003	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700083
J	Lindenmayer, DB; Barton, PS; Lane, PW; Westgate, MJ; McBurney, L; Blair, D; Gibbons, P; Likens, GE				Lindenmayer, David B.; Barton, Philip S.; Lane, Peter W.; Westgate, Martin J.; McBurney, Lachlan; Blair, David; Gibbons, Philip; Likens, Gene E.			An Empirical Assessment and Comparison of Species-Based and Habitat-Based Surrogates: A Case Study of Forest Vertebrates and Large Old Trees	PLOS ONE			English	Article							MONTANE ASH FORESTS; POSSUM GYMNOBELIDEUS-LEADBEATERI; STAND STRUCTURAL COMPLEXITY; SOUTH-EAST AUSTRALIA; ARBOREAL MARSUPIALS; CENTRAL HIGHLANDS; BIODIVERSITY INDICATORS; SOUTHEASTERN AUSTRALIA; KEYSTONE RESOURCE; CLIMATE-CHANGE	A holy grail of conservation is to find simple but reliable measures of environmental change to guide management. For example, particular species or particular habitat attributes are often used as proxies for the abundance or diversity of a subset of other taxa. However, the efficacy of such kinds of species-based surrogates and habitat-based surrogates is rarely assessed, nor are different kinds of surrogates compared in terms of their relative effectiveness. We use 30-year datasets on arboreal marsupials and vegetation structure to quantify the effectiveness of: (1) the abundance of a particular species of arboreal marsupial as a species-based surrogate for other arboreal marsupial taxa, (2) hollow-bearing tree abundance as a habitat-based surrogate for arboreal marsupial abundance, and (3) a combination of species-and habitat-based surrogates. We also quantify the robustness of species-based and habitat-based surrogates over time. We then use the same approach to model overall species richness of arboreal marsupials. We show that a species-based surrogate can appear to be a valid surrogate until a habitat-based surrogate is co-examined, after which the effectiveness of the former is lost. The addition of a species-based surrogate to a habitat-based surrogate made little difference in explaining arboreal marsupial abundance, but altered the co-occurrence relationship between species. Hence, there was limited value in simultaneously using a combination of kinds of surrogates. The habitat-based surrogate also generally performed significantly better and was easier and less costly to gather than the species-based surrogate. We found that over 30 years of study, the relationships which underpinned the habitat-based surrogate generally remained positive but variable over time. Our work highlights why it is important to compare the effectiveness of different broad classes of surrogates and identify situations when either species- or habitat-based surrogates are likely to be superior.	[Lindenmayer, David B.; Barton, Philip S.; Lane, Peter W.; Westgate, Martin J.; McBurney, Lachlan; Blair, David; Gibbons, Philip] Australian Natl Univ, ARC Ctr Excellence Environm Decis, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Lindenmayer, David B.; Barton, Philip S.; Lane, Peter W.; Westgate, Martin J.; McBurney, Lachlan; Blair, David; Gibbons, Philip] Australian Natl Univ, Natl Environm Res Program, Canberra, ACT, Australia; [Likens, Gene E.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Likens, Gene E.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA	Australian National University; Australian National University; Cary Institute of Ecosystem Studies; University of Connecticut	Lindenmayer, DB (corresponding author), Australian Natl Univ, ARC Ctr Excellence Environm Decis, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	david.lindenmayer@anu.edu.au	Gibbons, Philip/I-8248-2012; Barton, Philip S/A-6400-2010; Lindenmayer, David B/P-7183-2017; Westgate, Martin/I-1839-2019	Barton, Philip S/0000-0002-8377-2211; Lindenmayer, David B/0000-0002-4766-4088; Westgate, Martin/0000-0003-0854-2034; Lane, Peter/0000-0002-9292-407X	Australian Research Council, Parks Victoria; Department of Sustainability and Environment, Melbourne Water; Earthwatch Institute; Thomas Foundation and Lindenmayer's personal funds; Division Of Environmental Biology [1256696, 1114804] Funding Source: National Science Foundation	Australian Research Council, Parks Victoria(Australian Research Council); Department of Sustainability and Environment, Melbourne Water; Earthwatch Institute; Thomas Foundation and Lindenmayer's personal funds; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study has been funded by the Australian Research Council, Parks Victoria, the Department of Sustainability and Environment (and its predecessor departments), Melbourne Water, the Earthwatch Institute, the Thomas Foundation and Lindenmayer's personal funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Begg CB, 2000, J ROY STAT SOC A STA, V163, P15, DOI 10.1111/1467-985X.00153; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Cabeza M, 2008, J APPL ECOL, V45, P976, DOI 10.1111/j.1365-2664.2007.01364.x; Caro T. M, 2010, CONSERVATION PROXY I; Coppolillo P, 2004, BIOL CONSERV, V115, P419, DOI 10.1016/S0006-3207(03)00159-9; Cunningham RB, 2007, ECOL APPL, V17, P609, DOI 10.1890/05-1892; Cushman SA, 2010, CONSERV BIOL, V24, P830, DOI 10.1111/j.1523-1739.2009.01396.x; Duelli P, 2003, AGR ECOSYST ENVIRON, V98, P87, DOI 10.1016/S0167-8809(03)00072-0; Eltz T, 2003, FOREST ECOL MANAG, V172, P301, DOI 10.1016/S0378-1127(01)00792-7; Fleishman E, 2009, CONSERV BIOL, V23, P1109, DOI 10.1111/j.1523-1739.2009.01246.x; Fraser SEM, 2009, CONSERV BIOL, V23, P142, DOI 10.1111/j.1523-1739.2008.01069.x; Gibbons P., 2008, CONSERVATION VALUE I; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heink U, 2010, BIODIVERS CONSERV, V19, P3769, DOI 10.1007/s10531-010-9926-6; Hess GR, 2006, BIOL CONSERV, V132, P448, DOI 10.1016/j.biocon.2006.04.037; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hinds WT, 1984, ENVIRON CONSERV, V11, P11; Krauss J, 2004, BIOL CONSERV, V120, P355, DOI 10.1016/j.biocon.2004.03.007; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Lindenmayer D, 2009, FOREST PATTERN AND ECOLOGICAL PROCESS: A SYNTHESIS OF 25 YEARS OF RESEARCH, P1; Lindenmayer DB, 2011, ECOL MONOGR, V81, P557, DOI 10.1890/11-0279.1; Lindenmayer DB, 2009, FOREST ECOL MANAG, V258, P169, DOI 10.1016/j.foreco.2009.04.002; Lindenmayer David B., 2013, Australian Zoologist, V36, P441, DOI 10.7882/AZ.2013.007; Lindenmayer DB, 2014, CONSERV LETT, V7, P61, DOI 10.1111/conl.12013; Lindenmayer DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041864; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Lindenmayer DB, 2011, ECOSYSTEMS, V14, P47, DOI 10.1007/s10021-010-9394-6; Lindenmayer DB, 2010, CAN J FOREST RES, V40, P48, DOI 10.1139/X09-185; Lindenmayer DB, 2000, CONSERV BIOL, V14, P941, DOI 10.1046/j.1523-1739.2000.98533.x; Lindenmayer DB, 1997, J MAMMAL, V78, P1117, DOI 10.2307/1383054; Lindenmayer DB, 1999, ECOL APPL, V9, P594, DOI 10.1890/1051-0761(1999)009[0594:TROAMT]2.0.CO;2; LINDENMAYER DB, 1994, FOREST ECOL MANAG, V67, P113, DOI 10.1016/0378-1127(94)90011-6; LINDENMAYER DB, 1990, BIOL CONSERV, V54, P111, DOI 10.1016/0006-3207(90)90137-E; Lindenmayer DB, 1996, WILDLIFE RES, V23, P343, DOI 10.1071/WR9960343; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Lindenmayer DB, 1997, ECOL APPL, V7, P625, DOI 10.1890/1051-0761(1997)007[0625:DACOTW]2.0.CO;2; LINDENMAYER DB, 1990, BIOL CONSERV, V54, P133, DOI 10.1016/0006-3207(90)90138-F; LINDENMAYER DB, 1991, BIOL CONSERV, V56, P295, DOI 10.1016/0006-3207(91)90063-F; LINDENMAYER DB, 1991, FOREST ECOL MANAG, V40, P289, DOI 10.1016/0378-1127(91)90047-Y; LINDENMAYER DB, 1994, BIOL CONSERV, V70, P143, DOI 10.1016/0006-3207(94)90282-8; LINDENMAYER DB, 1995, WILDLIFE RES, V22, P445, DOI 10.1071/WR9950445; Macfarlane MA, 1998, LEADBEATERS POSSUM R; Mandelik Y, 2010, J APPL ECOL, V47, P1179, DOI 10.1111/j.1365-2664.2010.01864.x; Manning AD, 2013, BIOL CONSERV, V157, P204, DOI 10.1016/j.biocon.2012.06.028; McElhinny C, 2006, FOREST ECOL MANAG, V235, P54, DOI 10.1016/j.foreco.2006.07.024; McElhinny C, 2005, FOREST ECOL MANAG, V218, P1, DOI 10.1016/j.foreco.2005.08.034; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Milledge D.R., 1991, P53; Miller-Rushing AJ, 2008, GLOBAL CHANGE BIOL, V14, P1959, DOI 10.1111/j.1365-2486.2008.01619.x; Mistry J, 2008, BIODIVERS CONSERV, V17, P2383, DOI 10.1007/s10531-008-9388-2; Morrison ML., 2006, WILDLIFE HABITAT REL; Murphy DD, 2011, CONSERV BIOL, V25, P873, DOI 10.1111/j.1523-1739.2011.01711.x; Niemi GJ, 1997, J WILDLIFE MANAGE, V61, P1240, DOI 10.2307/3802123; Powers JE, 2010, NATURE, V468, P385, DOI 10.1038/468385a; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rose CL, 2001, WILDLIFE-HABITAT RELATIONSHIPS IN OREGON AND WASHINGTON, P580; Roth T, 2008, J APPL ECOL, V45, P987, DOI 10.1111/j.1365-2664.2007.01435.x; Saha HK, 2009, BIODIVERS CONSERV, V18, P2343, DOI 10.1007/s10531-009-9591-9; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Seddon PJ, 2008, ORYX, V42, P240, DOI 10.1017/S003060530806119X; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Sinclair JR, 2012, BIOL CONSERV, V145, P1, DOI 10.1016/j.biocon.2011.08.015; Skagen SK, 2011, CONSERV BIOL, V25, P48, DOI 10.1111/j.1523-1739.2010.01571.x; SMITH AP, 1982, AUST J ZOOL, V30, P737, DOI 10.1071/ZO9820737; SMITH AP, 1989, AUST WILDLIFE RES, V16, P575; Stokstad E, 2010, SCIENCE, V330, P1029, DOI 10.1126/science.330.6007.1029; Ward TJ, 1999, ECOL APPL, V9, P691; Watson DM, 2012, P ROY SOC B-BIOL SCI, V279, P3853, DOI 10.1098/rspb.2012.0856; Watson DM, 2001, ANNU REV ECOL SYST, V32, P219, DOI 10.1146/annurev.ecolsys.32.081501.114024	76	46	50	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89807	10.1371/journal.pone.0089807	http://dx.doi.org/10.1371/journal.pone.0089807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587050	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700092
J	Chateigner-Boutin, AL; Bouchet, B; Alvarado, C; Bakan, B; Guillon, F				Chateigner-Boutin, Anne-Laure; Bouchet, Brigitte; Alvarado, Camille; Bakan, Benedicte; Guillon, Fabienne			The Wheat Grain Contains Pectic Domains Exhibiting Specific Spatial and Development-Associated Distribution	PLOS ONE			English	Article							ENDOSPERM CELL-WALLS; ARABIDOPSIS-THALIANA; RHAMNOGALACTURONAN I; HOMOGALACTURONAN; POLYSACCHARIDES; BIOSYNTHESIS; IDENTIFICATION; METHYLESTERIFICATION; DEPOSITION; MUCILAGE	Cell walls are complex structures surrounding plant cells with a composition that varies among species and even within a species between organs, cell types and development stages. For years, cell walls in wheat grains were described as simple walls consisting mostly of arabinoxylans and mixed-linked beta glucans. Proteomic and transcriptomic studies identified enzyme families involved in the synthesis of many more cell wall polysaccharides in the wheat grains. Here we describe the discovery of pectic domains in wheat grain using monoclonal antibodies and enzymatic treatment to degrade the major cell wall polymers. Distinct spatial distributions were observed for rhamnogalacturonan I present in the endosperm and mostly in the aleurone layer and homogalacturonan especially found in the outer layers, and tight developmental regulations were unveiled. We also uncovered a massive deposition of homogalacturonan via large vesicular bodies in the seed coat (testa) beneath a thick cuticle during development. Our findings raise questions about the function of pectin in wheat grain.	[Chateigner-Boutin, Anne-Laure; Bouchet, Brigitte; Alvarado, Camille; Bakan, Benedicte; Guillon, Fabienne] INRA, Unite Rech Biopolymeres Interact Assemblages 1268, F-44026 Nantes, France	INRAE	Chateigner-Boutin, AL (corresponding author), INRA, Unite Rech Biopolymeres Interact Assemblages 1268, F-44026 Nantes, France.	anne-laure.chateigner-boutin@nantes.inra.fr	huang, dezhi/ABC-6566-2021; BAKAN, Benedicte/ABC-6953-2020; /U-1825-2018	/0000-0001-7925-3104	INRA CEPIA department	INRA CEPIA department	Funded by INRA CEPIA department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders N, 2012, P NATL ACAD SCI USA, V109, P989, DOI 10.1073/pnas.1115858109; Beaugrand J, 2004, J AGR FOOD CHEM, V52, P7108, DOI 10.1021/jf049529w; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Egelund J, 2006, PLANT CELL, V18, P2593, DOI 10.1105/tpc.105.036566; FINCHER GB, 1974, AUST J BIOL SCI, V27, P117, DOI 10.1071/BI9740117; Gou JY, 2012, PLANT CELL, V24, P50, DOI 10.1105/tpc.111.092411; Guillon F, 2011, J EXP BOT, V62, P1001, DOI 10.1093/jxb/erq332; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Harholt J, 2012, PLANTA, V236, P115, DOI 10.1007/s00425-012-1592-3; Jensen JK, 2008, PLANT CELL, V20, P1289, DOI 10.1105/tpc.107.050906; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Lee KJD, 2013, PLANT J, V75, P1018, DOI 10.1111/tpj.12263; Lee KJD, 2012, PLANT PHYSIOL, V160, P1551, DOI 10.1104/pp.112.203661; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; Lopez-Casado G, 2007, J EXP BOT, V58, P3875, DOI 10.1093/jxb/erm233; MacMaster G, 1997, AGR FOR METEOROL, V87, P291; Macquet A, 2007, PLANT CELL PHYSIOL, V48, P984, DOI 10.1093/pcp/pcm068; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; Mares D, 1973, AUST J BIOL SCI, V23, P793; MARES DJ, 1973, AUST J BIOL SCI, V26, P813; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; MORRISON IN, 1975, CAN J BOT, V53, P2077, DOI 10.1139/b75-232; Oury FX, 1998, AGRONOMIE, V18, P139, DOI 10.1051/agro:19980204; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Ralet MC, 2010, PLANTA, V231, P1373, DOI 10.1007/s00425-010-1116-y; Ralet MC, 2012, BIOMACROMOLECULES, V13, P1615, DOI 10.1021/bm300329r; Ralet MC, 2005, PHYTOCHEMISTRY, V66, P2800, DOI 10.1016/j.phytochem.2005.09.039; Ralet MC, 2003, BIOCHEM ENG J, V16, P191, DOI 10.1016/S1369-703X(03)00037-8; Saez-Aguayo S, 2013, PLANT CELL, V25, P308, DOI 10.1105/tpc.112.106575; Saulnier L., 2007, COMPR GLYCOSCI, V2, P653; Saulnier L, 2012, J CEREAL SCI, V56, P91, DOI 10.1016/j.jcs.2012.02.010; SHIBUYA N, 1984, PHYTOCHEMISTRY, V23, P1425, DOI 10.1016/S0031-9422(00)80479-3; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Suliman M, 2013, J PROTEOMICS, V78, P508, DOI 10.1016/j.jprot.2012.10.021; Tan L, 2013, PLANT CELL, V25, P270, DOI 10.1105/tpc.112.107334; Tan L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00140; THIERY JP, 1967, J MICROSC-PARIS, V6, P987; Vaughn KC, 1999, PROTOPLASMA, V209, P226, DOI 10.1007/BF01453451; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Wilson SM, 2012, PLANT PHYSIOL, V159, P655, DOI 10.1104/pp.111.192682; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Zhong RQ, 2003, TRENDS PLANT SCI, V8, P565, DOI 10.1016/j.tplants.2003.10.003	48	60	60	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89620	10.1371/journal.pone.0089620	http://dx.doi.org/10.1371/journal.pone.0089620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586916	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900130
J	Suntrup, S; Teismann, I; Wollbrink, A; Warnecke, T; Winkels, M; Pantev, C; Dziewas, R				Suntrup, Sonja; Teismann, Inga; Wollbrink, Andreas; Warnecke, Tobias; Winkels, Martin; Pantev, Christo; Dziewas, Rainer			Altered Cortical Swallowing Processing in Patients with Functional Dysphagia: A Preliminary Study	PLOS ONE			English	Article							PROSPECTIVE PSYCHOLOGICAL EVALUATION; TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CONVERSION DISORDER; PARKINSONS-DISEASE; VISCERAL SENSATION; PREFRONTAL CORTEX; BRAIN; ACTIVATION; SUPPLEMENTARY; CONNECTIVITY	Objective: Current neuroimaging research on functional disturbances provides growing evidence for objective neuronal correlates of allegedly psychogenic symptoms, thereby shifting the disease concept from a psychological towards a neurobiological model. Functional dysphagia is such a rare condition, whose pathogenetic mechanism is largely unknown. In the absence of any organic reason for a patient's persistent swallowing complaints, sensorimotor processing abnormalities involving central neural pathways constitute a potential etiology. Methods: In this pilot study we measured cortical swallow-related activation in 5 patients diagnosed with functional dysphagia and a matched group of healthy subjects applying magnetoencephalography. Source localization of cortical activation was done with synthetic aperture magnetometry. To test for significant differences in cortical swallowing processing between groups, a non-parametric permutation test was afterwards performed on individual source localization maps. Results: Swallowing task performance was comparable between groups. In relation to control subjects, in whom activation was symmetrically distributed in rostro-medial parts of the sensorimotor cortices of both hemispheres, patients showed prominent activation of the right insula, dorsolateral prefrontal cortex and lateral premotor, motor as well as inferolateral parietal cortex. Furthermore, activation was markedly reduced in the left medial primary sensory cortex as well as right medial sensorimotor cortex and adjacent supplementary motor area (p<0.01). Conclusions: Functional dysphagia - a condition with assumed normal brain function - seems to be associated with distinctive changes of the swallow-related cortical activation pattern. Alterations may reflect exaggerated activation of a widely distributed vigilance, self-monitoring and salience rating network that interferes with down-stream deglutition sensorimotor control.	[Suntrup, Sonja; Wollbrink, Andreas; Winkels, Martin; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Suntrup, Sonja; Teismann, Inga; Warnecke, Tobias; Dziewas, Rainer] Univ Munster, Dept Neurol, D-48149 Munster, Germany	University of Munster; University of Munster	Suntrup, S (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	sonjasuntrup@uni-muenster.de	Dziewas, Rainer/AAX-9505-2020	Dziewas, Rainer/0000-0003-1592-8461	Deutsche Forschungsgemeinschaft [PA-392/9-2, TE-840/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [Grant numbers: PA-392/9-2 and TE-840/1-1], http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Aziz Q, 1997, GASTROENTEROLOGY, V113, P50, DOI 10.1016/S0016-5085(97)70079-9; Aziz Q, 2000, J NEUROSCI, V20, P2657; Barofsky I, 1998, DYSPHAGIA, V13, P24, DOI 10.1007/PL00009545; Bonaz B, 2003, J Physiol Pharmacol, V54 Suppl 4, P27; Browning M, 2011, PSYCHOSOM MED, V73, P173, DOI 10.1097/PSY.0b013e31820824f6; Buchholz D, 1996, DYSPHAGIA, V11, P222, DOI 10.1007/BF00366391; Buchholz D W, 1994, Dysphagia, V9, P245, DOI 10.1007/BF00301918; Chastan N, 2009, J NEUROL NEUROSUR PS, V80, P94, DOI 10.1136/jnnp.2008.154302; Chau W, 2004, NEUROIMAGE, V23, P983, DOI 10.1016/j.neuroimage.2004.07.007; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; de Araujo IE, 2009, INT J OBESITY, V33, pS34, DOI 10.1038/ijo.2009.70; de Lange FP, 2010, NEUROPSYCHOLOGIA, V48, P1782, DOI 10.1016/j.neuropsychologia.2010.02.029; Dziewas R, 2003, NEUROIMAGE, V20, P135, DOI 10.1016/S1053-8119(03)00285-4; Dziewas R, 2009, HUM BRAIN MAPP, V30, P1352, DOI 10.1002/hbm.20603; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Furlong PL, 2004, NEUROIMAGE, V22, P1447, DOI 10.1016/j.neuroimage.2004.02.041; Galmiche JP, 2006, GASTROENTEROLOGY, V130, P1459, DOI 10.1053/j.gastro.2005.08.060; Gangitano M, 2008, SOC NEUROSCI-UK, V3, P289, DOI 10.1080/17470910701516838; Garcia-Campayo J, 2009, CURR OPIN PSYCHIATR, V22, P224, DOI 10.1097/YCO.0b013e3283252d43; Ghaffar O, 2006, NEUROLOGY, V67, P2036, DOI 10.1212/01.wnl.0000247275.68402.fc; Hamdy S, 1999, J NEUROPHYSIOL, V81, P1917, DOI 10.1152/jn.1999.81.4.1917; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; Hurwitz TA, 2006, NEUROLOGY, V67, P1914, DOI 10.1212/01.wnl.0000249127.69348.a4; Jefferson S, 2009, GASTROENTEROLOGY, V137, P841, DOI 10.1053/j.gastro.2009.04.056; JENKINS IH, 1992, ANN NEUROL, V32, P749, DOI 10.1002/ana.410320608; Kim CH, 1996, DYSPHAGIA, V11, P34, DOI 10.1007/BF00385798; Loose R, 2001, DYSPHAGIA, V16, P183, DOI 10.1007/s00455-001-0062-z; Lowell SY, 2012, EXP BRAIN RES, V219, P85, DOI 10.1007/s00221-012-3069-9; Malandraki GA, 2009, HUM BRAIN MAPP, V30, P3209, DOI 10.1002/hbm.20743; Martin RE, 2001, J NEUROPHYSIOL, V85, P938, DOI 10.1152/jn.2001.85.2.938; Michou E, 2012, GASTROENTEROLOGY, V142, P29, DOI 10.1053/j.gastro.2011.09.040; Montoya A, 2006, FUNCT NEUROL, V21, P193; Morgan V, 2005, GUT, V54, P601, DOI 10.1136/gut.2004.047423; Mosier KM, 1999, AM J NEURORADIOL, V20, P1520; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Ravich W J, 1989, Dysphagia, V4, P35, DOI 10.1007/BF02407400; Rolls ET, 2010, NEUROSCI BIOBEHAV R, V34, P237, DOI 10.1016/j.neubiorev.2008.03.010; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; Small DM, 2010, BRAIN STRUCT FUNCT, V214, P551, DOI 10.1007/s00429-010-0266-9; Steinstraeter O, 2009, EXP BRAIN RES, V193, P387, DOI 10.1007/s00221-008-1634-z; Suntrup S, 2013, NEUROIMAGE, V83, P346, DOI 10.1016/j.neuroimage.2013.06.055; Suntrup S, 2013, BRAIN, V136, P726, DOI 10.1093/brain/awt004; Taniguchi M, 2000, NEUROIMAGE, V12, P298, DOI 10.1006/nimg.2000.0611; Teismann IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019987; Teismann IK, 2010, NEUROBIOL AGING, V31, P1044, DOI 10.1016/j.neurobiolaging.2008.07.001; Teismann IK, 2009, HUM BRAIN MAPP, V30, P92, DOI 10.1002/hbm.20488; Tracy J, 2007, PSYCHOSOM MED, V69, P952, DOI 10.1097/PSY.0b013e31815b60cf; Vaiman Michael, 2007, Head Face Med, V3, P26, DOI 10.1186/1746-160X-3-26; van Beilen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025918; Voon V, 2011, MOVEMENT DISORD, V26, P2396, DOI 10.1002/mds.23890; Voon V, 2010, BRAIN, V133, P1526, DOI 10.1093/brain/awq054; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Watanabe Y, 2004, DYSPHAGIA, V19, P100, DOI 10.1007/s00455-003-0509-5; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Xu SC, 2010, EUR J RADIOL, V75, P352, DOI 10.1016/j.ejrad.2010.03.025	60	15	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89665	10.1371/journal.pone.0089665	http://dx.doi.org/10.1371/journal.pone.0089665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586948	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900154
J	Kambara, K; Shimizu, K; Makita, H; Hasegawa, M; Nagai, K; Konno, S; Nishimura, M				Kambara, Kenta; Shimizu, Kaoruko; Makita, Hironi; Hasegawa, Masaru; Nagai, Katsura; Konno, Satoshi; Nishimura, Masaharu			Effect of Lung Volume on Airway Luminal Area Assessed by Computed Tomography in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							THIN-SECTION CT; FLOW LIMITATION; HEALTHY-SUBJECTS; QUANTITATIVE CT; WALL THICKNESS; EMPHYSEMA; COPD; DIMENSIONS; ASTHMA; DISTENSIBILITY	Background: Although airway luminal area (Ai) is affected by lung volume (LV), how is not precisely understood. We hypothesized that the effect of LV on Ai would differ by airway generation, lung lobe, and chronic obstructive pulmonary disease (COPD) severity. Methods: Sixty-seven subjects (15 at risk, 18, 20, and 14 for COPD stages 1, 2, and 3) underwent pulmonary function tests and computed tomography scans at full inspiration and expiration (at functional residual capacity). LV and eight selected identical airways were measured in the right lung. Ai was measured at the mid-portion of the 3rd, the segmental bronchus, to 6th generation of the airways, leading to 32 measurements per subject. Results: The ratio of expiratory to inspiratory LV (LV E/I ratio) and Ai (Ai E/I ratio) was defined for evaluation of changes. The LV E/I ratio increased as COPD severity progressed. As the LV E/I ratio was smaller, the Ai E/I ratio was smaller at any generation among the subjects. Overall, the Ai E/I ratios were significantly smaller at the 5th (61.5%) and 6th generations (63.4%) and than at the 3rd generation (73.6%, p<0.001 for each), and also significantly lower in the lower lobe than in the upper or middle lobe (p<0.001 for each). And, the Ai E/I ratio decreased as COPD severity progressed only when the ratio was corrected by the LV E/I ratio (at risk v.s. stage3 p<0.001, stage1 v.s. stage3 p<0.05). Conclusions: From full inspiration to expiration, the airway luminal area shrinks more at the distal airways compared with the proximal airways and in the lower lobe compared with the other lobes. Generally, the airways shrink more as COPD severity progresses, but this phenomenon becomes apparent only when lung volume change from inspiration to expiration is taken into account.	[Kambara, Kenta] Toyama Univ, Dept Internal Med 1, Toyama 930, Japan; [Shimizu, Kaoruko; Makita, Hironi; Hasegawa, Masaru; Nagai, Katsura; Konno, Satoshi; Nishimura, Masaharu] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan	University of Toyama; Hokkaido University	Nishimura, M (corresponding author), Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan.	ma-nishi@med.hokudai.ac.jp	Nishimura, Masaharu/A-4062-2012; shimizu, kaoruko/G-1947-2012	Nishimura, Masaharu/0000-0002-6456-4361; 	Ministry of Education, Science, Culture and Sports of Japan [17390239, 2139053]; Nippon Boehringer Ingelheim, Pfizer, Inc.; Ministry of Health, Labor and Welfare, Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nippon Boehringer Ingelheim, Pfizer, Inc.; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	The Hokkaido COPD cohort study is supported by a scientific research grant from the Ministry of Education, Science, Culture and Sports of Japan (17390239 and 2139053 to MN), Nippon Boehringer Ingelheim, Pfizer, Inc., and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T, 2008, EUR RADIOL, V18, P2731, DOI 10.1007/s00330-008-1089-4; Akira M, 2009, AM J ROENTGENOL, V192, P267, DOI 10.2214/AJR.07.3953; Bakker ME, 2012, RESP MED, V106, P677, DOI 10.1016/j.rmed.2011.11.013; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Brown RH, 2001, AM J RESP CRIT CARE, V163, P994, DOI 10.1164/ajrccm.163.4.2007119; CARROLL N, 1993, AM REV RESPIR DIS, V147, P405, DOI 10.1164/ajrccm/147.2.405; Castagnaro A, 2008, RADIOL MED, V113, P43, DOI 10.1007/s11547-008-0223-3; de Jong PA, 2005, EUR RESPIR J, V26, P140, DOI 10.1183/09031936.05.00007105; Diaz AA, 2012, CHEST, V141, P736, DOI 10.1378/chest.11-1026; Ederle JR, 2003, EUR RADIOL, V13, P2454, DOI 10.1007/s00330-003-1909-5; Gevenois PA, 1996, RADIOLOGY, V199, P825, DOI 10.1148/radiology.199.3.8638012; *GOLD, 2003, GLOB STRAT DIAGN MAN; Grenier PA, 2002, EUR RADIOL, V12, P1022, DOI 10.1007/s00330-002-1342-1; Hasegawa M, 2009, THORAX, V64, P332, DOI 10.1136/thx.2008.103671; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Johns DP, 2000, J APPL PHYSIOL, V88, P1413, DOI 10.1152/jappl.2000.88.4.1413; King GG, 2000, AM J RESP CRIT CARE, V161, P574, DOI 10.1164/ajrccm.161.2.9812073; LAMERS RJ, 1994, RADIOLOGY, V193, P109, DOI 10.1148/radiology.193.1.8090878; Makita H, 2007, THORAX, V62, P932, DOI 10.1136/thx.2006.072777; Matsuoka S, 2008, RADIOLOGY, V248, P1042, DOI 10.1148/radiol.2491071650; Montaudon M, 2007, RADIOLOGY, V242, P563, DOI 10.1148/radiol.2422060029; Moroni C, 2003, J COMPUT ASSIST TOMO, V27, P375, DOI 10.1097/00004728-200305000-00013; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nishida O, 1976, Rinsho Byori, V24, P837; Nishimura M, 2012, AM J RESP CRIT CARE, V185, P44, DOI 10.1164/rccm.201106-0992OC; Nishimura Masaharu, 2008, Proc Am Thorac Soc, V5, P910, DOI 10.1513/pats.200809-109QC; Orlandi I, 2005, RADIOLOGY, V234, P604, DOI 10.1148/radiol.2342040013; Orlandi I, 2004, J COMPUT ASSIST TOMO, V28, P437, DOI 10.1097/00004728-200407000-00001; Reinhardt JM, 1997, IEEE T MED IMAGING, V16, P820, DOI 10.1109/42.650878; Scichilone N, 1985, J APPL PHYSIOL, V105, P832; Shimizu K, 2011, RESP MED, V105, P1275, DOI 10.1016/j.rmed.2011.04.007; Stoel Berend C, 2008, Proc Am Thorac Soc, V5, P919, DOI 10.1513/pats.200804-040QC; The Japanese Respiratory Society, 2004, GUID PULM FUNCT TEST; Yamashiro T, 2011, ACAD RADIOL, V18, P299, DOI 10.1016/j.acra.2010.11.005; Yamashiro T, 2010, ACAD RADIOL, V17, P489, DOI 10.1016/j.acra.2009.11.004	36	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90040	10.1371/journal.pone.0090040	http://dx.doi.org/10.1371/journal.pone.0090040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587205	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200117
J	Luo, LL; Chen, DP; Qu, Y; Wu, JL; Li, XH; Mu, DZ				Luo, Lili; Chen, Dapeng; Qu, Yi; Wu, Jinlin; Li, Xihong; Mu, Dezhi			Association between Hypoxia and Perinatal Arterial Ischemic Stroke: A Meta-Analysis	PLOS ONE			English	Article							NEONATAL CEREBRAL INFARCTION; RISK-FACTORS; TERM INFANTS; CHILDREN; BIRTH	Background: Perinatal arterial ischemic stroke (AIS) occurs in an estimated 17 to 93 per 100000 live births, yet the etiology is poorly understood. Although investigators have implicated hypoxia as a potential cause of AIS, the role of hypoxia in AIS remains controversial. The aim of this study was to estimate the association between perinatal hypoxia factors and perinatal arterial ischemic stroke through a meta-analysis of published observational studies. Patients and methods: A systematic search of electronically available studies published through July 2013 was conducted. Publication bias and heterogeneity across studies were evaluated and summary odds ratios (ORs) and 95% confidence intervals (CIs) were calculated with fixed-effects or random-effects models. Results: A total of 8 studies describing the association between perinatal hypoxia factors and neonatal arterial ischemic stroke (AIS) met inclusion criteria, and 550 newborns with AIS were enrolled. The associations were found for AIS: preeclampsia (OR 2.14; 95% CI, 1.25 to 3.66), ventouse delivery (OR 2.23; 95% CI, 1.26 to 3.97), fetal heart rate abnormalities (OR 6.30; 95% CI, 3.84 to 10.34), reduced fetal movement (OR 5.35; 95% CI, 2.17 to 13.23), meconium-stained liquor (OR 3.05; 95% CI, 2.02 to 4.60), low Apgar score (OR 5.77; 95% CI, 1.66 to 20.04) and resuscitation at birth (OR 4.59; 95% CI, 3.23 to 6.52). Our data did not show any significant change of the mean risk estimate for oxytocin induction (OR 1.33; 95% CI, 0.84 to 2.11) and low arterial umbilical cord ph (OR 4.63; 95% CI 2.14 to 9.98). Conclusions: There is a significant association between perinatal hypoxia factors and AIS. The result indicates that perinatal hypoxia maybe one of causes of AIS. Large scale prospective clinical studies are still warranted.	[Luo, Lili; Chen, Dapeng; Qu, Yi; Wu, Jinlin; Mu, Dezhi] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Sichuan, Peoples R China; [Luo, Lili; Qu, Yi; Mu, Dezhi] Sichuan Univ, Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Chengdu, Sichuan, Peoples R China; [Luo, Lili; Li, Xihong] Sichuan Univ, West China Univ Hosp 2, Dept Emergency, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Mu, DZ (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Sichuan, Peoples R China.	mudz@scu.edu.cn		Mu, Dezhi/0000-0002-2599-7041	National Science Foundation of China [81330016, 31171020, 81172174, 81270724]; Ministry of Health of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of China	All phases of this study were supported by the National Science Foundation of China (No. 81330016 and No. 31171020 to Dezhi Mu; No. 81172174 and 81270724 to Yi Qu), and the Grant of clinical discipline program (neonatology) from the Ministry of Health of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew M E, 2001, Hematology Am Soc Hematol Educ Program, P358; Benders MJNL, 2007, STROKE, V38, P1759, DOI 10.1161/STROKEAHA.106.479311; Caravale B, 2003, PEDIATR NEUROL, V29, P18, DOI 10.1016/S0887-8994(03)00046-8; Chabrier S, 2010, EUR J PAEDIATR NEURO, V14, P206, DOI 10.1016/j.ejpn.2009.05.004; Chalmers EA, 2005, BRIT J HAEMATOL, V130, P333, DOI 10.1111/j.1365-2141.2005.05554.x; Darmency-Stamboul V, 2012, STROKE, V43, P2307, DOI 10.1161/STROKEAHA.111.642181; DENNIS J, 1989, AM J OBSTET GYNECOL, V161, P213, DOI 10.1016/0002-9378(89)90269-X; Estan J, 1997, ARCH DIS CHILD-FETAL, V76, pF88, DOI 10.1136/fn.76.2.F88; Fahey J, 2005, J MIDWIFERY WOM HEAL, V50, P498, DOI 10.1016/j.jmwh.2005.08.007; GOLDABER KG, 1991, OBSTET GYNECOL, V78, P1103; Golomb MR, 2004, J CHILD NEUROL, V19, P493, DOI 10.1177/08830738040190070301; Gunther G, 2000, STROKE, V31, P2437, DOI 10.1161/01.STR.31.10.2437; Harteman JC, 2012, ARCH DIS CHILD-FETAL, V97, pF411, DOI 10.1136/archdischild-2011-300973; Hermansen MC, 2003, DEV MED CHILD NEUROL, V45, P353, DOI 10.1017/S0012162203000653; Kim Young Ju, 2013, Obstet Gynecol Sci, V56, P2, DOI 10.5468/OGS.2013.56.1.2; Kirton A, 2011, PEDIATRICS, V128, pE1402, DOI 10.1542/peds.2011-1148; Kirton A, 2010, ARCH NEUROL-CHICAGO, V67, P842, DOI 10.1001/archneurol.2010.140; Laugesaar R, 2007, STROKE, V38, P2234, DOI 10.1161/STROKEAHA.107.483743; Laugesaar R, 2010, PEDIATR NEUROL, V42, P93, DOI 10.1016/j.pediatrneurol.2009.08.009; Lee J, 2005, JAMA-J AM MED ASSOC, V293, P723, DOI 10.1001/jama.293.6.723; Leuthner SR, 2004, PEDIATR CLIN N AM, V51, P737, DOI 10.1016/j.pcl.2004.01.016; Lynch JK, 2009, SEMIN FETAL NEONAT M, V14, P245, DOI 10.1016/j.siny.2009.07.001; MENT LR, 1984, ANN NEUROL, V16, P559, DOI 10.1002/ana.410160506; Mercuri E, 1999, PEDIATRICS, V103, P39, DOI 10.1542/peds.103.1.39; Michoulas A, 2011, PEDIATR NEUROL, V44, P254, DOI 10.1016/j.pediatrneurol.2010.10.013; Nelson KB, 2007, STROKE, V38, P742, DOI 10.1161/01.STR.0000247921.97794.5e; Palsdottir Kolbrun, 2007, Laeknabladid, V93, P595; Rafay MF, 2009, STROKE, V40, P2402, DOI 10.1161/STROKEAHA.109.547281; Raju TNK, 2007, PEDIATRICS, V120, P609, DOI 10.1542/peds.2007-0336; Ramaswamy V, 2004, NEUROLOGY, V62, P2088, DOI 10.1212/01.WNL.0000129909.77753.C4; Tuckuviene R, 2012, ARCH DIS CHILD-FETAL, V97, pF417, DOI 10.1136/archdischild-2011-300665; Wells GA, 2014, NEWCASTLE OTTAWA SCA, DOI DOI 10.2307/632432; Wu YW, 2004, PEDIATRICS, V114, P612, DOI 10.1542/peds.2004-0385; Xu HR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.043; Zadro R, 2012, BIOCHEM MEDICA, V22, P298	35	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90106	10.1371/journal.pone.0090106	http://dx.doi.org/10.1371/journal.pone.0090106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587227	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200126
J	Meher, A; Joshi, A; Joshi, S				Meher, Akshaya; Joshi, Asmita; Joshi, Sadhana			Differential Regulation of Hepatic Transcription Factors in the Wistar Rat Offspring Born to Dams Fed Folic Acid, Vitamin B-12 Deficient Diets and Supplemented with Omega-3 Fatty Acids	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GLOBAL DNA METHYLATION; ONE-CARBON METABOLISM; PREGNANT RATS; MATERNAL MICRONUTRIENTS; PROTEIN RESTRICTION; TRANSPORT PROTEINS; FOLATE-DEFICIENCY; POTENTIAL ROLE; PPAR-GAMMA	Nutritional status of the mother is known to influence various metabolic adaptations required for optimal fetal development. These may be mediated by transcription factors like peroxisome proliferator activated receptors (PPARs), which are activated by long chain polyunsaturated fatty acids. The objective of the current study was to examine the expression of different hepatic transcription factors and the levels of global methylation in the liver of the offspring born to dams fed micronutrient deficient (folic acid and vitamin B-12) diets and supplemented with omega-3 fatty acids. Female rats were divided into five groups (n = 8/group) as follows; control, folic acid deficient (FD), vitamin B-12 deficient (BD) and omega-3 fatty acid supplemented groups (FDO and BDO). Diets were given starting from pre-conception and continued throughout pregnancy and lactation. Pups were dissected at the end of lactation. Liver tissues were removed; snap frozen and stored at -80 degrees C. Maternal micronutrients deficiency resulted in lower (p<0.05) levels of pup liver docosahexaenoic acid (DHA) and arachidonic acid (ARA) as compared to the control group. Pup liver PPAR alpha and PPAR gamma expression was lower (p<0.05) in the BD group although there were no differences in the expression of SREBP-1c, LXR alpha and RXR alpha expression. Omega-3 fatty acids supplementation to this group normalized (p<0.05) levels of both PPAR alpha and PPAR gamma but reduced (p<0.05) SREBP-1 gamma, LXR alpha and RXR alpha expression. There was no change in any of the transcription factors in the pup liver in the FD group. Omega-3 fatty acids supplementation to this group reduced (p<0.05) PPAR alpha, SREBP-1 gamma and RXR alpha expression. Pup liver global methylation levels were higher (p<0.01) in both the micronutrients deficient groups and could be normalized (p<0.05) by omega-3 fatty acid supplementation. Our novel findings suggest a role for omega-3 fatty acids in the one carbon cycle in influencing the hepatic expression of transcription factors in the offspring.	[Meher, Akshaya; Joshi, Asmita; Joshi, Sadhana] Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs, Dept Nutr Med, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University	Joshi, S (corresponding author), Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs, Dept Nutr Med, Pune, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001	'Department of Science and Technology', Government of India	'Department of Science and Technology', Government of India(Department of Science & Technology (India))	This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. Author, AM received the 'INSPIRE fellowship' from 'Department of Science and Technology', Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley HN, 2013, J OBES, V2013, DOI 10.1155/2013/312153; Belkacemi L, 2011, AM J PHYSIOL-REG I, V301, pR1599, DOI 10.1152/ajpregu.00100.2011; Benatti P, 2004, J AM COLL NUTR, V23, P281, DOI 10.1080/07315724.2004.10719371; Bordoni A, 2006, GENES NUTR, V1, P95, DOI 10.1007/BF02829951; Buckley JD, 2010, NUTRIENTS, V2, P1212, DOI 10.3390/nu2121212; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Cetin I, 2010, HUM REPROD UPDATE, V16, P80, DOI 10.1093/humupd/dmp025; Cottin SC, 2011, P NUTR SOC, V70, P215, DOI 10.1017/S0029665111000061; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Gambling L, 2003, J PHYSIOL-LONDON, V552, P603, DOI 10.1113/jphysiol.2003.051383; Joss-Moore LA, 2010, EARLY HUM DEV, V86, P785, DOI 10.1016/j.earlhumdev.2010.08.026; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kalhan SC, 2012, REV ENDOCR METAB DIS, V13, P109, DOI 10.1007/s11154-012-9215-7; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kim HW, 2013, MOL NUTR FOOD RES, V57, P671, DOI 10.1002/mnfr.201200558; Kulkarni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017706; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lopez SAR, 2013, J NUTR BIOCHEM, V24, P877, DOI 10.1016/j.jnutbio.2012.06.001; Maloney CA, 2007, BRIT J NUTR, V97, P1090, DOI 10.1017/S0007114507670834; Maloney CA, 2013, GENES NUTR, V8, P181, DOI 10.1007/s12263-012-0314-6; McDonald C, 2013, CAN J PHYSIOL PHARM, V91, P459, DOI 10.1139/cjpp-2012-0304; Meher AP, 2013, REPROD FERT DEVELOP, V25, P1085, DOI 10.1071/RD12210; Mikael LG, 2012, J NUTR, V142, P411, DOI 10.3945/jn.111.151753; Murphy RA, 2011, BRIT J CANCER, V105, P1469, DOI 10.1038/bjc.2011.391; Murphy RA, 2012, CURR OPIN CLIN NUTR, V15, P246, DOI 10.1097/MCO.0b013e328351c32f; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Niculescu MD, 2013, FASEB J, V27, P350, DOI 10.1096/fj.12-210724; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Rees WD, 2008, PPAR RES, V2008, DOI 10.1155/2008/459030; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rodriguez-Cruz M, 2005, REV INVEST CLIN, V57, P457; Sampath H, 2004, NUTR REV, V62, P333, DOI [10.1301/nr.2004.sept.333-339, 10.1111/j.1753-4887.2004.tb00058.x]; Schaiff WT, 2006, MOL CELL ENDOCRINOL, V249, P10, DOI 10.1016/j.mce.2006.02.009; Sie KKY, 2013, MOL NUTR FOOD RES, V57, P677, DOI 10.1002/mnfr.201200186; Sinclair K D, 2007, Soc Reprod Fertil Suppl, V64, P425; Suwaki N, 2007, PLACENTA, V28, P315, DOI 10.1016/j.placenta.2006.04.002; Teran-Garcia M, 2007, BIOCHEM J, V402, P591, DOI 10.1042/BJ20061722; Tian CY, 2011, CLIN NUTR, V30, P659, DOI 10.1016/j.clnu.2011.03.002; Wadhwani NS, 2013, PROSTAG LEUKOTR ESS, V88, P235, DOI 10.1016/j.plefa.2012.12.002; Wadhwani NS, 2012, PROSTAG LEUKOTR ESS, V86, P21, DOI 10.1016/j.plefa.2011.10.010; Wang XM, 2013, WORLD J PEDIATR, V9, P5, DOI 10.1007/s12519-013-0403-7; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Yessoufou A, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13071; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	50	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90209	10.1371/journal.pone.0090209	http://dx.doi.org/10.1371/journal.pone.0090209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587285	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200147
J	Takatani-Nakase, T; Matsui, C; Maeda, S; Kawahara, S; Takahashi, K				Takatani-Nakase, Tomoka; Matsui, Chihiro; Maeda, Sachie; Kawahara, Satomi; Takahashi, Koichi			High Glucose Level Promotes Migration Behavior of Breast Cancer Cells through Zinc and Its Transporters	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRACE-ELEMENTS; LIV-1; CARCINOMA; DISEASE; ASSOCIATION; EXPRESSION; PATHOLOGY; COPPER	Background: The diabetes patients have been associated with an increased risk of mortality by breast cancer and there are difference between the breast cancer patients with diabetes, and their nondiabetic counterparts in the regimen choice and effects of breast cancer treatment. However, the pathophysiological relationships of diabetes and breast cancer have not yet been elucidated in detail. In this study, we investigate the breast cancer cell line, MCF-7 motility, which linked to invasion and metastasis, in high glucose level corresponding to hyperglycemia and the role of Zn and its transporter. Methodology/Principal findings: We demonstrated the significant motility of MCF-7 cultured in hyperglycemic level (25 mM glucose) in comparison to normal physiological glucose level (5.5 mM glucose). The other hand, the osmotic control medium, 5.5 mM glucose with 19.5 mM mannitol or fructose had no effect on migratory, suggesting that high glucose level promotes the migration of MCF-7. Moreover, the activity of intracellular Zn2+ uptake significantly increased in high glucose-treated cells in comparison to 5.5 mM glucose, and the mRNA expression of zinc transporters, ZIP6 and ZIP10, was upregulated in 25 mM glucose-treated cells. The deficiency of ZIP6 or ZIP10 and intracellular Zn2+ significantly inhibited the high migration activity in 25 mM glucose medium, indicating that Zn2+ transported via ZIP6 and ZIP10 play an essential role in the promotion of cell motility by high glucose stimulation. Conclusion/Significance: Zinc and its transporters, ZIP6 and ZIP10, are required for the motility stimulated with high glucose level. These findings provide the first evidence proposing the novel strategies for the diagnosis and therapy of breast cancer with hyperglycemia.	[Takatani-Nakase, Tomoka; Matsui, Chihiro; Maeda, Sachie; Kawahara, Satomi; Takahashi, Koichi] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut, Nishinomiya, Hyogo, Japan	Mukogawa Women's University	Takatani-Nakase, T (corresponding author), Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut, Nishinomiya, Hyogo, Japan.	nakase@mukogawa-u.ac.jp; koichi@mukogawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T.T-N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAKRAVARTY PK, 1986, NEOPLASMA, V33, P85; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fleming ST, 2005, MED CARE, V43, P132, DOI 10.1097/00005650-200502000-00006; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Grattan BJ, 2012, NUTRIENTS, V4, P648, DOI 10.3390/nu4070648; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Gumulec J, 2011, CURR MED CHEM, V18, P5041, DOI 10.2174/092986711797636126; Gupta SK, 2005, J SURG ONCOL, V91, P204, DOI 10.1002/jso.20306; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Kagara N, 2007, CANCER SCI, V98, P692, DOI 10.1111/j.1349-7006.2007.00446.x; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kasper G, 2005, INT J CANCER, V117, P961, DOI 10.1002/ijc.21235; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leung KW, 2008, INVEST OPHTH VIS SCI, V49, P1221, DOI 10.1167/iovs.07-0781; Lopez V, 2010, EXP CELL RES, V316, P366, DOI 10.1016/j.yexcr.2009.10.011; Lyubartseva G, 2010, BRAIN PATHOL, V20, P343, DOI 10.1111/j.1750-3639.2009.00283.x; MANNING DL, 1994, EUR J CANCER, V30A, P675, DOI 10.1016/0959-8049(94)90543-6; MARGALIOTH EJ, 1983, CANCER, V52, P868, DOI 10.1002/1097-0142(19830901)52:5<868::AID-CNCR2820520521>3.0.CO;2-K; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; SCHWARTZ AE, 1974, SURGERY, V76, P325; Shen RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056542; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Tashiro H, 2003, BIOL TRACE ELEM RES, V95, P49, DOI 10.1385/BTER:95:1:49; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Unno J, 2009, INT J ONCOL, V35, P813, DOI 10.3892/ijo_00000394; van de Poll-Franse LV, 2007, INT J CANCER, V120, P1986, DOI 10.1002/ijc.22532; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104	32	49	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90136	10.1371/journal.pone.0090136	http://dx.doi.org/10.1371/journal.pone.0090136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587242	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200136
J	Peng, Y; Deng, LL; Ding, YD; Chen, QC; Wu, Y; Yang, ML; Wang, YP; Fu, Q				Peng, Ying; Deng, Lili; Ding, Yuedi; Chen, Quancheng; Wu, Yu; Yang, Meilin; Wang, Yaping; Fu, Qiang			Comparative Study of Somatostatin-Human Serum Albumin Fusion Proteins and Natural Somatostatin on Receptor Binding, Internalization and Activation	PLOS ONE			English	Article							IMPROVED PHARMACOKINETICS; GROWTH-HORMONE; IN-VITRO; TRAFFICKING; MONKEYS; OCTREOTIDE; PHYSIOLOGY; RELEASE; ANALOG; MICE	Albumin fusion technology, the combination of small molecular proteins or peptides with human serum albumin (HSA), is an effective method for improving the medicinal values of natural small molecular proteins or peptides. However, comparative studies between HSA-fusion proteins or peptides and the parent small molecules in biological and molecular mechanisms are less reported. In this study, we examined the binding property of two novel somatostatin-HSA fusion proteins, (SST14)(2)-HSA and (SST28)(2)-HSA, to human SSTRs in stably expressing SSTR1-5 HEK 293 cells; observed the regulation of receptor internalization and internalized receptor recycling; and detected the receptors activation of HSA fusion proteins in stably expressing SSTR2- and SSTR3-EGFP cells. We showed that both somatostatin-HSA fusion proteins had high affinity to all five SSTRs, stimulated the ERK1/2 phosphorylation and persistently inhibited the accumulation of forskolin-stimulated cAMP in SSTR2- and SSTR3-expressing cells; but were less potent than the synthetic somatostatin-14 (SST-14). Our experiments also showed that somatostatin-HSA fusion proteins did not induce the receptors internalization; rather, they accelerated the recycling of the internalized receptors induced by SST-14 to the plasma membrane. Our results indicated that somatostatin-HSA fusion proteins, different from SST-14, exhibit some particular properties in binding, regulating, and activating somatostatin receptors.	[Peng, Ying; Deng, Lili; Ding, Yuedi; Chen, Quancheng; Wu, Yu; Yang, Meilin; Fu, Qiang] Jiangsu Inst Nucl Med, Key Lab Nucl Med, Jiangsu Key Lab Mol Nucl Med, Minist Hlth, Wuxi, Jiangsu, Peoples R China; [Yang, Meilin] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Wang, Yaping] Nanjing Med Univ, Wuxi Peoples Hosp 2, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, YP (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp 2, Wuxi, Jiangsu, Peoples R China.	ypwnag0301@126.com; fuqiang@jsinm.org	Peng, Ying/AHD-4440-2022; Wu, Yu/HIK-1398-2022		Ministry of Health of China [LW201006]; Department of Scientific and Technological of Jiangsu Province [SBE201077641]; Natural Science Foundation of Jiangsu Province [BK2011165, BK2012104]; Wuxi hospital administrative center grant [YGZF1102]	Ministry of Health of China; Department of Scientific and Technological of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Wuxi hospital administrative center grant	This work was supported by the Ministry of Health of China grant LW201006, Department of Scientific and Technological of Jiangsu Province grant SBE201077641, Natural Science Foundation of Jiangsu Province BK2011165 and BK2012104, and Wuxi hospital administrative center grant YGZF1102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata M, 2012, HUM REPROD, V27, P2117, DOI 10.1093/humrep/des144; Barnett P, 2003, ENDOCRINE, V20, P255, DOI 10.1385/ENDO:20:3:255; Barone R, 2005, KIDNEY INT, V67, P969, DOI 10.1111/j.1523-1755.2005.00160.x; Colucci R, 2008, BRIT J PHARMACOL, V155, P198, DOI 10.1038/bjp.2008.268; Csaba Z, 2012, J MOL ENDOCRINOL, V48, pR1, DOI 10.1530/JME-11-0121; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Dickey DM, 2008, J BIOL CHEM, V283, P35003, DOI 10.1074/jbc.M804538200; Ding YD, 2013, APPL BIOCHEM BIOTECH, V170, P1637, DOI 10.1007/s12010-013-0304-1; Duttaroy A, 2005, DIABETES, V54, P251, DOI 10.2337/diabetes.54.1.251; Florio T, 2008, MOL CELL ENDOCRINOL, V286, P40, DOI 10.1016/j.mce.2007.08.012; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Halpern W, 2002, PHARMACEUT RES, V19, P1720, DOI 10.1023/A:1020917732218; Jacobs S, 2008, MOL CELL ENDOCRINOL, V286, P58, DOI 10.1016/j.mce.2007.10.005; Kariya Y, 2011, J BONE MINER RES, V26, P689, DOI 10.1002/jbmr.268; Kariya Y, 2009, J BONE MINER RES, V24, P1741, DOI [10.1359/JBMR.090409, 10.1359/jbmr.090409]; Lesche S, 2009, J CLIN ENDOCR METAB, V94, P654, DOI 10.1210/jc.2008-1919; Lewis I, 2003, J MED CHEM, V46, P2334, DOI 10.1021/jm021093t; Liu QS, 2009, MOL PHARMACOL, V76, P68, DOI 10.1124/mol.108.054262; Melder RJ, 2005, CANCER IMMUNOL IMMUN, V54, P535, DOI 10.1007/s00262-004-0624-7; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Nagel F, 2011, MOL ENDOCRINOL, V25, P859, DOI 10.1210/me.2010-0407; Olias G, 2004, J NEUROCHEM, V89, P1057, DOI 10.1111/j.1471-4159.2004.02402.x; Osborn BL, 2002, EUR J PHARMACOL, V456, P149, DOI 10.1016/S0014-2999(02)02644-4; Osborn BL, 2002, J PHARMACOL EXP THER, V303, P540, DOI 10.1124/jpet.102.037002; PATEL YC, 1994, BIOCHEM BIOPH RES CO, V198, P605, DOI 10.1006/bbrc.1994.1088; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; ROCA B, 1988, GUT, V29, P642, DOI 10.1136/gut.29.5.642; Sharma K, 1996, MOL ENDOCRINOL, V10, P1688, DOI 10.1210/me.10.12.1688; SHEPPARD M, 1979, J CLIN ENDOCR METAB, V48, P50, DOI 10.1210/jcem-48-1-50; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Sung C, 2003, J INTERF CYTOK RES, V23, P25, DOI 10.1089/10799900360520423; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; Tulipano G, 2007, EUR J ENDOCRINOL, V156, pS3, DOI 10.1530/eje.1.02354; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064301	36	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89932	10.1371/journal.pone.0089932	http://dx.doi.org/10.1371/journal.pone.0089932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587133	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800058
J	Chakravorty, S; Vu, H; Foelber, V; Vigoreaux, JO				Chakravorty, Samya; Vu, Hien; Foelber, Veronica; Vigoreaux, Jim O.			Mutations of the Drosophila Myosin Regulatory Light Chain Affect Courtship Song and Reduce Reproductive Success	PLOS ONE			English	Article							INSECT FLIGHT-MUSCLE; N-TERMINAL EXTENSION; MYOFILAMENT LATTICE; NEUROMUSCULAR BASIS; OPTOMOTOR CONTROL; SPECTRAL-ANALYSIS; SEXUAL SELECTION; POWER OUTPUT; WING BEAT; MELANOGASTER	The Drosophila indirect flight muscles (IFM) rely on an enhanced stretch-activation response to generate high power output for flight. The IFM is neurally activated during the male courtship song, but its role, if any, in generating the small amplitude wing vibrations that produce the song is not known. Here, we examined the courtship song properties and mating behavior of three mutant strains of the myosin regulatory light chain (DMLC2) that are known to affect IFM contractile properties and impair flight: (i) Dmlc2(Delta 2-46) (Ext), an N-terminal extension truncation; (ii) Dmlc2(S66A,S67A) (Phos), a disruption of two MLC kinase phosphorylation sites; and (iii) Dmlc2(Delta 2-46;S66A,S67A) (Dual), expressing both mutations. Our results show that the Dmlc2 gene is pleiotropic and that mutations that have a profound effect on flight mechanics (Phos and Dual) have minimal effects on courtship song. None of the mutations affect interpulse interval (IPI), a determinant of species-specific song, and intrapulse frequency (IPF) compared to Control (Dmlc2(+) rescued null strain). However, abnormalities in the sine song (increased frequency) and the pulse song (increased cycles per pulse and pulse length) evident in Ext males are not apparent in Dual males suggesting that Ext and Phos interact differently in song and flight mechanics, given their known additive effect on the latter. All three mutant males produce a less vigorous pulse song and exhibit impaired mating behavior compared to Control males. As a result, females are less receptive to Ext, Phos, and Dual males when a Control male is present. These results open the possibility that DMLC2, and perhaps contractile protein genes in general, are partly under sexual selection. That mutations in DMLC2 manifest differently in song and flight suggest that this protein fulfills different roles in song and flight and that stretch activation plays a smaller role in song production than in flight.	[Chakravorty, Samya; Vigoreaux, Jim O.] Univ Vermont, Dept Biol, Burlington, VT 05401 USA; [Vu, Hien; Foelber, Veronica] Univ Vermont, Biochem Undergrad Program, Burlington, VT USA; [Vigoreaux, Jim O.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	Vigoreaux, JO (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05401 USA.	jvigorea@uvm.edu		Chakravorty, Samya/0000-0002-0236-3281	National Science Foundation [IOS 0718417, MCB 1050834]; Div Of Molecular and Cellular Bioscience [1050834] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation grant IOS 0718417 and MCB 1050834 to JOV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETCLARK HC, 1968, J EXP BIOL, V49, P117; BENNETCLARK HC, 1976, BEHAV GENET, V6, P93, DOI 10.1007/BF01065681; BENNETCLARK HC, 1971, NATURE, V234, P255, DOI 10.1038/234255a0; Brodsky A. K., 1994, EVOLUTION INSECT FLI; Campbell KS, 2006, BIOPHYS J, V91, P4102, DOI 10.1529/biophysj.106.087312; Chakravorty S, 2012, METHODS, V56, P87, DOI 10.1016/j.ymeth.2011.09.007; CROSSLEY SA, 1995, ANIM BEHAV, V50, P827, DOI 10.1016/0003-3472(95)80142-1; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickinson MH, 1997, BIOPHYS J, V73, P3122, DOI 10.1016/S0006-3495(97)78338-3; DICKINSON MH, 1995, SCIENCE, V268, P87, DOI 10.1126/science.7701346; Dudley R, 2000, ANNU REV PHYSIOL, V62, P135, DOI 10.1146/annurev.physiol.62.1.135; Ejima A, 2007, COLD SPRING HARB PRO; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; EWING AW, 1977, J COMP PHYSIOL, V119, P249, DOI 10.1007/BF00656637; EWING AW, 1979, J COMP PHYSIOL, V130, P87, DOI 10.1007/BF02582977; Farman GP, 2009, J STRUCT BIOL, V168, P240, DOI 10.1016/j.jsb.2009.07.020; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gorczyca M, 1987, DROS INFO SERV, V66, P157; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; GOTZ KG, 1979, BIOL CYBERN, V35, P101, DOI 10.1007/BF00337435; GOTZ KG, 1984, BIOL CYBERN, V51, P135, DOI 10.1007/BF00357927; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hedwig B, 2006, J COMP PHYSIOL A, V192, P677, DOI 10.1007/s00359-006-0115-8; Irving T, 2001, J MUSCLE RES CELL M, V22, P675, DOI 10.1023/A:1016336024366; Iwamoto H, 2006, P ROY SOC B-BIOL SCI, V273, P677, DOI 10.1098/rspb.2005.3389; Iwamoto H, 2002, BIOPHYS J, V83, P1074, DOI 10.1016/S0006-3495(02)75231-4; Josephson RK, 2000, J EXP BIOL, V203, P2713; Kowalski S, 2004, CAN J ZOOL, V82, P1258, DOI 10.1139/Z04-102; Krzic U, 2010, J MOL BIOL, V397, P110, DOI 10.1016/j.jmb.2010.01.039; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Lehmann FO, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1050; LOWEY S, 1993, J BIOL CHEM, V268, P20414; LUO Y, 1993, AM J PHYSIOL, V265, pC279, DOI 10.1152/ajpcell.1993.265.1.C279; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Markow TA, 2005, ANNU REV GENET, V39, P263, DOI 10.1146/annurev.genet.39.073003.112454; Miller MS, 2011, BIOPHYS J, V100, P1737, DOI 10.1016/j.bpj.2011.02.028; Moore JR, 2000, BIOPHYS J, V78, P1431, DOI 10.1016/S0006-3495(00)76696-3; NACHTIGALL W, 1967, J EXP BIOL, V47, P77; Noor MAF, 1998, ANIM BEHAV, V56, P115, DOI 10.1006/anbe.1998.0779; PARKER VP, 1985, MOL CELL BIOL, V5, P3058, DOI 10.1128/MCB.5.11.3058; Qiu F, 2003, BIOCHEM J, V371, P811, DOI 10.1042/BJ20021814; Ritchie MG, 1998, ENDLESS FORMS, P291; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; Rybak F, 2002, CAN J ZOOL, V80, P987, DOI 10.1139/Z02-082; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; SPIETH HT, 1952, B AM MUS NAT HIST, V99, P401; Swank DM, 2006, P NATL ACAD SCI USA, V103, P17543, DOI 10.1073/pnas.0604972103; SWEENEY HL, 1995, BIOPHYS J, V68, pS112; Talyn BC, 2004, ANIM BEHAV, V68, P1165, DOI 10.1016/j.anbehav.2003.11.023; Tanner BCW, 2007, PLOS COMPUT BIOL, V3, P1195, DOI 10.1371/journal.pcbi.0030115; Tanner BCW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002506; Tauber E, 2001, J COMP PHYSIOL A, V187, P341, DOI 10.1007/s003590100206; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Trott AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046025; Vigoreaux JO, 1998, J EXP BIOL, V201, P2033; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; Wang Q, 2011, BIOPHYS J, V101, P2207, DOI 10.1016/j.bpj.2011.09.034; WARMKE J, 1992, J CELL BIOL, V119, P1523, DOI 10.1083/jcb.119.6.1523; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850; WHEELER DA, 1989, BEHAV GENET, V19, P503, DOI 10.1007/BF01066251	61	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90077	10.1371/journal.pone.0090077	http://dx.doi.org/10.1371/journal.pone.0090077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587213	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000132
J	Takizawa, A; Hyodo, H; Wada, K; Ishii, T; Satoh, S; Iwai, H				Takizawa, Ayami; Hyodo, Hiromi; Wada, Kanako; Ishii, Tadashi; Satoh, Shinobu; Iwai, Hiroaki			Regulatory Specialization of Xyloglucan (XG) and Glucuronoarabinoxylan (GAX) in Pericarp Cell Walls during Fruit Ripening in Tomato (Solanum lycopersicum)	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; ENDOTRANSGLUCOSYLASE/HYDROLASE XTH; D-XYLOSIDASE; GENES; BIOSYNTHESIS; METABOLISM; REVEALS; GLYCOSYLTRANSFERASE; IRREGULAR-XYLEM9; HEMICELLULOSE	Disassembly of cell wall polysaccharides by various cell wall hydrolases during fruit softening causes structural changes in hemicellulose and pectin that affect the physical properties and softening of tomato fruit. In a previous study, we showed that the changes in pectin during tomato fruit ripening were unique in each fruit tissue. In this study, to clarify the changes in hemicellulose in tissues during tomato fruit ripening, we focused on glucuronoarabinoxylan (GAX) and xyloglucan (XG). GAX was detected only in the skin and inner epidermis of the pericarp using LM11 antibodies, whereas a large increase in XG was detected in all fruit tissues using LM15 antibodies. The activity of hemicellulose degradation enzymes, such as beta-xylosidase and alpha-arabinofuranosidase, decreased gradually during fruit ripening, although the tomato fruits continued to soften. In contrast, GAX and XG biosynthesis-related genes were expressed in all tomato fruit tissues even during ripening, indicating that XG was synthesized throughout the fruit and that GAX may be synthesized only in the vascular bundles and the inner epidermis. Our results suggest that changes in the cell wall architecture and tissue-specific distribution of XG and GAX might be required for the regulation of fruit softening and the maintenance of fruit shape.	[Takizawa, Ayami; Hyodo, Hiromi; Wada, Kanako; Ishii, Tadashi; Satoh, Shinobu; Iwai, Hiroaki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Iwai, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	iwai.hiroaki.gb@u.tsukuba.ac.jp	Iwai, Hiroaki/B-3171-2014		MEXT, Japan [21024003, 25440125, 24114006]; Grants-in-Aid for Scientific Research [25440125] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas by MEXT, Japan (21024003 and 25440125 to HI) and a Grant-in-Aid for Scientific Research on Innovative Areas by MEXT, Japan (24114006 to SS and HI). Micro-Tom seeds were obtained from the National BioResource Project Tomato (NBRP Tomato). This research was supported by MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; BAUER WD, 1973, PLANT PHYSIOL, V51, P174, DOI 10.1104/pp.51.1.174; Beldman G, 1996, J CEREAL SCI, V23, P169, DOI 10.1006/jcrs.1996.0017; Brown DM, 2007, PLANT J, V52, P1154, DOI 10.1111/j.1365-313X.2007.03307.x; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cavalier DM, 2006, J BIOL CHEM, V281, P34197, DOI 10.1074/jbc.M606379200; CLEEMPUT G, 1995, J CEREAL SCI, V22, P139, DOI 10.1016/0733-5210(95)90043-8; Cosgrove DJ., 2003, PLANT CELL WALL, P237; Faik A, 2002, P NATL ACAD SCI USA, V99, P7797, DOI 10.1073/pnas.102644799; FINCHER GB, 1989, ANNU REV PLANT PHYS, V40, P305, DOI 10.1146/annurev.pp.40.060189.001513; FISCHER RL, 1991, ANNU REV PLANT PHYS, V42, P675, DOI 10.1146/annurev.pp.42.060191.003331; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Goulao LF, 2008, TRENDS FOOD SCI TECH, V19, P4, DOI 10.1016/j.tifs.2007.07.002; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Huysamer M, 1997, PLANT PHYSIOL, V114, P1523, DOI 10.1104/pp.114.4.1523; Hyodo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078949; Itai A, 2003, J EXP BOT, V54, P2615, DOI 10.1093/jxb/erg291; Itai A, 1999, MOL GEN GENET, V261, P42, DOI 10.1007/s004380050939; Keppler BD, 2010, MOL PLANT, V3, P834, DOI 10.1093/mp/ssq028; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Kotake T, 2006, J EXP BOT, V57, P2353, DOI 10.1093/jxb/erj206; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1624, DOI 10.1093/pcp/pcm135; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; Li X, 2010, CRIT REV PLANT SCI, V29, P222, DOI 10.1080/07352689.2010.487776; MACLACHLAN G, 1994, PLANT PHYSIOL, V105, P965, DOI 10.1104/pp.105.3.965; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; MCCANN MC, 1990, J CELL SCI, V96, P323; Miedes E, 2010, J AGR FOOD CHEM, V58, P5708, DOI 10.1021/jf100242z; Munoz-Bertomeu J, 2013, J PLANT PHYSIOL, V170, P1194, DOI 10.1016/j.jplph.2013.03.015; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Powell ALT, 2003, J AGR FOOD CHEM, V51, P7450, DOI 10.1021/jf034165d; Rose JK, 2003, PLANT CELL WALL, V8, P264, DOI DOI 10.1002/9781119312994.APR0075; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Rose JKC, 1999, TRENDS PLANT SCI, V4, P176, DOI 10.1016/S1360-1385(99)01405-3; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; Saladie M, 2006, PLANT J, V47, P282, DOI 10.1111/j.1365-313X.2006.02784.x; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schroder R, 2009, ANN BOT-LONDON, V104, P197, DOI 10.1093/aob/mcp120; Schultink A, 2013, PLANT PHYSIOL, V163, P86, DOI 10.1104/pp.113.221788; Sozzi GO, 2002, HORTSCIENCE, V37, P564, DOI 10.21273/HORTSCI.37.3.564; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; Tateishi A, 1996, PHYTOCHEMISTRY, V42, P295, DOI 10.1016/0031-9422(95)00931-0; Vicente AR, 2007, J SCI FOOD AGR, V87, P1435, DOI 10.1002/jsfa.2837; Wakabayashi K, 2000, J PLANT RES, V113, P231, DOI 10.1007/PL00013932; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; York WS, 2008, CURR OPIN PLANT BIOL, V11, P258, DOI 10.1016/j.pbi.2008.02.007; Zabotina OA, 2012, PLANT PHYSIOL, V159, P1367, DOI 10.1104/pp.112.198119	51	24	26	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89871	10.1371/journal.pone.0089871	http://dx.doi.org/10.1371/journal.pone.0089871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587088	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000103
J	Checa, AG; Salas, C; Harper, EM; Bueno-Perez, JD				Checa, Antonio G.; Salas, Carmen; Harper, Elizabeth M.; de Dios Bueno-Perez, Juan			Early Stage Biomineralization in the Periostracum of the 'Living Fossil' Bivalve Neotrigonia	PLOS ONE			English	Article							PHYLOGENETIC SIGNIFICANCE; ELECTRON-MICROSCOPE; UNIONIDAE BIVALVIA; MARINE BIVALVES; MOLLUSCA; NACRE; CELLS; MICROSTRUCTURE; CALCIFICATION; ORGANIZATION	A detailed investigation of the shell formation of the palaeoheterodont 'living fossil' Neotrigonia concentrated on the timing and manufacture of the calcified 'bosses' which stud the outside of all trigonioid bivalves (extant and fossil) has been conducted. Electron microscopy and optical microscopy revealed that Neotrigonia spp. have a spiral-shaped periostracal groove. The periostracum itself is secreted by the basal cell, as a thin dark pellicle, becoming progressively transformed into a thin dark layer by additions of secretions from the internal outer mantle fold. Later, intense secretion of the internal surface of the outer mantle fold forms a translucent layer, which becomes transformed by tanning into a dark layer. The initiation of calcified bosses occurred at a very early stage of periostracum formation, deep within the periostracal groove immediately below the initialmost dark layer. At this stage, they consist of a series of polycyclically twinned crystals. The bosses grow as the periostracum traverse through the periostracal groove, in coordination with the thickening of the dark periostracal layer and until, upon reaching the mantle edge, they impinge upon each other and become transformed into large prisms separated by dark periostracal walls. In conclusion, the initial bosses and the external part of the prismatic layer are fully intraperiostracal. With later growth, the prisms transform into fibrous aggregates, although the details of the process are unknown. This reinforces the relationships with other groups that have the ability to form intraperiostracal calcifications, for example the unionoids with which the trigonioids form the clade Paleoheterodonta. The presence of similar structures in anomalodesmatans and other euheterodonts raises the question of whether this indicates a relationship or represents a convergence. The identification of very early calcification within an organic sheet has interesting implications for our understanding of how shells may have evolved.	[Checa, Antonio G.] Univ Granada, Fac Ciencias, Dept Estratig & Paleontol, Granada, Spain; [Salas, Carmen] Univ Granada, Fac Ciencias, Dept Biol Anim, Granada, Spain; [Harper, Elizabeth M.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [de Dios Bueno-Perez, Juan] Univ Granada, Ctr Instrumentac Cient, Granada, Spain	University of Granada; University of Granada; University of Cambridge; University of Granada	Checa, AG (corresponding author), Univ Granada, Fac Ciencias, Dept Estratig & Paleontol, Granada, Spain.	acheca@ugr.es	Checa, Antonio/A-6157-2008; Harper, Elizabeth M/B-3890-2008; Salas, Carmen/ABI-1202-2020	Checa, Antonio/0000-0001-7873-7545; Harper, Elizabeth M/0000-0002-1092-3867; 	DGI, Spanish MICINN [CGL2010-20748-C02-01, CGL2010-20748-C02-02]; Consejeria de Economia, Investigacion, Ciencia y Empleo, Junta de Andalucia [RNM363]; European Community [TD0903]	DGI, Spanish MICINN; Consejeria de Economia, Investigacion, Ciencia y Empleo, Junta de Andalucia(Junta de Andalucia); European Community(European Commission)	Coordinated Research Projects CGL2010-20748-C02-01 (AGC, EMH) and 02 (CS) (DGI, Spanish MICINN; https://sede.micinn.gob.es/), the Research Group RNM363 (Consejeria de Economia, Investigacion, Ciencia y Empleo, Junta de Andalucia; http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html) and the FP7 COST Action TD0903 of the European Community (http://www.biomineralix.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; [Anonymous], 1983, SHELL FORMATION MO 1; BEEDHAM GE, 1968, J ZOOL, V154, P443; Ben Mlih A., 1983, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V296, P313; BENGTSON S., 1994, EARLY LIFE EARTH, V84, P412; Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019; BEVELANDER GERRIT, 1967, CALCIFIED TISSUE RES, V1, P55, DOI 10.1007/BF02008075; BOTTJER DJ, 1981, B MAR SCI, V31, P916; BOTTJER DJ, 1980, J PALEONTOL, V54, P200; BUBEL A, 1973, MAR BIOL, V20, P213; BUBEL A, 1973, MAR BIOL, V20, P222; Carter J.G., 1990, P135; Carter J.G., 1978, B PEABODY MUS NAT HI, V41, P1; CARTER JG, 1975, LETHAIA, V8, P315, DOI 10.1111/j.1502-3931.1975.tb00936.x; CARTWRIGHT JHE, 2012, ANGEW CHEM INT EDIT, V2012, P2; Checa A, 2000, TISSUE CELL, V32, P405, DOI 10.1054/tice.2000.0129; Checa AG, 2001, P ROY SOC B-BIOL SCI, V268, P771, DOI 10.1098/rspb.2000.1415; Checa AG, 2012, ACTA ZOOL; Checa AG, 2013, J STRUCT BIOL, V183, P368, DOI 10.1016/j.jsb.2013.07.014; Checa AG, 2010, BIOL BULL-US, V219, P231, DOI 10.1086/BBLv219n3p231; Checa AG, 2009, CRYST GROWTH DES, V9, P4574, DOI 10.1021/cg9005949; CLARK GR, 1976, AM ZOOL, V16, P617; DARRAGH TA, 1986, ALCHERINGA, V10, P1, DOI 10.1080/03115518608619039; dePaula SM, 2010, MICRON, V41, P983, DOI 10.1016/j.micron.2010.06.014; Esteban-Delgado FJ, 2008, BIOL BULL-US, V214, P153, DOI 10.2307/25066672; FLEMING C. A., 1964, AUSTRALIAN J SCI, V26, P196; Fortey R., 2011, SURVIVORS ANIMALS PL; Giribet G, 2003, SM S COMP E, P45; Glavinic A, 2006, ORG DIVER EVOL S, V6, P37; Glavinic A, 2010, THESIS FLINDERS U AD; Glover EA, 2010, J MOLLUS STUD, V76, P157, DOI 10.1093/mollus/eyp054; Gregoire C., 1972, P45; Harper EM, 2009, ACTA ZOOL-STOCKHOLM, V90, P132, DOI 10.1111/j.1463-6395.2008.00338.x; Harper EM, 1997, PALAEONTOLOGY, V40, P71; Harper EM, 1997, GEOL MAG, V134, P403, DOI 10.1017/S0016756897007061; Harper EM, 1993, SCRIPTA GEOLOGICA, V2, P128; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Kaplan DL, 1998, CURR OPIN SOLID ST M, V3, P232, DOI 10.1016/S1359-0286(98)80096-X; Kawaguti S., 1962, Biological Journal of Okayama University, V8, P1; Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6; Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2; LILJEDAHL L, 1992, Palaeontologische Zeitschrift, V66, P51; Lowenstam HA, 1989, BIOMINERALIZATION; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; MORTON B, 1987, Records of the Australian Museum, V39, P339; MUTVEI H, 1977, CALC TISS RES, V24, P11, DOI 10.1007/BF02223291; MUTVEI H, 1978, ZOOL SCR, V7, P287, DOI 10.1111/j.1463-6409.1978.tb00612.x; NEFF JM, 1972, TISSUE CELL, V4, P311, DOI 10.1016/S0040-8166(72)80050-8; Neumann M, 2002, J HISTOCHEM CYTOCHEM, V50, P437, DOI 10.1177/002215540205000315; Newell N.D., 1975, Bulletin Am Mus nat Hist, V154, P55; PREZANT RS, 1979, NAUTILUS, V93, P93; RAMALINGAM K, 1970, HISTOCHEMISTRY, V24, P322; RICHARDSON CA, 1981, TISSUE CELL, V13, P715, DOI 10.1016/S0040-8166(81)80008-0; Salas C, 2012, J MOLLUS STUD, V78, P34, DOI 10.1093/mollus/eyr040; Saleuddin A.S.M., 1983, P199; SALEUDDIN ASM, 1974, CAN J ZOOL, V52, P1463, DOI 10.1139/z74-188; Sharma PP, 2012, MOL PHYLOGENET EVOL, V65, P64, DOI 10.1016/j.ympev.2012.05.025; Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081; STANLEY S M, 1977, Palaeontology (Oxford), V20, P869; Stanley S.M., 1984, LIVING FOSSILS, P243, DOI DOI 10.1007/978-1-4613-8271-3_30; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; TAYLOR J D, 1972, Palaeontology (Oxford), V15, P73; TAYLOR JD, 1969, CALC TISS RES, V3, P274, DOI 10.1007/BF02058669; Taylor JD, 2004, MALACOLOGIA, V46, P277; Taylor JD, 1973, B BRIT MUS NAT HIST, V22, P225; TAYLOR JD, 1969, B BRIT MUSEUM NATU S, V3, P1; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Tevesz M.J.S., 1980, Topics in Geobiology, V1, P295; TEVESZ MJS, 1975, LETHAIA, V8, P321, DOI 10.1111/j.1502-3931.1975.tb00937.x; UBUKATA T, 1994, PALAEONTOLOGY, V37, P241; Vinther J, 2009, PALAEONTOLOGY, V52, P689, DOI 10.1111/j.1475-4983.2009.00881.x; Wang SN, 2013, J STRUCT BIOL, V183, P404, DOI 10.1016/j.jsb.2013.07.013; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; Wilbur K.M., 1972, P103; Wilson NG, 2010, MOL PHYLOGENET EVOL, V54, P187, DOI 10.1016/j.ympev.2009.07.028; Wood R, 2012, EARTH-SCI REV, V115, P249, DOI 10.1016/j.earscirev.2012.10.002; YONGE C. M., 1957, PUBBL STAZ ZOOL NAPOLI, V29, P151; YONGE CM, 1982, J MOLLUS STUD, V48, P102; Zieritz A, 2011, J ZOOL SYST EVOL RES, V49, P6, DOI 10.1111/j.1439-0469.2010.00583.x	81	29	30	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90033	10.1371/journal.pone.0090033	http://dx.doi.org/10.1371/journal.pone.0090033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587202	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900112
J	Axelsson, M; Gentili, F				Axelsson, Martin; Gentili, Francesco			A Single-Step Method for Rapid Extraction of Total Lipids from Green Microalgae	PLOS ONE			English	Article							BLIGH; DYER	Microalgae produce a wide range of lipid compounds of potential commercial interest. Total lipid extraction performed by conventional extraction methods, relying on the chloroform-methanol solvent system are too laborious and time consuming for screening large numbers of samples. In this study, three previous extraction methods devised by Folch et al. (1957), Bligh and Dyer (1959) and Selstam and Oquist (1985) were compared and a faster single-step procedure was developed for extraction of total lipids from green microalgae. In the single-step procedure, 8 ml of a 2:1 chloroform-methanol (v/v) mixture was added to fresh or frozen microalgal paste or pulverized dry algal biomass contained in a glass centrifuge tube. The biomass was manually suspended by vigorously shaking the tube for a few seconds and 2 ml of a 0.73% NaCl water solution was added. Phase separation was facilitated by 2 min of centrifugation at 350 g and the lower phase was recovered for analysis. An uncharacterized microalgal polyculture and the green microalgae Scenedesmus dimorphus, Selenastrum minutum, and Chlorella protothecoides were subjected to the different extraction methods and various techniques of biomass homogenization. The less labour intensive single-step procedure presented here allowed simultaneous recovery of total lipid extracts from multiple samples of green microalgae with quantitative yields and fatty acid profiles comparable to those of the previous methods. While the single-step procedure is highly correlated in lipid extractability (r(2) = 0.985) to the previous method of Folch et al. (1957), it allowed at least five times higher sample throughput.	[Axelsson, Martin; Gentili, Francesco] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences	Gentili, F (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	francesco.gentili@slu.se			Swedish Energy Agency; Processum Biorefinery Initiative AB	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Processum Biorefinery Initiative AB	The financial support from the Swedish Energy Agency (http://www.energimyndigheten.se/en/) and Processum Biorefinery Initiative AB (http://www.processum.se/sv/processum) was greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELQVIST LA, 1968, ARK KEMI, V28, P551; BENEMANN JR, 1992, J APPL PHYCOL, V4, P233, DOI 10.1007/BF02161209; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; Cardozo KHM, 2007, COMP BIOCHEM PHYS C, V146, P60, DOI 10.1016/j.cbpc.2006.05.007; Carrapiso AI, 2000, LIPIDS, V35, P1167, DOI 10.1007/s11745-000-0633-8; Chen W, 2011, BIORESOURCE TECHNOL, V102, P135, DOI 10.1016/j.biortech.2010.06.076; Cheng KC, 2013, BIORESOURCE TECHNOL, V128, P44, DOI 10.1016/j.biortech.2012.09.085; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Christie W. W., 1993, ADV LIPID METHODOLOG, VII, P195, DOI [10.1192/bjp.112.483.211-a, DOI 10.1192/BJP.112.483.211-A]; Eriksson SF, 2007, MEAT SCI, V76, P746, DOI 10.1016/j.meatsci.2007.02.021; FISHWICK MJ, 1977, PHYTOCHEMISTRY, V16, P1507, DOI 10.1016/0031-9422(77)84011-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; GUCKERT JB, 1988, J MICROBIOL METH, V8, P139, DOI 10.1016/0167-7012(88)90015-2; Halim R, 2011, BIORESOURCE TECHNOL, V102, P178, DOI 10.1016/j.biortech.2010.06.136; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Khozin-Goldberg I, 2011, APPL MICROBIOL BIOT, V91, P905, DOI 10.1007/s00253-011-3441-x; Lee JY, 2010, BIORESOURCE TECHNOL, V101, pS75, DOI 10.1016/j.biortech.2009.03.058; Meijer EA, 1998, BIOTECHNOL TECH, V12, P353, DOI 10.1023/A:1008814128995; Milledge JJ, 2011, REV ENVIRON SCI BIO, V10, P31, DOI 10.1007/s11157-010-9214-7; Phillips KM, 2008, J FOOD LIPIDS, V15, P309, DOI 10.1111/j.1745-4522.2008.00121.x; Ranjan A, 2010, IND ENG CHEM RES, V49, P2979, DOI 10.1021/ie9016557; Ryckebosch E, 2012, J AM OIL CHEM SOC, V89, P189, DOI 10.1007/s11746-011-1903-z; SELSTAM E, 1985, PLANT SCI, V42, P41, DOI 10.1016/0168-9452(85)90026-3; Sheng J, 2011, BIORESOURCE TECHNOL, V102, P1697, DOI 10.1016/j.biortech.2010.08.007; SIMON RD, 1974, ANAL BIOCHEM, V60, P51, DOI 10.1016/0003-2697(74)90130-4; Singh J, 2010, RENEW SUST ENERG REV, V14, P2596, DOI 10.1016/j.rser.2010.06.014; Smedes F, 1999, MAR POLLUT BULL, V38, P193, DOI 10.1016/S0025-326X(98)00170-2; Smedes F, 1996, MAR POLLUT BULL, V32, P681, DOI 10.1016/0025-326X(96)00079-3; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Vilchez C, 2011, MAR DRUGS, V9, P319, DOI 10.3390/md9030319	33	141	147	3	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89643	10.1371/journal.pone.0089643	http://dx.doi.org/10.1371/journal.pone.0089643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586930	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700067
J	Clark, SA; Lucidarme, J; Newbold, LS; Borrow, R				Clark, Stephen A.; Lucidarme, Jay; Newbold, Lynne S.; Borrow, Ray			Genotypic Analysis of Meningococcal Factor H-Binding Protein from Non-Culture Clinical Specimens	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; NEISSERIA-MENINGITIDIS; VACCINE; DISEASE; PCR; LIPOPROTEIN; LACTAMICA; PROGRAMS; ANTIGENS; BACTERIA	Factor H-Binding Protein (fHbp) is an outer membrane protein antigen included in two novel meningococcal group B vaccines and, as such, is an important typing target. Approximately 50% of meningococcal disease cases in England and Wales are confirmed using real-time PCR on non-culture clinical specimens only. Protocols for typing fHbp from this subset of cases have not yet been established. Here we present a nested PCR-based assay designed to amplify and sequence fHbp from non-culture clinical specimens. From analytical sensitivity experiments carried out using diluted DNA extracts, an estimated analytical sensitivity limit of 6 fg/mu L of DNA (<3 genome copies/mu L) was calculated. The sensitivity of the assay was shown to be comparable to the ctrA-directed real-time PCR assay currently used to confirm invasive disease diagnoses from submitted clinical specimens. A panel of 96 diverse, patient-matched clinical specimen/isolate pairs from invasive disease cases was used to illustrate the breadth of strain coverage for the assay. All fHbp alleles sequenced from the isolates matched those derived from previous whole genome analyses. The first-round PCR primer binding sites are highly conserved, however an exceptional second-round PCR primer site mismatch in one validation isolate prevented amplification. In this case, amplification from the corresponding clinical specimen was achieved, suggesting that the use of a nested PCR procedure may compensate for any minor mismatches in round-two primer sites. The assay was successful at typing 91/96 (94.8%) of the non-culture clinical specimens in this study and exhibits sufficient sensitivity to type fHbp from the vast majority of non-culture clinical specimens received by the Meningococcal Reference Unit, Public Health England.	[Clark, Stephen A.; Lucidarme, Jay; Newbold, Lynne S.; Borrow, Ray] Manchester Royal Infirm, Manchester Med Microbiol Partnership, Publ Hlth England, Manchester, Lancs, England	Public Health England; University of Manchester	Clark, SA (corresponding author), Manchester Royal Infirm, Manchester Med Microbiol Partnership, Publ Hlth England, Clin Sci Bldg, Manchester, Lancs, England.	stephen.clark@phe.gov.uk			Pfizer Vaccine Research	Pfizer Vaccine Research	This work was funded by Pfizer Vaccine Research, 401 N.Middletown Rd., Pearl River, New York, United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XL, 2011, EXPERT OPIN BIOL TH, V11, P969, DOI 10.1517/14712598.2011.585965; Bennett JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-652; Birtles A, 2005, J CLIN MICROBIOL, V43, P6007, DOI 10.1128/JCM.43.12.6007-6014.2005; Borrow R, 2013, VACCINE, V31, P4477, DOI 10.1016/j.vaccine.2013.07.083; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Cantini F, 2009, J BIOL CHEM, V284, P9022, DOI 10.1074/jbc.C800214200; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Daugla D, 2013, LANCET IN PRESS; Diggle MA, 2003, J MED MICROBIOL, V52, P51, DOI 10.1099/jmm.0.05032-0; European Medicines Agency, 2012, BEXS ASS REP; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; FINNE J, 1983, LANCET, V2, P355; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Heinsbroek E, 2013, J INFECTION, V67, P385, DOI 10.1016/j.jinf.2013.06.007; Holst J, 2013, HUM VACC IMMUNOTHER, V9, P1241, DOI 10.4161/hv.24129; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Lucidarme J, 2013, CLIN VACCINE IMMUNOL, V20, P1360, DOI 10.1128/CVI.00090-13; Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P1002, DOI 10.1128/CVI.00055-11; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Marshall HS, 2013, VACCINE, V31, P1569, DOI 10.1016/j.vaccine.2013.01.021; Mascioni A, 2009, J BIOL CHEM, V284, P8729, DOI 10.1074/jbc.M808831200; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Panatto D, 2011, EXPERT REV VACCINES, V10, P1337, DOI [10.1586/ERV.11.103, 10.1586/erv.11.103]; Richmond PC, 2012, VACCINE, V30, P6163, DOI 10.1016/j.vaccine.2012.07.065	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89921	10.1371/journal.pone.0089921	http://dx.doi.org/10.1371/journal.pone.0089921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587125	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700115
J	Ma, FQ; Xie, Y; Huang, C; Feng, Y; Yang, GY				Ma, Fuqiang; Xie, Yuan; Huang, Chen; Feng, Yan; Yang, Guangyu			An Improved Single Cell Ultrahigh Throughput Screening Method Based on In Vitro Compartmentalization	PLOS ONE			English	Article							DIRECTED EVOLUTION; ENZYME LIBRARIES; EMULSIONS	High-throughput screening is a key technique in discovery and engineering of enzymes. In vitro compartmentalization based fluorescence-activated cell sorting (IVC-FACS) has recently emerged as a powerful tool for ultrahigh-throughput screening of biocatalysts. However, the accuracy of current IVC-FACS assays is severely limited by the wide polydispersity of micro-reactors generated by homogenizing. Here, an improved protocol based on membrane-extrusion technique was reported to generate the micro-reactors in a more uniform manner. This crucial improvement enables ultrahigh-throughput screening of enzymatic activity at a speed of > 10(8) clones/day with an accuracy that could discriminate as low as two-fold differences in enzymatic activity inside the micro-reactors, which is higher than similar IVC-FACS systems ever have reported. The enzymatic reaction in the micro-reactors has very similar kinetic behavior compared to the bulk reaction system and shows wide dynamic range. By using the modified IVC-FACS, E. coli cells with esterase activity could be enriched 330-fold from large excesses of background cells through a single round of sorting. The utility of this new IVC-FACS system was further illustrated by the directed evolution of thermophilic esterase AFEST. The catalytic activity of the very efficient esterase was further improved by similar to 2-fold, resulting in several improved mutants with k(cat)/K-M values approaching the diffusion-limited efficiency of similar to 10(8) M(-1)s(-1).	[Ma, Fuqiang; Xie, Yuan; Huang, Chen; Feng, Yan; Yang, Guangyu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xie, Yuan; Feng, Yan] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China	Shanghai Jiao Tong University; Jilin University	Feng, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	yfeng2009@sjtu.edu.cn; yanggy@sjtu.edu.cn			National Basic Research Program of China (973 program) [2011CBA00800, 2012CB721000]; National Natural Science Foundation of China [31100611]; Research Fund for the Doctoral Program of Higher Education of China [20110073120062]; Genencor Innovation Grant	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Genencor Innovation Grant	This work was supported by National Basic Research Program of China (973 program, 2011CBA00800 and 2012CB721000), National Natural Science Foundation of China (No. 31100611), Research Fund for the Doctoral Program of Higher Education of China (No. 20110073120062), and Genencor Innovation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2011, LAB CHIP, V11, P253, DOI 10.1039/c01c00236d; Aharoni A, 2005, CHEM BIOL, V12, P1281, DOI 10.1016/j.chembiol.2005.09.012; Gupta RD, 2011, NAT CHEM BIOL, V7, P120, DOI [10.1038/nchembio.510, 10.1038/NCHEMBIO.510]; Hardiman E, 2010, APPL BIOCHEM BIOTECH, V161, P301, DOI 10.1007/s12010-009-8794-6; Hwang BY, 2012, BIOTECHNOL BIOPROC E, V17, P500, DOI 10.1007/s12257-012-0026-1; Jeong HS, 2001, ENZYME MICROB TECH, V28, P155, DOI 10.1016/S0141-0229(00)00315-X; Manco G, 2000, ARCH BIOCHEM BIOPHYS, V373, P182, DOI 10.1006/abbi.1999.1497; Mastrobattista E, 2005, CHEM BIOL, V12, P1291, DOI 10.1016/j.chembiol.2005.09.016; Ostafe R, 2013, ANAL BIOCHEM, V435, P93, DOI 10.1016/j.ab.2012.10.043; Prodanovic R, 2012, ANAL BIOANAL CHEM, V404, P1439, DOI 10.1007/s00216-012-6234-x; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Tu R, 2011, J BIOMOL SCREEN, V16, P285, DOI 10.1177/1087057110396361; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164; Xu WJ, 2012, MATER LETT, V77, P96, DOI 10.1016/j.matlet.2012.03.004; Yang GY, 2009, CHEMBIOCHEM, V10, P2704, DOI 10.1002/cbic.200900384	15	23	24	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89785	10.1371/journal.pone.0089785	http://dx.doi.org/10.1371/journal.pone.0089785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587033	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700090
J	Grodecka, L; Lockerova, P; Ravcukova, B; Buratti, E; Baralle, FE; Dusek, L; Freiberger, T				Grodecka, Lucie; Lockerova, Pavla; Ravcukova, Barbora; Buratti, Emanuele; Baralle, Francisco E.; Dusek, Ladislav; Freiberger, Tomas			Exon First Nucleotide Mutations in Splicing: Evaluation of In Silico Prediction Tools	PLOS ONE			English	Article							POLYPYRIMIDINE TRACT RECOGNITION; HUMAN-DISEASE GENES; CONFORMATIONAL SELECTION; COMPUTATIONAL TOOLS; SEQUENCE MOTIFS; FACTOR U2AF(35); MSH2 MISSENSE; SITE; ENHANCERS; U2AF(65)	Mutations in the first nucleotide of exons (E+1) mostly affect pre-mRNA splicing when found in AG-dependent 3' splice sites, whereas AG-independent splice sites are more resistant. The AG-dependency, however, may be difficult to assess just from primary sequence data as it depends on the quality of the polypyrimidine tract. For this reason, in silico prediction tools are commonly used to score 3' splice sites. In this study, we have assessed the ability of sequence features and in silico prediction tools to discriminate between the splicing-affecting and non-affecting E+1 variants. For this purpose, we newly tested 16 substitutions in vitro and derived other variants from literature. Surprisingly, we found that in the presence of the substituting nucleotide, the quality of the polypyrimidine tract alone was not conclusive about its splicing fate. Rather, it was the identity of the substituting nucleotide that markedly influenced it. Among the computational tools tested, the best performance was achieved using the Maximum Entropy Model and Position-Specific Scoring Matrix. As a result of this study, we have now established preliminary discriminative cut-off values showing sensitivity up to 95% and specificity up to 90%. This is expected to improve our ability to detect splicing-affecting variants in a clinical genetic setting.	[Grodecka, Lucie; Lockerova, Pavla; Ravcukova, Barbora; Freiberger, Tomas] Ctr Cardiovasc Surg & Transplantat, Mol Genet Lab, Brno, Czech Republic; [Grodecka, Lucie; Freiberger, Tomas] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Buratti, Emanuele; Baralle, Francisco E.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Dusek, Ladislav] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic; [Freiberger, Tomas] St Annes Univ Hosp, Inst Clin Immunol & Allergol, Brno, Czech Republic; [Freiberger, Tomas] Masaryk Univ, Brno, Czech Republic	Masaryk University Brno; International Center for Genetic Engineering & Biotechnology (ICGEB); Institute of Biostatistics & Analyses; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno	Freiberger, T (corresponding author), Ctr Cardiovasc Surg & Transplantat, Mol Genet Lab, Brno, Czech Republic.	tomas.freiberger@cktch.cz	Freiberger, Tomas/D-8421-2011; Buratti, Emanuele/K-4691-2016; Dušek, Ladislav/G-8794-2013; Grodecká, Lucie/L-6953-2019	Freiberger, Tomas/0000-0001-6532-7053; Buratti, Emanuele/0000-0002-1356-9074; Dusek, Ladislav/0000-0002-8589-4378; Grodecka, Lucie/0000-0002-4979-0352	Centre for Cardiovascular Surgery and Transplantation [201209]; project "CEITEC - Central European Institute of Technology'' [CZ.1.05/1.1.00/02.0068]; SuPReMMe [CZ.1.07/2.3.00/20.0045]	Centre for Cardiovascular Surgery and Transplantation; project "CEITEC - Central European Institute of Technology''; SuPReMMe	This work was supported by an internal grant of Centre for Cardiovascular Surgery and Transplantation, number 201209; and further by the project "CEITEC - Central European Institute of Technology'' (CZ.1.05/1.1.00/02.0068) and SuPReMMe (CZ.1.07/2.3.00/20.0045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Auclair J, 2006, HUM MUTAT, V27, P145, DOI 10.1002/humu.20280; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4250, DOI 10.1093/nar/gkm402; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; Doktor TK, 2011, HUM MUTAT, V32, P220, DOI 10.1002/humu.21419; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fu Y, 2011, NUCLEIC ACIDS RES, V39, P4396, DOI 10.1093/nar/gkr026; Gaildrat P, 2012, J MED GENET, V49, P609, DOI 10.1136/jmedgenet-2012-100965; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Guth S, 1999, MOL CELL BIOL, V19, P8263; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Houdayer C, 2008, HUM MUTAT, V29, P975, DOI 10.1002/humu.20765; Jenkins JL, 2013, NUCLEIC ACIDS RES, V41, P3859, DOI 10.1093/nar/gkt046; Kol G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/hmg/ddi164; Lastella P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-243; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Schwartz S, 2009, NUCLEIC ACIDS RES, V37, pW189, DOI 10.1093/nar/gkp320; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shariat N, 2008, CLIN GENET, V74, P539, DOI 10.1111/j.1399-0004.2008.01042.x; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Shen HH, 2004, MOL CELL, V16, P363, DOI 10.1016/j.molcel.2004.10.021; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zampieri S, 2011, EUR J HUM GENET, V19, P422, DOI 10.1038/ejhg.2010.188; Zhang WJ, 1996, MOL CELL BIOL, V16, P5400; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	42	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89570	10.1371/journal.pone.0089570	http://dx.doi.org/10.1371/journal.pone.0089570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586880	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900122
J	Choudhary, E; Bishai, W; Agarwal, N				Choudhary, Eira; Bishai, William; Agarwal, Nisheeth			Expression of a Subset of Heat Stress Induced Genes of Mycobacterium tuberculosis Is Regulated by 3 ',5 '-Cyclic AMP	PLOS ONE			English	Article							CAMP RECEPTOR PROTEIN; CYCLIC-AMP; ADENYLYL CYCLASES; ESCHERICHIA-COLI; NUCLEOTIDE CYCLASES; FATTY-ACID; VIRULENCE; FAMILY; IDENTIFICATION; TRANSCRIPTION	Mycobacterium tuberculosis (Mtb) secretes excess of a second messenger molecule, 3',5'-cyclic AMP (cAMP), which plays a critical role in the survival of Mtb in host macrophages. Although Mtb produces cAMP in abundance, its exact role in the physiology of mycobacteria is elusive. In this study we have analyzed the expression of 16 adenylate cyclases (ACs) and kinetics of intracellular cAMP levels in Mtb during in vitro growth under the regular culture conditions, and after exposure to different stress agents. We observed a distinct expression pattern of these ACs which is correlated with intracellular cAMP levels. Interestingly cAMP levels are significantly elevated in Mtb following heat stress, whereas other stress conditions such as oxidative, nitrosative or low pH do not affect intracellular cAMP pool in vitro. A significant increase in expression by >2-fold of five ACs namely Rv1647, Rv2212, Rv1625c, Rv2488c and Rv0386 after heat stress further suggested that cAMP plays an important role in controlling Mtb response to heat stress. In the light of these observations, effect of exogenous cAMP on global gene expression profile was examined by using microarrays. The microarray gene expression analysis demonstrated that cAMP regulates expression of a subset of heat stress-induced genes comprising of dnaK, grpE, dnaJ, and Rv2025c. Further we performed electrophoretic mobility shift assay by using cAMP-receptor protein of Mtb (CRPM), which demonstrated that CRPM specifically recognizes a sequence (-301)AGCGACCGTCAGCACG(-286) in 5'-untranslated region of dnaK.	[Choudhary, Eira; Agarwal, Nisheeth] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, Haryana, India; [Bishai, William] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Johns Hopkins University	Agarwal, N (corresponding author), Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, Haryana, India.	nisheeth@thsti.res.in			Department of Biotechnology, Government of India [BT/PR15063/GBD/27/296/2011]; NIH [AI36973, AI 37856]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI036973, R01AI037856, R01AI036973] Funding Source: NIH RePORTER	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support by Department of Biotechnology, Government of India (grant no. BT/PR15063/GBD/27/296/2011) to NA is highly acknowledged. The support of NIH grants AI36973 and AI 37856, and HHMI to WB is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, INFECT IMMUN, V75, P452, DOI 10.1128/IAI.01395-06; Agarwal N, 2006, MICROBIOL-SGM, V152, P2749, DOI 10.1099/mic.0.28924-0; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Agarwal N, 2009, INDIAN J EXP BIOL, V47, P393; Akhter Y, 2007, INT J MED MICROBIOL, V297, P451, DOI 10.1016/j.ijmm.2007.04.009; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai G, 2011, MOL MICROBIOL, V82, P180, DOI 10.1111/j.1365-2958.2011.07806.x; Bai G, 2011, CELL MICROBIOL, V13, P349, DOI 10.1111/j.1462-5822.2010.01562.x; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Castro LI, 2005, FEBS J, V272, P3085, DOI 10.1111/j.1742-4658.2005.04722.x; Cheng YY, 2009, J MICROBIOL BIOTECHN, V19, P1527, DOI 10.4014/jmb.0903.03030; Donovan GT, 2013, INFECT IMMUN, V81, P249, DOI 10.1128/IAI.00796-12; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Gazdik MA, 2005, J BACTERIOL, V187, P2681, DOI 10.1128/JB.187.8.2681-2692.2005; Gazdik MA, 2009, MOL MICROBIOL, V71, P434, DOI 10.1111/j.1365-2958.2008.06541.x; Guo YL, 2009, FEBS J, V276, P1094, DOI 10.1111/j.1742-4658.2008.06852.x; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Jeong KC, 2006, BBA-GENE STRUCT EXPR, V1759, P51, DOI 10.1016/j.bbaexp.2006.02.001; Ketkar AD, 2006, J MOL BIOL, V356, P904, DOI 10.1016/j.jmb.2005.12.017; LEE CH, 1977, J BACTERIOL, V132, P1031, DOI 10.1128/JB.132.3.1031-1033.1977; LEE CH, 1979, ARCH MICROBIOL, V120, P35, DOI 10.1007/BF00413269; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; MAKMAN RS, 1965, J BIOL CHEM, V240, P1309; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; Motaal AA, 2006, FEBS J, V273, P4219, DOI 10.1111/j.1742-4658.2006.05420.x; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Ohsaka Y, 2001, DNA CELL BIOL, V20, P667, DOI 10.1089/104454901753340659; OKABAYASHI T, 1963, ARCH BIOCHEM BIOPHYS, V100, P158, DOI 10.1016/0003-9861(63)90046-8; PADH H, 1977, LIFE SCI, V20, P1273, DOI 10.1016/0024-3205(77)90502-1; PERLMAN R, 1968, BIOCHEM BIOPH RES CO, V30, P656, DOI 10.1016/0006-291X(68)90563-9; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Raychaudhuri S, 1998, MICROBIOL-UK, V144, P2131, DOI 10.1099/00221287-144-8-2131; Reddy SK, 2001, J BIOL CHEM, V276, P35141, DOI 10.1074/jbc.M104108200; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rowland B, 1999, FEMS MICROBIOL LETT, V179, P317, DOI 10.1111/j.1574-6968.1999.tb08744.x; Shenoy AR, 2004, COMP FUNCT GENOM, V5, P17, DOI 10.1002/cfg.349; Shenoy AR, 2005, BIOCHEM J, V387, P541, DOI 10.1042/BJ20041040; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Singh R, 2013, J BACTERIOL, V195, P2839, DOI 10.1128/JB.00038-13; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Stewart GR, 2001, NAT MED, V7, P732, DOI 10.1038/89113; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; ULLMANN A, 1968, Febs Letters, V2, P57, DOI 10.1016/0014-5793(68)80100-0; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t	51	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89759	10.1371/journal.pone.0089759	http://dx.doi.org/10.1371/journal.pone.0089759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587015	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200077
J	Baran, NM; Adkins-Regan, E				Baran, Nicole M.; Adkins-Regan, Elizabeth			Breeding Experience, Alternative Reproductive Strategies and Reproductive Success in a Captive Colony of Zebra Finches (Taeniopygia guttata)	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; SEXUAL SELECTION; LIFE-HISTORY; MATE CHOICE; PARENTAL CARE; BIRDS; HETEROZYGOSITY; AGE; FERTILIZATIONS; AVAILABILITY	Birds exhibit a remarkable diversity of different reproductive strategies both between and within species. Species such as the zebra finch (Taeniopygia guttata) may evolve the flexible use of alternative reproductive strategies, as well as benefit from prior breeding experience, which allows them to adaptively respond to unpredictable environments. In birds, the flexible use of alternative reproductive strategies, such as extra-pair mating, has been reported to be associated with fast reproduction, high mortality and environmental variability. However, little is known about the role of previous breeding experience in the adaptive use of alternative reproductive strategies. Here we performed an in-depth study of reproductive outcomes in a population of domesticated zebra finches, testing the impact of prior breeding experience on the use of alternative reproductive strategies and reproductive success. We provide evidence that older females with prior breeding experience are quicker to initiate a clutch with a new partner and have increased success in chick rearing, even in a captive colony of zebra finches with minimal foraging demands. We also find evidence that the breeding experience of other females in the same social group influences reproductive investment by female zebra finches. Furthermore, we demonstrate that the use of alternative reproductive strategies in female zebra finches is associated with previous failed breeding attempts with the same pair partner. The results provide evidence that age and breeding experience play important roles in the flexible use of both facultative and adaptive reproductive strategies in female zebra finches.	[Baran, Nicole M.; Adkins-Regan, Elizabeth] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Adkins-Regan, Elizabeth] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University; Cornell University	Baran, NM (corresponding author), Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA.	nmb68@cornell.edu		Baran, Nicole/0000-0001-6270-0625	Frank M. Chapman Memorial Fund Research Grant	Frank M. Chapman Memorial Fund Research Grant	The genotyping was supported by a Frank M. Chapman Memorial Fund Research Grant awarded to N.M.B., http://www.amnh.org/our-research/vertebrate-zoology/ornithology/grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2007, BIOL LETTERS, V3, P617, DOI 10.1098/rsbl.2007.0388; Arnold KE, 2002, P ROY SOC B-BIOL SCI, V269, P1263, DOI 10.1098/rspb.2002.2013; Bennett P. M., 2002, OX ECOL EV; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Borgia G., 1979, SEXUAL SELECTION REP, P19; Botero CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032311; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Burley NT, 1996, BEHAV ECOL, V7, P218, DOI 10.1093/beheco/7.2.218; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Coulson J.C., 1983, P361; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Fenske B, 1995, AUK, V112, P415; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Forstmeier W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000952; Forstmeier W, 2007, MOL ECOL NOTES, V7, P1026, DOI 10.1111/j.1471-8286.2007.01762.x; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; FOWLER GS, 1995, AM ZOOL, V35, P318; GOWATY PA, 1991, ANIM BEHAV, V41, P661, DOI 10.1016/S0003-3472(05)80904-2; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2010, EMU, V110, P1, DOI 10.1071/MU09057; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Griffith SC, 2009, J AVIAN BIOL, V40, P97, DOI 10.1111/j.1600-048X.2009.04562.x; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; HEINSOHN RG, 1991, AM NAT, V137, P864, DOI 10.1086/285198; HOUTMAN AM, 1992, P ROY SOC B-BIOL SCI, V249, P3, DOI 10.1098/rspb.1992.0075; Ihle M, 2013, BEHAV ECOL, V24, P119, DOI 10.1093/beheco/ars142; Jones AE, 1996, J COMP PSYCHOL, V110, P354; Jones KM, 2001, ANIM BEHAV, V62, P1021, DOI 10.1006/anbe.2001.1843; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Lack D., 1954, P343; LACK D, 1973, POPULATION STUDIES B; LESSELLS CM, 1989, AUK, V106, P375; Locke JL, 2006, BEHAV BRAIN SCI, V29, P259, DOI 10.1017/S0140525X0600906X; Millam JR, 2001, HORM BEHAV, V40, P542, DOI 10.1006/hbeh.2001.1724; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Nisbet I.C.T., 1984, Colonial Waterbirds, V7, P117, DOI 10.2307/1521090; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; Perfito N, 2007, FUNCT ECOL, V21, P291, DOI 10.1111/j.1365-2435.2006.01237.x; Saether B.-E., 1990, Current Ornithology, V7, P251; Schielzeth H, 2010, ANIM BEHAV, V79, P1329, DOI 10.1016/j.anbehav.2010.03.006; SILCOX AP, 1982, ANIM BEHAV, V30, P1237, DOI 10.1016/S0003-3472(82)80216-9; Slater P.J.B., 1988, Advances in the Study of Behavior, V18, P1; SLATER PJB, 1974, ANIM BEHAV, V22, P506, DOI 10.1016/S0003-3472(74)80050-3; Smith SB, 2005, J AVIAN BIOL, V36, P146, DOI 10.1111/j.0908-8857.2005.03417.x; ten Cate C, 1999, ADV STUD BEHAV, V28, P1; Tschirren B, 2012, P ROY SOC B-BIOL SCI, V279, P1233, DOI 10.1098/rspb.2011.1543; VOS DR, 1993, BEHAVIOUR, V126, P137, DOI 10.1163/156853993X00380; VOS DR, 1995, ANIM BEHAV, V50, P645, DOI 10.1016/0003-3472(95)80126-X; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; Williams T., 2012, PHYSL ADAPTATIONS BR; Witte K, 2006, BEHAVIOUR, V143, P969, DOI 10.1163/156853906778623626; ZANN R, 1994, IBIS, V136, P136, DOI 10.1111/j.1474-919X.1994.tb01077.x; ZANN RA, 1994, EMU, V94, P285, DOI 10.1071/MU9940285; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208; Zann RA., 1996, ZEBRA FINCH SYNTHESI	61	15	17	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89808	10.1371/journal.pone.0089808	http://dx.doi.org/10.1371/journal.pone.0089808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587051	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800042
J	Lai, ECC; Hsieh, CY; Yang, YHK; Lin, SJ				Lai, Edward Chia-Cheng; Hsieh, Cheng-Yang; Yang, Yea-Huei Kao; Lin, Swu-Jane			Detecting Potential Adverse Reactions of Sulpiride in Schizophrenic Patients by Prescription Sequence Symmetry Analysis	PLOS ONE			English	Article							ORAL-HEALTH STATUS; DOUBLE-BLIND; ANTIEPILEPTIC DRUGS; HIP FRACTURE; RISK; PNEUMONIA; HALOPERIDOL; PREVALENCE; MEDICATION; PROLACTIN	Purpose: Previous studies have demonstrated sulpiride to be significantly more effective than haloperidol, risperidone and olanzapine in schizophrenic treatment; however, only limited information is available on the potential risks associated with sulpiride treatment. This study attempts to provide information on the potential risks of sulpiride treatment of schizophrenia, especially with regard to unexpected adverse effects. Materials and Methods: Patients with schizophrenia aged 18 and older, newly prescribed with a single antipsychotic medication from the National Health Insurance Research Database of Taiwan in the period from 2003 to 2010 were included. A within-subject comparison method, prescription sequence symmetry analysis (PSSA) was employed to efficiently identify potential causal relationships while controlling for potential selection bias. Results: A total of 5,750 patients, with a mean age of 39, approximately half of whom were male, constituted the study cohort. The PSSA found that sulpiride was associated with EPS (adjusted SR, 1.73; 95% CI, 1.46-2.06) and hyperprolactinemia (12.04; 1.59-91.2). In comparison, EPS caused by haloperidol has a magnitude of 1.99 when analyzed with PSSA, and hyperprolactinemia caused by amisulpride has a magnitude of 8.05, respectively. Another finding was the unexpected increase in the use of stomatological corticosteroids, emollient laxatives, dermatological preparations of corticosteroids, quinolone antibacterials, and topical products for joint and muscular pain, after initiation of sulpiride treatment. Conclusions: We found sulpiride to be associated with an increased risk of EPS and hyperprolactinemia, and the potential risk could be as high as that induced by haloperidol and amisulpride, respectively. Additionally, our study provides grounds for future investigations into the associations between sulpiride and the increased use of additional drugs for managing adverse effects, including stomatological, dermatological, and musculoskeletal or joint side effects, constipation, and pneumonia.	[Lai, Edward Chia-Cheng; Hsieh, Cheng-Yang; Yang, Yea-Huei Kao] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Hsieh, Cheng-Yang] Tainan Sin Lau Hosp, Dept Neurol, Tainan, Taiwan; [Yang, Yea-Huei Kao] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Tainan 70101, Taiwan; [Lin, Swu-Jane] Univ Illinois, Coll Pharm, Dept Pharm Adm, Chicago, IL USA	National Cheng Kung University; National Cheng Kung University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yang, YHK (corresponding author), Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan.	yhkao@mail.ncku.edu.tw	Hsieh, Cheng-Yang/W-4841-2019	Hsieh, Cheng-Yang/0000-0002-8772-4073	Food and Drug Administration, Department of Health, Executive Yuan, Taiwan	Food and Drug Administration, Department of Health, Executive Yuan, Taiwan	This study was supported in part by grants from the Food and Drug Administration, Department of Health, Executive Yuan, Taiwan. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zakwani IS, 2003, CURR MED RES OPIN, V19, P619, DOI 10.1185/030079903125002270; BRATFOS O, 1979, ACTA PSYCHIAT SCAND, V60, P1, DOI 10.1111/j.1600-0447.1979.tb00259.x; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Caughey GE, 2010, PHARMACOEPIDEM DR S, V19, P977, DOI 10.1002/pds.2009; Chen CC, 2012, EPILEPSIA, V53, P283, DOI 10.1111/j.1528-1167.2011.03332.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cookson J, 2012, J PSYCHOPHARMACOL, V26, P42, DOI 10.1177/0269881112442016; Farley JF, 2012, PRIM CARE COMPANION, V14; Garrison SR, 2012, ARCH INTERN MED, V172, P120, DOI 10.1001/archinternmed.2011.1029; GERLACH J, 1985, BRIT J PSYCHIAT, V147, P283, DOI 10.1192/bjp.147.3.283; Hallas J, 1996, EPIDEMIOLOGY, V7, P478, DOI 10.1097/00001648-199609000-00005; Inder WJ, 2011, AUST NZ J PSYCHIAT, V45, P830, DOI 10.3109/00048674.2011.589044; Kim EY, 2012, PHARMACOPSYCHIATRY, V45, P57, DOI 10.1055/s-0031-1291175; KIVELA SL, 1987, INT J GERIATR PSYCH, V2, P255, DOI 10.1002/gps.930020409; Kossioni AE, 2012, GERODONTOLOGY, V29, P272, DOI 10.1111/j.1741-2358.2012.00633.x; Kreyenbuhl J, 2010, SCHIZOPHRENIA BULL, V36, P94, DOI 10.1093/schbul/sbp130; Kuo CJ, 2012, SCHIZOPHR B, V39, P648; Lacro JP, 2002, J CLIN PSYCHIAT, V63, P892, DOI 10.4088/JCP.v63n1007; Lai ECC, 2013, PHARMACOEPIDEM DR S, V22, P1071, DOI 10.1002/pds.3498; Lai ECC, 2013, SCHIZOPHRENIA BULL, V39, P673, DOI 10.1093/schbul/sbs002; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Maclure M, 2012, PHARMACOEPIDEM DR S, V21, P50, DOI 10.1002/pds.2330; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; O'Brien JM, 1999, ANN PHARMACOTHER, V33, P1046, DOI 10.1345/aph.19017; Omori IM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007811; Ozbilen M, 2012, CURR MED CHEM, V19, P5214, DOI 10.2174/092986712803530476; Pratt N, 2011, DRUG SAFETY, V34, P567, DOI 10.2165/11588470-000000000-00000; PUGH CR, 1983, BRIT J PSYCHIAT, V143, P151, DOI 10.1192/bjp.143.2.151; Rummel-Kluge C, 2012, SCHIZOPHRENIA BULL, V38, P167, DOI 10.1093/schbul/sbq042; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; SCHWARTZ M, 1990, J NEUROL NEUROSUR PS, V53, P800, DOI 10.1136/jnnp.53.9.800; Sjogren R, 2000, J CLIN NURS, V9, P632, DOI 10.1046/j.1365-2702.2000.00380.x; Soares BG, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001162, 10.1002/14651858.CD001162, DOI 10.1002/14651858.CD001162.PUBMED:10796605]; Star K, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X532396; Trifiro Gianluca, 2011, Curr Infect Dis Rep, V13, P262, DOI 10.1007/s11908-011-0175-y; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; Tsiropoulos I, 2009, PHARMACOEPIDEM DR S, V18, P483, DOI 10.1002/pds.1736; Wahab IA, 2013, PHARMACOEPIDEM DR S, V22, P496, DOI 10.1002/pds.3417; World Health Organization Collaborating Centre for Drug Statistics Methodology, AN THER CHEM COD CLA; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Yang SY, 2007, CLIN PHARMACOL THER, V81, P586, DOI 10.1038/sj.clpt.6100069	41	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89795	10.1371/journal.pone.0089795	http://dx.doi.org/10.1371/journal.pone.0089795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587038	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800040
J	Sadaba, B; del Barrio, A; Campanero, MA; Azanza, JR; Gomez-Guiu, A; Lopez-Picazo, JM; Algarra, SM; Grima, FG; Prieto, MB; Perez-Gracia, JL; Gurpide, A				Sadaba, Belen; del Barrio, Anabel; Campanero, Miguel Angel; Azanza, Jose Ramon; Gomez-Guiu, Almudena; Lopez-Picazo, Jose Maria; Algarra, Salvador Martin; Grima, Francisco Guillen; Prieto, Maria Blanco; Perez-Gracia, Jose Luis; Gurpide, Alfonso			Randomized Pharmacokinetic Study Comparing Subcutaneous and Intravenous Palonosetron in Cancer Patients Treated with Platinum Based Chemotherapy	PLOS ONE			English	Article							MODERATELY EMETOGENIC CHEMOTHERAPY; INDUCED NAUSEA; PHASE-III; DOUBLE-BLIND; PREVENTION; TRIAL; ANTAGONIST; SAFETY	Background: Palonosetron is a potent second generation 5-hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even though it could have useful clinical applications. In this study, we evaluate the bioavailability of SC palonosetron. Patients and Methods: Patients treated with platinum-based chemotherapy were randomized to receive SC or IV palonosetron, followed by the alternative route in a crossover manner, during the first two cycles of chemotherapy. Blood samples were collected at baseline and 10, 15, 30, 45, 60, 90 minutes and 2, 3, 4, 6, 8, 12 and 24 h after palonosetron administration. Urine was collected during 12 hours following palonosetron. We compared pharmacokinetic parameters including AUC(0-24h), t(1/2), and C-max observed with each route of administration by analysis of variance (ANOVA). Results: From October 2009 to July 2010, 25 evaluable patients were included. AUC0-24h for IV and SC palonosetron were respectively 14.1 and 12.7 ng x h/ml (p = 0.160). Bioavalability of SC palonosetron was 118% (95% IC: 69-168). C-max was lower with SC than with IV route and was reached 15 minutes following SC administration. Conclusions: Palonosetron bioavailability was similar when administered by either SC or IV route. This new route of administration might be specially useful for outpatient management of emesis and for administration of oral chemotherapy.	[Sadaba, Belen; Campanero, Miguel Angel; Azanza, Jose Ramon; Gomez-Guiu, Almudena] Univ Navarra, Univ Navarra Clin, Sch Pharm, Dept Clin Pharmacol, E-31080 Pamplona, Spain; [del Barrio, Anabel; Lopez-Picazo, Jose Maria; Algarra, Salvador Martin; Perez-Gracia, Jose Luis; Gurpide, Alfonso] Univ Navarra, Univ Navarra Clin, Sch Pharm, Dept Oncol, E-31080 Pamplona, Spain; [Grima, Francisco Guillen] Univ Navarra, Univ Navarra Clin, Sch Pharm, Dept Prevent Med, E-31080 Pamplona, Spain; [Prieto, Maria Blanco] Univ Navarra, Univ Navarra Clin, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra; University of Navarra	Sadaba, B (corresponding author), Univ Navarra, Univ Navarra Clin, Sch Pharm, Dept Clin Pharmacol, E-31080 Pamplona, Spain.	bsadaba@unav.es	Guillen-Grima, Francisco/H-3359-2012; Perez-Gracia, Jose Luis/I-8372-2017; Azanza Perea, José Ramón/ABG-1593-2021; Lopez-Picazo, Jose Maria/J-2829-2017; Hatzis, Christos/M-3867-2015; Martin Algarra, Salvador/CAF-3626-2022; Blanco-prieto, Maria J/E-6665-2017	Guillen-Grima, Francisco/0000-0001-9749-8076; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Azanza Perea, José Ramón/0000-0003-3190-622X; Lopez-Picazo, Jose Maria/0000-0002-8814-3000; Hatzis, Christos/0000-0002-8120-2290; Martin Algarra, Salvador/0000-0002-3109-8026; Blanco-prieto, Maria J/0000-0003-0710-899X				Aapro MS, 2006, ANN ONCOL, V17, P1441, DOI 10.1093/annonc/mdl137; Aapro Matti S, 2007, Ther Clin Risk Manag, V3, P1009; Ballatori Enzo, 2003, Health Qual Life Outcomes, V1, P46, DOI 10.1186/1477-7525-1-46; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI [10.1200/JCO.2010.34.4614, 10.1200/JOP.2011.000397]; Chow S C, 1992, J Biopharm Stat, V2, P239, DOI 10.1080/10543409208835042; Eisenberg P, 2004, ANN ONCOL, V15, P330, DOI 10.1093/annonc/mdh047; Eisenberg P, 2003, CANCER-AM CANCER SOC, V98, P2473, DOI 10.1002/cncr.11817; Gomez JG, 2010, CLIN TRANSL ONCOL, V12, P770, DOI 10.1007/s12094-010-0594-5; Gralla R, 2003, ANN ONCOL, V14, P1570, DOI 10.1093/annonc/mdg417; Grunberg SM, 2004, CANCER-AM CANCER SOC, V100, P2261, DOI 10.1002/cncr.20230; Gurpide A, 2007, ONCOLOGIST, V12, P1151, DOI 10.1634/theoncologist.12-9-1151; Roila F, 2010, ANN ONCOL, V21, pv232, DOI 10.1093/annonc/mdq194; Ruhlmann C, 2010, EXPERT REV ANTICANC, V10, P137, DOI 10.1586/ERA.09.175; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Shah A, 2006, J CLIN PHARMACOL, V46, P1139, DOI 10.1177/0091270006291625; Stoltz R, 2004, BIOPHARM DRUG DISPOS, V25, P329, DOI 10.1002/bdd.410; WONG EHF, 1995, BRIT J PHARMACOL, V114, P851, DOI 10.1111/j.1476-5381.1995.tb13282.x	17	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89747	10.1371/journal.pone.0089747	http://dx.doi.org/10.1371/journal.pone.0089747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587006	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800035
J	Fan, SH; Wang, YY; Lu, J; Zheng, YL; Wu, DM; Li, MQ; Hu, B; Zhang, ZF; Cheng, W; Shan, Q				Fan, Shao-hua; Wang, Yan-yan; Lu, Jun; Zheng, Yuan-lin; Wu, Dong-mei; Li, Meng-qiu; Hu, Bin; Zhang, Zi-feng; Cheng, Wei; Shan, Qun			Luteoloside Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma Cells by Inhibition of NLRP3 Inflammasome	PLOS ONE			English	Article							LONICERA-JAPONICA; INDUCE APOPTOSIS; CANCER; ACTIVATION; AUTOPHAGY; LUTEOLIN-7-O-GLUCOSIDE; ACCUMULATION; INVASION; NECROSIS; RECEPTOR	The inflammasome is a multi-protein complex which when activated regulates caspase-1 activation and IL-1 beta secretion. Inflammasome activation is mediated by NLR proteins that respond to stimuli. Among NLRs, NLRP3 senses the widest array of stimuli. NLRP3 inflammasome plays an important role in the development of many cancer types. However, Whether NLRP3 inflammasome plays an important role in the process of hepatocellular carcinoma (HCC) is still unknown. Here, the anticancer effect of luteoloside, a naturally occurring flavonoid isolated from the medicinal plant Gentiana macrophylla, against HCC cells and the underlying mechanisms were investigated. Luteoloside significantly inhibited the proliferation of HCC cells in vitro and in vivo. Live-cell imaging and transwell assays showed that the migration and invasive capacities of HCC cells, which were treated with luteoloside, were significantly inhibited compared with the control cells. The inhibitory effect of luteoloside on metastasis was also observed in vivo in male BALB/c-nu/nu mouse lung metastasis model. Further studies showed that luteoloside could significantly reduce the intracellular reactive oxygen species (ROS) accumulation. The decreased levels of ROS induced by luteoloside was accompanied by decrease in expression of NLRP3 inflammasome resulting in decrease in proteolytic cleavage of caspase-1. Inactivation of caspase-1 by luteoloside resulted in inhibition of IL-1 beta. Thus, luteoloside exerts its inhibitory effect on proliferation, invasion and metastasis of HCC cells through inhibition of NLRP3 inflammasome. Our results indicate that luteoloside can be a potential therapeutic agent not only as an adjuvant therapy for HCC, but also, in the control and prevention of metastatic HCC.	[Fan, Shao-hua; Lu, Jun; Zheng, Yuan-lin; Wu, Dong-mei; Li, Meng-qiu; Hu, Bin; Zhang, Zi-feng; Shan, Qun] Jiangsu Normal Univ, Sch Life Sci, Key Lab Biotechnol Med Plants Jiangsu Prov, Xuzhou, Jiangsu, Peoples R China; [Wang, Yan-yan] First Peoples Hosp Xuzhou, Dept Funct Examinat, Xuzhou, Jiangsu, Peoples R China; [Cheng, Wei] China Univ Min & Technol, Sch Environm & Spatial Informat, Xuzhou, Jiangsu, Peoples R China	Jiangsu Normal University; China University of Mining & Technology	Zheng, YL (corresponding author), Jiangsu Normal Univ, Sch Life Sci, Key Lab Biotechnol Med Plants Jiangsu Prov, Xuzhou, Jiangsu, Peoples R China.	ylzheng@jsnu.edu.cn	cheng, wei/AAW-2548-2020; Lu, Jun/N-6109-2019	cheng, wei/0000-0003-4795-8104; Lu, Jun/0000-0002-2801-5330	Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation for Colleges and Universities in Jiangsu Province [12KJB320001]; National Natural Science Foundation of China [81171012, 81271225, 30950031]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation for Colleges and Universities in Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Natural Science Foundation for Colleges and Universities in Jiangsu Province (12KJB320001), the National Natural Science Foundation of China (81171012, 81271225, and 30950031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2013, TOXICOL APPL PHARM, V270, P70, DOI 10.1016/j.taap.2013.03.027; Ai J, 2011, JNCI-J NATL CANCER I, V103, P1696, DOI 10.1093/jnci/djr360; Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Baskar AA, 2011, NUTR CANCER, V63, P130, DOI 10.1080/01635581.2010.516869; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Chen GY, 2011, GASTROENTEROLOGY, V141, P1986, DOI 10.1053/j.gastro.2011.10.002; Chen KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072927; Chen LC, 2012, EMBO MOL MED, V4, P1276, DOI 10.1002/emmm.201201569; Chow MT, 2012, IMMUNOL CELL BIOL, V90, P983, DOI 10.1038/icb.2012.46; Chow MT, 2012, CANCER RES, V72, P5721, DOI 10.1158/0008-5472.CAN-12-0509; Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110; Dai ZJ, 2013, MOLECULES, V18, P934, DOI 10.3390/molecules18010934; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fan S, 2013, ONCOGENE, V32, P1682, DOI 10.1038/onc.2012.183; Fan SH, 2009, INT IMMUNOPHARMACOL, V9, P91, DOI 10.1016/j.intimp.2008.10.008; Fan ShaoHua, 2012, Journal of Medicinal Plants Research, V6, P3694, DOI 10.5897/JMPR11.170; Feng RT, 2010, J AGR FOOD CHEM, V58, P3957, DOI 10.1021/jf9025458; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Ghasemi R, 2013, NUTR CANCER, V65, P590, DOI 10.1080/01635581.2013.770043; Hu C, 2004, MOL CELL BIOCHEM, V265, P107, DOI 10.1023/B:MCBI.0000044364.73144.fe; Hu HZ, 2011, GUT, V60, P710, DOI 10.1136/gut.2010.220020; Hu QH, 2012, BIOCHEM PHARMACOL, V84, P113, DOI 10.1016/j.bcp.2012.03.005; Hua KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076754; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Lee YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081540; Li SG, 2010, CANCER LETT, V298, P222, DOI 10.1016/j.canlet.2010.07.009; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Menon SG, 2007, CANCER RES, V67, P6392, DOI 10.1158/0008-5472.CAN-07-0225; Miracco C, 2010, HUM PATHOL, V41, P503, DOI 10.1016/j.humpath.2009.09.004; Papeleu P, 2003, J HEPATOL, V39, P374, DOI 10.1016/S0168-8278(03)00288-5; Qiu F, 2013, BIOMED CHROMATOGR, V27, P311, DOI 10.1002/bmc.2793; Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144; Sahasrabuddhe VV, 2012, JNCI-J NATL CANCER I, V104, P1808, DOI 10.1093/jnci/djs452; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Sethman CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070994; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Sun X, 2011, J CELL BIOCHEM, V112, P2019, DOI 10.1002/jcb.23121; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Ungerback J, 2012, CARCINOGENESIS, V33, P2126, DOI 10.1093/carcin/bgs256; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; Walter A, 2010, FASEB J, V24, P3360, DOI 10.1096/fj.09-149419; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038285; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wen SM, 2014, CANCER TREAT REV, V40, P31, DOI 10.1016/j.ctrv.2013.07.008; Xiong JH, 2013, FOOD CHEM, V138, P327, DOI 10.1016/j.foodchem.2012.10.127; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Zamora-Ros R, 2013, INT J CANCER, V133, P2429, DOI 10.1002/ijc.28257; Zhang Y, 2014, ARCH TOXICOL, V88, P97, DOI 10.1007/s00204-013-1085-6; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	53	83	90	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89961	10.1371/journal.pone.0089961	http://dx.doi.org/10.1371/journal.pone.0089961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587153	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000118
J	Larsson, HM; Gorostidi, F; Hubbell, JA; Barrandon, Y; Frey, P				Larsson, Hans M.; Gorostidi, Francois; Hubbell, Jeffrey A.; Barrandon, Yann; Frey, Peter			Clonal, Self-Renewing and Differentiating Human and Porcine Urothelial Cells, a Novel Stem Cell Population	PLOS ONE			English	Article							DIFFERENT CAPACITIES; EPITHELIAL-CELLS; BLADDER; PROLIFERATION; KERATINOCYTE; LOCATION	Although urothelial progenitor-like cells have been described in the human urinary tract, the existence of stem cells remains to be proven. Using a culture system that favors clonogenic epithelial cell growth, we evaluated and characterized clonal human urothelial cells. We isolated human urothelial cells that were clonogenic, capable of self-renewal and could develop into fully differentiated urothelium once re-implanted into the subcapsular space of nude mice. In addition to final urothelial cell differentiation, spontaneous formation of bladder-like microstructures was observed. By examining an epithelial stem cell signature marker, we found p63 to correlate with the self-renewal capacity of the isolated human urothelial clonal populations. Since a clinically relevant, long-term model for functional reconstitution of human cells does not exist, we sought to establish a culture method for porcine urothelial cells in a clinically relevant porcine model. We isolated cells from porcine ureter, urethra and bladder that were clonogenic and capable of self-renewal and differentiation into fully mature urothelium. In conclusion, we could isolate human and porcine cell populations, behaving as urothelial stem cells and showing clonogenicity, self-renewal and, once re-implanted, morphological differentiation.	[Larsson, Hans M.; Hubbell, Jeffrey A.; Frey, Peter] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Regenerat Med & Pharmacobiol, Lausanne, Switzerland; [Larsson, Hans M.; Hubbell, Jeffrey A.; Frey, Peter] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland; [Gorostidi, Francois; Barrandon, Yann] CHU Vaudois, Dept Expt Surg, Expt Surg Lab, CH-1011 Lausanne, Switzerland; [Gorostidi, Francois; Barrandon, Yann] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Stem Cell Dynam, Lausanne, Switzerland; [Frey, Peter] CHU Vaudois, Dept Pediat Urol, Lab Expt Pediat Urol, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Frey, P (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Regenerat Med & Pharmacobiol, Lausanne, Switzerland.	peter.frey@epfl.ch	Hubbell, Jeffrey A/A-9266-2008	Hubbell, Jeffrey A/0000-0003-0276-5456	European Framework Program 6 EuroSTEC [LSHB- CT-2006-037409]	European Framework Program 6 EuroSTEC	This work was funded by the European Framework Program 6 EuroSTEC (Soft tissue engineering for congenital birth defects in children; reference: LSHB- CT-2006-037409, URL: http://ec.europa.eu/research/fp6/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; BARRANDON Y, 1988, J INVEST DERMATOL, V91, P315, DOI 10.1111/1523-1747.ep12475646; Barrandon Y, 2012, SEMIN CELL DEV BIOL, V23, P937, DOI 10.1016/j.semcdb.2012.09.011; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9; Dabelsteen S, 2009, STEM CELLS, V27, P1388, DOI 10.1002/stem.64; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Gaisa NT, 2011, J PATHOL, V225, P163, DOI 10.1002/path.2945; Grasset N, 2008, UNDERSTANDING ENGRAF; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; Liang FX, 2005, J CELL BIOL, V171, P835, DOI 10.1083/jcb.200505035; Nguyen MM, 2007, CELL PROLIFERAT, V40, P157, DOI 10.1111/j.1365-2184.2007.00424.x; Oottamasathien S, 2007, DEV BIOL, V304, P556, DOI 10.1016/j.ydbio.2007.01.010; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; SOUTHGATE J, 1994, LAB INVEST, V71, P583; Tanaka ST, 2010, J UROLOGY, V183, P386, DOI 10.1016/j.juro.2009.08.107; Thangappan R, 2009, CELL PROLIFERAT, V42, P770, DOI 10.1111/j.1365-2184.2009.00647.x; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5	31	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90006	10.1371/journal.pone.0090006	http://dx.doi.org/10.1371/journal.pone.0090006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587183	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000127
J	MacMillan, CJ; Doucette, CD; Warford, J; Furlong, SJ; Hoskin, DW; Easton, AS				MacMillan, Carolyn J.; Doucette, Carolyn D.; Warford, Jordan; Furlong, Suzanne J.; Hoskin, David W.; Easton, Alexander S.			Murine Experimental Autoimmune Encephalomyelitis Is Diminished by Treatment with the Angiogenesis Inhibitors B20-4.1.1 and Angiostatin (K1-3)	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; RECOMBINANT HUMAN ANGIOSTATIN; MULTIPLE-SCLEROSIS; GROWTH-FACTOR; ATP SYNTHASE; VEGF-A; CANCER; BRAIN; BEVACIZUMAB; APOPTOSIS	Angiogenesis is the formation of new blood vessels form pre-existing vasculature whose contribution to inflammatory conditions of the Central Nervous System is being studied in order to generate novel therapeutic targets. This study is the first to investigate the impact of two particular angiogenesis inhibitors on murine Experimental Autoimmune Encephalomyelitis (EAE), an inflammatory disease that mimics aspects of the human disease Multiple Sclerosis. The inhibitors were chosen to reduce angiogenesis by complimentary means. Extrinsic factors were targeted with B20-4.1.1 through its ability to bind to murine Vascular Endothelial Growth Factor (VEGF). Vascular processes connected to angiogenesis were targeted directly with K(1-3), the first three kringle domains of angiostatin. Mice treated with B20-4.1.1 and K(1-3) from onset of signs had reduced clinical scores 18-21 days after EAE induction. Both agents suppressed spinal cord angiogenesis without effect on local VEGF expression. B20-4.1.1 reduced spinal cord vascular permeability while K(1-3) had no effect. T cell infiltration into the spinal cord at day 21 was unaffected by either treatment. B20-4.1.1 reduced peripheral T cell proliferation while K(1-3) had no effect. Lymphoid cells from treated mice produced reduced levels of the T helper-17 (Th-17) cell cytokine interleukin (IL)-17 with no effect on the Th-1 cytokine interferon (IFN)-gamma or Th-2 cytokine IL-4. However, when both drugs were added in vitro to naive T cells or to antigen stimulated T cells from mice with untreated EAE they had no effect on proliferation or levels of IL-17 or IFN-gamma. We conclude that these angiogenesis inhibitors mitigate EAE by both suppressing spinal cord angiogenesis and reducing peripheral T cell activation.	[MacMillan, Carolyn J.; Warford, Jordan; Hoskin, David W.; Easton, Alexander S.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Doucette, Carolyn D.; Furlong, Suzanne J.; Hoskin, David W.; Easton, Alexander S.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Easton, Alexander S.] Dalhousie Univ, Dept Surg Neurosurg, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Easton, AS (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.	Alexander.Easton@dal.ca		Warford, Jordan/0000-0003-1654-4929	Nova Scotia Health Research Foundation [MED-Project-2008-4642]; Capital Health Research Fund [1012329]; Natural Sciences and Engineering Research Council [89358]	Nova Scotia Health Research Foundation; Capital Health Research Fund; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	1. Nova Scotia Health Research Foundation (Grant to AE); #MED-Project-2008-4642; http://www.nshrf.ca. 2. Capital Health Research Fund (Grant to AE): #1012329; http://www.cdha.nshealth.ca/discovery-innovation/research fund. 3. Natural Sciences and Engineering Research Council (Grant to DW); #89358; http://www.nserc-crsng.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerepoot LV, 2003, CLIN CANCER RES, V9, P4025; Cao YH, 2004, SEMIN CANCER BIOL, V14, P139, DOI 10.1016/j.semcancer.2003.09.018; Cao YH, 1996, J BIOL CHEM, V271, P29461, DOI 10.1074/jbc.271.46.29461; Cauden V, 2007, MICROCIRCULATION, V14, P767, DOI 10.1080/10739680701410421; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; des Guetz G, 2011, TARGET ONCOL, V6, P197, DOI 10.1007/s11523-011-0204-7; Easton AS, 1997, J PHYSIOL-LONDON, V503, P613, DOI 10.1111/j.1469-7793.1997.613bg.x; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Griscelli F, 1998, P NATL ACAD SCI USA, V95, P6367, DOI 10.1073/pnas.95.11.6367; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Joice SL, 2009, BRAIN RES, V1298, P13, DOI 10.1016/j.brainres.2009.08.076; Kirk SL, 2003, J AUTOIMMUN, V21, P353, DOI 10.1016/S0896-8411(03)00139-2; Kurup A, 2006, ANN ONCOL, V17, P97, DOI 10.1093/annonc/mdj055; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lu H, 1999, BIOCHEM BIOPH RES CO, V258, P668, DOI 10.1006/bbrc.1999.0612; Lucas R, 1998, BLOOD, V92, P4730; Ludwin SK, 2001, J NEUROPATH EXP NEUR, V60, P505; MacDonald NJ, 1999, BIOCHEM BIOPH RES CO, V264, P469, DOI 10.1006/bbrc.1999.1486; MacMillan CJ, 2012, J NEUROPATH EXP NEUR, V71, P983, DOI 10.1097/NEN.0b013e3182724831; MacMillan CJ, 2011, J NEUROPATH EXP NEUR, V70, P1107, DOI 10.1097/NEN.0b013e31823a8b6a; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; RAPOPORT SI, 1978, J THEOR BIOL, V74, P439, DOI 10.1016/0022-5193(78)90224-2; Roscoe WA, 2009, J NEUROIMMUNOL, V209, P6, DOI 10.1016/j.jneuroim.2009.01.009; Schlageter KE, 1999, MICROVASC RES, V58, P312, DOI 10.1006/mvre.1999.2188; Seabrook TJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-95; Tham E, 2006, SCAND J IMMUNOL, V64, P609, DOI 10.1111/j.1365-3083.2006.01851.x; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Young RJ, 2012, MICROCIRCULATION, V19, P115, DOI 10.1111/j.1549-8719.2011.00147.x; Yu LL, 2008, INVEST OPHTH VIS SCI, V49, P522, DOI 10.1167/iovs.07-1175	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89770	10.1371/journal.pone.0089770	http://dx.doi.org/10.1371/journal.pone.0089770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587024	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000091
J	Ritschl, LM; Fichter, AM; von During, M; Mitchell, DA; Wolff, KD; Mucke, T				Ritschl, Lucas M.; Fichter, Andreas M.; von Duering, Monika; Mitchell, David A.; Wolff, Klaus-Dietrich; Muecke, Thomas			Introduction of a Microsurgical In-Vivo Embolization-Model in Rats: The Aorta-Filter Model	PLOS ONE			English	Article							EMBOLIC PROTECTION; THROMBUS FORMATION; DISTURBED FLOW; ANASTOMOSES; HEAD; PREVENTION; DEVICES	Vascular thrombosis with subsequent distal embolization remains a critical event for patients. Prevention of this life-threatening event can be achieved pharmacologically or mechanically with intravascular filter systems. The ability to evaluate the risk of embolization of certain techniques and procedures in vascular and microvascular surgery, such as, tissue glue or fibrin based haemostatic agents lacks convincing models. We performed 64 microvascular anastomoses in 44 rats, including 44 micro-pore polyurethane filter-anastomoses and 20 non-filter anastomoses. The rats were re-anesthetized and the aorta was re-exposed and removed four hours, three, seven, fourteen, thirty-one days, and six months postoperatively. The specimens were examined macro-and microscopically with regard to the appearance of the vessel wall, condition of the filter and the amount of thrombembolic material. Typical postoperative histopathological changes in vessel architecture were observed. Media necrosis was the first significant change three days postoperatively. Localized intimal hyperplasia, media necrosis, increase of media fibromyocytes and adventitial hypercellularity were seen to a significant extent at day seven postoperatively. Significant neovascularization of adventitia adjacent to the filter was seen after 14 days. A significant amount of thrombotic material was seen after four hours, three and 14 days interval. Only three intravascular filters became completely occluded (6.82%). The aorta-filter-anastomosis model appeared to be a valid in-vivo model in situations at risk for thrombembolic events, for microsurgical research and allowed sensitive analysis of surgical procedures and protection of the vascularized tissue. It may be suitable for a wide range of in-vivo microvascular experiments particularly in the rat model.	[Ritschl, Lucas M.; Fichter, Andreas M.; Mitchell, David A.; Wolff, Klaus-Dietrich; Muecke, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany; [von Duering, Monika] Ruhr Univ Bochum, Dept Neuroanat, Bochum, Germany	Technical University of Munich; Ruhr University Bochum	Mucke, T (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany.	th.mucke@gmx.de	Mücke, Thomas/K-7106-2015	Mücke, Thomas/0000-0003-3561-1277; Mitchell, David/0000-0003-4830-5332				ANDERSON GL, 1988, MICROVASC RES, V36, P56, DOI 10.1016/0026-2862(88)90038-6; Askari M, 2006, J HAND SURG-AM, V31A, P836, DOI 10.1016/j.jhsa.2006.02.023; BARKER JH, 1992, PLAST RECONSTR SURG, V90, P94, DOI 10.1097/00006534-199207000-00014; BAXTER TJ, 1972, BRIT J SURG, V59, P617, DOI 10.1002/bjs.1800590809; Brands MT, 2010, INT J ORAL MAX SURG, V39, P101, DOI 10.1016/j.ijom.2009.11.020; Chen HC, 2006, MICROSURG, V26, P356, DOI 10.1002/micr.20252; Chen KT, 2007, PLAST RECONSTR SURG, V120, P187, DOI 10.1097/01.prs.0000264077.07779.50; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Chow S P, 1983, Microsurgery, V4, P5, DOI 10.1002/micr.1920040106; Close B, 1996, LAB ANIM-UK, V30, P293, DOI 10.1258/002367796780739871; Drake DB, 2000, ANN PLAS SURG, V45, P520, DOI 10.1097/00000637-200045050-00009; Dubel GJ, 2008, CARDIOVASC INTER RAD, V31, P14, DOI 10.1007/s00270-007-9211-6; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Hamood Hatem, 2005, Int J Cardiovasc Intervent, V7, P176; HAYHURST JW, 1975, BRIT J PLAST SURG, V28, P128, DOI 10.1016/0007-1226(75)90175-7; Hernandez-Fernandez F, 2012, CARDIOVASC INTERVENT; Jin B, 2012, CURR MED RES OPIN, V28, P871, DOI 10.1185/03007995.2012.686445; Kahlert P, 2012, CIRCULATION, V126, P1245, DOI 10.1161/CIRCULATIONAHA.112.092544; KERSH RA, 1989, PLAST RECONSTR SURG, V83, P866, DOI 10.1097/00006534-198905000-00016; Kiang SC, 2012, J CARDIOVASC SURG, V53, P755; Kimiagar I, 2012, VASC ENDOVASC SURG, V46, P536, DOI 10.1177/1538574412457471; LERICHE R, 1948, ANN SURG, V127, P193, DOI 10.1097/00000658-194802000-00001; Li L, 2008, KIDNEY INT, V74, P1247, DOI 10.1038/ki.2008.318; LIDMAN D, 1981, SCAND J PLAST RECONS, V15, P103, DOI 10.3109/02844318109103422; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Muke T, 2008, MINIM INVAS NEUROSUR, V51, P6, DOI 10.1055/s-2007-1004548; Okazaki M, 2006, ANN PLAS SURG, V56, P171, DOI 10.1097/01.sap.0000197620.03306.2f; Scholz M, 2008, MINIM INVAS NEUROSUR, V51, P76, DOI 10.1055/s-2008-1058088; SERVANT JM, 1976, PLAST RECONSTR SURG, V57, P329, DOI 10.1097/00006534-197603000-00008; Son JW, 2012, CIRC J, V76, P2640, DOI 10.1253/circj.CJ-12-0360; Spyropoulos AC, 2012, BLOOD, V120, P2954, DOI 10.1182/blood-2012-06-415943; TANGELDER GJ, 1992, PLAST RECONSTR SURG, V90, P103; Thatipelli MR, 2009, J VASC INTERV RADIOL, V20, P580, DOI 10.1016/j.jvir.2009.01.025; Winkler MS, 2013, J CARDIOVASC SURG, V54, P183; Wolff KD, 2008, MICROSURG, V28, P143, DOI 10.1002/micr.20468	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89947	10.1371/journal.pone.0089947	http://dx.doi.org/10.1371/journal.pone.0089947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587143	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000116
J	Dawany, N; Showe, LC; Kossenkov, AV; Chang, CL; Ive, P; Conradie, F; Stevens, W; Sanne, I; Azzoni, L; Montaner, LJ				Dawany, Noor; Showe, Louise C.; Kossenkov, Andrew V.; Chang, Celia; Ive, Prudence; Conradie, Francesca; Stevens, Wendy; Sanne, Ian; Azzoni, Livio; Montaner, Luis J.			Identification of a 251 Gene Expression Signature That Can Accurately Detect M-tuberculosis in Patients with and without HIV Co-Infection	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; MULTIDRUG-RESISTANT TUBERCULOSIS; LATENT TUBERCULOSIS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; DIAGNOSTIC-ACCURACY; INFECTION; METAANALYSIS; CELLS; ACTIVATION	Background: Co-infection with tuberculosis (TB) is the leading cause of death in HIV-infected individuals. However, diagnosis of TB, especially in the presence of an HIV co-infection, can be limiting due to the high inaccuracy associated with the use of conventional diagnostic methods. Here we report a gene signature that can identify a tuberculosis infection in patients co-infected with HIV as well as in the absence of HIV. Methods: We analyzed global gene expression data from peripheral blood mononuclear cell (PBMC) samples of patients that were either mono-infected with HIV or co-infected with HIV/TB and used support vector machines to identify a gene signature that can distinguish between the two classes. We then validated our results using publically available gene expression data from patients mono-infected with TB. Results: Our analysis successfully identified a 251-gene signature that accurately distinguishes patients co-infected with HIV/TB from those infected with HIV only, with an overall accuracy of 81.4% (sensitivity = 76.2%, specificity = 86.4%). Furthermore, we show that our 251-gene signature can also accurately distinguish patients with active TB in the absence of an HIV infection from both patients with a latent TB infection and healthy controls (88.9-94.7% accuracy; 69.2-90% sensitivity and 90.3-100% specificity). We also demonstrate that the expression levels of the 251-gene signature diminish as a correlate of the length of TB treatment. Conclusions: A 251-gene signature is described to (a) detect TB in the presence or absence of an HIV co-infection, and (b) assess response to treatment following anti-TB therapy.	[Dawany, Noor; Showe, Louise C.; Kossenkov, Andrew V.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Chang, Celia] Wistar Inst Anat & Biol, Genom Facil, Philadelphia, PA 19104 USA; [Ive, Prudence; Conradie, Francesca; Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Dept Clin Med, Clin HIV Res Unit, Johannesburg, South Africa; [Stevens, Wendy] Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Hematol, Johannesburg, South Africa; [Azzoni, Livio; Montaner, Luis J.] Wistar Inst Anat & Biol, HIV Immunopathogenesis Lab 1, Philadelphia, PA USA	The Wistar Institute; The Wistar Institute; University of Witwatersrand; University of Witwatersrand; The Wistar Institute	Montaner, LJ (corresponding author), Wistar Inst Anat & Biol, HIV Immunopathogenesis Lab 1, Philadelphia, PA USA.	montaner@wistar.org	Sanne, Ian/ABH-2231-2020		NIH/NIAID [UO1AI51986, R01 AI069996]; Philadelphia Foundation; Stengel-Miller family; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; Cancer Center Grant [P30 CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069996, P30AI045008, U01AI051986] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Philadelphia Foundation; Stengel-Miller family; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; Cancer Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: NIH/NIAID grant UO1AI51986 to LJM and R01 AI069996 to LA, The Philadelphia Foundation (Robert I. Jacobs Fund), The Stengel-Miller family, AIDS funds from the Commonwealth of Pennsylvania and from the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health, and Cancer Center Grant (P30 CA10815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Conradie F, 2011, JAIDS-J ACQ IMM DEF, V58, P309, DOI 10.1097/QAI.0b013e31822e0d15; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Fan L, 2012, FEMS IMMUNOL MED MIC, V65, P456, DOI 10.1111/j.1574-695X.2012.00972.x; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Jacobsen M, 2011, CLIN MICROBIOL INFEC, V17, P1323, DOI 10.1111/j.1469-0691.2010.03326.x; Kossenkov AV, 2011, CLIN CANCER RES, V17, P5867, DOI 10.1158/1078-0432.CCR-11-0737; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lesho E, 2011, TUBERCULOSIS, V91, P390, DOI 10.1016/j.tube.2011.07.002; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; McShane H, 2005, INT J STD AIDS, V16, P95, DOI 10.1258/0956462053057576; Mehta PK, 2012, FEMS IMMUNOL MED MIC; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Mikhailovich V, 2008, BIOESSAYS, V30, P673, DOI 10.1002/bies.20781; Nebozhyn M, 2006, BLOOD, V107, P3189, DOI 10.1182/blood-2005-07-2813; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Shah M, 2013, 20 C RETR OPP INF AT; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Stern JNH, 2009, IMMUNOL RES, V45, P1, DOI 10.1007/s12026-008-8024-2; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Toossi Z, 2013, J INFECT DIS, V207, P1841, DOI 10.1093/infdis/jit092; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; Weyer K, 2011, J INFECT DIS, V204, pS1196, DOI 10.1093/infdis/jir452; WHO, 2011, WHO GLOBAL TUBERCULO; Zhang Y, 2007, CLIN PHARMACOL THER, V82, P595, DOI 10.1038/sj.clpt.6100362	34	23	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89925	10.1371/journal.pone.0089925	http://dx.doi.org/10.1371/journal.pone.0089925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587128	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900097
J	Kim, TH; Hwang, HJ; Kim, SH				Kim, Tae Ho; Hwang, Hee-Jin; Kim, Sang-Hwan			Relationship between Serum Ferritin Levels and Sarcopenia in Korean Females Aged 60 Years and Older Using the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV-2, 3), 2008-2009	PLOS ONE			English	Article							INSULIN-RESISTANCE SYNDROME; BODY IRON STORES; METABOLIC SYNDROME; OXIDATIVE STRESS; SKELETAL-MUSCLE; DIABETES-MELLITUS; GENERAL-POPULATION; ASSOCIATION; OBESITY; ACCUMULATION	Context: It has been suggested that elevated serum ferritin is associated with several metabolic disorders. However, there is no reported study assessing any association between serum ferritin and sarcopenia despite the close relationship between sarcopenia and metabolic disorders. Objective: We investigated whether serum ferritin was associated with sarcopenia in older Koreans. Design and Setting: We conducted a cross-sectional study based on data acquired in the second and third years (2008-9) of the fourth Korean National Health and Nutrition Examination Survey. Participants: In total, 952 men (mean age 69.0 years) and 1,380 women (mean age 69.3 years) aged 60 years and older completed a body composition study using dual energy X-ray absorptiometry. Measurements: Serum ferritin levels were measured. Sarcopenia was defined as an appendicular skeletal mass as a percentage of body weight that was less than two standard deviations below the gender-specific mean for young adults. Results: Serum ferritin levels were lower in women than in men. Women with sarcopenia showed a higher level of serum ferritin than women without sarcopenia (men: without sarcopenia 115.7 ng/mL and with sarcopenia 134.4 ng/mL vs. women: without sarcopenia 70.7 ng/mL and with sarcopenia 85.4 ng/mL). The prevalence of sarcopenia increased as the tertile of serum ferritin increased. However, statistical significance was only seen in elderly women (1st tertile 6.3%, 2nd tertile 8.0%, 3rd tertile 12.0%; p = 0.008). Without adjustment, compared with those in the lowest tertile of serum ferritin level, participants in the highest tertile had an odds ratio of 2.02 (95% confidence interval = 1.26-3.23) for sarcopenia in women. After adjusting for known risk factors, the OR for sarcopenia was 1.74 (95% CI = 1.02-2.97) in women. There was no statistically significant association between sarcopenia and serum ferritin tertiles in men. Conclusions: Elevated serum ferritin levels were associated with an increased prevalence of sarcopenia in women but not in men from a representative sample of elderly Koreans.	[Kim, Tae Ho] Kwandong Univ Coll Med, Div Endocrinol, Dept Internal Med, Kangnung, South Korea; [Hwang, Hee-Jin] Kwandong Univ Coll Med, Dept Family Med, Kangnung, South Korea; [Kim, Sang-Hwan] Myongji Hosp, Geriatr Ctr, Goyang, South Korea; [Kim, Sang-Hwan] Myongji Hosp, Dept Family Med, Goyang, South Korea	Catholic Kwandong University; Catholic Kwandong University; Myongji Hospital; Myongji Hospital	Hwang, HJ (corresponding author), Kwandong Univ Coll Med, Dept Family Med, Kangnung, South Korea.	ydsfm3624@naver.com; fanink@naver.com		Kim, Tae Ho/0000-0002-3720-8011				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Altun M, 2007, MUSCLE NERVE, V36, P223, DOI 10.1002/mus.20808; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Chin SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060119; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Cooksey RC, 2004, ENDOCRINOLOGY, V145, P5305, DOI 10.1210/en.2004-0392; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Ferrannini E, 2000, LANCET, V355, P2181, DOI 10.1016/S0140-6736(00)02397-7; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Garry PJ, 2000, J AM COLL NUTR, V19, P262, DOI 10.1080/07315724.2000.10718925; GAVIN MW, 1994, AM J CLIN NUTR, V59, P1376, DOI 10.1093/ajcn/59.6.1376; Haidari M, 2001, CLIN CHEM, V47, P1666; Heeney MM, 2004, HEMATOL ONCOL CLIN N, V18, P1379, DOI 10.1016/j.hoc.2004.06.018; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Jung SH, 2008, EXP PHYSIOL, V93, P407, DOI 10.1113/expphysiol.2007.039453; Kalyani RR, 2012, J GERONTOL A-BIOL, V67, P74, DOI 10.1093/gerona/glr022; Kim CH, 2011, METABOLISM, V60, P414, DOI 10.1016/j.metabol.2010.03.007; Kim KS, 2012, DIABETES METAB J, V36, P336, DOI 10.4093/dmj.2012.36.5.336; Kim YS, 2012, J GERONTOL A-BIOL, V67, P1107, DOI 10.1093/gerona/gls071; KONDO H, 1992, PFLUG ARCH EUR J PHY, V421, P295, DOI 10.1007/BF00374844; Lee BK, 2011, METABOLISM, V60, P1416, DOI 10.1016/j.metabol.2011.02.008; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Marzetti E, 2009, BIOFACTORS, V35, P28, DOI 10.1002/biof.5; MERKEL PA, 1988, NEW ENGL J MED, V318, P809, DOI 10.1056/NEJM198803313181303; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Park SK, 2012, DIABETES CARE, V35, P2521, DOI 10.2337/dc12-0543; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x; Sheu WHH, 2003, CLIN ENDOCRINOL, V58, P380, DOI 10.1046/j.1365-2265.2003.01729.x; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Tuomainen TP, 1997, DIABETES CARE, V20, P426, DOI 10.2337/diacare.20.3.426; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vari IS, 2007, DIABETES CARE, V30, P1795, DOI 10.2337/dc06-2312; Williams MJA, 2002, ATHEROSCLEROSIS, V165, P179, DOI 10.1016/S0021-9150(02)00233-2; Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Yao DC, 2005, FREE RADICAL BIO MED, V39, P1385, DOI 10.1016/j.freeradbiomed.2005.07.015; Yoon JH, 2012, CLIN CHEM LAB MED, V50, P2057, DOI 10.1515/cclm-2011-0928	45	19	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90105	10.1371/journal.pone.0090105	http://dx.doi.org/10.1371/journal.pone.0090105			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587226	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900117
J	Shaw, KS; Goldstein, RER; He, X; Jacobs, JM; Crump, BC; Sapkota, AR				Shaw, Kristi S.; Goldstein, Rachel E. Rosenberg; He, Xin; Jacobs, John M.; Crump, Byron C.; Sapkota, Amy R.			Antimicrobial Susceptibility of Vibrio vulnificus and Vibrio parahaemolyticus Recovered from Recreational and Commercial Areas of Chesapeake Bay and Maryland Coastal Bays	PLOS ONE			English	Article							REAL-TIME PCR; ANTIBIOTIC-RESISTANCE; UNITED-STATES; WATER; OYSTERS; ENVIRONMENTS; DIVERSITY; LOUISIANA; PATHOGENS; SWINE	Vibrio vulnificus and V. parahaemolyticus in the estuarine-marine environment are of human health significance and may be increasing in pathogenicity and abundance. Vibrio illness originating from dermal contact with Vibrio laden waters or through ingestion of seafood originating from such waters can cause deleterious health effects, particularly if the strains involved are resistant to clinically important antibiotics. The purpose of this study was to evaluate antimicrobial susceptibility among these pathogens. Surface-water samples were collected from three sites of recreational and commercial importance from July to September 2009. Samples were plated onto species-specific media and resulting V. vulnificus and V. parahaemolyticus strains were confirmed using polymerase chain reaction assays and tested for antimicrobial susceptibility using the Sensititre(R) microbroth dilution system. Descriptive statistics, Friedman two-way Analysis of Variance (ANOVA) and Kruskal-Wallis one-way ANOVA were used to analyze the data. Vibrio vulnificus (n = 120) and V. parahaemolyticus (n = 77) were isolated from all sampling sites. Most isolates were susceptible to antibiotics recommended for treating Vibrio infections, although the majority of isolates expressed intermediate resistance to chloramphenicol (78% of V. vulnificus, 96% of V. parahaemolyticus). Vibrio parahaemolyticus also demonstrated resistance to penicillin (68%). Sampling location or month did not significantly impact V. parahaemolyticus resistance patterns, but V. vulnificus isolates from St. Martin's River had lower overall intermediate resistance than that of the other two sampling sites during the month of July (p = 0.0166). Antibiotics recommended to treat adult Vibrio infections were effective in suppressing bacterial growth, while some antibiotics recommended for pediatric treatment were not effective against some of the recovered isolates. To our knowledge, these are the first antimicrobial susceptibility data of V. vulnificus and V. parahaemolyticus recovered from the Chesapeake Bay. These data can serve as a baseline against which future studies can be compared to evaluate whether susceptibilities change over time.	[Shaw, Kristi S.; Crump, Byron C.] Univ Maryland, Horn Point Lab, Ctr Environm Sci, Cambridge, MD USA; [Goldstein, Rachel E. Rosenberg; Sapkota, Amy R.] Univ Maryland, Maryland Inst Appl Environm Hlth, Sch Publ Hlth, College Pk, MD 20742 USA; [He, Xin] Univ Maryland, Dept Epidemiol & Biostat, Sch Publ Hlth, College Pk, MD 20742 USA; [Jacobs, John M.] NOAA, Cooperat Oxford Lab, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Oxford, MD USA; [Crump, Byron C.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University System of Maryland; University of Maryland Center for Environmental Science; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Oregon State University	Shaw, KS (corresponding author), Univ Maryland, Horn Point Lab, Ctr Environm Sci, Cambridge, MD USA.	krististevensshaw@gmail.com	Goldstein, Rachel E. Rosenberg/AAJ-2513-2021; He, Xin/N-6742-2016; Sapkota, Amy R/A-6046-2011; Crump, Byron/ABF-3711-2020	Crump, Byron/0000-0001-7062-1273; He, Xin/0000-0002-9814-1666; Rosenberg Goldstein, Rachel/0000-0002-8190-9376	National Oceanic and Atmospheric Administration [EA133C07CN0163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support for this research was graciously provided by National Oceanic and Atmospheric Administration award EA133C07CN0163 (www.noaa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, but funder's employee, Dr. John Jacobs, was a collaborator in all portions of this study.	Baker-Austin C, 2009, MICROB ECOL, V57, P151, DOI 10.1007/s00248-008-9413-8; Baker-Austin C, 2008, J FOOD PROTECT, V71, P2552, DOI 10.4315/0362-028X-71.12.2552; Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P7, DOI 10.1111/j.1758-2229.2009.00096.x; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P76, DOI 10.1111/j.1758-2229.2009.00092.x; Banakar V, 2011, ECOHEALTH, V8, P456, DOI 10.1007/s10393-011-0736-4; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Campagnolo ER, 2002, SCI TOTAL ENVIRON, V299, P89, DOI 10.1016/S0048-9697(02)00233-4; CDC, 2012, DIARRH COMM ILLN GLO; CDC, 2013, VIBR VULN GEN INF; CFSAN (Center for Food Safety and Applied Nutrition USFDA, 2005, QUANT RISK ASS PUBL; Chiew YF, 1998, J ANTIMICROB CHEMOTH, V41, P247, DOI 10.1093/jac/41.2.247; CLSI, 2010, M45A2 CLSI; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; Daniels NA, 2000, INFECT MED, V17, P665; Eaton A., 1998, STANDARD METHODS EXA; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; de Oliveira AJFC, 2008, WATER RES, V42, P2242, DOI 10.1016/j.watres.2007.12.002; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Han F, 2007, APPL ENVIRON MICROB, V73, P7096, DOI 10.1128/AEM.01116-07; Jacobs JM, 2010, 112 NOAA NOS NCOOS; Johnson CN, 2012, APPL ENVIRON MICROB, V78, P7249, DOI 10.1128/AEM.01296-12; JONES A, 2004, WATER QUALITY ASSESS; JOSEPH SW, 1978, ANTIMICROB AGENTS CH, V13, P244, DOI 10.1128/AAC.13.2.244; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Martinez-Urtaza J, 2013, NEW ENGL J MED, V369, P1573, DOI 10.1056/NEJMc1305535; Newton A, 2012, CLIN INFECT DIS, V54, pS391, DOI 10.1093/cid/cis243; Nordstrom JL, 2007, APPL ENVIRON MICROB, V73, P5840, DOI 10.1128/AEM.00460-07; Ottaviani D, 2013, ENVIRON MICROBIOL, V15, P1377, DOI 10.1111/j.1462-2920.2012.02839.x; Panicker G, 2005, APPL ENVIRON MICROB, V71, P5702, DOI 10.1128/AEM.71.10.5702-5709.2005; Ralston EP, 2011, J WATER HEALTH, V9, P680, DOI 10.2166/wh.2011.157; Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P1040, DOI 10.1289/ehp.9770; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shaw K, 2011, VIBR 2011 4 C BIOL V; Thomas J, 2009, ST MARTIN RIVER SHIF, P89; Vizcaino MI, 2010, MICROB ECOL, V59, P646, DOI 10.1007/s00248-010-9644-3; WHO World Health Organization Food and Agriculture Organization of the United Nations, 2011, RISK ASS VIBR PAR SE, P183; World Health Organization Food and Agriculture Organization of the United Nations, 2005, RISK ASS VIBR VULN R, Vxvii, P114; Wright AC, 1996, APPL ENVIRON MICROB, V62, P717, DOI 10.1128/AEM.62.2.717-724.1996; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614	43	104	107	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89616	10.1371/journal.pone.0089616	http://dx.doi.org/10.1371/journal.pone.0089616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586914	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900058
J	Yu, DP; Wang, XY; Yin, Y; Zhan, JY; Lewis, BJ; Tian, J; Bao, Y; Zhou, WM; Zhou, L; Dai, LM				Yu, Dapao; Wang, Xiaoyu; Yin, You; Zhan, Jinyu; Lewis, Bernard J.; Tian, Jie; Bao, Ye; Zhou, Wangming; Zhou, Li; Dai, Limin			Estimates of Forest Biomass Carbon Storage in Liaoning Province of Northeast China: A Review and Assessment	PLOS ONE			English	Article							PRODUCTIVITY; VEGETATION	Accurate estimates of forest carbon storage and changes in storage capacity are critical for scientific assessment of the effects of forest management on the role of forests as carbon sinks. Up to now, several studies reported forest biomass carbon (FBC) in Liaoning Province based on data from China's Continuous Forest Inventory, however, their accuracy were still not known. This study compared estimates of FBC in Liaoning Province derived from different methods. We found substantial variation in estimates of FBC storage for young and middle-age forests. For provincial forests with high proportions in these age classes, the continuous biomass expansion factor method (CBM) by forest type with age class is more accurate and therefore more appropriate for estimating forest biomass. Based on the above approach designed for this study, forests in Liaoning Province were found to be a carbon sink, with carbon stocks increasing from 63.0 TgC in 1980 to 120.9 TgC in 2010, reflecting an annual increase of 1.9 TgC. The average carbon density of forest biomass in the province has increased from 26.2 Mg ha(-1) in 1980 to 31.0 Mg ha(-1) in 2010. While the largest FBC occurred in middle-age forests, the average carbon density decreased in this age class during these three decades. The increase in forest carbon density resulted primarily from the increased area and carbon storage of mature forests. The relatively long age interval in each age class for slow-growing forest types increased the uncertainty of FBC estimates by CBM-forest type with age class, and further studies should devote more attention to the time span of age classes in establishing biomass expansion factors for use in CBM calculations.	[Yu, Dapao; Wang, Xiaoyu; Lewis, Bernard J.; Bao, Ye; Zhou, Wangming; Zhou, Li; Dai, Limin] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Yin, You] Shenyang Agr Univ, Coll Forestry, Shenyang 110161, Peoples R China; [Zhan, Jinyu] Inst Forestry Invest & Planning, Shenyang, Peoples R China; [Tian, Jie] Agr Technol Promot Ctr Qianshan Dist, Anshan, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Shenyang Agricultural University	Dai, LM (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	lmdai@iae.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05050201]; 12th Five-Year Plan for national science and technology projects in rural areas [2011BAD37B010203]; CFERN & GENE Award Funds on Ecological Paper	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); 12th Five-Year Plan for national science and technology projects in rural areas; CFERN & GENE Award Funds on Ecological Paper	This study was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05050201), the 12th Five-Year Plan for national science and technology projects in rural areas (2011BAD37B010203) and by CFERN & GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; CHEN CG, 1986, J LIAONING FOR SCI T, V3, P27; CMF, 2010, FOR RES STAT CHIN 20; CMF (Chinese Ministry of Forestry), 1999, FOR RES STAT CHIN 19; CMF (Chinese Ministry of Forestry), 1989, FOR RES STAT CHIN 19; CMF (Chinese Ministry of Forestry), 1994, FOR RES STAT CHIN 19; CMF (Chinese Ministry of Forestry), 1977, FOR RES STAT CHIN 19; CMF (Chinese Ministry of Forestry), 1983, FOR RES STAT CHIN 19; CMF (Chinese Ministry of Forestry), 2004, FOR RES STAT CHIN 19; Dong FX, 2010, FORESTRY EC, V9, P54; Fang JY, 2007, SCI CHINA SER D, V50, P92, DOI 10.1007/s11430-007-2031-3; Fang JY, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002253; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY, 2001, ACTA BOT SIN, V43, P967; Fang JY, 1998, ECOL APPL, V8, P1084, DOI 10.2307/2640963; Fang JY., 1996, ACTA ECOL SIN, V16, P497, DOI DOI 10.1016/j.chnaes.2015.03.001; FDL (The Forestry Department of Liaoning Province), 2013, FOR BAS INF LIAON PR; Feng X, 2007, J ENVIRON MANAGE, V85, P563, DOI 10.1016/j.jenvman.2006.09.021; Forestry Bureau of Liaoning Province, 2008, SUMM STAT STAT FOR R; Guo ZD, 2010, FOREST ECOL MANAG, V259, P1225, DOI 10.1016/j.foreco.2009.09.047; Hui DF, 2012, FOREST ECOL MANAG, V264, P72, DOI 10.1016/j.foreco.2011.10.012; Institute of Forestry Investigation and Planning (IFIP), 2003, TREE VOL TABL LIAON; LIU GH, 2000, ACTA ECOLOGICA SINIC, V20, P733; Ma XZ, 2011, CHINESE SCI BULL, V56, P883, DOI 10.1007/s11434-011-4402-6; Pan YD, 2004, CLIMATIC CHANGE, V67, P211, DOI 10.1007/s10584-004-2799-5; SHI L, 2011, PLOS ONE, V6, P1; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; Wang XJ, 2011, FOREST RESOURCES MAN, V1, P100; [王雪军 WANG XueJun], 2008, [生态学报, Acta Ecologica Sinica], V28, P4757; [吴庆标 WU QingBiao], 2008, [生态学报, Acta Ecologica Sinica], V28, P517; Xu B, 2010, SCI CHINA LIFE SCI, V53, P776, DOI 10.1007/s11427-010-4030-4; Xu SS, 2009, J BEIJING FORESTRY U, V8, P109; [徐新良 XU Xinliang], 2007, [地理科学进展, Progress in Geography], V26, P1; Zhao M, 2006, CLIMATIC CHANGE, V74, P175, DOI 10.1007/s10584-006-6775-0; Zhu BA, 2010, J PLANT RES, V123, P439, DOI 10.1007/s10265-009-0301-1	35	21	26	7	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89572	10.1371/journal.pone.0089572	http://dx.doi.org/10.1371/journal.pone.0089572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586881	Green Submitted, gold, Green Published			2022-12-27	WOS:000332385900054
J	Atanassoff, AP; Wolfmeier, H; Schoenauer, R; Hostettler, A; Ring, A; Draeger, A; Babiychuk, EB				Atanassoff, Alexander P.; Wolfmeier, Heidi; Schoenauer, Roman; Hostettler, Andrea; Ring, Avi; Draeger, Annette; Babiychuk, Eduard B.			Microvesicle Shedding and Lysosomal Repair Fulfill Divergent Cellular Needs during the Repair of Streptolysin O-Induced Plasmalemmal Damage	PLOS ONE			English	Article							MEMBRANE REPAIR; NUCLEATED CELLS; ACTIN POLYMERIZATION; COMPLEMENT ATTACK; EXOCYTOSIS; CERAMIDE; ENDOCYTOSIS; RESISTANCE; PROTEINS; RECOVERY	Pathogenic bacteria secrete pore-forming toxins that permeabilize the plasma membrane of host cells. Nucleated cells possess protective mechanisms that repair toxin-damaged plasmalemma. Currently two putative repair scenarios are debated: either the isolation of the damaged membrane regions and their subsequent expulsion as microvesicles (shedding) or lysosome-dependent repair might allow the cell to rid itself of its toxic cargo and prevent lysis. Here we provide evidence that both mechanisms operate in tandem but fulfill diverse cellular needs. The prevalence of the repair strategy varies between cell types and is guided by the severity and the localization of the initial toxin-induced damage, by the morphology of a cell and, most important, by the incidence of the secondary mechanical damage. The surgically precise action of microvesicle shedding is best suited for the instant elimination of individual toxin pores, whereas lysosomal repair is indispensable for mending of self-inflicted mechanical injuries following initial plasmalemmal permeabilization by bacterial toxins. Our study provides new insights into the functioning of non-immune cellular defenses against bacterial pathogens.	[Atanassoff, Alexander P.; Wolfmeier, Heidi; Schoenauer, Roman; Hostettler, Andrea; Draeger, Annette; Babiychuk, Eduard B.] Univ Bern, Inst Anat, Dept Cell Biol, Bern, Switzerland; [Ring, Avi] Norwegian Def Res Estab, Dept Protect, N-2007 Kjeller, Norway	University of Bern; Norwegian Defence Research Establishment	Babiychuk, EB (corresponding author), Univ Bern, Inst Anat, Dept Cell Biol, Bern, Switzerland.	edik@ana.unibe.ch	Babiychuk, Eduard/AAV-7223-2021	Babiychuk, Eduard/0000-0003-1786-0085; Wolfmeier, Heidi/0000-0003-2474-3717	Swiss National Science Foundation (SNF) [320030_128064/1, 3100A0_121980/1]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This study was supported by grants from the Swiss National Science Foundation (SNF) to AD (320030_128064/1) and EB (3100A0_121980/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers L, 2011, THROMB RES, V127, P370, DOI 10.1016/j.thromres.2010.12.014; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Babiychuk EB, 2008, TRAFFIC, V9, P1757, DOI 10.1111/j.1600-0854.2008.00800.x; Babiychuk EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023706; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Cai QA, 2010, NEURON, V68, P73, DOI 10.1016/j.neuron.2010.09.022; CARNEY DF, 1985, J IMMUNOL, V134, P1804; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Draeger Annette, 2013, Handb Exp Pharmacol, P341, DOI 10.1007/978-3-7091-1511-4_17; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Galkina SI, 2005, EXP CELL RES, V304, P620, DOI 10.1016/j.yexcr.2004.12.005; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; HAMILTON KK, 1990, J BIOL CHEM, V265, P3809; Hind E, 2010, BIOCHEM BIOPH RES CO, V399, P465, DOI 10.1016/j.bbrc.2010.07.095; Hussein MNA, 2007, THROMB HAEMOSTASIS, V98, P1096, DOI 10.1160/TH05-04-0231; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Keller H, 1998, CELL MOTIL CYTOSKEL, V41, P181, DOI 10.1002/(SICI)1097-0169(1998)41:2<181::AID-CM8>3.3.CO;2-M; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kralj-Iglic V, 2012, INT J NANOMED, V7, P3579, DOI 10.2147/IJN.S29076; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Miyake K, 2001, J CELL SCI, V114, P3487; Miyoshi H, 1996, GASTROENTEROLOGY, V110, P1897, DOI 10.1053/gast.1996.v110.pm8964416; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; MORGAN BP, 1987, J IMMUNOL, V138, P246; MORGAN BP, 1989, BIOCHEM J, V264, P1; MORGAN BP, 1986, J CELL BIOCHEM, P68; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rubin O, 2010, TALANTA, V82, P1, DOI 10.1016/j.talanta.2010.04.025; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Urbanija J, 2007, CHEM PHYS LIPIDS, V150, P49, DOI 10.1016/j.chemphyslip.2007.06.216; Walev I, 2001, FASEB J, V15, P237, DOI 10.1096/fj.01-0572fje; YANO Y, 1993, THROMB RES, V71, P385, DOI 10.1016/0049-3848(93)90163-I	51	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89743	10.1371/journal.pone.0089743	http://dx.doi.org/10.1371/journal.pone.0089743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24587004	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900148
J	Bomberger, JM; Coutermarsh, BA; Barnaby, RL; Sato, JD; Chapline, MC; Stanton, BA				Bomberger, Jennifer M.; Coutermarsh, Bonita A.; Barnaby, Roxanna L.; Sato, J. Denry; Chapline, M. Christine; Stanton, Bruce A.			Serum and Glucocorticoid-Inducible Kinase1 Increases Plasma Membrane wt-CFTR in Human Airway Epithelial Cells by Inhibiting Its Endocytic Retrieval	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; LYSOSOMAL DEGRADATION; FUNDULUS-HETEROCLITUS; EGF RECEPTOR; WILD-TYPE; IN-VITRO; TRAFFICKING; DELTA-F508-CFTR; SGK1	Background: Chloride (Cl) secretion by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) located in the apical membrane of respiratory epithelial cells plays a critical role in maintenance of the airway surface liquid and mucociliary clearance of pathogens. Previously, we and others have shown that the serum and glucocorticoid-inducible kinase-1 (SGK1) increases wild type CFTR (wt-CFTR) mediated Cl transport in Xenopus oocytes by increasing the amount of wt-CFTR protein in the plasma membrane. However, the effect of SGK1 on the membrane abundance of wt-CFTR in airway epithelial cells has not been examined, and the mechanism whereby SGK1 increases membrane wt-CFTR has also not been examined. Thus, the goal of this study was to elucidate the mechanism whereby SGK1 regulates the membrane abundance of wt-CFTR in human airway epithelial cells. Methods and Results: We report that elevated levels of SGK1, induced by dexamethasone, increase plasma membrane abundance of wt-CFTR. Reduction of SGK1 expression by siRNA (siSGK1) and inhibition of SGK1 activity by the SGK inhibitor GSK 650394 abrogated the ability of dexamethasone to increase plasma membrane wt-CFTR. Overexpression of a constitutively active SGK1 (SGK1-S422D) increased plasma membrane abundance of wt-CFTR. To understand the mechanism whereby SGK1 increased plasma membrane wt-CFTR, we examined the effects of siSGK1 and SGK1-S442D on the endocytic retrieval of wt-CFTR. While siSGK1 increased wt-CFTR endocytosis, SGK1-S442D inhibited CFTR endocytosis. Neither siSGK1 nor SGK1-S442D altered the recycling of endocytosed wt-CFTR back to the plasma membrane. By contrast, SGK1 increased the endocytosis of the epidermal growth factor receptor (EGFR). Conclusion: This study demonstrates for the first time that SGK1 selectively increases wt-CFTR in the plasma membrane of human airway epithelia cells by inhibiting its endocytic retrieval from the membrane.	[Bomberger, Jennifer M.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Coutermarsh, Bonita A.; Barnaby, Roxanna L.; Stanton, Bruce A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol & Physiol, Hanover, NH 03755 USA; [Sato, J. Denry; Chapline, M. Christine; Stanton, Bruce A.] Mt Desert Isl Biol Lab, Salsbury Cove, ME USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; Mount Desert Island Biological Laboratory	Stanton, BA (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol & Physiol, Hanover, NH 03755 USA.	BAS@dartmouth.edu			National Institutes of Health (NIH) [R01 HL074175, P20-RR01878, R00HL098342, P20-RR016463]; Cystic Fibrosis Foundation [BOMBER08F0, STANTO07R0]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098342, R01HL074175] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants R01 HL074175 (BAS) and P20-RR01878 (BAS), R00HL098342 (JMB) and Cystic Fibrosis Foundation grants BOMBER08F0 (JMB) and STANTO07R0 (BAS). JDS and MCC were supported by NIH grant P20-RR016463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Andersen MN, 2013, J BIOL CHEM; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bomberger JM, 2012, J BIOL CHEM, V287, P17130, DOI 10.1074/jbc.M111.338855; Bomberger JM, 2011, METHODS MOL BIOL, V741, P271, DOI 10.1007/978-1-61779-117-8_18; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Cheng CJ, 2011, J AM SOC NEPHROL, V22, P460, DOI 10.1681/ASN.2010060681; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Gehring EM, 2009, BIOCHEM BIOPH RES CO, V390, P952, DOI 10.1016/j.bbrc.2009.10.084; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Heise CJ, 2010, J BIOL CHEM, V285, P25161, DOI 10.1074/jbc.M110.103432; Kim JY, 2004, J BIOL CHEM, V279, P10389, DOI 10.1074/jbc.M312871200; Koeppen K, 2012, AM J PHYSIOL-LUNG C, V303, pL720, DOI 10.1152/ajplung.00409.2011; Lang F, 2012, FASEB J OFFICIAL PUB; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Prota LFM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047405; Rossi L, 2004, BLOOD CELL MOL DIS, V33, P57, DOI 10.1016/j.bcmd.2004.04.004; Rubenstein RC, 2011, AM J PHYSIOL-LUNG C, V300, pL88, DOI 10.1152/ajplung.00142.2010; Saad S, 2005, KIDNEY INT, V68, P985, DOI 10.1111/j.1523-1755.2005.00492.x; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; Shaw JR, 2008, CELL PHYSIOL BIOCHEM, V22, P69, DOI 10.1159/000149784; Shaw JR, 2010, AQUAT TOXICOL, V98, P157, DOI 10.1016/j.aquatox.2010.02.001; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tomas A., 2013, TRENDS CELL BIOL; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Young A, 2009, BIOCHEM J, V421, P377, DOI 10.1042/BJ20090389	45	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89599	10.1371/journal.pone.0089599	http://dx.doi.org/10.1371/journal.pone.0089599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586903	Green Accepted, Green Published, gold			2022-12-27	WOS:000331717900127
J	Zhou, RG; Fong, PSW; Tan, PK				Zhou, Ronggang; Fong, Patrick S. W.; Tan, Peking			Internet Use and Its Impact on Engagement in Leisure Activities in China	PLOS ONE			English	Article							TYPOLOGY; LIFE	Introduction: Internet use has become an increasingly common leisure time activity among Chinese citizens. The association between Internet use and engagement in leisure activities is especially unclear among China population. This study aims to investigate Internet usage and to determine whether active Internet use is a marker for low or high levels of leisure time activities. Methods/Principal Findings: With the use of a face-to-face structured questionnaire interview, a total of 2,400 respondents who met all screening requirements were surveyed to answer the questions in eight major cities in China. 66.2% (n = 1,589) of all respondents were identified as Internet users. Of these Internet users, 30.0%, 24.1%, 26.4%, and 19.6% were clustered as "informative or instrumental users,'' "entertainment users,'' "communication users,'' and "advanced users,'' respectively. Regarding time spent on Internet use in leisure time, more than 96% reported going online in non-work situations, and 26.2% (n = 416) were classified as "heavy Internet users.'' A logistic regression analysis revealed that there were significant differences in some leisure activities between non-Internet users and Internet users, with an observed one-unit increase in the leisure time dependence category increasing the probability of engaging in mental or social activities. In contrast, Internet users were less engaged in physical exercise-related activities. In addition, advanced Internet users were generally more active in leisure time activities than non-Internet users and other types of users. Conclusion/Significance: Internet use is one of very common leisure activities in Chinese citizens, and age, gender, income, and education are the key factors affecting Internet access. According to different types of leisure activities, Internet usage has different impacts on leisure activity engagement. High Internet dependence has no significant negative influence on engagement in mental or social leisure activities, but this group respondent tended to be less engaged in physical activities.	[Zhou, Ronggang] Beihang Univ, Sch Econ & Management, Beijing, Peoples R China; [Fong, Patrick S. W.] Hong Kong Polytech Univ, Dept Bldg & Real Estate, Hong Kong, Hong Kong, Peoples R China; [Tan, Peking] Millward Brown, Res & Dev, Beijing, Peoples R China	Beihang University; Hong Kong Polytechnic University	Zhou, RG (corresponding author), Beihang Univ, Sch Econ & Management, Beijing, Peoples R China.	zhrg@buaa.edu.cn	Fong, Patrick S.W./O-7315-2014	Fong, Patrick S.W./0000-0002-2017-5698	National Natural Science Foundation of China (NSFC) [31271100]; Hong Kong Scholars Program; Panmedia Institute	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Hong Kong Scholars Program; Panmedia Institute	This research was supported by the National Natural Science Foundation of China (NSFC, 31271100), the Hong Kong Scholars Program, and Panmedia Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amichai-Hamburger Y, 2011, COMPUT HUM BEHAV, V27, P585, DOI 10.1016/j.chb.2010.10.009; [Anonymous], 2009, GENERATIONS ONLINE 2; Brajsa-Zganec A, 2011, SOC INDIC RES, V102, P81, DOI 10.1007/s11205-010-9724-2; Brandtzaeg PB, 2011, INT J HUM-COMPUT ST, V69, P123, DOI 10.1016/j.ijhcs.2010.11.004; Brandtzaeg PB, 2010, COMPUT HUM BEHAV, V26, P940, DOI 10.1016/j.chb.2010.02.008; CNNIC, 2013, 31 STAT REP INT DEV; Colley A, 2008, COMPUT HUM BEHAV, V24, P2005, DOI 10.1016/j.chb.2007.09.002; Cummings JN, 2002, INFORM SOC, V18, P221, DOI 10.1080/01972240290074977; Hamburger YA, 2000, COMPUT HUM BEHAV, V16, P441, DOI 10.1016/S0747-5632(00)00017-0; Hargittai E, 2010, SOCIOL INQ, V80, P92, DOI 10.1111/j.1475-682X.2009.00317.x; Jansen J, 2010, USE INTERNET HIGHER; Jerome GJ, 2011, COMPUT HUM BEHAV, V27, P1207, DOI 10.1016/j.chb.2010.12.017; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Louis Leung, 2005, Telematics and Informatics, V22, P161, DOI 10.1016/j.tele.2004.04.003; Nie N. H., 2002, INTERNET EVERYDAY LI, P215, DOI DOI 10.1002/9780470774298.CH7; Peng TQ, 2011, NEW MEDIA SOC, V13, P568, DOI 10.1177/1461444810375976; Pew Research Center, 2013, WHOS ONL FREQ UPD TA; Rodgers S, 2007, INT J ADVERT, V26, P447, DOI 10.1080/02650487.2007.11073028; Selwyn N, 2005, EUR J COMMUN, V20, P5, DOI 10.1177/0267323105049631; Tsatsou P, 2011, TECHNOL SOC, V33, P73, DOI 10.1016/j.techsoc.2011.03.016; Tyler TR, 2002, J SOC ISSUES, V58, P195, DOI 10.1111/1540-4560.00256; Vandelanotte C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1084; Wang H, 2010, AM BEHAV SCI, V53, P1148, DOI 10.1177/0002764209356247; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019660; Wang HX, 2012, BBA-MOL BASIS DIS, V1822, P482, DOI 10.1016/j.bbadis.2011.09.002; Wasserman IM, 2005, SOC SCI QUART, V86, P252, DOI 10.1111/j.0038-4941.2005.00301.x; Zhao SY, 2006, J COMPUT-MEDIAT COMM, V11	27	19	19	7	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89598	10.1371/journal.pone.0089598	http://dx.doi.org/10.1371/journal.pone.0089598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586902	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900126
J	Carroll, R; Metcalfe, C; Gunnell, D				Carroll, Robert; Metcalfe, Chris; Gunnell, David			Hospital Presenting Self-Harm and Risk of Fatal and Non-Fatal Repetition: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							TERM-FOLLOW-UP; EMERGENCY-DEPARTMENT; ATTEMPTED-SUICIDE; HETEROGENEITY; EPIDEMIOLOGY; MANAGEMENT; ACCIDENT; ADULTS	Background: Non-fatal self-harm is one of the most frequent reasons for emergency hospital admission and the strongest risk factor for subsequent suicide. Repeat self-harm and suicide are key clinical outcomes of the hospital management of self-harm. We have undertaken a comprehensive review of the international literature on the incidence of fatal and non-fatal repeat self-harm and investigated factors influencing variation in these estimates as well as changes in the incidence of repeat self-harm and suicide over the last 30 years. Methods and Findings: Medline, EMBASE, PsycINFO, Google Scholar, article reference lists and personal paper collections of the authors were searched for studies describing rates of fatal and non-fatal self-harm amongst people who presented to health care services for deliberate self-harm. Heterogeneity in pooled estimates of repeat self-harm incidence was investigated using stratified meta-analysis and meta-regression. The search identified 177 relevant papers. The risk of suicide in the 12 months after an index attempt was 1.6% (CI 1.2-2.4) and 3.9% (CI 3.2-4.8) after 5 years. The estimated 1 year rate of non-fatal repeat self-harm was 16.3% (CI 15.1-17.7). This proportion was considerably lower in Asian countries (10.0%, CI 7.3-13.6%) and varies between studies identifying repeat episodes using hospital admission data (13.7%, CI 12.3-15.3) and studies using patient report (21.9%, CI 14.3-32.2). There was no evidence that the incidence of repeat self-harm was lower in more recent (post 2000) studies compared to those from the 1980s and 1990s. Conclusions: One in 25 patients presenting to hospital for self-harm will kill themselves in the next 5 years. The incidence of repeat self-harm and suicide in this population has not changed in over 10 years. Different methods of identifying repeat episodes of self-harm produce varying estimates of incidence and this heterogeneity should be considered when evaluating interventions aimed at reducing non-fatal repeat self-harm.	[Carroll, Robert; Metcalfe, Chris; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Bristol	Carroll, R (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	robert.carroll@bristol.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Metcalfe, Chris/0000-0001-8318-8907	National Institute for Health Research (NIHR); National Institute for Health Research [DRF-2012-05-189, NF-SI-0512-10068] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	RC is funded by a National Institute for Health Research (NIHR) Doctoral Research Fellowship and DG is a NIHR Senior Investigator. The NIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Bennewith O, 2004, BMJ-BRIT MED J, V328, P1108, DOI 10.1136/bmj.328.7448.1108; Bergen H, 2012, J AFFECT DISORDERS, V136, P526, DOI 10.1016/j.jad.2011.10.036; Chen VCH, 2010, BRIT J PSYCHIAT, V196, P31, DOI 10.1192/bjp.bp.109.067009; Chung CH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-744; Eddleston M, 2005, BRIT J PSYCHIAT, V187, P583, DOI 10.1192/bjp.187.6.583; Foster T, 1999, BRIT J PSYCHIAT, V175, P175, DOI 10.1192/bjp.175.2.175; Gairin I, 2003, BRIT J PSYCHIAT, V183, P28, DOI 10.1192/bjp.183.1.28; Gilbody S, 1997, J ROY COLL PHYS LOND, V31, P171; Gunnell D, 2005, J PUBLIC HEALTH-UK, V27, P67, DOI 10.1093/pubmed/fdh192; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; Hassanian-Moghaddam H, 2011, BRIT J PSYCHIAT, V198, P309, DOI 10.1192/bjp.bp.109.067199; Hawton K, 2003, BRIT J PSYCHIAT, V182, P537, DOI 10.1192/bjp.182.6.537; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Horrocks J, 2003, BRIT J PSYCHIAT, V183, P34, DOI 10.1192/bjp.183.1.34; Ito T, 2004, SEISHIN IGAKU, V46, P389; Lee Y, 2012, ASIA-PAC PSYCHIAT, V4, P174, DOI 10.1111/j.1758-5872.2012.00189.x; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; [刘连忠 Liu Liangzhong], 2002, [中国心理卫生杂志, Chinese Mental Health Journal], V16, P253; Mohamed F, 2011, SOC PSYCH PSYCH EPID, V46, P517, DOI 10.1007/s00127-010-0217-z; Morthorst B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4972; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; Sinclair JMA, 2011, SOC PSYCH PSYCH EPID, V46, P263, DOI 10.1007/s00127-010-0183-5; Yip PSF, 2011, CRISIS, V32, P217, DOI 10.1027/0227-5910/a000069; Zahl DL, 2004, BRIT J PSYCHIAT, V185, P70, DOI 10.1192/bjp.185.1.70	28	304	305	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89944	10.1371/journal.pone.0089944	http://dx.doi.org/10.1371/journal.pone.0089944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587141	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200095
J	Gemmell, P; Burrage, K; Rodriguez, B; Quinn, TA				Gemmell, Philip; Burrage, Kevin; Rodriguez, Blanca; Quinn, T. Alexander			Population of Computational Rabbit-Specific Ventricular Action Potential Models for Investigating Sources of Variability in Cellular Repolarisation	PLOS ONE			English	Article							SHORT-TERM VARIABILITY; ELECTROPHYSIOLOGICAL PROPERTIES; INTRACELLULAR CA2+; D-SOTALOL; DURATION; HEART; MECHANISMS; ALTERNANS; ARRHYTHMIAS; DISPERSION	Variability is observed at all levels of cardiac electrophysiology. Yet, the underlying causes and importance of this variability are generally unknown, and difficult to investigate with current experimental techniques. The aim of the present study was to generate populations of computational ventricular action potential models that reproduce experimentally observed intercellular variability of repolarisation (represented by action potential duration) and to identify its potential causes. A systematic exploration of the effects of simultaneously varying the magnitude of six transmembrane current conductances (transient outward, rapid and slow delayed rectifier K+, inward rectifying K+, L-type Ca2+, and Na+/K+ pump currents) in two rabbit-specific ventricular action potential models (Shannon et al. and Mahajan et al.) at multiple cycle lengths (400, 600, 1,000 ms) was performed. This was accomplished with distributed computing software specialised for multi-dimensional parameter sweeps and grid execution. An initial population of 15,625 parameter sets was generated for both models at each cycle length. Action potential durations of these populations were compared to experimentally derived ranges for rabbit ventricular myocytes. 1,352 parameter sets for the Shannon model and 779 parameter sets for the Mahajan model yielded action potential duration within the experimental range, demonstrating that a wide array of ionic conductance values can be used to simulate a physiological rabbit ventricular action potential. Furthermore, by using clutter-based dimension reordering, a technique that allows visualisation of multi-dimensional spaces in two dimensions, the interaction of current conductances and their relative importance to the ventricular action potential at different cycle lengths were revealed. Overall, this work represents an important step towards a better understanding of the role that variability in current conductances may play in experimentally observed intercellular variability of rabbit ventricular action potential repolarisation.	[Gemmell, Philip; Burrage, Kevin; Rodriguez, Blanca] Univ Oxford, Dept Comp Sci, Oxford, England; [Burrage, Kevin] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Quinn, T. Alexander] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada	University of Oxford; Queensland University of Technology (QUT); Dalhousie University	Quinn, TA (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada.	alex.quinn@dal.ca		Gemmell, Philip/0000-0003-2942-0992; Quinn, T Alexander/0000-0002-2437-5785; Burrage, Kevin/0000-0002-8111-1137; Rodriguez, Blanca/0000-0001-6361-3339	Engineering and Physical Sciences Research Council (EPSRC) through the Systems Biology Doctoral Training Centre at the University of Oxford; Medical Research Council (MRC); EPSRC; British Heart Foundation; Magdi Yacoub Institute; British Heart Foundation [PG/09/066/27898] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F042868/2, EP/F042868/1] Funding Source: researchfish; Medical Research Council [G0700278] Funding Source: researchfish; EPSRC [EP/F042868/2, EP/F042868/1] Funding Source: UKRI; MRC [G0700278] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC) through the Systems Biology Doctoral Training Centre at the University of Oxford(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); Magdi Yacoub Institute; British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PG is supported by the Engineering and Physical Sciences Research Council (EPSRC) through the Systems Biology Doctoral Training Centre at the University of Oxford. BR holds Medical Research Council (MRC) Career Development, Centenary, and Industrial Partnership Awards. TAQ was holder of an EPSRC Postdoctoral Fellowship and was further supported by the British Heart Foundation and the Magdi Yacoub Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson D, 2011, IEEE T PARALL DISTR, V22, P960, DOI 10.1109/TPDS.2010.177; Abramson D, 2010, PHILOS T R SOC A, V368, P3907, DOI 10.1098/rsta.2010.0170; Biagetti MO, 2006, HEART RHYTHM, V3, P832, DOI 10.1016/j.hrthm.2006.03.010; Britton OJ, 2013, P NATL ACAD SCI USA, V110, pE2098, DOI 10.1073/pnas.1304382110; Burton RAB, 2012, EUROPACE, V14, pV73, DOI 10.1093/europace/eus276; Buyya R, 2000, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED PROCESSING TECHNIQUES AND APPLICATIONS, VOLS I-V, P517; Carusi A, 2012, AM J PHYSIOL-HEART C, V303, pH144, DOI 10.1152/ajpheart.01151.2011; Chen Man, 2006, Journal of Pharmacological and Toxicological Methods, V54, P261, DOI 10.1016/j.vascn.2006.02.005; Cheng Y, 2002, AM J PHYSIOL-HEART C, V282, pH2141, DOI 10.1152/ajpheart.00561.2001; Chou CC, 2007, J PHYSIOL-LONDON, V580, P895, DOI 10.1113/jphysiol.2006.120659; Corrias A, 2011, AM J PHYSIOL-HEART C, V300, pH1806, DOI 10.1152/ajpheart.01170.2010; Davies MR, 2012, AM J PHYSIOL-HEART C, V302, pH1466, DOI 10.1152/ajpheart.00808.2011; Dutta S, 2011, LECT NOTES COMPUT SC, V6666, P20, DOI 10.1007/978-3-642-21028-0_3; Eckardt L, 1998, J CARDIOVASC ELECTR, V9, P366, DOI 10.1111/j.1540-8167.1998.tb00925.x; Garny A, 2009, PHILOS T R SOC A, V367, P1885, DOI 10.1098/rsta.2008.0289; Gemmell P, 2010, IEEE ENG MED BIO, P2662, DOI 10.1109/IEMBS.2010.5626617; Goldhaber JI, 2005, CIRC RES, V96, P459, DOI 10.1161/01.RES.0000156891.66893.83; Hashambhoy YL, 2011, IEEE ENG MED BIO, P4665, DOI 10.1109/IEMBS.2011.6091155; Hinterseer M, 2010, AM J CARDIOL, V106, P216, DOI 10.1016/j.amjcard.2010.02.033; Hondeghem LM, 2001, CIRCULATION, V103, P2004; Johnson DM, 2010, J MOL CELL CARDIOL, V48, P122, DOI 10.1016/j.yjmcc.2009.08.033; Jung BC, 2011, J KOREAN MED SCI, V26, P1576, DOI 10.3346/jkms.2011.26.12.1576; Kirchhof P, 2003, J PHARMACOL EXP THER, V305, P257, DOI 10.1124/jpet.102.046755; KURZ RW, 1993, EUR HEART J, V14, P1410, DOI 10.1093/eurheartj/14.10.1410; LEBLANC J, 1990, PROCEEDINGS OF THE FIRST IEEE CONFERENCE ON VISUALIZATION - VISUALIZATION 90, P230, DOI 10.1109/VISUAL.1990.146386; Lemay M, 2011, J THEOR BIOL, V281, P84, DOI 10.1016/j.jtbi.2011.04.019; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Maltsev VA, 2013, J MOL CELL CARDIOL, V59, P181, DOI 10.1016/j.yjmcc.2013.03.004; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; McIntosh MA, 2000, CARDIOVASC RES, V45, P397, DOI 10.1016/S0008-6363(99)00360-0; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Morita N, 2009, AM J PHYSIOL-HEART C, V297, pH1594, DOI 10.1152/ajpheart.00579.2009; Myles RC, 2008, J MOL CELL CARDIOL, V45, P1, DOI 10.1016/j.yjmcc.2008.03.024; Myles RC, 2010, AM J PHYSIOL-HEART C, V299, pH1812, DOI 10.1152/ajpheart.00518.2010; Nattel S, 2008, PROG BIOPHYS MOL BIO, V98, P328, DOI 10.1016/j.pbiomolbio.2008.10.009; Niederer SA, 2009, EXP PHYSIOL, V94, P486, DOI 10.1113/expphysiol.2008.044610; Peng W, 2004, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2004, PROCEEDINGS, P89; Peng W, 2005, THESIS WORCESTER POL; Ponard JGC, 2007, BIOPHYS J, V92, P3734, DOI 10.1529/biophysj.106.091892; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Quinn TA, 2011, PROG BIOPHYS MOL BIO, V107, P4, DOI 10.1016/j.pbiomolbio.2011.07.001; Quinn TA, 2013, CARDIOVASC RES, V97, P601, DOI 10.1093/cvr/cvt003; Quinn TA, 2011, ANN NY ACAD SCI, V1245, P40, DOI 10.1111/j.1749-6632.2011.06327.x; Ripplinger CM, 2009, HEART RHYTHM, V6, P87, DOI 10.1016/j.hrthm.2008.09.019; Romero L, 2011, PROG BIOPHYS MOL BIO, V107, P60, DOI 10.1016/j.pbiomolbio.2011.06.012; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Sarkar AX, 2011, HEART RHYTHM, V8, P1749, DOI 10.1016/j.hrthm.2011.05.023; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Shannon TR, 2012, BIOPHYS J, V102, P1996, DOI 10.1016/j.bpj.2012.03.034; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Sims C, 2008, CIRC RES, V102, pE86, DOI 10.1161/CIRCRESAHA.108.173740; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Szigligeti P, 1996, J COMP PHYSIOL B, V166, P150, DOI 10.1007/BF00301179; Tanskanen AJ, 2005, BIOPHYS J, V88, P85, DOI 10.1529/biophysj.104.051508; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Thomsen MB, 2004, CIRCULATION, V110, P2453, DOI 10.1161/01.CIR.0000145162.64183.C8; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; Walmsley J, 2010, IEEE ENG MED BIO, P1457, DOI 10.1109/IEMBS.2010.5626858; Wu L, 2011, CIRCULATION, V123, P1713, DOI 10.1161/CIRCULATIONAHA.110.000661; Yan GX, 2001, AM J PHYSIOL-HEART C, V281, pH1968, DOI 10.1152/ajpheart.2001.281.5.H1968; Zabel M, 1997, J CARDIOVASC ELECTR, V8, P1239, DOI 10.1111/j.1540-8167.1997.tb01014.x; Zabel M, 1997, PACE, V20, P2405, DOI 10.1111/j.1540-8159.1997.tb06078.x	66	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90112	10.1371/journal.pone.0090112	http://dx.doi.org/10.1371/journal.pone.0090112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587229	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200128
J	Bahety, P; Tan, YM; Hong, YJ; Zhang, LQ; Chan, ECY; Ee, PLR				Bahety, Priti; Tan, Yee Min; Hong, Yanjun; Zhang, Luqi; Chan, Eric Chun Yong; Ee, Pui-Lai Rachel			Metabotyping of Docosahexaenoic Acid - Treated Alzheimer's Disease Cell Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; POLYUNSATURATED FATTY-ACIDS; ARACHIDONIC-ACID; MITOCHONDRIAL DYSFUNCTION; COGNITIVE DECLINE; OXIDATIVE DAMAGE; IN-VITRO; BETA; CHOLESTEROL; ACCUMULATION	Background: Despite the significant amount of work being carried out to investigate the therapeutic potential of docosahexaenoic acid (DHA) in Alzheimer's disease (AD), the mechanism by which DHA affects amyloid-b precursor protein (AbPP)-induced metabolic changes has not been studied. Objective: To elucidate the metabolic phenotypes (metabotypes) associated with DHA therapy via metabonomic profiling of an AD cell model using gas chromatography time-of-flight mass spectrometry (GC/TOFMS). Methods: The lysate and supernatant samples of CHO-wt and CHO-A beta PP695 cells treated with DHA and vehicle control were collected and prepared for GC/TOFMS metabonomics profiling. The metabolic profiles were analyzed by multivariate data analysis techniques using SIMCA-P+ software. Results: Both principal component analysis and subsequent partial least squares discriminant analysis revealed distinct metabolites associated with the DHA-treated and control groups. A list of statistically significant marker metabolites that characterized the metabotypes associated with DHA treatment was further identified. Increased levels of succinic acid, citric acid, malic acid and glycine and decreased levels of zymosterol, cholestadiene and arachidonic acid correlated with DHA treatment effect. DHA levels were also found to be increased upon treatment. Conclusion: Our study shows that DHA plays a role in mitigating AbPP-induced impairment in energy metabolism and inflammation by acting on tricarboxylic acid cycle, cholesterol biosynthesis pathway and fatty acid metabolism. The perturbations of these metabolic pathways by DHA in CHO-wt and CHO-A beta PP695 cells shed further mechanistic insights on its neuroprotective actions.	[Bahety, Priti; Tan, Yee Min; Hong, Yanjun; Zhang, Luqi; Chan, Eric Chun Yong; Ee, Pui-Lai Rachel] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore	National University of Singapore	Chan, ECY (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore.	phaccye@nus.edu.sg; phaeplr@nus.edu.sg	EE, P.L. Rachel/C-7538-2014; Chan, Eric Chun Yong/E-7101-2013	Bahety, Priti/0000-0002-5556-970X; Ee, Pui Lai Rachel/0000-0002-7277-6233; Chan, Eric Chun Yong/0000-0001-6107-9072; Bahety, Priti/0000-0002-9793-5288; Hong, Yanjun/0000-0003-3059-8130	National University of Singapore's Graduate Scholarship; National University of Singapore's Academic Research Fund [R148-000-135-112, R148-000-150-112]	National University of Singapore's Graduate Scholarship; National University of Singapore's Academic Research Fund	This work was supported by National University of Singapore's Graduate Scholarship to PB and LZ and National University of Singapore's Academic Research Fund grants R148-000-135-112 to ECYC and R148-000-150-112 to PLRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandatheerthavarada HK, 2007, NEUROSCIENTIST, V13, P626, DOI 10.1177/1073858407303536; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Chen KP, 2012, J MOL NEUROSCI, V46, P203, DOI 10.1007/s12031-011-9578-3; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Esposito G, 2008, J NUCL MED, V49, P1414, DOI 10.2967/jnumed.107.049619; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Florent-Bechard S, 2007, J NEUROL SCI, V262, P27, DOI 10.1016/j.jns.2007.06.046; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Hashimoto M, 2005, BBA-MOL CELL BIOL L, V1738, P91, DOI 10.1016/j.bbalip.2005.11.011; Hashimoto M, 2005, J NUTR, V135, P549, DOI 10.1093/jn/135.3.549; Kandiah N, 2009, J NEUROL SCI, V283, P230, DOI 10.1016/j.jns.2009.02.352; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; KUEHL FA, 1980, SCIENCE, V210, P978, DOI 10.1126/science.6254151; Kyle DJ, 1999, LIPIDS, V34, pS245, DOI 10.1007/BF02562306; Labrousse VF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036861; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mao P, 2013, J NEURODEGENER DIS, V2013, P15; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; Mendes Pedro, 2002, Brief Bioinform, V3, P134; Muskiet FAJ, 2006, PROSTAG LEUKOTR ESS, V75, P135, DOI 10.1016/j.plefa.2006.05.010; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Reddy PH, 2010, J ALZHEIMERS DIS, V20, pS499, DOI 10.3233/JAD-2010-100504; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Serhan CN, 2009, J THROMB HAEMOST, V7, P44, DOI 10.1111/j.1538-7836.2009.03396.x; Shioi J, 2007, J NEUROCHEM, V101, P674, DOI 10.1111/j.1471-4159.2006.04391.x; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Stonehouse W, 2013, AM J CLIN NUTR, V97, P1134, DOI 10.3945/ajcn.112.053371; Wilson DM, 1997, AM J PATHOL, V150, P2181; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	52	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90123	10.1371/journal.pone.0090123	http://dx.doi.org/10.1371/journal.pone.0090123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587236	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800079
J	Eyre-Walker, YC; Eyre-Walker, A				Eyre-Walker, Ying Chen; Eyre-Walker, Adam			The Role of Mutation Rate Variation and Genetic Diversity in the Architecture of Human Disease	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SUBSTITUTION RATES; REPLICATION; SELECTION; EVOLUTION; PATTERNS; REGIONS	Background: We have investigated the role that the mutation rate and the structure of genetic variation at a locus play in determining whether a gene is involved in disease. We predict that the mutation rate and its genetic diversity should be higher in genes associated with disease, unless all genes that could cause disease have already been identified. Results: Consistent with our predictions we find that genes associated with Mendelian and complex disease are substantially longer than non-disease genes. However, we find that both Mendelian and complex disease genes are found in regions of the genome with relatively low mutation rates, as inferred from intron divergence between humans and chimpanzees, and they are predicted to have similar rates of non-synonymous mutation as other genes. Finally, we find that disease genes are in regions of significantly elevated genetic diversity, even when variation in the rate of mutation is controlled for. The effect is small nevertheless. Conclusions: Our results suggest that gene length contributes to whether a gene is associated with disease. However, the mutation rate and the genetic architecture of the locus appear to play only a minor role in determining whether a gene is associated with disease.	[Eyre-Walker, Ying Chen; Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sussex	Eyre-Walker, A (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	a.c.eyre-walker@sussex.ac.uk	Eyre-Walker, Adam/G-6216-2011	Eyre-Walker, Adam/0000-0001-5527-8729				Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Ellegren H, 2007, P ROY SOC B-BIOL SCI, V274, P1, DOI 10.1098/rspb.2006.3720; Gossmann TI, 2011, GENETICS, V189, P1389, DOI 10.1534/genetics.111.132654; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Kondrashov FA, 2004, NUCLEIC ACIDS RES, V32, P1731, DOI 10.1093/nar/gkh330; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2010, GENOME RES, V20, P1503, DOI 10.1101/gr.106666.110; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nachman MW, 2000, GENETICS, V156, P297; Park C, 2012, EMBO REP, V13, P1123, DOI 10.1038/embor.2012.165; Pink CJ, 2010, MOL BIOL EVOL, V27, P1077, DOI 10.1093/molbev/msp314; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith NGC, 2003, GENE, V318, P169, DOI 10.1016/S0378-1119(03)00772-8; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Tyekucheva S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r76; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0	30	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90166	10.1371/journal.pone.0090166	http://dx.doi.org/10.1371/journal.pone.0090166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587257	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800084
J	Orueta, JF; Garcia-Alvarez, A; Garcia-Goni, M; Paolucci, F; Nuno-Solinis, R				Orueta, Juan F.; Garcia-Alvarez, Arturo; Garcia-Goni, Manuel; Paolucci, Francesco; Nuno-Solinis, Roberto			Prevalence and Costs of Multimorbidity by Deprivation Levels in the Basque Country: A Population Based Study Using Health Administrative Databases	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; PRIMARY-CARE; MANAGEMENT	Background: Multimorbidity is a major challenge for healthcare systems. However, currently, its magnitude and impact in healthcare expenditures is still mostly unknown. Objective: To present an overview of the prevalence and costs of multimorbidity by socioeconomic levels in the whole Basque population. Methods: We develop a cross-sectional analysis that includes all the inhabitants of the Basque Country (N = 2,262,698). We utilize data from primary health care electronic medical records, hospital admissions, and outpatient care databases, corresponding to a 4 year period. Multimorbidity was defined as the presence of two or more chronic diseases out of a list of 52 of the most important and common chronic conditions given in the literature. We also use socioeconomic and demographic variables such as age, sex, individual healthcare cost, and deprivation level. Predicted adjusted costs were obtained by log-gamma regression models. Results: Multimorbidity of chronic diseases was found among 23.61% of the total Basque population and among 66.13% of those older than 65 years. Multimorbid patients account for 63.55% of total healthcare expenditures. Prevalence of multimorbidity is higher in the most deprived areas for all age and sex groups. The annual cost of healthcare per patient generated for any chronic disease depends on the number of coexisting comorbidities, and varies from 637 (sic) for the first pathology in average to 1,657 (sic) for the ninth one. Conclusion: Multimorbidity is very common for the Basque population and its prevalence rises in age, and unfavourable socioeconomic environment. The costs of care for chronic patients with several conditions cannot be described as the sum of their individual pathologies in average. They usually increase dramatically according to the number of comorbidities. Given the ageing population, multimorbidity and its consequences should be taken into account in healthcare policy, the organization of care and medical research.	[Orueta, Juan F.] Osakidetza Basque Hlth Serv, Ctr Salud Astrabudua, Erandio, Bizkaia, Spain; [Garcia-Alvarez, Arturo; Nuno-Solinis, Roberto] Basque Inst Healthcare Innovat, O Berri, Sondika, Bizkaia, Spain; [Garcia-Goni, Manuel] Univ Complutense Madrid, Dept Economi Aplicada 2, Madrid, Spain; [Paolucci, Francesco] Australian Natl Univ, Acton, Australia; [Paolucci, Francesco] Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Complutense University of Madrid; Australian National University; Northumbria University	Orueta, JF (corresponding author), Osakidetza Basque Hlth Serv, Ctr Salud Astrabudua, Erandio, Bizkaia, Spain.	jon.orueta@osakidetza.net	Orueta, Juan F/H-4464-2019; Nuño-Solinís, Roberto/J-5443-2016; García-Goñi, Manuel/AAJ-5062-2020; Garcia-Alvarez, Arturo/GYV-2079-2022; Silva-Castillo, Vicente-Xavier xs/S-5324-2018	Orueta, Juan F/0000-0002-0172-636X; Nuño-Solinís, Roberto/0000-0001-9930-4589; García-Goñi, Manuel/0000-0001-5266-7112; Silva-Castillo, Vicente-Xavier xs/0000-0002-8158-2916; Garcia-Alvarez, Arturo/0000-0001-8481-0104; Paolucci, Francesco/0000-0001-6173-5324; PAOLUCCI, FRANCESCO/0000-0002-6585-7190				Anderson G, 2011, OECD HLTH REFORM M C, P15; [Anonymous], 2011, HLTH REF M CHALL AG; [Anonymous], 2010, STRAT TACKL CHALL CH; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Basu A, 2005, BIOSTATISTICS, V6, P93, DOI 10.1093/biostatistics/kxh020; Basu A, 2009, MED CARE, V47, pS109, DOI 10.1097/MLR.0b013e31819c94a1; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Cabrera-Leon A, 2012, INT J HEALTHCARE MAN, V5, P208, DOI 10.1179/2047971912Y.0000000022; Charlson M, 2007, J GEN INTERN MED, V22, P464, DOI 10.1007/s11606-007-0130-7; Chen AY, 2010, PREV CHRONIC DIS, V7; Dominguez-Berjon MF, 2008, GAC SANIT, V22, P179, DOI 10.1157/13123961; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Garcia-Goni M, 2012, HEALTH POLICY, V108, P236, DOI 10.1016/j.healthpol.2012.09.014; Gene-Badia J, 2012, HEALTH POLICY, V106, P23, DOI 10.1016/j.healthpol.2012.02.001; Gorina Y, 2011, HEALTH SERV RES, V46, P1610, DOI 10.1111/j.1475-6773.2011.01277.x; Hjerpe P, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-23; Johns Hopkins Bloomberg School of Public Health, 2009, J HOPK ACG CAS MIX S; Lehnert T, 2012, BUNDESGESUNDHEITSBLA, V55, P685, DOI 10.1007/s00103-012-1475-6; Lewis GH, 2010, MILBANK Q, V88, P240, DOI 10.1111/j.1468-0009.2010.00597.x; Maio Vittorio, 2005, J Health Serv Res Policy, V10, P232, DOI 10.1258/135581905774414259; Majeed Azeem, 2004, Health Stat Q, P5; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Martinez-Granado M., 2012, BASQUE COUNTRY SPAIN; Naessens JM, 2011, AM J MANAG CARE, V17, P118; Nuno R, 2010, STRATEGY TACKLING CH; Nuno Solinis R, 2013, DEV IMPLEMENTATION R; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Orueta JF, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-365; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Roland M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2510; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Spanish Institute of Health Information, 2012, SPAN VERS ECIE9MC EL, V8th; Starfield B, 2011, HEALTH POLICY, V103, P3, DOI 10.1016/j.healthpol.2011.09.004; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Van de Ven WPMM, 2000, HANDB ECON, V17, P755; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Weiner JP, 1996, HEALTH CARE FINANC R, V17, P77; WHO Collaborating Centre for Drug Statistics Methodology, 2012, INT LANG DRUG UT RES; Wirehn ABE, 2007, SCAND J PUBLIC HEALT, V35, P424, DOI 10.1080/14034940701195230; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000	40	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89787	10.1371/journal.pone.0089787	http://dx.doi.org/10.1371/journal.pone.0089787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24587035	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800039
J	Toyoshima, D; Mandai, K; Maruo, T; Supriyanto, I; Togashi, H; Inoue, T; Mori, M; Takai, Y				Toyoshima, Daisaku; Mandai, Kenji; Maruo, Tomohiko; Supriyanto, Irwan; Togashi, Hideru; Inoue, Takahito; Mori, Masahiro; Takai, Yoshimi			Afadin Regulates Puncta Adherentia Junction Formation and Presynaptic Differentiation in Hippocampal Neurons	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; SYNAPSES; RECEPTOR; PROTEIN; NECTIN; SPINE; GENE; AF-6; ORGANIZATION; PLASTICITY	The formation and remodeling of mossy fiber-CA3 pyramidal cell synapses in the stratum lucidum of the hippocampus are implicated in the cellular basis of learning and memory. Afadin and its binding cell adhesion molecules, nectin-1 and nectin-3, together with N-cadherin, are concentrated at puncta adherentia junctions (PAJs) in these synapses. Here, we investigated the roles of afadin in PAJ formation and presynaptic differentiation in mossy fiber-CA3 pyramidal cell synapses. At these synapses in the mice in which the afadin gene was conditionally inactivated before synaptogenesis by using nestin-Cre mice, the immunofluorescence signals for the PAJ components, nectin-1, nectin-3 and N-cadherin, disappeared almost completely, while those for the presynaptic components, VGLUT1 and bassoon, were markedly decreased. In addition, these signals were significantly decreased in cultured afadin-deficient hippocampal neurons. Furthermore, the interevent interval of miniature excitatory postsynaptic currents was prolonged in the cultured afadin-deficient hippocampal neurons compared with control neurons, indicating that presynaptic functions were suppressed or a number of synapse was reduced in the afadin-deficient neurons. Analyses of presynaptic vesicle recycling and paired recordings revealed that the cultured afadin-deficient neurons showed impaired presynaptic functions. These results indicate that afadin regulates both PAJ formation and presynaptic differentiation in most mossy fiber-CA3 pyramidal cell synapses, while in a considerable population of these neurons, afadin regulates only PAJ formation but not presynaptic differentiation.	[Toyoshima, Daisaku; Mandai, Kenji; Maruo, Tomohiko; Togashi, Hideru; Inoue, Takahito; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Supriyanto, Irwan; Mori, Masahiro] Kobe Univ, Grad Sch Hlth Sci, Fac Hlth Sci, Kobe, Hyogo 657, Japan; [Toyoshima, Daisaku; Mandai, Kenji; Maruo, Tomohiko; Supriyanto, Irwan; Togashi, Hideru; Inoue, Takahito; Mori, Masahiro; Takai, Yoshimi] Japan Sci & Technol Agcy, CREST, Kobe, Hyogo, Japan	Kobe University; Kobe University; Japan Science & Technology Agency (JST)	Mandai, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan.	mandai@med.kobe-u.ac.jp; ytakai@med.kobe-u.ac.jp	Toyoshima, Daisaku/ABH-7146-2020; Supriyanto, Irwan/AAG-5461-2019	Toyoshima, Daisaku/0000-0002-1111-7816; Supriyanto, Irwan/0000-0002-5114-6718; Togashi, Hideru/0000-0002-3967-5940; Mandai, Kenji/0000-0002-0115-6635	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science [21227005, 24590354, 22500293, 25860214]; Naito Foundation; Sagawa Foundation for Promotion of Cancer Research; Yasuda Medical Foundation; Grants-in-Aid for Scientific Research [21500372, 26400205] Funding Source: KAKEN	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Sagawa Foundation for Promotion of Cancer Research; Yasuda Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global COE Program "Global Center for Education and Research in Integrative Membrane Biology" (http://www.jsps.go.jp/english/eglobalcoe/) and the Targeted Proteins Research Program (http://www.tanpaku.org/e_index.php) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Grants-in-Aid for Scientific Research (S) (21227005 to Y.T.) and (C) (24590354 to K. M. and 22500293 to H. T.) and for Young Scientists (B) (25860214 to T. M.) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/), and the grants (to Y.T.) from the Naito Foundation (https://www.naito-f.or.jp/en/), the Sagawa Foundation for Promotion of Cancer Research (http://www.sagawa-gan.or.jp/), and the Yasuda Medical Foundation (http://www.yasuda-mf.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudoin GMJ, 2012, J NEUROSCI, V32, P99, DOI 10.1523/JNEUROSCI.4565-11.2012; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Kurita S, 2013, J BIOL CHEM IN PRESS; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Mandai K, 2013, PROG MOL BIOL TRANSL, V116, P433, DOI 10.1016/B978-0-12-394311-8.00019-4; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; PRASAD R, 1993, CANCER RES, V53, P5624; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SPACEK J, 1974, J ANAT, V117, P487; Srivastava DP, 2012, J BIOL CHEM, V287, P35964, DOI 10.1074/jbc.M112.363358; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	30	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89763	10.1371/journal.pone.0089763	http://dx.doi.org/10.1371/journal.pone.0089763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587018	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800036
J	Yu, WL; Qu, H; Hu, GQ; Zhang, Q; Song, K; Guan, HJ; Liu, TJ; Qin, JH				Yu, Weiliang; Qu, Hong; Hu, Guoqing; Zhang, Qian; Song, Kui; Guan, Haijie; Liu, Tingjiao; Qin, Jianhua			A Microfluidic-Based Multi-Shear Device for Investigating the Effects of Low Fluid-Induced Stresses on Osteoblasts	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; INTERSTITIAL CONVECTION; FLOW; DIFFERENTIATION; INCREASES; MATRIX; ACTIVATION; RESPOND	Interstitial fluid flow (IFF) within the extracellular matrix (ECM) produces low magnitude shear stresses on cells. Fluid flow-induced stress (FSS) plays an important role during tissue morphogenesis. To investigate the effect of low FSS generated by IFF on cells, we developed a microfluidic-based cell culture device that can generate multiple low shear stresses. By changing the length and width of the flow-in channels, different continuous low level shear stresses could be generated in individual cell culture chambers. Numerical calculations demonstrate uniform shear stress distributions of the major cell culture area of each chamber. This calculation is further confirmed by the wall shear stress curves. The effects of low FSS on MC3T3-E1 proliferation and differentiation were studied using this device. It was found that FSS ranging from 1.5 to 52.6 mu Pa promoted MC3T3-E1 proliferation and differentiation, but FSS over 412 mu Pa inhibited the proliferation and differentiation of MC3T3-E1 cells. FSS ranging from 1.5 to 52.6 mu Pa also increased the expression of Runx2, a key transcription factor regulating osteoblast differentiation. It is suggested that Runx2 might be an important regulator in low FSS-induced MC3T3-E1 differentiation. This device allows for detailed study of the effect of low FSS on the behaviors of cells; thus, it would be a useful tool for analysis of the effects of IFF-induced shear stresses on cells.	[Yu, Weiliang; Zhang, Qian; Guan, Haijie; Liu, Tingjiao] Dalian Med Univ, Coll Stomatol, Sect Oral Pathol, Dalian, Peoples R China; [Yu, Weiliang; Qu, Hong] Dalian Med Univ, Coll Stomatol, Sect Orthodont, Dalian, Peoples R China; [Qin, Jianhua] Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, Dalian, Peoples R China; [Hu, Guoqing; Song, Kui] Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech LNM, Beijing 100080, Peoples R China	Dalian Medical University; Dalian Medical University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS	Liu, TJ (corresponding author), Dalian Med Univ, Coll Stomatol, Sect Oral Pathol, Dalian, Peoples R China.	tingjiao@dlmedu.edu.cn; jhqin@dicp.ac.cn	Hu, Guoqing/B-7019-2012		National Natural Science Foundation of China [81171425]; Program for Liaoning Excellent Talents in University [LR201013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Excellent Talents in University	This work was supported by National Natural Science Foundation of China (No. 81171425) and Program for Liaoning Excellent Talents in University (No. LR201013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Bruus H., 2008, THEORETICAL MICROFLU, V18; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Chin LK, 2011, LAB CHIP, V11, P1856, DOI 10.1039/c0lc00651c; Christophis C, 2010, PHYS CHEM CHEM PHYS, V12, P4498, DOI 10.1039/b924304f; Dafni H, 2002, CANCER RES, V62, P6731; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; Delaine-Smith RM, 2012, EUR CELLS MATER, V24, P162, DOI 10.22203/eCM.v024a12; Delaine-Smith RM, 2011, VITAM HORM, V87, P417, DOI 10.1016/B978-0-12-386015-6.00039-1; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dvir T, 2007, TISSUE ENG, V13, P2185, DOI 10.1089/ten.2006.0364; El Haj AJ, 2010, P I MECH ENG H, V224, P1523, DOI 10.1243/09544119JEIM802; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Grellier M, 2009, J TISSUE ENG REGEN M, V3, P302, DOI 10.1002/term.166; Gurkan UA, 2008, ANN BIOMED ENG, V36, P1978, DOI 10.1007/s10439-008-9577-x; Hayward LNM, 2009, BIOMECH MODEL MECHAN, V8, P447, DOI 10.1007/s10237-009-0148-3; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Jang KJ, 2011, INTEGR BIOL-UK, V3, P134, DOI 10.1039/c0ib00018c; Kamioka H, 2006, J BONE MINER RES, V21, P1012, DOI 10.1359/JBMR.060408; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kou SZ, 2011, BIOCHEM BIOPH RES CO, V408, P350, DOI 10.1016/j.bbrc.2011.04.044; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Kwon RY, 2010, J BONE MINER RES, V25, P1798, DOI 10.1002/jbmr.74; Leclerc E, 2006, BIOMATERIALS, V27, P586, DOI 10.1016/j.biomaterials.2005.06.002; Liegibel UM, 2004, EXP CLIN ENDOCR DIAB, V112, P356, DOI 10.1055/s-2004-821014; Nauman EA, 2001, J APPL PHYSIOL, V90, P1849, DOI 10.1152/jappl.2001.90.5.1849; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Park J, 2012, BIORHEOLOGY, V47, P165; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; REDDY NP, 1981, J BIOMECH, V14, P879, DOI 10.1016/0021-9290(81)90015-4; Rotenberg MY, 2012, LAB CHIP, V12, P2696, DOI [10.1039/c2lc40144d, 10.1039/c21c40144d]; Scaglione S, 2008, J BIOMED MATER RES A, V86A, P411, DOI 10.1002/jbm.a.31607; Shao JB, 2009, LAB CHIP, V9, P3118, DOI 10.1039/b909312e; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Vera RH, 2009, TISSUE ENG PT A, V15, P175, DOI 10.1089/ten.tea.2007.0314; Wang JB, 2010, LAB CHIP, V10, P235, DOI 10.1039/b914874d; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zheng WF, 2012, INTEGR BIOL-UK, V4, P1102, DOI 10.1039/c2ib20094e	39	51	54	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89966	10.1371/journal.pone.0089966	http://dx.doi.org/10.1371/journal.pone.0089966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587156	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800061
J	Gheerbrant, E; Amaghzaz, M; Bouya, B; Goussard, F; Letenneur, C				Gheerbrant, Emmanuel; Amaghzaz, Mbarek; Bouya, Baadi; Goussard, Florent; Letenneur, Charlene			Ocepeia (Middle Paleocene of Morocco): The Oldest Skull of an Afrotherian Mammal	PLOS ONE			English	Article							VASTAN LIGNITE MINE; OULED-ABDOUN BASIN; EARLY EOCENE; INNER-EAR; NUMIDOTHERIUM-KOHOLENSE; ELEPHANT-SHREWS; EVOLUTION; MORPHOLOGY; ANATOMY; ORIGINS	While key early(iest) fossils were recently discovered for several crown afrotherian mammal orders, basal afrotherians, e. g., early Cenozoic species that comprise sister taxa to Paenungulata, Afroinsectiphilia or Afrotheria, are nearly unknown, especially in Africa. Possible stem condylarth-like relatives of the Paenungulata (hyraxes, sea-cows, elephants) include only Abdounodus hamdii and Ocepeia daouiensis from the Selandian of Ouled Abdoun Basin, Morocco, both previously only documented by lower teeth. Here, we describe new fossils of Ocepeia, including O. grandis n. sp., and a sub-complete skull of O. daouiensis, the first known before the Eocene for African placentals. O. daouiensis skull displays a remarkable mosaic of autapomophic, ungulate-like and generalized eutherian-like characters. Autapomorphies include striking anthropoid-like characters of the rostrum and dentition. Besides having a basically eutherian-like skull construction, Ocepeia daouiensis is characterized by ungulate-like, and especially paenungulate-like characters of skull and dentition (e. g., selenodonty). However, some plesiomorphies such as absence of hypocone exclude Ocepeia from crown Paenungulata. Such a combination of plesiomorphic and derived characters best fits with a stem position of Ocepeia relative to Paenungulata. In our cladistic analyses Ocepeia is included in Afrotheria, but its shared derived characters with paenungulates are not optimized as exclusive synapomorphies. Rather, within Afrotheria Ocepeia is reconstructed as more closely related to insectivore-like afroinsectiphilians (i.e., aardvarks, sengis, tenrecs, and golden moles) than to paenungulates. This results from conflict with undetected convergences of Paenungulata and Perissodactyla in our cladistic analysis, such as the shared bilophodonty. The selenodont pattern best supports the stem paenungulate position of Ocepeia; that, however, needs further support. The remarkable character mosaic of Ocepeia makes it the first known "transitional fossil'' between insectivore-like and ungulate-like afrotherians. In addition, the autapomorphic family Ocepeiidae supports the old - earliest Tertiary or Cretaceous - endemic evolution of placentals in Africa, in contrast to hypotheses rooting afrotherians in Paleogene Laurasian "condylarths''.	[Gheerbrant, Emmanuel; Goussard, Florent; Letenneur, Charlene] CNRS MNHN UPMC, Ctr Recherches Paleobiodivers & Paleoenvironm, Dpnt Hist Terre, Paris, France; [Amaghzaz, Mbarek; Bouya, Baadi] Ctr Minier Khouribga, Off Cherifien Phosphates OCP SA, Khouribga, Morocco	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Gheerbrant, E (corresponding author), CNRS MNHN UPMC, Ctr Recherches Paleobiodivers & Paleoenvironm, Dpnt Hist Terre, Paris, France.	gheerbra@mnhn.fr	Gheerbrant, Emmanuel/F-6943-2010	Gheerbrant, Emmanuel/0000-0003-3355-458X	Centre National de la Recherche Scientifique (Unite Mixte de Recherche 5143-7207) [4892]; Centre National pour la Recherche Scientifique et Technique (Rabat) [4892]; Museum National d'Histoire Naturelle - Department Histoire de la Terre (Bonus Qualite Recherche); Unite Mixte de Recherche 7204 - Centre de Recherche sur la Paleobiobiversite et les Paleoenvironnements (Centre national de la Recherche Scientifique-Museum National d'Histoire Naturelle)	Centre National de la Recherche Scientifique (Unite Mixte de Recherche 5143-7207); Centre National pour la Recherche Scientifique et Technique (Rabat); Museum National d'Histoire Naturelle - Department Histoire de la Terre (Bonus Qualite Recherche); Unite Mixte de Recherche 7204 - Centre de Recherche sur la Paleobiobiversite et les Paleoenvironnements (Centre national de la Recherche Scientifique-Museum National d'Histoire Naturelle)	Field work was funded by grant #4892 of the French-Moroccan International Program of Scientific Cooperation between the Centre National de la Recherche Scientifique (Unite Mixte de Recherche 5143-7207) and the Centre National pour la Recherche Scientifique et Technique (Rabat), by the Museum National d'Histoire Naturelle - Department Histoire de la Terre (Bonus Qualite Recherche 2005-2007, E. Gheerbrant & N. Bardet) and by the Unite Mixte de Recherche 7204 - Centre de Recherche sur la Paleobiobiversite et les Paleoenvironnements (Centre national de la Recherche Scientifique-Museum National d'Histoire Naturelle). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher RJ, 2010, CENOZOIC MAMMALS AFR, P911; Bajpai S., 2009, Journal of the Palaeontological Society of India, V54, P103; Bajpai Sunil, 2006, Journal of the Palaeontological Society of India, V51, P101; Benoit J, 2013, J SYST PALAEONTOL, V11, P907, DOI 10.1080/14772019.2012.713400; Benoit J, 2013, GEOBIOS-LYON, V46, P357, DOI 10.1016/j.geobios.2013.07.002; Chardin P. T. de, 1927, Memoires du Musee Histoire Naturelle Belgique, V36, P1; CIFELLI R, 1983, American Museum Novitates, P1; CIFELLI RL, 1993, MAMMAL PHYLOGENY : PLACENTALS, P195; COURT N, 1991, CR ACAD SCI II, V312, P559; COURT N, 1992, LETHAIA, V25, P211, DOI 10.1111/j.1502-3931.1992.tb01385.x; Cox PG, 2006, J ZOOL, V269, P514, DOI 10.1111/j.1469-7998.2006.00105.x; Crompton AW, 1971, ZOOLOGICAL J LINN S1, P65; Damuth J., 1990, P229; Damuth J., 1990, BODY SIZE MAMMALIAN; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Ekdale EG, 2011, J VERTEBR PALEONTOL, V31, P658, DOI 10.1080/02724634.2011.557284; Fischer MS, 1993, MAMMAL PHYLOGENY, P217; Gazin C. L., 1965, SMITHSONIAN MISCELLA, V149, P1; Geisler Jonathan H., 2007, P19; Gheerbrant E, 2003, B SOC GEOL FR, V174, P279, DOI 10.2113/174.3.279; Gheerbrant E, 2005, GEODIVERSITAS, V27, P239; Gheerbrant E, 1996, NATURE, V383, P68, DOI 10.1038/383068a0; Gheerbrant E, 2001, J VERTEBR PALEONTOL, V21, P107, DOI 10.1671/0272-4634(2001)021[0107:FAACMP]2.0.CO;2; Gheerbrant Emmanuel, 2005, P84; Gheerbrant Emmanuel, 2010, P563; Gheerbrant E, 2009, P NATL ACAD SCI USA, V106, P10717, DOI 10.1073/pnas.0900251106; Gheerbrant Emmanuel, 1998, Palaeovertebrata (Montpellier), V27, P155; Gheerbrant Emmanuel, 1994, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V231, P133; Gheerbrant Emmanuel, 1995, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V237, P39; Gheerbrant Emmanuel, 1992, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V224, P67; GINGERICH P D, 1979, Contributions from the Museum of Paleontology University of Michigan, V25, P117; Gingerich PD, 1997, J VERTEBR PALEONTOL, V17, P629, DOI 10.1080/02724634.1997.10011012; Gingerich PD, 1998, P 3 GEOS WORKSH HELD, P1; Gingerich Philip D., 1999, Contributions from the Museum of Paleontology University of Michigan, V30, P233; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; HUNT RM, 1980, J MORPHOL, V164, P167, DOI 10.1002/jmor.1051640206; Kocsis L, 2014, PALAEOGEOGR PALAEOCL, V394, P74, DOI 10.1016/j.palaeo.2013.11.002; Kondrashov PE, 2012, J PALEONTOL, V86, P25, DOI 10.1666/11-009.1; KUMAR K, 1991, GEOBIOS-LYON, V24, P221, DOI 10.1016/S0016-6995(91)80010-W; Kumar K., 1985, Journal of Vertebrate Paleontology, V5, P153; Lemoine V., 1891, Bulletin Soc Geol, V(3), P263; MACPHEE RDE, 1994, B AM MUS NAT HIST, P1; Macrini TE, 2010, J ANAT, V216, P600, DOI 10.1111/j.1469-7580.2010.01224.x; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Madsen O, 1997, MOL BIOL EVOL, V14, P363, DOI 10.1093/oxfordjournals.molbev.a025772; MARSHALL LG, 1982, SCIENCE, V215, P1351, DOI 10.1126/science.215.4538.1351; MARSHALL LG, 1988, NATL GEOGR RES, V4, P23; Matthew W. D., 1937, Transactions of the American Philosophical Society Philadelphia NS, V30, P1; McKenna M.C., 1977, GEOBIOS MEM SPEC, V1, P61; McKenna MC, 2000, ACTA PALAEONTOL POL, V45, P1; MENG J, 1995, ZOOL J LINN SOC-LOND, V115, P47, DOI 10.1006/zjls.1995.0033; Muizon C.D., 2000, GEODIVERSITAS, V22, P47; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NOVACEK M J, 1986, Cladistics, V2, P257, DOI 10.1111/j.1096-0031.1986.tb00463.x; O'Leary MA, 2012, J PALEONTOL, V86, P44, DOI 10.1666/10-091.1; OLEARY MA, 2010, B AM MUS NAT HIST, V335, P1; Pickford Martin, 2008, Geological Survey of Namibia Memoir, V20, P465; Prasad GVR, 2007, SCIENCE, V318, P937, DOI 10.1126/science.1149267; Robinson TJ, 2004, CURR TOP DEV BIOL, V63, P37, DOI 10.1016/S0070-2153(04)63002-X; RUSSELL DONALD E., 1964, MEM MUS NAT HIST NATUR NOW SER SER C SCI TERRE, V13, P1; Schlosser M, 1920, PALAEONTOGRAPHICA, V63, P97; SEGALL W, 1970, Fieldiana Zoology, V51, P169; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; Silcox MT, 2009, J HUM EVOL, V56, P315, DOI 10.1016/j.jhevol.2008.10.007; Simons E.L., 1974, Annals of the Geological Survey of Egypt, V4, P157; Simpson G. G., 1937, Bulletin United States National Museum, Vno. 169, P1; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Tabuce R, 2007, P ROY SOC B-BIOL SCI, V274, P1159, DOI 10.1098/rspb.2006.0229; Tabuce R, 2012, PALAEONTOLOGY, V55, P945, DOI 10.1111/j.1475-4983.2012.01163.x; Tassy P., 1988, Systematics Association Special Volume Series, P283; Teilhard De Chardin P., 1922, ANN PALEONTOL, V11, P1; THEWISSEN J G M, 1987, Contributions from the Museum of Paleontology University of Michigan, V27, P247; Thewissen JGM, 2001, J VERTEBR PALEONTOL, V21, P347, DOI 10.1671/0272-4634(2001)021[0347:EMFFNI]2.0.CO;2; von Koenigswald W, 2013, HIST BIOL, V25, P183, DOI 10.1080/08912963.2012.714658; WELLS N A, 1983, Contributions from the Museum of Paleontology University of Michigan, V26, P117; WEST CD, 1985, J ACOUST SOC AM, V77, P1091, DOI 10.1121/1.392227; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Wible JR, 2004, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2004)281<0001:NDOTSA>2.0.CO;2; Yans J, 2014, GONDWANA RES, V25, P257, DOI 10.1016/j.gr.2013.04.004; Zack SP, 2005, NATURE, V434, P497, DOI 10.1038/nature03351	81	24	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89739	10.1371/journal.pone.0089739	http://dx.doi.org/10.1371/journal.pone.0089739			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587000	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000088
J	Gray, JM; Harmin, DA; Boswell, SA; Cloonan, N; Mullen, TE; Ling, JJ; Miller, N; Kuersten, S; Ma, YC; McCarroll, SA; Grimmond, SM; Springer, M				Gray, Jesse M.; Harmin, David A.; Boswell, Sarah A.; Cloonan, Nicole; Mullen, Thomas E.; Ling, Joseph J.; Miller, Nimrod; Kuersten, Scott; Ma, Yong-Chao; McCarroll, Steven A.; Grimmond, Sean M.; Springer, Michael			SnapShot-Seq: A Method for Extracting Genome-Wide, In Vivo mRNA Dynamics from a Single Total RNA Sample	PLOS ONE			English	Article							GENE-EXPRESSION; NASCENT TRANSCRIPTION; MICROARRAY ANALYSIS; GLOBAL ANALYSIS; PROTEIN; PHOSPHORIBOSYLTRANSFERASE; KINETICS; SURVIVAL; ORDER; DECAY	mRNA synthesis, processing, and destruction involve a complex series of molecular steps that are incompletely understood. Because the RNA intermediates in each of these steps have finite lifetimes, extensive mechanistic and dynamical information is encoded in total cellular RNA. Here we report the development of SnapShot-Seq, a set of computational methods that allow the determination of in vivo rates of pre-mRNA synthesis, splicing, intron degradation, and mRNA decay from a single RNA-Seq snapshot of total cellular RNA. SnapShot-Seq can detect in vivo changes in the rates of specific steps of splicing, and it provides genome-wide estimates of pre-mRNA synthesis rates comparable to those obtained via labeling of newly synthesized RNA. We used SnapShot-Seq to investigate the origins of the intrinsic bimodality of metazoan gene expression levels, and our results suggest that this bimodality is partly due to spillover of transcriptional activation from highly expressed genes to their poorly expressed neighbors. SnapShot-Seq dramatically expands the information obtainable from a standard RNA-Seq experiment.	[Gray, Jesse M.; Mullen, Thomas E.; Ling, Joseph J.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02130 USA; [Harmin, David A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Boswell, Sarah A.; Springer, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Cloonan, Nicole] QIMR Berghofer Med Res Inst, Genom Biol Lab, Herston, Qld, Australia; [Miller, Nimrod; Ma, Yong-Chao] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Dept Neurol & Physiol, Chicago, IL 60611 USA; [Miller, Nimrod; Ma, Yong-Chao] Lurie Childrens Hosp Chicago, Res Ctr, Chicago, IL USA; [Kuersten, Scott] Epictr, Madison, WI USA; [Grimmond, Sean M.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; QIMR Berghofer Medical Research Institute; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Glasgow	Gray, JM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02130 USA.	gray@genetics.med.harvard.edu; Michael_Springer@hms.harvard.edu	Cloonan, Nicole/B-5272-2008; Grimmond, Sean M/J-5304-2016; Grimmond, Sean/K-3246-2019	Cloonan, Nicole/0000-0001-7802-6647; Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Ma, Yongchao/0000-0002-2469-4356; Miller, Nimrod/0000-0002-2221-139X; Boswell, Sarah/0000-0002-3118-3378	National Institute of Health [1 R01 MH101528-01]; Whitehall Foundation; Families of SMA; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101528] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Families of SMA; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Health Grant 1 R01 MH101528-01 (J.M.G). N.M. and Y.C. M. are supported by grants from the Whitehall Foundation and Families of SMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RD, 2010, RNA, V16, P2570, DOI 10.1261/rna.2162610; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; [Anonymous], 2010, GENE SPECIFIC RAN PO, V17, P1279; [Anonymous], 2008, METHOD ENZYMOL, V448, P379; [Anonymous], 2007, MOL BIOL CELL; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chen XG, 2003, CURR BIOL, V13, P2206, DOI 10.1016/j.cub.2003.11.028; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; France KA, 2011, J BIOL CHEM, V286, P22750, DOI 10.1074/jbc.M111.225433; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hahn CN, 2012, NAT GENET, V44, P9, DOI 10.1038/ng.1045; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huranova M, 2010, J CELL BIOL, V191, P75, DOI 10.1083/jcb.201004030; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kenzelmann M, 2007, P NATL ACAD SCI USA, V104, P6164, DOI 10.1073/pnas.0610439104; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Mordes D, 2006, MOL VIS, V12, P1259; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Patel AA, 2002, EMBO J, V21, P3804, DOI 10.1093/emboj/cdf297; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Zeisel A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.62	52	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89673	10.1371/journal.pone.0089673	http://dx.doi.org/10.1371/journal.pone.0089673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586954	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332389000074
J	Broch, K; Askevold, ET; Gjertsen, E; Ueland, T; Yndestad, A; Godang, K; Stueflotten, W; Andreassen, J; Svendsmark, R; Smith, HJ; Aakhus, S; Aukrust, P; Gullestad, L				Broch, Kaspar; Askevold, Erik T.; Gjertsen, Erik; Ueland, Thor; Yndestad, Arne; Godang, Kristin; Stueflotten, Wenche; Andreassen, Johanna; Svendsmark, Rolf; Smith, Hans-Jorgen; Aakhus, Svend; Aukrust, Pal; Gullestad, Lars			The Effect of Rosuvastatin on Inflammation, Matrix Turnover and Left Ventricular Remodeling in Dilated Cardiomyopathy: A Randomized, Controlled Trial	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; COA REDUCTASE INHIBITORS; STATIN THERAPY; DOUBLE-BLIND; PLACEBO; ATORVASTATIN; MARKERS; RECOMMENDATIONS; PARAMETERS; STATEMENT	Background: Dilated cardiomyopathy is characterized by left ventricular dilatation and dysfunction. Inflammation and adverse remodeling of the extracellular matrix may be involved in the pathogenesis. Statins reduce levels of low density lipoprotein cholesterol, but may also attenuate inflammation and affect matrix remodeling. We hypothesized that treatment with rosuvastatin would reduce or even reverse left ventricular remodeling in dilated cardiomyopathy. Materials and Methods: In this multicenter, randomized, double blind, placebo-controlled study, 71 patients were randomized to 10 mg of rosuvastatin or matching placebo. Physical examination, blood sampling, echocardiography and cardiac magnetic resonance imaging were performed at baseline and at six months' follow-up. The pre-specified primary end point was the change in left ventricular ejection fraction from baseline to six months. Results: Over all, left ventricular ejection fraction improved 5 percentage points over the duration of the study, but there was no difference in the change in left ventricular ejection fraction between patients allocated to rosuvastatin and those allocated to placebo. Whereas serum low density lipoprotein cholesterol concentration fell significantly in the treatment arm, rosuvastatin did not affect plasma or serum levels of a wide range of inflammatory variables, including C-reactive protein. The effect on markers of extracellular matrix remodeling was modest. Conclusion: Treatment with rosuvastatin does not improve left ventricular ejection fraction in patients with dilated cardiomyopathy.	[Broch, Kaspar; Askevold, Erik T.; Stueflotten, Wenche; Andreassen, Johanna; Aakhus, Svend; Gullestad, Lars] Univ Oslo, Rikshosp, Dept Cardiol, Oslo Univ Hosp, N-0027 Oslo, Norway; [Askevold, Erik T.; Ueland, Thor; Yndestad, Arne; Aukrust, Pal] Univ Oslo, Rikshosp, Internal Med Res Inst, Oslo Univ Hosp, N-0027 Oslo, Norway; [Godang, Kristin] Univ Oslo, Rikshosp, Dept Endocrinol, Oslo Univ Hosp, N-0027 Oslo, Norway; [Svendsmark, Rolf; Smith, Hans-Jorgen] Univ Oslo, Rikshosp, Dept Radiol, Oslo Univ Hosp, N-0027 Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo Univ Hosp, N-0027 Oslo, Norway; [Gjertsen, Erik] Vestre Viken Hosp Trust, Drammen Hosp, Dept Internal Med, Drammen, Norway; [Broch, Kaspar; Ueland, Thor; Smith, Hans-Jorgen; Aukrust, Pal; Gullestad, Lars] Univ Oslo, Fac Med, Oslo, Norway; [Gullestad, Lars] Univ Oslo, Fac Med, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Gullestad, Lars] Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo	Broch, K (corresponding author), Univ Oslo, Rikshosp, Dept Cardiol, Oslo Univ Hosp, N-0027 Oslo, Norway.	kaspar.broch@ous-hf.no			AstraZeneca(R)	AstraZeneca(R)(AstraZeneca)	The trial was supported by an unrestricted grant from AstraZeneca (R). The trial was also sponsored by an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton E, 2011, INT J CARDIOL, V146, P404, DOI 10.1016/j.ijcard.2009.12.028; Askevold ET, 2013, CIRC-HEART FAIL, V6, P91, DOI 10.1161/CIRCHEARTFAILURE.112.972653; Bielecka-Dabrowa A, 2009, MED SCI MONITOR, V15, pMS12; Bollerslev J, 2006, EUR J ENDOCRINOL, V154, P537, DOI 10.1530/eje.1.02125; Broch K, 2012, EUR J HEART FAIL, V14, P268, DOI 10.1093/eurjhf/hfs006; Bu DX, 2011, CURR OPIN LIPIDOL, V22, P165, DOI 10.1097/MOL.0b013e3283453e41; Chan KY, 2004, AM J HEALTH-SYST PH, V61, P1676, DOI 10.1093/ajhp/61.16.1676; Cicoira M, 2004, J CARD FAIL, V10, P403, DOI 10.1016/j.cardfail.2004.01.010; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; Crea F, 2002, CLIN CARDIOL, V25, P461, DOI 10.1002/clc.4960251005; D'Armiento J, 2002, TRENDS CARDIOVAS MED, V12, P97, DOI 10.1016/S1050-1738(01)00160-8; Dickstein K, 2008, EUR J HEART FAIL; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Galderisi M, 2011, EUR J ECHOCARDIOGR, V12, P339, DOI 10.1093/ejechocard/jer051; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Krum H, 2007, J CARD FAIL, V13, P1, DOI 10.1016/j.cardfail.2006.09.008; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lipinski MJ, 2009, AM J CARDIOL, V104, P1708, DOI 10.1016/j.amjcard.2009.07.055; McMurray JJV, 2009, CIRCULATION, V120, P2188, DOI 10.1161/CIRCULATIONAHA.109.849117; Mihos CG, 2010, CARDIOL REV, V18, P298, DOI 10.1097/CRD.0b013e3181f52a7f; Node K, 2003, CIRCULATION, V108, P839, DOI 10.1161/01.CIR.0000084539.58092.DE; PEDERSEN TR, 1994, LANCET, V344, P1383; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Rivera J M, 1994, J Am Soc Echocardiogr, V7, P480; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Ueland T, 2011, CIRC-HEART FAIL, V4, P145, DOI 10.1161/CIRCHEARTFAILURE.110.957332; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Waehre T, 2004, CIRCULATION, V109, P1966, DOI 10.1161/01.CIR.0000125700.33637.B1; Waehre T, 2003, J AM COLL CARDIOL, V41, P1460, DOI 10.1016/S0735-1097(03)00263-8; Wojnicz R, 2006, AM J CARDIOL, V97, P899, DOI 10.1016/j.amjcard.2005.09.142; Yndestad A, 2006, HEART FAIL REV, V11, P83, DOI 10.1007/s10741-006-9196-2; Zile MR, 2011, CIRC-HEART FAIL, V4, P246, DOI 10.1161/CIRCHEARTFAILURE.110.958199	38	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89732	10.1371/journal.pone.0089732	http://dx.doi.org/10.1371/journal.pone.0089732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586994	Green Published, gold			2022-12-27	WOS:000332385900074
J	Du, H; Li, J; Jiang, W; Yu, HT; Zhang, Y; Wang, JN; Wang, PZ; Bai, XF				Du, Hong; Li, Jing; Jiang, Wei; Yu, Haitao; Zhang, Ye; Wang, Junning; Wang, Pingzhong; Bai, Xuefan			Clinical Study of Critical Patients with Hemorrhagic Fever with Renal Syndrome Complicated by Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							HANTAVIRUS PULMONARY SYNDROME; THROMBOCYTOPENIA; CLASSIFICATION; MANAGEMENT; INFECTION; SEVERITY; THERAPY; SCORE	Objectives: The aim of this study was to investigate the clinical characteristics and outcomes of critical patients with hemorrhagic fever with renal syndrome (HFRS) complicated by acute respiratory distress syndrome (ARDS). Materials and Methods: To observe the demographic, epidemiological and clinical characteristics, and to explore the predictive effects for prognosis in laboratory findings, we conducted a detailed retrospective analysis of clinical records for critical patients with HFRS complicated by ARDS, treated at the center for infectious diseases, Tangdu Hospital, between January 2008 and December 2012. Results: A total of 48 critical patients with laboratory confirmed HFRS accompanied by ARDS were enrolled in the study, including 27 survivors and 21 non-survivors, with a fatality rate of 43.75%. Thirty-one individuals (64.6%) contracted HFRS between the months of September and December. The non-survivors tended to have lower incidence of overlapping phase (P = 0.025). There were no obvious differences in the needs for mechanical ventilation (MV) and renal replacement therapy (RRT), except for the need for vasoactive drugs between the survivors and non-survivors (P = 0.001). The non-survivors were found to have higher frequencies of encephalopathy, refractory shock and multiple organ dysfunction syndrome (MODS), lower incidences of acute renal failure (ARF) and secondary hypertension (P<0.05). The non-survivors tended to have lower levels of serum creatinine (Scr) (P<0.001) and fibrinogen (Fib) (P = 0.003), higher incidences of prolonged prothrombin time (PT) (P = 0.006) and activated partial thromboplastin time (APTT) (P = 0.020) and higher levels of aspartate aminotransferase (AST) (P = 0.015), and the laboratory parameters mentioned above reached statistical significance for predicting prognosis (P<0.05). Conclusion: The high mortality rate of critical patients with HFRS complicated by ARDS emphasizes the importance of clinicians' alertness and timely initiation of systemic supportive therapy.	[Du, Hong; Li, Jing; Jiang, Wei; Yu, Haitao; Zhang, Ye; Wang, Junning; Wang, Pingzhong; Bai, Xuefan] Fourth Mil Med Univ, Tangdu Hosp, Ctr Infect Dis, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Wang, PZ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Ctr Infect Dis, Xian 710032, Shaanxi, Peoples R China.	wangpz63@126.com; xfbai2011@163.com	Gaobo, Huang/AAP-9975-2020		National Basic Research Program of China (973 Program) [2012CB518905]; National Natural Science Foundation of China [30901346, 81071370]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by National Basic Research Program of China (973 Program) (No. 2012CB518905) and the National Natural Science Foundation of China (No. 30901346, No. 81071370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, Bull World Health Organ, V61, P269; Bai XF, 2013, HEMORRHAGIC FEVER RE, pP722; Bhargava M, 2012, TRANSL RES, V159, P205, DOI 10.1016/j.trsl.2012.01.007; BRACKETT LE, 1994, NEW ENGL J MED, V331, P545; Chinese Medical Association to severe medicine branch, 2006, GUID DIAGN TREATM AC; Chinese Medical Association to severe medicine branch, 2009, GUID BLOOD PUR ICU; Clement J, 2012, EUR J CLIN MICROBIOL, V31, P1, DOI 10.1007/s10096-011-1456-y; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Gavrilovskaya IN, 1999, J VIROL, V73, P3951, DOI 10.1128/JVI.73.5.3951-3959.1999; Ghahramani N, 2008, NEPHROLOGY, V13, P570, DOI 10.1111/j.1440-1797.2008.00966.x; Greer SE, 2009, CHEST, V136, P1413, DOI 10.1378/chest.08-2616; Hayasaka D, 2007, VIRUS RES, V123, P120, DOI 10.1016/j.virusres.2006.08.006; HUGGINS JW, 1991, J INFECT DIS, V164, P1119, DOI 10.1093/infdis/164.6.1119; Johnson D, 2001, CAN J ANAESTH, V48, P502, DOI 10.1007/BF03028318; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kim S, 2010, NEPHROL DIAL TRANSPL, V25, P2790, DOI 10.1093/ndt/gfq253; Kim YO, 2003, J KOREAN MED SCI, V18, P696, DOI 10.3346/jkms.2003.18.5.696; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Launay D, 2003, CLIN NEPHROL, V59, P297; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levi M, 2008, SEMIN THROMB HEMOST, V34, P417, DOI 10.1055/s-0028-1092871; Liu DV, 2010, PRACTICAL CRITICAL C, pP1054; Luo Cheng-wang, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1017; Ma CF, 2012, J GEN VIROL, V93, P2227, DOI 10.1099/vir.0.043364-0; Ma Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/812386; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Ministry of Health People's Republic of China, 1987, PREV TREATM PROGR EP; Muranyi W, 2005, J AM SOC NEPHROL, V16, P3669, DOI 10.1681/ASN.2005050561; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rasmuson J, 2011, EUR J CLIN MICROBIOL, V30, P685, DOI 10.1007/s10096-010-1141-6; Sarr MG, 2013, POL ARCH MED WEWN, V123, P118, DOI 10.20452/pamw.1627; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; SCHMALJOHN CS, 1985, SCIENCE, V227, P1041, DOI 10.1126/science.2858126; Song G, 1998, MANUAL PREVENTION CU, pP316; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wheeler AP, 2007, CHEST, V132, P1967, DOI 10.1378/chest.06-2535; Wu Chin-Chen, 2012, Acta Anaesthesiol Taiwan, V50, P74, DOI 10.1016/j.aat.2012.05.003	38	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89740	10.1371/journal.pone.0089740	http://dx.doi.org/10.1371/journal.pone.0089740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587001	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700082
J	Di Martino, MT; Gulla, A; Cantafio, MEG; Altomare, E; Amodio, N; Leone, E; Morelli, E; Lio, SG; Caracciolo, D; Rossi, M; Frandsen, NM; Tagliaferri, P; Tassone, P				Di Martino, Maria Teresa; Gulla, Annamaria; Cantafio, Maria Eugenia Gallo; Altomare, Emanuela; Amodio, Nicola; Leone, Emanuela; Morelli, Eugenio; Lio, Santo Giovanni; Caracciolo, Daniele; Rossi, Marco; Frandsen, Niels M.; Tagliaferri, Pierosandro; Tassone, Pierfrancesco			In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; MICRORNA EXPRESSION; PROSTATE CARCINOMA; DOWN-REGULATION; RENAL FIBROSIS; MIR-221; GLIOBLASTOMA; INHIBITION; SURVIVAL; PROGRESSION	Background & Aim: The miR-221/222 cluster is upregulated in malignant plasma cells from multiple myeloma (MM) patients harboring the t(4;14) translocation. We previously reported that silencing of miR-221/222 by an antisense oligonucleotide induces anti-MM activity and upregulates canonical miR-221/222 targets. The in vivo anti-tumor activity occurred when miR-221/222 inhibitors were delivered directly into MM xenografts. The aim of the present study was to evaluate the anti-MM activity of a novel phosphorothioate modified backbone 13-mer locked nucleic acid (LNA)-Inhibitor-miR-221 (LNA-i-miR-221) specifically designed for systemic delivery. Methods: In vitro anti-MM activity of LNA-i-miR-221 was evaluated by cell proliferation and BrdU uptake assays. In vivo studies were performed with non-obese diabetic/severe combined immunodeficient (NOD. SCID) mice bearing t(4;14) MM xenografts, which were intraperitoneally or intravenously treated with naked LNA-i-miR-221. RNA extracts from retrieved tumors were analyzed for miR-221 levels and modulation of canonical targets expression. H&E staining and immunohistochemistry were performed on retrieved tumors and mouse vital organs. Results: In vitro, LNA-i-miR-221 exerted strong antagonistic activity against miR-221 and induced upregulation of the endogenous target p27Kip1. It had a marked anti-proliferative effect on t(4; 14)-translocated MM cells but not on MM cells not carrying the translocation and not overexpressing miR-221. In vivo, systemic treatment with LNA-i-miR-221 triggered significant anti-tumor activity against t(4; 14) MM xenografts; it also induced miR-221 downregulation, upregulated p27Kip1 and reduced Ki-67. No behavioral changes or organ-related toxicity were observed in mice as a consequence of treatments. Conclusions: LNA-i-miR-221 is a highly stable, effective agent against t(4;14) MM cells, and is suitable for systemic use. These data provide the rationale for the clinical development of LNA-i-miR-221 for the treatment of MM.	[Di Martino, Maria Teresa; Gulla, Annamaria; Cantafio, Maria Eugenia Gallo; Altomare, Emanuela; Amodio, Nicola; Leone, Emanuela; Morelli, Eugenio; Caracciolo, Daniele; Rossi, Marco; Tagliaferri, Pierosandro; Tassone, Pierfrancesco] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Di Martino, Maria Teresa; Gulla, Annamaria; Cantafio, Maria Eugenia Gallo; Altomare, Emanuela; Amodio, Nicola; Leone, Emanuela; Morelli, Eugenio; Caracciolo, Daniele; Rossi, Marco; Tagliaferri, Pierosandro; Tassone, Pierfrancesco] Salvatore Venuta Univ, Med Oncol Unit, Catanzaro, Italy; [Di Martino, Maria Teresa; Rossi, Marco; Tagliaferri, Pierosandro; Tassone, Pierfrancesco] T Campanella Canc Ctr, Catanzaro, Italy; [Lio, Santo Giovanni] Giovanni Paolo II Hosp, Pathol Unit, Catanzaro, Italy; [Frandsen, Niels M.] Exiqon AS, Vedbaek, Denmark; [Tassone, Pierfrancesco] Temple Univ, Coll Sci & Technol, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Philadelphia, PA 19122 USA	Magna Graecia University of Catanzaro; Exiqon; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Tassone, P (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	tassone@unicz.it	Amodio, Nicola/K-7335-2016; Tagliaferri, Pierosandro/K-9546-2016; Tassone, Pierfrancesco/AIA-5373-2022; Rossi, Marco/AAF-6413-2020; Gulla, Annamaria/ABF-4307-2021	Amodio, Nicola/0000-0002-1345-4410; Tassone, Pierfrancesco/0000-0002-8298-6787; Rossi, Marco/0000-0002-7258-475X; DI MARTINO, Maria Teresa/0000-0002-8205-2706; Morelli, Eugenio/0000-0002-8850-0442; Gulla, Annamaria/0000-0003-4569-0095	Italian Association for Cancer Research (AIRC); Special Program Molecular Clinical Oncology - 5 per mille [9980, 2010/15]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology - 5 per mille(Fondazione AIRC per la ricerca sul cancro)	This work has been supported by the Italian Association for Cancer Research (AIRC), PI: PT. "Special Program Molecular Clinical Oncology - 5 per mille" n. 9980, 2010/15. http://www.airc.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.175; Amodio N, 2013, EXPERT OPIN BIOL TH, V13, pS125, DOI 10.1517/14712598.2013.796356; Amodio N, 2012, ONCOTARGET, V3, P1246; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Burger R, 2009, MOL CANCER THER, V8, P26, DOI 10.1158/1535-7163.MCT-08-0149; Chi JX, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-23; Corthals SL, 2011, LEUKEMIA, V25, P1784, DOI 10.1038/leu.2011.147; Di Martino MT, 2012, CLIN CANCER RES, V18, P6260, DOI 10.1158/1078-0432.CCR-12-1708; Di Martino MT, 2013, ONCOTARGET, V4, P242, DOI 10.18632/oncotarget.820; Dimopoulos K, 2013, EUR J HAEMATOL, V91, P95, DOI 10.1111/ejh.12124; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Geary R S, 2001, Curr Opin Investig Drugs, V2, P562; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Hwang MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066502; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jikuzono T, 2013, INT J ONCOL, V42, P1858, DOI 10.3892/ijo.2013.1879; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Leone E, 2013, CLIN CANCER RES, V19, P2096, DOI 10.1158/1078-0432.CCR-12-3325; Lionetti M, 2013, CLIN CANCER RES, V19, P3130, DOI 10.1158/1078-0432.CCR-12-2043; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maegdefessel L, 2012, J CLIN INVEST, V122, P497, DOI 10.1172/JCI61598; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Misso G, 2013, EXPERT OPIN BIOL TH, V13, pS95, DOI 10.1517/14712598.2013.807338; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Neri P, 2007, LEUKEMIA, V21, P2519, DOI 10.1038/sj.leu.2404912; Neri P, 2008, BRIT J HAEMATOL, V143, P520, DOI 10.1111/j.1365-2141.2008.07387.x; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Putta S, 2012, J AM SOC NEPHROL, V23, P458, DOI 10.1681/ASN.2011050485; Quintavalle C, 2012, ONCOGENE, V31, P858, DOI 10.1038/onc.2011.280; Rossi M, 2013, CURR DRUG TARGETS; Sredni ST, 2010, CHILD NERV SYST, V26, P279, DOI 10.1007/s00381-009-1028-y; Tagliaferri P, 2012, CURR CANCER DRUG TAR, V12, P838, DOI 10.2174/156800912802429355; Tassone P, 2005, BLOOD, V106, P713, DOI 10.1182/blood-2005-01-0373; Tassone P, 2005, CLIN CANCER RES, V11, P4251, DOI 10.1158/1078-0432.CCR-04-2611; Thorsen SB, 2012, CANCER J, V18, P275, DOI 10.1097/PPO.0b013e318258b5d6; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Wu P, 2013, BR J HAEMATOL; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229	48	71	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89659	10.1371/journal.pone.0089659	http://dx.doi.org/10.1371/journal.pone.0089659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586944	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900138
J	Mayo, CE; Osborne, CJ; Mullens, BA; Gerry, AC; Gardner, IA; Reisen, WK; Barker, CM; MacLachlan, NJ				Mayo, Christie E.; Osborne, Cameron J.; Mullens, Bradley A.; Gerry, Alec C.; Gardner, Ian A.; Reisen, William K.; Barker, Christopher M.; MacLachlan, N. James			Seasonal Variation and Impact of Waste-Water Lagoons as Larval Habitat on the Population Dynamics of Culicoides sonorensis (Diptera:Ceratpogonidae) at Two Dairy Farms in Northern California	PLOS ONE			English	Article							BLUETONGUE VIRUS-INFECTION; VARIIPENNIS COMPLEX DIPTERA; SOUTHERN-CALIFORNIA; BITING MIDGES; GLOBAL EPIDEMIOLOGY; LIGHT-TRAPS; CERATOPOGONIDAE; TRANSMISSION; ABUNDANCE; PATTERNS	The Sacramento (northern Central) Valley of California (CA) has a hot Mediterranean climate and a diverse ecological landscape that is impacted extensively by human activities, which include the intensive farming of crops and livestock. Waste-water ponds, marshes, and irrigated fields associated with these agricultural activities provide abundant larval habitats for C. sonorensis midges, in addition to those sites that exist in the natural environment. Within this region, C. sonorensis is an important vector of bluetongue (BTV) and related viruses that adversely affect the international trade and movement of livestock, the economics of livestock production, and animal welfare. To characterize the seasonal dynamics of immature and adult C. sonorensis populations, abundance was monitored intensively on two dairy farms in the Sacramento Valley from August 2012- to July 2013. Adults were sampled every two weeks for 52 weeks by trapping (CDC style traps without light and baited with dry-ice) along N-S and E-W transects on each farm. One farm had large operational waste-water lagoons, whereas the lagoon on the other farm was drained and remained dry during the study. Spring emergence and seasonal abundance of adult C. sonorensis on both farms coincided with rising vernal temperature. Paradoxically, the abundance of midges on the farm without a functioning waste-water lagoon was increased as compared to abundance on the farm with a waste-water lagoon system, indicating that this infrastructure may not serve as the sole, or even the primary larval habitat. Adult midges disappeared from both farms from late November until May; however, low numbers of parous female midges were detected in traps set during daylight in the inter-seasonal winter period. This latter finding is especially critical as it provides a potential mechanism for the "overwintering'' of BTV in temperate regions such as northern CA. Precise documentation of temporal changes in the annual abundance and dispersal of Culicoides midges is essential for the creation of models to predict BTV infection of livestock and to develop sound abatement strategies.	[Mayo, Christie E.; Osborne, Cameron J.; MacLachlan, N. James] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Gardner, Ian A.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Mullens, Bradley A.; Gerry, Alec C.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Reisen, William K.; Barker, Christopher M.] Univ Calif Davis, Ctr Vectorborne Dis, Davis, CA 95616 USA	University of California System; University of California Davis; University of Prince Edward Island; University of California System; University of California Riverside; University of California System; University of California Davis	Mayo, CE (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	cemayo@ucdavis.edu			Agriculture and Food Research Initiative competitive 393 grant from the USDA National Institute of Food and Agriculture, the Center for Food Animal Health at the University of California-Davis, the U.S. Department of Agriculture [2012-67015-19527]	Agriculture and Food Research Initiative competitive 393 grant from the USDA National Institute of Food and Agriculture, the Center for Food Animal Health at the University of California-Davis, the U.S. Department of Agriculture	These studies were supported by funds provided by the Agriculture and Food Research Initiative competitive 393 grant no. 2012-67015-19527 from the USDA National Institute of Food and Agriculture, the Center for Food Animal Health at the University of California-Davis, the U.S. Department of Agriculture under the Animal Health Act, 1977, Public Law 95-113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKEY DH, 1979, J MED ENTOMOL, V16, P67, DOI 10.1093/jmedent/16.1.67; AKEY DH, 1987, J MED ENTOMOL, V24, P106, DOI 10.1093/jmedent/24.1.106; ANDERSON JR, 1989, J AM MOSQUITO CONTR, V5, P325; BARNARD DR, 1980, J ECON ENTOMOL, V73, P844, DOI 10.1093/jee/73.6.844; BOWNE JG, 1966, VIROLOGY, V30, P127, DOI 10.1016/S0042-6822(66)81016-4; Carpenter S, 2008, MED VET ENTOMOL, V22, P175, DOI 10.1111/j.1365-2915.2008.00743.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Coetzee P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-198; Coetzer J., 2004, INFECT DIS LIVESTOCK; Darpel KE, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-40; Eagles D, 2013, PREV VET MED, V110, P312, DOI 10.1016/j.prevetmed.2013.02.022; Gerry AC, 2000, J MED ENTOMOL, V37, P675, DOI 10.1603/0022-2585-37.5.675; Gerry AC, 2001, J MED ENTOMOL, V38, P197, DOI 10.1603/0022-2585-38.2.197; GIBBS EPJ, 1994, COMP IMMUNOL MICROB, V17, P207, DOI 10.1016/0147-9571(94)90044-2; Gloster J, 2008, VET REC, V162, P298, DOI 10.1136/vr.162.10.298; Gonzalez M, 2013, VET PARASITOL, V191, P81, DOI 10.1016/j.vetpar.2012.08.025; Harrup LE, 2013, MED VET ENTOMOL; Holbrook FR, 2000, J MED ENTOMOL, V37, P65, DOI 10.1603/0022-2585-37.1.65; JENNINGS M, 1989, VET MICROBIOL, V21, P125, DOI 10.1016/0378-1135(89)90024-2; JONES ROBERT HENRY, 1961, ANN ENT SOC AMER, V54, P702, DOI 10.1093/aesa/54.5.702; KETTLE DS, 1977, ANNU REV ENTOMOL, V22, P33, DOI 10.1146/annurev.en.22.010177.000341; Kline D.L., 1985, Progress in Clinical and Biological Research, V178, P221; Lysyk TJ, 2007, J MED ENTOMOL, V44, P959, DOI 10.1603/0022-2585(2007)44[959:SAPASO]2.0.CO;2; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Maclachlan NJ, 2013, ANTIVIR RES, V99, P79, DOI 10.1016/j.antiviral.2013.04.021; Maclachlan NJ, 2011, PREV VET MED, V102, P107, DOI 10.1016/j.prevetmed.2011.04.005; MacLachlan NJ, 2006, JAVMA-J AM VET MED A, V228, P1346, DOI 10.2460/javma.228.9.1346; Mayo CE, 2010, TRANSBOUND EMERG DIS, V57, P277, DOI 10.1111/j.1865-1682.2010.01149.x; Mayo CE, 2012, VET PARASITOL, V187, P295, DOI 10.1016/j.vetpar.2012.01.004; Mayo CE, 2012, VET MICROBIOL, V155, P158, DOI 10.1016/j.vetmic.2011.08.029; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Monteiro DMS, 2012, PREV VET MED, V105, P17, DOI 10.1016/j.prevetmed.2012.01.011; MULLENS BA, 1984, J MED ENTOMOL, V21, P194, DOI 10.1093/jmedent/21.2.194; MULLENS BA, 1987, J AM MOSQUITO CONTR, V3, P512; MULLENS BA, 1989, J MED ENTOMOL, V26, P559, DOI 10.1093/jmedent/26.6.559; Mullens BA, 2004, VETER ITAL SER, V40, P160; MULLENS BA, 1989, J MED ENTOMOL, V26, P566, DOI 10.1093/jmedent/26.6.566; Napp S, 2013, MED VET ENTOMOL, V27, P19, DOI 10.1111/j.1365-2915.2012.01016.x; Napp S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-4; NELSON RL, 1971, J MED ENTOMOL, V8, P283, DOI 10.1093/jmedent/8.3.283; NEVILL E M, 1971, Onderstepoort Journal of Veterinary Research, V38, P65; Newhouse V F, 1966, J Med Entomol, V3, P340, DOI 10.1093/jmedent/3.3-4.340; OROURKE MJ, 1983, MOSQ NEWS, V43, P147; OSBURN BI, 1981, AM J VET RES, V42, P884; PAINE EO, 1994, ENVIRON ENTOMOL, V23, P154, DOI 10.1093/ee/23.1.154; POTTER HW, 1978, MOSQ NEWS, V38, P499; Rigot T, 2013, MED VET ENTOMOL, V27, P29, DOI 10.1111/j.1365-2915.2012.01032.x; Rigot T, 2012, MED VET ENTOMOL, V26, P152, DOI 10.1111/j.1365-2915.2011.00988.x; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Schmidtmann ET, 2000, J MED ENTOMOL, V37, P58, DOI 10.1603/0022-2585-37.1.58; STOTT J L, 1985, P571; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Tabachnick WJ, 2004, VETER ITAL SER, V40, P145; Thompson GM, 2013, PARASITOLOGY, V140, P699, DOI 10.1017/S0031182012002016; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Veronesi E, 2010, VACCINE, V28, P1397, DOI 10.1016/j.vaccine.2009.10.107; Verwoerd DW, 2009, ONDERSTEPOORT J VET, V76, P99; Walton TE, 2004, VETER ITAL SER, V40, P31; Wilson A, 2007, VET REC, V161, P487, DOI 10.1136/vr.161.14.487; Wilson A, 2008, PLOS BIOL, V6, P1612, DOI 10.1371/journal.pbio.0060210; Wirth W.W., 1985, Progress in Clinical and Biological Research, V178, P165; WIRTH W W, 1970, Entomological News, V81, P141; ZIMMERMAN RH, 1984, J MED ENTOMOL, V21, P527, DOI 10.1093/jmedent/21.5.527	63	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89633	10.1371/journal.pone.0089633	http://dx.doi.org/10.1371/journal.pone.0089633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586925	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900135
J	Villar, M; Popara, M; Ayllon, N; de Mera, IGF; Mateos-Hernandez, L; Galindo, RC; Manrique, M; Tobes, R; de la Fuente, J				Villar, Margarita; Popara, Marina; Ayllon, Nieves; Fernandez de Mera, Isabel G.; Mateos-Hernandez, Lourdes; Galindo, Ruth C.; Manrique, Marina; Tobes, Raquel; de la Fuente, Jose			A Systems Biology Approach to the Characterization of Stress Response in Dermacentor reticulatus Tick Unfed Larvae	PLOS ONE			English	Article							FEVER GROUP RICKETTSIAE; HEAT-SHOCK PROTEINS; PEPTIDE IDENTIFICATION; EXPRESSION; ALGORITHM; PATHOGENS; ANIMALS; HUMANS; VECTOR; GENE	Background: Dermacentor reticulatus (Fabricius, 1794) is distributed in Europe and Asia where it infests and transmits disease-causing pathogens to humans, pets and other domestic and wild animals. However, despite its role as a vector of emerging or re-emerging diseases, very little information is available on the genome, transcriptome and proteome of D. reticulatus. Tick larvae are the first developmental stage to infest hosts, acquire infection and transmit pathogens that are transovarially transmitted and are exposed to extremely stressing conditions. In this study, we used a systems biology approach to get an insight into the mechanisms active in D. reticulatus unfed larvae, with special emphasis on stress response. Principal Findings: The results support the use of paired end RNA sequencing and proteomics informed by transcriptomics (PIT) for the analysis of transcriptomics and proteomics data, particularly for organisms such as D. reticulatus with little sequence information available. The results showed that metabolic and cellular processes involved in protein synthesis were the most active in D. reticulatus unfed larvae, suggesting that ticks are very active during this life stage. The stress response was activated in D. reticulatus unfed larvae and a Rickettsia sp. similar to R. raoultii was identified in these ticks. Significance: The activation of stress responses in D. reticulatus unfed larvae likely counteracts the negative effect of temperature and other stress conditions such as Rickettsia infection and favors tick adaptation to environmental conditions to increase tick survival. These results show mechanisms that have evolved in D. reticulatus ticks to survive under stress conditions and suggest that these mechanisms are conserved across hard tick species. Targeting some of these proteins by vaccination may increase tick susceptibility to natural stress conditions, which in turn reduce tick survival and reproduction, thus reducing tick populations and vector capacity for tick-borne pathogens.	[Villar, Margarita; Popara, Marina; Ayllon, Nieves; Fernandez de Mera, Isabel G.; Mateos-Hernandez, Lourdes; de la Fuente, Jose] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ciudad Real, Spain; [Galindo, Ruth C.; de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Manrique, Marina; Tobes, Raquel] Era7 Bioinformat, Oh No Sequences Res Grp, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater	de la Fuente, J (corresponding author), Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ciudad Real, Spain.	jose_delafuente@yahoo.com	de la Fuente, José/AAU-1197-2020; Manrique, Marina/GYQ-5538-2022; Villar-Rayo, Marga M/J-4155-2012; Hernández, Lourdes Mateos/P-6717-2019; Garcia Fernandez de Mera, Isabel/F-6623-2013	de la Fuente, José/0000-0001-7383-9649; Villar-Rayo, Marga M/0000-0003-4172-9079; Hernández, Lourdes Mateos/0000-0001-9566-7710; Garcia Fernandez de Mera, Isabel/0000-0001-5936-4018; Tobes, Raquel/0000-0001-7032-8720	EU FP7 ANTIGONE [278976]; POSTICK ITN; FP7-PEOPLE - ITN programme (EU) [238511]; MEC, Spain;  [BFU2011-23896]	EU FP7 ANTIGONE; POSTICK ITN; FP7-PEOPLE - ITN programme (EU); MEC, Spain(Spanish Government); 	This research was supported by grants BFU2011-23896 and the EU FP7 ANTIGONE project number 278976. M. Popara is an Early Stage Researcher supported by the POSTICK ITN (Post-graduate training network for capacity building to control ticks and tick-borne diseases) within the FP7-PEOPLE - ITN programme (EU Grant No. 238511). N. Ayllon and R.C. Galindo were funded by MEC, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alberdi MP, 2012, TICKS TICK-BORNE DIS, V3, P348, DOI 10.1016/j.ttbdis.2012.10.020; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Baldridge GD, 2004, APPL ENVIRON MICROB, V70, P6628, DOI 10.1128/AEM.70.11.6628-6636.2004; Beugnet F, 2009, VET PARASITOL, V163, P298, DOI 10.1016/j.vetpar.2009.03.028; Burrows M, 1994, BLOCK SORTING LOSSLE; Busby AT, 2012, MED VET ENTOMOL, V26, P92, DOI 10.1111/j.1365-2915.2011.00973.x; Cappe O, 2009, J ROY STAT SOC B, V71, P593, DOI 10.1111/j.1467-9868.2009.00698.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; de la Fuente J, 2012, VET J, V194, P139, DOI 10.1016/j.tvjl.2012.07.029; Durack J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073603; Estrada-Pena A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00064; Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/nmeth.2227, 10.1038/NMETH.2227]; de Mera IGF, 2013, EMERG INFECT DIS, V19, P1163, DOI 10.3201/eid1907.130005; de Mera IGF, 2009, EMERG INFECT DIS, V15, P1869, DOI 10.3201/eid1511.090681; Ferragina P, 2001, SIAM PROC S, P269; FILCHAGOV AV, 1988, PARAZITOLOGIYA+, V22, P366; Francischetti IMB, 2008, J PROTEOMICS, V71, P493, DOI 10.1016/j.jprot.2008.07.006; Glickman LT, 2006, VECTOR-BORNE ZOONOT, V6, P14, DOI 10.1089/vbz.2006.6.14; Ishikura M, 2002, MICROBIOL IMMUNOL, V46, P241, DOI 10.1111/j.1348-0421.2002.tb02692.x; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kolonin G.V., 2009, FAUNA IXODID TICKS W; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu LM, 2013, APPL ENVIRON MICROB, V79, P2450, DOI 10.1128/AEM.03575-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Nijhof AM, 2007, VECTOR-BORNE ZOONOT, V7, P585, DOI 10.1089/vbz.2007.0130; PARDUE ML, 1992, ANN NY ACAD SCI, V663, P125, DOI 10.1111/j.1749-6632.1992.tb38656.x; Picard F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-588; Piersma SR, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-17; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schicht S, 2013, PARASITOLOGY, V18, P1; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sherman MY, 2013, TRENDS BIOCHEM SCI, V38, P585, DOI 10.1016/j.tibs.2013.09.003; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sonenshine DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024711; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Taylor M, 2012, FEMS IMMUNOL MED MIC, V64, P21, DOI 10.1111/j.1574-695X.2011.00916.x; Torina A, 2012, EMERG INFECT DIS, V18, P1008, DOI 10.3201/eid1806.110966; Tutar L, 2010, CURR PHARM BIOTECHNO, V11, P216, DOI 10.2174/138920110790909632; Villar Margarita, 2010, Int J Proteomics, V2010, P657261, DOI 10.1155/2010/657261; Wang JY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-783; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zahler M., 1995, Applied Parasitology, V36, P53; Zivkovic Z, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/705034	48	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89564	10.1371/journal.pone.0089564	http://dx.doi.org/10.1371/journal.pone.0089564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586875	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900120
J	Wu, HL; Pang, SL; Liu, QZ; Wang, Q; Cai, MX; Shang, J				Wu, Hua-Li; Pang, Si-Lin; Liu, Qiong-Zhen; Wang, Qian; Cai, Min-Xuan; Shang, Jing			5-HT1A/1B Receptors as Targets for Optimizing Pigmentary Responses in C57BL/6 Mouse Skin to Stress	PLOS ONE			English	Article							TRYPTOPHAN-HYDROXYLASE; RESTRAINT STRESS; HAIR CYCLE; MELATONINERGIC SYSTEMS; 5-HT RECEPTORS; TELOGEN STAGE; LEPTIN LEVELS; SEROTONIN; FLUOXETINE; MICE	Stress has been reported to induce alterations of skin pigmentary response. Acute stress is associated with increased turnover of serotonin (5-hydroxytryptamine; 5-HT) whereas chronic stress causes a decrease. 5-HT receptors have been detected in pigment cells, indicating their role in skin pigmentation. To ascertain the precise role of 5-HT in stress-induced pigmentary responses, C57BL/6 mice were subjected to chronic restraint stress and chronic unpredictable mild stress (CRS and CUMS, two models of chronic stress) for 21 days, finally resulting in abnormal pigmentary responses. Subsequently, stressed mice were characterized by the absence of a black pigment in dorsal coat. The down-regulation of tyrosinase (TYR) and tyrosinase-related proteins (TRP1 and TRP2) expression in stressed skin was accompanied by reduced levels of 5-HT and decreased expression of 5-HT receptor (5-HTR) system. In both murine B16F10 melanoma cells and normal human melanocytes (NHMCs), 5-HT had a stimulatory effect on melanin production, dendricity and migration. When treated with 5-HT in cultured hair follicles (HFs), the increased expression of melanogenesis-related genes and the activation of 5-HT1A, 1B and 7 receptors also occurred. The serum obtained from stressed mice showed significantly decreased tyrosinase activity in NHMCs compared to that from nonstressed mice. The decrease in tyrosinase activity was further augmented in the presence of 5-HTR1A, 1B and 7 antagonists, WAY100635, SB216641 and SB269970. In vivo, stressed mice received 5-HT precursor 5-hydroxy-l-tryptophan (5-HTP), a member of the class of selective serotonin reuptake inhibitors (fluoxetine; FX) and 5-HTR1A/1B agonists (8-OH-DPAT/CP94253), finally contributing to the normalization of pigmentary responses. Taken together, these data strongly suggest that the serotoninergic system plays an important role in the regulation of stress-induced depigmentation, which can be mediated by 5-HT1A/1B receptors. 5-HT and 5-HTR1A/1B may constitute novel targets for therapy of skin hypopigmentation disorders, especially those worsened with stress.	[Wu, Hua-Li; Pang, Si-Lin; Liu, Qiong-Zhen; Wang, Qian; Cai, Min-Xuan; Shang, Jing] China Pharmaceut Univ, New Drug Screening Ctr, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Shang, J (corresponding author), China Pharmaceut Univ, New Drug Screening Ctr, Nanjing, Jiangsu, Peoples R China.	shangjing21cn@163.com			National Science and Technology Infrastructure Program [2012BAI30B001]; Mega-projects of Science Research for the 12th Five-Year Plan of China [2011ZX09401-007]	National Science and Technology Infrastructure Program; Mega-projects of Science Research for the 12th Five-Year Plan of China	2012-2014 National Science and Technology Infrastructure Program (2012BAI30B001), PI; 2011-2013 Mega-projects of Science Research for the 12th Five-Year Plan of China (2011ZX09401-007), PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaria N, 2006, CELL MOL NEUROBIOL, V26, P145, DOI 10.1007/s10571-006-9024-1; Aioi A, 2001, J DERMATOL SCI, V25, P189, DOI 10.1016/S0923-1811(00)00133-X; Ali SA, 2012, BRIT J PHARMACOL, V165, P1515, DOI 10.1111/j.1476-5381.2011.01630.x; AMEISEN JC, 1989, J IMMUNOL, V142, P3171; Aoki E, 2003, EXP DERMATOL, V12, P371, DOI 10.1034/j.1600-0625.2002.120403.x; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; AZMITIA EC, 1969, SCIENCE, V166, P1274, DOI 10.1126/science.166.3910.1274; Azmitia EC, 2007, INT REV NEUROBIOL, V77, P31, DOI 10.1016/S0074-7742(06)77002-7; Baumann MH, 2011, DRUG ALCOHOL DEPEN, V114, P147, DOI 10.1016/j.drugalcdep.2010.09.015; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; CHAOULOFF F, 1993, BRAIN RES REV, V18, P1, DOI 10.1016/0165-0173(93)90005-K; CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; Ciribassi J, 2003, AM J VET RES, V64, P994, DOI 10.2460/ajvr.2003.64.994; Dawood Shazia, 2005, Pak J Pharm Sci, V18, P49; Dinan TG, 1996, INT CLIN PSYCHOPHARM, V11, P19, DOI 10.1097/00004850-199603001-00004; Fadda F, 2000, NEWS PHYSIOL SCI, V15, P260; FLORES CM, 1990, J NEUROIMMUNOL, V28, P219, DOI 10.1016/0165-5728(90)90015-F; Gamaro GD, 2008, PHARMACOL BIOCHEM BE, V90, P312, DOI 10.1016/j.pbb.2008.03.005; GRIGNASCHI G, 1993, NEUROSCI LETT, V152, P103, DOI 10.1016/0304-3940(93)90494-6; Hashizume H, 2006, CURR OPIN ALLERGY CL, V6, P335, DOI 10.1097/01.all.0000244793.03239.40; Hosoda H, 2004, CLIN CHEM, V50, P1077, DOI 10.1373/clinchem.2003.025841; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Huang J, 1999, NEUROSCI LETT, V270, P5, DOI 10.1016/S0304-3940(99)00439-5; Inoue K, 2003, J INVEST DERMATOL, V121, P165, DOI 10.1046/j.1523-1747.2003.12326.x; Jones K, 2002, PIGM CELL RES, V15, P335, DOI 10.1034/j.1600-0749.2002.02014.x; Jung E, 2013, INT J PHARMACEUT, V456, P362, DOI 10.1016/j.ijpharm.2013.08.080; KANEKO M, 1979, NEUROPSYCHOBIOLOGY, V5, P232, DOI 10.1159/000117687; Katayama M, 2007, EXP DERMATOL, V16, P553, DOI 10.1111/j.1600-0625.2007.00558.x; Khatri N, 2013, PSYCHOPHARMACOLOGY B, V24, P24; Kot M, 2012, PHARMACOL RES, V66, P292, DOI 10.1016/j.phrs.2012.06.009; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; KURBANOV K, 1976, VOP MED KHIM, V22, P683; Kushnir-Sukhov NM, 2007, J ALLERGY CLIN IMMUN, V119, P498, DOI 10.1016/j.jaci.2006.09.003; Lanfumey L, 1999, NEUROREPORT, V10, P3369, DOI 10.1097/00001756-199911080-00021; Lee HJ, 2011, BRIT J DERMATOL, V165, P1344, DOI 10.1111/j.1365-2133.2011.10490.x; Lee J, 2008, J INVEST DERMATOL, V128, P482, DOI 10.1038/sj.jid.5701024; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Leonard BE, 2009, HUM PSYCHOPHARM CLIN, V24, P165, DOI 10.1002/hup.1011; LEVITIN HP, 1980, GEN COMP ENDOCR, V40, P8, DOI 10.1016/0016-6480(80)90090-8; Liao S, 2012, EXP DERMATOL, V21, P635, DOI 10.1111/j.1600-0625.2012.01531.x; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061574; Lockridge A, 2013, BEHAV BRAIN RES, V246, P168, DOI 10.1016/j.bbr.2013.02.032; Lundeberg L, 2002, ARCH DERMATOL RES, V294, P393, DOI 10.1007/s00403-002-0350-y; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Noh SJ, 2012, INDIAN J EXP BIOL, V50, P447; Nordlind K, 2008, EXP DERMATOL, V17, P301, DOI 10.1111/j.1600-0625.2007.00670.x; Ossowska G, 2001, J NEURAL TRANSM, V108, P311, DOI 10.1007/s007020170077; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Papageorgiou A, 2007, ENDOCRINOLOGY, V148, P4509, DOI 10.1210/en.2007-0034; Parikh DK, 2005, AAPS PHARMSCITECH, V6; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Graziano P, 2006, PSYCHOPHARMACOLOGY, V186, P362, DOI 10.1007/s00213-005-0213-2; Schallreuter KU, 2012, FASEB J, V26, P2457, DOI 10.1096/fj.11-197137; SCHALLREUTER KU, 1995, J INVEST DERMATOL, V104, P953, DOI 10.1111/1523-1747.ep12606218; Semont A, 2000, J NEUROENDOCRINOL, V12, P736, DOI 10.1046/j.1365-2826.2000.00509.x; SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2002, FASEB J, V16, P896, DOI 10.1096/fj.01-0952fje; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2003, BBA-MOL BASIS DIS, V1639, P80, DOI 10.1016/S0925-4439(03)00124-8; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; SLOMINSKI A, 1991, J INVEST DERMATOL, V96, P172, DOI 10.1111/1523-1747.ep12460956; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Stenfors C, 2002, LIFE SCI, V71, P2867, DOI 10.1016/S0024-3205(02)02138-0; TOMITA Y, 1992, PIGM CELL RES, V5, P357, DOI 10.1111/j.1600-0749.1992.tb00562.x; Wang SH, 2009, PSYCHIAT RES, V170, P245, DOI 10.1016/j.psychres.2008.07.006; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yamada J, 1999, EUR J PHARMACOL, V383, P49, DOI 10.1016/S0014-2999(99)00580-4; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; Zhou J, 2013, INT J BIOCHEM CELL B, V45, P308, DOI 10.1016/j.biocel.2012.11.008; Zmijewski MA, 2011, DERM-ENDOCRINOL, V3, P3, DOI 10.4161/derm.3.1.14617	75	16	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89663	10.1371/journal.pone.0089663	http://dx.doi.org/10.1371/journal.pone.0089663			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586946	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900139
J	Xu, JJ; Tang, WM; Cheng, SM; Mahapatra, T; Zhou, L; Lai, YJ; Jiang, YJ; Liu, FY; Zhen, XN; He, JG; Zhang, J; Lu, JX; Mahapatra, S; Shang, H				Xu, Junjie; Tang, Weiming; Cheng, Shiming; Mahapatra, Tanmay; Zhou, Lin; Lai, Yuji; Jiang, Yongjun; Liu, Feiying; Zhen, Xinan; He, Jinge; Zhang, Jing; Lu, Jinxin; Mahapatra, Sanchita; Shang, Hong			Prevalence and Predictors of HIV among Chinese Tuberculosis Patients by Provider-Initiated HIV Testing and Counselling (PITC): A Multisite Study in South Central of China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; FEMALE SEX WORKERS; INJECTING DRUG-USE; PLASMA DONORS; RISK; DISEASE; EPIDEMIOLOGY; MIGRANTS; BEHAVIOR; CLIENTS	Background: Tuberculosis (TB) and HIV are two worldwide public health concerns. Co-infection of these two diseases has been considered to be a major obstacle for the global efforts in reaching the goals for the prevention of HIV and TB. Method: A comprehensive cross-sectional study was conducted to recruit TB patients in three provinces (Guangxi, Henan and Sichuan) of China between April 1 and September 30, 2010. Results: A total of 1,032 consenting TB patients attended this survey during the study period. Among the participants, 3.30% were HIV positive; about one quarter had opportunistic infections. Nearly half of the participants were 50 years or older, the majority were male and about one third were from minority ethnic groups. After adjusting for site, gender and areas of residence (using the partial/selective Model 1), former commercial plasma donors (adjusted OR [aOR] = 33.71) and injecting drug users(aOR = 15.86) were found to have significantly higher risk of being HIV-positivity. In addition, having extramarital sexual relationship (aOR = 307.16), being engaged in commercial sex (aOR = 252.37), suffering from opportunistic infections in the past six months (aOR = 2.79), losing 10% or more of the body weight in the past six months (aOR = 5.90) and having abnormal chest X-ray findings (aOR = 20.40) were all significantly associated with HIV seropositivity (each p<0.05). Conclusions: HIV prevalence among TB patients was high in the study areas of China. To control the dual epidemic, intervention strategies targeting socio-demographic and behavioral factors associated with higher risk of TB-HIV coinfection are urgently called for.	[Xu, Junjie; Jiang, Yongjun; Zhang, Jing; Lu, Jinxin; Shang, Hong] China Med Univ, Dept Lab Med, Affiliated Hosp 1, Key Lab AIDS Immunol,Natl Hlth & Family Planning, Shenyang, Liaoning, Peoples R China; [Xu, Junjie; Jiang, Yongjun; Zhang, Jing; Lu, Jinxin; Shang, Hong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Tang, Weiming; Mahapatra, Tanmay] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Cheng, Shiming; Zhou, Lin; Lai, Yuji] Natl Ctr Dis Control & Prevent CDC, Ctr TB Control & Prevent, Beijing, Peoples R China; [Liu, Feiying] Guangxi Autonomous Reg CDC, Ctr TB Control & Prevent, Nanning, Peoples R China; [Zhen, Xinan] HenanProvincialCDC, Ctr TB Control & Prevent, Zhengzhou, Peoples R China; [He, Jinge] SichuanProvincialCDC, Ctr TB Control & Prevent, Chengdu, Peoples R China	China Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of California System; University of California Los Angeles; Chinese Center for Disease Control & Prevention	Shang, H (corresponding author), China Med Univ, Dept Lab Med, Affiliated Hosp 1, Key Lab AIDS Immunol,Natl Hlth & Family Planning, Shenyang, Liaoning, Peoples R China.	hongshang100@hotmail.com		Tang, Weiming/0000-0002-9026-707X; xu, junjie/0000-0003-4303-7295	China Mega-project of National Science Research for the 12th Five-Year Plan [2012ZX10001-006]; Liaoning University Pandeng Scholar project [[2008]90]	China Mega-project of National Science Research for the 12th Five-Year Plan; Liaoning University Pandeng Scholar project	This study was supported by the China Mega-project of National Science Research for the 12th Five-Year Plan (2012ZX10001-006), and Liaoning University Pandeng Scholar project ([2008]90). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Bruus M., 2003, EPIDATA VERSION 3 CO; China Ministry of Health, 2012, 2011 UPD HIV AIDS EP; De Greef E, 2012, ARCH DIS CHILD, V97, P5, DOI 10.1136/archdischild-2011-300365; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010736; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Hampton MC, 2012, AIDS BEHAV, P1; He N, 2006, AIDS EDUC PREV, V18, P176, DOI 10.1521/aeap.2006.18.2.176; Jin X, 2010, JAIDS-J ACQ IMM DEF, V53, P131, DOI 10.1097/QAI.0b013e3181b3552a; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Li N, 2010, JAIDS-J ACQ IMM DEF, V53, pS41, DOI 10.1097/QAI.0b013e3181c7d717; Li S, 2008, CHINESE HLTH SERVICE, V11, P783; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; Lu L, 2008, OCCUPATION HLTH, V24, P964; Ma WJ, 2010, BIOMED ENVIRON SCI, V23, P287, DOI 10.1016/S0895-3988(10)60065-7; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Modjarrad K, 2010, LANCET INFECT DIS, V10, P455, DOI 10.1016/S1473-3099(10)70093-1; MOH U WHO, 2011, 2011 EST HIV AIDS EP; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; *SAS I, 1996, SAS SYST WIND; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Song D, 2013, INT J STD AIDS; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Wang LY, 2010, JAIDS-J ACQ IMM DEF, V53, pS61, DOI 10.1097/QAI.0b013e3181c7db2e; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; Wheeler DA, 1998, J ACQ IMMUN DEF SYND, V18, P80, DOI 10.1097/00042560-199805010-00012; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wu ZY, 2001, HEALTH POLICY PLANN, V16, P41, DOI 10.1093/heapol/16.1.41; Yang X, 2007, AIDS CARE, V19, P282, DOI 10.1080/09540120600909414	35	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89723	10.1371/journal.pone.0089723	http://dx.doi.org/10.1371/journal.pone.0089723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586987	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900144
J	McMurphy, T; Xiao, R; Magee, D; Slater, A; Zabeau, L; Tavernier, J; Cao, L				McMurphy, Travis; Xiao, Run; Magee, Daniel; Slater, Andrew; Zabeau, Lennart; Tavernier, Jan; Cao, Lei			The Anti-Tumor Activity of a Neutralizing Nanobody Targeting Leptin Receptor in a Mouse Model of Melanoma	PLOS ONE			English	Article							PANCREATIC BETA-CELL; BREAST-CANCER; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; BODY-WEIGHT; FOOD-INTAKE; IN-VIVO; EXPRESSION; OBESITY; PATHWAYS	Environmental and genetic activation of a brain-adipocyte axis inhibits cancer progression. Leptin is the primary peripheral mediator of this anticancer effect in a mouse model of melanoma. In this study we assessed the effect of a leptin receptor antagonist on melanoma progression. Local administration of a neutralizing nanobody targeting the leptin receptor at low dose adjacent to tumor decreased tumor mass with no effects on body weight or food intake. In contrast, systemic administration of the nanobody failed to suppress tumor growth. Daily intraperitoneal injection of high-dose nanobody led to weight gain, hyperphagia, increased adiposity, hyperleptinemia, and hyperinsulinemia, and central effects mimicking leptin deficiency. The blockade of central actions of leptin by systemic delivery of nanobody may compromise its anticancer effect, underscoring the need to develop peripherally acting leptin antagonists coupled with efficient cancer-targeting delivery.	[McMurphy, Travis; Xiao, Run; Magee, Daniel; Slater, Andrew; Cao, Lei] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [McMurphy, Travis; Xiao, Run; Magee, Daniel; Slater, Andrew; Cao, Lei] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Zabeau, Lennart; Tavernier, Jan] Univ Ghent, Dept Med Prot Res, Flanders Inst Biotechnol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Flanders Institute for Biotechnology (VIB); Ghent University	Cao, L (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	lei.cao@osumc.edu	Cao, Lei/H-3185-2019; Tavernier, Jan/AAG-3636-2019	Magee, Daniel/0000-0001-7352-7485; Cao, Lei/0000-0003-0322-4985	National Institutes of Health [CA163640, CA166590, CA178227, AG041250]; Fund for Scientific Research-Flanders [G.0521.12N]; Interuniversity Attraction Poles [P6:36]; Group-ID Multidisciplinary Research Partnership of Ghent University; NATIONAL CANCER INSTITUTE [R01CA166590, R21CA178227, R01CA163640, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Scientific Research-Flanders(FWO); Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Group-ID Multidisciplinary Research Partnership of Ghent University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants CA163640, CA166590, CA178227, and AG041250 (to L. Cao), and Fund for Scientific Research-Flanders (Project G.0521.12N), The Interuniversity Attraction Poles (grant P6:36), The Group-ID Multidisciplinary Research Partnership of Ghent University (to J. Tavernier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrova K, 2013, INT J CANC; Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Bjorbaek C, 1998, ENDOCRINOLOGY, V139, P3485, DOI 10.1210/en.139.8.3485; Brandon EL, 2009, CANCER BIOL THER, V8, P1871, DOI 10.4161/cbt.8.19.9650; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933; Chan JL, 2002, DIABETES, V51, P2105, DOI 10.2337/diabetes.51.7.2105; Cheunsuang O, 2005, GLIA, V52, P228, DOI 10.1002/glia.20239; Choi JH, 2004, J CLIN ENDOCR METAB, V89, P5508, DOI 10.1210/jc.2004-0044; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; De Ceuninck L, 2013, J CELL SCI, V126, P3770, DOI 10.1242/jcs.131250; De Rosa V, 2006, J CLIN INVEST, V116, P447, DOI 10.1172/JCI26523; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Faouzi M, 2007, ENDOCRINOLOGY, V148, P5414, DOI 10.1210/en.2007-0655; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fountzilas G, 2008, ANN ONCOL, V19, P853, DOI [10.1093/annonc/mdm539, 10.1093/annonc/mdm464]; Frankenberry KA, 2006, INT J ONCOL, V28, P985; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Ge HF, 2002, J BIOL CHEM, V277, P45898, DOI 10.1074/jbc.M205825200; Gonzalez RR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2321; Gray SL, 2010, ENDOCRINOLOGY, V151, P4178, DOI 10.1210/en.2010-0102; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Iversen PO, 2002, BLOOD, V100, P4123, DOI 10.1182/blood-2001-11-0134; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kastin AJ, 1999, PEPTIDES, V20, P1449, DOI 10.1016/S0196-9781(99)00156-4; Lam QLK, 2010, P NATL ACAD SCI USA, V107, P13812, DOI 10.1073/pnas.1004185107; Lammert A, 2001, BIOCHEM BIOPH RES CO, V283, P982, DOI 10.1006/bbrc.2001.4885; Levi J, 2011, ENDOCRINOLOGY, V152, P3385, DOI 10.1210/en.2011-0185; Maamra M, 2001, ENDOCRINOLOGY, V142, P4389, DOI 10.1210/en.142.10.4389; Marroqui L, 2012, J MOL ENDOCRINOL, V49, pR9, DOI 10.1530/JME-12-0025; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Purdham DM, 2008, AM J PHYSIOL-HEART C, V295, pH441, DOI 10.1152/ajpheart.91537.2007; Ray A, 2010, EXPERT OPIN THER TAR, V14, P443, DOI 10.1517/14728221003716466; Reinehr T, 2005, INT J OBESITY, V29, P1230, DOI 10.1038/sj.ijo.0803027; Schaab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034787; Simon M, 2013, EXPERT OPIN DRUG DEL, V10, P451, DOI 10.1517/17425247.2013.759938; Sun Q, 2010, DIABETES, V59, P611, DOI 10.2337/db09-1343; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tu H, 2008, J CELL PHYSIOL, V214, P301, DOI 10.1002/jcp.21195; van der Linden R, 2000, J IMMUNOL METHODS, V240, P185, DOI 10.1016/S0022-1759(00)00188-5; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; Wauters M, 2000, EUR J ENDOCRINOL, V143, P293, DOI 10.1530/eje.0.1430293; Zabeau L, 2012, BIOCHEM J, V441, P425, DOI 10.1042/BJ20110438; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	57	21	25	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89895	10.1371/journal.pone.0089895	http://dx.doi.org/10.1371/journal.pone.0089895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587106	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200094
J	Mishima, T; Fujiwara, T; Sanada, M; Kofuji, T; Kanai-Azuma, M; Akagawa, K				Mishima, Tatsuya; Fujiwara, Tomonori; Sanada, Masumi; Kofuji, Takefumi; Kanai-Azuma, Masami; Akagawa, Kimio			Syntaxin 1B, but Not Syntaxin 1A, Is Necessary for the Regulation of Synaptic Vesicle Exocytosis and of the Readily Releasable Pool at Central Synapses	PLOS ONE			English	Article							HPC-1/SYNTAXIN 1A; RIBBON SYNAPSES; HPC-1 ANTIGEN; SNAP-25; BINDING; LOCALIZATION; MECHANISMS; SYNTABULIN; TRANSPORT; MEMBRANE	Two syntaxin 1 (STX1) isoforms, HPC-1/STX1A and STX1B, are coexpressed in neurons and function as neuronal target membrane (t)-SNAREs. However, little is known about their functional differences in synaptic transmission. STX1A null mutant mice develop normally and do not show abnormalities in fast synaptic transmission, but monoaminergic transmissions are impaired. In the present study, we found that STX1B null mutant mice died within 2 weeks of birth. To examine functional differences between STX1A and 1B, we analyzed the presynaptic properties of glutamatergic and GABAergic synapses in STX1B null mutant and STX1A/1B double null mutant mice. We found that the frequency of spontaneous quantal release was lower and the paired-pulse ratio of evoked postsynaptic currents was significantly greater in glutamatergic and GABAergic synapses of STX1B null neurons. Deletion of STX1B also accelerated synaptic vesicle turnover in glutamatergic synapses and decreased the size of the readily releasable pool in glutamatergic and GABAergic synapses. Moreover, STX1A/1B double null neurons showed reduced and asynchronous evoked synaptic vesicle release in glutamatergic and GABAergic synapses. Our results suggest that although STX1A and 1B share a basic function as neuronal t-SNAREs, STX1B but not STX1A is necessary for the regulation of spontaneous and evoked synaptic vesicle exocytosis in fast transmission.	[Mishima, Tatsuya; Fujiwara, Tomonori; Sanada, Masumi; Akagawa, Kimio] Kyorin Univ, Sch Med, Dept Cell Physiol, Mitaka, Tokyo 181, Japan; [Kofuji, Takefumi] Kyorin Univ, Sch Med, Radio Isotope Lab, Mitaka, Tokyo 181, Japan; [Kanai-Azuma, Masami] Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 181, Japan	Kyorin University; Kyorin University; Kyorin University	Mishima, T (corresponding author), Kyorin Univ, Sch Med, Dept Cell Physiol, Mitaka, Tokyo 181, Japan.	mishimat@ks.kyorin-u.ac.jp		Mishima, Tatsuya/0000-0002-1088-6947	JSPS [24500462, 22500338, 24300142]; Promotion and Mutual Aid Cooperation for Private Schools of Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion and Mutual Aid Cooperation for Private Schools of Japan	This study was financially supported by a JSPS Grant-in-Aid for Scientific Research (C) to TM (No. 24500462) and TF (No. 22500338), a JSPS Grant-in-Aid for Scientific Research (B) to KA (No. 24300142), and a Grant-in-Aid from the Promotion and Mutual Aid Cooperation for Private Schools of Japan to KA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado F, 1999, NEUROSCIENCE, V88, P437, DOI 10.1016/S0306-4522(98)00247-4; Arancillo M, 2013, J NEUROSCI, V33, P16698, DOI 10.1523/JNEUROSCI.0187-13.2013; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Curtis L, 2010, NEUROSCIENCE, V166, P832, DOI 10.1016/j.neuroscience.2009.12.075; Curtis LB, 2008, J COMP NEUROL, V510, P550, DOI 10.1002/cne.21806; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Fujiwara T, 2009, NEUROSCI RES, V65, pS79, DOI 10.1016/j.neures.2009.09.293; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; INOUE A, 1992, J BIOL CHEM, V267, P10613; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; KOH S, 1993, J NEUROCYTOL, V22, P995, DOI 10.1007/BF01218356; Kushima Y, 1997, J MOL NEUROSCI, V8, P19, DOI 10.1007/BF02736860; Leenders AGM, 2001, MOL BIOL CELL, V12, P3095, DOI 10.1091/mbc.12.10.3095; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Ma H, 2009, J NEUROSCI, V29, P13019, DOI 10.1523/JNEUROSCI.2517-09.2009; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Mishima T, 2002, NEUROSCI LETT, V329, P273, DOI 10.1016/S0304-3940(02)00662-6; Mishima T, 2012, J NEUROSCI, V32, P381, DOI 10.1523/JNEUROSCI.2911-11.2012; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Peng LS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2462; Perez-Branguli F, 2002, MOL CELL NEUROSCI, V20, P169, DOI 10.1006/mcne.2002.1122; Prange O, 1999, J NEUROSCI, V19, P6427; Raingo J, 2012, NAT NEUROSCI, V15, P738, DOI 10.1038/nn.3067; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RuizMontasell B, 1996, EUR J NEUROSCI, V8, P2544, DOI 10.1111/j.1460-9568.1996.tb01548.x; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Xu J., 2013, COMMUNITY MENT HLT J, P1; Zhou P, 2012, EMBO J, P1	42	57	59	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90004	10.1371/journal.pone.0090004	http://dx.doi.org/10.1371/journal.pone.0090004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587181	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200109
J	Royce, LA; Boggess, E; Fu, Y; Liu, P; Shanks, JV; Dickerson, J; Jarboe, LR				Royce, Liam A.; Boggess, Erin; Fu, Yao; Liu, Ping; Shanks, Jacqueline V.; Dickerson, Julie; Jarboe, Laura R.			Transcriptomic Analysis of Carboxylic Acid Challenge in Escherichia coli: Beyond Membrane Damage	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GREEN FLUORESCENT PROTEIN; GAMMA-AMINOBUTYRIC-ACID; MICROTITER PLATE ASSAY; ORGANIC-ACIDS; PH; RESISTANCE; METABOLISM; STRESS; GENE	Carboxylic acids are an attractive biorenewable chemical. Enormous progress has been made in engineering microbes for production of these compounds though titers remain lower than desired. Here we used transcriptome analysis of Escherichia coli during exogenous challenge with octanoic acid (C8) at pH 7.0 to probe mechanisms of toxicity. This analysis highlights the intracellular acidification and membrane damage caused by C8 challenge. Network component analysis identified transcription factors with altered activity including GadE, the activator of the glutamate-dependent acid resistance system (AR2) and Lrp, the amino acid biosynthesis regulator. The intracellular acidification was quantified during exogenous challenge, but was not observed in a carboxylic acid producing strain, though this may be due to lower titers than those used in our exogenous challenge studies. We developed a framework for predicting the proton motive force during adaptation to strong inorganic acids and carboxylic acids. This model predicts that inorganic acid challenge is mitigated by cation accumulation, but that carboxylic acid challenge inverts the proton motive force and requires anion accumulation. Utilization of native acid resistance systems was not useful in terms of supporting growth or alleviating intracellular acidification. AR2 was found to be non-functional, possibly due to membrane damage. We proposed that interaction of Lrp and C8 resulted in repression of amino acid biosynthesis. However, this hypothesis was not supported by perturbation of lrp expression or amino acid supplementation. E. coli strains were also engineered for altered cyclopropane fatty acid content in the membrane, which had a dramatic effect on membrane properties, though C8 tolerance was not increased. We conclude that achieving higher production titers requires circumventing the membrane damage. As higher titers are achieved, acidification may become problematic.	[Royce, Liam A.; Shanks, Jacqueline V.; Jarboe, Laura R.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Boggess, Erin; Fu, Yao; Dickerson, Julie] Iowa State Univ, Dept Elect & Comp Engn, Ames, IA USA; [Liu, Ping; Jarboe, Laura R.] Iowa State Univ, Interdept Microbiol Program, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Jarboe, LR (corresponding author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.	ljarboe@iastate.edu	Shanks, Jacqueline/ABE-5353-2020	Dickerson, Julie A/0000-0003-4973-5641; Shanks, Jacqueline/0000-0001-9947-0181	National Science Foundation (NSF) Engineering Research Center for Biorenewable Chemicals (CBiRC), NSF award [EEC-0813570]	National Science Foundation (NSF) Engineering Research Center for Biorenewable Chemicals (CBiRC), NSF award(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF) Engineering Research Center for Biorenewable Chemicals (CBiRC), NSF award number EEC-0813570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; AXE DD, 1995, BIOTECHNOL BIOENG, V47, P8, DOI 10.1002/bit.260470103; Brynildsen MP, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.34; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; Carpenter CE, 2009, J FOOD SCI, V74, pR12, DOI 10.1111/j.1750-3841.2008.00994.x; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Courtois F, 2005, BIOCHEMISTRY-US, V44, P13583, DOI 10.1021/bi051159x; DECKER K, 1993, J BACTERIOL, V175, P5655, DOI 10.1128/JB.175.17.5655-5665.1993; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; DiezGonzalez F, 1997, MICROBIOL-UK, V143, P1175, DOI 10.1099/00221287-143-4-1175; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Evtodienko VY, 1996, BBA-BIOMEMBRANES, V1281, P245, DOI 10.1016/0005-2736(96)00023-5; Feehily C, 2013, J APPL MICROBIOL, V114, P11, DOI 10.1111/j.1365-2672.2012.05434.x; Foley P, 2012, CHEM SOC REV, V41, P1499, DOI 10.1039/c1cs15217c; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fu Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-233; Gagliardi JV, 2000, APPL ENV MICROBIOLOG, V66; Handke P, 2011, METAB ENG, V13, P28, DOI 10.1016/j.ymben.2010.10.007; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jarboe LR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00272; Jarboe LR, 2011, CURR OPIN CHEM ENG, V1, P38, DOI 10.1016/j.coche.2011.08.003; Johnson MD, 2011, J BACTERIOL, V193, P3653, DOI 10.1128/JB.05040-11; Kabara JJ, 2005, FOOD SCI, V143, P327; Kamp F, 2006, PROSTAG LEUKOTR ESS, V75, P149, DOI 10.1016/j.plefa.2006.05.003; Karatzas KAG, 2010, APPL ENVIRON MICROB, V76, P3529, DOI 10.1128/AEM.03063-09; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kobayashi H, 2000, J GEN APPL MICROBIOL, V46, P235, DOI 10.2323/jgam.46.235; Kochanowski K, 2013, P NATL ACAD SCI USA, V110, P1130, DOI 10.1073/pnas.1202582110; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Kung Y, 2012, ACS SYNTH BIOL, V1, P498, DOI 10.1021/sb300074k; Lennen RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054031; Lennen RM, 2012, TRENDS BIOTECHNOL, V30, P659, DOI 10.1016/j.tibtech.2012.09.006; Lennen RM, 2011, APPL ENVIRON MICROB, V77, P8114, DOI 10.1128/AEM.05421-11; Li M, 2012, METAB ENG, V14, P380, DOI 10.1016/j.ymben.2012.03.007; Liu P, 2013, APPL MICROBIOL BIOT, V97, P3239, DOI 10.1007/s00253-013-4773-5; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Miller EN, 2009, APPL ENVIRON MICROB, V75, P6132, DOI 10.1128/AEM.01187-09; Mills TY, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-26; Mulkidjanian AY, 2009, TRENDS BIOCHEM SCI, V34, P206, DOI 10.1016/j.tibs.2009.01.005; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; O'Byrne CP, 2011, J MICROBIOL METH, V84, P137, DOI 10.1016/j.mimet.2010.10.017; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Ranjit DK, 2013, J BACTERIOL, V195, P2452, DOI 10.1128/JB.00160-13; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Ricke SC, 2003, POULTRY SCI, V82, P632, DOI 10.1093/ps/82.4.632; Rottenberg H, 1979, Methods Enzymol, V55, P547; Royce LA, 2013, APPL MICROBIOL BIOT, V97, P8317, DOI 10.1007/s00253-013-5113-5; Salgado H, 2012, NUCL ACIDS RES; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; San K-Y, 2011, BACTERIA METHOD SYNT; Schlegel A, 2002, J MOL MICROB BIOTECH, V4, P301; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Takahashi C, 2012, ENZYME MICROB TECH, V51, P171, DOI 10.1016/j.enzmictec.2012.05.010; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Tsukatani T, 2005, ANAL CHIM ACTA, V540, P293, DOI 10.1016/j.aca.2005.03.056; Wanner B.L., 1994, METH MOL G, V3, P291; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Woodruff LBA, 2011, CURR OPIN BIOTECH, V22, P576, DOI 10.1016/j.copbio.2011.04.019; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Yazdani SS, 2008, METAB ENG, V10, P340, DOI 10.1016/j.ymben.2008.08.005; Zhang WM, 2004, BIOCHEMISTRY-US, V43, P13165, DOI 10.1021/bi048596g; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	68	23	24	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89580	10.1371/journal.pone.0089580	http://dx.doi.org/10.1371/journal.pone.0089580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586888	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200062
J	Schlichter, LC; Jiang, JH; Wang, J; Newell, EW; Tsui, FWL; Lam, D				Schlichter, Lyanne C.; Jiang, Jiahua; Wang, John; Newell, Evan W.; Tsui, Florence W. L.; Lam, Doris			Regulation of hERG and hEAG Channels by Src and by SHP-1 Tyrosine Phosphatase via an ITIM Region in the Cyclic Nucleotide Binding Domain	PLOS ONE			English	Article							LONG-QT SYNDROME; PROTEIN-KINASE-A; NATIVE KV1.3 CHANNELS; RECTIFYING K+ CURRENT; POTASSIUM CHANNEL; C-SRC; INTRAMOLECULAR REGULATION; MOLECULAR-BASIS; MESSENGER-RNA; UP-REGULATION	Members of the EAG K+ channel superfamily (EAG/Kv10. x, ERG/Kv11. x, ELK/Kv12. x subfamilies) are expressed in many cells and tissues. In particular, two prototypes, EAG1/Kv10.1/KCNH1 and ERG1/Kv11.1/KCNH2 contribute to both normal and pathological functions. Proliferation of numerous cancer cells depends on hEAG1, and in some cases, hERG. hERG is best known for contributing to the cardiac action potential, and for numerous channel mutations that underlie 'long-QT syndrome'. Many cells, particularly cancer cells, express Src-family tyrosine kinases and SHP tyrosine phosphatases; and an imbalance in tyrosine phosphorylation can lead to malignancies, autoimmune diseases, and inflammatory disorders. Ion channel contributions to cell functions are governed, to a large degree, by post-translational modulation, especially phosphorylation. However, almost nothing is known about roles of specific tyrosine kinases and phosphatases in regulating K+ channels in the EAG superfamily. First, we show that tyrosine kinase inhibitor, PP1, and the selective Src inhibitory peptide, Src40-58, reduce the hERG current amplitude, without altering its voltage dependence or kinetics. PP1 similarly reduces the hEAG1 current. Surprisingly, an 'immuno-receptor tyrosine inhibitory motif' (ITIM) is present within the cyclic nucleotide binding domain of all EAG-superfamily members, and is conserved in the human, rat and mouse sequences. When tyrosine phosphorylated, this ITIM directly bound to and activated SHP-1 tyrosine phosphatase (PTP-1C/PTPN6/HCP); the first report that a portion of an ion channel is a binding site and activator of a tyrosine phosphatase. Both hERG and hEAG1 currents were decreased by applying active recombinant SHP-1, and increased by the inhibitory substrate-trapping SHP-1 mutant. Thus, hERG and hEAG1 currents are regulated by activated SHP-1, in a manner opposite to their regulation by Src. Given the widespread distribution of these channels, Src and SHP-1, this work has broad implications in cell signaling that controls survival, proliferation, differentiation, and other ERG1 and EAG1 functions in many cell types.	[Schlichter, Lyanne C.; Jiang, Jiahua; Wang, John; Newell, Evan W.; Tsui, Florence W. L.; Lam, Doris] Univ Hlth Network, Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada; [Schlichter, Lyanne C.; Newell, Evan W.; Lam, Doris] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Tsui, Florence W. L.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Schlichter, LC (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada.	schlicht@uhnres.utoronto.ca	Lam, Doris/AAG-4796-2020; Newell, Evan W/F-9711-2012	Lam, Doris/0000-0002-3882-9514; Newell, Evan W/0000-0002-2889-243X	Canadian Institutes for Health Research [64402]; National Science Foundation (USA); Ruth L. Kirschstein National Research Service Award from National Institutes of Neurological Diseases and Stroke [F31NS049742]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS049742] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation (USA)(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award from National Institutes of Neurological Diseases and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant (#64402) to LCS and FWLT from the Canadian Institutes for Health Research. EWN was supported by a fellowship from the National Science Foundation (USA) and a Ruth L. Kirschstein National Research Service Award pre-doctoral scholarship from the National Institutes of Neurological Diseases and Stroke (#F31NS049742). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Aidery P, 2012, BIOCHEM BIOPH RES CO, V418, P830, DOI 10.1016/j.bbrc.2012.01.118; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Arcangeli A, 1997, EUR J NEUROSCI, V9, P2596, DOI 10.1111/j.1460-9568.1997.tb01689.x; Arcangeli A, 1995, J PHYSIOL-LONDON, V489, P455, DOI 10.1113/jphysiol.1995.sp021065; Asher V, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-78; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bauer CK, 1999, MOL CELL ENDOCRINOL, V148, P37, DOI 10.1016/S0303-7207(98)00241-X; Bianchi L, 1998, CANCER RES, V58, P815; Biskup C, 2004, J CELL SCI, V117, P5165, DOI 10.1242/jcs.01397; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cayabyab FS, 2000, EUR J NEUROSCI, V12, P1949, DOI 10.1046/j.1460-9568.2000.00083.x; Cayabyab FS, 2002, J BIOL CHEM, V277, P48130, DOI 10.1074/jbc.M208448200; Cayabyab FS, 2002, J BIOL CHEM, V277, P13673, DOI 10.1074/jbc.M108211200; Cheng YM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00083; Chung I, 1997, AM J PHYSIOL-CELL PH, V273, pC622, DOI 10.1152/ajpcell.1997.273.2.C622; Chung I, 1997, J MEMBRANE BIOL, V156, P73, DOI 10.1007/s002329900189; Cui J, 2001, J BIOL CHEM, V276, P17244, DOI 10.1074/jbc.M010904200; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Davis ME, 2003, AM J PHYSIOL-HEART C, V284, pH1449, DOI 10.1152/ajpheart.00918.2002; Delibrias CC, 1997, J EXP MED, V186, P1575, DOI 10.1084/jem.186.9.1575; Faravelli L, 1996, J PHYSIOL-LONDON, V496, P13, DOI 10.1113/jphysiol.1996.sp021661; Ferreira R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062345; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Garcia-Ferreiro RE, 2004, J GEN PHYSIOL, V124, P301, DOI 10.1085/jgp.200409041; Gingrich JR, 2004, P NATL ACAD SCI USA, V101, P6237, DOI 10.1073/pnas.0401413101; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Kiehn J, 1998, J BIOL CHEM, V273, P25285, DOI 10.1074/jbc.273.39.25285; Kupershmidt S, 2002, J BIOL CHEM, V277, P27442, DOI 10.1074/jbc.M112375200; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Kuppuswamy D, 1997, J BIOL CHEM, V272, P4500, DOI 10.1074/jbc.272.7.4500; Kyaw M, 2004, MOL PHARMACOL, V65, P832, DOI 10.1124/mol.65.4.832; Lastraioli E, 2004, CANCER RES, V64, P606, DOI 10.1158/0008-5472.CAN-03-2360; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Liu BS, 2013, J NEUROIMMUNE PHARM, V8, P227, DOI 10.1007/s11481-012-9365-0; London B, 1997, CIRC RES, V81, P870; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Martin A, 1999, J BIOL CHEM, V274, P21725, DOI 10.1074/jbc.274.31.21725; Mazhari R, 2001, CIRC RES, V89, P33, DOI 10.1161/hh1301.093633; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; MOK SC, 1995, GYNECOL ONCOL, V57, P299, DOI 10.1006/gyno.1995.1146; Nakao F, 2002, CIRC RES, V91, P953, DOI 10.1161/01.RES.0000042702.04920.BF; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Oka T, 2001, AM J PATHOL, V159, P1495, DOI 10.1016/S0002-9440(10)62535-7; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2008, CANCER RES, V68, P1611, DOI 10.1158/0008-5472.CAN-07-5710; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; Pillozzi S, 2002, LEUKEMIA, V16, P1791, DOI 10.1038/sj.leu.2402572; Schlichter LC, 2006, 50 ANN M BIOPH SOC J, V90; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Shi WM, 1998, J PHYSIOL-LONDON, V511, P675, DOI 10.1111/j.1469-7793.1998.675bg.x; Shi WM, 1997, J NEUROSCI, V17, P9423; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Suzuki T, 2004, INT J ONCOL, V25, P153; Takeishi Y, 2001, J MOL CELL CARDIOL, V33, P1989, DOI 10.1006/jmcc.2001.1463; Thomas D, 1999, J BIOL CHEM, V274, P27457, DOI 10.1074/jbc.274.39.27457; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Titus SA, 1997, J NEUROSCI, V17, P875; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Wang Z, 2002, J BIOL CHEM, V277, P24022, DOI 10.1074/jbc.M201949200; Wei Z, 2002, CHINESE MED J-PEKING, V115, P668; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Wu W, 2012, BBA-MOL CELL RES, V1823, P282, DOI 10.1016/j.bbamcr.2011.10.010; Wymore RS, 1997, CIRC RES, V80, P261, DOI 10.1161/01.RES.80.2.261; Yip SS, 2000, INT J CANCER, V88, P363, DOI 10.1002/1097-0215(20001101)88:3<363::AID-IJC7>3.0.CO;2-4; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zhang DY, 2008, CELL SIGNAL, V20, P1815, DOI 10.1016/j.cellsig.2008.06.006; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang YQ, 2003, FEBS LETT, V534, P125, DOI 10.1016/S0014-5793(02)03804-8; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	83	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90024	10.1371/journal.pone.0090024	http://dx.doi.org/10.1371/journal.pone.0090024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587194	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200114
J	Soulard, J; Boivin, N; Morse, D; Cappadocia, M				Soulard, Jonathan; Boivin, Nicolas; Morse, David; Cappadocia, Mario			eEF1A Is an S-RNase Binding Factor in Self-Incompatible Solanum chacoense	PLOS ONE			English	Article							POLLEN REJECTION THRESHOLDS; FACTOR 1 ALPHA; NICOTIANA-ALATA; ACTIN-BINDING; PETUNIA-INFLATA; ELONGATION FACTOR-1-ALPHA; IN-VITRO; RABBIT RETICULOCYTES; SEQUENCE VARIABILITY; PROTEIN-SYNTHESIS	Self-incompatibility (SI) is a genetic mechanism that allows flowering plants to identify and block fertilization by self-pollen. In the Solanaceae, SI is controlled by a multiallelic S-locus encoding both S-RNases and F-box proteins as female and male determinants, respectively. S-RNase activity is essential for pollen rejection, and a minimum threshold value of S-RNases in the style is also required. Here we present biochemical evidence that eEF1A is a novel S-RNase-binding partner in vitro. We further show that the normal actin binding activity of eEF1A is enhanced by the presence of S-RNase. Lastly, we find that there is a co-localization of S-RNase and actin in the incompatible pollen tubes in structures reminiscent of the actin bundles formed by eEF1A. We propose that increased binding of eEF1A to actin in the presence of S-RNase could help explain the disruption of the actin cytoskeleton observed during SI reactions.	[Soulard, Jonathan; Boivin, Nicolas; Morse, David; Cappadocia, Mario] Univ Montreal, Dept Sci Biol, IRBV, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Cappadocia, M (corresponding author), Univ Montreal, Dept Sci Biol, IRBV, CP 6128, Montreal, PQ H3C 3J7, Canada.	mario.cappadocia@umontreal.ca		Morse, David/0000-0003-4131-4367	National Science and Engineering Research Council of Canada (NSERC)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by financial assistance from the National Science and Engineering Research Council of Canada (NSERC) to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MA, 1989, PLANT CELL, V1, P483, DOI 10.1105/tpc.1.5.483; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; Cheung AY, 2008, MOL PLANT, V1, P686, DOI 10.1093/mp/ssn026; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; CLARK KR, 1990, PLANT CELL, V2, P815, DOI 10.1105/tpc.2.8.815; Clore AM, 1996, PLANT CELL, V8, P2003, DOI 10.2307/3870408; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Cruz-Garcia F, 2005, PLANT J, V42, P295, DOI 10.1111/j.1365-313X.2005.02375.x; de Leeuw M, 2007, ACTA CRYSTALLOGR F, V63, P716, DOI 10.1107/S1744309107034483; DEMMA M, 1990, J BIOL CHEM, V265, P2286; DHARMAWARDHANE S, 1991, CELL MOTIL CYTOSKEL, V20, P279, DOI 10.1002/cm.970200404; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; EDMONDS BT, 1993, J CELL BIOCHEM, V52, P134, DOI 10.1002/jcb.240520204; GRANT AG, 1992, INT J CANCER, V50, P740, DOI 10.1002/ijc.2910500513; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Guo YX, 2006, J INTEGR PLANT BIOL, V48, P584, DOI 10.1111/j.1744-7909.2006.00285.x; Guyon VN, 2000, PLANT PHYSIOL, V123, P699, DOI 10.1104/pp.123.2.699; Hancock CN, 2005, PLANT J, V43, P716, DOI 10.1111/j.1365-313X.2005.02490.x; HU GF, 1993, P NATL ACAD SCI USA, V90, P1217, DOI 10.1073/pnas.90.4.1217; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; HUANG S, 1994, PLANT CELL, V6, P1021, DOI 10.1105/tpc.6.7.1021; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Juarez-Diaz JA, 2006, J BIOL CHEM, V281, P3418, DOI 10.1074/jbc.M511687200; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; Kurasawa Y, 1996, J BIOCHEM-TOKYO, V119, P791; Lee CB, 2008, J BIOL CHEM, V283, P26965, DOI 10.1074/jbc.M804410200; LEE HS, 1994, NATURE, V367, P560, DOI 10.1038/367560a0; Liu BL, 2008, J EXP BOT, V59, P545, DOI 10.1093/jxb/erm339; Liu BL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005774; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Liu ZQ, 2007, PROTOPLASMA, V232, P61, DOI 10.1007/s00709-007-0269-4; Luu DT, 2000, NATURE, V407, P649, DOI 10.1038/35036623; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matsumoto D, 2012, J JPN SOC HORTIC SCI, V81, P41, DOI 10.2503/jjshs1.81.41; Matton DP, 1999, PLANT CELL, V11, P2087, DOI 10.1105/tpc.11.11.2087; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; McClure BA, 2000, ANN BOT-LONDON, V85, P113, DOI 10.1006/anbo.1999.1061; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McClure B, 2011, ANN BOT-LONDON, V108, P647, DOI 10.1093/aob/mcr179; McCubbin AG, 2000, ANNU REV CELL DEV BI, V16, P333, DOI 10.1146/annurev.cellbio.16.1.333; Meng XY, 2011, ANN BOT-LONDON, V108, P637, DOI 10.1093/aob/mcq253; MURFETT J, 1994, NATURE, V367, P563, DOI 10.1038/367563a0; Nettancourt, 2001, INCOMPATIBILITY INCO; O'Brien M, 2004, SEX PLANT REPROD, V17, P81, DOI 10.1007/s00497-004-0218-8; Qin X, 2001, PLANT MOL BIOL, V45, P295, DOI 10.1023/A:1006445120648; Qin XK, 2006, J EXP BOT, V57, P2001, DOI 10.1093/jxb/erj147; Qin XK, 2005, PLANTA, V221, P531, DOI 10.1007/s00425-004-1470-8; Roldan JA, 2012, ANN BOT-LONDON, V110, P787, DOI 10.1093/aob/mcs153; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; SIMM FC, 1987, EUR J BIOCHEM, V166, P49, DOI 10.1111/j.1432-1033.1987.tb13482.x; Sims TL, 2010, BIOCHEM SOC T, V38, P622, DOI 10.1042/BST0380622; Sims TL, 2001, PLANT MOL BIOL, V47, P771, DOI 10.1023/A:1013639528858; SLOBIN LI, 1980, EUR J BIOCHEM, V110, P555, DOI 10.1111/j.1432-1033.1980.tb04898.x; Staiger CJ, 2010, J EXP BOT, V61, P1969, DOI 10.1093/jxb/erq012; Sun PL, 2013, PLANT CELL, V25, P470, DOI 10.1105/tpc.112.106294; Takase K, 2002, J PROTEIN CHEM, V21, P427, DOI 10.1023/A:1021138718046; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031	59	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90206	10.1371/journal.pone.0090206	http://dx.doi.org/10.1371/journal.pone.0090206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587282	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800090
J	Wan, DS; Sun, YS; Zhang, X; Bai, XT; Wang, J; Wang, AL; Milne, R				Wan, Dongshi; Sun, Yongshuai; Zhang, Xu; Bai, Xiaotao; Wang, Jun; Wang, Ailan; Milne, Richard			Multiple ITS Copies Reveal Extensive Hybridization within Rheum (Polygonaceae), a Genus That Has Undergone Rapid Radiation	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; NUCLEAR RIBOSOMAL DNA; QINGHAI-TIBETAN PLATEAU; SPECIES-RICH GENUS; CONCERTED EVOLUTION; ADAPTIVE RADIATION; TRANSGRESSIVE SEGREGATION; MOLECULAR PHYLOGENY; PARALLEL EVOLUTION; DIVERSIFICATION	Background: During adaptive radiation events, characters can arise multiple times due to parallel evolution, but transfer of traits through hybridization provides an alternative explanation for the same character appearing in apparently non-sister lineages. The signature of hybridization can be detected in incongruence between phylogenies derived from different markers, or from the presence of two divergent versions of a nuclear marker such as ITS within one individual. Methodology/Principal Findings: In this study, we cloned and sequenced ITS regions for 30 species of the genus Rheum, and compared them with a cpDNA phylogeny. Seven species contained two divergent copies of ITS that resolved in different clades from one another in each case, indicating hybridization events too recent for concerted evolution to have homogenised the ITS sequences. Hybridization was also indicated in at least two further species via incongruence in their position between ITS and cpDNA phylogenies. None of the ITS sequences present in these nine species matched those detected in any other species, which provides tentative evidence against recent introgression as an explanation. Rheum globulosum, previously indicated by cpDNA to represent an independent origin of decumbent habit, is indicated by ITS to be part of clade of decumbent species, which acquired cpDNA of another clade via hybridization. However decumbent and glasshouse morphology are confirmed to have arisen three and two times, respectively. Conclusions: These findings suggested that hybridization among QTP species of Rheum has been extensive, and that a role of hybridization in diversification of Rheum requires investigation.	[Wan, Dongshi; Sun, Yongshuai; Zhang, Xu; Bai, Xiaotao; Wang, Jun; Wang, Ailan] Lanzhou Univ, Sch Life Sci, Gansu Key Lab Biomonitoring & Bioremediat Environ, Lanzhou 730000, Gansu, Peoples R China; [Wang, Ailan] Ludong Univ, Sch Life & Sci, Yantai, Shandong, Peoples R China; [Milne, Richard] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Sun, Yongshuai] Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China	Lanzhou University; Ludong University; University of Edinburgh; Sichuan University	Wang, AL (corresponding author), Lanzhou Univ, Sch Life Sci, Gansu Key Lab Biomonitoring & Bioremediat Environ, Lanzhou 730000, Gansu, Peoples R China.	tonywan2005@gmail.com	Sun, Yongshuai/L-4503-2016	Sun, Yongshuai/0000-0002-6926-8406	National Science Foundation of China [31000104]; Fundamental Research Funds for the Central Universities [lzujbky-2011-30]; Natural Science Foundation of Shandong Province [ZR2010CM056]; Starting Research Project of Importing Talented Teachers in Ludong University to Ailan Wang [ly2010010]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Starting Research Project of Importing Talented Teachers in Ludong University to Ailan Wang	Financial support was provided by the National Science Foundation of China (31000104), the Fundamental Research Funds for the Central Universities (lzujbky-2011-30), the Natural Science Foundation of Shandong Province (ZR2010CM056) and the Starting Research Project of Importing Talented Teachers in Ludong University to Ailan Wang (ly2010010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2005, EVOLUTION, V59, P686, DOI 10.1111/j.0014-3820.2005.tb01027.x; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Banfer G, 2006, MOL ECOL, V15, P4409, DOI 10.1111/j.1365-294X.2006.03064.x; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Besnard G, 2007, J BIOGEOGR, V34, P736, DOI 10.1111/j.1365-2699.2006.01653.x; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Buckler ES, 1997, GENETICS, V145, P821; Buckler ES, 1996, MOL BIOL EVOL, V13, P612, DOI 10.1093/oxfordjournals.molbev.a025621; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; CHIN TC, 1947, AM J BOT, V34, P401, DOI 10.2307/2437150; Denk T, 2005, BOT J LINN SOC, V147, P129, DOI 10.1111/j.1095-8339.2005.00354.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Dumolin-Lapegue S, 1999, MOL ECOL, V8, P2137, DOI 10.1046/j.1365-294x.1999.00788.x; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; GRIFFIN AR, 1988, AUST J BOT, V36, P41, DOI 10.1071/BT9880041; Grimm GW, 2008, ANN BOT-LONDON, V101, P403, DOI 10.1093/aob/mcm305; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hardig TM, 2000, MOL ECOL, V9, P9, DOI 10.1046/j.1365-294X.2000.00757.x; Harpke D, 2008, J PLANT RES, V121, P261, DOI 10.1007/s10265-008-0156-x; Harpke D, 2008, BOTANY, V86, P300, DOI 10.1139/B07-134; Harpke D, 2006, MOL PHYLOGENET EVOL, V41, P579, DOI 10.1016/j.ympev.2006.05.036; Hartmann S, 2001, J MOL EVOL, V53, P124, DOI 10.1007/s002390010200; Herder F, 2006, P R SOC B, V273, P2209, DOI 10.1098/rspb.2006.3558; Hu Yan-Ping, 2007, Acta Botanica Yunnanica, V29, P429; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Jaretzky R, 1928, JB WISS BOT, V69, P357; Jobes DV, 1997, PLANT MOL BIOL REP, V15, P326, DOI 10.1023/A:1007462330699; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Kao T.C., 1975, ACTA PHYTOTAXON SIN, V13, P69; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kiefer C, 2009, MOL PHYLOGENET EVOL, V52, P303, DOI 10.1016/j.ympev.2009.03.016; Kita Y, 2000, PLANT SYST EVOL, V225, P1, DOI 10.1007/BF00985455; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Kovarik A, 2008, ANN BOT-LONDON, V101, P815, DOI 10.1093/aob/mcn019; Lexer C, 2003, MOL ECOL, V12, P1225, DOI 10.1046/j.1365-294X.2003.01803.x; Li AR., 1998, FLORA REPUBLICAE POP; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; Liu BB, 2013, J SYST EVOL, V51, P134, DOI 10.1111/j.1759-6831.2012.00225.x; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu JQ, 2004, BOT J LINN SOC, V144, P329, DOI 10.1111/j.1095-8339.2003.00225.x; Liu JQ, 2002, MOL PHYLOGENET EVOL, V23, P307, DOI 10.1016/S1055-7903(02)00039-8; Liu RR, 2010, CARYOLOGIA, V63, P82; Losina-Losinskaya A., 1936, ACTA I BOT ACAD SCI, P5; Ma F, 2010, NEW PHYTOL, V185, P204, DOI 10.1111/j.1469-8137.2009.03037.x; Manen JF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-46; Mao KS, 2010, NEW PHYTOL, V188, P254, DOI 10.1111/j.1469-8137.2010.03351.x; Masuelli RW, 2009, PLANT SYST EVOL, V277, P143, DOI 10.1007/s00606-008-0116-x; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; Mayol M, 2001, MOL PHYLOGENET EVOL, V19, P167, DOI 10.1006/mpev.2001.0934; McKinnon GE, 1999, AM J BOT, V86, P1038, DOI 10.2307/2656621; Milne RI, 2010, PLANT SYST EVOL, V285, P233, DOI 10.1007/s00606-010-0269-2; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nylander J.A.A., 2004, MR MODELTEST V2; Ochieng JW, 2007, MOL PHYLOGENET EVOL, V44, P752, DOI 10.1016/j.ympev.2007.04.017; Parsons KJ, 2011, EVOL BIOL, V38, P306, DOI 10.1007/s11692-011-9126-7; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; RIESEBERG LH, 1995, AM J BOT, V82, P944, DOI 10.2307/2445981; Rieseberg LH, 1992, MOL SYSTEMATICS PLAN, P151, DOI DOI 10.1007/978-1-4615-3276-7_7; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Schliewen Ulrich K, 2004, Front Zool, V1, P5, DOI 10.1186/1742-9994-1-5; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shaw J, 2005, AM J BOT, V92, P2011, DOI 10.3732/ajb.92.12.2011; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wan DS, 2011, BIOCHEM SYST ECOL, V39, P651, DOI 10.1016/j.bse.2011.05.016; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang YJ, 2007, ANN BOT-LONDON, V99, P311, DOI 10.1093/aob/mcl259; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726; Xiao LQ, 2010, MOL PHYLOGENET EVOL, V55, P168, DOI 10.1016/j.ympev.2009.11.020; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang MH, 2001, NORD J BOT, V21, P411, DOI 10.1111/j.1756-1051.2001.tb00789.x; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Zhang DY, 2010, PLANTA, V231, P1505, DOI 10.1007/s00425-010-1133-x; Zheng XY, 2008, MOL PHYLOGENET EVOL, V48, P892, DOI 10.1016/j.ympev.2008.05.039	102	16	16	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89769	10.1371/journal.pone.0089769	http://dx.doi.org/10.1371/journal.pone.0089769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587023	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800038
J	Lembrechts, JJ; Milbau, A; Nijs, I				Lembrechts, Jonas J.; Milbau, Ann; Nijs, Ivan			Alien Roadside Species More Easily Invade Alpine than Lowland Plant Communities in a Subarctic Mountain Ecosystem	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; ALTITUDINAL DISTRIBUTION; SEED DISPERSAL; STAND AGE; FOREST; VEGETATION; DIVERSITY; FACILITATION; INVASIONS; PATTERNS	Effects of roads on plant communities are not well known in cold-climate mountain ecosystems, where road building and development are expected to increase in future decades. Knowledge of the sensitivity of mountain plant communities to disturbance by roads is however important for future conservation purposes. We investigate the effects of roads on species richness and composition, including the plant strategies that are most affected, along three elevational gradients in a subarctic mountain ecosystem. We also examine whether mountain roads promote the introduction and invasion of alien plant species from the lowlands to the alpine zone. Observations of plant community composition were made together with abiotic, biotic and anthropogenic factors in 60 T-shaped transects. Alpine plant communities reacted differently to road disturbances than their lowland counterparts. On high elevations, the roadside species composition was more similar to that of the local natural communities. Less competitive and ruderal species were present at high compared with lower elevation roadsides. While the effects of roads thus seem to be mitigated in the alpine environment for plant species in general, mountain plant communities are more invasible than lowland communities. More precisely, relatively more alien species present in the roadside were found to invade into the surrounding natural community at high compared to low elevations. We conclude that effects of roads and introduction of alien species in lowlands cannot simply be extrapolated to the alpine and subarctic environment.	[Lembrechts, Jonas J.; Nijs, Ivan] Univ Antwerp, Dept Biol, Res Grp Plant & Vegetat Ecol, Antwerp, Belgium; [Milbau, Ann] Umea Univ, Climate Impacts Res Ctr, Dept Ecol & Environm Sci, Abisko, Sweden	University of Antwerp; Umea University	Lembrechts, JJ (corresponding author), Univ Antwerp, Dept Biol, Res Grp Plant & Vegetat Ecol, Antwerp, Belgium.	jonas.lembrechts@uantwerpen.be	Lembrechts, Jonas/E-7651-2014; Milbau, Ann/AAF-3022-2020	Nijs, Ivan/0000-0003-3111-680X; Lembrechts, Jonas/0000-0002-1933-0750; Milbau, Ann/0000-0003-3555-8883	Research Group of Plant and Vegetation Ecology from the University of Antwerp; Climate Impact Research Centre from Umea University	Research Group of Plant and Vegetation Ecology from the University of Antwerp; Climate Impact Research Centre from Umea University	Internal funding was provided by the Research Group of Plant and Vegetation Ecology from the University of Antwerp and the Climate Impact Research Centre from Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2010, GLOBAL CHANGE BIOL, V16, P1071, DOI 10.1111/j.1365-2486.2009.01999.x; Aikio S, 2012, GLOBAL ECOL BIOGEOGR, V21, P778, DOI 10.1111/j.1466-8238.2011.00711.x; Alexander JM, 2011, P NATL ACAD SCI USA, V108, P656, DOI 10.1073/pnas.1013136108; Alm T, 2013, COMMUNICATION; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Arevalo JR, 2005, PERSPECT PLANT ECOL, V7, P185, DOI 10.1016/j.ppees.2005.09.003; Avon C, 2010, FOREST ECOL MANAG, V259, P1546, DOI 10.1016/j.foreco.2010.01.031; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker T, 2005, PERSPECT PLANT ECOL, V7, P173, DOI 10.1016/j.ppees.2005.09.006; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Berges L, 2013, APPL VEG SCI, V16, P470, DOI 10.1111/avsc.12019; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres LA, 2008, FUNCT ECOL, V22, P148, DOI 10.1111/j.1365-2435.2007.01338.x; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Daehler CC, 2005, PERSPECT PLANT ECOL, V7, P203, DOI 10.1016/j.ppees.2005.08.002; Dainese M, 2012, ALPINE BOT, V122, P11, DOI 10.1007/s00035-012-0101-4; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Eckstein RL, 2011, ANN BOT-LONDON, V108, P177, DOI 10.1093/aob/mcr097; Esseen PA, 1998, CONSERV BIOL, V12, P1307, DOI 10.1046/j.1523-1739.1998.97346.x; Flory SL, 2006, PLANT ECOL, V184, P131, DOI 10.1007/s11258-005-9057-4; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Gederaas L, 2007, 2007 NORWEGIAN BLACK, P152; Gederaas L, 2012, ALIEN SPECIES NORWAY, P216; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Giorgis MA, 2011, BIOL INVASIONS, V13, P1423, DOI 10.1007/s10530-010-9900-y; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Haider S, 2010, BIOL INVASIONS, V12, P4003, DOI 10.1007/s10530-010-9815-7; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Jakobs G, 2010, BIOL INVASIONS, V12, P4019, DOI 10.1007/s10530-010-9816-6; Johnston FM, 2004, ARCT ANTARCT ALP RES, V36, P201, DOI 10.1657/1523-0430(2004)036[0201:IORDOS]2.0.CO;2; Kuiters AT, 2013, J VEG SCI, V24, P453, DOI 10.1111/j.1654-1103.2012.01478.x; LaPaix R, 2012, APPL VEG SCI, V15, P525, DOI 10.1111/j.1654-109X.2012.01195.x; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; MacQuarrie K, 2003, CAN J BOT, V81, P1113, DOI [10.1139/B03-103, 10.1139/b03-103]; Marini L, 2012, GLOBAL ECOL BIOGEOGR, V21, P534, DOI 10.1111/j.1466-8238.2011.00702.x; McDougall KL, 2005, PERSPECT PLANT ECOL, V7, P159, DOI 10.1016/j.ppees.2005.09.001; Milbau A, 2013, NEW PHYTOL, V197, P1002, DOI 10.1111/nph.12054; Morgan JW, 2006, BIOL INVASIONS, V8, P159, DOI 10.1007/s10530-004-2881-y; Mossberg B, 2010, NYA NORDISKA FLORAN; Mullerova J, 2011, SCI TOTAL ENVIRON, V409, P3839, DOI 10.1016/j.scitotenv.2011.06.056; Norwegian Meteorological Institute, EKLIMA WEB PORT; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paiaro V, 2011, AUSTRAL ECOL, V36, P176, DOI 10.1111/j.1442-9993.2010.02134.x; Pakeman RJ, 2004, J ECOL, V92, P893, DOI 10.1111/j.0022-0477.2004.00928.x; Parendes LA, 2000, CONSERV BIOL, V14, P64, DOI 10.1046/j.1523-1739.2000.99089.x; Pauchard A, 2004, CONSERV BIOL, V18, P238, DOI 10.1111/j.1523-1739.2004.00300.x; Pauchard A, 2009, FRONT ECOL ENVIRON, V7, P479, DOI 10.1890/080072; Pickering C, 2010, J SUSTAIN TOUR, V18, P239, DOI 10.1080/09669580903406613; Pollnac F, 2012, BIOL INVASIONS, V14, P1753, DOI 10.1007/s10530-012-0188-y; Pysek P, 2011, P NATL ACAD SCI USA, V108, P439, DOI 10.1073/pnas.1017682108; Quiroz CL, 2011, BIOL INVASIONS, V13, P2889, DOI 10.1007/s10530-011-9971-4; R Core Team, 2021, R LANGUAGE ENV STAT; Seipel T, 2012, GLOBAL ECOL BIOGEOGR, V21, P236, DOI 10.1111/j.1466-8238.2011.00664.x; Selva N, 2011, ENVIRON MANAGE, V48, P865, DOI 10.1007/s00267-011-9751-z; Stohlgren TJ, 2006, RISK ANAL, V26, P163, DOI 10.1111/j.1539-6924.2006.00707.x; Taylor K, 2012, DIVERS DISTRIB, V18, P942, DOI 10.1111/j.1472-4642.2012.00926.x; The Global Biodiversity Information Facility, GBIF BACKB TAX; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Tybirk K, 2000, AMBIO, V29, P90, DOI 10.1639/0044-7447(2000)029[0090:NEDEFA]2.0.CO;2; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; Ware C, 2012, BIOL INVASIONS, V14, P567, DOI 10.1007/s10530-011-0098-4; Watkins RZ, 2003, CONSERV BIOL, V17, P411, DOI 10.1046/j.1523-1739.2003.01285.x; Weidema IR, 2000, INTRO SPECIES NORDIC; WHITTAKER RH, 1975, ECOLOGY, V56, P771, DOI 10.2307/1936291; Zeiter M, 2012, ANN BOT-LONDON, V110, P1385, DOI 10.1093/aob/mcs193; Zeng SL, 2011, PLANT ECOL, V212, P1213, DOI 10.1007/s11258-011-9899-x	71	36	41	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89664	10.1371/journal.pone.0089664	http://dx.doi.org/10.1371/journal.pone.0089664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586947	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000073
J	Zhang, Y; Lv, YR; Zhang, YY; Gao, HD				Zhang, Ying; Lv, Yanrong; Zhang, Yongyang; Gao, Haidong			Regulation of p53 Level by UBE4B in Breast Cancer	PLOS ONE			English	Article							SV40-TRANSFORMED CELLS; MDM2 GENE; UBIQUITIN; DEGRADATION; ANTIGEN; PROTEIN; POLYUBIQUITINATION; CARCINOMA; E4	p53 is possibly the most important mammalian tumor suppressor and it is mutated or lost in more than half of all human cancers. The stability of p53 is primarily determined by the RING domain E3 ubiquitin ligase Hdm2, which targets p53 for proteasomal degradation, restraining the potent activity of p53 and enabling cell survival and proliferation. UBE4B has been shown to physically interact with p53 and Hdm2 and to negatively regulate p53 stability and function. However, no one has determined whether UBE4B promotes p53 degradation in breast cancer. In this study, UBE4B promoted the degradation and ubiquitination of p53 to inhibit the apoptosis of cancer cells and promote tumorigenesis. Our results indicate that UBE4B regulates p53 in breast cancer and could be a viable target for developing new therapeutic strategies for breast cancer treatment.	[Zhang, Ying; Lv, Yanrong; Gao, Haidong] QiLu Hosp, Dept Breast Surg, Jinan, Peoples R China; [Zhang, Yongyang] Shandong Jining 1 Peoples Hosp, Emergency Dept, Jining, Peoples R China	Shandong University	Gao, HD (corresponding author), QiLu Hosp, Dept Breast Surg, Jinan, Peoples R China.	haidongao@163.com			Nature Science of Shandong Province [ZR2009CM007, ZR2010HM131]	Nature Science of Shandong Province	The source of funding that has supported this work is the Nature Science of Shandong Province, ZR2009CM007, ZR2010HM131 (http://www.sdnsf.gov.cn/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt P, 2012, FEBS J, V279, P370, DOI 10.1111/j.1742-4658.2011.08430.x; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Ginsburg OM, 2011, BREAST J, V17, P289, DOI 10.1111/j.1524-4741.2011.01067.x; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jerry DJ, 2010, CELL MOL LIFE SCI, V67, P1017, DOI 10.1007/s00018-009-0244-7; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Manic S, 2003, CURR CANCER DRUG TAR, V3, P21, DOI 10.2174/1568009033333727; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; SHEIKH MS, 1993, CANCER RES, V53, P3226; Wu H, 2011, CELL CYCLE, V10, P1912, DOI 10.4161/cc.10.12.15882; Wu H, 2011, NAT MED, V17, P347, DOI 10.1038/nm.2283; Zage PE, 2013, CANCER-AM CANCER SOC, V119, P915, DOI 10.1002/cncr.27785	23	21	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90154	10.1371/journal.pone.0090154	http://dx.doi.org/10.1371/journal.pone.0090154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587254	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000137
J	Jiang, JH; Chuang, DY; Zong, YJ; Patel, J; Brownstein, K; Lei, W; Lu, CH; Simonyi, A; Gu, ZZ; Cui, JK; Rottinghaus, GE; Fritsche, KL; Lubahn, DB; Folk, WR; Sun, GY				Jiang, Jinghua; Chuang, Dennis Y.; Zong, Yijia; Patel, Jayleenkumar; Brownstein, Korey; Lei, Wei; Lu, Chi-Hua; Simonyi, Agnes; Gu, Zezong; Cui, Jiankun; Rottinghaus, George E.; Fritsche, Kevin L.; Lubahn, Dennis B.; Folk, William R.; Sun, Grace Y.			Sutherlandia frutescens Ethanol Extracts Inhibit Oxidative Stress and Inflammatory Responses in Neurons and Microglial Cells	PLOS ONE			English	Article							INDUCED COX-2 EXPRESSION; SHOOT AQUEOUS EXTRACT; IFN-GAMMA; NADPH OXIDASE; SIGNALING PATHWAYS; FABACEAE; MECHANISMS; NEURODEGENERATION; INDUCTION; INOS	Sutherlandia frutescens (L.) R. Br. (SF) is a medicinal plant indigenous to southern Africa and used in folk and contemporary remedies for stress, chronic diseases, cancer, and HIV/AIDS. While previous studies have focused on physiological effects of SF on cellular and systemic abnormalities associated with these diseases, little is known about its effects in the brain and immune cells in the central nervous system. Results of this study indicate that ethanol extracts of SF (SF-E) suppress NMDA-induced reactive oxygen species (ROS) production in neurons, and LPS- and IFN gamma-induced ROS and nitric oxide (NO) production in microglial cells. SF-E's action on microglial cells appears to be mediated through inhibition of the IFN gamma-induced p-ERK1/2 signaling pathway which is central to regulating a number of intracellular metabolic processes including enhancing STAT1 alpha phosphorylation and filopodia formation. The involvement of SF in these pathways suggests the potential for novel therapeutics for stress and prevention, and/or treatment of HIV/AIDS as well as other inflammatory diseases in the brain.	[Jiang, Jinghua; Patel, Jayleenkumar; Brownstein, Korey; Simonyi, Agnes; Lubahn, Dennis B.; Folk, William R.; Sun, Grace Y.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Chuang, Dennis Y.; Zong, Yijia] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA; [Lei, Wei; Lu, Chi-Hua; Fritsche, Kevin L.; Lubahn, Dennis B.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Simonyi, Agnes; Gu, Zezong; Cui, Jiankun; Sun, Grace Y.] Univ Missouri, Ctr Translat Neurosci, Columbia, MO USA; [Gu, Zezong; Cui, Jiankun; Sun, Grace Y.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA; [Rottinghaus, George E.; Fritsche, Kevin L.; Lubahn, Dennis B.; Folk, William R.; Sun, Grace Y.] Univ Missouri, Ctr Bot Interact Studies, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sun, GY (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	sung@missouri.edu		Folk, William/0000-0003-2216-3233; Lei, Wei/0000-0002-0374-8642	NIH [2P01 AG08357]; NIA; National Center for Complementary and Alternative Medicines (NCCAM) [P50AT006273]; Office of Dietary Supplements (ODS); National Cancer Institute (NCI); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Complementary and Alternative Medicines (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This publication was made possible by NIH Grants 2P01 AG08357 from NIA and P50AT006273 from the National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIA, NCCAM, ODS, NCI, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; BERNATOWICZ A, 1995, J NEUROIMMUNOL, V60, P53, DOI 10.1016/0165-5728(95)00053-5; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Chen KQ, 2007, J IMMUNOL, V178, P1759, DOI 10.4049/jimmunol.178.3.1759; Chuang DY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-15; De Stefano D, 2006, J MOL MED, V84, P65, DOI 10.1007/s00109-005-0713-x; Faleschini MT, 2013, S AFR J BOT, V85, P48, DOI 10.1016/j.sajb.2012.11.007; Fernandes AC, 2004, J ETHNOPHARMACOL, V95, P1, DOI 10.1016/j.jep.2004.05.024; Fu X, 2010, PLANTA MED, V76, P178, DOI 10.1055/s-0029-1186030; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Guo LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070565; He Y, 2011, ASN NEURO, V3, P13, DOI 10.1042/AN20100025; Jensen MD, 2009, NEUROCHEM INT, V55, P362, DOI 10.1016/j.neuint.2009.04.002; Joska JA, 2010, AIDS BEHAV, V14, P371, DOI 10.1007/s10461-009-9538-x; Jung JS, 2010, BIOCHEM BIOPH RES CO, V397, P323, DOI 10.1016/j.bbrc.2010.05.117; Katerere DR, 2005, PHYTOTHER RES, V19, P779, DOI 10.1002/ptr.1719; Kundu JK, 2005, CANCER LETT, V218, P21, DOI 10.1016/j.canlet.2004.07.029; Mills E, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-19; Na HK, 2004, BIOFACTORS, V21, P149, DOI 10.1002/biof.552210130; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Ojewole JAO, 2004, METHOD FIND EXP CLIN, V26, P409; Ojewole JAO, 2008, BRAIN RES BULL, V75, P126, DOI 10.1016/j.brainresbull.2007.08.002; Prevoo D, 2004, ENDOCR RES, V30, P745, DOI 10.1081/ERC-200044020; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Spencer JPE, 2012, MOL ASPECTS MED, V33, P83, DOI 10.1016/j.mam.2011.10.016; Sun GY, 2010, MOL NEUROBIOL, V41, P53, DOI 10.1007/s12035-010-8119-3; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; van Wyk BE, 2008, J ETHNOPHARMACOL, V119, P620, DOI 10.1016/j.jep.2008.08.003; Wang JY, 2006, CURR PHARM DESIGN, V12, P3521, DOI 10.2174/138161206778343109	37	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89748	10.1371/journal.pone.0089748	http://dx.doi.org/10.1371/journal.pone.0089748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587007	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900076
J	Ning, N; Zhang, L; Gao, J; Zhang, YM; Ren, ZQ; Niu, G; Dai, YM; Wu, EX; Guo, YM; Yang, J				Ning, Ning; Zhang, Lei; Gao, Jie; Zhang, Yumiao; Ren, Zhuanqin; Niu, Gang; Dai, Yongming; Wu, Ed X.; Guo, Youmin; Yang, Jian			Assessment of Iron Deposition and White Matter Maturation in Infant Brains by Using Enhanced T2 Star Weighted Angiography (ESWAN): R2*versus Phase Values	PLOS ONE			English	Article							HIGH-FIELD MRI; PRETERM INFANTS; BASAL GANGLIA; GRAY-MATTER; AGE; MYELINATION; CONTRAST; ORIENTATION; MECHANISMS; CHILDHOOD	Background and Purpose: Iron deposition and white matter (WM) maturation are very important for brain development in infants. It has been reported that the R2* and phase values originating from the gradient-echo sequence could both reflect the iron and myelination. The aim of this study was to investigate age-related changes of R2* and phase value, and compare their performances for monitoring iron deposition and WM maturation in infant brains. Methods: 56 infants were examined by enhanced T2 star weighted angiography (ESWAN) and diffusion tensor imaging in the 1.5T MRI system. The R2* and phase values were measured from the deep gray nuclei and WM. Fractional anisotropy (FA) values were measured only in the WM regions. Correlation analyses were performed to explore the relation among the two parameters (R2* and phase values) and postmenstrual age (PMA), previously published iron concentrations as well as FA values. Results: We found significantly positive correlations between the R2* values and PMA in both of the gray nuclei and WM. Moreover, R2* values had a positive correlation with the iron reference concentrations in the deep gray nuclei and the FA in the WM. However, phase values only had the positive correlation with PMA and FA in the internal capsule, and no significant correlation with PMA and iron content in the deep gray nuclei. Conclusions: Compared with the phase values, R2* may be a preferable method to estimate the iron deposition and WM maturation in infant brains.	[Ning, Ning; Zhang, Lei; Gao, Jie; Zhang, Yumiao; Niu, Gang; Dai, Yongming; Guo, Youmin; Yang, Jian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China; [Zhang, Lei; Ren, Zhuanqin] Baoji Ctr Hosp, Dept Radiol, Baoji, Shaanxi, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China; [Ning, Ning] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Nucl Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; University of Hong Kong; Xi'an Jiaotong University	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China.	cjr.yangjian@vip.163.com	Wu, Ed Xuekui/C-1579-2009	Wu, Ed Xuekui/0000-0001-5581-1546	National Natural Foundation of China [81171317]; Ministry of Education of China [DWYXSJ11000007]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Foundation of China ( Grant No. 81171317) and the 2011 New Century Excellent Talent Support Plan from Ministry of Education of China (DWYXSJ11000007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1958, PRIM STAT NONST; Aquino D, 2009, RADIOLOGY, V252, P165, DOI 10.1148/radiol.2522081399; BARTZOKIS G, 1993, MAGN RESON MED, V29, P459, DOI 10.1002/mrm.1910290406; Bartzokis G, 2007, NEUROBIOL AGING, V28, P414, DOI 10.1016/j.neurobiolaging.2006.02.005; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Denk C, 2011, NMR BIOMED, V24, P246, DOI 10.1002/nbm.1581; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; Geng XJ, 2012, NEUROIMAGE, V61, P542, DOI 10.1016/j.neuroimage.2012.03.057; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hagemeier J, 2013, AJNR AM J N IN PRESS; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; Hwang D, 2010, NEUROIMAGE, V52, P198, DOI 10.1016/j.neuroimage.2010.04.023; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Lam WWM, 1998, NEURORADIOLOGY, V40, P315, DOI 10.1007/s002340050592; Lancaster JL, 2003, J MAGN RESON IMAGING, V17, P1, DOI 10.1002/jmri.10230; Langkammer C, 2012, NEUROIMAGE, V59, P1413, DOI 10.1016/j.neuroimage.2011.08.045; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Lee J, 2012, NEUROIMAGE, V59, P3967, DOI 10.1016/j.neuroimage.2011.10.076; Lee J, 2010, P NATL ACAD SCI USA, V107, P5130, DOI 10.1073/pnas.0910222107; Ling XY, 2013, EUR J RADIOL, V82, pE476, DOI 10.1016/j.ejrad.2013.04.003; Lodygensky GA, 2012, NEUROIMAGE, V59, P1979, DOI 10.1016/j.neuroimage.2011.09.057; Lobel U, 2009, NEURORADIOLOGY, V51, P253, DOI 10.1007/s00234-008-0488-1; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Neelavalli J, 2009, J MAGN RESON IMAGING, V29, P937, DOI 10.1002/jmri.21693; Nitz WR, 1999, EUR RADIOL, V9, P1032, DOI 10.1007/s003300050789; Niwa T, 2011, J MAGN RESON IMAGING, V34, P1031, DOI 10.1002/jmri.22782; ORDIDGE RJ, 1994, MAGNET RESON MED, V32, P335, DOI 10.1002/mrm.1910320309; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Provenzale JM, 2007, AM J ROENTGENOL, V189, P476, DOI 10.2214/AJR.07.2132; Rivkin MJ, 2004, MAGNET RESON MED, V51, P1287, DOI 10.1002/mrm.20098; Rose SE, 2008, MAGN RESON MED, V60, P761, DOI 10.1002/mrm.21689; Schenck JF, 2003, J NEUROL SCI, V207, P99, DOI 10.1016/S0022-510X(02)00431-8; Schneider JFL, 2004, NEURORADIOLOGY, V46, P258, DOI 10.1007/s00234-003-1154-2; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; VYMAZAL J, 1995, JMRI-J MAGN RESON IM, V5, P554; Walsh AJ, 2011, NEUROIMAGE, V57, P452, DOI 10.1016/j.neuroimage.2011.04.017; Wharton S, 2010, NEUROIMAGE, V53, P515, DOI 10.1016/j.neuroimage.2010.06.070; Xu X, 2008, NEUROIMAGE, V40, P35, DOI 10.1016/j.neuroimage.2007.11.017; Yan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031748; Zhang DD, 2011, PEDIATRICS, V127, pE1280, DOI 10.1542/peds.2010-2833; Zhong K, 2011, NEUROIMAGE, V55, P1068, DOI 10.1016/j.neuroimage.2010.11.086; Zhou B, 2013, ADV ALZHEIMER DIS, V2, P51, DOI DOI 10.4236/AAD.2013.22007	50	9	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89888	10.1371/journal.pone.0089888	http://dx.doi.org/10.1371/journal.pone.0089888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587101	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900091
J	Ultsch, A; Lotsch, J				Ultsch, Alfred; Loetsch, Joern			Functional Abstraction as a Method to Discover Knowledge in Gene Ontologies	PLOS ONE			English	Article							EXPRESSION DATA; NUMBER 7; PLUS	Computational analyses of functions of gene sets obtained in microarray analyses or by topical database searches are increasingly important in biology. To understand their functions, the sets are usually mapped to Gene Ontology knowledge bases by means of over-representation analysis (ORA). Its result represents the specific knowledge of the functionality of the gene set. However, the specific ontology typically consists of many terms and relationships, hindering the understanding of the 'main story'. We developed a methodology to identify a comprehensibly small number of GO terms as "headlines'' of the specific ontology allowing to understand all central aspects of the roles of the involved genes. The Functional Abstraction method finds a set of headlines that is specific enough to cover all details of a specific ontology and is abstract enough for human comprehension. This method exceeds the classical approaches at ORA abstraction and by focusing on information rather than decorrelation of GO terms, it directly targets human comprehension. Functional abstraction provides, with a maximum of certainty, information value, coverage and conciseness, a representation of the biological functions in a gene set plays a role. This is the necessary means to interpret complex Gene Ontology results thus strengthening the role of functional genomics in biomarker and drug discovery.	[Ultsch, Alfred] Univ Marburg, DataBion Res Grp, Marburg, Germany; [Loetsch, Joern] Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60054 Frankfurt, Germany; [Loetsch, Joern] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany	Philipps University Marburg; Goethe University Frankfurt; Fraunhofer Gesellschaft	Lotsch, J (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60054 Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958	"Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz'': "LOEWE-Schwerpunkt: Anwendungsorientierte Arzneimittelforschung''	"Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz'': "LOEWE-Schwerpunkt: Anwendungsorientierte Arzneimittelforschung''	This work was supported by the "Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz'': "LOEWE-Schwerpunkt: Anwendungsorientierte Arzneimittelforschung'' (JL). The funders had no role in method design, data selection and analysis, decision to publish, or preparation of the manuscript.	Accetturo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012742; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cover T. M., 1991, ELEMENTS INFORM THEO; Gaines P, 1996, ADV KNOWLEDGE DISCOV, p[XIV, 611 S]; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; Lotsch J, 2013, PHARMACOL THERAPEUT, V139, P60, DOI 10.1016/j.pharmthera.2013.04.004; Lotsch J, 2013, PHARM THER; Lotsch J, 2013, BRAIN STRUCT FUNCT; Mazandu GK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/292063; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Saaty TL, 2003, MATH COMPUT MODEL, V38, P233, DOI [10.1016/S0895-7177(03)90083-5, 10.1016/S0895-7177(03)00216-4]; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Shearer A. E., 1993, GENE REV; Ultsch A, 2007, EMERGENCE SELF ORG F	20	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90191	10.1371/journal.pone.0090191	http://dx.doi.org/10.1371/journal.pone.0090191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587272	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900124
J	Wu, ML; Li, H; Yu, LJ; Chen, XY; Kong, QY; Song, X; Shu, XH; Liu, J				Wu, Mo-Li; Li, Hong; Yu, Li-Jun; Chen, Xiao-Yan; Kong, Qing-You; Song, Xue; Shu, Xiao-Hong; Liu, Jia			Short-Term Resveratrol Exposure Causes In Vitro and In Vivo Growth Inhibition and Apoptosis of Bladder Cancer Cells	PLOS ONE			English	Article							INTRAVESICAL CHEMOTHERAPY; DOWN-REGULATION; MITOMYCIN-C; EXPRESSION; PATHWAY; GRADE; MEDULLOBLASTOMA; ACTIVATION; CISPLATIN; SURVIVAL	Conventional adjuvant chemotherapies for bladder transitional cell carcinomas (TCCs) may cause strong systemic toxicity and local irritation. Non-toxic resveratrol inhibits TCC cell growth but its feasibility in clinical management of TCCs remains obscure. This study aimed to evaluate the safety and anti-TCC efficacy of resveratrol, using the experimental models closer to the clinical treatment condition. Human TCC EJ cells were exposed to 100 mu M, 150 mu M and 200 mu M resveratrol respectively for 1 hour and 2 hours to mimic intravesical drug instillation and the cell responses were analyzed by multiple experimental approaches. An orthotopic TCC nude mouse model was established by injecting EJ cells into the sub-urothelial layer and used for short-term intravesical resveratrol instillation. The safety of resveratrol instillation was evaluated and compared with that of MCC. The results revealed that 2 h 150 mM or 200 mM resveratrol treatment leaded to remarkable S phase arrest and apoptosis at 72 h time-point, accompanied with attenuated phosphorylation, nuclear translocation and transcription of STAT3, down-regulation of STAT3 downstream genes (survivin, cyclinD1, c-Myc and VEGF) and nuclear translocations of Sirt1 and p53. The importance of STAT3 signaling in cell growth was confirmed by treating EJ cells with JAK2 inhibitor tyrphostin AG490. The efficacy and safety of resveratrol instillation were proved by the findings from nude mouse orthotopic xenograft models, because this treatment caused growth suppression, distinctive apoptosis and STAT3 inactivation of the transplanted tumors without affecting normal urothelium. Our results thus suggest for the first time the practical values of resveratrol as a safe and effective agent in the post-operative treatment of TCCs.	[Liu, Jia] Dalian Med Univ, Coll Basic Med Sci, Liaoning Lab Canc Genet & Epigen, Dalian, Peoples R China; Dalian Med Univ, Coll Basic Med Sci, Dept Cell Biol, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University	Liu, J (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Liaoning Lab Canc Genet & Epigen, Dalian, Peoples R China.	jialiudl@aliyun.com	Shu, Xiaohong/J-1920-2019	Shu, Xiaohong/0000-0003-0299-1963	National Natural Science Foundation of China [81272786, 30971038, 81071971, 81072063]; Research Fund for PhD supervisors from National Education Department of China [20122105110005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for PhD supervisors from National Education Department of China	This work is supported by the grants from National Natural Science Foundation of China (Nos. 81272786, 30971038, 81071971 and 81072063) and Research Fund for PhD supervisors from National Education Department of China (20122105110005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2011, J MED TOXICOL, V7, P118, DOI 10.1007/s13181-010-0103-9; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Barlow LJ, 2013, CURR UROL REP, V14, P65, DOI 10.1007/s11934-013-0312-2; Chan E, 2009, BJU INT, V104, P1286, DOI 10.1111/j.1464-410X.2009.08577.x; Chan ES, 2012, UROLOGY, V80, pe1; Chen CB, 2011, J BONE JOINT SURG AM, V93A, P1833, DOI 10.2106/JBJS.I.01553; Chen CL, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-78; Chen HJ, 2012, BIOCHEM PHARMACOL, V84, P1143, DOI 10.1016/j.bcp.2012.08.011; Cheung G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-13; Cirone M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031732; Colombo R, 2012, EUR UROL, V62, P797, DOI 10.1016/j.eururo.2012.05.032; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Grotzer MA, 2001, CLIN CANCER RES, V7, P2425; Hadaschik BA, 2008, CLIN CANCER RES, V14, P1510, DOI 10.1158/1078-0432.CCR-07-4475; Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875; Houghton BB, 2013, BJU INT, V111, P977, DOI 10.1111/j.1464-410X.2012.11390.x; Ikeguchi M, 2001, INT J MOL MED, V8, P661; Leon-Galicia I, 2013, EUR J CANCER PREV, V22, P11, DOI 10.1097/CEJ.0b013e328353edcb; Lin X, 2012, INT J UROL, V19, P757, DOI 10.1111/j.1442-2042.2012.03024.x; Liu J, 2003, INT J MOL MED, V11, P389; MEDIERO JMG, 2005, ACTAS UROL ESP, V29, P743; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Pinto-Leite R, 2013, BIOMED PHARMACOTHER, V67, P123, DOI 10.1016/j.biopha.2012.11.007; Shu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027484; Shu XH, 2010, BIOCHEM PHARMACOL, V79, P1516, DOI 10.1016/j.bcp.2010.01.022; Simile MM, 2004, CARCINOGENESIS, V25, P333, DOI 10.1093/carcin/bgh014; Stocco B, 2012, MATURITAS, V72, P72, DOI 10.1016/j.maturitas.2012.02.004; Takwi A, 2009, CURR GENOMICS, V10, P194, DOI 10.2174/138920209788185270; Tong C, 2013, FASEB J, V27, P4332, DOI 10.1096/fj.12-216473; Trung LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055183; Vachon P, 2000, LAB ANIM, V34, P84, DOI 10.1258/002367700780578082; Wen S, 2011, J NEURO-ONCOL, V104, P169, DOI 10.1007/s11060-010-0496-y; Yaseen A, 2012, MOL PHARMACOL, V82, P1030, DOI 10.1124/mol.112.079624; Yu LJ, 2008, NEOPLASIA, V10, P736, DOI 10.1593/neo.08304; Zou T, 2013, PLOS	36	62	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89806	10.1371/journal.pone.0089806	http://dx.doi.org/10.1371/journal.pone.0089806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587049	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900087
J	Lin, L; Tang, CY; Xu, JF; Ye, Y; Weng, LQ; Wei, W; Ge, JB; Liu, XB; Zou, YZ				Lin, Li; Tang, Chuyi; Xu, Jianfeng; Ye, Yong; Weng, Liqing; Wei, Wei; Ge, Junbo; Liu, Xuebo; Zou, Yunzeng			Mechanical Stress Triggers Cardiomyocyte Autophagy through Angiotensin II Type 1 Receptor-Mediated p38MAP Kinase Independently of Angiotensin II	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; HEART-FAILURE; HEMODYNAMIC STRESS; ACTIVATION; INVOLVEMENT; DYSFUNCTION; INHIBITION; DISEASE; TARGET	Angiotensin II (Ang II) type 1 (AT(1)) receptor is known to mediate a variety of physiological actions of Ang II including autophagy. However, the role of AT(1) receptor in cardiomyocyte autophagy triggered by mechanical stress still remains elusive. The aim of this study was therefore to examine whether and how AT(1) receptor participates in cardiomyocyte autophagy induced by mechanical stresses. A 48-hour mechanical stretch and a 4-week transverse aorta constriction (TAC) were imposed to cultured cardiomyocytes of neonatal rats and adult male C57B/L6 mice, respectively, to induce cardiomyocyte hypertrophy prior to the assessment of cardiomyocyte autophagy using LC3b-II. Losartan, an AT(1) receptor blocker, but not PD123319, the AT(2) inhibitor, was found to significantly reduce mechanical stretch-induced LC3b-II upregulation. Moreover, inhibition of p38MAP kinase attenuated not only mechanical stretch-induced cardiomyocyte hypertrophy but also autophagy. To the contrary, inhibition of ERK and JNK suppressed cardiac hypertrophy but not autophagy. Intriguingly, mechanical stretch-induced autophagy was significantly inhibited by Losartan in the absence of Ang II. Taken together, our results indicate that mechanical stress triggers cardiomyocyte autophagy through AT(1) receptor-mediated activation of p38MAP kinase independently of Ang II.	[Lin, Li; Tang, Chuyi; Wei, Wei; Liu, Xuebo] Tongji Univ, Sch Med, East Hosp, Dept Cardiovasc Med, Shanghai 200092, Peoples R China; [Xu, Jianfeng; Ye, Yong; Weng, Liqing; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China; [Xu, Jianfeng; Ye, Yong; Weng, Liqing; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Tongji University; Fudan University; Fudan University	Liu, XB (corresponding author), Tongji Univ, Sch Med, East Hosp, Dept Cardiovasc Med, Shanghai 200092, Peoples R China.	lxb70@hotmail.com; zou.yunzeng@zs-hospital.sh.cn		Weng, Liqing/0000-0002-4788-0012	National Natural Science Foundation of China [30930043, 81300082]; China Doctoral Foundation [20110071110051]; Science and Technology Commission of Shanghai Municipality [11JC1402400, 12ZR1425100]; Chinese Medical Doctor Association [DFCMDA201255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Doctoral Foundation; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Medical Doctor Association	This work was supported by the National Natural Science Foundation of China (30930043; 81300082) (http://www.nsfc.gov.cn/Portal0/default152.htm), China Doctoral Foundation (20110071110051), the Science and Technology Commission of Shanghai Municipality (11JC1402400; 12ZR1425100), and the Chinese Medical Doctor Association (DFCMDA201255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; De Meyer GRY, 2010, HEART FAIL REV, V15, P423, DOI 10.1007/s10741-010-9166-6; Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073; Finckenberg P, 2012, HYPERTENSION, V59, P76, DOI 10.1161/HYPERTENSIONAHA.111.179457; Francisco Nistal J, 2011, CIRCULATION, V124; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Hanatani S, 2011, CIRCULATION, V124; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022; Lin L, 2011, BIOCHEM BIOPH RES CO, V404, P28, DOI 10.1016/j.bbrc.2010.11.037; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Reudelhuber TL, 2007, HYPERTENSION, V49, P1196, DOI 10.1161/HYPERTENSIONAHA.106.075085; Rothermel BA, 2008, CIRC RES, V103, P1363, DOI 10.1161/CIRCRESAHA.108.186551; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Taglieri DM, 2011, J MOL CELL CARDIOL, V51, P988, DOI 10.1016/j.yjmcc.2011.09.016; Vigliano CA, 2011, J AM COLL CARDIOL, V57, P1523, DOI 10.1016/j.jacc.2010.09.080; Wang ZV, 2010, J BIOL CHEM, V285, P8509, DOI 10.1074/jbc.R109.025023; Zanchetti A, 2010, NAT REV CARDIOL, V7, P66, DOI 10.1038/nrcardio.2009.229; Zhou N, 2010, BIOCHEM BIOPH RES CO, V397, P263, DOI 10.1016/j.bbrc.2010.05.097; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523; Zou YZ, 2012, J CARDIOVASC PHARM, V59, P268, DOI 10.1097/FJC.0b013e31823f888f; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	30	24	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89629	10.1371/journal.pone.0089629	http://dx.doi.org/10.1371/journal.pone.0089629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586922	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900132
J	Hwang, S; Miller, WG; Ryu, S; Jeon, B				Hwang, Sunyoung; Miller, William G.; Ryu, Sangryeol; Jeon, Byeonghwa			Divergent Distribution of the Sensor Kinase CosS in Non-Thermotolerant Campylobacter Species and Its Functional Incompatibility with the Response Regulator CosR of Campylobacter jejuni	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; SYSTEM; COLONIZATION; FAMILY; INFECTIONS; EXPRESSION; APPARATUS; GROWTH; PYLORI	Two-component signal transduction systems are commonly composed of a sensor histidine kinase and a cognate response regulator, modulating gene expression in response to environmental changes through a phosphorylation-dependent process. CosR is an OmpR-type response regulator essential for the viability of Campylobacter jejuni, a major foodborne pathogenic species causing human gastroenteritis. Although CosR is a response regulator, its cognate sensor kinase has not been identified in C. jejuni. In this study, DNA sequence analysis of the cosR flanking regions revealed that a gene encoding a putative sensor kinase, which we named cosS, is prevalent in non-thermotolerant Campylobacter spp., but not in thermotolerant campylobacters. Phosphorylation assays indicated that C. fetus CosS rapidly autophosphorylates and then phosphorylates C. fetus CosR, suggesting that the CosRS system constitutes a paired two-component signal transduction system in C. fetus. However, C. fetus CosS does not phosphorylate C. jejuni CosR, suggesting that CosR may have different regulatory cascades between thermotolerant and non-thermotolerant Campylobacter species. Comparison of CosR homolog amino acid sequences showed that the conserved phosphorylation residue (D51), which is present in all non-thermotolerant Campylobacter spp., is absent from the CosR homologs of thermotolerant Campylobacter species. However, C. jejuni CosR was not phosphorylated by C. fetus CosS even after site-directed mutagenesis of N51D, implying that C. jejuni CosR may possibly function phosphorylation-independently. In addition, the results of cosS mutational analysis indicated that CosS is not associated with the temperature dependence of the Campylobacter spp. despite its unique divergent distribution only in non-thermotolerant campylobacters. The findings in this study strongly suggest that thermotolerant and non-thermotolerant Campylobacter spp. have different signal sensing mechanisms associated with the CosR regulation.	[Jeon, Byeonghwa] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Hwang, Sunyoung; Ryu, Sangryeol] Seoul Natl Univ, Dept Agr Biotechnol, Dept Food & Anim Biotechnol, Seoul, South Korea; [Hwang, Sunyoung; Ryu, Sangryeol] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Miller, William G.] ARS, USDA, Western Reg Res Ctr, Albany, CA USA	University of Alberta; Seoul National University (SNU); Seoul National University (SNU); United States Department of Agriculture (USDA)	Ryu, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Dept Food & Anim Biotechnol, Seoul, South Korea.	sangryu@snu.ac.kr; bjeon@ualberta.ca	Jeon, Byeonghwa/AAB-6806-2020	Jeon, Byeonghwa/0000-0002-6665-5558	NSERC [401843-2012-RGPIN]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2011-0015091]; Ministry of Education, Science and Technology	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study is supported by NSERC Discovery Grant 401843-2012-RGPIN to BJ. SH is supported by grant NRF-2011-0015091 from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2013, MICROBIOL-SGM, V159, P880, DOI 10.1099/mic.0.066548-0; Beier D, 2000, J BACTERIOL, V182, P2068, DOI 10.1128/JB.182.8.2068-2076.2000; Bras AM, 1999, J BACTERIOL, V181, P3298; Garenaux A, 2008, RES MICROBIOL, V159, P718, DOI 10.1016/j.resmic.2008.08.001; Garrity G. M., 2005, PROTEOBACTERIA, V2, P1145; GRANT IH, 1980, J CLIN MICROBIOL, V11, P508, DOI 10.1128/JCM.11.5.508-510.1980; Hendrixson DR, 2003, MOL MICROBIOL, V50, P687, DOI 10.1046/j.1365-2958.2003.03731.x; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Hwang S, 2012, J BACTERIOL, V194, P6883, DOI 10.1128/JB.01636-12; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; Itou H, 2001, J BIOCHEM-TOKYO, V129, P343, DOI 10.1093/oxfordjournals.jbchem.a002863; Joslin SN, 2009, J BACTERIOL, V191, P2656, DOI 10.1128/JB.01689-08; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763; MacKichan JK, 2004, MOL MICROBIOL, V54, P1269, DOI 10.1111/j.1365-2958.2004.04371.x; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Olekhnovich IN, 2013, J BACTERIOL; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PENNER J L, 1988, Clinical Microbiology Reviews, V1, P157; Raphael BH, 2005, J BACTERIOL, V187, P3662, DOI 10.1128/JB.187.11.3662-3670.2005; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Van Vliet AHM, 1998, METHOD MICROBIOL, V27, P407; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wosten MMSM, 2010, J BACTERIOL, V192, P2729, DOI 10.1128/JB.00024-10; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zhang MJ, 2009, JPN J INFECT DIS, V62, P356	32	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89774	10.1371/journal.pone.0089774	http://dx.doi.org/10.1371/journal.pone.0089774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587027	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200080
J	Nguyen, L; Robson, MJ; Healy, JR; Scandinaro, AL; Matsumoto, RR				Nguyen, Linda; Robson, Matthew J.; Healy, Jason R.; Scandinaro, Anna L.; Matsumoto, Rae R.			Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan	PLOS ONE			English	Article							FORCED SWIMMING TEST; BEHAVIORAL DESPAIR; DRUG DISCOVERY; RAT-BRAIN; BINDING; DEPRESSION; LIGANDS; MICE; NOREPINEPHRINE; SEROTONIN	Dextromethorphan is an antitussive with a high margin of safety that has been hypothesized to display rapid-acting antidepressant activity based on pharmacodynamic similarities to the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine. In addition to binding to NMDA receptors, dextromethorphan binds to sigma-1 (sigma(1)) receptors, which are believed to be protein targets for a potential new class of antidepressant medications. The purpose of this study was to determine whether dextromethorphan elicits antidepressant-like effects and the involvement of sigma(1) receptors in mediating its antidepressant-like actions. The antidepressant-like effects of dextromethorphan were assessed in male, Swiss Webster mice using the forced swim test. Next, sigma(1) receptor antagonists (BD1063 and BD1047) were evaluated in conjunction with dextromethorphan to determine the involvement of sigma receptors in its antidepressant-like effects. Quinidine, a cytochrome P450 (CYP) 2D6 inhibitor, was also evaluated in conjunction with dextromethorphan to increase the bioavailability of dextromethorphan and reduce exposure to additional metabolites. Finally, saturation binding assays were performed to assess the manner in which dextromethorphan interacts at the sigma(1) receptor. Our results revealed dextromethorphan displays antidepressant-like effects in the forced swim test that can be attenuated by pretreatment with sigma(1) receptor antagonists, with BD1063 causing a shift to the right in the dextromethorphan dose response curve. Concomitant administration of quinidine potentiated the antidepressant-like effects of dextromethorphan. Saturation binding assays revealed that a K-i concentration of dextromethorphan reduces both the K-d and the B-max of [H-3](+)-pentazocine binding to sigma(1) receptors. Taken together, these data suggest that dextromethorphan exerts some of its antidepressant actions through sigma(1) receptors.	[Matsumoto, Rae R.] W Virginia Univ, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; W Virginia Univ, Dept Behav Med & Psychiat, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Matsumoto, RR (corresponding author), W Virginia Univ, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA.	rmatsumoto@hsc.wvu.edu	Robson, Matthew/H-3127-2013	Robson, Matthew/0000-0002-3277-3062	Avanir Pharmaceuticals; West Virginia University; National Institutes of Health [DA013978, DA013583]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013583, R01DA013978] Funding Source: NIH RePORTER	Avanir Pharmaceuticals; West Virginia University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study and personnel were funded by Avanir Pharmaceuticals, West Virginia University, and the National Institutes of Health (DA013978, DA013583). Avanir Pharmaceuticals provided editorial suggestions to improve the clarity of the manuscript prior to submission. The funding entities had no further role in the design of the study; in the collection, analysis and interpretation of the data; in writing the report; and in deciding to submit the paper for publication.	ANDERSEN PH, 1989, EUR J PHARMACOL, V166, P493, DOI 10.1016/0014-2999(89)90363-4; Bermack J, 2002, INT J NEUROPSYCHOPH, V5, P53, DOI 10.1017/S1461145701002760; Bermack JE, 2001, BRIT J PHARMACOL, V134, P691, DOI 10.1038/sj.bjp.0704294; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Chou YC, 1999, BRAIN RES, V821, P516, DOI 10.1016/S0006-8993(99)01125-7; Cobos EJ, 2005, SYNAPSE, V55, P192, DOI 10.1002/syn.20103; CODD EE, 1995, J PHARMACOL EXP THER, V274, P1263; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; CUSACK B, 1994, PSYCHOPHARMACOLOGY, V114, P559, DOI 10.1007/BF02244985; Fishback JA, 2012, J PHARMACEUT BIOMED, V71, P157, DOI 10.1016/j.jpba.2012.07.023; Fishback JA, 2010, PHARMACOL THERAPEUT, V127, P271, DOI 10.1016/j.pharmthera.2010.04.003; Frazer A, 2002, MOL PSYCHIATR, V7, pS23, DOI 10.1038/sj.mp.4001015; Hayashi T, 2008, EXPERT OPIN THER TAR, V12, P45, DOI 10.1517/14728222.12.1.45; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lauterbach EC, 2012, MED HYPOTHESES, V78, P693, DOI 10.1016/j.mehy.2012.02.012; Lucas G, 2008, INT J NEUROPSYCHOPH, V11, P485, DOI 10.1017/S1461145708008547; Matsuno K, 1996, EUR J PHARMACOL, V312, P267, DOI 10.1016/0014-2999(96)00497-9; McArthur R, 2006, PHARMACOL BIOCHEM BE, V84, P436, DOI 10.1016/j.pbb.2006.06.005; Nam Y, 2012, NEUROCHEM INT, V61, P913, DOI 10.1016/j.neuint.2012.01.025; Narita N, 1996, EUR J PHARMACOL, V307, P117, DOI 10.1016/0014-2999(96)00254-3; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Nguyen EC, 2005, NEUROPHARMACOLOGY, V49, P638, DOI 10.1016/j.neuropharm.2005.04.016; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Pope LE, 2004, J CLIN PHARMACOL, V44, P1132, DOI 10.1177/0091270004269521; Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029; Robson MJ, 2012, EUR NEUROPSYCHOPHARM, V22, P308, DOI 10.1016/j.euroneuro.2011.08.002; Runyon SP, 2001, BIOORG MED CHEM LETT, V11, P655, DOI 10.1016/S0960-894X(01)00023-3; Sabino V, 2009, BEHAV BRAIN RES, V198, P472, DOI 10.1016/j.bbr.2008.11.036; SCHMID B, 1985, CLIN PHARMACOL THER, V38, P618, DOI 10.1038/clpt.1985.235; Skuza G, 2003, POL J PHARMACOL, V55, P923; Skuza G, 2002, BEHAV PHARMACOL, V13, P537, DOI 10.1097/00008877-200211000-00003; STANTON T, 1993, BIOCHEM PHARMACOL, V45, P2352, DOI 10.1016/0006-2952(93)90211-E; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; TRAN VT, 1978, P NATL ACAD SCI USA, V75, P6290, DOI 10.1073/pnas.75.12.6290; Ukai M, 1998, PHARMACOL BIOCHEM BE, V61, P247, DOI 10.1016/S0091-3057(98)00093-8; Urani A, 2001, J PHARMACOL EXP THER, V298, P1269; Volz HP, 2004, PHARMACOPSYCHIATRY, V37, pS214, DOI 10.1055/s-2004-832680; Wang JJ, 2007, EUR NEUROPSYCHOPHARM, V17, P708, DOI 10.1016/j.euroneuro.2007.02.007; Werling LL, 2007, EXP NEUROL, V207, P248, DOI 10.1016/j.expneurol.2007.06.013; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; WONG DT, 1982, J PHARMACOL EXP THER, V222, P61; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	49	56	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89985	10.1371/journal.pone.0089985	http://dx.doi.org/10.1371/journal.pone.0089985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587167	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200102
J	Smadbeck, J; Peterson, MB; Zee, BM; Garapaty, S; Mago, A; Lee, C; Giannis, A; Trojer, P; Garcia, BA; Floudas, CA				Smadbeck, James; Peterson, Meghan B.; Zee, Barry M.; Garapaty, Shivani; Mago, Aashna; Lee, Christina; Giannis, Athanassios; Trojer, Patrick; Garcia, Benjamin A.; Floudas, Christodoulos A.			De Novo Peptide Design and Experimental Validation of Histone Methyltransferase Inhibitors	PLOS ONE			English	Article							SEQUENCE SELECTION PROBLEM; PROTEIN-PROTEIN DOCKING; COMPSTATIN VARIANTS; EZH2; CANCER; METHYLATION; PREDICTIONS; OPTIMIZATION; FORMULATIONS; SPECIFICITY	Histones are small proteins critical to the efficient packaging of DNA in the nucleus. DNA-protein complexes, known as nucleosomes, are formed when the DNA winds itself around the surface of the histones. The methylation of histone residues by enhancer of zeste homolog 2 (EZH2) maintains gene repression over successive cell generations. Overexpression of EZH2 can silence important tumor suppressor genes leading to increased invasiveness of many types of cancers. This makes the inhibition of EZH2 an important target in the development of cancer therapeutics. We employed a three-stage computational de novo peptide design method to design inhibitory peptides of EZH2. The method consists of a sequence selection stage and two validation stages for fold specificity and approximate binding affinity. The sequence selection stage consists of an integer linear optimization model that was solved to produce a rank-ordered list of amino acid sequences with increased stability in the bound peptide-EZH2 structure. These sequences were validated through the calculation of the fold specificity and approximate binding affinity of the designed peptides. Here we report the discovery of novel EZH2 inhibitory peptides using the de novo peptide design method. The computationally discovered peptides were experimentally validated in vitro using dose titrations and mechanism of action enzymatic assays. The peptide with the highest in vitro response, SQ037, was validated in nucleo using quantitative mass spectrometry-based proteomics. This peptide had an IC50 of 13.5 mu M, demonstrated greater potency as an inhibitor when compared to the native and K27A mutant control peptides, and demonstrated competitive inhibition versus the peptide substrate. Additionally, this peptide demonstrated high specificity to the EZH2 target in comparison to other histone methyltransferases. The validated peptides are the first computationally designed peptides that directly inhibit EZH2. These inhibitors should prove useful for further chromatin biology investigations.	[Smadbeck, James; Peterson, Meghan B.; Floudas, Christodoulos A.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Zee, Barry M.; Mago, Aashna; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Garapaty, Shivani; Lee, Christina; Trojer, Patrick] Constellat Pharmaceut, Cambridge, MA USA; [Giannis, Athanassios] Univ Leipzig, Inst Organ Chem, D-04109 Leipzig, Germany; [Garcia, Benjamin A.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Epigenet Program, Perelman Sch Med, Philadelphia, PA 19104 USA	Princeton University; Princeton University; Leipzig University; Princeton University; University of Pennsylvania; Pennsylvania Medicine	Floudas, CA (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	floudas@titan.princeton.edu			National Institutes of Health (NIH) [5R01 GM052032]; National Science Foundation (NSF) [CBET-091143]; NSF Early Faculty CAREER award; Office of the Director, NIH [DP2OD007447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052032] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Early Faculty CAREER award; Office of the Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CAF acknowledges support from the National Institutes of Health (NIH; 5R01 GM052032). BAG and CAF acknowledge support from the National Science Foundation (NSF; CBET-091143). BAG also acknowledges support from an NSF Early Faculty CAREER award, and the NIH Innovator award (DP2OD007447) from the Office of the Director, NIH. BMZ is supported by an NSF graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellows ML, 2010, BIOPHYS J, V99, P3445, DOI 10.1016/j.bpj.2010.09.050; Bellows ML, 2010, BIOPHYS J, V98, P2337, DOI 10.1016/j.bpj.2010.01.057; Bellows-Peterson ML, 2012, J MED CHEM, V55, P4159, DOI 10.1021/jm201609k; Choudhury SR, 2011, CARCINOGENESIS, V32, P1525, DOI 10.1093/carcin/bgr171; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Daily MD, 2005, PROTEINS, V60, P181, DOI 10.1002/prot.20555; Diaz E, 2012, J BIOMOL SCREEN, V17, P1279, DOI 10.1177/1087057112453765; DiMaggio PA, 2010, J GLOBAL OPTIM, V47, P343, DOI 10.1007/s10898-008-9349-z; DiMaggio PA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-458; Fischle W, 2005, METHODS, V36, P362, DOI 10.1016/j.ymeth.2005.03.008; Fiskus W, 2009, CANCER BIOL THER, V8, P939, DOI 10.4161/cbt.8.10.8213; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Fung HK, 2007, OPTIM METHOD SOFTW, V22, P51, DOI 10.1080/10556780600882041; Fung HK, 2005, J COMB OPTIM, V10, P41, DOI 10.1007/s10878-005-1859-8; Fung HK, 2008, BIOPHYS J, V94, P584, DOI 10.1529/biophysj.107.110627; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gray JJ, 2003, PROTEINS, V52, P118, DOI 10.1002/prot.10384; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hubbard SJ., 1993, COMPUTER PROGRAM; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klepeis JL, 2004, IND ENG CHEM RES, V43, P3817, DOI 10.1021/ie0340995; Klepeis JL, 2003, J AM CHEM SOC, V125, P8422, DOI 10.1021/ja034846p; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lee MR, 2001, J AM CHEM SOC, V123, P1040, DOI 10.1021/ja003150i; Lilien RH, 2005, J COMPUT BIOL, V12, P740, DOI 10.1089/cmb.2005.12.740; Luo MK, 2012, ACS CHEM BIOL, V7, P443, DOI 10.1021/cb200519y; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mund C, 2010, BIOESSAYS, V32, P949, DOI 10.1002/bies.201000061; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; PONDER J, 1998, TINKER SOFTWARE TOOL; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rajgaria R, 2008, PROTEINS, V70, P950, DOI 10.1002/prot.21561; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rohl CA, 2002, J AM CHEM SOC, V124, P2723, DOI 10.1021/ja016880e; Sellers WR, 2002, CANCER CELL, V2, P349, DOI 10.1016/S1535-6108(02)00187-3; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Spannhoff A, 2009, INT J BIOCHEM CELL B, V41, P4, DOI 10.1016/j.biocel.2008.07.024; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784	48	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90095	10.1371/journal.pone.0090095	http://dx.doi.org/10.1371/journal.pone.0090095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587223	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200124
J	Benavente, JJM; Mogami, H; Sakurai, T; Sawada, K				Benavente, Johan Jaime Medina; Mogami, Hideo; Sakurai, Takashi; Sawada, Kazuaki			Evaluation of Silicon Nitride as a Substrate for Culture of PC12 Cells: An Interfacial Model for Functional Studies in Neurons	PLOS ONE			English	Article							GROWTH; SENSOR; ADHESION; FABRICATION; ATTACHMENT; RELEASE; DEVICE; ISFET; ARRAY; CHIP	Silicon nitride is a biocompatible material that is currently used as an interfacial surface between cells and large-scale integration devices incorporating ion-sensitive field-effect transistor technology. Here, we investigated whether a poly-L-lysine coated silicon nitride surface is suitable for the culture of PC12 cells, which are widely used as a model for neural differentiation, and we characterized their interaction based on cell behavior when seeded on the tested material. The coated surface was first examined in terms of wettability and topography using contact angle measurements and atomic force microscopy and then, conditioned silicon nitride surface was used as the substrate for the study of PC12 cell culture properties. We found that coating silicon nitride with poly-L-lysine increased surface hydrophilicity and that exposing this coated surface to an extracellular aqueous environment gradually decreased its roughness. When PC12 cells were cultured on a coated silicon nitride surface, adhesion and spreading were facilitated, and the cells showed enhanced morphological differentiation compared to those cultured on a plastic culture dish. A bromodeoxyuridine assay demonstrated that, on the coated silicon nitride surface, higher proportions of cells left the cell cycle, remained in a quiescent state and had longer survival times. Therefore, our study of the interaction of the silicon nitride surface with PC12 cells provides important information for the production of devices that need to have optimal cell culture-supporting properties in order to be used in the study of neuronal functions.	[Benavente, Johan Jaime Medina; Sawada, Kazuaki] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi, Japan; [Benavente, Johan Jaime Medina; Mogami, Hideo; Sakurai, Takashi; Sawada, Kazuaki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Program, Tokyo, Japan; [Mogami, Hideo] Hamamatsu Univ, Fac Hlth Promot Sci, Hamamatsu, Shizuoka 4312102, Japan; [Sakurai, Takashi] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi, Japan	Toyohashi University of Technology; Japan Science & Technology Agency (JST); Hamamatsu University School of Medicine; Toyohashi University of Technology	Benavente, JJM (corresponding author), Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi, Japan.	johan@int.ee.tut.ac.jp			Japan Science and Technology Agency (JST), an independent public body of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through the Core Research for Evolutional Science and Technology (CREST) program	Japan Science and Technology Agency (JST), an independent public body of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through the Core Research for Evolutional Science and Technology (CREST) program	This research was supported by the Japan Science and Technology Agency (JST), an independent public body of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through the Core Research for Evolutional Science and Technology (CREST) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688; Brigadski T, 2005, J NEUROSCI, V25, P7601, DOI 10.1523/JNEUROSCI.1776-05.2005; Carter EA, 2010, MOL BIOSYST, V6, P1316, DOI 10.1039/c001499k; Chin YL, 2001, SENSOR ACTUAT B-CHEM, V75, P36, DOI 10.1016/S0925-4005(00)00739-5; Chin YL, 2001, SENSOR ACTUAT B-CHEM, V76, P582, DOI 10.1016/S0925-4005(01)00639-6; Doyle A, 1998, CELLS TISSUE CULT; Eversmann B, 2003, IEEE J SOLID-ST CIRC, V38, P2306, DOI 10.1109/JSSC.2003.819174; Fahlman BD, 2011, MATER CHEM, P239; Felmy F, 2009, PFLUG ARCH EUR J PHY, V458, P403, DOI 10.1007/s00424-008-0623-1; FUJII DK, 1982, J NEUROSCI, V2, P1157; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRINNELL F, 1973, J CELL BIOL, V58, P602, DOI 10.1083/jcb.58.3.602; Happel P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-323; Hattori T, 2010, ANAL SCI, V26, P1039, DOI 10.2116/analsci.26.1039; HAWROT E, 1980, DEV BIOL, V74, P136, DOI 10.1016/0012-1606(80)90057-3; Hierra E. J., 2012, SILICON NITRIDE SYNT; Hirata I, 2000, JPN J APPL PHYS 1, V39, P6441, DOI 10.1143/JJAP.39.6441; Hizawa T, 2006, JPN J APPL PHYS 1, V45, P9259, DOI 10.1143/JJAP.45.9259; Hizawa T, 2006, SENSOR ACTUAT B-CHEM, V117, P509, DOI 10.1016/j.snb.2006.01.056; Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X; Hwang SR, 2007, J BIOL CHEM, V282, P9556, DOI 10.1074/jbc.M605510200; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; LETOURNEAU PC, 1979, EXP CELL RES, V124, P127, DOI 10.1016/0014-4827(79)90263-5; LETOURNEAU PC, 1975, DEV BIOL, V44, P77, DOI 10.1016/0012-1606(75)90378-4; Levine PM, 2008, IEEE J SOLID-ST CIRC, V43, P1859, DOI 10.1109/JSSC.2008.925407; Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015; Martin-Lopez E, 2012, J BIOMATER APPL, V26, P791, DOI 10.1177/0885328210379928; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Nishiyama H, 2010, J STRUCT BIOL, V172, P191, DOI 10.1016/j.jsb.2010.08.006; Ohta J, 2006, IEEE ENG MED BIOL, V25, P47, DOI 10.1109/MEMB.2006.1705747; Patolsky F, 2006, NAT PROTOC, V1, P1711, DOI 10.1038/nprot.2006.227; Peterman MC, 2004, P NATL ACAD SCI USA, V101, P9951, DOI 10.1073/pnas.0402089101; Peterman MC, 2003, ARTIF ORGANS, V27, P975, DOI 10.1046/j.1525-1594.2003.07307.x; Peterman MC, 2003, INVEST OPHTH VIS SCI, V44, P3144, DOI 10.1167/iovs.02-1097; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Rak K, 2011, J BIOMED MATER RES A, V97A, P158, DOI 10.1002/jbm.a.33042; Riley FL, 2000, J AM CERAM SOC, V83, P245, DOI 10.1111/j.1151-2916.2000.tb01182.x; Sawada K, 1999, IEEE T ELECTRON DEV, V46, P1846, DOI 10.1109/16.784183; Shprung T, 2009, J MOL NEUROSCI, V37, P254, DOI 10.1007/s12031-008-9129-8; Thewes R., 2002, 2002 IEEE International Solid-State Circuits Conference. Digest of Technical Papers (Cat. No.02CH37315), P350, DOI 10.1109/ISSCC.2002.993076; TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; YANKNER BA, 1982, ANNU REV BIOCHEM, V51, P845, DOI 10.1146/annurev.bi.51.070182.004213	44	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90189	10.1371/journal.pone.0090189	http://dx.doi.org/10.1371/journal.pone.0090189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587271	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800089
J	Kularatne, SAM; Silva, A; Weerakoon, K; Maduwage, K; Walathara, C; Paranagama, R; Mendis, S				Kularatne, Senanayake A. M.; Silva, Anjana; Weerakoon, Kosala; Maduwage, Kalana; Walathara, Chamara; Paranagama, Ranjith; Mendis, Suresh			Revisiting Russell's Viper (Daboia russelii) Bite in Sri Lanka: Is Abdominal Pain an Early Feature of Systemic Envenoming?	PLOS ONE			English	Article							ANTIVENOM; VENOM	The Russell's viper (Daboia russelii) is responsible for 30-40% of all snakebites and the most number of life-threatening bites of any snake in Sri Lanka. The clinical profile of Russell's viper bite includes local swelling, coagulopathy, renal dysfunction and neuromuscular paralysis, based on which the syndromic diagnostic tools have been developed. The currently available Indian polyvalent antivenom is not very effective in treating Russell's viper bite patients in Sri Lanka and the decision regarding antivenom therapy is primarily driven by clinical and laboratory evidence of envenoming. The non-availability of early predictors of Russell's viper systemic envenoming is responsible for considerable delay in commencing antivenom. The objective of this study is to evaluate abdominal pain as an early feature of systemic envenoming following Russell's viper bites. We evaluated the clinical profile of Russell's viper bite patients admitted to a tertiary care centre in Sri Lanka. Fifty-five patients were proven Russell's viper bite victims who produced the biting snake, while one hundred and fifty-four were suspected to have been bitten by the same snake species. Coagulopathy (159, 76.1%), renal dysfunction (39, 18.7%), neuromuscular paralysis (146, 69.9%) and local envenoming (192, 91.9%) were seen in the victims, ranging from mono-systemic involvement to various combinations. Abdominal pain was present in 79.5% of these patients, appearing 5 minutes to 4 hours after the bite. The severity of the abdominal pain, assessed using a scoring system, correlated well with the severity of the coagulopathy (p<0.001) and the neurotoxicity (p<0.001). Its diagnostic validity to predict systemic envenoming is - Sensitivity 81.6%, Specificity 82.4%, Positive predictive value 91.2%. Thus, abdominal pain is an early clinical feature of systemic Russell's viper bite envenoming in Sri Lanka. However, it is best to judge abdominal pain together with other clinical manifestations on decision making.	[Kularatne, Senanayake A. M.] Univ Peradeniya, Dept Med, Fac Med, Peradeniya, Sri Lanka; [Silva, Anjana; Weerakoon, Kosala] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Parasitol, Anuradhapura, Sri Lanka; [Maduwage, Kalana] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Walathara, Chamara; Paranagama, Ranjith; Mendis, Suresh] Teaching Hosp, Anuradhapura, Sri Lanka	University of Peradeniya; Rajarata University of Sri Lanka; University of Newcastle	Kularatne, SAM (corresponding author), Univ Peradeniya, Dept Med, Fac Med, Peradeniya, Sri Lanka.	samkul@sltnet.lk	Silva, Anjana/AAB-7764-2019; Weerakoon, Kosala/L-5667-2013	Silva, Anjana/0000-0002-9968-3707; Weerakoon, Kosala/0000-0002-4814-6928; Maduwage, Kalana/0000-0001-5351-808X				Abercromby A.F., 1910, SNAKES CEYLON; [Anonymous], 2007, ANN HLTH B; Antonypillai CN, 2011, QJM-INT J MED, V104, P97, DOI 10.1093/qjmed/hcq214; Ariaratnam CA, 2008, T ROY SOC TROP MED H, V102, P1120, DOI 10.1016/j.trstmh.2008.03.023; Ariaratnam CA, 1999, AM J TROP MED HYG, V61, P259, DOI 10.4269/ajtmh.1999.61.259; Ariaratnam CA, 2001, T ROY SOC TROP MED H, V95, P74, DOI 10.1016/S0035-9203(01)90339-6; Ariaratnam CA, 2009, AM J TROP MED HYG, V81, P725, DOI 10.4269/ajtmh.2009.09-0225; de Silva A., 1983, Ceylon Medical Journal, V28, P144; Herath HMNJ, 2012, POSTGRAD MED J, V88, P138, DOI 10.1136/postgradmedj-2011-130225; Isbister GK, 2013, QJM-INT J MED, V106, P925, DOI 10.1093/qjmed/hct102; JEYARAJAH R, 1984, AM J TROP MED HYG, V33, P506, DOI 10.4269/ajtmh.1984.33.506; Kasturiratne A., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P733; Kularatne K, 2011, ASIAN PAC J TROP MED, V4, P564, DOI 10.1016/S1995-7645(11)60147-8; Kularatne S A M, 2003, Southeast Asian J Trop Med Public Health, V34, P855; Kularatne SAM, 2002, POSTGRAD MED J, V78, P276, DOI 10.1136/pmj.78.919.276; Kularatne SAM, 2001, 4 WORLD C HERP, P58; Pathmeswaran A, 2006, T ROY SOC TROP MED H, V100, P874, DOI 10.1016/j.trstmh.2005.10.003; PHILLIPS RE, 1988, Q J MED, V68, P691; Silva Anjana, 2012, BMC Res Notes, V5, P500, DOI 10.1186/1756-0500-5-500; Suzuki M, 2010, BIOMED RES-TOKYO, V31, P71, DOI 10.2220/biomedres.31.71; Thorpe RS, 2007, HERPETOL J, V17, P209; WARRELL DA, 1989, T ROY SOC TROP MED H, V83, P732, DOI 10.1016/0035-9203(89)90311-8; Wuster Wolfgang, 1998, Hamadryad, V23, P33	23	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90198	10.1371/journal.pone.0090198	http://dx.doi.org/10.1371/journal.pone.0090198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587278	Green Submitted, gold, Green Published			2022-12-27	WOS:000332389000142
J	Kumar, S; Rana, ML; Verma, K; Singh, N; Sharma, AK; Maria, AK; Dhaliwal, GS; Khaira, HK; Saini, S				Kumar, Satwant; Rana, Madhu Lata; Verma, Khushboo; Singh, Narayanjeet; Sharma, Anil Kumar; Maria, Arun Kumar; Dhaliwal, Gobind Singh; Khaira, Harkiran Kaur; Saini, Sunil			PrediQt-Cx: Post Treatment Health Related Quality of Life Prediction Model for Cervical Cancer Patients	PLOS ONE			English	Article							RADICAL HYSTERECTOMY; SEXUAL FUNCTION; VAGINAL CHANGES; WOMEN; RADIOTHERAPY; CARCINOMA; MACHINE; IMPACT; SVM	Background: Cervical cancer is the third largest cause of cancer mortality in India. The objectives of the study were to compare the pre and the post treatment quality of life in cervical cancer patients and to develop a prediction model to provide an insight into the possibilities in the treatment modules. Methodology/Principal Findings: A total of 198 patients were assessed with two structured questionnaires of Health Related Quality of Life (The European Organisation for Research and Treatment of Cancer, EORTC QLQ C-30 and CX-24). The baseline observations were recorded when the patients first reported (T1) and second evaluation was done at 6 months post treatment (T2). The mean age of detection was 50.9 years with the literacy level being non-educated or less than high school. Majority of them were married/cohabiting 179 (90.4%). On histopathological examination (HPE) squamous cell carcinoma was found to be the most common cell type carcinoma 147 (74.2%) followed by Adenocarcinoma 31 (15.7%). Radical hysterectomy was the most common treatment modality 76 (38.4%), followed by Wertheims Hysterectomy 46 (23.2%) and Radiochemotherapy 59 (29.8%). The mean score of global health of cervical cancer patients post treatment was 77.90, which was significantly higher than the pre - treatment score (54.32). Mean "symptoms score'' post treatment was 21.69 with an aggravation of 7.32 compared to pre treatment scores. Patients experienced substantial decrease in sexual activity post treatment. Conclusions/Significance: The prediction model(PrediQt-Cx), based on Support Vector Machine(SVM) for predicting post treatment HRQoL in cervical cancer patients was developed and internally cross validated. After external validation PrediQt-Cx can be easily employed to support decision making by clinicians and patients from north India region, through openly made available for access at http://prediqt.org.	[Kumar, Satwant] Inst Bioinformat, Bangalore, Karnataka, India; [Kumar, Satwant; Rana, Madhu Lata; Singh, Narayanjeet; Sharma, Anil Kumar; Maria, Arun Kumar; Dhaliwal, Gobind Singh; Khaira, Harkiran Kaur] Adesh Inst Med Sci & Res, Bathinda, Punjab, India; [Rana, Madhu Lata; Singh, Narayanjeet; Saini, Sunil] HIMS, Dehra Dun, Uttarkhand, India; [Verma, Khushboo] Rabindra Nath Tagore Med Coll, Udaipur, Rajasthan, India	Adesh Institute of Medical Science & Research (AIMSR)	Kumar, S (corresponding author), Inst Bioinformat, Bangalore, Karnataka, India.	satwant@ibioinformatics.org	Kumar, Satwant/AAA-1015-2022	Kumar, Satwant/0000-0002-9054-2123				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Ambard M, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00078; Arrossi S, 2007, GYNECOL ONCOL, V105, P335, DOI 10.1016/j.ygyno.2006.12.010; Baze C, 2008, GYNECOL ONCOL, V109, pS12, DOI 10.1016/j.ygyno.2008.01.022; Bergmark K, 1999, NEW ENGL J MED, V340, P1383, DOI 10.1056/NEJM199905063401802; Bishop A, 1996, Bull Pan Am Health Organ, V30, P378; Chen CF, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/395690; Chen ST, 2009, KOREAN J RADIOL, V10, P464, DOI 10.3348/kjr.2009.10.5.464; Dabash Rasha, 2005, Reprod Health, V2, P11, DOI 10.1186/1742-4755-2-11; de Barros GC, 2008, REV LAT-AM ENFERM, V16, P1049, DOI 10.1590/S0104-11692008000600018; Fayers P, 2001, EORTC QLQ C30 SCORIN; Ferlay J, 2010, INT J CANCER, V127; Fernandes WC, 2010, REV LAT-AM ENFERM, V18, P360, DOI 10.1590/S0104-11692010000300010; Ferrell B R, 1995, Oncol Nurs Forum, V22, P915; Frumovitz M, 2005, J CLIN ONCOL, V23, P7428, DOI 10.1200/JCO.2004.00.3996; Greimel E, 2002, GYNECOL ONCOL, V85, P140, DOI 10.1006/gyno.2002.6586; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Jensen PT, 2004, CANCER, V100, P97, DOI 10.1002/cncr.11877; Jensen PT, 2003, INT J RADIAT ONCOL, V56, P937, DOI 10.1016/S0360-3016(03)00362-6; Kagawa-Singer Marjorie, 2010, Semin Oncol Nurs, V26, P59, DOI 10.1016/j.soncn.2009.11.008; Kirwan JM, 2003, RADIOTHER ONCOL, V68, P217, DOI 10.1016/S0167-8140(03)00197-X; Klee M, 2000, GYNECOL ONCOL, V76, P14, DOI 10.1006/gyno.1999.5642; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Kurkure Arun P, 2006, Asian Pac J Cancer Prev, V7, P36; LAEDTKE TW, 1992, SOUTHERN MED J, V85, P5, DOI 10.1097/00007611-199201000-00003; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manne S, 2008, PSYCHOSOM MED, V70, P677, DOI 10.1097/PSY.0b013e31817b935d; McLaren CE, 2009, ACAD RADIOL, V16, P842, DOI 10.1016/j.acra.2009.01.029; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Park SY, 2007, CANCER-AM CANCER SOC, V110, P2716, DOI 10.1002/cncr.23094; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Possover M, 2002, SURG ENDOSC, V16, P847, DOI 10.1007/s00464-001-9082-x; Roura E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-145; Sato JR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00178; Schaul T, 2010, J MACH LEARN RES, V11, P743; Shi HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051285; Sprangers MAG, 1998, QUAL LIFE RES, V7, P291; STRYKER JA, 1990, CANCER, V66, P1488, DOI 10.1002/1097-0142(19901001)66:7<1488::AID-CNCR2820660709>3.0.CO;2-Y; Taylor CLC, 2004, J CLIN ONCOL, V22, P881, DOI 10.1200/JCO.2004.08.150; Team RC, 2012, R LANG ENV STAT COMP; Vallikad E, 2006, INT J GYNECOL OBSTET, V95, pS215, DOI 10.1016/S0020-7292(06)60037-4; Vinh NX, 2010, J MACHINE LEARNING R, V11; WHO/ICO information centre on HPV and cervical cancer (HPV information centre), 2013, HUM PAP REL CANC IND; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036	45	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89851	10.1371/journal.pone.0089851	http://dx.doi.org/10.1371/journal.pone.0089851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587074	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000099
J	Thomas, GN; Wang, MP; Ho, SY; Mak, KH; Cheng, KK; Lam, TH				Thomas, G. Neil; Wang, Man Ping; Ho, Sai Yin; Mak, Kwok Hang; Cheng, Kar Keung; Lam, Tai Hing			Adverse Lifestyle Leads to an Annual Excess of 2 Million Deaths in China	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; ALL-CAUSE MORTALITY; HEALTH BEHAVIORS; CARDIOVASCULAR-DISEASE; 10-YEAR MORTALITY; HONG-KONG; MEN; SMOKING; WOMEN; POPULATION	Background: Adverse lifestyle factors have been associated with increased mortality, but data are lacking on their combined effect in developing populations, which we address in the present study. Methods: In a death registry-based, case-control study among Hong Kong Chinese aged 30+y, proxy-reported lifestyle factors 10 y ago were collected for 21,363 cases (81% of all deaths) and 12,048 living controls. Risks associated with poor diet, inactivity, heavy alcohol intake, and smoking for all-cause and cause-specific mortality, adjusting for potential confounders, were determined, and excess deaths for the Chinese population were calculated. Results: Adjusted odds ratios for all-cause mortality were 1.15 (95% CI 1.09, 1.23), 1.34 (1.27, 1.43), 1.36 (1.21, 1.52), and 1.58 (1.46, 1.70) for poor diet, inactivity, heavy alcohol intake and smoking, respectively. Increasing numbers of adverse lifestyle factors were associated with a dose-dependent increase in adjusted odds ratios of 1.30 (1.20, 1.40), 1.67 (1.54, 1.81), 2.32 (2.08, 2.60), and 3.85 (3.12, 4.75) for 1, 2, 3, and 4 risk factors relative to those with none. The population attributable fraction for all-cause, all-CVD and all-cancer mortality were 26.6%, 15.0%, and 32.1%, resulting in an excess of 2,017,541; 489,884; and 607,517 deaths annually, respectively. Although smoking was associated with the greatest excess loss of life (867,530), heavy drinking (680,466), and physical inactivity (678,317) were similarly important. Conclusion: Adverse lifestyle factors contribute to one quarter of all deaths in China. Improving lifestyle practices, particularly focussing on moderating alcohol intake and increasing activity, and smoking cessation are critical to reducing the lifestyle-associated health burden.	[Thomas, G. Neil; Cheng, Kar Keung] Univ Birmingham, Birmingham, W Midlands, England; [Thomas, G. Neil] Heidelberg Univ, Mannheim Med Fac, Inst Publ Hlth Social & Prevent Med, Mannheim, Germany; [Wang, Man Ping] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Ho, Sai Yin; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Mak, Kwok Hang] Hong Kong SAR Govt, Dept Hlth, Hong Kong, Hong Kong, Peoples R China	University of Birmingham; Ruprecht Karls University Heidelberg; University of Hong Kong; University of Hong Kong	Ho, SY (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	syho@hku.hk	Thomas, G. Neil/A-1879-2013; Cheng, Kar/AAL-8899-2021; Ho, Daniel Sai Yin/C-4307-2009; Lam, Tai Hing/C-4317-2009	Thomas, G. Neil/0000-0002-2777-1847; Cheng, Kar/0000-0002-1516-1857; Ho, Daniel Sai Yin/0000-0001-9485-0273; Lam, Tai Hing/0000-0002-2033-9971; Wang, Man Ping/0000-0003-4000-2388	Hong Kong Health Services Research Committee [631012]; Hong Kong Council on Smoking and Health	Hong Kong Health Services Research Committee; Hong Kong Council on Smoking and Health	This work was supported by the Hong Kong Health Services Research Committee (631012) and Hong Kong Council on Smoking and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini GL, 2003, J NUTR, V133, P2663, DOI 10.1093/jn/133.8.2663; Canaves S., 2009, WALL STREET J; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; Eguchi E, 2012, EUR HEART J; Gopinath B, 2010, ARCH INTERN MED, V170, P1605, DOI 10.1001/archinternmed.2010.303; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; HEBERT JR, 1995, INT J EPIDEMIOL, V24, P389, DOI 10.1093/ije/24.2.389; Ho MG, 2007, TOB CONTROL, V16, P359, DOI 10.1136/tc.2007.022061; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Lam TH, 2001, BRIT MED J, V323, P361, DOI 10.1136/bmj.323.7309.361; LAM TH, 1999, REPORT HLTH LIVING S; LERCHEN ML, 1986, AM J EPIDEMIOL, V123, P481, DOI 10.1093/oxfordjournals.aje.a114263; Lin CC, 2012, DIABETES CARE, V35, P105, DOI 10.2337/dc11-0930; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; Ma G, 2008, OBES REV, V9, P113, DOI 10.1111/j.1467-789X.2007.00451.x; Ma Yu-Xia, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P323; Mackay J, 2006, TOBACCO ATLAS; Mak YW, 2005, ADDICT BEHAV, V30, P841, DOI 10.1016/j.addbeh.2004.08.008; McCullough ML, 2011, CANCER EPIDEM BIOMAR, V20, P1089, DOI 10.1158/1055-9965.EPI-10-1173; McGhee SM, 2005, BMJ-BRIT MED J, V330, P287, DOI 10.1136/bmj.38342.706748.47; Nechuta SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000339; Odegaard AO, 2011, CIRCULATION, V124, P2847, DOI 10.1161/CIRCULATIONAHA.111.048843; Office for National Statistics, 2011, GEN LIF SURV 2009, P1; Popkin BM, 2008, HEALTH AFFAIR, V27, P1064, DOI 10.1377/hlthaff.27.4.1064; Rhee Chul Woo, 2012, J Prev Med Public Health, V45, P14, DOI 10.3961/jpmph.2012.45.1.14; Tamakoshi A, 2010, J EPIDEMIOL, V20, P370, DOI 10.2188/jea.JE20100017; Taylor AL, 2000, TOBACCO CONTROL DEV, P343; van Dam RM, 2003, EUR J EPIDEMIOL, V18, P1115; Wannamethee SG, 1998, ARCH INTERN MED, V158, P2433, DOI 10.1001/archinte.158.22.2433; Wright AA, 2007, NEW ENGL J MED, V356, P1493, DOI 10.1056/NEJMp078018; Yun JE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-673; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	35	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89650	10.1371/journal.pone.0089650	http://dx.doi.org/10.1371/journal.pone.0089650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24586936	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000072
J	Sharma, A; Dehzangi, A; Lyons, J; Imoto, S; Miyano, S; Nakai, K; Patil, A				Sharma, Alok; Dehzangi, Abdollah; Lyons, James; Imoto, Seiya; Miyano, Satoru; Nakai, Kenta; Patil, Ashwini			Evaluation of Sequence Features from Intrinsically Disordered Regions for the Estimation of Protein Function	PLOS ONE			English	Article							DOMAINS; HUBS	With the exponential increase in the number of sequenced organisms, automated annotation of proteins is becoming increasingly important. Intrinsically disordered regions are known to play a significant role in protein function. Despite their abundance, especially in eukaryotes, they are rarely used to inform function prediction systems. In this study, we extracted seven sequence features in intrinsically disordered regions and developed a scheme to use them to predict Gene Ontology Slim terms associated with proteins. We evaluated the function prediction performance of each feature. Our results indicate that the residue composition based features have the highest precision while bigram probabilities, based on sequence profiles of intrinsically disordered regions obtained from PSIBlast, have the highest recall. Amino acid bigrams and features based on secondary structure show an intermediate level of precision and recall. Almost all features showed a high prediction performance for GO Slim terms related to extracellular matrix, nucleus, RNA and DNA binding. However, feature performance varied significantly for different GO Slim terms emphasizing the need for a unique classifier optimized for the prediction of each functional term. These findings provide a first comprehensive and quantitative evaluation of sequence features in intrinsically disordered regions and will help in the development of a more informative protein function predictor.	[Sharma, Alok] Univ S Pacific, Sch Phys & Engn, Suva, Fiji; [Sharma, Alok; Dehzangi, Abdollah] Griffith Univ, Inst Integrated & Intelligent Syst, Brisbane, Qld 4111, Australia; [Dehzangi, Abdollah] NICTA, Brisbane, Qld, Australia; [Lyons, James] Griffith Univ, Sch Engn, Brisbane, Qld 4111, Australia; [Imoto, Seiya; Miyano, Satoru; Nakai, Kenta; Patil, Ashwini] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	University of the South Pacific; Griffith University; Australian National University; Griffith University; University of Tokyo	Patil, A (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan.	ashwini@hgc.jp	Nakai, Kenta/B-7293-2009; Sharma, Alok/AAE-4725-2022	Nakai, Kenta/0000-0002-8721-8883; Sharma, Alok/0000-0002-7668-3501; Miyano, Satoru/0000-0002-1753-6616; Patil, Ashwini/0000-0002-3353-1970	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [24113704, 26830135] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by the Grant-in-Aid for Scientific Research on Innovative Areas, "Target recognition and expression mechanism of intrinsically disordered proteins'' from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ba ANN, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002515; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Ghanty P, 2009, IEEE T NANOBIOSCI, V8, P100, DOI 10.1109/TNB.2009.2016488; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Minneci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063754; Moesa HA, 2012, MOL BIOSYST, V8, P3262, DOI 10.1039/c2mb25202c; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Patil A, 2012, BIOCOMPUT-PAC SYM, P164; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Sharma A, 2013, J THEOR BIOL, V320, P41, DOI 10.1016/j.jtbi.2012.12.008; Taguchi YH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-404; Teraguchi S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S7; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002	19	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89890	10.1371/journal.pone.0089890	http://dx.doi.org/10.1371/journal.pone.0089890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587103	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700111
J	Tondon, A; Kaunas, R				Tondon, Abhishek; Kaunas, Roland			The Direction of Stretch-Induced Cell and Stress Fiber Orientation Depends on Collagen Matrix Stress	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SUBSTRATE STIFFNESS; FOCAL ADHESIONS; CYCLIC STRETCH; ALIGNMENT; MIGRATION; FIBROBLASTS; RIGIDITY; MODEL; REORIENTATION	Cell structure depends on both matrix strain and stiffness, but their interactive effects are poorly understood. We investigated the interactive roles of matrix properties and stretching patterns on cell structure by uniaxially stretching U2OS cells expressing GFP-actin on silicone rubber sheets supporting either a surface-adsorbed coating or thick hydrogel of type-I collagen. Cells and their actin stress fibers oriented perpendicular to the direction of cyclic stretch on collagen-coated sheets, but oriented parallel to the stretch direction on collagen gels. There was significant alignment parallel to the direction of a steady increase in stretch for cells on collagen gels, while cells on collagen-coated sheets did not align in any direction. The extent of alignment was dependent on both strain rate and duration. Stretch-induced alignment on collagen gels was blocked by the myosin light-chain kinase inhibitor ML7, but not by the Rho-kinase inhibitor Y27632. We propose that active orientation of the actin cytoskeleton perpendicular and parallel to direction of stretch on stiff and soft substrates, respectively, are responses that tend to maintain intracellular tension at an optimal level. Further, our results indicate that cells can align along directions of matrix stress without collagen fibril alignment, indicating that matrix stress can directly regulate cell morphology.	[Tondon, Abhishek; Kaunas, Roland] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Kaunas, R (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	rkaunas@tamu.edu			National Science Foundation [CBET-0854129]	National Science Foundation(National Science Foundation (NSF))	The authors were supported by a grant from the National Science Foundation (CBET-0854129) to Roland Kaunas. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLOWS CG, 1982, J CELL SCI, V58, P125; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2; DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974; Deshpande VS, 2006, P NATL ACAD SCI USA, V103, P14015, DOI 10.1073/pnas.0605837103; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Faust U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028963; Fung Y.C., 1994, 1 COURSE CONTINUUM M; Gavara N, 2008, BIOPHYS J, V95, P464, DOI 10.1529/biophysj.107.124180; Girton TS, 2002, J BIOMECH ENG-T ASME, V124, P568, DOI 10.1115/1.1504099; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Kanda K, 1992, ASAIO J, V38, pM382, DOI 10.1097/00002480-199207000-00060; Kang HJ, 2011, J BIOL CHEM, V286, P42017, DOI 10.1074/jbc.M111.290841; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2011, CELL HEALTH CYTOSKEL, V3, P13, DOI 10.2147/CHC.S14984; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Lee SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045512; Pang YG, 2011, BIOMATERIALS, V32, P3776, DOI 10.1016/j.biomaterials.2011.02.003; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Quinlan AMT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023272; Reinhart-King CA, 2008, METHOD ENZYMOL, V443, P45, DOI 10.1016/S0076-6879(08)02003-X; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Roby T, 2008, ANN BIOMED ENG, V36, P1744, DOI 10.1007/s10439-008-9545-5; Ronan W, 2013, BIOMECH MODEL MECHAN; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z; Tanner K, 2010, BIOPHYS J, V99, P2775, DOI 10.1016/j.bpj.2010.08.071; Tondon A, 2012, J BIOMECH, V45, P728, DOI 10.1016/j.jbiomech.2011.11.012; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Xu F, 2011, TISSUE ENG PART C-ME, V17, P641, DOI 10.1089/ten.tec.2011.0038; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zhang WJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02332	43	55	57	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89592	10.1371/journal.pone.0089592	http://dx.doi.org/10.1371/journal.pone.0089592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586898	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700065
J	Warnke, P; Harnack, T; Ottl, P; Kundt, G; Podbielski, A				Warnke, Philipp; Harnack, Tim; Ottl, Peter; Kundt, Guenther; Podbielski, Andreas			Nasal Screening for Staphylococcus aureus - Daily Routine with Improvement Potentials	PLOS ONE			English	Article							HOSPITAL ADMISSION; UNITED-STATES; CARRIAGE; RISK; COLONIZATION; INFECTION; MRSA	Objectives: Staphylococcus aureus causes purulent bacterial infections with a considerable number of life-threatening complications and thus, is a serious cost factor in public health. Up to 50% of a given population could asymptomatically carry Staphylococcus aureus in their nares, thereby serving as a source for contact transmissions and endogenous infections. Nasal swab-based screening techniques are widely used to identify suchcarriers. This study investigated the skill of medical professionals in taking nasal swabs and the effect of teaching on improving bacterial recovery rates. Methods: 364 persons with different medical educational background participated in this study. A novel anatomically correct artificial nose model was implemented and inoculated with a numerically defined mixture of Staphylococcus aureus and Staphylococcus epidermidis bacteria. Utilizing regular clinical swabs, participants performed screening of the inoculated nose models before and after standardized theoretical, visual, and practical teaching. Recovery of bacteria was measured by standard viable count techniques. Data were analyzed statistically by nonparametric tests. Results: It could be demonstrated that combined theoretical and practical teaching improved bacterial recovery rates. Even experienced medical professionals increased their detection levels after training. Recovery rates of bacteria varied significantly between trained (158.1 CFU) and untrained (47.5 CFU) participants (Wilcoxon test, p<0.001; Kolmogorov-Smirnov test, p<0.001). Conclusions: Swabs are commonly used to detect nasal carriage of Staphylococcus aureus in patients. The present teaching algorithm combined with the novel nose model offers an excellent precondition to improve knowledge and performance of this technique. Increased detection rates may prevent from contact transmission due to suboptimum hygienic patient handling. Consecutively, this effect could reduce costs for patient care. This study highlights the tremendous potential of combined theoretical, visual, and practical teaching methods in this field - and uncovers its actual necessity. Therefore, this training method can be recommended for all medical institutions.	[Warnke, Philipp; Harnack, Tim; Podbielski, Andreas] Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Ottl, Peter] Univ Hosp Rostock, Dept Prosthodont & Mat Sci, Rostock, Germany; [Kundt, Guenther] Univ Hosp Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Warnke, P (corresponding author), Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	philipp.warnke@med.uni-rostock.de						Bradley P, 2005, MED EDUC, V39, P649, DOI 10.1111/j.1365-2929.2005.02189.x; Bradley Paul, 2002, Med Teach, V24, P209, DOI 10.1080/014215902753549175; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Datta R, 2014, J CLIN MICROBIOL, V52, P312, DOI 10.1128/JCM.01606-13; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Gupta K, 2011, INFECT CONT HOSP EP, V32, P791, DOI 10.1086/660362; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Lam TP, 2002, MED EDUC, V36, P233, DOI 10.1046/j.1365-2923.2002.01142.x; Lofaso DP, 2011, MED EDUC ONLINE, V16, DOI 10.3402/meo.v16i0.7132; MARCUS E, 1994, ACAD MED, V69, P415, DOI 10.1097/00001888-199405000-00030; NELSON MS, 1993, ACAD MED, V68, P926, DOI 10.1097/00001888-199312000-00015; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Peeraer G, 2007, EDUC HEALTH, V20, P125; Plouin-Gaudon I, 2006, RHINOLOGY, V44, P249; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; Van Horn KG, 2008, DIAGN MICR INFEC DIS, V62, P471, DOI 10.1016/j.diagmicrobio.2008.08.004; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; York MK, 2010, CLIN MICROBIOLOGY PR, V1, P3319	27	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89667	10.1371/journal.pone.0089667	http://dx.doi.org/10.1371/journal.pone.0089667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586949	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700071
J	Hou, T; Zheng, GY; Zhang, PY; Jia, J; Li, J; Xie, L; Wei, CC; Li, YX				Hou, Ting; Zheng, Guangyong; Zhang, Pingyu; Jia, Jia; Li, Jing; Xie, Lu; Wei, Chaochun; Li, Yixue			LAceP: Lysine Acetylation Site Prediction Using Logistic Regression Classifiers	PLOS ONE			English	Article							N-TERMINAL ACETYLATION; HIDDEN MARKOV-MODELS; ARF-LIKE GTPASE; HISTONE ACETYLATION; PROTEIN; SEQUENCE; DEACETYLATION; METHYLATION; AAINDEX; TARGET	Background: Lysine acetylation is a crucial type of protein post-translational modification, which is involved in many important cellular processes and serious diseases. However, identification of protein acetylated sites through traditional experiment methods is time-consuming and laborious. Those methods are not suitable to identify a large number of acetylated sites quickly. Therefore, computational methods are still very valuable to accelerate lysine acetylated site finding. Result: In this study, many biological characteristics of acetylated sites have been investigated, such as the amino acid sequence around the acetylated sites, the physicochemical property of the amino acids and the transition probability of adjacent amino acids. A logistic regression method was then utilized to integrate these information for generating a novel lysine acetylation prediction system named LAceP. When compared with existing methods, LAceP overwhelms most of state-of-the-art methods. Especially, LAceP has a more balanced prediction capability for positive and negative datasets. Conclusion: LAceP can integrate different biological features to predict lysine acetylation with high accuracy. An online web server is freely available at http://www.scbit.org/iPTM/.	[Hou, Ting; Li, Yixue] E China Univ Sci & Technol, Sch Biol Engn, Shanghai 200237, Peoples R China; [Hou, Ting; Jia, Jia; Li, Jing; Xie, Lu; Wei, Chaochun; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Hou, Ting; Zhang, Pingyu; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Zheng, Guangyong] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Wei, Chaochun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	East China University of Science & Technology; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Shanghai Jiao Tong University	Zheng, GY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	zhenggy@sibs.ac.cn; ccwei@sjtu.edu.cn; yxli@sibs.ac.cn	wei, chaochun/AAW-2846-2020	Wei, Chaochun/0000-0002-1031-034X	National Natural Science Foundation of China [61272250, 31100957]; National Basic Research Program of China [2013CB956103]; SA-SIBS Scholarship Program; National High-Tech RD Program (863) [2012AA101601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); SA-SIBS Scholarship Program; National High-Tech RD Program (863)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (61272250,.31100957), the National Basic Research Program of China (2013CB956103), SA-SIBS Scholarship Program, and the National High-Tech R&D Program (863) (2012AA101601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1968, SCIENCE, V159, P314, DOI 10.1126/science.159.3812.314; Archer SY, 1999, CURR OPIN GENET DEV, V9, P171, DOI 10.1016/S0959-437X(99)80026-4; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; CHESTIER A, 1979, P NATL ACAD SCI USA, V76, P46, DOI 10.1073/pnas.76.1.46; Collyda C, 2006, STUD HEALTH TECHNOL, V124, P99; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; Duffy SK, 2012, CELL, V149, P936, DOI 10.1016/j.cell.2012.02.064; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Gnad F, 2010, BIOINFORMATICS, V26, P1666, DOI 10.1093/bioinformatics/btq260; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kamita M, 2011, J PROTEOMICS, V74, P431, DOI 10.1016/j.jprot.2010.12.007; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lee TY, 2010, J COMPUT CHEM, V31, P2759, DOI 10.1002/jcc.21569; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; Li TT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011080; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Mottet D, 2008, CLIN EXP METASTAS, V25, P183, DOI 10.1007/s10585-007-9131-5; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Shao JL, 2012, MOL BIOSYST, V8, P2964, DOI 10.1039/c2mb25251a; Shi SP, 2012, MOL BIOSYST, V8, P1520, DOI 10.1039/c2mb05502c; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Suo SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049108; Umlauf David, 2004, Methods Mol Biol, V287, P99; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Van Damme P, 2011, FEBS J, V278, P3822, DOI 10.1111/j.1742-4658.2011.08230.x; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; WELSCH DJ, 1988, BIOCHEMISTRY-US, V27, P4939, DOI 10.1021/bi00413a052; Witten IH, 2011, MOR KAUF D, P1; Xu Y, 2010, J THEOR BIOL, V264, P130, DOI 10.1016/j.jtbi.2010.01.013; Yoon BJ, 2009, CURR GENOMICS, V10, P402, DOI 10.2174/138920209789177575; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng GY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-388; Zheng GY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S6; Zhou Huilin, 2004, Methods Mol Biol, V261, P511; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	47	79	81	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89575	10.1371/journal.pone.0089575	http://dx.doi.org/10.1371/journal.pone.0089575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586884	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700130
J	da Silva, FM; Coronel, DA; Vieira, KM				da Silva, Fabiano Mello; Coronel, Daniel Arruda; Vieira, Kelmara Mendes			Causality and Cointegration Analysis between Macroeconomic Variables and the Bovespa	PLOS ONE			English	Article							UNIT-ROOT	The aim of this study is to analyze the causality relationship among a set of macroeconomic variables, represented by the exchange rate, interest rate, inflation (CPI), industrial production index as a proxy for gross domestic product in relation to the index of the Sao Paulo Stock Exchange (Bovespa). The period of analysis corresponded to the months from January 1995 to December 2010, making a total of 192 observations for each variable. Johansen tests, through the statistics of the trace and of the maximum eigenvalue, indicated the existence of at least one cointegration vector. In the analysis of Granger (1988) causality tests via error correction, it was found that a short-term causality existed between the CPI and the Bovespa. Regarding the Granger (1988) long-term causality, the results indicated a long-term behaviour among the macroeconomic variables with the BOVESPA. The results of the long-term normalized vector for the Bovespa variable showed that most signals of the cointegration equation parameters are in accordance with what is suggested by the economic theory. In other words, there was a positive behaviour of the GDP and a negative behaviour of the inflation and of the exchange rate (expected to be a positive relationship) in relation to the Bovespa, with the exception of the Selic rate, which was not significant with that index. The variance of the Bovespa was explained by itself in over 90% at the twelth month, followed by the country risk, with less than 5%.	[da Silva, Fabiano Mello; Coronel, Daniel Arruda; Vieira, Kelmara Mendes] Univ Fed Santa Maria, Dept Business, BR-97119900 Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM)	Coronel, DA (corresponding author), Univ Fed Santa Maria, Dept Business, BR-97119900 Santa Maria, RS, Brazil.	daniel.coronel@uol.com.br	Vieira, Kelmara Mendes/AAU-7480-2020; CORONEL, DANIEL DAC ARRUDA/J-4898-2014	Vieira, Kelmara Mendes/0000-0002-8847-0941; CORONEL, DANIEL DAC ARRUDA/0000-0003-0264-6502				Araujo E., 2008, BBR BRAZ BUS REV, V5, P51; Davidson J, 1998, J ECONOMETRICS, V87, P87, DOI 10.1016/S0304-4076(98)00007-4; Enders W., 1995, APPL ECONOMETRIC TIM; Engle R., 1987, ECONOMETRICA, V55, P251, DOI DOI 10.2307/1913236; GRANGER CWJ, 1986, OXFORD B ECON STAT, V48, P213, DOI 10.1111/j.1468-0084.1986.mp48003002.x; Groppo GS, 2004, CAUSALIDADE VARIAVEI; Hidalgo J, 2000, ECONOMETRICA, V68, P1465, DOI 10.1111/1468-0262.00168; IPEA - Instituto de Pesquisa Economica Aplicada, 2011, IPEADATA BAS DAD ON; JOHANSEN S, 1988, J ECON DYN CONTROL, V12, P231, DOI 10.1016/0165-1889(88)90041-3; Margarido MA, 2004, PESQUISA DEBATE, V15, P69; Mayorga RO, 2007, EC SOCIOLOGIA RURAL, V45, P675; Maysami RC, 2004, JURNAL PENGURUSAN, V24, P47; Nunes Maurício S., 2005, Rev. Bras. Econ., V59, P585, DOI 10.1590/S0034-71402005000400004; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Pimenta Junior T, 2008, REV ELETRONICA ADM, V14, P120; Pohlman EV, 2008, PERSPECTIVA EC, V2, P22; Siqueira KB, 2007, DYNAMICS FARM MILK P; Wang DB, 2007, AM J AGR ECON, V89, P873, DOI 10.1111/j.1467-8276.2007.01031.x	18	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89765	10.1371/journal.pone.0089765	http://dx.doi.org/10.1371/journal.pone.0089765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587019	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200079
J	Gangl, R; Behmuller, R; Tenhaken, R				Gangl, Roman; Behmueller, Robert; Tenhaken, Raimund			Molecular Cloning of a Novel Glucuronokinase/Putative Pyrophosphorylase from Zebrafish Acting in an UDP-Glucuronic Acid Salvage Pathway	PLOS ONE			English	Article							BROAD SUBSTRATE-SPECIFICITY; GLUCOSE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; SUGAR PYROPHOSPHORYLASE; MYOINOSITOL OXYGENASE; LIQUID-CHROMATOGRAPHY; ESCHERICHIA-COLI; GHMP KINASE; GENE; ENZYME	In animals, the main precursor for glycosaminoglycan and furthermore proteoglycan biosynthesis, like hyaluronic acid, is UDP-glucuronic acid, which is synthesized via the nucleotide sugar oxidation pathway. Mutations in this pathway cause severe developmental defects (deficiency in the initiation of heart valve formation). In plants, UDP-glucuronic acid is synthesized via two independent pathways. Beside the nucleotide sugar oxidation pathway, a second minor route to UDP-glucuronic acid exist termed the myo-inositol oxygenation pathway. Within this myo-inositol is ring cleaved into glucuronic acid, which is subsequently converted to UDP-glucuronic acid by glucuronokinase and UDP-sugar pyrophosphorylase. Here we report on a similar, but bifunctional enzyme from zebrafish (Danio rerio) which has glucuronokinase/putative pyrophosphorylase activity. The enzyme can convert glucuronic acid into UDP-glucuronic acid, required for completion of the alternative pathway to UDP-glucuronic acid via myo-inositol and thus establishes a so far unknown second route to UDP-glucuronic acid in animals. Glucuronokinase from zebrafish is a member of the GHMP-kinase superfamily having unique substrate specificity for glucuronic acid with a K-m of 31 +/- 8 mu M and accepting ATP as the only phosphate donor (K-m: 59 +/- 9 mu M). UDP-glucuronic acid pyrophosphorylase from zebrafish has homology to bacterial nucleotidyltransferases and requires UTP as nucleosid diphosphate donor. Genes for bifunctional glucuronokinase and putative UDP-glucuronic acid pyrophosphorylase are conserved among some groups of lower animals, including fishes, frogs, tunicates, and polychaeta, but are absent from mammals. The existence of a second pathway for UDP-glucuronic acid biosynthesis in zebrafish likely explains some previous contradictory finding in jekyll/ugdh zebrafish developmental mutants, which showed residual glycosaminoglycans and proteoglycans in knockout mutants of UDP-glucose dehydrogenase.	[Gangl, Roman; Behmueller, Robert; Tenhaken, Raimund] Salzburg Univ, Div Plant Physiol, Dept Cell Biol, A-5020 Salzburg, Austria; [Behmueller, Robert] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria	Salzburg University; Salzburg University	Tenhaken, R (corresponding author), Salzburg Univ, Div Plant Physiol, Dept Cell Biol, A-5020 Salzburg, Austria.	Raimund.tenhaken@sbg.ac.at	Tenhaken, Raimund/O-6556-2019	Tenhaken, Raimund/0000-0002-6764-4826; Gangl, Roman/0000-0002-7641-2939	Austrian science foundation (FWF) [P25339]; University of Salzburg; Austrian Science Fund (FWF) [P 25339] Funding Source: researchfish	Austrian science foundation (FWF)(Austrian Science Fund (FWF)); University of Salzburg; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian science foundation (FWF, P25339) to RT and by the University of Salzburg. (www.fwf.ac.at) (www.uni-salzburg.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Arner RJ, 2001, BIOCHEM J, V360, P313, DOI 10.1042/bj3600313; Diez MDA, 2012, J BACTERIOL, V194, P1485, DOI 10.1128/JB.06377-11; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BORK P, 1993, PROTEIN SCI, V2, P31; Busch-Nentwich E, 2004, DEVELOPMENT, V131, P943, DOI 10.1242/dev.00961; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; DEANGELIS PL, 1993, J BIOL CHEM, V268, P19181; Drouin G, 2011, CURR GENOMICS, V12, P371, DOI 10.2174/138920211796429736; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Hacker U, 1997, DEVELOPMENT, V124, P3565; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Holt CE, 2005, NEURON, V46, P169, DOI 10.1016/j.neuron.2005.03.021; Huisjes EH, 2012, APPL ENVIRON MICROB, V78, P5052, DOI 10.1128/AEM.07617-11; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; Kaplan CP, 1997, PLANT MOL BIOL, V34, P497, DOI 10.1023/A:1005816104743; Kirn-Safran Catherine B, 2004, Birth Defects Res C Embryo Today, V72, P69, DOI 10.1002/bdrc.20005; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; Kotake T, 2008, J BIOL CHEM, V283, P8125, DOI 10.1074/jbc.M710078200; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; LOEWUS FA, 1962, P NATL ACAD SCI USA, V48, P421, DOI 10.1073/pnas.48.3.421; LOEWUS MW, 1983, J REPROD FERTIL, V69, P215, DOI 10.1530/jrf.0.0690215; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Martinez LI, 2011, BIOCHIMIE, V93, P260, DOI 10.1016/j.biochi.2010.09.019; Mehl AL, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e4; Mehl AL, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e7; Mizanur RM, 2004, J AM CHEM SOC, V126, P15993, DOI 10.1021/ja046070d; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Oka T, 2006, FEBS J, V273, P2645, DOI 10.1111/j.1742-4658.2006.05281.x; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; Pieslinger AM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.069369; Pieslinger AM, 2009, ANAL BIOCHEM, V388, P254, DOI 10.1016/j.ab.2009.03.002; SCHELL MA, 1977, J BIOL CHEM, V252, P1162; Sherson S, 1999, PLANT MOL BIOL, V39, P1003, DOI 10.1023/A:1006181908753; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Thoden JB, 2007, PROTEIN SCI, V16, P1379, DOI 10.1110/ps.072864707; Timson David J, 2003, BMC Biochem, V4, P16, DOI 10.1186/1471-2091-4-16; Velleman SG, 2000, POULTRY SCI, V79, P985, DOI 10.1093/ps/79.7.985; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WEISSBORN AC, 1994, J BACTERIOL, V176, P2611, DOI 10.1128/JB.176.9.2611-2618.1994; Yang T, 2010, BIOCHEM J, V429, P533, DOI 10.1042/BJ20100238; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; Yoon SH, 2003, CARBOHYD RES, V338, P1127, DOI 10.1016/S0008-6215(03)00097-1; Zuccotti S, 2001, J MOL BIOL, V313, P831, DOI 10.1006/jmbi.2001.5073	51	7	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89690	10.1371/journal.pone.0089690	http://dx.doi.org/10.1371/journal.pone.0089690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586965	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200072
J	Michal, M; Reuchlein, B; Adler, J; Reiner, I; Beutel, ME; Vogele, C; Schachinger, H; Schulz, A				Michal, Matthias; Reuchlein, Bettina; Adler, Julia; Reiner, Iris; Beutel, Manfred E.; Voegele, Claus; Schaechinger, Hartmut; Schulz, Andre			Striking Discrepancy of Anomalous Body Experiences with Normal Interoceptive Accuracy in Depersonalization-Derealization Disorder	PLOS ONE			English	Article							HEART BEAT PERCEPTION; CAMBRIDGE DEPERSONALIZATION; PANIC DISORDER; FEELING UNREAL; AWARENESS; ANXIETY; EMOTION; BRAIN; SCALE; DEREALISATION	Background: Disembodiment is a core feature of depersonalization disorder (DPD). Given the narratives of DPD patients about their disembodiment and emotional numbing and neurobiological findings of an inhibition of insular activity, DPD may be considered as a mental disorder with specific impairments of interoceptive awareness and body perception. Methods: We investigated cardioceptive accuracy (CA) of DPD patients (n = 24) as compared to healthy controls (n = 26) with two different heartbeat detection tasks ("Schandry heartbeat counting task" and "Whitehead heartbeat discrimination task"). Self-rated clearness of body perception was measured by questionnaire. Results: Contrary to our hypothesis, DPD patients performed similarly to healthy controls on the two different heartbeat detection tasks, and they had equal scores regarding their self-rated clearness of body perception. There was no correlation of the severity of "anomalous body experiences" and depersonalization with measures of interoceptive accuracy. Only among healthy controls CA in the Schandry task was positively correlated with self-rated clearness of body perception. Depersonalization was unrelated to severity of depression or anxiety, while depression and anxiety were highly correlated. Anxiety and depression did not modify the associations of depersonalization with interoceptive accuracy. Conclusions: Our main findings highlight a striking discrepancy of normal interoception with overwhelming experiences of disembodiment in DPD. This may reflect difficulties of DPD patients to integrate their visceral and bodily perceptions into a sense of their selves. This problem may be considered an important target for psychotherapeutic treatment approaches.	[Michal, Matthias; Reuchlein, Bettina; Adler, Julia; Reiner, Iris; Beutel, Manfred E.] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Voegele, Claus; Schulz, Andre] Univ Luxembourg, Res Grp Self Regulat & Hlth, Res Unit INSIDE, Luxembourg, Luxembourg; [Schaechinger, Hartmut] Univ Trier, Inst Psychobiol, Dept Clin Psychophysiol, Trier, Germany	Johannes Gutenberg University of Mainz; University of Luxembourg; Universitat Trier	Michal, M (corresponding author), Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	michal@uni-mainz.de	Vögele, Claus/I-5682-2013; Schulz, André/AAC-5576-2021	Schulz, André/0000-0002-9381-2651; Vogele, Claus/0000-0001-8086-0788				Ainley V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055568; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baker D, 2003, BRIT J PSYCHIAT, V182, P428, DOI 10.1192/bjp.182.5.428; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Berntson GG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P182, DOI 10.1017/CBO9780511546396.008; Brener J, 1995, HEART BRAIN PSYCHOPH, P193; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley Hugo D, 2013, Handb Clin Neurol, V117, P59, DOI 10.1016/B978-0-444-53491-0.00006-7; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008; Dunn BD, 2007, BEHAV RES THER, V45, P1921, DOI 10.1016/j.brat.2006.09.008; EHLERS A, 1995, BEHAV RES THER, V33, P69, DOI 10.1016/0005-7967(94)E0002-Z; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; GARDNER RM, 1990, PERCEPT MOTOR SKILL, V70, P1179; Garfinkel SN, 2013, SOC COGN AFFECT NEUR, V8, P231, DOI 10.1093/scan/nss140; Gast U., 2000, SKID D STRUKTURIERTE; Hart N, 2012, J PERS DISORD; Hart N, 2013, J PERS DISORD, V27, P506, DOI 10.1521/pedi_2012_26_049; Herbert BM, 2013, APPETITE, V70, P22, DOI 10.1016/j.appet.2013.06.082; Herbert BM, 2012, TOP COGN SCI, V4, P692, DOI 10.1111/j.1756-8765.2012.01189.x; Herbert BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036646; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Hoyer J, 2013, J ANXIETY DISORD, V27, P178, DOI 10.1016/j.janxdis.2013.01.002; Hunter ECM, 2004, SOC PSYCH PSYCH EPID, V39, P9, DOI 10.1007/s00127-004-0701-4; Hunter ECM, 2003, BEHAV RES THER, V41, P1451, DOI 10.1016/S0005-7967(03)00066-4; Joraschky P, 2009, KORPERERLEBEN KORPER; Khalsa SS, 2008, PSYCHOPHYSIOLOGY, V45, P671, DOI 10.1111/j.1469-8986.2008.00666.x; Knapp-Kline K, 2005, BIOL PSYCHOL, V69, P387, DOI 10.1016/j.biopsycho.2004.09.002; Lenggenhager B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050757; Mantovani A, 2011, PSYCHIAT RES, V186, P138, DOI 10.1016/j.psychres.2010.08.022; Medford N, 2012, EMOT REV, V4, P139, DOI 10.1177/1754073911430135; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Michal M, 2004, PSYCHOTHER PSYCH MED, V54, P367, DOI 10.1055/s-2004-828296; Michal M, 2012, NERVENHEILKUNDE, V31, P934; Michal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074331; Michal M, 2011, PSYCHIAT RES, V188, P264, DOI 10.1016/j.psychres.2010.11.004; Michal M, 2011, J AFFECT DISORDERS, V128, P106, DOI 10.1016/j.jad.2010.06.033; Michal M, 2009, Z PSYCHOSOM MED PSYC, V55, P113, DOI 10.13109/zptm.2009.55.2.113; Mussgay L, 1999, J PSYCHOPHYSIOL, V13, P27, DOI 10.1027//0269-8803.13.1.27; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Phillips GC, 1999, PSYCHOPHYSIOLOGY, V36, P504, DOI 10.1017/S0048577299980071; Phillips ML, 2001, PSYCHIAT RES-NEUROIM, V108, P145, DOI 10.1016/S0925-4927(01)00119-6; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos O, 2009, DEPRESS ANXIETY, V26, P167, DOI 10.1002/da.20504; Schaefer M, 2012, J ABNORM PSYCHOL, V121, P719, DOI 10.1037/a0028509; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; SCHANDRY R, 1993, PSYCHOPHYSIOLOGY, V30, P467, DOI 10.1111/j.1469-8986.1993.tb02070.x; Schilder P, 1939, Bull N Y Acad Med, V15, P258; Schilder P., 1950, IMAGE APPEARANCE HUM; Schulz A, 2013, PSYCHONEUROENDOCRINO, V38, P2686, DOI 10.1016/j.psyneuen.2013.06.027; Schulz A, 2013, BIOL PSYCHOL, V93, P167, DOI 10.1016/j.biopsycho.2013.01.007; Seth A. K., 2011, FRONT PSYCHOL, V2, P395, DOI [10.3389/fpsyg.2011.00395, DOI 10.3389/FPSYG.2011.00395]; Seth AK, 2013, BEHAV BRAIN SCI, V36, P227, DOI 10.1017/S0140525X12002270; Sierra M, 2005, PSYCHOL MED, V35, P1523, DOI 10.1017/S0033291705005325; Sierra M, 2000, PSYCHIAT RES, V93, P153, DOI 10.1016/S0165-1781(00)00100-1; Sierra M, 2006, PSYCHIAT RES, V145, P225, DOI 10.1016/j.psychres.2005.05.022; Sierra Mauricio, 2008, Expert Rev Neurother, V8, P19; Sierra M, 2012, PSYCHIAT RES, V197, P123, DOI 10.1016/j.psychres.2011.12.017; Sierra M, 2011, CONSCIOUS COGN, V20, P99, DOI 10.1016/j.concog.2010.10.018; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Simeon D, 2003, J CLIN PSYCHIAT, V64, P990, DOI 10.4088/JCP.v64n0903; Simeon D, 2002, BIOL PSYCHIAT, V51, p46S; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stein DJ, 2009, CNS SPECTRUMS, V14, P467, DOI 10.1017/S109285290002352X; Terhaar J, 2012, CLIN NEUROPHYSIOL, V123, P1950, DOI 10.1016/j.clinph.2012.02.086; Van der Does AJW, 2000, BEHAV RES THER, V38, P47, DOI 10.1016/S0005-7967(98)00184-3; WHITEHEAD WE, 1980, PSYCHOPHYSIOLOGY, V17, P552, DOI 10.1111/j.1469-8986.1980.tb02296.x; WHITEHEAD WE, 1977, BIOFEEDBACK SELF-REG, V2, P371, DOI 10.1007/BF00998623; Wickens T.D., 2001, ELEMENTARY SIGNAL DE; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Wiens S, 2001, BIOL PSYCHOL, V58, P159, DOI 10.1016/S0301-0511(01)00110-7	73	46	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89823	10.1371/journal.pone.0089823	http://dx.doi.org/10.1371/journal.pone.0089823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24587061	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800045
J	Nissen, J; Rasmussen, LB; Ravn-Haren, G; Andersen, EW; Hansen, B; Andersen, R; Mejborn, H; Madsen, KH; Vogel, U				Nissen, Janna; Rasmussen, Lone Banke; Ravn-Haren, Gitte; Andersen, Elisabeth Wreford; Hansen, Bettina; Andersen, Rikke; Mejborn, Heddie; Madsen, Katja Howarth; Vogel, Ulla			Common Variants in CYP2R1 and GC Genes Predict Vitamin D Concentrations in Healthy Danish Children and Adults	PLOS ONE			English	Article							D-BINDING PROTEIN; GENOME-WIDE ASSOCIATION; 25-HYDROXYVITAMIN D; PLASMA-CONCENTRATIONS; SERUM; POLYMORPHISMS; DETERMINANTS; METABOLITES; POPULATION; FAMILIES	Environmental factors such as diet, intake of vitamin D supplements and exposure to sunlight are known to influence serum vitamin D concentrations. Genetic epidemiology of vitamin D is in its infancy and a better understanding on how genetic variation influences vitamin D concentration is needed. We aimed to analyse previously reported vitamin D-related polymorphisms in relation to serum 25(OH)D concentrations in 201 healthy Danish families with dependent children in late summer in Denmark. Serum 25(OH)D concentrations and a total of 25 SNPs in GC, VDR, CYP2R1, CYP24A1, CYP27B1, C10or88 and DHCR7/NADSYN1 genes were analysed in 758 participants. Genotype distributions were in Hardy-Weinberg equilibrium for the adult population for all the studied polymorphisms. Four SNPs in CYP2R1 (rs1562902, rs7116978, rs10741657 and rs10766197) and six SNPs in GC (rs4588, rs842999, rs2282679, rs12512631, rs16846876 and rs17467825) were statistically significantly associated with serum 25(OH)D concentrations in children, adults and all combined. Several of the SNPs were in strong linkage disequilibrium, and the associations were driven by CYP2R1-rs10741657 and rs10766197, and by GC-rs4588 and rs842999. Genetic risk score analysis showed that carriers with no risk alleles of CYP2R1-rs10741657 and rs10766197, and/or GC rs4588 and rs842999 had significantly higher serum 25(OH)D concentrations compared to carriers of all risk alleles. To conclude, our results provide supporting evidence that common polymorphisms in GC and CYP2R1 are associated with serum 25(OH)D concentrations in the Caucasian population and that certain haplotypes may predispose to lower 25(OH)D concentrations in late summer in Denmark.	[Nissen, Janna; Rasmussen, Lone Banke; Andersen, Rikke; Mejborn, Heddie; Madsen, Katja Howarth] Tech Univ Denmark, Natl Food Inst, Div Nutr, Soborg, Denmark; [Ravn-Haren, Gitte] Tech Univ Denmark, Natl Food Inst, Div Toxicol & Risk Assessment, Soborg, Denmark; [Andersen, Elisabeth Wreford] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Hansen, Bettina] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; Technical University of Denmark; Aarhus University; National Research Centre for the Working Environment	Nissen, J (corresponding author), Tech Univ Denmark, Natl Food Inst, Div Nutr, Soborg, Denmark.	ioni@food.dtu.dk	Vogel, Ulla/ABC-2212-2020; Ravn-Haren, Gitte/I-8551-2018; Andersen, Rikke/GRS-3064-2022; Vogel, Ulla B/I-5048-2012	Vogel, Ulla/0000-0001-6807-1524; Ravn-Haren, Gitte/0000-0002-4587-089X; Vogel, Ulla B/0000-0001-6807-1524; Andersen, Rikke/0000-0002-5091-6995; Nissen, Janna/0000-0002-8891-8451; Mejborn, Heddie/0000-0002-6302-8575	Danish Dairy Research Fund; European Region Development Fund; Centre for Advanced Food Studies	Danish Dairy Research Fund; European Region Development Fund; Centre for Advanced Food Studies	The work was supported by grants from the Danish Dairy Research Fund, Centre for Advanced Food Studies, and The European Region Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, CANCER EPIDEM BIOMAR, V17, P1339, DOI 10.1158/1055-9965.EPI-08-0162; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Arguelles LM, 2009, J CLIN ENDOCR METAB, V94, P3273, DOI 10.1210/jc.2008-1532; ARNAUD J, 1993, HUM GENET, V92, P183; Berry DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037465; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Brown SD, 2012, DERM-ENDOCRINOL, V4, P137, DOI 10.4161/derm.20434; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Burgaz A, 2007, AM J CLIN NUTR, V86, P1399, DOI 10.1093/ajcn/86.5.1399; Carter GD, 2011, CURR DRUG TARGETS, V12, P19; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dastani Z, 2013, CALCIFIED TISSUE INT, V92, P106, DOI 10.1007/s00223-012-9660-z; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Engelman CD, 2013, J NUTR, V143, P17, DOI 10.3945/jn.112.169482; Fang Y, 2009, CALCIFIED TISSUE INT, V85, P85, DOI 10.1007/s00223-009-9251-9; Fu L, 2009, CLIN BIOCHEM, V42, P1174, DOI 10.1016/j.clinbiochem.2009.03.008; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Gozdzik A, 2011, J STEROID BIOCHEM, V127, P405, DOI 10.1016/j.jsbmb.2011.05.009; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2007, J STEROID BIOCHEM, V103, P631, DOI 10.1016/j.jsbmb.2006.12.066; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Jorde R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037295; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; KAWAKAMI M, 1981, J CLIN ENDOCR METAB, V53, P1110, DOI 10.1210/jcem-53-6-1110; Kurylowicz A, 2006, EXP CLIN ENDOCR DIAB, V114, P329, DOI 10.1055/s-2006-924256; Lasky-Su J, 2012, HUM GENET, V131, P1495, DOI 10.1007/s00439-012-1185-z; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Lips P, 2011, BEST PRACT RES CL EN, V25, P585, DOI 10.1016/j.beem.2011.05.002; Lu L, 2012, HUM GENET, V131, P505, DOI 10.1007/s00439-011-1099-1; Madsen KH, 2013, AM J CLIN NUTR, V98, P374, DOI 10.3945/ajcn.113.059469; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; National Board of Health, 2010, FOR DIAGN BEH AF D V; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Perna L, 2013, EPIDEMIOLOGY, V24, P104, DOI 10.1097/EDE.0b013e318276c4b0; Pilz S, 2011, CLIN ENDOCRINOL, V75, P575, DOI 10.1111/j.1365-2265.2011.04147.x; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Saliba W, 2012, OSTEOPOROSIS INT, V25; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Signorello LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028623; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Snellman G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007747; Sung CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/634195; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Wang TJ, 2010, COMMON GENETIC DETER; Weinstock-Guttman B, 2012, NEUROLOGIST, V18, P179, DOI 10.1097/NRL.0b013e31825bbf35; Wjst M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-60; Zhang Z, 2013, J BONE MINER RES, V28, P1784, DOI 10.1002/jbmr.1926	52	85	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89907	10.1371/journal.pone.0089907	http://dx.doi.org/10.1371/journal.pone.0089907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587115	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800055
J	Gaillard, C; Meagher, RK; von Keyserlingk, MAG; Weary, DM				Gaillard, Charlotte; Meagher, Rebecca K.; von Keyserlingk, Marina A. G.; Weary, Daniel M.			Social Housing Improves Dairy Calves' Performance in Two Cognitive Tests	PLOS ONE			English	Article							EXTRADIMENSIONAL SHIFTS; BEHAVIORAL FLEXIBILITY; OBJECT RECOGNITION; RATS; RESPONSES; STRESS; STEREOTYPIES; ENVIRONMENT; RODENTS; SINGLE	Early social housing is known to benefit cognitive development in laboratory animals. Pre-weaned dairy calves are typically separated from their dam immediately after birth and housed alone, but no work to date has addressed the effect of individual housing on cognitive performance of these animals. The aim of this study was to determine the effects of individual versus social housing on two measures of cognitive performance: reversal learning and novel object recognition. Holstein calves were either housed individually in a standard calf pen (n = 8) or kept in pairs using a double pen (n = 10). Calves were tested twice daily in a Y-maze starting at 3 weeks of age. Calves were initially trained to discriminate two colours (black and white) until they reached a learning criterion of 80% correct over three consecutive sessions. Training stimuli were then reversed (i.e. the previously rewarded colour was now unrewarded, and vice-versa). Calves from the two treatments showed similar rates of learning in the initial discrimination task, but the individually housed calves showed poorer performance in the reversal task. At 7 weeks of age, calves were tested for their response to a novel object in eight tests over a two-day period. Pair-housed calves showed declining exploration with repeated testing but individually reared calves did not. The results of these experiments provide the first direct evidence that individual housing impairs cognitive performance in dairy calves.	[Gaillard, Charlotte; Meagher, Rebecca K.; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	danweary@mail.ubc.ca	von Keyserlingk, Marina/AAB-6353-2019; Weary, Daniel M/A-8868-2010; Gaillard, Charlotte/AAE-7872-2021; Meagher, Rebecca/G-6530-2013	von Keyserlingk, Marina/0000-0002-1427-3152; Weary, Daniel M/0000-0002-0917-3982; Meagher, Rebecca/0000-0002-6576-8155	Canada's Natural Sciences and Engineering Research Council (Ottawa, ON, Canada)	Canada's Natural Sciences and Engineering Research Council (Ottawa, ON, Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The research was supported by Canada's Natural Sciences and Engineering Research Council (Ottawa, ON, Canada) via a Discovery Grant to D. M. Weary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Birrell JM, 2000, J NEUROSCI, V20, P4320; Braithwaite VA, 2005, P ROY SOC B-BIOL SCI, V272, P1107, DOI 10.1098/rspb.2005.3062; CAMPIONE JC, 1969, AM J PSYCHOL, V82, P212, DOI 10.2307/1421245; Chudasama Y, 2012, J NEUROSCI, V32, P10915, DOI 10.1523/JNEUROSCI.1463-12.2012; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Dallaire JA, 2011, BEHAV BRAIN RES, V224, P213, DOI 10.1016/j.bbr.2011.03.061; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; EINON DF, 1978, DEV PSYCHOBIOL, V11, P213, DOI 10.1002/dev.420110305; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Faerevik G, 2006, APPL ANIM BEHAV SCI, V99, P205, DOI 10.1016/j.applanim.2005.10.012; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Garner JP, 2003, BEHAV BRAIN RES, V145, P125, DOI 10.1016/S0166-4328(03)00115-3; GELLERMANN LW, 1933, J GENET PSYCHOL, V42, P207; HOLSON R, 1984, PSYCHOL LEARN MOTIV, V18, P199, DOI 10.1016/S0079-7421(08)60363-1; Jensen MB, 1997, APPL ANIM BEHAV SCI, V54, P109, DOI 10.1016/S0168-1591(96)01183-5; JONES GH, 1991, BEHAV BRAIN RES, V43, P35, DOI 10.1016/S0166-4328(05)80050-6; KRECH D, 1962, J COMP PHYSIOL PSYCH, V55, P801, DOI 10.1037/h0044220; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Mason G, 2013, ANIM BEHAV, V85, P1113, DOI 10.1016/j.anbehav.2013.02.002; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; McLean SL, 2010, J PSYCHOPHARMACOL, V24, P57, DOI 10.1177/0269881108093842; Meagher RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049180; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; MORGAN M, 1975, PHYSIOL BEHAV, V15, P405, DOI 10.1016/0031-9384(75)90205-X; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; ROBERTS AC, 1988, Q J EXP PSYCHOL-B, V40, P321; Schrijver NCA, 2001, BEHAV NEUROSCI, V115, P437, DOI 10.1037/0735-7044.115.2.437; Shepherdson D., 1994, P167; Silvers JM, 2007, J NEUROSCI METH, V166, P99, DOI 10.1016/j.jneumeth.2007.06.032; Swaisgood RR, 2003, ZOO BIOL, V22, P347, DOI 10.1002/zoo.10111; Van Reenen CG, 2005, PHYSIOL BEHAV, V85, P557, DOI 10.1016/j.physbeh.2005.06.015; Vieira AD, 2012, J DAIRY SCI, V95, P5149, DOI 10.3168/jds.2011-5073; Vieira AD, 2012, J DAIRY SCI, V95, P3218, DOI 10.3168/jds.2011-4821; Vieira AD, 2010, J DAIRY SCI, V93, P3079, DOI 10.3168/jds.2009-2516; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5	37	69	69	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90205	10.1371/journal.pone.0090205	http://dx.doi.org/10.1371/journal.pone.0090205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587281	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000332389000144
J	Khemiri, A; Carriere, M; Bremond, N; Ben Mlouka, MA; Coquet, L; Llorens, I; Chapon, V; Jouenne, T; Cosette, P; Berthomieu, C				Khemiri, Arbia; Carriere, Marie; Bremond, Nicolas; Ben Mlouka, Mohamed Amine; Coquet, Laurent; Llorens, Isabelle; Chapon, Virginie; Jouenne, Thierry; Cosette, Pascal; Berthomieu, Catherine			Escherichia coli Response to Uranyl Exposure at Low pH and Associated Protein Regulations	PLOS ONE			English	Article							RAY-ABSORPTION SPECTROSCOPY; URANIUM BIOMINERALIZATION; PSEUDOMONAS-FLUORESCENS; MICROBIAL COMMUNITIES; RESISTANCE; CELLS; ACCUMULATION; COMPLEXATION; PHOSPHATASE; MECHANISM	Better understanding of uranyl toxicity in bacteria is necessary to optimize strains for bioremediation purposes or for using bacteria as biodetectors for bioavailable uranyl. In this study, after different steps of optimization, Escherichia colicells were exposed to uranyl at low pH to minimize uranyl precipitation and to increase its bioavailability. Bacteria were adapted to mid acidic pH before exposure to 50 or 80 mu M uranyl acetate for two hours at pH approximate to 3. To evaluate the impact of uranium, growth in these conditions were compared and the same rates of cells survival were observed in control and uranyl exposed cultures. Additionally, this impact was analyzed by two-dimensional differential gel electrophoresis proteomics to discover protein actors specifically present or accumulated in contact with uranium. Exposure to uranium resulted in differential accumulation of proteins associated with oxidative stress and in the accumulation of the NADH/quinone oxidoreductase WrbA. This FMN dependent protein performs obligate two-electron reduction of quinones, and may be involved in cells response to oxidative stress. Interestingly, this WrbA protein presents similarities with the chromate reductase from E. coli, which was shown to reduce uranyl in vitro.	[Khemiri, Arbia; Bremond, Nicolas; Chapon, Virginie; Berthomieu, Catherine] CEA, DSV, IBEB, Lab Interact Proteine Me,Commissarist Energie Ato, St Paul Les Durance, France; [Khemiri, Arbia; Bremond, Nicolas; Chapon, Virginie; Berthomieu, Catherine] CNRS, UMR Biol Vegetale & Microbiol Environm 7265, St Paul Les Durance, France; [Khemiri, Arbia; Bremond, Nicolas; Chapon, Virginie; Berthomieu, Catherine] Univ Aix Marseille, St Paul Les Durance, France; [Carriere, Marie] Univ Grenoble 1, CEA, Lab Les Acides Nucl LAN, UMR E3,Serv Chim Inorgan & Biol, Grenoble, France; [Ben Mlouka, Mohamed Amine; Coquet, Laurent; Jouenne, Thierry; Cosette, Pascal] Univ Rouen, IRIB, Plateforme Proteom PISSARO, UMR CNRS 6270, Mont St Aignan, France; [Llorens, Isabelle] ESRF CRG FAME Beamline, Polygone Sci Louis Neel, Grenoble, France; [Llorens, Isabelle] CEA, DSM, INAC, Lab Nanostruct & Rayonnement Synchrotron,Commissa, Grenoble, France	CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie; CEA	Cosette, P (corresponding author), Univ Rouen, IRIB, Plateforme Proteom PISSARO, UMR CNRS 6270, Mont St Aignan, France.	pascal.cosette@univ-rouen.fr; catherine.berthomieu@cea.fr	BM30, Beamline FAME/G-9313-2012; Berthomieu, Catherine/AAX-9559-2021; chapon, virginie/AAY-1669-2021; carriere, marie/F-2149-2011	chapon, virginie/0000-0002-2365-3464; Cosette, Pascal/0000-0002-7588-0167; jouenne, thierry/0000-0003-0994-9944; carriere, marie/0000-0001-8446-6462; COQUET, Laurent/0000-0001-7778-7321; Berthomieu, Catherine/0000-0001-8784-5396	CNRS; Commissariat a l'Energie Atomique CEA	CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique CEA(French Atomic Energy Commission)	This work was funded in part by the CNRS program EC2CO (Cytrix and MicrobiEn), and the "Toxicologie" program of the Commissariat a l'Energie Atomique CEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley DF, 2004, APPL ENVIRON MICROB, V70, P873, DOI 10.1128/AEM.70.2.873-882.2004; Akob DM, 2007, FEMS MICROBIOL ECOL, V59, P95, DOI 10.1111/j.1574-6941.2006.00203.x; Allen PG, 1996, INORG CHEM, V35, P784, DOI 10.1021/ic9508536; Bar C, 2007, J BIOTECHNOL, V128, P444, DOI 10.1016/j.jbiotec.2006.11.010; Barak Y, 2006, APPL ENVIRON MICROB, V72, P7074, DOI 10.1128/AEM.01334-06; Barre O, 2007, J BACTERIOL, V189, P5947, DOI 10.1128/JB.00576-07; Beazley MJ, 2007, ENVIRON SCI TECHNOL, V41, P5701, DOI 10.1021/es070567g; Bencheikh-Latmani R, 2005, APPL ENVIRON MICROB, V71, P7453, DOI 10.1128/AEM.71.11.7453-7460.2005; Brugge Doug, 2005, Reviews on Environmental Health, V20, P177; Cardenas E, 2008, APPL ENVIRON MICROB, V74, P3718, DOI 10.1128/AEM.02308-07; Choudhary S, 2009, BIORESOURCE TECHNOL, V100, P2482, DOI 10.1016/j.biortech.2008.12.015; Collet A, 2008, J PROTEOME RES, V7, P4659, DOI 10.1021/pr8001723; De Lay N, 2011, RNA, V17, P1172, DOI 10.1261/rna.2531211; Finlay JA, 1999, BIOTECHNOL BIOENG, V63, P87, DOI 10.1002/(SICI)1097-0290(19990405)63:1<87::AID-BIT9>3.0.CO;2-0; FOSTER JW, 1991, J BACTERIOL, V173, P5129, DOI 10.1128/jb.173.16.5129-5135.1991; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Grandori R, 1998, J BIOL CHEM, V273, P20960, DOI 10.1074/jbc.273.33.20960; Hillson NJ, 2007, APPL ENVIRON MICROB, V73, P7615, DOI 10.1128/AEM.01566-07; Holmes DE, 2009, ISME J, V3, P216, DOI 10.1038/ismej.2008.89; Hu P, 2005, J BACTERIOL, V187, P8437, DOI 10.1128/JB.187.24.8437-8449.2005; Hudson EA, 1996, PHYS REV B, V54, P156, DOI 10.1103/PhysRevB.54.156; Jroundi F, 2007, GEOMICROBIOL J, V24, P441, DOI 10.1080/01490450701437651; Kazy SK, 2009, J HAZARD MATER, V163, P65, DOI 10.1016/j.jhazmat.2008.06.076; Kelly SD, 2001, J SYNCHROTRON RADIAT, V8, P946, DOI 10.1107/S0909049500021014; Kilic NK, 2010, BIORESOURCE TECHNOL, V101, P2134, DOI 10.1016/j.biortech.2009.11.008; Koban A, 2004, RADIOCHIM ACTA, V92, P903, DOI 10.1524/ract.92.12.903.55114; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; LI WC, 1980, ANAL CHEM, V52, P520, DOI 10.1021/ac50053a033; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Lok CN, 2008, J PROTEOME RES, V7, P2351, DOI 10.1021/pr700646b; Lutke L, 2012, DALTON T, V41, P13370, DOI 10.1039/c2dt31080e; Macaskie LE, 2000, MICROBIOL-SGM, V146, P1855, DOI 10.1099/00221287-146-8-1855; Maher K, 2013, INORG CHEM, V52, P3510, DOI 10.1021/ic301686d; Malard V, 2005, PROTEOMICS, V5, P4568, DOI 10.1002/pmic.200402038; Malard V, 2009, BBA-PROTEINS PROTEOM, V1794, P882, DOI 10.1016/j.bbapap.2009.01.010; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Mondani L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025771; Mrvcic J, 2013, WORLD J MICROB BIOT, V29, P75, DOI 10.1007/s11274-012-1160-9; Nedelkova M, 2007, FEMS MICROBIOL ECOL, V59, P694, DOI 10.1111/j.1574-6941.2006.00261.x; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Prat O, 2005, PROTEOMICS, V5, P297, DOI 10.1002/pmic.200400896; Proux O, 2005, PHYS SCRIPTA, VT115, P970; Rahman M, 2006, BIOTECHNOL BIOENG, V94, P585, DOI 10.1002/bit.20858; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Renninger N, 2004, APPL ENVIRON MICROB, V70, P7404, DOI 10.1128/AEM.70.12.7404-7412.2004; Revington M, 2005, PROTEIN SCI, V14, P3115, DOI 10.1110/ps.051809305; Sharma S, 2006, J BIOTECHNOL, V126, P374, DOI 10.1016/j.jbiotec.2006.04.032; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STRANDBERG GW, 1981, APPL ENVIRON MICROB, V41, P237, DOI 10.1128/AEM.41.1.237-245.1981; Suzuki Y, 2004, GEOMICROBIOL J, V21, P113, DOI 10.1080/01490450490266361; Swaramoorthy S, 2012, PLOS ONE, V7; Taylor David M., 1997, Reviews on Environmental Health, V12, P147; Teixeira LSG, 1999, J BRAZIL CHEM SOC, V10, P519, DOI 10.1590/S0103-50531999000600016; Thomas JG, 2000, MOL MICROBIOL, V36, P1360, DOI 10.1046/j.1365-2958.2000.01951.x; Thomas RAP, 1998, APPL MICROBIOL BIOT, V49, P202, DOI 10.1007/s002530051159; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09	58	16	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89863	10.1371/journal.pone.0089863	http://dx.doi.org/10.1371/journal.pone.0089863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587082	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000101
J	May, C; Nordhoff, E; Casjens, S; Turewicz, M; Eisenacher, M; Gold, R; Bruning, T; Pesch, B; Stephan, C; Woitalla, D; Penke, B; Janaky, T; Virok, D; Siklos, L; Engelhardt, JI; Meyer, HE				May, Caroline; Nordhoff, Eckhard; Casjens, Swaantje; Turewicz, Michael; Eisenacher, Martin; Gold, Ralf; Bruening, Thomas; Pesch, Beate; Stephan, Christian; Woitalla, Dirk; Penke, Botond; Janaky, Tamas; Virok, Dezsoe; Siklos, Laszlo; Engelhardt, Jozsef I.; Meyer, Helmut E.			Highly Immunoreactive IgG Antibodies Directed against a Set of Twenty Human Proteins in the Sera of Patients with Amyotrophic Lateral Sclerosis Identified by Protein Array	PLOS ONE			English	Article							SPINAL-CORD; CEREBROSPINAL-FLUID; CALCIUM-CHANNELS; MICROARRAY DATA; ALS PATIENTS; CELLS; AUTOANTIBODIES; TRAFFICKING; REACTIVITY; MUTATIONS	Amyotrophic lateral sclerosis (ALS), the most common adult-onset motor neuron disorder, is characterized by the progressive and selective loss of upper and lower motor neurons. Diagnosis of this disorder is based on clinical assessment, and the average survival time is less than 3 years. Injections of IgG from ALS patients into mice are known to specifically mark motor neurons. Moreover, IgG has been found in upper and lower motor neurons in ALS patients. These results led us to perform a case-control study using human protein microarrays to identify the antibody profiles of serum samples from 20 ALS patients and 20 healthy controls. We demonstrated high levels of 20 IgG antibodies that distinguished the patients from the controls. These findings suggest that a panel of antibodies may serve as a potential diagnostic biomarker for ALS.	[May, Caroline; Nordhoff, Eckhard; Turewicz, Michael; Eisenacher, Martin; Stephan, Christian; Meyer, Helmut E.] Ruhr Univ Bochum, Med Proteom Ctr, Dept Med Proteom Bioanalyt, Bochum, Germany; [Casjens, Swaantje; Bruening, Thomas; Pesch, Beate] Ruhr Univ Bochum, German Social Accid Insurance Inst, Inst Prevent & Occupat Med, Bochum, Germany; [Gold, Ralf; Woitalla, Dirk] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany; [Penke, Botond; Janaky, Tamas] Univ Szeged, Dept Med Chem, Szeged, Hungary; [Virok, Dezsoe] Univ Szeged, Inst Clin Microbiol, Szeged, Hungary; [Siklos, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Engelhardt, Jozsef I.] Univ Szeged, Dept Neurol, Szeged, Hungary; [Meyer, Helmut E.] Leibniz Inst Analyt Wissensch, ISAS eV, Dortmund, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Szeged University; Szeged University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	May, C (corresponding author), Ruhr Univ Bochum, Med Proteom Ctr, Dept Med Proteom Bioanalyt, Univ Str 150, Bochum, Germany.	Caroline.May@rub.de	Turewicz, Michael/M-5026-2019; Eisenacher, Martin/J-8044-2014; Brüning, Thomas/G-8120-2015	Turewicz, Michael/0000-0003-0737-1114; Eisenacher, Martin/0000-0003-2687-7444; Brüning, Thomas/0000-0001-9560-5464; Janaky, Tamas/0000-0002-6466-8283	European Regional Development Fond (ERDF) of the European Union; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (ParkChip) [FZ 280381102]; Creating the Center of Excellence at the University of Szeged [TAMOP-4.2.1./B-09/1/KONV-2010-0005]; European Union; European Regional Development Fund	European Regional Development Fond (ERDF) of the European Union; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (ParkChip); Creating the Center of Excellence at the University of Szeged; European Union(European Commission); European Regional Development Fund(European Commission)	This work was supported by the European Regional Development Fond (ERDF) of the European Union and the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (ParkChip, FZ 280381102) and TAMOP-4.2.1./B-09/1/KONV-2010-0005-Creating the Center of Excellence at the University of Szeged/Supported by the European Union and co-financed by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; APPEL SH, 1986, ARCH NEUROL-CHICAGO, V43, P234, DOI 10.1001/archneur.1986.00520030026007; Baek S, 2009, BRIEF BIOINFORM, V10, P537, DOI 10.1093/bib/bbp016; Behrens T, 2013, BIOCH BIOPHYS ACTA; Bowser R, 2011, NAT REV NEUROL, V7, P631, DOI 10.1038/nrneurol.2011.151; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Couratier P, 1998, J NEUROL SCI, V154, P137, DOI 10.1016/S0022-510X(97)00219-0; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Engelhardt JI, 2005, ACTA NEUROL SCAND, V112, P126, DOI 10.1111/j.1600-0404.2005.00445.x; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; ENGELHARDT JI, 1990, ARCH NEUROL-CHICAGO, V47, P1210, DOI 10.1001/archneur.1990.00530110068019; ENGELHARDT JI, 1995, SYNAPSE, V20, P185, DOI 10.1002/syn.890200302; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fialova L, 2010, EUR J NEUROL, V17, P562, DOI 10.1111/j.1468-1331.2009.02853.x; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GONATAS NK, 1992, AM J PATHOL, V140, P731; GREINER A, 1992, LANCET, V340, P378, DOI 10.1016/0140-6736(92)91462-H; Han M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032383; Hastie T, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-2-RESEARCH0003; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Irobi J, 2010, HUM MOL GENET, V19, P3254, DOI 10.1093/hmg/ddq234; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Kretzschmar S, 1996, NEUROSCI RES, V26, P141, DOI 10.1016/S0168-0102(96)01086-3; Lasiene J, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/718987; LINIAL M, 1993, FEBS LETT, V315, P91, DOI 10.1016/0014-5793(93)81140-U; Love B., 2007, ANAL PROTEIN ARRAYS, P381; LOWE J, 1992, NEUROPATH APPL NEURO, V18, P341, DOI 10.1111/j.1365-2990.1992.tb00796.x; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MIZUNO Y, 1995, BRAIN RES, V686, P115, DOI 10.1016/0006-8993(95)00467-5; Nagele E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023112; Nawa M, 2008, CELL SIGNAL, V20, P493, DOI 10.1016/j.cellsig.2007.11.004; Niebroj-Dobosz I, 2006, FOLIA NEUROPATHOL, V44, P191; Noguchi K, 2002, J BIOL CHEM, V277, P39655, DOI 10.1074/jbc.M204599200; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; ORDONEZ G, 1989, NEUROLOGY, V39, P683, DOI 10.1212/WNL.39.5.683; Pagani MR, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/497080; Pestronk A, 1997, NEUROLOGY, V49, P1289, DOI 10.1212/WNL.49.5.1289; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rodrigues MCO, 2012, INT REV NEUROBIOL, V102, P91, DOI 10.1016/B978-0-12-386986-9.00004-1; Sakane A, 2010, MOL CELL BIOL, V30, P1077, DOI 10.1128/MCB.01067-09; Sboner A, 2009, J PROTEOME RES, V8, P5451, DOI 10.1021/pr900412k; SMITH RG, 1992, NEW ENGL J MED, V327, P1721, DOI 10.1056/NEJM199212103272405; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soo KY, 2011, INT J MOL SCI, V12, P9057, DOI 10.3390/ijms12129057; Sta M, 2011, NEUROBIOL DIS, V42, P211, DOI 10.1016/j.nbd.2011.01.002; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Team RDC, 2011, R LANG ENVR STAT COM; Turewicz M, 2013, PROTEOMICS, V13, P2083, DOI 10.1002/pmic.201200518; Valdez AC, 1999, J CELL SCI, V112, P845; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Yi FH, 2000, J NEUROIMMUNOL, V109, P211, DOI 10.1016/S0165-5728(00)00288-5	62	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89596	10.1371/journal.pone.0089596	http://dx.doi.org/10.1371/journal.pone.0089596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586901	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000332389000066
J	Nell, AS; D'lom, E; Bouic, P; Sabate, M; Bosser, R; Picas, J; Amat, M; Churchyard, G; Cardona, PJ				Nell, Andre S.; D'lom, Eva; Bouic, Patrick; Sabate, Montserrat; Bosser, Ramon; Picas, Jordi; Amat, Merce; Churchyard, Gavin; Cardona, Pere-Joan			Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNOLOGY; MVA85A; ADULTS	Objectives: To evaluate the safety, tolerability and immunogenicity of three different doses (5, 25 and 50 mg) of the novel antituberculous vaccine RUTI compared to placebo in subjects with latent tuberculosis infection. Methods and Findings: Double-blind, randomized, placebo-controlled Phase II Clinical Trial (95 patients randomized). Three different RUTI doses and placebo were tested, randomized both in HIV-positive (n = 47) and HIV-negative subjects (n = 48), after completion of one month isoniazid (INH) pre-vaccination. Each subject received two vaccine administrations, 28 Days apart. Five patients withdrew and 90 patients completed the study. Assessment of safety showed no deaths during study. Two subjects had serious adverse events one had a retinal detachment while taking INH and was not randomized and the other had a severe local injection site abscess on each arm and was hospitalized; causality was assessed as very likely and by the end of the study the outcome had resolved. All the patients except 5 (21%) patients of the placebo group (3 HIV+ and 2 HIV-) reported at least one adverse event (AE) during the study. The most frequently occurring AEs among RUTI recipients were (% in HIV+/-): injection site reactions [erythema (91/92), induration (94/92), local nodules (46/25), local pain (66/75), sterile abscess (6/6), swelling (74/83), ulcer (20/11), headache (17/22) and nasopharyngitis (20/5)]. These events were mostly mild and well tolerated. Overall, a polyantigenic response was observed, which differed by HIV2 status. The best polyantigenic response was obtained when administrating 25 mg RUTI, especially in HIV-positive subjects which was not increased after the second inoculation. Conclusion: This Phase II clinical trial demonstrates reasonable tolerability of RUTI. The immunogenicity profile of RUTI vaccine in LTBI subjects, even being variable among groups, allows us considering one single injection of one of the highest doses in future trials, preceded by an extended safety clinical phase.	PAREXEL Early Phase Clin Unit, Bloemfontein, South Africa; [D'lom, Eva] PAREXEL Int, Madrid, Spain; [Bouic, Patrick] Synexa Life Sci, Cape Town, South Africa; [Sabate, Montserrat] TFS Develop, Barcelona, Catalonia, Spain; [Bosser, Ramon] Janus Dev, Barcelona, Catalonia, Spain; [Picas, Jordi; Amat, Merce; Cardona, Pere-Joan] Archivel Farma, Badalona, Catalonia, Spain; [Churchyard, Gavin] Aurum Inst, Johannesburg, South Africa; [Cardona, Pere-Joan] Univ Autonoma Barcelona, Inst Invest Ciencies Salut Germans Trias & Pujol, UTE, Badalona, Catalonia, Spain	Parexel International; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP)	Cardona, PJ (corresponding author), Archivel Farma, Badalona, Catalonia, Spain.	pj.cardona@gmail.com	Cardona, Pere-Joan/A-5258-2011	Cardona, Pere-Joan/0000-0001-5623-7873; Churchyard, Gavin/0000-0002-4269-3699	Archivel Farma s.l. (Badalona, Catalonia, Spain)	Archivel Farma s.l. (Badalona, Catalonia, Spain)	As the owner and manufacturer of the vaccine to be studied (RUTI), Archivel Farma s.l. (Badalona, Catalonia, Spain) was the sponsor of this trial and funded it. Jordi Picas, Merce Amat are employees of Archivel Farma S.L. Pere-Joan Cardona is consultant of Archivel Farma S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2001, VACCINE, V19, P2298, DOI 10.1016/S0264-410X(00)00519-3; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona PJ, 2006, TUBERCULOSIS, V86, P273, DOI 10.1016/j.tube.2006.01.024; Cardona PJ, 2010, ARCH IMMUNOL THER EX, V58, P7, DOI 10.1007/s00005-009-0062-5; Castro P, 2009, AIDS RES HUM RETROV, V25, P1249, DOI 10.1089/aid.2009.0015; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Giralt M, 2011, BEST PRACT RES CL EN, V25, P487, DOI 10.1016/j.beem.2010.12.001; Guirado E, 2008, CLIN VACCINE IMMUNOL, V15, P1229, DOI 10.1128/CVI.00094-08; Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145; HARRIS A, 2004, TB HIV CLIN MANUAL; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Kaufmann SHE, 2006, INT J TUBERC LUNG D, V10, P1068; Lin PL, J CLIN INVEST, V122, P303; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Vilaplana C, 2010, VACCINE, V28, P1106, DOI 10.1016/j.vaccine.2009.09.134; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; World Health Organization, 2011, GLOB TUB CONTR EP S	22	65	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89612	10.1371/journal.pone.0089612	http://dx.doi.org/10.1371/journal.pone.0089612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586912	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000068
J	Rychli, K; Muller, A; Zaiser, A; Schoder, D; Allerberger, F; Wagner, M; Schmitz-Esser, S				Rychli, Kathrin; Mueller, Anneliese; Zaiser, Andreas; Schoder, Dagmar; Allerberger, Franz; Wagner, Martin; Schmitz-Esser, Stephan			Genome Sequencing of Listeria monocytogenes "Quargel" Listeriosis Outbreak Strains Reveals Two Different Strains with Distinct In Vitro Virulence Potential	PLOS ONE			English	Article							INNATE RESISTANCE; PROTEIN SECRETION; CONTRIBUTES; EVOLUTION; ECOLOGY; SYSTEM; NISIN; GP96; TRANSPORTER; MECHANISMS	A large listeriosis outbreak occurred in Austria, Germany and the Czech Republic in 2009 and 2010. The outbreak was traced back to a traditional Austrian curd cheese called "Quargel" which was contaminated with two distinct serovar 1/2a Listeria monocytogenes strains (QOC1 and QOC2). In this study we sequenced and analysed the genomes of both outbreak strains in order to investigate the extent of genetic diversity between the two strains belonging to MLST sequence types 398 (QOC2) and 403 (QOC1). Both genomes are highly similar, but also display distinct properties: The QOC1 genome is approximately 74 kbp larger than the QOC2 genome. In addition, the strains harbour 93 (QOC1) and 45 (QOC2) genes encoding strain-specific proteins. A 21 kbp region showing highest similarity to plasmid pLMIV encoding three putative internalins is integrated in the QOC1 genome. In contrast to QOC1, strain QOC2 harbours a vip homologue, which encodes a LPXTG surface protein involved in cell invasion. In accordance, in vitro virulence assays revealed distinct differences in invasion efficiency and intracellular proliferation within different cell types. The higher virulence potential of QOC1 in non-phagocytic cells may be explained by the presence of additional internalins in the pLMIV-like region, whereas the higher invasion capability of QOC2 into phagocytic cells may be due to the presence of a vip homologue. In addition, both strains show differences in stress-related gene content. Strain QOC1 encodes a so-called stress survival islet 1, whereas strain QOC2 harbours a homologue of the uncharacterized LMOf2365_0481 gene. Consistently, QOC1 shows higher resistance to acidic, alkaline and gastric stress. In conclusion, our results show that strain QOC1 and QOC2 are distinct and did not recently evolve from a common ancestor.	[Rychli, Kathrin; Mueller, Anneliese; Zaiser, Andreas; Schoder, Dagmar; Wagner, Martin; Schmitz-Esser, Stephan] Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria; [Allerberger, Franz] Austrian Agcy Hlth & Food Safety AGES, Vienna, Austria; [Wagner, Martin] Univ Vet Med, Christian Doppler Lab Mol Biol Food Analyt, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Schmitz-Esser, S (corresponding author), Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria.	stephan.schmitz-esser@vetmeduni.ac.at	Schmitz-Esser, Stephan/AAA-7287-2019	Schmitz-Esser, Stephan/0000-0002-1907-0709; Kober-Rychli, Kathrin/0000-0001-6147-577X; Allerberger, Franz/0000-0002-0045-8164	Christian-Doppler Society; Austrian Science Fund (FWF) [P22703-B17]; University of Veterinary Medicine Vienna; Austrian Science Fund (FWF) [P 22703] Funding Source: researchfish	Christian-Doppler Society; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Veterinary Medicine Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Christian-Doppler Society (https://www.cdg.ac.at/). Moreover, the work was partly supported by a grant from the Austrian Science Fund (FWF, http://www.fwf.ac.at/) to SSE (grant no. P22703-B17) and by a start-up project from the University of Veterinary Medicine Vienna to KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLERBERGER F, 1989, ACTA MICROBIOL HUNG, V36, P149; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson M, 2011, J BACTERIOL, V193, P1583, DOI 10.1128/JB.01096-10; Asano K, 2011, INT J MED MICROBIOL, V301, P480, DOI 10.1016/j.ijmm.2011.01.002; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BACCARINI M, 1985, J IMMUNOL, V134, P2658; Begley M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005; Begley M, 2010, APPL ENVIRON MICROB, V76, P6541, DOI 10.1128/AEM.00203-10; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Buchrieser C, 2007, MICROBES INFECT, V9, P1147, DOI 10.1016/j.micinf.2007.05.002; Buchrieser C, 2011, GENOMES OF FOODBORNE AND WATERBORNE PATHOGENS, P125; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; CDC, 2013, MULT OUTBR LIST LINK; Centers for Disease Control and Prevention, 2012, MULT OUTBR LIST LINK; Chen YH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-219; Collins B, 2010, ANTIMICROB AGENTS CH, V54, P4658, DOI 10.1128/AAC.00290-10; Collins B, 2010, ANTIMICROB AGENTS CH, V54, P4416, DOI 10.1128/AAC.00503-10; Cotter PD, 2001, MOL MICROBIOL, V40, P465, DOI 10.1046/j.1365-2958.2001.02398.x; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; den Bakker HC, 2012, APPL ENVIRON MICROB, V78, P1876, DOI 10.1128/AEM.06969-11; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; FRETZ R, 2010, EUROSURVEILLANCE, V15, P2; Fretz R, 2010, EURO SURVEILL, V15, p[pii, 19543]; Garufi G, 2008, J BACTERIOL, V190, P7004, DOI 10.1128/JB.00458-08; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; GOHMANN S, 1990, MOL MICROBIOL, V4, P1091, DOI 10.1111/j.1365-2958.1990.tb00683.x; Haase JK, 2011, ENVIRON MICROBIOL, V13, P3163, DOI 10.1111/j.1462-2920.2011.02610.x; Hain T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-144; Hein I, 2011, APPL ENVIRON MICROB, V77, P2169, DOI 10.1128/AEM.02159-10; Ivanek R, 2006, FOODBORNE PATHOG DIS, V3, P319, DOI 10.1089/fpd.2006.3.319; Kim JW, 2012, APPL ENVIRON MICROB, V78, P1995, DOI 10.1128/AEM.07086-11; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Lee S, 2012, APPL ENVIRON MICROB, V78, P2623, DOI 10.1128/AEM.07203-11; Martins M, 2012, J BIOL CHEM, V287, P43083, DOI 10.1074/jbc.M112.422568; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Milillo SR, 2012, CRIT REV FOOD SCI, V52, P712, DOI 10.1080/10408398.2010.507909; Milohanic E, 2001, MOL MICROBIOL, V39, P1212, DOI 10.1046/j.1365-2958.2001.02208.x; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Ooi ST, 2005, CLIN INFECT DIS, V40, P1327, DOI 10.1086/429324; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pichler J., 2011, Food Protection Trends, V31, P268; Pizarro-Cerda J, 2012, COLD SPRING HARB PER, V2; Pricope L, 2013, FOOD CONTROL, V31, P230, DOI 10.1016/j.foodcont.2012.09.031; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Renier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042982; Ryan S, 2010, J APPL MICROBIOL, V109, P984, DOI 10.1111/j.1365-2672.2010.04726.x; Ryan S, 2008, ADV APPL MICROBIOL, V65, P67, DOI 10.1016/S0065-2164(08)00603-5; Schaferkordt S, 1997, J BACTERIOL, V179, P2707, DOI 10.1128/jb.179.8.2707-2716.1997; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Schoder D, 2014, FOOD MICROBIOL, V39, P68, DOI 10.1016/j.fm.2013.11.006; Schoder D, 2013, INT J FOOD MICROBIOL, V167, P353, DOI 10.1016/j.ijfoodmicro.2013.09.020; Schoder D, 2012, INT J FOOD MICROBIOL, V157, P326, DOI 10.1016/j.ijfoodmicro.2012.04.023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tasara T, 2006, J FOOD PROTECT, V69, P1473, DOI 10.4315/0362-028X-69.6.1473; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Way SS, 2005, INFECT IMMUN, V73, P6151, DOI 10.1128/IAI.73.9.6151-6153.2005; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yde M, 2012, EURO SURVEILL, V17; Yildirim S, 2010, APPL ENVIRON MICROB, V76, P5577, DOI 10.1128/AEM.00648-10; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	69	39	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89964	10.1371/journal.pone.0089964	http://dx.doi.org/10.1371/journal.pone.0089964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587155	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000119
J	Fernandez-Estevez, MA; Casarejos, MJ; Sendon, JL; Caldentey, JG; Ruiz, C; Gomez, A; Perucho, J; de Yebenes, JG; Mena, MA				Angeles Fernandez-Estevez, Maria; Jose Casarejos, Maria; Lopez Sendon, Jose; Garcia Caldentey, Juan; Ruiz, Carolina; Gomez, Ana; Perucho, Juan; Garcia de Yebenes, Justo; Angeles Mena, Maria			Trehalose Reverses Cell Malfunction in Fibroblasts from Normal and Huntington's Disease Patients Caused by Proteosome Inhibition	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; TERMINAL HUNTINGTIN; MUTANT HUNTINGTIN; DOWN-REGULATION; IN-VIVO; CHAPERONES; SURVIVAL; CULTURES; STRESS; MICE	Huntington's disease (HD) is a neurodegenerative disorder characterized by progressive motor, cognitive and psychiatric deficits, associated with predominant loss of striatal neurons and is caused by polyglutamine expansion in the huntingtin protein. Mutant huntingtin protein and its fragments are resistant to protein degradation and produce a blockade of the ubiquitin proteasome system (UPS). In HD models, the proteasome inhibitor epoxomicin aggravates protein accumulation and the inductor of autophagy, trehalose, diminishes it. We have investigated the effects of epoxomicin and trehalose in skin fibroblasts of control and HD patients. Untreated HD fibroblasts have increased the levels of ubiquitinized proteins and higher levels of reactive oxygen species (ROS), huntingtin and the autophagy marker LAMP2A. Baseline replication rates were higher in HD than in controls fibroblasts but that was reverted after 12 passages. Epoxomicin increases the activated caspase-3, HSP70, huntingtin, ubiquitinated proteins and ROS levels in both HD and controls. Treatment with trehalose counteracts the increase in ROS, ubiquitinated proteins, huntingtin and activated caspase-3 levels induced by epoxomicin, and also increases the LC3 levels more in HD fibroblast than controls. These results suggest that trehalose could revert protein processing abnormalities in patients with Huntington's Disease.	[Angeles Fernandez-Estevez, Maria; Jose Casarejos, Maria; Gomez, Ana; Perucho, Juan; Angeles Mena, Maria] Hosp Ramon & Cajal, Dept Neurobiol, E-28034 Madrid, Spain; [Lopez Sendon, Jose; Garcia Caldentey, Juan; Ruiz, Carolina; Garcia de Yebenes, Justo] Hosp Ramon & Cajal, Dept Neurol, E-28034 Madrid, Spain; [Angeles Fernandez-Estevez, Maria; Jose Casarejos, Maria; Lopez Sendon, Jose; Ruiz, Carolina; Gomez, Ana; Perucho, Juan; Garcia de Yebenes, Justo; Angeles Mena, Maria] Inst Salud Carlos III, CIBERNED, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; CIBERNED; Instituto de Salud Carlos III	Mena, MA (corresponding author), Hosp Ramon & Cajal, Dept Neurobiol, E-28034 Madrid, Spain.	maria.a.mena@hrc.es	Fernandez-Estevez, Marian/AAP-4474-2020; Casarejos, María jose/AAA-9629-2019	Fernandez-Estevez, Marian/0000-0002-7349-9127; Casarejos, María jose/0000-0003-1288-1717; Lopez-Sendon Moreno, Jose Luis/0000-0001-9414-3990	Spanish Ministry of Health [FIS 2010/172, CIBER 2006/05/0059, CIBERNED PI 2010/06, CIBERNED PI 2013/05, CAM 2011/BMD-2308]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This study has been supported in part by grants from the Spanish Ministry of Health, FIS 2010/172, CIBER 2006/05/0059, CIBERNED PI 2010/06, CIBERNED PI 2013/05, and CAM 2011/BMD-2308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arenas J, 1998, ANN NEUROL, V43, P397, DOI 10.1002/ana.410430321; Bahr BA, 2012, REJUV RES, V15, P189, DOI 10.1089/rej.2011.1282; Bassermann F, 2013, BIOCH BIOPHYS ACTA; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Canals S, 2003, MOL CELL NEUROSCI, V24, P1012, DOI 10.1016/j.mcn.2003.08.004; Casarejos MJ, 2011, NEUROCHEM INT, V58, P512, DOI 10.1016/j.neuint.2011.01.008; Casarejos MJ, 2005, J NEUROCHEM, V94, P1005, DOI 10.1111/j.1471-4159.2005.03249.x; Chai YH, 1999, J NEUROSCI, V19, P10338; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; Chen Chiung-Mei, 2011, Chang Gung Med J, V34, P135; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; de Bernardo S, 2003, J NEUROSCI RES, V73, P818, DOI 10.1002/jnr.10704; del Hoyo P, 2006, NEUROCHEM RES, V31, P1103, DOI 10.1007/s11064-006-9110-2; Domingues AF, 2008, FREE RADICAL BIO MED, V45, P820, DOI 10.1016/j.freeradbiomed.2008.06.007; Fasanaro P, 2010, CARDIOVASC RES, V85, P272, DOI 10.1093/cvr/cvp244; Fisher M, 2001, ATHEROSCLEROSIS, V156, P289, DOI 10.1016/S0021-9150(00)00656-0; GOETZ IE, 1981, AM J HUM GENET, V33, P187; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Jeong JC, 2012, ONCOL REP, V27, P1467, DOI 10.3892/or.2012.1637; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaushik S., 2008, V445, P227, DOI 10.1007/978-1-59745-157-4_15; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Seo SR, 2001, J NEUROCHEM, V78, P600, DOI 10.1046/j.1471-4159.2001.00438.x; Solano RM, 2008, J NEUROSCI, V28, P598, DOI 10.1523/JNEUROSCI.4609-07.2008; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Torres CA, 2008, FREE RADICAL BIO MED, V44, P403, DOI 10.1016/j.freeradbiomed.2007.10.002; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zheng ZQ, 2012, PROG MOL BIOL TRANSL, V107, P189, DOI 10.1016/B978-0-12-385883-2.00010-2	45	44	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90202	10.1371/journal.pone.0090202	http://dx.doi.org/10.1371/journal.pone.0090202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587280	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900127
J	Solino, M; Farizo, BA				Solino, Mario; Farizo, Begona A.			Personal Traits Underlying Environmental Preferences: A Discrete Choice Experiment	PLOS ONE			English	Article							LATENT-CLASS MODEL; HETEROGENEOUS PREFERENCES; ATTITUDES; BENEFITS; VALUES	Personality plays a role in human behavior, and thus can influence consumer decisions on environmental goods and services. This paper analyses the influence of the big five personality dimensions (extraversion, agreeableness, conscientiousness, neuroticism and openness) in a discrete choice experiment dealing with preferences for the development of an environmental program for forest management in Spain. For this purpose, a reduced version of the Big Five Inventory survey (the BFI-10) is implemented. Results show a positive effect of openness and extraversion and a negative effect of agreeableness and neuroticism in consumers' preferences for this environmental program. Moreover, results from a latent class model show that personal traits help to explain preference heterogeneity.	[Solino, Mario] Forest Res Ctr CIFOR, Natl Inst Agr & Food Res & Technol INIA, Madrid, Spain; [Solino, Mario] Univ Valladolid, Sustainable Forest Management Inst, Palencia, Spain; [Solino, Mario] INIA, Palencia, Spain; [Farizo, Begona A.] CSIC, Inst Publ Goods & Policies IPP, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Politicas y Bienes Publicos (IPP)	Solino, M (corresponding author), Forest Res Ctr CIFOR, Natl Inst Agr & Food Res & Technol INIA, Madrid, Spain.	solino.mario@inia.es	Solino, Mario/A-5648-2012; Alvarez Farizo, Begona/B-4805-2011	Solino, Mario/0000-0001-7065-7348; Alvarez Farizo, Begona/0000-0003-2397-7204	SUDOE Interreg IV B - UE/EU FEDER/ERDF program (project SUST-FOREST) [SOE2/P2/E261]; Spanish Ministry of Science and Technology (project AVEHETERO) [ECO2010-22037]	SUDOE Interreg IV B - UE/EU FEDER/ERDF program (project SUST-FOREST); Spanish Ministry of Science and Technology (project AVEHETERO)	Financial support from the SUDOE Interreg IV B - UE/EU FEDER/ERDF program (project SUST-FOREST, ref. SOE2/P2/E261) and the Spanish Ministry of Science and Technology (project AVEHETERO, ref. ECO2010-22037) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman IJ, 1996, THESIS U NOTTINGHAM; Birol E, 2006, ECOL ECON, V60, P145, DOI 10.1016/j.ecolecon.2006.06.002; Boxall PC, 2002, ENVIRON RESOUR ECON, V23, P421, DOI 10.1023/A:1021351721619; Breffle WS, 2011, ENVIRON RESOUR ECON, V50, P83, DOI 10.1007/s10640-011-9463-0; Choi AS, 2013, ECOL ECON, V89, P24, DOI 10.1016/j.ecolecon.2013.01.027; Costa P.T., 1985, NEO PERSONALITY INVE; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Farizo BA, 2014, LAND USE POLICY, V38, P477, DOI 10.1016/j.landusepol.2013.12.009; Farizo BA, 2014, LAND ECON, V90, P181, DOI 10.3368/le.90.1.181; Fishbein M., 1975, BELIEF ATTITUDE INTE; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Grebitus C, 2013, J ECON PSYCHOL, V36, P11, DOI 10.1016/j.joep.2013.02.004; Greene WH, 2003, TRANSPORT RES B-METH, V37, P681, DOI 10.1016/S0191-2615(02)00046-2; Hess S, 2013, CHOICE MODELLING: THE STATE OF THE ART AND THE STATE OF PRACTICE, P1, DOI 10.4337/9781781007273; Hirsh JB, 2010, J ENVIRON PSYCHOL, V30, P245, DOI 10.1016/j.jenvp.2010.01.004; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Johnston RJ, 2007, ENVIRON RESOUR ECON, V38, P331, DOI 10.1007/s10640-006-9073-4; Lee JA, 2008, J PERS ASSESS, V90, P335, DOI 10.1080/00223890802107925; Lopez-Mosquera N, 2013, J ENVIRON PSYCHOL, V34, P27, DOI 10.1016/j.jenvp.2012.11.004; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Milfont TL, 2012, J ENVIRON PSYCHOL, V32, P187, DOI 10.1016/j.jenvp.2011.12.006; Morey E, 2006, ENVIRON RESOUR ECON, V34, P91, DOI 10.1007/s10640-005-3794-7; Nocella G, 2012, PSYCHOL MARKET, V29, P850, DOI 10.1002/mar.20569; North D. C., 1990, I I CHANGE EC PERFOR; Rammstedt B, 2002, EUR J PERSONALITY, V16, P369, DOI 10.1002/per.454; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; SCHWARTZ SH, 1994, J SOC ISSUES, V50, P19, DOI 10.1111/j.1540-4560.1994.tb01196.x; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Solino M, 2009, ENERG POLICY, V37, P4055, DOI 10.1016/j.enpol.2009.04.054; Street D. J., 2007, CONSTRUCTION OPTIMAL; Train K. E., 2003, DISCRETE CHOICE METH; Vermunt J., 2016, TECHNICAL GUIDE LATE	35	30	30	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89603	10.1371/journal.pone.0089603	http://dx.doi.org/10.1371/journal.pone.0089603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586905	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700132
J	Fekete, C; Siegrist, J; Reinhardt, JD; Brinkhof, MWG				Fekete, Christine; Siegrist, Johannes; Reinhardt, Jan D.; Brinkhof, Martin W. G.		SwiSCI Study Grp	Is Financial Hardship Associated with Reduced Health in Disability? The Case of Spinal Cord Injury in Switzerland	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; REHABILITATION-PARTICIPATION; RHEUMATOID-ARTHRITIS; ECONOMIC HARDSHIP; UTRECHT SCALE; MORTALITY; DEPRESSION; VALIDITY; INCOME; DISEASE	Objective: To investigate socioeconomic inequalities in a comprehensive set of health indicators among persons with spinal cord injury in a wealthy country, Switzerland. Methods: Observational cross-sectional data from 1549 participants of the Swiss Spinal Cord Injury Cohort Study (SwiSCI), aged over 16 years, and living in Switzerland were analyzed. Socioeconomic circumstances were operationalized by years of formal education, net equivalent household income and financial hardship. Health indicators including secondary conditions, comorbidities, pain, mental health, participation and quality of life were used as outcomes. Associations between socioeconomic circumstances and health indicators were evaluated using ordinal regressions. Results: Financial hardship was consistently associated with more secondary conditions (OR 3.37, 95% CI 2.18-5.21), comorbidities (OR 2.88, 95% CI 1.83-4.53) and pain (OR 3.32, 95% CI 2.21-4.99), whereas mental health (OR 0.23, 95% CI 0.15-0.36), participation (OR 0.30, 95% CI 0.21-0.43) and quality of life (OR 0.22, 95% CI 0.15-0.33) were reduced. Persons with higher education reported better mental health (OR 1.04, 95% CI 1.00-1.07) and higher quality of life (OR 1.06, 95% CI 1.02-1.09); other health indicators were not associated with education. Household income was not related to any of the studied health indicators when models were controlled for financial hardship. Conclusions: Suffering from financial hardship goes along with significant reductions in physical health, functioning and quality of life, even in a wealthy country with comprehensive social and health policies.	[Fekete, Christine; Reinhardt, Jan D.; Brinkhof, Martin W. G.] Swiss Parapleg Res, Nottwil, Switzerland; [Siegrist, Johannes] Univ Dusseldorf, Fac Med, Life Sci Ctr, Dusseldorf, Germany; [Reinhardt, Jan D.] Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu 610064, Sichuan Provinc, Peoples R China; [Reinhardt, Jan D.] Hong Kong Polytech Univ, Chengdu, Sichuan Provinc, Peoples R China; [Brinkhof, Martin W. G.] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland	Swiss Paraplegic Research; Heinrich Heine University Dusseldorf; Sichuan University; Hong Kong Polytechnic University; University of Lucerne	Fekete, C (corresponding author), Swiss Parapleg Res, Nottwil, Switzerland.	Christine.fekete@paraplegie.ch	Siegrist, Johannes/AAL-6814-2021	Siegrist, Johannes/0000-0002-7530-4178; Fekete, Christine/0000-0002-3753-3017; Brinkhof, Martin/0000-0002-9319-665X	Swiss Spinal Cord Injury Cohort Study (SwiSCI); Swiss Paraplegic Foundation; European Commission [HEALTH-F3-2011-278350]	Swiss Spinal Cord Injury Cohort Study (SwiSCI); Swiss Paraplegic Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study has been financed in the framework of the Swiss Spinal Cord Injury Cohort Study (SwiSCI), supported by the Swiss Paraplegic Foundation. JS was additionally supported by the grant agreement HEALTH-F3-2011-278350 (DRIVERS) of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Berkman LF, 2004, AM J EPIDEMIOL, V159, P167, DOI 10.1093/aje/kwh020; Bickenbach J, 2013, INTERNATIONAL PERSPECTIVES ON SPINAL CORD INJURY, P3; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Butterworth P, 2009, SOC SCI MED, V69, P229, DOI 10.1016/j.socscimed.2009.05.008; Camacho EM, 2012, ARTHRIT CARE RES, V64, P1225, DOI 10.1002/acr.21677; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dallmeijer AJ, 2001, SPINAL CORD, V39, P577, DOI 10.1038/sj.sc.3101215; Friedman B, 2005, J AM GERIATR SOC, V53, P1978, DOI 10.1111/j.1532-5415.2005.00469.x; Green CR, 2012, J PAIN, V13, P176, DOI 10.1016/j.jpain.2011.10.008; Hagenaars A., 1994, POVERTY STAT LATE 19; Jensen MP, 2010, SPINAL CORD, V48, P230, DOI 10.1038/sc.2009.112; Kalpakjian CZ, 2007, J SPINAL CORD MED, V30, P131, DOI 10.1080/10790268.2007.11753924; Knight J, 2011, PRIORITY OF DEMOCRACY: POLITICAL CONSEQUENCES OF PRAGMATISM, P51; Krause JS, 2012, SPINAL CORD, V50, P609, DOI 10.1038/sc.2012.24; Krause JS, 2009, SPINAL CORD, V47, P592, DOI 10.1038/sc.2009.15; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P339, DOI 10.1016/j.apmr.2010.09.032; Krause JS, 2006, J SPINAL CORD MED, V29, P17, DOI 10.1080/10790268.2006.11753852; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; LI KH, 1991, J AM STAT ASSOC, V86, P1065, DOI 10.2307/2290525; Lynch JW, 1997, NEW ENGL J MED, V337, P1889, DOI 10.1056/NEJM199712253372606; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Margaretten M, 2011, ARTHRIT CARE RES, V63, P240, DOI 10.1002/acr.20345; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Massardo L, 2012, ARTHRIT CARE RES, V64, P1135, DOI 10.1002/acr.21680; McCaffery M, 1993, PAIN CLIN MANUAL NUR; Mirowsky J, 2001, J HEALTH SOC BEHAV, V42, P132, DOI 10.2307/3090174; Moffett JAK, 2009, DISABIL REHABIL, V31, P783, DOI 10.1080/09638280802309327; O'Connell AA, 2006, LOGISTIC REGRESSION; OECD, 2017, OECD REV HLTH SYSTEM, DOI [10.1787/9789264269453-en, DOI 10.1787/146D0DEA-EN, 10.1787/9789264120914-en]; Plantinga LC, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110052; Post MWM, 2012, DISABIL REHABIL, V34, P478, DOI 10.3109/09638288.2011.608148; Post Marcel W M, 2011, Am J Phys Med Rehabil, V90, pS5, DOI 10.1097/PHM.0b013e318230fd41; Reinhardt JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038782; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Saunders LL, 2012, ARCH PHYS MED REHAB, V93, P972, DOI 10.1016/j.apmr.2012.02.004; Spoerri A, 2006, SWISS MED WKLY, V136, P145; Tucker-Seeley RD, 2009, ANN EPIDEMIOL, V19, P850, DOI 10.1016/j.annepidem.2009.08.003; UNESCO, 2006, INT STAND CLASS ED I; van der Zee CH, 2010, J REHABIL MED, V42, P752, DOI 10.2340/16501977-0589; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; World Health Organisation (WHO), 2001, INT CLASS FUNCT DIS; World Health Organization, 2004, WHO QUAL LIF WHOQOL; Yamout B, 2013, EUR J NEUROL; Yan T, 2010, INT J PUBLIC OPIN R, V22, P535, DOI 10.1093/ijpor/edq037	47	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90130	10.1371/journal.pone.0090130	http://dx.doi.org/10.1371/journal.pone.0090130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587239	Green Published, gold			2022-12-27	WOS:000332396200134
J	Lee, SH; Jung, JY; Jeon, CO				Lee, Se Hee; Jung, Ji Young; Jeon, Che Ok			Microbial Successions and Metabolite Changes during Fermentation of Salted Shrimp (Saeu-Jeot) with Different Salt Concentrations	PLOS ONE			English	Article							BACTERIAL COMMUNITY; FISH; IDENTIFICATION; NAREZUSHI; SEAFOOD; WATER	To investigate the effects of salt concentration on saeu-jeot (salted shrimp) fermentation, four sets of saeu-jeot samples with 20%, 24%, 28%, and 32% salt concentrations were prepared, and the pH, bacterial and archaeal abundances, bacterial communities, and metabolites were monitored during the entire fermentation period. Quantitative PCR showed that Bacteria were much more abundant than Archaea in all saeu-jeot samples, suggesting that bacterial populations play more important roles than archaeal populations even in highly salted samples. Community analysis indicated that Vibrio, Photobacterium, Psychrobacter, Pseudoalteromonas, and Enterovibrio were identified as the initially dominant genera, and the bacterial successions were significantly different depending on the salt concentration. During the early fermentation period, Salinivibrio predominated in the 20% salted samples, whereas Staphylococcus, Halomonas, and Salimicrobium predominated in the 24% salted samples; eventually, Halanaerobium predominated in the 20% and 24% salted samples. The initially dominant genera gradually decreased as the fermentation progressed in the 28% and 32% salted samples, and eventually Salimicrobium became predominant in the 28% salted samples. However, the initially dominant genera still remained until the end of fermentation in the 32% salted samples. Metabolite analysis showed that the amino acid profile and the initial glycerol increase were similar in all saeu-jeot samples regardless of the salt concentration. After 30-80 days of fermentation, the levels of acetate, butyrate, and methylamines in the 20% and 24% salted samples increased with the growth of Halanaerobium, even though the amino acid concentrations steadily increased until approximately 80-107 days of fermentation. This study suggests that a range of 24-28% salt concentration in saeu-jeot fermentation is appropriate for the production of safe and tasty saeu-jeot.	[Lee, Se Hee; Jung, Ji Young; Jeon, Che Ok] Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea	Chung Ang University	Jeon, CO (corresponding author), Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea.	cojeon@cau.ac.kr		Jung, Ji Young/0000-0002-6703-3072	Technology Development Program for Agriculture and Forestry (TDPAF) of the Ministry for Agriculture, Food and Rural Affairs, Republic of Korea	Technology Development Program for Agriculture and Forestry (TDPAF) of the Ministry for Agriculture, Food and Rural Affairs, Republic of Korea	This work was supported by the Technology Development Program for Agriculture and Forestry (TDPAF) of the Ministry for Agriculture, Food and Rural Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An C, 2010, J SCI FOOD AGR, V90, P1796, DOI 10.1002/jsfa.4015; An Doohyun, 2011, Korean Journal of Microbiology and Biotechnology, V39, P294; AOAC, 2000, OFFICIAL METHODS ANA; Aponte M, 2010, LETT APPL MICROBIOL, V51, P697, DOI 10.1111/j.1472-765X.2010.02956.x; Broekaert K, 2011, FOOD MICROBIOL, V28, P1162, DOI 10.1016/j.fm.2011.03.009; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Choi EJ, 2013, INT J SYST EVOL MICR, V63, P3430, DOI 10.1099/ijs.0.049197-0; Chung S. Y., 1976, Bulletin of the Korean Fisheries Society, V9, P79; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Dobson A, 2011, FEMS MICROBIOL LETT, V320, P56, DOI 10.1111/j.1574-6968.2011.02290.x; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Ercolini D, 2011, APPL ENVIRON MICROB, V77, P7372, DOI 10.1128/AEM.05521-11; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Fakpetch P, 2008, J FOOD SCI, V73, pS95, DOI 10.1111/j.1750-3841.2007.00630.x; Felsenstein J., 2002, PHYLIP PHYLOGENY INF; Figueiredo IM, 2006, J AGR FOOD CHEM, V54, P4102, DOI 10.1021/jf0525176; Gildberg A., 2001, J AQUAT FOOD PROD T, V10, P77, DOI DOI 10.1300/J030V10N01_07; Guan L, 2011, FOOD MICROBIOL, V28, P101, DOI 10.1016/j.fm.2010.09.001; Haugland RA, 2005, WATER RES, V39, P559, DOI 10.1016/j.watres.2004.11.011; Hernandez-Cortes P, 1997, J FOOD BIOCHEM, V21, P497, DOI 10.1111/j.1745-4514.1997.tb00202.x; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Hur S. H., 1996, J KOREAN SOC FOOD SC, V25, P885; Jeong SH, 2013, INT J FOOD MICROBIOL, V164, P46, DOI 10.1016/j.ijfoodmicro.2013.03.016; Jeong SH, 2013, INT J FOOD MICROBIOL, V160, P252, DOI 10.1016/j.ijfoodmicro.2012.10.015; Ji GD, 2011, BIORESOURCE TECHNOL, V102, P550, DOI 10.1016/j.biortech.2010.07.075; Juck D, 2000, FEMS MICROBIOL ECOL, V33, P241, DOI 10.1111/j.1574-6941.2000.tb00746.x; Jung JY, 2013, FOOD MICROBIOL, V34, P360, DOI 10.1016/j.fm.2013.01.009; Jung JY, 2012, INT J FOOD MICROBIOL, V153, P378, DOI 10.1016/j.ijfoodmicro.2011.11.030; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Kim B., 1988, KOREAN J FOOD SCI TE, V20, P883; Kim Min-Soo, 2009, [Korean Journal of Microbiology, 미생물학회지], V45, P26; Kimura M, 2003, FISHERIES SCI, V69, P414, DOI 10.1046/j.1444-2906.2003.00637.x; Kivisto A, 2011, INT J HYDROGEN ENERG, V36, P7074, DOI 10.1016/j.ijhydene.2011.03.012; Kiyohara M, 2012, BIOSCI BIOTECH BIOCH, V76, P48, DOI 10.1271/bbb.110424; Lapsongphon N, 2013, J AGR FOOD CHEM, V61, P6604, DOI 10.1021/jf4014923; Lee C. H., 1993, FISH FERMENTATION TE; Lee HJ, 2012, APPL ENVIRON MICROB, V78, P5983, DOI 10.1128/AEM.00104-12; Lee SH, 2014, FOOD MICROBIOL, V38, P16, DOI 10.1016/j.fm.2013.08.004; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez JR, 2012, AQUACULTURE, V324, P33, DOI 10.1016/j.aquaculture.2011.10.043; Matsui H, 2013, J FOOD SCI TECH MYS, V50, P791, DOI 10.1007/s13197-011-0382-4; Mok C.K., 2000, KOREAN J FOOD SCI TE, V32, P187; Nam E.-J., 1998, KOREAN J FOOD SCI TE, V30, P82; Oksanen J., 2016, R PACKAG; Paludan-Muller C, 2002, INT J FOOD MICROBIOL, V73, P61, DOI 10.1016/S0168-1605(01)00688-2; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Roh SW, 2010, INT J SYST EVOL MICR, V60, P1187, DOI 10.1099/ijs.0.013037-0; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Saisithi P., 1994, FISHERIES PROCESSING, P111, DOI [10.1007/978-1-4615-5303-8_5, DOI 10.1007/978-1-4615-5303-8_5]; Sakamoto N, 2011, INT J FOOD MICROBIOL, V144, P352, DOI 10.1016/j.ijfoodmicro.2010.10.017; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shahidi F, 2001, TRENDS FOOD SCI TECH, V12, P435, DOI 10.1016/S0924-2244(02)00021-3; Shannon C.E., 1963, MATH THEORY COMMUNIC; Sila A, 2012, J AQUAT FOOD PROD T, V21, P118, DOI 10.1080/10498850.2011.587149; Tapingkae W, 2010, ENZYME MICROB TECH, V46, P92, DOI 10.1016/j.enzmictec.2009.10.011; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yongsawatdigul J, 2007, J FOOD SCI, V72, pM382, DOI 10.1111/j.1750-3841.2007.00532.x; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	59	20	27	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90115	10.1371/journal.pone.0090115	http://dx.doi.org/10.1371/journal.pone.0090115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587230	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200129
J	Slot, IGM; van den Borst, B; Hellwig, VACV; Barreiro, E; Schols, AMWJ; Gosker, HR				Slot, Ilse G. M.; van den Borst, Bram; Hellwig, Valery A. C. V.; Barreiro, Esther; Schols, Annemie M. W. J.; Gosker, Harry R.			The Muscle Oxidative Regulatory Response to Acute Exercise Is Not Impaired in Less Advanced COPD Despite a Decreased Oxidative Phenotype	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN SKELETAL-MUSCLE; MESSENGER-RNA EXPRESSION; VASTUS LATERALIS MUSCLE; PERIPHERAL MUSCLE; GENE-EXPRESSION; HYPOBARIC HYPOXIA; ENDURANCE; STRESS; DYSFUNCTION	Already in an early disease stage, patients with chronic obstructive pulmonary disease (COPD) are confronted with impaired skeletal muscle function and physical performance due to a loss of oxidative type I muscle fibers and oxidative capacity (i.e. oxidative phenotype; Oxphen). Physical activity is a well-known stimulus of muscle Oxphen and crucial for its maintenance. We hypothesized that a blunted response of Oxphen genes to an acute bout of exercise could contribute to decreased Oxphen in COPD. For this, 28 patients with less advanced COPD (age 65 +/- 7 yrs, FEV1 59 +/- 16% predicted) and 15 age-and gender-matched healthy controls performed an incremental cycle ergometry test. The Oxphen response to exercise was determined by the measurement of gene expression levels of Oxphen markers in pre and 4h-post exercise quadriceps biopsies. Because exercise-induced hypoxia and oxidative stress may interfere with Oxphen response, oxygen saturation and oxidative stress markers were assessed as well. Regardless of oxygen desaturation and absolute exercise intensities, the Oxphen regulatory response to exercise was comparable between COPD patients and controls with no evidence of increased oxidative stress. In conclusion, the muscle Oxphen regulatory response to acute exercise is not blunted in less advanced COPD, regardless of exercise-induced hypoxia. Hence, this study provides further rationale for incorporation of exercise training as integrated part of disease management to prevent or slow down loss of muscle Oxphen and related functional impairment in COPD.	[Slot, Ilse G. M.; van den Borst, Bram; Hellwig, Valery A. C. V.; Schols, Annemie M. W. J.; Gosker, Harry R.] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Resp Med, Maastricht, Netherlands; [Barreiro, Esther] Pompeu Fabra Univ UPF, Dept Expt & Hlth Sci CEXS, Pulmonol Dept,Res Inst,Barcelona Biomed Res Pk PR, Hosp del Mar IMIM,Muscle & Resp Syst Res Unit URM, Barcelona, Spain; [Barreiro, Esther] Inst Hlth Carlos III ISCIII, Network Excellence Resp Res CIBERES, Mallorca, Balearic Island, Spain	Maastricht University; Maastricht University Medical Centre (MUMC); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Gosker, HR (corresponding author), Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Resp Med, Maastricht, Netherlands.	h.gosker@maastrichtuniversity.nl	van den Borst, Bram/W-9253-2019	van den Borst, Bram/0000-0002-4597-2722; Gosker, Harry/0000-0002-7659-0225	Dutch Top Institute Pharma project [T1-201]; Netherlands Asthma Foundation [NAF 3.2.09.068]	Dutch Top Institute Pharma project; Netherlands Asthma Foundation	This study was performed within the framework of the Dutch Top Institute Pharma project T1-201. Partners within this project are Maastricht University Medical Centre+, University Medical Center Utrecht, University Medical Center Groningen, AstraZeneca, Nycomed, GlaxoSmithKline and Danone Research. All the partners approved the manuscript. Dr Gosker was funded by a Netherlands Asthma Foundation grant (NAF 3.2.09.068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire J, 2004, THORAX, V59, P673, DOI 10.1136/thx.2003.020636; Allen D, 2008, J DERMATOL SCI, V49, P217, DOI 10.1016/j.jdermsci.2007.10.001; Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Barreiro E, 2009, THORAX, V64, P13, DOI 10.1136/thx.2008.105163; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bergmeyer HU., 1974, METHOD ENZYMAT AN, V1, P474; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; Couillard A, 2003, AM J RESP CRIT CARE, V167, P1664, DOI 10.1164/rccm.200209-1028OC; Franssen FME, 2005, MED SCI SPORT EXER, V37, P2, DOI 10.1249/01.MSS.0000150082.59155.4F; Gosker HR, 2007, THORAX, V62, P944, DOI 10.1136/thx.2007.078980; Gosker HR, 2005, RESP MED, V99, P118, DOI 10.1016/j.rmed.2004.05.018; Gouzi F, 2013, J APPL PHYSIOL, V115, P346, DOI 10.1152/japplphysiol.01352.2012; Hollander J, 2001, PFLUG ARCH EUR J PHY, V442, P426, DOI 10.1007/s004240100539; Hoppeler H, 2003, EXP PHYSIOL, V88, P109, DOI 10.1113/eph8802513; ITOH K, 1995, ACTA PHYSIOL SCAND, V154, P417, DOI 10.1111/j.1748-1716.1995.tb09925.x; Koechlin C, 2005, THORAX, V60, P834, DOI 10.1136/thx.2004.037531; Layec G, 2011, AM J PHYSIOL-REG I, V300, pR1142, DOI 10.1152/ajpregu.00835.2010; Ling K. H., 1966, METHODS ENZYMOL, V9, P425, DOI [10.1016/0076-6879(66)09087-6, DOI 10.1016/0076-6879(66)09087-6]; Lundby C, 2006, EUR J APPL PHYSIOL, V96, P363, DOI 10.1007/s00421-005-0085-5; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Maltais F, 1999, EUR RESPIR J, V13, P850, DOI 10.1034/j.1399-3003.1999.13d26.x; Maltais F, 2000, THORAX, V55, P848, DOI 10.1136/thorax.55.10.848; Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288; Mercken EM, 2009, CHEST, V136, P1291, DOI 10.1378/chest.08-2767; Natanek SA, 2013, MUSCLE NERVE, V48, P488, DOI 10.1002/mus.23784; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Park SK, 2013, HEART LUNG, V42, P235, DOI 10.1016/j.hrtlng.2013.04.005; Picard M, 2008, AM J RESP CRIT CARE, V178, P1040, DOI 10.1164/rccm.200807-1005OC; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Puente-Maestu L, 2012, AM J RESP CELL MOL, V47, P358, DOI 10.1165/rcmb.2011-0382OC; Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031; Remels AHV, 2013, J APPL PHYSIOL, V114, P1253, DOI 10.1152/japplphysiol.00790.2012; Russell AP, 2005, FASEB J, V19, P986, DOI 10.1096/fj.04-3168fje; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Steiner MC, 2005, THORAX, V60, P932, DOI 10.1136/thx.2004.038802; Stoller JK, 2010, CHEST, V138, P179, DOI 10.1378/chest.09-2555; Tobina T, 2011, J SPORT MED PHYS FIT, V51, P683; van den Borst B, 2013, J APPL PHYSIOL, V114, P1319, DOI 10.1152/japplphysiol.00508.2012; van den Borst B, 2013, AM J RESP CRIT CARE, V187, P8, DOI 10.1164/rccm.201208-1441OE; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004	45	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90150	10.1371/journal.pone.0090150	http://dx.doi.org/10.1371/journal.pone.0090150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587251	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200139
J	Almagro, P; Martinez-Camblor, P; Soriano, JB; Marin, JM; Alfageme, I; Casanova, C; Esteban, C; Soler-Cataluna, JJ; De-Torres, JP; Celli, BR; Miravitlles, M				Almagro, Pere; Martinez-Camblor, Pablo; Soriano, Joan B.; Marin, Jose M.; Alfageme, Inmaculada; Casanova, Ciro; Esteban, Cristobal; Soler-Cataluna, Juan J.; De-Torres, Juan P.; Celli, Bartolome R.; Miravitlles, Marc			Finding the Best Thresholds of FEV1 and Dyspnea to Predict 5-Year Survival in COPD Patients: The COCOMICS Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BODE INDEX; MORTALITY; RISK; CLASSIFICATION; EXACERBATIONS; COMORBIDITY; DISABILITY; SEVERITY; OUTCOMES	Background: FEV1 is universally used as a measure of severity in COPD. Current thresholds are based on expert opinion and not on evidence. Objectives: We aimed to identify the best FEV1 (% predicted) and dyspnea (mMRC) thresholds to predict 5-yr survival in COPD patients. Design and Methods: We conducted a patient-based pooled analysis of eleven COPD Spanish cohorts (COCOMICS). Survival analysis, ROC curves, and C-statistics were used to identify and compare the best FEV1 (%) and mMRC scale thresholds that predict 5-yr survival. Results: A total of 3,633 patients (93% men), totaling 15,878 person-yrs. were included, with a mean age 66.469.7, and predicted FEV1 of 53.8% (+/- 19.4%). Overall 975 (28.1%) patients died at 5 years. The best thresholds that spirometrically split the COPD population were: mild >= 70%, moderate 56-69%, severe 36-55%, and very severe <= 35%. Survival at 5 years was 0.89 for patients with FEV1 >= 70 vs. 0.46 in patients with FEV1 <= 35% (H. R: 6; 95% C. I.: 4.69-7.74). The new classification predicts mortality significantly better than dyspnea (mMRC) or FEV1 GOLD and BODE cutoffs (all p<0.001). Prognostic reliability is maintained at 1, 3, 5, and 10 years. In younger patients, survival was similar for FEV1 (%) values between 70% and 100%, whereas in the elderly the relationship between FEV1 (%) and mortality was inversely linear. Conclusions: The best thresholds for 5-yr survival were obtained stratifying FEV1 (%) by >= 70%, 56-69%, 36-55%, and <= 35%. These cutoffs significantly better predict mortality than mMRC or FEV1 (%) GOLD and BODE cutoffs.	[Almagro, Pere] Hosp Univ Mutua Terrassa, Dept Internal Med, Acute Geriatr Care Unit, Barcelona, Spain; [Martinez-Camblor, Pablo] Asturias Biomed Res Off, Oviedo, Spain; [Soriano, Joan B.] Hosp Univ Son Espases, Fdn Invest Saniat Illes Balers, Balearic Islands, Spain; [Marin, Jose M.] Hosp Univ Miguel Servet, Resp Dept, Zaragoza, Spain; [Alfageme, Inmaculada] Valme Univ Hosp, Resp Dept, Seville, Spain; [Alfageme, Inmaculada] Hosp Nuestra Senora Candelaria, Resp Dept, Tenerife, Spain; [Esteban, Cristobal] Hosp Galdakao Usansolo, Resp Dept, Bizkaia, Spain; [Soler-Cataluna, Juan J.] Hosp Arnau Vilanova, Resp Dept, Valencia, Spain; [De-Torres, Juan P.] Cli nica Univ Navarra, Resp Dept, Pamplona, Spain; [Celli, Bartolome R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Miravitlles, Marc] Hosp Univ Vall dHebron, Dept Pneumol, CIBER Enfermedades Resp CIBERES, Barcelona, Spain	Hospital Universitario Mutua Terrassa; Hospital Universitari Son Espases; Miguel Servet University Hospital; Hospital Valme; Galdakao Hospital; University of Navarra; Harvard University; Brigham & Women's Hospital; Harvard Medical School; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitari Vall d'Hebron	Almagro, P (corresponding author), Hosp Univ Mutua Terrassa, Dept Internal Med, Acute Geriatr Care Unit, Barcelona, Spain.	19908pam@comb.cat	Camblor, Pablo Martinez/Z-4834-2019; Martinez-Camblor, Pablo/Q-1715-2015; Miravitlles, Marc/AAH-5284-2019; Alfageme, Inmaculada/K-2092-2014; Soriano, Joan B/O-1215-2017; RG, SMABSS/N-3322-2018	Camblor, Pablo Martinez/0000-0001-7845-3905; Miravitlles, Marc/0000-0002-9850-9520; Alfageme, Inmaculada/0000-0002-5106-1669; Soriano, Joan B/0000-0001-9740-2994; RG, SMABSS/0000-0001-9944-3861; ESTEBAN, CRISTOBAL/0000-0001-9878-7806; Soler-Cataluna, Juan Jose/0000-0003-1134-0783; Marin Trigo, Jose Maria/0000-0001-9096-2294; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942	Spanish Society of Pneumology and Thoracic surgery [057/12.SEPAR 2013]; Spanish Ministerio de Ciencia e Innovacion (FEDER) [MTM2011-23204]	Spanish Society of Pneumology and Thoracic surgery; Spanish Ministerio de Ciencia e Innovacion (FEDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The COCOMICS study was financed in part with a grant of the Spanish Society of Pneumology and Thoracic surgery coded with the number 057/12.SEPAR 2013. PMC was supported by research grant MTM2011-23204 from the Spanish Ministerio de Ciencia e Innovacion (FEDER support included). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2013, EUR RESPIR J, V42, P636, DOI 10.1183/09031936.00195212; Alfageme Inmaculada, 2010, Chron Respir Dis, V7, P135, DOI 10.1177/1479972310368692; Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; Almagro P, 2012, RESPIRATION, V84, P36, DOI 10.1159/000331224; Azarisman MS, 2007, POSTGRAD MED J, V83, P492, DOI 10.1136/pgmj.2006.052399; Baughman P, 2012, EUR J EPIDEMIOL, V27, P933, DOI 10.1007/s10654-012-9750-2; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Burgel PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051048; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Clini EM, 2013, AM J RESP CRIT CARE, V187, P668, DOI 10.1164/rccm.201302-0230ED; Cox D. R., 1984, ANAL SURVIVAL DATA; de Torres JP, 2011, CHEST, V139, P36, DOI 10.1378/chest.10-0984; Diez-Manglano J, 2013, INTERN EMERG MED; Esteban C, 2008, J GEN INTERN MED, V23, P1829, DOI 10.1007/s11606-008-0783-x; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hole DJ, 1996, BRIT MED J, V313, P711; Johannessen A, 2013, AM J RESP CRIT CARE, V188, P602; Johnson LS, 2013, EUROPACE; Jones RC, 2009, AM J RESP CRIT CARE, V180, P1189, DOI 10.1164/rccm.200902-0271OC; Soler-Cataluna JJ, 2009, RESP MED, V103, P692, DOI 10.1016/j.rmed.2008.12.005; Kim S, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-35; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marin JM, 2013, EUR RESPIR J, V42, P323, DOI 10.1183/09031936.00121012; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Martinez-Camblor P, 2012, J STAT PLAN INFER, V142, P589, DOI 10.1016/j.jspi.2011.09.003; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miravitlles M, 2009, THORAX, V64, P863, DOI 10.1136/thx.2009.115725; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P247, DOI 10.1016/j.arbres.2012.04.001; Moayyeri A, 2009, J BONE MINER RES, V24, P956, DOI 10.1359/JBMR.081231; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Nourizadeh Mohammad, 2013, J Cardiovasc Dis Res, V4, P130, DOI 10.1016/j.jcdr.2012.06.001; Oga T, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-85; Pearson MG, 1997, THORAX, V52, pS1; POSTMA DS, 1989, AM REV RESPIR DIS, V140, pS100, DOI 10.1164/ajrccm/140.3_Pt_2.S100; Puhan MA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002152; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sanjaume M, 2009, REV CLIN ESP, V209, P364, DOI 10.1016/S0014-2565(09)72339-2; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Soriano JB, 2013, CHEST, V143, P694, DOI 10.1378/chest.12-1053; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Yu D, 2013, DIABET MED	50	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89866	10.1371/journal.pone.0089866	http://dx.doi.org/10.1371/journal.pone.0089866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587085	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800050
J	Farrar, CT; William, CM; Hudry, E; Hashimoto, T; Hyman, BT				Farrar, Christian T.; William, Christopher M.; Hudry, Eloise; Hashimoto, Tadafumi; Hyman, Bradley T.			RNA Aptamer Probes as Optical Imaging Agents for the Detection of Amyloid Plaques	PLOS ONE			English	Article							A-BETA OLIGOMERS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; SENILE PLAQUES; ANTIBODIES RECOGNIZE; EMERGING CLASS; SYNAPSE LOSS; IN-VIVO; PROTEIN; BRAIN	Optical imaging using multiphoton microscopy and whole body near infrared imaging has become a routine part of biomedical research. However, optical imaging methods rely on the availability of either small molecule reporters or genetically encoded fluorescent proteins, which are challenging and time consuming to develop. While directly labeled antibodies can also be used as imaging agents, antibodies are species specific, can typically not be tagged with multiple fluorescent reporters without interfering with target binding, and are bioactive, almost always eliciting a biological response and thereby influencing the process that is being studied. We examined the possibility of developing highly specific and sensitive optical imaging agents using aptamer technology. We developed a fluorescently tagged anti-A beta RNA aptamer, beta 55, which binds amyloid plaques in both ex vivo human Alzheimer's disease brain tissue and in vivo APP/PS1 transgenic mice. Diffuse beta 55 positive halos, attributed to oligomeric A beta, were observed surrounding the methoxy-XO4 positive plaque cores. Dot blots of synthetic A beta aggregates provide further evidence that beta 55 binds both fibrillar and non-fibrillar A beta. The high binding affinity, the ease of probe development, and the ability to incorporate multiple and multimodal imaging reporters suggest that RNA aptamers may have complementary and perhaps advantageous properties compared to conventional optical imaging probes and reporters.	[Farrar, Christian T.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Farrar, Christian T.; William, Christopher M.; Hudry, Eloise; Hashimoto, Tadafumi; Hyman, Bradley T.] Harvard Univ, Sch Med, Charlestown, MA USA; [William, Christopher M.] Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA USA; [Hudry, Eloise; Hashimoto, Tadafumi; Hyman, Bradley T.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Farrar, CT (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	cfarrar@nmr.mgh.harvard.edu		William, Christopher/0000-0001-8933-1639; Farrar, Christian/0000-0001-6623-8220; Hashimoto, Tadafumi/0000-0001-5442-4800	Massachusetts Alzheimer's Disease Research Center National Institutes of Health (NIH) [P50-AG05134]; NIH [K25-AG029415, K08-NS069811, R01-AG08487]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS069811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008487, P50AG005134, K25AG029415] Funding Source: NIH RePORTER	Massachusetts Alzheimer's Disease Research Center National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Massachusetts Alzheimer's Disease Research Center National Institutes of Health (NIH) grant P50-AG05134 and by NIH grants K25-AG029415, K08-NS069811, and R01-AG08487. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Cheng CS, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.59; DaRocha-Souto B, 2011, J NEUROPATH EXP NEUR, V70, P360, DOI 10.1097/NEN.0b013e318217a118; Drolet DW, 2000, PHARMACEUT RES, V17, P1503, DOI 10.1023/A:1007657109012; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hicke BJ, 2000, J CLIN INVEST, V106, P923, DOI 10.1172/JCI11324; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jayasena SD, 1999, CLIN CHEM, V45, P1628; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lesne S, 2008, NEUROSCIENCE, V151, P745, DOI 10.1016/j.neuroscience.2007.10.054; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Marcinkiewicz M, 2002, J NEUROPATH EXP NEUR, V61, P815, DOI 10.1093/jnen/61.9.915; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mathura VS, 2005, BIOCHEM BIOPH RES CO, V332, P585, DOI 10.1016/j.bbrc.2005.04.164; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; PIRTTILA T, 1994, J NEUROL SCI, V127, P90, DOI 10.1016/0022-510X(94)90140-6; Que-Gewirth NS, 2007, GENE THER, V14, P283, DOI 10.1038/sj.gt.3302900; Rahimi F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007694; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Takahashi T, 2009, MOL BIOSYST, V5, P986, DOI 10.1039/b903391b; Thiel KW, 2009, OLIGONUCLEOTIDES, V19, P209, DOI 10.1089/oli.2009.0199; Tsukakoshi K, 2012, ANAL CHEM, V84, P5542, DOI 10.1021/ac300330g; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354; Ylera F, 1999, THESIS; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	52	31	33	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89901	10.1371/journal.pone.0089901	http://dx.doi.org/10.1371/journal.pone.0089901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587111	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000108
J	Wei, A; Fascetti, AJ; Kim, K; Lee, A; Graham, JL; Havel, PJ; Ramsey, JJ				Wei, Alfreda; Fascetti, Andrea J.; Kim, Kyoungmi; Lee, Ada; Graham, James L.; Havel, Peter J.; Ramsey, Jon J.			Early Effects of Neutering on Energy Expenditure in Adult Male Cats	PLOS ONE			English	Article							INCREASES FOOD-INTAKE; DOMESTIC CATS; INDIRECT CALORIMETRY; BODY CONDITION; WEIGHT-GAIN; GHRELIN; ADIPONECTIN; LEPTIN; MASS; REQUIREMENT	The initial cause of post-neutering weight gain in male cats is not entirely known. There is evidence that energy intake (EI) increases rapidly post-neutering, but it is not clear if neutering also decreases energy expenditure (EE) prior to weight gain. Thus, the purpose of this study was to determine if a decrease in EE contributes to the initial shift toward positive energy balance in neutered male cats. To determine the influence of neutering on EE independent of changes in EI and body weight (BW), male cats were fed at their pre-neutering maintenance EI and EE was measured at 4 days pre-neutering, 3-4 days post-neutering, and 9 days post-neutering. Ad libitum food access was then provided for 6 months. Body composition was measured and blood samples collected for serum chemistry at pre-neutering and 7 days, 13 days and 6 months post-neutering. Total energy expenditure (TEE) adjusted for lean body mass (LBM) did not change in cats from pre-neutering to 9 days post-neutering. However, TEE adjusted for BW and resting energy expenditure adjusted for either LBM or BW showed a small, but significant (P<0.05) increase from pre-neutering to 9 days post-neutering. When allowed free choice food access, cats showed significant increases of food intake (FI) and BW. Circulating concentrations of ghrelin increased, while adiponectin levels decreased following neutering. The results of this study indicate that initial post-neutering weight gain in male cats results from increased FI and not decreased EE. Long-term control of FI should be initiated after neutering to prevent hyperphagia and weight gain in male cats.	[Wei, Alfreda; Fascetti, Andrea J.; Lee, Ada; Graham, James L.; Havel, Peter J.; Ramsey, Jon J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Kim, Kyoungmi] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA; [Graham, James L.; Havel, Peter J.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Wei, A (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	awei@ucdavis.edu		Havel, Peter/0000-0003-3652-8301; Graham, James/0000-0001-6507-8149				AAFCO, 2012, 2012 OFF PUBL AM FEE; ALLISON DB, 1995, INT J OBESITY, V19, P644; Appleton DJ, 2000, J FELINE MED SURG, V2, P191, DOI 10.1053/jfms.2000.0103; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Backus RC, 2000, AM J VET RES, V61, P796, DOI 10.2460/ajvr.2000.61.796; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Crane SW, 1983, CURRENT TECHNIQUES S, P369; Druce MR, 2005, INT J OBESITY, V29, P1130, DOI 10.1038/sj.ijo.0803001; Fettman MJ, 1997, RES VET SCI, V62, P131, DOI 10.1016/S0034-5288(97)90134-X; Flynn MF, 1996, J AM VET MED ASSOC, V209, P1572; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Hoenig M, 2002, AM J VET RES, V63, P634, DOI 10.2460/ajvr.2002.63.634; Ishioka K, 2009, J VET MED SCI, V71, P189, DOI 10.1292/jvms.71.189; Kanchuk ML, 2003, J NUTR, V133, P1866, DOI 10.1093/jn/133.6.1866; Laflamme D, 1997, FELINE PRACT, V25, P13; Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88; Martin L, 2001, J ANIM PHYSIOL AN N, V85, P195, DOI 10.1046/j.1439-0396.2001.00322.x; Mitsuhashi Y, 2011, BRIT J NUTR, V106, pS135, DOI 10.1017/S0007114511001899; Muranaka S, 2011, RES VET SCI, V91, P358, DOI 10.1016/j.rvsc.2010.09.012; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Nguyen P, 2004, J NUTR, V134, p2084S, DOI 10.1093/jn/134.8.2084S; Root MV, 1996, AM J VET RES, V57, P371; Scarlett JM, 1998, J AM VET MED ASSOC, V212, P1725; Swarbrick Michael M., 2008, Metabolic Syndrome and Related Disorders, V6, P87, DOI 10.1089/met.2007.0029; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Tvarijonaviciute A, 2012, J FELINE MED SURG, V14, P138, DOI 10.1177/1098612X11432236; Villaverde C, 2008, J NUTR, V138, P856, DOI 10.1093/jn/138.5.856; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Zoran DL, 2010, VET CLIN N AM-SMALL, V40, P221, DOI 10.1016/j.cvsm.2009.10.009	33	17	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89557	10.1371/journal.pone.0089557	http://dx.doi.org/10.1371/journal.pone.0089557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586869	gold, Green Published			2022-12-27	WOS:000332389000061
J	Vu, LH; Araki, T; Na, JB; Clemen, CS; Williams, JG; Eichinger, L				Linh Hai Vu; Araki, Tsuyoshi; Na, Jianbo; Clemen, Christoph S.; Williams, Jeffrey G.; Eichinger, Ludwig			Identification of the Protein Kinases Pyk3 and Phg2 as Regulators of the STATc-Mediated Response to Hyperosmolarity	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM; OSMOTIC SHOCK; CELL POLARITY; STRESS; PATHWAY; RAP1; AGGREGATION; CHEMOTAXIS; ADHESION; INSIGHTS	Cellular adaptation to changes in environmental osmolarity is crucial for cell survival. In Dictyostelium, STATc is a key regulator of the transcriptional response to hyperosmotic stress. Its phosphorylation and consequent activation is controlled by two signaling branches, one cGMP-and the other Ca2+-dependent, of which many signaling components have yet to be identified. The STATc stress signalling pathway feeds back on itself by upregulating the expression of STATc and STATc-regulated genes. Based on microarray studies we chose two tyrosine-kinase like proteins, Pyk3 and Phg2, as possible modulators of STATc phosphorylation and generated single and double knock-out mutants to them. Transcriptional regulation of STATc and STATc dependent genes was disturbed in pyk3(-), phg2(-), and pyk3(-)/phg2(-) cells. The absence of Pyk3 and/or Phg2 resulted in diminished or completely abolished increased transcription of STATc dependent genes in response to sorbitol, 8-Br-cGMP and the Ca2+ liberator BHQ. Also, phospho-STATc levels were significantly reduced in pyk3(-) and phg2(-) cells and even further decreased in pyk3(-)/phg2(-) cells. The reduced phosphorylation was mirrored by a significant delay in nuclear translocation of GFP-STATc. The protein tyrosine phosphatase 3 (PTP3), which dephosphorylates and inhibits STATc, is inhibited by stress-induced phosphorylation on S448 and S747. Use of phosphoserine specific antibodies showed that Phg2 but not Pyk3 is involved in the phosphorylation of PTP3 on S747. In pull-down assays Phg2 and PTP3 interact directly, suggesting that Phg2 phosphorylates PTP3 on S747 in vivo. Phosphorylation of S448 was unchanged in phg2(-) cells. We show that Phg2 and an, as yet unknown, S448 protein kinase are responsible for PTP3 phosphorylation and hence its inhibition, and that Pyk3 is involved in the regulation of STATc by either directly or indirectly activating it. Our results add further complexities to the regulation of STATc, which presumably ensure its optimal activation in response to different environmental cues.	[Linh Hai Vu; Na, Jianbo; Clemen, Christoph S.; Eichinger, Ludwig] Univ Cologne, Ctr Biochem, Inst Biochem 1, Fac Med, D-50931 Cologne, Germany; [Araki, Tsuyoshi; Williams, Jeffrey G.] Univ Dundee, Coll Life Sci, Dundee, Scotland	University of Cologne; University of Dundee	Eichinger, L (corresponding author), Univ Cologne, Ctr Biochem, Inst Biochem 1, Fac Med, D-50931 Cologne, Germany.	ludwig.eichinger@uni-koeln.de	Eichinger, Ludwig/AAJ-8895-2021; Clemen, Christoph/B-2761-2011	Eichinger, Ludwig/0000-0003-1594-6117; Clemen, Christoph/0000-0002-1291-4219	German Research Foundation (Deutsche Forschungsgemeinschaft) [EI 399/4-1]; Koln Fortune; Wellcome Trust [082579/Z]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Koln Fortune; Wellcome Trust(Wellcome TrustEuropean Commission)	LE acknowledges support of this work by the German Research Foundation (Deutsche Forschungsgemeinschaft: EI 399/4-1) and by Koln Fortune. This work was supported by Wellcome Trust Program Grant 082579/Z (JGW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler K, 1996, FEBS LETT, V395, P286, DOI 10.1016/0014-5793(96)01053-8; Araki T, 2003, J CELL SCI, V116, P2907, DOI 10.1242/jcs.00501; Araki T, 2008, DEVELOPMENT, V135, P1347, DOI 10.1242/dev.009936; Araki T, 2012, P NATL ACAD SCI USA, V109, pE1931, DOI 10.1073/pnas.1202715109; Araki T, 2010, J CELL SCI, V123, P837, DOI 10.1242/jcs.064436; Blanc C, 2005, EUR J CELL BIOL, V84, P951, DOI 10.1016/j.ejcb.2005.09.014; BRINK M, 1990, J CELL BIOL, V111, P1477, DOI 10.1083/jcb.111.4.1477; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Faix Jan, 2013, Methods Mol Biol, V983, P249, DOI 10.1007/978-1-62703-302-2_13; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; Fukuzawa M, 2001, MOL CELL, V7, P779, DOI 10.1016/S1097-2765(01)00222-2; Gamper M, 1999, J BIOL CHEM, V274, P12129, DOI 10.1074/jbc.274.17.12129; Gatsios P, 1998, J BIOL CHEM, V273, P22962, DOI 10.1074/jbc.273.36.22962; Gebbie L, 2004, MOL BIOL CELL, V15, P3915, DOI 10.1091/mbc.E03-12-0908; Gilsbach BK, 2012, P NATL ACAD SCI USA, V109, P10322, DOI 10.1073/pnas.1203223109; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; Insall RH, 1996, CURR BIOL, V6, P516, DOI 10.1016/S0960-9822(02)00530-4; Kang RJ, 2002, J CELL SCI, V115, P3675, DOI 10.1242/jcs.00039; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Kortholt A, 2008, CELL SIGNAL, V20, P1415, DOI 10.1016/j.cellsig.2008.02.006; Kortholt A, 2006, J BIOL CHEM, V281, P23367, DOI 10.1074/jbc.M600804200; Kuwayama H, 1996, J BIOL CHEM, V271, P23718, DOI 10.1074/jbc.271.39.23718; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Langenick J, 2008, J CELL SCI, V121, P3524, DOI 10.1242/jcs.036798; Lee MR, 2012, J MICROBIOL, V50, P555, DOI 10.1007/s12275-012-2246-7; Lee NS, 2008, DEV GROWTH DIFFER, V50, P607, DOI 10.1111/j.1440-169X.2008.01058.x; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Na JB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-123; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WILLIAMS KL, 1976, GENETICS, V82, P287	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90025	10.1371/journal.pone.0090025	http://dx.doi.org/10.1371/journal.pone.0090025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587195	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900110
J	Norton, GJ; Douglas, A; Lahner, B; Yakubova, E; Guerinot, ML; Pinson, SRM; Tarpley, L; Eizenga, GC; McGrath, SP; Zhao, FJ; Islam, MR; Islam, S; Duan, GL; Zhu, YG; Salt, DE; Meharg, AA; Price, AH				Norton, Gareth J.; Douglas, Alex; Lahner, Brett; Yakubova, Elena; Guerinot, Mary Lou; Pinson, Shannon R. M.; Tarpley, Lee; Eizenga, Georgia C.; McGrath, Steve P.; Zhao, Fang-Jie; Islam, M. Rafiqul; Islam, Shofiqul; Duan, Guilan; Zhu, Yongguan; Salt, David E.; Meharg, Andrew A.; Price, Adam H.			Genome Wide Association Mapping of Grain Arsenic, Copper, Molybdenum and Zinc in Rice (Oryza sativa L.) Grown at Four International Field Sites	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRANSPORTER; IDENTIFICATION; ACCUMULATION; MOLYBDATE; CULTIVARS; GENOTYPE; REVEALS; CROPS; PANEL	The mineral concentrations in cereals are important for human health, especially for individuals who consume a cereal subsistence diet. A number of elements, such as zinc, are required within the diet, while some elements are toxic to humans, for example arsenic. In this study we carry out genome-wide association (GWA) mapping of grain concentrations of arsenic, copper, molybdenum and zinc in brown rice using an established rice diversity panel of,300 accessions and 36.9 k single nucleotide polymorphisms (SNPs). The study was performed across five environments: one field site in Bangladesh, one in China and two in the US, with one of the US sites repeated over two years. GWA mapping on the whole dataset and on separate subpopulations of rice revealed a large number of loci significantly associated with variation in grain arsenic, copper, molybdenum and zinc. Seventeen of these loci were detected in data obtained from grain cultivated in more than one field location, and six co-localise with previously identified quantitative trait loci. Additionally, a number of candidate genes for the uptake or transport of these elements were located near significantly associated SNPs (within 200 kb, the estimated global linkage disequilibrium previously employed in this rice panel). This analysis highlights a number of genomic regions and candidate genes for further analysis as well as the challenges faced when mapping environmentally-variable traits in a highly genetically structured diversity panel.	[Norton, Gareth J.; Douglas, Alex; Salt, David E.; Price, Adam H.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Lahner, Brett; Yakubova, Elena] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Guerinot, Mary Lou] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Pinson, Shannon R. M.; Eizenga, Georgia C.] USDA ARS, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Tarpley, Lee] Texas A&M Univ Syst, Texas A&M AgriLife Res, Beaumont, TX USA; [McGrath, Steve P.; Zhao, Fang-Jie] Rothamsted Res, Harpenden, Herts, England; [Zhao, Fang-Jie] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Islam, M. Rafiqul; Islam, Shofiqul] Bangladesh Agr Univ, Dept Soil Sci, Mymensingh, Bangladesh; [Duan, Guilan; Zhu, Yongguan] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Meharg, Andrew A.] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland	University of Aberdeen; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Dartmouth College; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Nanjing Agricultural University; Bangladesh Agricultural University (BAU); Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Queens University Belfast	Price, AH (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	a.price@abdn.ac.uk	Zhao, Fang-Jie/A-8339-2008; Meharg, Andrew Alexander/F-8182-2014; Duan, Guilan/C-1188-2018; Norton, Gareth J/D-7512-2012; McGrath, Steve P/B-5127-2008; Zhu, Yong-Guan/A-1412-2009; Islam, Shofiqul/L-2010-2016	Zhao, Fang-Jie/0000-0002-0164-169X; Meharg, Andrew Alexander/0000-0003-2019-0449; Duan, Guilan/0000-0002-2880-5017; McGrath, Steve P/0000-0003-0952-8947; Zhu, Yong-Guan/0000-0003-3861-8482; Islam, Shofiqul/0000-0002-8306-5357; Norton, Gareth/0000-0003-4560-170X; Douglas, Alex/0000-0001-6606-1058	BBSRC-DFID [BBF0040871]; U.S. National Science Foundation, Plant Genome Research Program [IOS 0701119, PRGP 0606461]; U.S. National Institute of Environmental Health Sciences [P42ES007373]; BBSRC [BB/H006303/1, BB/F004087/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F004087/1, BB/H006303/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER; Direct For Biological Sciences [1026555] Funding Source: National Science Foundation	BBSRC-DFID(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. National Science Foundation, Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); U.S. National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by BBSRC-DFID grant BBF0040871, the U.S. National Science Foundation, Plant Genome Research Program (grant #IOS 0701119). Research conducted in Arkansas was supported in part by the U.S. National Science Foundation, Plant Genome Research Program (grant #PRGP 0606461) and research at Dartmouth College was supported by the U.S. National Institute of Environmental Health Sciences (grant P42ES007373). The plant material was imported into the UK under import licence IMP/SOIL/18/2009 issued by Science and Advice for Scottish Agriculture. Mention of a trademark or proprietary product does not constitute a guarantee or warranty of the product by the U.S. Department of Agriculture or Texas A&M AgriLife Research, and does not imply its approval to the exclusion of other products that also can be suitable. USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomako EE, 2009, ENVIRON INT, V35, P476, DOI 10.1016/j.envint.2008.07.010; Agusa T, 2009, ENVIRON POLLUT, V157, P396, DOI 10.1016/j.envpol.2008.09.043; Anastasio AE, 2011, PLANT J, V67, P554, DOI 10.1111/j.1365-313X.2011.04606.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Cui K, 2004, PLANT PROD SCI, V7, P309, DOI 10.1626/pps.7.309; Eizenga GC, 2014, J PLANT REGIST, V8, P109, DOI 10.3198/jpr2013.03.0013crmp; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fitzpatrick KL, 2008, FEBS LETT, V582, P1508, DOI 10.1016/j.febslet.2008.03.045; Gasber A, 2011, PLANT BIOLOGY, V13, P710, DOI 10.1111/j.1438-8677.2011.00448.x; Graham R, 1999, FIELD CROP RES, V60, P57, DOI 10.1016/S0378-4290(98)00133-6; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Kiani SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002814; Kile ML, 2007, ENVIRON HEALTH PERSP, V115, P889, DOI 10.1289/ehp.9462; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Lee S. H., 2010, MOL CELLS, V29, P311, DOI DOI 10.1007/s10059-010-0053-8; Lee SC, 2010, PLANT MOL BIOL, V73, P409, DOI 10.1007/s11103-010-9629-0; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lu Y, 2009, ENVIRON SCI TECHNOL, V43, P1724, DOI 10.1021/es802794w; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Mendel RR, 2011, PLANT CELL REP, V30, P1787, DOI 10.1007/s00299-011-1100-4; Mondal D, 2008, APPL GEOCHEM, V23, P2987, DOI 10.1016/j.apgeochem.2008.06.025; Norton GJ, 2012, ANN APPL BIOL, V161, P46, DOI 10.1111/j.1744-7348.2012.00549.x; NRC (National Research Council), 2001, ARSENIC DRINKING WAT; Pillai TR, 2010, CROP SCI, V50, P2065, DOI 10.2135/cropsci2009.10.0568; Price AH, 2013, FOOD ENERGY SECUR, V2, P120, DOI 10.1002/fes3.29; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramesh SA, 2003, PLANT PHYSIOL, V133, P126, DOI 10.1104/pp.103.026815; Sun GX, 2009, ENVIRON INT, V35, P473, DOI 10.1016/j.envint.2008.07.020; Tejada-Jimenez M, 2011, P NATL ACAD SCI USA, V108, P6420, DOI 10.1073/pnas.1100700108; Tomatsu H, 2007, P NATL ACAD SCI USA, V104, P18807, DOI 10.1073/pnas.0706373104; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Waters BM, 2011, PLANT SCI, V180, P562, DOI 10.1016/j.plantsci.2010.12.003; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; WHO, 2009, MICR DEF IR DEF AN; WHO, 2002, WORLD HLTH REP RED R; Williams PN, 2006, ENVIRON SCI TECHNOL, V40, P4903, DOI 10.1021/es060222i; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Yang X, 2009, MOL BIOL REP, V36, P281, DOI 10.1007/s11033-007-9177-0; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yuan M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-69; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zeng YW, 2010, ENVIRON GEOCHEM HLTH, V32, P165, DOI 10.1007/s10653-009-9272-3; Zhang M, 2013, THEOR APPL GENET, DOI [10.1007/s0012-013-2207-5, DOI 10.1007/S0012-013-2207-5]; Zhang XQ, 2011, EUPHYTICA, V180, P173, DOI 10.1007/s10681-011-0346-9; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	69	117	125	0	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89685	10.1371/journal.pone.0089685	http://dx.doi.org/10.1371/journal.pone.0089685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586963	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900067
J	Ree, AH; Saelen, MG; Kalanxhi, E; Ostensen, IHG; Schee, K; Roe, K; Abrahamsen, TW; Dueland, S; Flatmark, K				Ree, Anne Hansen; Saelen, Marie Gron; Kalanxhi, Erta; Ostensen, Ingrid H. G.; Schee, Kristina; Roe, Kathrine; Abrahamsen, Torveig Weum; Dueland, Svein; Flatmark, Kjersti			Biomarkers of Histone Deacetylase Inhibitor Activity in a Phase 1 Combined-Modality Study with Radiotherapy	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; REPAIR PROTEIN MSH6; C-MYC; I TRIAL; GENOMIC INSTABILITY; HDAC INHIBITORS; DOWN-REGULATION; CANCER; VORINOSTAT; RADIOSENSITIZATION	Background: Following the demonstration that histone deacetylase inhibitors enhanced experimental radiation-induced clonogenic suppression, the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study, combining fractionated radiotherapy with daily vorinostat for pelvic carcinoma, was designed to evaluate both clinical and novel biomarker endpoints, the latter relating to pharmacodynamic indicators of vorinostat action in clinical radiotherapy. Patients and Methods: Potential biomarkers of vorinostat radiosensitizing action, not simultaneously manifesting molecular perturbations elicited by the radiation itself, were explored by gene expression array analysis of study patients peripheral blood mononuclear cells (PBMC), sampled at baseline (T0) and on-treatment two and 24 hours (T2 and T24) after the patients had received vorinostat. Results: This strategy revealed 1,600 array probes that were common for the comparisons T2 versus T0 and T24 versus T2 across all of the patients, and furthermore, that no significantly differential expression was observed between the T0 and T24 groups. Functional annotation analysis of the array data showed that a significant number of identified genes were implicated in gene regulation, the cell cycle, and chromatin biology. Gene expression was validated both in patients PBMC and in vorinostat-treated human carcinoma xenograft models, and transient repression of MYC was consistently observed. Conclusion: Within the design of the PRAVO study, all of the identified genes showed rapid and transient induction or repression and therefore, in principle, fulfilled the requirement of being pharmacodynamic biomarkers of vorinostat action in fractionated radiotherapy, possibly underscoring the role of MYC in this therapeutic setting.	[Ree, Anne Hansen; Kalanxhi, Erta; Roe, Kathrine] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway; [Ree, Anne Hansen; Saelen, Marie Gron] Univ Oslo, Inst Clin Med, Oslo, Norway; [Saelen, Marie Gron; Schee, Kristina; Abrahamsen, Torveig Weum; Flatmark, Kjersti] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Tumor Biol, Oslo, Norway; [Ostensen, Ingrid H. G.] Norwegian Inst Publ Hlth, Dept Genes & Environm, Oslo, Norway; [Dueland, Svein] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Flatmark, Kjersti] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Gastroenterol Surg, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo	Ree, AH (corresponding author), Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway.	a.h.ree@medisin.uio.no	Redalen, Kathrine Roe/AAA-6623-2019; Redalen, Kathrine/F-3383-2017	Redalen, Kathrine/0000-0002-1172-4632; Kalanxhi, Erta/0000-0002-3614-6058; Ree, Anne H./0000-0002-8264-3223	MSD (Norge) AS; Norway branch of Merck Co., Inc.; Akershus University Hospital [2012-101]; Norwegian Cancer Society [2012-105]; South-Eastern Norway Regional Health Authority [2010-014, 2012-002, 2013-101]	MSD (Norge) AS; Norway branch of Merck Co., Inc.; Akershus University Hospital; Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority	This work was supported by MSD (Norge) AS, the Norway branch of Merck & Co., Inc., directed at overheads associated with the study (to AHR, SD, and KF), Akershus University Hospital Grant 2012-101 (to AHR), the Norwegian Cancer Society Grant 2012-105 (to AHR), and the South-Eastern Norway Regional Health Authority Grants 2010-014, 2012-002, and 2013-101 (all to AHR). MGS is PhD Research Fellow and EK and KR are Postdoctoral Research Fellows of the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangert A, 2012, ONCOGENE, V31, P4677, DOI 10.1038/onc.2011.614; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bratland A, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-33; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; Chen SY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197946; Chinnaiyan P, 2012, NEURO-ONCOLOGY, V14, P93, DOI 10.1093/neuonc/nor187; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Ellis L, 2008, CLIN CANCER RES, V14, P4500, DOI 10.1158/1078-0432.CCR-07-4262; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Flatmark K, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-25; Folkvord S, 2010, INT J RADIAT ONCOL, V78, P555, DOI 10.1016/j.ijrobp.2010.04.036; Folkvord S, 2009, INT J RADIAT ONCOL, V74, P546, DOI 10.1016/j.ijrobp.2009.01.068; FORUS A, 1994, CANCER GENET CYTOGEN, V78, P165, DOI 10.1016/0165-4608(94)90085-X; Fotheringham S, 2009, CANCER CELL, V15, P57, DOI 10.1016/j.ccr.2008.12.001; Groselj B, 2013, BRIT J CANCER, V108, P748, DOI 10.1038/bjc.2013.21; Hirohata T, 2013, J CLIN ENDOCR METAB, V98, P1130, DOI 10.1210/jc.2012-2924; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Rodriguez-Jimenez FJ, 2008, STEM CELLS, V26, P2052, DOI 10.1634/stemcells.2007-1016; Jones DR, 2012, J THORAC ONCOL, V7, P1683, DOI 10.1097/JTO.0b013e318267928d; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Khan O, 2010, P NATL ACAD SCI USA, V107, P6532, DOI 10.1073/pnas.0913912107; Khanim FL, 2009, BRIT J HAEMATOL, V144, P332, DOI 10.1111/j.1365-2141.2008.07449.x; Kretzner L, 2011, CANCER RES, V71, P3912, DOI 10.1158/0008-5472.CAN-10-2259; LETOURNEAU C, 2009, JNCI-J NATL CANCER I, V101, P1; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; LoRusso PM, 2010, CLIN CANCER RES, V16, P1710, DOI 10.1158/1078-0432.CCR-09-1993; Los G, 1999, CLIN CANCER RES, V5, P1610; Luoto KR, 2010, CANCER RES, V70, P8748, DOI 10.1158/0008-5472.CAN-10-0944; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Noordhuis P, 2008, BIOCHEM PHARMACOL, V76, P53, DOI 10.1016/j.bcp.2008.04.007; Podar K, 2010, CELL CYCLE, V9, P1722, DOI 10.4161/cc.9.9.11358; Ramaswamy B, 2012, BREAST CANCER RES TR, V132, P1063, DOI 10.1007/s10549-011-1928-x; Ree AH, 2008, NAT GENET, V40, P812, DOI 10.1038/ng0708-812; Ree AH, 2013, RADIOTHER ONCOL, V108, P3, DOI 10.1016/j.radonc.2013.06.007; Ree AH, 2010, LANCET ONCOL, V11, P459, DOI 10.1016/S1470-2045(10)70058-9; Saelen MG, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-165; Sandor V, 2002, CLIN CANCER RES, V8, P718; Scuto A, 2008, BLOOD, V111, P5093, DOI 10.1182/blood-2007-10-117762; Seo SK, 2011, J THORAC ONCOL, V6, P1313, DOI 10.1097/JTO.0b013e318220caff; Shabason JE, 2011, J CELL MOL MED, V15, P2735, DOI 10.1111/j.1582-4934.2011.01296.x; Shahi A, 2011, NUCLEIC ACIDS RES, V39, P2130, DOI 10.1093/nar/gkq1095; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thompson ME, 2010, FEBS J, V277, P3072, DOI 10.1111/j.1742-4658.2010.07733.x; Ting S, 2013, CLIN LUNG CANCER, V14, P558, DOI 10.1016/j.cllc.2013.04.013; Venugopal B, 2013, CLIN CANCER RES, V19, P4262, DOI 10.1158/1078-0432.CCR-13-0312; Wang WJ, 2013, CANCER RES, V73, P1219, DOI 10.1158/0008-5472.CAN-12-1408; Xie YX, 2012, CANCER SCI, V103, P1238, DOI 10.1111/j.1349-7006.2012.02285.x; Yeo W, 2012, J CLIN ONCOL, V30, P3361, DOI 10.1200/JCO.2011.41.2395; Yoo YG, 2009, ANN NY ACAD SCI, V1177, P198, DOI 10.1111/j.1749-6632.2009.05043.x; Zhang Y, 2007, RADIAT RES, V168, P115, DOI 10.1667/RR0811.1; Zhu CH, 2011, J MOL MED, V89, P279, DOI 10.1007/s00109-010-0701-7	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89750	10.1371/journal.pone.0089750	http://dx.doi.org/10.1371/journal.pone.0089750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587009	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900077
J	Arja, C; Ravuri, RR; Pulamaghatta, VN; Surapaneni, KM; Raya, P; Adimoolam, C; Kanala, KR				Arja, Cholendra; Ravuri, Rajasekhara Reddy; Pulamaghatta, Venugopal N.; Surapaneni, Krishna Mohan; Raya, Premanand; Adimoolam, Chandrasekhar; Kanala, Kodanda Reddy			Genetic Determinants of Chronic Obstructive Pulmonary Disease in South Indian Male Smokers	PLOS ONE			English	Article							SERPINE2 GENE; LUNG-FUNCTION; POLYMORPHISMS; ASSOCIATION; EMPHYSEMA; VARIANTS; IL-13; COPD; SUSCEPTIBILITY; EXPRESSION	The development of chronic obstructive pulmonary disease, upon exposure to tobacco smoke, is the cumulative effect of defects in several genes. With the aim of understanding the genetic structure that is characteristic of our patient population, we selected forty two single nucleotide polymorphisms of twenty genes based on previous studies and genotyped a total of 382 samples, which included 236 patients and 146 controls using Sequenom MassARRAY system. Allele frequencies of rs2276109 (MMP12) and rs1800925 (IL13) differed significantly between patients and controls (p = 0.013 and 0.044 respectively). Genotype analysis showed association of rs2276109 (MMP12) under additive and dominant models (p = 0.017, p = 0.012 respectively), rs1800925 (IL13) under additive model (p = 0.047) and under recessive model, rs1695 (GSTP1; p = 0.034), rs729631, rs975278, rs7583463 (SERPINE2; p = 0.024, 0.024 and 0.012 respectively), rs2568494, rs10851906 (IREB2; p = 0.026 and 0.041 respectively) and rs7671167 (FAM13A; p = 0.029). The minor alleles of rs1695 (G), rs7671167 (T), rs729631 (G), rs975278 (A) and rs7583463 (A) showed significant negative association whereas those of rs2276109 (G), rs2568494 (A), rs10851906 (G) and rs1800469 (T; TGF-beta) showed significant positive association with lung function under different genetic models. Haplotypes carrying A allele of rs2276109, G allele of rs1695 showed negative correlation with lung function. Haplotypes carrying major alleles of rs7671167 (C) of FAM13A and rs729631 (C), rs975278 (G), rs7583463 (C) of SERPINE2 had protective effect on lung function. Haplotypes of IREB2 carrying major alleles of rs2568494 (G), rs2656069 (A), rs10851906 (A), rs965604 (C) and minor alleles of rs1964678 (T), rs12593229 (T) showed negative correlation with lung function. In conclusion, our study replicated the results of most of the previous studies. However, the positive correlation between the minor alleles of rs2568494 (A) and rs10851906 (G) of IREB2 and lung function needs further investigation.	[Arja, Cholendra; Kanala, Kodanda Reddy] Sri Venkateswara Univ, Dept Anthropol, Div Human Genet, Tirupati 517502, Andhra Pradesh, India; [Ravuri, Rajasekhara Reddy] Punjabi Univ, Dept Human Genet, Patiala, Punjab, India; [Pulamaghatta, Venugopal N.; Adimoolam, Chandrasekhar] Anthropol Survey India, Southern Reg Ctr, Mysore, Karnataka, India; [Surapaneni, Krishna Mohan] Saveetha Univ, Dept Biochem, Saveetha Med Coll & Hosp, Fac Med, Madras, Tamil Nadu, India; [Raya, Premanand] Premananda Allergy & Chest Hosp, Tirupati, Andhra Pradesh, India	Sri Venkateswara University; Punjabi University; Saveetha Institute of Medical & Technical Science; Saveetha Medical College & Hospital	Kanala, KR (corresponding author), Sri Venkateswara Univ, Dept Anthropol, Div Human Genet, Tirupati 517502, Andhra Pradesh, India.	Kanalakr@yahoo.com	Krishna Mohan, Surapaneni/K-4865-2013	Krishna Mohan, Surapaneni/0000-0002-5204-5708	Indian Council of Medical Research (ICMR; New Delhi) [IRIS ID: 2009-07590, 54/08/2009/HUM-BMS]	Indian Council of Medical Research (ICMR; New Delhi)(Indian Council of Medical Research (ICMR))	The Indian Council of Medical Research (ICMR; New Delhi) provided the grant for completing this research (IRIS ID: 2009-07590; File no. 54/08/2009/HUM-BMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CANTLAY AM, 1994, THORAX, V49, P1010, DOI 10.1136/thx.49.10.1010; Caramori G, 2004, HISTOPATHOLOGY, V45, P477, DOI 10.1111/j.1365-2559.2004.01952.x; Celedon JC, 2004, HUM MOL GENET, V13, P1649, DOI 10.1093/hmg/ddh171; Chappell SL, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-24; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828; Elkington PT, 2010, NEW ENGL J MED, V362, P1241, DOI 10.1056/NEJMc1000959; Fujimoto K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-159; Global Initiative for Chronic Obstructive Lung Disease, 2006, GLOB STRAT DIAGN MAN; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Haq I, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-7; Harries LW, 1997, CARCINOGENESIS, V18, P641, DOI 10.1093/carcin/18.4.641; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; He JQ, 2004, AM J RESP CRIT CARE, V170, P388, DOI 10.1164/rccm.200312-1763OC; He JQ, 2002, AM J RESP CRIT CARE, V166, P323, DOI 10.1164/rccm.2111059; Hersh Craig P, 2008, Proc Am Thorac Soc, V5, P486, DOI 10.1513/pats.200706-078ET; Ishii T, 1999, THORAX, V54, P693, DOI 10.1136/thx.54.8.693; Jain NK, 2011, LUNG INDIA, V28, P258, DOI 10.4103/0970-2113.85686; Jindal S K, 2001, Indian J Chest Dis Allied Sci, V43, P139; Jormsjo S, 2000, CIRC RES, V86, P998, DOI 10.1161/01.RES.86.9.998; Kim WJ, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-16; Kraan TCTMV, 2002, GENES IMMUN, V3, P436, DOI 10.1038/sj.gene.6363896; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Kumar Raj, 2010, Indian J Chest Dis Allied Sci, V52, P19; Lin S, 2010, HANDBOOK ON ANALYZING HUMAN GENETIC DATA, P1; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Mahadeva R, 1998, THORAX, V53, P501, DOI 10.1136/thx.53.6.501; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Roberts AB, 2003, NATURE, V422, P130, DOI 10.1038/422130a; Ryberg D, 1997, CARCINOGENESIS, V18, P1285, DOI 10.1093/carcin/18.7.1285; Sadeghnejad A, 2007, AM J RESP CRIT CARE, V176, P748, DOI 10.1164/rccm.200704-543OC; Sundberg K, 1998, CARCINOGENESIS, V19, P433, DOI 10.1093/carcin/19.3.433; Vibhuti A, 2007, BIOCHEM BIOPH RES CO, V359, P136, DOI 10.1016/j.bbrc.2007.05.076; Wood AM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-130; Young RP, 2011, APPL CLIN GENET, V4, P1, DOI 10.2147/TACG.S15758; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zhu G, 2007, AM J RESP CRIT CARE, V176, P167, DOI 10.1164/rccm.200611-1723OC; ZIMNIAK P, 1994, EUR J BIOCHEM, V224, P893, DOI 10.1111/j.1432-1033.1994.00893.x	42	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89957	10.1371/journal.pone.0089957	http://dx.doi.org/10.1371/journal.pone.0089957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587150	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700120
J	Huang, SF; Chen, YT; Lee, WC; Chang, IC; Chiu, YT; Chang, Y; Tu, HC; Yuh, CH; Matsuura, I; Shih, LY; Lai, MW; Wu, HDI; Chen, MF; Yeh, CT				Huang, Shiu-Feng; Chen, Ya-Ting; Lee, Wei-Chen; Chang, Il-Chi; Chiu, Yu-Ting; Chang, Yu; Tu, Hsiao-Chen; Yuh, Chiou-Hwa; Matsuura, Isao; Shih, Liang-Yu; Lai, Ming-Wei; Wu, Hong-Dar Isaac; Chen, Miin-Fu; Yeh, Chau-Ting			Identification of Transforming Hepatitis B Virus S Gene Nonsense Mutations Derived from Freely Replicative Viruses in Hepatocellular Carcinoma	PLOS ONE			English	Article							MUTANTS; LIVER; PROTEIN; HEPATOCARCINOGENESIS; TRANSACTIVATOR; PROLIFERATION; PATHOGENESIS; PROGRESSION; INTEGRATION; EXPRESSION	Background & Aims: The correlation between chronic hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC) has been well-established. But the roles of viral factor remain uncertain. Only HBV X gene and nonsense mutations of S gene (C-terminal truncation of HBV surface protein) have been demonstrated to have transforming activity. Whether they play a significant role in hepatocarcinogenesis is still uncertain. Methods: Twenty-five HBV-related HCC patients were positive for hepatitis B core antigen (HBcAg) in the cancerous parts of their HCC liver tissues by immunohistochemistry studies, and had available tissue for whole HBV genome sequence analysis. The results were compared with 25 gender and age-matched HBcAg negative HCCs. Plasmids encoding HBV S gene nonsense mutations identified from HBcAg (+) HCC tissue were constructed to investigate their cell proliferation, transformation activity and the oncogenic potentials by xenograft study and in vivo migration assay. Results: HBcAg (+) HCC patients were significantly associated with cirrhosis and small tumor size (<= 2 cm) when compared with HBcAg (-) HCC patients. Southern blot analyses revealed freely replicative forms of HBV in the cancerous parts of HBcAg(+) HCC. Three nonsense mutations of S gene (sL95*, sW182*, and sL216*) were identified in the HBcAg(+) HCC tumor tissues. sW182* and sL216* were recurrently found in the 25 HBcAg (-) HCC tumor tissue, too. Functional studies of the above 3 non-sense mutations all demonstrated higher cell proliferation activities and transformation abilities than wild type S, especially sW182*. Tumorigenicity analysis by xenograft experiments and in vitro migration assay showed potent oncogenic activity of sW182* mutant. Conclusions: This study has demonstrated potent oncogenic activity of nonsense mutations of HBV S gene, suggesting they may play an important role in hepatocarcinogenesis.	[Huang, Shiu-Feng; Chen, Ya-Ting; Chang, Il-Chi; Chiu, Yu-Ting; Chang, Yu; Tu, Hsiao-Chen; Yuh, Chiou-Hwa; Matsuura, Isao] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Huang, Shiu-Feng; Shih, Liang-Yu] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Lee, Wei-Chen; Chen, Miin-Fu] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Gen Surg, Tao Yuan, Taiwan; [Lai, Ming-Wei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Dept Appl Math, Taichung 40227, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Inst Stat, Taichung 40227, Taiwan; [Yeh, Chau-Ting] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Liver Res Ctr, Tao Yuan, Taiwan; [Huang, Shiu-Feng] Tzu Chi Univ, Sch Med, Tzu Chi Gen Hosp, Dept Pathol,Taipei Branch, Hualien, Taiwan; [Shih, Liang-Yu] Tzu Chi Gen Hosp, Dalin Branch, Dept Pathol, Chiayi, Taiwan	National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Chung Hsing University; National Chung Hsing University; Chang Gung Memorial Hospital; Chang Gung University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital	Huang, SF (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan.	sfhuang@nhri.org.tw; chauting@adm.cgmh.org.tw	Yuh, Chiou-Hwa/AAL-3531-2020; Matsuura, Isao/E-3979-2010; Huang, Shiu-Feng Kathy/E-3977-2010; Yuh, Chiou-Hwa/AAL-2938-2020; Yuh, Chiou-Hwa/E-3972-2010		National Health Research Institutes for Shiu-Feng Huang [NHRI-A1-MG-093-PP-04, NHRI-A1-MG-096-PP-04, NHRI-A1-MG-98-PP-04, NHRI-A1-MG-100-PP-04]; National Science Council for Shiu-Feng Huang [NSC92-2320-B-400-002, NSC97-2320-B-400-006-MY3]	National Health Research Institutes for Shiu-Feng Huang; National Science Council for Shiu-Feng Huang	This work was supported by grants from National Health Research Institutes for Shiu-Feng Huang (NHRI-A1-MG-093-PP-04, NHRI-A1-MG-096-PP-04, NHRI-A1-MG-98-PP-04, NHRI-A1-MG-100-PP-04) and National Science Council for Shiu-Feng Huang (NSC92-2320-B-400-002, NSC97-2320-B-400-006-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; CASELMANN WH, 1990, P NATL ACAD SCI USA, V87, P2970, DOI 10.1073/pnas.87.8.2970; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; DUNSFORD HA, 1990, CANCER RES, V50, P3400; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; FEITELSON M, 1992, CLIN MICROBIOL REV, V5, P275, DOI 10.1128/CMR.5.3.275-301.1992; Hessein M, 2005, TUMORI J, V91, P241, DOI 10.1177/030089160509100306; Hsia CC, 1997, BIOCHEM BIOPH RES CO, V241, P726, DOI 10.1006/bbrc.1997.7882; Hsu CW, 2011, HEPATOLOGY, V54, P101, DOI 10.1002/hep.24363; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KEKULE AS, 1990, NATURE, V343, P457, DOI 10.1038/343457a0; KOIKE K, 1994, HEPATOLOGY, V19, P810, DOI 10.1002/hep.1840190403; Lai MW, 2009, ANTIVIR THER, V14, P249; LAUER U, 1992, J VIROL, V66, P5284, DOI 10.1128/JVI.66.9.5284-5289.1992; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; London WT, 2006, CANC EPIDEMIOLOGY PR; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; OHAKI Y, 1983, CANCER, V51, P822, DOI 10.1002/1097-0142(19830301)51:5<822::AID-CNCR2820510513>3.0.CO;2-C; ROBINSON WS, 1994, ANNU REV MED, V45, P297; SHIH CH, 1987, J VIROL, V61, P3491, DOI 10.1128/JVI.61.11.3491-3498.1987; Tralhao JG, 2002, P NATL ACAD SCI USA, V99, P6991, DOI 10.1073/pnas.092657699; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Yeh CT, 1998, J MED VIROL, V55, P42, DOI 10.1002/(SICI)1096-9071(199805)55:1<42::AID-JMV8>3.0.CO;2-O; Yeh CT, 2000, ONCOGENE, V19, P5213, DOI 10.1038/sj.onc.1203903; Yeh CT, 2000, HEPATOLOGY, V31, P1318, DOI 10.1053/jhep.2000.7296; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043	28	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89753	10.1371/journal.pone.0089753	http://dx.doi.org/10.1371/journal.pone.0089753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587012	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700085
J	Haussig, JM; Matuschewski, K; Kooij, TWA				Haussig, Joana M.; Matuschewski, Kai; Kooij, Taco W. A.			Identification of Vital and Dispensable Sulfur Utilization Factors in the Plasmodium Apicoplast	PLOS ONE			English	Article							FE-S CLUSTER; BIOGENESIS; PROTEIN; SUFC; BERGHEI; SYSTEM; STAGE; DNA; TRANSFECTION; EUKARYOTES	Iron-sulfur [Fe-S] clusters are ubiquitous and critical cofactors in diverse biochemical processes. They are assembled by distinct [Fe-S] cluster biosynthesis pathways, typically in organelles of endosymbiotic origin. Apicomplexan parasites, including Plasmodium, the causative agent of malaria, harbor two separate [Fe-S] cluster biosynthesis pathways in the their mitochondrion and apicoplast. In this study, we systematically targeted the five nuclear-encoded sulfur utilization factors (SUF) of the apicoplast [Fe-S] cluster biosynthesis pathway by experimental genetics in the murine malaria model parasite Plasmodium berghei. We show that four SUFs, namely SUFC, D, E, and S are refractory to targeted gene deletion, validating them as potential targets for antimalarial drug development. We achieved targeted deletion of SUFA, which encodes a potential [Fe-S] transfer protein, indicative of a dispensable role during asexual blood stage growth in vivo. Furthermore, no abnormalities were observed during Plasmodium life cycle progression in the insect and mammalian hosts. Fusion of a fluorescent tag to the endogenous P. berghei SUFs demonstrated that all loci were accessible to genetic modification and that all five tagged SUFs localize to the apicoplast. Together, our experimental genetics analysis identifies the key components of the SUF [Fe-S] cluster biosynthesis pathway in the apicoplast of a malarial parasite and shows that absence of SUFC, D, E, or S is incompatible with Plasmodium blood infection in vivo.	[Haussig, Joana M.; Matuschewski, Kai; Kooij, Taco W. A.] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany; [Matuschewski, Kai] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Max Planck Society; Humboldt University of Berlin	Kooij, TWA (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany.	kooij@mpiib-berlin.mpg.de	Kooij, Taco W.A./L-5623-2015	Kooij, Taco W.A./0000-0002-8547-7523; Haussig, Joana M./0000-0002-5216-3472; Matuschewski, Kai/0000-0001-6147-8591	Max Planck Society; EVIMalaR network [34]	Max Planck Society(Max Planck SocietyFoundation CELLEX); EVIMalaR network	This work was supported by the Max Planck Society and partly by the EVIMalaR network (#34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Cilingir G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036598; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Deligianni E, 2011, CELL MICROBIOL, V13, P1714, DOI 10.1111/j.1462-5822.2011.01652.x; Ecker A, 2011, J INFECT DIS, V203, P228, DOI 10.1093/infdis/jiq036; Ellis KES, 2001, MOL MICROBIOL, V41, P973, DOI 10.1046/j.1365-2958.2001.02588.x; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; Gisselberg JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003655; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Haussig JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067269; Haussig JM, 2011, MOL MICROBIOL, V81, P1511, DOI 10.1111/j.1365-2958.2011.07787.x; Hidese R, 2011, APPL MICROBIOL BIOT, V91, P47, DOI 10.1007/s00253-011-3336-x; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kenthirapalan S, 2012, INT J PARASITOL, V42, P1185, DOI 10.1016/j.ijpara.2012.10.006; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kitaoka S, 2006, FEBS LETT, V580, P137, DOI 10.1016/j.febslet.2005.11.058; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kooij TWA, 2012, MOL BIOCHEM PARASIT, V185, P19, DOI 10.1016/j.molbiopara.2012.06.001; Kumar B, 2011, INT J PARASITOL, V41, P991, DOI 10.1016/j.ijpara.2011.05.006; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; MALKIN R, 1966, BIOCHEM BIOPH RES CO, V23, P822, DOI 10.1016/0006-291X(66)90561-4; Matz JM, 2013, MOL BIOCHEM PARASIT, V191, P44, DOI 10.1016/j.molbiopara.2013.09.003; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Rangachari K, 2002, FEBS LETT, V514, P225, DOI 10.1016/S0014-5793(02)02369-4; SAKURAI H, 1985, J BIOCHEM-TOKYO, V98, P69, DOI 10.1093/oxfordjournals.jbchem.a135274; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Xu XM, 2011, ANTIOXID REDOX SIGN, V15, P271, DOI 10.1089/ars.2010.3259; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	54	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89718	10.1371/journal.pone.0089718	http://dx.doi.org/10.1371/journal.pone.0089718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586983	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900142
J	Connelly, WM				Connelly, William M.			Autaptic Connections and Synaptic Depression Constrain and Promote Gamma Oscillations	PLOS ONE			English	Article							HIPPOCAMPAL INTERNEURON NETWORKS; FAST-SPIKING INTERNEURONS; VISUAL-CORTEX; GABAERGIC INTERNEURONS; RAT NEOCORTEX; LAYER-V; INHIBITION; SYNAPSES; NEURONS; CELLS	Computational models of gamma oscillations have helped increase our understanding of the mechanisms that shape these 40-80 Hz cortical rhythms. Evidence suggests that interneurons known as basket cells are responsible for the generation of gamma oscillations. However, current models of gamma oscillations lack the dynamic short term synaptic plasticity seen at basket cell-basket cell synapses as well as the large autaptic synapses basket cells are known to express. Hence, I sought to extend the Wang-Buzsaki model of gamma oscillations to include these features. I found that autapses increased the synchrony of basket cell membrane potentials across the network during neocortical gamma oscillations as well as allowed the network to oscillate over a broader range of depolarizing drive. I also found that including realistic synaptic depression filtered the output of the network. Depression restricted the network to oscillate in the 60-80 Hz range rather than the 40120 Hz range seen in the standard model. This work shows the importance of including accurate synapses in any future model of gamma oscillations.	Cardiff Univ, Sch Biosci, Neurosci Div, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Connelly, WM (corresponding author), Cardiff Univ, Sch Biosci, Neurosci Div, Life Sci Bldg, Cardiff CF10 3AX, S Glam, Wales.	connelly.bill@gmail.com		Connelly, William/0000-0002-0986-6260	Neurological Foundation of New Zealand	Neurological Foundation of New Zealand	This work was funded by the Neurological Foundation of New Zealand (http://www.neurological.org.nz) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Bacci A, 2003, J NEUROSCI, V23, P859; Bagnall MW, 2011, NEURON, V71, P180, DOI 10.1016/j.neuron.2011.05.032; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bush P, 1996, J COMPUT NEUROSCI, V3, P91, DOI 10.1007/BF00160806; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carnevale NT, 2006, NEURON BOOK; Connelly WM, 2010, J PHYSIOL-LONDON, V588, P2047, DOI 10.1113/jphysiol.2009.185199; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Fukuda T, 2003, NEUROSCIENCE, V120, P5, DOI 10.1016/S0306-4522(03)00328-2; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Golomb D, 2006, J NEUROPHYSIOL, V95, P1049, DOI 10.1152/jn.00932.2005; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; KISVARDAY ZF, 1993, J COMP NEUROL, V327, P398, DOI 10.1002/cne.903270307; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Tamas G, 1998, J NEUROSCI, V18, P4255; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wang XJ, 1996, J NEUROSCI, V16, P6402; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740	36	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89995	10.1371/journal.pone.0089995	http://dx.doi.org/10.1371/journal.pone.0089995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587175	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332396200105
J	Rowan, BG; Gimble, JM; Sheng, M; Anbalagan, M; Jones, RK; Frazier, TP; Asher, M; Lacayo, EA; Friedlander, PL; Kutner, R; Chiu, ES				Rowan, Brian G.; Gimble, Jeffrey M.; Sheng, Mei; Anbalagan, Muralidharan; Jones, Ryan K.; Frazier, Trivia P.; Asher, Majdouline; Lacayo, Eduardo A.; Friedlander, Paul L.; Kutner, Robert; Chiu, Ernest S.			Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Triple Negative Breast Cancer Xenografts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; AUTOLOGOUS FAT TRANSFER; ASSISTED LIPOTRANSFER; REGENERATIVE THERAPY; GROWTH; TRANSPLANTATION; INTERLEUKIN-6; TRANSITION; INHIBITOR; INJECTION	Background: Fat grafting is used to restore breast defects after surgical resection of breast tumors. Supplementing fat grafts with adipose tissue-derived stromal/stem cells (ASCs) is proposed to improve the regenerative/restorative ability of the graft and retention. However, long term safety for ASC grafting in proximity of residual breast cancer cells is unknown. The objective of this study was to determine the impact of human ASCs derived from abdominal lipoaspirates of three donors, on a human breast cancer model that exhibits early metastasis. Methodology/Principal Findings: Human MDA-MB-231 breast cancer cells represents "triple negative" breast cancer that exhibits early micrometastasis to multiple mouse organs [1]. Human ASCs were derived from abdominal adipose tissue from three healthy female donors. Indirect co-culture of MDA-MB-231 cells with ASCs, as well as direct co-culture demonstrated that ASCs had no effect on MDA-MB-231 growth. Indirect co-culture, and ASC conditioned medium (CM) stimulated migration of MDA-MB-231 cells. ASC/RFP cells from two donors co-injected with MDA-MB-231/GFP cells exhibited a donor effect for stimulation of primary tumor xenografts. Both ASC donors stimulated metastasis. ASC/RFP cells were viable, and integrated with MDA-MB-231/GFP cells in the tumor. Tumors from the co-injection group of one ASC donor exhibited elevated vimentin, matrix metalloproteinase-9 (MMP-9), IL-8, VEGF and microvessel density. The co-injection group exhibited visible metastases to the lung/liver and enlarged spleen not evident in mice injected with MDA-MB-231/GFP alone. Quantitation of the total area of GFP fluorescence and human chromosome 17 DNA in mouse organs, H&E stained paraffin sections and fluorescent microscopy confirmed multi-focal metastases to lung/liver/spleen in the co-injection group without evidence of ASC/RFP cells. Conclusions: Human ASCs derived from abdominal lipoaspirates of two donors stimulated metastasis of MDA-MB-231 breast tumor xenografts to multiple mouse organs. MDA-MB-231 tumors co-injected with ASCs from one donor exhibited partial EMT, expression of MMP-9, and increased angiogenesis.	[Rowan, Brian G.; Anbalagan, Muralidharan; Jones, Ryan K.; Frazier, Trivia P.; Asher, Majdouline] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, New Orleans, LA 70112 USA; [Gimble, Jeffrey M.] Louisiana State Univ, Pennington Biomed Res Ctr, Stem Cell Biol Lab, Baton Rouge, LA 70808 USA; [Sheng, Mei; Lacayo, Eduardo A.; Friedlander, Paul L.] Tulane Univ, Sch Med, Dept Otolaryngol, New Orleans, LA 70112 USA; [Kutner, Robert] Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, New Orleans, LA USA; [Chiu, Ernest S.] NYU, Langone Med Ctr, Dept Plast Surg, New York, NY USA	Tulane University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; New York University; NYU Langone Medical Center	Rowan, BG (corresponding author), Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	browan@tulane.edu; Ernest.chiu@nyumc.org		Anbalagan, Muralidharan/0000-0001-5797-7558; Lacayo, Eduardo/0000-0001-9148-6285	Plastic Surgery Education Fund; Aesthetic Surgery Education and Research Foundation; Tulane University School of Medicine Pilot Funds; Pennington Biomedical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Plastic Surgery Education Fund; Aesthetic Surgery Education and Research Foundation; Tulane University School of Medicine Pilot Funds; Pennington Biomedical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported, in part, by grants from the Plastic Surgery Education Fund and the Aesthetic Surgery Education and Research Foundation (to ESC), and Tulane University School of Medicine Pilot Funds (BGR, ESC, PLF, JMG), as well as the Pennington Biomedical Research Foundation (JMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarenque SM, 2011, STEM CELL RES, V7, P163, DOI 10.1016/j.scr.2011.05.002; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Anbalagan M, 2012, MOL CANCER THER, V11, P1936, DOI 10.1158/1535-7163.MCT-12-0146; Anbalagan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033017; Anbalagan M, 2012, BREAST CANCER RES TR, V132, P391, DOI 10.1007/s10549-011-1513-3; Becker M, 2002, BRIT J CANCER, V87, P1328, DOI 10.1038/sj.bjc.6600573; Bertolini F, 2012, BBA-REV CANCER, V1826, P209, DOI 10.1016/j.bbcan.2012.04.004; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Chandler EM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015008; Chandler EM, 2012, P NATL ACAD SCI USA, V109, P9786, DOI 10.1073/pnas.1121160109; Chandler EM, 2011, BIOTECHNOL BIOENG, V108, P1683, DOI 10.1002/bit.23079; Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]; Coleman SR, 1997, CLIN PLAST SURG, V24, P347; Cook Todd, 2004, Facial Plast Surg, V20, P145, DOI 10.1055/s-2004-861755; Curry JM, 2008, LARYNGOSCOPE, V118, P210, DOI 10.1097/MLG.0b013e3181581f94; Delay E, 2009, AESTHET SURG J, V29, P360, DOI 10.1016/j.asj.2009.08.010; Devarajan E, 2012, INT J CANCER, V131, P1023, DOI 10.1002/ijc.26493; Donnenberg VS, 2010, TISSUE ENG PART B-RE, V16, P567, DOI [10.1089/ten.teb.2010.0352, 10.1089/ten.TEB.2010.0352]; Dubois Severine G., 2008, V449, P69, DOI 10.1007/978-1-60327-169-1_5; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; FOURNIER PF, 1990, DERMATOL CLIN, V8, P523, DOI 10.1016/S0733-8635(18)30484-4; Fromigue O, 2011, J BONE MINER RES, V26, P1533, DOI 10.1002/jbmr.343; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Guijarro-Martinez R, 2010, J CRANIOMAXILLOFAC S; Hanson SE, 2010, AESTHET SURG J, V30, P838, DOI 10.1177/1090820X10386364; Hu SD, 2007, ANN PLAS SURG, V58, P602, DOI 10.1097/01.sap.0000248110.59452.49; Illouz YG, 2009, AESTHET PLAST SURG, V33, P706, DOI 10.1007/s00266-009-9377-1; Jotzu C, 2011, CELL ONCOL, V34, P55, DOI 10.1007/s13402-011-0012-1; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kaufman MR, 2007, PLAST RECONSTR SURG, V119, P2287, DOI 10.1097/01.prs.0000260712.44089.e7; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li ZS, 2009, BREAST CANCER RES TR, V118, P33, DOI 10.1007/s10549-008-0216-x; Lohsiriwat V, 2011, BREAST, V20, P351, DOI 10.1016/j.breast.2011.01.003; Marsden CG, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-10; Martin FT, 2010, BREAST CANCER RES TR, V124, P317, DOI 10.1007/s10549-010-0734-1; Martin-Padura I, 2012, CANCER RES, V72, P325, DOI 10.1158/0008-5472.CAN-11-1739; Mizuno H, 2010, AESTHET SURG J, V30, P381, DOI 10.1177/1090820X10373063; Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e; Muehlberg FL, 2009, CARCINOGENESIS, V30, P589, DOI 10.1093/carcin/bgp036; Pearl RA, 2012, J PLAST RECONSTR AES, V65, P283, DOI 10.1016/j.bjps.2011.07.017; Perez-Cano R, 2012, EJSO-EUR J SURG ONC, V38, P382, DOI 10.1016/j.ejso.2012.02.178; Pinilla S, 2009, CANCER LETT, V284, P80, DOI 10.1016/j.canlet.2009.04.013; Rhodes LV, 2010, BREAST CANCER RES TR, V121, P293, DOI 10.1007/s10549-009-0458-2; Rigotti G, 2010, AESTHET PLAST SURG, V34, P475, DOI 10.1007/s00266-010-9481-2; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Sasser AK, 2007, CANCER LETT, V254, P255, DOI 10.1016/j.canlet.2007.03.012; Shin SY, 2010, J BIOL CHEM, V285, P30731, DOI 10.1074/jbc.M110.128124; Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028; Strong AL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3569; Sun B, 2009, CYTOTHERAPY, V11, P289, DOI 10.1080/14653240902807026; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Welte G, 2012, MOL CARCINOGEN, V51, P861, DOI 10.1002/mc.20854; Xie Y, 2007, ANN PLAS SURG, V59, P645, DOI 10.1097/SAP.0b013e318038fcb7; Xu QL, 2012, INT J ONCOL, V41, P959, DOI 10.3892/ijo.2012.1541; Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Yoshimura K, 2010, BREAST J, V16, P169, DOI 10.1111/j.1524-4741.2009.00873.x; Yoshimura K, 2009, REGEN MED, V4, P265, DOI 10.2217/17460751.4.2.265; Yu G, 2011, METHODS MOL BIOL, V702, P193, DOI 10.1007/978-1-61737-960-4_14; Zheng DN, 2008, J PLAST RECONSTR AES, V61, P792, DOI 10.1016/j.bjps.2007.08.036; Zimmerlin L, 2011, TISSUE ENG PT A, V17, P93, DOI [10.1089/ten.tea.2010.0248, 10.1089/ten.TEA.2010.0248]	61	138	142	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89595	10.1371/journal.pone.0089595	http://dx.doi.org/10.1371/journal.pone.0089595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586900	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200064
J	Wang, JM; Yang, JM; Jia, QJ; Zhu, JH; Shang, Y; Hua, W; Zhou, MX				Wang, Junmei; Yang, Jianming; Jia, Qiaojun; Zhu, Jinghuan; Shang, Yi; Hua, Wei; Zhou, Meixue			A New QTL for Plant Height in Barley (Hordeum vulgare L.) Showing No Negative Effects on Grain Yield	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RECOMBINANT INBRED LINES; LINKAGE MAP; WATERLOGGING TOLERANCE; AGRONOMIC TRAITS; CONSENSUS MAP; DART MARKERS; GENOME; GENES; IDENTIFICATION	Introduction: Reducing plant height has played an important role in improving crop yields. The success of a breeding program relies on the source of dwarfing genes. For a dwarfing or semi-dwarfing gene to be successfully used in a breeding program, the gene should have minimal negative effects on yield and perform consistently in different environments. Methods: In this study, 182 doubled haploid lines, generated from a cross between TX9425 and Naso Nijo, were grown in six different environments to identify quantitative trait loci (QTL) controlling plant height and investigate QTL 6 environments interaction. Results: A QTL for plant was identified on 7H. This QTL showed no significant effects on other agronomic traits and yield components and consistently expressed in the six environments. A sufficient allelic effect makes it possible for this QTL to be successfully used in breeding programs.	[Wang, Junmei; Yang, Jianming; Jia, Qiaojun; Zhu, Jinghuan; Shang, Yi; Hua, Wei] Zhejiang Acad Agr Sci, Inst Crop & Nucl Technol Utilizat, Hangzhou, Zhejiang, Peoples R China; [Zhou, Meixue] Univ Tasmania, Tasmanian Inst Agr, Kings Meadows, Tas, Australia; [Zhou, Meixue] Univ Tasmania, Sch Land & Food, Kings Meadows, Tas, Australia	Zhejiang Academy of Agricultural Sciences; University of Tasmania; University of Tasmania	Yang, JM (corresponding author), Zhejiang Acad Agr Sci, Inst Crop & Nucl Technol Utilizat, Hangzhou, Zhejiang, Peoples R China.	jmyang@163.com; Meixue.Zhou@utas.edu.au			National Natural Science Foundation of China [31271719]; China Agriculture Research System [CARS-5]; National 863 Program [2012AA101105]; Key Research Foundation of Science and Technology Department of Zhejiang Province of China [2012C12902-2]; Grains Research and Development Corporation (GRDC) of Australia	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; National 863 Program(National High Technology Research and Development Program of China); Key Research Foundation of Science and Technology Department of Zhejiang Province of China; Grains Research and Development Corporation (GRDC) of Australia(Grains R&D Corp)	This work was supported by National Natural Science Foundation of China (31271719), China Agriculture Research System (CARS-5), the National 863 Program (2012AA101105), the Key Research Foundation of Science and Technology Department of Zhejiang Province of China (2012C12902-2), and Grains Research and Development Corporation (GRDC) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop BP, 2011, MOL BREEDING, V27, P77, DOI 10.1007/s11032-010-9415-3; BACKES G, 1995, THEOR APPL GENET, V90, P294, DOI 10.1007/BF00222217; Baghizadeh A., 2007, International Journal of Agriculture and Biology, V9, P372; BARUA UM, 1993, GENOME, V36, P1080, DOI 10.1139/g93-143; Bezant J, 1996, HEREDITY, V77, P64, DOI 10.1038/hdy.1996.109; Chen GD, 2012, THEOR APPL GENET, V125, P1385, DOI 10.1007/s00122-012-1918-3; Hellewell KB, 2000, CROP SCI, V40, P352, DOI 10.2135/cropsci2000.402352x; Hori K, 2003, THEOR APPL GENET, V107, P806, DOI 10.1007/s00122-003-1342-9; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Kjaeer B, 1995, GENOME, V38, P1098, DOI 10.1139/g95-146; Li HB, 2010, MOL GENET GENOMICS, V284, P319, DOI 10.1007/s00438-010-0570-3; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; LIN YR, 1995, GENETICS, V141, P391; Marquez-Cedillo LA, 2001, THEOR APPL GENET, V103, P625, DOI 10.1007/PL00002919; MICKELSON HR, 1994, CROP SCI, V34, P1180, DOI 10.2135/cropsci1994.0011183X003400050007x; Neatby R, 1929, SCI AGR, V9, P701; Pang JY, 2004, AUST J AGR RES, V55, P895, DOI 10.1071/AR03097; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; Ramsay L, 2000, GENETICS, V156, P1997; Rasmusson DC, 1997, CROP SCI, V37, P303, DOI 10.2135/cropsci1997.0011183X003700020001x; Sameri M, 2009, THEOR APPL GENET, V118, P643, DOI 10.1007/s00122-008-0926-9; Sameri M, 2006, BREEDING SCI, V56, P243, DOI 10.1270/jsbbs.56.243; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Swenson S. P., 1944, JOUR AMER SOC AGRON, V36, P429; Talame V, 2004, ANN APPL BIOL, V144, P309, DOI 10.1111/j.1744-7348.2004.tb00346.x; Tang JH, 2007, EUPHYTICA, V155, P117, DOI 10.1007/s10681-006-9312-3; Tang Q., 2007, DPS DATA PROCESSING; THOMAS WTB, 1984, HEREDITY, V53, P177, DOI 10.1038/hdy.1984.73; Tinker NA, 1996, CROP SCI, V36, P1053, DOI 10.2135/cropsci1996.0011183X003600040040x; Tsuchiya T., 1972, BARLEY GENET NEWSL, P87; Vagner Haahr D.v.W., 1976, P 3 INT BARL GEN S V, P215; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JM, 2010, EUPHYTICA, V175, P331, DOI 10.1007/s10681-010-0175-2; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Xu RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043079; Yu GT, 2010, THEOR APPL GENET, V120, P853, DOI 10.1007/s00122-009-1216-x; Zhang J, 2003, PLANT BREEDING, V122, P112, DOI 10.1046/j.1439-0523.2003.00819.x; Zhou MX, 2012, CROP SCI, V52, P2082, DOI 10.2135/cropsci2012.01.0008	45	29	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90144	10.1371/journal.pone.0090144	http://dx.doi.org/10.1371/journal.pone.0090144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587247	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200138
J	Austin, D; Cross, RM; Hayes, T; Kaye, J				Austin, Daniel; Cross, Robin M.; Hayes, Tamara; Kaye, Jeffrey			Regularity and Predictability of Human Mobility in Personal Space	PLOS ONE			English	Article							LIFE-STYLE REGULARITY; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; ACTIVITY PATTERNS; SCALING LAWS; NETWORKS; DEMENTIA; TRIALS; TRAVEL	Fundamental laws governing human mobility have many important applications such as forecasting and controlling epidemics or optimizing transportation systems. These mobility patterns, studied in the context of out of home activity during travel or social interactions with observations recorded from cell phone use or diffusion of money, suggest that in extra-personal space humans follow a high degree of temporal and spatial regularity - most often in the form of time-independent universal scaling laws. Here we show that mobility patterns of older individuals in their home also show a high degree of predictability and regularity, although in a different way than has been reported for out-of-home mobility. Studying a data set of almost 15 million observations from 19 adults spanning up to 5 years of unobtrusive longitudinal home activity monitoring, we find that in-home mobility is not well represented by a universal scaling law, but that significant structure (predictability and regularity) is uncovered when explicitly accounting for contextual data in a model of in-home mobility. These results suggest that human mobility in personal space is highly stereotyped, and that monitoring discontinuities in routine room-level mobility patterns may provide an opportunity to predict individual human health and functional status or detect adverse events and trends.	[Austin, Daniel; Hayes, Tamara; Kaye, Jeffrey] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Cross, Robin M.] Oregon State Univ, Corvallis, OR 97331 USA; [Kaye, Jeffrey] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon State University; Oregon Health & Science University	Austin, D (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.	austidan@ohsu.edu		Kaye, Jeffrey/0000-0002-9971-3478	National Institutes of Health; National Institute on Aging [R01AG024059, P30 AG024978, P30AG008017]; Intel Corporation; NATIONAL INSTITUTE ON AGING [R01AG024059, P30AG008017, P30AG024978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intel Corporation(Intel Corporation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health and the National Institute on Aging under Grants R01AG024059, P30 AG024978, and P30AG008017. Some of the computers used to collect data in this study were purchased with funds from Intel Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Campbell IH, 2011, IEEE ENG MED BIO, P6793, DOI 10.1109/IEMBS.2011.6091675; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Carlsson CM, 2008, J ALZHEIMERS DIS, V15, P327; Chon Y, 2012, INT CONF PERVAS COMP, P206, DOI 10.1109/PerCom.2012.6199868; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cook DJ, 2006, J UNIVERS COMPUT SCI, V12, P15; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Evans DA, 2011, ALZHEIMERS DEMENT, V7, P110, DOI 10.1016/j.jalz.2010.11.008; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gushulak BD, 2000, CLIN INFECT DIS, V31, P776, DOI 10.1086/313998; Hagler S, 2010, IEEE T BIO-MED ENG, V57, P813, DOI 10.1109/TBME.2009.2036732; Hayes TL, 2008, ALZHEIMERS DEMENT, V4, P395, DOI 10.1016/j.jalz.2008.07.004; Hayes TL, 2007, IEEE PERVAS COMPUT, V6, P36, DOI 10.1109/MPRV.2007.9; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Hui P, 2008, PHILOS T R SOC A, V366, P2005, DOI 10.1098/rsta.2008.0010; Kaye J, 2008, ALZHEIMERS DEMENT, V4, pS60, DOI 10.1016/j.jalz.2007.10.003; Kaye J, 2012, GAIT POSTURE, V35, P197, DOI 10.1016/j.gaitpost.2011.09.006; Kaye JA, 2011, J GERONTOL B-PSYCHOL, V66, P180, DOI [10.1093/geronb/ghq095, 10.1093/geronb/gbq095]; Long J.S., 2006, REGRESSION MODELS CA; Lu X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02923; Monk TH, 2004, CHRONOBIOL INT, V21, P435, DOI 10.1081/CBI-120038614; Monk TH, 1997, CHRONOBIOL INT, V14, P295, DOI 10.3109/07420529709001421; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Qin SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051353; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Schlich R, 2003, TRANSPORTATION, V30, P13, DOI 10.1023/A:1021230507071; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Skubic Marjorie, 2009, Technol Health Care, V17, P183, DOI 10.3233/THC-2009-0551; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Varaiya P, 2008, PHILOS T R SOC A, V366, P1921, DOI 10.1098/rsta.2008.0015; Wilson E, 2008, PHILOS T R SOC A, V366, P2017, DOI 10.1098/rsta.2008.0018	37	18	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90256	10.1371/journal.pone.0090256	http://dx.doi.org/10.1371/journal.pone.0090256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587302	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800097
J	Maier, W; Scheidt-Nave, C; Holle, R; Kroll, LE; Lampert, T; Du, Y; Heidemann, C; Mielck, A				Maier, Werner; Scheidt-Nave, Christa; Holle, Rolf; Kroll, Lars E.; Lampert, Thomas; Du, Yong; Heidemann, Christin; Mielck, Andreas			Area Level Deprivation Is an Independent Determinant of Prevalent Type 2 Diabetes and Obesity at the National Level in Germany. Results from the National Telephone Health Interview Surveys 'German Health Update' GEDA 2009 and 2010	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS; REGIONAL DEPRIVATION; ADULTS; MELLITUS; POSITION; INEQUALITIES; ASSOCIATION; WEIGHT	Objective: There is increasing evidence that prevention programmes for type 2 diabetes mellitus (T2DM) and obesity need to consider individual and regional risk factors. Our objective is to assess the independent association of area level deprivation with T2DM and obesity controlling for individual risk factors in a large study covering the whole of Germany. Methods: We combined data from two consecutive waves of the national health interview survey 'GEDA' conducted by the Robert Koch Institute in 2009 and 2010. Data collection was based on computer-assisted telephone interviews. After exclusion of participants <30 years of age and those with missing responses, we included n = 33,690 participants in our analyses. The outcome variables were the 12-month prevalence of known T2DM and the prevalence of obesity (BMI >30 kg/m(2)). We also controlled for age, sex, BMI, smoking, sport, living with a partner and education. Area level deprivation of the districts was defined by the German Index of Multiple Deprivation. Logistic multilevel regression models were performed using the software SAS 9.2. Results: Of all men and women living in the most deprived areas, 8.6% had T2DM and 16.9% were obese (least deprived areas: 5.8% for T2DM and 13.7% for obesity). For women, higher area level deprivation and lower educational level were both independently associated with higher T2DM and obesity prevalence [highest area level deprivation: OR 1.28 (95% CI: 1.05-1.55) for T2DM and OR 1.28 (95% CI: 1.10-1.49) for obesity]. For men, a similar association was only found for obesity [OR 1.20 (95% CI: 1.02-1.41)], but not for T2DM. Conclusion: Area level deprivation is an independent, important determinant of T2DM and obesity prevalence in Germany. Identifying and targeting specific area-based risk factors should be considered an essential public health issue relevant to increasing the effectiveness of diabetes and obesity prevention.	[Maier, Werner; Holle, Rolf; Mielck, Andreas] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Scheidt-Nave, Christa; Kroll, Lars E.; Lampert, Thomas; Du, Yong; Heidemann, Christin] Robert Koch Inst, Berlin, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Robert Koch Institute	Maier, W (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.	werner.maier@helmholtz-muenchen.de	Holle, Rolf/D-9333-2013	Holle, Rolf/0000-0001-5395-2695; Maier, Werner/0000-0003-4356-7296	Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); Federal Ministry of Education and Research [FKZ 01GI1104A]	Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research (FKZ 01GI1104A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; American Association for Public Opinion Research, 2009, STAND DEF FIN DISP C; Andersen AF, 2008, DIABETIC MED, V25, P1462, DOI 10.1111/j.1464-5491.2008.02594.x; Bocquier A, 2011, DIABETES METAB, V37, P39, DOI 10.1016/j.diabet.2010.07.004; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Burgoine T, 2011, HEALTH PLACE, V17, P738, DOI 10.1016/j.healthplace.2011.01.011; Chaix B, 2011, EPIDEMIOLOGY, V22, P18, DOI 10.1097/EDE.0b013e3181fd2961; Chang SA, 2012, DIABETES METAB J, V36, P399, DOI 10.4093/dmj.2012.36.6.399; Du Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-166; Espelt A, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112698; Fano V, 2013, EUR J PUBLIC HEALTH, V23, P991, DOI 10.1093/eurpub/cks168; Fuchs J, 2012, BUNDESGESUNDHEITSBLA, V55, P576, DOI 10.1007/s00103-012-1464-9; Gabler S, 2002, INT J PUBLIC OPIN R, V14, P339, DOI 10.1093/ijpor/14.3.339; Heidemann C, 2009, DIABETIC MED, V26, P655, DOI 10.1111/j.1464-5491.2009.02739.x; Hempler NF, 2013, SCAND J PUBLIC HEALT, V41, P340, DOI 10.1177/1403494813482535; Hoffmann W, 2004, GESUNDHEITSWESEN, V66, P482, DOI 10.1055/s-2004-813094; International Diabetes Federation, IDF DIAB ATL UPD 201; Kavanagh A, 2010, SOC SCI MED, V71, P1150, DOI 10.1016/j.socscimed.2010.05.038; Koller D, 2013, INFECTION, V41, P121, DOI 10.1007/s15010-012-0302-1; Krishnan S, 2010, AM J EPIDEMIOL, V171, P564, DOI 10.1093/aje/kwp443; Kroll LE, 2012, BEITRAGE GESUNDHEITS, P51; Lampert T, 2012, BUNDESGESUNDHEITSBLA, V55, P102, DOI 10.1007/s00103-011-1401-3; Laraia BA, 2012, SOC SCI MED, V74, P1082, DOI 10.1016/j.socscimed.2011.11.036; Larranaga I, 2005, DIABETIC MED, V22, P1047, DOI 10.1111/j.1464-5491.2005.01598.x; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Maier W, 2012, GESUNDHEITSWESEN, V74, P416, DOI 10.1055/s-0031-1280846; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Muller G, 2013, AM J EPIDEMIOL, V178, P221, DOI 10.1093/aje/kws466; Muller G, 2013, LECT NOTES BUS INF P, V160, P3; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; Oldendick RW, 1988, J OFF STAT, V4, P307; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Robert Koch-Institut, 2011, BEITRAGE GESUNDHEITS, P153; Robert Koch-Institut, 2012, BEITRAGE GESUNDHEITS, P173; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Roskam AJR, 2008, PUBLIC HEALTH NUTR, V11, P1256, DOI 10.1017/S1368980008002747; Rothman RL, 2004, JAMA-J AM MED ASSOC, V292, P1711, DOI 10.1001/jama.292.14.1711; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Sacerdote C, 2012, INT J EPIDEMIOL, V41, P1162, DOI 10.1093/ije/dys091; Schafer T, 2013, OSTEOARTHR CARTILAGE, V21, P279, DOI 10.1016/j.joca.2012.11.006; Schipf S, 2012, DIABETIC MED, V29, pE88, DOI 10.1111/j.1464-5491.2012.03578.x; Schuurman N, 2007, J URBAN HEALTH, V84, P591, DOI 10.1007/s11524-007-9193-3; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sobal J, 1991, Med Anthropol, V13, P231; Steppuhn H, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-46; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; Tang M, 2003, INT J EPIDEMIOL, V32, P381, DOI 10.1093/ije/dyg075; Tompkins JW, 2010, INT J ENV RES PUB HE, V7, P2407, DOI 10.3390/ijerph7052407; Tonstad S, 2009, DIABETES RES CLIN PR, V85, P4, DOI 10.1016/j.diabres.2009.04.013; van Jaarsveld CHM, 2007, J CLIN EPIDEMIOL, V60, P712, DOI 10.1016/j.jclinepi.2006.10.005; Walker JJ, 2011, DIABETES CARE, V34, P1127, DOI 10.2337/dc10-1862; Wild S, 2008, DIABETIC MED, V25, P194, DOI 10.1111/j.1464-5491.2008.02382.x; Williams ED, 2012, DIABETES CARE, V35, P1455, DOI 10.2337/dc11-1410; Wolfenstetter SB, 2012, ECON HUM BIOL, V10, P127, DOI 10.1016/j.ehb.2011.08.008	57	56	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89661	10.1371/journal.pone.0089661	http://dx.doi.org/10.1371/journal.pone.0089661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24586945	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800033
J	Buffum, B; Modisette, C; McWilliams, SR				Buffum, Bill; Modisette, Christopher; McWilliams, Scott R.			Encouraging Family Forest Owners to Create Early Successional Wildlife Habitat in Southern New England	PLOS ONE			English	Article							PRIVATE LANDS; PROGRAMS; MANAGEMENT	Encouraging family forest owners to create early successional habitat is a high priority for wildlife conservation agencies in the northeastern USA, where most forest land is privately owned. Many studies have linked regional declines in wildlife populations to the loss of early successional habitat. The government provides financial incentives to create early successional habitat, but the number of family forest owners who actively manage their forests remains low. Several studies have analyzed participation of family forest owners in federal forestry programs, but no study to date has focused specifically on creation of wildlife habitat. The objective of our study was to analyze the experience of a group of wildlife-oriented family forest owners who were trained to create early successional habitat. This type of family forest owners represents a small portion of the total population of family forest owners, but we believe they can play an important role in creating wildlife habitat, so it is important to understand how outreach programs can best reach them. The respondents shared some characteristics but differed in terms of forest holdings, forestry experience and interest in earning forestry income. Despite their strong interest in wildlife, awareness about the importance of early successional habitat was low. Financial support from the federal government appeared to be important in motivating respondents to follow up after the training with activities on their own properties: 84% of respondents who had implemented activities received federal financial support and 47% would not have implemented the activities without financial assistance. In order to mobilize greater numbers of wildlife-oriented family forest owners to create early successional habitat we recommend focusing outreach efforts on increasing awareness about the importance of early successional habitat and the availability of technical and financial assistance.	[Buffum, Bill] Univ Rhode Isl, Dept Nat Resources Management, Kingston, RI 02881 USA; [Modisette, Christopher] Nat Resources Conservat Serv, USDA, Warwick, RI USA; [McWilliams, Scott R.] Univ Rhode Isl, Dept Nat Resources Management, Kingston, RI 02881 USA	University of Rhode Island; United States Department of Agriculture (USDA); University of Rhode Island	Buffum, B (corresponding author), Univ Rhode Isl, Dept Nat Resources Management, Kingston, RI 02881 USA.	buffum@uri.edu	Buffum, Bill/M-2756-2013; McWilliams, Scott R/B-8728-2013	McWilliams, Scott R/0000-0002-9727-1151	URI; United States Department of Agriculture through a McIntire-Stennis Cooperative Research Grant [RIAES-MS975]	URI; United States Department of Agriculture through a McIntire-Stennis Cooperative Research Grant	This research was conducted as part of a University of Rhode Island (URI) project entitled "Forest Management for Wildlife Habitat in Rhode Island" with funding from URI and the United States Department of Agriculture through a McIntire-Stennis Cooperative Research Grant (RIAES-MS975). This is contribution #5354 of the University of Rhode Island Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot T, 2013, SO NEW ENGLAND STRUM; [Anonymous], 2005, DESIGN IMPLEMENTATIO; Askins RA, 2007, FOREST ECOL MANAG, V250, P137, DOI 10.1016/j.foreco.2007.05.009; Berlick MM, 2002, 26 HARV U HARV FOR; Buffum B, 2011, FOREST ECOL MANAG, V262, P1775, DOI 10.1016/j.foreco.2011.07.024; Butler B.J, 2008, NRS27 USDA FOR SERV; Butler BJ, 2011, 55 NRS USDA FOR SERV; Butler BJ, 2011, NORTH J APPL FOR, V28, P13, DOI 10.1093/njaf/28.1.13; Daley SS, 2004, WILDLIFE SOC B, V32, P209, DOI 10.2193/0091-7648(2004)32[209:LARWMO]2.0.CO;2; Daniels S, 2010, PERFORM RES, V15, P1, DOI 10.1080/13528165.2010.539871; DeGraaf RM, 2003, FOREST ECOL MANAG, V185, P179, DOI 10.1016/S0378-1127(03)00254-8; DeGraaf RM, 2006, TECHNICAL GUIDE FORE, Vxiii; Foster D.R., 2004, FORESTS TIME ENV CON; Gray RL, 2005, 98 USDA U NEBR FOR S; Kammin LA, 2009, J WILDLIFE MANAGE, V73, P973, DOI 10.2193/2007-074; Kilgore MA, 2007, J FOREST, V105, P184; Litvaitis JA, 2001, WILDLIFE SOC B, V29, P466; Ma Z, 2012, SMALL-SCALE FOR, V11, P87, DOI 10.1007/s11842-011-9170-2; Ma Z, 2012, LAND USE POLICY, V29, P53, DOI 10.1016/j.landusepol.2011.05.004; Oehler JD, 2003, FOREST ECOL MANAG, V185, P169, DOI 10.1016/S0378-1127(03)00253-6; Poudyal N.C., 2009, HUM DIMENS WILDL, V14, P240, DOI [DOI 10.1080/10871200902838185, 10.1080/10871200902838185]; Rickenbach M., 2009, Small-scale Forestry, V8, P95, DOI 10.1007/s11842-008-9071-1; Sampson N, 2000, J FOREST, V98, P4; Schlossberg S., 2007, ECOLOGY MANAGEMENT S; USFS, 2006, NAT WOODL OWN SURV T	25	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89972	10.1371/journal.pone.0089972	http://dx.doi.org/10.1371/journal.pone.0089972			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587160	Green Published, gold			2022-12-27	WOS:000332389000123
J	Sun, HY; Cheng, CY; Lee, NY; Yang, CJ; Liang, SH; Tsai, MS; Ko, WC; Liu, WC; Wu, PY; Wu, CH; Lin, HH; Hung, CC				Sun, Hsin-Yun; Cheng, Chien-Yu; Lee, Nan-Yao; Yang, Chia-Jui; Liang, Shiou-Haur; Tsai, Mao-Song; Ko, Wen-Chien; Liu, Wen-Chun; Wu, Pei-Ying; Wu, Cheng-Hsin; Lin, Hsi-Hsun; Hung, Chien-Ching			Seroprevalence of Hepatitis B Virus among Adults at High Risk for HIV Transmission Two Decades after Implementation of Nationwide Hepatitis B Virus Vaccination Program in Taiwan	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNIZATION PROGRAM; UNITED-STATES; HEPATOCELLULAR-CARCINOMA; C VIRUS; INFECTION; CHILDREN; RECOMMENDATIONS; ANTIBODY; IMMUNITY	Background: Seroprevalence of hepatitis B virus (HBV) after implementation of universal neonatal HBV vaccination and catch-up vaccination programs remains rarely investigated among the adults who were born in the vaccination era (in or after 1986) and engaged in high-risk sexual behaviors. Materials and Methods: Between 2006 and 2012, we determined HBV surface antigen ([HBsAg), anti-HBs, and HBV core antibody (anti-HBc), hepatitis C virus antibody (anti-HCV) and rapid plasma reagin titers among HIV-infected men who have sex with men (MSM) born during 1984-1985 (Group I: 244 persons) and those born in or after 1986 (Group II: 523), and HIV-uninfected MSM (Group III: 377) and heterosexuals (Group IV: 217) born in or after 1986. Prevalence and incidence of HBV infection were estimated and multivariate analysis was performed to identify factors associated with HBsAg positivity. Results: Compared with Group I, Groups II-IV had a significantly lower prevalence of HBsAg positivity (7.8% vs 3.7%, 2.4%, and 3.2%, respectively); and the prevalence of anti-HBc positivity was also lower for Groups III and IV (30.3% vs. 19.6%, and 18.0%, respectively), but no difference was observed between Groups I and II (30.3% vs. 26.3%). In multivariate analysis, HBsAg positivity was significantly associated with syphilis (adjusted odds ratio, 2.990; 95% confidence interval, 1.502-5.953) and anti-HCV positivity (adjusted odds ratio, 3.402; 95% confidence interval, 1.091-10.614). In subjects of Group II with all-negative HBV markers at baseline, the incidence rate of HBsAg seroconversion was 0.486 episodes per 100 person-years; and for those who received combination antiretroviral therapy containing lamivudine and/or tenofovir, none developed HBsAg seroconversion during the follow-up. Conclusions: Among the adults who were born in or after 1986 and engaged in high-risk sexual behaviors in Taiwan, neonatal HBV vaccination and catch-up vaccination programs conferred long-term protection against HBsAg seroconversion and HBsAg positivity was associated with syphilis and anti-HCV positivity.	[Sun, Hsin-Yun; Liu, Wen-Chun; Wu, Cheng-Hsin; Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Sun, Hsin-Yun; Liu, Wen-Chun; Wu, Cheng-Hsin; Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Cheng, Chien-Yu] Tao Yuan Gen Hosp, Minist Hlth & Welf, Dept Internal Med, Tao Yuan, Taiwan; [Lee, Nan-Yao; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Lee, Nan-Yao; Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan; [Yang, Chia-Jui; Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Liang, Shiou-Haur; Lin, Hsi-Hsun] I Shou Univ, Dept Med, E Da Hosp, Kaohsiung, Taiwan; [Wu, Pei-Ying] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Far Eastern Memorial Hospital; E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lin, HH (corresponding author), I Shou Univ, Dept Med, E Da Hosp, Kaohsiung, Taiwan.	ed100233@yahoo.com.tw; hcc0401@ntu.edu.tw	cheng, chien-yu/M-1108-2019; Ko, Wen-Chien/ABG-4316-2020	cheng, chien-yu/0000-0002-1886-0370; Ko, Wen-Chien/0000-0001-7497-149X; SUN, HSIN-YUN/0000-0003-0074-7721; Hung, Chien-Ching/0000-0001-7345-0836				Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6; Chang MH, 2007, SEMIN FETAL NEONAT M, V12, P160, DOI 10.1016/j.siny.2007.01.013; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; Chiang CJ, 2013, JAMA-J AM MED ASSOC, V310, P974, DOI 10.1001/jama.2013.276701; COLLIER AC, 1988, ANN INTERN MED, V109, P101, DOI 10.7326/0003-4819-109-2-101; Gatanaga H, 2000, EUR J CLIN MICROBIOL, V19, P237, DOI 10.1007/s100960050468; Gatanaga H, 2013, CLIN INFECT DIS, V56, P1812, DOI 10.1093/cid/cit145; HORVATH J, 1994, CLIN INFECT DIS, V18, P339, DOI 10.1093/clinids/18.3.339; Hsu HY, 2004, GUT, V53, P1499, DOI 10.1136/gut.2003.034223; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Laurence JC, 2005, AM J MED, V118, P75, DOI 10.1016/j.amjmed.2005.07.024; Leuridan E, 2011, CLIN INFECT DIS, V53, P68, DOI 10.1093/cid/cir270; Lu CY, 2004, HEPATOLOGY, V40, P1415, DOI 10.1002/hep.20490; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; McMahon BJ, 2005, ANN INTERN MED, V142, P333, DOI 10.7326/0003-4819-142-5-200503010-00008; McMahon BJ, 2011, HEPATOLOGY, V54, P801, DOI 10.1002/hep.24442; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Ni YH, 2012, J HEPATOL, V57, P730, DOI 10.1016/j.jhep.2012.05.021; OSMOND DH, 1993, J INFECT DIS, V167, P66, DOI 10.1093/infdis/167.1.66; PIOT P, 1990, VACCINE, V8, pS36, DOI 10.1016/0264-410X(90)90215-8; Ponde RAA, 2010, ARCH VIROL, V155, P149, DOI 10.1007/s00705-009-0559-6; ROSENBLUM L, 1992, JAMA-J AM MED ASSOC, V267, P2477, DOI 10.1001/jama.267.18.2477; STEVENS CE, 1984, NEW ENGL J MED, V311, P496, DOI 10.1056/NEJM198408233110803; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Su WJ, 2012, J INFECT DIS, V205, P757, DOI 10.1093/infdis/jir852; Sun HY, 2012, J CLIN MICROBIOL, V50, P781, DOI 10.1128/JCM.06014-11; Sun HY, 2009, AM J GASTROENTEROL, V104, P877, DOI 10.1038/ajg.2008.159; Szu-Ming C, 2011, J CLIN VIROL, V52, P11, DOI 10.1016/j.jcv.2011.06.012; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tseng YT, 2012, J FORMOS MED ASSOC, V111, P431, DOI 10.1016/j.jfma.2011.06.022; Weinbaum C., 2006, Morbidity and Mortality Weekly Report, V55, P509; Wu H, 2012, SEX TRANSM INFECT, V88, P612, DOI 10.1136/sextrans-2011-050354; Yang CJ, 2010, CLIN INFECT DIS, V51, P976, DOI 10.1086/656419	35	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90194	10.1371/journal.pone.0090194	http://dx.doi.org/10.1371/journal.pone.0090194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587275	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000141
J	Thiel, SD; Bitzer, S; Nierhaus, T; Kalberlah, C; Preusser, S; Neumann, J; Nikulin, VV; van der Meer, E; Villringer, A; Pleger, B				Thiel, Sabrina D.; Bitzer, Sebastian; Nierhaus, Till; Kalberlah, Christian; Preusser, Sven; Neumann, Jane; Nikulin, Vadim V.; van der Meer, Elke; Villringer, Arno; Pleger, Burkhard			Hysteresis as an Implicit Prior in Tactile Spatial Decision Making	PLOS ONE			English	Article							FREE-ENERGY PRINCIPLE; PERCEPTUAL HYSTERESIS; MOTION PERCEPTION; DISCRIMINATION; REPRESENTATIONS; ORGANIZATION; BRAIN; TASK	Perceptual decisions not only depend on the incoming information from sensory systems but constitute a combination of current sensory evidence and internally accumulated information from past encounters. Although recent evidence emphasizes the fundamental role of prior knowledge for perceptual decision making, only few studies have quantified the relevance of such priors on perceptual decisions and examined their interplay with other decision-relevant factors, such as the stimulus properties. In the present study we asked whether hysteresis, describing the stability of a percept despite a change in stimulus property and known to occur at perceptual thresholds, also acts as a form of an implicit prior in tactile spatial decision making, supporting the stability of a decision across successively presented random stimuli (i.e., decision hysteresis). We applied a variant of the classical 2-point discrimination task and found that hysteresis influenced perceptual decision making: Participants were more likely to decide 'same' rather than 'different' on successively presented pin distances. In a direct comparison between the influence of applied pin distances (explicit stimulus property) and hysteresis, we found that on average, stimulus property explained significantly more variance of participants' decisions than hysteresis. However, when focusing on pin distances at threshold, we found a trend for hysteresis to explain more variance. Furthermore, the less variance was explained by the pin distance on a given decision, the more variance was explained by hysteresis, and vice versa. Our findings suggest that hysteresis acts as an implicit prior in tactile spatial decision making that becomes increasingly important when explicit stimulus properties provide decreasing evidence.	[Thiel, Sabrina D.; Bitzer, Sebastian; Nierhaus, Till; Kalberlah, Christian; Preusser, Sven; Neumann, Jane; Villringer, Arno; Pleger, Burkhard] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Pleger, Burkhard] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Nierhaus, Till; van der Meer, Elke] Charite, Mind Brain Inst, D-13353 Berlin, Germany; [Nierhaus, Till; van der Meer, Elke] Charite, Berlin Sch Mind & Brain, D-13353 Berlin, Germany; [Nierhaus, Till; van der Meer, Elke] Humboldt Univ, D-10099 Berlin, Germany; [Neumann, Jane; Villringer, Arno; Pleger, Burkhard] Univ Leipzig, IFB Adipos Dis, Med Ctr, D-04109 Leipzig, Germany; [Thiel, Sabrina D.; van der Meer, Elke] Humboldt Univ, Fac Math & Nat Sci 2, Dept Psychol, D-10099 Berlin, Germany; [Nikulin, Vadim V.] Charite, Campus Benjamin Franklin, Dept Neurol, Neurophys Grp, D-13353 Berlin, Germany; [Nikulin, Vadim V.] Natl Res Univ, Ctr Cognit & Decis Making, Higher Sch Econ, Moscow, Russia	Max Planck Society; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Leipzig University; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; HSE University (National Research University Higher School of Economics)	Thiel, SD (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.	sthiel@cbs.mpg.de	Nierhaus, Till/ABG-8386-2020; Nikulin, Vadim V/A-6050-2014	Nierhaus, Till/0000-0003-0906-592X; Nikulin, Vadim V/0000-0001-6082-3859; Villringer, Arno/0000-0003-2604-2404	Federal Ministry of Education and Research (BMBF) of Germany [01GQ0975, 18GL4DW4, FKZ: 01EO1001]; German Research Foundation [SFB 1052]; Basic Research Program of the National Research University Higher School of Economics	Federal Ministry of Education and Research (BMBF) of Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Basic Research Program of the National Research University Higher School of Economics	This work was supported by the Federal Ministry of Education and Research (BMBF) of Germany (Bernstein Focus, State Dependencies of Learning 01GQ0975; Project 18GL4DW4 to Burkhard Pleger, and FKZ: 01EO1001, research grant to Jane Neuman). Jane Neumann further acknowledges funding by the German Research Foundation (SFB 1052). Vadim V. Nikulin was partially supported by the Basic Research Program of the National Research University Higher School of Economics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady TF, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00462; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Garcia-Perez MA, 2000, SPATIAL VISION, V13, P431, DOI 10.1163/156856800741306; Gepshtein S, 2005, EXP BRAIN RES, V160, P487, DOI 10.1007/s00221-004-2038-3; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Hellstrom A, 1985, PSYCHOL BULL, V97, P1161; Helson H, 1964, ADAPTATION LEVEL THE; Hock HS, 2005, SPATIAL VISION, V18, P317, DOI 10.1163/1568568054089393; HOCK HS, 1993, J EXP PSYCHOL HUMAN, V19, P63, DOI 10.1037/0096-1523.19.1.63; Karim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037580; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Melloni L, 2011, J NEUROSCI, V31, P1386, DOI 10.1523/JNEUROSCI.4570-10.2011; Odic D, 2012, J EXP PSYCHOL GEN; Pleger B, 2003, NEURON, V40, P643, DOI 10.1016/S0896-6273(03)00677-9; Pleger B, 2001, P NATL ACAD SCI USA, V98, P12255, DOI 10.1073/pnas.191176298; Preuschhof C, 2010, J COGNITIVE NEUROSCI, V22, P875, DOI 10.1162/jocn.2009.21260; Raczaszek J, 1999, J PSYCHOLINGUIST RES, V28, P367, DOI 10.1023/A:1023289031747; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2013, PROG NEUROBIOL, V103, P41, DOI 10.1016/j.pneurobio.2012.03.007; Rushworth MFS, 2009, CURR OPIN NEUROBIOL, V19, P75, DOI 10.1016/j.conb.2009.02.005; Sacharin V, 2012, COGNITION EMOTION, V26, P1273, DOI 10.1080/02699931.2012.656583; Schutz C, 2011, MOTOR CONTROL, V15, P321, DOI 10.1123/mcj.15.3.321; Schwiedrzik CM, 2014, CEREB CORTEX, V24, P1152, DOI 10.1093/cercor/bhs396; Sekuler R, 1996, PERCEPTION, V25, P1243, DOI 10.1068/p251243; Sinclair RJ, 1996, PERCEPT PSYCHOPHYS, V58, P680, DOI 10.3758/BF03213100; VONBEKESY G, 1947, ACTA OTO-LARYNGOL, V35, P411; Weigelt M, 2009, ACTA PSYCHOL, V132, P68, DOI 10.1016/j.actpsy.2009.06.005; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89802	10.1371/journal.pone.0089802	http://dx.doi.org/10.1371/journal.pone.0089802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24587045	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000095
J	Van Meter, RJ; Swan, CM				Van Meter, Robin J.; Swan, Christopher M.			Road Salts as Environmental Constraints in Urban Pond Food Webs	PLOS ONE			English	Article							GREATER TORONTO AREA; STORMWATER DETENTION PONDS; FRESH-WATER; PHYTOPLANKTON COMMUNITIES; ZOOPLANKTON COMMUNITIES; WILDLIFE COMMUNITIES; RELATIVE IMPORTANCE; LOCAL PROCESSES; DEICING SALT; SALINITY	Freshwater salinization is an emerging environmental filter in urban aquatic ecosystems that receive chloride road salt runoff from vast expanses of impervious surface cover. Our study was designed to evaluate the effects of chloride contamination on urban stormwater pond food webs through changes in zooplankton community composition as well as density and biomass of primary producers and consumers. From May - July 2009, we employed a 2x2x2 full-factorial design to manipulate chloride concentration (low = 177 mg L-1 Cl(-/)high = 1067 mg L-1 Cl-), gray treefrog (Hyla versicolor) tadpoles (presence/absence) and source of stormwater pond algae and zooplankton inoculum (low conductance/high conductance urban ponds) in 40, 600-L mesocosms. Road salt did serve as a constraint on zooplankton community structure, driving community divergence between the low and high chloride treatments. Phytoplankton biomass (chlorophyll[a]mu g L-1) in the mesocosms was significantly greater for the high conductance inoculum (P<0.001) and in the high chloride treatment (P = 0.046), whereas periphyton biomass was significantly lower in the high chloride treatment (P = 0.049). Gray treefrog tadpole time to metamorphosis did not vary significantly between treatments. However, mass at metamorphosis was greater among tadpoles that experienced a faster than average time to metamorphosis and exposure to high chloride concentrations (P = 0.039). Our results indicate differential susceptibility to chloride salts among algal resources and zooplankton taxa, and further suggest that road salts can act as a significant environmental constraint on urban stormwater pond communities.	[Van Meter, Robin J.] Univ Maryland, Marine Estuarine Environm Sci Program, Baltimore, MD 21201 USA; [Swan, Christopher M.] Univ Maryland, Dept Geog & Environm Syst, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Van Meter, RJ (corresponding author), Univ Maryland, Marine Estuarine Environm Sci Program, Baltimore, MD 21201 USA.	rvanmeter2@washcoll.edu			US National Science Foundation (NSF) [DEB-0423476, 0549469]; US Geological Survey [2008MD171B]; Division Of Environmental Biology [1027188] Funding Source: National Science Foundation	US National Science Foundation (NSF)(National Science Foundation (NSF)); US Geological Survey(United States Geological Survey); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	US National Science Foundation (NSF), Long-Term Ecological Research (DEB-0423476) Integrated Graduate Education Research and Training programs (NSF award #0549469) US Geological Survey (Project # 2008MD171B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Benbow ME, 2004, WETLANDS, V24, P68, DOI 10.1672/0277-5212(2004)024[0068:RTOSMW]2.0.CO;2; Bilkovic DM, 2012, WETLANDS, V32, P425, DOI 10.1007/s13157-012-0276-x; Bishop CA, 2000, WATER QUAL RES J CAN, V35, P437, DOI 10.2166/wqrj.2000.027; Bishop CA, 2000, WATER QUAL RES J CAN, V35, P399, DOI 10.2166/wqrj.2000.026; Blackwell BF, 2008, LANDSCAPE URBAN PLAN, V86, P162, DOI 10.1016/j.landurbplan.2008.02.004; Blasius BJ, 2002, ENVIRON POLLUT, V120, P219, DOI 10.1016/S0269-7491(02)00142-2; Brand AB, 2010, ARCH ENVIRON CON TOX, V58, P325, DOI 10.1007/s00244-009-9373-0; Brand AB, 2010, CONSERV BIOL, V24, P295, DOI 10.1111/j.1523-1739.2009.01301.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Dahl T., 1990, WETLANDS LOSSES US 1; Designs Turner, 2006, TRIL LAB FLUOR US MA, P38; Dougherty Christopher K., 2006, Applied Herpetology, V3, P87, DOI 10.1163/157075406776984266; Elphick JRF, 2011, ENVIRON TOXICOL CHEM, V30, P239, DOI 10.1002/etc.365; Environment Canada, 2001, PRIOR SUBST LIST ASS; Environmental Protection Agency (EPA), 2001, EPA842F01007; Foltz S, 2009, HYDROBIOLOGIA, V621, P49, DOI 10.1007/s10750-008-9631-6; Gallagher M, 2009, THESIS TOWSON U TOWS; Gallagher MT, 2011, URBAN ECOSYST, V14, P469, DOI 10.1007/s11252-011-0162-y; Gosner K. L., 1960, Herpetologica, V16, P183; Hamer AJ, 2008, BIOL CONSERV, V141, P2432, DOI 10.1016/j.biocon.2008.07.020; HANSSON LA, 1988, LIMNOL OCEANOGR, V33, P121, DOI 10.4319/lo.1988.33.1.0121; Harmon SM, 2003, ARCH ENVIRON CON TOX, V45, P79, DOI 10.1007/s00244-002-0116-8; Hauer FR, 2006, METHODS STREAM ECOLO, V2; Howard KWF, 2007, J CONTAM HYDROL, V91, P146, DOI 10.1016/j.jconhyd.2006.10.005; Jackson RB, 2005, P NATL ACAD SCI USA, V102, P14487, DOI 10.1073/pnas.0507389102; Karraker NE, 2007, THESIS STATE U NEW Y; Kaushal SS, 2005, P NATL ACAD SCI USA, V102, P13517, DOI 10.1073/pnas.0506414102; Kelly VR, 2008, ENVIRON SCI TECHNOL, V42, P410, DOI 10.1021/es071391l; Khemakhem H, 2010, ESTUAR COAST SHELF S, V88, P33, DOI 10.1016/j.ecss.2010.02.019; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LILIUS H, 1995, ENVIRON TOXICOL CHEM, V14, P2085, DOI 10.1002/etc.5620141211; Littell R.C., 1996, SAS SYSTEM MIXED MOD; Loeuille N, 2008, AM NAT, V171, P788, DOI 10.1086/587745; Lopes PM, 2011, ECOL INDIC, V11, P1171, DOI 10.1016/j.ecolind.2010.12.017; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; Medley KA, 2007, WETLANDS, V27, P864, DOI 10.1672/0277-5212(2007)27[864:HALEFI]2.0.CO;2; Mullaney J. R., 2009, N US SCI INVESTIG RE; National Research Council, 2008, REP URB STORMW MAN U; Nielsen DL, 2008, MAR FRESHWATER RES, V59, P549, DOI 10.1071/MF07166; Nielsen DL, 2012, FRESHWATER BIOL, V57, P1306, DOI 10.1111/j.1365-2427.2012.02782.x; Olding DD, 2000, WATER QUAL RES J CAN, V35, P489, DOI 10.2166/wqrj.2000.029; Petranka JW, 2010, AQUAT ECOL, V44, P155, DOI 10.1007/s10452-009-9286-z; Pilkaityte R, 2004, HYDROBIOLOGIA, V513, P27, DOI 10.1023/B:hydr.0000018162.50270.54; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sanzo D, 2006, ENVIRON POLLUT, V140, P247, DOI 10.1016/j.envpol.2005.07.013; Sarma SSS, 2006, AQUAT ECOL, V40, P349, DOI 10.1007/s10452-006-9039-1; SAS Institute Inc, SAS 9 1 3 HELP DOC; Snodgrass JW, 2008, ENVIRON POLLUT, V154, P291, DOI 10.1016/j.envpol.2007.10.003; Soininen J, 2009, FUND APPL LIMNOL, V174, P205, DOI 10.1127/1863-9135/2009/0174-0205; Steiner CF, 2004, ECOLOGY, V85, P107, DOI 10.1890/03-3010; Susana JD, 2008, J ENVIRON BIOL, V29, P693; THORP JH, 2001, ECOLOGY CLASSIFICATI; Toruan Reliana Lumban, 2012, Ecohydrology & Hydrobiology, V12, P53, DOI 10.2478/v10104-012-0003-5; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Van Meter RJ, 2011, URBAN ECOSYST, V14, P723, DOI 10.1007/s11252-011-0180-9; Van Meter RJ, 2011, WETLANDS, V31, P843, DOI 10.1007/s13157-011-0199-y; Vanormelingen P, 2008, FRESHWATER BIOL, V53, P2170, DOI 10.1111/j.1365-2427.2008.02040.x; Vanschoenwinkel B, 2010, J N AM BENTHOL SOC, V29, P1267, DOI 10.1899/09-114.1; Waterkeyn A, 2008, FRESHWATER BIOL, V53, P1808, DOI 10.1111/j.1365-2427.2008.02005.x; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; Woodcock TS, 2010, WETLANDS, V30, P461, DOI 10.1007/s13157-010-0057-3	62	43	43	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90168	10.1371/journal.pone.0090168	http://dx.doi.org/10.1371/journal.pone.0090168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587259	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000139
J	Liu, LY; Zhang, J; Adrian, J; Gissot, L; Coupland, G; Yu, DQ; Turck, F				Liu, Liangyu; Zhang, Jian; Adrian, Jessika; Gissot, Lionel; Coupland, George; Yu, Diqiu; Turck, Franziska			Elevated Levels of MYB30 in the Phloem Accelerate Flowering in Arabidopsis through the Regulation of FLOWERING LOCUS T	PLOS ONE			English	Article							HYPERSENSITIVE CELL-DEATH; TRANSCRIPTION FACTOR MYB30; SUMO E3 LIGASE; SALICYLIC-ACID; FLORAL INDUCTION; PHARBITIS-NIL; CONSTANS; THALIANA; PROTEIN; PATHWAY	In Arabidopsis thaliana, the R2R3 MYB-like transcription factor MYB30 is a positive regulator of the pathogen-induced hypersensitive response and of brassinosteroid and abscisic acid signaling. Here, we show that MYB30 expressed under the control of the strong phloem-specific SUC2 promoter accelerates flowering both in long and short days. Early flowering is mediated by elevated expression of FLOWERING LOCUS T (FT), which can be observed in the absence and presence of CONSTANS (CO), the main activator of FT. CO-independent activation by high MYB30 expression results in FT levels that remain below those observed in the wild-type plants, which show an additive CO-dependent activation. In contrast, TWIN SISTER OF FT (TSF) is repressed in plants expressing high levels of MYB30 in the phloem. In transient assays, MYB30 and CO additively increase the activity of a reporter construct driven by a 1 kb FT promoter. Acceleration of flowering by MYB30 does not require the presence of salicylic acid and is independent of FLC. Taken together, increased levels of MYB30, which was reported to be induced in response to the perception of pathogens, can accelerate flowering and MYB30 may thus be a candidate to mediate cross-talk between gene networks involved in biotic stress perception and flowering time.	[Liu, Liangyu; Yu, Diqiu] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China; [Liu, Liangyu; Adrian, Jessika; Gissot, Lionel; Coupland, George; Turck, Franziska] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Zhang, Jian] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Liu, Liangyu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Max Planck Society; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Turck, F (corresponding author), Max Planck Inst Plant Breeding Res, Cologne, Germany.	turck@mpipz.mpg.de	yu, diqiu/D-2011-2009; Coupland, George/AAP-8609-2020; Turck, Franziska/G-1240-2013	Coupland, George/0000-0001-6988-4172; Turck, Franziska/0000-0002-4982-5949; Adrian, Jessika/0000-0002-8078-5308	Chinese Academy of Sciences (CAS); Max Planck Society (MPS)	Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Max Planck Society (MPS)(Max Planck Society)	The authors thank the Chinese Academy of Sciences (CAS) and the Max Planck Society (MPS) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Castrillo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021524; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; D'Aloia M, 2011, PLANT J, V65, P972, DOI 10.1111/j.1365-313X.2011.04482.x; Daniel X, 1999, PLANT J, V20, P57, DOI 10.1046/j.1365-313X.1999.00578.x; Davis SJ, 2009, PLANT CELL ENVIRON, V32, P1201, DOI 10.1111/j.1365-3040.2009.01968.x; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Gomez-Mena C, 2001, PLANT CELL, V13, P1011, DOI 10.1105/tpc.13.5.1011; Hatayama T, 2003, J PLANT PHYSIOL, V160, P461, DOI 10.1078/0176-1617-01041; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; Jin JB, 2008, PLANT J, V53, P530, DOI 10.1111/j.1365-313X.2007.03359.x; Kolar J, 2008, J PLANT PHYSIOL, V165, P1601, DOI 10.1016/j.jplph.2007.11.010; Korves TM, 2003, PLANT PHYSIOL, V133, P339, DOI 10.1104/pp.103.027094; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Li L, 2009, PLANT J, V58, P275, DOI 10.1111/j.1365-313X.2008.03778.x; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Marino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2479; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Porri A, 2012, DEVELOPMENT, V139, P2198, DOI 10.1242/dev.077164; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Raffaele S, 2006, FEBS LETT, V580, P3498, DOI 10.1016/j.febslet.2006.05.027; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Shimakawa A, 2012, J PLANT PHYSIOL, V169, P987, DOI 10.1016/j.jplph.2012.02.009; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Takeno K, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P331, DOI 10.1007/978-1-4614-0634-1_17; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Torti S, 2012, PLANT CELL, V24, P444, DOI 10.1105/tpc.111.092791; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wada KC, 2010, J PLANT PHYSIOL, V167, P447, DOI 10.1016/j.jplph.2009.10.006; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P12822, DOI 10.1073/pnas.1202630109	57	26	33	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89799	10.1371/journal.pone.0089799	http://dx.doi.org/10.1371/journal.pone.0089799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587042	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900085
J	Lo, MK; Sogaard, TM; Karlin, DG				Lo, Michael K.; Sogaard, Teit Max; Karlin, David G.			Evolution and Structural Organization of the C Proteins of Paramyxovirinae	PLOS ONE			English	Article							VIRUS V-PROTEIN; NEWCASTLE-DISEASE-VIRUS; OVERLAPPING READING FRAMES; N-TERMINAL DOMAIN; MEASLES-VIRUS; NIPAH-VIRUS; WILD-TYPE; P-GENE; HOST INTERFERON; RNA-SYNTHESIS	The phosphoprotein (P) gene of most Paramyxovirinae encodes several proteins in overlapping frames: P and V, which share a common N-terminus (PNT), and C, which overlaps PNT. Overlapping genes are of particular interest because they encode proteins originated de novo, some of which have unknown structural folds, challenging the notion that nature utilizes only a limited, well-mapped area of fold space. The C proteins cluster in three groups, comprising measles, Nipah, and Sendai virus. We predicted that all C proteins have a similar organization: a variable, disordered N-terminus and a conserved, alpha-helical C-terminus. We confirmed this predicted organization by biophysically characterizing recombinant C proteins from Tupaia paramyxovirus (measles group) and human parainfluenza virus 1 (Sendai group). We also found that the C of the measles and Nipah groups have statistically significant sequence similarity, indicating a common origin. Although the C of the Sendai group lack sequence similarity with them, we speculate that they also have a common origin, given their similar genomic location and structural organization. Since C is dispensable for viral replication, unlike PNT, we hypothesize that C may have originated de novo by overprinting PNT in the ancestor of Paramyxovirinae. Intriguingly, in measles virus and Nipah virus, PNT encodes STAT1-binding sites that overlap different regions of the C-terminus of C, indicating they have probably originated independently. This arrangement, in which the same genetic region encodes simultaneously a crucial functional motif (a STAT1-binding site) and a highly constrained region (the C-terminus of C), seems paradoxical, since it should severely reduce the ability of the virus to adapt. The fact that it originated twice suggests that it must be balanced by an evolutionary advantage, perhaps from reducing the size of the genetic region vulnerable to mutations.	[Lo, Michael K.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA USA; [Sogaard, Teit Max; Karlin, David G.] Univ Oxford, Div Struct Biol, Oxford, England; [Karlin, David G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Centers for Disease Control & Prevention - USA; University of Oxford; University of Oxford	Karlin, DG (corresponding author), Univ Oxford, Div Struct Biol, Oxford, England.	dkarlin@strubi.ox.ac.uk		Lo, Michael/0000-0002-0409-7896; Sogaard, Teit Max Moscote/0000-0001-6224-4818	Wellcome Trust [090005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007610] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Wellcome Trust grant number 090005 to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Audsley Michelle D, 2013, World J Virol, V2, P57, DOI 10.5501/wjv.v2.i2.57; Bankamp B, 2005, VIROLOGY, V336, P120, DOI 10.1016/j.virol.2005.03.009; Bartlett EJ, 2005, VACCINE, V23, P4631, DOI 10.1016/j.vaccine.2005.04.035; Bartlett EJ, 2006, VACCINE, V24, P2674, DOI 10.1016/j.vaccine.2005.10.047; Bartlett EJ, 2008, J VIROL, V82, P8965, DOI 10.1128/JVI.00853-08; Batts WN, 2008, J AQUAT ANIM HEALTH, V20, P215, DOI 10.1577/H07-050.1; BELLINI WJ, 1985, J VIROL, V53, P908, DOI 10.1128/JVI.53.3.908-919.1985; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bird LE, 2014, METHODS MOL BIOL, V1116, P209, DOI 10.1007/978-1-62703-764-8_15; BOECK R, 1992, J VIROL, V66, P1765, DOI 10.1128/JVI.66.3.1765-1768.1992; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Boonyaratanakornkit JB, 2009, J VIROL, V83, P1892, DOI 10.1128/JVI.01373-08; Boxer EL, 2009, VIROLOGY, V385, P134, DOI 10.1016/j.virol.2008.11.022; Cadd T, 1996, J VIROL, V70, P5067, DOI 10.1128/JVI.70.8.5067-5074.1996; Caignard G, 2007, VIROLOGY, V368, P351, DOI 10.1016/j.virol.2007.06.037; Caignard G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000587; Carter JJ, 2013, P NATL ACAD SCI USA, V110, P12744, DOI 10.1073/pnas.1303526110; Cento V, 2013, J GEN VIROL, V94, P143, DOI 10.1099/vir.0.046524-0; Chambers R, 2009, VIRUSES-BASEL, V1, P574, DOI 10.3390/v1030574; Chen MZ, 2007, J VIROL, V81, P13478, DOI 10.1128/JVI.01244-07; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060098; CHINCHAR VG, 1981, VIROLOGY, V109, P59, DOI 10.1016/0042-6822(81)90471-2; CHINCHAR VG, 1981, VIROLOGY, V115, P192, DOI 10.1016/0042-6822(81)90101-X; Chinnakannan SK, 2014, J GEN VIROL, V95, P44, DOI 10.1099/vir.0.056739-0; Chinnakannan SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057063; Ciancanelli MJ, 2009, J VIROL, V83, P7828, DOI 10.1128/JVI.02610-08; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; CURRAN J, 1988, EMBO J, V7, P245, DOI 10.1002/j.1460-2075.1988.tb02806.x; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; CURRAN J, 1991, EMBO J, V10, P3079, DOI 10.1002/j.1460-2075.1991.tb07860.x; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; de Breyne S, 2005, FEBS LETT, V579, P5685, DOI 10.1016/j.febslet.2005.09.052; de Breyne S, 2004, J BIOL CHEM, V279, P16571, DOI 10.1074/jbc.M312391200; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; Devaux P, 2013, VIROLOGY, V444, P250, DOI 10.1016/j.virol.2013.06.019; Devaux P, 2011, J VIROL, V85, P348, DOI 10.1128/JVI.00802-10; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dunbrack RL, 2006, CURR OPIN STRUC BIOL, V16, P374, DOI 10.1016/j.sbi.2006.05.006; Durbin AP, 1999, VIROLOGY, V261, P319, DOI 10.1006/viro.1999.9878; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; Fontana JM, 2008, VIROLOGY, V374, P71, DOI 10.1016/j.virol.2007.12.031; Fridell F, 2004, DIS AQUAT ORGAN, V59, P11, DOI 10.3354/dao059011; Fujii Y, 2001, VIRUS GENES, V22, P47, DOI 10.1023/A:1008130318633; Garcin D, 2003, J VIROL, V77, P2321, DOI 10.1128/JVI.77.4.2321-2329.2003; Garcin D, 2002, VIROLOGY, V295, P256, DOI 10.1006/viro.2001.1342; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 2001, J VIROL, V75, P6800, DOI 10.1128/JVI.75.15.6800-6807.2001; Garcin D, 1997, VIROLOGY, V238, P424, DOI 10.1006/viro.1997.8836; GIORGI C, 1983, CELL, V35, P829, DOI 10.1016/0092-8674(83)90115-0; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grogan CC, 2001, VIROLOGY, V288, P96, DOI 10.1006/viro.2001.1068; Guyader S, 2002, J GEN VIROL, V83, P1799, DOI 10.1099/0022-1317-83-7-1799; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; Iakoucheva LM, 2001, PROTEIN SCI, V10, P1353, DOI 10.1110/ps.40101; Irie T, 2014, J VIROL, V88, P690, DOI 10.1128/JVI.02798-13; Irie T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073740; Irie T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010719; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Ito M, 2013, J VIROL, V87, P9633, DOI 10.1128/JVI.00714-13; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Jordan IK, 2000, MOL BIOL EVOL, V17, P75, DOI 10.1093/oxfordjournals.molbev.a026240; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Karlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031719; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato A, 2002, J VIROL, V76, P7114, DOI 10.1128/JVI.76.14.7114-7124.2002; Kato A, 2007, J VIROL, V81, P3264, DOI 10.1128/JVI.02590-06; Kaushik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056449; Kawano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066211; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Komase K, 2006, VACCINE, V24, P826, DOI 10.1016/j.vaccine.2005.06.036; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Krakauer DC, 2000, EVOLUTION, V54, P731, DOI 10.1111/j.0014-3820.2000.tb00075.x; Kuchibhatla DB, 2014, J VIROL, V88, P10, DOI 10.1128/JVI.02595-13; Kurath G, 2004, J VIROL, V78, P2045, DOI 10.1128/JVI.78.4.2045-2056.2004; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; Kvellestad A, 2003, J GEN VIROL, V84, P2179, DOI 10.1099/vir.0.18962-0; Latorre P, 1998, MOL CELL BIOL, V18, P5021, DOI 10.1128/MCB.18.9.5021; Leyrat C, 2010, PROTEIN PEPTIDE LETT, V17, P979, DOI 10.2174/092986610791498939; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Lo MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047790; Lo MK, 2008, J CLIN VIROL, V43, P396, DOI 10.1016/j.jcv.2008.08.007; Lo MK, 2009, J GEN VIROL, V90, P398, DOI 10.1099/vir.0.007294-0; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Malur AG, 2005, J VIROL, V79, P7877, DOI 10.1128/JVI.79.12.7877-7882.2005; Maman Y, 2011, J VIROL, V85, P4558, DOI 10.1128/JVI.02142-10; Mao HX, 2010, GENE EXPRESSION, V15, P43, DOI 10.3727/105221610X12819686555132; Mao HX, 2009, VIROLOGY, V394, P143, DOI 10.1016/j.virol.2009.08.026; Marq JB, 2007, J VIROL, V81, P3187, DOI 10.1128/JVI.02465-06; Mathieu C, 2012, J VIROL, V86, P10766, DOI 10.1128/JVI.01203-12; Mavrakis M, 2006, VIROLOGY, V349, P422, DOI 10.1016/j.virol.2006.01.030; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; McCarthy AJ, 2010, INFECT GENET EVOL, V10, P97, DOI 10.1016/j.meegid.2009.11.002; Meier C, 2006, STRUCTURE, V14, P1157, DOI 10.1016/j.str.2006.05.012; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; Mizokami M, 1997, J MOL EVOL, V44, pS83, DOI 10.1007/PL00000061; Nakatsu Y, 2008, J VIROL, V82, P8296, DOI 10.1128/JVI.00108-08; Nakatsu Y, 2006, J VIROL, V80, P11861, DOI 10.1128/JVI.00751-06; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Narechania A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/vir.0.80747-0; Nishie T, 2007, MICROBES INFECT, V9, P344, DOI 10.1016/j.micinf.2006.12.008; Ohno S, 2004, J GEN VIROL, V85, P2991, DOI 10.1099/vir.0.80308-0; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Parks CL, 2006, VIROLOGY, V348, P96, DOI 10.1016/j.virol.2005.12.018; Pavesi A, 2006, J GEN VIROL, V87, P1013, DOI 10.1099/vir.0.81375-0; Pavesi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003162; Peeters B, 2004, J GEN VIROL, V85, P2375, DOI 10.1099/vir.0.80160-0; Pei JM, 2007, NUCLEIC ACIDS RES, V35, pW649, DOI 10.1093/nar/gkm227; Peleg O, 2004, J MOL EVOL, V59, P520, DOI 10.1007/s00239-004-2644-5; Procter JB, 2010, NAT METHODS, V7, pS16, DOI [10.1038/NMETH.1434, 10.1038/nmeth.1434]; Radecke F, 1996, VIROLOGY, V217, P418, DOI 10.1006/viro.1996.0134; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Reutter GL, 2001, VIROLOGY, V285, P100, DOI 10.1006/viro.2001.0962; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rothlisberger A, 2010, J VIROL, V84, P6328, DOI 10.1128/JVI.01878-09; Sabath N, 2012, MOL BIOL EVOL, V29, P3767, DOI 10.1093/molbev/mss179; SANDER C, 1979, J MOL EVOL, V13, P245, DOI 10.1007/BF01739483; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Schomacker H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028382; Shaffer JA, 2003, VIROLOGY, V315, P389, DOI 10.1016/S0042-6822(03)00537-3; Shaji D, 1999, VIROLOGY, V258, P415, DOI 10.1006/viro.1999.9740; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Simon-Loriere E, 2013, MOL BIOL EVOL, V30, P1916, DOI 10.1093/molbev/mst094; Skolnick J, 2012, J PHYS CHEM B, V116, P6654, DOI 10.1021/jp211052j; Sleeman K, 2008, J GEN VIROL, V89, P1300, DOI 10.1099/vir.0.83582-0; Soding J, 2011, CURR OPIN STRUC BIOL, V21, P404, DOI 10.1016/j.sbi.2011.03.005; Sparrer KMJ, 2012, J VIROL, V86, P796, DOI 10.1128/JVI.05899-11; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sweetman DA, 2001, VIROLOGY, V281, P193, DOI 10.1006/viro.2000.0805; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Torres C, 2013, VIROLOGY, V441, P40, DOI 10.1016/j.virol.2013.02.027; Van Cleve W, 2006, VIROLOGY, V352, P61, DOI 10.1016/j.virol.2006.04.011; van Knippenberg I, 2010, J GEN VIROL, V91, P2002, DOI 10.1099/vir.0.021774-0; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wells G, 2012, VIRUS RES, V167, P385, DOI 10.1016/j.virusres.2012.05.009; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WINTON J R, 1985, Fish Pathology, V20, P373; Yamaguchi M, 2014, FEBS LETT, V588, P28, DOI 10.1016/j.febslet.2013.11.015; Yoneda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012709; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103	156	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90003	10.1371/journal.pone.0090003	http://dx.doi.org/10.1371/journal.pone.0090003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587180	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900107
J	Sacca, ML; Fajardo, C; Martinez-Gomariz, M; Costa, G; Nande, M; Martin, M				Ludovica Sacca, Maria; Fajardo, Carmen; Martinez-Gomariz, Montserrat; Costa, Gonzalo; Nande, Mar; Martin, Margarita			Molecular Stress Responses to Nano-Sized Zero-Valent Iron (nZVI) Particles in the Soil Bacterium Pseudomonas stutzeri	PLOS ONE			English	Article							ESCHERICHIA-COLI; NANOPARTICLES; NANOMATERIALS; AERUGINOSA; SYSTEMS; IMPACT	Nanotoxicological studies were performed in vitro using the common soil bacterium Pseudomonas stutzeri to assess the potentially toxic impact of commercial nano-sized zero-valent iron (nZVI) particles, which are currently used for environmental remediation projects. The phenotypic response of P. stutzeri to nZVI toxicity includes an initial insult to the cell wall, as evidenced by TEM micrographs. Transcriptional analyses using genes of particular relevance in cellular activity revealed that no significant changes occurred among the relative expression ratios of narG, nirS, pykA or gyrA following nZVI exposure; however, a significant increase in katB expression was indicative of nZVI-induced oxidative stress in P. stutzeri. A proteomic approach identified two major defence mechanisms that occurred in response to nZVI exposure: a downregulation of membrane proteins and an upregulation of proteins involved in reducing intracellular oxidative stress. These biomarkers served as early indicators of nZVI response in this soil bacterium, and may provide relevant information for environmental hazard assessment.	[Ludovica Sacca, Maria; Fajardo, Carmen; Costa, Gonzalo; Nande, Mar; Martin, Margarita] Univ Complutense Madrid, Fac Vet, Madrid, Spain; [Ludovica Sacca, Maria] Moncloa Campus Int Excellence, Madrid, Spain; [Martinez-Gomariz, Montserrat] Univ Complutense Madrid, Prote Facil, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Sacca, ML (corresponding author), Univ Complutense Madrid, Fac Vet, Madrid, Spain.	marialudovicasacca@pdi.ucm.es	Saccà, Maria Ludovica/A-5611-2015; Sacca', Maria Ludovica/Q-9562-2019; ADAN, CARMEN FAJARDO/S-1875-2018; Costa, Gonzalo/GRF-1322-2022	Saccà, Maria Ludovica/0000-0003-4222-9527; Sacca', Maria Ludovica/0000-0003-4222-9527; FAJARDO, CARMEN/0000-0001-9810-1923; Costa, Gonzalo/0000-0001-8110-1222	Comunidad de Madrid (EIADES Project) [S2009/AMB-1478]; Ministerio de Ciencia e Inovacion [CTM2010-20617-C02-01]; PICATA postdoctoral fellowship of the Moncloa Campus of International Excellence (UCM-UPM)	Comunidad de Madrid (EIADES Project); Ministerio de Ciencia e Inovacion(Spanish Government); PICATA postdoctoral fellowship of the Moncloa Campus of International Excellence (UCM-UPM)	Funding for this study was provided by Comunidad de Madrid (EIADES Project S2009/AMB-1478), Ministerio de Ciencia e Inovacion (CTM2010-20617-C02-01). Research by MLS was supported by a PICATA postdoctoral fellowship of the Moncloa Campus of International Excellence (UCM-UPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Auffan M, 2008, ENVIRON SCI TECHNOL, V42, P6730, DOI 10.1021/es800086f; Barnes RJ, 2010, J HAZARD MATER, V184, P73, DOI 10.1016/j.jhazmat.2010.08.006; BIEL AJ, 1992, J BACTERIOL, V174, P5272, DOI 10.1128/JB.174.16.5272-5274.1992; Chen JW, 2011, WATER RES, V45, P1995, DOI 10.1016/j.watres.2010.11.036; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Diao MH, 2009, WATER RES, V43, P5243, DOI 10.1016/j.watres.2009.08.051; Fajardo C, 2012, CHEMOSPHERE, V86, P802, DOI 10.1016/j.chemosphere.2011.11.041; Feeney MA, 2012, J BACTERIOL, V194, P1515, DOI 10.1128/JB.05989-11; Handy RD, 2012, ECOTOXICOLOGY, V21, P933, DOI 10.1007/s10646-012-0862-y; Hansen SF, 2012, DOSE-RESPONSE, V10, P364, DOI 10.2203/dose-response.10-029.Hansen; Lee C, 2008, ENVIRON SCI TECHNOL, V42, P4927, DOI 10.1021/es800408u; Lemos MFL, 2010, PROTEOMICS, V10, P873, DOI 10.1002/pmic.200900470; Sacca ML, 2013, MICROB ECOL, V66, P806, DOI 10.1007/s00248-013-0269-1; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Mueller NC, 2012, ENVIRON SCI POLLUT R, V19, P550, DOI 10.1007/s11356-011-0576-3; Rao VA, 2013, ACTA CRYSTALLOGR F, V69, P243, DOI 10.1107/S1744309113002352; Schmalisch M, 2002, J MOL MICROB BIOTECH, V4, P495; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Touati D., 1997, OXIDATIVE STRESS MOL, P447; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Yang Y, 2011, ENVIRON SCI TECHNOL, V45, P4988, DOI 10.1021/es1042673	27	55	57	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89677	10.1371/journal.pone.0089677	http://dx.doi.org/10.1371/journal.pone.0089677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586957	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900066
J	Vinn, O; Motus, MA				Vinn, Olev; Motus, Mari-Ann			Endobiotic Rugosan Symbionts in Stromatoporoids from the Sheinwoodian (Silurian) of Baltica	PLOS ONE			English	Article							PARASITISM; TRACE; PALEOECOLOGY; SAAREMAA; ORIGIN	A paleoecological study of stromatoporoid endobionts was carried out to discern the relationships between symbiotic rugosans and their stromatoporoid hosts. The earliest endobiotic rugosan symbiont Palaeophyllum sp. in Baltica has only been found in the stromatoporoid Ecclimadictyon astrolaxum from Saaremaa, Estonia. The rugosans are vertically oriented inside the stromatoporoid skeleton. Numerous rugosans have their corallites open at the upper, external surface of stromatoporoids, but many are completely embedded within the stromatoporoids. Stromatoporoid hosts were presumably beneficial for rugosans as elevated substrates on a sea floor that offered a higher tier for feeding. Relative substrate stability in the hydrodynamically active shallow waters may have also been beneficial for the rugosans.	[Vinn, Olev] Univ Tartu, Dept Geol, EE-50090 Tartu, Estonia; [Motus, Mari-Ann] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia	University of Tartu; Tallinn University of Technology	Vinn, O (corresponding author), Univ Tartu, Dept Geol, Ulikooli 18, EE-50090 Tartu, Estonia.	olev.vinn@ut.ee	Vinn, Olev/AAG-6806-2020	Vinn, Olev/0000-0002-2889-2544	Estonian Science Foundation [ETF9064]; Estonian Ministry of Education and Science [SF0180051s08, SF0140020s08]; SEPKOSKI Grant (Paleontological Society)	Estonian Science Foundation; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); SEPKOSKI Grant (Paleontological Society)	O.V. is indebted to the SEPKOSKI Grant (Paleontological Society), Estonian Science Foundation grant ETF9064 and the target-financed project (from the Estonian Ministry of Education and Science) SF0180051s08 (Ordovician and Silurian climate changes, as documented from the biotic changes and depositional environments in the Baltoscandian Palaeobasin) for financial support. M-A.M. was supported by the target-financed project (from the Estonian Ministry of Education and Science) SF0140020s08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ F, 1987, PALAEOGEOGR PALAEOCL, V61, P17, DOI 10.1016/0031-0182(87)90039-3; Berkowski B, 2014, LETHAIA, V47, P176, DOI 10.1111/let.12048; Berkowski B, 2012, LETHAIA, V45, P24, DOI 10.1111/j.1502-3931.2011.00278.x; Bohaty J, 2012, J PALEONTOL, V86, P282, DOI 10.1666/11-007.1; Brice D., 1992, GEOBIOS-LYON, V25, P45, DOI DOI 10.1016/S0016-6995(06)80313-X; Einasto R, 1990, FIELD M EST 1990 EXC, P165; HINTS O, 2008, 7 BALT STRAT C FIELD; Kaljo D, 1970, SILURINA ESTONIA; KERSHAW S, 1987, LETHAIA, V20, P371, DOI 10.1111/j.1502-3931.1987.tb00798.x; KERSHAW S, 1981, J PALEONTOL, V55, P1284; Klaamann E., 1958, EESTI LOODUS, V5, P306; Lapid ED, 2004, MAR ECOL PROG SER, V282, P161, DOI 10.3354/meps282161; Melchin M.J., 2004, GEOLOGIC TIME SCALE, P188; Mori K., 1970, Stockh. Contr. Geol., V22, P1; Mori K, 1969, STOCKHOLM CONTRIBUTI, V19, P1; Nestor H., 1966, STROMATOPOROIDEI VEN, P1; NESTOR H, 1997, GEOLOGY MINERAL RESO, P192; Nestor Heldur, 1999, Proceedings of the Estonian Academy of Sciences Geology, V48, P123; PALMER TJ, 1988, PALAEONTOLOGY, V31, P939; RICHARDS RP, 1976, J PALEONTOL, V50, P858; Sorauf JE, 2012, GEOL BELG, V15, P220; Soto F., 1985, TRAB GEOL, V15, P203; STEL JH, 1976, NEUES JB GEOLOGIE PA, V12, P726; Tapanila L, 2005, LETHAIA, V38, P89, DOI 10.1080/00241160510013123; Tapanila L, 2006, J PALEONTOL, V80, P750, DOI 10.1666/0022-3360(2006)80[750:EIOCAS]2.0.CO;2; TAYLOR PD, 1990, PALAEONTOLOGY, V33, P1; TAYLOR PD, 1990, PALAEONTOLOGY, V33, P19; Vinn O, 2012, ANN SOC GEOL POL, V82, P195; Vinn O, 2012, CARNETS GEOL, P183; Vinn O, 2010, NEUES JAHRB GEOL P-A, V257, P13, DOI 10.1127/0077-7749/2010/0048; Zapalski MK, 2007, PALAEONTOLOGY, V50, P1375, DOI 10.1111/j.1475-4983.2007.00716.x; Zapalski MK, 2011, PALAEOGEOGR PALAEOCL, V302, P484, DOI 10.1016/j.palaeo.2011.01.013; Zapalski MK, 2011, PARASITOLOGY, V138, P132, DOI 10.1017/S0031182010001071; Zapalski MK, 2005, GEOBIOS-LYON, V38, P677, DOI 10.1016/j.geobios.2004.05.002	34	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90197	10.1371/journal.pone.0090197	http://dx.doi.org/10.1371/journal.pone.0090197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587277	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900126
J	Wang, J; Mittendorf, EA; Sahin, AA; Yi, M; Caudle, A; Hunt, KK; Wu, Y				Wang, Jun; Mittendorf, Elizabeth A.; Sahin, Aysegul A.; Yi, Min; Caudle, Abigail; Hunt, Kelly K.; Wu, Yun			Outcomes of Sentinel Lymph Node Dissection Alone vs. Axillary Lymph Node Dissection in Early Stage Invasive Lobular Carcinoma: A Retrospective Study of the Surveillance, Epidemiology and End Results (SEER) Database	PLOS ONE			English	Article							POSITIVE BREAST-CANCER; RADIATION-THERAPY; RECURRENCE; BIOPSY	Background: The American College of Surgeons Oncology Group (ACOSOG) Z0011 trial demonstrated no difference in local-regional recurrence (LRR), disease-specific survival (DSS) or overall survival (OS) for sentinel lymph node dissection (SLND) and completion axillary lymph node dissection (ALND) among patients undergoing breast-conserving therapy for clinical T1-T2, N0 breast cancer with 1 or 2 positive SLNs. However, Only 7% of study participants had invasive lobular carcinoma (ILC). Because ILC has a different pattern of metastases, frequently presenting as small foci requiring immunohistochemistry for detection, the applicability of ACOSOG Z0011 trial data to ILC patients is unclear. Study Design: We identified all ILC patients in the Surveillance, Epidemiology, and End Results (SEER) database (1998-2009) who met the ACOSOG Z0011 eligibility criteria. Patients were evaluated on the basis of the extent of axillary surgery (SLND alone or ALND), and the clinical outcomes of these 2 groups were compared. Results: 1269 patients (393 SLND and 876 ALND) were identified from the SEER database. At a median follow-up time of 71 months, there were no differences in OS or disease-specific survival between the two groups. Conclusion: SLND alone may result in outcomes comparable to those achieved with ALND for patients with early-stage ILC who meet the ACOSOG Z0011 eligibility criteria.	[Wang, Jun] Jinan Command Peoples Liberat Army, Gen Hosp, Dept Oncol, Jinan, Peoples R China; [Wang, Jun; Sahin, Aysegul A.; Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Mittendorf, Elizabeth A.; Yi, Min; Caudle, Abigail; Hunt, Kelly K.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, Y (corresponding author), Jinan Command Peoples Liberat Army, Gen Hosp, Dept Oncol, Jinan, Peoples R China.	yunwu@mdanderson.org	Caudle, Abigail/G-5355-2015; Wang, Jun/AAZ-2098-2020; Yi, Min/J-8963-2017	Yi, Min/0000-0001-8662-6546	MD Anderson Cancer Center [CA01667233]; National Nature Science Foundation of China [30901788, 81272619]; Shandong Provincial Nature Science Foundation [ZR2010HQ038, ZR2010HM059]	MD Anderson Cancer Center; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Nature Science Foundation	This study was supported in part by the MD Anderson Cancer Center Support Grant (CA01667233). Dr. Jun Wang was supported in part by the National Nature Science Foundation of China (Nos. 30901788 and 81272619) and the Shandong Provincial Nature Science Foundation ( Nos. ZR2010HQ038 and ZR2010HM059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; Bilimoria KY, 2009, J CLIN ONCOL, V27, P2946, DOI 10.1200/JCO.2008.19.5750; Caudle AS, 2011, ANN SURG ONCOL, V18, P2407, DOI 10.1245/s10434-011-1593-7; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Leitch AM, 2006, J CLIN ONCOL, V24, P601; Peiro G, 2000, BREAST CANCER RES TR, V59, P49, DOI 10.1023/A:1006384407690; Pestalozzi BC, 2008, J CLIN ONCOL, V26, P3006, DOI 10.1200/JCO.2007.14.9336; Reznik J, 2005, INT J RADIAT ONCOL, V61, P163, DOI 10.1016/j.ijrobp.2004.04.065; Ribeiro G G, 1993, Clin Oncol (R Coll Radiol), V5, P278, DOI 10.1016/S0936-6555(05)80900-8; Ribeiro G G, 1990, Clin Oncol (R Coll Radiol), V2, P27, DOI 10.1016/S0936-6555(05)80215-8; Smith BD, 2009, INT J RADIAT ONCOL, V74, P987, DOI 10.1016/j.ijrobp.2009.02.031; Stephen BE, 2010, AJCC CANC STAGING MA, V7th, P355; TAVASSOLI FA, 2003, WHO CLASSIFICATION T, P23; Vo TN, 2006, AM J SURG, V192, P552, DOI 10.1016/j.amjsurg.2006.06.020; Yi M, 2010, ANN SURG ONCOL, V17, pS343, DOI 10.1245/s10434-010-1253-3	16	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89778	10.1371/journal.pone.0089778	http://dx.doi.org/10.1371/journal.pone.0089778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587029	Green Submitted, gold, Green Published			2022-12-27	WOS:000332385900082
J	Li, QR; Wang, D; Lv, SM; Zhang, YL				Li, Qiurong; Wang, Dun; Lv, Shumin; Zhang, Yalin			Comparative Proteomics and Expression Analysis of Five Genes in Epicauta chinensis Larvae from the First to Fifth Instar	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; JUVENILE-HORMONE; VITELLOGENIN SYNTHESIS; MEVALONATE PATHWAY; DROSOPHILA-MELANOGASTER; BRAIN REVEALS; BOMBYX-MORI; BIOSYNTHESIS; LYSOZYME; IDENTIFICATION	Blister beetle is an important insect model for both medicinal and pure research. Previous research has mainly focused on its biology and biochemistry, but very little data is yet available in the molecular biology. This study uses differential proteomics technology to analyze the soluble proteins extracted from each of the 5 instars larvae of Epicauta chinensis. 42 of the differentially-expressed proteins were identified successfully by MALDI-TOF/TOF-MS. Some of these proteins' function and their expression profiles are analyzed. Our analysis revealed dynamics regulation of the following proteins: Axin-like protein pry-1 (APR-1), dihydrolipoyl dehydrogenase (DLD), vitellogenin (Vg) and lysozyme C (Lmz-S). APR-1 negatively regulates the Wnt signaling pathway. Its overexpression could result in embryo, leg, eye and ovary ectopica or malformation. DLD catalyzes the pyruvate into acetyl-CoA, the latter is the starting material of juvenile hormone (JH) and ipsdienol biosynthesis through the MVA pathway in insects. While Vg synthesis can be regulated by JH and stimulated by food factors. So DLD may affect the synthesis of JH, ipsdienol and Vg indirectly. The activity of lysozyme is an indicator of the immunity. Nutrition/food should be taken into account for its potential role during the development of larva in the future. Among the five genes and their corresponding proteins' expression, only hsc70 gene showed a good correspondence with the protein level. This reflects the fluctuating relationship between mRNA and protein levels.	[Li, Qiurong; Lv, Shumin; Zhang, Yalin] Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China; [Wang, Dun] Northwest A&F Univ, Inst Entomol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zhang, YL (corresponding author), Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China.	yalinzh@nwsuaf.edu.cn			Special Fund for the Public Interest (Agriculture) [200903052]; "13115'' Sci-Tech Innovation Project of Shaanxi Province [2009ZDKG-06]	Special Fund for the Public Interest (Agriculture); "13115'' Sci-Tech Innovation Project of Shaanxi Province	This work is supported by the Special Fund for the Public Interest (Agriculture) (grant number 200903052) and the "13115'' Sci-Tech Innovation Project of Shaanxi Province (number 2009ZDKG-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AR, 2012, AM J PHYSIOL-LUNG C, V303, pL889, DOI 10.1152/ajplung.00219.2012; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Balduf WV, 1969, BIONOMICS ENTOMOPHAG; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burdge GC, 2007, BRIT J NUTR, V97, P1036, DOI 10.1017/S0007114507682920; CARREL JE, 1974, SCIENCE, V183, P755, DOI 10.1126/science.183.4126.755; Chan QWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024794; Chang WWP, 2000, PLANT PHYSIOL, V122, P295, DOI 10.1104/pp.122.2.295; Chen T. T., 1976, The juvenile hormones., P505; Clausen C. P., 1940, ENTOMOPHAGOUS INSECT; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; DOMINGUEZPUIGJANER E, 1992, PLANT PHYSIOL, V98, P157, DOI 10.1104/pp.98.1.157; Dubey VS, 2003, J BIOSCIENCES, V28, P637, DOI 10.1007/BF02703339; Falabella P, 2009, INSECT BIOCHEM MOLEC, V39, P801, DOI 10.1016/j.ibmb.2009.09.005; FESCEMYER HW, 1992, COMP BIOCHEM PHYS B, V103, P533, DOI 10.1016/0305-0491(92)90366-Y; Fu JP, 2012, P NATL ACAD SCI USA, V109, P7782, DOI 10.1073/pnas.1116641109; GRANIER F, 1988, ELECTROPHORESIS, V9, P712, DOI 10.1002/elps.1150091106; GUENTHER H, 1969, J PHARM SCI, V58, P1274, DOI 10.1002/jps.2600581027; Hall GM, 2002, NATURWISSENSCHAFTEN, V89, P79, DOI 10.1007/s00114-001-0290-y; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Harper JT, 2004, GENE, V340, P227, DOI 10.1016/j.gene.2004.06.048; Hegan PS, 2007, MOL BIOL CELL, V18, P4625, DOI 10.1091/mbc.E07-02-0191; Jensen ON, 1999, METH MOL B, V112, P513; [贾俊峰 JIA Jun-Feng], 2009, [环境昆虫学报, Journal of Environmental Entomology], V31, P203; Jiang ZL, 2007, CLIN CHIM ACTA, V376, P136, DOI 10.1016/j.cca.2006.08.005; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Liu K.-J., 2007, J CANC MOL, V3, P45; MARESCA B, 1994, EXPERIENTIA, V50, P1067, DOI 10.1007/BF01923463; Matsuura A, 2002, BIOCHEMISTRY-US, V41, P12086, DOI 10.1021/bi016099j; MATSUZAWA M, 1987, J AGR FOOD CHEM, V35, P823, DOI 10.1021/jf00077a045; MCCORMICK JP, 1986, J AM CHEM SOC, V108, P8071, DOI 10.1021/ja00285a032; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Naaby-Hansen S, 2001, TRENDS PHARMACOL SCI, V22, P376, DOI 10.1016/S0165-6147(00)01663-1; Nishikawa M, 2008, INT J PHARM, V354, P23, DOI 10.1016/j.ijpharm.2007.09.030; Nogueira SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078150; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PETER MG, 1977, HELV CHIM ACTA, V60, P844, DOI 10.1002/hlca.19770600314; Pinto LZ, 2000, J INSECT PHYSIOL, V46, P153, DOI 10.1016/S0022-1910(99)00111-0; POWNING RF, 1973, COMP BIOCHEM PHYSIOL, V45, P669, DOI 10.1016/0305-0491(73)90205-8; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; SATYANARAYANA K, 1992, INVERTEBR REPROD DEV, V21, P169, DOI 10.1080/07924259.1992.9672235; SCHLATTE.C, 1968, EXPERIENTIA, V24, P994, DOI 10.1007/BF02138701; SELANDER RICHARD B., 1964, ANN ENTOMOL SOC AMER, V57, P711; Sheoran IS, 2007, J EXP BOT, V58, P3525, DOI 10.1093/jxb/erm199; Song LS, 2006, APPL BIOCHEM BIOTECH, V128, P149, DOI 10.1385/ABAB:128:2:149; Sotelo-Mundo RR, 2007, PROTEIN PEPTIDE LETT, V14, P774; SOUTHWICK FS, 1990, J CELL BIOL, V110, P1965, DOI 10.1083/jcb.110.6.1965; Suarez RK, 2012, J EXP BIOL, V215, P2351, DOI 10.1242/jeb.059725; Thi TAN, 2013, J INSECT PHYSIOL, V59, P11, DOI 10.1016/j.jinsphys.2012.11.002; Vattem DA, 2013, PHARMACOGN RES, V5, P1, DOI 10.4103/0974-8490.105636; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Venesky MD, 2012, OECOLOGIA, V169, P23, DOI 10.1007/s00442-011-2171-1; Vierstraete E, 2003, BIOCHEM BIOPH RES CO, V304, P831, DOI 10.1016/S0006-291X(03)00683-1; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Volkmann N, 2000, CURR OPIN CELL BIOL, V12, P26, DOI 10.1016/S0955-0674(99)00053-8; Willert K, 1999, DEVELOPMENT, V126, P4165; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; ZHAI QH, 1984, INSECT BIOCHEM, V14, P299, DOI 10.1016/0020-1790(84)90064-7; Zhang JZ, 1996, GENE, V175, P193, DOI 10.1016/0378-1119(96)00147-3; Zhang JZ, 1996, MOL CELL ENDOCRINOL, V122, P15, DOI 10.1016/0303-7207(96)03884-1; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zhang YQ, 2005, MOL CELL PROTEOMICS, V4, P278, DOI 10.1074/mcp.M400174-MCP200; Zhang ZY, 1998, J PLANT RES, V25, P166; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhou ZH, 2008, J PROTEOME RES, V7, P5103, DOI 10.1021/pr800383r	75	4	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89607	10.1371/journal.pone.0089607	http://dx.doi.org/10.1371/journal.pone.0089607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586908	gold, Green Submitted, Green Published			2022-12-27	WOS:000331717900128
J	Tao, ZX; Wang, HY; Li, Y; Liu, GF; Xu, AQ; Lin, XJ; Song, LZ; Ji, F; Wang, ST; Cui, N; Song, YY				Tao, Zexin; Wang, Haiyan; Li, Yan; Liu, Guifang; Xu, Aiqiang; Lin, Xiaojuan; Song, Lizhi; Ji, Feng; Wang, Suting; Cui, Ning; Song, Yanyan			Molecular Epidemiology of Human Enterovirus Associated with Aseptic Meningitis in Shandong Province, China, 2006-2012	PLOS ONE			English	Article							MOUTH-DISEASE; OUTBREAK; IDENTIFICATION; CHILDREN; HAND; FOOT; INFECTION; DIVERSITY; EVOLUTION; TOOL	Background: Human enteroviruses (HEVs) are common causes of acute meningitis. However, there is limited information about HEV associated with aseptic meningitis in mainland China because it has not been classified as a notifiable disease. Objectives: To characterize the HEVs associated with sporadic aseptic meningitis in China and to analyze their genetic features. Study Design: Cerebrospinal fluid, throat swab and feces specimens were collected from patients with aseptic meningitis in 5 sentinel hospitals in Shandong Province, China between 2006 and 2012. Virological investigation (viral isolation and molecular identification) and phylogenetic analysis were performed. Results: A total of 437 hospitalized patients were reported, and enteroviruses were detected in the specimens from 84 patients (19.2%) and were identified into 17 serotypes. The nine main serotypes were echovirus (E) 30 (27.4%), EV71 (13.1%), coxsackievirus (CV) B1 (9.5%), CVB3 (7.1%), CVB5 (7.1%), E6 (7.1%), E9 (7.1%), CVA9 (6.0%), and CVA10 (3.6%). Monthly distribution of isolated enteroviruses revealed a major peak in summer-fall season and a small second peak in winter constituted totally by EV71. Sequence analysis on VP1 coding region suggested Shandong strains had great genetic divergence with isolates from other countries. Conclusions: Multiple serotypes were responsible for enterovirus meningitis in mainland China. Aseptic meningitis caused by EV71 and coxsackie A viruses-the predominant pathogens for the hand, foot, and mouth disease-is currently an important concern in mainland China.	[Tao, Zexin; Wang, Haiyan; Li, Yan; Liu, Guifang; Xu, Aiqiang] Shandong Univ, Acad Prevent Med, Jinan 250100, Peoples R China; [Tao, Zexin; Wang, Haiyan; Li, Yan; Liu, Guifang; Xu, Aiqiang; Lin, Xiaojuan; Song, Lizhi; Ji, Feng; Wang, Suting] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Peoples R China; [Xu, Aiqiang; Song, Yanyan] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China; [Cui, Ning] Shandong Univ Tradit Chinese Med, Coll Basic Med Sci, Dept Prevent Med, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University of Traditional Chinese Medicine	Xu, AQ (corresponding author), Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China.	aqxuepi@163.com; yysong@sdu.edu.cn		Tao, Zexin/0000-0002-1747-2034	Health Department of Shandong Province [2011QZ013, 2011HZ058]; Science and Technology Department of Shandong Province [2012YD18044]	Health Department of Shandong Province; Science and Technology Department of Shandong Province	This study was supported by two grants from the Health Department of Shandong Province (2011QZ013 and 2011HZ058) and a grant from the Science and Technology Department of Shandong Province (2012YD18044). URL: http://jihlx.sdstc.gov.cn/stdpms/; http://60.216.104.27/mstmis/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen P, 2013, J MED VIROL, V85, P483, DOI 10.1002/jmv.23478; Cui AL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-72; dos Santos GPL, 2006, J MED VIROL, V78, P98, DOI 10.1002/jmv.20509; Fan XL, 2013, VIRUS GENES, V46, P1, DOI 10.1007/s11262-012-0814-x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kumar A, 2012, J CLIN MICROBIOL, V50, P3509, DOI 10.1128/JCM.01483-12; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Mao NY, 2010, J MED VIROL, V82, P441, DOI 10.1002/jmv.21707; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Mirand A, 2008, J CLIN MICROBIOL, V46, P87, DOI 10.1128/JCM.01020-07; Oberste MS, 1999, J CLIN MICROBIOL, V37, P3928, DOI 10.1128/JCM.37.12.3928-3933.1999; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457; Rao DC, 2013, INFECT GENET EVOL, V17, P153, DOI 10.1016/j.meegid.2013.04.011; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2012, EMERG INFECT DIS, V18, P1865, DOI 10.3201/eid1811.120090; Tao ZX, 2012, J CLIN MICROBIOL, V50, P1823, DOI 10.1128/JCM.06850-11; Villarruel G. R., 2010, Morbidity and Mortality Weekly Report, V59, P1577; Wang HX, 2006, PEPTIDES, V27, P27, DOI 10.1016/j.peptides.2005.06.009; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; World Health Organization, 2004, POL LAB MAN, V4th; Yang XH, 2013, J MED VIROL, V85, P696, DOI 10.1002/jmv.23503; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao YN, 2005, EMERG INFECT DIS, V11, P562, DOI 10.3201/eid1104.040995	36	49	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89766	10.1371/journal.pone.0089766	http://dx.doi.org/10.1371/journal.pone.0089766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24587020	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900149
J	Ohtani, M; Villumsen, KR; Strom, HK; Raida, MK				Ohtani, Maki; Villumsen, Kasper Romer; Strom, Helene Kragelund; Raida, Martin Kristian			3D Visualization of the Initial Yersinia ruckeri Infection Route in Rainbow Trout (Oncorhynchus mykiss) by Optical Projection Tomography	PLOS ONE			English	Article							VIBRIO-ANGUILLARUM; GENE-EXPRESSION; IMMUNE-RESPONSE; GILL EPITHELIA; FISH; MORPHOLOGY; CELLS; ENTRY; PROTECTION; RESISTANCE	Despite the fact that enteric redmouth disease (ERM) in farmed rainbow trout is one of the most devastating disease problems, little is known about the initial route of infection and pathogenicity of the aetiological agent, Yersinia ruckeri. In order to determine the initially infected organs, optical projection tomography (OPT), a novel three-dimensional (3D) bio-imaging technique, was applied. OPT not only enables the visualization of Y. ruckeri on mucosal surfaces but also the 3D spatial distribution in whole organs, without sectioning. Rainbow trout were infected by bath challenge exposure to 1 x 10(8) CFU/ml of Y. ruckeri O1 for 1 hour. Three fish were sampled for OPT and immunohistochemistry (IHC) 1, 10 and 30 minutes, 1, 3, 6, 12 and 24 hours, as well as 2, 3, 7 and 21 days after the start of the infection period. Y. ruckeri was re-isolated from the blood of infected fish as early as 1 minute post infection. Both OPT and IHC analysis confirmed that the secondary gill lamellae were the only tissues infected at this early time point, indicating that Y. ruckeri initially infects gill epithelial cells. The experimentally induced infection caused septicemia, and Y. ruckeri was found in all examined organs 7 days post infection including the brain, which correlated with the peak in mortality. To the best of our knowledge this is the first description of Y. ruckeri infection in the brain, which is likely to cause encephalitis. This in part could explain the lethality of ERM in rainbow trout. Using OPT scanning it was possible to visualize the initial route of entry, as well as secondary infection routes along with the proliferation and spread of Y. ruckeri, ultimately causing significant mortality in the exposed rainbow trout. These results demonstrate that OPT is a state-of-the-art technique capable of visualizing pathogenesis at high resolution.	[Ohtani, Maki; Villumsen, Kasper Romer; Strom, Helene Kragelund; Raida, Martin Kristian] Univ Copenhagen, Sect Vet Clin Microbiol, Res Grp Fish Dis & Immunol, Dept Vet Dis Biol,Fac Hlth & Med Sci, Frederiksberg, Denmark	University of Copenhagen	Raida, MK (corresponding author), Univ Copenhagen, Sect Vet Clin Microbiol, Res Grp Fish Dis & Immunol, Dept Vet Dis Biol,Fac Hlth & Med Sci, Frederiksberg, Denmark.	mr@sund.ku.dk	Villumsen, Kasper Rømer/L-2471-2019	Villumsen, Kasper Rømer/0000-0002-0616-4095	Danish Research Council [11-105095]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was financially supported by grant no. 11-105095 from the Danish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DP, 1974, J FISH RES BOARD CAN, V31, P214, DOI 10.1139/f74-035; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; BLAZER VS, 1985, J FISH BIOL, V27, P167, DOI 10.1111/j.1095-8649.1985.tb04018.x; Broadbent J, 1999, MOL METHODS DEV BIOL; Bryson-Richardson RJ, 2004, METHOD CELL BIOL, V76, P37; Chang PH, 1996, J FISH DIS, V19, P235, DOI 10.1111/j.1365-2761.1996.tb00130.x; Chettri JK, 2012, DEV COMP IMMUNOL, V36, P463, DOI 10.1016/j.dci.2011.08.014; Costes B, 2009, J VIROL, V83, P2819, DOI 10.1128/JVI.02305-08; DAVIES RL, 1991, VET MICROBIOL, V29, P289, DOI 10.1016/0378-1135(91)90136-4; Eldar A, 1999, DIS AQUAT ORGAN, V36, P227, DOI 10.3354/dao036227; Fisher ME, 2008, DEV BIOL, V317, P13, DOI 10.1016/j.ydbio.2008.01.031; Fouz B, 2006, J FISH DIS, V29, P339, DOI 10.1111/j.1365-2761.2006.00723.x; Fuhrmann H., 1984, Bulletin of the European Association of Fish Pathologists, V4, P42; Furones M. D., 1993, Annual Review of Fish Diseases, V3, P105, DOI 10.1016/0959-8030(93)90031-6; GRIFFIN BR, 1983, DEV COMP IMMUNOL, V7, P253, DOI 10.1016/0145-305X(83)90006-X; GRINDE B, 1989, J FISH DIS, V12, P95, DOI 10.1111/j.1365-2761.1989.tb00281.x; Gudmundsdottir BK, 2014, J FISH DIS, V37, P511, DOI 10.1111/jfd.12139; Haig SJ, 2011, VET MICROBIOL, V147, P155, DOI 10.1016/j.vetmic.2010.06.022; Hastein T, 2005, DEV BIOLOGICALS, V121, P55; JOHNSON KA, 1983, J FISH DIS, V6, P331, DOI 10.1111/j.1365-2761.1983.tb00084.x; JOHNSON KA, 1983, J FISH DIS, V6, P473, DOI 10.1111/j.1365-2761.1983.tb00101.x; Kaneko Toyoji, 2008, Aqua-Bioscience Monographs, V1, P1; Kawula TH, 1996, MICROB PATHOGENESIS, V20, P119, DOI 10.1006/mpat.1996.0011; Kerwin J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-27; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; Kirjavainen V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000140; LAURENT P, 1980, AM J PHYSIOL, V238, pR147, DOI 10.1152/ajpregu.1980.238.3.R147; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Ling SHM, 2001, FEMS MICROBIOL LETT, V194, P239, DOI 10.1111/j.1574-6968.2001.tb09476.x; Macdonald R, 1999, METH MOL B, V127, P77, DOI 10.1385/1-59259-678-9:77; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; McIntosh D, 2000, J FISH BIOL, V56, P1053, DOI 10.1111/j.1095-8649.2000.tb02122.x; Mendez J, 2013, ENV MICROBIOL REP, V5, P179, DOI 10.1111/1758-2229.12030; O'Toole R, 2004, MICROB PATHOGENESIS, V37, P41, DOI 10.1016/j.micpath.2004.03.001; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Raida MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018832; Raida MK, 2009, DEV COMP IMMUNOL, V33, P35, DOI 10.1016/j.dci.2008.07.001; Ringo E, 2004, CELL TISSUE RES, V318, P305, DOI 10.1007/s00441-004-0934-2; ROSS AJ, 1966, CAN J MICROBIOL, V12, P763, DOI 10.1139/m66-103; Ruckner R. R., 1966, Bulletin Office International des Epizooties, V65, P825; Ryckaert J, 2010, FISH SHELLFISH IMMUN, V29, P648, DOI 10.1016/j.fsi.2010.06.009; Sharpe J, 2004, ANNU REV BIOMED ENG, V6, P209, DOI 10.1146/annurev.bioeng.6.040803.140210; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Svendsen YS, 1997, FISH SHELLFISH IMMUN, V7, P317, DOI 10.1006/fsim.1997.0087; Tebbit GL, 1981, DEV USE YERSINIA RUC; Tobback E, 2007, J FISH DIS, V30, P257, DOI 10.1111/j.1365-2761.2007.00816.x; Tobback E, 2010, DIS AQUAT ORGAN, V90, P175, DOI 10.3354/dao02230; Tobback E, 2009, DIS AQUAT ORGAN, V84, P219, DOI 10.3354/dao02057; TORROBA M, 1993, HISTOL HISTOPATHOL, V8, P363; VALTONEN ET, 1992, J FISH DIS, V15, P163, DOI 10.1111/j.1365-2761.1992.tb00650.x; Vuillaume A., 1987, Bulletin of the European Association of Fish Pathologists, V7, P18; Welch TJ, 2005, DIS AQUAT ORGAN, V67, P267, DOI 10.3354/dao067267; Wilson JM, 2002, J EXP ZOOL, V293, P192, DOI 10.1002/jez.10124; Witters H, 1996, CELL TISSUE RES, V283, P461, DOI 10.1007/s004410050557; ZAPATA AG, 1987, J FISH BIOL, V31, P209, DOI 10.1111/j.1095-8649.1987.tb05315.x	56	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89672	10.1371/journal.pone.0089672	http://dx.doi.org/10.1371/journal.pone.0089672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586953	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200070
J	Park, HS; Nam, TY; Han, KH; Kim, SC; Yu, JH				Park, Hee-Soo; Nam, Tae-Young; Han, Kap-Hoon; Kim, Sun Chang; Yu, Jae-Hyuk			VelC Positively Controls Sexual Development in Aspergillus nidulans	PLOS ONE			English	Article							SECONDARY METABOLISM; ASEXUAL SPORULATION; PENICILLIN BIOSYNTHESIS; SCLEROTIAL PRODUCTION; MYCOTOXIN PRODUCTION; VEA; GENE; FLAVUS; FLUG; TRANSFORMATION	Fungal development and secondary metabolism is intimately associated via activities of the fungi-specific velvet family proteins including VeA, VosA, VelB and VelC. Among these, VelC has not been characterized in Aspergillus nidulans. In this study, we characterize the role of VelC in asexual and sexual development in A. nidulans. The velC mRNA specifically accumulates during the early phase of sexual development. The deletion of velC leads to increased number of conidia and reduced production of sexual fruiting bodies (cleistothecia). In the velC deletion mutant, mRNA levels of the brlA, abaA, wetA and vosA genes that control sequential activation of asexual sporulation increase. Overexpression of velC causes increased formation of cleistothecia. These results suggest that VelC functions as a positive regulator of sexual development. VelC is one of the five proteins that physically interact with VosA in yeast two-hybrid and GST pull down analyses. The Delta velC Delta vosA double mutant produced fewer cleistothecia and behaved similar to the DvosA mutant, suggesting that VosA is epistatic to VelC in sexual development, and that VelC might mediate control of sex through interacting with VosA at specific life stages for sexual fruiting.	[Park, Hee-Soo; Nam, Tae-Young; Han, Kap-Hoon; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Han, Kap-Hoon] Woosuk Univ, Dept Pharmaceut Engn, Wonju, South Korea; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Woosuk University; Korea Advanced Institute of Science & Technology (KAIST)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jyu1@wisc.edu	Park, Hee-Soo/AAC-6422-2019; Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011; Yu, Jae-Hyuk/A-2343-2008	Yu, Jae-Hyuk/0000-0002-6530-8407	USDA CSREES Hatch [WIS01195]; Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031955]; Ministry of Education, Science and Technology; Basic Science Research Program through the National Research Foundation (NRF) of Korea; Ministry of Education [NRF 2012R1A1A4A01012864]; Ministry of Education, Science and Technology, Republic of Korea	USDA CSREES Hatch(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program through the National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The work at UW-Madison was supported by USDA CSREES Hatch (WIS01195) and the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Education, Science and Technology grants to JHY. The work at WU (KHH) was supported by Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (NRF 2012R1A1A4A01012864). The work at KAIST (SCK) was supported by the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Education, Science and Technology, Republic of Korea to SCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001750; Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; ARST HN, 1979, MOL GEN GENET, V174, P89, DOI 10.1007/BF00433309; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; Bennett JW, 2010, ASPERGILLUS: MOLECULAR BIOLOGY AND GENOMICS, P1; Beyhan S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001614; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Cary JW, 2007, APPL MICROBIOL BIOT, V76, P1107, DOI 10.1007/s00253-007-1081-y; Casselton L, 2002, NAT REV GENET, V3, P683, DOI 10.1038/nrg889; Chang PK, 2013, FUNGAL GENET BIOL, V58-59, P71, DOI 10.1016/j.fgb.2013.08.009; Cho JH, 2003, J MICROBIOL, V41, P46; Dhingra S, 2012, EUKARYOT CELL, V11, P1531, DOI 10.1128/EC.00222-12; Duran RM, 2007, APPL MICROBIOL BIOT, V73, P1158, DOI 10.1007/s00253-006-0581-5; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; GWYNNE DI, 1987, GENE, V51, P205, DOI 10.1016/0378-1119(87)90309-X; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kopke K, 2013, EUKARYOT CELL, V12, P299, DOI 10.1128/EC.00272-12; Kwon NJ, 2010, FUNGAL GENET BIOL, V47, P981, DOI 10.1016/j.fgb.2010.08.009; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; Martinelli S D, 1994, Prog Ind Microbiol, V29, P33; Marui J, 2010, J BIOSCI BIOENG, V110, P8, DOI 10.1016/j.jbiosc.2010.01.001; MCKNIGHT GL, 1985, EMBO J, V4, P2093, DOI 10.1002/j.1460-2075.1985.tb03897.x; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Park Hee Soo, 2012, Methods Mol Biol, V944, P183, DOI 10.1007/978-1-62703-122-6_13; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Park HS, 2012, MOL MICROBIOL, V86, P937, DOI 10.1111/mmi.12032; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; Seo JA, 2003, GENETICS, V165, P1083; Seo JA, 2004, MOL MICROBIOL, V53, P1611, DOI 10.1111/j.1365-2958.2004.04232.x; Shaaban MI, 2010, EUKARYOT CELL, V9, P1816, DOI 10.1128/EC.00189-10; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tian XB, 2002, EUKARYOT CELL, V1, P249, DOI 10.1128/EC.1.2.249-256.2002; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; Webster RH, 2008, P NATL ACAD SCI USA, V105, P14573, DOI 10.1073/pnas.0806221105; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	52	49	58	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89883	10.1371/journal.pone.0089883	http://dx.doi.org/10.1371/journal.pone.0089883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587098	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200092
J	Smith, DP; Peay, KG				Smith, Dylan P.; Peay, Kabir G.			Sequence Depth, Not PCR Replication, Improves Ecological Inference from Next Generation DNA Sequencing	PLOS ONE			English	Article							FUNGAL; DIVERSITY; COMMUNITIES; PATTERNS; REVEAL	Recent advances in molecular approaches and DNA sequencing have greatly progressed the field of ecology and allowed for the study of complex communities in unprecedented detail. Next generation sequencing (NGS) can reveal powerful insights into the diversity, composition, and dynamics of cryptic organisms, but results may be sensitive to a number of technical factors, including molecular practices used to generate amplicons, sequencing technology, and data processing. Despite the popularity of some techniques over others, explicit tests of the relative benefits they convey in molecular ecology studies remain scarce. Here we tested the effects of PCR replication, sequencing depth, and sequencing platform on ecological inference drawn from environmental samples of soil fungi. We sequenced replicates of three soil samples taken from pine biomes in North America represented by pools of either one, two, four, eight, or sixteen PCR replicates with both 454 pyrosequencing and Illumina MiSeq. Increasing the number of pooled PCR replicates had no detectable effect on measures of alpha-and beta-diversity. Pseudo-beta-diversity - which we define as dissimilarity between re-sequenced replicates of the same sample - decreased markedly with increasing sampling depth. The total richness recovered with Illumina was significantly higher than with 454, but measures of alpha-and beta-diversity between a larger set of fungal samples sequenced on both platforms were highly correlated. Our results suggest that molecular ecology studies will benefit more from investing in robust sequencing technologies than from replicating PCRs. This study also demonstrates the potential for continuous integration of older datasets with newer technology.	[Smith, Dylan P.; Peay, Kabir G.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Peay, KG (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	kpeay@stanford.edu		Peay, Kabir/0000-0002-7998-7412	National Science Foundation (NSF) Dimensions of Biodiversity [DBI 1249341]	National Science Foundation (NSF) Dimensions of Biodiversity(National Science Foundation (NSF))	Financial support for this work was provided by National Science Foundation (NSF) Dimensions of Biodiversity grant (DBI 1249341) to KGP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gilbert J.A., 2010, STAND GENOMIC SCI, V3, P3; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Martin M, 2011, EMBNET J N AM; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058020; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Peay KG, 2013, ISME J, V7, P1852, DOI 10.1038/ismej.2013.66; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R Core Team, 2021, R LANGUAGE ENV STAT; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206	32	335	342	3	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90234	10.1371/journal.pone.0090234	http://dx.doi.org/10.1371/journal.pone.0090234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587293	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200150
J	Wang, N; Feng, YY; Wang, QJ; Liu, SH; Xiang, L; Sun, MX; Zhang, XY; Liu, GX; Qu, X; Wei, FC				Wang, Ning; Feng, Yuanyong; Wang, Qingjie; Liu, Shaohua; Xiang, Lei; Sun, Mingxia; Zhang, Xiaoying; Liu, Guixiang; Qu, Xun; Wei, Fengcai			Neutrophils Infiltration in the Tongue Squamous Cell Carcinoma and Its Correlation with CEACAM1 Expression on Tumor Cells	PLOS ONE			English	Article							ADHESION MOLECULE; ELEVATED EXPRESSION; MYELOID CELLS; CANCER; MELANOMA; GROWTH; ANGIOGENESIS; CONTRIBUTES; METASTASIS; CHEMOKINES	Objective: The present study aimed to explore the clinical significance of neutrophils infiltration and carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1) expression in the tongue squamous cell carcinoma (TSCC), and to probe the possible relationship between them. Materials and Methods: Tissue microarray and immunohistochemistry were used to detect neutrophils density and CEACAM1 expression in 74 cases of primary TSCC specimens and 17 cases of corresponding peritumoral tissues. The relationship of CEACAM1 expression and neutrophils density with clinicopathologic parameters and cancer-related survival of TSCC patients were evaluated. The correlation between CEACAM1 expression and neutrophils density was also evaluated. Real-time quantitative transcription polymerase chain reaction (qRT-PCR) was used to explore the possible molecular mechanisms between CEACAM1 expression and neutrophils infiltration. Results: Immunohistochemistry evaluation revealed that there was more neutrophils infiltration in TSCC tissues than in peritumoral tissues. High neutrophil density was associated with LN metastasis (P=0.01), higher clinical stage (P=0.037) and tumor recurrence (P=0.024). CEACAM1 overexpression was also associated with lymph node metastasis (P=0.000) and higher clinical stage (P=0.001). Survival analysis revealed that both neutrophils infiltration and CEACAM1 overexpression were associated with poorer cancer-related survival of TSCC patients (P<0.05), and neutrophils infiltration was an independent prognostic factor for TSCC (P<0.05). Furthermore, overexpression of CEACAM1 was correlated with more neutrophils infiltration in TSCC tissues (P<0.01). qRT-PCR results showed that CEACAM1-4L can upregulate the mRNA expression of IL-8 and CXCL-6, which were strong chemotactic factors of neutrophils. Conclusion: Our results demonstrated that more neutrophils infiltration and overexpression of CEACAM1 were associated with poor clinical outcomes in TSCC tissues. Overexpression of CEACAM1 on tumor cells correlated with more neutrophils infiltration to some extent through upregulating mRNA expression of IL-8 and CXCL-6.	[Wang, Ning; Liu, Shaohua; Sun, Mingxia; Zhang, Xiaoying; Liu, Guixiang; Wei, Fengcai] Shandong Univ, Qilu Hosp, Dept Stomatol, Jinan 250100, Shandong, Peoples R China; [Wang, Ning; Liu, Shaohua; Sun, Mingxia; Zhang, Xiaoying; Liu, Guixiang; Wei, Fengcai] Shandong Univ, Inst Stomatol, Jinan 250100, Shandong, Peoples R China; [Wang, Ning] Qingdao Univ, Coll Med, Dept Pathol, Qingdao 266071, Shandong, Peoples R China; [Feng, Yuanyong] Qingdao Univ, Affiliated Hosp, Dept Oral & Maxillofacial Surg, Qingdao 266071, Shandong, Peoples R China; [Wang, Qingjie; Qu, Xun] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250100, Shandong, Peoples R China; [Wang, Ning; Xiang, Lei] Shandong Univ, Coll Med, Dept Pathol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Qingdao University; Qingdao University; Shandong University; Shandong University	Qu, X (corresponding author), Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250100, Shandong, Peoples R China.	quxun@sdu.edu.cn; weifengcai@aliyun.com		Wei, Fengcai/0000-0002-3509-9640; Wang, Qing-jie/0000-0002-4845-3696	National Natural Science Foundation of China [81072202, 31100650]; China Postdoctoral Science Foundation [2013M541922]; Independent Innovation Foundation of Shandong University [2012TS143]; Scientific Research Foundation of Shandong Province of Outstanding Young Scientist Award [BS2013YY041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Independent Innovation Foundation of Shandong University; Scientific Research Foundation of Shandong Province of Outstanding Young Scientist Award	This work is supported by the National Natural Science Foundation of China (No. 81072202, 31100650); China Postdoctoral Science Foundation (No. 2013M541922); Independent Innovation Foundation of Shandong University (No. 2012TS143); and the Scientific Research Foundation of Shandong Province of Outstanding Young Scientist Award (No. BS2013YY041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Arabzadeh A., 2012, ONCOGENE; Barnes H, 2005, WHO PATHOLOGY GENETI, P163; Bellocq A, 1998, AM J PATHOL, V152, P83; Campbell RM, 2013, MOL CANC THER; Chen ZG, 2011, J EXP MED, V208, P2633, DOI 10.1084/jem.20102575; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; Ebrahimnejad A, 2004, AM J PATHOL, V165, P1781, DOI 10.1016/S0002-9440(10)63433-5; Gijsbers K, 2005, EXP CELL RES, V303, P331, DOI 10.1016/j.yexcr.2004.09.027; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Gu FM, 2012, ANN SURG ONCOL, V19, P2506, DOI 10.1245/s10434-012-2268-8; Himmel ME, 2011, EUR J IMMUNOL, V41, P306, DOI 10.1002/eji.201040459; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Ieda J, 2011, INT J CANCER, V129, P1351, DOI 10.1002/ijc.26072; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Kawai H, 2005, CLIN CANCER RES, V11, P5084, DOI 10.1158/1078-0432.CCR-05-0200; Kilic N, 2005, J BIOL CHEM, V280, P2361, DOI 10.1074/jbc.M409407200; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044; Lievin-Le Moal V, 2011, CELL MICROBIOL, V13, P764, DOI 10.1111/j.1462-5822.2011.01575.x; Liu W, 2007, ONCOGENE, V26, P2747, DOI 10.1038/sj.onc.1210077; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Munoz L, 2010, EUR J PHARMACOL, V635, P212, DOI 10.1016/j.ejphar.2010.02.037; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Prall F, 1996, J HISTOCHEM CYTOCHEM, V44, P35, DOI 10.1177/44.1.8543780; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Rahmoun M, 2009, J INVEST DERMATOL, V129, P671, DOI 10.1038/jid.2008.303; Rodrigues VC, 1998, ORAL ONCOL, V34, P454, DOI 10.1016/S1368-8375(98)00052-9; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rotondo R, 2009, INT J CANCER, V125, P887, DOI 10.1002/ijc.24448; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Sato T, 2006, SURG ONCOL, V15, P217, DOI 10.1016/j.suronc.2007.01.003; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Sienel W, 2003, CLIN CANCER RES, V9, P2260; Singer BB, 2005, EUR J IMMUNOL, V35, P1949, DOI 10.1002/eji.200425691; Singer BB, 2000, CANCER RES, V60, P1236; Strell C, 2010, EXP CELL RES, V316, P138, DOI 10.1016/j.yexcr.2009.09.003; Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x; Thies A, 2002, J CLIN ONCOL, V20, P2530, DOI 10.1200/JCO.2002.05.033; Trellakis S, 2011, INT J IMMUNOPATH PH, V24, P683, DOI 10.1177/039463201102400314; WELCH DR, 1989, P NATL ACAD SCI USA, V86, P5859, DOI 10.1073/pnas.86.15.5859; Wu QD, 2001, AM J PHYSIOL-CELL PH, V280, pC814, DOI 10.1152/ajpcell.2001.280.4.C814; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033655; Zhou CJ, 2009, ORAL ONCOL, V45, P883, DOI 10.1016/j.oraloncology.2009.03.002; Zhu JK, 2011, WORLD J SURG, V35, P2259, DOI 10.1007/s00268-011-1119-2; Zhu L, 2014, PLANT PHYSIOL BIOCH, V75, P24, DOI 10.1016/j.plaphy.2013.11.028	55	38	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89991	10.1371/journal.pone.0089991	http://dx.doi.org/10.1371/journal.pone.0089991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587171	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800064
J	Cho, H; Cho, CS; Indig, GL; Lavasanifar, A; Vakili, MR; Kwon, GS				Cho, Hyunah; Cho, Clifford S.; Indig, Guilherme L.; Lavasanifar, Afsaneh; Vakili, Mohammad Reza; Kwon, Glen S.			Polymeric Micelles for Apoptosis-Targeted Optical Imaging of Cancer and Intraoperative Surgical Guidance	PLOS ONE			English	Article							DRUG-DELIVERY; NANOPARTICLES; PEPTIDES	In a two-step strategy, an intraperitoneal (IP) injection of poly(ethylene glycol)-block-poly(epsilon-caprolactone) (PEG-b-PCL) micelles containing paclitaxel (PTX), cyclopamine (CYP), and gossypol (GSP) at 30, 30, and 30 mg/kg, respectively, debulked tumor tissues by 1.3-fold, based on loss of bioluminescence with <10% body weight change, and induced apoptosis in peritoneal tumors when used as neoadjuvant chemotherapy (NACT) in an ES-2-luc-bearing xenograft model for ovarian cancer. In a second step, a single intravenous (IV) injection of apoptosis-targeting GFNFRLKAGAKIRFGS-PEG-b-PCL micelles containing a near-infrared (NIR) fluorescence probe, DiR (1,1'-dioctadecyltetramethyl indotricarbocyanine iodide), resulted in increased peritoneal DiR accumulation in apoptosis-induced ES-2-luc tumor tissues (ex vivo) by 1.5-fold compared with DiR molecules delivered by methoxy PEG-b-PCL micelles (non-targeted) at 48 h after IV injection in a second step. As a result, a tandem of PEG-b-PCL micelles enabled high-resolution detection of ca. 1 mm diameter tumors, resulting in resection of approximately 90% of tumors, and a low peritoneal cancer index (PCI) of ca. 7. Thus, a tandem of PEG-b-PCL micelles used for NCAT and NIR fluorescence imaging of therapy-induced apoptosis for intraoperative surgical guidance may be a promising treatment strategy for metastatic ovarian cancer.	[Cho, Hyunah; Kwon, Glen S.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53706 USA; [Cho, Clifford S.] Univ Wisconsin, Dept Surg, Sect Surg Oncol, Madison, WI 53706 USA; [Indig, Guilherme L.] Univ Wisconsin, Dept Chem & Biochem, Madison, WI 53706 USA; [Lavasanifar, Afsaneh; Vakili, Mohammad Reza] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Alberta	Kwon, GS (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 425 N Charter St, Madison, WI 53706 USA.	gskwon@pharmacy.wisc.edu			National Institutes of Health [R21 CA-161537]; Carbone Cancer Center at University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE [P30CA014520, R21CA161537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carbone Cancer Center at University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was financially supported by National Institutes of Health (R21 CA-161537) and Carbone Cancer Center at University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinoglu EI, 2008, ACS NANO, V2, P2075, DOI 10.1021/nn800448r; Bae YH, 2011, J CONTROL RELEASE, V154, P213, DOI 10.1016/j.jconrel.2011.08.024; Cho H, 2012, J CONTROL RELEASE, V166, P1; Cho H, 2012, NANOMED-NANOTECHNOL, V8, P228, DOI 10.1016/j.nano.2011.06.009; Cho H, 2011, ACS NANO, V5, P8721, DOI 10.1021/nn202676u; Frangioni JV, 2008, J CLIN ONCOL, V26, P4012, DOI 10.1200/JCO.2007.14.3065; Gunasekera UA, 2009, TARGET ONCOL, V4, P169, DOI 10.1007/s11523-009-0118-9; Hirche C., 2012, SURG INNOV; IGARASHI K, 1995, J BIOL CHEM, V270, P29075, DOI 10.1074/jbc.270.49.29075; Janib SM, 2010, ADV DRUG DELIVER REV, V62, P1052, DOI 10.1016/j.addr.2010.08.004; Jin ZH, 2006, MOL IMAGING, V5, P188; Kapty J, 2012, J BIOMOL SCREEN, V17, P1293, DOI 10.1177/1087057112453313; Keereweer S, 2011, MOL IMAGING BIOL, V13, P199, DOI 10.1007/s11307-010-0373-2; Keramidas M, 2010, BRIT J SURG, V97, P737, DOI 10.1002/bjs.6986; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kim K, 2006, J AM CHEM SOC, V128, P3490, DOI 10.1021/ja057712f; Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P193, DOI 10.1016/j.nano.2005.06.004; Kumar R, 2008, ACS NANO, V2, P449, DOI 10.1021/nn700370b; Lalwani N, 2011, RADIOGRAPHICS, V31, P625, DOI 10.1148/rg.313105066; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Lee S, 2011, BIOCONJUGATE CHEM, V22, P125, DOI 10.1021/bc1004119; Miyai K, 2010, INT J GYNECOL PATHOL, V29, P321, DOI 10.1097/PGP.0b013e3181c4f35f; Park K, 2007, J CONTROL RELEASE, V122, P305, DOI 10.1016/j.jconrel.2007.04.009; Schorge John O, 2010, Rev Obstet Gynecol, V3, P111; Schutters K, 2010, APOPTOSIS, V15, P1072, DOI 10.1007/s10495-010-0503-y; Sugarbaker PH, 1999, LANGENBECK ARCH SURG, V384, P576, DOI 10.1007/s004230050246; Thurber GM, 2010, J SURG ONCOL, V102, P758, DOI 10.1002/jso.21735; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Xiong CY, 2011, J MED CHEM, V54, P1825, DOI 10.1021/jm101477d; Xiong XB, 2007, BIOMACROMOLECULES, V8, P874, DOI 10.1021/bm060967g; Yokoyama M, 2010, EXPERT OPIN DRUG DEL, V7, P145, DOI 10.1517/17425240903436479	32	9	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89968	10.1371/journal.pone.0089968	http://dx.doi.org/10.1371/journal.pone.0089968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587157	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000120
J	Chu, YH; Hsieh, MJ; Chiou, HL; Liou, YS; Yang, CC; Yang, SF; Kuo, WH				Chu, Yin-Hung; Hsieh, Ming-Ju; Chiou, Hui-Ling; Liou, Yi-Sheng; Yang, Chen-Chieh; Yang, Shun-Fa; Kuo, Wu-Hsien			MicroRNA Gene Polymorphisms and Environmental Factors Increase Patient Susceptibility to Hepatocellular Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HEPATITIS-B-VIRUS; CANCER-RISK; BREAST-CANCER; BINDING-SITE; MIR-146A; ASSOCIATION; EXPRESSION; RADIOTHERAPY; METASTASIS	Background: Micro RNAs (miRNAs) are small RNA fragments that naturally exist in the human body. Through various physiological mechanisms, miRNAs can generate different functions for regulating RNA protein levels and balancing abnormalities. Abnormal miRNA expression has been reported to be highly related to several diseases and cancers. Single-nucleotide polymorphisms (SNPs) in miRNAs have been reported to increase patient susceptibility and affect patient prognosis and survival. We adopted a case-control research design to verify the relationship between miRNAs and hepatocellular carcinoma. Methodology/Principal Findings: A total of 525 subjects, including 377 controls and 188 hepatocellular carcinoma patients, were selected. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and real-time PCR were used to analyze miRNA146a (rs2910164), miRNA149 (rs2292832), miRNA196 (rs11614913), and miRNA499 (rs3746444) genetic polymorphisms between the control group and the case group. The results indicate that people who carry the rs3746444 CT or CC genotypes may have a significantly increased susceptibility to hepatocellular carcinoma (adjusted odds ratio [AOR] = 2.84, 95% confidence interval [CI] = 1.88-4.30). In addition, when combined with environmental risk factors, such as smoking and alcohol consumption, interaction effects were observed between gene polymorphisms and environmental factors (odds ratio [OR] = 4.69, 95% CI = 2.52-8.70; AOR = 3.38, 95% CI = 1.68-6.80). Conclusions: These results suggest that a significant association exists between miRNA499 SNPs and hepatocellular carcinoma. Gene-environment interactions of miRNA499 polymorphisms, smoking, and alcohol consumption might alter hepatocellular carcinoma susceptibility.	[Chu, Yin-Hung; Hsieh, Ming-Ju; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Chiou, Hui-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Liou, Yi-Sheng] Taichung Vet Gen Hosp, Dept Family Med, Taichung, Taiwan; [Liou, Yi-Sheng] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan; [Yang, Chen-Chieh] Mennonite Christian Hosp, Dept Internal Med, Div Gastroenterol, Hualien, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Kuo, Wu-Hsien] Armed Force Taichung Gen Hosp, Dept Med, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Taichung Veterans General Hospital; National Defense Medical Center; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; wuhsienku@gmail.com	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234	National Science Council, Taiwan [NSC-100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from National Science Council, Taiwan (NSC-100-2632-B-040-001-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Buurman R, 2012, GASTROENTEROLOGY, V143, P811, DOI 10.1053/j.gastro.2012.05.033; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Chen P, 2012, MOL BIOL REP, V39, P10433, DOI 10.1007/s11033-012-1922-3; Chu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039777; de Rinaldis E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-643; Feng MJ, 2012, INT IMMUNOPHARMACOL, V13, P347, DOI 10.1016/j.intimp.2012.05.001; de Larrea CF, 2012, CLIN CANCER RES, V18, P3697, DOI 10.1158/1078-0432.CCR-12-0191; Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365; Han YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058564; Huang YW, 2013, CLIN INFECT DIS, V57, P1695, DOI 10.1093/cid/cit603; Ichii O, 2012, KIDNEY INT, V81, P280, DOI 10.1038/ki.2011.345; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Koehler EM, 2014, LIVER INT, V34, P296, DOI 10.1111/liv.12311; Li T, 2013, WORLD J GASTROENTERO, V19, P5615, DOI 10.3748/wjg.v19.i34.5615; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Linhares JJ, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-119; Liu CJ, 2014, INT J CANCER, V134, P811, DOI 10.1002/ijc.28358; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Matysiak M, 2013, J IMMUNOL, V190, P5102, DOI 10.4049/jimmunol.1202397; Oster B, 2013, INT J CANCER, V132, P2303, DOI 10.1002/ijc.27921; Perry MM, 2014, AM J RESP CELL MOL, V50, P7, DOI 10.1165/rcmb.2013-0067OC; Popovic R, 2009, BLOOD, V113, P3314, DOI 10.1182/blood-2008-04-154310; Qiu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050887; Rani SB, 2013, NEURO-ONCOLOGY, V15, P1302, DOI 10.1093/neuonc/not090; Sabina S, 2013, J MOL CELL CARDIOL, V60, P84, DOI 10.1016/j.yjmcc.2013.04.002; Schotte D, 2010, HAEMATOL-HEMATOL J, V95, P1675, DOI 10.3324/haematol.2010.023481; Serrano NA, 2012, OTOLARYNG HEAD NECK, V147, P501, DOI 10.1177/0194599812442490; Sureban SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073940; Teo MTW, 2012, CARCINOGENESIS, V33, P581, DOI 10.1093/carcin/bgr300; Tu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051606; Wang F, 2012, PLOS ONE, V7; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; Wang LN, 2012, GENE, V508, P9, DOI 10.1016/j.gene.2012.08.005; Wang Y, 2012, GENE, V509, P267, DOI 10.1016/j.gene.2012.08.008; Wei CW, 2009, ACTA PHARMACOL SIN, V30, P1297, DOI 10.1038/aps.2009.124; Weinmann A, 2013, J CLIN GAST IN PRESS; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Xu L, 2013, PLOS ONE, V8; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Zhang Q, 2011, HEPAT MON, V11, P86; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073803; Zheng J, 2013, CANCER RES, V73, P5151, DOI 10.1158/0008-5472.CAN-13-0395; Zhong SL, 2013, MOL BIOL REP, V40, P3181, DOI 10.1007/s11033-012-2392-3; Zhuang LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061361	51	44	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89930	10.1371/journal.pone.0089930	http://dx.doi.org/10.1371/journal.pone.0089930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587132	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000112
J	Mahmud, H; Candido, WM; van Genne, L; Vreeswijk-Baudoin, I; Yu, HJ; van de Sluis, B; van Deursen, J; van Gilst, WH; Sillje, HHW; de Boer, RA				Mahmud, Hasan; Candido, Wellington Mardoqueu; van Genne, Linda; Vreeswijk-Baudoin, Inge; Yu, Hongjuan; van de Sluis, Bart; van Deursen, Jan; van Gilst, Wiek H.; Sillje, Herman H. W.; de Boer, Rudolf A.			Cardiac Function and Architecture Are Maintained in a Model of Cardiorestricted Overexpression of the Prorenin-Renin Receptor	PLOS ONE			English	Article							HUMAN (PRO)RENIN RECEPTOR; TRANSGENIC RATS; RENIN/PRORENIN RECEPTOR; HYPERTROPHY; ACTIVATION; BINDING; CELLS; MICE; GLOMERULOSCLEROSIS; HYPERTENSION	The (pro) renin-renin receptor, (P) RR has been claimed to be a novel element of the renin-angiotensin system (RAS). The function of (P) RR has been widely studied in renal and vascular pathology but the cardio-specific function of (P)RR has not been studied in detail. We therefore generated a transgenic mouse (Tg) with cardio-restricted (P) RR overexpression driven by the alpha-MHC promotor. The mRNA expression of (P) RR was similar to 170-fold higher (P<0.001) and protein expression similar to 5-fold higher (P<0.001) in hearts of Tg mice as compared to non-transgenic (wild type, Wt) littermates. This level of overexpression was not associated with spontaneous cardiac morphological or functional abnormalities in Tg mice. To assess whether (P) RR could play a role in cardiac hypertrophy, we infused ISO for 28 days, but this caused an equal degree of cardiac hypertrophy and fibrosis in Wt and Tg mice. In addition, ischemia-reperfusion injury was performed in Langendorff perfused isolated mouse hearts. We did not observe differences in parameters of cardiac function or damage between Wt and Tg mouse hearts under these conditions. Finally, we explored whether the hypoxia sensing response would be modulated by (P) RR using HeLa cells with and without (P)RR overexpression. We did not establish any effect of (P) RR on expression of genes associated with the hypoxic response. These results demonstrate that cardio-specific overexpression of (P) RR does not provoke phenotypical differences in the heart, and does not affect the hearts' response to stress and injury. It is concluded that increased myocardial (P)RR expression is unlikely to have a major role in pathological cardiac remodeling.	[Mahmud, Hasan; Candido, Wellington Mardoqueu; van Genne, Linda; Vreeswijk-Baudoin, Inge; Yu, Hongjuan; van Gilst, Wiek H.; Sillje, Herman H. W.; de Boer, Rudolf A.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Dept Mol Genet, Groningen, Netherlands; [van Deursen, Jan] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [van Deursen, Jan] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	University of Groningen; University of Groningen; Mayo Clinic; Mayo Clinic	de Boer, RA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	r.a.de.boer@umcg.nl	van Gilst, Wiek/R-1806-2019; de Boer, Rudolf/ABE-9879-2020	van Gilst, Wiek/0000-0003-2968-8585; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365	Netherlands Heart Foundation [2007T046]; Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VENI) [916.10.117]; Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VIDI) [917.13.350]	Netherlands Heart Foundation(Netherlands Heart Foundation); Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VENI); Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VIDI)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Heart Foundation (grant 2007T046) and the Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VENI, grant 916.10.117, and NWO VIDI, grant 917.13.350), all to Dr. de Boer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batenburg WW, 2007, J HYPERTENS, V25, P2441, DOI 10.1097/HJH.0b013e3282f05bae; Batenburg WW, 2011, HYPERTENSION, V58, P1111, DOI 10.1161/HYPERTENSIONAHA.111.180737; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Burckle CA, 2006, HYPERTENSION, V47, P552, DOI 10.1161/01.HYP.0000199912.47657.04; Burckle C, 2006, HYPERTENSION, V48, P549, DOI 10.1161/01.HYP.0000241132.48495.df; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; Cross HR, 1998, CIRC RES, V83, P1215, DOI 10.1161/01.RES.83.12.1215; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Cuadra AE, 2010, PHARMACOL THERAPEUT, V125, P27, DOI 10.1016/j.pharmthera.2009.07.007; Feldt S, 2008, J AM SOC NEPHROL, V19, P743, DOI 10.1681/ASN.2007091030; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hirose T, 2010, REGUL PEPTIDES, V159, P93, DOI 10.1016/j.regpep.2009.11.006; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Ichihara A, 2008, J MOL MED, V86, P629, DOI 10.1007/s00109-008-0327-1; Ichihara A, 2006, J AM SOC NEPHROL, V17, P2495, DOI 10.1681/ASN.2005121278; Ichihara A, 2006, J AM SOC NEPHROL, V17, P1950, DOI 10.1681/ASN.2006010029; Kaneshiro Y, 2006, KIDNEY INT, V70, P641, DOI 10.1038/sj.ki.5001627; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kuipers I, 2010, EUR J HEART FAIL, V12, P1042, DOI 10.1093/eurjhf/hfq109; Kuipers I, 2010, LAB INVEST, V90, P630, DOI 10.1038/labinvest.2010.7; Mahmud H, 2012, J CELL MOL MED, V16, P722, DOI 10.1111/j.1582-4934.2011.01377.x; Meems LMG, 2012, J STEROID BIOCHEM, V132, P282, DOI 10.1016/j.jsbmb.2012.06.004; Moilanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041404; Nabi AHMN, 2006, INT J MOL MED, V18, P483; Nguyen G, 1996, KIDNEY INT, V50, P1897, DOI 10.1038/ki.1996.511; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2011, CURR HYPERTENS REP, V13, P79, DOI 10.1007/s11906-010-0172-9; Nguyen G, 2011, CLIN SCI, V120, P169, DOI 10.1042/CS20100432; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Prieto MC, 2011, AM J PHYSIOL-RENAL, V300, pF581, DOI 10.1152/ajprenal.00433.2010; Schroten NF, 2012, HEART FAIL REV, V17, P191, DOI 10.1007/s10741-011-9262-2; Siragy HM, 2008, EXP PHYSIOL, V93, P709, DOI 10.1113/expphysiol.2007.040550; Taglieri DM, 2011, J MOL CELL CARDIOL, V51, P988, DOI 10.1016/j.yjmcc.2011.09.016; Takahashi K, 2010, PEPTIDES, V31, P1405, DOI 10.1016/j.peptides.2010.04.003; Takahashi K, 2009, PEPTIDES, V30, P1575, DOI 10.1016/j.peptides.2009.05.018; van Esch JHM, 2011, HYPERTENSION, V57, P852, DOI 10.1161/HYPERTENSIONAHA.110.169060; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89929	10.1371/journal.pone.0089929	http://dx.doi.org/10.1371/journal.pone.0089929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587131	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900100
J	Pae, EK; Kim, G				Pae, Eung-Kwon; Kim, Gyuyoup			Insulin Production Hampered by Intermittent Hypoxia via Impaired Zinc Homeostasis	PLOS ONE			English	Article							GLUCOSE-HOMEOSTASIS; TRANSPORTER; ZIP; EXPRESSION; TYPE-1; FAMILY; RISK	Without zinc, pancreatic beta cells cannot either assemble insulin molecules or precipitate insulin crystals; thus, a lack of zinc concentration in the beta cells would result in a decreased insulin production. ZIP8 is one of the zinc uptake transporters involved in zinc influx into the cytosol of beta cells. Thus, if ZIP8 is down-regulated, a decreased insulin production would result. We assumed that intermittent hypoxic exposure to the beta cells may result in a decreased production of insulin due to a lack of zinc. To test this hypothesis we harvested pancreatic islets from the rats conditioned under intermittent hypoxia (IH) (fluctuating between 20.5% and 10% every 4 min for 1 h) and compared the results with those from control animals and islets. We also compared their insulin and glucose homeostasis using glucose tolerance tests (GTT) after 3 weeks. GTT results show a significant delay (P < 0.05) in recovery of the blood glucose level in IH treated pups. ZIP8 expression in the beta cell membrane was down-regulated. The zinc concentration in the cell as well as insulin production was significantly decreased in the islets harvested from IH animals. However, mRNA for insulin and C-peptide/insulin protein levels in the total cell lysates remained the same as those of controls. When we treated the beta cells using siRNA mediated ZIP8, we observed the commensurate results from the IH-treated islets. We conclude that a transient IH exposure could knockdown ZIP8 transporters at mRNA as well as protein levels in the beta cells, which would decrease the level of blood insulin. However, the transcriptional activity of insulin remains the same. We conclude that the precipitation process of insulin crystal may be disturbed by a lack of zinc in the cytosol that is modulated by mainly ZIP8 after IH exposure.	[Pae, Eung-Kwon; Kim, Gyuyoup] Univ Maryland, Sch Dent, Dept Orthodont & Pediat Dent, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Pae, EK (corresponding author), Univ Maryland, Sch Dent, Dept Orthodont & Pediat Dent, Baltimore, MD 21201 USA.	epae@umaryland.edu		Kim, Gyuyoup/0000-0002-4261-9958				Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Bosco Mariea D, 2010, Rev Diabet Stud, V7, P263, DOI 10.1900/RDS.2010.7.263; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Dereke J, 2012, DIABETIC MED, V29, pe436, DOI 10.1111/j.1464-5491.2012.03766.x; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Duprez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046831; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Facco FL, 2012, AM J PERINAT, V29, P277, DOI 10.1055/s-0031-1295658; GRANT PT, 1972, BIOCHEM J, V126, P433, DOI 10.1042/bj1260433; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; HARKNESS RA, 1987, J CLIN PATHOL, V40, P1128, DOI 10.1136/jcp.40.9.1128; He L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/j.taap.2009.02.017; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; Izci-Balserak B, 2010, CURR OPIN PULM MED, V16, P574, DOI 10.1097/MCP.0b013e32833f0d55; Jansen J, 2012, J NUTR BIOCHEM, V23, P1458, DOI 10.1016/j.jnutbio.2011.09.008; Jansen J, 2009, J NUTR BIOCHEM, V20, P399, DOI 10.1016/j.jnutbio.2009.01.009; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; Liu Z, 2008, BIOCHEM BIOPH RES CO, V365, P814, DOI 10.1016/j.bbrc.2007.11.067; Maret W, 2011, BIOMETALS, V24, P411, DOI 10.1007/s10534-010-9406-1; MCNAIR P, 1981, CLIN CHIM ACTA, V112, P343, DOI 10.1016/0009-8981(81)90457-5; Montgomery-Downs HE, 2010, SLEEP MED, V11, P263, DOI 10.1016/j.sleep.2009.06.007; Myers SA, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/173712; Napolitano JR, 2012, AM J PHYSIOL-LUNG C, V302, pL909, DOI 10.1152/ajplung.00351.2011; Pae EK, 2013, BIOCHEM BIOPH RES CO, V441, P637, DOI 10.1016/j.bbrc.2013.10.102; Pae EK, 2011, INT J DEV NEUROSCI, V29, P819, DOI 10.1016/j.ijdevneu.2011.09.003; Reeves SR, 2006, RESP PHYSIOL NEUROBI, V150, P135, DOI 10.1016/j.resp.2005.03.018; Rutter GA, 2010, ISLETS, V2, P49, DOI 10.4161/isl.2.1.10259; Shimizu Y, 2007, ADV EXP MED BIOL, V594, P37; Shimizu Y, 2009, ANTIOXID REDOX SIGN, V11, P2317, DOI [10.1089/ars.2009.2501, 10.1089/ARS.2009.2501]; Slepchenko KG, 2012, EXP DIABETES RES, DOI 10.1155/2012/190309; Song J, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-31; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; Tuominen JT, 1999, DIABETES CARE, V22, P1196, DOI 10.2337/diacare.22.7.1196; Venkata C, 2009, J AM BOARD FAM MED, V22, P158, DOI 10.3122/jabfm.2009.02.080057; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Williams MJ, 2012, CELL MOL LIFE SCI, V69, P3819, DOI 10.1007/s00018-012-1022-5; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhang L, 2011, J DIABETES, V3, P48, DOI 10.1111/j.1753-0407.2010.00102.x	40	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90192	10.1371/journal.pone.0090192	http://dx.doi.org/10.1371/journal.pone.0090192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587273	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900125
J	Votinov, M; Pripfl, J; Windischberger, C; Kalcher, K; Zimprich, A; Zimprich, F; Moser, E; Lamm, C; Sailer, U				Votinov, Mikhail; Pripfl, Juergen; Windischberger, Christian; Kalcher, Klaudius; Zimprich, Alexander; Zimprich, Fritz; Moser, Ewald; Lamm, Claus; Sailer, Uta			A Genetic Polymorphism of the Endogenous Opioid Dynorphin Modulates Monetary Reward Anticipation in the Corticostriatal Loop	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; PRODYNORPHIN GENE; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; HUMAN AMYGDALA; HUMAN BRAIN; FUNCTIONAL POLYMORPHISM; COCAINE DEPENDENCE; DOPAMINE RELEASE; NEURAL RESPONSES	The dynorphin/kappa-opioid receptor (KOP-R) system has been shown to play a role in different types of behavior regulation, including reward-related behavior and drug craving. It has been shown that alleles with 3 or 4 repeats (HH genotype) of the variable nucleotide tandem repeat (68-bp VNTR) functional polymorphism of the prodynorphin (PDYN) gene are associated with higher levels of dynorphin peptides than alleles with 1 or 2 repeats (LL genotype). We used fMRI on N = 71 prescreened healthy participants to investigate the effect of this polymorphism on cerebral activation in the limbic-corticostriatal loop during reward anticipation. Individuals with the HH genotype showed higher activation than those with the LL genotype in the medial orbitofrontal cortex (mOFC) when anticipating a possible monetary reward. In addition, the HH genotype showed stronger functional coupling (as assessed by effective connectivity analyses) of mOFC with VMPFC, subgenual anterior cingulate cortex, and ventral striatum during reward anticipation. This hints at a larger sensitivity for upcoming rewards in individuals with the HH genotype, resulting in a higher motivation to attain these rewards. These findings provide first evidence in humans that the PDYN polymorphism modulates neural processes associated with the anticipation of rewards, which ultimately may help to explain differences between genotypes with respect to addiction and drug abuse.	[Votinov, Mikhail; Pripfl, Juergen; Lamm, Claus; Sailer, Uta] Univ Vienna, Fac Psychol, Dept Basic Psychol Res & Res Methods, Social Cognit & Affect Neurosci Unit, Vienna, Austria; [Windischberger, Christian; Kalcher, Klaudius; Moser, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, MR Ctr Excellence, Vienna, Austria; [Zimprich, Alexander; Zimprich, Fritz] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Sailer, Uta] Univ Gothenburg, Dept Psychol, S-40020 Gothenburg, Sweden	University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Gothenburg	Votinov, M (corresponding author), Univ Vienna, Fac Psychol, Dept Basic Psychol Res & Res Methods, Social Cognit & Affect Neurosci Unit, Vienna, Austria.	mikhail.votinov@univie.ac.at	Votinov, Mikhail/N-5346-2019; Zimprich, Fritz/W-1738-2017; Zimprich, Fritz/O-1406-2019; Zimprich, Alexander/A-5232-2017; Moser, Ewald/B-3666-2013; Lamm, Claus/B-3357-2014	Votinov, Mikhail/0000-0001-6970-6093; Zimprich, Fritz/0000-0002-6998-5480; Zimprich, Fritz/0000-0002-6998-5480; Zimprich, Alexander/0000-0002-1668-5177; Moser, Ewald/0000-0001-8278-9583; Kalcher, Klaudius/0000-0003-4558-7987; Windischberger, Christian/0000-0002-9944-0190; Lamm, Claus/0000-0002-5422-0653; Votinov, Mikhail/0000-0003-3722-4406	Austrian Science Fund (FWF) [P22813-B09]; MMI-CNS (University of Vienna, Medical University of Vienna); Austrian Science Fund (FWF) [P 22813] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); MMI-CNS (University of Vienna, Medical University of Vienna); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF), P22813-B09, and by the research cluster MMI-CNS (University of Vienna, Medical University of Vienna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana FS, 2003, J NEUROSCI, V23, P9632; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Buhler M, 2010, BIOL PSYCHIAT, V67, P745, DOI 10.1016/j.biopsych.2009.10.029; Butelman ER, 2012, TRENDS NEUROSCI, V35, P587, DOI 10.1016/j.tins.2012.05.005; Camara E, 2010, CEREB CORTEX, V20, P1985, DOI 10.1093/cercor/bhp263; Carter RM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.021.2009; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Chefer VI, 2005, J NEUROSCI, V25, P5029, DOI 10.1523/JNEUROSCI.0854-05.2005; Chen ACH, 2002, AM J MED GENET, V114, P429, DOI 10.1002/ajmg.10362; Clithero JA, 2011, FRONT HUM NEUROSCI, V5; Dahl JP, 2005, AM J MED GENET B, V139B, P106, DOI 10.1002/ajmg.b.30238; Di Benedetto M, 2006, NEUROSCIENCE, V137, P187, DOI 10.1016/j.neuroscience.2005.09.015; DICHIARA G, 1988, J PHARMACOL EXP THER, V244, P1067; Diekhof EK, 2012, NEUROPSYCHOLOGIA, V50, P1252, DOI 10.1016/j.neuropsychologia.2012.02.007; Dolan RJ, 2007, PHILOS T R SOC B, V362, P787, DOI 10.1098/rstb.2007.2088; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GOLDSTEIN A, 1979, P NATL ACAD SCI USA, V76, P6666, DOI 10.1073/pnas.76.12.6666; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hariri AR, 2003, BRIT MED BULL, V65, P259, DOI 10.1093/bmb/65.1.259; Heck RH, 2010, QUANT METH SER, P1; Hjelmstad GO, 2003, J NEUROPHYSIOL, V89, P2389, DOI 10.1152/jn.01115.2002; Holsen LM, 2005, NEUROIMAGE, V27, P669, DOI 10.1016/j.neuroimage.2005.04.043; Hurd YL, 1996, NEUROSCIENCE, V72, P767, DOI 10.1016/0306-4522(96)00002-4; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koob GF, 2014, NEUROPHARMACOLOGY, V76, P370, DOI 10.1016/j.neuropharm.2013.05.024; Kosterlitz H W, 1989, NIDA Res Monogr, V95, P159; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Marco-Pallares J, 2009, BIOL PSYCHIAT, V66, P154, DOI 10.1016/j.biopsych.2009.01.006; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; McCulloch C. E., 2006, GEN LINEAR MIXED MOD; Nikoshkov A, 2008, P NATL ACAD SCI USA, V105, P786, DOI 10.1073/pnas.0710902105; Nomura A, 2006, NEUROSCI LETT, V400, P158, DOI 10.1016/j.neulet.2006.02.038; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Plichta MM, 2012, NEUROIMAGE, V60, P1746, DOI 10.1016/j.neuroimage.2012.01.129; Rademacher L, 2010, NEUROIMAGE, V49, P3276, DOI 10.1016/j.neuroimage.2009.10.089; Roesch MR, 2010, J NEUROPHYSIOL, V104, P587, DOI 10.1152/jn.00173.2010; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sescousse G, 2013, NEUROSCIENCE BIOBEHA; Sescousse G, 2013, BRAIN; Shippenberg TS, 2007, PHARMACOL THERAPEUT, V116, P306, DOI 10.1016/j.pharmthera.2007.06.011; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; Steiner H, 1996, J COMP NEUROL, V376, P530, DOI 10.1002/(SICI)1096-9861(19961223)376:4<530::AID-CNE3>3.0.CO;2-2; Stogmann E, 2002, ANN NEUROL, V51, P260, DOI 10.1002/ana.10108; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wei SG, 2011, BRAIN RES BULL, V85, P238, DOI 10.1016/j.brainresbull.2011.02.010; Winstanley CA, 2008, LEARNING MEMORY COMP, P193; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Zimprich A, 2000, J NEUROCHEM, V74, P472, DOI 10.1046/j.1471-4159.2000.740472.x	66	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89954	10.1371/journal.pone.0089954	http://dx.doi.org/10.1371/journal.pone.0089954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587148	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900103
J	Xie, C; Miyasaka, T; Yoshimura, S; Hatsuta, H; Yoshina, S; Kage-Nakadai, E; Mitani, S; Murayama, S; Ihara, Y				Xie, Ce; Miyasaka, Tomohiro; Yoshimura, Satomi; Hatsuta, Hiroyuki; Yoshina, Sawako; Kage-Nakadai, Eriko; Mitani, Shohei; Murayama, Shigeo; Ihara, Yasuo			The Homologous Carboxyl-Terminal Domains of Microtubule-Associated Protein 2 and TAU Induce Neuronal Dysfunction and Have Differential Fates in the Evolution of Neurofibrillary Tangles	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; CAENORHABDITIS-ELEGANS MODEL; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; MAP2; HYPERPHOSPHORYLATION; NEURODEGENERATION; ANTIBODIES; DENDRITES; EPITOPES	Microtubule-associated protein 2 (MAP2) and Tau are abundant neuronal microtubule-associated proteins. Both proteins have highly homologous carboxyl-terminal sequences that function as microtubule-binding domains. Whereas Tau is widely accepted as a pathoetiological factor in human tauopathies, including Alzheimer's disease (AD), it is not known whether there is a relationship between MAP2 and tauopathy. To better understand the pathological roles of MAP2 and Tau, we compared their behaviors in transgenic Caenorhabditis elegans in which MAP2 or Tau was expressed pan-neuronally. Both MAP2 and Tau elicited severe neuronal dysfunction and neuritic abnormalities, despite the absence of detergent-insoluble aggregates in worm neurons. Biochemical analysis revealed that the expressed MAP2 or Tau in worms was highly phosphorylated and did not bind to microtubules. Newly raised antibodies to MAP2 that effectively distinguished between the highly homologous carboxyl-terminal sequences of MAP2 and Tau showed that MAP2 was not involved in the growth process of neurofibrillary tangles in the AD brain. These results indicate that Tau and MAP2 have different fates in the inclusion formation and raise the possibility that MAP2 plays a significant role in neurotoxicity in the AD brain despite the absence of MAP2-aggregates.	[Xie, Ce; Miyasaka, Tomohiro; Yoshimura, Satomi; Ihara, Yasuo] Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kyotanabe, Kyoto, Japan; [Yoshina, Sawako; Kage-Nakadai, Eriko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo, Japan; [Hatsuta, Hiroyuki; Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Itabashi Ku, Tokyo, Japan	Doshisha University; Tokyo Women's Medical University; Tokyo Metropolitan Institute of Gerontology	Miyasaka, T (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kyotanabe, Kyoto, Japan.	tomiyasa@mail.doshisha.ac.jp			KAKENHI [20700324, 24700368, 22650074]; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [24700368, 23790256] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI; Grant-in-Aid for Young Scientists (B); 20700324; T. M. and 24700368; C. X. and Grant-in-Aid for Challenging Exploratory Research; 22650074; T. M.) and by Core Research for Evolutional Science and Technology (CREST; T. M., C. X., and Y.I.), Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadoro G, 2004, CELL DEATH DIFFER, V11, P217, DOI 10.1038/sj.cdd.4401314; Ashford JW, 1998, J NEUROPATH EXP NEUR, V57, P972, DOI 10.1097/00005072-199810000-00009; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brandt R, 2009, NEUROBIOL AGING, V30, P22, DOI 10.1016/j.neurobiolaging.2007.05.011; BRENNER S, 1974, GENETICS, V77, P71; Calahorro F, 2011, INVERTEBR NEUROSCI, V11, P73, DOI 10.1007/s10158-011-0126-1; DAMMERMAN M, 1989, J NEUROSCI RES, V24, P487, DOI 10.1002/jnr.490240405; Dehmelt L, 2005, GENOME BIOL, V6; ENDOH R, 1993, BRAIN RES, V601, P164, DOI 10.1016/0006-8993(93)91707-Y; Fatouros C, 2012, HUM MOL GENET, V21, P3587, DOI 10.1093/hmg/dds190; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Kanaan NM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.006; KANAI Y, 1995, NEURON, V14, P421, DOI 10.1016/0896-6273(95)90298-8; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1984, P NATL ACAD SCI-BIOL, V81, P7941, DOI 10.1073/pnas.81.24.7941; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lippa CF, 2000, ANN NEUROL, V48, P850, DOI 10.1002/1531-8249(200012)48:6<850::AID-ANA5>3.3.CO;2-M; MADURO M, 1995, GENETICS, V141, P977; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Mello C, 1995, METHOD CELL BIOL, V48, P451; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Miyasaka T, 2005, NEUROBIOL DIS, V20, P372, DOI 10.1016/j.nbd.2005.03.017; Miyasaka T, 2005, J NEUROPATH EXP NEUR, V64, P665, DOI 10.1097/01.jnen.0000173890.79058.1d; Miyasaka T, 2010, FEBS LETT, V584, P3227, DOI 10.1016/j.febslet.2010.06.014; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Neumann M, 2001, ANN NEUROL, V50, P503, DOI 10.1002/ana.1223; Nicholl DJ, 2003, ANN NEUROL, V54, P682, DOI 10.1002/ana.10747; NUKINA N, 1987, P NATL ACAD SCI USA, V84, P3415, DOI 10.1073/pnas.84.10.3415; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Pickering-Brown SM, 2004, BRAIN, V127, P1415, DOI 10.1093/brain/awh147; ROSEMBLATT M, 1989, FEBS LETT, V252, P91, DOI 10.1016/0014-5793(89)80895-6; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Watanabe A, 1999, J BIOL CHEM, V274, P7368, DOI 10.1074/jbc.274.11.7368; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	43	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89796	10.1371/journal.pone.0089796	http://dx.doi.org/10.1371/journal.pone.0089796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587039	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900083
J	Wang, H; Cai, YY; Cai, L; Hu, YC; Chen, XX; Deng, JL				Wang, Han; Cai, Yingying; Cai, Lin; Hu, Yingchun; Chen, Xianxiang; Deng, Juelin			Altered Lipid Levels in Untreated Patients with Early Polymyositis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CARDIOVASCULAR RISK; METABOLIC SYNDROME; SERUM-LIPIDS; DERMATOMYOSITIS; INFLAMMATION; MECHANISMS; INFECTION; PROFILES; EVENTS	Background: Little is known so far on the lipid profile in polymyositis (PM) patients. Our aim is to identify lipid profiles in untreated patients with early PM, to assess the association between lipid profiles and C-reactive protein (a sensitive marker of inflammation) in these patients. Methods and Findings: This work was conducted as a case-control study. Sixty untreated patients with PM and 60 age-and sex-matched healthy controls were included. The duration of PM was less than six months, and none of them had received intermittent or regular corticosteroids or disease-modifying antirheumatic drugs or biological agents prior to the study. Triglyceride (TG), total cholesterol (TC), LDL-cholesterol (LDL-C), and HDL-cholesterol (HDL-C), and C-reactive protein (CRP) were assessed using standard techniques. Thirty patients (50%) had a decreased level of HDL-C and 47% had an increased level of TG. The levels of HDL-C, LDL-C, and TC in PM were significantly lower than in controls (P<0.001, P<0.01, P<0.001, respectively). The level of TG was significantly higher in PM than in controls (P<0.001). The level of very low LDL-cholesterol (VLDL-C), and the ratios of VLDL-C/LDL-C, TC/HDL-C, and LDL-C/HDL-C were significantly higher than in controls ( all P<0.001). Serum CRP levels correlated negatively with HDL-C (r = -0.352, P = 0.006) and TC (r = -0.262, P = 0.043). After adjustment for age, gender, smoking, drinking, body mass index, and pulmonary fibrosis/infection, linear regression model demonstrated that CRP is associated with HDL-C among PM patients (P = 0.028). Conclusions: Dyslipidemia is a common feature in patients with PM that is characterized by a decrease in HDL-C and an increase in TG, suggesting a high risk of atherosclerosis. The Inflammatory condition in PM may account for the metabolism of HDL-C.	[Wang, Han; Cai, Lin] Chongqing Med Univ, Affiliated Chengdu Clin Coll 2, Peoples Hosp Chengdu 3, Cardiovasc Dis Res Inst, Chengdu, Sichuan, Peoples R China; [Wang, Han; Chen, Xianxiang] Hubei Univ Med, Renmin Hosp, Dept Surg, Shiyan, Hubei, Peoples R China; [Cai, Yingying; Hu, Yingchun; Deng, Juelin] Sichuan Univ, West China Hosp, Dept Geriatr, Chengdu 610064, Sichuan, Peoples R China	Chongqing Medical University; Hubei University of Medicine; Sichuan University	Chen, XX (corresponding author), Hubei Univ Med, Renmin Hosp, Dept Surg, Shiyan, Hubei, Peoples R China.	chenxian881@hotmail.com; wh7967@hotmail.com	Hu, Ying/GQZ-8100-2022	Wang, Han/0000-0002-1123-4086	The National Natural Science Funds [81300243]	The National Natural Science Funds	Support was provided by The National Natural Science Funds (Grant No. 81300243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS CG, 1992, CANCER CHEMOTH PHARM, V30, P412, DOI 10.1007/BF00689971; Alves JD, 2003, RHEUMATOLOGY, V42, P893, DOI 10.1093/rheumatology/keg248; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Borba EF, 2000, ARTHRITIS RHEUM, V43, P1033, DOI 10.1002/1529-0131(200005)43:5<1033::AID-ANR11>3.0.CO;2-B; Bradley WG, 2004, NEUROLOGY, V63, P402; Chait A, 2005, J LIPID RES, V46, P389, DOI 10.1194/jlr.R400017-JLR200; Choy E, 2009, ANN RHEUM DIS, V68, P460, DOI 10.1136/ard.2008.101964; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; de Carvalho JF, 2008, AUTOIMMUN REV, V7, P246, DOI 10.1016/j.autrev.2007.11.016; de Moraes MT, 2013, ARTHRIT CARE RES, V65, P793, DOI 10.1002/acr.21879; Dessein PH, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar428; Eimer MJ, 2011, J PEDIATR-US, V159, P795, DOI 10.1016/j.jpeds.2011.05.015; Gupta R, 2011, INT J CARDIOL, V148, P261, DOI 10.1016/j.ijcard.2010.08.013; Hengstman GJD, 2004, NEUROLOGY, V63, P402; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Khovidhunkit W, 2000, J INFECT DIS, V181, pS462, DOI 10.1086/315611; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Lodde BM, 2006, RHEUMATOLOGY, V45, P481, DOI 10.1093/rheumatology/kei190; Marik PE, 2006, CRIT CARE CLIN, V22, P151, DOI 10.1016/j.ccc.2005.08.008; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; SoRelle R, 2001, Circulation, V104, pE9011; Steiner G, 2009, SEMIN ARTHRITIS RHEU, V38, P372, DOI 10.1016/j.semarthrit.2008.01.015; Tisseverasinghe A, 2009, J RHEUMATOL, V36, P1943, DOI 10.3899/jrheum.090061; van der Meulen MFG, 2003, NEUROLOGY, V61, P316, DOI 10.1212/WNL.61.3.316; Vermont CL, 2005, CRIT CARE MED, V33, P1610, DOI 10.1097/01.CCM.0000171272.50888.AD; Wang H, 2013, J EUR ACAD DERMATOL, V27, P175, DOI 10.1111/j.1468-3083.2011.04437.x; Wang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0050175, 10.1371/journal.pone.0064617]	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89827	10.1371/journal.pone.0089827	http://dx.doi.org/10.1371/journal.pone.0089827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587064	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700099
J	Merino, S; Fulton, KM; Twine, SM; Wilhelms, M; Molero, R; Tomas, JM				Merino, Susana; Fulton, Kelly M.; Twine, Susan M.; Wilhelms, Markus; Molero, Raquel; Tomas, Juan M.			Aeromonas hydrophila Flagella Glycosylation: Involvement of a Lipid Carrier	PLOS ONE			English	Article							LINKED PROTEIN GLYCOSYLATION; O-ANTIGEN; FUNCTIONAL-CHARACTERIZATION; ESCHERICHIA-COLI; BIOSYNTHESIS; TRANSFERASE; POLAR; GENE; CARBOHYDRATE; MOTILITY	Polar flagellin proteins from Aeromonas hydrophila strain AH-3 (serotype O34) were found to be O-glycosylated with a heterogeneous glycan. Mutants unable to produce WecP or Gne enzymes showed altered motility, and the study of their polar flagellin glycosylation showed that the patterns of glycosylation differed from that observed with wild type polar flagellin. This suggested the involvement of a lipid carrier in glycosylation. A gene coding for an enzyme linking sugar to a lipid carrier was identified in strain AH-3 (WecX) and subsequent mutation abolished completely motility, flagella production by EM, and flagellin glycosylation. This is the first report of a lipid carrier involved in flagella O-glycosylation. A molecular model has been proposed. The results obtained suggested that the N-acetylhexosamines are N-acetylgalactosamines and that the heptasaccharide is completely independent of the O34-antigen lipopolysaccharide. Furthermore, by comparing the mutants with differing degrees of polar flagellin glycosylation, we established their importance in A. hydrophila flagella formation and motility.	[Merino, Susana; Wilhelms, Markus; Molero, Raquel; Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain; [Fulton, Kelly M.; Twine, Susan M.] Natl Res Council Canada, Ottawa, ON, Canada	University of Barcelona; National Research Council Canada	Tomas, JM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain.	jtomas@ub.edu	Merino, Susana/D-4342-2014; Tomas, Juan M/L-1398-2015	Merino, Susana/0000-0001-6040-4259; Tomas, Juan M/0000-0002-3575-7113	Plan Nacional de I+D+ i (Ministerio de Economia y Competitividad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia); National Research Council Canada	Plan Nacional de I+D+ i (Ministerio de Economia y Competitividad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya); National Research Council Canada	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by Plan Nacional de I+D+ i (Ministerio de Economia y Competitividad, Spain), Generalitat de Catalunya (Centre de Referencia en Biotecnologia), and the National Research Council Canada.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banerjee A, 2002, J EXP MED, V196, P147, DOI 10.1084/jem.20012022; Canals R, 2006, INFECT IMMUN, V74, P537, DOI 10.1128/IAI.74.1.537-548.2006; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Horzempa J, 2006, J BIOL CHEM, V281, P1128, DOI 10.1074/jbc.M510975200; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jimenez N, 2008, J BACTERIOL; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Kirov SM, 2002, J BACTERIOL, V184, P547, DOI 10.1128/JB.184.2.547-555.2002; Knirel YA, 2002, CARBOHYD RES, V337, P1381, DOI 10.1016/S0008-6215(02)00136-2; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; LEHRMAN MA, 1994, GLYCOBIOLOGY, V4, P768, DOI 10.1093/glycob/4.6.768; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Merino S, 2011, J BACTERIOL, V193, P1943, DOI 10.1128/JB.01441-10; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Post DMB, 2012, J BIOL CHEM, V287, P8515, DOI 10.1074/jbc.M111.324012; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Saldias MS, 2008, MICROBIOL-SGM, V154, P440, DOI 10.1099/mic.0.2007/013136-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; SHIMADA T, 1985, JPN J MED SCI BIOL, V38, P141, DOI 10.7883/yoken1952.38.141; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; Twine SM, 2012, BACTERIAL FLAGELLAR; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Twine SM, 2012, BACTERIAL GLYCOMICS: CURRENT RESEARCH, TECHNOLOGY AND APPLICATIONS, P69; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Weerapana E, 2005, J AM CHEM SOC, V127, P13766, DOI 10.1021/ja054265v; Wilhelms M, 2012, J BIOL CHEM, V287, P27851, DOI 10.1074/jbc.M112.376525; Yu HB, 2004, INFECT IMMUN, V72, P1248, DOI 10.1128/IAI.72.3.1248-1256.2004	43	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89630	10.1371/journal.pone.0089630	http://dx.doi.org/10.1371/journal.pone.0089630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586923	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900133
J	Vegter, RJK; Lamoth, CJ; de Groot, S; Veeger, DHEJ; van der Woude, LHV				Vegter, Riemer J. K.; Lamoth, Claudine J.; de Groot, Sonja; Veeger, Dirkjan H. E. J.; van der Woude, Lucas H. V.			Inter-Individual Differences in the Initial 80 Minutes of Motor Learning of Handrim Wheelchair Propulsion	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MECHANICAL EFFICIENCY; SHOULDER PAIN; INDIVIDUAL-DIFFERENCES; PHYSICAL CAPACITY; VARIABLE PRACTICE; ENERGY COSTS; VARIABILITY; COORDINATION; USERS	Handrim wheelchair propulsion is a cyclic skill that needs to be learned during rehabilitation. Yet it is unclear how inter-individual differences in motor learning impact wheelchair propulsion practice. Therefore we studied how early-identified motor learning styles in novice able-bodied participants impact the outcome of a low-intensity wheelchair-practice intervention. Over a 12-minute pre-test, 39 participants were split in two groups based on a relative 10% increase in mechanical efficiency. Following the pretest the participants continued one of four different low-intensity wheelchair practice interventions, yet all performed in the same trial-setup with a total 80-minute dose at 1.11 m/s at 0.20 W/kg. Instead of focusing on the effect of the different interventions, we focused on differences in motor learning between participants over the intervention. Twenty-six participants started the pretest with a lower mechanical efficiency and a less optimal propulsion technique, but showed a fast improvement during the first 12 minutes and this effect continued over the 80 minutes of practice. Eventually these initially fast improvers benefitted more from the given practice indicated by a better propulsion technique (like reduced frequency and increased stroke angle) and a higher mechanical efficiency. The initially fast improvers also had a higher intra-individual variability in the pre and posttest, which possibly relates to the increased motor learning of the initially fast improvers. Further exploration of the common characteristics of different types of learners will help to better tailor rehabilitation to the needs of wheelchair-dependent persons and improve our understanding of cyclic motor learning processes.	[Vegter, Riemer J. K.; Lamoth, Claudine J.; de Groot, Sonja; van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [de Groot, Sonja] Amsterdam Rehabil Res Ctr Reade, Amsterdam, Netherlands; [Veeger, Dirkjan H. E. J.] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands; [Veeger, Dirkjan H. E. J.] Delft Univ Technol, Fac Mech Maritime & Mat Engn, Sect Biomechatron & Biorobot, Delft, Netherlands; [van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands	University of Groningen; Vrije Universiteit Amsterdam; Delft University of Technology; University of Groningen	Vegter, RJK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	r.j.k.vegter@umcg.nl	JK, Vegter Riemer/N-3385-2013; van der Woude, Lucas H/E-7986-2018; Lamoth, Claudine JC/N-4325-2013	JK, Vegter Riemer/0000-0002-4294-6086; van der Woude, Lucas H/0000-0002-8472-334X; Lamoth, Claudine JC/0000-0002-6495-2823; veeger, dirkjan/0000-0003-0292-6520				Almasbakk B, 2001, BIOL CYBERN, V84, P75, DOI 10.1007/s004229900075; Ballinger DA, 2000, ARCH PHYS MED REHAB, V81, P1575, DOI 10.1053/apmr.2000.18216; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Boninger ML, 2002, ARCH PHYS MED REHAB, V83, P718, DOI 10.1053/apmr.2002.32455; Boninger ML, 1999, ARCH PHYS MED REHAB, V80, P910, DOI 10.1016/S0003-9993(99)90082-5; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bouchard C, 2012, EXP PHYSIOL, V97, P347, DOI 10.1113/expphysiol.2011.058735; Bouwsema H, 2010, ARCH PHYS MED REHAB, V91, P1442, DOI 10.1016/j.apmr.2010.06.025; Busquets A, 2011, RES Q EXERCISE SPORT, V82, P9, DOI 10.1080/02701367.2011.10599717; Consortium for Spinal Cord Medicine, 2005, PRES UPP LIMB FUNCT; Curtis KA, 1999, SPINAL CORD, V37, P421, DOI 10.1038/sj.sc.3100860; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; de Groot S, 2002, CLIN BIOMECH, V17, P219, DOI 10.1016/S0268-0033(02)00005-0; de Groot S, 2008, CLIN BIOMECH, V23, P434, DOI 10.1016/j.clinbiomech.2007.11.001; de Groot S, 2005, MED ENG PHYS, V27, P41, DOI 10.1016/j.medengphy.2004.08.007; de Groot S, 2003, AM J PHYS MED REHAB, V82, P504, DOI 10.1097/01.PHM.0000069941.77921.AA; de Groot S, 2002, MED SCI SPORT EXER, V34, P756, DOI 10.1097/00005768-200205000-00005; Dyson-Hudson TA, 2004, J SPINAL CORD MED, V27, P4, DOI 10.1080/10790268.2004.11753724; Elferink-Gemser MT, 2007, J SPORT SCI, V25, P481, DOI 10.1080/02640410600719945; Galna B, 2006, J MOTOR BEHAV, V38, P411, DOI 10.3200/JMBR.38.6.411-422; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; Goosey-Tolfrey VL, 2011, INT J SPORTS MED, V32, P126, DOI 10.1055/s-0030-1268439; Haisma JA, 2006, SPINAL CORD, V44, P642, DOI 10.1038/sj.sc.3101915; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Jantzen KJ, 2009, J COGNITIVE NEUROSCI, V21, P2420, DOI 10.1162/jocn.2008.21182; King AC, 2012, NEUROSCI LETT, V529, P144, DOI 10.1016/j.neulet.2012.08.014; Kostrubiec V, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00222; Lamoth CJC, 2009, HUM MOVEMENT SCI, V28, P371, DOI 10.1016/j.humov.2008.10.001; Lamoth CJC, 2006, EUR SPINE J, V15, P23, DOI 10.1007/s00586-004-0825-y; Lenton J. P., 2010, DISABILITY REHABILIT, V0, P1; Mercer JL, 2006, CLIN BIOMECH, V21, P781, DOI 10.1016/j.clinbiomech.2006.04.010; Moon Y, 2013, CLIN BIOMECH, V28, P967, DOI 10.1016/j.clinbiomech.2013.10.004; Newell K.M, 1993, VARIABILITY MOTOR CO; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; PENTLAND WE, 1994, PARAPLEGIA, V32, P211, DOI 10.1038/sc.1994.40; Qi L, 2013, NEURAL SYSTEMS REHAB, P1; Rasbash J, 2009, MLWIN VERSION 21; Richter WM, 2011, ARCH PHYS MED REHAB, V92, P572, DOI 10.1016/j.apmr.2010.11.001; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Rimmer JH, 2006, DISABIL REHABIL, V28, P1087, DOI 10.1080/09638280500493860; Seifert L, 2011, HUM MOVEMENT SCI, V30, P550, DOI 10.1016/j.humov.2010.12.003; Seifert L, 2007, HUM MOVEMENT SCI, V26, P68, DOI 10.1016/j.humov.2006.09.003; Sparrow WA, 2007, J MOTOR BEHAV, V39, P259, DOI 10.3200/JMBR.39.4.259-275; Sparrow WA, 1998, PSYCHON B REV, V5, P173, DOI 10.3758/BF03212943; Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007; van den Berg R, 2010, DISABIL REHABIL, V32, P2244, DOI 10.3109/09638288.2010.535688; VANDERWOUDE LHV, 1989, J MED ENG TECHNOL, V13, P136, DOI 10.3109/03091908909030214; VANDERWOUDE LHV, 1988, MED SCI SPORT EXER, V20, P70, DOI 10.1249/00005768-198802000-00011; VANDERWOUDE LHV, 1986, ERGONOMICS, V29, P1561, DOI 10.1080/00140138608967269; VEEGER D, 1989, Journal of Rehabilitation Research and Development, V26, P37; Vegter R, 2013, NEURAL SYSTEMS REHAB; Vegter RJK, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-9; Wang LJ, 2012, PSYCHOL METHODS, V17, P567, DOI 10.1037/a0029317; WHO, 2001, WHO INT CLASS FUNCT; Withagen R, 2009, ATTEN PERCEPT PSYCHO, V71, P64, DOI 10.3758/APP.71.1.64; Yao WX, 2012, EUR J PHYS REHAB MED, V48, P209; Yao WX, 2009, PERCEPT MOTOR SKILL, V109, P133, DOI 10.2466/PMS.109.1.133-139	58	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89729	10.1371/journal.pone.0089729	http://dx.doi.org/10.1371/journal.pone.0089729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586992	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900146
J	HAinmhire, EO; Quartuccio, SM; Cheng, W; Ahmed, RA; King, SM; Burdette, JE				HAinmhire, Eoghainin O.; Quartuccio, Suzanne M.; Cheng, Whay; Ahmed, Roshan A.; King, Shelby M.; Burdette, Joanna E.			Mutation or Loss of p53 Differentially Modifies TGF beta Action in Ovarian Cancer	PLOS ONE			English	Article							WILD-TYPE P53; TUMOR-SUPPRESSOR; GROWTH; GENE; EXPRESSION; INVASION; CARCINOMA; PATHWAY; BREAST; INACTIVATION	Ovarian cancer is the most lethal gynecological disease affecting women in the US. The Cancer Genome Atlas Network identified p53 mutations in 96% of high-grade serous ovarian carcinomas, demonstrating its critical role. Additionally, the Transforming Growth Factor Beta (TGF beta) pathway is dysfunctional in various malignancies, including ovarian cancer. This study investigated how expression of wild-type, mutant, or the absence of p53 alters ovarian cancer cell response to TGF beta signaling, as well as the response of the ovarian surface epithelium and the fallopian tube epithelium to TGF beta. Only ovarian cancer cells expressing wild-type p53 were growth inhibited by TGF beta, while ovarian cancer cells that were mutant or null p53 were not. TGF beta induced migration in p53 null SKOV3 cells, which was not observed in SKOV3 cells with stable expression of mutant p53 R273H. Knockdown of wild-type p53 in the OVCA 420 ovarian cancer cells enhanced cell migration in response to TGF beta. Increased protein expression of DKK1 and TMEPAI, two pro-invasive genes with enhanced expression in late stage metastatic ovarian cancer, was observed in p53 knockdown and null cells, while cells stably expressing mutant p53 demonstrated lower DKK1 and TMEPAI induction. Expression of mutant p53 or loss of p53 permit continued proliferation of ovarian cancer cell lines in the presence of TGF beta; however, cells expressing mutant p53 exhibit reduced migration and decreased protein levels of DKK1 and TMEPAI.	[HAinmhire, Eoghainin O.; Quartuccio, Suzanne M.; Cheng, Whay; Ahmed, Roshan A.; King, Shelby M.; Burdette, Joanna E.] Univ Illinois, Ctr Pharmaceut Biotechnol, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Burdette, JE (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.	joannab@uic.edu		, Suzanne/0000-0002-7568-5871; Burdette, Joanna/0000-0002-7271-6847	Liz Tilberis Ovarian Cancer Research Fund [L/T/UIC/0.1.2011]; Vahlteich Award from the UIC College of Pharmacy; American Cancer Society Research Scholar Illinois Division [RSG-12-230-01-TBG]	Liz Tilberis Ovarian Cancer Research Fund; Vahlteich Award from the UIC College of Pharmacy; American Cancer Society Research Scholar Illinois Division(American Cancer Society)	This research was supported in part by grants from the Liz Tilberis Ovarian Cancer Research Fund L/T/UIC/0.1.2011, Vahlteich Award from the UIC College of Pharmacy and American Cancer Society Research Scholar Grant Illinois Division RSG-12-230-01-TBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cheon DJ, 2014, CLIN CANCER RES, V20, P711, DOI 10.1158/1078-0432.CCR-13-1256; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Clark-Knowles KV, 2007, EXP CELL RES, V313, P133, DOI 10.1016/j.yexcr.2006.09.026; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Dong P, 2007, CLIN EXP METASTAS, V24, P471, DOI 10.1007/s10585-007-9084-8; Giannini G, 2003, MOL CARCINOGEN, V38, P188, DOI 10.1002/mc.10162; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Hu Y, 2013, CARCINOGENESIS, P1; Hwang CI, 2011, CELL CYCLE, V10, P3834, DOI 10.4161/cc.10.22.18294; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Jackson KS, 2009, ENDOCRINOLOGY, V150, P3921, DOI 10.1210/en.2008-1674; JOHNSON P, 1991, MOL CELL BIOL, V11, P1; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; King SM, 2011, JOVE-J VIS EXP, DOI 10.3791/2804; King SM, 2013, CARCINOGENESIS, V34, P1125, DOI 10.1093/carcin/bgt003; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Modesitt SC, 2001, CLIN CANCER RES, V7, P1765; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Rodriguez GC, 2001, GYNECOL ONCOL, V80, P245, DOI 10.1006/gyno.2000.6042; Secord AA, 2006, GYNECOL ONCOL, V101, P390, DOI 10.1016/j.ygyno.2006.02.014; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singha PK, 2010, CANCER RES, V70, P6377, DOI 10.1158/0008-5472.CAN-10-1180; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Toh MF, 2012, STEROIDS, V77, P765, DOI 10.1016/j.steroids.2012.03.013; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; Vaughan Catherine A, 2012, Genes Cancer, V3, P491, DOI 10.1177/1947601912462719; Wang SZE, 2007, J BIOL CHEM, V282, P5661, DOI 10.1074/jbc.M608499200; Wang SZ, 2009, INT J BIOL MARKER, V24, P165, DOI 10.1177/172460080902400306; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Yamamura S, 2012, INT J CANCER, V130, P20, DOI 10.1002/ijc.25961	47	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89553	10.1371/journal.pone.0089553	http://dx.doi.org/10.1371/journal.pone.0089553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586866	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700126
J	Chai, LYA; Kullberg, BJ; Earnest, A; Johnson, EM; Teerenstra, S; Vonk, AG; Schlamm, HT; Herbrecht, R; Netea, MG; Troke, PF				Chai, Louis Yi Ann; Kullberg, Bart Jan; Earnest, Arul; Johnson, Elizabeth M.; Teerenstra, Steven; Vonk, Alieke G.; Schlamm, Haran T.; Herbrecht, Raoul; Netea, Mihai G.; Troke, Peter F.			Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis	PLOS ONE			English	Article							ENZYME-IMMUNOASSAY; ANTIGENEMIA; UK-109,496; FUMIGATUS; DISEASE	An improved number of anti-fungal drugs are currently available for the treatment of invasive aspergillosis (IA). While serial galactomannan index (GMI) measurement can be used to monitor response to treatment, the extent to which different antifungal regimens can affect galactomannan levels is unknown. In 147 IA patients receiving either voriconazole (VCZ) or conventional amphotericin B (CAB) in a multicentre clinical trial, we performed post-hoc analyses of GMI trends in relation to outcomes. The generalized estimation equations approach was used to estimate changes in the effect size for GMI over time within patients. Patients who received VCZ primary therapy and had good treatment response 12 weeks later showed earlier decreases in GMI values at Week 1 and Week 2 (p = 0.001 and 0.046 respectively) as compared to patients who only received CAB. At end-of-randomized therapy (EORT), which was a pre-set secondary assessment point for all patients who switched from randomized primary (CAB or VCZ) to an alternative anti-fungal drug, treatment failure was associated with increasing GMI at Weeks 1 and 2 in CAB-primary treated patients (p = 0.022 and 0.046 respectively). These distinct trends highlight the variations in GMI kinetics with the use of different anti-fungal drugs and their implications in relation to IA treatment response.	[Chai, Louis Yi Ann; Kullberg, Bart Jan; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Chai, Louis Yi Ann; Kullberg, Bart Jan; Netea, Mihai G.] Nijmegen Inst Infect Inflammat & Immun N4i, Nijmegen, Netherlands; [Chai, Louis Yi Ann] Natl Univ Hlth Syst, Univ Med Cluster, Div Infect Dis, Singapore, Singapore; [Earnest, Arul] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Johnson, Elizabeth M.] Hlth Protect Agcy, Mycol Reference Lab, Bristol, Avon, England; [Teerenstra, Steven] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Vonk, Alieke G.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Schlamm, Haran T.] Pfizer Global Res & Dev, New York, NY USA; [Herbrecht, Raoul] Hop Univ Strasbourg, Dept Hematol & Oncol, Strasbourg, France; [Troke, Peter F.] Old Court, Broadstairs, Kent, England	Radboud University Nijmegen; Radboud University Nijmegen; National University of Singapore; National University of Singapore; Health Protection Agency; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Pfizer; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chai, LYA (corresponding author), Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	chailouis@hotmail.com	Herbrecht, Raoul/AAT-1763-2021; Herbrecht, Raoul/GVU-1333-2022; Kullberg, BJ/C-8520-2013; Netea, Mihai/N-5155-2014; Herbrecht, Raoul/D-3471-2013; Teerenstra, Steven/C-2870-2018	Herbrecht, Raoul/0000-0002-9381-4876; Kullberg, BJ/0000-0002-6813-8167; Teerenstra, Steven/0000-0003-4103-7451	National Medical Research Council (NMRC), Singapore; National Kidney Foundation, Singapore; European Research Council [310372]; Pfizer [150-307]	National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore); National Kidney Foundation, Singapore; European Research Council(European Research Council (ERC)European Commission); Pfizer(Pfizer)	L.C. was supported by New Investigator Grant (NIG), Clinician Scientist Award (CSA), Individual Research Grant (IRG) and Bedside & Bench (B&B) grants of the National Medical Research Council (NMRC), Singapore, and the National Kidney Foundation, Singapore. M.G.N. was supported by a European Research Council Consolidator Grant (nr. 310372). The original study protocol 150-307 was sponsored by Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger P, 1997, ANTIMICROB AGENTS CH, V41, P1840, DOI 10.1128/AAC.41.8.1840; Boutboul F, 2002, CLIN INFECT DIS, V34, P939, DOI 10.1086/339324; Chai LY, 2010, J CLIN MICROBIOL, V50, P2330; Chakrabarti A, 2011, MED MYCOL, V49, pS35, DOI 10.3109/13693786.2010.505206; Czub J, 2006, J PHYS CHEM B, V110, P16743, DOI 10.1021/jp061916g; Ferreira MED, 2006, CURR GENET, V50, P32, DOI 10.1007/s00294-006-0073-2; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; El Saleeby CM, 2005, J CLIN MICROBIOL, V43, P3560, DOI 10.1128/JCM.43.7.3560-3563.2005; Gautam P, 2008, ANTIMICROB AGENTS CH, V52, P4220, DOI 10.1128/AAC.01431-07; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Kirkpatrick WR, 2000, ANTIMICROB AGENTS CH, V44, P2865, DOI 10.1128/AAC.44.10.2865-2868.2000; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Maertens JA, 2007, CLIN INFECT DIS, V44, P1329, DOI 10.1086/514349; Musher B, 2004, J CLIN MICROBIOL, V42, P5517, DOI 10.1128/JCM.42.12.5517-5522.2004; Patterson TF, 2005, CLIN INFECT DIS, V41, P1448, DOI 10.1086/497126; Sanati H, 1997, ANTIMICROB AGENTS CH, V41, P2492, DOI 10.1128/AAC.41.11.2492; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wingard JR, 2008, CANCER, V112, P2309, DOI 10.1002/cncr.23441	19	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90176	10.1371/journal.pone.0090176	http://dx.doi.org/10.1371/journal.pone.0090176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587262	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200142
J	Goto, T; Terada, N; Inoue, T; Nakayama, K; Okada, Y; Yoshikawa, T; Miyazaki, Y; Uegaki, M; Sumiyoshi, S; Kobayashi, T; Kamba, T; Yoshimura, K; Ogawa, O				Goto, Takayuki; Terada, Naoki; Inoue, Takahiro; Nakayama, Kenji; Okada, Yoshiyuki; Yoshikawa, Takeshi; Miyazaki, Yu; Uegaki, Masayuki; Sumiyoshi, Shinji; Kobayashi, Takashi; Kamba, Tomomi; Yoshimura, Koji; Ogawa, Osamu			The Expression Profile of Phosphatidylinositol in High Spatial Resolution Imaging Mass Spectrometry as a Potential Biomarker for Prostate Cancer	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LYSOPHOSPHATIDIC ACID; TISSUE-SECTIONS; CELL; IDENTIFICATION; MS; VISUALIZATION; METABOLISM; PROTEINS; PATHWAY	High-resolution matrix-assisted laser desorption/ionization imaging mass spectrometry (HR-MALDI-IMS) is an emerging application for the comprehensive and detailed analysis of the spatial distribution of ionized molecules in situ on tissue slides. HR-MALDI-IMS in negative mode in a mass range of m/z 500-1000 was performed on optimal cutting temperature (OCT) compound-embedded human prostate tissue samples obtained from patients with prostate cancer at the time of radical prostatectomy. HR-MALDI-IMS analysis of the 14 samples in the discovery set identified 26 molecules as highly expressed in the prostate. Tandem mass spectrometry (MS/MS) showed that these molecules included 14 phosphatidylinositols (PIs), 3 phosphatidylethanolamines (PEs) and 3 phosphatidic acids (PAs). Among the PIs, the expression of PI(18:0/18:1), PI(18:0/20:3) and PI(18:0/20:2) were significantly higher in cancer tissue than in benign epithelium. A biomarker algorithm for prostate cancer was formulated by analyzing the expression profiles of PIs in cancer tissue and benign epithelium of the discovery set using orthogonal partial least squares discriminant analysis (OPLS-DA). The sensitivity and specificity of this algorithm for prostate cancer diagnosis in the 24 validation set samples were 87.5 and 91.7%, respectively. In conclusion, HR-MALDI-IMS identified several PIs as being more highly expressed in prostate cancer than benign prostate epithelium. These differences in PI expression profiles may serve as a novel diagnostic tool for prostate cancer.	[Goto, Takayuki; Terada, Naoki; Inoue, Takahiro; Nakayama, Kenji; Okada, Yoshiyuki; Yoshikawa, Takeshi; Miyazaki, Yu; Uegaki, Masayuki; Kobayashi, Takashi; Kamba, Tomomi; Yoshimura, Koji; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Sumiyoshi, Shinji] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan	Kyoto University; Kyoto University	Ogawa, O (corresponding author), Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan.	ogawao@kuhp.kyoto-u.ac.jp	Terada, Naoki/ABD-2387-2020	Miyazaki, Yu/0000-0003-0949-4812	Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP) (http://www.first-ms3d.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Bonnel D, 2011, ANAL BIOANAL CHEM, V401, P149, DOI 10.1007/s00216-011-5020-5; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Chaurand P, 2006, J PROTEOME RES, V5, P2889, DOI 10.1021/pr060346u; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; Eberlin LS, 2010, ANAL CHEM, V82, P3430, DOI 10.1021/ac9029482; Enomoto H, 2011, ANAL BIOANAL CHEM, V400, P1913, DOI 10.1007/s00216-011-4924-4; Freeman VL, 2007, CANCER CAUSE CONTROL, V18, P211, DOI 10.1007/s10552-006-0095-6; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; HOLUB BJ, 1970, J LIPID RES, V11, P558; Ishikawa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048873; Kawashima M, 2013, CANCER SCI, V104, P1372, DOI 10.1111/cas.12229; Kubo A, 2011, ANAL BIOANAL CHEM, V400, P1895, DOI 10.1007/s00216-011-4895-5; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; Lee HC, 2012, GENES CELLS, V17, P748, DOI 10.1111/j.1365-2443.2012.01624.x; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Miura D, 2010, ANAL CHEM, V82, P9789, DOI 10.1021/ac101998z; Pallua JD, 2013, J PROTEOMICS, V91, P500, DOI 10.1016/j.jprot.2013.08.003; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pirro V, 2012, ANALYST, V137, P2374, DOI 10.1039/c2an35122f; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Schober Y, 2012, ANAL CHEM, V84, P6293, DOI 10.1021/ac301337h; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Schwamborn K, 2007, INT J MOL MED, V20, P155; Schwamborn K, 2010, NAT REV CANCER, V10, P639, DOI 10.1038/nrc2917; Schwartz SA, 2003, J MASS SPECTROM, V38, P699, DOI 10.1002/jms.505; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Steurer S, 2013, INT J CANCER, V133, P920, DOI 10.1002/ijc.28080; Terada N, 2010, CANCER RES, V70, P1606, DOI 10.1158/0008-5472.CAN-09-2984; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Xie YH, 2002, J BIOL CHEM, V277, P32516, DOI 10.1074/jbc.M203864200; Yasunaga M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03050; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889; Zhuang LY, 2005, J CLIN INVEST, V115, P959	46	53	56	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90242	10.1371/journal.pone.0090242	http://dx.doi.org/10.1371/journal.pone.0090242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587297	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200151
J	Pin-Barre, C; Laurin, J; Felix, MS; Pertici, V; Kober, F; Marqueste, T; Matarazzo, V; Muscatelli-Bossy, F; Temprado, JJ; Brisswalter, J; Decherchi, P				Pin-Barre, Caroline; Laurin, Jerome; Felix, Marie-Solenne; Pertici, Vincent; Kober, Frank; Marqueste, Tanguy; Matarazzo, Valery; Muscatelli-Bossy, Francoise; Temprado, Jean-Jacques; Brisswalter, Jeanick; Decherchi, Patrick			Acute Neuromuscular Adaptation at the Spinal Level Following Middle Cerebral Artery Occlusion-Reperfusion in the Rat	PLOS ONE			English	Article							SOLEUS H-REFLEX; INFARCT VOLUME; MOTOR FUNCTION; BEHAVIORAL RECOVERY; EARLY EXERCISE; ISCHEMIA; STROKE; IMPAIRMENT; MODEL; QUANTIFICATION	The purpose of the study was to highlight the acute motor reflex adaptation and to deepen functional deficits following a middle cerebral artery occlusion-reperfusion (MCAO-r). Thirty-six Sprague-Dawley rats were included in this study. The middle cerebral artery occlusion (MCAO; 120 min) was performed on 16 rats studied at 1 and 7 days, respectively (MCAO-D1 and MCAO-D7, n = 8 for each group). The other animals were divided into 3 groups: SHAM-D1 (n = 6), SHAM-D7 (n = 6) and Control (n = 8). Rats performed 4 behavioral tests (the elevated body swing test, the beam balance test, the ladder-climbing test and the forelimb grip force) before the surgery and daily after MCAO-r. H-reflex on triceps brachii was measured before and after isometric exercise. Infarction size and cerebral edema were respectively assessed by histological (Cresyl violet) and MRI measurements at the same time points than H-reflex recordings. Animals with cerebral ischemia showed persistent functional deficits during the first week post-MCAO-r. H-reflex was not decreased in response to isometric exercise one day after the cerebral ischemia contrary to the other groups. The motor reflex regulation was recovered 7 days post-MCAO-r. This result reflects an acute sensorimotor adaptation at the spinal level after MCAO-r.	[Pin-Barre, Caroline; Laurin, Jerome; Felix, Marie-Solenne; Pertici, Vincent; Marqueste, Tanguy; Temprado, Jean-Jacques; Decherchi, Patrick] Aix Marseille Univ, Ctr Natl Rech Sci, Inst Sci Mouvement, Fac Sci Sport, Marseille, France; [Pin-Barre, Caroline; Brisswalter, Jeanick] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Pin-Barre, Caroline; Brisswalter, Jeanick] Univ Sud Toulon Var, Nice, France; [Matarazzo, Valery; Muscatelli-Bossy, Francoise] Aix Marseille Univ, Inst Natl Sante & Rech Med, Inst Neurobiol Mediterranee, Marseille, France; [Kober, Frank] Aix Marseille Univ, Ctr Natl Rech Sci, Ctr Resonance Magnet Biol & Med, Fac Med Timone, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Laurin, J (corresponding author), Aix Marseille Univ, Ctr Natl Rech Sci, Inst Sci Mouvement, Fac Sci Sport, Marseille, France.	jerome.laurin@univ-amu.fr	Muscatelli, Françoise/P-4650-2016; Kober, Frank/L-8737-2013; Marqueste, Tanguy/AAM-9751-2021; LAURIN, Jérôme/Q-3503-2018; Matarazzo, Valery/V-2359-2019; DECHERCHI, Patrick/AAE-7756-2019; Matarazzo, Valery/M-9040-2016	Muscatelli, Françoise/0000-0003-4001-6528; Kober, Frank/0000-0002-7869-3615; Marqueste, Tanguy/0000-0002-2620-1551; Matarazzo, Valery/0000-0002-0833-203X; DECHERCHI, Patrick/0000-0001-5639-852X; Matarazzo, Valery/0000-0002-0833-203X; LAURIN, Jerome/0000-0001-9692-0060; FELIX, Marie-Solenne/0000-0003-3271-3964				Adreani CM, 1997, J APPL PHYSIOL, V82, P1811, DOI 10.1152/jappl.1997.82.6.1811; Akhtar M, 2008, HUM EXP TOXICOL, V27, P761, DOI 10.1177/0960327108094608; Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; BORLONGAN CV, 1995, PHYSIOL BEHAV, V58, P909, DOI 10.1016/0031-9384(95)00103-P; Braeuninger Stefan, 2009, Exp Transl Stroke Med, V1, P8, DOI 10.1186/2040-7378-1-8; Broussalis E, 2012, DRUG DISCOV TODAY, V17, P671, DOI 10.1016/j.drudis.2012.02.011; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; Chang HC, 2010, CHINESE J PHYSIOL, V53, P337, DOI 10.4077/CJP.2010.AMK080; Chen JR, 2008, J ANAT, V213, P249, DOI 10.1111/j.1469-7580.2008.00948.x; Cliffer KD, 1998, MUSCLE NERVE, V21, P1405, DOI 10.1002/(SICI)1097-4598(199811)21:11<1405::AID-MUS7>3.3.CO;2-D; CRONE C, 1989, EXP BRAIN RES, V78, P28, DOI 10.1007/bf00230683; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Deshmukh Aaishwarya, 2011, PHYTOPHARMACOLOGY, V1, P138; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Duchateau J, 2002, J PHYSIOL-LONDON, V541, P959, DOI 10.1113/jphysiol.2002.016790; Erdo F, 2006, BRAIN RES BULL, V68, P269, DOI 10.1016/j.brainresbull.2005.08.018; Felix MS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00045; Forrester LW, 2006, ARCH PHYS MED REHAB, V87, P229, DOI 10.1016/j.apmr.2005.10.016; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; GARLAND SJ, 1991, J PHYSIOL-LONDON, V435, P547, DOI 10.1113/jphysiol.1991.sp018524; Gharbawie OA, 2006, BEHAV BRAIN RES, V175, P249, DOI 10.1016/j.bbr.2006.08.039; Gozariu M, 1998, BRAIN RES, V782, P343, DOI 10.1016/S0006-8993(97)01402-9; Gupta Y. K., 2004, Indian Journal of Physiology and Pharmacology, V48, P379; GUTKNECHT J, 1991, ANN GASTROENT HEPATO, V27, P269; Hwang IS, 2004, J ELECTROMYOGR KINES, V14, P653, DOI 10.1016/j.jelekin.2004.01.002; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; Kleim JA, 2007, ILAR J, V48, P374, DOI 10.1093/ilar.48.4.374; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; Kober F, 2008, NMR BIOMED, V21, P781, DOI 10.1002/nbm.1253; Krakauer JW, 2005, SEMIN NEUROL, V25, P384, DOI 10.1055/s-2005-923533; Lee SU, 2009, CAN J NEUROL SCI, V36, P443, DOI 10.1017/S0317167100007769; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Matsuda F, 2011, ACTA PHYSIOL, V201, P275, DOI [10.1111/j.1748-1716.2010.02174.x, 10.1111/j.1748-1708.2010.02174.x]; Metz GA, 2009, J VIS EXP; Misiaszek JE, 1997, J NEUROPHYSIOL, V78, P2975, DOI 10.1152/jn.1997.78.6.2975; Phadke CP, 2012, CLIN NEUROPHYSIOL, V123, P1606, DOI 10.1016/j.clinph.2011.12.012; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Stowe AM, 2013, NEUROSCI LETT, V535, P1, DOI 10.1016/j.neulet.2012.11.063; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Uluc K, 2011, JOVE-J VIS EXP, DOI 10.3791/1978; Virley D, 2000, J CEREBR BLOOD F MET, V20, P563, DOI 10.1097/00004647-200003000-00015; Wang-Fischer Y., 2008, MANUAL STROKE MODELS; Ward NS, 2005, POSTGRAD MED J, V81, P510, DOI 10.1136/pgmj.2004.030809; YAMAGUCHI T, 1995, BRAIN RES, V669, P107, DOI 10.1016/0006-8993(94)01268-M; Yang YR, 2012, J MOTOR BEHAV, V44, P97, DOI 10.1080/00222895.2012.654524; Yang YR, 2003, CAN J NEUROL SCI, V30, P252, DOI 10.1017/S0317167100002687; Yang YR, 2003, NEUROSCI LETT, V339, P91, DOI 10.1016/S0304-3940(03)00010-7; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zehr EP, 2006, J APPL PHYSIOL, V101, P1783, DOI 10.1152/japplphysiol.00540.2006; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	57	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89953	10.1371/journal.pone.0089953	http://dx.doi.org/10.1371/journal.pone.0089953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587147	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200100
J	Bayes, HK; Bicknell, S; MacGregor, G; Evans, TJ				Bayes, Hannah K.; Bicknell, Stephen; MacGregor, Gordon; Evans, Tom J.			T Helper Cell Subsets Specific for Pseudomonas aeruginosa in Healthy Individuals and Patients with Cystic Fibrosis	PLOS ONE			English	Article							INTERLEUKIN 22; HOST-DEFENSE; INFECTION; IL-22; NEUTROPHILS; PROTECTION; PATHWAY; INNATE; IL-17	Background: We set out to determine the magnitude of antigen-specific memory T helper cell responses to Pseudomonas aeruginosa in healthy humans and patients with cystic fibrosis. Methods: Peripheral blood human memory CD4(+) T cells were co-cultured with dendritic cells that had been infected with different strains of Pseudomonas aeruginosa. The T helper response was determined by measuring proliferation, immunoassay of cytokine output, and immunostaining of intracellular cytokines. Results: Healthy individuals and patients with cystic fibrosis had robust antigen-specific memory CD4+ T cell responses to Pseudomonas aeruginosa that not only contained a Th1 and Th17 component but also Th22 cells. In contrast to previous descriptions of human Th22 cells, these Pseudomonal-specific Th22 cells lacked the skin homing markers CCR4 or CCR10, although were CCR6(+). Healthy individuals and patients with cystic fibrosis had similar levels of Th22 cells, but the patient group had significantly fewer Th17 cells in peripheral blood. Conclusions: Th22 cells specific to Pseudomonas aeruginosa are induced in both healthy individuals and patients with cystic fibrosis. Along with Th17 cells, they may play an important role in the pulmonary response to this microbe in patients with cystic fibrosis and other conditions.	[Bayes, Hannah K.; Evans, Tom J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immunol & Inflammat, Glasgow, Lanark, Scotland; [Bicknell, Stephen; MacGregor, Gordon] Gartnavel Royal Hosp, West Scotland Cyst Fibrosis Ctr, Glasgow, Lanark, Scotland	University of Glasgow; Gartnavel Royal Hospital	Evans, TJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immunol & Inflammat, Glasgow, Lanark, Scotland.	tom.evans@glasgow.ac.uk			Wellcome Trust through the award of a Clinical Research Fellowship under the Scottish Translational Medicine and Therapeutics Initiative	Wellcome Trust through the award of a Clinical Research Fellowship under the Scottish Translational Medicine and Therapeutics Initiative	The work was funded by the Wellcome Trust through the award of a Clinical Research Fellowship to HB under the Scottish Translational Medicine and Therapeutics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Brodlie M, 2011, EUR RESPIR J, V37, P1378, DOI 10.1183/09031936.00067110; Brodlie M, 2012, AM J RESP CRIT CARE, V185, P108, DOI 10.1164/ajrccm.185.1.108a; Chan YR, 2012, J ALLERGY CLIN IMMUN; Chen K, 2011, IMMUNITY, V35, P997, DOI 10.1016/j.immuni.2011.10.018; DORING G, 1989, ACTA PAEDIATR SCAND, P37; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Dubin Patricia J, 2007, Expert Rev Respir Med, V1, P121, DOI 10.1586/17476348.1.1.121; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Gaffen SL, 2011, IMMUNOL RES, V50, P181, DOI 10.1007/s12026-011-8226-x; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; MARKHAM RB, 1988, J IMMUNOL, V140, P2039; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Pier GB, 2005, MANDELL DOUGLAS BENN, V6th, P2587; Priebe GP, 2008, J IMMUNOL, V181, P4965, DOI 10.4049/jimmunol.181.7.4965; Ratjen F, 2012, AM J RESP CRIT CARE, V185, P933, DOI 10.1164/rccm.201202-0306UP; Rieber N, 2013, J IMMUNOL, V190, P1276, DOI 10.4049/jimmunol.1202144; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; STOODLEY BJ, 1970, J MED MICROBIOL, V3, P367, DOI 10.1099/00222615-3-3-367; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Vallis AJ, 1999, INFECT IMMUN, V67, P2040; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wuthrich M, 2011, J IMMUNOL, V187, P1421, DOI 10.4049/jimmunol.1100921; Wunderink Richard G, 2005, Proc Am Thorac Soc, V2, P440, DOI 10.1513/pats.2005080-83JS; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	36	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90263	10.1371/journal.pone.0090263	http://dx.doi.org/10.1371/journal.pone.0090263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587305	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000332390800098
J	Ferrari, V; Mastria, S; Bruno, N				Ferrari, Vera; Mastria, Serena; Bruno, Nicola			Crossmodal Interactions during Affective Picture Processing	PLOS ONE			English	Article							SPEEDED CLASSIFICATION; ATTENTIONAL SENSITIZATION; EMOTIONAL PERCEPTION; HUMAN AMYGDALA; MODULATE; FACILITATION; ACTIVATION; SIMILARITY; STIMULI; COLOR	"Natural" crossmodal correspondences, such as the spontaneous tendency to associate high pitches with high spatial locations, are often hypothesized to occur preattentively and independently of task instructions (top-down attention). Here, we investigate bottom-up attentional engagement by using emotional scenes that are known to naturally and reflexively engage attentional resources. We presented emotional (pleasant and unpleasant) or neutral pictures either below or above a fixation cross, while participants were required to discriminate between a high or a low pitch tone (experiment 1). Results showed that despite a robust crossmodal attentional capture of task-irrelevant emotional pictures, the general advantage in classifying the tones for congruent over incongruent visual-auditory stimuli was similar for emotional and neutral pictures. On the other hand, when picture position was task-relevant (experiment 2), task-irrelevant tones did not interact with pictures with regard to their combination of pitch and visual vertical spatial position, but instead they were effective in minimizing the interference effect of emotional picture processing on the ongoing task. These results provide constraints on our current understanding of natural crossmodal correspondences.	[Ferrari, Vera; Bruno, Nicola] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Mastria, Serena] Univ Bologna, Dept Psychol, Bologna, Italy	University of Parma; University of Bologna	Ferrari, V (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	vera.ferrari@unipr.it	Ferrari, Vera/K-8976-2019; Mastria, Serena/ABW-2289-2022	Mastria, Serena/0000-0003-4987-8255	Progetti di Ricerca di Interesse Nazionale (PRIN) [2008RBFNLH]	Progetti di Ricerca di Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The study was supported by Progetti di Ricerca di Interesse Nazionale (PRIN) 2008RBFNLH (N.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; BENARTZI E, 1995, PERCEPT PSYCHOPHYS, V57, P1151, DOI 10.3758/BF03208371; BERNSTEIN IH, 1969, J EXP PSYCHOL, V80, P567, DOI 10.1037/h0027444; BERNSTEIN IH, 1971, J EXP PSYCHOL, V87, P241, DOI 10.1037/h0030524; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Bradley MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00493; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; Chiou R, 2012, PERCEPTION, V41, P339, DOI 10.1068/p7161; Codispoti M, 2006, PROG BRAIN RES, V156, P53, DOI 10.1016/S0079-6123(06)56003-0; Codispoti M, 2012, PSYCHOPHYSIOLOGY, V49, P11, DOI 10.1111/j.1469-8986.2011.01284.x; De Cesarei A, 2008, EMOTION, V8, P352, DOI 10.1037/1528-3542.8.3.352; Donohue SE, 2011, J NEUROSCI, V31, P7982, DOI 10.1523/JNEUROSCI.5298-10.2011; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Ferrari V, 2008, J COGNITIVE NEUROSCI, V20, P1753, DOI 10.1162/jocn.2008.20121; Ferrari V, 2013, SOC COGN AFFECT NEUR, V8, P847, DOI 10.1093/scan/nss081; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; Gallace A, 2006, PERCEPT PSYCHOPHYS, V68, P1191, DOI 10.3758/BF03193720; Hackley SA, 1999, J COGNITIVE NEUROSCI, V11, P321, DOI 10.1162/089892999563427; Jepma M, 2009, J COGNITIVE NEUROSCI, V21, P847, DOI 10.1162/jocn.2009.21063; Keetels M, 2011, J EXP PSYCHOL HUMAN, V37, P699, DOI 10.1037/a0020564; Keil A, 2004, EMOTION, V4, P23, DOI 10.1037/1528-3542.4.1.23; Keil A, 2007, COGN AFFECT BEHAV NE, V7, P18, DOI 10.3758/CABN.7.1.18; Kiefer M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00061; Kiefer M, 2010, J EXP PSYCHOL GEN, V139, P464, DOI 10.1037/a0019561; Klapetek A, 2012, ATTEN PERCEPT PSYCHO, V74, P1154, DOI 10.3758/s13414-012-0317-9; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Lang PJ, 2008, A6 U FLOR; Marks L. E., 2004, HDB MULTISENSORY PRO, P85; MARKS LE, 1987, J EXP PSYCHOL HUMAN, V13, P384, DOI 10.1037/0096-1523.13.3.384; MARKS LE, 1987, MONOGR SOC RES CHILD, V52, P1; Martino G, 1999, PERCEPTION, V28, P903, DOI 10.1068/p2866; MELARA RD, 1987, J EXP PSYCHOL GEN, V116, P323; MELARA RD, 1989, J EXP PSYCHOL HUMAN, V15, P69, DOI 10.1037/0096-1523.15.1.69; Okon-Singer H, 2013, BIOL PSYCHOL, V92, P480, DOI 10.1016/j.biopsycho.2012.05.010; Parise CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005664; Patching GR, 2002, J EXP PSYCHOL HUMAN, V28, P755, DOI 10.1037//0096-1523.28.4.755; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Posner M., 1975, INFORM PROCESSING CO; Sabatinelli D, 2009, J NEUROSCI, V29, P14864, DOI 10.1523/JNEUROSCI.3278-09.2009; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Schneider W., 2002, E PRIME USERS GUIDE; Schwabe L, 2010, EMOTION, V10, P283, DOI 10.1037/a0017751; Spence C., 2004, CROSSMODAL SPACE CRO; Spence C, 2013, CONSCIOUS COGN, V22, P245, DOI 10.1016/j.concog.2012.12.006; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Spruyt A, 2012, COGNITION, V122, P91, DOI 10.1016/j.cognition.2011.08.017; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; von Hornbostel E. M., 1927, MELOS Z MUSIK, Viv, P290; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wangelin BC, 2012, BIOL PSYCHOL, V91, P103, DOI 10.1016/j.biopsycho.2012.05.002	53	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89858	10.1371/journal.pone.0089858	http://dx.doi.org/10.1371/journal.pone.0089858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24587078	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800048
J	Scribano, D; Petrucca, A; Pompili, M; Ambrosi, C; Bruni, E; Zagaglia, C; Prosseda, G; Nencioni, L; Casalino, M; Polticelli, F; Nicoletti, M				Scribano, Daniela; Petrucca, Andrea; Pompili, Monica; Ambrosi, Cecilia; Bruni, Elena; Zagaglia, Carlo; Prosseda, Gianni; Nencioni, Lucia; Casalino, Mariassunta; Polticelli, Fabio; Nicoletti, Mauro			Polar Localization of PhoN2, a Periplasmic Virulence-Associated Factor of Shigella flexneri, Is Required for Proper IcsA Exposition at the Old Bacterial Pole	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; ENTEROINVASIVE ESCHERICHIA-COLI; AUTOTRANSPORTER ICSA; SURFACE PRESENTATION; ACID-PHOSPHATASE; H-NS; PROTEIN; SECRETION; MEMBRANE; APYRASE	Proper protein localization is critical for bacterial virulence. PhoN2 is a virulence-associated ATP-diphosphohydrolase (apyrase) involved in IcsA-mediated actin-based motility of S. flexneri. Herein, by analyzing a DphoN2 mutant of the S. flexneri strain M90T and by generating phoN2::HA fusions, we show that PhoN2, is a periplasmic protein that strictly localizes at the bacterial poles, with a strong preference for the old pole, the pole where IcsA is exposed, and that it is required for proper IcsA exposition. PhoN2-HA was found to be polarly localized both when phoN2:: HA was ectopically expressed in a Escherichia coli K-12 strain and in a S. flexneri virulence plasmid-cured mutant, indicating a conserved mechanism of PhoN2 polar delivery across species and that neither IcsA nor the expression of other virulence-plasmid encoded genes are involved in this process. To assess whether PhoN2 and IcsA may interact, two-hybrid and cross-linking experiments were performed. While no evidence was found of a PhoN2-IcsA interaction, unexpectedly the outer membrane protein A (OmpA) was shown to bind PhoN2-HA through its periplasmic-exposed C-terminal domain. Therefore, to identify PhoN2 domains involved in its periplasmic polar delivery as well as in the interaction with OmpA, a deletion and a set of specific amino acid substitutions were generated. Analysis of these mutants indicated that neither the (183)PAPAP(187) motif of OmpA, nor the N-terminal polyproline (PPPP46)-P-43 motif and the Y155 residue of PhoN2 are involved in this interaction while P45, P46 and Y155 residues were found to be critical for the correct folding and stability of the protein. The relative rapid degradation of these amino acid-substituted recombinant proteins was found to be due to unknown S. flexneri-specific protease(s). A model depicting how the PhoN2-OmpA interaction may contribute to proper polar IcsA exposition in S. flexneri is presented.	[Scribano, Daniela; Petrucca, Andrea] Univ G DAnnunzio, Dipartimento Sci Sperimentali & Clin, Chieti, Italy; [Pompili, Monica; Ambrosi, Cecilia; Bruni, Elena; Zagaglia, Carlo; Casalino, Mariassunta] Univ Roma La Sapienza, Dipartimento Sanita Pubbl & Malattie Infect, Rome, Italy; [Prosseda, Gianni] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, Rome, Italy; [Casalino, Mariassunta; Polticelli, Fabio] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Polticelli, Fabio] Ist Nazl Fis Nucl, Sez Roma Tre, Rome, Italy	G d'Annunzio University of Chieti-Pescara; Sapienza University Rome; Sapienza University Rome; Roma Tre University; Istituto Nazionale di Fisica Nucleare (INFN)	Nicoletti, M (corresponding author), Univ G DAnnunzio, Dipartimento Sci Sperimentali & Clin, Chieti, Italy.	mauro.nicoletti@uniroma1.it	Polticelli, Fabio/A-4573-2009; ambrosi, cecilia/AAM-3939-2020; Scribano, Daniela/AAY-1714-2021; Nencioni, Lucia/K-5988-2016; Nicoletti, Mauro/AAI-7702-2020	Polticelli, Fabio/0000-0002-7657-2019; ambrosi, cecilia/0000-0003-2163-1613; Nencioni, Lucia/0000-0003-4427-4823; SCRIBANO, Daniela/0000-0002-2901-265X; PROSSEDA, Gianni/0000-0001-5235-0086	Ministero della Ricerca e dell'Istruzione (PRIN) [2009/KJ9SRT_002, 2007/W52X9M_003]; University "G. D'Annunzio'' of Chieti	Ministero della Ricerca e dell'Istruzione (PRIN); University "G. D'Annunzio'' of Chieti	This work was supported by Ministero della Ricerca e dell'Istruzione (PRIN projects 2009/KJ9SRT_002 and 2007/W52X9M_003) and by Faculty 60% funds of the University "G. D'Annunzio'' of Chieti granted to M.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049625; Ansai T, 2002, ARCH BIOCHEM BIOPHYS, V408, P144, DOI 10.1016/S0003-9861(02)00524-6; Babu MM, 2002, FEBS LETT, V512, P8, DOI 10.1016/S0014-5793(02)02287-1; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Berlutti F, 1998, INFECT IMMUN, V66, P4957, DOI 10.1128/IAI.66.10.4957-4964.1998; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; BHARGAVA T, 1995, CURR SCI INDIA, V68, P293; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Charles M, 2001, P NATL ACAD SCI USA, V98, P9871, DOI 10.1073/pnas.171310498; Chen XC, 1999, J BACTERIOL, V181, P7107, DOI 10.1128/JB.181.22.7107-7114.1999; Tran CN, 2011, NUCLEIC ACIDS RES, V39, P8122, DOI 10.1093/nar/gkr521; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x; deCock H, 1996, J BIOL CHEM, V271, P12885, DOI 10.1074/jbc.271.22.12885; dHauteville H, 1996, INFECT IMMUN, V64, P511, DOI 10.1128/IAI.64.2.511-517.1996; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P651, DOI 10.1016/j.ijmm.2013.09.007; Egile C, 1997, MOL MICROBIOL, V23, P1063, DOI 10.1046/j.1365-2958.1997.2871652.x; GOLDBERG MB, 1994, INFECT IMMUN, V62, P5664, DOI 10.1128/IAI.62.12.5664-5668.1994; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Ishikawa K, 2000, EMBO J, V19, P2412, DOI 10.1093/emboj/19.11.2412; Jain S, 2006, J BACTERIOL, V188, P4841, DOI 10.1128/JB.00326-06; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Khalid S, 2008, BBA-BIOMEMBRANES, V1778, P1871, DOI 10.1016/j.bbamem.2007.05.024; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; KOEBNIK R, 1995, J MOL BIOL, V250, P617, DOI 10.1006/jmbi.1995.0403; Komoszynski M, 1996, BBA-MOL CELL RES, V1310, P233, DOI 10.1016/0167-4889(95)00135-2; Krishnan S, 2012, FEBS J, V279, P919, DOI 10.1111/j.1742-4658.2012.08482.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Makde RD, 2007, BIOCHEMISTRY-US, V46, P2079, DOI 10.1021/bi062180g; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Miller J.H, 1972, EXPT MOL GENETICS, P252; Morona R, 2003, FEMS MICROBIOL LETT, V221, P173, DOI 10.1016/S0378-1097(03)00210-6; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Onodera NT, 2012, J BACTERIOL, V194, P3022, DOI 10.1128/JB.00393-12; Purdy GE, 2007, J BACTERIOL, V189, P5566, DOI 10.1128/JB.00483-07; Robbins JR, 2001, MOL MICROBIOL, V41, P861, DOI 10.1046/j.1365-2958.2001.02552.x; Rokney A, 2009, J MOL BIOL, V392, P589, DOI 10.1016/j.jmb.2009.07.009; Rossolini GM, 1998, CELL MOL LIFE SCI, V54, P833, DOI 10.1007/s000180050212; Sambrook J., 2001, MOL CLONING LAB MANU; Santapaola D, 2006, J BACTERIOL, V188, P1620, DOI 10.1128/JB.188.4.1620-1627.2006; Santapaola D, 2002, MICROBIOL-SGM, V148, P2519, DOI 10.1099/00221287-148-8-2519; Sarli S, 2005, MICROBIOL-SGM, V151, P2853, DOI 10.1099/mic.0.28142-0; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; Shere KD, 1997, MOL MICROBIOL, V25, P451, DOI 10.1046/j.1365-2958.1997.4681827.x; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Steinhauer J, 1999, MOL MICROBIOL, V32, P367, DOI 10.1046/j.1365-2958.1999.01356.x; Sugawara E, 1996, J BACTERIOL, V178, P6067, DOI 10.1128/jb.178.20.6067-6069.1996; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Suzuki T, 2001, INFECT IMMUN, V69, P5959, DOI 10.1128/IAI.69.10.5959-5966.2001; TANJI K, 1992, J PHARM PHARMACOL, V44, P1036; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; VONGABAIN A, 1983, P NATL ACAD SCI-BIOL, V80, P653; Wagner JK, 2009, J BACTERIOL, V191, P815, DOI 10.1128/JB.00989-08; Zakharian E, 2005, BIOCHEMISTRY-US, V44, P6701, DOI 10.1021/bi047278e; Zakharian E, 2003, FEBS LETT, V555, P229, DOI 10.1016/S0014-5793(03)01236-5	67	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90230	10.1371/journal.pone.0090230	http://dx.doi.org/10.1371/journal.pone.0090230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587292	gold, Green Submitted, Green Published			2022-12-27	WOS:000332390800093
J	Blanchard, OL; Friesenhahn, G; Javors, MA; Smoliga, JM				Blanchard, Otis L.; Friesenhahn, Gregory; Javors, Martin A.; Smoliga, James M.			Development of a Lozenge for Oral Transmucosal Delivery of Trans-Resveratrol in Humans: Proof of Concept	PLOS ONE			English	Article							HEALTHY-VOLUNTEERS; IN-VIVO; BIOAVAILABILITY; WINE; INHIBITION; GROWTH; MODEL; DRUG; PHARMACOKINETICS; GLUCURONIDATION	Resveratrol provides multiple physiologic benefits which promote healthspan in various model species and clinical trials support continued exploration of resveratrol treatment in humans. However, there remains concern regarding low bioavailability and wide inter-individual differences in absorption and metabolism in humans, which suggests a great need to develop novel methods for resveratrol delivery. We hypothesized that oral transmucosal delivery, using a lozenge composed of a resveratrol-excipient matrix, would allow resveratrol to be absorbed rapidly into the bloodstream. We pursued proof of concept through two experiments. In the first experiment, the solubility of trans-resveratrol (tRES) in water and 2.0 M solutions of dextrose, fructose, ribose, sucrose, and xylitol was determined using HPLC. Independent t-tests with a Bonferroni correction were used to compare the solubility of tRES in each of the solutions to that in water. tRES was significantly more soluble in the ribose solution (p = 0.0013) than in the other four solutions. Given the enhanced solubility of tRES in a ribose solution, a resveratrol-ribose matrix was developed into a lozenge suitable for human consumption. Lozenges were prepared, each containing 146+/-5.5 mg tRES per 2000 mg of lozenge mass. Two healthy human participants consumed one of the prepared lozenges following an overnight fast. Venipuncture was performed immediately before and 15, 30, 45, and 60 minutes following lozenge administration. Maximal plasma concentrations (C-max) for tRES alone (i.e., resveratrol metabolites not included) were 325 and 332 ng.mL(-1) for the two participants at 15 minute post-administration for both individuals. These results suggest a resveratrol-ribose matrix lozenge can achieve greater C-max and enter the bloodstream faster than previously reported dosage forms for gastrointestinal absorption. While this study is limited by small sample size and only one method of resveratrol delivery, it does provide proof of concept to support further exploration of novel delivery methods for resveratrol administration.	[Blanchard, Otis L.] Wilmore Labs LLC, San Antonio, TX USA; [Friesenhahn, Gregory; Javors, Martin A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Smoliga, James M.] High Point Univ, Dept Phys Therapy, High Point, NC 27262 USA	University of Texas System; University of Texas Health San Antonio	Smoliga, JM (corresponding author), High Point Univ, Dept Phys Therapy, High Point, NC 27262 USA.	jsmoliga@highpoint.edu		Smoliga, James/0000-0002-1895-5687	Wilmore Laboratories	Wilmore Laboratories	Wilmore Laboratories has funded this work. OLB contributed to the study design, however, JMS was primarily in charge of the study design and had the final say in all decisions. OLB did not influence the decision to publish this data. JMS made the executive decision to publish this data. OLB did review the contents of this manuscript. However, JMS made all final decisions regarding every aspect of this manuscript.	Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Amiot MJ, 2013, BIOCHIMIE, V95, P1233, DOI 10.1016/j.biochi.2013.01.008; Ansari KA, 2011, AAPS PHARMSCITECH, V12, P279, DOI 10.1208/s12249-011-9584-3; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Better Homes and Gardens, 1978, BETT HOM GARD COMPL; Bode LM, 2013, AM J CLIN NUTR, V97, P295, DOI 10.3945/ajcn.112.049379; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Chow HHS, 2010, CANCER PREV RES, V3, P1168, DOI 10.1158/1940-6207.CAPR-09-0155; Clark D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047792; De Santi C, 2000, XENOBIOTICA, V30, P857, DOI 10.1080/004982500433282; De Santi C, 2000, XENOBIOTICA, V30, P1047, DOI 10.1080/00498250010002487; Elsner F, 2011, CLIN DRUG INVEST, V31, P605, DOI 10.2165/11592910-000000000-00000; Eseberri I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063918; ETMAN MA, 1990, INT J PHARM, V58, P177, DOI 10.1016/0378-5173(90)90193-8; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; Guha P, 2010, BRIT J PHARMACOL, V159, P726, DOI 10.1111/j.1476-5381.2009.00572.x; JANADO M, 1985, B CHEM SOC JPN, V58, P1913, DOI 10.1246/bcsj.58.1913; Johnson JJ, 2011, MOL NUTR FOOD RES, V55, P1169, DOI 10.1002/mnfr.201100117; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Kesherwani V, 2013, NEUROSCIENCE, V241, P80, DOI 10.1016/j.neuroscience.2013.03.015; Kuhnle G, 2000, BIOCHEM BIOPH RES CO, V272, P212, DOI 10.1006/bbrc.2000.2750; Lakshmi T.S., 1976, J PHYS CHEM-US, V80, P249, DOI DOI 10.1021/J100544A008; LAKSHMI TS, 1978, J SOLUTION CHEM, V7, P283; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Lu DL, 2013, CHEMBIOCHEM, V14, P1094, DOI 10.1002/cbic.201300080; Madhav NVS, 2009, J CONTROL RELEASE, V140, P2, DOI 10.1016/j.jconrel.2009.07.016; Maier-Salamon A, 2006, PHARM RES-DORDR, V23, P2107, DOI 10.1007/s11095-006-9060-z; Lopez-Nicolas JM, 2008, J AGR FOOD CHEM, V56, P7600, DOI 10.1021/jf800843e; Miksits M, 2005, XENOBIOTICA, V35, P1101, DOI 10.1080/00498250500354253; Miksits M, 2010, CANCER LETT, V289, P237, DOI 10.1016/j.canlet.2009.08.020; Nunes T, 2009, J CLIN PHARMACOL, V49, P1477, DOI 10.1177/0091270009339191; Patel KR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005870; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Peltz L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037162; Petyaev IM, 2012, MED HYPOTHESES, V79, P746, DOI 10.1016/j.mehy.2012.08.018; Polycarpou E, 2013, MOL NUTR FOOD RES, V57, P1708, DOI 10.1002/mnfr.201200742; Popat R, 2013, BRIT J HAEMATOL, V160, P714, DOI 10.1111/bjh.12154; Robich MP, 2012, J AM COLL SURGEONS, V215, P681, DOI 10.1016/j.jamcollsurg.2012.06.417; Rossi D, 2012, MOLECULES, V17, P12393, DOI 10.3390/molecules171012393; Rub MA, 2012, J SURFACTANTS DETERG, V15, P765, DOI 10.1007/s11743-012-1354-z; Sacerdote MG, 2005, P NATL ACAD SCI USA, V102, P6004, DOI 10.1073/pnas.0408440102; Shen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051223; Shojaei A H, 1998, J Pharm Pharm Sci, V1, P15; Singh G, 2012, J ADV PHARM TECHNOL, V3, P130, DOI 10.4103/2231-4040.97296; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; Vaz-Da-Silva M, 2008, INT J CLIN PHARM TH, V46, P564; Vitaglione P, 2005, MOL NUTR FOOD RES, V49, P495, DOI 10.1002/mnfr.200500002; Walle T, 2006, DRUG METAB DISPOS, V34, P346, DOI 10.1124/dmd.105.007948; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P472, DOI 10.1002/mnfr.200500010; Wong RHX, 2011, NUTR METAB CARDIOVAS, V21, P851, DOI 10.1016/j.numecd.2010.03.003; YANO Y, 1988, B CHEM SOC JPN, V61, P2963, DOI 10.1246/bcsj.61.2963; Zhang H, 2002, CLIN PHARMACOKINET, V41, P661, DOI 10.2165/00003088-200241090-00003	59	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90131	10.1371/journal.pone.0090131	http://dx.doi.org/10.1371/journal.pone.0090131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587240	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000134
J	Foix-L'Helias, L; Grynberg, M; Ducot, B; Frydman, N; Kerbrat, V; Bouyer, J; Labrune, P				Foix-L'Helias, Laurence; Grynberg, Michael; Ducot, Beatrice; Frydman, Nelly; Kerbrat, Violaine; Bouyer, Jean; Labrune, Philippe			Growth Development of French Children Born after In Vitro Maturation	PLOS ONE			English	Article							POLYCYSTIC OVARIAN SYNDROME; FERTILIZATION; OUTCOMES; MOTHERS; WOMEN; PCOS	Background: Several lines of evidence indicate that immature oocyte retrieval and subsequent in vitro maturation (IVM) without ovarian stimulation may be a reliable option in assisted reproductive technologies (ART). However, few outcome data are available for children born following this technique. Objective: We assessed height and weight development of French children conceived after IVM. Methods: All children conceived after IVM at Antoine Beclere Hospital (Clamart, France) and born between June 2003 and October 2008 (n = 38) were included in a prospective cohort study and compared with a control group of children conceived by ICSI without IVM, matched for maternal age, gestational age and singleton/twin pregnancies. Follow-up included clinical examination at one year and a questionnaire completed by parents when the children were two years old (97% follow-up rate). Results: No statistical differences between IVM and control groups were found for boys. Mean weight, height and head circumference at birth were significantly greater for IVM than for ICSI girls (3.236 kg vs 2.701 kg (p = 0.03); 49 cm vs 47 cm (p = 0.01) and 34 cm vs 33 cm (p = 0.04), respectively). At one year, IVM girls remained heavier (mean weight 10.2 kg vs 8.6 kg (p = 0.001)) and taller (76 cm vs 73 cm (p = 0.03)), and there was a two-point difference in BMI between the two groups of girls (18 vs 16 (p = 0.01)). Conclusion: Our results in girls born after IVM should be interpreted with caution. It remains unclear whether the observed sexual dimorphism is due to IVM technology or to maternal characteristics such as underlying infertility in patients with polycystic ovary syndrome (PCOS). Further monitoring of the outcomes of these infants is required.	[Foix-L'Helias, Laurence] INSERM, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Unite Mixte Rech S953, Paris, France; [Foix-L'Helias, Laurence] Hop Trousseau, AP HP, Serv Neonatol, F-75571 Paris, France; [Foix-L'Helias, Laurence] Univ Paris 06, Paris, France; [Grynberg, Michael; Kerbrat, Violaine] Hop Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Gynecol Obstetr & Med Reprod, Clamart, France; [Grynberg, Michael] INSERM, U782, Clamart, France; [Ducot, Beatrice; Bouyer, Jean] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Ducot, Beatrice; Bouyer, Jean] Univ Paris Sud, UMRS 1018, Villejuif, France; [Frydman, Nelly; Labrune, Philippe] Univ Paris Sud, Unite Format & Rech Kremlin Bicetre, F-94275 Le Kremlin Bicetre, France; [Frydman, Nelly] Hop Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Biol Reprod, Clamart, France; [Labrune, Philippe] Hop Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Pediat, Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay	Foix-L'Helias, L (corresponding author), INSERM, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Unite Mixte Rech S953, Paris, France.	laurencefoix@gmail.com	Foix-L'Hélias, Laurence/AAH-4933-2019; Foix-L'Helias, Laurence/AAB-4375-2020; bouyer, jean/G-2717-2013	Foix-L'Hélias, Laurence/0000-0002-5699-4839; bouyer, jean/0000-0003-4861-0783; Achour Frydman, Nelly/0000-0002-9027-0586	grant (PHRC) from the Assistance Publique - Hopitaux de Paris (APHP); l'Agence de Biomedecine (ABM)	grant (PHRC) from the Assistance Publique - Hopitaux de Paris (APHP); l'Agence de Biomedecine (ABM)(French National Research Agency (ANR))	This work was supported by a grant (PHRC) from the Assistance Publique - Hopitaux de Paris (APHP) and a grant from l'Agence de Biomedecine (ABM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Barry JA, 2010, J OBSTET GYNAECOL, V30, P444, DOI 10.3109/01443615.2010.485254; Basatemur E, 2008, PLACENTA, V29, pS135, DOI 10.1016/j.placenta.2008.08.013; Basatemur E, 2011, J ASSIST REPROD GEN, V28, P489, DOI 10.1007/s10815-011-9561-5; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Buckett WM, 2007, OBSTET GYNECOL, V110, P885, DOI 10.1097/01.AOG.0000284627.38540.80; Carlsen SM, 2012, PEDIATRICS, V130, pE1222, DOI 10.1542/peds.2012-0346; Cha KY, 2005, FERTIL STERIL, V83, P1461, DOI 10.1016/j.fertnstert.2004.11.044; Fadini R, 2013, HUM REPROD, V27, P3601; Haakova L, 2003, HUM REPROD, V18, P1438, DOI 10.1093/humrep/deg289; Kerjean A, 2003, EUR J HUM GENET, V11, P493, DOI 10.1038/sj.ejhg.5200990; Le Du A, 2005, HUM REPROD, V20, P420, DOI 10.1093/humrep/deh603; Mikkelsen AL, 2005, REPROD BIOMED ONLINE, V10, P593, DOI 10.1016/S1472-6483(10)61666-5; Mikola M, 2001, HUM REPROD, V16, P226, DOI 10.1093/humrep/16.2.226; Miles HL, 2010, ARCH DIS CHILD-FETAL, V95, pF435, DOI 10.1136/adc.2009.173575; Nogueira D, 2000, FERTIL STERIL, V74, P295, DOI 10.1016/S0015-0282(00)00642-7; Roos N, 2011, BMJ-BRIT MED J, V117, P233; Shu-Chi M, 2006, EARLY HUM DEV, V82, P677, DOI 10.1016/j.earlhumdev.2006.01.012; Sir-Petermann T, 2005, HUM REPROD, V20, P2122, DOI 10.1093/humrep/dei009; Siristatidis CS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006606.pub3; Soderstrom-Anttila V, 2006, HUM REPROD, V21, P1508, DOI 10.1093/humrep/dei503; Sutcliffe AG, 2007, LANCET, V370, P351, DOI 10.1016/S0140-6736(07)60456-5; Veiga-Lopez A, 2011, BIOL REPROD, V84, P87, DOI 10.1095/biolreprod.110.086686; Vollenhoven B, 2000, AUST NZ J OBSTET GYN, V40, P54, DOI 10.1111/j.1479-828X.2000.tb03167.x; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	25	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89713	10.1371/journal.pone.0089713	http://dx.doi.org/10.1371/journal.pone.0089713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586979	Green Published, gold			2022-12-27	WOS:000332389000086
J	Garcia, P; Hopkins, KL; Garcia, V; Beutlich, J; Mendoza, MC; Threlfall, J; Mevius, D; Helmuth, R; Rodicio, MR; Guerra, B				Garcia, Patricia; Hopkins, Katie L.; Garcia, Vanesa; Beutlich, Janine; Mendoza, M. Carmen; Threlfall, John; Mevius, Dik; Helmuth, Reiner; Rodicio, M. Rosario; Guerra, Beatriz		Med-Vet-Net WP21 Project Grp	Diversity of Plasmids Encoding Virulence and Resistance Functions in Salmonella enterica subsp enterica Serovar Typhimurium Monophasic Variant 4,[5],12:i:- Strains Circulating in Europe	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANCE; SPANISH CLONE; DETERMINANTS; REGION; GENES	Plasmids encoding resistance and virulence properties in multidrug resistant (MDR) Salmonella enterica (S.) serovar Typhimurium monophasic variant 4,[5],12:i:- isolates recovered from pigs and humans (2006-2008) in Europe were characterised. The isolates were selected based on the detection by PCR-amplification of S. Typhimurium virulence plasmid pSLT genes and were analysed by multi-locus sequence typing (MLST). The resistance genes present in the isolates and the association of these genes with integrons, transposons and insertion sequences were characterised by PCR-sequencing, and their plasmid location was determined by alkaline lysis and by S1-nuclease pulsed-field gel electrophoresis (PFGE) Southern-blot hybridisation. Plasmids were further analysed by replicon typing, plasmid MLST and conjugation experiments. The 10 S. 4,[5],12,i:- selected isolates belonged to ST19. Each isolate carried a large plasmid in which MDR with pSLT-associated virulence genes were located. After analysis, eight different plasmids of three incompatibility groups (IncA/C, IncR and IncF) were detected. Two IncA/C plasmids represented novel variants within the plasmid family of the S. 4,[5],12:i:- Spanish clone, and carried an empty class 1 integron with a conventional qacED1-sul1 3' conserved segment or an In-sul3 type III with estX-psp-aadA2-cmlA1-aadA1-qacH variable region linked to tnpA440-sul3, part of Tn2, Tn21 and Tn1721 transposons, and ISCR2. Four newly described IncR plasmids contained the resistance genes within In-sul3 type I (dfrA12-orfF-aadA2-cmlA1-aadA1-qacH/tnpA440-sul3) and part of Tn10 [tet(B)]. Two pSLT-derivatives with FIIs-ST1+FIB-ST17 replicons carried cmlA1-[aadA1-aadA2]-sul3-dfrA12 and bla(TEM-1) genes linked to an In-sul3 type I integron and to Tn2, respectively. In conclusion, three emerging European clones of S. 4,[5],12:i:- harboured MDR plasmids encoding additional virulence functions that could contribute significantly to their evolutionary success.	[Garcia, Patricia; Garcia, Vanesa; Mendoza, M. Carmen; Rodicio, M. Rosario] Univ Oviedo, Dept Funct Biol, Area Microbiol, Oviedo, Asturias, Spain; [Hopkins, Katie L.; Threlfall, John] Publ Hlth England, Antimicrobial Resistance & Healthcare Associated, London, England; [Beutlich, Janine; Helmuth, Reiner; Guerra, Beatriz] BfR Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Mevius, Dik] Cent Vet Inst, Dept Bacteriol, Lelystad, Netherlands; [Mevius, Dik] Cent Vet Inst, TSEs, Lelystad, Netherlands	University of Oviedo; Public Health England; Federal Institute for Risk Assessment; Wageningen University & Research; Wageningen University & Research	Guerra, B (corresponding author), BfR Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany.	beatriz.guerra@bfr.bund.de	Rodicio, M. Rosario/H-2159-2015; García, Vanesa/Y-5086-2019	Rodicio, M. Rosario/0000-0002-3402-2908; García, Vanesa/0000-0001-5459-8325; Garcia, Patricia/0000-0002-0418-296X	EU Network of Excellence Med-Vet-Net [WP 21]; "Fondo de Investigacion Sanitaria" of the "Instituto de Salud Carlos III" (Spain) [FIS PI11-00808]; European Regional Development Fund of the European Union; Federal Institute for Risk Assessment (Germany) [BfR: 46-001, 45-004]; "Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia" (FICYT) [BP08-031]	EU Network of Excellence Med-Vet-Net; "Fondo de Investigacion Sanitaria" of the "Instituto de Salud Carlos III" (Spain); European Regional Development Fund of the European Union; Federal Institute for Risk Assessment (Germany); "Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia" (FICYT)	This work was supported by the EU Network of Excellence Med-Vet-Net (WP 21), the "Fondo de Investigacion Sanitaria" of the "Instituto de Salud Carlos III" (FIS PI11-00808, Spain), co-funded by European Regional Development Fund of the European Union: a way to making Europe, and the Federal Institute for Risk Assessment (BfR: 46-001, 45-004, Germany). PG was the recipient of a grant from the "Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia" (FICYT, Ref. BP08-031). She performed a short stay at the Department of Biological Safety of the Federal Institute for Risk Assessment (BfR), Berlin, Germany, supported by the same grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1826; Antunes P, 2011, J ANTIMICROB CHEMOTH, V66, P2028, DOI 10.1093/jac/dkr228; Beutlich J, 2013, MICROB DRUG RESIST, V19, P437, DOI 10.1089/mdr.2012.0226; Beutlich J, 2011, APPL ENVIRON MICROB, V77, P5655, DOI 10.1128/AEM.00425-11; Bugarel M, 2012, FOOD RES INT, V45, P1016, DOI 10.1016/j.foodres.2011.06.057; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2006, EMERG INFECT DIS, V12, P1145, DOI 10.3201/eid1207.051555; Garcia P, 2013, J CLIN MICROBIOL, V51, P973, DOI 10.1128/JCM.02777-12; Garcia P, 2011, J ANTIMICROB CHEMOTH, V66, P543, DOI 10.1093/jac/dkq481; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Guerra B, 2001, ANTIMICROB AGENTS CH, V45, P1305, DOI 10.1128/AAC.45.4.1305-1308.2001; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Herrero A, 2009, EUR J CLIN MICROBIOL, V28, P1087, DOI 10.1007/s10096-009-0753-1; Hopkins KL, 2010, EUROSURVEILLANCE, V15, P2; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lucarelli C, 2012, J ANTIMICROB CHEMOTH, V67, P111, DOI 10.1093/jac/dkr391; Rodicio MR, 2011, REV MED MICROBIOL, V22, P55, DOI 10.1097/MRM.0b013e328346d87d; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309	18	23	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89635	10.1371/journal.pone.0089635	http://dx.doi.org/10.1371/journal.pone.0089635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586926	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000069
J	Dinh, H; Nguyen, NH				Hung Dinh; Nguyen Hong Nguyen			Genetic Inheritance of Female and Male Morphotypes in Giant Freshwater Prawn Macrobrachium rosenbergii	PLOS ONE			English	Article							HARVEST WEIGHT; VIETNAM; SELECTION; BODY; DIFFERENTIATION; POLYCULTURE; POPULATION; CULTURE; TRAITS; GROWTH	Giant freshwater prawn (GFP) Macrobrachium rosenbergii is unique with males categorized in five different morphotypes (small claw, orange claw, blue claw, old blue claw and no claw males) and females in three reproductive statuses (mature ovary, berried and spawned females). In the present study we examined genetic inheritance of female and male morphotypes, their body weights and genetic associations between morphotypes and body traits. Restricted maximum likelihood fitting a multi-trait animal model was performed on a total of 21,459 body records collected over five generations in a GFP population selected for high growth rate. The estimates of variance components showed that there were substantial differences in additive genetic variance in body weight between male morphotypes. The low and significantly different from one genetic correlations between the expressions of body weight in male morphotypes also suggest that these traits should be treated as genetically different traits in selective breeding programs. By contrast, body weights of female types are essentially the same characters as indicated by the high genetic correlations between homologous trait expressions. In addition to body weight, male morphotypes and female reproductive statuses were treated as traits in themselves and were analysed as binary observations using animal and sire linear mixed models, and logit and probit threshold models. The estimates of heritability back-transformed from the liability scale were in good agreement with those obtained from linear mixed models, ranging from 0.02 to 0.43 for male morphotypes and 0.06 to 0.10 for female types. The genetic correlations among male morphoptypes were generally favourable. Body weight showed negative genetic associations with SM (-0.96), whereas those of body weight with other male morphotypes were positive (0.25 to 0.76). Our results showed that there is existence of heritable (additive genetic) component for male morphotypes, giving prospects for genetic selection to change population structure of GFP.	[Hung Dinh] Res Inst Aquaculture 2, Ho Chi Minh City, Vietnam; [Nguyen Hong Nguyen] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	University of the Sunshine Coast	Nguyen, NH (corresponding author), Res Inst Aquaculture 2, Ho Chi Minh City, Vietnam.	NNguyen@usc.edu.au	Nguyen, Nguyen/GVT-4511-2022; Nguyen, Ngoc/HHZ-0886-2022	Nguyen, Nguyen Hong/0000-0002-4143-955X	Ministry of Agriculture and Rural Development (MARD) in Vietnam	Ministry of Agriculture and Rural Development (MARD) in Vietnam	This work was supported by the Ministry of Agriculture and Rural Development (MARD) in Vietnam through the "Family-based selective breeding program on giant freshwater prawn in Vietnam". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflalo ED, 2012, AQUACULTURE, V338, P197, DOI 10.1016/j.aquaculture.2012.01.025; ANH NTN, 2009, AQUAC RES, V40, P669, DOI DOI 10.1111/J.1365-2109.2008.02143.X; DIAZ G G, 1990, Journal of the Faculty of Applied Biological Science Hiroshima University, V29, P19; Hung D, 2013, AQUACULTURE, V412, P70, DOI 10.1016/j.aquaculture.2013.07.015; Hung D, 2013, AQUACULTURE, V404, P122, DOI 10.1016/j.aquaculture.2013.04.027; Gilmour AR, 2009, ASREML USER GUIDE RE; HULATA G, 1988, ISR J AQUACULT-BAMID, V40, P9; HULATA G, 1990, Journal of the World Aquaculture Society, V21, P295, DOI 10.1111/j.1749-7345.1990.tb00542.x; Dinh H, 2012, AQUAC RES, V43, P1471, DOI 10.1111/j.1365-2109.2011.02949.x; KARPLUS I, 1986, AQUACULTURE, V56, P257, DOI 10.1016/0044-8486(86)90341-8; Karplus I., 2009, FRESHWATER PRAWNS, P316; KURIS AM, 1987, J CRUSTACEAN BIOL, V7, P219, DOI 10.2307/1548603; Luan S, 2012, AQUACULTURE, V362, P88, DOI 10.1016/j.aquaculture.2012.05.011; Nguyen NH, 2007, AQUACULTURE, V272, pS38, DOI 10.1016/j.aquaculture.2007.08.013; Nhan DT, 2010, AQUACULTURE, V300, P80, DOI 10.1016/j.aquaculture.2009.12.012; Phuong NT, 2006, FISHERIES SCI, V72, P1, DOI 10.1111/j.1444-2906.2006.01109.x; RAANAN Z, 1991, BIOL BULL-US, V181, P379, DOI 10.2307/1542358; ROBERTSON A, 1959, BIOMETRICS, V15, P469, DOI 10.2307/2527750; ROBERTSON A, 1949, GENETICS, V34, P395; Rutten MJM, 2002, J HERED, V93, P456, DOI 10.1093/jhered/93.6.456; SAGI A, 1988, J CRUSTACEAN BIOL, V8, P43, DOI 10.2307/1548428; Sorensen D, 2002, LIKELIHOOD BAYESIAN, Vxvii; Thanh NM, 2010, AQUACULTURE, V299, P30, DOI 10.1016/j.aquaculture.2009.12.011; Thanh NM, 2009, AQUACULTURE, V287, P75, DOI 10.1016/j.aquaculture.2008.10.051; Tidwell JH, 2005, AQUAC RES, V36, P264, DOI 10.1111/j.1365-2109.2005.01241.x	25	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90142	10.1371/journal.pone.0090142	http://dx.doi.org/10.1371/journal.pone.0090142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587246	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000135
J	Jeremias, TD; Machado, RG; Visoni, SBC; Pereima, MJ; Leonardi, DF; Trentin, AG				Jeremias, Talita da Silva; Machado, Rafaela Grecco; Coutinho Visoni, Silvia Beatriz; Pereima, Mauricio Jose; Leonardi, Dilmar Francisco; Trentin, Andrea Goncalves			Dermal Substitutes Support the Growth of Human Skin-Derived Mesenchymal Stromal Cells: Potential Tool for Skin Regeneration	PLOS ONE			English	Article							STEM-CELLS; DIFFERENTIATION; EXPRESSION; DELIVERY; SCAFFOLD; MARKERS	New strategies for skin regeneration are needed in order to provide effective treatment for cutaneous wounds and disease. Mesenchymal stem cells (MSCs) are an attractive source of cells for tissue engineering because of their prolonged self-renewal capacity, multipotentiality, and ability to release active molecules important for tissue repair. In this paper, we show that human skin-derived mesenchymal stromal cells (SD-MSCs) display similar characteristics to the multipotent MSCs. We also evaluate their growth in a three-dimensional (3D) culture system with dermal substitutes (Integra and Pelnac). When cultured in monolayers, SD-MSCs expressed mesenchymal markers, such as CD105, Fibronectin, and alpha-SMA; and neural markers, such as Nestin and beta III-Tubulin; at transcriptional and/or protein level. Integra and Pelnac equally supported the adhesion, spread and growth of human SD-MSCs in 3D culture, maintaining the MSC characteristics and the expression of multilineage markers. Therefore, dermal substitutes support the growth of mesenchymal stromal cells from human skin, promising an effective tool for tissue engineering and regenerative technology.	[Jeremias, Talita da Silva; Machado, Rafaela Grecco; Coutinho Visoni, Silvia Beatriz; Trentin, Andrea Goncalves] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil; [Pereima, Mauricio Jose] Univ Fed Santa Catarina, Dept Pediat, Ctr Ciencias Saude, Florianopolis, SC, Brazil; [Pereima, Mauricio Jose] Hosp Infantil Joana de Gusmao, Florianopolis, SC, Brazil; [Leonardi, Dilmar Francisco] Hosp Governador Celso Ramos, Florianopolis, SC, Brazil; [Leonardi, Dilmar Francisco] Univ Sul Santa Catarina, Dept Cirurg, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade do Sul de Santa Catarina	Trentin, AG (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil.	andrea.trentin@ufsc.br	Trentin, Andrea/ABC-6215-2020	Trentin, Andrea/0000-0003-4961-5754; Grecco Machado, Rafaela/0000-0002-8010-5931	Ministerio da Saude (MS-SCTIE-DECIT); Ministerio da Ciencia, Tecnologia e Inovacao/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCTI/CNPq/Brazil); CNPq/PIBIC/PIBIT (Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Fundacao de Amparo a Pesquisa do Estado de Santa Catarina (FAPESC-PPSUS, Brazil)	Ministerio da Saude (MS-SCTIE-DECIT); Ministerio da Ciencia, Tecnologia e Inovacao/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCTI/CNPq/Brazil); CNPq/PIBIC/PIBIT (Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Santa Catarina (FAPESC-PPSUS, Brazil)	This work was supported by the Ministerio da Saude (MS-SCTIE-DECIT), Ministerio da Ciencia, Tecnologia e Inovacao/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCTI/CNPq/Brazil), CNPq/PIBIC/PIBIT (Brazil), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), and Fundacao de Amparo a Pesquisa do Estado de Santa Catarina (FAPESC-PPSUS, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliot F, 1999, J NEUROSCI RES, V58, P367; Barnabe GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005222; Birbrair A, 2013, STEM CELL RES, V10, P67, DOI 10.1016/j.scr.2012.09.003; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005; Coura GS, 2008, J PERIODONTAL RES, V43, P531, DOI 10.1111/j.1600-0765.2007.01065.x; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Formigli L, 2012, J TISSUE ENG REGEN M, V6, P125, DOI 10.1002/term.405; Foudah D, 2013, CELL MOL BIOL LETT, V18, P163, DOI 10.2478/s11658-013-0083-2; Godier Amandine F. G., 2008, Birth Defects Research, V84, P335, DOI 10.1002/bdrc.20138; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hamdi H, 2009, ANN THORAC SURG, V87, P1196, DOI 10.1016/j.athoracsur.2008.12.074; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Ko SH, 2011, PLAST RECONSTR SURG, V127, p10S, DOI 10.1097/PRS.0b013e3181fbe2d8; Krupkova O, 2011, TUMOR BIOL, V32, P631, DOI 10.1007/s13277-011-0162-9; Liu YX, 2013, DEV GROWTH DIFFER, V55, P591, DOI 10.1111/dgd.12052; Masaeli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057157; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Serpooshan V, 2010, ACTA BIOMATER, V6, P3978, DOI 10.1016/j.actbio.2010.04.028; Sharma RI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031504; Stapor PC, 2012, MICROVASC RES, V83, P257, DOI 10.1016/j.mvr.2011.09.003; SUZUKI S, 1995, BRIT J PLAST SURG, V48, P222, DOI 10.1016/0007-1226(95)90006-3; Egana JT, 2009, TISSUE ENG PT A, V15, P1191, DOI 10.1089/ten.tea.2008.0097; Vaculik C, 2012, J INVEST DERMATOL, V132, P563, DOI 10.1038/jid.2011.355; Vishnubalaji R, 2012, CELL TISSUE RES, V350, P1, DOI 10.1007/s00441-012-1471-z; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wong DJ, 2009, SKIN TISSUE ENG, P1	35	22	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89542	10.1371/journal.pone.0089542	http://dx.doi.org/10.1371/journal.pone.0089542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586857	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000055
J	Murciano-Calles, J; Corbi-Verge, C; Candel, AM; Luque, I; Martinez, JC				Murciano-Calles, Javier; Corbi-Verge, Carles; Candel, Adela M.; Luque, Irene; Martinez, Jose C.			Post-Translational Modifications Modulate Ligand Recognition by the Third PDZ Domain of the MAGUK Protein PSD-95	PLOS ONE			English	Article							SUPERTERTIARY STRUCTURE; ASPARAGINYL RESIDUES; BETA-SHEET; BINDING; PEPTIDES; INTERMEDIATE; ENERGETICS; PATHWAYS; DYNAMICS; ASPARTYL	The relative promiscuity of hub proteins such as postsynaptic density protein-95 (PSD-95) can be achieved by alternative splicing, allosteric regulation, and post-translational modifications, the latter of which is the most efficient method of accelerating cellular responses to environmental changes in vivo. Here, a mutational approach was used to determine the impact of phosphorylation and succinimidation post-translational modifications on the binding affinity of the postsynaptic density protein-95/discs large/zonula occludens-1 (PDZ3) domain of PSD-95. Molecular dynamics simulations revealed that the binding affinity of this domain is influenced by an interplay between salt-bridges linking the alpha 3 helix, the beta 2-beta 3 loop and the positively charged Lys residues in its high-affinity hexapeptide ligand KKETAV. The alpha 3 helix is an extra structural element that is not present in other PDZ domains, which links PDZ3 with the following SH3 domain in the PSD-95 protein. This regulatory mechanism was confirmed experimentally via thermodynamic and NMR chemical shift perturbation analyses, discarding intra-domain long-range effects. Taken together, the results presented here reveal the molecular basis of the regulatory role of the alpha 3 extra-element and the effects of post-translational modifications of PDZ3 on its binding affinity, both energetically and dynamically.	[Martinez, Jose C.] Univ Granada, Dept Phys Chem, Fac Sci, Granada, Spain; Univ Granada, Inst Biotechnol, Fac Sci, Granada, Spain	University of Granada; University of Granada	Martinez, JC (corresponding author), Univ Granada, Dept Phys Chem, Fac Sci, Granada, Spain.	jcmh@ugr.es	Murciano-Calles, Javier/J-8897-2012; Martinez, Jose C./J-8721-2012; Luque, Inmaculada/K-9464-2014; Luque, Irene/K-4758-2012; Verge, Carles Corbi/I-4852-2019	Murciano-Calles, Javier/0000-0002-8667-1651; Martinez, Jose C./0000-0003-2657-2456; Luque, Inmaculada/0000-0003-1838-2636; Luque, Irene/0000-0003-2757-4779; Verge, Carles Corbi/0000-0002-7654-4405	Andalusian Regional Government [CVI-05915]; Spanish Ministry of Science and Innovation [BIO2009-13261-C02, BIO2012-39922-C02]; FEDER; Spanish Ministry of Science and Innovation; Formacion de Personal Investigador fellowship from the Spanish Ministry of Science and Innovation	Andalusian Regional Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Formacion de Personal Investigador fellowship from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN))	This research was supported by grants CVI-05915, from the Andalusian Regional Government (http://www.juntadeandalucia.es), BIO2009-13261-C02 and BIO2012-39922-C02, from the Spanish Ministry of Science and Innovation (http://www.idi.mineco.gob.es/portal/site/MICINN/) and FEDER. JMC received a postdoctoral contract from the Spanish Ministry of Science and Innovation. CCV was a recipient of a Formacion de Personal Investigador fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; BRENNAN TV, 1993, PROTEIN SCI, V2, P331; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Camara-Artigas A, 2010, J STRUCT BIOL, V170, P565, DOI 10.1016/j.jsb.2010.03.005; Chi CN, 2012, BIOCHEMISTRY-US, V51, P8971, DOI 10.1021/bi300792h; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Feng HQ, 2005, J MOL BIOL, V346, P345, DOI 10.1016/j.jmb.2004.11.040; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Gianni S, 2006, STRUCTURE, V14, P1801, DOI 10.1016/j.str.2006.10.010; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goddard TD, 2004, SPARKY; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hoffmann R, 2003, TRENDS GENET, V19, P681, DOI 10.1016/j.tig.2003.10.011; Korkin D, 2006, PLOS COMPUT BIOL, V2, P1365, DOI 10.1371/journal.pcbi.0020153; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Marin-Argany M, 2012, BIOPHYS J, V103, P738, DOI 10.1016/j.bpj.2012.07.029; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; Mostarda S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002429; Murciano-Calles J, 2014, BIOPHYS CHEM, V185, P1, DOI 10.1016/j.bpc.2013.10.005; Murciano-Calles J, 2011, BIOPHYS CHEM, V158, P104, DOI 10.1016/j.bpc.2011.05.018; Murciano-Calles J, 2010, BIOPHYS J, V99, P263, DOI 10.1016/j.bpj.2010.04.003; Nussinov R, 2012, TRENDS BIOCHEM SCI, V37, P447, DOI 10.1016/j.tibs.2012.07.001; Orpiszewski J, 1999, J MOL BIOL, V289, P413, DOI 10.1006/jmbi.1999.2768; Palencia A, 2004, J MOL BIOL, V336, P527, DOI 10.1016/j.jmb.2003.12.030; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Saro D, 2004, ORG LETT, V6, P3429, DOI 10.1021/ol049181q; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Sierralta J, 2004, BRAIN RES REV, V47, P105, DOI 10.1016/j.brainresrev.2004.06.002; Takemoto L, 2001, EXP EYE RES, V72, P559, DOI 10.1006/exer.2001.0983; Tompa P, 2012, NAT CHEM BIOL, V8, P597, DOI 10.1038/nchembio.1009; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; van den Berk LCJ, 2007, BIOCHEMISTRY-US, V46, P13629, DOI 10.1021/bi700954e; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang J, 2011, J BIOL CHEM, V286, P41776, DOI 10.1074/jbc.M111.272583	41	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90030	10.1371/journal.pone.0090030	http://dx.doi.org/10.1371/journal.pone.0090030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587199	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000130
J	Zhang, CL; Wang, GZ; Wang, JM; Ji, ZB; Dong, F; Chao, TL				Zhang, Chunlan; Wang, Guizhi; Wang, Jianmin; Ji, Zhibin; Dong, Fei; Chao, Tianle			Analysis of Differential Gene Expression and Novel Transcript Units of Ovine Muscle Transcriptomes	PLOS ONE			English	Article							BETA RECEPTOR; CELLS; BINDING; SHEEP; NETWORK; MODEL	In this study, we characterized differentially expressed genes (DEGs) between the muscle transcriptomes of Small-tailed Han sheep and Dorper sheep and predicted novel transcript units using high-throughput RNA sequencing technology. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses showed that 1,300 DEGs were involved in cellular processes, metabolic pathways, and the actin cytoskeleton pathway. Importantly, we identified 34 DEGs related to muscle cell development and differentiation. Additionally, we were able to optimize the gene structure and predict the untranslated regions (UTRs) for some of the DEGs. Among the 123,678 novel predicted transcript units (TUs), 15,015 units were predicted protein sequences. The reliability of the sequencing data was verified through qRT-PCR analysis of 12 genes. These results will provide useful information for functional genetic research in the future.	[Zhang, Chunlan; Wang, Guizhi; Wang, Jianmin; Ji, Zhibin; Dong, Fei; Chao, Tianle] Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China; [Zhang, Chunlan] Weifang Univ, Shandong Univ, Coll Biol & Agr Engn, Key Lab Biochem & Mol Biol, Weifang, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University; Shandong University; Weifang University	Wang, JM (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China.	wangjm@sdau.edu.cn	WANG, Jianmin/M-2002-2016	WANG, Jianmin/0000-0001-5678-8202; tianle, chao/0000-0001-9721-0634	Innovation Research of Agriculture and Biology Resources [2011186125]; Shandong Provincial Modern Agriculture Industry Technology System Sheep Industry Innovation Team [SATS2012263]	Innovation Research of Agriculture and Biology Resources; Shandong Provincial Modern Agriculture Industry Technology System Sheep Industry Innovation Team	This work was financially supported by the Innovation Research of Agriculture and Biology Resources (No. 2011186125) and the Shandong Provincial Modern Agriculture Industry Technology System Sheep Industry Innovation Team (No. SATS2012263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bonnet A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-417; Byrne K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-378; CROUSE JD, 1986, J ANIM SCI, V63, P1824, DOI 10.2527/jas1986.6361824x; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; Dhorne-Pollet S, 2012, ANIM GENET, V43, P199, DOI 10.1111/j.1365-2052.2011.02237.x; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Govoni KE, 2006, GROWTH HORM IGF RES, V16, P49, DOI 10.1016/j.ghir.2005.10.001; Graham NS, 2011, ANIMAL, V5, P861, DOI 10.1017/S1751731110002533; Jager M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-158; Kamanga-Sollo E, 2005, EXP CELL RES, V311, P167, DOI 10.1016/j.yexcr.2005.09.003; Kang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071763; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-115; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; Legant WR, 2013, P NATL ACAD SCI USA, V110, P881, DOI 10.1073/pnas.1207997110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; McCabe M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-193; Miao XY, 2013, REPRODUCTION, V145, P587, DOI 10.1530/REP-12-0507; Ren HX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-411; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Sharples AP, 2011, J CELL BIOCHEM, V112, P3773, DOI 10.1002/jcb.23308; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Streftaris G, 2004, P ROY SOC B-BIOL SCI, V271, P1111, DOI 10.1098/rspb.2004.2715; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Tripathi AK, 2012, GENE, V493, P124, DOI 10.1016/j.gene.2011.11.007; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686	36	22	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89817	10.1371/journal.pone.0089817	http://dx.doi.org/10.1371/journal.pone.0089817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587058	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000097
J	Sadeghi, A; Tonazzini, A; Popova, L; Mazzolai, B				Sadeghi, Ali; Tonazzini, Alice; Popova, Liyana; Mazzolai, Barbara			A Novel Growing Device Inspired by Plant Root Soil Penetration Behaviors	PLOS ONE			English	Article							MAIZE ZEA-MAYS; MECHANICAL IMPEDANCE; GROWTH; RESISTANCE; CAP; PENETROMETER; CELL; ELONGATION; STRENGTH; RHIZOSPHERE	Moving in an unstructured environment such as soil requires approaches that are constrained by the physics of this complex medium and can ensure energy efficiency and minimize friction while exploring and searching. Among living organisms, plants are the most efficient at soil exploration, and their roots show remarkable abilities that can be exploited in artificial systems. Energy efficiency and friction reduction are assured by a growth process wherein new cells are added at the root apex by mitosis while mature cells of the root remain stationary and in contact with the soil. We propose a new concept of root-like growing robots that is inspired by these plant root features. The device penetrates soil and develops its own structure using an additive layering technique: each layer of new material is deposited adjacent to the tip of the device. This deposition produces both a motive force at the tip and a hollow tubular structure that extends to the surface of the soil and is strongly anchored to the soil. The addition of material at the tip area facilitates soil penetration by omitting peripheral friction and thus decreasing the energy consumption down to 70% comparing with penetration by pushing into the soil from the base of the penetration system. The tubular structure provides a path for delivering materials and energy to the tip of the system and for collecting information for exploratory tasks.	[Sadeghi, Ali; Tonazzini, Alice; Popova, Liyana; Mazzolai, Barbara] Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy; [Tonazzini, Alice; Popova, Liyana] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna	Sadeghi, A (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy.	ali.sadeghi@iit.it; barbara.mazzolai@iit.it	Mazzolai, Barbara/I-8876-2016; sadeghi, ali/AAV-8756-2020	Mazzolai, Barbara/0000-0003-0722-8350; Sadeghi, Ali/0000-0003-2987-9541	Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET open [293431]	Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET open	This work was supported by the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: 293431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA AM, 1969, J AGR ENG RES, V14, P236, DOI 10.1016/0021-8634(69)90126-7; Ani Anthony Ozoemena, 2011, International Journal of Agricultural and Biological Engineering, V4, P16, DOI 10.3965/j.issn.1934-6344.2011.03.016-025; Arnaud C, 2010, CR BIOL, V333, P335, DOI 10.1016/j.crvi.2010.01.011; ASABE Standards ASAE S313.3, 1999, S31313 ASABE; *ASAE, 1999, EP542 ASAE; Bailey SA, 2000, ROBOTICS RESEARCH, P403; Baluska F, 2004, BIOLOGIA, V59, P7; Baluska F, 2010, TRENDS PLANT SCI, V15, P402, DOI 10.1016/j.tplants.2010.04.007; Bar-Cohen Y, 2006, BIOINSPIR BIOMIM, V1, pP1, DOI 10.1088/1748-3182/1/1/P01; BARLEY K. P., 1967, Advances in agronomy. Vol. 19., P1, DOI 10.1016/S0065-2113(08)60731-2; Barlow PW, 2002, J PLANT GROWTH REGUL, V21, P261, DOI 10.1007/s00344-002-0034-z; BARLOW PW, 1993, ENVIRON EXP BOT, V33, P1, DOI 10.1016/0098-8472(93)90051-G; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; BENGOUGH AG, 1990, PLANT SOIL, V123, P73, DOI 10.1007/BF00009928; BENGOUGH AG, 1991, PLANT SOIL, V131, P59, DOI 10.1007/BF00010420; Bengough AG, 2006, J EXP BOT, V57, P437, DOI 10.1093/jxb/erj003; BENGOUGH AG, 1991, J AGR ENG RES, V48, P223, DOI 10.1016/0021-8634(91)80017-9; BENGOUGH AG, 1990, J SOIL SCI, V41, P341, DOI 10.1111/j.1365-2389.1990.tb00070.x; Bengough AG, 1997, J THEOR BIOL, V186, P327, DOI 10.1006/jtbi.1996.0367; Bengough AG, 1999, NEW PHYTOL, V142, P421, DOI 10.1046/j.1469-8137.1999.00406.x; Bengough AG, 1997, J EXP BOT, V48, P885, DOI 10.1093/jxb/48.4.885; Bengough AG, 1997, PLANT ROOTS CELLS SY, P107; Bingham IJ, 2003, PLANT SOIL, V250, P273, DOI 10.1023/A:1022891519039; Boncheva M, 2003, PURE APPL CHEM, V75, P621, DOI 10.1351/pac200375050621; BROWN AH, 1993, PLANT PHYSIOL, V101, P345, DOI 10.1104/pp.101.2.345; Campbell M, 2011, NEW SCI, V212, P24; Chen GH, 2010, PLANT SOIL, V331, P31, DOI 10.1007/s11104-009-0223-7; Clark LJ, 2008, PLANT SOIL, V307, P235, DOI 10.1007/s11104-008-9602-8; Clark LJ, 2003, PLANT SOIL, V255, P93, DOI 10.1023/A:1026140122848; COOPER GA, 1994, SCI AM, V270, P82, DOI 10.1038/scientificamerican0594-82; Croser C, 2000, PHYSIOL PLANTARUM, V109, P150, DOI 10.1034/j.1399-3054.2000.100207.x; Crump SS., 1992, United States Patent, Patent No. [No. 5,121,329A, 5121329, 5,121,329]; Czarnes S, 1999, PLANT SOIL, V211, P69, DOI 10.1023/A:1004656510344; Darwin C, 1880, POWER MOVEMENT PLANT; DEXTER AR, 1987, PLANT SOIL, V98, P303, DOI 10.1007/BF02378351; Ding Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028001; Fitzgerald M, 2010, J ENG MECH, V136, P263, DOI 10.1061/(ASCE)0733-9399(2010)136:3(263); French A, 2008, BIOSIGNALS 2008: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, VOL 1, P108; French A, 2009, PLANT PHYSIOL, V150, P1784, DOI 10.1104/pp.109.140558; Fukuda T., 1990, Proceedings 1990 IEEE International Conference on Robotics and Automation (Cat. No.90CH2876-1), P662, DOI 10.1109/ROBOT.1990.126059; Gao Y, 2007, J SPACECRAFT ROCKETS, V44, P703, DOI 10.2514/1.23025; Gilroy S, 2008, PLANT TROPISMS, P1; Goodman AM, 1999, ANN BOT-LONDON, V83, P293, DOI 10.1006/anbo.1998.0822; Gouache TP, 2011, PLANET SPACE SCI, V59, P1529, DOI 10.1016/j.pss.2011.06.019; GREACEN EL, 1972, NATURE-NEW BIOL, V235, P24, DOI 10.1038/newbio235024a0; Hawes MC, 2002, J PLANT GROWTH REGUL, V21, P352, DOI 10.1007/s00344-002-0035-y; Herrick JE, 2002, SOIL SCI SOC AM J, V66, P1320, DOI 10.2136/sssaj2002.1320; Hochholdinger F, 2009, CURR OPIN PLANT BIOL, V12, P172, DOI 10.1016/j.pbi.2008.12.002; Iida F, 2012, P INT S DISTR AUT RO; Iijima M, 2004, ANN BOT-LONDON, V94, P473, DOI 10.1093/aob/mch166; Iijima M, 2003, NEW PHYTOL, V160, P127, DOI 10.1046/j.1469-8137.2003.00860.x; Iijima M, 2003, J EXP BOT, V54, P2105, DOI 10.1093/jxb/erg226; Iijima M, 2008, PLANT PROD SCI, V11, P17, DOI 10.1626/pps.11.17; Inoue N, 1999, ECOL RES, V14, P31, DOI 10.1046/j.1440-1703.1999.141282.x; ISHIKAWA H, 1995, PLANT PHYSIOL, V109, P725, DOI 10.1104/pp.109.3.725; Jones R, 2011, ROBOTICA, V29, P177, DOI 10.1017/S026357471000069X; Kirby JM, 2002, EUR J SOIL SCI, V53, P119, DOI 10.1046/j.1365-2389.2002.00429.x; Koemle NI, 2008, ADV SPACE RES, V42, P363, DOI 10.1016/j.asr.2007.02.088; Kurup Tumay, 2001, ELECT J GEOTECHNICAL, V6; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; Lobet G, 2011, PLANT PHYSIOL, V157, P29, DOI 10.1104/pp.111.179895; Lunne T, 1997, RECENT DEVELOPMENTS IN SOIL AND PAVEMENT MECHANICS, P81; Maladen RD, 2011, J R SOC INTERFACE, V8, P1332, DOI 10.1098/rsif.2010.0678; MATERECHERA SA, 1992, PLANT SOIL, V144, P297, DOI 10.1007/BF00012888; Maurer W.C., 1980, ADV DRILLING TECHNIQ; Menon C., 2006, P CANEUS TOUL FRANC; Minasny B, 2012, GEODERMA, V177, P57, DOI 10.1016/j.geoderma.2012.01.026; Munoz-Carpena R., 2004, FIELD DEVICES MONITO; Murata S, 2000, 2000 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2000), VOLS 1-3, PROCEEDINGS, P2210, DOI 10.1109/IROS.2000.895297; Nagaoka K, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P4104, DOI 10.1109/IROS.2008.4650693; Powell J.J.M., 1997, GEOTECHNICAL PRACTIC; Rykwalder PR, 2005, WATER ENCY; Sadeghi A, 2013, P IEEE ICRA 2013; Schopfer P, 2006, AM J BOT, V93, P1415, DOI 10.3732/ajb.93.10.1415; Simon C, 2007, SPE IADC DRILL C; Smith CW, 1997, GEODERMA, V78, P93, DOI 10.1016/S0016-7061(97)00029-3; Suh JW, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P4095, DOI 10.1109/ROBOT.2002.1014385; Sun LH, 2008, WEAR, V264, P693, DOI 10.1016/j.wear.2007.06.005; Tonazzini Alice, 2013, Biomimetic and Biohybrid Systems. Second International Conference, Living Machines 2013. Proceedings. LNCS 8064, P447, DOI 10.1007/978-3-642-39802-5_62; Tonazzini A, 2012, P IEEE RAS-EMBS INT, P1134, DOI 10.1109/BioRob.2012.6290772; UNGER PW, 1994, AGRON J, V86, P759, DOI 10.2134/agronj1994.00021962008600050004x; Verbelen JP, 2006, PLANT SIGNAL BEHAV, V1, P296, DOI 10.4161/psb.1.6.3511; Vollsnes AV, 2010, EUR J SOIL SCI, V61, P926, DOI 10.1111/j.1365-2389.2010.01297.x; WHITELEY GM, 1981, PLANT SOIL, V61, P351, DOI 10.1007/BF02182016; Winter AG, 2011, INTEGR COMP BIOL, V51, P151, DOI 10.1093/icb/icr038; Wood RJ, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2885509; Xu X, 2008, GEOTECHNIQUE, V58, P187, DOI 10.1680/geot.2008.58.3.187; Ylikorpi T, 2001, P 35 AER MECH S; Zacny K., 2009, DRILLING EXTREME ENV, P347; Zacny K, 2002, NOVEL METHOD CUTTING, P107; Zacny K, 2012, 2012 IEEE AER C IEEE, P1; Zobel R.W., 1991, RHIZOSPHERE PLANT GR, P61, DOI [10.1007/978-94-011-3336-4_7, DOI 10.1007/978-94-011-3336-4_7]; [No title captured], DOI DOI 10.1109/IR0S.2004.1389702	93	79	78	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90139	10.1371/journal.pone.0090139	http://dx.doi.org/10.1371/journal.pone.0090139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587244	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900118
J	Calvet, CY; Andre, FM; Mir, LM				Calvet, Christophe Y.; Andre, Franck M.; Mir, Lluis M.			The Culture of Cancer Cell Lines as Tumorspheres Does Not Systematically Result in Cancer Stem Cell Enrichment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO PROPAGATION; BREAST-CANCER; MAMMOSPHERE CULTURE; MURINE MELANOMA; GENE DELIVERY; E-CADHERIN; IDENTIFICATION; METASTASIS; VIMENTIN	Cancer stem cells (CSC) have raised great excitement during the last decade and are promising targets for an efficient treatment of tumors without relapses and metastases. Among the various methods that enable to enrich cancer cell lines in CSC, tumorspheres culture has been predominantly used. In this report, we attempted to generate tumorspheres from several murine and human cancer cell lines: B16-F10, HT-29, MCF-7 and MDA-MB-231 cells. Tumorspheres were obtained with variable efficiencies from all cell lines except from MDA-MB-231 cells. Then, we studied several CSC characteristics in both tumorspheres and adherent cultures of the B16-F10, HT-29 and MCF-7 cells. Unexpectedly, tumorspheres-forming cells were less clonogenic and, in the case of B16-F10, less proliferative than attached cells. In addition, we did not observe any enrichment in the population expressing CSC surface markers in tumorspheres from B16-F10 (CD133, CD44 and CD24 markers) or MCF-7 (CD44 and CD24 markers) cells. On the contrary, tumorspheres culture of HT-29 cells appeared to enrich in cells expressing colon CSC markers, i.e. CD133 and CD44 proteins. For the B16-F10 cell line, when 1 000 cells were injected in syngenic C57BL/6 mice, tumorspheres-forming cells displayed a significantly lower tumorigenic potential than adherent cells. Finally, tumorspheres culture of B16-F10 cells induced a down-regulation of vimentin which could explain, at least partially, the lower tumorigenicity of tumorspheres-forming cells. All these results, along with the literature, indicate that tumorspheres culture of cancer cell lines can induce an enrichment in CSC but in a cell line-dependent manner. In conclusion, extensive characterization of CSC properties in tumorspheres derived from any cancer cell line or cancer tissue must be performed in order to ensure that the generated tumorspheres are actually enriched in CSC.	[Calvet, Christophe Y.; Andre, Franck M.; Mir, Lluis M.] Univ Paris 11, Lab Vectorol & Therapeut Anticanc, UMR 8203, Villejuif, France; [Calvet, Christophe Y.; Andre, Franck M.; Mir, Lluis M.] CNRS, Lab Vectorol & Therapeut Anticanc, UMR 8203, Villejuif, France; [Calvet, Christophe Y.; Andre, Franck M.; Mir, Lluis M.] Gustave Roussy, Lab Vectorol & Therapeut Anticanc, UMR 8203, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Mir, LM (corresponding author), Univ Paris 11, Lab Vectorol & Therapeut Anticanc, UMR 8203, Villejuif, France.	luis.mir@igr.fr	MIR, Lluis M/AAJ-9110-2020		Agence Nationale de la Recherche (IPSIOAT); Departement du Val-de-Marne	Agence Nationale de la Recherche (IPSIOAT)(French National Research Agency (ANR)); Departement du Val-de-Marne	Research was conducted in the scope of the EBAM European Associated Laboratory. This work was partly supported by grants from the Agence Nationale de la Recherche (IPSIOAT) and the Departement du Val-de-Marne through the TELVAC project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Collura A, 2013, CELL MOL LIFE SCI, V70, P729, DOI 10.1007/s00018-012-1160-9; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dou J, 2007, CELL MOL IMMUNOL, V4, P467; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Fan XL, 2011, INT J COLORECTAL DIS, V26, P1279, DOI 10.1007/s00384-011-1248-y; Gil J, 2008, J APPL GENET, V49, P193, DOI 10.1007/BF03195612; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Hittelman WN, 2010, FUTURE ONCOL, V6, P1563, DOI [10.2217/fon.10.121, 10.2217/FON.10.121]; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Huang Ming-zhu, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P500; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Kondo Toru, 2007, Cancer Biomarkers, V3, P245; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mesojednik S, 2007, GENE THER, V14, P1261, DOI 10.1038/sj.gt.3302989; Mir LM, 2005, ADV GENET, V54, P83, DOI 10.1016/S0065-2660(05)54005-7; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Myong NH, 2012, KOREAN J PATHOL, V46, P341, DOI 10.4132/KoreanJPathol.2012.46.4.341; Nijkamp MM, 2011, RADIOTHER ONCOL, V99, P344, DOI 10.1016/j.radonc.2011.05.066; Omene CO, 2012, INVEST NEW DRUG, V30, P1279, DOI 10.1007/s10637-011-9667-8; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Qiu XF, 2012, CANCER LETT, V323, P161, DOI 10.1016/j.canlet.2012.04.004; Rols MP, 1998, NAT BIOTECHNOL, V16, P168, DOI 10.1038/nbt0298-168; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Schulenburg A, 2010, CRIT REV ONCOL HEMAT, V76, P79, DOI 10.1016/j.critrevonc.2010.01.001; Shi Z, 2012, J ZHEJIANG UNIV-SC B, V13, P11, DOI 10.1631/jzus.B1100154; Vincent A, 2012, BBA-REV CANCER, V1826, P83, DOI 10.1016/j.bbcan.2012.03.009; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039069; Wu J, 2011, CANCER LETT, V308, P43, DOI 10.1016/j.canlet.2011.04.012; Xie GZ, 2012, CANCER LETT, V316, P53, DOI 10.1016/j.canlet.2011.10.018; Zhang LL, 2012, J CANCER RES CLIN, V138, P675, DOI 10.1007/s00432-011-1146-2; Zhao RH, 2012, J THORAC CARDIOV SUR, V144, P1192, DOI 10.1016/j.jtcvs.2012.08.008; Zhong Y, 2010, CANCER LETT, V292, P17, DOI 10.1016/j.canlet.2009.10.021; Zhou HM, 2012, WORLD J GASTROENTERO, V18, P2640, DOI 10.3748/wjg.v18.i21.2640	46	58	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89644	10.1371/journal.pone.0089644	http://dx.doi.org/10.1371/journal.pone.0089644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586931	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700068
J	Hernan, AE; Alexander, A; Lenck-Santini, PP; Scott, RC; Holmes, GL				Hernan, Amanda E.; Alexander, Abigail; Lenck-Santini, Pierre-Pascal; Scott, Rod C.; Holmes, Gregory L.			Attention Deficit Associated with Early Life Interictal Spikes in a Rat Model Is Improved with ACTH	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; INFANTILE SPASMS; BEHAVIOR; AMYGDALA; EPILEPSY; CHILDREN; THERAPY	Children with epilepsy often present with pervasive cognitive and behavioral comorbidities including working memory impairments, attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder. These non-seizure characteristics are severely detrimental to overall quality of life. Some of these children, particularly those with epilepsies classified as Landau-Kleffner Syndrome or continuous spike and wave during sleep, have infrequent seizure activity but frequent focal epileptiform activity. This frequent epileptiform activity is thought to be detrimental to cognitive development; however, it is also possible that these IIS events initiate pathophysiological pathways in the developing brain that may be independently associated with cognitive deficits. These hypotheses are difficult to address due to the previous lack of an appropriate animal model. To this end, we have recently developed a rat model to test the role of frequent focal epileptiform activity in the prefrontal cortex. Using microinjections of a GABA(A) antagonist (bicuculline methiodine) delivered multiple times per day from postnatal day (p) 21 to p25, we showed that rat pups experiencing frequent, focal, recurrent epileptiform activity in the form of interictal spikes during neurodevelopment have significant long-term deficits in attention and sociability that persist into adulthood. To determine if treatment with ACTH, a drug widely used to treat early-life seizures, altered outcome we administered ACTH once per day subcutaneously during the time of the induced interictal spike activity. We show a modest amelioration of the attention deficit seen in animals with a history of early life interictal spikes with ACTH, in the absence of alteration of interictal spike activity. These results suggest that pharmacological intervention that is not targeted to the interictal spike activity is worthy of future study as it may be beneficial for preventing or ameliorating adverse cognitive outcomes.	[Hernan, Amanda E.; Alexander, Abigail] Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH 03755 USA; [Scott, Rod C.] UCL, Inst Child Hlth, London, England; [Hernan, Amanda E.; Lenck-Santini, Pierre-Pascal; Scott, Rod C.; Holmes, Gregory L.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT USA	Dartmouth College; University of London; University College London; University of Vermont	Hernan, AE (corresponding author), Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH 03755 USA.	Amanda.Hernan@uvm.edu	lenck-santini, pierre-pascal/N-3662-2016	lenck-santini, pierre-pascal/0000-0001-9925-9220; Scott, Rod/0000-0002-8944-928X; Hernan, Amanda/0000-0003-4931-3481	Questcor Pharmaceuticals through an Independent Investigator Study grant; Emmory R. Shapses Research Fund; Michael J. Pietroniro Fund [R01NS075249, R01NS076763]; Great Ormond Street Children's Charity;  [1R01NS073083]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073083, R01NS076763, R01NS075249] Funding Source: NIH RePORTER	Questcor Pharmaceuticals through an Independent Investigator Study grant; Emmory R. Shapses Research Fund; Michael J. Pietroniro Fund; Great Ormond Street Children's Charity; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding and study drug were provided by Questcor Pharmaceuticals through an Independent Investigator Study grant awarded to AEH and GLH. Questcor did not dictate or control study design, experiments or techniques described, data analyses, or manuscript preparation. Questcor Pharmaceuticals was informed prior to submission of this work for publication. This work is funded by 1R01NS073083 (awarded to GLH), Emmory R. Shapses Research Fund, and Michael J. Pietroniro Fund (GLH), R01NS075249 (RCS) and R01NS076763 (PPLS). RCS is funded by Great Ormond Street Children's Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAM TZ, 1991, DEV BRAIN RES, V61, P97, DOI 10.1016/0165-3806(91)90118-3; Baram TZ, 1996, PEDIATRICS, V97, P375; BARAM TZ, 1992, ANN NEUROL, V31, P488, DOI 10.1002/ana.410310505; Benjamins JA, 2013, GLIA, V61, P1206, DOI 10.1002/glia.22504; Brunson KL, 2001, ANN NEUROL, V49, P304, DOI 10.1002/ana.66.abs; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Delgado R, 1998, J LEUKOCYTE BIOL, V63, P740, DOI 10.1002/jlb.63.6.740; Gupta R, 2005, ARCH DIS CHILD, V90, P379, DOI 10.1136/adc.2004.051375; Hernan AE, 2013, NEUROBIOLOG IN PRESS, DOI [10.1016/j.nbd.2013.11.012, DOI 10.1016/J.NBD.2013.11.012]; Holmes GL, 1991, EPILIPSIA, V32, pS11; Holmes GL, 2006, EPILEPSY BEHAV, V8, P504, DOI 10.1016/j.yebeh.2005.11.014; HRACHOVY RA, 1980, EPILEPSIA, V21, P631, DOI 10.1111/j.1528-1157.1980.tb04316.x; Khan S, 2012, EPILEPSY RES TREATME, V2012, P1, DOI [10.1016/j.yebeh.2009.10.024, DOI 10.1016/J.YEBEH.2009.10.024]; LERMAN P, 1991, DEV MED CHILD NEUROL, V33, P257; Low M.J., 1994, CURR OPIN ENDOCRINOL, V1, P79; Lux AL, 2005, LANCET NEUROL, V4, P712, DOI 10.1016/S1474-4422(05)70199-X; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nordli DR, 2012, J CLIN NEUROPHYSIOL, V29, P420, DOI 10.1097/WNP.0b013e31826bd961; Pass D, 1993, ANZCCART NEWS, V6, P1, DOI DOI 10.1016/J.NEUINT.2005.04.013; Pressler RM, 2005, J PEDIATR-US, V146, P112, DOI 10.1016/j.jpeds.2004.08.084; Specchio Nicola, 2012, Epilepsy Res Treat, V2012, P460256, DOI 10.1155/2012/460256; Wirrell E., 2009, PAEDIAT CHILD HLTH, V19, pS226, DOI DOI 10.1016/J.PAED.2009.08.002	23	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89812	10.1371/journal.pone.0089812	http://dx.doi.org/10.1371/journal.pone.0089812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587054	Green Submitted, gold, Green Published			2022-12-27	WOS:000331880700095
J	Na, R; Yu, D; Chapman, BP; Zhang, Y; Kuflu, K; Austin, R; Qutob, D; Zhao, J; Wang, YC; Gijzen, M				Na, Ren; Yu, Dan; Chapman, B. Patrick; Zhang, Yun; Kuflu, Kuflom; Austin, Ryan; Qutob, Dinah; Zhao, Jun; Wang, Yuanchao; Gijzen, Mark			Genome Re-Sequencing and Functional Analysis Places the Phytophthora sojae Avirulence Genes Avr1c and Avr1a in a Tandem Repeat at a Single Locus	PLOS ONE			English	Article							NUCLEOTIDE-BINDING SITE; DISEASE-RESISTANCE; RXLR EFFECTOR; CAUSES GAIN; VIRULENCE; PATHOGEN; MARKERS; PROTEIN; ENCODES; IDENTIFICATION	The aim of this work was to map and identify the Phytophthora sojae Avr1c gene. Progeny from a cross of P. sojae strains ACR10xP7076 were tested for virulence on plants carrying Rps1c. Results indicate that avirulence segregates as a dominant trait. We mapped the Avr1c locus by performing whole genome re-sequencing of composite libraries created from pooled samples. Sequence reads from avirulent (Pool1) and virulent (Pool2) samples were aligned to the reference genome and single nucleotide polymorphisms (SNP) were identified for each pool. High quality SNPs were filtered to select for positions where SNP frequency was close to expected values for each pool. Only three SNP positions fit all requirements, and these occurred in close proximity. Additional DNA markers were developed and scored in the F-2 progeny, producing a fine genetic map that places Avr1c within the Avr1a gene cluster. Transient expression of Avr1c or Avr1a triggers cell death on Rps1c plants, but Avr1c does not trigger cell death on Rps1a plants. Sequence comparisons show that the RXLR effector genes Avr1c and Avr1a are closely related paralogs. Gain of virulence on Rps1c in P. sojae strain P7076 is achieved by gene deletion, but in most other strains this is accomplished by gene silencing. This work provides practical tools for crop breeding and diagnostics, as the Rps1c gene is widely deployed in commercial soybean cultivars.	[Na, Ren; Yu, Dan; Chapman, B. Patrick; Zhang, Yun; Kuflu, Kuflom; Austin, Ryan; Qutob, Dinah; Gijzen, Mark] Agr & Agri Food Canada, London, ON, Canada; [Na, Ren; Zhao, Jun] Inner Mongolia Agr Univ, Coll Agron, Hohhot, Peoples R China; [Yu, Dan; Wang, Yuanchao] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Agriculture & Agri Food Canada; Inner Mongolia Agricultural University; Nanjing Agricultural University	Gijzen, M (corresponding author), Agr & Agri Food Canada, London, ON, Canada.	mark.gijzen@agr.gc.ca	wang, yuanchao/G-9667-2011	wang, yuanchao/0000-0001-5803-5343	AAFC-GRDI program [RPBI-2582]; China Scholarship Council; Ministry of Education, China	AAFC-GRDI program; China Scholarship Council(China Scholarship Council); Ministry of Education, China(Ministry of Education, China)	This work was funded by the AAFC-GRDI program (RPBI-2582). Support for RN and DY was provided by the China Scholarship Council, Ministry of Education, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Abu-El Samen FM, 2003, PHYTOPATHOLOGY, V93, P293, DOI 10.1094/PHYTO.2003.93.3.293; Anderson RG, 2012, PLANT J, V72, P882, DOI 10.1111/j.1365-313X.2012.05079.x; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Bhattacharyya MK, 2005, THEOR APPL GENET, V111, P75, DOI 10.1007/s00122-005-1993-9; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Chamnanpunt J, 2001, P NATL ACAD SCI USA, V98, P14530, DOI 10.1073/pnas.251464498; Chen Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002595; CHURCHILL GA, 1993, P NATL ACAD SCI USA, V90, P16, DOI 10.1073/pnas.90.1.16; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Dong SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020172; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2010, MOL PLANT MICROBE IN, V23, P425, DOI 10.1094/MPMI-23-4-0425; Gao H, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-29; Goritschnig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002502; Halterman DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010536; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jiang RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/annurev-phyto-081211-172912; Kasuga T, 2013, TRENDS MICROBIOL, V21, P575, DOI 10.1016/j.tim.2013.09.003; Krasileva KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028765; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacGregor T, 2002, GENETICS, V160, P949; May KJ, 2002, FUNGAL GENET BIOL, V37, P1, DOI 10.1016/S1087-1845(02)00027-0; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Na R, 2013, MOL PLANT MICROBE IN, V26, P969, DOI 10.1094/MPMI-02-13-0036-R; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Qutob D, 2000, PLANT PHYSIOL, V123, P243, DOI 10.1104/pp.123.1.243; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Qutob D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2354; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rietman H, 2012, MOL PLANT MICROBE IN, V25, P910, DOI 10.1094/MPMI-01-12-0010-R; RUTHERFORD FS, 1985, PHYTOPATHOLOGY, V75, P371, DOI 10.1094/Phyto-75-371; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Song TQ, 2013, MOL PLANT MICROBE IN, V26, P711, DOI 10.1094/MPMI-12-12-0289-R; Stassen JHM, 2013, MOL PLANT MICROBE IN, V26, P1259, DOI 10.1094/MPMI-05-13-0142-R; Takagi H, 2013, NEW PHYTOL, V200, P276, DOI 10.1111/nph.12369; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; TYLER BM, 1995, MOL PLANT MICROBE IN, V8, P515, DOI 10.1094/MPMI-8-0515; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Whisson SC, 1995, MOL PLANT MICROBE IN, V8, P988, DOI 10.1094/MPMI-8-0988; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400	50	18	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89738	10.1371/journal.pone.0089738	http://dx.doi.org/10.1371/journal.pone.0089738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586999	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700081
J	Wan, CH; Liu, J; Nie, XK; Zhao, JY; Zhou, SL; Duan, ZQ; Tang, CY; Liang, LW; Xu, GF				Wan, Chunhua; Liu, Jiao; Nie, Xiaoke; Zhao, Jianya; Zhou, Songlin; Duan, Zhiqing; Tang, Cuiying; Liang, Lingwei; Xu, Guangfei			2, 3, 7, 8-Tetrachlorodibenzo-P-Dioxin (TCDD) Induces Premature Senescence in Human and Rodent Neuronal Cells via ROS-Dependent Mechanisms	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; REACTIVE OXYGEN PRODUCTION; CEREBELLAR GRANULE CELLS; DNA-DAMAGE RESPONSE; OXIDATIVE STRESS; CELLULAR SENESCENCE; SUBCHRONIC EXPOSURE; AGING ROS; DIOXIN; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN	The widespread environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a potent toxicant that causes significant neurotoxicity. However, the biological events that participate in this process remain largely elusive. In the present study, we demonstrated that TCDD exposure triggered apparent premature senescence in rat pheochromocytoma (PC12) and human neuroblastoma SH-SY5Y cells. Senescence-associated beta-galactosidase (SA-beta-Gal) assay revealed that TCDD induced senescence in PC12 neuronal cells at doses as low as 10 nM. TCDD led to F-actin reorganization and the appearance of an alternative senescence marker, gamma-H2AX foci, both of which are important features of cellular senescence. In addition, TCDD exposure altered the expression of senescence marker proteins, such as p16, p21 and p-Rb, in both dose- and time-dependent manners. Furthermore, we demonstrated that TCDD promotes mitochondrial dysfunction and the accumulation of cellular reactive oxygen species (ROS) in PC12 cells, leading to the activation of signaling pathways that are involved in ROS metabolism and senescence. TCDD-induced ROS generation promoted significant oxidative DNA damage and lipid peroxidation. Notably, treatment with the ROS scavenger N-acetylcysteine (NAC) markedly attenuated TCDD-induced ROS production, cellular oxidative damage and neuronal senescence. Moreover, we found that TCDD induced a similar ROS-mediated senescence response in human neuroblastoma SH-SY5Y cells. In sum, these results demonstrate for the first time that TCDD induces premature senescence in neuronal cells by promoting intracellular ROS production, supporting the idea that accelerating the onset of neuronal senescence may be an important mechanism underlying TCDD-induced neurotoxic effects.	[Wan, Chunhua; Liu, Jiao; Nie, Xiaoke; Zhao, Jianya; Zhou, Songlin; Duan, Zhiqing; Tang, Cuiying; Liang, Lingwei; Xu, Guangfei] Nantong Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Nantong, Jiangsu, Peoples R China	Nantong University	Xu, GF (corresponding author), Nantong Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Nantong, Jiangsu, Peoples R China.	xugf@ntu.edu.cn			National Natural Science Foundation of China [21077061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 21077061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 1998, J CELL SCI, V111, P3311; Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; CAPUTO R, 1988, J AM ACAD DERMATOL, V19, P812, DOI 10.1016/S0190-9622(88)70238-8; Chen SC, 2010, MOL HUM REPROD, V16, P361, DOI 10.1093/molehr/gaq004; Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collins LL, 2008, TOXICOL SCI, V103, P125, DOI 10.1093/toxsci/kfn017; Filbrandt CR, 2004, NEUROTOXICOLOGY, V25, P605, DOI 10.1016/j.neuro.2003.08.007; Hassoun EA, 2004, J BIOCHEM MOL TOXIC, V18, P196, DOI 10.1002/jbt.20030; Hassoun EA, 2000, TOXICOLOGY, V145, P103, DOI 10.1016/S0300-483X(99)00221-8; Heimler I, 1998, ENDOCRINOLOGY, V139, P4373, DOI 10.1210/en.139.10.4373; Ikeda M, 2005, TOXICOL APPL PHARM, V205, P98, DOI 10.1016/j.taap.2004.09.010; Jin DQ, 2004, NEUROSCI LETT, V363, P69, DOI 10.1016/j.neulet.2004.03.047; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Kim SY, 2007, CHEMOSPHERE, V67, pS421, DOI 10.1016/j.chemosphere.2006.05.138; Kim SY, 2005, EXP MOL MED, V37, P58, DOI 10.1038/emm.2005.8; Kloet DEA, 2011, BBA-MOL CELL RES, V1813, P1926, DOI 10.1016/j.bbamcr.2011.04.003; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Latchney SE, 2011, STEM CELLS DEV, V20, P313, DOI 10.1089/scd.2009.0529; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lin PH, 2007, TOXICOL LETT, V172, P146, DOI 10.1016/j.toxlet.2007.06.003; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Mates JM, 2010, FREE RADICAL BIO MED, V49, P1328, DOI 10.1016/j.freeradbiomed.2010.07.028; Morales-Hernandez A, 2012, APOPTOSIS, V17, P1170, DOI 10.1007/s10495-012-0760-z; Neuberger M, 1998, TOXICOL LETT, V96-7, P347, DOI 10.1016/S0378-4274(98)00092-7; Nishijo M, 2007, TOXICOL LETT, V173, P41, DOI 10.1016/j.toxlet.2007.06.007; Pani G, 2010, AGING-US, V2, P514, DOI 10.18632/aging.100182; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; POHJANVIRTA R, 1990, PHARMACOL TOXICOL, V66, P93, DOI 10.1111/j.1600-0773.1990.tb00712.x; Pospelova TV, 2009, CELL CYCLE, V8, P4112, DOI 10.4161/cc.8.24.10215; Ray SS, 2004, J BIOL CHEM, V279, P27187, DOI 10.1074/jbc.M402771200; Ray SS, 2003, TOXICOL APPL PHARM, V192, P131, DOI 10.1016/S0041-008X(03)00277-1; Sanchez-Martin FJ, 2010, NEUROTOXICOLOGY, V31, P267, DOI 10.1016/j.neuro.2010.03.005; Sanchez-Martin FJ, 2011, J NEUROCHEM, V118, P153, DOI 10.1111/j.1471-4159.2011.07291.x; Senft AP, 2002, TOXICOL APPL PHARM, V178, P15, DOI 10.1006/taap.2001.9314; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Shen DX, 2005, J BIOL CHEM, V280, P25305, DOI 10.1074/jbc.M500095200; Shertzer HG, 2006, TOXICOL APPL PHARM, V217, P363, DOI 10.1016/j.taap.2006.09.014; Sul D, 2009, TOXICOLOGY, V255, P65, DOI 10.1016/j.tox.2008.10.006; Toussaint O, 2002, BIOCHEM PHARMACOL, V64, P1007, DOI 10.1016/S0006-2952(02)01170-X; Xu G, 2013, HUM EXP TOXICOL, V32, P1278, DOI 10.1177/0960327113482595; Xu GF, 2013, NEUROTOXICOLOGY, V37, P63, DOI 10.1016/j.neuro.2013.04.005; Yang NC, 2005, EXP GERONTOL, V40, P813, DOI 10.1016/j.exger.2005.07.011; Zhao H, 2013, AGING-US, V5, P623, DOI 10.18632/aging.100593	49	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89811	10.1371/journal.pone.0089811	http://dx.doi.org/10.1371/journal.pone.0089811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587053	Green Submitted, gold, Green Published			2022-12-27	WOS:000331880700094
J	Ball, D; Kliese, R; Windels, F; Nolan, C; Stratton, P; Sah, P; Wiles, J				Ball, David; Kliese, Russell; Windels, Francois; Nolan, Christopher; Stratton, Peter; Sah, Pankaj; Wiles, Janet			Rodent Scope: A User-Configurable Digital Wireless Telemetry System for Freely Behaving Animals	PLOS ONE			English	Article							RECORDING-SYSTEM; MOVING ANIMALS; AMPLIFIER	This paper describes the design and implementation of a wireless neural telemetry system that enables new experimental paradigms, such as neural recordings during rodent navigation in large outdoor environments. RoSco, short for Rodent Scope, is a small lightweight user-configurable module suitable for digital wireless recording from freely behaving small animals. Due to the digital transmission technology, RoSco has advantages over most other wireless modules of noise immunity and online user-configurable settings. RoSco digitally transmits entire neural waveforms for 14 of 16 channels at 20 kHz with 8-bit encoding which are streamed to the PC as standard USB audio packets. Up to 31 RoSco wireless modules can coexist in the same environment on non-overlapping independent channels. The design has spatial diversity reception via two antennas, which makes wireless communication resilient to fading and obstacles. In comparison with most existing wireless systems, this system has online user-selectable independent gain control of each channel in 8 factors from 500 to 32,000 times, two selectable ground references from a subset of channels, selectable channel grounding to disable noisy electrodes, and selectable bandwidth suitable for action potentials (300 Hz-3 kHz) and low frequency field potentials (4 Hz-3 kHz). Indoor and outdoor recordings taken from freely behaving rodents are shown to be comparable to a commercial wired system in sorting for neural populations. The module has low input referred noise, battery life of 1.5 hours and transmission losses of 0.1% up to a range of 10 m.	[Ball, David] Queensland Univ Technol, Sch Elect Engn & Comp Sci, Brisbane, Qld 4001, Australia; [Kliese, Russell] TOPTICA Photon AG, Grafelfing, Germany; [Windels, Francois; Nolan, Christopher; Stratton, Peter; Sah, Pankaj] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Wiles, Janet] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld 4072, Australia	Queensland University of Technology (QUT); TOPTICA Photonics AG; University of Queensland; University of Queensland	Ball, D (corresponding author), Queensland Univ Technol, Sch Elect Engn & Comp Sci, Brisbane, Qld 4001, Australia.	david.ball@qut.edu.au	Windels, Francois/G-5432-2010; Wiles, Janet/C-1989-2008	Stratton, Peter/0000-0002-3312-7505; Nolan, Christopher/0000-0002-0621-2907; Sah, Pankaj/0000-0001-5063-1589; Wiles, Janet/0000-0002-4051-4116; Windels, Francois/0000-0001-5341-2197	Australian Research Council; National Health and Medical Research Council Special Research Initiative, "Thinking Systems: Navigating through Real and Conceptual Spaces" [TS0669699]	Australian Research Council(Australian Research Council); National Health and Medical Research Council Special Research Initiative, "Thinking Systems: Navigating through Real and Conceptual Spaces"	This work was supported in part by the Australian Research Council and National Health and Medical Research Council Special Research Initiative TS0669699, "Thinking Systems: Navigating through Real and Conceptual Spaces." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranauskas G, 2012, J NEUROPHYSIOL, V107, P984, DOI 10.1152/jn.00470.2011; Bashirullah R, 2007, IEEE INT SYMP CIRC S, P2084, DOI 10.1109/ISCAS.2007.378509; Chae MS, 2009, IEEE T NEUR SYS REH, V17, P312, DOI 10.1109/TNSRE.2009.2021607; Chen HY, 2008, MED BIOL ENG COMPUT, V46, P833, DOI 10.1007/s11517-008-0355-6; Chestek CA, 2009, IEEE T NEUR SYS REH, V17, P330, DOI 10.1109/TNSRE.2009.2023293; Fan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022033; Farshchi S, 2007, EMBEDDED SYSTEM ARCH, P327; Fenton AA, 2011, NEUROMETHODS, V54, P77, DOI 10.1007/978-1-60327-202-5_4; Gosselin B, 2011, SENSORS-BASEL, V11, P4572, DOI 10.3390/s110504572; Hampson RE, 2009, J NEUROSCI METH, V182, P195, DOI 10.1016/j.jneumeth.2009.06.007; Harrison RR, 2008, IEEE INT SYMP CIRC S, P1748, DOI 10.1109/ISCAS.2008.4541776; Kliese R, 2013, ROSCO FIRMWARE DOCUM, DOI DOI 10.6084/M9.FIGSHARE.881900); Kliese R, 2013, ROSCO SCHEMATICS FIG, DOI DOI 10.6084/M9.FIGSHARE.881900); Knapen G, 1997, UNIVERSAL SERIAL BUS; Miranda H, 2010, IEEE T BIOMED CIRC S, V4, P181, DOI 10.1109/TBCAS.2010.2044573; Muller S, 2001, J AUDIO ENG SOC, V49, P443; Nyquist H., 1928, T AM I ELECT ING, V47, P617, DOI [10.1109/T-AIEE.1928.5055024, DOI 10.1109/T-AIEE.1928.5055024]; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Renshaw B, 1940, J NEUROPHYSIOL, V3, P74, DOI 10.1152/jn.1940.3.1.74; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SKUTT HR, 1967, ELECTROEN CLIN NEURO, V22, P275; Szuts TA, 2011, NAT NEUROSCI, V14, P263, DOI 10.1038/nn.2730; Windels F, 2006, BRAIN RES, V1086, P104, DOI 10.1016/j.brainres.2006.02.064	25	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89949	10.1371/journal.pone.0089949	http://dx.doi.org/10.1371/journal.pone.0089949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587144	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200097
J	Patel, S; Schechter, MT; Sewankambo, NK; Atim, S; Kiwanuka, N; Spittal, PM				Patel, Sheetal; Schechter, Martin T.; Sewankambo, Nelson K.; Atim, Stella; Kiwanuka, Noah; Spittal, Patricia M.			Lost in Transition: HIV Prevalence and Correlates of Infection among Young People Living in Post-Emergency Phase Transit Camps in Gulu District, Northern Uganda	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; TO-CHILD-TRANSMISSION; VAGINAL PRACTICES; DRY SEX; PREVENTION; WOMEN; RISK; WAR; CONFLICT; MEN	Objective: Little is known about HIV infection and the related vulnerabilities of young people living in resource-scarce, post-emergency transit camps that are now home to thousands of Internally Displaced Persons (IDPs) following two decades of war in northern Uganda. The objective of this analysis was to assess the prevalence and correlates of HIV infection among young people living in post-conflict transition in Gulu District, northern Uganda. Methods: In 2010, a cross-sectional demographic and behavioural survey was conducted in two of Gulu District's sub-counties with 384 purposively selected transit camp residents aged 15 to 29 years. Biological specimens were collected for rapid HIV testing in the field and confirmatory laboratory testing. Multivariable logistic regression identified independent determinants of HIV infection. Results: HIV prevalence was alarmingly high at 12.8% (95% CI: 9.6%, 16.5%). The strongest determinant of HIV infection among young people was a non-consensual sexual debut (adjusted odds ratio [AOR], 9.88; 95% CI: 1.70-18.06). Residing in Awach sub-county (AOR, 2.93; 95% CI: 1.28-6.68), experiencing STI symptoms in the previous 12 months (AOR, 2.36; 95% CI: 1.43-6.17), and practicing dry sex (AOR, 2.31; 95% CI: 1.04-5.13) were other key determinants of HIV infection. Conclusions: Study findings contribute to filling an important gap in epidemiological evidence and are useful for planning public health interventions in northern Uganda that effectively target young people in post-conflict transition and support them in the resettlement process. Findings serve to recommend reaching beyond traditional prevention programming in a way more effectively beneficial to young people in post-conflict settings by developing population-specific responses sensitive to local contexts and sufficient to address the underlying causes of the complex risk factors influencing the spread of HIV.	[Patel, Sheetal; Schechter, Martin T.; Spittal, Patricia M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Patel, Sheetal; Schechter, Martin T.; Spittal, Patricia M.] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Sewankambo, Nelson K.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Kiwanuka, Noah] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	University of British Columbia; Makerere University; Makerere University	Patel, S (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	shepatel@ohri.ca		Schechter, Martin/0000-0001-6063-2155; Sewankambo, Nelson/0000-0001-9362-053X	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research (CIHR) Doctoral Research Award to Sheetal Patel. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi S, 2005, T ROY SOC TROP MED H, V99, P226, DOI 10.1016/j.trstmh.2004.09.008; Annan J, 2006, STAT YOUTH YOUTH PRO; Bagnol B, 2008, CULT HEALTH SEX, V10, P573, DOI 10.1080/13691050801999071; Becker Joseph U, 2008, Med Confl Surviv, V24, P101, DOI 10.1080/13623690801950351; Beksinska ME, 1999, SEX TRANSM INFECT, V75, P178, DOI 10.1136/sti.75.3.178; Carpenter LM, 2002, J ACQ IMMUN DEF SYND, V29, P174, DOI 10.1097/00042560-200202010-00011; Fabiani M, 2006, T ROY SOC TROP MED H, V100, P586, DOI 10.1016/j.trstmh.2005.09.002; Fabiani M, 2005, AIDS, V19, P823, DOI 10.1097/01.aids.0000168977.51843.d6; Fabiani M, 2001, AIDS, V15, P97, DOI 10.1097/00002030-200101050-00014; Fabiani Massimo, 2007, Confl Health, V1, P3, DOI 10.1186/1752-1505-1-3; Fabiani M, 2007, JAIDS-J ACQ IMM DEF, V46, P328, DOI 10.1097/QAI.0b013e31815724e7; Gafos M, 2010, CULT HEALTH SEX, V12, P929, DOI 10.1080/13691058.2010.507876; Hankins CA, 2002, AIDS, V16, P2245, DOI 10.1097/00002030-200211220-00003; Hanson BW, 2008, AIDS, V22, pS95, DOI 10.1097/01.aids.0000327441.66656.da; Hyena H, 1999, DRY SEX WORSENS AIDS; Internal Displacement Monitoring Centre, 2010, UG DIFF CONT RET REM; KAISER R, 2002, HIV SEROPREVALENCE B; Kaiser R, 2003, HIV STI SEROPREVALEN; Khaw AJ, 2000, DISASTERS, V24, P181, DOI 10.1111/1467-7717.00141; Koenig MA, 2004, SOC SCI MED, V58, P787, DOI 10.1016/S0277-9536(03)00244-2; Kun KE, 1998, INT FAM PLAN PERSPEC, V24, P93, DOI 10.2307/2991933; McInnes C, 2009, GLOB CHANG PEACE SEC, V21, P99, DOI 10.1080/14781150802659440; Mehta SD, 2007, SEX TRANSM INFECT, V84, P42, DOI 10.1136/sti.2007.025718; Mehta SD, 2007, SEX TRANSM DIS, V34, P892, DOI 10.1097/OLQ.0b013e318063c75d; Ministry of Health and ORC Macro, 2006, UG HIV AIDS SER SURV; Ministry of Health [Uganda] ICF International Centers for Disease Control and Prevention [Uganda] U. S. Agency for International Development & WHO Uganda, 2012, UG AIDS IND SURV 201; Mock Nancy B, 2004, Emerg Themes Epidemiol, V1, P6, DOI 10.1186/1742-7622-1-6; Obasi AI, 2001, TROP MED INT HEALTH, V6, P517, DOI 10.1046/j.1365-3156.2001.00738.x; Patel SH, 2006, THESIS S FRASER U VA; Patel S, 2011, CHILDREN'S RIGHTS AND INTERNATIONAL DEVELOPMENT: LESSONS AND CHALLENGES FROM THE FIELD, P195; Patel SH, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-38; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; Republic of Uganda World Health Organization, 2005, HLTH MORT SURV INT D; *SAV CHILDR, 2002, HIV CONFL DOUBL EM; Save the Children, 2001, STUD HIV AIDS PREV H; Schwandt M, 2006, SEX TRANSM INFECT, V82, P392, DOI 10.1136/sti.2006.019794; Scorgie F, 2009, CULT HEALTH SEX, V11, P267, DOI 10.1080/13691050802395915; Smith A, 2002, 38 HPN OV DEV I; Spiegel PB, 2007, LANCET, V369, P2187, DOI 10.1016/S0140-6736(07)61015-0; Spiegel PB, 2004, DISASTERS, V28, P322, DOI 10.1111/j.0361-3666.2004.00261.x; Spittal PM, 2008, WAYO PROGRAMME BUILD; Strand RT, 2007, INT J STD AIDS, V18, P467, DOI 10.1258/095646207781147300; Uganda National Council for Science and Technology, 2007, NAT GUID RES INV HUM; *UN, 2001, DECL COMM HIV AIDS; UNAIDS Office of the United Nations High Commissioner for Refugees, 2008, HIV REL NEEDS INT DI; UNICEF, 2002, ED HIV PREV; Westerhaus M., 2007, HUMAN SCI RES COUNCI, V4, P590; Westerhaus M J, 2008, Glob Public Health, V3, P39, DOI 10.1080/17441690600909294; Westerhaus MJ, 2007, AM J PUBLIC HEALTH, V97, P1184, DOI 10.2105/AJPH.2005.072777; Women's Commission for Refugee Women and Children, 2004, NO SAF PLAC CALL HOM; Women's Commission for Refugee Women and Children, 2005, LEARN WAR ZON ED NO; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	52	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89786	10.1371/journal.pone.0089786	http://dx.doi.org/10.1371/journal.pone.0089786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587034	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200082
J	Perera, PND; Hu, Q; Tang, JJ; Li, L; Barnhart, M; Doycheva, DM; Zhang, JH; Tang, JP				Perera, Pradilka N. Drunalini; Hu, Qin; Tang, Junjia; Li, Li; Barnhart, Margaret; Doycheva, Desislava M.; Zhang, John H.; Tang, Jiping			Delayed Remote Ischemic Postconditioning Improves Long Term Sensory Motor Deficits in a Neonatal Hypoxic Ischemic Rat Model	PLOS ONE			English	Article							BRAIN-INJURY; STIMULATING FACTOR; DAMAGE; BEHAVIOR	Objective: Remote Ischemic Postconditioning (RIPC) is a promising therapeutic intervention wherein a sub-lethal ischemic insult induced in one organ (limb) improves ischemia in an organ distant to it (brain). The main objective of this study was to investigate the long-term functional effects of delayed RIPC in a neonatal hypoxia-ischemia (HI) rat model. Method: 10 day old rat pups were subjected to delayed RIPC treatment and randomized into four groups: 1) Sham, 2) HI induced, 3) HI +24 hr delayed RIPC, and 4) HI +24 hr delayed RIPC with three consecutive daily treatments. Neurobehavioral tests, brain weights, gross and microscopic brain tissue morphologies, and systemic organ weights were evaluated at five weeks post surgery. Results: HI induced rats performed significantly worse than sham but both groups of delayed RIPC treatment showed improvement of sensory motor functions. Furthermore, compared to the HI induced group, the delayed RIPC treatment groups showed no further detrimental changes on brain tissue, both grossly and morphologically, and no changes on the systemic organ weights. Conclusion: Delayed RIPC significantly improves long term sensory motor deficits in a neonatal HI rat model. A 24 hr delayed treatment does not significantly attenuate morphological brain injury but does attenuate sensory motor deficits. Sensory motor deficits improve with both a single treatment and with three consecutive daily treatments, and the consecutive treatments are possibly being more beneficial.	[Perera, Pradilka N. Drunalini; Hu, Qin; Tang, Junjia; Li, Li; Doycheva, Desislava M.; Zhang, John H.; Tang, Jiping] Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Loma Linda, CA 92350 USA; [Barnhart, Margaret; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Neurosurg, Loma Linda, CA USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University	Tang, JP (corresponding author), Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Loma Linda, CA 92350 USA.	jtang@llu.edu	Hu, Qin/N-8930-2017	Hu, Qin/0000-0002-2270-8822; Doycheva, Desislava/0000-0001-7795-5989	NIH [NS060936, NS078755]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078755, R01NS060936] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH grant NS060936 to Jiping Tang and NS078755 to John H. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Dezfulian C, 2013, TRANSL STROKE RES, V4, P19, DOI 10.1007/s12975-012-0224-3; Dobrivojevic M, 2013, CROAT MED J, V54, P3, DOI 10.3325/cmj.2013.54.3; Doycheva D, 2013, TRANSL STROKE RES, V4, P171, DOI 10.1007/s12975-012-0225-2; Fathali N, 2010, INTENS CARE MED, V36, P1602, DOI 10.1007/s00134-010-1913-6; Hasegawa Y, 2013, TRANSL STROKE RES, V4, P524, DOI 10.1007/s12975-013-0260-7; Hasseldam H, 2013, NEUROL RES, V35, P336, DOI 10.1179/1743132812Y.0000000130; Hu Q, 2009, EXP NEUROL, V216, P35, DOI 10.1016/j.expneurol.2008.11.007; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Kim BR, 2008, YONSEI MED J, V49, P836, DOI 10.3349/ymj.2008.49.5.836; Lai MC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/609813; Lekic T, 2011, EXP NEUROL, V227, P96, DOI 10.1016/j.expneurol.2010.09.017; Lekic T, 2010, J NEUROTRAUM, V27, P627, DOI 10.1089/neu.2009.1163; Loukogeorgakis SP, 2007, CIRCULATION, V116, P1386, DOI 10.1161/CIRCULATIONAHA.106.653782; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; PALMER C, 1990, PEDIATR RES, V27, P332, DOI 10.1203/00006450-199004000-00003; Pazaiti A, 2009, NEONATOLOGY, V95, P33, DOI 10.1159/000151753; Peng B, 2012, BRAIN RES, V1445, P92, DOI 10.1016/j.brainres.2012.01.033; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Sidhu RS, 1997, NEUROSCI LETT, V223, P129, DOI 10.1016/S0304-3940(97)13426-7; Soejima Y, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-9; Sun J, 2012, J CEREBR BLOOD F MET, V32, P851, DOI 10.1038/jcbfm.2011.199; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Vannucci R.C, 1997, NEONATAL PERINATAL M, P856; Vannucci RC, 1997, PEDIATRICS, V100, P1004, DOI 10.1542/peds.100.6.1004; VANNUCCI RC, 1997, NEONATAL PERINATAL M, V4, P877; Vinten-Johansen J, 2013, J CARDIOVASC MED, V14, P206, DOI 10.2459/JCM.0b013e32835cecc6; Wang Q, 2011, ANESTH ANALG, V113, P1180, DOI 10.1213/ANE.0b013e31822b885f; Wei M, 2011, CIRC RES, V108, P1220, DOI 10.1161/CIRCRESAHA.110.236190; Yata K, 2007, BRAIN RES, V1145, P227, DOI 10.1016/j.brainres.2007.01.144; Zhao H, 2012, CURR DRUG TARGETS, V13, P173, DOI 10.2174/138945012799201621; Zhao YD, 2013, J NEUROSCI RES, V91, P1165, DOI 10.1002/jnr.23247; Zhou YL, 2011, STROKE, V42, P439, DOI 10.1161/STROKEAHA.110.592162; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757	35	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90258	10.1371/journal.pone.0090258	http://dx.doi.org/10.1371/journal.pone.0090258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587303	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200155
J	Rodriguez, CA; Turner, BM; McClure, SM				Rodriguez, Christian A.; Turner, Brandon M.; McClure, Samuel M.			Intertemporal Choice as Discounted Value Accumulation	PLOS ONE			English	Article							DRIFT-DIFFUSION MODEL; DECISION-MAKING; PERCEPTUAL DECISION; VISUAL FIXATIONS; TIME PRESSURE; NEURAL BASIS; ACCURACY; DISTRIBUTIONS; NEUROBIOLOGY; COMPUTATION	Two separate cognitive processes are involved in choosing between rewards available at different points in time. The first is temporal discounting, which consists of combining information about the size and delay of prospective rewards to represent subjective values. The second involves a comparison of available rewards to enable an eventual choice on the basis of these subjective values. While several mathematical models of temporal discounting have been developed, the reward selection process has been largely unexplored. To address this limitation, we evaluated the applicability of the Linear Ballistic Accumulator (LBA) model as a theory of the selection process in intertemporal choice. The LBA model formalizes the selection process as a sequential sampling algorithm in which information about different choice options is integrated until a decision criterion is reached. We compared several versions of the LBA model to demonstrate that choice outcomes and response times in intertemporal choice are well captured by the LBA process. The relationship between choice outcomes and response times that derives from the LBA model cannot be explained by temporal discounting alone. Moreover, the drift rates that drive evidence accumulation in the best-fitting LBA model are related to independently estimated subjective values derived from various temporal discounting models. These findings provide a quantitative framework for predicting dynamics of choice-related activity during the reward selection process in intertemporal choice and link intertemporal choice to other classes of decisions in which the LBA model has been applied.	[Rodriguez, Christian A.; Turner, Brandon M.; McClure, Samuel M.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Rodriguez, CA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	carodrig@stanford.edu		Rodriguez Mercado, Christian/0000-0002-8029-4998	National Science Foundation's (NSF) Graduate Research Fellowship Program (GRFP); NSF's Integrative Graduate Education and Research Traineeship (IGERT) program; National Institutes of Health [F32GM103288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091068] Funding Source: NIH RePORTER	National Science Foundation's (NSF) Graduate Research Fellowship Program (GRFP); NSF's Integrative Graduate Education and Research Traineeship (IGERT) program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Science Foundation's (NSF) Graduate Research Fellowship Program (GRFP), the NSF's Integrative Graduate Education and Research Traineeship (IGERT) program, and National Institutes of Health (F32GM103288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE G, 1991, AM ECON REV, V81, P334; Ando T, 2007, BIOMETRIKA, V94, P443, DOI 10.1093/biomet/asm017; Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; BUSEMEYER JR, 1993, PSYCHOL REV, V100, P432, DOI 10.1037/0033-295X.100.3.432; BUSEMEYER JR, 1985, J EXP PSYCHOL LEARN, V11, P538, DOI 10.1037/0278-7393.11.3.538; De Martino B., 2012, NAT NEUROSCI, V16, P105, DOI [10.1038/nn.3279, DOI 10.1038/NN.3279]; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2011, J NEUROSCI, V31, P17242, DOI 10.1523/JNEUROSCI.0309-11.2011; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Gelman A., 2004, BAYESIAN DATA ANAL; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Krajbich I, 2011, P NATL ACAD SCI USA, V108, P13852, DOI 10.1073/pnas.1101328108; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Lee M. D., 2012, COURSE BAYESIAN GRAP; Lee MD, 2008, PSYCHON B REV, V15, P1, DOI 10.3758/PBR.15.1.1; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rouder JN, 2005, PSYCHON B REV, V12, P573, DOI 10.3758/BF03196750; Rouder JN, 2005, PSYCHON B REV, V12, P195, DOI 10.3758/BF03257252; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shiffrin R, 2008, COGNITIVE SCI, V32, P1248, DOI 10.1080/03640210802414826; Ter Braak CJF, 2006, STAT COMPUT, V16, P239, DOI 10.1007/s11222-006-8769-1; Towal RB, 2013, P NATL ACAD SCI USA, V110, pE3858, DOI 10.1073/pnas.1304429110; Turner BM, 2013, NEUROIMAGE; Turner BM, 2013, INTRO MODEL BASED CO, P22; Turner BM, 2013, PSYCHOL METHODS, V18, P368, DOI 10.1037/a0032222; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; van den Bos W, 2013, J EXP ANAL BEHAV, V99, P58, DOI 10.1002/jeab.6	34	50	50	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90138	10.1371/journal.pone.0090138	http://dx.doi.org/10.1371/journal.pone.0090138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587243	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200137
J	Sun, X; Feng, ZC; Zhang, P; Shen, XL; Wei, L; Tian, MM				Sun, Xi; Feng, Zhanchun; Zhang, Ping; Shen, Xingliang; Wei, Li; Tian, Miaomiao			Association between Time of Pay-for-Performance for Patients and Community Health Services Use by Chronic Patients	PLOS ONE			English	Article							INCENTIVES; BEHAVIOR; IMPACT; TRIAL	Background: Pay-for-performance for patients is a cost-effective means of improving health behaviours. This study examined the association between the pay time for performance for patients and CHS use by chronic patients. Methods: A cross-sectional study was undertaken to estimate distribution characteristics of CHS use in 2011 and collect data of socio-demographic characteristics (sex, age, education level, occupation, disposable personal income in 2011, distance between home and community health agency), chronic disease number, and time of pay-for-performance for patients. Participants were 889 rural adults with hypertension or type II diabetes aged 35 and above. Standardized CHS use means chronic patients use CHS at least once per quarter. Results: Patients who received incentives prior to services had 2.724 times greater odds of using standardized CHS than those who received incentives after services (95% CI, 1.986-3.736, P<0.001). For all subgroups (socio-demographic characteristics and chronic disease number), patients who received incentives prior to services were more likely to use standardized CHS than those receiving incentives after services. Conclusions: Pay time for performance for patients was associated with CHS use by chronic patients. Patients receiving incentive prior to services were more likely to use standardized CHS. And pay time should not be ignored when the policy on pay-for-performance for patients is designed.	[Sun, Xi; Feng, Zhanchun] Huazhong Univ Sci & Technol, Med & Hlth Management Sch, Wuhan 430074, Hubei, Peoples R China; [Zhang, Ping; Shen, Xingliang] Hlth Bur Jiulongpo, Chongqing, Peoples R China; [Wei, Li] Wuhan Union Hosp, Wuhan, Hubei, Peoples R China; [Tian, Miaomiao] Chinese Acad Med Sci, Inst Med Informat, Ctr Hlth Policy & Management, Beijing 100730, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Information - CAMS	Feng, ZC (corresponding author), Huazhong Univ Sci & Technol, Med & Hlth Management Sch, Wuhan 430074, Hubei, Peoples R China.	zcfeng@hust.edu.cn			National Natural Science Foundation of China [70973042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by the National Natural Science Foundation of China (Program No: 70973042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland D, 2010, HABIT FORMATION NAIV; Benabou, 2005, INCENTIVES PROSOCIAL; BIRKHEAD GS, 1995, JAMA-J AM MED ASSOC, V274, P312, DOI 10.1001/jama.274.4.312; Chinese Center for Disease Control and Prevention, 2009, NPC CPPCC SPECILA CH; Chinese Preventive Medicine Association Chronic Disease Prevention and Control Branch, 2005, CHINESE J PREVENTION, V13, P1; DEREN S, 1994, PUBLIC HEALTH REP, V109, P548; Ellingsen T, 2007, J ECON PERSPECT, V21, P135, DOI 10.1257/jep.21.4.135; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; Gneezy U, 2000, Q J ECON, V115, P791, DOI 10.1162/003355300554917; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Haveman RH, 2010, PREV CHRONIC DIS, V7; [华思敏 Hua Simin], 2012, [中国全科医学, Chinese General Practice], V15, P737; Kane RL, 2004, AM J PREV MED, V27, P327, DOI 10.1016/j.amepre.2004.07.002; Meier S, 2007, J EUR ECON ASSOC, V5, P1203, DOI 10.1162/JEEA.2007.5.6.1203; Nissinen A, 2001, B WORLD HEALTH ORGAN, V79, P963; Owen N, 1990, Am J Health Promot, V5, P58, DOI 10.4278/0890-1171-5.1.58; Shao X, 2010, CHINESE PRIMARY HLTH, V24, P74; Tian HG, 1995, J HUM HYPERTENS, V9, P959; Volpp KG, 2009, HEALTH AFFAIR, V28, P206, DOI 10.1377/hlthaff.28.1.206; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Yu D, 2011, CHINESE GEN PRACTICE, V14, P288	22	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89793	10.1371/journal.pone.0089793	http://dx.doi.org/10.1371/journal.pone.0089793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587037	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200083
J	Brons, S; van Beusichem, ME; Bronkhorst, EM; Draaisma, JM; Berge, SJ; Schols, JG; Kuijpers-Jagtman, AM				Brons, Sander; van Beusichem, Machteld E.; Bronkhorst, Ewald M.; Draaisma, Jos M.; Berge, Stefaan J.; Schols, Jan G.; Kuijpers-Jagtman, Anne Marie			Methods to Quantify Soft Tissue-Based Cranial Growth and Treatment Outcomes in Children: A Systematic Review	PLOS ONE			English	Review							LOW-BIRTH-WEIGHT; RANDOMIZED CONTROLLED-TRIAL; MOLDING HELMET THERAPY; EARLY HEAD GROWTH; CATCH-UP GROWTH; 1ST 2 YEARS; PRETERM INFANTS; FOLLOW-UP; GESTATIONAL-AGE; TERM INFANTS	Context: Longitudinal assessment of cranial dimensions of growing children provides healthcare professionals with information about normal and deviating growth as well as treatment outcome. Objective: To give an overview of soft tissue-based methods for quantitative longitudinal assessment of cranial dimensions in children until age 6 years and to assess the reliability of these methods in studies with good methodological quality. Data source: PubMed, EMBASE, Cochrane Library, Web of Science, Scopus, and CINAHL were searched. A manual search was performed to check for additional relevant studies. Study selection: Primary publications on facial growth and treatment outcomes in children younger than age 6 years were included. Data extraction: Independent data extraction was performed by two observers. A quality assessment instrument was used to determine methodological quality. Methods used in studies with good methodological quality were assessed for reliability expressed as the magnitude of the measurement error and the correlation coefficient between repeated measurements. Results: In total, 165 studies were included, forming three groups of methods: head circumference anthropometry, direct anthropometry, and 2D photography and 3D imaging techniques (surface laser scanning and stereophotogrammetry). In general, the measurement error was below 2 mm, and correlation coefficients were very good. Conclusion: Various methods for measuring cranial dimensions have shown to be reliable. Stereophotogrammetry is the most versatile method for quantitative longitudinal assessment of cranial dimensions and shapes in children. However, direct anthropometry continues to be the best method for routine clinical assessments of linear cranial dimensions in growing children until age 6 years.	[Brons, Sander; van Beusichem, Machteld E.; Schols, Jan G.; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands; [Bronkhorst, Ewald M.] Radboud Univ Nijmegen, Med Ctr, Dept Prevent & Curat Dent, NL-6525 ED Nijmegen, Netherlands; [Draaisma, Jos M.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands; [Berge, Stefaan J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Brons, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.	orthodontics@dent.umcn.nl	Bronkhorst, Ewald/AAR-2250-2020; Schols, J.G.J.H./L-4635-2015; Bergé, S.J./H-8011-2014; Draaisma, J.M.T./L-4283-2015; Berge, Stefaan/AAP-3708-2020; Brons, Sander/I-2714-2018; Bronkhorst, Ewald/L-4230-2015; Schols, Jan G.J.H./AAD-9418-2022; Kuijpers-Jagtman, Anne Marie/A-9413-2008	Bronkhorst, Ewald/0000-0003-0953-8053; Schols, J.G.J.H./0000-0002-4452-4389; Brons, Sander/0000-0001-5263-4804; Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090; Draaisma, Jos/0000-0003-4829-6173	Dutch Technology Foundation [10315]	Dutch Technology Foundation(Technologiestichting STW)	This work was supported by a grant from the Dutch Technology Foundation to STW (grant number 10315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2006, J NEUROSURG, V105, P357, DOI 10.3171/ped.2006.105.5.357; Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Ayoub A, 2003, CLEFT PALATE-CRAN J, V40, P523, DOI 10.1597/02-067; Tinoco SMB, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-23; Bartzela TN, 2011, INT J ORAL IN PRESS; Belfort MB, 2011, PEDIATRICS, V128, pE899, DOI 10.1542/peds.2011-0282; Bendersky M, 1998, CLIN PEDIATR, V37, P469, DOI 10.1177/000992289803700802; Berry MA, 1997, PEDIATRICS, V100, P647, DOI 10.1542/peds.100.4.647; Bhalla A K, 1993, Indian Pediatr, V30, P41; Binns HJ, 1996, ARCH PEDIAT ADOL MED, V150, P842, DOI 10.1001/archpedi.1996.02170330068012; Boluyt N, 2008, ARCH PEDIAT ADOL MED, V162, P111, DOI 10.1001/archpediatrics.2007.40; Boros CA, 2007, ARTHRIT RHEUM-ARTHR, V57, P261, DOI 10.1002/art.22543; Bouthoorn SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039798; Bracewell MA, 2008, ARCH DIS CHILD-FETAL, V93, pF108, DOI 10.1136/adc.2007.118596; Broadbent BH, 1931, ANGLE ORTHOD, V1, P45, DOI [10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1931)001<0045:ANXTAI>2.0.CO;2]; Brons S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041898; Butz AM, 2005, J CHILD ADOLES SUBST, V14, P15, DOI 10.1300/J029v14n04_02; Cardoso LE, 2007, NUTR HOSP, P22322; Carlson SE, 1996, AM J CLIN NUTR, V63, P687, DOI 10.1093/ajcn/63.5.687; Cevidanes LH, 2011, ORAL SURG O IN PRESS; Chan FC, 2013, J CRANIOFAC SURG, V24, P416, DOI 10.1097/SCS.0b013e31827ff296; Chatterjee JS, 2009, J PLAST RECONSTR AES, V62, P211, DOI 10.1016/j.bjps.2007.10.042; Chaudhari S, 2012, INDIAN PEDIATR, V49, P727, DOI 10.1007/s13312-012-0165-7; Clark HD, 1999, CONTROL CLIN TRIALS, V20, P448, DOI 10.1016/S0197-2456(99)00026-4; Collett BR, 2012, J PEDIATR-US, V160, P673, DOI 10.1016/j.jpeds.2011.09.059; Davis JP, 2010, FORENSIC SCI INT, V200, P165, DOI 10.1016/j.forsciint.2010.04.012; de Bruin NC, 1998, AM J CLIN NUTR, V67, P885, DOI 10.1093/ajcn/67.5.885; deRegnier RAO, 1996, J NUTR, V126, P168, DOI 10.1093/jn/126.1.168; Desmyttere S, 2009, EARLY HUM DEV, V85, P755, DOI 10.1016/j.earlhumdev.2009.10.003; Desmyttere S, 2009, HUM REPROD, V24, P470, DOI 10.1093/humrep/den402; Djordjevic J, 2011, EUR J ORTHOD; Donma MM, 1997, BRAIN DEV-JPN, V19, P393, DOI 10.1016/S0387-7604(97)00041-7; DSOUZA SW, 1986, ARCH DIS CHILD, V61, P1090, DOI 10.1136/adc.61.11.1090; Durmus B, 2011, AM J CLIN NUTR, V94, P164, DOI 10.3945/ajcn.110.009225; Ekblad M, 2010, J PEDIATR-US, V156, P185, DOI 10.1016/j.jpeds.2009.07.061; ELWOOD PC, 1987, ANN HUM BIOL, V14, P543, DOI 10.1080/03014468700009381; Erasmus HD, 2002, J PEDIATR-US, V141, P532, DOI 10.1067/mpd.2002.127499; Eregie CO, 2001, J TROP PEDIATRICS, V47, P329, DOI 10.1093/tropej/47.6.329; ERNST JA, 1990, J PEDIATR-US, V117, pS156, DOI 10.1016/S0022-3476(05)80014-9; FARKAS LG, 1980, PLAST RECONSTR SURG, V66, P346, DOI 10.1097/00006534-198066030-00004; Farooqi A, 2006, PEDIATRICS, V118, pE1452, DOI 10.1542/peds.2006-1069; Fearon JA, 2006, PLAST RECONSTR SURG, V117, P532, DOI 10.1097/01.prs.0000200774.31311.09; Fearon JA, 2009, PLAST RECONSTR SURG, V123, P635, DOI 10.1097/PRS.0b013e318195661a; FORD G, 1986, EARLY HUM DEV, V13, P329, DOI 10.1016/0378-3782(86)90068-X; Ford GW, 2000, ARCH PEDIAT ADOL MED, V154, P778, DOI 10.1001/archpedi.154.8.778; FRIEL JK, 1993, J PEDIATR GASTR NUTR, V17, P97, DOI 10.1097/00005176-199307000-00015; Fukumoto A, 2008, J AUTISM DEV DISORD, V38, P411, DOI 10.1007/s10803-007-0405-1; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034; GEORGIEFF MK, 1985, J PEDIATR-US, V107, P581, DOI 10.1016/S0022-3476(85)80028-7; GEORGIEFF MK, 1989, J PEDIATR-US, V114, P288, DOI 10.1016/S0022-3476(89)80799-1; Gordon JM, 2009, ANGLE ORTHOD, V79, P1000, DOI 10.2319/082108-441.1; GROSS SJ, 1983, J PEDIATR-US, V103, P946, DOI 10.1016/S0022-3476(83)80727-6; GROSS SJ, 1983, PEDIATRICS, V71, P70; GUO S, 1988, J PEDIATR-US, V113, P490, DOI 10.1016/S0022-3476(88)80634-6; HAGELBERG S, 1990, ACTA PAEDIATR SCAND, V79, P1163; Hansen-Pupp I, 2011, PEDIATR RES, V69, P448, DOI 10.1203/PDR.0b013e3182115000; Herrmann KR, 2010, NUTR CLIN PRACT, V25, P69, DOI 10.1177/0884533609359001; Hutchison BL, 2011, ARCH DIS CHILD, V96, P85, DOI 10.1136/adc.2010.190934; Hutchison BL, 2010, ACTA PAEDIATR, V99, P1556, DOI 10.1111/j.1651-2227.2010.01872.x; Hutchison BL, 2004, PEDIATRICS, V114, P970, DOI 10.1542/peds.2003-0668-F; ISHIKAWA T, 1987, ACTA PAEDIATR SCAND, V76, P824, DOI 10.1111/j.1651-2227.1987.tb10571.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JAFFE M, 1992, PEDIATRICS, V90, P190; Jaldin Maria da Graça M, 2011, Rev. paul. pediatr., V29, P509; Jaruratanasirikul Somchit, 1999, Journal of the Medical Association of Thailand, V82, P325; Kan E, 2008, EARLY HUM DEV, V84, P409, DOI 10.1016/j.earlhumdev.2007.11.002; Karatza AA, 2003, CLIN PEDIATR, V42, P533, DOI 10.1177/000992280304200608; Kau CH, 2011, AM J ORTHOD DENTOFAC, V139, pE285, DOI 10.1016/j.ajodo.2009.03.054; Kiran PSS, 2007, INDIAN J PEDIATR, V74, P463, DOI 10.1007/s12098-007-0079-x; Kitchen WH, 1992, AM J DIS CHILD, P14646; Koo WWK, 2006, AM J CLIN NUTR, V84, P1357, DOI 10.1093/ajcn/84.6.1357; Lagravere MO, 2005, ANGLE ORTHOD, V75, P1046; Lainhart JE, 1997, J AM ACAD CHILD PSY, V36, P282, DOI 10.1097/00004583-199702000-00019; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lasekan JB, 2006, J AM COLL NUTR, V25, P12, DOI 10.1080/07315724.2006.10719509; Lasekan JB, 2011, CLIN PEDIATR, V50, P330, DOI 10.1177/0009922810390511; Lee RP, 2008, CLEFT PALATE-CRAN J, V45, P240, DOI 10.1597/06-210.1; Lee WT, 2006, J CRANIOFAC SURG, V17, P139, DOI 10.1097/01.scs.0000195375.24754.38; Lipira AB, 2010, PEDIATRICS, V126, pE936, DOI 10.1542/peds.2009-1249; Lira PIC, 2010, DEV MED CHILD NEUROL, V52, P40, DOI 10.1111/j.1469-8749.2009.03353.x; Littlefield TR, 1998, J CRANIOFAC SURG, V9, P11, DOI 10.1097/00001665-199801000-00004; Lucas A, 2001, PEDIATRICS, V108, P703, DOI 10.1542/peds.108.3.703; Maal TJJ, 2010, J ORAL MAXIL SURG, V68, P2391, DOI 10.1016/j.joms.2009.10.017; Maguire CM, 2008, PEDIATRICS, V121, pE239, DOI 10.1542/peds.2007-1189; Makrides M, 2000, AM J CLIN NUTR, V71, P120; Makrides M, 1999, PEDIATRICS, V104, P468, DOI 10.1542/peds.104.3.468; Mamabolo RL, 2004, NUTRITION, V20, P327, DOI 10.1016/j.nut.2003.11.011; MARKS KH, 1979, J PEDIATR-US, V94, P282, DOI 10.1016/S0022-3476(79)80844-6; Masarei AG, 2007, CLEFT PALATE-CRAN J, V44, P182, DOI 10.1597/05-184.1; Mathur NB, 2009, INDIAN J PEDIATR, V76, P1003, DOI 10.1007/s12098-009-0204-0; McCowan L, 1999, EARLY HUM DEV, V56, P205, DOI 10.1016/S0378-3782(99)00044-4; McGarry A, 2008, DEV MED CHILD NEUROL, V50, P568, DOI 10.1111/j.1469-8749.2008.03017.x; McLeod G, 2011, J PAEDIATR CHILD H, V47, P127, DOI 10.1111/j.1440-1754.2010.01900.x; Mercuri E, 2000, PEDIATRICS, V106, P235, DOI 10.1542/peds.106.2.235; Meyer-Marcotty P, 2012, J OROFAC ORTHOP, V73, P151, DOI 10.1007/s00056-011-0070-z; MOORE WMO, 1995, EARLY HUM DEV, V42, P111, DOI 10.1016/0378-3782(95)01643-H; Morhardt DR, 2013, J CHILD NEUROL; Moye J, 1996, J PEDIATR-US, V128, P58, DOI 10.1016/S0022-3476(96)70428-6; Mulliken JB, 1999, PLAST RECONSTR SURG, V103, P371, DOI 10.1097/00006534-199902000-00003; Nada RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016520; Nelson KG, 1997, ACTA OBSTET GYN SCAN, V76, P87; Nollet PJPM, 2008, INT J ORAL MAX SURG, V37, P123, DOI 10.1016/j.ijom.2007.09.168; Ochiai M, 2008, J PERINAT MED, V36, P341, DOI 10.1515/JPM.2008.042; Olivan G, 2003, CHILD ABUSE NEGLECT, V27, P103, DOI 10.1016/S0145-2134(02)00513-6; Oliveira MG, 2008, J TROP PEDIATRICS, V54, P36, DOI 10.1093/tropej/fmm103; Padilla N, 2010, ACTA PAEDIAT; Paul B, 2008, Indian J Public Health, V52, P16; Pedroso FS, 2008, J CHILD NEUROL, V23, P1419, DOI 10.1177/0883073808319318; Peng YM, 2005, ACTA PAEDIATR, V94, P843, DOI 10.1080/08035250510027589; Piemontese P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028010; Plank LH, 2006, J CRANIOFAC SURG, V17, P1084, DOI 10.1097/01.scs.0000244920.07383.85; Polberger S, 1999, J PEDIATR GASTR NUTR, V29, P332, DOI 10.1097/00005176-199909000-00017; Rijken M, 2007, EARLY HUM DEV, V83, P527, DOI 10.1016/j.earlhumdev.2006.10.002; Roberfroid D, 2012, AM J CLIN NUTR, V95, P916, DOI 10.3945/ajcn.111.029033; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; ROCHE AF, 1987, PEDIATRICS, V79, P706; Rodriguez Garcia J, 2003, An Pediatr (Barc), V58, P241; Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009; Ross GS, 2012, EARLY HUM DEV, V88, P753, DOI 10.1016/j.earlhumdev.2012.04.001; Rothenberg SJ, 1999, NEUROTOXICOL TERATOL, V21, P1, DOI 10.1016/S0892-0362(98)00034-8; SALIBA E, 1990, ARCH DIS CHILD-FETAL, V65, P1029, DOI 10.1136/adc.65.10_Spec_No.1029; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sawada A, 2010, PEDIATR INT, V52, P343, DOI 10.1111/j.1442-200X.2009.03002.x; Schaaf H, 2010, J CRANIOFAC SURG, V21, P1677, DOI 10.1097/SCS.0b013e3181f3c630; SCHAEFER F, 1994, ACTA PAEDIATR, V83, P534, DOI 10.1111/j.1651-2227.1994.tb13075.x; Sharma PK, 2011, INDIAN J PEDIATR, V78, P1485, DOI 10.1007/s12098-011-0442-9; Shaw WC, 1999, CLEFT PALATE-CRAN J, V36, P262, DOI 10.1597/1545-1569(1999)036<0262:AFIMRF>2.3.CO;2; SHETH RD, 1995, ARCH PEDIAT ADOL MED, V149, P1358, DOI 10.1001/archpedi.1995.02170250064011; Shortland GJ, 1998, ARCH DIS CHILD-FETAL, V78, pF185, DOI 10.1136/fn.78.3.F185; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Swennen GRJ, 2004, J CRANIOFAC SURG, V15, P399, DOI 10.1097/00001665-200405000-00010; Tan M, 2008, ARCH DIS CHILD-FETAL, V93, pF342, DOI 10.1136/adc.2007.124255; Teichgraeber JF, 2004, J CRANIOFAC SURG, V15, P118, DOI 10.1097/00001665-200401000-00031; Teichgraeber JF, 2002, CLEFT PALATE-CRAN J, V39, P582, DOI 10.1597/1545-1569(2002)039<0582:DPPDAT>2.0.CO;2; Toma AM, 2008, ORTHOD CRANIOFAC RES, V11, P180, DOI 10.1111/j.1601-6343.2008.00428.x; Toma R, 2010, J CRANIOFAC SURG, V21, P637, DOI 10.1097/SCS.0b013e3181d841d9; Touwslager RNH, 2008, HORM RES, V70, P273, DOI 10.1159/000157873; Vaidya A, 2008, LANCET, V371, P492, DOI 10.1016/S0140-6736(08)60172-5; van Daalen E, 2007, PEDIATR NEUROL, V37, P324, DOI 10.1016/j.pediatrneurol.2007.06.006; van Loon B, 2011, RHINOLOGY, V49, P121, DOI 10.4193/Rhino10.056; van Vlijmen OJC, 2012, J AM DENT ASSOC, V143, P241, DOI 10.14219/jada.archive.2012.0148; van Vlimmeren LA, 2008, ARCH PEDIAT ADOL MED, V162, P712, DOI 10.1001/archpedi.162.8.712; van Vlimmeren LA, 2007, PEDIATRICS, V119, pE408, DOI 10.1542/peds.2006-2012; Whitehouse AJO, 2010, DEV MED CHILD NEUROL, V52, pE73, DOI 10.1111/j.1469-8749.2009.03546.x; Wong JY, 2008, CLEFT PALATE-CRAN J, V45, P232, DOI 10.1597/06-175; Wood NS, 2003, ARCH DIS CHILD-FETAL, V88, pF492, DOI 10.1136/fn.88.6.F492; Zabaneh R, 2012, AM J PERINAT, V29, P203, DOI 10.1055/s-0031-1285094	149	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89602	10.1371/journal.pone.0089602	http://dx.doi.org/10.1371/journal.pone.0089602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586904	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800029
J	Di Martino, MT; Campani, V; Misso, G; Cantafio, MEG; Gulla, A; Foresta, U; Guzzi, PH; Castellano, M; Grimaldi, A; Gigantino, V; Franco, R; Lusa, S; Cannataro, M; Tagliaferri, P; De Rosa, G; Tassone, P; Caraglia, M				Di Martino, Maria Teresa; Campani, Virginia; Misso, Gabriella; Cantafio, Maria Eugenia Gallo; Gulla, Annamaria; Foresta, Umberto; Guzzi, Pietro Hiram; Castellano, Maria; Grimaldi, Anna; Gigantino, Vincenzo; Franco, Renato; Lusa, Sara; Cannataro, Mario; Tagliaferri, Pierosandro; De Rosa, Giuseppe; Tassone, Pierfrancesco; Caraglia, Michele			In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma	PLOS ONE			English	Article							GENE-EXPRESSION; ANTITUMOR-ACTIVITY; CANCER; MODEL; THERAPEUTICS; ACTIVATION; MICRORNAS; PATHWAY; TARGET; CELLS	Multiple myeloma (MM) is a disease with an adverse outcome and new therapeutic strategies are urgently awaited. A rising body of evidence supports the notion that microRNAs (miRNAs), master regulators of eukaryotic gene expression, may exert anti-MM activity. Here, we evaluated the activity of synthetic miR-34a in MM cells. We found that transfection of miR-34a mimics in MM cells induces a significant change of gene expression with relevant effects on multiple signal transduction pathways. We detected early inactivation of pro-survival and proliferative kinases Erk-2 and Akt followed at later time points by caspase-6 and -3 activation and apoptosis induction. To improve the in vivo delivery, we encapsulated miR-34a mimics in stable nucleic acid lipid particles (SNALPs). We found that SNALPs miR-34a were highly efficient in vitro in inhibiting growth of MM cells. Then, we investigated the activity of the SNALPs miR-34a against MM xenografts in SCID mice. We observed significant tumor growth inhibition (p<0.05) which translated in mice survival benefits (p = 0.0047). Analysis of miR-34a and NOTCH1 expression in tumor retrieved from animal demonstrated efficient delivery and gene modulation induced by SNALPs miR-34a in the absence of systemic toxicity. We here therefore provide evidence that SNALPs miR-34a may represent a promising tool for miRNA-therapeutics in MM.	[Di Martino, Maria Teresa; Cantafio, Maria Eugenia Gallo; Gulla, Annamaria; Foresta, Umberto; Tagliaferri, Pierosandro; Tassone, Pierfrancesco] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Di Martino, Maria Teresa; Cantafio, Maria Eugenia Gallo; Gulla, Annamaria; Foresta, Umberto; Tagliaferri, Pierosandro; Tassone, Pierfrancesco] Med Oncol Unit, Catanzaro, Italy; [Di Martino, Maria Teresa; Tagliaferri, Pierosandro; Tassone, Pierfrancesco] Salvatore Venuta Univ Campus, T Campanella Canc Ctr, Catanzaro, Italy; [Campani, Virginia; Lusa, Sara; De Rosa, Giuseppe] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Misso, Gabriella; Castellano, Maria; Grimaldi, Anna; Caraglia, Michele] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Guzzi, Pietro Hiram] Salvatore Venuta Univ Campus, Dept Med & Surg Sci, Lab Bioinformat Unit, Catanzaro, Italy; [Gigantino, Vincenzo; Franco, Renato] Natl Inst Tumours Naples Pascale, Pathol Unit, Naples, Italy; [Tassone, Pierfrancesco; Caraglia, Michele] Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA	Magna Graecia University of Catanzaro; University of Naples Federico II; Universita della Campania Vanvitelli; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Cantafio, MEG (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	michele.caraglia@unina2.it	Tagliaferri, Pierosandro/K-9546-2016; Caraglia, Michele/AAK-4569-2020; Tassone, Pierfrancesco/AIA-5373-2022; Caraglia, Michele/N-5670-2015; campani, virginia/AAB-8654-2022; Cannataro, Mario/B-1503-2012; Guzzi, Pietro Hiram/AAF-4094-2020; Gulla, Annamaria/ABF-4307-2021; Caraglia, Michele/AFY-9729-2022	Caraglia, Michele/0000-0003-2408-6091; Tassone, Pierfrancesco/0000-0002-8298-6787; Caraglia, Michele/0000-0003-2408-6091; campani, virginia/0000-0002-9339-922X; Cannataro, Mario/0000-0003-1502-2387; Caraglia, Michele/0000-0003-2408-6091; Gigantino, Vincenzo/0000-0002-8914-8823; Gulla, Annamaria/0000-0003-4569-0095; Franco, Renato/0000-0002-8340-3184; DI MARTINO, Maria Teresa/0000-0002-8205-2706; Misso, Gabriella/0000-0002-7787-2531	Italian Association for Cancer Research (AIRC); Special Program Molecular Clinical Oncology - "5 per mille" [9980]; Italian Ministry of Education and Research [PRIN 2009-2009EHW394]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology - "5 per mille"(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR))	This work has been supported by the Italian Association for Cancer Research (AIRC) PI: P.T., Special Program Molecular Clinical Oncology - "5 per mille", grant n. 9980, 2010-15. MC received a financial support by the Italian Ministry of Education and Research (PRIN 2009-2009EHW394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.175; Amodio N, 2013, CELL CYCLE, V12, P3650, DOI 10.4161/cc.26585; Amodio N, 2013, EXPERT OPIN BIOL TH, V13, pS125, DOI 10.1517/14712598.2013.796356; Amodio N, 2012, ONCOTARGET, V3, P1246; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bravo V, 2007, BIOCHEM BIOPH RES CO, V353, P1052, DOI 10.1016/j.bbrc.2006.12.135; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chim CS, 2010, CARCINOGENESIS, V31, P745, DOI 10.1093/carcin/bgq033; de Antonellis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024584; De Rosa G, 2010, EXPERT OPIN DRUG DEL, V7, P1263, DOI 10.1517/17425247.2010.527942; Di Martino MT, 2012, CLIN CANCER RES, V18, P6260, DOI 10.1158/1078-0432.CCR-12-1708; Di Martino MT, 2013, ONCOTARGET, V4, P242, DOI 10.18632/oncotarget.820; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lee YH, 2011, ONCOGENE, V30, P4175, DOI 10.1038/onc.2011.126; Leone E, 2013, CLIN CANCER RES, V19, P2096, DOI 10.1158/1078-0432.CCR-12-3325; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lionetti M, 2012, CURR CANCER DRUG TAR, V12, P823, DOI 10.2174/156800912802429274; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackiewicz M, 2011, BREAST CANCER RES TR, V130, P663, DOI 10.1007/s10549-011-1690-0; Maeda H, 2012, J CONTROL RELEASE, V164, P138, DOI 10.1016/j.jconrel.2012.04.038; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Neri P, 2008, BRIT J HAEMATOL, V143, P520, DOI 10.1111/j.1365-2141.2008.07387.x; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rossi M, 2013, CURR DRUG TARGETS, V14, P1144, DOI 10.2174/13894501113149990186; Rossi M, 2013, J CELL PHYSIOL, V228, P1506, DOI 10.1002/jcp.24306; Rossi M, 2012, CURR CANCER DRUG TAR, V12, P757, DOI 10.2174/156800912802429300; Semple SC, 2001, BBA-BIOMEMBRANES, V1510, P152, DOI 10.1016/S0005-2736(00)00343-6; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Tagliaferri P, 2012, CURR CANCER DRUG TAR, V12, P838, DOI 10.2174/156800912802429355; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tassone P, 2005, BLOOD, V106, P713, DOI 10.1182/blood-2005-01-0373; Tassone P, 2005, BLOOD, V106, P1341, DOI 10.1182/blood-2004-11-4477; Tassone P, 2012, CURR CANCER DRUG TAR, V12, P814, DOI 10.2174/156800912802429292; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tili Esmerina, 2007, Future Oncol, V3, P521, DOI 10.2217/14796694.3.5.521; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Tu YP, 2000, CANCER RES, V60, P6763; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Younes H, 2007, CLIN CANCER RES, V13, P3771, DOI 10.1158/1078-0432.CCR-06-2921; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	49	85	87	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90005	10.1371/journal.pone.0090005	http://dx.doi.org/10.1371/journal.pone.0090005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587182	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800065
J	Dupont, CL; Larsson, J; Yooseph, S; Ininbergs, K; Goll, J; Asplund-Samuelsson, J; McCrow, JP; Celepli, N; Allen, LZ; Ekman, M; Lucas, AJ; Hagstrom, A; Thiagarajan, M; Brindefalk, B; Richter, AR; Andersson, AF; Tenney, A; Lundin, D; Tovchigrechko, A; Nylander, JAA; Brami, D; Badger, JH; Allen, AE; Rusch, DB; Hoffman, J; Norrby, E; Friedman, R; Pinhassi, J; Venter, JC; Bergman, B				Dupont, Chris L.; Larsson, John; Yooseph, Shibu; Ininbergs, Karolina; Goll, Johannes; Asplund-Samuelsson, Johannes; McCrow, John P.; Celepli, Narin; Allen, Lisa Zeigler; Ekman, Martin; Lucas, Andrew J.; Hagstrom, Ake; Thiagarajan, Mathangi; Brindefalk, Bjorn; Richter, Alexander R.; Andersson, Anders F.; Tenney, Aaron; Lundin, Daniel; Tovchigrechko, Andrey; Nylander, Johan A. A.; Brami, Daniel; Badger, Jonathan H.; Allen, Andrew E.; Rusch, Douglas B.; Hoffman, Jeff; Norrby, Erling; Friedman, Robert; Pinhassi, Jarone; Venter, J. Craig; Bergman, Birgitta			Functional Tradeoffs Underpin Salinity-Driven Divergence in Microbial Community Composition	PLOS ONE			English	Article							BACTERIAL-GROWTH EFFICIENCY; BALTIC SEA; OCEAN; METAGENOMICS; RESPIRATION; PERFORMANCE; ESTUARINE; DIVERSITY; SEQUENCES; GRADIENT	Bacterial community composition and functional potential change subtly across gradients in the surface ocean. In contrast, while there are significant phylogenetic divergences between communities from freshwater and marine habitats, the underlying mechanisms to this phylogenetic structuring yet remain unknown. We hypothesized that the functional potential of natural bacterial communities is linked to this striking divide between microbiomes. To test this hypothesis, metagenomic sequencing of microbial communities along a 1,800 km transect in the Baltic Sea area, encompassing a continuous natural salinity gradient from limnic to fully marine conditions, was explored. Multivariate statistical analyses showed that salinity is the main determinant of dramatic changes in microbial community composition, but also of large scale changes in core metabolic functions of bacteria. Strikingly, genetically and metabolically different pathways for key metabolic processes, such as respiration, biosynthesis of quinones and isoprenoids, glycolysis and osmolyte transport, were differentially abundant at high and low salinities. These shifts in functional capacities were observed at multiple taxonomic levels and within dominant bacterial phyla, while bacteria, such as SAR11, were able to adapt to the entire salinity gradient. We propose that the large differences in central metabolism required at high and low salinities dictate the striking divide between freshwater and marine microbiomes, and that the ability to inhabit different salinity regimes evolved early during bacterial phylogenetic differentiation. These findings significantly advance our understanding of microbial distributions and stress the need to incorporate salinity in future climate change models that predict increased levels of precipitation and a reduction in salinity.	[Dupont, Chris L.; McCrow, John P.; Allen, Lisa Zeigler; Allen, Andrew E.; Friedman, Robert; Venter, J. Craig] J Craig Venter Inst, Microbial & Environm Genom, San Diego, CA USA; [Larsson, John; Ininbergs, Karolina; Asplund-Samuelsson, Johannes; Celepli, Narin; Ekman, Martin; Brindefalk, Bjorn; Bergman, Birgitta] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Yooseph, Shibu; Richter, Alexander R.; Tenney, Aaron; Badger, Jonathan H.] J Craig Venter Inst, Informat Grp, San Diego, CA USA; [Goll, Johannes; Thiagarajan, Mathangi; Tovchigrechko, Andrey; Rusch, Douglas B.] J Craig Venter Inst, Informat Grp, Rockville, MD USA; [Lucas, Andrew J.] Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, San Diego, CA 92103 USA; [Hagstrom, Ake] Univ Gothenburg, SIME, Gothenburg, Sweden; [Andersson, Anders F.; Lundin, Daniel] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Solna, Sweden; [Nylander, Johan A. A.] Swedish Museum Nat Hist, Dept Biodivers Informat, S-10405 Stockholm, Sweden; [Norrby, Erling] Royal Swedish Acad Sci, Ctr Hist Sci, Stockholm, Sweden; [Pinhassi, Jarone] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden	J. Craig Venter Institute; Stockholm University; J. Craig Venter Institute; J. Craig Venter Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Gothenburg; Royal Institute of Technology; Swedish Museum of Natural History; Royal Swedish Academy of Sciences; Linnaeus University	Dupont, CL (corresponding author), J Craig Venter Inst, Microbial & Environm Genom, San Diego, CA USA.	cdupont@jcvi.org; john.larsson@su.se	Andersson, Anders/J-9310-2019; Allen, Andrew E/C-4896-2012; Hagström, Åke/Q-9257-2019	Andersson, Anders/0000-0002-3627-6899; Allen, Andrew E/0000-0001-5911-6081; Yooseph, Shibu/0000-0001-5581-5002; McCrow, John/0000-0002-7014-5040; Lundin, Daniel/0000-0002-8779-6464; Lucas, Andrew/0000-0001-7722-7252; Asplund-Samuelsson, Johannes/0000-0001-8077-5305	Beyster Family Fund of the San Diego Foundation; Life Technologies Foundation; National Science Foundation [0850256]; BalticSea2020 Foundation; O. Engkvist Byggmastare Foundation; Science for Life Laboratory, Stockholm; Baltic Ecosystem Adaptive Management Program; EcoChange	Beyster Family Fund of the San Diego Foundation; Life Technologies Foundation; National Science Foundation(National Science Foundation (NSF)); BalticSea2020 Foundation; O. Engkvist Byggmastare Foundation; Science for Life Laboratory, Stockholm; Baltic Ecosystem Adaptive Management Program; EcoChange(European Commission)	This work was supported by the Beyster Family Fund of the San Diego Foundation; Life Technologies Foundation; National Science Foundation (grant 0850256); BalticSea2020 Foundation; O. Engkvist Byggmastare Foundation; Science for Life Laboratory, Stockholm; Baltic Ecosystem Adaptive Management Program; EcoChange. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LZ, 2012, ISME J, V6, P1403, DOI 10.1038/ismej.2011.201; Campbell BJ, 2013, ISME J, V7, P210, DOI 10.1038/ismej.2012.93; CHINLEO G, 1992, MAR ECOL PROG SER, V87, P87, DOI 10.3354/meps087087; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; de Leeuw E, 1999, MOL MICROBIOL, V31, P983, DOI 10.1046/j.1365-2958.1999.01245.x; Debroas D., 2011, HDB MOL MICROBIAL EC, P287; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Eiler A, 2014, ENVIRON MICROBIOL, V16, P2682, DOI 10.1111/1462-2920.12301; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Goll J, 2010, BIOINFORMATICS, V26, P2631, DOI 10.1093/bioinformatics/btq455; Grote J, 2012, MBIO, V3; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hewson I, 2009, LIMNOL OCEANOGR, V54, P1981, DOI 10.4319/lo.2009.54.6.1981; Kogure K, 1998, CURR OPIN BIOTECH, V9, P278, DOI 10.1016/S0958-1669(98)80059-1; Langenheder S, 2003, FEMS MICROBIOL ECOL, V45, P189, DOI 10.1016/S0168-6496(03)00149-1; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meier HEM, 2012, CLIM DYNAM, V39, P2421, DOI 10.1007/s00382-012-1339-7; Meier HEM, 2006, CLIM DYNAM, V27, P39, DOI 10.1007/s003S2-006-0124-x; Molina N, 2009, TRENDS GENET, V25, P243, DOI 10.1016/j.tig.2009.04.004; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Odom AR, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002323, DOI 10.1371/J0URNAL.PPAT.1002323]; Oh HM, 2011, J BACTERIOL, V193, P3379, DOI 10.1128/JB.05033-11; Patel PV, 2010, GENOME RES, V20, P960, DOI 10.1101/gr.102814.109; Raes J, 2011, MOL SYST BIOL, V7; Ram ASP, 2003, MICROBIAL ECOL, V45, P88, DOI 10.1007/s00248-002-3005-9; Reissmann JH, 2009, PROG OCEANOGR, V82, P47, DOI 10.1016/j.pocean.2007.10.004; Remane A., 1934, VERHANDLUNGEN DTSCH; Rivkin RB, 2001, SCIENCE, V291, P2398, DOI 10.1126/science.291.5512.2398; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schwalbach MS, 2010, ENVIRON MICROBIOL, V12, P490, DOI 10.1111/j.1462-2920.2009.02092.x; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vergin KL, 2013, ISME J, V7, P1322, DOI 10.1038/ismej.2013.32; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	45	124	126	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89549	10.1371/journal.pone.0089549	http://dx.doi.org/10.1371/journal.pone.0089549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586863	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800027
J	Yin, AH; Li, B; Luo, MY; Xu, LC; Wu, L; Zhang, L; Ma, YZ; Chen, TT; Gao, S; Liang, JQ; Guo, H; Qin, DQ; Wang, JC; Yuan, TL; Wang, YX; Huang, WW; He, WF; Zhang, Y; Liu, C; Xia, SJ; Chen, QS; Zhao, QG; Zhang, XZ				Yin, Aihua; Li, Bing; Luo, Mingyong; Xu, Longchang; Wu, Li; Zhang, Liang; Ma, Yuanzhu; Chen, Tingting; Gao, Shuang; Liang, Juqing; Guo, Hao; Qin, Danqing; Wang, Jicheng; Yuan, Tenglong; Wang, Yixia; Huang, Wei-Wei; He, Wen-Fei; Zhang, Yanxia; Liu, Chang; Xia, Sujian; Chen, Qingshan; Zhao, Qingguo; Zhang, Xiaozhuang			The Prevalence and Molecular Spectrum of alpha- and beta-Globin Gene Mutations in 14,332 Families of Guangdong Province, China	PLOS ONE			English	Article							ZHUANG AUTONOMOUS REGION; THALASSEMIA MUTATIONS; MINORITY POPULATIONS; GUANGXI; SHENZHEN; HEALTH; CITY	Objective: To reveal the familial prevalence and molecular variation of alpha- and beta-globin gene mutations in Guangdong Province. Methods: A total of 40,808 blood samples from 14,332 families were obtained and analyzed for both hematological and molecular parameters. Results: A high prevalence of alpha- and beta-globin gene mutations was found. Overall, 17.70% of pregnant women, 15.94% of their husbands, 16.03% of neonates, and 16.83% of couples (pregnant women and their husbands) were heterozygous carriers of alpha- or beta-thalassemia. The regions with the highest prevalence were the mountainous and western regions, followed by the Pearl River Delta; the region with the lowest prevalence was Chaoshan. The total familial carrier rate (both spouses were alpha- or beta-thalassemia carriers) was 1.87%, and the individual carrier rates of alpha- and beta-thalassemia were 1.68% and 0.20%, respectively. The total rate of moderate-to-severe fetal thalassemia was 12.78% among couples in which both parents were carriers. Conclusions: There was a high prevalence of alpha- and beta-thalassemia in Guangdong Province. This study will contribute to the development of thalassemia prevention and control strategies in Guangdong Province.	[Yin, Aihua; Luo, Mingyong; Liang, Juqing; Guo, Hao; Qin, Danqing; Wang, Jicheng; Yuan, Tenglong; Wang, Yixia; Zhang, Yanxia; Liu, Chang] Guangdong Women & Children Hosp, Prenatal Diag Ctr, Guangzhou, Guangdong, Peoples R China; [Yin, Aihua; Luo, Mingyong; Liang, Juqing; Guo, Hao; Qin, Danqing; Wang, Jicheng; Yuan, Tenglong; Wang, Yixia; Zhang, Yanxia; Liu, Chang] Guangdong Women & Children Hosp, Maternal & Children Metabolic Genet Key Lab, Guangzhou, Guangdong, Peoples R China; [Yin, Aihua; Li, Bing; Luo, Mingyong; Xu, Longchang; Wu, Li; Ma, Yuanzhu; Chen, Tingting; Gao, Shuang; Liang, Juqing; Guo, Hao; Qin, Danqing; Wang, Jicheng; Yuan, Tenglong; Wang, Yixia; Zhang, Yanxia; Liu, Chang; Zhao, Qingguo; Zhang, Xiaozhuang] Guangdong Women & Children Hosp, Thalassemia Diag Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Bing; Xu, Longchang; Wu, Li; Ma, Yuanzhu; Chen, Tingting; Gao, Shuang; Zhao, Qingguo] Guangdong Women & Children Hosp, Dept Healthcare, Guangzhou, Guangdong, Peoples R China; [Zhang, Liang; Huang, Wei-Wei; He, Wen-Fei] BioChain Beijing Sci & Technol Inc, Beijing, Peoples R China; [Xia, Sujian] Jinan Univ, Dept Epidemiol, Coll Med, Guangzhou, Guangdong, Peoples R China; [Chen, Qingshan] Jinan Univ, Dept Hlth Stat, Coll Med, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Zhang, XZ (corresponding author), Guangdong Women & Children Hosp, Thalassemia Diag Ctr, Guangzhou, Guangdong, Peoples R China.	zhangxiaozhuang55@126.com	Huang, WW/GXH-0977-2022; Xu, Lon Chang/HGU-1004-2022; huang, wen/GXW-0661-2022	Luo, Mingyong/0000-0002-1202-1429	program of the medical scientific research fund of Guangdong [C2012009, C2012010]; program of thalassemia prevention and control of Guangdong Province [[2011] 531]	program of the medical scientific research fund of Guangdong; program of thalassemia prevention and control of Guangdong Province	The study was the program of the medical scientific research fund of Guangdong; the numbers were C2012009 and C2012010. This work was supported by the fund from the program of thalassemia prevention and control of Guangdong Province (the number of government document was Guangdong Finance [2011] 531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai Ren, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P281; Chen JK ZY, 2005, J GANNAN MED COLL, V25; Cousens NE, 2010, EUR J HUM GENET, V18, P1077, DOI 10.1038/ejhg.2010.90; Filon D, 2000, HEMOGLOBIN, V24, P99, DOI 10.3109/03630260009003428; FUCHAROEN S, 1989, HUM GENET, V84, P41, DOI 10.1007/BF00210668; Fucharoen Suthat, 2011, Indian J Med Res, V134, P498; Lau YL, 1997, NEW ENGL J MED, V336, P1298, DOI 10.1056/NEJM199705013361805; Li CG, 2009, HEMOGLOBIN, V33, P296, DOI 10.3109/03630260903211698; Li ZS, 2006, HEMOGLOBIN, V30, P9, DOI 10.1080/03630260500453818; Liao C, 2005, PRENATAL DIAG, V25, P163, DOI 10.1002/pd.1079; Lin M, 2012, CLIN GENET, V81, P165, DOI 10.1111/j.1399-0004.2011.01627.x; Lin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055024; Lu B CJ, 1992, ZHANJIANG YI XUE YUA, V10, P3; Pan HF, 2007, CLIN GENET, V71, P419, DOI 10.1111/j.1399-0004.2007.00791.x; Premawardhena A, 2004, HUM MOL GENET, V13, pR203, DOI 10.1093/hmg/ddh250; Ren C, 2004, HEMOGLOBIN, V28, P325, DOI 10.1081/HEM-200037743; Song SZ CS, 2004, CHIN J FAM PLANN, V105, P3; Tan JR LW, 2003, J 1 MIL MED U, V23, P4; Verma Ishwar C, 2011, Indian J Med Res, V134, P507; Wang Xia, 2011, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V28, P135; Weatherall DJ, 2005, ANN NY ACAD SCI, V1054, P11, DOI 10.1196/annals.1345.002; Weatherall DJ, 2004, NAT REV GENET, V5, P625, DOI 10.1038/nrg1406; Weatherall DJ, 2003, SCIENCE, V302, P597, DOI 10.1126/science.1089864; Xiong F, 2010, CLIN GENET, V78, P139, DOI 10.1111/j.1399-0004.2010.01430.x; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456; Yanjie Z, 2004, CHINESE J FAMILY PLA, V12, P409; Yong ST LH, 2006, MODERN PREV MED, V33, P12; Yu Fang, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P700, DOI 10.3760/cma.j.issn.1003-9406.2010.06.023; ZENG YT, 1985, LANCET, V1, P304; Zhang CM, 2010, HEMOGLOBIN, V34, P55, DOI 10.3109/03630260903547724; Zhang J, 2012, HEMOGLOBIN, V36, P464, DOI 10.3109/03630269.2012.717327; Zhao Zhong-Ming, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P352; Zheng CG, 2011, HEMOGLOBIN, V35, P28, DOI 10.3109/03630269.2010.547429	33	66	97	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89855	10.1371/journal.pone.0089855	http://dx.doi.org/10.1371/journal.pone.0089855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587075	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800047
J	Ajibade, AA; Kirk, JS; Karasik, E; Gillard, B; Moser, MT; Johnson, CS; Trump, DL; Foster, BA				Ajibade, Adebusola Alagbala; Kirk, Jason S.; Karasik, Ellen; Gillard, Bryan; Moser, Michael T.; Johnson, Candace S.; Trump, Donald L.; Foster, Barbara A.			Early Growth Inhibition Is Followed by Increased Metastatic Disease with Vitamin D (Calcitriol) Treatment in the TRAMP Model of Prostate Cancer	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; TRANSGENIC MOUSE MODEL; HIGH-DOSE CALCITRIOL; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; INTRAEPITHELIAL NEOPLASIA; E-CADHERIN; IN-VIVO; CELLS; ANALOGS; CARCINOMA	The active metabolite of vitamin D-3, 1,25-dihydroxyvitamin D-3 (calcitriol) has antiproliferative effects in non-aggressive prostate cancer, however, its effects in more aggressive model systems are still unclear. In these studies, effects of calcitriol and a less-calcemic vitamin D analog, QW-1624F(2)-2 (QW), were tested in vivo, using the aggressive autochthonous transgenic adenocarcinoma of mouse prostate (TRAMP) model. To study prevention of androgen-stimulated prostate cancer, vehicle, calcitriol (20 mu g/kg), or QW (50 mu g/kg) were administered to 4 week-old TRAMP mice intraperitoneal (i.p.) 3x/week on a MWF schedule for 14 weeks. Calcitriol and QW slowed progression of prostate cancer as indicated by reduced urogenital tract (p = 0.0022, calcitriol; p = 0.0009, QW) and prostate weights (p = 0.0178, calcitriol; p = 0.0086, QW). However, only calcitriol increased expression of the pro-differentiation marker, cadherin 1 (p = 0.0086), and reduced tumor proliferation (p = 0.0467). By contrast, neither vitamin D analog had any effect on castration resistant prostate cancer in mice treated pre- or post-castration. Interestingly, although vitamin D showed inhibitory activity against primary tumors in hormone-intact mice, distant organ metastases seemed to be enhanced following treatment (p = 0.0823). Therefore, TRAMP mice were treated long-term with calcitriol to further examine effects on metastasis. Calcitriol significantly increased the number of distant organ metastases when mice were treated from 4 weeks-of-age until development of palpable tumors (20-25 weeks-of-age)(p = 0.0003). Overall, data suggest that early intervention with vitamin D in TRAMP slowed androgen-stimulated tumor progression, but prolonged treatment resulted in development of a resistant and more aggressive disease associated with increased distant organ metastasis.	[Ajibade, Adebusola Alagbala; Kirk, Jason S.; Karasik, Ellen; Gillard, Bryan; Moser, Michael T.; Johnson, Candace S.; Foster, Barbara A.] Roswell Pk Canc Inst, Dept Pharmacol, Buffalo, NY 14263 USA; [Trump, Donald L.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Foster, BA (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol, Buffalo, NY 14263 USA.	barbara.foster@roswellpark.org			Roswell Park Cancer Institute; National Cancer Institute (NCI) [P30 CA016056]; NIH/NCI [5R01 CA95367]; department of defense (DOD) [W81XWH-05-1-0571]; NATIONAL CANCER INSTITUTE [R01CA095367, P30CA016056] Funding Source: NIH RePORTER	Roswell Park Cancer Institute; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); department of defense (DOD)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Roswell Park Cancer Institute and National Cancer Institute (NCI) grant #P30 CA016056, by NIH/NCI grant # 5R01 CA95367 (to BAF), and by the department of defense (DOD) Pre-doctoral Fellowship grant #W81XWH-05-1-0571 (to AAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Alagbala AA, 2006, ONCOLOGY-BASEL, V70, P483, DOI 10.1159/000098813; Banach-Petrosky W, 2006, CLIN CANCER RES, V12, P5895, DOI 10.1158/1078-0432.CCR-06-1039; Barnett CM, 2010, CANCER CAUSE CONTROL, V21, P1297, DOI 10.1007/s10552-010-9557-y; Beer TM, 2006, CLIN CANCER RES, V12, P2812, DOI 10.1158/1078-0432.CCR-05-2310; Beer TM, 2003, CANCER-AM CANCER SOC, V97, P1217, DOI 10.1002/cncr.11179; Beer TM, 2005, INT J CLIN ONCOL, P4516; Beer TM, 2007, J CLIN ONCOL, V25, P669, DOI 10.1200/JCO.2006.06.8197; Blutt SE, 2000, CANCER RES, V60, P779; Bostwick David G, 2004, Rev Urol, V6, P171; Campbell MJ, 1997, J MOL ENDOCRINOL, V19, P15, DOI 10.1677/jme.0.0190015; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Gingrich JR, 1996, CANCER RES, V56, P4096; Gingrich JR, 1997, CANCER RES, V57, P4687; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gross C, 1998, J UROLOGY, V159, P2035, DOI 10.1016/S0022-5347(01)63236-1; Guzey M, 2002, MOL CANCER THER, V1, P667; Han GZ, 2001, J BIOL CHEM, V276, P11204, DOI 10.1074/jbc.M008207200; Hedlund TE, 1997, CLIN CANCER RES, V3, P1331; IWAMURA M, 1993, CANCER RES, V53, P1724; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kensler TW, 2000, CARCINOGENESIS, V21, P1341, DOI 10.1093/carcin/21.7.1341; Klein EA, 2006, ANNU REV MED, V57, P49, DOI 10.1146/annurev.med.57.121304.131435; Konety BR, 1996, CELL GROWTH DIFFER, V7, P1563; Kurita T, 2001, CELL DEATH DIFFER, V8, P192, DOI 10.1038/sj.cdd.4400797; Leman ES, 2003, J CELL BIOCHEM, V90, P138, DOI 10.1002/jcb.10605; Liu G, 2002, CLIN CANCER RES, V8, P2820; Lokeshwar BL, 1999, CANCER EPIDEM BIOMAR, V8, P241; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Osborn J L, 1995, Urol Oncol, V1, P195, DOI 10.1016/1078-1439(95)00061-5; Perez-Stable CM, 2002, CANCER EPIDEM BIOMAR, V11, P555; Posner GH, 1998, J MED CHEM, V41, P3008, DOI 10.1021/jm980031t; Raghow S, 2002, CANCER RES, V62, P1370; Raghow S, 2000, CANCER RES, V60, P4093; Rankin W, 1997, CANCER, V80, P1564, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1564::AID-CNCR6>3.0.CO;2-K; SAKR WA, 1993, J UROLOGY, V150, P379, DOI 10.1016/S0022-5347(17)35487-3; Scher HI, 2011, J CLIN ONCOL, V29, P2191, DOI 10.1200/JCO.2010.32.8815; SCHWARTZ GG, 1990, ANTICANCER RES, V10, P1307; Schwartz GG, 1997, CANCER EPIDEM BIOMAR, V6, P727; SCHWARTZ GG, 1995, UROLOGY, V46, P365, DOI 10.1016/S0090-4295(99)80221-0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soloway M, 2005, CANCER, V104, P2310, DOI 10.1002/cncr.21441; Sung V, 2000, MOL CELL ENDOCRINOL, V164, P133, DOI 10.1016/S0303-7207(00)00226-4; Trump DL, 2006, CANCER-AM CANCER SOC, V106, P2136, DOI 10.1002/cncr.21890; UMBAS R, 1992, CANCER RES, V52, P5104; Zhuang SH, 1998, ENDOCRINOLOGY, V139, P1197, DOI 10.1210/en.139.3.1197	48	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89555	10.1371/journal.pone.0089555	http://dx.doi.org/10.1371/journal.pone.0089555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586868	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000060
J	Calderari, S; Irminger, JC; Giroix, MH; Ehses, JA; Gangnerau, MN; Coulaud, J; Rickenbach, K; Gauguier, D; Halban, P; Serradas, P; Homo-Delarche, F				Calderari, Sophie; Irminger, Jean-Claude; Giroix, Marie-Helene; Ehses, Jan A.; Gangnerau, Marie-Noelle; Coulaud, Josiane; Rickenbach, Katharina; Gauguier, Dominique; Halban, Philippe; Serradas, Patricia; Homo-Delarche, Francoise			Regenerating 1 and 3b Gene Expression in the Pancreas of Type 2 Diabetic Goto-Kakizaki (GK) Rats	PLOS ONE			English	Article							STONE PROTEIN/REGENERATING PROTEIN; BETA-CELL; REG GENE; ISLET INFLAMMATION; SPONTANEOUS MODEL; OXIDATIVE STRESS; REG3-BETA GENES; KNOCKOUT MICE; UP-REGULATION; FAMILY	Regenerating (REG) proteins are associated with islet development, beta-cell damage, diabetes and pancreatitis. Particularly, REG-1 and REG-3-beta are involved in cell growth/survival and/or inflammation and the Reg1 promoter contains interleukin-6 (IL-6)-responsive elements. We showed by transcriptome analysis that islets of Goto-Kakizaki (GK) rats, a model of spontaneous type 2 diabetes, overexpress Reg1, 3 alpha, 3 beta and 3 gamma, vs Wistar islets. Goto-Kakizaki rat islets also exhibit increased cytokine/chemokine expression/release, particularly IL-6. Here we analyzed Reg1 and Reg3 beta expression and REG-1 immunolocalization in the GK rat pancreas in relationship with inflammation. Isolated pancreatic islets and acinar tissue from male adult Wistar and diabetic GK rats were used for quantitative RT-PCR analysis. REG-1 immunohistochemistry was performed on paraffin sections with a monoclonal anti-rat REG-1 antibody. Islet cytokine/chemokine release was measured after 48 h-culture. Islet macrophage-positive area was quantified on cryostat sections using anti-CD68 and major histocompatibility complex (MHC) class II antibodies. Pancreatic exocrine-to-endocrine Reg1 and Reg3 beta mRNA ratios were markedly increased in Wistar vs GK rats. Conversely, both genes were upregulated in isolated GK rat islets. These findings were unexpected, because Reg genes are expressed in the pancreatic acinar tissue. However, we observed REG-1 protein labeling in acinar peri-ductal tissue close to islets and around large, often disorganized, GK rat islets, which may retain acinar cells due to their irregular shape. These large islets also showed peri-islet macrophage infiltration and increased release of various cytokines/chemokines, particularly IL-6. Thus, IL-6 might potentially trigger acinar REG-1 expression and secretion in the vicinity of large diabetic GK rat islets. This increased acinar REG-1 expression might reflect an adaptive though unsuccessful response to deleterious microenvironment.	[Calderari, Sophie; Coulaud, Josiane; Gauguier, Dominique; Homo-Delarche, Francoise] Univ Paris 06, CRC, INSERM, Team 6,UMRS 872, Paris, France; [Irminger, Jean-Claude; Rickenbach, Katharina; Halban, Philippe] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Giroix, Marie-Helene; Gangnerau, Marie-Noelle] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Unite Biol Fonctionnelle & Adaptat BFA 4413,Team, Paris, France; [Ehses, Jan A.] Univ British Columbia, Fac Med, Dept Surg, Vancouver, BC, Canada; [Ehses, Jan A.] Child & Family Res Inst, Vancouver, BC, Canada; [Serradas, Patricia] Univ Paris 06, CRC, INSERM, UMRS 872,Team 9, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Geneva; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of British Columbia; Child & Family Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Homo-Delarche, F (corresponding author), Univ Paris 06, CRC, INSERM, Team 6,UMRS 872, Paris, France.	fhomodel@orange.fr	Ehses, Jan/AAK-1635-2020; Gauguier, Dominique/G-2190-2016; Serradas, Patricia/R-2185-2017	Gauguier, Dominique/0000-0001-6156-9530; Serradas, Patricia/0000-0002-6652-9746; Calderari, Sophie/0000-0002-9669-681X; Ehses, Jan/0000-0001-9066-7607	French Ministry for National Education, Education and Research; Foundation for Medical Research	French Ministry for National Education, Education and Research; Foundation for Medical Research	S. Calderari was a recipient of doctoral fellowships from the French Ministry for National Education, Education and Research and the Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azman J, 2011, ACTA HISTOCHEM, V113, P793, DOI 10.1016/j.acthis.2010.11.008; Bimmler D, 2004, J SURG RES, V118, P122, DOI 10.1016/S0022-4804(03)00342-1; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; DUSETTI NJ, 1995, J BIOL CHEM, V270, P22417, DOI 10.1074/jbc.270.38.22417; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses Jan A., 2007, Current Immunology Reviews, V3, P216; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; Giroix MH, 2011, DIABETOLOGIA, V54, P2451, DOI 10.1007/s00125-011-2223-4; Gurr W, 2007, DIABETES, V56, P34, DOI 10.2337/db06-0669; Homo-Delarche F, 2004, TRENDS IMMUNOL, V25, P222, DOI 10.1016/j.it.2004.02.012; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Imaoka H, 2010, AM J PHYSIOL-GASTR L, V299, pG311, DOI 10.1152/ajpgi.00469.2009; Jin CX, 2011, INTERNAL MED, V50, P1507, DOI 10.2169/internalmedicine.50.5362; Konishi H, 2013, J BIOL CHEM, V288, P10205, DOI 10.1074/jbc.M112.395301; Kyithar MP, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-156; Lacraz G, 2010, AM J PHYSIOL-ENDOC M, V298, pE17, DOI 10.1152/ajpendo.90871.2008; Lacraz G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006963; Lacraz G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006500; Lammert E, 2008, EXP CLIN ENDOCRINOL, V116, pS1; Liu Jun-Li, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P1, DOI 10.2174/187153008783928361; Luo C, 2013, MOL CELL ENDOCRINOL, V365, P187, DOI 10.1016/j.mce.2012.10.018; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Meili S, 2003, CELL TISSUE RES, V312, P291, DOI 10.1007/s00441-003-0733-1; Movahedi B, 2008, DIABETES, V57, P2128, DOI 10.2337/db07-1705; Ota H, 2013, LIFE SCI, V93, P664, DOI 10.1016/j.lfs.2013.09.001; Plachot C, 2001, HISTOCHEM J, V33, P141, DOI 10.1023/A:1017935808074; Planas R, 2006, DIABETOLOGIA, V49, P2379, DOI 10.1007/s00125-006-0365-6; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; RAFAELOFF R, 1995, DIABETOLOGIA, V38, P906, DOI 10.1007/BF00400578; Rodriguez-Diaz R, 2012, P NATL ACAD SCI USA, V109, P21456, DOI 10.1073/pnas.1211659110; Shervani NJ, 2004, EUR J CLIN INVEST, V34, P752, DOI 10.1111/j.1365-2362.2004.01419.x; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Unno M, 2002, DIABETES, V51, pS478, DOI 10.2337/diabetes.51.2007.S478; Van Ba I. Acquatella-Tran, 2012, J BIOL CHEM, V287, P4726; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Wang XH, 2009, LIFE SCI, V84, P240, DOI 10.1016/j.lfs.2008.12.010; Wang Y, 2011, GROWTH FACTORS, V29, P72, DOI 10.3109/08977194.2011.562866; WATANABE T, 1994, P NATL ACAD SCI USA, V91, P3589, DOI 10.1073/pnas.91.9.3589; Xia B, 2009, BIOCHEM BIOPH RES CO, V383, P383, DOI 10.1016/j.bbrc.2009.03.114; Xiong XQ, 2011, AM J PHYSIOL-ENDOC M, V300, pE669, DOI 10.1152/ajpendo.00600.2010; Yamaoka T, 2000, BIOCHEM BIOPH RES CO, V278, P368, DOI 10.1006/bbrc.2000.3813; Zenilman ME, 1996, SURGERY, V119, P576, DOI 10.1016/S0039-6060(96)80270-4; Zenilman ME, 1997, ANN SURG, V225, P327, DOI 10.1097/00000658-199703000-00013; Zenilman ME, 2000, ANN SURG, V232, P646, DOI 10.1097/00000658-200011000-00005; Zhang H, 2004, SCAND J GASTROENTERO, V39, P870, DOI 10.1080/00365520410006477; Zhu MJ, 2010, BIOMED PHARMACOTHER, V64, P208, DOI 10.1016/j.biopha.2009.08.005	48	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90045	10.1371/journal.pone.0090045	http://dx.doi.org/10.1371/journal.pone.0090045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587207	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000131
J	Mpondo, BCT; Kalluvya, SE; Peck, RN; Kabangila, R; Kidenya, BR; Ephraim, L; Fitzgerald, DW; Downs, JA				Mpondo, Bonaventura C. T.; Kalluvya, Samuel E.; Peck, Robert N.; Kabangila, Rodrick; Kidenya, Benson R.; Ephraim, Lucheri; Fitzgerald, Daniel W.; Downs, Jennifer A.			Impact of Antiretroviral Therapy on Renal Function among HIV-Infected Tanzanian Adults: A Retrospective Cohort Study	PLOS ONE			English	Article							SEROPOSITIVE PATIENTS; KIDNEY-FUNCTION; DISEASE; RISK; DYSFUNCTION; DEATH; PROTEINURIA; NEPHROPATHY; PREVALENCE; PREDICTORS	Background: Data regarding the outcomes of HIV-infected adults with baseline renal dysfunction who start antiretroviral therapy are conflicting. Methods: We followed up a previously-published cohort of HIV-infected adult outpatients in northwest Tanzania who had high prevalence of renal dysfunction at the time of starting antiretroviral therapy (between November 2009 and February 2010). Patients had serum creatinine, proteinuria, microalbuminuria, and CD4(+) T-cell count measured at the time of antiretroviral therapy initiation and at follow-up. We used the adjusted Cockroft-Gault equation to calculate estimated glomerular filtration rates (eGFRs). Results: In this cohort of 171 adults who had taken antiretroviral therapy for a median of two years, the prevalence of renal dysfunction (eGFR <90 mL/min/1.73 m(2)) decreased from 131/171 (76.6%) at the time of ART initiation to 50/171 (29.2%) at the time of follow-up (p<0.001). Moderate dysfunction (eGFR<60 mL/min/1.73 m(2)) decreased from 21.1% at antiretroviral therapy initiation to 1.1% at follow-up (p<0.001), as did the prevalence of microalbuminuria (72% to 44%, p<0.001). Use of tenofovir was not associated with renal dysfunction at follow-up. Conclusion: Mild and moderate renal dysfunction were common in this cohort of HIV-infected adults initiating antiretroviral therapy, and both significantly improved after a median follow-up time of 2 years. Our work supports the renal safety of antiretroviral therapy in African adults with mild-moderate renal dysfunction, suggesting that these regimens do not lead to renal damage in the majority of patients and that they may even improve renal function in patients with mild to moderate renal dysfunction.	[Mpondo, Bonaventura C. T.; Kalluvya, Samuel E.; Peck, Robert N.; Kabangila, Rodrick; Ephraim, Lucheri; Downs, Jennifer A.] Catholic Univ Hlth & Allied Sci, Dept Med, Mwanza, Tanzania; [Mpondo, Bonaventura C. T.; Kalluvya, Samuel E.; Peck, Robert N.; Kabangila, Rodrick; Ephraim, Lucheri; Downs, Jennifer A.] Bugando Med Ctr, Dept Med, Mwanza, Tanzania; [Peck, Robert N.; Fitzgerald, Daniel W.; Downs, Jennifer A.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Kidenya, Benson R.] Catholic Univ Hlth & Allied Sci, Dept Biochem & Mol Biol, Mwanza, Tanzania	Cornell University	Downs, JA (corresponding author), Catholic Univ Hlth & Allied Sci, Dept Med, Mwanza, Tanzania.	jna2002@med.cornell.edu		Downs, Jennifer/0000-0001-9537-204X; Peck, Robert/0000-0002-4526-2480	United States National Institutes of Health Fogarty International Center [TW 00018]; National Institute of Allergy and Infectious Diseases [K24 AI098627]; Weill Cornell Medical College; Pfizer Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI098627] Funding Source: NIH RePORTER	United States National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Weill Cornell Medical College; Pfizer Inc.(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part by a grant from the United States National Institutes of Health Fogarty International Center (TW 00018), the National Institute of Allergy and Infectious Diseases (K24 AI098627), and a scholarship program at Weill Cornell Medical College supported by Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atta MG, 2006, NEPHROL DIAL TRANSPL, V21, P2809, DOI 10.1093/ndt/gfl337; Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609; Chi BH, 2011, JAIDS-J ACQ IMM DEF, V58, P475, DOI 10.1097/QAI.0b013e31823058a3; Choi AI, 2009, AIDS, V23, P2143, DOI 10.1097/QAD.0b013e3283313c91; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Cosgrove CJ, 2002, AM J MED SCI, V323, P102, DOI 10.1097/00000441-200202000-00009; De Beaudrap P, 2010, AIDS RES HUM RETROV, V26, P1221, DOI 10.1089/aid.2009.0261; Emem CP, 2008, NEPHROL DIAL TRANSPL, V23, P741, DOI 10.1093/ndt/gfm836; Estrella M, 2006, CLIN INFECT DIS, V43, P377, DOI 10.1086/505497; Han TM, 2006, KIDNEY INT, V69, P2243, DOI 10.1038/sj.ki.5000339; Ibrahim F, 2012, AM J KIDNEY DIS, V60, P539, DOI 10.1053/j.ajkd.2012.03.006; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kirchner Jeffrey T, 2002, AIDS Read, V12, P103; Laradi A, 1998, J AM SOC NEPHROL, V9, P2327; Lucas GM, 2004, AIDS, V18, P541, DOI 10.1097/00002030-200402200-00022; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Msango L, 2011, AIDS, V25, P1421, DOI 10.1097/QAD.0b013e328348a4b1; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peters PJ, 2008, KIDNEY INT, V74, P925, DOI 10.1038/ki.2008.305; Post FA, 2008, CLIN INFECT DIS, V46, P1282, DOI 10.1086/529385; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Sarfo FS, 2013, J INFECTION, V67, P43, DOI 10.1016/j.jinf.2013.03.008; Scheurer Danielle, 2004, AIDS Read, V14, P443; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Szczech A, 2002, CLIN NEPHROL, V57, P336; Szczech LA, 2002, KIDNEY INT, V61, P195, DOI 10.1046/j.1523-1755.2002.00094.x; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223	29	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89573	10.1371/journal.pone.0089573	http://dx.doi.org/10.1371/journal.pone.0089573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586882	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000063
J	Roder, PV; Geillinger, KE; Zietek, TS; Thorens, B; Koepsell, H; Daniel, H				Roeder, Pia V.; Geillinger, Kerstin E.; Zietek, Tamara S.; Thorens, Bernard; Koepsell, Hermann; Daniel, Hannelore			The Role of SGLT1 and GLUT2 in Intestinal Glucose Transport and Sensing	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; RAT SMALL-INTESTINE; APICAL GLUT2; INCRETIN SECRETION; SUGAR ABSORPTION; DIFFUSIVE COMPONENT; CALCIUM-ABSORPTION; MICE; COTRANSPORTER; PHOSPHORYLATION	Intestinal glucose absorption is mediated by SGLT1 whereas GLUT2 is considered to provide basolateral exit. Recently, it was proposed that GLUT2 can be recruited into the apical membrane after a high luminal glucose bolus allowing bulk absorption of glucose by facilitated diffusion. Moreover, SGLT1 and GLUT2 are suggested to play an important role in intestinal glucose sensing and incretin secretion. In mice that lack either SGLT1 or GLUT2 we re-assessed the role of these transporters in intestinal glucose uptake after radiotracer glucose gavage and performed Western blot analysis for transporter abundance in apical membrane fractions in a comparative approach. Moreover, we examined the contribution of these transporters to glucose-induced changes in plasma GIP, GLP-1 and insulin levels. In mice lacking SGLT1, tissue retention of tracer glucose was drastically reduced throughout the entire small intestine whereas GLUT2-deficient animals exhibited higher tracer contents in tissue samples than wild type animals. Deletion of SGLT1 resulted also in reduced blood glucose elevations and abolished GIP and GLP-1 secretion in response to glucose. In mice lacking GLUT2, glucose-induced insulin but not incretin secretion was impaired. Western blot analysis revealed unchanged protein levels of SGLT1 after glucose gavage. GLUT2 detected in apical membrane fractions mainly resulted from contamination with basolateral membranes but did not change in density after glucose administration. SGLT1 is unequivocally the prime intestinal glucose transporter even at high luminal glucose concentrations. Moreover, SGLT1 mediates glucose-induced incretin secretion. Our studies do not provide evidence for GLUT2 playing any role in either apical glucose influx or incretin secretion.	[Roeder, Pia V.; Geillinger, Kerstin E.; Zietek, Tamara S.; Daniel, Hannelore] Univ Munich, Biochem Unit, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Bavaria, Germany; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Koepsell, Hermann] Univ Wurzburg, Julius von Sachs Inst, Dept Mol Plant Physiol & Biophys, D-97070 Wurzburg, Bavaria, Germany	University of Munich; University of Lausanne; University of Wurzburg	Daniel, H (corresponding author), Univ Munich, Biochem Unit, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Bavaria, Germany.	hannelore.daniel@tum.de			Deutsche Forschungsgemeinschaft [GZ DA 190/10-1, Nutra2Sense]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (GZ DA 190/10-1, Nutra2Sense). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Omar A, 2011, DIABETES, V60, P2598, DOI 10.2337/db10-1740; Au A, 2002, BIOCHEM J, V367, P247, DOI 10.1042/BJ20020393; Cani PD, 2007, MOL CELL ENDOCRINOL, V276, P18, DOI 10.1016/j.mce.2007.06.003; Chaudhry RM, 2012, J GASTROINTEST SURG, V16, P312, DOI 10.1007/s11605-011-1752-y; DEBNAM ES, 1975, J PHYSIOL-LONDON, V246, P181, DOI 10.1113/jphysiol.1975.sp010885; Dray C, 2013, GASTROENTEROLOGY, V144, P771, DOI 10.1053/j.gastro.2013.01.004; Fullerton PM, 1956, EXP PHYSIOL, V41, P387; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; Helliwell PA, 2000, BIOCHEM J, V350, P163, DOI 10.1042/0264-6021:3500163; Helliwell PA, 2000, BIOCHEM J, V350, P149, DOI 10.1042/0264-6021:3500149; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Mace OJ, 2007, J PHYSIOL-LONDON, V580, P605, DOI 10.1113/jphysiol.2006.124784; Mace OJ, 2012, J PHYSIOL-LONDON, V590, P2917, DOI 10.1113/jphysiol.2011.223800; Morgan EL, 2007, J PHYSIOL-LONDON, V580, P593, DOI 10.1113/jphysiol.2006.124768; Moriya R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1358, DOI 10.1152/ajpendo.00412.2009; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; PAPPENHEIMER JR, 1987, J MEMBRANE BIOL, V100, P123, DOI 10.1007/BF02209145; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; Punjabi M, 2011, PHYSIOL BEHAV, V105, P71, DOI 10.1016/j.physbeh.2011.02.038; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Scow JS, 2011, J SURG RES, V167, P56, DOI 10.1016/j.jss.2010.04.026; Shepherd EJ, 2004, J PHYSIOL-LONDON, V560, P281, DOI 10.1113/jphysiol.2004.072447; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; Tavakkolizadeh A, 2001, AM J PHYSIOL-GASTR L, V280, pG209, DOI 10.1152/ajpgi.2001.280.2.G209; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; Walker J, 2005, BIOCHEM J, V385, P485, DOI 10.1042/BJ20040694; Wertheimer E, 1934, PFLUG ARCH GES PHYS, V233, P514, DOI 10.1007/BF01751462; Wolffram S, 2002, J NUTR, V132, P630, DOI 10.1093/jn/132.4.630; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yoshikawa T, 2011, HISTOCHEM CELL BIOL, V135, P183, DOI 10.1007/s00418-011-0779-1	35	250	257	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89977	10.1371/journal.pone.0089977	http://dx.doi.org/10.1371/journal.pone.0089977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587162	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000124
J	Morand, S; Jittapalapong, S; Suputtamongkol, Y; Abdullah, MT; Huan, TB				Morand, Serge; Jittapalapong, Sathaporn; Suputtamongkol, Yupin; Abdullah, Mohd Tajuddin; Huan, Tan Boon			Infectious Diseases and Their Outbreaks in Asia-Pacific: Biodiversity and Its Regulation Loss Matter	PLOS ONE			English	Article							LAND-USE CHANGE; HOST DIVERSITY; ECOLOGY; TRANSMISSION; LANDSCAPES; MAMMALS; RISK	Despite increasing control measures, numerous parasitic and infectious diseases are emerging, re-emerging or causing recurrent outbreaks particularly in Asia and the Pacific region, a hot spot of both infectious disease emergence and biodiversity at risk. We investigate how biodiversity affects the distribution of infectious diseases and their outbreaks in this region, taking into account socio-economics (population size, GDP, public health expenditure), geography (latitude and nation size), climate (precipitation, temperature) and biodiversity (bird and mammal species richness, forest cover, mammal and bird species at threat). We show, among countries, that the overall richness of infectious diseases is positively correlated with the richness of birds and mammals, but the number of zoonotic disease outbreaks is positively correlated with the number of threatened mammal and bird species and the number of vector-borne disease outbreaks is negatively correlated with forest cover. These results suggest that, among countries, biodiversity is a source of pathogens, but also that the loss of biodiversity or its regulation, as measured by forest cover or threatened species, seems to be associated with an increase in zoonotic and vector-borne disease outbreaks.	[Morand, Serge] Rech Agron Dev Agr Res Dev CIRAD, Unite Rech Anim & Gest Integree Risques AGIRs, Montpellier, France; [Morand, Serge] Univ Montpellier 2, Ctr Natl Rech Sci CNRS, Inst Sci Evolut ISEM, Inst Rech Dev IRD, Montpellier, France; [Morand, Serge] Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok, Thailand; [Jittapalapong, Sathaporn] Kasetsart Univ, Fac Vet Sci, Dept Vet Parasitol, Bangkok, Thailand; [Jittapalapong, Sathaporn] AG BIO PERDO CHE PERDO 2555 01, Ctr Excellence Agr Biotechnol, Pathum Thani, Thailand; [Suputtamongkol, Yupin] Mahidol Univ, Fac Med Sci, Siriraj Hosp, Bangkok 10700, Thailand; [Abdullah, Mohd Tajuddin] Univ Malaysia Sarawak, Dept Zool, Kota Samarahan, Sarawak, Malaysia; [Huan, Tan Boon] Natl Univ Singapore, Dept Civil & Environm Engn, Fac Engn, Singapore 117548, Singapore	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Mahidol University; Kasetsart University; Mahidol University; University of Malaysia Sarawak; National University of Singapore	Morand, S (corresponding author), Rech Agron Dev Agr Res Dev CIRAD, Unite Rech Anim & Gest Integree Risques AGIRs, Montpellier, France.	serge.morand@univ-montp2.fr	ABDULLAH, MOHD TAJUDDIN/H-8932-2018; JITTAPALAPONG, SATHAPORN/V-6453-2019; Morand, Serge/M-5433-2018	ABDULLAH, MOHD TAJUDDIN/0000-0002-9592-9722; JITTAPALAPONG, SATHAPORN/0000-0001-6566-8050; Morand, Serge/0000-0003-3986-7659	French ANR programme CPES [ANR 11CPEL 002]	French ANR programme CPES(French National Research Agency (ANR))	This work was part of the BiodivHealthSEA project (http://www.biodivhealthsea.org) funded by the French ANR programme CP&ES (grant number ANR 11CPEL 002) and part of the unfunded participatory project CERoPath (http://www.ceropath.org). The authors also thank the ATPd "Emergence and Risques Sanitaires'' of CIRAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein AS, 2004, ENV HLTH PREV MED, V1, P12; Bonds MH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001456; Bordes F, 2011, OIKOS, V120, P1889, DOI 10.1111/j.1600-0706.2011.19314.x; Chivian E., 2003, BIODIVERSITY ITS IMP; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2009, PRINCETON GUIDE ECOL, P634; Dunn RR, 2010, P ROY SOC B-BIOL SCI, V277, P2587, DOI 10.1098/rspb.2010.0340; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Keith DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062111; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; MEA (Millennium Ecosystem Assessment), 2005, EC HUM WELL BEING BI; Morand S, 2003, SCI REPORT, V3, P1774; MORAND S., 2012, B EPIDEMIOLOGIQUE HE, V12-13, P156; Murray KA, 2013, CURR OPIN VIROL, V3, P79, DOI 10.1016/j.coviro.2013.01.006; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Salkeld DJ, 2013, ECOL LETT, V16, P679, DOI 10.1111/ele.12101; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Wilcox Bruce A., 2005, Environmental Health and Preventive Medicine, V10, P263, DOI 10.1007/BF02897701	30	63	65	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90032	10.1371/journal.pone.0090032	http://dx.doi.org/10.1371/journal.pone.0090032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587201	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900111
J	Mueller, B; de Goeij, JM; Vermeij, MJA; Mulders, Y; van der Ent, E; Ribes, M; van Duyl, FC				Mueller, Benjamin; de Goeij, Jasper M.; Vermeij, Mark J. A.; Mulders, Yannick; van der Ent, Esther; Ribes, Marta; van Duyl, Fleur C.			Natural Diet of Coral-Excavating Sponges Consists Mainly of Dissolved Organic Carbon (DOC)	PLOS ONE			English	Article							MATTER RELEASE; REEF; PHYTOPLANKTON; COMPETITION; GROWTH; RATES; COMMUNITIES; POPULATIONS; METABOLISM; BIOEROSION	Coral-excavating sponges are the most important bioeroders on Caribbean reefs and increase in abundance throughout the region. This increase is commonly attributed to a concomitant increase in food availability due to eutrophication and pollution. We therefore investigated the uptake of organic matter by the two coral-excavating sponges Siphonodictyon sp. and Cliona delitrix and tested whether they are capable of consuming dissolved organic carbon (DOC) as part of their diet. A device for simultaneous sampling of water inhaled and exhaled by the sponges was used to directly measure the removal of DOC and bacteria in situ. During a single passage through their filtration system 14% and 13% respectively of the total organic carbon (TOC) in the inhaled water was removed by the sponges. 82% (Siphonodictyon sp.; mean +/- SD; 13 +/- 17 mu mol L-1) and 76% (C. delitrix; 10 +/- 12 mmol L-1) of the carbon removed was taken up in form of DOC, whereas the remainder was taken up in the form of particulate organic carbon (POC; bacteria and phytoplankton) despite high bacteria retention efficiency (72 +/- 15% and 87 +/- 10%). Siphonodictyon sp. and C. delitrix removed DOC at a rate of 461 +/- 773 and 354 +/- 562 mu mol C h(-1) respectively. Bacteria removal was 1.8 +/- 0.9 x10(10) and 1.7 +/- 0.6x10(10) cells h(-1), which equals a carbon uptake of 46.0 +/- 21.2 and 42.5 +/- 14.0 mu mol C h(-1) respectively. Therefore, DOC represents 83 and 81% of the TOC taken up by Siphonodictyon sp. and C. delitrix per hour. These findings suggest that similar to various reef sponges coral-excavating sponges also mainly rely on DOC to meet their carbon demand. We hypothesize that excavating sponges may also benefit from an increasing production of more labile algal-derived DOC (as compared to coral-derived DOC) on reefs as a result of the ongoing coral-algal phase shift.	[Mueller, Benjamin; van Duyl, Fleur C.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, Den Hoorn, Netherlands; [Mueller, Benjamin; de Goeij, Jasper M.; Vermeij, Mark J. A.; van Duyl, Fleur C.] CARMABI, Willemstad, Netherlands; [Mueller, Benjamin; Mulders, Yannick; van der Ent, Esther] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands; [de Goeij, Jasper M.] Univ Amsterdam, Dept Aquat Ecol & Ecotoxicol, Amsterdam, Netherlands; [Vermeij, Mark J. A.] Univ Amsterdam, Dept Aquat Microbiol, Amsterdam, Netherlands; [Ribes, Marta] Inst Ciencies Mar ICM CSIC, Dept Biol Marina & Oceanog, Barcelona, Spain	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Amsterdam; University of Amsterdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Mueller, B (corresponding author), Royal Netherlands Inst Sea Res, Dept Biol Oceanog, Den Hoorn, Netherlands.	muellerb@ymail.com	Ribes, Marta/B-2495-2013; van Duyl, Fleur C./P-9711-2016; Vermeij, Mark/B-2752-2013; Vermeij, Mark/AAR-6757-2020; de Goeij, Jasper/L-6992-2017	Ribes, Marta/0000-0001-9747-295X; van Duyl, Fleur C./0000-0002-8410-4151; Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527; Mulders, Yannick/0000-0002-4879-4773; de Goeij, Jasper/0000-0002-3411-3084; Benjamin, Mueller/0000-0001-9335-0437	European Union [244161]; Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI) [863.10.009]	European Union(European Commission); Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI)	The research leading to these results has received funding from the European Union Seventh Framework Programme (P7/2007-2013) under grant agreement no 244161 (Future of Reefs in a Changing Environment) and the Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI; 863.10.009; pers. grant to JMdG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; AYUKAI T, 1995, CORAL REEFS, V14, P141, DOI 10.1007/BF00367231; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Calcinai B, 2007, PORIFERA RES BIODIVE, P255; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Cebrian E, 2006, MAR ECOL PROG SER, V323, P83, DOI 10.3354/meps323083; Cebrian E, 2010, MAR ECOL-EVOL PERSP, V31, P533, DOI 10.1111/j.1439-0485.2010.00401.x; Chaves-Fonnegra Andia, 2007, Bol. Invest. Mar. Cost., V36, P63; Colvard NB, 2011, J EXP MAR BIOL ECOL, V397, P153, DOI 10.1016/j.jembe.2010.11.015; Coma R, 2001, MAR ECOL PROG SER, V219, P305, DOI 10.3354/meps219305; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; Duckworth AR, 2013, MAR BIOL, V160, P27, DOI 10.1007/s00227-012-2053-z; Fang JKH, 2013, GLOBAL CHANGE BIOL, V19, P3581, DOI 10.1111/gcb.12334; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; GERRODETTE T, 1979, MAR BIOL, V55, P103, DOI 10.1007/BF00397305; Glynn Peter W., 1997, P68; Gonzalez-Rivero M, 2012, MAR ECOL PROG SER, V444, P133, DOI 10.3354/meps09424; Gonzalez-Rivero M, 2011, ECOL MODEL, V222, P1847, DOI 10.1016/j.ecolmodel.2011.03.020; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.108; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; HEIN FJ, 1975, B MAR SCI, V25, P133; Hill MS, 1996, MAR BIOL, V125, P649, DOI 10.1007/BF00349246; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holmes KE, 2000, INVERTEBR BIOL, V119, P125; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kotter I., 2003, THESIS; Lopez-Victoria M, 2006, MAR ECOL PROG SER, V312, P113, DOI 10.3354/meps312113; Maliao RJ, 2008, MAR BIOL, V154, P841, DOI 10.1007/s00227-008-0977-0; Mallela J, 2007, CORAL REEFS, V26, P129, DOI 10.1007/s00338-006-0169-7; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Perea-Blazquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029569; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; REISWIG HM, 1975, CAN J ZOOL, V53, P582, DOI 10.1139/z75-072; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Ribes M, 1999, MAR ECOL PROG SER, V176, P179, DOI 10.3354/meps176179; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; RISK MJ, 1995, CORAL REEFS, V14, P79, DOI 10.1007/BF00303427; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; Rutzler K., 2002, Acta Geologica Hispanica, V37, P61; Rutzler K, 1971, SMITHSON CONTRIB ZOO, V77, P37; Schonberg CHL, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P165, DOI 10.1007/978-3-540-77598-0_9; Schonberg CHL, 2012, AQUAT BIOL, V17, P1, DOI 10.3354/ab00473; Tompkins-MacDonald GJ, 2008, MAR BIOL, V154, P973, DOI 10.1007/s00227-008-0987-y; VACELET J, 1995, NATURE, V373, P333, DOI 10.1038/373333a0; van Duyl FC, 2002, CORAL REEFS, V21, P293, DOI 10.1007/s00338-002-0248-3; van Duyl FC, 2008, MAR ECOL PROG SER, V358, P137, DOI 10.3354/meps07370; VANDUYL FC, 1985, STUDIES FLORA FAUNA, V117; Ward-Paige CA, 2005, MAR POLLUT BULL, V51, P570, DOI 10.1016/j.marpolbul.2005.04.006; Weisz JB, 2010, BIOL BULL-US, V219, P189, DOI 10.1086/BBLv219n3p189; Wild C., 2008, P 11 INT COR REEF S, P1319; Wisshak M, 2013, AQUAT BIOL, V19, P111, DOI 10.3354/ab00527; Wisshak M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045124; Yahel G, 1998, LIMNOL OCEANOGR, V43, P551, DOI 10.4319/lo.1998.43.4.0551; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Yahel G, 2005, LIMNOL OCEANOGR-METH, V3, P46, DOI 10.4319/lom.2005.3.46; Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428	66	72	73	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90152	10.1371/journal.pone.0090152	http://dx.doi.org/10.1371/journal.pone.0090152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587253	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900121
J	Sedeaud, A; Marc, A; Marck, A; Dor, F; Schipman, J; Dorsey, M; Haida, A; Berthelot, G; Toussaint, JF				Sedeaud, Adrien; Marc, Andy; Marck, Adrien; Dor, Frederic; Schipman, Julien; Dorsey, Maya; Haida, Amal; Berthelot, Geoffroy; Toussaint, Jean-Francois			BMI, a Performance Parameter for Speed Improvement	PLOS ONE			English	Article							BODY-MASS; DISTANCE RUNNERS; RUNNING ECONOMY; ENERGY-COST; HEIGHT; ADVANTAGES; TRIATHLON; EVOLUTION; TREADMILL; PHYSIQUE	The purpose of this study is to investigate the association between anthropometric characteristics and performance in all track and field running events and assess Body Mass Index (BMI) as a relevant performance indicator. Data of mass, height, BMI and speed were collected for the top 100 international men athletes in track events from 100 m to marathon for the 1996-2011 seasons, and analyzed by decile of performance. Speed is significantly associated with mass (r = 0.71) and BMI (r = 0.71) in world-class runners and moderately with height (r = 0.39). Athletes, on average were continuously lighter and smaller with distance increments. In track and field, speed continuously increases with BMI. In each event, performances are organized through physique gradients. << Lighter and smaller is better >> in endurance events but << heavier and taller is better >> for sprints. When performance increases, BMI variability progressively tightens, but it is always centered around a distance-specific optimum. Running speed is organized through biometric gradients, which both drives and are driven by performance optimization. The highest performance level is associated with narrower biometric intervals. Through BMI indicators, diversity is possible for sprints whereas for long distance events, there is a more restrictive aspect in terms of physique. BMI is a relevant indicator, which allows for a clear differentiation of athletes' capacities between each discipline and level of performance in the fields of human possibilities.	[Sedeaud, Adrien; Marc, Andy; Marck, Adrien; Dor, Frederic; Schipman, Julien; Dorsey, Maya; Haida, Amal; Berthelot, Geoffroy; Toussaint, Jean-Francois] INSEP, IRMES Inst Rech BioMed & Epidemiol Sport, Paris, France; [Sedeaud, Adrien; Berthelot, Geoffroy; Toussaint, Jean-Francois] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Haida, Amal] Univ Rouen, CETAPS EA 3832, Mont St Aignan, France; [Toussaint, Jean-Francois] Hop Hotel Dieu, AP HP, CIMS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Sedeaud, A (corresponding author), INSEP, IRMES Inst Rech BioMed & Epidemiol Sport, Paris, France.	adrien.sedeaud@insep.fr		Sedeaud, Adrien/0000-0002-8492-3579				Bejan A, 2006, J EXP BIOL, V209, P238, DOI 10.1242/jeb.01974; Bejan A., 2010, INT J DES NAT ECODYN, V5, P199, DOI DOI 10.2495/DNE-V5-N3-199-211; Berg K, 2003, SPORTS MED, V33, P59, DOI 10.2165/00007256-200333010-00005; BERGH U, 1991, MED SCI SPORT EXER, V23, P205; BOSCH AN, 1990, EUR J APPL PHYSIOL O, V61, P68, DOI 10.1007/BF00236696; BOURDIN M, 1993, EUR J APPL PHYSIOL O, V66, P439, DOI 10.1007/BF00599618; Charles JD, 2009, J EXP BIOL, V212, P2419, DOI 10.1242/jeb.031161; CHU NS, 1989, ELECTROEN CLIN NEURO, V74, P481, DOI 10.1016/0168-5597(89)90039-7; Dawkins R., 1990, SELFISH GENE; De Garay AL, 1974, AM J PHYS ANTHROPOL, V45, P125, DOI [10.1002/ajpa.1330450117, DOI 10.1002/AJPA.1330450117]; DEITRICK RW, 1991, J SPORT MED PHYS FIT, V31, P367; Dennis SC, 1999, EUR J APPL PHYSIOL, V79, P280, DOI 10.1007/s004210050507; Desgorces FD, 2012, J EVOLUTION BIOL, V25, P1792, DOI 10.1111/j.1420-9101.2012.02563.x; Floud R., 2011, CHANGING BODY HLTH N; Hirata K., 1979, SELECTION OLYMPIC CH; Hirata K I, 1966, J Sports Med Phys Fitness, V6, P207; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; Khosla T, 1978, Br J Sports Med, V12, P97; KHOSLA T, 1974, LANCET, V1, P30; Knechtle B, 2007, BRIT J SPORT MED, V41, P644, DOI 10.1136/bjsm.2006.035014; Kong PW, 2008, J SPORT SCI MED, V7, P499; Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7; Maldonado S, 2002, INT J SPORTS MED, V23, P268, DOI 10.1055/s-2002-29083; Marc A, 2013, J SPORTS SC IN PRESS; Marc A, 2014, J SPORT SCI, V32, P524, DOI 10.1080/02640414.2013.835436; Marino FE, 2000, PFLUG ARCH EUR J PHY, V441, P359, DOI 10.1007/s004240000432; McShea D. W., 2010, BIOL 1 LAW TENDENCY; MORGAN DW, 1989, SPORTS MED, V7, P310, DOI 10.2165/00007256-198907050-00003; Nevill AM, 2010, J SPORT SCI, V28, P1009, DOI 10.1080/02640414.2010.487071; Norton K, 2001, SPORTS MED, V31, P763, DOI 10.2165/00007256-200131110-00001; Norton K, 1996, ANTHROPOMETRICA TXB; O'Connor H, 2007, J SPORT SCI, V25, pS49, DOI 10.1080/02640410701607296; Pere S, 1954, AM J PHYS ANTHROP-NE, V12, P201, DOI 10.1002/ajpa.1330120217; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PUGH LGCE, 1971, J PHYSIOL-LONDON, V213, P255, DOI 10.1113/jphysiol.1971.sp009381; Samaras TT, 2007, HUMAN BODY SIZE LAWS; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Sedeaud A, 2012, BRIT J SPORT MED, V46, P580, DOI 10.1136/bjsports-2011-090506; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Sleivert GG, 1996, SPORTS MED, V22, P8, DOI 10.2165/00007256-199622010-00002; WARDSMITH AJ, 1985, J BIOMECH, V18, P337, DOI 10.1016/0021-9290(85)90289-1; Watts AS, 2011, J SPORTS SCI; Weston AR, 2000, MED SCI SPORT EXER, V32, P1130, DOI 10.1097/00005768-200006000-00015; Weyand PG, 2005, J EXP BIOL, V208, P2625, DOI 10.1242/jeb.01609	44	45	45	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90183	10.1371/journal.pone.0090183	http://dx.doi.org/10.1371/journal.pone.0090183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587266	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900122
J	Keglowich, L; Baraket, M; Tamm, M; Borger, P				Keglowich, Laura; Baraket, Melissa; Tamm, Michael; Borger, Peter			Hypoxia Exerts Dualistic Effects on Inflammatory and Proliferative Responses of Healthy and Asthmatic Primary Human Bronchial Smooth Muscle Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OBSTRUCTIVE PULMONARY-DISEASE; INDUCIBLE FACTOR; C/EBP-ALPHA; AIRWAY; ANGIOGENESIS; EXPRESSION; CHILDREN; INTERLEUKIN-8; MIGRATION	Background: For oxygen supply, airway wall cells depend on diffusion though the basement membrane, as well as on delivery by micro-vessels. In the asthmatic lung, local hypoxic conditions may occur due to increased thickness and altered composition of the basement membrane, as well as due to edema of the inflamed airway wall. Objective: In our study we investigated the effect of hypoxia on proliferation and pro-inflammatory and pro-angiogenic parameter production by human bronchial smooth muscle cells (BSMC). Furthermore, conditioned media of hypoxiaexposed BSMC was tested for its ability to induce sprout outgrowth from endothelial cells spheroids. Methods: BSMC were cultured in RPMI1640 (5% FCS) under normoxic (21% O-2) and hypoxic (1% and 5% O2) conditions. Proliferation was determined by cell count and Western blot analysis for cyclin E and Proliferating Cell Nuclear Antigen (PCNA). Secretion of IL-6, IL-8, ENA-78 and VEGF-A was analyzed by ELISA. BSMC conditioned medium was tested for its angiogenic capacity by endothelial cell (EC)-spheroid in vitro angiogenesis assay. Results: Proliferation of BSMC obtained from asthmatic and non-asthmatic patients was significantly reduced in the presence of 1% O-2, whereas 5% O-2 reduced proliferation of asthmatic BSMC only. Hypoxia induced HIF-1 alpha expression in asthmatic and non-asthmatic BSMC, which coincided with significantly increased release of IL-6, IL-8 and VEGF-A, but not ENA-78. Finally, endothelial sprout outgrowth from EC spheroids was increased when exposed to hypoxia conditioned BSMC medium. Conclusion: Hypoxia had dualistic effects on proliferative and inflammatory responses of asthmatic and non-asthmatic BSMC. First, hypoxia reduced BSMC proliferation. Second, hypoxia induced a pro-inflammatory, pro-angiogenic response. BSMC and EC may thus be promising new targets to counteract and/or alleviate airway wall remodeling.	[Keglowich, Laura; Tamm, Michael; Borger, Peter] Univ Basel, Dept Biomed, Basel, Switzerland; [Baraket, Melissa] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Tamm, Michael] Univ Basel Hosp, Dept Pneumol, CH-4031 Basel, Switzerland	University of Basel; University of Sydney; University of Basel	Borger, P (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	pieter.borger@unibas.ch	Borger, Pieter (Peter)/HIR-2495-2022		Swiss National Foundation [320030_124905/1]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by a research grant of the Swiss National Foundation (# 320030_124905/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman AMO, 2006, CHEST, V129, P266, DOI 10.1378/chest.129.2.266; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Ammit AJ, 2007, AM J PHYSIOL-LUNG C, V292, pL199, DOI 10.1152/ajplung.00230.2006; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Borger P, 2007, J ALLERGY CLIN IMMUN, V119, P98, DOI 10.1016/j.jaci.2006.07.056; Borger P, 2009, J ALLERGY CLIN IMMUN, V123, P639, DOI 10.1016/j.jaci.2008.11.006; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Chambers LS, 2003, AM J PHYSIOL-LUNG C, V285, pL619, DOI 10.1152/ajplung.00416.2002; Chetta A, 2005, CLIN EXP ALLERGY, V35, P1437, DOI 10.1111/j.1365-2222.2005.02360.x; Cogo A, 2003, J APPL PHYSIOL, V94, P1403, DOI 10.1152/japplphysiol.00363.2002; Coma S, 2011, CELL ADHES MIGR, V5, P266, DOI 10.4161/cam.5.3.16294; Hakonarson H, 2003, RESP PHYSIOL NEUROBI, V137, P263, DOI 10.1016/S1569-9048(03)00152-6; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; JOHNSON PRA, 1995, AM J PHYSIOL-LUNG C, V269, pL514, DOI 10.1152/ajplung.1995.269.4.L514; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Kim ES, 2007, ALLERGY, V62, P635, DOI 10.1111/j.1398-9995.2007.01375.x; Lee SY, 2006, ANN ALLERG ASTHMA IM, V97, P794, DOI 10.1016/S1081-1206(10)60971-4; Miglino N, 2011, EUR RESPIR J, V38, P50, DOI 10.1183/09031936.00068010; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12; Osada-Oka M, 2008, J ATHEROSCLER THROMB, V15, P26, DOI 10.5551/jat.E533; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Raidl M, 2007, CELL BIOCHEM BIOPHYS, V49, P98, DOI 10.1007/s12013-007-0043-4; Ray JB, 2008, AM J PHYSIOL-HEART C, V294, pH839, DOI 10.1152/ajpheart.00587.2007; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Rydell-Tormanen K, 2013, PULM PHARMACOL THER, V26, P13, DOI 10.1016/j.pupt.2012.04.003; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Seidel P, 2011, EUR RESPIR J, V38, P1444, DOI 10.1183/09031936.00129610; Simcock DE, 2008, AM J RESP CRIT CARE, V178, P460, DOI 10.1164/rccm.200707-1046OC; Simcock DE, 2007, AM J RESP CRIT CARE, V176, P146, DOI 10.1164/rccm.200701-042OC; Stankiewicz W, 2002, MEDIAT INFLAMM, V11, P307, DOI 10.1080/09629350210000015719; Timmins Nicholas E., 2007, V140, P141; Tuder RM, 2007, J MOL MED, V85, P1317, DOI 10.1007/s00109-007-0280-4; Vrugt B, 2000, EUR RESPIR J, V15, P1014, DOI 10.1034/j.1399-3003.2000.01507.x; Wilson John W, 2002, Paediatr Respir Rev, V3, P219, DOI 10.1016/S1526-0542(02)00200-2; Yao JHS, 2006, BIOCHEM BIOPH RES CO, V342, P1396, DOI 10.1016/j.bbrc.2006.02.100	38	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89875	10.1371/journal.pone.0089875	http://dx.doi.org/10.1371/journal.pone.0089875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587090	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700106
J	Rubio-del-Campo, A; Coll-Marques, JM; Yebra, MJ; Buesa, J; Perez-Martinez, G; Monedero, V; Rodriguez-Diaz, J				Rubio-del-Campo, Antonio; Coll-Marques, Jose M.; Yebra, Maria J.; Buesa, Javier; Perez-Martinez, Gaspar; Monedero, Vicente; Rodriguez-Diaz, Jesus			Noroviral P-Particles as an In Vitro Model to Assess the Interactions of Noroviruses with Probiotics	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; INTESTINAL EPITHELIAL-CELLS; BLOOD GROUP ANTIGENS; CAPSID PROTEIN FORMS; LACTOBACILLUS STRAINS; ROTAVIRUS INFECTION; BOLIVIAN CHILDREN; GNOTOBIOTIC PIGS; CONTROLLED-TRIAL; VIRUS-INFECTION	Noroviruses (NoVs) are the main etiologic agents of acute epidemic gastroenteritis and probiotic bacteria have been reported to exert a positive effect on viral diarrhea. The protruding (P) domain from NoVs VP1 capsid protein has the ability to assemble into the so-called P-particles, which retain the binding ability to host receptors. We purified the P-domains from NoVs genotypes GI.1 and GII.4 as 6X(His)-tagged proteins and determined that, similar to native domains, they were structured into P-particles that were functional in the recognition of the specific glycoconjugated receptors, as established by surface plasmon resonance experiments. We showed that several lactic acid bacteria (probiotic and non-probiotic) and a Gram-negative probiotic strain have the ability to bind P-particles on their surfaces irrespective of their probiotic status. The binding of P-particles (GI.1) to HT-29 cells in the presence of selected strains showed that bacteria can inhibit P-particle attachment in competitive exclusion experiments. However, pre-treatment of cells with bacteria or adding bacteria to cells with already attached P-particles enhanced the retention of the particles. Although direct viral binding and blocking of viral receptors have been postulated as mechanisms of protection against viral infection by probiotic bacteria, these results highlight the need for a careful evaluation of this hypothesis. The work presented here investigates for the first time the probiotic-NoVs-host interactions and points up the NoVs P-particles as useful tools to overcome the absence of in vitro cellular models to propagate these viruses.	[Rubio-del-Campo, Antonio; Coll-Marques, Jose M.; Yebra, Maria J.; Perez-Martinez, Gaspar; Monedero, Vicente; Rodriguez-Diaz, Jesus] Inst Agrochem & Food Technol IATA CSIC, Dept Biotechnol, Lab Lact Acid Bacteria & Probiot, Valencia, Spain; [Buesa, Javier] Univ Valencia, Fac Med, Dept Microbiol & Ecol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia	Monedero, V (corresponding author), Inst Agrochem & Food Technol IATA CSIC, Dept Biotechnol, Lab Lact Acid Bacteria & Probiot, Valencia, Spain.	btcmon@iata.csic.es; btcjrd@iata.csic.es	Martinez, Gaspar Perez/H-4167-2012; Buesa, Javier/D-8927-2014; Monedero, Vicente/H-3876-2012; Rodriguez-Diaz, Jesus/B-2091-2012; Yebra, Maria J/H-4665-2012	Martinez, Gaspar Perez/0000-0003-3501-1626; Buesa, Javier/0000-0002-3328-3428; Monedero, Vicente/0000-0001-7461-8047; Rodriguez-Diaz, Jesus/0000-0002-9698-7684; Yebra, Maria J/0000-0003-4638-986X; Rubio del Campo, Antonio/0000-0002-8482-2778; Coll-Marques, Jose Maria/0000-0003-2624-7936	Valencian Government [GV/2011/079]; Spanish Ministry of Economy and Competitiveness through Consolider Fun-c-Food [CSD2007-00063]; CSIC/FSE	Valencian Government; Spanish Ministry of Economy and Competitiveness through Consolider Fun-c-Food; CSIC/FSE	This work was financed by funds of the Valencian Government through project GV/2011/079 and of the Spanish Ministry of Economy and Competitiveness through Consolider Fun-c-Food CSD2007-00063 project. JRD was supported by a JAE-doc contract from CSIC/FSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo-Felix E, 2003, INT J SYST EVOL MICR, V53, P67, DOI 10.1099/ijs.0.02325-0; Altenhoefer A, 2004, FEMS IMMUNOL MED MIC, V40, P223, DOI 10.1016/S0928-8244(03)00368-7; Azevedo MSP, 2012, BENEF MICROBES, V3, P33, DOI 10.3920/BM2011.0041; Botic T, 2007, INT J FOOD MICROBIOL, V115, P227, DOI 10.1016/j.ijfoodmicro.2006.10.044; Buesa J, 2006, FOOD MICROBIOL FOOD, P43; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; DALE GE, 1994, PROTEIN ENG, V7, P925, DOI 10.1093/protein/7.7.925; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Dubey AP, 2008, J CLIN GASTROENTEROL, V42, pS126, DOI 10.1097/MCG.0b013e31816fc2f6; Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d; Grandy G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-253; Halttunen T, 2008, LETT APPL MICROBIOL, V46, P160, DOI 10.1111/j.1472-765X.2007.02276.x; Harrington PR, 2004, J VIROL, V78, P3035, DOI 10.1128/JVI.78.6.3035-3045.2004; Herbst-Kralovetz MM, 2013, EMERG INFECT DIS, V19, P431, DOI 10.3201/eid1903.121029; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Ivec M, 2007, ANTIVIR RES, V75, P266, DOI 10.1016/j.antiviral.2007.03.013; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; Kroneman A, 2013, ARCH VIROL; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lee YK, 2003, J MED MICROBIOL, V52, P925, DOI 10.1099/jmm.0.05009-0; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Maragkoudakis PA, 2010, INT J FOOD MICROBIOL, V141, pS91, DOI 10.1016/j.ijfoodmicro.2009.12.024; Miura T, 2013, J VIROL, V87, P9441, DOI 10.1128/JVI.01060-13; Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x; Munoz-Provencio D, 2012, APPL ENVIRON MICROB, V78, P8684, DOI 10.1128/AEM.02287-12; Murakami K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066534; Murakami K, 2010, BIOSCI BIOTECH BIOCH, V74, P541, DOI 10.1271/bbb.90729; Pfeiffer JK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00092; Rinkinen M, 2003, VET MICROBIOL, V92, P111, DOI 10.1016/S0378-1135(02)00356-5; Rodriguez-Diaz J, 2013, BIOACT FOOD CHRON, P271, DOI 10.1016/B978-0-12-397154-8.00031-2; Rosenfeldt V, 2002, PEDIATR INFECT DIS J, V21, P411, DOI 10.1097/00006454-200205000-00012; Rydell GE, 2009, GLYCOBIOLOGY, V19, P309, DOI 10.1093/glycob/cwn139; Salminen S, 1996, ANTON LEEUW INT J G, V70, P347, DOI 10.1007/BF00395941; Salminen S, 2010, CURR OPIN BIOTECH, V21, P157, DOI 10.1016/j.copbio.2010.03.016; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2011, VIROLOGY, V410, P345, DOI 10.1016/j.virol.2010.11.017; Teran CG, 2009, INT J INFECT DIS, V13, P518, DOI 10.1016/j.ijid.2008.09.014; Thompson A, 2010, PROBIOTICS ANTIMICRO, V2, P90, DOI 10.1007/s12602-009-9032-9; Tuomola EM, 1999, FEMS IMMUNOL MED MIC, V26, P137, DOI 10.1111/j.1574-695X.1999.tb01381.x; Uchida H, 2006, BIOSCI BIOTECH BIOCH, V70, P3073, DOI 10.1271/bbb.60407; Uchida H, 2006, RES MICROBIOL, V157, P659, DOI 10.1016/j.resmic.2006.03.001; White LJ, 1996, J VIROL, V70, P6589, DOI 10.1128/JVI.70.10.6589-6597.1996; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Zhang W, 2008, VET IMMUNOL IMMUNOP, V121, P222, DOI 10.1016/j.vetimm.2007.10.001	50	31	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89586	10.1371/journal.pone.0089586	http://dx.doi.org/10.1371/journal.pone.0089586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586892	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900123
J	Nelson, EAS; Bloom, DE; Mahoney, RT				Nelson, E. A. S.; Bloom, David E.; Mahoney, Richard T.			Monitoring What Governments "Give for'' and "Spend on'' Vaccine Procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline	PLOS ONE			English	Article							OFFICIAL DEVELOPMENT ASSISTANCE; CHILD HEALTH; COUNTDOWN; NEWBORN; COUNTRIES; COSTS	Background: The Global Vaccine Action Plan will require, inter alia, the mobilization of financial resources from donors and national governments - both rich and poor. Vaccine Procurement Assistance (VPA) and Vaccine Procurement Baseline (VPB) are two metrics that could measure government performance and track resources in this arena. VPA is proposed as a new subcategory of Official Development Assistance (ODA) given for the procurement of vaccines and VPB is a previously suggested measure of the share of Gross Domestic Product (GDP) that governments spend on their own vaccine procurement. Objective: To determine realistic targets for VPA and VPB. Methods: Organization for Economic Co-Operation and Development (OECD) and World Bank data for 2009 were analyzed to determine the proportions of bilateral ODA from the 23 Development Assistance Committee (DAC) countries disbursed (as % of GDP in current US$) for infectious disease control. DAC country contributions to the GAVI Alliance for 2009 were assessed as a measure of multilateral donor support for vaccines and immunization programs. Findings: In 2009, total DAC bilateral ODA was 0.16% of global GDP and 0.25% of DAC GDP. As a percentage of GDP, Norway (0.013%) and United Kingdom (0.0085%) disbursed the greatest proportion of bilateral ODA for infectious disease control, and Norway (0.024%) and Canada (0.008%) made the greatest contributions to the GAVI Alliance. In 2009 0.02% of DAC GDP was US$ 7.61 billion and 0.02% of the GDP of the poorest 117 countries was US$ 2.88 billion. Conclusions: Adopting 0.02% GDP as minimum targets for both VPA and VPB is based on realistic estimates of what both developed and developing countries should spend, and can afford to spend, to jointly ensure procurement of vaccines recommended by national and global bodies. New OECD purpose codes are needed to specifically track ODA disbursed for a) vaccine procurement; and b) immunization programs.	[Nelson, E. A. S.] Chinese Univ Hong Kong, Fac Med, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Bloom, David E.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Mahoney, Richard T.] Global Hlth Consultant, Sedona, AZ USA	Chinese University of Hong Kong; Harvard University; Harvard T.H. Chan School of Public Health	Nelson, EAS (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Paediat, Hong Kong, Hong Kong, Peoples R China.	tony-nelson@cuhk.edu.hk	Nelson, E Anthony S/ABF-4238-2020	Nelson, E Anthony S/0000-0002-2521-3403				[Anonymous], 2011, NEW DECADE VACCINES; Barnighausen T, 2012, CLIN MICROBIOL INFEC, V18, P70, DOI 10.1111/j.1469-0691.2012.03977.x; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; De la Hoz-Restrepo F, 2013, VACCINE, V31, pC80, DOI 10.1016/j.vaccine.2013.05.064; Deogaonkar R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-878; Gandhi G, 2013, VACCINE, V31, pB137, DOI 10.1016/j.vaccine.2013.01.036; Gates WH, 2013, COMMUNICATION; GAVI, 2012, KEY FIG DON CONTR PL; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Gronseth L, 2013, ACCELERATING PROGR S; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Mahoney RT, 2000, VACCINE, V18, P2625, DOI 10.1016/S0264-410X(00)00073-6; McDonnell I, 2002, SEARCH VIRTOUS CIRCL; Nelson EAS, 1996, LANCET, V348, P1642, DOI 10.1016/S0140-6736(96)06389-1; OECD, 2012, OECD GLOSS STAT TERM; OECD, 2002, DAC J, V3, pIII9; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; WHO, 2013, GLOB VACC ACT PLAN; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096; World Bank, 2012, WORLD BANK DAT BANK; World Health Organization, 2013, GLOB VACC ACT PLAN R; World Health Organization, 2013, SYST HLTH ACC SHA 20; World Public Opinion, 2010, AM PUBL VASTL OV AM	24	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89593	10.1371/journal.pone.0089593	http://dx.doi.org/10.1371/journal.pone.0089593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586899	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700131
J	Reum, JCP; Alin, SR; Feely, RA; Newton, J; Warner, M; McElhany, P				Reum, Jonathan C. P.; Alin, Simone R.; Feely, Richard A.; Newton, Jan; Warner, Mark; McElhany, Paul			Seasonal Carbonate Chemistry Covariation with Temperature, Oxygen, and Salinity in a Fjord Estuary: Implications for the Design of Ocean Acidification Experiments	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; LEAST-SQUARES REGRESSION; CALANUS-PACIFICUS; INORGANIC CARBON; MIDWATER HYPOXIA; CLIMATE-CHANGE; MARINE; VARIABILITY; CO2; PATTERNS	Carbonate chemistry variability is often poorly characterized in coastal regions and patterns of covariation with other biologically important variables such as temperature, oxygen concentration, and salinity are rarely evaluated. This absence of information hampers the design and interpretation of ocean acidification experiments that aim to characterize biological responses to future pCO(2) levels relative to contemporary conditions. Here, we analyzed a large carbonate chemistry data set from Puget Sound, a fjord estuary on the U. S. west coast, and included measurements from three seasons (winter, summer, and fall). pCO(2) exceeded the 2008-2011 mean atmospheric level (392 mu atm) at all depths and seasons sampled except for the near-surface waters (<10 m) in the summer. Further, undersaturated conditions with respect to the biogenic carbonate mineral aragonite were widespread (Omega(ar)<1). We show that pCO(2) values were relatively uniform throughout the water column and across regions in winter, enriched in subsurface waters in summer, and in the fall some values exceeded 2500 mu atm in near-surface waters. Carbonate chemistry covaried to differing levels with temperature and oxygen depending primarily on season and secondarily on region. Salinity, which varied little (27 to 31), was weakly correlated with carbonate chemistry. We illustrate potential high-frequency changes in carbonate chemistry, temperature, and oxygen conditions experienced simultaneously by organisms in Puget Sound that undergo diel vertical migrations under present-day conditions. We used simple calculations to estimate future pCO(2) and Omega(ar) values experienced by diel vertical migrators based on an increase in atmospheric CO2. Given the potential for non-linear interactions between pCO(2) and other abiotic variables on physiological and ecological processes, our results provide a basis for identifying control conditions in ocean acidification experiments for this region, but also highlight the wide range of carbonate chemistry conditions organisms may currently experience in this and similar coastal ecosystems.	[Reum, Jonathan C. P.; McElhany, Paul] NOAA, Conservat Biol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Alin, Simone R.; Feely, Richard A.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Newton, Jan] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Warner, Mark] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Reum, JCP (corresponding author), NOAA, Conservat Biol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Jonathan.Reum@noaa.gov	Feely, Richard A./ABI-5740-2020; Alin, Simone/J-6836-2017	Alin, Simone/0000-0002-8283-1910; Warner, Mark J/0000-0001-7678-441X	NOAA Ocean Acidification Program, NOAA Pacific Marine Environmental Laboratory; University of Washington including the PRISM program; Washington State Department of Ecology; Hood Canal Dissolved Oxygen Program via Naval Sea Systems Command Contract [N00024-02-D-6602]; National Research Fellowship award; National Oceanic and Atmospheric Administration (a) over cap (sic)(TM)s Northwest Fisheries Science Center; Pacific Marine Environmental Laboratory; Ocean Acidification Program; Integrated Ocean Observing System Program; University of Washington including Northwest Association of Networked Ocean Observing Systems (NANOOS); Puget Sound Regional Synthesis Model (PRISM); Applied Physics Laboratory; School of Oceanography	NOAA Ocean Acidification Program, NOAA Pacific Marine Environmental Laboratory; University of Washington including the PRISM program; Washington State Department of Ecology; Hood Canal Dissolved Oxygen Program via Naval Sea Systems Command Contract; National Research Fellowship award; National Oceanic and Atmospheric Administration (a) over cap (sic)(TM)s Northwest Fisheries Science Center; Pacific Marine Environmental Laboratory; Ocean Acidification Program; Integrated Ocean Observing System Program; University of Washington including Northwest Association of Networked Ocean Observing Systems (NANOOS); Puget Sound Regional Synthesis Model (PRISM); Applied Physics Laboratory; School of Oceanography	This research was supported by the NOAA Ocean Acidification Program, NOAA Pacific Marine Environmental Laboratory, the University of Washington including the PRISM program, and the Washington State Department of Ecology. Work in Hood Canal was partially funded through the Hood Canal Dissolved Oxygen Program via Naval Sea Systems Command Contract #N00024-02-D-6602 Task 50. J.C.P.R. was supported by a National Research Fellowship award. This work was co-sponsored by the National Oceanic and Atmospheric Administration (a) over cap (sic)(TM) s Northwest Fisheries Science Center, Pacific Marine Environmental Laboratory, Ocean Acidification Program, and Integrated Ocean Observing System Program; the University of Washington including Northwest Association of Networked Ocean Observing Systems (NANOOS), Puget Sound Regional Synthesis Model (PRISM), Applied Physics Laboratory, and School of Oceanography; and the Washington State Department of Ecology. Work in Hood Canal was partially funded through the Hood Canal Dissolved Oxygen Program via Naval Sea Systems Command Contract #N00024-02-D-6602 Task 50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alin SR, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007511; Andersson AJ, 2012, BIOGEOSCIENCES, V9, P893, DOI 10.5194/bg-9-893-2012; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bianucci L, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001849; BOLLENS SM, 1992, MAR BIOL, V114, P219, DOI 10.1007/BF00349522; Borges AV, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 5: BIOGEOCHEMISTRY, P119; Borges AV, 2010, LIMNOL OCEANOGR, V55, P346, DOI 10.4319/lo.2010.55.1.0346; Brandenberger JM, 2011, AQUAT GEOCHEM, V17, P645, DOI 10.1007/s10498-011-9129-0; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CANNON GA, 1990, ESTUARIES, V13, P31, DOI 10.2307/1351430; CARPENTER JAMES H., 1965, LIMNOL OCEANOGR, V10, P141; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Delille B, 2009, ESTUAR COAST SHELF S, V81, P114, DOI 10.1016/j.ecss.2008.10.004; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Duarte C.M., 2013, ESTUAR COAST, P1; Dufault AM, 2012, P ROY SOC B-BIOL SCI, V279, P2951, DOI 10.1098/rspb.2011.2545; Evans W, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006625; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; FROST BW, 1988, B MAR SCI, V43, P675; Gattuso J.-P., 2011, OCEAN ACIDIFICATION, P1; Gray SEC, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004114; Gypens N, 2004, BIOGEOSCIENCES, V1, P147, DOI 10.5194/bg-1-147-2004; Harris KE, 2013, GEOPHYS RES LETT, V40, P2720, DOI 10.1002/grl.50460; Hassellov IM, 2013, GEOPHYS RES LETT, V40, P2731, DOI 10.1002/grl.50521; Hauri C, 2013, BIOGEOSCIENCES, V10, P193, DOI 10.5194/bg-10-193-2013; Hettinger A, 2013, BIOGEOSCIENCES, V10, P6629, DOI 10.5194/bg-10-6629-2013; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; JOHNSON KM, 1985, MAR CHEM, V16, P61, DOI 10.1016/0304-4203(85)90028-3; JOHNSON KM, 1987, MAR CHEM, V21, P117, DOI 10.1016/0304-4203(87)90033-8; Juranek LW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040778; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kutner M., 2005, APPL LINEAR STAT MOD; LAVELLE JW, 1991, J GEOPHYS RES-OCEANS, V96, P16779, DOI 10.1029/91JC01450; Lavigne H., 2010, SEACARB SEAWATER CAR; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Mackas DL, 1997, ESTUAR COAST SHELF S, V44, P1, DOI 10.1006/ecss.1996.0110; McElhany P, 2013, MAR BIOL, V160, P1807, DOI 10.1007/s00227-012-2052-0; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; Moore SK, 2008, ESTUAR COAST SHELF S, V80, P545, DOI 10.1016/j.ecss.2008.09.016; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Newton J, 2008, P 2007 GEORG BAS PUG; Orr J.C., 2011, OCEAN ACIDIFICATION, V1, P41; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; OSGOOD KE, 1994, MAR ECOL PROG SER, V104, P13, DOI 10.3354/meps104013; Parker-Stetter SL, 2009, ICES J MAR SCI, V66, P1296, DOI 10.1093/icesjms/fsp006; Parker-Stetter SL, 2009, ESTUAR COAST SHELF S, V81, P13, DOI 10.1016/j.ecss.2008.09.021; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner H, 2011, OCEAN ACIDIFICATION, P154; PSP, 2007, PUG SOUND CONS REC P; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Steinberg PD, 2011, BIOGEOCHEMISTRY, V106, P415, DOI 10.1007/s10533-010-9521-7; Sunda WG, 2012, ENVIRON SCI TECHNOL, V46, P10651, DOI 10.1021/es300626f; Sutherland DA, 2011, J PHYS OCEANOGR, V41, P1125, DOI [10.1175/2011JPO4540.1, 10.1175/2010JPO4540.1]; Waldbusser GG, 2014, ANNU REV MAR SCI, V6, P221, DOI 10.1146/annurev-marine-121211-172238; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yu PC, 2011, J EXP MAR BIOL ECOL, V400, P288, DOI 10.1016/j.jembe.2011.02.016	69	61	61	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89619	10.1371/journal.pone.0089619	http://dx.doi.org/10.1371/journal.pone.0089619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586915	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900153
J	Jones, KD; Kaye, TN				Jones, Katherine D.; Kaye, Thomas N.			Factors Influencing Germination of a Functionally Important Grassland Plant, Iris tenax	PLOS ONE			English	Article							SEED-GERMINATION; DORMANCY; GROWTH; MANAGEMENT; MECHANISMS; IRIDACEAE; SIZE	Grassland prairies of western Oregon and Washington are among the most endangered ecosystems in the United States. Active management and restoration are needed to promote biodiversity in the region. To support plant production for use in habitat restoration, we developed germination protocols for greenhouse propagation of Iris tenax (Oregon iris). Dormancy was most effectively overcome (63% germination) by four weeks of warm stratification at 20/30 degrees C followed by 6-12 weeks of cold stratification at 5 degrees C suggesting that I. tenax may have morphophysiological dormancy. This result was consistent across multiple source populations.	[Jones, Katherine D.; Kaye, Thomas N.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Kaye, Thomas N.] Inst Appl Ecol, Corvallis, OR USA	Oregon State University	Jones, KD (corresponding author), NEON, Boulder, CO USA.	kjones@neoninc.org			Portland Garden Club; Native Plant Society of Oregon Willamette Chapter	Portland Garden Club; Native Plant Society of Oregon Willamette Chapter	Partial financial support was provided by the Portland Garden Club (http://portland.www66.a2hosting.com/) and the Native Plant Society of Oregon Willamette Chapter(http://www.npsoregon.org/chapters/wv.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson E., 2005, PLANT TALK, V40, P23; AMEN RD, 1963, AM SCI, V51, P408; ARDITTI J, 1969, AM J BOT, V56, P254, DOI 10.2307/2440847; Association of Official Seed Analysis (AOSA)/Society of Commercial Seed Technologies (SCST), 2010, TETR TEST HDB; Barton, 1953, PHYSL SEEDS INTRO EX; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; BASKIN JM, 1973, AM MIDL NAT, V90, P493, DOI 10.2307/2424478; BLUMENTHAL A, 1986, ANN BOT-LONDON, V58, P551, DOI 10.1093/annbot/58.4.551; Cook T., 2011, OREGON VASCULAR PLAN; COOPS H, 1995, FRESHWATER BIOL, V34, P13, DOI 10.1111/j.1365-2427.1995.tb00418.x; Crawford R. C., 1997, ECOLOGY CONSERVATION, P11; Doherty JM, 2011, ECOL APPL, V21, P2143, DOI 10.1890/10-1534.1; Franklin J.F., 1988, US DEP AGR FOR SERV, P8; GRIME JP, 1981, J ECOL, V69, P1017, DOI 10.2307/2259651; Holdsworth M, 1999, TRENDS PLANT SCI, V4, P275, DOI 10.1016/S1360-1385(99)01429-6; Holzel N, 2004, FLORA, V199, P12, DOI 10.1078/0367-2530-00132; Huang Y, 2013, BASIC APPL ECOL; INGERSOLL CA, 1991, RESTORATION PLANS MA, V9, P110; Jones K., 2012, THESIS OREGON STATE; Kaye T.N., 2001, NATIVE PLANT PROPAGA, P5; KAYE TN, 2003, ECOLOGICAL RESTORATI, V21, P224; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Lenz LW, 1955, EL ALISO, V3, P173; Mondoni A, 2008, SEED SCI RES, V18, P213, DOI 10.1017/S0960258508084997; MORGAN MD, 1990, AM MIDL NAT, V124, P209, DOI 10.2307/2426170; Nichols GE, 1934, ECOLOGY, V15, P364, DOI 10.2307/1932351; Noss R.F., 1995, ENDANGERED ECOSYSTEM; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Russell M, 2011, NORTHWEST SCI, V85, P389, DOI 10.3955/046.085.0222; Severns P, 2003, BIOL CONSERV, V110, P221, DOI 10.1016/S0006-3207(02)00191-X; SHIPLEY B, 1991, FUNCT ECOL, V5, P111, DOI 10.2307/2389561; Stanley AG, 2011, NORTHWEST SCI, V85, P233, DOI 10.3955/046.085.0212; STOLTZ LP, 1968, PHYSIOL PLANTARUM, V21, P1328, DOI 10.1111/j.1399-3054.1968.tb07366.x; Sun YC, 2006, HORTSCIENCE, V41, P773, DOI 10.21273/HORTSCI.41.3.773; THORPE AS, 2011, NATIVE PLANTS J, V12, P289; Tillich HJ, 2003, FLORA, V198, P220, DOI 10.1078/0367-2530-00094; Van Zandt PA, 2004, EVOL ECOL RES, V6, P813; Volis S, 2007, IRIS ATROFUSCA NO NE; Wees D, 2002, 26 INT HORT C FUT ME, V629, P391; WILSON MV, 1992, NORTHWEST ENVIRON J, V8, P201; Wilson MV, 2000, RESTORATION FENDERS; Wilson MV, 1996, REP BUR LAND MANAGE; Zavaleta ES, 2007, PLANT ECOL, V188, P39, DOI 10.1007/s11258-006-9146-z	44	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90084	10.1371/journal.pone.0090084	http://dx.doi.org/10.1371/journal.pone.0090084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587217	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200121
J	Kochupurakkal, NM; Kruger, AJ; Tripathi, S; Zhu, B; Adams, L; Rainbow, DB; Rossini, A; Greiner, DL; Sayegh, MH; Wicker, LS; Guleria, I				Kochupurakkal, Nora M.; Kruger, Annie J.; Tripathi, Sudipta; Zhu, Bing; Adams, La Tonya; Rainbow, Daniel B.; Rossini, Aldo; Greiner, Dale L.; Sayegh, Mohamed H.; Wicker, Linda S.; Guleria, Indira			Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes	PLOS ONE			English	Article							T-CELL FUNCTION; IDD10 REGION; MOUSE MODEL; NOD MICE; EXPRESSION; TOLERANCE; NRAMP1; LOCUS; PD-1; PROGRESSION	Aims/Hypothesis: Inhibition of PD1-PDL1 signaling in NOD mice accelerates onset of type 1 diabetes implicating this pathway in suppressing the emergence of pancreatic beta cell reactive T-cells. However, the molecular mechanism by which PD1 signaling protects from type 1 diabetes is not clear. We hypothesized that differential susceptibility of Idd mouse strains to type 1 diabetes when challenged with anti PDL1 will identify genomic loci that collaborate with PD1 signaling in suppressing type 1 diabetes. Methods: Anti PDL1 was administered to NOD and various Idd mouse strains at 10 weeks of age and onset of disease was monitored by measuring blood glucose levels. Additionally, histological evaluation of the pancreas was performed to determine degree of insulitis. Statistical analysis of the data was performed using Log-Rank and Student's t-test. Results: Blockade of PDL1 rapidly precipitated type 1 diabetes in nearly all NOD Idd congenic strains tested, despite the fact that all are moderately (Idd5, Idd3 and Idd10/18) or highly (Idd3/10/18 and Idd9) protected from spontaneous type 1 diabetes by virtue of their protective Idd genes. Only the Idd3/5 strain, which is nearly 100% protected from spontaneous disease, remained normoglycemic following PDL1 blockade. Conclusions: These results indicate that multiple Idd loci collaborate with PD1 signaling. Anti PDL1 treatment undermines a large portion of the genetic protection mediated by Idd genes in the NOD model of type 1 diabetes. Basal insulitis correlated with higher susceptibility to type 1 diabetes. These findings have important implications since the PD1 pathway is a target for immunotherapy.	[Kochupurakkal, Nora M.; Tripathi, Sudipta; Adams, La Tonya; Sayegh, Mohamed H.; Guleria, Indira] Harvard Univ, Brigham & Womens Hosp, Sch Med, Transplantat Res Ctr,Renal Div, Boston, MA 02115 USA; [Kochupurakkal, Nora M.; Tripathi, Sudipta; Adams, La Tonya; Sayegh, Mohamed H.; Guleria, Indira] Harvard Univ, Sch Med, Div Renal, Childrens Hosp Boston, Boston, MA 02115 USA; [Kruger, Annie J.; Rossini, Aldo; Greiner, Dale L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Zhu, Bing] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Rainbow, Daniel B.; Wicker, Linda S.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; University of Cambridge	Guleria, I (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Transplantat Res Ctr,Renal Div, Boston, MA 02115 USA.	Indira.Guleria@childrens.harvard.edu	Kruger, Annie J./AAP-2207-2020	Kruger, Annie J./0000-0001-8227-5996; Sayegh, Mohamed/0000-0002-2847-588X; GULERIA, INDIRA/0000-0002-0622-3585	JDRF [1-2007-756]; Wellcome Trust [096388, 100140]; Juvenile Diabetes Research Foundation International Grant [9-2011-253]; National Institute of Allergy and Infectious Disease (NIAID) [AI 070351, P01AI039671, AI 46629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070351, P01AI046629, P01AI039671] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation International Grant(Juvenile Diabetes Research Foundation); National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by JDRF Grant # 1-2007-756 (I. Guleria). LSW is supported by Wellcome Trust Grant 096388 and Juvenile Diabetes Research Foundation International Grant 9-2011-253. This work was also supported by National Institute of Allergy and Infectious Disease (NIAID) grants AI 070351, P01AI039671 (LSW), and AI 46629. The Cambridge Institute for Medical Research is the recipient of a Wellcome Trust Strategic Award (100140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2008, J IMMUNOL, V181, P7449, DOI 10.4049/jimmunol.181.11.7449; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Araki M, 2009, J IMMUNOL, V183, P5146, DOI 10.4049/jimmunol.0802610; Blank C, 2007, CANCER IMMUNOL IMMUN, V56, P739, DOI 10.1007/s00262-006-0272-1; Bour-Jordan H, 2013, J AUTOIMMUN, V45, P58, DOI 10.1016/j.jaut.2013.06.005; Cameron MJ, 2000, J IMMUNOL, V165, P1102, DOI 10.4049/jimmunol.165.2.1102; Cannons JL, 2005, J AUTOIMMUN, V25, P13, DOI 10.1016/j.jaut.2005.04.007; Chamberlain G, 2006, J IMMUNOL, V177, P5105, DOI 10.4049/jimmunol.177.8.5105; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Dai YD, 2009, DIABETES, V58, P156, DOI 10.2337/db07-1608; Driver JP, 2011, SEMIN IMMUNOPATHOL, V33, P67, DOI 10.1007/s00281-010-0204-1; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Fraser HI, 2010, J IMMUNOL, V184, P5075, DOI 10.4049/jimmunol.0903734; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Hamilton-Williams EE, 2013, MAMM GENOME, V24, P358, DOI 10.1007/s00335-013-9466-y; Hamilton-Williams EE, 2012, DIABETES, V61, P166, DOI 10.2337/db11-0790; Hamilton-Williams EE, 2010, DIABETES, V59, P1478, DOI 10.2337/db09-1801; Hamilton-Williams EE, 2009, J IMMUNOL, V183, P1533, DOI 10.4049/jimmunol.0900428; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; Hunter K, 2007, J IMMUNOL, V179, P8341, DOI 10.4049/jimmunol.179.12.8341; Irie J, 2008, J IMMUNOL, V180, P1071, DOI 10.4049/jimmunol.180.2.1071; Kadri N, 2012, J IMMUNOL, V188, P3138, DOI 10.4049/jimmunol.1101390; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Lin XT, 2013, J IMMUNOL, V190, P3109, DOI 10.4049/jimmunol.1203422; Liu SM, 2011, J CLIN INVEST, V121, P4303, DOI 10.1172/JCI46187; Luhder F, 1998, J EXP MED, V187, P379, DOI 10.1084/jem.187.3.379; Lyons PA, 2000, IMMUNITY, V13, P107, DOI 10.1016/S1074-7613(00)00012-1; Matsuki N, 2003, J IMMUNOL, V170, P5429, DOI 10.4049/jimmunol.170.11.5429; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Pearson T, 2003, DIABETES, V52, P321, DOI 10.2337/diabetes.52.2.321; Penha-Goncalves C, 2003, DIABETES, V52, P1551, DOI 10.2337/diabetes.52.6.1551; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Rainbow DB, 2011, J IMMUNOL, V187, P325, DOI 10.4049/jimmunol.1003523; Ridgway WM, 2008, ADV IMMUNOL, V100, P151, DOI 10.1016/S0065-2776(08)00806-7; Robles DT, 2003, DIABETES, V52, P882, DOI 10.2337/diabetes.52.3.882; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Topalian SL, N ENGL J MED, V366, P2443; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Waldner H, 2006, J IMMUNOL, V176, P5455, DOI 10.4049/jimmunol.176.9.5455; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wicker LS, 2004, J IMMUNOL, V173, P164, DOI 10.4049/jimmunol.173.1.164; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yamanouchi J, 2010, DIABETES, V59, P272, DOI 10.2337/db09-0648; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhang L, 2009, BLOOD, V114, P1545, DOI 10.1182/blood-2009-03-206672; Zhou Q, 2010, BLOOD, V116, P2484, DOI 10.1182/blood-2010-03-275446	51	38	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89561	10.1371/journal.pone.0089561	http://dx.doi.org/10.1371/journal.pone.0089561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586872	gold, Green Published			2022-12-27	WOS:000332396200059
J	Komatsu, H; Maruyama, M; Yao, SH; Shinohara, T; Sakuma, K; Imaichi, S; Chikatsu, T; Kuniyeda, K; Siu, FK; Peng, LS; Zhuo, K; Mun, LS; Han, TM; Matsumoto, Y; Hashimoto, T; Miyajima, N; Itoh, Y; Ogi, K; Habata, Y; Mori, M				Komatsu, Hidetoshi; Maruyama, Minoru; Yao, Shuuhei; Shinohara, Tokuyuki; Sakuma, Kensuke; Imaichi, Sachiko; Chikatsu, Tomoko; Kuniyeda, Kanako; Siu, Foo Kok; Peng, Lam Sock; Zhuo, Katherine; Mun, Lay Sock; Han, Tan Min; Matsumoto, Yoshio; Hashimoto, Tadatoshi; Miyajima, Nobuyuki; Itoh, Yasuaki; Ogi, Kazuhiro; Habata, Yugo; Mori, Masaaki			Anatomical Transcriptome of G Protein-Coupled Receptors Leads to the Identification of a Novel Therapeutic Candidate GPR52 for Psychiatric Disorders	PLOS ONE			English	Article							ATYPICAL ANTIPSYCHOTIC-DRUGS; NUCLEOTIDE-GATED CHANNELS; DOPAMINE D1 RECEPTORS; OLFACTORY GLOMERULI; LATERAL HABENULA; EXPRESSION; NEURON; CLONING; REWARD; NEUROBIOLOGY	Many drugs of abuse and most neuropharmacological agents regulate G protein-coupled receptors (GPCRs) in the central nervous system (CNS)_ENREF_1. The striatum, in which dopamine D1 and D2 receptors are enriched, is strongly innervated by the ventral tegmental area (VTA), which is the origin of dopaminergic cell bodies of the mesocorticolimbic dopamine system_ENREF_3 and plays a central role in the development of psychiatric disorders_ENREF_4. Here we report the comprehensive and anatomical transcript profiling of 322 non-odorant GPCRs in mouse tissue by quantitative real-time PCR (qPCR), leading to the identification of neurotherapeutic receptors exclusively expressed in the CNS, especially in the striatum. Among them, GPR6, GPR52, and GPR88, known as orphan GPCRs, were shown to co-localize either with a D2 receptor alone or with both D1 and D2 receptors in neurons of the basal ganglia. Intriguingly, we found that GPR52 was well conserved among vertebrates, is Gs-coupled and responsive to the antipsychotic drug, reserpine. We used three types of transgenic (Tg) mice employing a Cre-lox system under the control of the GPR52 promoter, namely, GPR52-LacZ Tg, human GPR52 (hGPR52) Tg, and hGPR52-GFP Tg mice. Detailed histological investigation suggests that GPR52 may modulate dopaminergic and glutamatergic transmission in neuronal circuits responsible for cognitive function and emotion. In support of our prediction, GPR52 knockout and transgenic mice exhibited psychosis-related and antipsychotic-like behaviors, respectively. Therefore, we propose that GPR52 has the potential of being a therapeutic psychiatric receptor. This approach may help identify potential therapeutic targets for CNS diseases.	[Komatsu, Hidetoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cent Nervous Syst Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Maruyama, Minoru; Sakuma, Kensuke; Chikatsu, Tomoko; Habata, Yugo; Mori, Masaaki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Yao, Shuuhei; Matsumoto, Yoshio; Miyajima, Nobuyuki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Biomol Res Labs, Fujisawa, Kanagawa, Japan; [Shinohara, Tokuyuki; Imaichi, Sachiko; Ogi, Kazuhiro] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Adv Sci Res Labs, Fujisawa, Kanagawa, Japan; [Kuniyeda, Kanako] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Extra Value Generat & Gen Med Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Siu, Foo Kok; Peng, Lam Sock] Takeda Pharmaceut Co Ltd, TSP CNS Phenotyping, Singapore, Singapore; [Zhuo, Katherine; Mun, Lay Sock; Han, Tan Min] Takeda Pharmaceut Co Ltd, TSP Transgen pipeline, Singapore, Singapore; [Hashimoto, Tadatoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Res Adm Dept, Fujisawa, Kanagawa, Japan; [Itoh, Yasuaki] Takeda Pharmaceut Co Ltd, Pharmaceut Mkt Div, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Komatsu, H (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cent Nervous Syst Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	hidetkomatsu@fuji.waseda.jp		Kuniyeda, Kanako/0000-0002-4466-0145; Maruyama, Minoru/0000-0002-1478-9415; Komatsu, Hidetoshi/0000-0003-1630-0537				Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Ananth J, 2001, J PSYCHIATR NEUROSCI, V26, P385; Arac D, 2012, ANN NY ACAD SCI, V1276, P1, DOI 10.1111/j.1749-6632.2012.06820.x; Bouwmeester H, 2002, J COMP NEUROL, V442, P239, DOI 10.1002/cne.10084; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Clevenger AC, 2008, CHEM SENSES, V33, P531, DOI 10.1093/chemse/bjn021; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Ena S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00047; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; Fagan KA, 2001, FEBS LETT, V500, P85, DOI 10.1016/S0014-5793(01)02564-9; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gonzalez-Maeso J, 2009, CURR MED CHEM, V16, P1017, DOI 10.2174/092986709787581851; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; HINUMA S, 1994, BBA-GENE STRUCT EXPR, V1219, P251, DOI 10.1016/0167-4781(94)90046-9; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Lei G, 2009, J NEUROCHEM, V109, P1017, DOI 10.1111/j.1471-4159.2009.06030.x; Lindsley CW, 2006, CURR TOP MED CHEM, V6, P771, DOI 10.2174/156802606777057599; Lobo MK, 2007, NAT NEUROSCI, V10, P1395, DOI 10.1038/nn1987; Massart R, 2009, EUR J NEUROSCI, V30, P397, DOI 10.1111/j.1460-9568.2009.06842.x; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; MELTZER HY, 1992, SCHIZOPHRENIA BULL, V18, P515, DOI 10.1093/schbul/18.3.515; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; Ouagazzal AM, 2001, PSYCHOPHARMACOLOGY, V156, P273, DOI 10.1007/s002130100763; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Preskorn Sheldon H, 2007, J Psychiatr Pract, V13, P253, DOI 10.1097/01.pra.0000281486.34817.8b; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Roxo MR, 2011, THESCIENTIFICWORLDJO, V11, P2427, DOI 10.1100/2011/157150; Royal SJ, 1999, J NEUROSCI, V19, P9856; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Sharp FR, 2001, TRENDS NEUROSCI, V24, P330, DOI 10.1016/S0166-2236(00)01817-8; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Takahashi H, 2012, J CEREBR BLOOD F MET, V32, P1248, DOI 10.1038/jcbfm.2011.194; Treloar H, 1996, J COMP NEUROL, V367, P550; Varchi G, 2005, J NAT PROD, V68, P1629, DOI 10.1021/np050179x; Walters E, 1996, J NEUROSCI RES, V43, P146; Xiong GX, 2012, BRAIN RES, V1474, P40, DOI 10.1016/j.brainres.2012.07.042; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Yui K, 2000, ANN NY ACAD SCI, V914, P1, DOI 10.1111/j.1749-6632.2000.tb05178.x; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	53	36	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90134	10.1371/journal.pone.0090134	http://dx.doi.org/10.1371/journal.pone.0090134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587241	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200135
J	Zhang, S; An, QZ; Li, QY; Huang, J; Chen, X; Chen, XY; Zhang, J; Wang, YT; Yang, GY; Zhu, W				Zhang, Song; An, Qingzhu; Li, Qianyun; Huang, Jun; Chen, Xi; Chen, Xiaoyan; Zhang, Jun; Wang, Yongting; Yang, Guo-Yuan; Zhu, Wei			Therapeutic Benefit of Bone Marrow-Derived Endothelial Progenitor Cell Transplantation after Experimental Aneurysm Embolization with Coil in Rats	PLOS ONE			English	Article							GUGLIELMI DETACHABLE COIL; INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS; SACCULAR ANEURYSMS; MOBILIZATION; NEOVASCULARIZATION; RETREATMENT; PLATINUM; REPAIR	Aneurysm embolization with coil is now widely used clinically. However, the recurrence of aneurysms after embolization has always plagued neurosurgeons because the endothelial layer of the aneurysm neck loses its integrity after being embolized by coil. Bone marrow-derived endothelial progenitor cells (BM-EPCs) could be incorporated into injured endothelium and differentiate into mature endothelial cells during vascular repairing processes. The aim of our study is to explore the effects of BM-EPCs on aneurysm repairing and remodeling in a rat embolization model of abdominal aortic aneurysm. BM-EPC proliferation, migration and tube formation were not affected by super-paramagnetic iron oxide nanoparticle (SPIO) labeling compared to the controls (p>0.05). The number of SPIO-labeled cells greatly increased in EPC transplanted rats compared to that of phosphate buffered saline treated rats. SPIO-labeled EPC (SPIO-EPC) are mainly located in the aneurysm neck and surrounded by fibrous tissue. A histology study showed that the aneurysm orifice was closed with neointima and the aneurysm was filled with newly formed fibrous tissue. The SPIO-EPC accumulated in the aneurysm neck, which accelerated focal fibrous tissue remodeling, suggesting that BM-EPCs play a crucial role in repairing and remodeling the aneurysm neck orifice.	[Zhang, Song; An, Qingzhu; Chen, Xi; Zhu, Wei] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Zhang, Jun] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Li, Qianyun; Huang, Jun; Chen, Xiaoyan; Wang, Yongting; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Neurosci & Neuroengn Res Ctr, Med X Res Inst, Shanghai 200030, Peoples R China; [Li, Qianyun; Huang, Jun; Chen, Xiaoyan; Wang, Yongting; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, GY (corresponding author), Shanghai Jiao Tong Univ, Neurosci & Neuroengn Res Ctr, Med X Res Inst, Shanghai 200030, Peoples R China.	gyyang0626@gmail.com; weszhu398@yahoo.com	Wang, Yongting/C-2916-2014	zhang, jun/0000-0003-1849-9199; Qianyun, li/0000-0001-5089-2084	National Natural Science Foundation of China [30973105, 81070939, 81100868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China 30973105 (WZ), 81070939 (GYY), and 81100868 (YTW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson JP, 2012, J NEUROSURG, V117, P546, DOI 10.3171/2012.5.JNS091308; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Cekirge HS, 2000, ACTA RADIOL, V41, P111; Dai D, 2005, AM J NEURORADIOL, V26, P1932; Fang XG, 2012, J CLIN NEUROSCI, V19, P1283, DOI 10.1016/j.jocn.2011.09.038; Friedman JA, 2003, AM J NEURORADIOL, V24, P526; Fujinaka Toshiyuki, 2012, Masui, V61, P962; Grasso G, 2009, MED SCI MONITOR, V15, pCS63; GUGLIELMI G, 1991, J NEUROSURG, V75, P1, DOI 10.3171/jns.1991.75.1.0001; Horowitz M, 1999, NEUROSURGERY, V44, P712, DOI 10.1097/00006123-199904000-00013; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; JUVELA S, 1992, NEUROSURGERY, V30, P7, DOI 10.1227/00006123-199201000-00002; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kallmes DF, 1999, RADIOLOGY, V213, P217, DOI 10.1148/radiology.213.1.r99oc16217; Kamei N, 2012, J NEUROSCI RES, V90, P2281, DOI 10.1002/jnr.23113; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Lehtinen T, 2012, J INVASIVE CARDIOL, V24, P631; Li H, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-46; Matsumaru Y, 2004, INTERV NEURORADIOL, V10, P167, DOI 10.1177/15910199040100S129; Miller-Kasprzak E, 2007, ARCH IMMUNOL THER EX, V55, P247, DOI 10.1007/s00005-007-0027-5; Morris LM, 2010, WOUND REPAIR REGEN, V18, P383, DOI 10.1111/j.1524-475X.2010.00596.x; Reul J, 1997, AM J NEURORADIOL, V18, P35; Scacciatella P, 2013, MINERVA CARDIOANGIOL, V61, P211; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Solander S, 1999, J NEUROSURG, V90, P857, DOI 10.3171/jns.1999.90.5.0857; Spetzger U, 1998, SURG NEUROL, V49, P491, DOI 10.1016/S0090-3019(96)00437-5; Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340; Sung SH, 2013, INT J CARDIOL, V168, P1070, DOI 10.1016/j.ijcard.2012.11.002; Tong FC, 2000, J CLIN NEUROSCI, V7, P244, DOI 10.1054/jocn.1999.0211; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wei HJ, 2011, NEUROSCI LETT, V498, P114, DOI 10.1016/j.neulet.2011.04.061; Wei HJ, 2011, J NEUROSCI RES, V89, P1822, DOI 10.1002/jnr.22696; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	34	14	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90069	10.1371/journal.pone.0090069	http://dx.doi.org/10.1371/journal.pone.0090069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587209	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200118
J	Liu, J; Wang, ZS; Huo, YK; Davidson, SM; Klahr, K; Herder, CL; Sikora, CO; Peterson, BS				Liu, Jie; Wang, Zhishun; Huo, Yuankai; Davidson, Stephanie M.; Klahr, Kristin; Herder, Carl L.; Sikora, Chamonix O.; Peterson, Bradley S.			A Functional Imaging Study of Self-Regulatory Capacities in Persons Who Stutter	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BASAL GANGLIA CIRCUITS; GRANGER CAUSALITY; CONFLICT; FMRI; RESOLUTION; CONNECTIVITY; PERCEPTION; ACTIVATION; SPEAKERS	Developmental stuttering is a disorder of speech fluency with an unknown pathogenesis. The similarity of its phenotype and natural history with other childhood neuropsychiatric disorders of frontostriatal pathology suggests that stuttering may have a closely related pathogenesis. We investigated in this study the potential involvement of frontostriatal circuits in developmental stuttering. We collected functional magnetic resonance imaging data from 46 persons with stuttering and 52 fluent controls during performance of the Simon Spatial Incompatibility Task. We examined differences between the two groups of blood-oxygen-level-dependent activation associated with two neural processes, the resolution of cognitive conflict and the context-dependent adaptation to changes in conflict. Stuttering speakers and controls did not differ on behavioral performance on the task. In the presence of conflict-laden stimuli, however, stuttering speakers activated more strongly the cingulate cortex, left anterior prefrontal cortex, right medial frontal cortex, left supplementary motor area, right caudate nucleus, and left parietal cortex. The magnitude of activation in the anterior cingulate cortex correlated inversely in stuttering speakers with symptom severity. Stuttering speakers also showed blunted activation during context-dependent adaptation in the left dorsolateral prefrontal cortex, a brain region that mediates cross-temporal contingencies. Frontostriatal hyper-responsivity to conflict resembles prior findings in other disorders of frontostriatal pathology, and therefore likely represents a general mechanism supporting functional compensation for an underlying inefficiency of neural processing in these circuits. The reduced activation of dorsolateral prefrontal cortex likely represents the inadequate readiness of stuttering speakers to execute a sequence of motor responses.	[Liu, Jie; Wang, Zhishun; Huo, Yuankai; Davidson, Stephanie M.; Klahr, Kristin; Peterson, Bradley S.] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA; [Herder, Carl L.; Sikora, Chamonix O.] Amer Inst Stuttering, New York, NY USA	Columbia University; New York State Psychiatry Institute	Peterson, BS (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA.	PetersoB@nyspi.columbia.edu	Liu, Jie/K-3142-2015	Davidson, Stephanie/0000-0003-1177-1559	McGue Millhiser Family Trust; Suzanne Crosby Murphy Endowment at Columbia University	McGue Millhiser Family Trust; Suzanne Crosby Murphy Endowment at Columbia University	This work is supported by the McGue Millhiser Family Trust and the Suzanne Crosby Murphy Endowment at Columbia University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; ANDREWS G, 1983, J SPEECH HEAR DISORD, V48, P226, DOI 10.1044/jshd.4803.226; BARRIS RW, 1953, NEUROLOGY, V3, P44, DOI 10.1212/WNL.3.1.44; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Chang SE, 2011, CEREB CORTEX, V21, P2507, DOI 10.1093/cercor/bhr028; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Chen YH, 2004, PHYS LETT A, V324, P26, DOI 10.1016/j.physleta.2004.02.032; Choo AL, 2011, J COMMUN DISORD, V44, P470, DOI 10.1016/j.jcomdis.2011.03.001; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Cykowski MD, 2010, NEUROIMAGE, V52, P1495, DOI 10.1016/j.neuroimage.2010.05.011; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eggers K, 2013, J FLUENCY DISORD, V38, P1, DOI 10.1016/j.jfludis.2012.10.001; Eggers K, 2010, J FLUENCY DISORD, V35, P355, DOI 10.1016/j.jfludis.2010.10.004; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Felsenfeld S, 2010, J SPEECH LANG HEAR R, V53, P1147, DOI 10.1044/1092-4388(2010/09-0164); First MB, 2002, STRUCTURED CLIN INTE; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Karrass J, 2006, J COMMUN DISORD, V39, P402, DOI 10.1016/j.jcomdis.2005.12.004; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Kerns JG, 2005, AM J PSYCHIAT, V162, P1833, DOI 10.1176/appi.ajp.162.10.1833; Kikuchi Y, 2011, NEUROIMAGE, V55, P891, DOI 10.1016/j.neuroimage.2010.12.083; Loucks T, 2011, J FLUENCY DISORD, V36, P302, DOI 10.1016/j.jfludis.2011.04.004; Lu C, 2009, NEUROSCIENCE, V161, P1008, DOI 10.1016/j.neuroscience.2009.04.020; Lu CM, 2012, NEUROLOGY, V79, P625, DOI 10.1212/WNL.0b013e31826356d2; Lu CM, 2010, EXP NEUROL, V221, P146, DOI 10.1016/j.expneurol.2009.10.016; Lu CM, 2010, CORTEX, V46, P49, DOI 10.1016/j.cortex.2009.02.017; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Marsh R, 2011, AM J PSYCHIAT, V168, P1210, DOI 10.1176/appi.ajp.2011.11010094; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; McMillan CT, 2012, NEUROPSYCHOLOGIA, V50, P674, DOI 10.1016/j.neuropsychologia.2012.01.004; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Novais-Santos S, 2007, NEUROIMAGE, V37, P361, DOI 10.1016/j.neuroimage.2007.03.077; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Peterson BS, 2002, COGNITIVE BRAIN RES, V13, P427, DOI 10.1016/S0926-6410(02)00054-X; POOL KD, 1991, ARCH NEUROL-CHICAGO, V48, P509, DOI 10.1001/archneur.1991.00530170069022; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Smits-Bandstra S, 2007, J FLUENCY DISORD, V32, P251, DOI 10.1016/j.jfludis.2007.06.001; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Walden TA, 2012, J ABNORM CHILD PSYCH, V40, P633, DOI 10.1007/s10802-011-9581-8; Wechsler D., 1981, WAIS R MANUAL WECHSL; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097; Yaruss J. S., 2006, AM SPEECH LANG HEAR; Yaruss JS, 2006, J FLUENCY DISORD, V31, P90, DOI 10.1016/j.jfludis.2006.02.002	49	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89891	10.1371/journal.pone.0089891	http://dx.doi.org/10.1371/journal.pone.0089891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24587104	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800051
J	Gal, R; Kaiser, M; Haspel, G; Libersat, F				Gal, Ram; Kaiser, Maayan; Haspel, Gal; Libersat, Frederic			Sensory Arsenal on the Stinger of the Parasitoid Jewel Wasp and Its Possible Role in Identifying Cockroach Brains	PLOS ONE			English	Article							AMPULEX-COMPRESSA; HYMENOPTERA-BRACONIDAE; OVIPOSITOR APPARATUS; HOST DISCRIMINATION; VENOM; MORPHOLOGY; BEHAVIOR; ORGANS; INSECTS; EQUIPMENT	The parasitoid jewel wasp uses cockroaches as live food supply for its developing larva. To this end, the adult wasp stings a cockroach and injects venom directly inside its brain, turning the prey into a submissive 'zombie'. Here, we characterize the sensory arsenal on the wasp's stinger that enables the wasp to identify the brain target inside the cockroach's head. An electron microscopy study of the stinger reveals (a) cuticular depressions innervated by a single mechanosensory neuron, which are presumably campaniform sensilla; and (b) dome-shaped structures innervated by a single mechanosensory neuron and 4-5 chemosensory neurons, which are presumably contact-chemoreceptive sensilla. Extracellular electrophysiological recordings from stinger afferents show increased firing rate in response to mechanical stimulation with agarose. This response is direction-selective and depends upon the concentration (density) of the agarose, such that the most robust response is evoked when the stinger is stimulated in the distal-to-proximal direction (concomitant with the penetration during the natural stinging behavior) and penetrating into relatively hard (0.75%-2.5%) agarose pellets. Accordingly, wasps demonstrate a normal stinging behavior when presented with cockroaches in which the brain was replaced with a hard (2.5%) agarose pellet. Conversely, wasps demonstrate a prolonged stinging behavior when the cockroach brain was either removed or replaced by a soft (0.5%) agarose pellet, or when stinger sensory organs were ablated prior to stinging. We conclude that the parasitoid jewel wasp uses at least mechanosensory inputs from its stinger to identify the brain within the head capsule of the cockroach prey.	[Gal, Ram; Kaiser, Maayan; Libersat, Frederic] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Gal, Ram; Kaiser, Maayan; Libersat, Frederic] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Haspel, Gal] New Jersey Inst Technol, Dept Biol Sci, Newark, NJ 07102 USA	Ben Gurion University; Ben Gurion University; New Jersey Institute of Technology	Gal, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	galra@bgu.ac.il	LIBERSAT, FREDERIC/AAL-1437-2020; Haspel, Gal/AAH-1269-2019	Haspel, Gal/0000-0001-6701-697X; libersat, frederic/0000-0002-2379-6078	Israel Academy of Sciences and Humanities [1181/11]	Israel Academy of Sciences and Humanities	This work was supported by the Israel Academy of Sciences and Humanities (1181/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR AP, 1969, NATURE, V223, P966, DOI 10.1038/223966a0; Belshaw R, 2003, ZOOL J LINN SOC-LOND, V139, P213, DOI 10.1046/j.1096-3642.2003.00078.x; Benedet F, 2002, P ROY SOC B-BIOL SCI, V269, P1879, DOI 10.1098/rspb.2002.2077; Dweck HKM, 2008, MICRON, V39, P1255, DOI 10.1016/j.micron.2008.03.012; FOUAD K, 1994, ZOOL-ANAL COMPLEX SY, V98, P23; Fouad K, 1996, J COMP PHYSIOL A, V178, P91, DOI 10.1007/BF00189593; Gal R, 2005, ARCH INSECT BIOCHEM, V60, P198, DOI 10.1002/arch.20092; Gal R, 2006, J COMP PHYSIOL A, V192, P1003, DOI 10.1007/s00359-006-0135-4; Gal R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010019; Ghara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023642; Goubault M, 2011, MICROSC RES TECHNIQ, V74, P1145, DOI 10.1002/jemt.21007; Haspel G, 2003, J NEUROBIOL, V56, P287, DOI 10.1002/neu.10238; Haspel G, 2003, THESIS BENGURION U N; HAWKE SD, 1973, TISSUE CELL, V5, P171, DOI 10.1016/S0040-8166(73)80014-X; Herzner G, 2011, ZOOLOGY, V114, P36, DOI 10.1016/j.zool.2010.10.002; KING PE, 1970, J EXP BIOL, V53, P245; LeRalec A, 1996, CAN ENTOMOL, V128, P413; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Libersat F, 2013, J EXP BIOL, V216, P47, DOI 10.1242/jeb.073999; NETTLES WC, 1982, SCIENCE, V218, P164, DOI 10.1126/science.218.4568.164; Obonyo M, 2011, ANN SOC ENTOMOL FR, V47, P119, DOI 10.1080/00379271.2011.10697703; Ogawa H, 2011, J INSECT PHYSIOL, V57, P1358, DOI 10.1016/j.jinsphys.2011.07.003; PIEK T, 1989, COMP BIOCHEM PHYS C, V92, P175, DOI 10.1016/0742-8413(89)90036-4; QUICKE DLJ, 1995, P ROY SOC B-BIOL SCI, V261, P99, DOI 10.1098/rspb.1995.0122; Shah ZA, 2012, MICROSC RES TECHNIQ, V75, P876, DOI 10.1002/jemt.22007; van Lenteren JC, 2007, ARTHROPOD STRUCT DEV, V36, P271, DOI 10.1016/j.asd.2007.02.001; Vilhelmsen L, 2000, ZOOL SCR, V29, P319, DOI 10.1046/j.1463-6409.2000.00046.x; Vilhelmsen L, 2003, ARTHROPOD STRUCT DEV, V32, P277, DOI 10.1016/S1467-8039(03)00045-8; Vilhelmsen L, 2001, ZOOMORPHOLOGY, V121, P63, DOI 10.1007/s004350100046; WILLIAMS F. X., 1942, Proceedings of the Hawaiian Entomological Society, V11, P221; YACK JE, 1993, J NEUROSCI METH, V49, P17, DOI 10.1016/0165-0270(93)90105-Z	31	20	21	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89683	10.1371/journal.pone.0089683	http://dx.doi.org/10.1371/journal.pone.0089683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586962	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000077
J	Gao, N; Qi, B; Liu, FJ; Fang, Y; Zhou, J; Jia, LJ; Qiao, HL				Gao, Na; Qi, Bing; Liu, Fang-jun; Fang, Yan; Zhou, Jun; Jia, Lin-jing; Qiao, Hai-ling			Inhibition of Baicalin on Metabolism of Phenacetin, a Probe of CYP1A2, in Human Liver Microsomes and in Rats	PLOS ONE			English	Article							MECHANISM-BASED INHIBITION; IN-VITRO; POLYMORPHISM; PLASMA; ENZYMES; CYP2C9; DISPLACEMENT; FLUVOXAMINE; BINDING; RADIX	Baicalin has been used as mainly bioactive constituent of about 100 kinds of traditional Chinese medicines in Chinese pharmacopoeia. The effect of baicalin on cytochrome P450 should be paid more attention because baicalin was used widely. The aim of this study was to investigate whether baicalin could inhibit CYP1A2 in pooled human liver microsomes (HLMs) and in rats in vivo and the gene polymorphisms could affect inter-individual variation in IC50 in 28 human livers. Phenacetin was used as probe of CYP1A2. Kinetic parameter of CYP1A2 and IC50 of baicalin on CYP1A2 to each sample were measured and the common CYP1A2 polymorphisms (-3860G>A and -163C>A) were genotyped. The results showed that baicalin exhibited a mixed-type inhibition in pooled HLMs, with a K-i value of 25.4 mu M. There was substantial variation in K-m, V-max, CLint of CYP1A2 and IC50 of baicalin on CYP1A2 (3 similar to 10-fold). The range was from 26.6 to 114.8 mu M for K-m, from 333 to 1330 pmol.min(-1).mg(-1) protein for V-max and from 3.8 to 45.3 mu L.min(-1).mg(-1) protein for CLint in HLMs (n = 28). The Mean (range) value of IC50 in 28 HLMs was 36.3 (18.9 to 56.1) mu M. The genotypes of -3860G>A and -163C>A had no significant effect on the inhibition of baicalin on CYP1A2. The animal experiment results showed that baicalin (450 mg/kg, i.v.) significantly decreased the C-max and CL of phenacetin, and increased C-60 min, t(1/2), V-d and AUC (P<0.05). There were significant correlations between percentage of control in C-60 (min), t(1/2), CL, AUC of phenacetin and C-max of baicalin in 11 rats (P<.05). Protein binding experiments in vitro showed that baicalin (0-2000 mg/L) increased the unbound phenacetin from 14.5% to 28.3%. In conclusion, baicalin can inhibit the activity of CYP1A2 in HLMs and exhibit large inter-individual variation that has no relationship with gene polymorphism. Baicalin can change the pharmacokinetics of phenacetin in rats.	[Gao, Na; Qi, Bing; Fang, Yan; Zhou, Jun; Jia, Lin-jing; Qiao, Hai-ling] Zhengzhou Univ, Inst Clin Pharmacol, Zhengzhou 450052, Peoples R China; [Liu, Fang-jun] Chinese Peoples Liberat Army, Hosp 89, Weifang, Peoples R China	Zhengzhou University	Qiao, HL (corresponding author), Zhengzhou Univ, Inst Clin Pharmacol, Zhengzhou 450052, Peoples R China.	qiaohl@zzu.edu.cn		qi, bing/0000-0001-8025-493X	National Natural Science Foundation of China [81041113]; Science and Technology Innovative Scholar Program of Henan Province [134200510019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovative Scholar Program of Henan Province	This work was partly supported by the National Natural Science Foundation of China (No. 81041113) and Science and Technology Innovative Scholar Program of Henan Province (No. 134200510019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2013, BIOL PHARM BULL, V36, P748, DOI 10.1248/bpb.b12-00850; Bjornsson TD, 2003, DRUG METAB DISPOS, V31, P815, DOI 10.1124/dmd.31.7.815; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Court MH, 1997, BIOCHEM PHARMACOL, V53, P1041, DOI 10.1016/S0006-2952(97)00072-5; Elvin-Lewis M, 2001, J ETHNOPHARMACOL, V75, P141, DOI 10.1016/S0378-8741(00)00394-9; Ernst E, 1998, AM J MED, V104, P170, DOI 10.1016/S0002-9343(97)00397-5; Foster BC, 2005, ANNU REV PHARMACOL, V45, P203, DOI 10.1146/annurev.pharmtox.45.120403.095950; Gao N, 2013, J ETHNOPHARMACOL, V150, P477, DOI 10.1016/j.jep.2013.08.062; Gao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053038; Han XM, 2000, ACTA PHARMACOL SIN, V21, P1031; Hu LW, 2010, J PHARM PHARMACOL, V62, P658, DOI [10.1211/jpp.62.05.0015, 10.1211/jpp/62.05.0015]; Hummel MA, 2005, MOL PHARMACOL, V68, P644, DOI 10.1124/mol.105.013763; Ju Wen-zheng, 2007, Yaoxue Xuebao, V42, P1074; Kumar V, 2008, DRUG METAB DISPOS, V36, P1242, DOI 10.1124/dmd.108.020396; LUCAS D, 1993, ALCOHOL CLIN EXP RES, V17, P900, DOI 10.1111/j.1530-0277.1993.tb00861.x; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; Or PMY, 2012, PHYTOMEDICINE, V19, P535, DOI 10.1016/j.phymed.2011.12.005; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; Saebo M, 2008, ANTICANCER RES, V28, P2289; SCHWEIKL H, 1993, PHARMACOGENETICS, V3, P239, DOI 10.1097/00008571-199310000-00003; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Soligard HT, 2011, PHYTOTHER RES, V25, P1068, DOI 10.1002/ptr.3402; Tian X, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/179643; Tian X, 2013, CHEM-BIOL INTERACT, V203, P522, DOI 10.1016/j.cbi.2013.02.005; Uno T, 2006, BRIT J CLIN PHARMACO, V61, P309, DOI 10.1111/j.1365-2125.2005.02556.x; Usia T, 2005, LIFE SCI, V76, P2381, DOI 10.1016/j.lfs.2004.12.005; Yang X, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/268065; Yasui-Furukori N, 2004, BRIT J CLIN PHARMACO, V57, P487, DOI 10.1111/j.1365-2125.2003.02047.x; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483; Zhu Q, 2009, XENOBIOTICA, V39, P293, DOI 10.1080/00498250802709428	31	23	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89752	10.1371/journal.pone.0089752	http://dx.doi.org/10.1371/journal.pone.0089752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587011	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000090
J	Haider, BA; Baras, AS; McCall, MN; Hertel, JA; Cornish, TC; Halushka, MK				Haider, Baqer A.; Baras, Alexander S.; McCall, Matthew N.; Hertel, Joshua A.; Cornish, Toby C.; Halushka, Marc K.			A Critical Evaluation of microRNA Biomarkers in Non-Neoplastic Disease	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; CANCER; MIR-126; SERUM; IDENTIFICATION; SIGNATURE; MECHANISM	Background: MicroRNAs (miRNAs) are small (similar to 22-nt), stable RNAs that critically modulate post-transcriptional gene regulation. MicroRNAs can be found in the blood as components of serum, plasma and peripheral blood mononuclear cells (PBMCs). Many microRNAs have been reported to be specific biomarkers in a variety of non-neoplastic diseases. To date, no one has globally evaluated these proposed clinical biomarkers for general quality or disease specificity. We hypothesized that the cellular source of circulating microRNAs should correlate with cells involved in specific non-neoplastic disease processes. Appropriate cell expression data would inform on the quality and usefulness of each microRNA as a biomarker for specific diseases. We further hypothesized a useful clinical microRNA biomarker would have specificity to a single disease. Methods and Findings: We identified 416 microRNA biomarkers, of which 192 were unique, in 104 publications covering 57 diseases. One hundred and thirty-nine microRNAs (33%) represented biologically plausible biomarkers, corresponding to non-ubiquitous microRNAs expressed in disease-appropriate cell types. However, at a global level, many of these microRNAs were reported as "specific" biomarkers for two or more unrelated diseases with 6 microRNAs (miR-21, miR-16, miR-146a, miR-155, miR-126 and miR-223) being reported as biomarkers for 9 or more distinct diseases. Other biomarkers corresponded to common patterns of cellular injury, such as the liver-specific microRNA, miR-122, which was elevated in a disparate set of diseases that injure the liver primarily or secondarily including hepatitis B, hepatitis C, sepsis, and myocardial infarction. Conclusions: Only a subset of reported blood-based microRNA biomarkers have specificity for a particular disease. The remainder of the reported non-neoplastic biomarkers are either biologically implausible, non-specific, or uninterpretable due to limitations of our current understanding of microRNA expression.	[Haider, Baqer A.; Baras, Alexander S.; Hertel, Joshua A.; Cornish, Toby C.; Halushka, Marc K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [McCall, Matthew N.] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA	Johns Hopkins University; University of Rochester	Halushka, MK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	mhalush1@jhmi.edu	Cornish, Toby C/A-4394-2015	Cornish, Toby C/0000-0002-1902-2109; Halushka, Marc/0000-0002-7112-7389	Doris Duke Charitable Foundation [2009040]; NIH [T32 CA009363]; NATIONAL CANCER INSTITUTE [T32CA009363] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MKH was supported by a Clinician Scientist Award from the Doris Duke Charitable Foundation Grant #2009040 (http://www.ddcf.org/). MNM was supported by NIH grant T32 CA009363 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Friedman EB, 2012, J BIOMED SCI ENG, V5, P647; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Haider KH, 2010, CARDIOVASC RES, V88, P168, DOI 10.1093/cvr/cvq151; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hua YJ, 2008, GENOMICS, V92, P122, DOI 10.1016/j.ygeno.2008.04.002; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Munding JB, 2012, INT J CANCER, V131, pE86, DOI 10.1002/ijc.26466; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Seglen PO, 1997, BRIT MED J, V314, P498; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang G, 2010, J RHEUMATOL, V37, P2516, DOI 10.3899/jrheum.100308; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Witwer KW, 2013, CLIN CHEM, V59, P392, DOI 10.1373/clinchem.2012.193813; Wu ZS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-51; Wu ZJ, 2010, J COMPUT BIOL, V17, P1385, DOI 10.1089/cmb.2010.0049; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; Zheng HW, 2012, CNS NEUROSCI THER, V18, P1003, DOI 10.1111/cns.12019	51	126	128	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89565	10.1371/journal.pone.0089565	http://dx.doi.org/10.1371/journal.pone.0089565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586876	Green Submitted, gold, Green Published			2022-12-27	WOS:000332389000062
J	Arslan, RC; Penke, L; Johnson, W; Iacono, WG; McGue, M				Arslan, Ruben C.; Penke, Lars; Johnson, Wendy; Iacono, William G.; McGue, Matt			The Effect of Paternal Age on Offspring Intelligence and Personality when Controlling for Paternal Trait Level	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; COPY NUMBER VARIANTS; DE-NOVO MUTATIONS; MASSIVE IQ GAINS; BIRTH-ORDER; TEST-SCORES; INTELLECTUAL DISABILITY; CHILDHOOD INTELLIGENCE; EVOLUTIONARY GENETICS; COGNITIVE-ABILITY	Paternal age at conception has been found to predict the number of new genetic mutations. We examined the effect of father's age at birth on offspring intelligence, head circumference and personality traits. Using the Minnesota Twin Family Study sample we tested paternal age effects while controlling for parents' trait levels measured with the same precision as offspring's. From evolutionary genetic considerations we predicted a negative effect of paternal age on offspring intelligence, but not on other traits. Controlling for parental intelligence (IQ) had the effect of turning an initially positive association non-significantly negative. We found paternal age effects on offspring IQ and Multidimensional Personality Questionnaire Absorption, but they were not robustly significant, nor replicable with additional covariates. No other noteworthy effects were found. Parents' intelligence and personality correlated with their ages at twin birth, which may have obscured a small negative effect of advanced paternal age (< 1% of variance explained) on intelligence. We discuss future avenues for studies of paternal age effects and suggest that stronger research designs are needed to rule out confounding factors involving birth order and the Flynn effect.	[Arslan, Ruben C.] Humboldt Univ, Inst Psychol, D-10099 Berlin, Germany; [Arslan, Ruben C.; Penke, Lars] Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany; [Johnson, Wendy] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Johnson, Wendy] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Iacono, William G.; McGue, Matt] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	Humboldt University of Berlin; University of Gottingen; University of Edinburgh; University of Edinburgh; University of Minnesota System; University of Minnesota Twin Cities	Arslan, RC (corresponding author), Humboldt Univ, Inst Psychol, D-10099 Berlin, Germany.	ruben.arslan@gmail.com	Penke, Lars/F-6918-2014; Arslan, Ruben C./I-5763-2019	Arslan, Ruben C./0000-0002-6670-5658; Penke, Lars/0000-0002-9484-580X	NATIONAL INSTITUTE ON DRUG ABUSE [R37DA005147] Funding Source: NIH RePORTER; Medical Research Council [MR/K026992/1] Funding Source: Medline; NIDA NIH HHS [R37 DA005147] Funding Source: Medline; ESRC [RES-000-23-1246] Funding Source: UKRI; Economic and Social Research Council [RES-000-23-1246] Funding Source: researchfish	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Agarwala V, 2013, NAT GENET; Agrawal AF, 2011, ANNU REV ECOL EVOL S, V43, P115, DOI [10.1146/annurev-ecolsys-110411-160257, DOI 10.1146/ANNUREV-EC0LSYS-110411-160257]; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; AUROUX MR, 1989, HUM REPROD, V4, P794, DOI 10.1093/oxfordjournals.humrep.a136988; Bagshaw ATM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055208; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Bates TC, 2007, INTELLIGENCE, V35, P41, DOI 10.1016/j.intell.2006.03.013; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; BERENBAUM SA, 1994, J ABNORM PSYCHOL, V103, P475, DOI 10.1037/0021-843X.103.3.475; Berg V, 2013, J RES PERS, V47, P296, DOI 10.1016/j.jrp.2013.01.010; Billari FC, 2011, HUM REPROD, V26, P616, DOI 10.1093/humrep/deq360; Bjerkedal T, 2007, INTELLIGENCE, V35, P503, DOI 10.1016/j.intell.2007.01.004; Blanchard JJ, 1998, SCHIZOPHRENIA BULL, V24, P413, DOI 10.1093/oxfordjournals.schbul.a033336; Blondel B, 2002, SEMIN PERINATOL, V26, P239, DOI 10.1053/sper.2002.34775; BOOK J A, 1953, Acta Genet Stat Med, V4, P133; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Briley DA, 2013, PSYCHOL SCI, DOI DOI 10.1177/0956797613478618.ACCESSED; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Buss DM, 2009, PERSPECT PSYCHOL SCI, V4, P359, DOI 10.1111/j.1745-6924.2009.01138.x; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Choi SK, 2008, P NATL ACAD SCI USA, V105, P10143, DOI 10.1073/pnas.0801267105; CHURCH AT, 1994, J PERS SOC PSYCHOL, V67, P898, DOI 10.1037/0022-3514.67.5.898; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Crow JF, 2003, SCIENCE, V301, P606, DOI 10.1126/science.1088552; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; David AS, 1997, PSYCHOL MED, V27, P1311, DOI 10.1017/S0033291797005680; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Derom R, 1995, MULTIPLE PREGNANCY E, P145; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Edwards RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012157; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fergusson D M, 1993, Paediatr Perinat Epidemiol, V7, P77, DOI 10.1111/j.1365-3016.1993.tb00604.x; Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464; Flatscher-Bader T, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.30; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Friedman L, 2000, SCHIZOPHR RES, V42, P1, DOI 10.1016/S0920-9964(99)00098-5; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Gabis L, 2010, PEDIATR NEUROL, V43, P300, DOI 10.1016/j.pediatrneurol.2010.05.022; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Glaser RL, 2003, AM J HUM GENET, V73, P939, DOI 10.1086/378419; GLASER RL, 2004, SCI AGING KNOWLEDGE, pRE1, DOI DOI 10.1126/SAGEKE.2004.3.RE1; Glicksohn J, 2003, APPL COGNITIVE PSYCH, V17, P833, DOI 10.1002/acp.913; Golding J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009939; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; HARKNESS AR, 1995, PSYCHOL ASSESSMENT, V7, P104, DOI 10.1037/1040-3590.7.1.104; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Hughes KA, 2000, GENETIC INFLUENCES ON HUMAN FERTILITY AND SEXUALITY, P7; Hutteman R, 2013, J PERS, V81, P487, DOI 10.1111/jopy.12006; Iacono WG, 1999, DEV PSYCHOPATHOL, V11, P869, DOI 10.1017/S0954579499002369; Iacono WG, 2002, TWIN RES, V5, P482, DOI 10.1375/twin.5.5.482; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johnson W, 2002, TWIN RES, V5, P125, DOI 10.1375/1369052022992; Johnson W, 2011, EUR J PERSONALITY, V25, P254, DOI 10.1002/per.836; Johnson W, 2009, PERSPECT PSYCHOL SCI, V4, P598, DOI 10.1111/j.1745-6924.2009.01168.x; Jokela M, 2012, PSYCHOL SCI, V23, P835, DOI 10.1177/0956797612439067; Jokela M, 2011, EUR J PERSONALITY, V25, P487, DOI 10.1002/per.822; Jokela M, 2010, EUR J PERSONALITY, V24, P151, DOI 10.1002/per.749; Jokela M, 2009, J PERS SOC PSYCHOL, V96, P218, DOI 10.1037/a0014058; JONES KL, 1975, J PEDIATR-US, V86, P84, DOI 10.1016/S0022-3476(75)80709-8; Keightley PD, 2012, GENETICS, V190, P295, DOI 10.1534/genetics.111.134668; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Keyes MA, 2009, TWIN RES HUM GENET, V12, P489, DOI 10.1375/twin.12.5.489; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kristensen P, 2007, SCIENCE, V316, P1717, DOI 10.1126/science.1141493; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P1673, DOI 10.4088/JCP.v68n1106; Li NP, 2002, J PERS SOC PSYCHOL, V82, P947, DOI 10.1037//0022-3514.82.6.947; Lopez-Castroman J, 2010, SCHIZOPHR RES, V116, P184, DOI 10.1016/j.schres.2009.11.006; Lukaszewski AW, 2011, PERS SOC PSYCHOL B, V37, P409, DOI 10.1177/0146167210397209; Lundstrom S, 2010, J CHILD PSYCHOL PSYC, V51, P850, DOI 10.1111/j.1469-7610.2010.02223.x; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McMurry M, 1993, POPUL NOTES, P1; McRae AF, 2013, BEHAV GENET, V43, P202, DOI 10.1007/s10519-013-9587-9; Miller B, 2011, SCHIZOPHRENIA BULL, V37, P1039, DOI 10.1093/schbul/sbq011; Miller G, 2000, Novartis Found Symp, V233, P260; Miller GF, 2007, Q REV BIOL, V82, P97, DOI 10.1086/517857; Miller GF, 2007, INTELLIGENCE, V35, P97, DOI 10.1016/j.intell.2006.08.008; Mingroni MA, 2007, PSYCHOL REV, V114, P806, DOI 10.1037/0033-295X.114.3.806; Mitchell KJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-237; Muers M, 2012, NAT REV GENET, V13, P377, DOI 10.1038/nrg3248; Munafo MR, 2011, TRENDS COGN SCI, V15, P395, DOI 10.1016/j.tics.2011.07.007; Muthen B., 2010, MPLUS USERS GUIDE; Neiss M, 2002, J BIOSOC SCI, V34, P259, DOI 10.1017/S0021932002002596; Olson MV, 2012, ANNU REV GENOM HUM G, V13, P1, DOI 10.1146/annurev-genom-090711-163825; Paul C, 2013, NAT REV UROL, V10, P227, DOI 10.1038/nrurol.2013.18; Penke L., 2010, EVOLUTION PERSONALIT, P243, DOI [10.1093/acprof:oso/9780195372090.003.0009, DOI 10.1093/ACPROF:OSO/9780195372090.003.0009]; Penke L, 2007, EUR J PERSONALITY, V21, P549, DOI 10.1002/per.629; Perrin MC, 2007, SCHIZOPHRENIA BULL, V33, P1270, DOI 10.1093/schbul/sbm093; Plomin R, 2004, J PERS SOC PSYCHOL, V86, P112, DOI 10.1037/0022-3514.86.1.112; Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952; Posthuma D, 2000, Twin Res, V3, P83, DOI 10.1375/136905200320565535; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Raykov T, 2012, EDUC PSYCHOL MEAS, V72, P954, DOI 10.1177/0013164412441607; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Reichman NE, 2006, AM J PUBLIC HEALTH, V96, P862, DOI 10.2105/AJPH.2005.066324; Reynolds MA, 2003, PEDIATRICS, V111, P1159; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Robinson EB, 2011, J AUTISM DEV DISORD, V41, P1733, DOI 10.1007/s10803-011-1202-4; Rodgers JL, 1998, INTELLIGENCE, V26, P337, DOI 10.1016/S0160-2896(99)00004-5; Rodgers JL, 2008, AM J SOCIOL, V114, pS202, DOI 10.1086/592205; Royle NA, 2013, NEUROBIOL AGING; Rushton JP, 2009, INT J NEUROSCI, V119, P691, DOI 10.1080/00207450802325843; Saha S, 2009, SCHIZOPHR RES, V115, P130, DOI 10.1016/j.schres.2009.09.012; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sartorius GA, 2010, HUM REPROD UPDATE, V16, P65, DOI 10.1093/humupd/dmp027; Sattler JM, 1974, ASSESSMENT CHILDRENS; Sellbom M, 2005, J PERS ASSESS, V85, P179, DOI 10.1207/s15327752jpa8502_10; Smit DJA, 2010, TWIN RES HUM GENET, V13, P370, DOI 10.1375/twin.13.4.370; Stone EA, 2012, INTELLIGENCE, V40, P33, DOI 10.1016/j.intell.2011.10.003; Sundet JM, 2004, INTELLIGENCE, V32, P349, DOI 10.1016/j.intell.2004.06.004; Sundet JM, 2010, INTELLIGENCE, V38, P38, DOI 10.1016/j.intell.2009.11.005; Svensson AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024771; Teasdale TW, 2008, INTELLIGENCE, V36, P121, DOI 10.1016/j.intell.2007.01.007; Teasdale TW, 2000, INTELLIGENCE, V28, P115, DOI 10.1016/S0160-2896(99)00034-3; Teasdale TW, 2005, PERS INDIV DIFFER, V39, P837, DOI 10.1016/j.paid.2005.01.029; TELLEGEN A, 2008, HDB PERSONALITY THEO, V0002, P00261, DOI DOI 10.4135/9781849200479.N13; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Trzaskowski M, 2013, MOL PSYCHIATR, DOI DOI 10.1038/MP.2012.191.ACCESSED; UDRY JR, 1978, SOC BIOL, V25, P10, DOI 10.1080/19485565.1978.9988313; Uher R, 2009, MOL PSYCHIATR, V14, P1072, DOI 10.1038/mp.2009.85; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Verweij KJH, 2012, EVOLUTION, V66, P3238, DOI 10.1111/j.1558-5646.2012.01679.x; Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; von Stumm S, 2011, INTELLIGENCE, V39, P161, DOI 10.1016/j.intell.2011.02.007; Wakschlag LS, 2000, J RES ADOLESCENCE, V10, P417, DOI 10.1207/SJRA1004_03; Weiser M, 2008, SCHIZOPHRENIA BULL, V34, P1042, DOI 10.1093/schbul/sbn109; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819; Whitcomb BW, 2009, PAEDIATR PERINAT EP, V23, P394, DOI 10.1111/j.1365-3016.2009.01053.x; Whitley E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052112; Wicherts JM, 2004, INTELLIGENCE, V32, P509, DOI 10.1016/j.intell.2004.07.002; Wichman AL, 2006, PERS SOC PSYCHOL B, V32, P117, DOI 10.1177/0146167205279581; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yeo RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016339; Yoon SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000558	153	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90097	10.1371/journal.pone.0090097	http://dx.doi.org/10.1371/journal.pone.0090097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24587224	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900116
J	Belfield, C; Queenan, C; Rao, H; Kitamura, K; Walworth, NC				Belfield, Carrie; Queenan, Craig; Rao, Hui; Kitamura, Kenji; Walworth, Nancy C.			The Oxidative Stress Responsive Transcription Factor Pap1 Confers DNA Damage Resistance on Checkpoint-Deficient Fission Yeast Cells	PLOS ONE			English	Article							BREFELDIN-A RESISTANCE; SCHIZOSACCHAROMYCES-POMBE; PROTEIN-KINASE; TOPOISOMERASE-I; TYROSINE PHOSPHORYLATION; CAFFEINE TOLERANCE; REPLICATION FORKS; HYDROGEN-PEROXIDE; H2O2 LEVELS; S-PHASE	Eukaryotic cells invoke mechanisms to promote survival when confronted with cellular stress or damage to the genome. The protein kinase Chk1 is an integral and conserved component of the DNA damage response pathway. Mutation or inhibition of Chk1 results in mitotic death when cells are exposed to DNA damage. Oxidative stress activates a pathway that results in nuclear accumulation of the bZIP transcription factor Pap1. We report the novel finding that fission yeast Pap1 confers resistance to drug-and non-drug-induced DNA damage even when the DNA damage checkpoint is compromised. Multi-copy expression of Pap1 restores growth to chk1-deficient cells exposed to camptothecin or hydroxyurea. Unexpectedly, increased Pap1 expression also promotes survival of chk1-deficient cells with mutations in genes encoding DNA ligase (cdc17) or DNA polymerase delta (cdc6), but not DNA replication initiation mutants. The ability of Pap1 to confer resistance to DNA damage was not specific to chk1 mutants, as it also improved survival of rad1-and rad9-deficient cells in the presence of CPT. To confer resistance to DNA damage Pap1 must localize to the nucleus and be transcriptionally active.	[Belfield, Carrie; Queenan, Craig; Rao, Hui; Walworth, Nancy C.] Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA; [Belfield, Carrie; Walworth, Nancy C.] Rutgers Grad Sch Biomed Sci, Grad Program Cellular & Mol Pharmacol, Piscataway, NJ USA; [Kitamura, Kenji] Hiroshima Univ, Ctr Gene Sci, Higashihiroshima 724, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Hiroshima University	Walworth, NC (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA.	walworna@rwjms.rutgers.edu	Kitamura, Kenji/C-4173-2018	Kitamura, Kenji/0000-0003-1046-7133; Walworth, Nancy/0000-0001-5940-8236	National Institute of General Medical Sciences [R01 GM053194, R25 GM055145]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053194, R25GM055145] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Award Number R01 GM053194, and Carrie Belfield was partially supported by Award Number R25 GM055145, both from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Arioka M, 1998, BIOSCI BIOTECHNOL BI, V62, P390; Bellini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047987; Benko Z, 1997, CURR GENET, V31, P481, DOI 10.1007/s002940050233; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen L, 1999, GENE DEV, V13, P675, DOI 10.1101/gad.13.6.675; DENHAESE GJ, 1995, MOL BIOL CELL, V6, P371, DOI 10.1091/mbc.6.4.371; Dunaway S, 2005, J CELL SCI, V118, P39, DOI 10.1242/jcs.01570; Fleig U, 2000, J CELL BIOL, V151, P1101, DOI 10.1083/jcb.151.5.1101; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hollomon MG, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-500; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kitamura K, 2011, MOL MICROBIOL, V80, P739, DOI 10.1111/j.1365-2958.2011.07605.x; Kudo N, 1999, J BIOL CHEM, V274, P15151, DOI 10.1074/jbc.274.21.15151; LEE MS, 1992, MOL BIOL CELL, V3, P73, DOI 10.1091/mbc.3.1.73; Lee YY, 2002, MOL CELLS, V14, P43; Lin SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002801; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NAGAO K, 1995, J BACTERIOL, V177, P1536, DOI 10.1128/jb.177.6.1536-1543.1995; Nakagawa CW, 2000, J BIOCHEM-TOKYO, V127, P233, DOI 10.1093/oxfordjournals.jbchem.a022599; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; NISHI K, 1992, MOL MICROBIOL, V6, P761, DOI 10.1111/j.1365-2958.1992.tb01526.x; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Paduch R, 2010, ONCOL RES, V18, P419, DOI 10.3727/096504010X12671222663593; Palermo C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001427; Qu M, 2013, MOL CELL, V51, P723, DOI 10.1016/j.molcel.2013.08.030; Qu M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002817; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Raleigh JM, 2000, J CELL SCI, V113, P1727; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Song JY, 2008, J MICROBIOL, V46, P408, DOI 10.1007/s12275-008-0076-4; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Toone WM, 1999, CURR OPIN GENET DEV, V9, P55, DOI 10.1016/S0959-437X(99)80008-2; TURI TG, 1995, BIOCHEM BIOPH RES CO, V213, P410, DOI 10.1006/bbrc.1995.2147; TURI TG, 1994, J BIOL CHEM, V269, P24229; Umeda M, 2005, GENETICS, V171, P7, DOI 10.1534/genetics.105.042598; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wan S, 2001, CURR GENET, V38, P299, DOI 10.1007/s002940000172; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Weir IE, 2003, CYTOM PART A, V54A, P109, DOI 10.1002/cyto.a.10054; Yin L, 2008, MOL BIOL CELL, V19, P4374, DOI 10.1091/mbc.E08-01-0020; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200	69	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89936	10.1371/journal.pone.0089936	http://dx.doi.org/10.1371/journal.pone.0089936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587136	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900101
J	Hawwa, AF; AlBawab, A; Rooney, M; Wedderburn, LR; Beresford, MW; McElnay, JC				Hawwa, Ahmed F.; AlBawab, AbdelQader; Rooney, Madeleine; Wedderburn, Lucy R.; Beresford, Michael W.; McElnay, James C.			A Novel Dried Blood Spot-LCMS Method for the Quantification of Methotrexate Polyglutamates as a Potential Marker for Methotrexate Use in Children	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; ACUTE LYMPHOBLASTIC-LEUKEMIA; RHEUMATOID-ARTHRITIS; LIQUID-CHROMATOGRAPHY; HPLC DETERMINATION; PHARMACOKINETICS; THERAPY; DERMATOMYOSITIS; SPECTROMETRY; IMMUNOASSAY	Objective: Development and validation of a selective and sensitive LCMS method for the determination of methotrexate polyglutamates in dried blood spots (DBS). Methods: DBS samples [spiked or patient samples] were prepared by applying blood to Guthrie cards which was then dried at room temperature. The method utilised 6-mm disks punched from the DBS samples (equivalent to approximately 12 mu l of whole blood). The simple treatment procedure was based on protein precipitation using perchloric acid followed by solid phase extraction using MAX cartridges. The extracted sample was chromatographed using a reversed phase system involving an Atlantis T3-C18 column (3 mu m, 2.1x150 mm) preceded by Atlantis guard column of matching chemistry. Analytes were subjected to LCMS analysis using positive electrospray ionization. Key Results: The method was linear over the range 5-400 nmol/L. The limits of detection and quantification were 1.6 and 5 nmol/L for individual polyglutamates and 1.5 and 4.5 nmol/L for total polyglutamates, respectively. The method has been applied successfully to the determination of DBS finger-prick samples from 47 paediatric patients and results confirmed with concentrations measured in matched RBC samples using conventional HPLC-UV technique. Conclusions and Clinical Relevance: The methodology has a potential for application in a range of clinical studies (e.g. pharmacokinetic evaluations or medication adherence assessment) since it is minimally invasive and easy to perform, potentially allowing parents to take blood samples at home. The feasibility of using DBS sampling can be of major value for future clinical trials or clinical care in paediatric rheumatology.	[Hawwa, Ahmed F.; AlBawab, AbdelQader; McElnay, James C.] Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland; [Hawwa, Ahmed F.] Aston Univ, Aston Pharm Sch, Birmingham B4 7ET, W Midlands, England; [Rooney, Madeleine] Queens Univ Belfast, Sch Med, Belfast, Antrim, North Ireland; [Rooney, Madeleine] Musgrave Pk Hosp, Belfast, Antrim, North Ireland; [Wedderburn, Lucy R.] UCL, Inst Child Hlth, London, England; [Wedderburn, Lucy R.] UCL, Univ Coll London Hosp, Arthrit Res UK Ctr Adolescent Rheumatol, London, England; [Wedderburn, Lucy R.] Great Ormond St Hosp NHS Fdn Trust, London, England; [Beresford, Michael W.] Univ Liverpool, Dept Womens & Childrens Hlth, Alder Hey Childrens NHS Fdn Trust, Liverpool L69 3BX, Merseyside, England	Queens University Belfast; Aston University; Queens University Belfast; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; University of Liverpool	McElnay, JC (corresponding author), Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland.	j.mcelnay@qub.ac.uk	Beresford, Michael William/AAB-5261-2021; al bawab, abdel qader/D-2168-2015	Beresford, Michael William/0000-0002-5400-9911; al bawab, abdel qader/0000-0002-6215-7949; Wedderburn, Lucy/0000-0002-7495-1429; Hawwa, Ahmed/0000-0003-0547-7361	Arthritis Research UK (ARUK) [19421]; Great Ormond Street Childrens Chairty [V1304]; Sparks Charity [08ICH09, 12ICH08] Funding Source: researchfish	Arthritis Research UK (ARUK)(Versus Arthritis); Great Ormond Street Childrens Chairty; Sparks Charity	The authors would like to acknowledge the funding received from Arthritis Research UK (ARUK; Grant no. 19421; http://www.arthritisresearchuk.org/). LW is partly supported by a grant from Great Ormond Street Childrens Chairty (Grant no. V1304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Bannwarth B, 1996, CLIN PHARMACOKINET, V30, P194, DOI 10.2165/00003088-199630030-00002; Becker ML, 2010, ARTHRITIS RHEUM-US, V62, P1803, DOI 10.1002/art.27434; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Bostrom BC, 2003, J PEDIAT HEMATOL ONC, V25, P114, DOI 10.1097/00043426-200302000-00006; Brooks AJ, 2007, THER DRUG MONIT, V29, P619, DOI 10.1097/FTD.0b013e31811f39bb; BUICE RG, 1980, CLIN CHEM, V26, P1902; Chambers E, 2007, J CHROMATOGR B, V852, P22, DOI 10.1016/j.jchromb.2006.12.030; Chen G, 2009, J PHARMACEUT BIOMED, V50, P262, DOI 10.1016/j.jpba.2009.04.025; Chladek J, 1998, EUR J CLIN PHARMACOL, V53, P437, DOI 10.1007/s002280050404; Choy EHS, 2002, RHEUMATOLOGY, V41, P7, DOI 10.1093/rheumatology/41.1.7; Cutolo M, 2001, ANN RHEUM DIS, V60, P729, DOI 10.1136/ard.60.8.729; Dalrymple JM, 2008, ARTHRITIS RHEUM-US, V58, P3299, DOI 10.1002/art.24034; Dervieux T, 2003, CLIN CHEM, V49, P1632, DOI 10.1373/49.10.1632; Dervieux T, 2002, LEUKEMIA, V16, P209, DOI 10.1038/sj.leu.2402373; Emara S, 1997, BIOMED CHROMATOGR, V11, P42, DOI 10.1002/(SICI)1099-0801(199701)11:1<42::AID-BMC621>3.0.CO;2-F; Hayashi H, 2008, TOHOKU J EXP MED, V215, P95, DOI 10.1620/tjem.215.95; KAMEN BA, 1976, ANAL BIOCHEM, V70, P54, DOI 10.1016/S0003-2697(76)80047-4; Murray KJ, 2002, BEST PRACT RES CL RH, V16, P361, DOI 10.1053/berh.2002.0234; Pilkington CA, 2005, DRUGS, V65, P1355, DOI 10.2165/00003495-200565100-00004; Ramanan AV, 2005, ARTHRITIS RHEUM-US, V52, P3570, DOI 10.1002/art.21378; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Schmiegelow K, 2003, J CLIN ONCOL, V21, P1332, DOI 10.1200/JCO.2003.04.039; Shabir GA, 2003, J CHROMATOGR A, V987, P57, DOI 10.1016/S0021-9673(02)01536-4; Suyagh MF, 2010, ANAL BIOANAL CHEM, V397, P687, DOI 10.1007/s00216-010-3571-5; The European Agency for the Evaluation of Medicinal Products, 1996, CPMPICH28195 EUR AG; U.S. FDA, 1998, GUIDANCE IND BIOANAL; van Haandel L, 2009, RAPID COMMUN MASS SP, V23, P3693, DOI 10.1002/rcm.4300	28	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89908	10.1371/journal.pone.0089908	http://dx.doi.org/10.1371/journal.pone.0089908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587116	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332385900094
J	Lee, CW; Zhang, HL; Geng, L; Peng, HB				Lee, Chi Wai; Zhang, Hailong; Geng, Lin; Peng, H. Benjamin			Crosslinking-Induced Endocytosis of Acetylcholine Receptors by Quantum Dots	PLOS ONE			English	Article							VERTEBRATE NEUROMUSCULAR-JUNCTION; CULTURED MUSCLE-CELLS; TYROSINE PHOSPHATASE; MYASTHENIA-GRAVIS; IN-VIVO; GROWTH-FACTOR; RAPSYN; AGRIN; CLUSTERS; MUSK	In a majority of patients with myasthenia gravis (MG), anti-acetylcholine receptor (AChR) antibodies target postsynaptic AChR clusters and thus compromise the membrane integrity of neuromuscular junctions (NMJs) and lead to muscle weakness. Antibody-induced endocytosis of AChRs in the postsynaptic membrane represents the initial step in the pathogenesis of MG; however, the molecular mechanisms underlying AChR endocytosis remain largely unknown. Here, we developed an approach to mimic the pathogenic antibodies for inducing the crosslinking and internalization of AChRs from the postsynaptic membrane. Using biotin-a-bungarotoxin and quantum dot (QD)-streptavidin, cell-surface and internalized AChRs could be readily distinguished by comparing the size, fluorescence intensity, trajectory, and subcellular localization of the QD signals. QD-induced AChR endocytosis was mediated by clathrin-dependent and caveolin-independent mechanisms, and the trafficking of internalized AChRs in the early endosomes required the integrity of microtubule structures. Furthermore, activation of the agrin/MuSK (muscle-specific kinase) signaling pathway strongly suppressed QD-induced internalization of AChRs. Lastly, QD-induced AChR crosslinking potentiated the dispersal of aneural AChR clusters upon synaptic induction. Taken together, our results identify a novel approach to study the mechanisms of AChR trafficking upon receptor crosslinking and endocytosis, and demonstrate that agrin-MuSK signaling pathways protect against crosslinking-induced endocytosis of AChRs.	[Lee, Chi Wai; Zhang, Hailong; Geng, Lin; Peng, H. Benjamin] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Lee, Chi Wai] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Geng, Lin] Univ Hong Kong, Dept Physiol, Fac Med, Pok Fu Lam, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; National University of Singapore; University of Hong Kong	Lee, CW (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China.	leechiwai@nuhs.edu.sg; penghb@ust.hk		Lee, Chi Wai/0000-0003-4619-3189; Zhang, Hailong/0000-0002-1280-2348	Muscular Dystrophy Association [186316]; National University of Singapore [2012-067-SU-01]; Hong Kong Research Grants Council [662312]	Muscular Dystrophy Association(Muscular Dystrophy Association); National University of Singapore(National University of Singapore); Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This study was partly supported by a research development grant (186316) from Muscular Dystrophy Association and a start-up grant (2012-067-SU-01) from National University of Singapore to C.W.L., and a General Research Fund grant (662312) from Hong Kong Research Grants Council to H.B.P. and C.W.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; AXELROD D, 1980, P NATL ACAD SCI-BIOL, V77, P4823, DOI 10.1073/pnas.77.8.4823; Banks GB, 2003, J NEUROCYTOL, V32, P709, DOI 10.1023/B:NEUR.0000020619.24681.2b; Barroso MM, 2011, J HISTOCHEM CYTOCHEM, V59, P237, DOI 10.1369/0022155411398487; Bartoli M, 2001, J BIOL CHEM, V276, P24911, DOI 10.1074/jbc.M103258200; BEROUKHIM R, 1995, NEURON, V15, P323, DOI 10.1016/0896-6273(95)90037-3; Bezakova G, 2001, P NATL ACAD SCI USA, V98, P9924, DOI 10.1073/pnas.171539698; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Crimeen-Irwin B, 2003, J BIOL CHEM, V278, P46927, DOI 10.1074/jbc.M308261200; Daggett DF, 1996, MOL CELL NEUROSCI, V8, P272, DOI 10.1006/mcne.1996.0063; Dai ZS, 1998, J CELL BIOL, V141, P1613, DOI 10.1083/jcb.141.7.1613; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Dobbins GC, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-18; ENGEL AG, 1982, CIBA F SYMP, V90, P197; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; Geng L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-80; Gervasio OL, 2005, J PHYSIOL-LONDON, V562, P673, DOI 10.1113/jphysiol.2004.077685; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HERTEL C, 1985, J BIOL CHEM, V260, P2547; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; Lee CW, 2009, NAT NEUROSCI, V12, P848, DOI 10.1038/nn.2322; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; LINDSTROM J, 1979, MUSCLE NERVE, V2, P173, DOI 10.1002/mus.880020304; Lindstrom JM, 2000, MUSCLE NERVE, V23, P453, DOI 10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O; Losen M, 2008, ANN NY ACAD SCI, V1132, P174, DOI 10.1196/annals.1405.034; Madhavan R, 2005, MOL CELL NEUROSCI, V28, P403, DOI 10.1016/j.mcn.2004.10.005; Martinez-Martinez P, 2007, AM J PATHOL, V170, P644, DOI 10.2353/ajpath.2007.060676; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; PENG HB, 1981, NATURE, V292, P831, DOI 10.1038/292831a0; Peng HB, 2003, J NEUROSCI, V23, P5050; PENG HB, 1986, J NEUROSCI, V6, P581; PENG HB, 1995, J NEUROSCI, V15, P3027; PENG HB, 1991, METHOD CELL BIOL, V36, P511; Qian YPK, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-70; Ramarao MK, 2001, J BIOL CHEM, V276, P7475, DOI 10.1074/jbc.M009888200; SALPETER MM, 1986, J CELL BIOL, V103, P1399, DOI 10.1083/jcb.103.4.1399; SALPETER MM, 1985, PROG NEUROBIOL, V25, P297, DOI 10.1016/0301-0082(85)90018-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; SHYNG SL, 1989, J CELL BIOL, V108, P647, DOI 10.1083/jcb.108.2.647; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Tang J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1993567; Wang ZZ, 1999, J NEUROSCI, V19, P1998; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026805	53	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90187	10.1371/journal.pone.0090187	http://dx.doi.org/10.1371/journal.pone.0090187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587270	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900123
J	Teismann, H; Wollbrink, A; Okamoto, H; Schlaug, G; Rudack, C; Pantev, C				Teismann, Henning; Wollbrink, Andreas; Okamoto, Hidehiko; Schlaug, Gottfried; Rudack, Claudia; Pantev, Christo			Combining Transcranial Direct Current Stimulation and Tailor-Made Notched Music Training to Decrease Tinnitus-Related Distress - A Pilot Study	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; LEFT AUDITORY-CORTEX; NEUROSCIENCE; PLASTICITY; RESPONSES; SESSIONS; STROKE; TDCS	The central auditory system has a crucial role in tinnitus generation and maintenance. Curative treatments for tinnitus do not yet exist. However, recent attempts in the therapeutic application of both acoustic stimulation/training procedures and electric/magnetic brain stimulation techniques have yielded promising results. Here, for the first time we combined tailor-made notched music training (TMNMT) with transcranial direct current stimulation (tDCS) in an effort to modulate TMNMT efficacy in the treatment of 32 patients with tonal tinnitus and without severe hearing loss. TMNMT is characterized by regular listening to so-called notched music, which is generated by digitally removing the frequency band of one octave width centered at the individual tinnitus frequency. TMNMT was applied for 10 subsequent days (2.5 hours of daily treatment). During the initial 5 days of treatment and the initial 30 minutes of TMNMT sessions, tDCS (current strength: 2 mA; anodal (N = 10) vs. cathodal (N = 11) vs. sham (N = 11) groups) was applied simultaneously. The active electrode was placed on the head surface over left auditory cortex; the reference electrode was put over right supra-orbital cortex. To evaluate treatment outcome, tinnitus-related distress and perceived tinnitus loudness were assessed using standardized tinnitus questionnaires and a visual analogue scale. The results showed a significant treatment effect reflected in the Tinnitus Handicap Questionnaire that was largest after 5 days of treatment. This effect remained significant at the end of follow-up 31 days after treatment cessation. Crucially, tDCS did not significantly modulate treatment efficacy - it did not make a difference whether anodal, cathodal, or sham tDCS was applied. Possible explanations for the findings and functional modifications of the experimental design for future studies (e.g. the selection of control conditions) are discussed.	[Teismann, Henning; Wollbrink, Andreas; Pantev, Christo] Univ Hosp, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Teismann, Henning] Univ Hosp, Inst Epidemiol & Social Med, Munster, Germany; [Okamoto, Hidehiko] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan; [Schlaug, Gottfried] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Schlaug, Gottfried] Harvard Univ, Sch Med, Boston, MA USA; [Rudack, Claudia] Univ Hosp, Dept Otorhinolaryngol, Munster, Germany	University of Munster; University of Munster; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Munster	Teismann, H (corresponding author), Univ Hosp, Inst Biomagnetism & Biosignalanal, Munster, Germany.	h.teismann@uni-muenster.de	Okamoto, Hidehiko/A-7934-2008	Okamoto, Hidehiko/0000-0003-2799-3340	Interdisziplinare Zentrum fur Klinische Forschung Munster [CRA05]; Japan Society for the Promotion of Science for Young Scientists [23689070]; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of the University of Munster	Interdisziplinare Zentrum fur Klinische Forschung Munster; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Munster	This work was supported by the "Interdisziplinare Zentrum fur Klinische Forschung Munster'' (CRA05) and the ''Japan Society for the Promotion of Science for Young Scientists'' (23689070). We acknowledge support by the "Deutsche Forschungsgemeinschaft'' and the "Open Access Publication Fund of the University of Munster''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Davis PB, 2007, EAR HEARING, V28, P242, DOI 10.1097/AUD.0b013e3180312619; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Del Bo L, 2011, TEXTBOOK OF TINNITUS, P597, DOI 10.1007/978-1-60761-145-5_74; DYMOND AM, 1975, BIOL PSYCHIAT, V10, P101; Eggermont JJ, 2006, ACTA OTO-LARYNGOL, V126, P9, DOI 10.1080/03655230600895259; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00053; Faber M, 2012, BRAIN STIMUL, V5, P492, DOI 10.1016/j.brs.2011.09.003; Frank E, 2012, J NEUROL, V259, P327, DOI 10.1007/s00415-011-6189-4; Fregni F, 2006, EUR J NEUROL, V13, P996, DOI 10.1111/j.1468-1331.2006.01414.x; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Garin P, 2011, J NEUROL, V258, P1940, DOI 10.1007/s00415-011-6037-6; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Hautzinger M, 1977, PSYCHIAT PRAX, V39, P302, DOI DOI 10.1055/S-0032-1326702; Kaltenbach JA, 2011, TEXTBOOK OF TINNITUS, P259, DOI 10.1007/978-1-60761-145-5_31; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; KUK FK, 1990, EAR HEARING, V11, P434, DOI 10.1097/00003446-199012000-00005; Langguth B, 2006, ACTA OTO-LARYNGOL, V126, P84, DOI 10.1080/03655230600895317; Langguth B, 2012, LANCET, V379, P1926, DOI 10.1016/S0140-6736(12)60561-3; Langguth B, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00015; Langguth B, 2009, EXPERT OPIN EMERG DR, V14, P687, DOI 10.1517/14728210903206975; Lindenberg R, 2012, NEUROREHAB NEURAL RE, V26, P479, DOI 10.1177/1545968311427568; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Mathys C, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00193; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Neuling Toralf, 2012, Front Psychiatry, V3, P83; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; NITSCHE MA, 2007, TMS BUCH HDB TRANSKR, P533; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Okamoto H, 2005, EUR J NEUROSCI, V21, P1957, DOI 10.1111/j.1460-9568.2005.04022.x; Okamoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017022; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Pantev C, 1999, BRAIN RES, V842, P192, DOI 10.1016/S0006-8993(99)01835-1; Pantev C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00050; Plewnia C, 2007, HUM BRAIN MAPP, V28, P238, DOI 10.1002/hbm.20270; PREECE J, 2003, GERIATR AGEING, V6, DOI DOI 10.1288/00005537-195005000-00002/ABSTRACT.ACCESSED; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Roberts LE, 2011, TEXTBOOK OF TINNITUS, P563, DOI 10.1007/978-1-60761-145-5_72; Schlaug G, 2011, NEUROPSYCHOL REV, V21, P288, DOI 10.1007/s11065-011-9181-y; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Stracke Henning, 2010, Commun Integr Biol, V3, P274; Tass PA, 2012, RESTOR NEUROL NEUROS, V30, P137, DOI 10.3233/RNN-2012-110218; Teismann H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024685; Tyler RS, 2012, J AM ACAD AUDIOL, V23, P115, DOI 10.3766/jaaa.23.2.6; Vanneste S, 2011, BRAIN STIMUL, V4, P242, DOI 10.1016/j.brs.2010.12.001; Vanneste S, 2011, EUR J NEUROSCI, V34, P605, DOI 10.1111/j.1460-9568.2011.07778.x; Vanneste S, 2011, EXP BRAIN RES, V210, P217, DOI 10.1007/s00221-011-2617-z; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; Vines BW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00230; Wang HT, 2001, CHINESE MED J-PEKING, V114, P848; Zaehle T, 2011, EXP BRAIN RES, V215, P135, DOI 10.1007/s00221-011-2879-5; Zheng Y, 2011, NEUROSCIENCE, V193, P143, DOI 10.1016/j.neuroscience.2011.07.026	61	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89904	10.1371/journal.pone.0089904	http://dx.doi.org/10.1371/journal.pone.0089904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587113	Green Published, gold			2022-12-27	WOS:000332385900093
J	Wu, CC; Hsu, TW; Chang, CM; Yu, CH; Wang, YF; Lee, CC				Wu, Chin-Chia; Hsu, Ta-Wen; Chang, Chun-Ming; Yu, Chia-Hui; Wang, Yuh-Feng; Lee, Ching-Chih			The Effect of Individual and Neighborhood Socioeconomic Status on Gastric Cancer Survival	PLOS ONE			English	Article							RISK; DISPARITIES; TRENDS; IMPACT; DEATH	Purpose: Gastric cancer is a leading cause of death, particularly in the developing world. The literature reports individual socioeconomic status (SES) or neighborhood SES as related to survival, but the effect of both has not been studied. This study investigated the effect of individual and neighborhood SES simultaneously on mortality in gastric cancer patients in Taiwan. Materials and Methods: A study was conducted of 3,396 patients diagnosed with gastric cancer between 2002 and 2006. Each patient was followed for five years or until death. Individual SES was defined by income-related insurance premium (low, moderate, and high). Neighborhood SES was based on household income dichotomized into advantaged and disadvantaged areas. Multilevel logistic regression model was used to compare survival rates by SES group after adjusting for possible confounding factors. Results: In patients younger than 65 years, 5-year overall survival rates were lowest for those with low individual SES. After adjusting for patient characteristics (age, gender, Charlson Comorbidity Index Score), gastric cancer patients with high individual SES had 68% risk reduction of mortality (adjusted odds ratio [OR] of mortality, 0.32; 95% confidence interval [CI], 0.17-0.61). Patients aged 65 and above had no statistically significant difference in mortality rates by individual SES group. Different neighborhood SES did not statistically differ in the survival rates. Conclusion: Gastric cancer patients aged less than 65 years old with low individual SES have higher risk of mortality, even under an universal healthcare system. Public health strategies, education and welfare policies should seek to correct the inequality in gastric cancer survival, especially in those with lower individual SES.	[Wu, Chin-Chia; Hsu, Ta-Wen; Chang, Chun-Ming] Dalin Tzu Chi Hosp, Dept Surg, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Dept Otolaryngol, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Wang, Yuh-Feng] Dalin Tzu Chi Hosp, Dept Nucl Med, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Dept Educ, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Yu, Chia-Hui] Dalin Tzu Chi Hosp, Dept Res, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Hsu, Ta-Wen; Chang, Chun-Ming; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wu, Chin-Chia; Hsu, Ta-Wen; Chang, Chun-Ming; Wang, Yuh-Feng; Lee, Ching-Chih] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Ctr Canc, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Lee, CC (corresponding author), Dalin Tzu Chi Hosp, Dept Otolaryngol, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan.	hematcd@hotamil.com						[Anonymous], 2012, 2011 STAT CAUS DEATH; Boyd C, 1999, J CLIN ONCOL, V17, P2244, DOI 10.1200/JCO.1999.17.7.2244; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; CELLA DF, 1991, J CLIN ONCOL, V9, P1500, DOI 10.1200/JCO.1991.9.8.1500; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040590; Chou FHC, 2011, SCHIZOPHR RES, V129, P97, DOI 10.1016/j.schres.2011.02.018; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dixon A., 2003, LSE HLTH SOCIAL CARE, V11, P1; Fontana V, 1998, EUR J CANCER, V34, P537, DOI 10.1016/S0959-8049(97)10098-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Kunz PL, 2012, J CLIN ONCOL, V30, P3507, DOI 10.1200/JCO.2011.35.8028; Kuwahara A, 2010, GASTRIC CANCER, V13, P222, DOI 10.1007/s10120-010-0561-4; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Lee CC, 2012, ORAL ONCOL, V48, P253, DOI 10.1016/j.oraloncology.2011.10.002; Lee HY, 2010, CANCER EPIDEM BIOMAR, V19, P1919, DOI 10.1158/1055-9965.EPI-09-1308; Leigh Y, 2006, BRIT J CANCER, V95, P940, DOI 10.1038/sj.bjc.6603315; Lemstra M, 2006, CAN J PUBLIC HEALTH, V97, P435, DOI 10.1007/BF03405223; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; McCavit TL, 2011, AM J HEMATOL, V86, P377, DOI 10.1002/ajh.21977; Nakash O, 2013, MED CARE, V51, P137, DOI 10.1097/MLR.0b013e318270bab5; NHI, 2008, NHI PROF; Pereira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041200; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Siemerink EJM, 2011, CANCER EPIDEMIOL, V35, P413, DOI 10.1016/j.canep.2011.02.015; TORGERSEN O, 1956, BRIT J CANCER, V10, P299, DOI 10.1038/bjc.1956.34; TORGERSEN O, 1956, Acta Pathol Microbiol Scand Suppl, V39, P86; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9	33	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89655	10.1371/journal.pone.0089655	http://dx.doi.org/10.1371/journal.pone.0089655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24586941	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900063
J	Ballak, DB; van Essen, P; van Diepen, JA; Jansen, H; Hijmans, A; Matsuguchi, T; Sparrer, H; Tack, CJ; Netea, MG; Joosten, LAB; Stienstra, R				Ballak, Dov B.; van Essen, Peter; van Diepen, Janna A.; Jansen, Henry; Hijmans, Anneke; Matsuguchi, Tetsuya; Sparrer, Helmut; Tack, Cees J.; Netea, Mihai G.; Joosten, Leo A. B.; Stienstra, Rinke			MAP3K8 (TPL2/COT) Affects Obesity-Induced Adipose Tissue Inflammation without Systemic Effects in Humans and in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; KINASE; ONCOPROTEIN; DISEASE; TPL-2	Chronic low-grade inflammation in adipose tissue often accompanies obesity, leading to insulin resistance and increasing the risk for metabolic diseases. MAP3K8 (TPL2/COT) is an important signal transductor and activator of pro-inflammatory pathways that has been linked to obesity-induced adipose tissue inflammation. We used human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines (IL-1 beta, IL-6 and IL-8). Moreover, we evaluated obesity-induced adipose tissue inflammation and insulin resistance in mice lacking MAP3K8 and WT mice on a high-fat diet (HFD) for 16 weeks. Individuals with a BMI >30 displayed a higher mRNA expression of MAP3K8 in adipose tissue compared to individuals with a normal BMI. Additionally, high mRNA expression levels of IL-1 beta, IL-6 and IL-8, but not TNF -alpha, in human adipose tissue were associated with higher expression of MAP3K8. Moreover, high plasma SAA and CRP did not associate with increased MAP3K8 expression in adipose tissue. Similarly, no association was found for MAP3K8 expression with plasma insulin or glucose levels. Mice lacking MAP3K8 had similar bodyweight gain as WT mice, yet displayed lower mRNA expression levels of IL-1 beta, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to WT animals. However, MAP3K8 deficient mice were not protected against HFD-induced adipose tissue macrophage infiltration or the development of insulin resistance. Together, the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1 beta and its responsive cytokines IL-6 and IL-8, but does not seem to have systemic effects on insulin resistance.	[Ballak, Dov B.; van Essen, Peter; van Diepen, Janna A.; Jansen, Henry; Hijmans, Anneke; Tack, Cees J.; Netea, Mihai G.; Joosten, Leo A. B.; Stienstra, Rinke] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Ballak, Dov B.; van Essen, Peter; van Diepen, Janna A.; Stienstra, Rinke] Radboud Univ Nijmegen, Med Ctr, Inst Genom & Metab Dis, NL-6525 ED Nijmegen, Netherlands; [Ballak, Dov B.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands; [Matsuguchi, Tetsuya] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Biochem, Field Dev Med, Kagoshima 890, Japan; [Sparrer, Helmut] Novartis Pharma AG, Basel, Switzerland; [Stienstra, Rinke] Univ Wageningen & Res Ctr, Dept Human Nutr, Wageningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Kagoshima University; Novartis; Wageningen University & Research	Stienstra, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	rinke.stienstra@radboudumc.nl	Stienstra, Rinke/A-4763-2015; Netea, Mihai/N-5155-2014; Tack, Cees J/A-2368-2014; van Diepen, Janna/E-9485-2010; Matsuguchi, Tetsuya/HGU-0412-2022; Ballak, Dov B/E-1188-2017; Joosten, Leo AB/H-3138-2015; van Essen, Peter/E-8659-2018	Stienstra, Rinke/0000-0001-6729-7193; van Diepen, Janna/0000-0001-9091-1075; Joosten, Leo AB/0000-0001-6166-9830; 	Vici grant of the Netherlands Organization for Scientific Research; Ruby Grant of the Dutch Diabetes Research Foundation	Vici grant of the Netherlands Organization for Scientific Research; Ruby Grant of the Dutch Diabetes Research Foundation	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MGN was supported by a Vici grant of the Netherlands Organization for Scientific Research. RS was supported by a Ruby Grant of the Dutch Diabetes Research Foundation.	Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Chassaing B, 2012, ADV IMMUNOL, V116, P93, DOI 10.1016/B978-0-12-394300-2.00003-X; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Dinarello CA, 2010, ARTHRITIS RHEUM-US, V62, P3140, DOI 10.1002/art.27663; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; Gregor MF, 2011, ANN REV IMMUNOL; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Lancaster GI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039100; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Perfield JW, 2011, DIABETES, V60, P1168, DOI 10.2337/db10-0715; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004	19	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89615	10.1371/journal.pone.0089615	http://dx.doi.org/10.1371/journal.pone.0089615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586913	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700066
J	Akhiani, AA; Werlenius, O; Aurelius, J; Movitz, C; Martner, A; Hellstrand, K; Thoren, FB				Akhiani, Ali A.; Werlenius, Olle; Aurelius, Johan; Movitz, Charlotta; Martner, Anna; Hellstrand, Kristoffer; Thoren, Fredrik B.			Role of the ERK Pathway for Oxidant-Induced Parthanatos in Human Lymphocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; ACUTE MYELOID-LEUKEMIA; NATURAL-KILLER-CELLS; PERIPHERAL T-CELLS; HYDROGEN-PEROXIDE; NK CELLS; HISTAMINE DIHYDROCHLORIDE; ZETA-CHAIN; OXIDATIVE STRESS	Reactive oxygen species (ROS) are formed by myeloid cells as a defense strategy against microorganisms. ROS however also trigger poly(ADP-ribose) polymerase 1- (PARP-1) dependent cell death (parthanatos) in adjacent lymphocytes, which has been forwarded as a mechanism of immune escape in several forms of cancer. The present study assessed the role of mitogen-activated protein kinases (MAPKs), in particular the extracellular signal-regulated kinase (ERK), in ROS-induced signal transduction leading to lymphocyte parthanatos. We report that inhibitors of ERK1/2 phosphorylation upheld natural killer (NK) cell-mediated cytotoxicity under conditions of oxidative stress and rescued NK cells and CD8(+)T lymphocytes from cell death induced by ROS-producing monocytes. ERK1/2 phosphorylation inhibition also protected lymphocytes from cell death induced by exogenous hydrogen peroxide (H2O2) and from ROS generated by xanthine oxidase or glucose oxidase. Phosphorylation of ERK1/2 was observed in lymphocytes shortly after exposure to ROS. ROS-generating myeloid cells and exogenous H2O2 triggered PARP 1-dependent accumulation of poly ADP-ribose (PAR), which was prevented by ERK pathway inhibitors. ERK1/2 phosphorylation was induced by ROS independently of PARP-1. Our findings are suggestive of a role for ERK1/2 in ROS-induced lymphocyte parthanatos, and that the ERK axis may provide a therapeutic target for the protection of lymphocytes against oxidative stress.	[Akhiani, Ali A.; Werlenius, Olle; Aurelius, Johan; Movitz, Charlotta; Martner, Anna; Hellstrand, Kristoffer; Thoren, Fredrik B.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Werlenius, Olle] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Sahlgrenska Canc Ctr, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Hellstrand, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Sahlgrenska Canc Ctr, Gothenburg, Sweden.	kristoffer.hellstrand@gu.se	Thorén, Fredrik B/I-5285-2019	Thorén, Fredrik B/0000-0003-2167-7451; Martner, Anna/0000-0002-6598-5221; Hellstrand, Kristoffer/0000-0002-6617-5976	Swedish Cancer Foundation (Cancerfonden); Torsten and Ragnar Soderberg Foundation; Swedish Research Council/Medicine; Ingabritt and Arne Lundberg Foundation; Assar Gabrielsson Foundation; Lundgren Research Foundation; Royal Society of Arts and Sciences in Goteborg; ALF Funds at Sahlgrenska University Hospital	Swedish Cancer Foundation (Cancerfonden)(Swedish Cancer Society); Torsten and Ragnar Soderberg Foundation; Swedish Research Council/Medicine(Swedish Research Council); Ingabritt and Arne Lundberg Foundation; Assar Gabrielsson Foundation; Lundgren Research Foundation; Royal Society of Arts and Sciences in Goteborg; ALF Funds at Sahlgrenska University Hospital	This study was supported by the Swedish Cancer Foundation (Cancerfonden), the Torsten and Ragnar Soderberg Foundation, the Swedish Research Council/Medicine, ALF Funds at Sahlgrenska University Hospital, the Ingabritt and Arne Lundberg Foundation, the Assar Gabrielsson Foundation, the Lundgren Research Foundation, and by the Royal Society of Arts and Sciences in Goteborg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; ALVAREZGONZALEZ R, 1989, MUTAT RES, V218, P67, DOI 10.1016/0921-8777(89)90012-8; Aurelius J, 2013, J LEUKOCYTE BIOL, V93, P155, DOI 10.1189/jlb.0512257; Aurelius J, 2012, HAEMATOL-HEMATOL J, V97, P1904, DOI 10.3324/haematol.2012.066399; Aurelius J, 2012, BLOOD, V119, P5832, DOI 10.1182/blood-2011-11-391722; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Brand A, 2001, J NEUROCHEM, V76, P910, DOI 10.1046/j.1471-4159.2001.00085.x; Brune M, 2006, BLOOD, V108, P88, DOI 10.1182/blood-2005-10-4073; Buggins AGS, 1998, BRIT J HAEMATOL, V100, P784; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Fatokun AA, 2007, NEUROSCI LETT, V416, P34, DOI 10.1016/j.neulet.2007.01.078; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gutierrez-Venegas G, 2010, TOXICOL IN VITRO, V24, P319, DOI 10.1016/j.tiv.2009.08.007; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hansson M, 1996, J IMMUNOL, V156, P42; Harlin H, 2007, J IMMUNOL, V179, P4513, DOI 10.4049/jimmunol.179.7.4513; Healy CG, 1998, CYTOMETRY, V32, P109, DOI 10.1002/(SICI)1097-0320(19980601)32:2<109::AID-CYTO6>3.0.CO;2-G; HELLSTRAND K, 1994, J IMMUNOL, V153, P4940; Hellstrand K, 2003, TRENDS IMMUNOL, V24, P232, DOI 10.1016/S1471-4906(03)00070-X; HELLSTRAND K, 1994, J LEUKOCYTE BIOL, V55, P392, DOI 10.1002/jlb.55.3.392; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Ishikawa Y, 2000, KIDNEY INT, V58, P1078, DOI 10.1046/j.1523-1755.2000.00265.x; Karlsson A, 2000, J LEUKOCYTE BIOL, V67, P396, DOI 10.1002/jlb.67.3.396; Kiessling R, 1999, CANCER IMMUNOL IMMUN, V48, P353, DOI 10.1007/s002620050586; Klebanoff S.J., 1999, INFLAMMATION BASIC P, P721; Kondadasula V, 2008, CANCER IMMUNOL IMMUN, V57, P1137, DOI 10.1007/s00262-007-0444-7; Kono K, 1996, CLIN CANCER RES, V2, P1825; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; Lee WC, 2005, NEUROCHEM RES, V30, P263, DOI 10.1007/s11064-005-2449-y; Ma CL, 2008, J BIOL CHEM, V283, P9248, DOI 10.1074/jbc.M707316200; Martner A, 2011, J IMMUNOL, V187, P6243, DOI 10.4049/jimmunol.1102138; Martner A, 2010, EXPERT REV HEMATOL, V3, P381, DOI 10.1586/EHM.10.30; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Mellqvist UH, 2000, BLOOD, V96, P1961, DOI 10.1182/blood.V96.5.1961.h8001961_1961_1968; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; Oh PS, 2008, ENVIRON TOXICOL PHAR, V25, P114, DOI 10.1016/j.etap.2007.10.001; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Otsuji M, 1996, P NATL ACAD SCI USA, V93, P13119, DOI 10.1073/pnas.93.23.13119; Rabinowich H, 1996, CLIN CANCER RES, V2, P1263; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Romero AI, 2009, SCAND J IMMUNOL, V70, P194, DOI 10.1111/j.1365-3083.2009.02303.x; Romero AI, 2006, BRIT J HAEMATOL, V132, P91, DOI 10.1111/j.1365-2141.2005.05842.x; Schmielau J, 2001, CLIN CANCER RES, V7, p933S; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Thoren FB, 2007, J IMMUNOL, V179, P21, DOI 10.4049/jimmunol.179.1.21; Thoren FB, 2006, J IMMUNOL, V176, P7301, DOI 10.4049/jimmunol.176.12.7301; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008	61	28	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89646	10.1371/journal.pone.0089646	http://dx.doi.org/10.1371/journal.pone.0089646			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586933	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900136
J	Bailey, A; van Hateren, A; Elliott, T; Werner, JM				Bailey, Alistair; van Hateren, Andy; Elliott, Tim; Werner, Joern M.			Two Polymorphisms Facilitate Differences in Plasticity between Two Chicken Major Histocompatibility Complex Class I Proteins	PLOS ONE			English	Article							MHC CLASS-I; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGE; PEPTIDE-BINDING; TAPASIN; TAP; SELECTION; QUALITY; ASSOCIATION; COEVOLUTION	Major histocompatibility complex class I molecules (MHC I) present peptides to cytotoxic T-cells at the surface of almost all nucleated cells. The function of MHC I molecules is to select high affinity peptides from a large intracellular pool and they are assisted in this process by co-factor molecules, notably tapasin. In contrast to mammals, MHC homozygous chickens express a single MHC I gene locus, termed BF2, which is hypothesised to have co-evolved with the highly polymorphic tapasin within stable haplotypes. The BF2 molecules of the B15 and B19 haplotypes have recently been shown to differ in their interactions with tapasin and in their peptide selection properties. This study investigated whether these observations might be explained by differences in the protein plasticity that is encoded into the MHC I structure by primary sequence polymorphisms. Furthermore, we aimed to demonstrate the utility of a complimentary modelling approach to the understanding of complex experimental data. Combining mechanistic molecular dynamics simulations and the primary sequence based technique of statistical coupling analysis, we show how two of the eight polymorphisms between BF2*15:01 and BF2*19:01 facilitate differences in plasticity. We show that BF2*15: 01 is intrinsically more plastic than BF2*19: 01, exploring more conformations in the absence of peptide. We identify a protein sector of contiguous residues connecting the membrane bound alpha(3) domain and the heavy chain peptide binding site. This sector contains two of the eight polymorphic residues. One is residue 22 in the peptide binding domain and the other 220 is in the alpha(3) domain, a putative tapasin binding site. These observations are in correspondence with the experimentally observed functional differences of these molecules and suggest a mechanism for how modulation of MHC I plasticity by tapasin catalyses peptide selection allosterically.	[Bailey, Alistair; van Hateren, Andy; Elliott, Tim; Werner, Joern M.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Bailey, Alistair; van Hateren, Andy; Elliott, Tim] Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO9 5NH, Hants, England; [Werner, Joern M.] Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Elliott, T (corresponding author), Univ Southampton, Inst Life Sci, Southampton, Hants, England.	T.J.Elliott@soton.ac.uk; J.M.Werner@soton.ac.uk	van Hateren, Andy/GZL-0129-2022; Werner, Joern/E-1148-2013	Elliott, Tim/0000-0003-1097-0222; van Hateren, Andy/0000-0002-3915-0239; Werner, Jorn/0000-0002-4712-1833; Bailey, Alistair/0000-0003-0023-8679	MRC/Microsoft Research UK; CRUK [CRUK/A10601]; BBSRC [BB/L010402/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L010402/1] Funding Source: researchfish	MRC/Microsoft Research UK; CRUK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a MRC/Microsoft Research UK studentship and centenary award and CRUK (Programme number CRUK/A10601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amadei A, 1996, J BIOMOL STRUCT DYN, V13, P615, DOI 10.1080/07391102.1996.10508874; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berendsen H., 1981, INTERMOLECULAR FORCE; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; Bowman GR, 2012, P NATL ACAD SCI USA, V109, P11681, DOI 10.1073/pnas.1209309109; Boyle LH, 2013, P NATL ACAD SCI US; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; de Groot BL, 1998, PROTEINS, V31, P116, DOI 10.1002/(SICI)1097-0134(19980501)31:2<116::AID-PROT2>3.0.CO;2-K; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Dubay KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002168; Elliott T, 1997, IMMUNOL TODAY, V18, P375, DOI 10.1016/S0167-5699(97)01097-9; ELLIOTT T, 1992, EUR J IMMUNOL, V22, P2085, DOI 10.1002/eji.1830220819; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hess B, 2009, AM CHEM SOC, V237; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kaufman J, 1999, IMMUNOGENETICS, V50, P228, DOI 10.1007/s002510050597; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaw I, 2007, J IMMUNOL, V178, P5744, DOI 10.4049/jimmunol.178.9.5744; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simone LC, 2012, MOL IMMUNOL, V49, P628, DOI 10.1016/j.molimm.2011.11.002; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Hateren A, 2010, TISSUE ANTIGENS, V76, P259, DOI 10.1111/j.1399-0039.2010.01550.x; van Hateren A, 2013, J BIOL CHEM, V288, P32797, DOI 10.1074/jbc.M113.474031; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; Walker BA, 2011, P NATL ACAD SCI USA, V108, P8396, DOI 10.1073/pnas.1019496108; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156	69	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89657	10.1371/journal.pone.0089657	http://dx.doi.org/10.1371/journal.pone.0089657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586943	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000331714700133
J	Asiimwe, SB; Okello, S; Moore, CC				Asiimwe, Stephen B.; Okello, Samson; Moore, Christopher C.			Frequency of Vital Signs Monitoring and its Association with Mortality among Adults with Severe Sepsis Admitted to a General Medical Ward in Uganda	PLOS ONE			English	Article							RAPID-RESPONSE SYSTEMS; MANAGEMENT; RECOMMENDATIONS; GUIDELINES; HOSPITALS; FAILURE; LACTATE	Introduction: Optimal vital signs monitoring of patients with severe sepsis in resource-limited settings may improve outcomes. The objective of this study was to determine the frequency of vital signs monitoring of patients with severe sepsis and its association with mortality in a regional referral hospital in Uganda. Methods: We reviewed medical records of patients admitted to Mbarara Regional Referral Hospital in Southwestern Uganda with severe sepsis defined by the presence of infection plus >= 2 of the systemic inflammatory response syndrome criteria, and >= 1 organ dysfunction (altered mental state, hypotension, jaundice, or thrombocytopenia). We recorded frequency of vital signs monitoring in addition to socio-demographic, clinical, and outcome data. We analyzed the data using logistic regression. Results: We identified 202 patients with severe sepsis. The median age was 35 years (IQR, 25-47) and 98 (48%) were female. HIV infection and anemia was present in 115 (57%) and 83 (41%) patients respectively. There were 67 (33%) in-hospital deaths. The median monitoring frequency per day was 1.1 (IQR 0.9-1.5) for blood pressure, 1.0 (IQR, 0.8-1.3) for temperature and pulse, and 0.5 (IQR, 0.3-1.0) for respiratory rate. The frequency of vital signs monitoring decreased during the course of hospitalization. Patients who died had a higher frequency of vital signs monitoring (p<0.05). The admission respiratory rate was associated with both frequency of monitoring (coefficient of linear regression 0.6, 95% CI 0.5-0.8, p<0.001) and mortality (AOR 2.5, 95% CI 1.3-5.3, p = 0.01). Other predictors of mortality included severity of illness, HIV infection, and anemia (p<0.05). Conclusions: More research is needed to determine the optimal frequency of vital signs monitoring for severely septic patients in resource-limited settings such as Uganda.	[Asiimwe, Stephen B.] Mbarara Reg Referral Hosp, Dept Internal Med, Mbarara, Uganda; [Asiimwe, Stephen B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Okello, Samson] Mbarara Univ Sci & Technol, Dept Internal Med, Mbarara, Uganda; [Moore, Christopher C.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA	University of California System; University of California San Francisco; Mbarara University of Science & Technology; University of Virginia	Moore, CC (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	ccm5u@virginia.edu	Okello, Samson/I-1877-2019	Okello, Samson/0000-0001-7377-6094	Pfizer Initiative in International Health; Center for Global Health at the University of Virginia; Pfizer, Inc.	Pfizer Initiative in International Health; Center for Global Health at the University of Virginia; Pfizer, Inc.(Pfizer)	Funding for the study was provided by the Pfizer Initiative in International Health and the Center for Global Health at the University of Virginia. This initiative was conceived to fund global infectious disease research and exchange programs between post-doctoral fellows and students from the University of Virginia and several international partners to conduct research on global health issues. The major purpose of this program is to foster and enhance bidirectional research training. An independent board at the University of Virginia determines which research proposals are funded. Pfizer, Inc. provided funds to promote the Initiative but has no role in the planning or execution of research protocols, including the study described in our article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Bauer TT, 2006, J INTERN MED, V260, P93, DOI 10.1111/j.1365-2796.2006.01657.x; Bouferrache K, 2012, CRIT CARE MED, V40, P2821, DOI 10.1097/CCM.0b013e31825bc565; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Jacob ST, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-107; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Jacob ST, 2011, CRIT CARE, V15, DOI 10.1186/cc9981; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Jacob ST, 2013, IMAI DISTRICT CLIN M; Kavanagh BP, 2005, INTENS CARE MED, V31, P1161, DOI 10.1007/s00134-005-2729-7; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Moore CC, 2008, CLIN INFECT DIS, V46, P215, DOI 10.1086/524665; Oglesby KJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10329; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Schulman CS, 2010, CRIT CARE NURSE, V30, P74, DOI 10.4037/ccn2010406; Ssekitoleko R, 2011, AM J TROP MED HYG, V85, P697, DOI 10.4269/ajtmh.2011.10-0692; Ssekitoleko R, 2011, CRIT CARE MED, V39, P2271, DOI 10.1097/CCM.0b013e3182227bd2; Trinkle RM, 2011, RESUSCITATION, V82, P810, DOI 10.1016/j.resuscitation.2011.03.019; Webb SAR, 2012, CRIT CARE RESUSC, V14, P253; Winters BD, 2013, ANN INTERN MED, V158, P417, DOI 10.7326/0003-4819-158-5-201303051-00009	24	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89879	10.1371/journal.pone.0089879	http://dx.doi.org/10.1371/journal.pone.0089879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587094	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200091
J	Azevedo, OGR; Bolick, DT; Roche, JK; Pinkerton, RF; Lima, AAM; Vitek, MP; Warren, CA; Oria, RB; Guerrant, RL				Azevedo, Orleancio G. R.; Bolick, David T.; Roche, James K.; Pinkerton, Relana F.; Lima, Aldo A. M.; Vitek, Michael P.; Warren, Cirle A.; Oria, Reinaldo B.; Guerrant, Richard L.			Apolipoprotein E Plays a Key Role against Cryptosporidial Infection in Transgenic Undernourished Mice	PLOS ONE			English	Article							EARLY-CHILDHOOD DIARRHEA; INNATE IMMUNE-RESPONSES; PARVUM INFECTION; SHANTYTOWN CHILDREN; APOE GENOTYPE; DISEASE; GROWTH; TRANSPORT; SUPPLEMENTATION; MALNUTRITION	Apolipoliprotein E (apoE), a critical targeting protein in lipid homeostasis, has been found to have immunoinflammatory effects on murine models of infection and malnutrition. The effects of apoE in undernourished and Cryptosporidium parvum-infected mice have not been investigated. In order to study the role of apoE in a model of C. parvum infection, we used the following C57BL6J mouse genetic strains: APOE-deficient, wild-type controls, and APOE targeted replacement (TR) mice expressing human APOE genes (E3/3; E4/4). Experimental mice were orally infected with 10(7)-unexcysted-C. parvum oocysts between post-natal days 34-35 followed by malnutrition induced with a low-protein diet. Mice were euthanized seven days after C. parvum-challenge to investigate ileal morphology, cytokines, and cationic arginine transporter (CAT-1), arginase 1, Toll-like receptor 9 (TLR9), and inducible nitric oxide synthase (iNOS) expression. In addition, we analyzed stool oocyst shedding by qRT-PCR and serum lipids. APOE4/4-TR mice had better weight gains after infection plus malnutrition compared with APOE3/3-TR and wild-type mice. APOE4/4-TR and APOE knockout mice had lower oocyst shedding, however the latter exhibited with villus blunting and higher ileal pro-inflammatory cytokines and iNOS transcripts. APOE4/4-TR mice had increased ileal CAT-1, arginase-1, and TLR9 transcripts relative to APOE knockout. Although with anti-parasitic effects, APOE deficiency exacerbates intestinal inflammatory responses and mucosal damage in undernourished and C. parvum-infected mice. In addition, the human APOE4 gene was found to be protective against the compounded insult of Cryptosporidium infection plus malnutrition, thus extending our previous findings of the protection against diarrhea in APOE4 children. Altogether our findings suggest that apoE plays a key role in the intestinal restitution and immunoinflammatory responses with Cryptosporidium infection and malnutrition.	[Azevedo, Orleancio G. R.; Bolick, David T.; Roche, James K.; Pinkerton, Relana F.; Lima, Aldo A. M.; Warren, Cirle A.; Oria, Reinaldo B.; Guerrant, Richard L.] Univ Virginia, Sch Med, Div Infect Dis & Internal Med, Ctr Global Hlth, Charlottesville, VA 22908 USA; [Lima, Aldo A. M.; Guerrant, Richard L.] Univ Fed Ceara, Sch Med, Inst Brazilian Semiarid, Lab Infect Dis,Clin Res Unit, Fortaleza, Ceara, Brazil; [Azevedo, Orleancio G. R.; Oria, Reinaldo B.] Univ Fed Ceara, Sch Med, Inst Brazilian Semiarid, Lab Biol Tissue Healing,Ontogeny & Nutr, Fortaleza, Ceara, Brazil; [Vitek, Michael P.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of Virginia; Universidade Federal do Ceara; Universidade Federal do Ceara; Duke University	Oria, RB (corresponding author), Univ Virginia, Sch Med, Div Infect Dis & Internal Med, Ctr Global Hlth, Charlottesville, VA 22908 USA.	oria@ufc.br	Lima, Aldo AM/D-8251-2018; Bolick, David/A-3467-2017; Oria, Reinaldo B/D-6440-2014; Azevedo, Orleancio/AAX-7234-2020	Lima, Aldo AM/0000-0002-0299-1747; Oria, Reinaldo/0000-0002-6914-5481; Azevedo, Orleancio/0000-0003-4588-0366; Vitek, Michael/0000-0001-8140-8048	NIH [5R01HD053131]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH Office of Dietary Supplements (ODS); National Institute of Allergy and Infectious Diseases [U54 AI57168]; Fogarty International Center [TW006713-01]; Center Global Infectious Diseases Research Training (GIDRT) program at NIH [5 D43 TW006578-08/GIDRT]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053131] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW006578, R21TW006713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH Office of Dietary Supplements (ODS); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center Global Infectious Diseases Research Training (GIDRT) program at NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH Research Grant #5R01HD053131 funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the NIH Office of Dietary Supplements (ODS). WNIH Cooperative Agreement U54 AI57168 for the Mid-Atlantic Regional Center for Excellence (MARCE) funded by the National Institute of Allergy and Infectious Diseases, and by Fogarty International Center grant TW006713-01. Orleancio de Azevedo was supported by the Center Global Infectious Diseases Research Training (GIDRT) program at NIH, grant 5 D43 TW006578-08/GIDRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcia AM, 2005, CLIN INFECT DIS, V41, pS498, DOI 10.1086/432005; Barrier M, 2006, J INFECT DIS, V193, P1400, DOI 10.1086/503748; Bhat BG, 2003, J LIPID RES, V44, P1614, DOI 10.1194/jlr.M200469-JLR200; Castro IC, 2012, NUTRITION, V28, P678, DOI 10.1016/j.nut.2011.09.011; Chapman J, 2001, NEUROLOGY, V56, P312, DOI 10.1212/WNL.56.3.312; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Chuang K, 2010, AM J SURG, V200, P391, DOI 10.1016/j.amjsurg.2009.10.017; Colton CA, 2002, ANN NY ACAD SCI, V962, P212, DOI 10.1111/j.1749-6632.2002.tb04070.x; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Costa LB, 2012, J INFECT DIS, V205, P1464, DOI 10.1093/infdis/jis216; Costa LB, 2011, J PARASITOL, V97, P1113, DOI 10.1645/GE-2848.1; Coutinho BP, 2008, J PARASITOL, V94, P1225, DOI 10.1645/GE-1411.1; de Bont N, 1999, J LIPID RES, V40, P680; de Bont N, 2000, EUR J CLIN INVEST, V30, P818; Dillingham RA, 2002, MICROBES INFECT, V4, P1059, DOI 10.1016/S1286-4579(02)01630-1; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Hoare S, 1996, BRIT J NUTR, V76, P479, DOI 10.1079/BJN19960057; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Marcos LA, 2013, CURR OPIN INFECT DIS, V26, P302, DOI [10.1097/QCO.0b013e3283630e85, 10.1097/QCO.0b013e3283630be3]; McDonald V, 2013, PARASITE IMMUNOL, V35, P55, DOI 10.1111/pim.12020; Mitter SS, 2012, CLINICS, V67, P11, DOI 10.6061/clinics/2012(01)03; Moreau PH, 2013, BEHAV BRAIN RES, V243, P1, DOI 10.1016/j.bbr.2012.12.043; Oria RB, 2010, BRAZ J MED BIOL RES, V43, P249, DOI 10.1590/S0100-879X2010007500003; Oria RB, 2005, PEDIATR RES, V57, P310, DOI 10.1203/01.PDR.0000148719.82468.CA; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Oria RB, 2006, NUTR RES, V26, P427, DOI 10.1016/j.nutres.2006.06.020; Pan M, 2004, J NUTR, V134, p2826S, DOI 10.1093/jn/134.10.2826S; Pinkerton RC, 2011, AM J TROP MED HYG, V85, P893, DOI 10.4269/ajtmh.2011.11-0159; Rensen PCN, 1997, J CLIN INVEST, V99, P2438, DOI 10.1172/JCI119427; ROESCHLA.P, 1974, Z KLIN CHEM KLIN BIO, V12, P226; Roselaar SE, 1998, J LIPID RES, V39, P1740; Hernandez AS, 2009, REUMATOL CLIN, V5, P1, DOI 10.1016/j.reuma.2008.11.012; Strittmatter WJ, 2002, CURR OPIN LIPIDOL, V13, P119, DOI 10.1097/00041433-200204000-00002; Turan N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-10; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Van Oosten MV, 2001, J BIOL CHEM, V276, P8820, DOI 10.1074/jbc.M009915200; Vasunilashorn S, 2011, BIODEMOGR SOC BIOL, V57, P33, DOI 10.1080/19485565.2011.564475; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Zhang HL, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/949072	46	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89562	10.1371/journal.pone.0089562	http://dx.doi.org/10.1371/journal.pone.0089562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586873	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200060
J	Lin, B; Wang, YF; Wang, Z; Tan, HL; Kong, XH; Shu, Y; Zhang, YC; Huang, Y; Zhu, YF; Xu, H; Wang, ZQ; Wang, P; Ning, G; Kong, XY; Hu, GH; Hu, LD				Lin, Bin; Wang, Yufeng; Wang, Zhen; Tan, Huilian; Kong, Xianghua; Shu, Yang; Zhang, Yuchao; Huang, Yun; Zhu, Yufei; Xu, Heng; Wang, Zhiqiang; Wang, Ping; Ning, Guang; Kong, Xiangyin; Hu, Guohong; Hu, Landian			Uncovering the Rare Variants of DLC1 Isoform 1 and Their Functional Effects in a Chinese Sporadic Congenital Heart Disease Cohort	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; FOCAL ADHESION-LOCALIZATION; TUMOR-SUPPRESSOR PROTEIN; GENETIC-BASIS; HUMAN JAGGED1; CELL-LINES; MUTATIONS; LIVER; PROLIFERATION; MIGRATION	Congenital heart disease (CHD) is the most common birth defect affecting the structure and function of fetal hearts. Despite decades of extensive studies, the genetic mechanism of sporadic CHD remains obscure. Deleted in liver cancer 1 (DLC1) gene, encoding a GTPase-activating protein, is highly expressed in heart and essential for heart development according to the knowledge of Dlc1-deficient mice. To determine whether DLC1 is a susceptibility gene for sporadic CHD, we sequenced the coding region of DLC1 isoform 1 in 151 sporadic CHD patients and identified 13 non-synonymous rare variants (including 6 private variants) in the case cohort. Importantly, these rare variants (8/13) were enriched in the N-terminal region of the DLC1 isoform 1 protein. Seven of eight amino acids at the N-terminal variant positions were conserved among the primates. Among the 9 rare variants that were predicted as "damaging", five were located at the N-terminal region. Ensuing in vitro functional assays showed that three private variants (Met360Lys, Glu418Lys and Asp554Val) impaired the ability of DLC1 to inhibit cell migration or altered the subcellular location of the protein compared to wild-type DLC1 isoform 1. These data suggest that DLC1 might act as a CHD-associated gene in addition to its role as a tumor suppressor in cancer.	[Lin, Bin; Wang, Yufeng; Shu, Yang; Zhang, Yuchao; Huang, Yun; Zhu, Yufei; Xu, Heng; Wang, Zhiqiang; Wang, Ping; Kong, Xiangyin; Hu, Guohong; Hu, Landian] SJTUSM, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Lin, Bin; Wang, Yufeng; Shu, Yang; Zhang, Yuchao; Huang, Yun; Zhu, Yufei; Xu, Heng; Wang, Zhiqiang; Wang, Ping; Kong, Xiangyin; Hu, Guohong; Hu, Landian] Chinese Acad Sci, SIBS, Shanghai, Peoples R China; [Wang, Zhen; Tan, Huilian] Hebei Med Univ, Hosp 1, Diag & Treatment Ctr Congenital Heart Dis, Shijiazhuang, Hebei, Peoples R China; [Kong, Xianghua] Binzhou Med Coll, Affiliated Hosp, Clin Lab, Binzhou, Shandong, Peoples R China; [Ning, Guang; Kong, Xiangyin; Hu, Landian] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Hebei Medical University; Binzhou Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Kong, XY (corresponding author), SJTUSM, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; ghhu@sibs.ac.cn; ldhu@sibs.ac.cn	Xu, Heng/AAS-3465-2021; Wang, Yufeng/ABD-1199-2020	Xu, Heng/0000-0002-7748-2621; Shu, Yang/0000-0002-8304-1531; Hu, Guohong/0000-0002-2980-5166	National Basic Research Program of China [2007CB512103, 2011CB510100]; National Natural Science Foundation of China [81030015]; E-Institutes of Shanghai Municipal Education Commission	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); E-Institutes of Shanghai Municipal Education Commission	This work is supported by the National Basic Research Program of China (No. 2007CB512103, 2011CB510100) (http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (No. 81030015) (http://www.nsfc.gov.cn/Portal0/default166.htm), and the E-Institutes of Shanghai Municipal Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Cao X, 2012, P NATL ACAD SCI USA, V109, P1455, DOI 10.1073/pnas.1114368109; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; COFFIN JD, 1991, ANAT REC, V231, P383; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Feng MH, 2011, MOL BIOL REP, V38, P1915, DOI 10.1007/s11033-010-0311-z; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Garg V, 2006, CELL MOL LIFE SCI, V63, P1141, DOI 10.1007/s00018-005-5532-2; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Guan M, 2008, CANCER GENE THER, V15, P371, DOI 10.1038/cgt.2008.13; Hankins GR, 2008, NEUROSURGERY, V63, P771, DOI 10.1227/01.NEU.0000325488.72518.9E; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Kawai K, 2004, BIOCHEM SOC T, V32, P1107, DOI 10.1042/BST0321107; Kawai K, 2009, GENES CELLS, V14, P227, DOI 10.1111/j.1365-2443.2008.01265.x; Keyte A, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.005; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; Ko FCF, 2010, LIVER INT, V30, P139, DOI 10.1111/j.1478-3231.2009.02133.x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurosaka Satoshi, 2008, Birth Defects Research, V84, P102, DOI 10.1002/bdrc.20125; Leung KW, 2007, BRIT J PHARMACOL, V152, P207, DOI 10.1038/sj.bjp.0707359; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Ng IOL, 2000, CANCER RES, V60, P6581; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; PAYNE RM, 1995, CIRCULATION, V91, P494, DOI 10.1161/01.CIR.91.2.494; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Richards AA, 2010, CURR CARDIOL REV, V6, P91, DOI 10.2174/157340310791162703; Sabbir MG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-17; Sakabe Masahide, 2005, Congenital Anomalies, V45, P107, DOI 10.1111/j.1741-4520.2005.00079.x; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Wessels MW, 2010, CLIN GENET, V78, P103, DOI 10.1111/j.1399-0004.2010.01435.x; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Wu PP, 2009, ANN CLIN LAB SCI, V39, P263; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yuan BZ, 2007, EXP CELL RES, V313, P3868, DOI 10.1016/j.yexcr.2007.08.009; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zhang T, 2009, CANCER LETT, V283, P59, DOI 10.1016/j.canlet.2009.03.025; Zhong D, 2009, J CELL SCI, V122, P414, DOI 10.1242/jcs.027482	49	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90215	10.1371/journal.pone.0090215	http://dx.doi.org/10.1371/journal.pone.0090215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587289	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200148
J	Rubio-Valera, M; Pons-Vigues, M; Martinez-Andres, M; Moreno-Peral, P; Berenguera, A; Fernandez, A				Rubio-Valera, Maria; Pons-Vigues, Mariona; Martinez-Andres, Maria; Moreno-Peral, Patricia; Berenguera, Anna; Fernandez, Ana			Barriers and Facilitators for the Implementation of Primary Prevention and Health Promotion Activities in Primary Care: A Synthesis through Meta-Ethnography	PLOS ONE			English	Article							PHYSICAL-ACTIVITY PROMOTION; HEART-DISEASE PREVENTION; LIFE-STYLE INTERVENTION; GENERAL-PRACTITIONERS; COMPLEX INTERVENTIONS; ALCOHOL-USE; ATTITUDES; NURSES; PERSPECTIVES; PERCEPTIONS	Background: Evidence supports the implementation of primary prevention and health promotion (PP&HP) activities but primary care (PC) professionals show resistance to implementing these activities. The aim was to synthesize the available qualitative research on barriers and facilitators identified by PC physicians and nurses in the implementation of PP&HP in adults. Methods and Findings: A systematic search of three databases was conducted and supported by manual searches. The 35 articles included were translated into each other and a new interpretation of the concepts extracted was generated. The factors affecting the implementation of PP&HP activities in PC according to professionals were fitted into a five-level ecological model: intrapersonal factors, interpersonal processes, institutional factors, community factors and public policy. At the intrapersonal level we find professionals' beliefs about PP&HP, experiences, skills and knowledge, and selfconcept. The attitudes and behavior towards PP&HP of patients, specialists, practice managers and colleagues (interpersonal factors) affect the feasibility of implementing PP&HP. Institutional level: PC is perceived as well-placed to implement PP&HP but workload, lack of time and referral resources, and the predominance of the biomedical model (which prioritizes disease treatment) hamper the implementation of PP&HP. The effectiveness of financial incentives and tools such as guidelines and alarms/reminders is conditioned by professionals' attitudes to them. Community factors include patients' social and cultural characteristics (religion, financial resources, etc.), local referral resources, mass-media messages and pharmaceutical industry campaigns, and the importance given to PP&HP in the curriculum in university. Finally, policies affect the distribution of resources, thus affecting the implementation of PP&HP. Conclusions: Research on barriers and facilitators in the implementation of PP&HP activities in multirisk management is scarce. The conceptual overview provided by this synthesis resulted in the development of practical recommendations for the design of PP&HP in PC. However, the effectiveness of these recommendations needs to be demonstrated.	[Rubio-Valera, Maria; Fernandez, Ana] Fundacio St Joan de Deu, Res & Dev Unit, Barcelona, Spain; [Pons-Vigues, Mariona; Berenguera, Anna] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Res Dept, Barcelona, Spain; [Pons-Vigues, Mariona; Berenguera, Anna] Univ Autonoma Barcelona, Dept Psicol Clin & Salud, Bellaterra, Spain; [Martinez-Andres, Maria] Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain; [Moreno-Peral, Patricia] Fdn Publ Andaluza Invest Malaga Biomed & Salud IM, Res Unit, Dist Sanitario Malaga, Malaga, Spain; [Fernandez, Ana] Univ Sydney, Fac Hlth Sci, Ctr Disabil Res & Policy, Sydney, NSW 2006, Australia	Autonomous University of Barcelona; Universidad de Castilla-La Mancha; University of Sydney	Rubio-Valera, M (corresponding author), Fundacio St Joan de Deu, Res & Dev Unit, Barcelona, Spain.	mrubio@pssjd.org	Moreno-Peral, Patricia/I-3594-2012; PRISMA, Grupo/AAI-6753-2021; Pons-Vigués, Mariona/D-6079-2019; Andres, Maria Martinez/R-4866-2019; Rubio-Valera, Maria/H-4840-2012; Fernandez, Ana/H-4545-2012	Moreno-Peral, Patricia/0000-0003-4130-9090; Pons-Vigués, Mariona/0000-0002-7929-3701; Rubio-Valera, Maria/0000-0003-2856-1697; Fernandez, Ana/0000-0002-0333-1345; Martinez Andres, Maria/0000-0001-5312-7361; Berenguera, Anna/0000-0002-0889-2002	Carlos III Health Institute [Instituto de Salud Carlos III]	Carlos III Health Institute [Instituto de Salud Carlos III](Instituto de Salud Carlos III)	This study was carried out with the help from the Network of Preventive Activities and Health Promotion in Primary Care [Red de Actividades Preventivas y Promocion de la Salud en Atencion Primaria; redIAPP] granted by the Carlos III Health Institute [Instituto de Salud Carlos III]. We thank Edurne Zabaleta from the Network of Preventive Activities and Health Promotion in Primary Care for her contributions to the search strategy.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albert D, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120106; Ampt AJ, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-59; Badertscher N, 2012, SWISS MED WEEKLY, V1, P142; Beich A, 2002, BMJ-BRIT MED J, V325, P870; Blaxter M., 1996, MED SOCIOLOGY NEWS, V22, P68; Blumenthal DS, 2007, J AM BOARD FAM MED, V20, P272, DOI 10.3122/jabfm.2007.03.060115; Boase S, 2012, J CLIN NURS, V21, P2590, DOI 10.1111/j.1365-2702.2012.04167.x; Bosch-Capblanch X, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001185; Brandling J, 2009, BRIT J GEN PRACT, V59, P454, DOI 10.3399/bjgp09X421085; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Brotons C, 2012, GAC SANIT, V26, P151, DOI 10.1016/j.gaceta.2011.10.006; Calderón Carlos, 2002, Rev. Esp. Salud Publica, V76, P473, DOI 10.1590/s1135-57272002000500009; Calderon C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-62; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Campbell R, 2011, HEALTH TECHNOL ASSES, V15, pIII, DOI 10.3310/hta15430; Carlfjord S, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-99; Coleman T, 2000, BRIT J GEN PRACT, V50, P207; Costa B, 2012, DIABETOLOGIA, V55, P1319, DOI 10.1007/s00125-012-2492-6; Dixon-Woods Mary, 2007, J Health Serv Res Policy, V12, P42, DOI 10.1258/135581907779497486; Epstein RM, 2010, HEALTH AFFAIR, V29, P1489, DOI 10.1377/hlthaff.2009.0888; Fairhurst K, 1998, BMJ-BRIT MED J, V317, P1130; Fixsen D.L., 2005, FMHI PUBLICATION, V231; Fuller TL, 2003, AM J CLIN NUTR, V77, p1043S, DOI 10.1093/ajcn/77.4.1043S; Gale NK, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-59; Graham RC, 2005, ERGONOMICS, V48, P1411, DOI 10.1080/00140130500101064; Gunther Stephen, 2012, Qual Prim Care, V20, P93; Hernandez J, 2012, J AM ACAD NURSE PRAC, V24, P89, DOI 10.1111/j.1745-7599.2011.00663.x; Heymann Anthony D, 2010, Qual Prim Care, V18, P173; Hudon E, 2004, FAM PRACT, V21, P11, DOI 10.1093/fampra/cmh104; Jacobsen ET, 2005, SCAND J PUBLIC HEALT, V33, P4, DOI 10.1080/14034940410028181; Johansson K, 2005, ADDICT BEHAV, V30, P1049, DOI 10.1016/j.addbeh.2004.09.008; Kedward J, 2003, BRIT J GEN PRACT, V53, P684; Kerse NM, 1997, MED J AUSTRALIA, V167, P423, DOI 10.5694/j.1326-5377.1997.tb126654.x; Lamb J, 2012, HEALTH-LONDON, V16, P76, DOI 10.1177/1363459311403945; Lambe B, 2010, FAM PRACT, V27, P219, DOI 10.1093/fampra/cmp086; Leverence RR, 2007, AM J PREV MED, V32, P334, DOI 10.1016/j.amepre.2006.12.008; Lock CA, 2002, J ADV NURS, V39, P333, DOI 10.1046/j.1365-2648.2002.02294.x; Makrides L, 1997, PATIENT EDUC COUNS, V32, P207, DOI 10.1016/S0738-3991(97)00031-1; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Mirand AL, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-16; Muller-Riemenschneider F, 2010, ARCH INTERN MED, V170, P719, DOI 10.1001/archinternmed.2010.66; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Nolan Christine, 2012, Prim Health Care Res Dev, V13, P353, DOI 10.1017/S1463423612000059; Pope C., 2007, SYNTHESIZING QUALITA; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Rasmussen SR, 2007, SCAND J PUBLIC HEALT, V35, P365, DOI 10.1080/14034940701219642; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub4; Ribera AP, 2006, HEALTH EDUC RES, V21, P538, DOI 10.1093/her/cyl008; Ribera AP, 2005, EUR J PUBLIC HEALTH, V15, P569, DOI 10.1093/eurpub/cki045; RUSH BR, 1995, CAN MED ASSOC J, V152, P863; Shaw K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003817.pub3; Sondergaard A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-53; Starfield B., 1992, PRIMARY CARE CONCEPT; Swinburn BA, 1997, BRIT J GEN PRACT, V47, P567; van Steenkiste B, 2004, SCAND J PRIM HEALTH, V22, P32, DOI 10.1080/02813430310004489; Vazquez ML, 2006, INTRO TCNICAS CUALIA; Walter U, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-68; WHO, 2008, WORLD HLTH REP PRIM; Williams R, 2004, BRIT J GEN PRACT, V54, P531; WILLIAMS SJ, 1994, SOCIOL HEALTH ILL, V16, P372, DOI 10.1111/1467-9566.ep11348775	63	111	116	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89554	10.1371/journal.pone.0089554	http://dx.doi.org/10.1371/journal.pone.0089554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24586867	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200058
J	Yuan, JJ; Chen, J; Yang, JM; Ju, EX; Norman, GJ; Ding, NX				Yuan, Jiajin; Chen, Jie; Yang, Jiemin; Ju, Enxia; Norman, Greg J.; Ding, Nanxiang			Negative Mood State Enhances the Susceptibility to Unpleasant Events: Neural Correlates from a Music-Primed Emotion Classification Task	PLOS ONE			English	Article							ELECTROCORTICAL RESPONSE; FACIAL EXPRESSIONS; ATTENTIONAL BIAS; POTENTIALS; PICTURES; ANXIETY; BRAIN; STIMULI; VALENCE; DISSOCIATION	Background: Various affective disorders are linked with enhanced processing of unpleasant stimuli. However, this link is likely a result of the dominant negative mood derived from the disorder, rather than a result of the disorder itself. Additionally, little is currently known about the influence of mood on the susceptibility to emotional events in healthy populations. Method: Event-Related Potentials (ERP) were recorded for pleasant, neutral and unpleasant pictures while subjects performed an emotional/neutral picture classification task during positive, neutral, or negative mood induced by instrumental Chinese music. Results: Late Positive Potential (LPP) amplitudes were positively related to the affective arousal of pictures. The emotional responding to unpleasant pictures, indicated by the unpleasant-neutral differences in LPPs, was enhanced during negative compared to neutral and positive moods in the entire LPP time window (600-1000 ms). The magnitude of this enhancement was larger with increasing self-reported negative mood. In contrast, this responding was reduced during positive compared to neutral mood in the 800-1000 ms interval. Additionally, LPP reactions to pleasant stimuli were similar across positive, neutral and negative moods except those in the 800-900 ms interval. Implications: Negative mood intensifies the humans' susceptibility to unpleasant events in healthy individuals. In contrast, music-induced happy mood is effective in reducing the susceptibility to these events. Practical implications of these findings were discussed.	[Yuan, Jiajin; Chen, Jie; Yang, Jiemin; Ding, Nanxiang] Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Chen, Jie] Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Liaoning, Peoples R China; [Ju, Enxia] Chongqing Three Gorges Normal Sch, Chongqing, Peoples R China; [Norman, Greg J.] Univ Chicago, Dept Psychol, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA	Southwest University - China; Liaoning Normal University; Chongqing Three Gorges University; University of Chicago	Yuan, JJ (corresponding author), Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	yuanjiajin168@126.com; xlxchen@163.com	洁敏, 杨/AAB-5609-2022; Campailla, Jasmin/AAK-2420-2021	Ju, Enxia/0000-0002-7458-4737	National Natural Science Foundation of China [NSFC31170989, 31371042, 31300866]; Doctoral Foundation of Southwest University [SWU109028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation of Southwest University(Southwest University - China)	This research was funded by the National Natural Science Foundation of China (NSFC31170989; 31371042 and 31300866); and the Doctoral Foundation of Southwest University (SWU109028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Blomhoff S, 1998, BIOL PSYCHIAT, V44, P1045, DOI 10.1016/S0006-3223(98)00058-4; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; BOUHUYS AL, 1995, J AFFECT DISORDERS, V33, P215, DOI 10.1016/0165-0327(94)00092-N; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Bradley BP, 1997, BEHAV RES THER, V35, P911, DOI 10.1016/S0005-7967(97)00053-3; BRICKMAN P, 1978, J PERS SOC PSYCHOL, V36, P917, DOI 10.1037/0022-3514.36.8.917; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Cacioppo JT, 1999, J PERS SOC PSYCHOL, V76, P839, DOI 10.1037/0022-3514.76.5.839; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; Campanella S, 2002, BIOL PSYCHOL, V59, P171, DOI 10.1016/S0301-0511(02)00005-4; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, 2003, PSYCHOPHYSIOLOGY, V40, P381, DOI 10.1111/1469-8986.00041; Carretie L, 2006, EXP BRAIN RES, V174, P630, DOI 10.1007/s00221-006-0510-y; Carretie L, 2013, SOC COGN AFFECT NEUR, V8, P764, DOI 10.1093/scan/nss068; Caseras X, 2007, J ABNORM PSYCHOL, V116, P491, DOI 10.1037/0021-843X.116.3.491; Chen J, 2008, NEUROSCI LETT, V445, P135, DOI 10.1016/j.neulet.2008.08.061; Clark D. M., 1988, PANIC PSYCHOL PERSPE, P71; DAVID AS, 1989, NEUROPSYCHOLOGIA, V27, P1289, DOI 10.1016/0028-3932(89)90041-9; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Dennis TA, 2007, BIOL PSYCHOL, V76, P1, DOI 10.1016/j.biopsycho.2007.05.001; Diener E, 1996, PSYCHOL SCI, V7, P181, DOI 10.1111/j.1467-9280.1996.tb00354.x; Dunn BD, 2004, J ABNORM PSYCHOL, V113, P654, DOI 10.1037/0021-843X.113.4.654; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Francois C, 2010, NEUROREPORT, V21, P928, DOI 10.1097/WNR.0b013e32833ddd5e; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431; Goerlich KS, 2012, J COGNITIVE NEUROSCI, V24, P1725, DOI 10.1162/jocn_a_00213; Goerlich KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019501; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Hammond M, 1996, INT J SOCIOL SOC POL, V16, P53; [黄宇霞 Huang Yuxia], 2004, [中国心理卫生杂志, Chinese Mental Health Journal], V18, P631; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Jeong JW, 2011, NEUROIMAGE, V54, P2973, DOI 10.1016/j.neuroimage.2010.11.017; Jomori I, 2013, COGN NEUROSCI-UK, V4, P21, DOI 10.1080/17588928.2012.751366; Kamiyama KS, 2012, NEUROPSYCHOLOGIA, P500; Kenealy P., 1988, COGNITION EMOTION, V2, P41, DOI DOI 10.1080/02699938808415228; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; KOK A, 1988, BIOL PSYCHOL, V27, P51, DOI 10.1016/0301-0511(88)90005-1; Kolassa IT, 2005, PSYCHOPHYSIOLOGY, V42, P520, DOI 10.1111/j.1469-8986.2005.00315.x; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Krompinger JW, 2009, BIOL PSYCHOL, V81, P153, DOI 10.1016/j.biopsycho.2009.03.007; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lee TMC, 2008, PSYCHIAT RES, V159, P37, DOI 10.1016/j.psychres.2007.04.022; Lense MD, 2013, SOC COGN AF IN PRESS; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; Logeswaran N, 2009, NEUROSCI LETT, V455, P129, DOI 10.1016/j.neulet.2009.03.044; Lu B, 2005, CHINESE MENTAL HLTH, V19.11; Luck S.J., 2005, INTRO EVENT RELATED; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Marin MM, 2012, EMOTION, V12, P618, DOI 10.1037/a0025020; MATHEWS A, 1995, BEHAV RES THER, V33, P293, DOI 10.1016/0005-7967(94)E0022-B; Mercado F, 2006, J ANXIETY DISORD, V20, P72, DOI 10.1016/j.janxdis.2004.10.003; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Morrison SJ, 2009, PROG BRAIN RES, V178, P67, DOI 10.1016/S0079-6123(09)17805-6; Moser JS, 2008, BIOL PSYCHOL, V78, P93, DOI 10.1016/j.biopsycho.2008.01.005; Moser JS, 2010, COGN AFFECT BEHAV NE, V10, P195, DOI 10.3758/CABN.10.2.195; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Nandrino JL, 2004, J PSYCHIAT RES, V38, P475, DOI 10.1016/j.jpsychires.2004.03.002; Phillips LH, 2002, EMOTION, V2, P12, DOI 10.1037/1528-3542.2.1.12; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Schon D, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00167; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Sloan DM, 2001, J ABNORM PSYCHOL, V110, P488, DOI 10.1037//0021-843X.110.3.488; Smith NK, 2006, J PERS SOC PSYCHOL, V90, P210, DOI 10.1037/0022-3514.90.2.210; SPITZ MC, 1986, ELECTROEN CLIN NEURO, V65, P161, DOI 10.1016/0168-5597(86)90050-X; Stanford MS, 2001, PSYCHIAT RES, V102, P125, DOI 10.1016/S0165-1781(01)00236-0; Steinbeis N, 2011, J COGNITIVE NEUROSCI, V23, P604, DOI 10.1162/jocn.2009.21383; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Wang Y, 2011, NEUROSCI LETT, V502, P112, DOI 10.1016/j.neulet.2011.07.039; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Williams LM, 2007, J COGNITIVE NEUROSCI, V19, P1595, DOI 10.1162/jocn.2007.19.10.1595; Yang JM, 2013, BRAIN RES, V1533, P91, DOI 10.1016/j.brainres.2013.08.020; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan JJ, 2012, COGN AFFECT BEHAV NE, V12, P175, DOI 10.3758/s13415-011-0064-8; Yuan JJ, 2011, BIOL PSYCHOL, V87, P17, DOI 10.1016/j.biopsycho.2011.01.004; Yuan JJ, 2009, HUM BRAIN MAPP, V30, P3676, DOI 10.1002/hbm.20796; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	92	12	13	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89844	10.1371/journal.pone.0089844	http://dx.doi.org/10.1371/journal.pone.0089844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587070	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200087
J	Chen, ZH; Qin, XC; Song, R; Shen, Y; Chen, XP; Wang, W; Zhao, YX; Zhang, JS; He, JR; Li, MH; Zhao, XH; Liu, DW; Fu, XK; Tian, D; Li, XW; Xu, JG; Plyusnin, A; Holmes, EC; Zhang, YZ				Chen, Zhi-Hai; Qin, Xin-Cheng; Song, Rui; Shen, Yi; Chen, Xiao-Ping; Wang, Wen; Zhao, Yong-Xiang; Zhang, Jing-Shan; He, Jin-Rong; Li, Ming-Hui; Zhao, Xue-Hua; Liu, De-Wei; Fu, Xiao-Kang; Tian, Di; Li, Xing-Wang; Xu, Jianguo; Plyusnin, Alexander; Holmes, Edward C.; Zhang, Yong-Zhen			Co-Circulation of Multiple Hemorrhagic Fever Diseases with Distinct Clinical Characteristics in Dandong, China	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RENAL SYNDROME HFRS; REPUBLIC-OF-CHINA; HUAIYANGSHAN VIRUS; GENETIC DIVERSITY; HANTAVIRUSES; PATHOGENESIS; INFECTIONS; BUNYAVIRUS; ECOLOGY	Hemorrhagic fevers (HF) caused by viruses and bacteria are a major public health problem in China and characterized by variable clinical manifestations, such that it is often difficult to achieve accurate diagnosis and treatment. The causes of HF in 85 patients admitted to Dandong hospital, China, between 2011-2012 were determined by serological and PCR tests. Of these, 34 patients were diagnosed with Huaiyangshan hemorrhagic fever (HYSHF), 34 with Hemorrhagic Fever with Renal Syndrome (HFRS), one with murine typhus, and one with scrub typhus. Etiologic agents could not be determined in the 15 remaining patients. Phylogenetic analyses of recovered bacterial and viral sequences revealed that the causative infectious agents were closely related to those described in other geographical regions. As these diseases have no distinctive clinical features in their early stage, only 13 patients were initially accurately diagnosed. The distinctive clinical features of HFRS and HYSHF developed during disease progression. Enlarged lymph nodes, cough, sputum, and diarrhea were more common in HYSHF patients, while more HFRS cases presented with headache, sore throat, oliguria, percussion pain kidney area, and petechiae. Additionally, HYSHF patients displayed significantly lower levels of white blood cells (WBC), higher levels of creations kinase (CK) and alanine aminotransferase (ALT), while HFRS patients presented with an elevation of blood urea nitrogen (BUN) and creatinine (CREA). These clinical features will assist in the accurate diagnosis of both HYSHF and HFRS. Overall, our data reveal the complexity of pathogens causing HFs in a single Chinese hospital, and highlight the need for accurate early diagnosis and a better understanding of their distinctive clinical features.	[Chen, Zhi-Hai; Song, Rui; Fu, Xiao-Kang; Tian, Di; Li, Xing-Wang] Capital Med Univ, Beijing Ditan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Qin, Xin-Cheng; Chen, Xiao-Ping; Wang, Wen; Zhang, Jing-Shan; He, Jin-Rong; Li, Ming-Hui; Xu, Jianguo; Plyusnin, Alexander; Zhang, Yong-Zhen] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control,Dept Z, Beijing, Peoples R China; [Shen, Yi; Zhao, Yong-Xiang; Zhao, Xue-Hua; Liu, De-Wei] Dandong Infect Hosp, Dept Infect Dis, Dandong, Liaoning Provin, Peoples R China; [Plyusnin, Alexander] Univ Helsinki, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland; [Holmes, Edward C.] Univ Sydney, Sch Biol Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Capital Medical University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of Helsinki; University of Sydney; University of Sydney	Zhang, YZ (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control,Dept Z, Beijing, Peoples R China.	zhangyongzhen@icdc.cn	Zhang, Yong-Zhen/AAE-6957-2019; Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019	Holmes, Edward/0000-0001-9596-3552	National Natural Science Foundation of China [81290343, 81273014]; State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID101, 2012SKLID309]; NHMRC Australia Fellowship	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Disease Prevention and Control; NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by National Natural Science Foundation of China (Grants 81290343 and 81273014), and by the State Key Laboratory for Infectious Disease Prevention and Control (Grants 2011SKLID101 and 2012SKLID309). ECH is funded by an NHMRC Australia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burt FJ, 1998, J VIROL METHODS, V70, P129, DOI 10.1016/S0166-0934(97)00182-1; CHEN HX, 1986, J INFECT DIS, V154, P394, DOI 10.1093/infdis/154.3.394; Chen XP, 2012, J GEN VIROL, V93, P1288, DOI 10.1099/vir.0.041053-0; Dai Xiang, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1048; FAN MY, 1987, REV INFECT DIS, V9, P823; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Guo WP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003159; Guo WP, 2011, INFECT GENET EVOL, V11, P1862, DOI 10.1016/j.meegid.2011.07.013; Hjertqvist M, 2010, EMERG INFECT DIS, V16, P1584, DOI 10.3201/eid1610.100242; Ippolito G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-31; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kariwa H, 2012, AM J TROP MED HYG, V86, P545, DOI 10.4269/ajtmh.2012.11-0297; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; Lee JS, 1999, MANUAL HEMORRHAGIC F; Li W, 2013, INT J INFECT DIS, V17, pE556, DOI 10.1016/j.ijid.2013.03.007; Lin XD, 2012, J VIROL, V86, P11171, DOI 10.1128/JVI.00021-12; Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; OHASHI N, 1995, FEMS MICROBIOL LETT, V125, P299, DOI 10.1111/j.1574-6968.1995.tb07372.x; Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041; Parola P, 2000, T ROY SOC TROP MED H, V94, P707, DOI 10.1016/S0035-9203(00)90243-8; Parola P., 2007, RICKETTSIAL DIS; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sironen T, 2001, J VIROL, V75, P11803, DOI 10.1128/JVI.75.23.11803-11810.2001; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Wang H, 2000, VIROLOGY, V278, P332, DOI 10.1006/viro.2000.0630; Wang W, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002484; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-229; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang CL, 2012, MICROBES INFECT, V14, P317, DOI 10.1016/j.micinf.2011.11.007; Zhang Cui-cai, 2009, Zhonghua Weishengwuxue He Mianyixue Zazhi, V29, P1144, DOI 10.3760/cma.j.issn.0254-5101.2009.12.025; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; Zhang X, 2011, SCAND J INFECT DIS, V43, P632, DOI 10.3109/00365548.2011.566279; Zhang YZ, 2007, J GEN VIROL, V88, P1295, DOI 10.1099/vir.0.82534-0; Zhang YZ, 2012, J VIROL, V86, P2864, DOI 10.1128/JVI.06192-11; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470; Zhang YZ, 2009, EMERG INFECT DIS, V15, P200, DOI 10.3201/eid1502.080291; Zhang YZ, 2006, DIS SURVEILLANCE, V21, P229; Zou Y, 2008, J GEN VIROL, V89, P1987, DOI 10.1099/vir.0.2008/000497-0; Zou Y, 2008, J MED VIROL, V80, P1033, DOI 10.1002/jmv.21149	48	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89896	10.1371/journal.pone.0089896	http://dx.doi.org/10.1371/journal.pone.0089896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587107	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800052
J	Kumar, R; Kaur, R; Singh, AP; Arora, S				Kumar, Rakesh; Kaur, Rajbir; Singh, Amrit Pal; Arora, Saroj			Diminution of Hepatic Response to 7, 12-dimethylbenz(alpha) anthracene by Ethyl Acetate Fraction of Acacia catechu Willd. through Modulation of Xenobiotic and Anti-Oxidative Enzymes in Rats	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; LIPID-PEROXIDATION; LIVER-MICROSOMES; EXTRACT; PHYTOCHEMICALS; PURIFICATION; HEPATOTOXIN; REDUCTASE; ASSAY	Background: Liver is the primary metabolizing site of body and is prone to damage by exogenous as well as endogenous intoxicants. Polycyclic aromatic hydrocarbons such as 7, 12-dimethylbenz(a) anthracene (DMBA) is an exogenous hepatotoxin, which is well known for modulating phase I, II and anti-oxidative enzymes of liver. Plants contain plethora of polyphenolic compounds which can reverse the damaging effect of various xenobiotics. The present study investigated protective role of the ethyl acetate fraction of Acacia catechu Willd. (EAF) against DMBA induced alteration in hepatic metabolizing and anti-oxidative enzymes in rats. Methodology and Principal Findings: The rats were subjected to hepatic damage by treating with DMBA for 7 weeks on alternative days and treatment schedule was terminated at the end of 14 weeks. The rats were euthanized at the end of protocol and livers were homogenized. The liver homogenates were used to analyse phase I (NADPH-cytochrome P450 reducatse, NADH-cytochrome b5 reductase, cytochrome P420, cytochrome b5), phase II (glutathione-S-transferase, DT diaphorase and gamma-Glutamyl transpeptidase) and antioxidative enzymes (catalase, superoxide dismutase, ascorbate peroxidase, glutathione reductase, guiacol peroxidase and lactate dehydrogenase). Furthermore, other oxidative stress parameters (thiobarbituric acid reactive substances, lipid hydroperoxides and conjugated dienes and reduced glutathione) and liver marker enzymes (serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase and alkaline phosphatase) were also studied. The DMBA induced significant changes in activity of hepatic enzymes that was reversed by treatment with three dose levels of EAF. Conclusion: It is concluded that EAF affords hepato-protection against DMBA in rats through modulation of phase I, II and anti-oxidative enzymes.	[Kumar, Rakesh; Kaur, Rajbir; Arora, Saroj] Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India; [Singh, Amrit Pal] Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar, Punjab, India	Guru Nanak Dev University; Guru Nanak Dev University	Arora, S (corresponding author), Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India.	jrosh1@rediffmail.com	Kumar, Rakesh/ABD-1065-2020; Singh, Amrit Pal/ABI-8109-2020; Arora, Saroj/AAV-3682-2021	Kumar, Rakesh/0000-0001-7664-0803; Singh, Amrit Pal/0000-0002-7658-241X; Arora, Saroj/0000-0002-4086-5653	Guru Nanak Dev University, Amritsar; University Grants Commission, New Delhi	Guru Nanak Dev University, Amritsar; University Grants Commission, New Delhi(University Grants Commission, India)	The authors thank financial support of Guru Nanak Dev University, Amritsar and University Grants Commission, New Delhi, under the university with potential for excellence (UPE), BSR and CPEPA programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Al-Attar A. M., 2004, Pakistan Journal of Nutrition, V3, P304; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Barros L, 2011, FOOD CHEM, V127, P1600, DOI 10.1016/j.foodchem.2011.02.024; Bharali Rupjyoti, 2003, Asian Pac J Cancer Prev, V4, P131; Bursal E, 2011, FOOD RES INT, V44, P1482, DOI 10.1016/j.foodres.2011.03.031; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chauhan G, 2011, IND J RES, V5, P1; Chiu CS, 2013, FOOD CHEM, V141, P1087, DOI 10.1016/j.foodchem.2013.04.031; Choi SJ, 2003, J BIOCHEM MOL BIOL, V36, P332; Deckers GH, 2002, EUR J CANCER, V38, P443, DOI 10.1016/S0959-8049(01)00391-4; Devasagayam TPA, 2003, INDIAN J BIOCHEM BIO, V40, P300; El-Demerdash FM, 2011, J ENVIRON SCI HEAL C, V29, P145, DOI 10.1080/10590501.2011.577679; Ernster, 1967, METHOD ENZYMOL, V10, P309, DOI [DOI 10.1016/0076-6879(67)10059-1, 10.1016/0076-6879(67)10059-1]; Gayathari V., 2011, INT J PHARM SCI, V3, P108; Gnaiger E., 2010, MITO PHYSL NET, V08, P1; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harmeet Singh, 2011, European Journal of Medicinal Plants, V1, P162; HOOSER SB, 1989, VET PATHOL, V26, P246, DOI 10.1177/030098588902600309; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Jones V, 2013, CANCER LETT, V335, P251, DOI 10.1016/j.canlet.2013.02.056; Kamel R, 2013, ARCH PHARM RES, DOI [10.1007/s12272-013-0110-x, DOI 10.1007/S]; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Kwon HJ, 2014, HEPATOLOGY, V59, P1094, DOI 10.1002/hep.26748; Landi L, 1997, FREE RADICAL BIO MED, V22, P329, DOI 10.1016/S0891-5849(96)00294-8; Liu JY, 2013, TOXICOL SCI, V135, P144, DOI 10.1093/toxsci/kft135; MIHARA K, 1972, J BIOCHEM-TOKYO, V71, P725; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; Partridge A H, 2001, J Natl Cancer Inst Monogr, P135; Pistol GC, 2013, BR J NUTR, V20, P1; Putter J., 1974, METHODS ENZYMATIC AN, P685, DOI [DOI 10.1016/B978-0-12-091302-2.50033-5, 10.1016/B978-0-12-091302-2.50033-5]; Ray D., 2006, Indian Journal of Pharmacology, V38, P408; Raza H, 1997, COMP BIOCHEM PHYS B, V118, P829, DOI 10.1016/S0305-0491(97)00234-4; Robinson K, 2003, DIGEST DIS SCI, V48, P1804, DOI 10.1023/A:1025415616592; Salama SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-56; Seigler DS, 2003, BIOCHEM SYST ECOL, V31, P845, DOI 10.1016/S0305-1978(03)00082-6; SOFFER EE, 1983, SOUTHERN MED J, V76, P681, DOI 10.1097/00007611-198305000-00043; SZASZ G, 1976, CLIN CHEM, V22, P2051; YANG SK, 1975, P NATL ACAD SCI USA, V72, P2601, DOI 10.1073/pnas.72.7.2601; zen T, 2003, PHYTOMEDICINE, V10, P405; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhou QM, 2011, EUR J CANCER, V47, P2240, DOI 10.1016/j.ejca.2011.04.032	46	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90083	10.1371/journal.pone.0090083	http://dx.doi.org/10.1371/journal.pone.0090083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587216	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800074
J	Liou, YR; Torng, W; Kao, YC; Sung, KB; Lee, CH; Kuo, PL				Liou, Yu-Ren; Torng, Wen; Kao, Yu-Chiu; Sung, Kung-Bin; Lee, Chau-Hwang; Kuo, Po-Ling			Substrate Stiffness Regulates Filopodial Activities in Lung Cancer Cells	PLOS ONE			English	Article							NEURONAL GROWTH CONES; CONFOCAL MICROSCOPY; DYNAMICS; ADENOCARCINOMA; PLASTICIZER	Microenvironment stiffening plays a crucial role in tumorigenesis. While filopodia are generally thought to be one of the cellular mechanosensors for probing environmental stiffness, the effects of environmental stiffness on filopodial activities of cancer cells remain unclear. In this work, we investigated the filopodial activities of human lung adenocarcinoma cells CL1-5 cultured on substrates of tunable stiffness using a novel platform. The platform consists of an optical system called structured illumination nano-profilometry, which allows time-lapsed visualization of filopodial activities without fluorescence labeling. The culturing substrates were composed of polyvinyl chloride mixed with an environmentally friendly plasticizer to yield Young's modulus ranging from 20 to 60 kPa. Cell viability studies showed that the viability of cells cultured on the substrates was similar to those cultured on commonly used elastomers such as polydimethylsiloxane. Time-lapsed live cell images were acquired and the filopodial activities in response to substrates with varying degrees of stiffness were analyzed. Statistical analyses revealed that lung cancer cells cultured on softer substrates appeared to have longer filopodia, higher filopodial densities with respect to the cellular perimeter, and slower filopodial retraction rates. Nonetheless, the temporal analysis of filopodial activities revealed that whether a filopodium decides to extend or retract is purely a stochastic process without dependency on substrate stiffness. The discrepancy of the filopodial activities between lung cancer cells cultured on substrates with different degrees of stiffness vanished when the myosin II activities were inhibited by treating the cells with blebbistatin, which suggests that the filopodial activities are closely modulated by the adhesion strength of the cells. Our data quantitatively relate filopodial activities of lung cancer cells with environmental stiffness and should shed light on the understanding and treatment of cancer progression and metastasis.	[Liou, Yu-Ren; Kao, Yu-Chiu; Sung, Kung-Bin; Kuo, Po-Ling] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Torng, Wen; Kuo, Po-Ling] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan; [Kao, Yu-Chiu; Lee, Chau-Hwang] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan; [Lee, Chau-Hwang] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Kuo, Po-Ling] Natl Taiwan Univ Hosp, Dept Rehabil, Taipei, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Kuo, PL (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	poling@ntu.edu.tw	Sung, Kung-Bin/B-6506-2009; Lee, Chau-Hwang/B-2204-2008	Sung, Kung-Bin/0000-0002-7253-1332; Lee, Chau-Hwang/0000-0001-5013-7062	National Science Council of Taiwan [NSC 100-2112-M-001-022-MY3, NSC101-2220-E-002-011]; Ministry of Economic Affairs of Taiwan [101-EC-17-A-19-S1-174]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs of Taiwan(Ministry of Economic Affairs, Taiwan)	The authors are grateful for the financial support under grant numbers NSC 100-2112-M-001-022-MY3 and NSC101-2220-E-002-011 provided by the National Science Council of Taiwan (http://web1.nsc.gov.tw/) and grant number 101-EC-17-A-19-S1-174 provided by the Ministry of Economic Affairs of Taiwan (http://www.moea.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratyn-Schaus Y, 2008, SCIENCE, V322, P1646, DOI 10.1126/science.1168102; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Crespo JE, 2007, J APPL POLYM SCI, V104, P1215, DOI 10.1002/app.25760; Curl CL, 2005, CYTOM PART A, V65A, P88, DOI 10.1002/cyto.a.20134; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Fouchard J, 2011, CELL ADHES MIGR, V5, P16, DOI 10.4161/cam.5.1.13281; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Grosberg A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001088; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Klee D, 1999, ADV POLYM SCI, V149, P1; Knight MM, 2003, AM J PHYSIOL-CELL PH, V284, pC1083, DOI 10.1152/ajpcell.00276.2002; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Landry S, 2004, OPT EXPRESS, V12, P5754, DOI 10.1364/OPEX.12.005754; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Lu M, 1997, J CELL BIOL, V138, P1279, DOI 10.1083/jcb.138.6.1279; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; RodriguezFernandez OS, 1997, J APPL POLYM SCI, V66, P2121, DOI 10.1002/(SICI)1097-4628(19971219)66:11<2121::AID-APP8>3.0.CO;2-J; Storck J, 1996, BIOMATERIALS, V17, P1791, DOI 10.1016/0142-9612(95)00360-6; Su JW, 2013, J BIOPHOTONICS, V6, P416, DOI 10.1002/jbio.201200022; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Tse J.R., 2010, CURR PROTOC CELL BIO, V47, pS1; Wadey BL, 2003, J VINYL ADDIT TECHN, V9, P172, DOI 10.1002/vnl.10080; Wang CC, 2011, LAB CHIP, V11, P695, DOI 10.1039/c0lc00155d; Wang CC, 2009, OPT LETT, V34, P3538, DOI 10.1364/OL.34.003538; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015	33	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89767	10.1371/journal.pone.0089767	http://dx.doi.org/10.1371/journal.pone.0089767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587021	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800037
J	Iranzo, A; Fernandez-Arcos, A; Tolosa, E; Serradell, M; Molinuevo, JL; Valldeoriola, F; Gelpi, E; Vilaseca, I; Sanchez-Valle, R; Llado, A; Gaig, C; Santamaria, J				Iranzo, Alex; Fernandez-Arcos, Ana; Tolosa, Eduard; Serradell, Monica; Luis Molinuevo, Jose; Valldeoriola, Francesc; Gelpi, Ellen; Vilaseca, Isabel; Sanchez-Valle, Raquel; Llado, Albert; Gaig, Carles; Santamaria, Joan			Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PARKINSONIAN DISORDER; DELAYED EMERGENCE; DISEASE; DIAGNOSIS; DEMENTIA; PATHOLOGY	Objective: To estimate the risk for developing a defined neurodegenerative syndrome in a large cohort of idiopathic REM sleep behavior disorder (IRBD) patients with long follow-up. Methods: Using the Kaplan-Meier method, we estimated the disease-free survival rate from defined neurodegenerative syndromes in all the consecutive IRBD patients diagnosed and followed-up in our tertiary referal sleep center between November 1991 and July 2013. Results: The cohort comprises 174 patients with a median age at diagnosis of IRBD of 69 years and a median follow-up of four years. The risk of a defined neurodegenerative syndrome from the time of IRBD diagnosis was 33.1% at five years, 75.7% at ten years, and 90.9% at 14 years. The median conversion time was 7.5 years. Emerging diagnoses (37.4%) were dementia with Lewy bodies (DLB) in 29 subjects, Parkinson disease (PD) in 22, multiple system atrophy (MSA) in two, and mild cognitive impairment (MCI) in 12. In six cases, in whom postmortem was performed, neuropathological examination disclosed neuronal loss and widespread Lewy-type pathology in the brain in each case. Conclusions: In a large IRBD cohort diagnosed in a tertiary referal sleep center, prolonged follow-up indicated that the majority of patients are eventually diagnosed with the synucleinopathies PD, DLB and less frequently MSA. IRBD represented the prodromal period of these conditions. Our findings in IRBD have important implications in clinical practice, in the investigation of the early pathological events occurring in the synucleinopathies, and for the design of interventions with potential disease-modifying agents.	[Iranzo, Alex; Fernandez-Arcos, Ana; Tolosa, Eduard; Serradell, Monica; Luis Molinuevo, Jose; Valldeoriola, Francesc; Sanchez-Valle, Raquel; Llado, Albert; Gaig, Carles; Santamaria, Joan] Hosp Clin Barcelona, IDIBAPS, Neurol Serv, Barcelona, Spain; [Iranzo, Alex; Tolosa, Eduard; Valldeoriola, Francesc; Gaig, Carles; Santamaria, Joan] CIBERNED, Barcelona, Spain; [Gelpi, Ellen] Biobanc Hosp Clin, Neurol Tissue Bank, IDIBAPS, Barcelona, Spain; [Vilaseca, Isabel] Hosp Clin Barcelona, CIBER Enfermedades Respiratorias, Serv Otorhinolaryngol, Bunyola, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona	Iranzo, A (corresponding author), Hosp Clin Barcelona, IDIBAPS, Neurol Serv, Barcelona, Spain.	airanzo@clinic.ub.es	Vilaseca, Isabel/J-1528-2019; Molinuevo, Jose Luis/HCH-3881-2022; Sanchez-Valle, Raquel/I-4217-2015	Vilaseca, Isabel/0000-0003-4399-5522; Sanchez-Valle, Raquel/0000-0001-7750-896X; Molinuevo, Jose Luis/0000-0003-0485-6001				Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; [Anonymous], 2000, DSM 4 TR DIAGN STAT; Arnulf I, 2012, MOVEMENT DISORD, V27, P677, DOI 10.1002/mds.24957; Boeve BF, 2010, ANN NY ACAD SCI, V1184, P15, DOI 10.1111/j.1749-6632.2009.05115.x; Boot BP, 2012, ANN NEUROL, V71, P49, DOI 10.1002/ana.22655; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Iranzo A, 2013, PARKINSONISM RELAT D, V19, P600, DOI 10.1016/j.parkreldis.2013.02.009; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; Iranzo A, 2011, LANCET NEUROL, V10, P797, DOI 10.1016/S1474-4422(11)70152-1; Iranzo A, 2006, LANCET NEUROL, V5, P572, DOI 10.1016/S1474-4422(06)70476-8; Iranzo A, 2010, LANCET NEUROL, V9, P1070, DOI 10.1016/S1474-4422(10)70216-7; Iranzo A, 2009, SLEEP MED REV, V13, P385, DOI 10.1016/j.smrv.2008.11.003; Jankovic J, 2002, PARKINSONS DIS MOVEM, P73; Jellinger KA, 2008, ACT NEUROPATHOL, V115, P709; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kovacs GG, 2008, DEMENT GERIATR COGN, V26, P343, DOI 10.1159/000161560; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Molano J, 2010, BRAIN, V133, P540, DOI 10.1093/brain/awp280; Morales JM, 2004, PUBLIC HEALTH, V118, P426, DOI 10.1016/j.puhe.2003.10.007; Pedersen KF, 2013, JAMA NEUROL, V70, P580, DOI 10.1001/jamaneurol.2013.2110; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Postuma RB, 2009, BRAIN, V132, P3298, DOI 10.1093/brain/awp244; Postuma RB, 2009, NEUROLOGY, V72, P1296, DOI 10.1212/01.wnl.0000340980.19702.6e; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Postuma RB, 2011, ANN NEUROL, V69, P811, DOI 10.1002/ana.22282; Schenck CH, 2013, SLEEP MED, V14, P744, DOI 10.1016/j.sleep.2012.10.009; Schenck CH, 1996, NEUROLOGY, V46, P388, DOI 10.1212/WNL.46.2.388; Scherfler C, 2011, ANN NEUROL, V69, P400, DOI 10.1002/ana.22245; Tolosa E, 2009, NEUROLOGY, V72, pS12, DOI 10.1212/WNL.0b013e318198db11; Wenning GK, 2004, LANCET NEUROL, V3, P93, DOI 10.1016/S1474-4422(03)00662-8	33	279	286	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89741	10.1371/journal.pone.0089741	http://dx.doi.org/10.1371/journal.pone.0089741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587002	Green Published, gold			2022-12-27	WOS:000332389000089
J	Ruban, A; Fuchs, J; Marques, A; Schubert, V; Soloviev, A; Raskina, O; Badaeva, E; Houben, A				Ruban, Alevtina; Fuchs, Joerg; Marques, Andre; Schubert, Veit; Soloviev, Alexander; Raskina, Olga; Badaeva, Ekaterina; Houben, Andreas			B Chromosomes of Aegilops speltoides Are Enriched in Organelle Genome-Derived Sequences	PLOS ONE			English	Article							SUPERNUMERARY CHROMOSOMES; NATURAL-POPULATIONS; TANDEM REPEATS; DNA; EVOLUTION; NUCLEUS; PLANTS; RYE	B chromosomes (Bs) are dispensable components of the genome exhibiting non-Mendelian inheritance. Chromosome counts and flow cytometric analysis of the grass species Aegilops speltoides revealed a tissue-type specific distribution of the roughly 570 Mbp large B chromosomes. To address the question whether organelle-to-nucleus DNA transfer is a mechanism that drives the evolution of Bs, in situ hybridization was performed with labelled organellar DNA. The observed B-specific accumulation of chloroplast-and mitochondria-derived sequences suggests a reduced selection against the insertion of organellar DNA in supernumerary chromosomes. The distribution of B-localised organellar-derived sequences and other sequences differs between genotypes of different geographical origins.	[Ruban, Alevtina; Soloviev, Alexander] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Dept Genet & Biotechnol, Moscow, Russia; [Ruban, Alevtina; Fuchs, Joerg; Schubert, Veit; Houben, Andreas] Leibniz Inst Plant Genet & Crop Plant Res IPK, Chromosome Struct & Funct Lab, Gatersleben, Germany; [Marques, Andre] Univ Fed Pernambuco, Dept Bot, Lab Plant Cytogenet & Evolut, Recife, PE, Brazil; [Raskina, Olga] Univ Haifa, Inst Evolut, Lab Plant Mol Cytogenet, IL-31999 Haifa, Israel; [Badaeva, Ekaterina] Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Mol Karyol, Moscow, Russia	Russian State Agrarian University - Moscow Timiryazev Agricultural Academy; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Universidade Federal de Pernambuco; University of Haifa; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Houben, A (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Chromosome Struct & Funct Lab, Gatersleben, Germany.	houben@ipk-gatersleben.de	Badaeva, Ekaterina D./N-4368-2017; Raskina, Olga/U-5788-2019; Soloviev, Alexander A/G-2872-2013; Soloviev, Alexander/AAV-2213-2021; Houben, Andreas/I-1517-2015; Soloviev, Alexander A./Q-1589-2015; Marques, André/E-8834-2018	Badaeva, Ekaterina D./0000-0001-7101-9639; Raskina, Olga/0000-0003-4994-0856; Soloviev, Alexander/0000-0003-4480-8776; Soloviev, Alexander A./0000-0003-4480-8776; Marques, André/0000-0002-9567-2576; Fuchs, Joerg/0000-0003-4171-5371; Ruban, Alevtina/0000-0002-9011-6730; Houben, Andreas/0000-0003-3419-239X; Schubert, Veit/0000-0002-3072-0485	DFG Germany [HO 1779/14-1]	DFG Germany(German Research Foundation (DFG))	This work was supported by the DFG Germany (HO 1779/14-1, http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAENZIGER H., 1962, CANADIAN JOUR BOT, V40, P549, DOI 10.1139/b62-052; Banaei-Moghaddam AM, 2013, PLANT CELL IN PRESS; Belyayev A, 2013, ANN BOT-LONDON, V111, P531, DOI 10.1093/aob/mct023; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; FRIEBE B, 1995, PLANT SYST EVOL, V196, P131, DOI 10.1007/BF00982954; FUKUI K, 1994, GENOME, V37, P105, DOI 10.1139/g94-013; Hosid E, 2012, GENETICS, V190, P263, DOI 10.1534/genetics.111.134643; Houben A, 2013, CELLULAR MOL LIFE SC, P1; Houben A, 2013, PLANT GENOME DIVERSI, V2, P149, DOI DOI 10.1007/978-3-7091-1160-4_10; Jones N, 2003, TRENDS PLANT SCI, V8, P417, DOI 10.1016/S1360-1385(03)00187-0; Jones R. N., 1982, B chromosomes.; Klemme S, 2013, NEW PHYTOL, V199, P550, DOI 10.1111/nph.12289; Ma L, 2010, CHROMOSOME RES, V18, P841, DOI 10.1007/s10577-010-9166-3; Marques A, 2013, ANN BOT-LONDON, V112, P527, DOI 10.1093/aob/mct121; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; MENDELSON D, 1972, HEREDITY, V29, P329, DOI 10.1038/hdy.1972.97; MUNTZING A, 1948, HEREDITY, V2, P49, DOI 10.1038/hdy.1948.3; OHTA S, 1995, JPN J GENET, V70, P93, DOI 10.1266/jjg.70.93; Raskina O, 2004, P NATL ACAD SCI USA, V101, P14818, DOI 10.1073/pnas.0405817101; Raskina O, 2011, CHROMOSOME RES, V19, P607, DOI 10.1007/s10577-011-9220-9; Salina EA, 1998, EUPHYTICA, V100, P231, DOI 10.1023/A:1018360324242; Sheppard AE, 2008, PLANT PHYSIOL, V148, P328, DOI 10.1104/pp.108.119107; Sheppard AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000323; SIMCHEN G, 1971, CHROMOSOMA, V33, P63, DOI 10.1007/BF00326384; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; Wang D, 2012, P NATL ACAD SCI USA, V109, P2444, DOI 10.1073/pnas.1117890109	27	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90214	10.1371/journal.pone.0090214	http://dx.doi.org/10.1371/journal.pone.0090214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587288	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000146
J	Searcy, JL; Le Bihan, T; Salvadores, N; McCulloch, J; Horsburgh, K				Searcy, James L.; Le Bihan, Thierry; Salvadores, Natalia; McCulloch, James; Horsburgh, Karen			Impact of Age on the Cerebrovascular Proteomes of Wild-Type and Tg-SwDI Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TRANSGENIC MOUSE MODEL; AMYLOID-BETA-PROTEIN; MYELIN BASIC-PROTEIN; DNA-BINDING-PROTEIN; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; CEREBRAL MICROVESSELS; EARLY-ONSET; HTRA1	The structural integrity of cerebral vessels is compromised during ageing. Abnormal amyloid (Ab) deposition in the vasculature can accelerate age-related pathologies. The cerebrovascular response associated with ageing and microvascular Ab deposition was defined using quantitative label-free shotgun proteomic analysis. Over 650 proteins were quantified in vessel-enriched fractions from the brains of 3 and 9 month-old wild-type (WT) and Tg-SwDI mice. Sixty-five proteins were significantly increased in older WT animals and included several basement membrane proteins (nidogen-1, basement membrane-specific heparan sulfate proteoglycan core protein, laminin subunit gamma-1 precursor and collagen alpha-2(IV) chain preproprotein). Twenty-four proteins were increased and twenty-one decreased in older Tg-SwDI mice. Of these, increases in Apolipoprotein E (APOE) and high temperature requirement serine protease-1 (HTRA1) and decreases in spliceosome and RNA-binding proteins were the most prominent. Only six shared proteins were altered in both 9-month old WT and Tg-SwDI animals. The age-related proteomic response in the cerebrovasculature was distinctly different in the presence of microvascular A beta deposition. Proteins found differentially expressed within the WT and Tg-SwDI animals give greater insight to the mechanisms behind age-related cerebrovascular dysfunction and pathologies and may provide novel therapeutic targets.	[Searcy, James L.; Salvadores, Natalia] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Le Bihan, Thierry] Univ Edinburgh, SynthSys Synthet & Syst Biol, Edinburgh, Midlothian, Scotland; [Le Bihan, Thierry] Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh, Midlothian, Scotland; [McCulloch, James] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh, Midlothian, Scotland; [McCulloch, James; Horsburgh, Karen] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Searcy, JL (corresponding author), Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland.	Luke.Searcy@ed.ac.uk; Karen.Horsburgh@ed.ac.uk	Le Bihan, Thierry/AAN-2534-2020	Horsburgh, Karen/0000-0002-9620-3691; Le Bihan, Thierry/0000-0003-0498-8063	Alzheimer Society [1742]; Alzheimer's Research UK; SynthSys; BBSRC; EPSRC [BB/D019621/1]; AXA Research Fund; Alzheimers Research UK [ART-PG2010-3] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish; BBSRC [BB/D019621/1] Funding Source: UKRI	Alzheimer Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); SynthSys; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); AXA Research Fund(AXA Research Fund); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to acknowledge funding from the Alzheimer Society (http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID = 1742) and Alzheimer's Research UK (http://www.alzheimersresearchuk.org/project-detail/10026/Linking-Alzheimers-and-vascular-disease/). The research is also performed under the aegis of the Centre for Cognitive Aging and Cognitive Epidemiology (part of the Lifelong Health and Wellbeing initiative of UK Research Councils). TLB is funded by SynthSys which is a Centre for Integrative Systems Biology (CISB) funded by BBSRC (http://www.bbsrc.ac.uk/funding) and EPSRC (http://www.epsrc.ac.uk/research/Pages/research.aspx); reference BB/D019621/1. NS is funded by a doctoral fellowship from AXA Research Fund (http://www.axa-research.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriel E, 2012, CURR ATHEROSCLER REP, V14, P343, DOI 10.1007/s11883-012-0254-z; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; BELL MA, 1981, ACTA NEUROPATHOL, V53, P299, DOI 10.1007/BF00690372; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bergerat A, 2011, MOL MED, V17, P588, DOI 10.2119/molmed.2010.00228; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Christie R, 2001, AM J PATHOL, V158, P1065, DOI 10.1016/S0002-9440(10)64053-9; Chun HB, 2011, J CEREBR BLOOD F MET, V31, P2267, DOI 10.1038/jcbfm.2011.104; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Davis J, 1996, P NATL ACAD SCI USA, V93, P2996, DOI 10.1073/pnas.93.7.2996; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Davis J, 2006, NEUROBIOL AGING, V27, P946, DOI 10.1016/j.neurobiolaging.2005.05.031; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; del Zoppo GJ, 2012, ANN NY ACAD SCI, V1268, P127, DOI 10.1111/j.1749-6632.2012.06686.x; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Farkas E, 2006, ACTA NEUROPATHOL, V111, P150, DOI 10.1007/s00401-005-0007-y; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Groschel K, 2007, EUR J NEUROL, V14, P125, DOI 10.1111/j.1468-1331.2006.01563.x; HAAS S, 1995, J BIOL CHEM, V270, P12503, DOI 10.1074/jbc.270.21.12503; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hartz AMS, 2012, STROKE, V43, P514, DOI 10.1161/STROKEAHA.111.627562; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Hinman JD, 2006, J COMP NEUROL, V495, P351, DOI 10.1002/cne.20886; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; James R, 2012, J CEREBR BLOOD F MET, V32, P164, DOI 10.1038/jcbfm.2011.120; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; JUCKER M, 1990, NEUROBIOL AGING, V11, P39, DOI 10.1016/0197-4580(90)90060-D; Kalaria RN, 1995, BRAIN RES, V705, P349, DOI 10.1016/0006-8993(95)01250-8; Kalaria RN, 1996, PHARMACOL THERAPEUT, V72, P193, DOI 10.1016/S0163-7258(96)00116-7; Kim J, 2012, J EXP MED, V209, P2149, DOI 10.1084/jem.20121274; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Le Bihan T, 2010, RAPID COMMUN MASS SP, V24, P1093, DOI 10.1002/rcm.4487; Miao JT, 2005, J NEUROSCI, V25, P6271, DOI 10.1523/JNEUROSCI.1306-05.2005; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Montague P, 2006, DEV NEUROSCI-BASEL, V28, P479, DOI 10.1159/000095110; Moreira Paula I, 2005, Curr Alzheimer Res, V2, P403; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; Padgett RA, 2012, TRENDS GENET, V28, P147, DOI 10.1016/j.tig.2012.01.001; REBECK GW, 1993, NEURON, V11, P575; Reimer MM, 2011, J NEUROSCI, V31, P18185, DOI 10.1523/JNEUROSCI.4936-11.2011; Riddle DR, 2003, AGEING RES REV, V2, P149, DOI 10.1016/S1568-1637(02)00064-8; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156; Sloane JA, 2003, J NEUROCHEM, V84, P157, DOI 10.1046/j.1471-4159.2003.01541.x; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Suon S, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-44; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Tang Y, 1997, NEUROBIOL AGING, V18, P609, DOI 10.1016/S0197-4580(97)00155-3; Tennstaedt A, 2012, J BIOL CHEM, V287, P20931, DOI 10.1074/jbc.M111.316232; Thal DR, 2007, NEUROBIOL AGING, V28, P1221, DOI 10.1016/j.neurobiolaging.2006.05.029; Thal DR, 2002, J NEUROPATH EXP NEUR, V61, P282, DOI 10.1093/jnen/61.3.282; Toda N, 2012, PHARMACOL THERAPEUT, V133, P159, DOI 10.1016/j.pharmthera.2011.10.004; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Verbeek MM, 1997, J NEUROCHEM, V68, P1135; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516; Wang DS, 2004, NEUROSCI RES, V48, P93, DOI 10.1016/j.neures.2003.10.002; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Weighardt F, 1996, BIOESSAYS, V18, P747, DOI 10.1002/bies.950180910; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Xu F, 2008, J NEUROSCI, V28, P5312, DOI 10.1523/JNEUROSCI.1042-08.2008; Yang J, 2011, J ALZHEIMERS DIS, V24, P269, DOI 10.3233/JAD-2011-101401; Yousif S, 2007, BRAIN RES, V1134, P1, DOI 10.1016/j.brainres.2006.11.089; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	79	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89970	10.1371/journal.pone.0089970	http://dx.doi.org/10.1371/journal.pone.0089970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587158	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000121
J	Cikanek, SJ; Nockold, S; Brown, JL; Carpenter, JW; Estrada, A; Guerrel, J; Hope, K; Ibanez, R; Putman, SB; Gratwicke, B				Cikanek, Shawna J.; Nockold, Simon; Brown, Janine L.; Carpenter, James W.; Estrada, Angie; Guerrel, Jorge; Hope, Katharine; Ibanez, Roberto; Putman, Sarah B.; Gratwicke, Brian			Evaluating Group Housing Strategies for the Ex-Situ Conservation of Harlequin Frogs (Atelopus spp.) Using Behavioral and Physiological Indicators	PLOS ONE			English	Article							CORTICOSTERONE RESPONSES; STRESS; EXTINCTIONS; METABOLISM; AMPHIBIA; DECLINES; CAPTURE	We have established ex situ assurance colonies of two endangered Panamanian harlequin frogs, Atelopus certus and Atelopus glyphus, but observed that males fought with each other when housed as a group. Housing frogs individually eliminated this problem, but created space constraints. To evaluate the potential stress effects from aggressive interactions when grouping frogs, we housed male frogs in replicated groups of one, two, and eight. We measured aggressive behavioral interactions and fecal glucocorticoid metabolite (GC) concentrations as indicators of stress in each tank. In both small and large groups, frogs initially interacted aggressively, but aggressive interactions and fecal GCs declined significantly after the first 2 weeks of being housed together, reaching the lowest levels by week 4. We conclude that aggressive interactions in same-sex groups of captive Atelopus may initially cause stress, but the frogs become habituated within a few weeks and they can safely be housed in same-sex groups for longer periods of time.	[Cikanek, Shawna J.; Carpenter, James W.] Kansas State Univ, Coll Vet Med, Dept Clin Sci, Manhattan, KS 66506 USA; [Nockold, Simon; Estrada, Angie; Guerrel, Jorge; Ibanez, Roberto] Smithsonian Trop Res Inst, Panama Amphibian Rescue & Conservat Project, Gamboa, Panama; [Brown, Janine L.; Hope, Katharine; Putman, Sarah B.; Gratwicke, Brian] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA	Kansas State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Gratwicke, B (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA.	gratwickeb@si.edu		Gratwicke, Brian/0000-0002-7332-4060	Africam Safari; Cheyenne Mountain Zoo; Houston Zoo; Smithsonian Conservation Biology Institute; Smithsonian Tropical Research Institute; Zoo New England; US Fish and Wildlife Service program Wildlife Without Borders, USAID; Shared Earth Foundation; Anele Kolohe Foundation; Defenders of Wildlife	Africam Safari; Cheyenne Mountain Zoo; Houston Zoo; Smithsonian Conservation Biology Institute(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Zoo New England; US Fish and Wildlife Service program Wildlife Without Borders, USAID(United States Agency for International Development (USAID)); Shared Earth Foundation; Anele Kolohe Foundation; Defenders of Wildlife	The authors conducted this research under the auspices of the Panama Amphibian Rescue and Conservation Project, a partnership between Africam Safari, the Cheyenne Mountain Zoo, Defenders of Wildlife, the Houston Zoo, the Smithsonian Conservation Biology Institute, the Smithsonian Tropical Research Institute and Zoo New England. The authors would like to thank the US Fish and Wildlife Service program Wildlife Without Borders, USAID, the Shared Earth Foundation and the Anele Kolohe Foundation for financial support of aspects of this program that made this work possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belden LK, 2003, FUNCT ECOL, V17, P409, DOI 10.1046/j.1365-2435.2003.00746.x; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Cockrem JF, 2009, GEN COMP ENDOCR, V163, P158, DOI 10.1016/j.ygcen.2009.03.029; COCROFT RB, 1990, COPEIA, P631; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; CRUMP ML, 1986, COPEIA, P438; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Gendron AD, 1997, ENVIRON TOXICOL CHEM, V16, P1694, DOI [10.1897/1551-5028(1997)016&lt;1694:IVTOTF&gt;2.3.CO;2, 10.1002/etc.5620160818]; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Graham LH, 1996, ZOO BIOL, V15, P71, DOI 10.1002/(SICI)1098-2361(1996)15:1<71::AID-ZOO7>3.0.CO;2-9; Haislip NA, 2012, CAN J ZOOL, V90, P893, DOI [10.1139/Z2012-060, 10.1139/z2012-060]; JASLOW AP, 1979, J HERPETOL, V13, P141, DOI 10.2307/1563919; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lindquist ED, 1996, J HERPETOL, V30, P347, DOI 10.2307/1565171; Lips K, 2008, IUCN RED LIST THREAT; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Munro C J, 1988, Prog Clin Biol Res, V285, P289; Narayan EJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot011; Narayan EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073564; Narayan EJ, 2011, GEN COMP ENDOCR, V174, P238, DOI 10.1016/j.ygcen.2011.09.004; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schad K., 2008, AMPH POP MAN GUID AM; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; Zippel K, 2011, HERPETOL CONSERV BIO, V6, P340	29	16	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90218	10.1371/journal.pone.0090218	http://dx.doi.org/10.1371/journal.pone.0090218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587290	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900129
J	Luo, T; Yang, CG; Pang, Y; Zhao, YL; Mei, J; Gao, Q				Luo, Tao; Yang, Chongguang; Pang, Yu; Zhao, Yanlin; Mei, Jian; Gao, Qian			Development of a Hierarchical Variable-Number Tandem Repeat Typing Scheme for Mycobacterium tuberculosis in China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; BEIJING GENOTYPE; DISCRIMINATORY ABILITY; STRAINS; POPULATION; LOCI; FAMILY; POLYMORPHISM; DIVERSITY; SYSTEMS	Molecular typing based on variable-number tandem repeats (VNTR) analysis is a promising tool for identifying transmission of Mycobacterium tuberculosis. However, the currently proposed 15-and 24-locus VNTR sets (VNTR-15/24) only have limited resolution and contain too many loci for large-scale typing in high burden countries. To develop an optimal typing scheme in China, we evaluated the resolution and robustness of 25 VNTR loci, using population-based collections of 1362 clinical isolates from six provinces across the country. The resolution of most loci showed considerable variations among regions. By calculating the average resolution of all possible combinations of 20 robust loci, we identified an optimal locus set with a minimum of 9 loci (VNTR-9) that could achieve comparable resolution of the standard VNTR-15. The VNTR-9 had consistently high resolutions in all six regions, and it was highly concordant with VNTR-15 for defining both clustered and unique genotypes. Furthermore, VNTR-9 was phylogenetically informative for classifying lineages/sublineages of M. tuberculosis. Three hypervariable loci (HV-3), VNTR 3232, VNTR 3820 and VNTR 4120, were proved important for further differentiating unrelated clustered strains based on VNTR-9. We propose the optimized VNTR-9 as first-line method and the HV-3 as second-line method for molecular typing of M. tuberculosis in China and surrounding countries. The development of hierarchical VNTR typing methods that can achieve high resolution with a small number of loci could be suitable for molecular epidemiology study in other high burden countries.	[Luo, Tao; Yang, Chongguang; Gao, Qian] Fudan Univ, Inst Biomed Sci, Key Lab Med Mol, Minist Educ, Shanghai 200433, Peoples R China; [Luo, Tao; Yang, Chongguang; Gao, Qian] Fudan Univ, Inst Biomed Sci, Key Lab Med Mol, Minist Hlth, Shanghai 200433, Peoples R China; [Luo, Tao; Yang, Chongguang; Gao, Qian] Fudan Univ, Inst Med Microbiol, Sch Basic Med Sci, Shanghai 200433, Peoples R China; [Pang, Yu; Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Pang, Yu; Zhao, Yanlin] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Mei, Jian] Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Gao, Q (corresponding author), Fudan Univ, Inst Biomed Sci, Key Lab Med Mol, Minist Educ, Shanghai 200433, Peoples R China.	qgao99@yahoo.com	, 罗涛/AHA-1191-2022; Yang, Chongguang/S-9117-2019; Yang, Chongguang/N-3298-2016	Yang, Chongguang/0000-0001-8109-4974; Yang, Chongguang/0000-0001-8109-4974	Key Project of Chinese National Programs [2013ZX10003004-001]; National Natural Science Foundation of China [31301033]; China Postdoctoral Science Foundation [2012M52082]	Key Project of Chinese National Programs; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the grant of the Key Project of Chinese National Programs [2013ZX10003004-001], National Natural Science Foundation of China (31301033, http://www.nsfc.gov.cn/publish/portal1/), and China Postdoctoral Science Foundation 2012M52082. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C, 2013, J CLIN MICROBIOL; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Alonso-Rodriguez N, 2009, J CLIN MICROBIOL, V47, P2026, DOI 10.1128/JCM.02308-08; Chen YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039792; Chongxiang T, 2010, CHINESE J ZOONOSES, V26, P627; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Dong HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033904; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Jiao WW, 2008, J CLIN MICROBIOL, V46, P1045, DOI 10.1128/JCM.01869-07; Kam KM, 2006, FEMS MICROBIOL LETT, V256, P258, DOI 10.1111/j.1574-6968.2006.00126.x; Liu Q, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-288; Luo T, 2012, J CLIN MICROBIOL, V50, P633, DOI 10.1128/JCM.05539-11; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Velji P, 2009, EMERG INFECT DIS, V15, P1609, DOI 10.3201/eid1510.090463; Wada T, 2007, J MED MICROBIOL, V56, P1052, DOI 10.1099/jmm.0.46990-0; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670; Zhang L, 2008, FEMS MICROBIOL LETT, V282, P22, DOI 10.1111/j.1574-6968.2008.01081.x; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zhao YD, 2012, INFECT GENET EVOL, V12, P718, DOI 10.1016/j.meegid.2011.09.022	34	34	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89726	10.1371/journal.pone.0089726	http://dx.doi.org/10.1371/journal.pone.0089726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586989	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900072
J	Ying, CM; Yao, DT; Ding, HH; Yang, CD				Ying, Chun-Mei; Yao, Dong-Ting; Ding, Hui-Hua; Yang, Cheng-De			Infective Endocarditis with Antineutrophil Cytoplasmic Antibody: Report of 13 Cases and Literature Review	PLOS ONE			English	Article							SUBACUTE BACTERIAL-ENDOCARDITIS; GLOMERULONEPHRITIS; ANCA; PATIENT; VASCULITIS; KIDNEY	Objective: Chronic infections tend to induce the production of antineutrophil cytoplasmic antibody (ANCA). Infective endocarditis (IE) has been reported to exhibit positive ANCA tests and to mimic ANCA-associated vasculitis, which may lead to a misdiagnosis and inappropriate treatment. The aim of this study was to clarify whether there is any difference in the clinical features between ANCA-positive IE and ANCA-negative IE. Methods: A retrospective study was carried out on 39 IE patients whose proteinase 3 (PR3)-ANCA and myeloperoxidase (MPO)-ANCA levels were measured. After dividing the patients into ANCA-positive and ANCA-negative IE, we compared their clinical features. Results: we compared 13 ANCA-positive IE patients with 26 ANCA-negative IE patients. All 13 ANCA-positive IE patients were proteinase-3-ANCA positive. Compared with the ANCA-negative IE group, the prevalence of edema of the lower extremities, the serum lactate dehydrogenase (LDH) level and positive blood cultures rate were higher in ANCA-positive IE group, but there was no significant difference in other clinical features. Conclusion: Therefore, if a patient presents with fever, arthralgia, skin rash and is ANCA-positive, appropriate steps should be taken to exclude infection (especially IE) before confirming the diagnosis of ANCA-associated vasculitis and embarking on long-term immunosuppressive therapy.	[Ying, Chun-Mei; Yao, Dong-Ting; Ding, Hui-Hua; Yang, Cheng-De] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Rheumatol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Yang, CD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Rheumatol, Shanghai, Peoples R China.	yangchengde@hotmail.com	Ding, Huihua/H-7768-2019	Ding, Huihua/0000-0002-7530-8953				Bauer A, 2004, CLIN NEPHROL, V62, P144; Bonaci-Nikolic B, 2010, CLIN RHEUMATOL, V29, P893, DOI 10.1007/s10067-010-1424-4; Bosch X, 2006, LANCET, V368, P404, DOI 10.1016/S0140-6736(06)69114-9; Chirinos JA, 2007, CLIN RHEUMATOL, V26, P590, DOI 10.1007/s10067-005-0176-z; Choi HK, 2000, ARTHRITIS RHEUM, V43, P226, DOI 10.1002/1529-0131(200001)43:1<226::AID-ANR27>3.0.CO;2-Q; de Corla-Souza A, 2003, HEART LUNG, V32, P140, DOI 10.1067/mhl.2003.2; Fukasawa H, 2012, INTERNAL MED, V51, P2587, DOI 10.2169/internalmedicine.51.8081; Fukuda M, 2006, CLIN NEPHROL, V66, P202; Haseyama T, 1998, NEPHROL DIAL TRANSPL, V13, P2142, DOI 10.1093/ndt/13.8.2142; Kishimoto N, 2006, CLIN NEPHROL, V66, P447; Konstantinov KN, 2012, CASE REP NEPHROL DIA, V2, P25, DOI 10.1159/000339409; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Osafune K, 2000, CLIN EXP NEPHROL, V4, P329; Peng H, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-174; Satake K, 2011, MOD RHEUMATOL, V21, P536, DOI 10.1007/s10165-011-0434-7; SOTO A, 1994, CLIN EXP RHEUMATOL, V12, P203; Subra JF, 1998, CLIN NEPHROL, V49, P15; Sugiyama H, 2009, CARDIOLOGY, V114, P208, DOI 10.1159/000228645; Tiliakos AM, 2008, JCR-J CLIN RHEUMATOL, V14, P38, DOI 10.1097/RHU.0b013e318164187a; Uh M, 2011, J RHEUMATOL, V38, P1528, DOI 10.3899/jrheum.101322; WAGNER J, 1991, LANCET, V337, P799, DOI 10.1016/0140-6736(91)91427-V	21	44	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89777	10.1371/journal.pone.0089777	http://dx.doi.org/10.1371/journal.pone.0089777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587028	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900081
J	Barbier, M; Damron, FH; Bielecki, P; Suarez-Diez, M; Puchalka, J; Alberti, S; dos Santos, VM; Goldberg, JB				Barbier, Mariette; Damron, F. Heath; Bielecki, Piotr; Suarez-Diez, Maria; Puchalka, Jacek; Alberti, Sebastian; dos Santos, Vitor Martins; Goldberg, Joanna B.			From the Environment to the Host: Re-Wiring of the Transcriptome of Pseudomonas aeruginosa from 22 degrees C to 37 degrees C	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT TRANSCRIPTOME; ANAEROBIC REGULATION; REGULATORY PROTEIN; GROWTH TEMPERATURE; GENOME DATABASE; VIRULENCE; OPERON; GENES; IRON; EXPRESSION	Pseudomonas aeruginosa is a highly versatile opportunistic pathogen capable of colonizing multiple ecological niches. This bacterium is responsible for a wide range of both acute and chronic infections in a variety of hosts. The success of this microorganism relies on its ability to adapt to environmental changes and re-program its regulatory and metabolic networks. The study of P. aeruginosa adaptation to temperature is crucial to understanding the pathogenesis upon infection of its mammalian host. We examined the effects of growth temperature on the transcriptome of the P. aeruginosa PAO1. Microarray analysis of PAO1 grown in Lysogeny broth at mid-exponential phase at 22 degrees C and 37 degrees C revealed that temperature changes are responsible for the differential transcriptional regulation of 6.4% of the genome. Major alterations were observed in bacterial metabolism, replication, and nutrient acquisition. Quorum-sensing and exoproteins secreted by type I, II, and III secretion systems, involved in the adaptation of P. aeruginosa to the mammalian host during infection, were up-regulated at 37 degrees C compared to 22 degrees C. Genes encoding arginine degradation enzymes were highly up-regulated at 22 degrees C, together with the genes involved in the synthesis of pyoverdine. However, genes involved in pyochelin biosynthesis were up-regulated at 37 degrees C. We observed that the changes in expression of P. aeruginosa siderophores correlated to an overall increase in Fe2+ extracellular concentration at 37 degrees C and a peak in Fe3+ extracellular concentration at 22 degrees C. This suggests a distinct change in iron acquisition strategies when the bacterium switches from the external environment to the host. Our work identifies global changes in bacterial metabolism and nutrient acquisition induced by growth at different temperatures. Overall, this study identifies factors that are regulated in genome-wide adaptation processes and discusses how this life-threatening pathogen responds to temperature.	[Barbier, Mariette; Damron, F. Heath; Goldberg, Joanna B.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Bielecki, Piotr; Puchalka, Jacek; dos Santos, Vitor Martins] Helmholtz Ctr Infect Res, Synthet & Syst Biol Res Grp, Braunschweig, Germany; [Alberti, Sebastian] Univ Balearic Isl, IUNICS, Palma De Mallorca, Spain; [Suarez-Diez, Maria; dos Santos, Vitor Martins] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [dos Santos, Vitor Martins] LifeGlimmer GmbH, Berlin, Germany; [Goldberg, Joanna B.] Emory Univ, Sch Med, Dept Pediat, Childrens Healthcare Atlanta Inc, Atlanta, GA USA; [Goldberg, Joanna B.] Emory Univ, Sch Med, Cyst Fibrosis Res Ctr, Childrens Healthcare Atlanta Inc, Atlanta, GA USA	University of Virginia; Helmholtz Association; Helmholtz-Center for Infection Research; Universitat de les Illes Balears; Wageningen University & Research; Children's Healthcare of Atlanta (CHOA); Emory University; Children's Healthcare of Atlanta (CHOA); Emory University	Goldberg, JB (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	joanna.goldberg@emory.edu	Diez, Maria Suarez/AAI-1354-2020; Alberti, Sebastian/H-2490-2013	Alberti, Sebastian/0000-0003-0020-6861; Damron, Fredrick/0000-0002-3140-402X; Barbier, Mariette/0000-0002-3250-3636; Suarez-Diez, Maria/0000-0001-5845-146X	Cystic Fibrosis Foundation [GOLDBE10G0, DAMRON10F0]; Ministerio de Economia y Competitividad and Instituto de Salud Carlos III [SAF2008-03967, REIPI RD06/0008]; European Union project MICROME (KBBE) [222886]; European Union project INFECT (Health) [305340]; Helmholtz Centre for Infection Research, Germany (project: Systems Biology of Pseudomonas) [1100187]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Ministerio de Economia y Competitividad and Instituto de Salud Carlos III; European Union project MICROME (KBBE); European Union project INFECT (Health); Helmholtz Centre for Infection Research, Germany (project: Systems Biology of Pseudomonas)	This work was supported by a grant from the Cystic Fibrosis Foundation to J.B.G. (GOLDBE10G0). F.H.D. was supported by a postdoctoral fellowship from the Cystic Fibrosis Foundation (DAMRON10F0). S.A. was supported by Ministerio de Economia y Competitividad and Instituto de Salud Carlos III (SAF2008-03967 and REIPI RD06/0008). The authors also gratefully acknowledge the financial support of the European Union projects MICROME (KBBE, #222886), and INFECT (Health, 305340) to V.M.d.S. P.B. was supported by the Helmholtz Centre for Infection Research, Germany (project: Systems Biology of Pseudomonas, number 1100187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; [Anonymous], 1982, TECHNICAL REV; Attila C, 2008, APPL MICROBIOL BIOT, V78, P293, DOI 10.1007/s00253-007-1308-y; Barbier M, 2008, J INFECT DIS, V197, P465, DOI 10.1086/525048; Behrends V, 2013, ENVIRON MICROBIOL, V15, P398, DOI 10.1111/j.1462-2920.2012.02840.x; Bielecki P, 2013, ENVIRON MICROBIOL, V15, P570, DOI 10.1111/1462-2920.12024; Bielecki P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024235; Conibear TCR, 2012, J MED MICROBIOL, V61, P180, DOI 10.1099/jmm.0.034561-0; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Damron FH, 2012, J BACTERIOL, V194, P1317, DOI 10.1128/JB.06105-11; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Farinha MA, 1996, CAN J MICROBIOL, V42, P326, DOI 10.1139/m96-048; Fazzeli H, 2012, J RES MED SCI, V17, P332; GAMPER M, 1991, J BACTERIOL, V173, P4742, DOI 10.1128/jb.173.15.4742-4750.1991; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GUGI B, 1991, J BACTERIOL, V173, P3814; Hassett DJ, 1997, J BACTERIOL, V179, P1452, DOI 10.1128/jb.179.5.1452-1459.1997; Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366; Huang JF, 2009, APPL ENVIRON MICROB, V75, P6568, DOI 10.1128/AEM.01148-09; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen TL, 2010, IPNI PLANT NUTR  FAL; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KROPINSKI AMB, 1987, J BACTERIOL, V169, P1960, DOI 10.1128/jb.169.5.1960-1966.1987; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; Lu CD, 1999, J BACTERIOL, V181, P2459, DOI 10.1128/JB.181.8.2459-2464.1999; LUTHI E, 1986, J GEN MICROBIOL, V132, P2667; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; MATSUI H, 1993, J BACTERIOL, V175, P1257, DOI 10.1128/JB.175.5.1257-1263.1993; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Park SM, 1997, J BACTERIOL, V179, P5309, DOI 10.1128/jb.179.17.5309-5317.1997; Parret AHA, 2002, TRENDS MICROBIOL, V10, P107, DOI 10.1016/S0966-842X(02)02307-7; PRINCE RW, 1993, J BACTERIOL, V175, P2589, DOI 10.1128/JB.175.9.2589-2598.1993; Smirnova A, 2001, ARCH MICROBIOL, V176, P393, DOI 10.1007/s002030100344; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Sousse LE, 2011, SHOCK, V36, P466, DOI 10.1097/SHK.0b013e3182336b45; SUNG W, 1980, ENVIRON SCI TECHNOL, V14, P561, DOI 10.1021/es60165a006; Taguchi K, 1997, MICROBIOL-UK, V143, P3223, DOI 10.1099/00221287-143-10-3223; Termine E, 2009, INT MICROBIOL, V12, P7, DOI 10.2436/20.1501.01.76; Trautmann M, 2005, AM J INFECT CONTROL, V33, pS41, DOI 10.1016/j.ajic.2005.03.006; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; TSUJI A, 1982, MICROBIOL IMMUNOL, V26, P15, DOI 10.1111/j.1348-0421.1982.tb00149.x; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Wu DQ, 2012, APPL MICROBIOL BIOT, V96, P1007, DOI 10.1007/s00253-012-4466-5; Wu DQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-438; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Xiao R, 1997, MICROBIOL-UK, V143, P2509, DOI 10.1099/00221287-143-7-2509	56	26	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89941	10.1371/journal.pone.0089941	http://dx.doi.org/10.1371/journal.pone.0089941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587139	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700119
J	Orr, AL; Ashok, D; Sarantos, MR; Ng, R; Shi, T; Gerencser, AA; Hughes, RE; Brand, MD				Orr, Adam L.; Ashok, Deepthi; Sarantos, Melissa R.; Ng, Ryan; Shi, Tong; Gerencser, Akos A.; Hughes, Robert E.; Brand, Martin D.			Novel Inhibitors of Mitochondrial sn-Glycerol 3-phosphate Dehydrogenase	PLOS ONE			English	Article							GLYCEROL-3-PHOSPHATE DEHYDROGENASE; SUPEROXIDE-PRODUCTION; MICE LACKING; COMPLEX-I; NERVE-TERMINALS; SHUTTLE; LIVER; OXIDOREDUCTASE; EXPRESSION; CALCIUM	Mitochondrial sn-glycerol 3-phosphate dehydrogenase (mGPDH) is a ubiquinone-linked enzyme in the mitochondrial inner membrane best characterized as part of the glycerol phosphate shuttle that transfers reducing equivalents from cytosolic NADH into the mitochondrial electron transport chain. Despite the widespread expression of mGPDH and the availability of mGPDH-null mice, the physiological role of this enzyme remains poorly defined in many tissues, likely because of compensatory pathways for cytosolic regeneration of NAD(+) and mechanisms for glycerol phosphate metabolism. Here we describe a novel class of cell-permeant small-molecule inhibitors of mGPDH (iGP) discovered through small-molecule screening. Structure-activity analysis identified a core benzimidazole-phenyl-succinamide structure as being essential to inhibition of mGPDH while modifications to the benzimidazole ring system modulated both potency and off-target effects. Live-cell imaging provided evidence that iGPs penetrate cellular membranes. Two compounds (iGP-1 and iGP-5) were characterized further to determine potency and selectivity and found to be mixed inhibitors with IC50 and K-i values between similar to 1-15 mu M. These novel mGPDH inhibitors are unique tools to investigate the role of glycerol 3-phosphate metabolism in both isolated and intact systems.	[Orr, Adam L.; Ashok, Deepthi; Sarantos, Melissa R.; Ng, Ryan; Shi, Tong; Gerencser, Akos A.; Hughes, Robert E.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Brand, MD (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	mbrand@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Ashok, Deepthi/0000-0003-0252-4716	National Institutes of Health [R01 AG033542, RL1 GM084432, TL 1 AG032116]; Ellison Medical Foundation [AG-SS-2288-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033542, TL1AG032116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants R01 AG033542 (MDB), RL1 GM084432 (REH), and TL 1 AG032116 (ALO) as well as The Ellison Medical Foundation grant AG-SS-2288-09 (MDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2012, METHODS MOL BIOL, V810, P165, DOI 10.1007/978-1-61779-382-0_11; BELEZNAI Z, 1989, BIOCHEM BIOPH RES CO, V159, P132, DOI 10.1016/0006-291X(89)92414-5; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Brown LJ, 2002, J BIOL CHEM, V277, P32899, DOI 10.1074/jbc.M202409200; Brown LJ, 2002, J BIOL CHEM, V277, P32892, DOI 10.1074/jbc.M202408200; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; BUKOWIEC.LJ, 1974, BIOCHIM BIOPHYS ACTA, V348, P115, DOI 10.1016/0005-2760(74)90097-6; Choi SW, 2011, J NEUROSCI, V31, P4524, DOI 10.1523/JNEUROSCI.5817-10.2011; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; COONEY GJ, 1979, BIOCHEM PHARMACOL, V28, P1067, DOI 10.1016/0006-2952(79)90305-8; Cornish-Bowden A, 1999, FUNDAMENTALS ENZYME; Dawson A P, 1975, Methods Enzymol, V41, P254; DAWSON AP, 1969, BIOCHEM J, V111, P27, DOI 10.1042/bj1110027; DONNELLAN JF, 1970, BIOCHEM J, V120, P467, DOI 10.1042/bj1200467; Dossantos RA, 2003, ENDOCRINOLOGY, V144, P5469, DOI 10.1210/en.2003-0687; DRAHOTA Z, 1994, J BIOENERG BIOMEMBR, V26, P583, DOI 10.1007/BF00762743; DRAHOTA Z, 1995, BIOCHEM BIOPH RES CO, V210, P760, DOI 10.1006/bbrc.1995.1724; Dummler K, 1996, BIOCHEM J, V317, P913; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; GARRIB A, 1986, J BIOL CHEM, V261, P8042; Grimmsmann T, 1998, BRIT J PHARMACOL, V123, P781, DOI 10.1038/sj.bjp.0701663; HUNT SM, 1970, CANCER RES, V30, P1764; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; KLINGENBERG M, 1970, EUR J BIOCHEM, V13, P247, DOI 10.1111/j.1432-1033.1970.tb00924.x; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Rauchova H, 2003, ACTA BIOCHIM POL, V50, P405; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Saheki T, 2007, J BIOL CHEM, V282, P25041, DOI 10.1074/jbc.M702031200; SCHRYVERS A, 1978, J BIOL CHEM, V253, P783; Schurr A, 2000, SCIENCE, V287, P931; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tretter L, 2007, J NEUROSCI RES, V85, P3471, DOI 10.1002/jnr.21405; Ward MW, 2000, J NEUROSCI, V20, P7208; Weitzel JM, 2001, EUR J BIOCHEM, V268, P4095, DOI 10.1046/j.1432-1327.2001.02332.x; WERNETTE ME, 1981, J BIOL CHEM, V256, P2767; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105	50	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89938	10.1371/journal.pone.0089938	http://dx.doi.org/10.1371/journal.pone.0089938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587137	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700118
J	Elman, JS; Murray, RM; Wang, FJ; Shen, KY; Gao, S; Conway, KE; Yarmush, ML; Tannous, BA; Weissleder, R; Parekkadan, B				Elman, Jessica S.; Murray, Ryan M.; Wang, Fangjing; Shen, Keyue; Gao, Shan; Conway, Kevin E.; Yarmush, Martin L.; Tannous, Bakhos A.; Weissleder, Ralph; Parekkadan, Biju			Pharmacokinetics of Natural and Engineered Secreted Factors Delivered by Mesenchymal Stromal Cells	PLOS ONE			English	Article							STEM-CELLS; IN-VIVO; THERAPY INDUSTRY; REGENERATION; RESPONSES; RAT; TRANSPLANTATION; INFUSION; IMMUNE; INJURY	Transient cell therapy is an emerging drug class that requires new approaches for pharmacological monitoring during use. Human mesenchymal stem cells (MSCs) are a clinically-tested transient cell therapeutic that naturally secrete antiinflammatory factors to attenuate immune-mediated diseases. MSCs were used as a proof-of-concept with the hypothesis that measuring the release of secreted factors after cell transplantation, rather than the biodistribution of the cells alone, would be an alternative monitoring tool to understand the exposure of a subject to MSCs. By comparing cellular engraftment and the associated serum concentration of secreted factors released from the graft, we observed clear differences between the pharmacokinetics of MSCs and their secreted factors. Exploration of the effects of natural or engineered secreted proteins, active cellular secretion pathways, and clearance mechanisms revealed novel aspects that affect the systemic exposure of the host to secreted factors from a cellular therapeutic. We assert that a combined consideration of cell delivery strategies and molecular pharmacokinetics can provide a more predictive model for outcomes of MSC transplantation and potentially other transient cell therapeutics.	[Elman, Jessica S.; Murray, Ryan M.; Wang, Fangjing; Shen, Keyue; Gao, Shan; Yarmush, Martin L.; Parekkadan, Biju] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg,Ctr Engn Med, Boston, MA 02114 USA; [Elman, Jessica S.; Murray, Ryan M.; Wang, Fangjing; Shen, Keyue; Gao, Shan; Yarmush, Martin L.; Parekkadan, Biju] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Surg Serv, Boston, MA USA; [Elman, Jessica S.; Murray, Ryan M.; Wang, Fangjing; Shen, Keyue; Gao, Shan; Yarmush, Martin L.; Parekkadan, Biju] Shriners Hosp Children, Boston, MA USA; [Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Weissleder, Ralph] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA; [Conway, Kevin E.; Tannous, Bakhos A.] Massachusetts Gen Hosp, Dept Neurol, Expt Therapeut & Mol Imaging Lab, Charlestown, MA USA; [Parekkadan, Biju] Harvard Stem Cell Inst, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Rutgers State University New Brunswick; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Parekkadan, B (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg,Ctr Engn Med, Boston, MA 02114 USA.	biju_parekkadan@hms.harvard.edu		Yarmush, Martin/0000-0003-4986-8444; /0000-0003-0828-4143; Parekkadan, Biju/0000-0002-3408-8085	National Institutes of Health [R01EB012521, K01DK087770]; Broad Medical Research Program of The Broad Foundation [BMRP498382]; Shriners Hospitals for Children; NATIONAL CANCER INSTITUTE [P01CA069246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK087770, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Medical Research Program of The Broad Foundation; Shriners Hospitals for Children; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported of the National Institutes of Health (R01EB012521 and K01DK087770) and the Broad Medical Research Program of The Broad Foundation (BMRP498382) and Shriners Hospitals for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Balyasnikova IV, PLOS ONE, V5, pe9750; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Brindley DA, 2012, CELL STEM CELL, V10, P492, DOI 10.1016/j.stem.2012.04.018; CASTELL JV, 1988, EUR J BIOCHEM, V177, P357, DOI 10.1111/j.1432-1033.1988.tb14384.x; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Culme-Seymour EJ, 2012, REGEN MED, V7, P455, DOI [10.2217/RME.12.45, 10.2217/rme.12.45]; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Fu XB, 2009, CELL TISSUE RES, V335, P317, DOI 10.1007/s00441-008-0724-3; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Love Z, 2007, J NUCL MED, V48, P2011, DOI 10.2967/jnumed.107.043166; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; Mason C, 2011, REGEN MED, V6, P265, DOI [10.2217/RME.11.28, 10.2217/rme.11.28]; McFarlin K, 2006, WOUND REPAIR REGEN, V14, P471, DOI 10.1111/j.1743-6109.2006.00153.x; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Parekkadan B, 2008, STEM CELLS, V26, P1913, DOI 10.1634/stemcells.2007-0790; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Shumakov VI, 2003, B EXP BIOL MED+, V136, P192, DOI 10.1023/A:1026387411627; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Stagg J, 2004, HUM GENE THER, V15, P597, DOI 10.1089/104303404323142042; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Tolar J, 2006, BLOOD, V107, P4182, DOI 10.1182/blood-2005-08-3289; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217	40	27	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89882	10.1371/journal.pone.0089882	http://dx.doi.org/10.1371/journal.pone.0089882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24587097	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900151
J	Nakata, J; Suzuki, Y; Suzuki, H; Sato, D; Kano, T; Yanagawa, H; Matsuzaki, K; Horikoshi, S; Novak, J; Tomino, Y				Nakata, Junichiro; Suzuki, Yusuke; Suzuki, Hitoshi; Sato, Daisuke; Kano, Tatsuya; Yanagawa, Hiroyuki; Matsuzaki, Keiichi; Horikoshi, Satoshi; Novak, Jan; Tomino, Yasuhiko			Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; ABERRANTLY GLYCOSYLATED IGA1; CLINICAL REMISSION; IMMUNE-COMPLEXES; GLOMERULAR IGA; PULSE THERAPY; BONE-MARROW; O-GLYCOSYLATION; TONSILLAR IGA1; EARLY-ONSET	Background: Recent studies have shown that galactose-deficient IgA1 (GdIgA1) has an important role in the pathogenesis of IgA nephropathy (IgAN). Although emerging data suggest that serum GdIgA1 can be a useful non-invasive IgAN biomarker, the localization of nephritogenic GdIgA1-producing B cells remains unclear. Recent clinical and experimental studies indicate that immune activation tonsillar toll-like receptor (TLR) 9 may be involved in the pathogenesis of IgAN. Here we assessed the possibility of GdIgA1 production in the palatine tonsils in IgAN patients. Methods: We assessed changes in serum GdIgA1 levels in IgAN patients with clinical remission of hematuria and proteinuria following combined tonsillectomy and steroid pulse therapy. Further, the association between clinical outcome and tonsillar TLR9 expression was evaluated. Results: Patients (n = 37) were divided into two groups according to therapy response. In one group, serum GdIgA1 levels decreased after tonsillectomy (59%) alone, whereas in the other group most levels only decreased after the addition of steroid pulse therapy to tonsillectomy (41%). The former group showed significantly higher tonsillar TLR9 expression and better improvement in hematuria immediately after tonsillectomy than the latter group. Conclusions: The present study indicates that the palatine tonsils are probably a major sites of GdIgA1-producing cells. However, in some patients these cells may propagate to other lymphoid organs, which may partially explain the different responses observed to tonsillectomy alone. These findings help to clarify some of the clinical observations in the management of IgAN, and may highlight future directions for research.	[Nakata, Junichiro; Suzuki, Yusuke; Suzuki, Hitoshi; Sato, Daisuke; Kano, Tatsuya; Yanagawa, Hiroyuki; Matsuzaki, Keiichi; Horikoshi, Satoshi; Tomino, Yasuhiko] Juntendo Univ, Dept Internal Med, Div Nephrol, Fac Med, Tokyo, Japan; [Suzuki, Hitoshi; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Matsuzaki, Keiichi] Kyoto Univ, Hlth Serv, Kyoto, Japan	Juntendo University; University of Alabama System; University of Alabama Birmingham; Kyoto University	Tomino, Y (corresponding author), Juntendo Univ, Dept Internal Med, Div Nephrol, Fac Med, Tokyo, Japan.	yasu@juntendo.ac.jp			Ministry of Health, Labor and Welfare of Japan; Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgA Nephropathy in Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgA Nephropathy in Japan	A part of this study was supported by research funds from Grant-in-Aids for Progressive Renal Disease Research, Research on intractable disease, from the Ministry of Health, Labor and Welfare of Japan, a grant from Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program and a grant from the Study Group on IgA Nephropathy in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; BAKE AWLV, 1989, NEPHROLOGIE, V10, P141; BAKE AWLV, 1989, J CLIN INVEST, V84, P1070, DOI 10.1172/JCI114269; Barratt J, 2009, NEPHROL DIAL TRANSPL, V24, P3620, DOI 10.1093/ndt/gfp441; BERGER J, 1968, J UROL NEPHROL, V74, P694; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Coppo R, 2010, CLIN EXP IMMUNOL, V159, P73, DOI 10.1111/j.1365-2249.2009.04045.x; Coppo R, 2010, NEPHROL DIAL TRANSPL, V25, P2395, DOI 10.1093/ndt/gfq266; CUEVAS X, 1987, TRANSPL P, V19, P2208; deFijter JW, 1996, KIDNEY INT, V50, P952, DOI 10.1038/ki.1996.396; EMANCIPATOR SN, 1990, KIDNEY INT, V38, P1216, DOI 10.1038/ki.1990.337; FEEHALLY J, 1988, NEPHROL DIAL TRANSPL, V3, P361, DOI 10.1093/oxfordjournals.ndt.a091683; Floege J, 1998, NEPHROL DIAL TRANSPL, V13, P1933, DOI 10.1093/ndt/13.8.1933; Floege J, 2004, SEMIN NEPHROL, V24, P287, DOI 10.1016/j.semnephrol.2004.01.008; Glassock RJ, 2008, CLEV CLIN J MED, V75, P569, DOI 10.3949/ccjm.75.8.569; Harper SJ, 1996, J CLIN PATHOL, V49, P38, DOI 10.1136/jcp.49.1.38; Hashimoto A, 2012, AM J PATHOL, V181, P1338, DOI 10.1016/j.ajpath.2012.06.038; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; Hiki Y, 2009, CLIN EXP NEPHROL, V13, P415, DOI 10.1007/s10157-009-0173-7; Horie A, 2003, AM J KIDNEY DIS, V42, P486, DOI 10.1016/S0272-6386(03)00743-1; Hotta O, 2001, AM J KIDNEY DIS, V38, P736, DOI 10.1053/ajkd.2001.27690; Hu SL, 2010, NEPHROL DIAL TRANSPL, V25, P1708, DOI 10.1093/ndt/gfp693; Imasawa T, 1999, KIDNEY INT, V56, P1809, DOI 10.1046/j.1523-1755.1999.00750.x; Inoue T, 2007, CONTRIB NEPHROL, V157, P120, DOI 10.1159/000102315; Itoh A, 2003, NEPHROL DIAL TRANSPL, V18, P1108, DOI 10.1093/ndt/gfg108; Iwanami N, 2008, J NEPHROL, V21, P118; Kajiyama T, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/819646; Kobayashi I, 2002, NEPHROL DIAL TRANSPL, V17, P2108, DOI 10.1093/ndt/17.12.2108; Komatsu H, 2008, CLIN J AM SOC NEPHRO, V3, P1301, DOI 10.2215/CJN.00310108; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Maeda I, 2012, NEPHROL DIAL TRANSPL, V27, P2806, DOI 10.1093/ndt/gfs053; Miyawaki S, 1997, NEPHRON, V76, P201, DOI 10.1159/000190169; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Moore JS, 2007, MOL IMMUNOL, V44, P2598, DOI 10.1016/j.molimm.2006.12.011; Nakata J, 2013, NEPHROL DIAL TRANSPL, V28, P320, DOI 10.1093/ndt/gfs467; Nishie T, 2007, AM J PATHOL, V170, P447, DOI 10.2353/ajpath.2007.060559; Novak J, 2008, SEMIN NEPHROL, V28, P78, DOI 10.1016/j.semnephrol.2007.10.009; Okazaki K, 2012, J AM SOC NEPHROL, V23, P1364, DOI 10.1681/ASN.2011121160; Roodnat JI, 1999, NEPHROL DIAL TRANSPL, V14, P353, DOI 10.1093/ndt/14.2.353; SANFILIPPO F, 1982, TRANSPLANTATION, V33, P370, DOI 10.1097/00007890-198204000-00006; Sato D, 2012, NEPHROL DIAL TRANSPL, V27, P1090, DOI 10.1093/ndt/gfr403; Sato M, 2003, NEPHRON CLIN PRACT, V93, pC137, DOI 10.1159/000070233; Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Suzuki Y, 2013, CLIN EXP NE IN PRESS; Suzuki Y, 2008, SEMIN NEPHROL, V28, P66, DOI 10.1016/j.semnephrol.2007.10.008; Suzuki Yusuke, 2009, P387, DOI 10.1142/9789812835871_0026; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; TOMINO Y, 1981, NEW ENGL J MED, V305, P1159; VANES LA, 1995, CONTRIB NEPHROL, V111, P169; Wang Y, 2011, NEPHROL DIAL TRANSPL, V26, P1923, DOI 10.1093/ndt/gfq674; Xie YS, 2004, KIDNEY INT, V65, P1135, DOI 10.1111/j.1523-1755.2004.00486.x	58	62	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89707	10.1371/journal.pone.0089707	http://dx.doi.org/10.1371/journal.pone.0089707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586974	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900141
J	Liu, P; Liu, LX; Shen, HM; Jia, QZ; Wang, JB; Zheng, HM; Ma, J; Zhou, D; Liu, SJ; Su, XH				Liu, Peng; Liu, Lixiang; Shen, Hongmei; Jia, Qingzhen; Wang, Jinbiao; Zheng, Heming; Ma, Jing; Zhou, Dan; Liu, Shoujun; Su, Xiaohui			The Standard, Intervention Measures and Health Risk for High Water Iodine Areas	PLOS ONE			English	Article							ENDEMIC GOITER; DRINKING-WATER; EXCESSIVE IODINE	Our study aims to clarify the population nutrient status in locations with different levels of iodine in the water in China; to choose effective measurements of water improvement(finding other drinking water source of iodine not excess) or non-iodised salt supply or combinations thereof; to classify the areas of elevated water iodine levels and the areas with endemic goiter; and to evaluate the risk factors of water iodine excess on pregnant women, lactating women and the overall population of women. From Henan, Hebei, Shandong and Shanxi province of China, for each of 50 similar to 99 mu g/L, 100 similar to 149 mu g/L, 150 similar to 299 mu g/L, and >= 300 mu g/L water iodine level, three villages were selected respectively. Students of 6-12 years old and pregnant were sampled from villages of each water-iodine level of each province, excluded iodized salt consumer. Then the children's goiter volume, the children and pregnant's urinary iodine and water iodine were tested. In addition, blood samples were collected from pregnant women, lactating women and other women of reproductive age for each water iodine level in the Shanxi Province for thyroid function tests. These indicators should be matched for each person. When the water iodine exceeds 100 mu g/L; the iodine nutrient of children are iodine excessive, and are adequate or more than adequate for the pregnant women. It is reasonable to define elevated water iodine areas as locations where the water iodine levels exceed 100 mu g/L. The supply of non-iodised salt alone cannot ensure adequate iodine nutrition of the residents, and water improvement must be adopted, as well. Iodine excess increases the risk of certain thyroid diseases in women from one-to eightfold.	[Liu, Peng; Liu, Lixiang; Shen, Hongmei; Zhou, Dan; Liu, Shoujun; Su, Xiaohui] Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Harbin, Heilongjiang, Peoples R China; [Jia, Qingzhen] Inst Endem Dis Control Shanxi Prov, Linfen, Shanxi, Peoples R China; [Wang, Jinbiao] Inst Endem Dis Control Shandong Prov, Jinan, Shandong, Peoples R China; [Zheng, Heming] Ctr Dis Control Henan Prov, Zhengzhou, Henan, Peoples R China; [Ma, Jing] Ctr Dis Control Hebei Prov, Shijiazhuang, Hebei, Peoples R China	Chinese Center for Disease Control & Prevention; Harbin Medical University	Shen, HM (corresponding author), Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Harbin, Heilongjiang, Peoples R China.	shenhm119@126.com			world organisation UNICEF [2011 HN IR1 Act 17]; world organisation GAIN [104641]	world organisation UNICEF; world organisation GAIN	The world organisations of UNICEF and GAIN funded the project. The grant numbers of UNICEF is 2011 H&N IR1 Act 17 and that of GAIN is 104641. The URL of UNICEF' website is http://www.unicef.cn, that of GAIN is http://www.gainhealth.org/. No financial relationships with any organizations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. The UNICEF and GAIN offer valuable technique support during design and found process of the project, they also reviewed and offered valuable comments for the research report. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	CLARKE K. H., 1960, MED JOUR AUSTRALIA I, V47, P89; Fordyce FM, 2000, SCI TOTAL ENVIRON, V263, P127, DOI 10.1016/S0048-9697(00)00684-7; Gaitan E, 1983, Ecol Dis, V2, P295; He YX, 2011, J ENV HYG, V1, P1; Henjum S, 2010, PUBLIC HEALTH NUTR, V13, P1472, DOI 10.1017/S1368980010000650; Kirchner S, 1996, Z LEBENSM UNTERS FOR, V203, P311, DOI 10.1007/BF01231067; LI M, 1987, LANCET, V2, P257; MA T, 1982, CHINESE MED J-PEKING, V95, P692; Medani AM, 2012, PUBLIC HEALTH NUTR, V16, P1; *MIN HLTH, 2007, DIAGN CRIT END GOIT; Pearce EN, 2013, THYROID, V23, P523, DOI 10.1089/thy.2013.0128; Pearce EN, 2002, J CLIN ENDOCR METAB, V87, P5499, DOI 10.1210/jc.2002-020692; Pedersen KM, 1999, EUR J ENDOCRINOL, V140, P400, DOI 10.1530/eje.0.1400400; Sang ZN, 2012, J CLIN ENDOCR METAB, V97, pE1363, DOI 10.1210/jc.2011-3438; Shen HM, 2011, BRIT J NUTR, V106, P243, DOI 10.1017/S0007114511000055; SUZUKI H, 1962, Jpn J Med Sci Biol, V51, P781; SUZUKI H, 1965, ACTA ENDOCRINOL-COP, V50, P161, DOI 10.1530/acta.0.0500161; WHO UNICEF ICCIDD, 2007, GUID MAN ASS IOD DEF	18	17	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89608	10.1371/journal.pone.0089608	http://dx.doi.org/10.1371/journal.pone.0089608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586909	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200065
J	Dutertre, CA; Clement, M; Morvan, M; Schakel, K; Castier, Y; Alsac, JM; Michel, JB; Nicoletti, A				Dutertre, Charles-Antoine; Clement, Marc; Morvan, Marion; Schaekel, Knut; Castier, Yves; Alsac, Jean-Marc; Michel, Jean-Baptiste; Nicoletti, Antonino			Deciphering the Stromal and Hematopoietic Cell Network of the Adventitia from Non-Aneurysmal and Aneurysmal Human Aorta	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; SMOOTH-MUSCLE-CELLS; 6-SULFO LACNAC; LYMPHOID-TISSUE; ALTERNATIVE ACTIVATION; STEADY-STATE; TNF-ALPHA; ATHEROSCLEROSIS; IMMUNE; MACROPHAGES	Aneurysm is associated to a complex remodeling of arteries that affects all their layers. Although events taking place in the intima and the media have received a particular attention, molecular and cellular events taking place in the adventitia have started to be deciphered only recently. In this study, we have precisely described the composition and distribution of stromal and hematopoietic cells in human arterial adventitia, both at steady state and in the setting of aortic aneurysm. Using polychromatic immunofluorescent and flow cytometry analyses, we observed that unlike the medial layer (which comprises mostly macrophages and T cells among leukocytes), the adventitia comprises a much greater variety of leukocytes. We observed an altered balance in macrophages subsets in favor of M2-like macrophages, an increased proliferation of macrophages, a greater number of all stromal cells in aneurysmal aortas. We also confirmed that in this pathological setting, adventitia comprised blood vessels and arterial tertiary lymphoid organs (ATLOs), which contained also M-DC8(+) dendritic cells (slanDCs) that could participate in the induction of T-cell responses. Finally, we showed that lymphatic vessels can be detected in aneurysmal adventitia, the functionality of which will have to be evaluated in future studies. All together, these observations provide an integrative outlook of the stromal and hematopoietic cell network of the human adventitia both at steady state and in the context of aneurysm.	[Dutertre, Charles-Antoine; Clement, Marc; Morvan, Marion; Michel, Jean-Baptiste; Nicoletti, Antonino] Hop Bichat Claude Bernard, INSERM, U698, F-75877 Paris, France; [Clement, Marc; Castier, Yves; Michel, Jean-Baptiste; Nicoletti, Antonino] Univ Paris 07, Paris, France; [Schaekel, Knut] Univ Heidelberg Hosp, Dept Dermatol, Heidelberg, Germany; [Castier, Yves] Hop Bichat Claude Bernard, AP HP, Serv Chirurg Vasc & Thorac, F-75877 Paris, France; [Alsac, Jean-Marc] Univ Paris 05, AP HP, Serv Chirurg Cardiaque & Vasc, Hop Europe Georges Pompidou,Fac Med Rene Descarte, Paris, France; [Michel, Jean-Baptiste; Nicoletti, Antonino] DHU Fire, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Dutertre, CA (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.	cadutertre@yahoo.fr; antonino.nicoletti@inserm.fr	Michel, Jean-Baptiste/AAH-9336-2020; Nicoletti, Antonino/A-9460-2015; CLEMENT, Marc/GVS-8052-2022	Nicoletti, Antonino/0000-0002-2623-0897; CLEMENT, Marc/0000-0002-6479-8360; Dutertre, Charles-Antoine/0000-0001-7950-3652	Institut National de la Sante et de la Recherche Medicale (INSERM); Paris Denis Diderot University; Fondation de la Recherche Medicale (FRM); Agence Nationale de la Recherche (ANR) ['MI2' ATHLO']; Region Ile de France (CORDDIM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Paris Denis Diderot University; Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Region Ile de France (CORDDIM)(Region Ile-de-France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Paris Denis Diderot University, the Region Ile de France (CORDDIM), the Fondation de la Recherche Medicale (FRM), and the Agence Nationale de la Recherche (ANR, grant 'MI2' ATHLO'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bobryshev YV, 2001, ATHEROSCLEROSIS, V154, P15, DOI 10.1016/S0021-9150(00)00441-X; Boyle JJ, 2012, CURR OPIN LIPIDOL, V23, P453, DOI 10.1097/MOL.0b013e328356b145; Boytard L, 2013, ARTERIOSCL THROM VAS, V33, P431, DOI 10.1161/ATVBAHA.112.300663; Campbell KA, 2012, CIRC RES, V110, P889, DOI 10.1161/CIRCRESAHA.111.263186; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Cupedo T, 2003, SEMIN IMMUNOL, V15, P243, DOI 10.1016/j.smim.2003.08.002; de Baey A, 2003, J IMMUNOL, V170, P5089, DOI 10.4049/jimmunol.170.10.5089; Delbosc S, 2013, CARDIOVASC RES, V100, P307, DOI 10.1093/cvr/cvt194; Delbosc S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018679; Dutertre CA, 2012, BLOOD, V120, P2259, DOI 10.1182/blood-2012-03-418681; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gil M, 2010, IMMUNOLOGY, V130, P536, DOI 10.1111/j.1365-2567.2010.03252.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Hansel A, 2013, J AUTOIMMUN, V40, P1, DOI 10.1016/j.jaut.2012.07.005; Hansel A, 2011, J ALLERGY CLIN IMMUN, V127, P787, DOI 10.1016/j.jaci.2010.12.009; Ho-Tin-Noe B, 2011, TRENDS CARDIOVAS MED, V21, P183, DOI 10.1016/j.tcm.2012.05.007; Houtkamp MA, 2001, J PATHOL, V193, P263, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH774>3.0.CO;2-N; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jones JA, 2009, AM J PATHOL, V175, P1746, DOI 10.2353/ajpath.2009.081141; Kain MJW, 2013, IMMUNOLOGY, V140, P12, DOI 10.1111/imm.12119; KOCH AE, 1990, AM J PATHOL, V137, P1199; Kolodgie FD, 2007, J AM COLL CARDIOL, V49, P2093, DOI 10.1016/j.jacc.2006.10.083; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Patel A, 2008, EUR J VASC ENDOVASC, V36, P20, DOI 10.1016/j.ejvs.2008.01.014; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Sakata N, 2007, PATHOL RES PRACT, V203, P21, DOI 10.1016/j.prp.2006.08.008; Saphir O, 1950, ARCH PATHOL, V48, P9; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Schakel K, 1998, EUR J IMMUNOL, V28, P4084, DOI 10.1002/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; SCHWARTZ CJ, 1962, CIRCULATION, V26, P73, DOI 10.1161/01.CIR.26.1.73; Siedlar M, 2000, IMMUNOBIOLOGY, V202, P11, DOI 10.1016/S0171-2985(00)80047-9; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	48	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89983	10.1371/journal.pone.0089983	http://dx.doi.org/10.1371/journal.pone.0089983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587165	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800062
J	Morgenthaler, J; Wiesner, CD; Hinze, K; Abels, LC; Prehn-Kristensen, A; Goder, R				Morgenthaler, Jarste; Wiesner, Christian D.; Hinze, Karoline; Abels, Lena C.; Prehn-Kristensen, Alexander; Goeder, Robert			Selective REM-Sleep Deprivation Does Not Diminish Emotional Memory Consolidation in Young Healthy Subjects	PLOS ONE			English	Article							DECLARATIVE MEMORY; IMPROVEMENT; THETA	Sleep enhances memory consolidation and it has been hypothesized that rapid eye movement (REM) sleep in particular facilitates the consolidation of emotional memory. The aim of this study was to investigate this hypothesis using selective REM-sleep deprivation. We used a recognition memory task in which participants were shown negative and neutral pictures. Participants (N = 29 healthy medical students) were separated into two groups (undisturbed sleep and selective REM-sleep deprived). Both groups also worked on the memory task in a wake condition. Recognition accuracy was significantly better for negative than for neutral stimuli and better after the sleep than the wake condition. There was, however, no difference in the recognition accuracy (neutral and emotional) between the groups. In summary, our data suggest that REM-sleep deprivation was successful and that the resulting reduction of REM-sleep had no influence on memory consolidation whatsoever.	[Morgenthaler, Jarste; Goeder, Robert] Univ Kiel, Sch Med, Dept Psychiat & Psychotherapy, Kiel, Germany; [Wiesner, Christian D.; Prehn-Kristensen, Alexander] Univ Kiel, Sch Med, Dept Child & Adolescent Psychiat & Psychotherapy, Kiel, Germany; [Hinze, Karoline; Abels, Lena C.] Univ Kiel, Inst Psychol, Kiel, Germany	University of Kiel; University of Kiel; University of Kiel	Goder, R (corresponding author), Univ Kiel, Sch Med, Dept Psychiat & Psychotherapy, Kiel, Germany.	robert.goeder@uksh.de	Prehn-Kristensen, Alexander/A-3234-2019	Prehn-Kristensen, Alexander/0000-0002-3510-9888; Wiesner, Christian/0000-0003-1287-4955	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft: SFB 654 Sleep and Plasticity, project A9 (RG). http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Sleep Medicine, 2007, AAM MAN SCOR SCHLAF; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; BORN J, 1988, BIOL PSYCHIAT, V24, P801, DOI 10.1016/0006-3223(88)90256-9; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Christman SD, 2010, INT REV NEUROBIOL, V92, P215, DOI 10.1016/S0074-7742(10)92011-4; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Franke G.H., 2002, SCL 90 R SYMPTOM CHE; Gonnissen HKJ, 2013, BRIT J NUTR, V109, P748, DOI 10.1017/S0007114512001894; Groch S, 2013, NEUROBIOL LEARN MEM, V99, P1, DOI 10.1016/j.nlm.2012.10.006; Groch S, 2011, PSYCHONEUROENDOCRINO, V36, P1342, DOI 10.1016/j.psyneuen.2011.03.006; H?rting, 2000, WECHSLER GEDACHTNIST; Horne J, 2013, BIOL PSYCHOL, V92, P152, DOI 10.1016/j.biopsycho.2012.10.010; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Jahne A, 2010, NERVENARZT, V81, P844, DOI 10.1007/s00115-009-2926-7; Kaestner EJ, 2013, J COGNITIVE NEUROSCI, V25, P1597, DOI 10.1162/jocn_a_00433; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Lang P. J., 2005, INT AFFECTIVE PICTUR; Lewis PA, 2011, NEUROPSYCHOLOGIA, V49, P2619, DOI 10.1016/j.neuropsychologia.2011.05.009; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00108; Plihal W, 1999, PSYCHONEUROENDOCRINO, V24, P313, DOI 10.1016/S0306-4530(98)00080-8; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Prehn-Kristensen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065098; Prehn-Kristensen A, 2011, SLEEP MED, V12, P672, DOI 10.1016/j.sleep.2010.10.010; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Vertes RP, 2000, BEHAV BRAIN SCI, V23, P867, DOI 10.1017/S0140525X00004003; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wagner U, 2005, BIOL PSYCHIAT, V58, P885, DOI 10.1016/j.biopsych.2005.05.008; Wagner U, 2008, STRESS, V11, P28, DOI 10.1080/10253890701408822; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Walker MP, 2009, ANN NY ACAD SCI, V1156, P169; YAROUSH R, 1971, J EXP PSYCHOL, V88, P361, DOI 10.1037/h0030914	39	31	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89849	10.1371/journal.pone.0089849	http://dx.doi.org/10.1371/journal.pone.0089849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24587073	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800046
J	Beaver, CM; Ahmed, A; Masters, JR				Beaver, Charlotte M.; Ahmed, Aamir; Masters, John R.			Clonogenicity: Holoclones and Meroclones Contain Stem Cells	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; DIFFERENTIATED PROGENY; HAIR-FOLLICLES; PATTERNS; LINE; KERATINOCYTE; LOCATION; BEHAVIOR; RENEWAL; GENE	When primary cultures of normal cells are cloned, three types of colony grow, called holoclones, meroclones and paraclones. These colonies are believed to be derived from stem cells, transit-amplifying cells and differentiated cells respectively. More recently, this approach has been extended to cancer cell lines. However, we observed that meroclones from the prostate cancer cell line DU145 produce holoclones, a paradoxical observation as meroclones are thought to be derived from transit-amplifying cells. The purpose of this study was to confirm this observation and determine if both holoclones and meroclones from cancer cell lines contain stem cells. We demonstrated that both holoclones and meroclones can be serially passaged indefinitely, are highly proliferative, can self-renew to form spheres, are serially tumorigenic and express stem cell markers. This study demonstrates that the major difference between holoclones and meroclones derived from a cancer cell line is the proportion of stem cells within each colony, not the presence or absence of stem cells. These findings may reflect the properties of cancer as opposed to normal cells, perhaps indicating that the hierarchy of stem cells is more extensive in cancer.	[Beaver, Charlotte M.; Ahmed, Aamir; Masters, John R.] UCL, Prostate Canc Res Ctr, London, England	University of London; University College London	Masters, JR (corresponding author), UCL, Prostate Canc Res Ctr, London, England.	j.masters@ucl.ac.uk		Ahmed, Aamir/0000-0001-7405-5336	PCRC (UK Charity) [802545]	PCRC (UK Charity)	This study was supported by grant funding from PCRC (UK Charity number 802545). The funders paid for the research, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Beaver CM, 2012, CELL BIOL TOXICOLOGY; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Doherty RE, 2011, BIOCHEM BIOPH RES CO, V414, P801, DOI 10.1016/j.bbrc.2011.10.010; Felthaus O, 2011, BIOCHEM BIOPH RES CO, V407, P28, DOI 10.1016/j.bbrc.2011.02.084; Ferrand A, 2009, BBA-MOL CELL RES, V1793, P477, DOI 10.1016/j.bbamcr.2009.01.004; Gao QL, 2009, ULTRASTRUCT PATHOL, V33, P175, DOI 10.1080/01913120903086072; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Harper LJ, 2007, J ORAL PATHOL MED, V36, P594, DOI 10.1111/j.1600-0714.2007.00617.x; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jiang LL, 2009, ACTA BIOCH BIOPH SIN, V41, P527, DOI 10.1093/abbs/gmp040; Kalirai H, 2011, INVEST OPHTH VIS SCI, V52, P8458, DOI 10.1167/iovs.11-7379; Keith WN, 2004, ONCOGENE, V23, P5092, DOI 10.1038/sj.onc.1207762; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu TJ, 2012, ONCOGENE; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Marian CO, 2010, INT J CANCER, V127, P321, DOI 10.1002/ijc.25043; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Miloszewska J, 2010, CELL PROLIFERAT, V43, P229, DOI 10.1111/j.1365-2184.2010.00671.x; Murayama K, 2007, ONCOGENE, V26, P4882, DOI 10.1038/sj.onc.1210274; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; PFEIFFER MJ, 2009, EUR UROL; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Tan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023383; Tokar EJ, 2010, JNCI-J NATL CANCER I, V102, P638, DOI 10.1093/jnci/djq093; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018; Tudor D, 2007, CELL PROLIFERAT, V40, P706, DOI 10.1111/j.1365-2184.2007.00467.x; Tudor D, 2004, J INVEST DERM SYMP P, V9, P208, DOI 10.1111/j.1087-0024.2004.09310.x; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhang KX, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-319; Zhang LL, 2012, J CANCER RES CLIN, V138, P675, DOI 10.1007/s00432-011-1146-2	39	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89834	10.1371/journal.pone.0089834	http://dx.doi.org/10.1371/journal.pone.0089834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587067	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000098
J	Bigelow, J; Poremba, A				Bigelow, James; Poremba, Amy			Achilles' Ear? Inferior Human Short-Term and Recognition Memory in the Auditory Modality	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; PERIRHINAL CORTEX; VISUAL RECOGNITION; WORKING-MEMORY; MONKEYS; INFORMATION; ROLES	Studies of the memory capabilities of nonhuman primates have consistently revealed a relative weakness for auditory compared to visual or tactile stimuli: extensive training is required to learn auditory memory tasks, and subjects are only capable of retaining acoustic information for a brief period of time. Whether a parallel deficit exists in human auditory memory remains an outstanding question. In the current study, a short-term memory paradigm was used to test human subjects' retention of simple auditory, visual, and tactile stimuli that were carefully equated in terms of discriminability, stimulus exposure time, and temporal dynamics. Mean accuracy did not differ significantly among sensory modalities at very short retention intervals (1-4 s). However, at longer retention intervals (8-32 s), accuracy for auditory stimuli fell substantially below that observed for visual and tactile stimuli. In the interest of extending the ecological validity of these findings, a second experiment tested recognition memory for complex, naturalistic stimuli that would likely be encountered in everyday life. Subjects were able to identify all stimuli when retention was not required, however, recognition accuracy following a delay period was again inferior for auditory compared to visual and tactile stimuli. Thus, the outcomes of both experiments provide a human parallel to the pattern of results observed in nonhuman primates. The results are interpreted in light of neuropsychological data from nonhuman primates, which suggest a difference in the degree to which auditory, visual, and tactile memory are mediated by the perirhinal and entorhinal cortices.	[Bigelow, James; Poremba, Amy] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	University of Iowa	Poremba, A (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.	amy-poremba@uiowa.edu			University of Iowa; National Institute on Deafness and Other Communication Disorders [DC0007156]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007156] Funding Source: NIH RePORTER	University of Iowa; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by funding awarded to Amy Poremba from the University of Iowa and grant DC0007156 from the National Institute on Deafness and Other Communication Disorders (http://www.nidcd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow J, 2013, LEARN BEHAV, V41, P319, DOI 10.3758/s13420-013-0107-9; Bigelow J, 2013, AM J PRIMATOL, V75, P425, DOI 10.1002/ajp.22076; Blatt GJ, 2003, J COMP NEUROL, V466, P161, DOI 10.1002/cne.10866; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buffalo EA, 1999, LEARN MEMORY, V6, P572, DOI 10.1101/lm.6.6.572; Cohen MA, 2011, PSYCHON B REV, V18, P586, DOI 10.3758/s13423-011-0074-0; Cohen MA, 2009, P NATL ACAD SCI USA, V106, P6008, DOI 10.1073/pnas.0811884106; Cohen Yale E, 2005, Behav Cogn Neurosci Rev, V4, P218, DOI 10.1177/1534582305285861; COLOMBO M, 1986, Q J EXP PSYCHOL-B, V38, P425; CORBALLIS MC, 1966, CAN J PSYCHOLOGY, V20, P43, DOI 10.1037/h0082923; DAMATO MR, 1985, ANIM LEARN BEHAV, V13, P375, DOI 10.3758/BF03208013; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fritz J, 2005, P NATL ACAD SCI USA, V102, P9359, DOI 10.1073/pnas.0503998102; Greene R. L., 1992, HUMAN MEMORY; Hartshorne JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002716; Hashiya K, 2001, Anim Cogn, V4, P231, DOI 10.1007/s10071-001-0118-3; JENSEN AR, 1971, J EDUC PSYCHOL, V62, P123, DOI 10.1037/h0030655; Kirkpatrick E. A., 1894, PSYCHOL REV, V1, P602; KOJIMA S, 1985, INT J NEUROSCI, V25, P255, DOI 10.3109/00207458508985378; Larsson M, 1998, EXP AGING RES, V24, P63; Matsuzawa T., 2001, PRIMATE ORIGINS HUMA; Medin DL, 1976, PROCESSES ANIMAL MEM; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Milner B, 1972, Clin Neurosurg, V19, P421; Mohedano-Moriano A, 2007, J ANAT, V211, P250, DOI 10.1111/j.1469-7580.2007.00764.x; Munoz-Lopez MM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00129; Munsterberg H., 1894, PSYCHOL REV, V1, P34, DOI [10.1037/h0068876, DOI 10.1037/H0068876]; Murray EA, 1998, J NEUROSCI, V18, P6568; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; OVERMAN WH, 1980, NEUROSCIENCE, V5, P1825, DOI 10.1016/0306-4522(80)90032-9; PASCUALLEONE A, 1992, BRAIN, V115, P109, DOI 10.1093/brain/115.1.109; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; PENNEY CG, 1989, MEM COGNITION, V17, P398, DOI 10.3758/BF03202613; PENNEY CG, 1975, PSYCHOL BULL, V82, P68, DOI 10.1037/h0076166; Peters J, 2007, EUR J NEUROSCI, V26, P1333, DOI 10.1111/j.1460-9568.2007.05752.x; Scott BH, 2012, P NATL ACAD SCI USA, V109, P12237, DOI 10.1073/pnas.1209685109; Shelton J., 2010, NEUROSCIENCE MED, V1, P30, DOI [10.4236/nm.2010.11004, DOI 10.4236/NM.2010.11004]; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2001, LEARN MEMORY, V8, P252, DOI 10.1101/lm.42001; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Visscher KM, 2007, PLOS BIOL, V5, P662, DOI 10.1371/journal.pbio.0050056; Ward G, 2005, MEMORY, V13, P308, DOI 10.1080/09658210344000279; WEGENER JG, 1964, J AUD RES, V4, P81; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Wright Anthony A., 2006, P164; Zentall, 2006, COMP COGNITION EXPT	46	52	53	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89914	10.1371/journal.pone.0089914	http://dx.doi.org/10.1371/journal.pone.0089914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24587119	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000111
J	Bohorquez, DV; Samsa, LA; Roholt, A; Medicetty, S; Chandra, R; Liddle, RA				Bohorquez, Diego V.; Samsa, Leigh A.; Roholt, Andrew; Medicetty, Satish; Chandra, Rashmi; Liddle, Rodger A.			An Enteroendocrine Cell - Enteric Glia Connection Revealed by 3D Electron Microscopy	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; GLUCAGON-LIKE PEPTIDE-1; NEMATODE CAENORHABDITIS-ELEGANS; GASTROINTESTINAL-TRACT; NEUROTROPHIC FACTOR; IN-VITRO; RECEPTOR; SECRETION; NEURONS; RELEASE	The enteroendocrine cell is the cornerstone of gastrointestinal chemosensation. In the intestine and colon, this cell is stimulated by nutrients, tastants that elicit the perception of flavor, and bacterial by-products; and in response, the cell secretes hormones like cholecystokinin and peptide YY - both potent regulators of appetite. The development of transgenic mice with enteroendocrine cells expressing green fluorescent protein has allowed for the elucidation of the apical nutrient sensing mechanisms of the cell. However, the basal secretory aspects of the enteroendocrine cell remain largely unexplored, particularly because a complete account of the enteroendocrine cell ultrastructure does not exist. Today, the fine ultrastructure of a specific cell can be revealed in the third dimension thanks to the invention of serial block face scanning electron microscopy (SBEM). Here, we bridged confocal microscopy with SBEM to identify the enteroendocrine cell of the mouse and study its ultrastructure in the third dimension. The results demonstrated that 73.5% of the peptide-secreting vesicles in the enteroendocrine cell are contained within an axon-like basal process. We called this process a neuropod. This neuropod contains neurofilaments, which are typical structural proteins of axons. Surprisingly, the SBEM data also demonstrated that the enteroendocrine cell neuropod is escorted by enteric glia - the cells that nurture enteric neurons. We extended these structural findings into an in vitro intestinal organoid system, in which the addition of glial derived neurotrophic factors enhanced the development of neuropods in enteroendocrine cells. These findings open a new avenue of exploration in gastrointestinal chemosensation by unveiling an unforeseen physical relationship between enteric glia and enteroendocrine cells.	[Bohorquez, Diego V.; Chandra, Rashmi; Liddle, Rodger A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Liddle, Rodger A.] Vet Affairs Med Ctr, Durham, NC USA; [Samsa, Leigh A.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Medicetty, Satish; Chandra, Rashmi] Renovo Neural Inc, Cleveland, OH USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of North Carolina; University of North Carolina Chapel Hill	Bohorquez, DV (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	diego.bohorquez@duke.edu		Samsa, Leigh/0000-0002-7629-0660	National Institutes of Health - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKK); NIH [R01 DK-091946, DK-098796, F32 DK-094704]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK094704, R01DK098796, R01DK091946] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002230] Funding Source: NIH RePORTER	National Institutes of Health - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Funding support was provided by the National Institutes of Health - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKK; http://www.niddk.nih.gov). NIH grants R01 DK-091946 and DK-098796 to R. A. L. and F32 DK-094704 to D. V. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aube AC, 2006, GUT, V55, P630, DOI 10.1136/gut.2005.067595; Bach-Ngohou K, 2010, J PHYSIOL-LONDON, V588, P2533, DOI 10.1113/jphysiol.2010.188409; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Bohorquez DV, 2011, CTS-CLIN TRANSL SCI, V4, P387, DOI 10.1111/j.1752-8062.2011.00299.x; Bohorquez DV, 2011, J MOL HISTOL, V42, P3, DOI 10.1007/s10735-010-9302-6; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Chandra R, 2013, J CLIN INVEST, V123, P3343, DOI 10.1172/JCI68587; Chandra R, 2010, CELL TISSUE RES, V341, P289, DOI 10.1007/s00441-010-0997-1; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Deerinck T. J., 2010, MICROSCOPY-JPN, V1, P6; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dogiel AS, 1899, ARCH ANAT PHYSL LEIP, V1899, P130; Egerod KL, 2012, ENDOCRINOLOGY, V153, P5782, DOI 10.1210/en.2012-1595; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Engelstoft MS, 2008, CELL METAB, V8, P447, DOI 10.1016/j.cmet.2008.11.004; GABELLA G, 1981, NEUROSCIENCE, V6, P425, DOI 10.1016/0306-4522(81)90135-4; GERSHON MD, 1991, GLIA, V4, P195, DOI 10.1002/glia.440040211; GREENE LA, 1974, NEUROBIOLOGY, V4, P286; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Gustafsson BI, 2006, SCAND J GASTROENTERO, V41, P390, DOI 10.1080/00365520500331281; Habib AM, 2013, DIABETOLOGIA, V56, P1413, DOI 10.1007/s00125-013-2887-z; HANANI M, 1994, CELL TISSUE RES, V278, P153; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; JESSEN KR, 1980, NATURE, V286, P736, DOI 10.1038/286736a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; KOMURO T, 1985, CELL TISSUE RES, V239, P183, DOI 10.1007/BF00214918; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; LARSSON LI, 1979, SCIENCE, V205, P1393, DOI 10.1126/science.382360; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Luciano L, 2003, J HISTOCHEM CYTOCHEM, V51, P187, DOI 10.1177/002215540305100207; Madduri S, 2009, NEUROSCI RES, V65, P88, DOI 10.1016/j.neures.2009.06.003; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; McDonagh SC, 2007, AM J PHYSIOL-GASTR L, V293, pG461, DOI 10.1152/ajpgi.00424.2006; Mellitzer G, 2010, J CLIN INVEST, V120, P1708, DOI 10.1172/JCI40794; MIZUHIRA V, 1972, Acta Histochemica et Cytochemica, V5, P233; Mwangi S, 2008, GASTROENTEROLOGY, V134, P727, DOI 10.1053/j.gastro.2007.12.033; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Raybould HE, 2010, AUTON NEUROSCI-BASIC, V153, P41, DOI 10.1016/j.autneu.2009.07.007; Reimann F, 2012, CELL METAB, V15, P421, DOI 10.1016/j.cmet.2011.12.019; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rogers GJ, 2011, J PHYSIOL-LONDON, V589, P1081, DOI 10.1113/jphysiol.2010.198069; Ruhl A, 2005, NEUROGASTROENT MOTIL, V17, P777, DOI 10.1111/j.1365-2982.2005.00687.x; SAKAGUCHI T, 1993, NEUROSCI LETT, V153, P65, DOI 10.1016/0304-3940(93)90078-Y; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wang Y, 2011, AM J PHYSIOL-GASTR L, V300, pG528, DOI 10.1152/ajpgi.00387.2010; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilke SA, 2013, J NEUROSCI, V33, P507, DOI 10.1523/JNEUROSCI.1600-12.2013; YASUDA T, 1990, BRAIN RES, V524, P54, DOI 10.1016/0006-8993(90)90491-S; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729	65	127	132	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89881	10.1371/journal.pone.0089881	http://dx.doi.org/10.1371/journal.pone.0089881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587096	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000105
J	Chen, M; Knifley, T; Subramanian, T; Spielmann, HP; O'Connor, KL				Chen, Min; Knifley, Teresa; Subramanian, Thangaiah; Spielmann, H. Peter; O'Connor, Kathleen L.			Use of Synthetic Isoprenoids to Target Protein Prenylation and Rho GTPases in Breast Cancer Invasion	PLOS ONE			English	Article							EPITHELIAL-CELLS; GERANYLGERANYLTRANSFERASE-I; EXCHANGE FACTOR; TUMOR-MODELS; ANTI-RHOA; ACTIVATION; INHIBITORS; METASTASIS; RAS; FARNESYLTRANSFERASE	Dysregulation of Ras and Rho family small GTPases drives the invasion and metastasis of multiple cancers. For their biological functions, these GTPases require proper subcellular localization to cellular membranes, which is regulated by a series of post-translational modifications that result in either farnesylation or geranylgeranylation of the C-terminal CAAX motif. This concept provided the rationale for targeting farnesyltransferase (FTase) and geranylgeranyltransferases (GGTase) for cancer treatment. However, the resulting prenyl transferase inhibitors have not performed well in the clinic due to issues with alternative prenylation and toxicity. As an alternative, we have developed a unique class of potential anti-cancer therapeutics called Prenyl Function Inhibitors (PFIs), which are farnesol or geranyl-geraniol analogs that act as alternate substrates for FTase or GGTase. Here, we test the ability of our lead PFIs, anilinogeraniol (AGOH) and anilinofarnesol (AFOH), to block the invasion of breast cancer cells. We found that AGOH treatment effectively decreased invasion of MDA-MB-231 cells in a two-dimensional (2D) invasion assay at 100 mu M while it blocked invasive growth in three-dimensional (3D) culture model at as little as 20 mM. Notably, the effect of AGOH on 3D invasive growth was phenocopied by electroporation of cells with C3 exotransferase. To determine if RhoA and RhoC were direct targets of AGOH, we performed Rho activity assays in MDA-MB-231 and MDA-MB-468 cells and found that AGOH blocked RhoA and RhoC activation in response to LPA and EGF stimulation. Notably, the geranylgeraniol analog AFOH was more potent than AGOH in inhibiting RhoA and RhoC activation and invasive growth. Interestingly, neither AGOH nor AFOH impacted 3D growth of MCF10A cells. Collectively, this study demonstrates that AGOH and AFOH dramatically inhibit breast cancer invasion, at least in part by blocking Rho function, thus, suggesting that targeting prenylation by using PFIs may offer a promising mechanism for treatment of invasive breast cancer.	[Chen, Min; Knifley, Teresa; Spielmann, H. Peter; O'Connor, Kathleen L.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA; [Chen, Min] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Subramanian, Thangaiah; Spielmann, H. Peter; O'Connor, Kathleen L.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA; [Spielmann, H. Peter] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Spielmann, H. Peter] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Chen, M (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA.	mch235@uky.edu	O'Connor, Kathleen L/H-2569-2013	O'Connor, Kathleen L/0000-0002-1088-9734	National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000117, R01CA109136, R01 GM66152]; NATIONAL CANCER INSTITUTE [R01CA109136] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066152] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000117 (pilot award to KLO and HPS), R01CA109136 (KLO) and R01 GM66152 (HPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BLASCHKE RJ, 1994, METHOD ENZYMOL, V245, P535; Chang SY, 2012, J LIPID RES, V53, P1176, DOI 10.1194/jlr.M026161; Chehade KAH, 2000, J ORG CHEM, V65, P3027, DOI 10.1021/jo991735t; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; DECREMOUX P, 1994, INT J CANCER, V59, P408, DOI 10.1002/ijc.2910590320; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Khan OM, 2011, J CLIN INVEST, V121, P628, DOI 10.1172/JCI43758; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; McHenry PR, 2010, CURR DRUG TARGETS, V11, P1043, DOI 10.2174/138945010792006852; O'Connor KL, 2012, AM J PHYSIOL-CELL PH, V302, pC605, DOI 10.1152/ajpcell.00095.2011; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Ochocki JD, 2013, MEDCHEMCOMM, V4, P476, DOI 10.1039/c2md20299a; Onono F, 2013, J BIOL CHEM, V288, P27444, DOI 10.1074/jbc.M113.482307; Onono FO, 2010, MOL CELL PROTEOMICS, V9, P742, DOI 10.1074/mcp.M900597-MCP200; Philips MR, 2007, J CLIN INVEST, V117, P1223, DOI 10.1172/JCI32108; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Pille JY, 2006, HUM GENE THER, V17, P1019, DOI 10.1089/hum.2006.17.1019; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Rosenthal DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040979; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Subramanian T, 2005, ORG LETT, V7, P2109, DOI 10.1021/ol050386o; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Troutman JM, 2007, BIOCHEMISTRY-US, V46, P11299, DOI 10.1021/bi700513n; Troutman JM, 2005, BIOCONJUGATE CHEM, V16, P1209, DOI 10.1021/bc050068+; Troutman JM, 2004, BIOORG MED CHEM LETT, V14, P4979, DOI 10.1016/j.bmcl.2004.07.017; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440; Young TW, 2004, CANCER RES, V64, P4577, DOI 10.1158/0008-5472.CAN-04-0222; ZHANG RD, 1991, INVAS METAST, V11, P204; Zhao XS, 2009, CANCER RES, V69, P483, DOI 10.1158/0008-5472.CAN-08-2907	52	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89892	10.1371/journal.pone.0089892	http://dx.doi.org/10.1371/journal.pone.0089892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587105	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000106
J	de Oliveira, LL; Calazans, LSB; de Morais, EB; Mayo, SJ; Schrago, CG; Sakuragui, CM				de Oliveira, Leticia Loss; Calazans, Luana Silva Braucks; de Morais, Erica Barroso; Mayo, Simon Joseph; Schrago, Carlos Guerra; Sakuragui, Cassia Monica			Floral Evolution of Philodendron Subgenus Meconostigma (Araceae)	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; INFERENCE; MRBAYES	Elucidating the evolutionary patterns of flower and inflorescence structure is pivotal to understanding the phylogenetic relationships of Angiosperms as a whole. The inflorescence morphology and anatomy of Philodendron subgenus Meconostigma, belonging to the monocot family Araceae, has been widely studied but the evolutionary relationships of subgenus Meconostigma and the evolution of its flower characters have hitherto remained unclear. This study examines gynoecium evolution in subgenus Meconostigma in the context of an estimated molecular phylogeny for all extant species of subgenus Meconostigma and analysis of ancestral character reconstructions of some gynoecial structures. The phylogenetic reconstructions of all extant Meconostigma species were conducted under a maximum likelihood approach based on the sequences of two chloroplast (trnk and matK) and two nuclear (ETS and 18S) markers. This topology was used to reconstruct the ancestral states of seven floral characters and to elucidate their evolutionary pattern in the Meconostigma lineage. Our phylogeny shows that Meconostigma is composed of two major clades, one comprising two Amazonian species and the other all the species from the Atlantic Forest and Cerrado biomes with one Amazonian species. The common ancestor of the species of subgenus Meconostigma probably possessed short stylar lobes, long stylar canals, a stylar body, a vascular plexus in the gynoecium and druses in the stylar parenchyma but it is uncertain whether raphide inclusions were present in the parenchyma. The ancestral lineage also probably possessed up to 10 ovary locules. The evolution of these characters seems to have occurred independently in some lineages. We propose that the morphological and anatomical diversity observed in the gynoecial structures of subgenus Meconostigma is the result of an ongoing process of fusion of floral structures leading to a reduction of energy wastage and increase in stigmatic surface.	[de Oliveira, Leticia Loss; Schrago, Carlos Guerra] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil; [Calazans, Luana Silva Braucks; Sakuragui, Cassia Monica] Univ Fed Rio de Janeiro, Inst Biol, Dept Bot, Rio De Janeiro, Brazil; [de Morais, Erica Barroso] Univ Fed Rio de Janeiro, Museu Nacl, Dept Bot, Rio De Janeiro, Brazil; [Mayo, Simon Joseph] Royal Bot Gardens, Herbarium, Richmond, Surrey, England	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Royal Botanic Gardens, Kew	Sakuragui, CM (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Bot, Rio De Janeiro, Brazil.	cmsakura12@gmail.com	Sakuragui, Cassia/J-8603-2014; Calazans, Luana S.B./I-1442-2012; Schrago, Carlos/E-4612-2012	Calazans, Luana S.B./0000-0002-3308-3725; Schrago, Carlos/0000-0001-6257-8906	National Research Council of Brazil (CNPq) [308147/2009-0, 307982/2012-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [110.838/2010, 110.028/2011, 111.831/2011]; CNPq [149000/2010-3, 026123/11-52, 134723/2010-4]	National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by National Research Council of Brazil (CNPq) (grant numbers 308147/2009-0 and 307982/2012-2 to CGS) and by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (grant numbers 110.838/2010, 110.028/2011 and 111.831/2011 to CGS). LL-O, LSBC and EBM were funded by scholarships from CNPq (grant numbers 149000/2010-3, 026123/11-52 and 134723/2010-4, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], GEN BAS 5 5 3 CREAT; Boyce P.C., 2013, UBERLIST ARACEAE TOT; Calazans Luana S. B., 2012, Journal of Threatened Taxa, V4, P3390; Croat TB, 1997, ANN MO BOT GARD, V84, P311, DOI 10.2307/2992022; Cronquist A., 1981, INTEGRATED SYSTEM CL; DILCHER DL, 1977, AM J BOT, V64, P526, DOI 10.2307/2442000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endress PK, 2011, AM J BOT, V98, P370, DOI 10.3732/ajb.1000299; ENDRESS PK, 1982, TAXON, V31, P48, DOI 10.2307/1220588; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Gauthier MPL, 2008, BOT J LINN SOC, V156, P13, DOI 10.1111/j.1095-8339.2007.00733.x; Gibernau M, 2002, INT J PLANT SCI, V163, P1017, DOI 10.1086/342628; Goncalves EG, 2002, AROIDEANA, V25, P2; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grayum M. H., 1996, SYST BOT MONOGR, V47, P1, DOI DOI 10.2307/25027858; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Maddison WP, 2009, MESQUITE MODULAR SYS; MAYO S J, 1991, Kew Bulletin, V46, P601, DOI 10.2307/4110410; MAYO SJ, 1989, BOT J LINN SOC, V100, P139, DOI 10.1111/j.1095-8339.1989.tb01714.x; Mayo SJ., 1988, ACTA BOT BRAS, V1, P27; Mayo SJ, 1986, THESIS U READING UK; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakuragui Cassia M., 2005, Kew Bulletin, V60, P465; Sakuragui Cassia Monica, 2012, Feddes Repertorium, V122, P472, DOI 10.1002/fedr.201200014; Sakuragui CM, 1998, THESIS U SAO PAULO B; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valente T. P., 2011, Forests, Trees and Livelihoods, V20, P211; WCSP, 2013, WORLD CHECKL SEL PLA	31	4	4	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89701	10.1371/journal.pone.0089701	http://dx.doi.org/10.1371/journal.pone.0089701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586972	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000079
J	Persson, M; Elfstrom, KM; Wendel, SB; Weiderpass, E; Andersson, S				Persson, Maria; Elfstrom, K. Miriam; Wendel, Sophia Brismar; Weiderpass, Elisabete; Andersson, Sonia			Triage of HR-HPV Positive Women with Minor Cytological Abnormalities: A Comparison of mRNA Testing, HPV DNA Testing, and Repeat Cytology Using a 4-Year Follow-Up of a Population-Based Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; INTRAEPITHELIAL NEOPLASIA; CLINICAL-PERFORMANCE; ASSAY; SAMPLES; CARCINOMAS; GUIDELINES; MANAGEMENT; DIAGNOSIS	Objective: Expression of the viral E6/E7 oncogenes of high-risk human papillomaviruses (HR-HPV) is necessary for malignant conversion and maintenance in cervical tissue. In order to determine whether HR-HPV E6/E7 mRNA testing more effectively predicts precancerous lesions and invasive cervical cancer than HR-HPV DNA testing, we aimed to compare triage using HR-HPV E6/E7 mRNA testing by APTIMA HPV Assay (APTIMA) to HPV16 DNA testing, HPV16/18 DNA testing, and repeat cytology. Methods: Liquid-based (PreservCyt) cell samples were obtained from HR-HPV-positive women diagnosed with atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesions (LSIL) within the framework of the population-based cervical cancer screening program in Stockholm, Sweden. Samples were tested for HR-HPV E6/E7 mRNA by APTIMA (Gene-Probe Inc., San Diego, CA, USA). Women were followed up for 4 years after the index cytology via medical and laboratory records, and the Stockholm Oncology Center. Results: Nine of 25 (36%) women in the ASCUS group, and 64 of 180 (36%) women in the LSIL group developed cervical intraepithelial neoplasia (CIN) grade 2 or worse during 4 years of follow-up. 162 (74%) women were APTIMA-positive, and APTIMA had the highest sensitivity to predict CIN2 or worse and CIN3 or worse in the ASCUS (77.8% and 100%) and LSIL (78.1 and 75.8%) groups, although specificity was insufficient (<50%). HPV16 DNA testing and repeat cytology were more specific than APTIMA. Conclusion: The results of this population-based study with comprehensive follow-up support the use of APTIMA as a triage test for women with ASCUS. More focused investigation is required for women with LSIL.	[Persson, Maria; Wendel, Sophia Brismar; Andersson, Sonia] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Elfstrom, K. Miriam; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Canc Registry Norway, Oslo, Norway; [Weiderpass, Elisabete] Univ Tromso, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Univ Helsinki, Folkhalsan Res Ctr, Genet Epidemiol Grp, Samfundet Folkhalsan, Helsinki, Finland	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Oslo; UiT The Arctic University of Tromso; Folkhalsan Research Center; Samfundet Folkhalsan; University of Helsinki	Andersson, S (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden.	sonia.andersson@karolinska.se	Weiderpass, Elisabete/M-4029-2016; Weiderpass, Elisabete/AAP-2747-2021; Brismar Wendel, Sophia/AFS-4418-2022	Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128; Brismar Wendel, Sophia/0000-0002-9401-8062	Swedish Cancer Foundation [070623, CAN 2007/1044, 110544, CAN 2011/471]; Karolinska Institutet Cancer Strategic Grants [5888/05-722]; Swedish Research Council [521-2008-2899]; Medical Research Council; Cancer Society in Stockholm; Stockholm County Council	Swedish Cancer Foundation; Karolinska Institutet Cancer Strategic Grants; Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Society in Stockholm; Stockholm County Council(Stockholm County Council)	This study was supported by the Swedish Cancer Foundation (070623, CAN 2007/1044; 110544, CAN 2011/471), Karolinska Institutet Cancer Strategic Grants (5888/05-722), the Swedish Research Council (521-2008-2899), the Medical Research Council and the Cancer Society in Stockholm, the Stockholm County Council. The study sponsors had no role in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	[Anonymous], 2012, SWEDISH NATL QUALITY; Arbyn M, 2012, INT J CANC; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brismar-Wendel S, 2009, BRIT J CANCER, V101, P511, DOI 10.1038/sj.bjc.6605165; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.0b013e31805152ab; Clad A, 2011, J CLIN MICROBIOL, V49, P1071, DOI 10.1128/JCM.01674-10; Cuschieri K, 2008, CANCER EPIDEM BIOMAR, V17, P2536, DOI 10.1158/1055-9965.EPI-08-0306; Cuschieri KS, 2004, J MED VIROL, V73, P65, DOI 10.1002/jmv.20062; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Cuzick J, 2008, JNCI-J NATL CANCER I, V100, P605, DOI 10.1093/jnci/djn131; Dockter J, 2009, J CLIN VIROL, V45, pS55, DOI 10.1016/S1386-6532(09)70009-5; Dockter J, 2009, J CLIN VIROL, V45, pS39, DOI 10.1016/S1386-6532(09)70007-1; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; Getman D, 2009, J CLIN VIROL, V45, pS49, DOI 10.1016/S1386-6532(09)70008-3; Hemminki K, 2002, EUR J OBSTET GYN R B, V101, P64, DOI 10.1016/S0301-2115(01)00508-5; IARC, 2012, IARC MON EV CARC R B, V100B; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Mesher D, 2013, EUR J CANC; Monsonego J, 2011, INT J CANCER, V129, P691, DOI 10.1002/ijc.25726; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nakagawa S, 2000, J MED VIROL, V62, P251, DOI 10.1002/1096-9071(200010)62:2<251::AID-JMV18>3.0.CO;2-V; Ovestad IT, 2011, GYNECOL ONCOL, V123, P278, DOI 10.1016/j.ygyno.2011.07.024; Persson M, 2012, ONCOL REP, V28, P346, DOI 10.3892/or.2012.1755; Richart R M, 1973, Pathol Annu, V8, P301; Rijkaart DC, 2012, J CLIN MICROBIOL, V50, P2390, DOI 10.1128/JCM.06587-11; Scott DR, 2002, CANCER CYTOPATHOL, V96, P14, DOI 10.1002/cncr.10317; SFOG, 2010, CERV CANC PREV; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Vaccarella S, 2013, EUR J CANC; Waldstrom M, 2011, ARCH PATHOL LAB MED, V135, P1052, DOI 10.5858/2010-0411-OAR; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	35	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90023	10.1371/journal.pone.0090023	http://dx.doi.org/10.1371/journal.pone.0090023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587193	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000129
J	Rabosky, DL				Rabosky, Daniel L.			Automatic Detection of Key Innovations, Rate Shifts, and Diversity-Dependence on Phylogenetic Trees	PLOS ONE			English	Article							DIVERSIFICATION RATES; EXTINCTION RATES; EVOLUTIONARY RADIATIONS; MOLECULAR PHYLOGENIES; TAXONOMIC DIVERSITY; MARKOV-CHAINS; SPECIATION; DYNAMICS; MODEL; TIME	A number of methods have been developed to infer differential rates of species diversification through time and among clades using time-calibrated phylogenetic trees. However, we lack a general framework that can delineate and quantify heterogeneous mixtures of dynamic processes within single phylogenies. I developed a method that can identify arbitrary numbers of time-varying diversification processes on phylogenies without specifying their locations in advance. The method uses reversible-jump Markov Chain Monte Carlo to move between model subspaces that vary in the number of distinct diversification regimes. The model assumes that changes in evolutionary regimes occur across the branches of phylogenetic trees under a compound Poisson process and explicitly accounts for rate variation through time and among lineages. Using simulated datasets, I demonstrate that the method can be used to quantify complex mixtures of time-dependent, diversity-dependent, and constant-rate diversification processes. I compared the performance of the method to the MEDUSA model of rate variation among lineages. As an empirical example, I analyzed the history of speciation and extinction during the radiation of modern whales. The method described here will greatly facilitate the exploration of macroevolutionary dynamics across large phylogenetic trees, which may have been shaped by heterogeneous mixtures of distinct evolutionary processes.	[Rabosky, Daniel L.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Rabosky, Daniel L.] Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rabosky, DL (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	drabosky@umich.edu	Rabosky, Daniel L/G-4530-2015		Miller Institute for Basic Research in Science at the University of California, Berkeley; University of Michigan;  [NSF-DEB-1256330]	Miller Institute for Basic Research in Science at the University of California, Berkeley(University of California System); University of Michigan(University of Michigan System); 	Financial support was provided by the Miller Institute for Basic Research in Science at the University of California, Berkeley, by the University of Michigan, and by NSF-DEB-1256330. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Bartolucci F, 2006, BIOMETRIKA, V93, P41, DOI 10.1093/biomet/93.1.41; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bokma F, 2008, EVOLUTION, V62, P2718, DOI 10.1111/j.1558-5646.2008.00492.x; Brock CD, 2011, SYST BIOL, V60, P410, DOI 10.1093/sysbio/syr007; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Didier G, 2012, J THEOR BIOL, V315, P26, DOI 10.1016/j.jtbi.2012.08.046; Eastman JM, 2011, EVOLUTION, V65, P3578, DOI 10.1111/j.1558-5646.2011.01401.x; Etienne RS, 2012, AM NAT, V180, pE75, DOI 10.1086/667574; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hohna S, 2011, MOL BIOL EVOL, V28, P2577, DOI 10.1093/molbev/msr095; Huelsenbeck JP, 2000, GENETICS, V154, P1879; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jonsson KA, 2012, P NATL ACAD SCI USA, V109, P6620, DOI 10.1073/pnas.1115835109; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; O'Meara BC, 2012, ANNU REV ECOL EVOL S, V43, P267, DOI 10.1146/annurev-ecolsys-110411-160331; Paradis E, 2005, EVOLUTION, V59, P1; Paradis E, 2011, EVOLUTION, V65, P661, DOI 10.1111/j.1558-5646.2010.01179.x; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pybus OG, 2010, P R SOC B, V267, P2267; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Quental TB, 2009, EVOLUTION, V63, P3158, DOI 10.1111/j.1558-5646.2009.00794.x; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Rabosky DL, 2012, METHODS ECOL EVOL, V3, P224, DOI 10.1111/j.2041-210X.2011.00166.x; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Rabosky DL, 2010, SYST BIOL, V59, P634, DOI 10.1093/sysbio/syq060; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Ruber L, 2005, EVOLUTION, V59, P1119; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Silvestro D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-311; Sisson SA, 2005, J AM STAT ASSOC, V100, P1077, DOI 10.1198/016214505000000664; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Stadler T, 2013, J EVOLUTION BIOL, V26, P1203, DOI 10.1111/jeb.12139; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Venditti C, 2011, NATURE, V479, P393, DOI 10.1038/nature10516; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001	63	668	672	7	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89543	10.1371/journal.pone.0089543	http://dx.doi.org/10.1371/journal.pone.0089543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586858	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000056
J	Fry, JP; Laestadius, LI; Grechis, C; Nachman, KE; Neff, RA				Fry, Jillian P.; Laestadius, Linnea I.; Grechis, Clare; Nachman, Keeve E.; Neff, Roni A.			Investigating the Role of State Permitting and Agriculture Agencies in Addressing Public Health Concerns Related to Industrial Food Animal Production	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FEEDING OPERATIONS; SWINE OPERATIONS; ENVIRONMENTAL INJUSTICE; RESPIRATORY HEALTH; EXPOSURE; ASTHMA; ODORS	Objectives: Industrial food animal production (IFAP) operations adversely impact environmental public health through air, water, and soil contamination. We sought to determine how state permitting and agriculture agencies respond to these public health concerns. Methods: We conducted semi-structured qualitative interviews with staff at 12 state agencies in seven states, which were chosen based on high numbers or rapid increase of IFAP operations. The interviews served to gather information regarding agency involvement in regulating IFAP operations, the frequency and type of contacts received about public health concerns, how the agency responds to such contacts, and barriers to additional involvement. Results: Permitting and agriculture agencies' responses to health-based IFAP concerns are constrained by significant barriers including narrow regulations, a lack of public health expertise within the agencies, and limited resources. Conclusions: State agencies with jurisdiction over IFAP operations are unable to adequately address relevant public health concerns due to multiple factors. Combining these results with previously published findings on barriers facing local and state health departments in the same states reveals significant gaps between these agencies regarding public health and IFAP. There is a clear need for regulations to protect public health and for public health professionals to provide complementary expertise to agencies responsible for regulating IFAP operations.	[Fry, Jillian P.; Laestadius, Linnea I.; Grechis, Clare; Nachman, Keeve E.; Neff, Roni A.] Johns Hopkins Univ, Ctr Livable Future, Baltimore, MD 21218 USA; [Fry, Jillian P.; Nachman, Keeve E.; Neff, Roni A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Laestadius, Linnea I.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Grechis, Clare; Nachman, Keeve E.; Neff, Roni A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Wisconsin System; University of Wisconsin Milwaukee; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fry, JP (corresponding author), Johns Hopkins Univ, Ctr Livable Future, Baltimore, MD 21218 USA.	jfry@jhsph.edu	Laestadius, Linnea/AAC-1911-2019	Laestadius, Linnea/0000-0003-3272-9317; Neff, Roni/0000-0002-0010-2635; Nachman, Keeve/0000-0003-4925-4151	GRACE Communications Foundation	GRACE Communications Foundation	Salary support for all authors was provided by a gift agreement from the GRACE Communications Foundation (www.gracelinks.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery RC, 2004, ARCH ENVIRON HEALTH, V59, P101, DOI 10.3200/AEOH.59.2.101-108; Avis M, 2003, QUAL HEALTH RES, V13, P995, DOI 10.1177/1049732303253298; BURKE TA, 1995, POLICY STUD J, V23, P76, DOI 10.1111/j.1541-0072.1995.tb00507.x; Burke Thomas A., 1995, WHOS CHARGE 50 STATE; Burkholder J, 2007, ENVIRON HEALTH PERSP, V115, P308, DOI 10.1289/ehp.8839; Casey JA, 2013, JAMA INTERN MED, V173, P1980, DOI 10.1001/jamainternmed.2013.10408; Centner TJ, 2011, J ANIM SCI, V89, P4364, DOI 10.2527/jas.2011-4256; Freudenberg N, 2011, AM J PUBLIC HEALTH, V101, pS123, DOI 10.2105/AJPH.2011.300265; Fry JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054720; Hendrick S, 2008, CONCENTRATED ANIMAL; Horton RA., 2009, AM J PUBLIC HEALTH, V99, pS610, DOI [10.2105/ajph.2008.148924, 10.2105/AJPH.2008.148924., DOI 10.2105/AJPH.2008.148924, 10.2105/AJPH.2008.148924]; Johns Hopkins Center for a Livable Future, 2013, IND FOOD AN PROD AM; Koski C, 2007, J ENVIRON PLANN MAN, V50, P483, DOI 10.1080/09640560701402000; Lenaway D, 2006, AM J PUBLIC HEALTH, V96, P410, DOI 10.2105/AJPH.2004.046037; Maxwell JA, 2010, QUAL INQ, V16, P475, DOI 10.1177/1077800410364740; Merchant JA, 2005, ENVIRON HEALTH PERSP, V113, P350, DOI 10.1289/ehp.7240; Mirabelli MC, 2006, ENVIRON HEALTH PERSP, V114, P591, DOI 10.1289/ehp.8586; National Association of State Departments of Agriculture, NASDA MEMB GEN OV; Nimmermark S, 2004, ANN AGR ENV MED, V11, P163; O'Donoghue E.J., 2011, EIB88 USDA EC RES SE; Osterberg D, 2004, AM J PUBLIC HEALTH, V94, P1703, DOI 10.2105/AJPH.94.10.1703; Pavilonis BT, 2013, ENVIRON RES, V122, P74, DOI 10.1016/j.envres.2012.12.008; PCIFAP (Pew Commission on Industrial Farm Animal Production), 2008, PUTT MEAT TABL IND F; Radon K, 2007, EPIDEMIOLOGY, V18, P300, DOI 10.1097/01.ede.0000259966.62137.84; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Sarisky J, 2011, J ENVIRON HEALTH, V73, P24; Schenker MB, 1998, AM J RESP CRIT CARE, V158, pS1; Schiffman SS, 2001, AGR FOREST METEOROL, V108, P213, DOI 10.1016/S0168-1923(01)00239-8; SCHIFFMAN SS, 1995, BRAIN RES BULL, V37, P369, DOI 10.1016/0361-9230(95)00015-1; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Smith Joanna, 2011, Nurse Res, V18, P39; Smith TJS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085342; Thu K, 1997, J AGR SAF HLTH, V3, P13, DOI DOI 10.13031/2013.17747; Trabue S, 2010, ATMOS ENVIRON, V44, P3538, DOI 10.1016/j.atmosenv.2010.06.009; U. S. Census Bureau, 2010, INCOME POVERTY HLTH; US Department of Agriculture, CENS AGR QUICK STATS; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Williams DL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-72; Wilson SM, 2007, ATMOS ENVIRON, V41, P4977, DOI 10.1016/j.atmosenv.2006.12.055; Wilson SM, 2002, ENVIRON HEALTH PERSP, V110, P195, DOI 10.1289/ehp.02110s2195; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P225, DOI 10.2307/3454438; Wing S, 2013, ENVIRON HEALTH PERSP, V121, P92, DOI 10.1289/ehp.1205109; Zinn Matthew D., 2002, STAN ENV LJ, V21, P81	43	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89870	10.1371/journal.pone.0089870	http://dx.doi.org/10.1371/journal.pone.0089870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB6EP	24587087	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700105
J	Moon, AM; Biggs, HM; Rubach, MP; Crump, JA; Maro, VP; Saganda, W; Reddy, EA				Moon, Andrew M.; Biggs, Holly M.; Rubach, Matthew P.; Crump, John A.; Maro, Venace P.; Saganda, Wilbrod; Reddy, Elizabeth A.			Evaluation of In-Hospital Management for Febrile Illness in Northern Tanzania before and after 2010 World Health Organization Guidelines for the Treatment of Malaria	PLOS ONE			English	Article							PARASITE DENSITY; CASE DEFINITIONS; ADOLESCENTS; INFECTIONS; ENDEMICITY; COUNTRIES; AFRICA; ADULTS; FEVER; AREAS	Objective: In 2010, the World Health Organization (WHO) published updated guidelines emphasizing and expanding recommendations for a parasitological confirmation of malaria before treating with antimalarials. This study aimed to assess differences in historic (2007-2008) (cohort 1) and recent (2011-2012) (cohort 2) hospital cohorts in the diagnosis and treatment of febrile illness in a low malaria prevalence area of northern Tanzania. Materials and Methods: We analyzed data from two prospective cohort studies that enrolled febrile adolescents and adults aged >= 13 years. All patients received quality-controlled aerobic blood cultures and malaria smears. We compared patients' discharge diagnoses, treatments, and outcomes to assess changes in the treatment of malaria and bacterial infections. Results: In total, 595 febrile inpatients were enrolled from two referral hospitals in Moshi, Tanzania. Laboratory-confirmed malaria was detected in 13 (3.2%) of 402 patients in cohort 1 and 1 (0.5%) of 193 patients in cohort 2 (p = 0.041). Antimalarials were prescribed to 201 (51.7%) of 389 smear-negative patients in cohort 1 and 97 (50.5%) of 192 smear-negative patients in cohort 2 (p = 0.794). Bacteremia was diagnosed from standard blood culture in 58 (14.5%) of 401 patients in cohort 1 compared to 18 (9.5%) of 190 patients in cohort 2 (p = 0.091). In cohort 1, 40 (69.0%) of 58 patients with a positive blood culture received antibacterials compared to 16 (88.9%) of 18 patients in cohort 2 (p = 0.094). In cohort 1, 43 (10.8%) of the 399 patients with known outcomes died during hospitalization compared with 12 (6.2%) deaths among 193 patients in cohort 2 (p = 0.073). Discussion: In a setting of low malaria transmission, a high proportion of smear-negative patients were diagnosed with malaria and treated with antimalarials despite updated WHO guidelines on malaria treatment. Improved laboratory diagnostics for non-malaria febrile illness might help to curb this practice.	[Moon, Andrew M.; Crump, John A.; Reddy, Elizabeth A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA; [Biggs, Holly M.; Rubach, Matthew P.; Crump, John A.; Reddy, Elizabeth A.] Duke Univ, Dept Med, Div Infect Dis & Int Hlth, Durham, NC USA; [Crump, John A.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Crump, John A.] Univ Otago, Dunedin Sch Med, Ctr Int Hlth, Dunedin, New Zealand; [Crump, John A.; Maro, Venace P.; Reddy, Elizabeth A.] Tumaini Univ, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Crump, John A.; Maro, Venace P.; Reddy, Elizabeth A.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Saganda, Wilbrod] Mawenzi Reg Hosp, Moshi, Tanzania	Duke University; Duke University; Duke University; University of Otago; Kilimanjaro Christian Medical Centre	Reddy, EA (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA.	elizabeth.reddy@gmail.com	Moon, Andrew/AAS-9615-2021; Crump, John A./AAZ-6412-2020; Crump, John A./AAZ-6289-2020; Moon, Andrew/GXV-9316-2022	Moon, Andrew/0000-0001-7163-2062; Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X; Rubach, Matthew/0000-0001-5262-1421	International Studies on AIDS-Associated Co-infections (ISAAC); United States National Institutes of Health (NIH) [U01 AI062563]; NIH Fogarty International Center AIDS International Training and Research Program [D43 PA-03-018]; Duke Clinical Trials Unit and Clinical Research Sites [U01 AI069484, R01TW009237]; NIH-NSF Ecology of Infectious Disease program and the UK Economic and Social Research Council and Biotechnology and Biological Sciences Research Council [NIAID-AI007392]; Fogarty International Center Global Health Fellowship [R25TW009343]; NIH [2P30 AI064518]; BBSRC [BB/J010367/1] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [R25TW009343, R25TW009337, R01TW009237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, T32AI007392, U01AI069484, U01AI062563] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J010367/1] Funding Source: researchfish	International Studies on AIDS-Associated Co-infections (ISAAC); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Fogarty International Center AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Duke Clinical Trials Unit and Clinical Research Sites; NIH-NSF Ecology of Infectious Disease program and the UK Economic and Social Research Council and Biotechnology and Biological Sciences Research Council; Fogarty International Center Global Health Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by an International Studies on AIDS-Associated Co-infections (ISAAC) award, a United States National Institutes of Health (NIH) funded program (U01 AI062563). Authors received support from the NIH Fogarty International Center AIDS International Training and Research Program D43 PA-03-018 (JAC, VPM), the Duke Clinical Trials Unit and Clinical Research Sites U01 AI069484 (JAC, VPM), R01TW009237 as part of the joint NIH-NSF Ecology of Infectious Disease program and the UK Economic and Social Research Council and Biotechnology and Biological Sciences Research Council (JAC), NIAID-AI007392 (HMB), and the Fogarty International Center Global Health Fellowship R25TW009343 (MPR). This publication was made possible with help from the Duke University Center for AIDS Research (CFAR), an NIH funded program (2P30 AI064518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOMERIEUX APIWEB; Archibald LK, 2001, EMERG INFECT DIS, V7, P302, DOI 10.3201/eid0702.010232; ASAP, 2008, HIV EP TANZ MAINL HA; Batwala V, 2011, MALARIA J, V10, DOI [10.1186/1475-2875-10-377, 10.1186/1475-2875-10-373]; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176; Bouley AJ, 2012, AM J TROP MED HYG, V87, P1105, DOI 10.4269/ajtmh.2012.12-0327; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandler CIR, 2006, TROP MED INT HEALTH, V11, P1178, DOI 10.1111/j.1365-3156.2006.01672.x; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393; National Bureau of Statistics, 2010, TANZ DEM HLTH SURV; National Bureau of Statistics, 2006, 2002 POP HOUS CENS R; OforiAdjei D, 1996, SOC SCI MED, V42, P1169, DOI 10.1016/0277-9536(95)00389-4; PETIT PLC, 1995, J TROP MED HYG, V98, P217; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; WHO, 2011, IMAI DISTR CLIN MAN; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2007, GUID PROV IN HIV TES	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89814	10.1371/journal.pone.0089814	http://dx.doi.org/10.1371/journal.pone.0089814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587056	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700096
J	Pehlevan, C; Sompolinsky, H				Pehlevan, Cengiz; Sompolinsky, Haim			Selectivity and Sparseness in Randomly Connected Balanced Networks	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; ODOR REPRESENTATIONS; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; MODEL; MECHANISMS; INTENSITY; STRIATE; INPUT	Neurons in sensory cortex show stimulus selectivity and sparse population response, even in cases where no strong functionally specific structure in connectivity can be detected. This raises the question whether selectivity and sparseness can be generated and maintained in randomly connected networks. We consider a recurrent network of excitatory and inhibitory spiking neurons with random connectivity, driven by random projections from an input layer of stimulus selective neurons. In this architecture, the stimulus-to-stimulus and neuron-to-neuron modulation of total synaptic input is weak compared to the mean input. Surprisingly, we show that in the balanced state the network can still support high stimulus selectivity and sparse population response. In the balanced state, strong synapses amplify the variation in synaptic input and recurrent inhibition cancels the mean. Functional specificity in connectivity emerges due to the inhomogeneity caused by the generative statistical rule used to build the network. We further elucidate the mechanism behind and evaluate the effects of model parameters on population sparseness and stimulus selectivity. Network response to mixtures of stimuli is investigated. It is shown that a balanced state with unselective inhibition can be achieved with densely connected input to inhibitory population. Balanced networks exhibit the "paradoxical'' effect: an increase in excitatory drive to inhibition leads to decreased inhibitory population firing rate. We compare and contrast selectivity and sparseness generated by the balanced network to randomly connected unbalanced networks. Finally, we discuss our results in light of experiments.	[Pehlevan, Cengiz; Sompolinsky, Haim] Harvard Univ, Swartz Program Theoret Neurosci, Ctr Brain Sci, Cambridge, MA 02138 USA; [Sompolinsky, Haim] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel	Harvard University; Hebrew University of Jerusalem	Pehlevan, C (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	pehlevanc@janelia.hhmi.org	Sompolinsky, Haim/ABB-8398-2021	Pehlevan, Cengiz/0000-0001-9767-6063	Max Planck Hebrew University Center; Swartz Foundation; Gatsby Charitable Foundation	Max Planck Hebrew University Center; Swartz Foundation; Gatsby Charitable Foundation	CP was supported by a fellowship from the Swartz Foundation. HS is partially supported by the Gatsby Charitable Foundation, the Max Planck Hebrew University Center, and the Swartz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Barbour DL, 2011, NEUROSCI BIOBEHAV R, V35, P2064, DOI 10.1016/j.neubiorev.2011.04.009; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Billimoria CP, 2008, J NEUROSCI, V28, P6304, DOI 10.1523/JNEUROSCI.0961-08.2008; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bressloff PC, 2003, PHILOS T R SOC B, V358, P1643, DOI 10.1098/rstb.2002.1109; Carandini M, 1997, VISION RES, V37, P3061, DOI 10.1016/S0042-6989(97)00100-4; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Franks KM, 2011, NEURON, V72, P49, DOI 10.1016/j.neuron.2011.08.020; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Hertz J, 2010, NEURAL COMPUT, V22, P427, DOI 10.1162/neco.2009.06-08-806; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kumar A, 2008, NEURAL COMPUT, V20, P1, DOI 10.1162/neco.2008.20.1.1; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lehky SR, 2005, VISION RES, V45, P57, DOI 10.1016/j.visres.2004.07.021; Lerchner A, 2006, NETWORK-COMP NEURAL, V17, P131, DOI 10.1080/09548980500444933; Loebel A, 2007, FRONT NEUROSCI-SWITZ, V1, P197, DOI 10.3389/neuro.01.1.1.015.2007; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Miura K, 2012, NEURON, V74, P1087, DOI 10.1016/j.neuron.2012.04.021; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; Pehlevan C, 2011, 2011 NEUR M PLANN; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Persi E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001078; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; TREVES A, 1991, NETWORK-COMP NEURAL, V2, P371, DOI 10.1088/0954-898X/2/4/004; Tsodyks MV, 1997, J NEUROSCI, V17, P4382; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; van Vreeswijk C., 2005, LECT NOTES LES HOUCH, VLXXX, P341, DOI DOI 10.1016/S0924-8099(05)80015-0; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wiechert MT, 2010, NAT NEUROSCI, V13, P1003, DOI 10.1038/nn.2591; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Willmore BDB, 2011, J NEUROPHYSIOL, V105, P2907, DOI 10.1152/jn.00594.2010; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wilson SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008778	61	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89992	10.1371/journal.pone.0089992	http://dx.doi.org/10.1371/journal.pone.0089992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587172	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700123
J	Uvarov, P; Kajander, T; Airaksinen, MS				Uvarov, Pavel; Kajander, Tommi; Airaksinen, Matti S.			Origin and Loss of Nested LRRTM/alpha-Catenin Genes during Vertebrate Evolution	PLOS ONE			English	Article							REPEAT TRANSMEMBRANE PROTEINS; WHOLE-GENOME DUPLICATION; SYNAPSE FORMATION; NEUREXIN; FAMILY; NEUROLIGINS; PERFORMANCE; COMPLEXITY; INSIGHTS	Leucine-rich repeat transmembrane neuronal proteins (LRRTMs) form in mammals a family of four postsynaptic adhesion proteins, which have been shown to bind neurexins and heparan sulphate proteoglycan (HSPG) glypican on the presynaptic side. Mutations in the genes encoding LRRTMs and neurexins are implicated in human cognitive disorders such as schizophrenia and autism. Our analysis shows that in most jawed vertebrates, lrrtm1, lrrtm2, and lrrtm3 genes are nested on opposite strands of large conserved intron of a-catenin genes ctnna2, ctnna1, and ctnna3, respectively. No lrrtm genes could be found in tunicates or lancelets, while two lrrtm genes are found in the lamprey genome, one of which is adjacent to a single ctnna homolog. Based on similar highly positive net charge of lamprey LRRTMs and the HSPG-binding LRRTM3 and LRRTM4 proteins, we speculate that the ancestral LRRTM might have bound HSPG before acquiring neurexins as binding partners. Our model suggests that lrrtm gene translocated into the large ctnna intron in early vertebrates, and that subsequent duplications resulted in three lrrtm/ctnna gene pairs present in most jawed vertebrates. However, we detected three prominent exceptions: (1) the lrrtm3/ctnna3 gene structure is absent in the ray-finned fish genomes, (2) the genomes of clawed frogs contain ctnna1 but lack the corresponding nested (lrrtm2) gene, and (3) contain lrrtm3 gene in the syntenic position but lack the corresponding host (ctnna3) gene. We identified several other protein-coding nested gene structures of which either the host or the nested gene has presumably been lost in the frog or chicken lineages. Interestingly, majority of these nested genes comprise LRR domains.	[Uvarov, Pavel; Airaksinen, Matti S.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Kajander, Tommi] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; University of Helsinki	Airaksinen, MS (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	matti.airaksinen@helsinki.fi	Uvarov, Pavel/AGR-2614-2022	Uvarov, Pavel/0000-0001-8439-6150; Airaksinen, Matti/0000-0002-7199-4984; Kajander, Tommi/0000-0002-5094-227X	Academy of Finland; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by grants from the Academy of Finland and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Assis R, 2008, TRENDS GENET, V24, P475, DOI 10.1016/j.tig.2008.08.003; Boyce R, 2009, NUCLEIC ACIDS RES, V37, pW222, DOI 10.1093/nar/gkp379; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Ehrmann I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003474; Emes RD, 2012, ANNU REV NEUROSCI, V35, P111, DOI 10.1146/annurev-neuro-062111-150433; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Galarneau A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-47; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Ho MR, 2012, GENOMICS, V100, P231, DOI 10.1016/j.ygeno.2012.06.011; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Laakso T, 2012, J ALZHEIMERS DIS, V31, P759, DOI 10.3233/JAD-2012-120193; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Qiu H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-325; Rissone A, 2007, MOL BIOL EVOL, V24, P236, DOI 10.1093/molbev/msl147; Siddiqui TJ, 2013, NEURON, V79, P680, DOI 10.1016/j.neuron.2013.06.029; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Voikar V, 2013, BEHAV BRAIN RES, V238, P69, DOI 10.1016/j.bbr.2012.10.013; Zhao ZM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-198	39	6	6	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89910	10.1371/journal.pone.0089910	http://dx.doi.org/10.1371/journal.pone.0089910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587117	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700113
J	Chon, SJ; Yun, BH; Jung, YS; Cho, SH; Choi, YS; Kim, SY; Lee, BS; Seo, SK				Chon, Seung Joo; Yun, Bo Hyon; Jung, Yeon Soo; Cho, Si Hyun; Choi, Young Sik; Kim, Suk Young; Lee, Byung Seok; Seo, Seok Kyo			Association between Vitamin D Status and Risk of Metabolic Syndrome among Korean Postmenopausal Women	PLOS ONE			English	Article							INCREASED CARDIOVASCULAR RISK; NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; BLOOD-PRESSURE; POPULATION; DISEASE; HDL	This study aimed to investigate the association between serum levels of 25-hydroxyvitamin D [25(OH)D] and metabolic syndrome along with its associated risk factors in Korean postmenopausal women. This study was performed using data from the KNHANES 2008-2010 study and included 4,364 postmenopausal Korean women. Clinical and other objective characteristics, seasonality, and presence of metabolic syndrome with its five components were evaluated and correlated with the serum levels of 25(OH)D. Although no statistically significant associations were observed between the levels of serum 25(OH)D and the prevalence of metabolic syndrome, the adjusted OR for elevated blood pressure, elevated triglycerides (TGs), and reduced high-density lipoprotein cholesterol (HDL-C) showed tendency to decrease sequentially as tertiles of serum 25(OH)D levels increased (p for trends = 0.066, 0.043, and 0.010, respectively). Women in the highest tertile of serum 25(OH)D showed a significant decrease in the prevalence of elevated blood pressure, elevated TGs, and reduced HDL-C as compared with those in the lowest tertile of serum 25(OH)D (p = 0.020, 0.014, and 0.002, respectively). Based on these results, we consider that adequate serum levels of 25(OH)D in Korean postmenopausal women may not entirely indicate a lower risk of developing metabolic syndrome. However, adequate serum levels of 25(OH)D are significantly associated with a decrease in elevated blood pressure, elevated TGs, and reduced HDL-C levels in postmenopausal women.	[Chon, Seung Joo; Yun, Bo Hyon; Jung, Yeon Soo; Choi, Young Sik; Seo, Seok Kyo] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Severance Hosp, Seoul, South Korea; [Cho, Si Hyun; Lee, Byung Seok] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Gangnam Severance Hosp, Seoul, South Korea; [Kim, Suk Young] Gachon Univ, Dept Obstet & Gynecol, Gil Hosp, Inchon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University	Seo, SK (corresponding author), Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Severance Hosp, Seoul, South Korea.	tudeolseo@yuhs.ac		Yun, Bo Hyon/0000-0001-5703-797X; Cho, SiHyun/0000-0003-2718-6645; Seo, Seok Kyo/0000-0003-3404-0484; LEE, Byung Seok/0000-0001-6001-2079; Choi, Young Sik/0000-0002-1157-4822				Alessi MC, 2008, THROMB HAEMOSTASIS, V99, P995, DOI 10.1160/TH07-11-0682; Awumey EMK, 1998, J CLIN ENDOCR METAB, V83, P169, DOI 10.1210/jc.83.1.169; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Choi SH, 2004, J KOREAN SOC STUDY O, V13, P53; Chowdhury TA, 2009, PRIM CARE DIABETES, V3, P115, DOI 10.1016/j.pcd.2009.03.004; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Dayspring TD, 2011, INT J WOMENS HEALTH, V3, P87, DOI 10.2147/IJWH.S16702; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Freeman MS, 2003, THROMB HAEMOSTASIS, V89, P161; George JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061282; Hintzpeter B, 2008, EUR J CLIN NUTR, V62, P1079, DOI 10.1038/sj.ejcn.1602825; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; International Physical Activity Questionnaire (IPAQ) Core Group, 2005, GUID DAT PROC AN INT; Jorde R, 2010, HYPERTENSION, V55, P792, DOI 10.1161/HYPERTENSIONAHA.109.143990; Kim S, 2012, DIABETES RES CLIN PR, V96, P230, DOI 10.1016/j.diabres.2012.01.001; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lim S, 2005, DIABETES CARE, V28, P1810, DOI 10.2337/diacare.28.7.1810; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Mascarenhas-Melo F, 2013, DIS MARKERS, V2013, P85, DOI 10.1155/2013/724706; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; On JY, 2004, DIABETES CARE, V27, P2027, DOI 10.2337/diacare.27.8.2027; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pasco JA, 2009, BONE, V44, P1085, DOI 10.1016/j.bone.2009.02.020; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Schnatz PF, 2011, MENOPAUSE, V18, P994, DOI 10.1097/gme.0b013e318212539d; Seo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075197; SITRUKWARE R, 1989, MATURITAS, V11, P259, DOI 10.1016/0378-5122(89)90023-6; Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x; Song J, 2004, DIABETIC MED, V21, P1064; Soules Michael R., 2001, Fertility and Sterility, V76, P874, DOI 10.1016/S0015-0282(01)02909-0; Stoney CM, 1997, HEALTH PSYCHOL, V16, P349, DOI 10.1037/0278-6133.16.4.349; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127	34	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89721	10.1371/journal.pone.0089721	http://dx.doi.org/10.1371/journal.pone.0089721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586986	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900143
J	Coelho, AL; Araujo, A; Gomes, M; Catarino, R; Marques, A; Medeiros, R				Coelho, Ana L.; Araujo, Antonio; Gomes, Monica; Catarino, Raquel; Marques, Agostinho; Medeiros, Rui			Circulating Ang-2 Mrna Expression Levels: Looking ahead to a New Prognostic Factor for NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR; ANGIOGENESIS; ANGIOPOIETIN-2	Non-small cell lung cancer (NSCLC) is the most common cancer and the leading cause of death from cancer worldwide. Antiangiogenic strategies directed towards tumor stroma are becoming gold standard in NSCLC treatment and researchers have been searching for biomarkers to identify patients for whom therapy with antiangiogenic inhibitors may be most beneficial and the importance of these as prognostic factors in NSCLC. The purpose of this study was to evaluate the prognostic value of circulating Ang-2 mRNA levels prior to treatment in NSCLC patients. The mRNA levels were determined by quantitative real-time PCR in the peripheral blood of 92 NSCLC patients. Our results demonstrate that patients with high circulating Ang-2 mRNA levels have diminished overall survival when compared to those with low mRNA levels (20.3 months vs 34.3 months, respectively; Log Rank Test, p = 0.016), when considering all NSCLC stages and this difference is even bigger when considering only patients with stage IV (15.9 months vs 31.3 months, respectively; Log Rank Test, p = 0.036). Moreover, circulating Ang-2 mRNA levels independently determine overall survival, and the concordance (c) index analysis showed that the definition of a nomogram that contains information regarding tumor stage, patients' smoking status and circulating Ang-2 mRNA levels present an increased capacity to predict overall survival in NSCLC patients (c-index 0.798). These results suggest that this nomogram could serve as a unique and practical tool to determine prognosis in NSCLC, not relying on the availability of adequate surgical or biopsy specimens of NSCLC. Attending to our results, the circulating Ang-2 mRNA levels should also be included in the design of preclinical studies and clinical trials involving antiangiogenic drugs targeting Ang-2, to guide adequate patient stratification and dose selection and increasing the likelihood of benefit to a level that is acceptable to patients and clinicians.	[Coelho, Ana L.; Araujo, Antonio; Gomes, Monica; Catarino, Raquel; Medeiros, Rui] Portuguese Inst Oncol Porto, Mol Oncol Grp, Oporto, Portugal; [Coelho, Ana L.; Marques, Agostinho] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Araujo, Antonio] Ctr Hosp Entre Douro & Vouga, Dept Med Oncol, Santa Maria Feira, Portugal; [Araujo, Antonio; Gomes, Monica; Catarino, Raquel; Medeiros, Rui] Univ Porto, Abel Salazar Inst Biomed Sci, P-4100 Oporto, Portugal; [Marques, Agostinho] Ctr Hosp S Joao, Dept Pulmonol, Oporto, Portugal; [Medeiros, Rui] Portuguese League Canc NRNorte, Res Dept, Oporto, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade do Porto; Sao Joao Hospital	Coelho, AL (corresponding author), Portuguese Inst Oncol Porto, Mol Oncol Grp, Oporto, Portugal.	pequenocoelho@hotmail.com	Medeiros, Rui/C-7938-2009; Araújo, António/B-5047-2008; Soares, Raquel/L-2349-2013	Medeiros, Rui/0000-0003-3010-8373; Araújo, António/0000-0002-7267-3584; Soares, Raquel/0000-0002-9157-5541; Gomes, Monica/0000-0001-9947-5775; Marques, Agostinho/0000-0002-4227-2093	Liga Portuguesa Contra o Cancro - Centro Regional do Norte; Novartis Portugal	Liga Portuguesa Contra o Cancro - Centro Regional do Norte; Novartis Portugal	The authors would like to thank the Liga Portuguesa Contra o Cancro - Centro Regional do Norte for the educational grant given to Ana L Coelho. This project was partially sponsored by a grant for basic research in molecular oncology from Novartis Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019773; [Anonymous], 2011, J CLIN ONCOLOGY, V29; Araujo A, 2007, ONCOLOGIST, V12, P201, DOI 10.1634/theoncologist.12-2-201; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bonomi M, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-115; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hegde PS, 2013, CLIN CANCER RES, V19, P929, DOI 10.1158/1078-0432.CCR-12-2535; Kienast Y, 2013, CLIN CANC RES; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lammers PE, 2013, J NATL COMPR CANC NE, V11, P1235, DOI 10.6004/jnccn.2013.0146; Li TH, 2013, J CLIN ONCOL, V31, P1039, DOI 10.1200/JCO.2012.45.3753; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nasarre P, 2009, CANCER RES, V69, P1324, DOI 10.1158/0008-5472.CAN-08-3030; Naumnik W, 2013, ADV EXP MED BIOL, V788, P341, DOI 10.1007/978-94-007-6627-3_46; Naumnik W, 2009, CANCER INVEST, V27, P741, DOI 10.1080/07357900802672704; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Palmer GM, 2012, BRIT J PHARMACOL, V165, P1891, DOI 10.1111/j.1476-5381.2011.01677.x; Park JH, 2007, CHEST, V132, P200, DOI 10.1378/chest.06-2915; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Rennel ES, 2011, MICROCIRCULATION, V18, P598, DOI 10.1111/j.1549-8719.2011.00120.x; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Takanami I, 2004, ONCOL REP, V12, P849; Thomas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054923	28	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90009	10.1371/journal.pone.0090009	http://dx.doi.org/10.1371/journal.pone.0090009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587185	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200111
J	Strazzullo, M; Gasparrini, B; Neglia, G; Balestrieri, ML; Francioso, R; Rossetti, C; Nassa, G; De Filippo, MR; Weisz, A; Di Francesco, S; Vecchio, D; D'Esposito, M; D'Occhio, MJ; Zicarelli, L; Campanile, G				Strazzullo, Maria; Gasparrini, Bianca; Neglia, Gianluca; Balestrieri, Maria Luisa; Francioso, Romina; Rossetti, Cristina; Nassa, Giovanni; De Filippo, Maria Rosaria; Weisz, Alessandro; Di Francesco, Serena; Vecchio, Domenico; D'Esposito, Maurizio; D'Occhio, Michael John; Zicarelli, Luigi; Campanile, Giuseppe			Global Transcriptome Profiles of Italian Mediterranean Buffalo Embryos with Normal and Retarded Growth	PLOS ONE			English	Article							CIRCULATING PROGESTERONE; COMPLEMENT ACTIVATION; MATERNAL RECOGNITION; PREGNANCY; CONCEPTUS; ENDOMETRIUM; MORTALITY; CATTLE; IMPLANTATION; ELONGATION	The transcriptome profiles were compared for buffalo embryos with normal growth and embryos with retarded growth on Day 25 after mating. Embryos with retarded growth on Day 25 after mating have a reduced likelihood of undergoing attachment to the uterine endometrium and establishing a pregnancy. Italian Mediterranean buffaloes were mated by AI and on Day 25 underwent trans-rectal ultrasonography to ascertain embryo development. Embryos with an embryonic width (EW)>2.7 mm were classed as normal embryos and embryos with an EW<2.7 mm were classed as retarded embryos. Three buffaloes with embryos of the largest EW (3.7, 3.7 and 3.9 mm) and three buffaloes with embryos of the smallest EW (1.5, 1.6 and 1.9 mm) were slaughtered on Day 27 to recover embryos for transcriptome analysis using a bovine custom designed oligo array. A total of 1,047 transcripts were differentially expressed between embryos with normal growth and embryos with retarded growth. Retarded embryos showed 773/1,047 (74%) transcripts that were down-regulated and 274/1, 047 (26%) transcripts that were up-regulated relative to normal embryos; in silico analyses focused on 680/1,047 (65%) of the differentially expressed transcripts. The most altered transcripts observed in retarded embryos were associated with membrane structure and function and with metabolic and homeostasis maintenance functions. Other notable functions altered in retarded embryos were developmental processes and in particular nervous system differentiation and function. Specific biochemical pathways such as the complement cascade and coagulation were also altered in retarded embryos. It was concluded from the findings that buffalo embryos with retarded growth on Day 25 after mating show altered gene expression compared with normal embryos, and some de-regulated functions are associated with attachment to the uterine endometrium.	[Strazzullo, Maria; Rossetti, Cristina] CNR, Inst Anim Prod Syst Mediterranean Environm, Naples, Italy; [Gasparrini, Bianca; Neglia, Gianluca; Di Francesco, Serena; Vecchio, Domenico; Zicarelli, Luigi; Campanile, Giuseppe] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Balestrieri, Maria Luisa] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Francioso, Romina; D'Esposito, Maurizio] CNR, Inst Genet & Biophys ABT, Naples, Italy; [Francioso, Romina; D'Esposito, Maurizio] Ist Ricovero & Cura Carattere Sci IRCSS Neuromed, Pozzilli, Italy; [Nassa, Giovanni; Weisz, Alessandro] Univ Salerno, Dept Med & Surg, Lab Mol Med & Genom, I-84081 Baronissi, SA, Italy; [De Filippo, Maria Rosaria] Fdn Ist Ricovero & Cura Carattere Sci SDN, Naples, Italy; [D'Occhio, Michael John] Univ Sydney, Fac Agr & Environm, Camden, NSW, Australia	Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Neuromed; University of Salerno; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Sydney	Neglia, G (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy.	neglia@unina.it	Vecchio, Domenico/I-4102-2013; Weisz, Alessandro/A-1317-2014; Campanile, Giuseppe/L-1843-2015; Nassa, Giovanni/AAB-2059-2022; Strazzullo, Maria/B-6050-2015; D'Esposito, Maurizio/J-9205-2016; D'Esposito, Maurizio/AAY-6376-2020; Neglia, Gianluca/A-9099-2008	Vecchio, Domenico/0000-0002-8766-7224; Weisz, Alessandro/0000-0003-0455-2083; Campanile, Giuseppe/0000-0002-3242-7274; Neglia, Gianluca/0000-0002-0989-6072; gasparrini, bianca/0000-0002-5086-7767; Balestrieri, Maria Luisa/0000-0001-6001-1789	Ministry of University and Research P.R.I.N./MIUR [2008X2PNYX_005]; Italian Association for Cancer Research [IG-13176]; University of Salerno (Fondi FARB); EU COST Action 'SEQAHEAD: Next Generation Sequencing Data Analysis Network' [BM1006]; Italian Foundation for Cancer Research	Ministry of University and Research P.R.I.N./MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); University of Salerno (Fondi FARB); EU COST Action 'SEQAHEAD: Next Generation Sequencing Data Analysis Network'; Italian Foundation for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from Ministry of University and Research P.R.I.N./MIUR 2008 code 2008X2PNYX_005 (MS), the Italian Association for Cancer Research (Grant IG-13176), the University of Salerno (Fondi FARB 2011-2013), EU COST Action 'SEQAHEAD: Next Generation Sequencing Data Analysis Network' (BM1006). GN was supported by a 'Mario e Valeria Rindi' fellowship of the Italian Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Balestrieri ML, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108696; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; Barone V, 2012, CURR OPIN CELL BIOL, V24, P148, DOI 10.1016/j.ceb.2011.11.006; Beltman ME, 2009, THERIOGENOLOGY, V72, P986, DOI 10.1016/j.theriogenology.2009.06.018; Campanile G, 2005, THERIOGENOLOGY, V63, P2334, DOI 10.1016/j.theriogenology.2004.10.012; Campanile G, 2007, ITAL J ANIM SCI, V6, P119; Campanile G, 2010, ANIM REPROD SCI, V121, P1, DOI 10.1016/j.anireprosci.2010.03.012; Carter F, 2010, BIOL REPROD, V83, P707, DOI 10.1095/biolreprod.109.082354; Clemente M, 2011, BIOL REPROD, V85, P285, DOI 10.1095/biolreprod.111.091587; Clemente M, 2009, REPRODUCTION, V138, P507, DOI 10.1530/REP-09-0152; Davey MW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-436; Di Francesco S, 2012, THERIOGENOLOGY, V78, P1839, DOI 10.1016/j.theriogenology.2012.07.022; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2012, J REPROD DEVELOP, V58, P189, DOI 10.1262/jrd.2011-021; Garrido-Gomez T, 2012, FASEB J, V26, P3715, DOI 10.1096/fj.12-204008; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Gu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043325; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Leeb M, 2012, CHROMOSOMA, V121, P251, DOI 10.1007/s00412-012-0365-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonergan P, 2011, THERIOGENOLOGY, V76, P1594, DOI 10.1016/j.theriogenology.2011.06.012; Mamo S, 2012, ANIM REPROD SCI, V134, P56, DOI 10.1016/j.anireprosci.2012.08.011; Mamo S, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099945; Mamo S, 2011, BIOL REPROD, V85, P1143, DOI 10.1095/biolreprod.111.092643; Mann GE, 1999, REPROD DOMEST ANIM, V34, P269, DOI 10.1111/j.1439-0531.1999.tb01250.x; Maruotti J, 2012, MOL REPROD DEV, V79, P461, DOI 10.1002/mrd.22051; Menezo Y, 2013, J ASSIST REPROD GEN, V30, P293, DOI 10.1007/s10815-013-9953-9; Nazar RN, 2010, MOL BIOTECHNOL, V44, P8, DOI 10.1007/s12033-009-9212-6; Neglia G, 2012, REPROD DOMEST ANIM, V47, P26, DOI 10.1111/j.1439-0531.2011.01794.x; Oestrup O, 2009, REPROD DOMEST ANIM, V44, P39, DOI 10.1111/j.1439-0531.2009.01482.x; Ostrup E, 2011, REPROD FERT DEVELOP, V23, P964, DOI 10.1071/RD11140; Parks JC, 2011, FERTIL STERIL, V95, P1367, DOI 10.1016/j.fertnstert.2010.08.009; Robert C, 2011, MOL REPROD DEV, V78, P651, DOI 10.1002/mrd.21364; Russo M, 2010, REPROD DOMEST ANIM, V45, P988, DOI 10.1111/j.1439-0531.2009.01472.x; Santos JEP, 2004, ANIM REPROD SCI, V82-3, P513, DOI 10.1016/j.anireprosci.2004.04.015; Scarano MI, 2005, J CELL PHYSIOL, V204, P21, DOI 10.1002/jcp.20280; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; Strazzullo M, 2010, CYTOGENET GENOME RES, V128, P222, DOI 10.1159/000308359; Takahashi M, 2012, J REPROD DEVELOP, V58, P1, DOI 10.1262/jrd.11-138N; Talbot NC, 2010, ANIM REPROD SCI, V120, P187, DOI 10.1016/j.anireprosci.2010.03.009; Tincani A, 2010, CLIN REV ALLERG IMMU, V39, P153, DOI 10.1007/s12016-009-8183-5; Ushizawa Koichi, 2004, Reprod Biol Endocrinol, V2, P77; Vecchio D, 2012, THERIOGENOLOGY, V77, P1811, DOI 10.1016/j.theriogenology.2011.12.025; Vecchio D, 2010, REPROD DOMEST ANIM, V45, P614, DOI 10.1111/j.1439-0531.2008.01312.x; Yang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S14	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90027	10.1371/journal.pone.0090027	http://dx.doi.org/10.1371/journal.pone.0090027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587197	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200115
J	Bravo-Nuevo, A; Marcy, A; Huang, MZ; Kappler, F; Mulgrew, J; Laury-Kleintop, L; Reichman, M; Tobia, A; Prendergast, GC				Bravo-Nuevo, Arturo; Marcy, Alice; Huang, Minzhou; Kappler, Frank; Mulgrew, Jennifer; Laury-Kleintop, Lisa; Reichman, Melvin; Tobia, Annette; Prendergast, George C.			Meglumine Exerts Protective Effects against Features of Metabolic Syndrome and Type II Diabetes	PLOS ONE			English	Article							SNARK-DEFICIENT MICE; GLUCOSE-TRANSPORT; INSULIN SENSITIVITY; SKELETAL-MUSCLE; EXERCISE; KINASE; IDENTIFICATION; DIARRHEA; NUAK2	Metabolic syndrome, diabetes and diabetes complications pose a growing medical challenge worldwide, accentuating the need of safe and effective strategies for their clinical management. Here we present preclinical evidence that the sorbitol derivative meglumine (N-methyl-D-glucamine) can safely protect against several features of metabolic syndrome and diabetes, as well as elicit enhancement in muscle stamina. Meglumine is a compound routinely used as an approved excipient to improve drug absorption that has not been ascribed any direct biological effects in vivo. Normal mice (SV129) administered 18 mM meglumine orally for six weeks did not display any gastrointestinal or other observable adverse effects, but had a marked effect on enhancing muscle stamina and at longer times in limiting weight gain. In the established KK.Cg-Ay/J model of non-insulin dependent diabetes, oral administration of meglumine significantly improved glycemic control and significantly lowered levels of plasma and liver triglycerides. Compared to untreated control animals, meglumine reduced apparent diabetic nephropathy. Sorbitol can improve blood glucose uptake by liver and muscle in a manner associated with upregulation of the AMPK-related enzyme SNARK, but with undesirable gastrointestinal side effects not seen with meglumine. In murine myoblasts, we found that meglumine increased steady-state SNARK levels in a dose-dependent manner more potently than sorbitol. Taken together, these findings provide support for the clinical evaluation of meglumine as a low-cost, safe supplement offering the potential to improve muscle function, limit metabolic syndrome and reduce diabetic complications.	[Bravo-Nuevo, Arturo; Huang, Minzhou; Mulgrew, Jennifer; Laury-Kleintop, Lisa; Prendergast, George C.] LIMR, Wynnewood, PA USA; [Marcy, Alice; Kappler, Frank; Tobia, Annette] Dynamis Pharmaceut Co Inc, Jenkintown, PA USA; [Reichman, Melvin] LIMR Chem Genom Ctr Inc, Wynnewood, PA USA	Lankenau Medical Center; Lankenau Institute for Medical Research	Bravo-Nuevo, A (corresponding author), LIMR, Wynnewood, PA USA.	bravo-nuevo@LIMR.org	Nuevo, Arturo Bravo/AAQ-1900-2020	Nuevo, Arturo Bravo/0000-0001-8237-7802	Dynamis Therapeutics Inc.	Dynamis Therapeutics Inc.	This work was funded by a grant from Dynamis Therapeutics Inc. (http://www.dynamis-therapeutics.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADCOCK LH, 1957, BIOCHEM J, V65, P554, DOI 10.1042/bj0650554; Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; GRYBOSKI JD, 1966, NEW ENGL J MED, V275, P718, DOI 10.1056/NEJM196609292751309; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; HEEG JF, 1977, J PHARM SCI, V66, P96, DOI 10.1002/jps.2600660124; Ichinoseki-Sekine N, 2009, AM J PHYSIOL-ENDOC M, V296, pE1013, DOI 10.1152/ajpendo.90891.2008; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; Lefebvre DL, 2005, BBA-GEN SUBJECTS, V1724, P71, DOI 10.1016/j.bbagen.2005.03.015; Lefebvre DL, 2001, BIOCHEM J, V355, P297, DOI 10.1042/0264-6021:3550297; Loughlin DT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011093; Loughlin DT, 2009, WOUND REPAIR REGEN, V17, P739, DOI 10.1111/j.1524-475X.2009.00532.x; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Ramasamy R, 2010, CIRC RES, V106, P1449, DOI 10.1161/CIRCRESAHA.109.213447; RAVRY MJR, 1980, JAMA-J AM MED ASSOC, V244, P270; Rune A, 2009, DIABETOLOGIA, V52, P2182, DOI 10.1007/s00125-009-1465-x; Tsuchihara K, 2008, CANCER SCI, V99, P677, DOI 10.1111/j.1349-7006.2008.00734.x; Vallenius T, 2011, J CELL SCI, V124, P384, DOI 10.1242/jcs.072660; WANG YM, 1981, ANNU REV NUTR, V1, P437, DOI 10.1146/annurev.nu.01.070181.002253; Yamamoto H, 2008, BIOCHEM BIOPH RES CO, V365, P541, DOI 10.1016/j.bbrc.2007.11.013	22	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90031	10.1371/journal.pone.0090031	http://dx.doi.org/10.1371/journal.pone.0090031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587200	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800069
J	Brittain, C; Kremen, C; Garber, A; Klein, AM				Brittain, Claire; Kremen, Claire; Garber, Andrea; Klein, Alexandra-Maria			Pollination and Plant Resources Change the Nutritional Quality of Almonds for Human Health	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; CLIMATE-CHANGE; CARDIOVASCULAR-DISEASE; SELF-POLLINATION; WATER-RESOURCES; OIL CONTENT; YIELD; VULNERABILITY; RESPONSES; SERVICES	Insect-pollinated crops provide important nutrients for human health. Pollination, water and nutrients available to crops can influence yield, but it is not known if the nutritional value of the crop is also influenced. Almonds are an important source of critical nutrients for human health such as unsaturated fat and vitamin E. We manipulated the pollination of almond trees and the resources available to the trees, to investigate the impact on the nutritional composition of the crop. The pollination treatments were: (a) exclusion of pollinators to initiate self-pollination and (b) hand cross-pollination; the plant resource treatments were: (c) reduced water and (d) no fertilizer. In an orchard in northern California, trees were exposed to a single treatment or a combination of two (one pollination and one resource). Both the fat and vitamin E composition of the nuts were highly influenced by pollination. Lower proportions of oleic to linoleic acid, which are less desirable from both a health and commercial perspective, were produced by the self-pollinated trees. However, higher levels of vitamin E were found in the self-pollinated nuts. In some cases, combined changes in pollination and plant resources sharpened the pollination effects, even when plant resources were not influencing the nutrients as an individual treatment. This study highlights the importance of insects as providers of cross-pollination for fruit quality that can affect human health, and, for the first time, shows that other environmental factors can sharpen the effect of pollination. This contributes to an emerging field of research investigating the complexity of interactions of ecosystem services affecting the nutritional value and commercial quality of crops.	[Brittain, Claire; Klein, Alexandra-Maria] Univ Luneburg, Inst Ecol, Luneburg, Germany; [Brittain, Claire] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Kremen, Claire] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Garber, Andrea] Univ Calif San Francisco, Div Adolescent Med, San Francisco, CA 94143 USA; [Klein, Alexandra-Maria] Univ Freiburg, Chair Nat Conservat & Landscape Ecol, Freiburg, Germany	Leuphana University Luneburg; University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of Freiburg	Brittain, C (corresponding author), Univ Luneburg, Inst Ecol, Luneburg, Germany.	cabrittain@ucdavis.edu	Klein, Alexandra-Maria/J-5871-2016	Klein, Alexandra-Maria/0000-0003-2139-8575	Alexander von Humboldt Foundation; Hellmann Foundation; McDonnell 21st Century Foundation; University of California, Berkeley; Germany Science Foundation [KL 1849/4-1]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Hellmann Foundation; McDonnell 21st Century Foundation; University of California, Berkeley(University of California System); Germany Science Foundation	We acknowledge the Alexander von Humboldt, Hellmann and the McDonnell 21st Century Foundations, the Chancellor's Partnership Fund of the University of California, Berkeley, and the Germany Science Foundation (KL 1849/4-1) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Almond Board of California, 2011, 2011 ALM ALM; Benard C, 2009, J AGR FOOD CHEM, V57, P4112, DOI 10.1021/jf8036374; Bommarco R, 2012, OECOLOGIA, V169, P1025, DOI 10.1007/s00442-012-2271-6; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Cardoso AII, 2004, SCI AGR, V61, P224, DOI 10.1590/S0103-90162004000200016; Carman H, 2007, CALIF AGR, V61, P177, DOI 10.3733/ca.v061n04p177; CASTILLO EG, 1992, AGRON J, V84, P152, DOI 10.2134/agronj1992.00021962008400020006x; Certal AC, 2002, SEX PLANT REPROD, V15, P13, DOI 10.1007/s00497-002-0138-4; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garratt MPD, 2014, AGR ECOSYST ENVIRON, V184, P34, DOI 10.1016/j.agee.2013.10.032; Goldhamer D. A., 1995, California Agriculture, V49, P19, DOI 10.3733/ca.v049n01p19; Greenwald P, 2001, EUR J CANCER, V37, P948, DOI 10.1016/S0959-8049(01)00070-3; Greven M, 2009, AGR WATER MANAGE, V96, P1525, DOI 10.1016/j.agwat.2009.06.002; Groeneveld JH, 2010, PERSPECT PLANT ECOL, V12, P183, DOI 10.1016/j.ppees.2010.02.005; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hu FB, 2003, AM J CLIN NUTR, V78, p544S, DOI 10.1093/ajcn/78.3.544S; Jalali-Khanabadi BA, 2010, J ALTERN COMPLEM MED, V16, P1279, DOI 10.1089/acm.2009.0693; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Klein AM, 2015, PLANT BIOLOGY, V17, P201, DOI 10.1111/plb.12180; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kodad O, 2008, J AGR FOOD CHEM, V56, P4096, DOI 10.1021/jf8001679; Kris-Etherton PM, 1999, AM J CLIN NUTR, V70, P1009; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; PACKER L, 1991, AM J CLIN NUTR, V53, pS1050, DOI 10.1093/ajcn/53.4.1050S; PIMIENTA E, 1983, ANN BOT-LONDON, V51, P469, DOI 10.1093/oxfordjournals.aob.a086492; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Sathe SK, 2008, J FOOD SCI, V73, pC607, DOI 10.1111/j.1750-3841.2008.00936.x; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; SOLER L, 1988, J AGR FOOD CHEM, V36, P695, DOI 10.1021/jf00082a007; Subramanian KS, 2006, SCI HORTIC-AMSTERDAM, V107, P245, DOI 10.1016/j.scienta.2005.07.006; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Vicuna S, 2007, J AM WATER RESOUR AS, V43, P482, DOI 10.1111/j.1752-1688.2007.00038.x; Volz RK, 1996, SCI HORTIC-AMSTERDAM, V66, P169, DOI 10.1016/S0304-4238(96)00934-X; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wallace HM, 1999, J HORTIC SCI BIOTECH, V74, P82, DOI 10.1080/14620316.1999.11511077; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Yada S, 2011, J FOOD COMPOS ANAL, V24, P469, DOI 10.1016/j.jfca.2011.01.007	41	38	41	3	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90082	10.1371/journal.pone.0090082	http://dx.doi.org/10.1371/journal.pone.0090082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587215	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800073
J	Filosi, M; Visintainer, R; Riccadonna, S; Jurman, G; Furlanello, C				Filosi, Michele; Visintainer, Roberto; Riccadonna, Samantha; Jurman, Giuseppe; Furlanello, Cesare			Stability Indicators in Network Reconstruction	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; P53-INDUCIBLE MICRORNAS; INFERENCE ALGORITHMS; CANCER; METASTASIS; CHALLENGES; ALIGNMENT; SURVIVAL	The number of available algorithms to infer a biological network from a dataset of high-throughput measurements is overwhelming and keeps growing. However, evaluating their performance is unfeasible unless a 'gold standard' is available to measure how close the reconstructed network is to the ground truth. One measure of this is the stability of these predictions to data resampling approaches. We introduce NetSI, a family of Network Stability Indicators, to assess quantitatively the stability of a reconstructed network in terms of inference variability due to data subsampling. In order to evaluate network stability, the main NetSI methods use a global/local network metric in combination with a resampling (bootstrap or cross-validation) procedure. In addition, we provide two normalized variability scores over data resampling to measure edge weight stability and node degree stability, and then introduce a stability ranking for edges and nodes. A complete implementation of the NetSI indicators, including the Hamming-Ipsen-Mikhailov (HIM) network distance adopted in this paper is available with the R package nettools. We demonstrate the use of the NetSI family by measuring network stability on four datasets against alternative network reconstruction methods. First, the effect of sample size on stability of inferred networks is studied in a gold standard framework on yeast-like data from the Gene Net Weaver simulator. We also consider the impact of varying modularity on a set of structurally different networks (50 nodes, from 2 to 10 modules), and then of complex feature covariance structure, showing the different behaviours of standard reconstruction methods based on Pearson correlation, Maximum Information Coefficient (MIC) and False Discovery Rate (FDR) strategy. Finally, we demonstrate a strong combined effect of different reconstruction methods and phenotype subgroups on a hepatocellular carcinoma miRNA microarray dataset (240 subjects), and we validate the analysis on a second dataset (166 subjects) with good reproducibility.	[Filosi, Michele; Visintainer, Roberto; Jurman, Giuseppe; Furlanello, Cesare] Fdn Bruno Kessler, MPBA Ctr Informat & Commun Technol, Trento, Italy; [Filosi, Michele] Univ Trent, CIBIO, Trento, Italy; [Riccadonna, Samantha] FEM, Res & Innovat Ctr, Dept Computat Biol, San Michele All Adige, Italy	Fondazione Bruno Kessler; University of Trento; Fondazione Edmund Mach	Jurman, G (corresponding author), Fdn Bruno Kessler, MPBA Ctr Informat & Commun Technol, Trento, Italy.	jurman@fbk.eu	Jurman, Giuseppe/GRS-8221-2022; Riccadonna, Samantha/H-7247-2019	Riccadonna, Samantha/0000-0002-9737-8274; Jurman, Giuseppe/0000-0002-2705-5728; Visintainer, Roberto/0000-0003-1289-6871; Furlanello, Cesare/0000-0002-5384-3605; Filosi, Michele/0000-0002-3872-347X	Fondazione Bruno Kessler	Fondazione Bruno Kessler	The authors acknowledge funding by Fondazione Bruno Kessler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese D, 2013, BIOINFORMATICS, V29, P407, DOI 10.1093/bioinformatics/bts707; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Altay G, 2012, IET SYST BIOL, V6, P35, DOI 10.1049/iet-syb.2010.0091; Altay G, 2010, BIOINFORMATICS, V26, P1738, DOI 10.1093/bioinformatics/btq259; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambroise J, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1695; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Atay FM, 2006, PHYSICA D, V224, P35, DOI 10.1016/j.physd.2006.09.018; Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Baralla A, 2009, ANN NY ACAD SCI, V1158, P246, DOI 10.1111/j.1749-6632.2008.04099.x; Barla A, 2013, SPRINGER HDB BIONEUR, P1200; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cai XD, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003068; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chung F., 1997, SPECTRAL GRAPH THEOR; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; Davison AC, 1997, BOOTSTRAP METHODS TH; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Dougherty ER, 2011, BRIEF BIOINFORM, V12, P245, DOI 10.1093/bib/bbq078; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fay D, 2013, GRAPH METRI IN PRESS; Feizi S, 2013, NAT BIOTECHNOL, V31, P726, DOI 10.1038/nbt.2635; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gillis J, 2011, BIOINFORMATICS, V27, P1860, DOI 10.1093/bioinformatics/btr288; Gu ZG, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-32; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Ipsen M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046109; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jiao Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-403; Jurman G, 2013, ARXIV12012931MATHCO; Jurman G, 2011, FRONT ARTIF INTEL AP, V226, P227, DOI 10.3233/978-1-60750-692-8-227; Kamburov A, 2012, NUCLEIC ACIDS RES, V40, pW140, DOI 10.1093/nar/gks492; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krishnan A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000562; Krzywinski M, 2012, BRIEF BIOINFORM, V13, P627, DOI 10.1093/bib/bbr069; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law PTY, 2011, J GASTROEN HEPATOL, V26, P437, DOI 10.1111/j.1440-1746.2010.06512.x; Li X, 2014, DIGEST DIS SCI, V2014, P1; Liu Y, 2013, CELL RES, V23, P440, DOI 10.1038/cr.2013.8; Logsdon BA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001014; Madhamshettiwar PB, 2012, GENOME MED, V4, DOI 10.1186/gm340; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mellios N, 2012, SCHIZOPHRENIA BULL, V38, P433, DOI 10.1093/schbul/sbq091; Meyer P, 2011, NAT BIOTECHNOL, V29, P811, DOI 10.1038/nbt.1968; Miller MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037664; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Noor Amina, 2013, Advances in Bioinformatics, V2013, P953814, DOI 10.1155/2013/953814; Oates CJ, 2012, ANN APPL STAT, V6, P1209, DOI 10.1214/11-AOAS532; Phenix H, 2013, CHAOS, V23, DOI 10.1063/1.4807483; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Qiu SW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-10; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Simon N, 2012, NAT BIOTECHNOL, V30, P334, DOI 10.1038/nbt.2182; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Speed T, 2011, SCIENCE, V334, P1502, DOI 10.1126/science.1215894; Spielman D. A., 2009, LECT NOTES; Szederkenyi G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-177; Tonjes R, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026202; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tun K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-24; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Visintainer R, 2012, THESIS U TRENTO; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wei RR, 2013, CLIN CANCER RES, V19, P4780, DOI 10.1158/1078-0432.CCR-12-2728; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	77	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89815	10.1371/journal.pone.0089815	http://dx.doi.org/10.1371/journal.pone.0089815			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587057	Green Submitted, gold, Green Published			2022-12-27	WOS:000332390800044
J	Wang, JT; Wang, H; Guo, C; Luo, W; Lawler, A; Reddy, A; Wang, JL; Sun, EB; Eitzman, DT				Wang, Jintao; Wang, Hui; Guo, Chiao; Luo, Wei; Lawler, Alyssa; Reddy, Aswin; Wang, Julia; Sun, Eddy B.; Eitzman, Daniel T.			Mebendazole Reduces Vascular Smooth Muscle Cell Proliferation and Neointimal Formation Following Vascular Injury in Mice	PLOS ONE			English	Article							TRIPLE ANTIPLATELET THERAPY; ELUTING STENT IMPLANTATION; CORONARY STENT; IN-VITRO; RESTENOSIS; ECHINOCOCCOSIS; CHEMOTHERAPY; INHIBITION; CILOSTAZOL; APOPTOSIS	Mebendazole is an antihelminthic drug that exerts its effects via interference with microtubule function in parasites. To determine the utility of mebendazole as a potential treatment for vascular diseases involving proliferation of vascular smooth muscle cells, the effects of mebendazole on vascular smooth muscle cell proliferation were tested in vitro and in a mouse model of arterial injury. In vitro, mebendazole inhibited proliferation and migration of murine vascular smooth muscle cells and this was associated with altered intracellular microtubule organization. To determine in vivo effects of mebendazole following vascular injury, femoral arterial wire injury was induced in wild-type mice treated with either mebendazole or placebo control. Compared with placebo-treated mice, mebendazole-treated mice formed less neointima at the site of injury. Mebendazole is effective at inhibiting vascular smooth muscle cell proliferation and migration, and neointimal formation following arterial injury in mice.	[Wang, Jintao; Wang, Hui; Guo, Chiao; Luo, Wei; Lawler, Alyssa; Reddy, Aswin; Wang, Julia; Sun, Eddy B.; Eitzman, Daniel T.] Univ Michigan, Dept Internal Med, Cardiovasc Res Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eitzman, DT (corresponding author), Univ Michigan, Dept Internal Med, Cardiovasc Res Ctr, Ann Arbor, MI 48109 USA.	deitzman@umich.edu	Wang, Julia/AAZ-7000-2020	Wang, Julia/0000-0002-6984-8283	NIH [HL073150]; VA [BX000353]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073150] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH grant HL073150 and VA grant BX000353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMANN RW, 1994, HEPATOLOGY, V19, P735, DOI 10.1002/hep.1840190328; Canete R, 2009, T ROY SOC TROP MED H, V103, P437, DOI 10.1016/j.trstmh.2008.11.029; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Doudican N, 2008, MOL CANCER RES, V6, P1308, DOI 10.1158/1541-7786.MCR-07-2159; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Farb A, 2002, CIRCULATION, V105, P2974, DOI 10.1161/01.CIR.0000019071.72887.BD; Geng DF, 2012, CARDIOLOGY, V122, P148, DOI 10.1159/000338812; Gershlick A, 2004, CIRCULATION, V109, P487, DOI 10.1161/01.CIR.0000109694.58299.A0; GULL K, 1987, BIOCHEM SOC T, V15, P59, DOI 10.1042/bst0150059; LACLETTE JP, 1980, BIOCHEM BIOPH RES CO, V92, P417, DOI 10.1016/0006-291X(80)90349-6; LEVIN MH, 1983, JAMA-J AM MED ASSOC, V249, P2929, DOI 10.1001/jama.249.21.2929; Mukhopadhyay T, 2002, CLIN CANCER RES, V8, P2963; MULLER E, 1982, HEPATO-GASTROENTEROL, V29, P236; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pourgholami MH, 2005, CANCER CHEMOTH PHARM, V55, P425, DOI 10.1007/s00280-004-0927-6; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Sasaki J, 2002, MOL CANCER THER, V1, P1201; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Thyberg J, 1997, J HISTOCHEM CYTOCHEM, V45, P837, DOI 10.1177/002215549704500608; Vockel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019740	23	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90146	10.1371/journal.pone.0090146	http://dx.doi.org/10.1371/journal.pone.0090146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587248	Green Submitted, gold, Green Published			2022-12-27	WOS:000332390800081
J	Ducatez, S; Lefebvre, L				Ducatez, Simon; Lefebvre, Louis			Patterns of Research Effort in Birds	PLOS ONE			English	Article							CONSERVATION; SIZE	Between species differences in research effort can lead to biases in our global view of evolution, ecology and conservation. The increase in meta-taxonomic comparative analyses on birds underlines the need to better address how research effort is distributed in this class. Methods have been developed to choose which species should be studied to obtain unbiased comparative data sets, but a precise and global knowledge of research effort is required to be able to properly apply them. We address this issue by providing a data set of research effort (number of papers from 1978 to 2008 in the Zoological Record database) estimates for the 10 064 species of birds. We then test whether research effort is associated with phylogeny, geography and eleven different life history and ecological traits. We show that phylogeny accounts for a large proportion of the variance, while geographic range and all the tested traits are also significant contributors to research effort variance. We identify avian taxa that are under-and overstudied and address the importance of research effort biases in evaluating vulnerability to extinction, with non-threatened species studied twice as much as threatened ones. Our research effort data set covering the entire class Aves provides a tool for researchers to incorporate this potential confounding variable in comparative analyses.	[Ducatez, Simon; Lefebvre, Louis] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Ducatez, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	simon.ducatez@gmail.com	Ducatez, Simon/AAA-5378-2020	Ducatez, Simon/0000-0003-2865-4674	Fondation Fyssen; NSERC	Fondation Fyssen; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a post-doctoral fellowship from the Fondation Fyssen to SD and an NSERC Discovery grant to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2010, AM NAT, V176, P601, DOI 10.1086/656490; Bennett P. M., 2002, OX ECOL EV; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Brito D, 2009, TROP CONSERV SCI, V2, P353, DOI 10.1177/194008290900200305; Byrne RW, 2004, P ROY SOC B-BIOL SCI, V271, P1693, DOI 10.1098/rspb.2004.2780; Clark JA, 2002, SCIENCE, V297, P191; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; de Lima RF, 2011, BIOL CONSERV, V144, P627, DOI 10.1016/j.biocon.2010.10.021; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; Lefebvre Louis, 2001, Animal Cognition, V4, P91, DOI 10.1007/s100710100102; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Pawar S, 2003, BIOSCIENCE, V53, P861, DOI 10.1641/0006-3568(2003)053[0861:TCATMC]2.0.CO;2; Reader SM, 2011, PHILOS T R SOC B, V366, P1017, DOI 10.1098/rstb.2010.0342; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Stahlschmidt ZR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024192; Garamszegi LZ, 2012, BEHAV ECOL SOCIOBIOL, V66, P1363, DOI 10.1007/s00265-012-1370-z; Zuur Alain F., 2009, P1	22	42	42	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89955	10.1371/journal.pone.0089955	http://dx.doi.org/10.1371/journal.pone.0089955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587149	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000117
J	Thibault, PA; Wilson, JA				Thibault, Patricia A.; Wilson, Joyce A.			Transient Replication of Hepatitis C Virus Sub-Genomic RNA in Murine Cell Lines Is Enabled by miR-122 and Varies with Cell Passage	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; EFFICIENT REPLICATION; MOUSE MODEL; INFECTION; RECEPTOR; ENTRY; EXPRESSION; MICE; METABOLISM; INTERFERON	Hepatitis C Virus (HCV) is a serious global health problem, infecting almost 3% of the world's population. The lack of model systems for studying this virus limit research options in vaccine and therapeutic development, as well as for studying the pathogenesis of chronic HCV infection. Herein we make use of the liver-specific microRNA miR-122 to render mouse cell lines permissive to HCV replication in an attempt to develop additional model systems for the identification of new features of the virus and its life cycle. We have determined that some wild-type and knockout mouse cell lines - NCoA6 and PKR knockout embryonic fibroblasts - can be rendered permissive to transient HCV sub-genomic RNA replication upon addition of miR-122, but we did not observe replication of full-length HCV RNA in these cells. However, other wild-type and knockout cell lines cannot be rendered permissive to HCV replication by addition of miR-122, and in fact, different NCoA6 and PKR knockout cell line passages and isolates from the same mice demonstrated varying permissiveness phenotypes and eventually complete loss of permissiveness. When we tested knockdown of NCoA6 and PKR in Huh7.5 cells, we saw no substantial impact in sub-genomic HCV replication, which we would expect if these genes were inhibitory to the virus' life cycle. This leads us to conclude that along with the influence of specific gene knockouts there are additional factors within the cell lines that affect their permissiveness for HCV replication; we suggest that these may be epigenetically regulated, or modulated by cell line immortalization and transformation.	[Wilson, Joyce A.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; Univ Saskatchewan, Vaccine & Infect Dis Org, Int Vaccine Ctr, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Wilson, JA (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	joyce.wilson@usask.ca	Thibault, Patricia A./K-1570-2015	Thibault, Patricia A./0000-0002-7313-0848; Wilson, Joyce/0000-0002-5051-3088	University of Saskatchewan, Saskatchewan Health Research Foundation [10156, 1927]; National Sciences and Engineering Research Council [RGPIN-342475]; Canadian Foundation for Innovation [18622]; NSERC; National CIHR Training Program in Hepatitis C	University of Saskatchewan, Saskatchewan Health Research Foundation; National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National CIHR Training Program in Hepatitis C(Canadian Institutes of Health Research (CIHR))	The study was supported by funds from the University of Saskatchewan, Saskatchewan Health Research Foundation (establishment, 10156; and team grant, RAPID, 1927), National Sciences and Engineering Research Council (RGPIN-342475), and the Canadian Foundation for Innovation (18622). P. A. T. held a CGS-M scholarship from NSERC and is currently a scholarship recipient from the National CIHR Training Program in Hepatitis C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Aly HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021284; Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Antonson P, 2003, MOL CELL BIOL, V23, P1260, DOI 10.1128/MCB.23.4.1260-1268.2003; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Bility MT, 2012, NAT PROTOC, V7, P1608, DOI 10.1038/nprot.2012.083; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598; Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427; Dorner M, 2013, METHODS, V59, P249, DOI 10.1016/j.ymeth.2012.05.010; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Frentzen A, 2013, HEPATOLOGY; Frentzen A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002029; Fukuhara T, 2012, J VIROL, V86, P7918, DOI 10.1128/JVI.00567-12; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jopling CL, 2006, COLD SPRING HARB SYM, V71, P369, DOI 10.1101/sqb.2006.71.022; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kambara H, 2012, J VIROL, V86, P1382, DOI 10.1128/JVI.06242-11; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Kim SW, 2003, MOL CELL BIOL, V23, P3583, DOI 10.1128/MCB.23.10.3583-3592.2003; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li QT, 2007, MOL CELL BIOL, V27, P8073, DOI 10.1128/MCB.00451-07; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; MacArthur KL, 2012, WORLD J GASTROENTERO, V18, P2909, DOI 10.3748/wjg.v18.i23.2909; Mahajan MA, 2005, ENDOCR REV, V26, P583, DOI 10.1210/er.2004-0012; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Nandakumar R, 2013, GASTROENTEROLOGY; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Norman KL, 2010, J VIROL, V84, P666, DOI 10.1128/JVI.01156-09; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Robinet E, 2011, J HEPATOL, V55, P718, DOI 10.1016/j.jhep.2011.02.038; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shi Q, 2013, J VIROL, V87, P6866, DOI 10.1128/JVI.03475-12; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Thibault PA, 2013, VIROLOGY, V436, P179, DOI 10.1016/j.virol.2012.11.007; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Vogt A, 2013, VIROLOGY; Wadman M, 2013, NATURE, V495, P289, DOI 10.1038/495289a; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Wilson JA, 2011, J VIROL, V85, P2342, DOI 10.1128/JVI.02046-10; World Health Organization, 2012, HEP C; Xie ZC, 1998, VIROLOGY, V244, P513, DOI 10.1006/viro.1998.9127; Xu J, 2012, LIVER INT, V32, P752, DOI 10.1111/j.1478-3231.2011.02750.x; Xu XP, 2007, J GEN VIROL, V88, P2504, DOI 10.1099/vir.0.82878-0; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	61	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89971	10.1371/journal.pone.0089971	http://dx.doi.org/10.1371/journal.pone.0089971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587159	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000122
J	Durighello, E; Christie-Oleza, JA; Armengaud, J				Durighello, Emie; Christie-Oleza, Joseph Alexander; Armengaud, Jean			Assessing the Exoproteome of Marine Bacteria, Lesson from a RTX-Toxin Abundantly Secreted by Phaeobacter Strain DSM 17395	PLOS ONE			English	Article							INHIBENS DSM 17395; PHAEOBACTER-GALLAECIENSIS; MASS-SPECTROMETRY; SP-NOV.; ROSEOBACTER; IDENTIFICATION; PROTEOMICS; MICROBIOLOGY; RUEGERIA; GENOMICS	Bacteria from the Roseobacter clade are abundant in surface marine ecosystems as over 10% of bacterial cells in the open ocean and 20% in coastal waters belong to this group. In order to document how these marine bacteria interact with their environment, we analyzed the exoproteome of Phaeobacter strain DSM 17395. We grew the strain in marine medium, collected the exoproteome and catalogued its content with high-throughput nanoLC-MS/MS shotgun proteomics. The major component represented 60% of the total protein content but was refractory to either classical proteomic identification or proteogenomics. We de novo sequenced this abundant protein with high-resolution tandem mass spectra which turned out being the 53 kDa RTX-toxin ZP_02147451. It comprised a peptidase M10 serralysin domain. We explained its recalcitrance to trypsin proteolysis and proteomic identification by its unusual low number of basic residues. We found this is a conserved trait in RTX-toxins from Roseobacter strains which probably explains their persistence in the harsh conditions around bacteria. Comprehensive analysis of exoproteomes from environmental bacteria should take into account this proteolytic recalcitrance.	[Durighello, Emie; Christie-Oleza, Joseph Alexander; Armengaud, Jean] CEA, DSV, IBEB, Lab Biochim Syst Perturb, Bagnols Sur Ceze, France	CEA	Armengaud, J (corresponding author), CEA, DSV, IBEB, Lab Biochim Syst Perturb, Bagnols Sur Ceze, France.	jean.armengaud@cea.fr	Christie-Oleza, Joseph/B-5207-2011; Christie-Oleza, Joseph/AAJ-7581-2021; Christie-Oleza, Joseph Alexander/AAB-5447-2019	Christie-Oleza, Joseph Alexander/0000-0002-0992-2226; ARMENGAUD, Jean/0000-0003-1589-445X	Commissariat a l'Energie Atomique et aux Energies Alternatives; fellowship from the Fundacion Ramon Areces	Commissariat a l'Energie Atomique et aux Energies Alternatives; fellowship from the Fundacion Ramon Areces	JA Christie-Oleza was supported by a fellowship from the Fundacion Ramon Areces. The authors thank the Commissariat a l'Energie Atomique et aux Energies Alternatives for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengaud J, 2013, PROTEOMICS, V13, P2731, DOI 10.1002/pmic.201200576; Armengaud J, 2013, ENVIRON MICROBIOL, V15, P12, DOI 10.1111/j.1462-2920.2012.02811.x; Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Berger M, 2011, J BACTERIOL, V193, P6576, DOI 10.1128/JB.05818-11; Bland C, 2014, J PROTEOME IN PRESS; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Buddruhs N, 2013, INT J SYST EVOL MICR, V63, P4340, DOI 10.1099/ijs.0.053900-0; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Christie-Oleza JA, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013110; Christie-Oleza JA, 2012, ISME J, V6, P124, DOI 10.1038/ismej.2011.86; Christie-Oleza JA, 2010, MAR DRUGS, V8, P2223, DOI 10.3390/md8082223; Clair G, 2013, J PROTEOMICS, V94, P527, DOI 10.1016/j.jprot.2013.10.024; Clair G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013102; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; Dedieu A, 2011, J BIOL CHEM, V286, P259, DOI 10.1074/jbc.M110.159483; Druppel K, 2014, ENVIRON MICROBIOL, V16, P218, DOI 10.1111/1462-2920.12276; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Geng HF, 2010, CURR OPIN BIOTECH, V21, P332, DOI 10.1016/j.copbio.2010.03.013; Giebel HA, 2011, ISME J, V5, P8, DOI 10.1038/ismej.2010.87; Kossmehl S, 2013, PROTEOMICS, V13, P2743, DOI 10.1002/pmic.201300112; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martens T, 2006, INT J SYST EVOL MICR, V56, P1293, DOI 10.1099/ijs.0.63724-0; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Preston GM, 2005, FEMS MICROBIOL REV, V29, P331, DOI 10.1016/j.femsre.2004.12.004; Ruiz-Ponte C, 1998, INT J SYST BACTERIOL, V48, P537, DOI 10.1099/00207713-48-2-537; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Seyedsayamdost MR, 2011, J AM CHEM SOC, V133, P18343, DOI 10.1021/ja207172s; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vigil PD, 2011, INFECT IMMUN, V79, P2335, DOI 10.1128/IAI.00110-11; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wohlbrand L, 2013, PROTEOMICS, V13, P2700, DOI 10.1002/pmic.201300175; Yoon JH, 2007, INT J SYST EVOL MICR, V57, P856, DOI 10.1099/ijs.0.64779-0; Zech H, 2013, PROTEOMICS, V13, P2869, DOI 10.1002/pmic.201200560; Zech H, 2013, PROTEOMICS, V13, P2851, DOI 10.1002/pmic.201200513; Zhang DC, 2008, INT J SYST EVOL MICR, V58, P1384, DOI 10.1099/ijs.0.65708-0; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	42	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89691	10.1371/journal.pone.0089691	http://dx.doi.org/10.1371/journal.pone.0089691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586966	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700074
J	Bica, L; Liddell, JR; Donnelly, PS; Duncan, C; Caragounis, A; Volitakis, I; Paterson, BM; Cappai, R; Grubman, A; Camakaris, J; Crouch, PJ; White, AR				Bica, Laura; Liddell, Jeffrey R.; Donnelly, Paul S.; Duncan, Clare; Caragounis, Aphrodite; Volitakis, Irene; Paterson, Brett M.; Cappai, Roberto; Grubman, Alexandra; Camakaris, James; Crouch, Peter J.; White, Anthony R.			Neuroprotective Copper Bis(thiosemicarbazonato) Complexes Promote Neurite Elongation	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; NERVE GROWTH-FACTOR; MAP KINASE KINASE; N-TERMINAL KINASE; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; PC12 CELLS; A-BETA; TRANSGENIC MICE; CYCLOSPORINE-A	Abnormal biometal homeostasis is a central feature of many neurodegenerative disorders including Alzheimer's disease (AD), Parkinson's disease (PD), and motor neuron disease. Recent studies have shown that metal complexing compounds behaving as ionophores such as clioquinol and PBT2 have robust therapeutic activity in animal models of neurodegenerative disease; however, the mechanism of neuroprotective action remains unclear. These neuroprotective or neurogenerative processes may be related to the delivery or redistribution of biometals, such as copper and zinc, by metal ionophores. To investigate this further, we examined the effect of the bis(thiosemicarbazonato)-copper complex, Cu-II (gtsm) on neuritogenesis and neurite elongation (neurogenerative outcomes) in PC12 neuronal-related cultures. We found that Cu-II (gtsm) induced robust neurite elongation in PC12 cells when delivered at concentrations of 25 or 50 nM overnight. Analogous effects were observed with an alternative copper bis(thiosemicarbazonato) complex, Cu-II (atsm), but at a higher concentration. Induction of neurite elongation by Cu-II (gtsm) was restricted to neurites within the length range of 75-99 mu m with a 2.3-fold increase in numbers of neurites in this length range with 50 nM Cu-II (gtsm) treatment. The mechanism of neurogenerative action was investigated and revealed that Cu-II (gtsm) inhibited cellular phosphatase activity. Treatment of cultures with 5 nM FK506 (calcineurin phosphatase inhibitor) resulted in analogous elongation of neurites compared to 50 nM Cu-II (gtsm), suggesting a potential link between Cu-II (gtsm)-mediated phosphatase inhibition and neurogenerative outcomes.	[Bica, Laura; Liddell, Jeffrey R.; Duncan, Clare; Caragounis, Aphrodite; Cappai, Roberto; Grubman, Alexandra; Crouch, Peter J.; White, Anthony R.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Donnelly, Paul S.; Paterson, Brett M.; Cappai, Roberto] Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic, Australia; [Donnelly, Paul S.; Paterson, Brett M.] Univ Melbourne, Sch Chem, Melbourne, Vic, Australia; [Volitakis, Irene; Crouch, Peter J.; White, Anthony R.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	White, AR (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia.	arwhite@unimelb.edu.au	Grubman, Alexandra/AAD-3109-2019; Paterson, Brett M/A-2402-2016; Liddell, Jeffrey/AAH-3685-2021; Cappai, Roberto/B-3347-2010; White, Anthony/P-5596-2016	Grubman, Alexandra/0000-0003-4408-4499; Paterson, Brett M/0000-0002-7768-811X; Liddell, Jeffrey/0000-0002-0798-5338; Crouch, Peter/0000-0002-7777-4747; Cappai, Roberto/0000-0002-9505-8496; White, Anthony/0000-0003-1802-9891	ANZ Trustees Wicking Foundation; Mason Trust; Brain Foundation of Australia; Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC)	ANZ Trustees Wicking Foundation; Mason Trust; Brain Foundation of Australia; Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the ANZ Trustees Wicking Foundation and Mason Trust, the Brain Foundation of Australia, Australian Research Council (ARC) and National Health and Medical Research Council of Australia (NHMRC). ARW is a recipient of an ARC Future Fellowship. RC is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017669; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Beraldo H, 1998, TRANSIT METAL CHEM, V23, P67; Bica L, 2011, BIOMETALS, V24, P117, DOI 10.1007/s10534-010-9380-7; Birkaya B, 2005, J NEUROBIOL, V63, P49, DOI 10.1002/neu.20114; Blower PJ, 2003, DALTON T, P4416, DOI 10.1039/b307499d; BOTTOMLEY GA, 1994, AUST J CHEM, V47, P143, DOI 10.1071/CH9940143; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Crouch PJ, 2011, J NEUROCHEM, V119, P220, DOI 10.1111/j.1471-4159.2011.07402.x; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; Donnelly PS, 2012, P NATL ACAD SCI USA, V109, P47, DOI 10.1073/pnas.1116227108; Duncan C, 2012, METALLOMICS, V4, P127, DOI 10.1039/c2mt00174h; El Meskini R, 2005, DEV NEUROSCI-BASEL, V27, P333, DOI 10.1159/000086713; Eom DS, 2004, BIOCHEM BIOPH RES CO, V314, P377, DOI 10.1016/j.bbrc.2003.12.094; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Gaier ED, 2012, J NEUROSCI RES; GINGRAS BA, 1962, CAN J CHEM, V40, P1053, DOI 10.1139/v62-161; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hung LW, 2012, J EXP MED, V209, P837, DOI 10.1084/jem.20112285; Jeon CY, 2010, SYNAPSE, V64, P765, DOI 10.1002/syn.20789; Jouvenceau A, 2006, J PHYSIOL-PARIS, V99, P154, DOI 10.1016/j.jphysparis.2005.12.009; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Kaden Daniela, 2011, Int J Alzheimers Dis, V2011, P345614, DOI 10.4061/2011/345614; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kessler H, 2005, NERVENARZT, V76, P581, DOI 10.1007/s00115-004-1849-6; Kiddie G, 2005, PROG BRAIN RES, V147, P67, DOI 10.1016/S0079-6123(04)47006-X; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; LYONS WE, 1994, P NATL ACAD SCI USA, V91, P3191, DOI 10.1073/pnas.91.8.3191; Malm TM, 2007, J NEUROSCI, V27, P3712, DOI 10.1523/JNEUROSCI.0059-07.2007; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Parker SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042277; Price KA, 2012, CHEM SCI, V3, P2748, DOI 10.1039/c2sc20397a; Price KA, 2011, METALLOMICS, V3, P1280, DOI 10.1039/c1mt00092f; Price KA, 2011, INORG CHEM, V50, P9594, DOI 10.1021/ic201334q; Rozkalne A, 2011, NEUROBIOL DIS, V41, P650, DOI 10.1016/j.nbd.2010.11.014; Schrag M, 2011, PROG NEUROBIOL, V94, P296, DOI 10.1016/j.pneurobio.2011.05.001; Soon CPW, 2011, J BIOL CHEM, V286, P44035, DOI 10.1074/jbc.M111.274407; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tamano H, 2011, METALLOMICS, V3, P656, DOI 10.1039/c1mt00008j; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Waetzig V, 2003, MOL CELL NEUROSCI, V24, P238, DOI 10.1016/S1044-7431(03)00126-X; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Xiao JN, 2003, J NEUROCHEM, V86, P1516, DOI 10.1046/j.1471-4159.2003.01961.x; Yoshii Y, 2011, NUCL MED BIOL, V38, P151, DOI 10.1016/j.nucmedbio.2010.08.009	57	34	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90070	10.1371/journal.pone.0090070	http://dx.doi.org/10.1371/journal.pone.0090070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587210	gold, Green Published			2022-12-27	WOS:000332396200119
J	Delaine-Smith, RM; Green, NH; Matcher, SJ; MacNeil, S; Reilly, GC				Delaine-Smith, Robin M.; Green, Nicola H.; Matcher, Stephen J.; MacNeil, Sheila; Reilly, Gwendolen C.			Monitoring Fibrous Scaffold Guidance of Three-Dimensional Collagen Organisation Using Minimally-Invasive Second Harmonic Generation	PLOS ONE			English	Article							ELECTROSPUN SCAFFOLDS; FIBER ORIENTATION; IN-VITRO; TISSUE; ALIGNMENT; DIAMETER; DIFFERENTIATION; PROLIFERATION; FIBROBLASTS; BEHAVIOR	The biological and mechanical function of connective tissues is largely determined by controlled cellular alignment and therefore it seems appropriate that tissue-engineered constructs should be architecturally similar to the in vivo tissue targeted for repair or replacement. Collagen organisation dictates the tensile properties of most tissues and so monitoring the deposition of cell-secreted collagen as the construct develops is essential for understanding tissue formation. In this study, electrospun fibres with a random or high degree of orientation, mimicking two types of tissue architecture found in the body, were used to culture human fibroblasts for controlling cell alignment. The minimally-invasive technique of second harmonic generation was used with the aim of monitoring and profiling the deposition and organisation of collagen at different construct depths over time while construct mechanical properties were also determined over the culture period. It was seen that scaffold fibre organisation affected cell migration and orientation up to 21 days which in turn had an effect on collagen organisation. Collagen in random fibrous constructs was deposited in alternating configurations at different depths however a high degree of organisation was observed throughout aligned fibrous constructs orientated in the scaffold fibre direction. Three-dimensional second harmonic generation images showed that deposited collagen was more uniformly distributed in random constructs but aligned constructs were more organised and had higher intensities. The tensile properties of all constructs increased with increasing collagen deposition and were ultimately dictated by collagen organisation. This study highlights the importance of scaffold architecture for controlling the development of well-organised tissue engineered constructs and the usefulness of second harmonic generation imaging for monitoring collagen maturation in a minimally invasive manner.	[Delaine-Smith, Robin M.; Green, Nicola H.; Matcher, Stephen J.; MacNeil, Sheila; Reilly, Gwendolen C.] Univ Sheffield, Dept Mat Sci & Engn, Kroto Res Inst, Sheffield, S Yorkshire, England; [Reilly, Gwendolen C.] Univ Sheffield, Dept Mat Sci & Engn, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Reilly, GC (corresponding author), Univ Sheffield, Dept Mat Sci & Engn, Kroto Res Inst, Sheffield, S Yorkshire, England.	g.reilly@sheffield.ac.uk	Reilly, Gwendolen C./C-3456-2009; Green, Nicola/K-4674-2019	Reilly, Gwendolen C./0000-0003-1456-1071; Green, Nicola/0000-0001-5413-0642	Engineering and Physical Sciences Research Council (EPSRC)	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Engineering and Physical Sciences Research Council (EPSRC) (http://www.epsrc.ac.uk)on a doctoral training account from the department of Materials Science and Engineering, University of Sheffield. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084; Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072; Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005; Bayan C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116626; Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037; Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008; Bye FJ, 2013, BIOMATER SCI-UK, V1, P942, DOI 10.1039/c3bm60074b; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8; Deng D, 2009, BIOMATERIALS, V30, P6724, DOI 10.1016/j.biomaterials.2009.08.054; Deshpande P, 2010, REGEN MED, V5, P395, DOI [10.2217/rme.10.16, 10.2217/RME.10.16]; Dugan JM, 2013, ACTA BIOMATER, V9, P4707, DOI 10.1016/j.actbio.2012.08.050; Fu XL, 2012, TISSUE ENG PT A, V18, P631, DOI [10.1089/ten.tea.2011.0069, 10.1089/ten.TEA.2011.0069]; Hasirci V, 2006, NANOMEDICINE-UK, V1, P73, DOI 10.2217/17435889.1.1.73; Hong JK, 2010, ACTA BIOMATER, V6, P4734, DOI 10.1016/j.actbio.2010.07.003; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64; Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028; Laurencin CT, 2006, J BIOMECH, V39, pS59; Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037; Lee JB, 2011, TISSUE ENG PT A, V17, P2695, DOI [10.1089/ten.tea.2010.0709, 10.1089/ten.TEA.2010.0709]; Lee SB, 2005, BIOMATERIALS, V26, P1961, DOI 10.1016/j.biomaterials.2004.06.032; Liu Y, 2009, J BIOMED MATER RES A, V90A, P1092, DOI 10.1002/jbm.a.32165; Lynch HA, 2003, J BIOMECH ENG-T ASME, V125, P726, DOI 10.1115/1.1614819; Martin RB, 1998, SKELETAL TISSUE MECH; Matcher SJ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116620; Menard C, 2000, BIOMATERIALS, V21, P1867, DOI 10.1016/S0142-9612(00)00062-4; Milleret V, 2011, EUR CELLS MATER, V21, P286, DOI 10.22203/eCM.v021a22; Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078; Ralston DR, 1997, BRIT J PLAST SURG, V50, P408, DOI 10.1016/S0007-1226(97)90327-1; Rutledge GC, 2007, ADV DRUG DELIVER REV, V59, P1384, DOI 10.1016/j.addr.2007.04.020; Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	35	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89761	10.1371/journal.pone.0089761	http://dx.doi.org/10.1371/journal.pone.0089761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587017	Green Accepted, Green Published, gold			2022-12-27	WOS:000332396200078
J	Michon, AL; Jumas-Bilak, E; Chiron, R; Lamy, B; Marchandin, H				Michon, Anne-Laure; Jumas-Bilak, Estelle; Chiron, Raphael; Lamy, Brigitte; Marchandin, Helene			Advances toward the Elucidation of Hypertonic Saline Effects on Pseudomonas aeruginosa from Cystic Fibrosis Patients	PLOS ONE			English	Article							BIOFILM; CLEARANCE; NACL; PH	Objectives: Nebulized hypertonic saline (HTS) has beneficial effects including reducing pulmonary exacerbations in Cystic Fibrosis (CF) patients. Several mechanisms may explain these effects but antimicrobial activity of NaCl remains largely unexplored. We aimed to measure the antimicrobial effect of NaCl on Pseudomonas aeruginosa isolated from the respiratory tract in CF patients. Methods: NaCl minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were determined for strains characterized for mucoidy, antimicrobial resistance, and ability to form biofilm using 0,9% to 15% NaCl solutions. NaCl effects on biofilm formation, preformed biofilm, and mobility were evaluated. Kinetics of antimicrobial effects was studied. Results: The growth of all isolates (n = 85) from 34 patients was inhibited by 6% NaCl solution. A 10% concentration had a bactericidal activity on 90% of the isolates. Mucoid and multidrug resistant (MDR) isolates displayed lower MICs compared to non-mucoid and to non-MDR isolates, respectively. Time-kill kinetics showed that NaCl exhibited a rapid, dose and growth phase dependent bactericidal effect. Three percent or more of NaCl inhibited biofilm formation for 69% of strongly adherent isolates. A dose-dependent decrease of preformed biofilm viability and an inhibitory activity on bacterial motility were observed. Conclusions: NaCl inhibited the growth of all isolates and killed 38% of tested isolates within concentration range currently used in therapeutics. Our results suggest that anti-pseudomonal activity is another mechanism of action of HTS to add to those already established. Clinical trials are needed to compare diverse HTS conditions of use (rhythm, dose and mode of delivery) to obtain efficient and optimized anti-P. aeruginosa effects. More generally, NaCl effect on other opportunistic pathogens as well as on global microbiotae recovered during polymicrobial diseases warrants further investigations.	[Michon, Anne-Laure; Jumas-Bilak, Estelle; Lamy, Brigitte; Marchandin, Helene] Univ Montpellier I, Equipe Pathogenes & Environm, UFR Sci Pharmaceut & Biol, UMR ECOSYM 5119, Montpellier, France; [Michon, Anne-Laure; Lamy, Brigitte; Marchandin, Helene] Ctr Hosp Reg Univ Montpellier, Hop Arnaud de Villeneuve, Bacteriol Lab, Montpellier, France; [Jumas-Bilak, Estelle] Ctr Hosp Reg Univ Montpellier, Lab Hyg Hosp, Montpellier, France; [Chiron, Raphael] Ctr Hosp Reg Univ Montpellier, Hop Arnaud de Villeneuve, Ctr Ressources & Competences Mucoviscidose, Montpellier, France	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Michon, AL (corresponding author), Univ Montpellier I, Equipe Pathogenes & Environm, UFR Sci Pharmaceut & Biol, UMR ECOSYM 5119, Montpellier, France.	al-michon@chu-montpellier.fr	MARCHANDIN, Hélène/AAM-8288-2021; Lamy, Brigitte/A-8401-2015	MARCHANDIN, Hélène/0000-0003-2130-6335; Lamy, Brigitte/0000-0003-2370-8186	Ministere de l'enseignement superieur et de la recherche, France	Ministere de l'enseignement superieur et de la recherche, France	This work was supported by the Ministere de l'enseignement superieur et de la recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelraouf K, 2011, J ANTIMICROB CHEMOTH, V66, P1311, DOI 10.1093/jac/dkr105; Ballmann Manfred, 2002, J Cyst Fibros, V1, P35, DOI 10.1016/S1569-1993(01)00009-1; Behrends V, 2010, MOL BIOSYST, V6, P562, DOI 10.1039/b918710c; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Bye PTP, 2007, PAEDIATR RESPIR REV, V8, P30, DOI 10.1016/j.prrv.2007.02.008; Clunes Mark T, 2007, Drug Discov Today Dis Mech, V4, P63, DOI 10.1016/j.ddmec.2007.09.001; Courvalin P., 2009, ANTIBIOGRAM; Cystic Fibrosis Foundation, 1994, MICR INF DIS CYST FI, V5, P1; Deligianni E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-38; Dmello D, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000019; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Eng PA, 1996, PEDIATR PULM, V21, P77, DOI 10.1002/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.3.CO;2-R; Havasi V, 2008, J CYST FIBROS, V7, P267, DOI 10.1016/j.jcf.2007.11.009; O'Connell OJ, 2011, RESP CARE, V56, P771, DOI 10.4187/respcare.00866; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Oguzhan N, 2012, RENAL FAILURE, V34, P181, DOI 10.3109/0886022X.2011.646884; Parmar JH, 2011, MOL BIOSYST, V7, P1138, DOI 10.1039/c0mb00224k; Patel JB, 2011, MANUAL CLIN MICROBIO, P1122, DOI DOI 10.1128/9781555816728.CH68; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pompilio A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-145; Reeves EP, 2012, SCI WORLD J, DOI 10.1100/2012/465230; Robinson M, 1997, THORAX, V52, P900, DOI 10.1136/thx.52.10.900; Seo K, 2012, J FOOD PROTECT, V75, P533, DOI 10.4315/0362-028X.JFP-11-199; Shkilnyj P, 2007, J BACTERIOL, V189, P3115, DOI 10.1128/JB.01857-06; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; van der Waal SV, 2011, INT ENDOD J, V44, P1110, DOI 10.1111/j.1365-2591.2011.01929.x; Wark P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001506.pub3; Williams HD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00120; Williamson SJ, 2006, MICROB ECOL, V52, P217, DOI 10.1007/s00248-006-9113-1	34	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90164	10.1371/journal.pone.0090164	http://dx.doi.org/10.1371/journal.pone.0090164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587256	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200140
J	Monticone, M; Taherian, R; Stigliani, S; Carra, E; Monteghirfo, S; Longo, L; Daga, A; Dono, M; Zupo, S; Giaretti, W; Castagnola, P				Monticone, Massimiliano; Taherian, Razieh; Stigliani, Sara; Carra, Elisa; Monteghirfo, Stefano; Longo, Luca; Daga, Antonio; Dono, Mariella; Zupo, Simona; Giaretti, Walter; Castagnola, Patrizio			NAC, Tiron and Trolox Impair Survival of Cell Cultures Containing Glioblastoma Tumorigenic Initiating Cells by Inhibition of Cell Cycle Progression	PLOS ONE			English	Article							LARGE GENE LISTS; S-PHASE CELLS; OXIDATIVE STRESS; FLOW-CYTOMETRY; MELANOMA-CELLS; SIGNALING PATHWAYS; CANCER PREVENTION; PROSTATE-CANCER; GROWTH; BROMODEOXYURIDINE	Reactive oxygen species (ROS) are metabolism by-products that may act as signaling molecules to sustain tumor growth. Antioxidants have been used to impair cancer cell survival. Our goal was to determine the mechanisms involved in the response to antioxidants of a human cell culture (PT4) containing glioblastoma (GBM) tumorigenic initiating cells (TICs). ROS production in the absence or presence of N-acetyl-L-cysteine (NAC), tiron, and trolox was evaluated by flow cytometry (FCM). The effects of these antioxidants on cell survival and apoptosis were evaluated by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (MTT) and FCM. The biological processes modulated by these drugs were determined by oligonucleotide microarray gene expression profiling. Our results showed that NAC, tiron and trolox impaired PT4 cell survival, had minor effects on ROS levels and caused wide deregulation of cell cycle genes. Furthermore, tiron and trolox caused inhibition of cell survival in two additional cell cultures containing TICs, FO-1 and MM1, established from a melanoma and a mesothelioma patient, respectively. NAC, instead, impaired survival of the MM1 cells but not of the FO-1 cells. However, when used in combination, NAC enhanced the inhibitory effect of PLX4032 (BRAF V600E inhibitor) and Gefitinib (EGFR inhibitor), on FO-1 and PT4 cell survival. Collectively, NAC, tiron and trolox modulated gene expression and impaired the growth of cultures containing TICs primarily by inhibiting cell cycle progression.	[Monticone, Massimiliano; Taherian, Razieh; Stigliani, Sara; Carra, Elisa; Monteghirfo, Stefano; Longo, Luca; Daga, Antonio; Dono, Mariella; Zupo, Simona; Giaretti, Walter; Castagnola, Patrizio] IRCCS AOU San Martino IST, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST	Castagnola, P (corresponding author), IRCCS AOU San Martino IST, Genoa, Italy.	patrizio.castagnola@hsanmartino.it	Dono, Mariella/AAP-4379-2020; stigliani, sara/AAB-2797-2020; Daga, Antonio/Z-2417-2019; Zupo, Simona/AAC-2757-2020; Castagnola, Patrizio/H-2029-2012; Longo, Luca/K-6156-2018	Dono, Mariella/0000-0003-1280-0278; stigliani, sara/0000-0001-5115-2520; Daga, Antonio/0000-0001-5845-8530; Zupo, Simona/0000-0001-6837-5763; Castagnola, Patrizio/0000-0003-2008-9199; Longo, Luca/0000-0002-5153-4243	Compagnia di San Paolo - Programma Oncologia [3031.2011.0173]; Italian Neuroblastoma Foundation; Italian Ministry of Health [GR-2010-2311890]	Compagnia di San Paolo - Programma Oncologia(Compagnia di San Paolo); Italian Neuroblastoma Foundation; Italian Ministry of Health(Ministry of Health, Italy)	This study has been supported by "Compagnia di San Paolo - Programma Oncologia" (n. 3031.2011.0173). L. Longo has been supported by the Italian Neuroblastoma Foundation and he is now the recipient of the "Young Investigators" grant GR-2010-2311890 from the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bittinger F, 1998, MELANOMA RES, V8, P381, DOI 10.1097/00008390-199810000-00001; Callapina M, 2005, FREE RADICAL BIO MED, V39, P925, DOI 10.1016/j.freeradbiomed.2005.05.009; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Castriconi R, 2009, J IMMUNOL, V182, P3530, DOI 10.4049/jimmunol.0802845; Chinery R, 1998, CANCER RES, V58, P2323; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; DEFAZIO A, 1987, J HISTOCHEM CYTOCHEM, V35, P571, DOI 10.1177/35.5.3549891; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; DOLBEARE F, 1985, CYTOMETRY, V6, P521, DOI 10.1002/cyto.990060606; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; FREEMAN BA, 1982, LAB INVEST, V47, P412; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Hartmann C, 2005, ACTA NEUROPATHOL, V109, P639, DOI 10.1007/s00401-005-1000-1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Kamata H, 2000, EUR J BIOCHEM, V267, P1933, DOI 10.1046/j.1432-1327.2000.01194.x; Kim JS, 2006, TOXICOLOGY, V223, P36, DOI 10.1016/j.tox.2006.03.004; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kondo S, 1999, FREE RADICAL BIO MED, V27, P401, DOI 10.1016/S0891-5849(99)00087-8; KRISHNA CM, 1992, ARCH BIOCHEM BIOPHYS, V294, P98, DOI 10.1016/0003-9861(92)90142-J; Lazzeroni M, 2011, BREAST, V20, pS36, DOI 10.1016/S0960-9776(11)70292-2; Liu M, 1998, CANCER RES, V58, P1723; Liu M, 1999, CARCINOGENESIS, V20, P1869, DOI 10.1093/carcin/20.9.1869; Ma NY, 2013, J RADIAT RES, V54, P13, DOI 10.1093/jrr/rrs135; Malik A, 2006, CELL CYCLE, V5, P371, DOI 10.4161/cc.5.4.2486; Martin V, 2007, FREE RADICAL BIO MED, V42, P1715, DOI 10.1016/j.freeradbiomed.2007.02.028; Martinez EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046792; Melotti A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-54; Mesquita FS, 2010, BIOL REPROD, V82, P341, DOI 10.1095/biolreprod.108.075887; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Monticone M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-358; Monticone M, 2009, MOL CANCER RES, V7, P1822, DOI 10.1158/1541-7786.MCR-09-0225; Nargi Jennifer L., 1999, Neoplasia (New York), V1, P544; OTTO FJ, 1994, METHOD CELL BIOL, V41, P211; PAPACCIO G, 1986, DIABETES, V35, P470, DOI 10.2337/diabetes.35.4.470; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; RICCARDI A, 1988, CANCER RES, V48, P6238; Sadowska AM, 2012, THER ADV RESPIR DIS, V6, P127, DOI 10.1177/1753465812437563; Saeidnia S., 2013, TOXICOL APPL PHARM; Santillo M, 2001, CURR BIOL, V11, P614, DOI 10.1016/S0960-9822(01)00159-2; SCHUTTE B, 1987, CYTOMETRY, V8, P372, DOI 10.1002/cyto.990080405; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Sharma R, 2012, LEUKEMIA LYMPHOMA, V53, P1203, DOI 10.3109/10428194.2011.637213; Staib F, 2005, CANCER RES, V65, P10255, DOI 10.1158/0008-5472.CAN-05-1714; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; WILSON GD, 1985, CYTOMETRY, V6, P641, DOI 10.1002/cyto.990060621; ZOLZER F, 1993, INT J RADIAT BIOL, V63, P77, DOI 10.1080/09553009314550101; Zolzer F, 1999, INT J RADIAT ONCOL, V45, P1019, DOI 10.1016/S0360-3016(99)00294-1	61	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90085	10.1371/journal.pone.0090085	http://dx.doi.org/10.1371/journal.pone.0090085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587218	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200122
J	Pryazhnikov, E; Kislin, M; Tibeykina, M; Toptunov, D; Ptukha, A; Shatillo, A; Grohn, O; Giniatullin, R; Khiroug, L				Pryazhnikov, Evgeny; Kislin, Mikhail; Tibeykina, Marina; Toptunov, Dmytro; Ptukha, Anna; Shatillo, Artem; Grohn, Olli; Giniatullin, Rashid; Khiroug, Leonard			Opposite Reactivity of Meningeal versus Cortical Microvessels to the Nitric Oxide Donor Glyceryl Trinitrate Evaluated In Vivo with Two-Photon Imaging	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; TRANSCRANIAL DOPPLER; VASCULAR THEORY; LONG-TERM; MIGRAINE; NITROGLYCERIN; HEADACHE; MODEL; VASODILATATION; INFLAMMATION	Vascular changes underlying headache in migraine patients induced by Glyceryl trinitrate (GTN) were previously studied with various imaging techniques. Despite the long history of medical and experimental use of GTN, its effects on the brain vasculature are still poorly understood presumably due to low spatial resolution of the imaging modalities used so far. We took advantage of the micrometer-scale vertical resolution of two-photon microscopy to differentiate between the vasodynamic effects of GTN on meningeal versus cortical vessels imaged simultaneously in anesthetized rats through either thinned skull or glass-sealed cranial window. Intermediate and small calibre vessels were visualized in vivo by imaging intravascular fluorescent dextran, and detection of blood flow direction allowed identification of individual arterioles and venules. We found that i.p.-injected GTN induced a transient constriction of meningeal arterioles, while their cortical counterparts were, in contrast, dilated. These opposing effects of GTN were restricted to arterioles, whereas the effects on venules were insignificant. Interestingly, the NO synthase inhibitor L-NAME did not affect the diameter of meningeal vessels but induced a constriction of cortical vessels. The different cellular environment in cortex versus meninges as well as distinct vessel wall anatomical features probably play crucial role in the observed phenomena. These findings highlight differential region-and vessel-type-specific effects of GTN on cranial vessels, and may implicate new vascular mechanisms of NO-mediated primary headaches.	[Pryazhnikov, Evgeny; Kislin, Mikhail; Ptukha, Anna; Khiroug, Leonard] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Pryazhnikov, Evgeny; Tibeykina, Marina; Toptunov, Dmytro; Khiroug, Leonard] Neurotar LTD, Helsinki, Finland; [Shatillo, Artem; Grohn, Olli; Giniatullin, Rashid] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland	University of Helsinki; University of Eastern Finland	Khiroug, L (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	leonard.khirug@helsinki.fi	Kislin, Mikhail/ABC-6334-2021; Giniatullin, Rashid/Y-9687-2018	Kislin, Mikhail/0000-0002-5447-8881; Giniatullin, Rashid/0000-0002-1580-6280	Academy of Finland (ROSim, Photonics Program); Center for International Mobility (CIMO) of Finland	Academy of Finland (ROSim, Photonics Program); Center for International Mobility (CIMO) of Finland	This work was supported by grants from the Academy of Finland (ROSim, Photonics Program) and Center for International Mobility (CIMO) of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; Antonova M, 2011, CEPHALALGIA, V31, P1532, DOI 10.1177/0333102411423314; Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; DAHL A, 1989, STROKE, V20, P1733, DOI 10.1161/01.STR.20.12.1733; Daugaard D, 2009, CEPHALALGIA, V29, P1294, DOI 10.1111/j.1468-2982.2009.01887.x; De Col R, 2003, NEUROREPORT, V14, P229, DOI 10.1097/01.wnr.0000054966.99678.lf; Frese A, 2007, CEPHALALGIA, V27, P1265, DOI 10.1111/j.1468-2982.2007.01449.x; Goadsby PJ, 2009, BRAIN, V132, P6, DOI 10.1093/brain/awn321; Gozalov A, 2008, HEADACHE, V48, P1202, DOI 10.1111/j.1526-4610.2008.01205.x; Greco R, 2011, J HEADACHE PAIN, V12, P177, DOI 10.1007/s10194-010-0274-4; Greco R, 2011, CEPHALALGIA, V31, P190, DOI 10.1177/0333102410379887; Harrington MG, 2011, CEPHALALGIA, V31, P1254, DOI 10.1177/0333102411408360; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; HODGSON JM, 1989, CIRCULATION, V79, P1043, DOI 10.1161/01.CIR.79.5.1043; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hotta H, 2013, J CEREBR BLOOD F MET, V33, P1440, DOI 10.1038/jcbfm.2013.92; IMHOF PR, 1980, EUR J CLIN PHARMACOL, V18, P455, DOI 10.1007/BF00874655; IVERSEN HK, 1989, PAIN, V38, P17, DOI 10.1016/0304-3959(89)90067-5; Nguyen J, 2011, J CEREBR BLOOD F MET, V31, P2243, DOI 10.1038/jcbfm.2011.95; Kassab Mounzer Y, 2007, J Headache Pain, V8, P289, DOI 10.1007/s10194-007-0413-8; KISTLER JP, 1982, ARCH NEUROL-CHICAGO, V39, P631, DOI 10.1001/archneur.1982.00510220029006; Kruuse C, 2010, CEPHALALGIA, V30, P467, DOI 10.1111/j.1468-2982.2009.01963.x; Kudo C, 2008, EXP NEUROL, V212, P201, DOI 10.1016/j.expneurol.2008.03.026; Levy D, 2012, CURR PAIN HEADACHE R, V16, P270, DOI 10.1007/s11916-012-0255-1; Levy D, 2009, CURR PAIN HEADACHE R, V13, P237, DOI 10.1007/s11916-009-0040-y; Mehrotra S, 2006, N-S ARCH PHARMACOL, V374, P163, DOI 10.1007/s00210-006-0108-8; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Olesen J, 2012, CEPHALALGIA, V32, P578, DOI 10.1177/0333102412441719; Olesen J, 2010, NEUROTHERAPEUTICS, V7, P183, DOI 10.1016/j.nurt.2010.03.006; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; Sances G, 2004, CEPHALALGIA, V24, P110, DOI 10.1111/j.1468-2982.2004.00639.x; Schoonman GG, 2008, BRAIN, V131, P2192, DOI 10.1093/brain/awn094; Shevel E, 2011, HEADACHE, V51, P409, DOI 10.1111/j.1526-4610.2011.01844.x; Shevel E, 2009, HEADACHE, V49, P1541, DOI 10.1111/j.1526-4610.2009.01495.x; Squier W, 2012, CHILD NERV SYST, V28, P2005, DOI 10.1007/s00381-012-1870-1; Srikiatkhachorn A, 2002, HEADACHE, V42, P566, DOI 10.1046/j.1526-4610.2002.02142.x; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; TODA N, 1984, J CARDIOVASC PHARM, V6, P1230; Williamson DJ, 1997, CEPHALALGIA, V17, P518, DOI 10.1046/j.1468-2982.1997.1704518.x; Wolff H., 1948, HEADACHE OTHER HEAD, P255; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Zaproudina N, 2013, CLIN PHYSIOL FUNCT I, V33, P409, DOI 10.1111/cpf.12042	44	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89699	10.1371/journal.pone.0089699	http://dx.doi.org/10.1371/journal.pone.0089699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586970	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200074
J	Awad, L; Fady, B; Khater, C; Roig, A; Cheddadi, R				Awad, Lara; Fady, Bruno; Khater, Carla; Roig, Anne; Cheddadi, Rachid			Genetic Structure and Diversity of the Endangered Fir Tree of Lebanon (Abies cilicica Carr.): Implications for Conservation	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; DISTANCE SEED DISPERSAL; POPULATION-STRUCTURE; COMPUTER-PROGRAM; BAYESIAN-ANALYSIS; HIGH-LEVEL; DIFFERENTIATION; NUMBER; LOCI; SIZE	The threatened conifer Abies cilicica currently persists in Lebanon in geographically isolated forest patches. The impact of demographic and evolutionary processes on population genetic diversity and structure were assessed using 10 nuclear microsatellite loci. All remnant 15 local populations revealed a low genetic variation but a high recent effective population size. F-ST-based measures of population genetic differentiation revealed a low spatial genetic structure, but Bayesian analysis of population structure identified a significant Northeast-Southwest population structure. Populations showed significant but weak isolation-by-distance, indicating non-equilibrium conditions between dispersal and genetic drift. Bayesian assignment tests detected an asymmetric Northeast-Southwest migration involving some long-distance dispersal events. We suggest that the persistence and Northeast-Southwest geographic structure of Abies cilicica in Lebanon is the result of at least two demographic processes during its recent evolutionary history: (1) recent migration to currently marginal populations and (2) local persistence through altitudinal shifts along a mountainous topography. These results might help us better understand the mechanisms involved in the species response to expected climate change.	[Awad, Lara; Cheddadi, Rachid] Univ Montpellier 2, Inst Evolutionary Sci, CNRS UMR 5554, Montpellier, France; [Fady, Bruno; Roig, Anne] INRA, Ecol Forets Mediterraneennes URFM, UR629, Avignon, France; [Khater, Carla] Natl Council Sci Research Lebanon, Ctr Remote Sensing, Beirut, Lebanon	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; INRAE; Centre National de la Recherche Scientifique (CNRS) - Lebanon	Awad, L (corresponding author), Univ Montpellier 2, Inst Evolutionary Sci, CNRS UMR 5554, Montpellier, France.	lara.awad@univ-montp2.fr	Cheddadi, Rachid/GXM-6391-2022; Fady, Bruno/R-5171-2017	Fady, Bruno/0000-0003-2379-7617	Institut Ecologie et Environnement (INEE) of the Centre National de la Recherche Scientifique (CNRS) [245303]; National Council for Scientific Research-Lebanon (NCSR); EcoChange project	Institut Ecologie et Environnement (INEE) of the Centre National de la Recherche Scientifique (CNRS); National Council for Scientific Research-Lebanon (NCSR); EcoChange project	This paper represents a part of the doctoral research of Lara Awad who acknowledges a scholarship from the Institut Ecologie et Environnement (INEE) of the Centre National de la Recherche Scientifique (CNRS) (Contract number 245303) (http://www.cnrs.fr/inee/) and (http://www.cnrs.fr/index.php). Fieldwork in Lebanon was facilitated by a financial support from the Grant Research Program (GRP) of the National Council for Scientific Research-Lebanon (NCSR) (http://www.cnrs.edu.lb/). The stay of Lara Awad at INRA-URFM for the laboratory work was facilitated by a financial support from the EcoChange project (http://www.ecochange-project.eu/ecochange-project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizoti P. G., 2011, EUFORGEN TECHNICAL G; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bardinet T, 2008, ETUDES MEMOIRES EGYP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; BILLINGTON HL, 1991, CONSERV BIOL, V5, P115, DOI 10.1111/j.1523-1739.1991.tb00394.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; CHELIAK WM, 1985, GENETICS, V109, P569; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Conord C, 2012, ECOL EVOL, V2, P2595, DOI 10.1002/ece3.350; Corander J, 2003, GENETICS, V163, P367; Corander J., 2013, DEP MATH STAT; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Corander J, 2006, FISH B-NOAA, V104, P550; Cornuet JM, 1999, GENETICS, V153, P1989; Cornuet JM, 1996, GENETICS, V144, P2001; Cremer E, 2006, MOL ECOL NOTES, V6, P374, DOI 10.1111/j.1471-8286.2005.01238.x; Cuervo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077654; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Eliades NGH, 2011, PLANT SYST EVOL, V294, P185, DOI 10.1007/s00606-011-0453-z; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Estoup A, 1998, NATO ADV SCI I A-LIF, V306, P55; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Fady B, 2005, TAXON, V54, P905, DOI 10.2307/25065477; Fady B., 1999, Forest Genetics, V6, P129; FADY B, 1993, SILVAE GENET, V42, P351; Fady B, 2010, DIVERS DISTRIB, V16, P53, DOI 10.1111/j.1472-4642.2009.00621.x; Falush D, 2003, GENETICS, V164, P1567; Feurdean A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071797; Gardner M, 2013, IUCN 2013 IUCN RED L; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; GILPIN M, 1991, BIOL J LINN SOC, V42, P165, DOI 10.1111/j.1095-8312.1991.tb00558.x; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hansen OK, 2005, MOL ECOL NOTES, V5, P784, DOI 10.1111/j.1471-8286.2005.01062.x; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KIMURA M, 1964, GENETICS, V49, P725; KONNERT M, 1995, PLANT SYST EVOL, V196, P19, DOI 10.1007/BF00985333; Koskela J, 2013, BIOL CONSERV, V157, P39, DOI 10.1016/j.biocon.2012.07.023; LANDE R, 1992, EVOLUTION, V46, P381, DOI 10.1111/j.1558-5646.1992.tb02046.x; LeCorre V, 1997, GENET RES, V69, P117, DOI 10.1017/S0016672397002668; Liepelt S, 2010, PLANT SYST EVOL, V284, P141, DOI 10.1007/s00606-009-0247-8; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; LUIKART G, 1997, THESIS U MONTANA MIS; Manly B.F.J., 1994, MULTIVARIATE STAT ME; Michalakis Y, 1996, GENETICS, V142, P1061; MIKESELL MW, 1969, GEOGR REV, V59, P1, DOI 10.2307/213080; Mimura M, 2007, HEREDITY, V99, P224, DOI 10.1038/sj.hdy.6800987; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Mitton J. B., 1992, New Forests, V6, P197, DOI 10.1007/BF00120645; MOA DRDNR, 2005, NAT FOR TREE ASS INV; NEI M, 1978, GENETICS, V89, P583; Nei M., 1987, MOL EVOLUTIONARY GEN; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Parducci L, 2001, THEOR APPL GENET, V102, P733, DOI 10.1007/s001220051704; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2011, HEREDITY, V106, P203, DOI 10.1038/hdy.2010.60; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; PIMM SL, 1989, TRENDS ECOL EVOL, V4, P176, DOI 10.1016/0169-5347(89)90123-7; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pluess AR, 2011, MOL ECOL, V20, P473, DOI 10.1111/j.1365-294X.2010.04972.x; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; QGIS, 2020, QGIS GEOGR INF SYST; R Core Team, 2018, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodriguez-Ramilo ST, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-49; Roques L, 2010, THEOR POPUL BIOL, V77, P205, DOI 10.1016/j.tpb.2010.02.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Scaltsoyiannes A, 1999, PLANT SYST EVOL, V216, P289, DOI 10.1007/BF01084404; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Vendramin GG, 1999, MOL ECOL, V8, P1117, DOI 10.1046/j.1365-294x.1999.00666.x; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS., 1996, METHODS DISCRETE POP; Wessel P., 1998, EOS T AM GEOPHYS UN, V79, P579, DOI [10.1029/98EO00426, DOI 10.1029/98EO00426, DOI 10.1029/98E000426]; WHITLOCK MC, 1992, EVOLUTION, V46, P608, DOI [10.2307/2409631, 10.1111/j.1558-5646.1992.tb02069.x]; Wright S, 1943, GENETICS, V28, P114; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	108	32	33	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90086	10.1371/journal.pone.0090086	http://dx.doi.org/10.1371/journal.pone.0090086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587219	gold, Green Submitted, Green Published			2022-12-27	WOS:000332390800075
J	Li, L; Zhang, ZW; Wang, CY; Miao, L; Zhang, JP; Wang, JS; Jiao, BH; Zhao, SW				Li, Li; Zhang, Zhenwei; Wang, Chengyu; Miao, Lei; Zhang, Jianpeng; Wang, Jiasen; Jiao, Binghua; Zhao, Shuwei			Quantitative Proteomics Approach to Screening of Potential Diagnostic and Therapeutic Targets for Laryngeal Carcinoma	PLOS ONE			English	Article							MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; BIOMARKER DISCOVERY; CELL-PROLIFERATION; PROTEIN EXPRESSION; GASTRIC-CARCINOMA; GENE-EXPRESSION; NECK-CANCER; IDENTIFICATION; NUCLEOLIN; MIMECAN	To discover candidate biomarkers for diagnosis and detection of human laryngeal carcinoma and explore possible mechanisms of this cancer carcinogenesis, two-dimensional strong cation-exchange/reversed-phase nano-scale liquid chromatography/mass spectrometry analysis was used to identify differentially expressed proteins between the laryngeal carcinoma tissue and the adjacent normal tissue. As a result, 281 proteins with significant difference in expression were identified, and four differential proteins, Profilin-1 (PFN1), Nucleolin (NCL), Cytosolic non-specific dipeptidase (CNDP2) and Mimecan (OGN) with different subcellular localization were selectively validated. Semiquantitative RT-PCR and Western blotting were performed to detect the expression of the four proteins employing a large collection of human laryngeal carcinoma tissues, and the results validated the differentially expressed proteins identified by the proteomics. Furthermore, we knocked down PFN1 in immortalized human laryngeal squamous cell line Hep-2 cells and then the proliferation and metastasis of these transfected cells were measured. The results showed that PFN1 silencing inhibited the proliferation and affected the migration ability of Hep-2 cells, providing some new insights into the pathogenesis of PFN1 in laryngeal carcinoma. Altogether, our present data first time show that PFN1, NCL, CNDP2 and OGN are novel potential biomarkers for diagnosis and therapeutic targets for laryngeal carcinoma, and PFN1 is involved in the metastasis of laryngeal carcinoma.	[Li, Li; Wang, Chengyu; Wang, Jiasen; Zhao, Shuwei] Second Mil Med Univ, Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Zhang, Zhenwei; Zhang, Jianpeng; Jiao, Binghua] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China; [Zhang, Zhenwei] Guangzhou 458 Hosp, Ctr Infect Dis, Key Lab Liver Dis, Guangzhou, Peoples R China; [Miao, Lei] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China; [Miao, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Fudan University; Fudan University	Zhang, JP (corresponding author), Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China.	zjp80072002@hotmail.com; jiaobh@live.cn; zhaoshw@live.cn			Shanghai Science and Technology Commission [13431900303]; Shanghai Health and Family Planning Commission; Young Start-up Projects of Changzheng Hospital [2012CZQN07]	Shanghai Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)Shanghai Science & Technology Committee); Shanghai Health and Family Planning Commission; Young Start-up Projects of Changzheng Hospital	This study was supported by funds from the Shanghai Science and Technology Commission (13431900303, 13431900303); Shanghai Health and Family Planning Commission and Young Start-up Projects of Changzheng Hospital (2012CZQN07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Cheng L, 2009, ACTA OTO-LARYNGOL, V129, P774, DOI 10.1080/00016480802412797; DeSouza LV, 2007, MOL CELL PROTEOMICS, V6, P1170, DOI 10.1074/mcp.M600378-MCP200; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Galzio R, 2012, J CELL BIOCHEM, V113, P571, DOI 10.1002/jcb.23381; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Herrmann PC, 2001, DIS MARKERS, V17, P49, DOI 10.1155/2001/327047; Hu SM, 2005, J CLIN ENDOCR METAB, V90, P6657, DOI 10.1210/jc.2005-0322; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Johann DJ, 2004, ANN NY ACAD SCI, V1022, P295, DOI 10.1196/annals.1318.045; Kavallaris M, 2005, MED J AUSTRALIA, V182, P575, DOI 10.5694/j.1326-5377.2005.tb06817.x; Lee JH, 2012, CLIN CANCER RES, V18, P524, DOI 10.1158/1078-0432.CCR-11-1903; Lefebvre JL, 2006, LANCET ONCOL, V7, P747, DOI 10.1016/S1470-2045(06)70860-9; Li ZB, 2003, PROTEOMICS, V3, P1325, DOI 10.1002/pmic.200300454; Liu CB, 2011, TUMOR BIOL, V32, P1139, DOI 10.1007/s13277-011-0216-z; Ma YL, 2009, MOL CELL PROTEOMICS, V8, P1878, DOI 10.1074/mcp.M800541-MCP200; Medina JE, 2011, HEAD NECK-J SCI SPEC, V33, P746, DOI 10.1002/hed.21453; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Moon PG, 2013, J PROTEOMICS, V85, P174, DOI 10.1016/j.jprot.2013.04.004; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Mourmouras V, 2009, J CUTAN PATHOL, V36, P637, DOI 10.1111/j.1600-0560.2008.01126.x; Oien KA, 2003, ONCOGENE, V22, P4287, DOI 10.1038/sj.onc.1206615; Okamura N, 2008, PROTEOMICS, V8, P3194, DOI 10.1002/pmic.200700619; Orr B, 2012, ONCOGENE, V31, P1130, DOI 10.1038/onc.2011.312; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Peng L, 2010, CLIN CANCER RES, V16, P3734, DOI 10.1158/1078-0432.CCR-09-3411; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Sewell DA, 2007, ORL-J OTO-RHIN-LARYN, V69, P77, DOI 10.1159/000097406; Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Tomasino RM, 1996, ANTICANCER RES, V16, P2257; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; Wang JG, 2012, ARTHRITIS RHEUM-US, V64, P993, DOI 10.1002/art.33425; Wang YH, 2007, EXP BIOL MED, V232, P1152, DOI 10.3181/0701-RM-8; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Zeng GQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013946; Zhang PP, 2006, CLIN CANCER RES, V12, P6617, DOI 10.1158/1078-0432.CCR-06-1307; Zhang ZW, 2012, INT J BIOL SCI, V8, P383, DOI 10.7150/ijbs.3579; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054674; Zheng CX, 2009, ONCOL REP, V22, P1057, DOI 10.3892/or_00000536; Zvrko E, 2012, COLLEGIUM ANTROPOL, V36, P119	42	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90181	10.1371/journal.pone.0090181	http://dx.doi.org/10.1371/journal.pone.0090181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587265	gold, Green Submitted, Green Published			2022-12-27	WOS:000332390800086
J	Campolo, J; Vozzi, F; Penco, S; Cozzi, L; Caruso, R; Domenici, C; Ahluwalia, A; Rial, M; Marraccini, P; Parodi, O				Campolo, Jonica; Vozzi, Federico; Penco, Silvana; Cozzi, Lorena; Caruso, Raffaele; Domenici, Claudio; Ahluwalia, Arti; Rial, Michela; Marraccini, Paolo; Parodi, Oberdan			Vascular Injury Post Stent Implantation: Different Gene Expression Modulation in Human Umbilical Vein Endothelial Cells (HUVECs) Model	PLOS ONE			English	Article							WALL SHEAR-STRESS; DISTURBED FLOW; ACTIVATION; FLUID; A20; ATHEROSCLEROSIS; CYTOSKELETON; DETERMINANT; RESTENOSIS; SYSTEM	To explore whether stent procedure may influence transcriptional response of endothelium, we applied different physical (flow changes) and/or mechanical (stent application) stimuli to human endothelial cells in a laminar flow bioreactor (LFB) system. Gene expression analysis was then evaluated in each experimental condition. Human umbilical vein endothelial cells (HUVECs) were submitted to low and physiological (1 and 10 dyne/cm(2)) shear stress in absence (AS) or presence (PS) of stent positioning in a LFB system for 24 h. Different expressed genes, coming from Affymetrix results, were identified based on one-way ANOVA analysis with p values <0.01 and a fold changed >3 in modulus. Low shear stress was compared with physiological one in AS and PS conditions. Two major groups include 32 probes commonly expressed in both 1AS versus 10AS and 1PS versus 10PS comparison, and 115 probes consisting of 83 in addition to the previous 32, expressed only in 1PS versus 10PS comparison. Genes related to cytoskeleton, extracellular matrix, and cholesterol transport/metabolism are differently regulated in 1PS versus 10PS condition. Inflammatory and apoptotic mediators seems to be, instead, closely modulated by changes in flow (1 versus 10), independently of stent application. Low shear stress together with stent procedure are the experimental conditions that mainly modulate the highest number of genes in our human endothelial model. Those genes belong to pathways specifically involved in the endothelial dysfunction.	[Campolo, Jonica; Vozzi, Federico; Cozzi, Lorena; Caruso, Raffaele; Domenici, Claudio; Rial, Michela; Marraccini, Paolo; Parodi, Oberdan] CNR Inst Clin Physiol, Milan, Italy; [Campolo, Jonica; Vozzi, Federico; Cozzi, Lorena; Caruso, Raffaele; Domenici, Claudio; Rial, Michela; Marraccini, Paolo; Parodi, Oberdan] CNR Inst Clin Physiol, Pisa, Italy; [Penco, Silvana] Niguarda Ca Granda Hosp Milan, Dept Lab Med, Milan, Italy; [Ahluwalia, Arti] Univ Pisa, Interdept Res Ctr E Piaggio, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pisa	Campolo, J (corresponding author), CNR Inst Clin Physiol, Milan, Italy.	jonica.campolo@ospedaleniguarda.it	Vozzi, Federico/O-3276-2019; Vozzi, Federico/C-9706-2014; Campolo, Jonica/ABC-5841-2020	Vozzi, Federico/0000-0001-5457-2328; Vozzi, Federico/0000-0001-5457-2328; Penco, Silvana/0000-0003-1050-095X; Ahluwalia, Arti/0000-0001-5370-6750	FP7-ICT ARTreat project [224297]; CNR National Project ME.01 Malattie Cardiopolmonari Dept. of Medicine	FP7-ICT ARTreat project; CNR National Project ME.01 Malattie Cardiopolmonari Dept. of Medicine	This study was supported by grant from FP7-ICT-2007 ARTreat project (grant agreement 224297) and CNR National Project ME.01 Malattie Cardiopolmonari Dept. of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bakker SJL, 2000, CARDIOVASC RES, V45, P270, DOI 10.1016/S0008-6363(99)00392-2; Bogatcheva NV, 2008, MICROVASC RES, V76, P202, DOI 10.1016/j.mvr.2008.06.003; Brooks AR, 2004, ENDOTHELIUM-J ENDOTH, V11, P45, DOI 10.1080/10623320490432470; Brooks AR, 2002, PHYSIOL GENOMICS, V9, P27, DOI 10.1152/physiolgenomics.00075.2001; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Conway DE, 2010, AM J PHYSIOL-HEART C, V298, pH367, DOI 10.1152/ajpheart.00565.2009; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; Damrauer SM, 2010, ATHEROSCLEROSIS, V211, P404, DOI 10.1016/j.atherosclerosis.2010.03.029; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; He Y, 2005, J BIOMECH ENG-T ASME, V127, P637, DOI 10.1115/1.1934122; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KASTRATI A, 1993, CIRCULATION, V87, P1498, DOI 10.1161/01.CIR.87.5.1498; Li Y, 2003, BIOL REPROD, V69, P1053, DOI 10.1095/biolreprod.102.013474; Liu Y, 2002, ARTERIOSCL THROM VAS, V22, P76, DOI 10.1161/hq0102.101822; Mazzei D, 2008, IEEE T IND ELECTRON, V55, P3273, DOI 10.1109/TIE.2008.928122; Moore JE, 2002, ANN BIOMED ENG, V30, P498, DOI 10.1114/1.1458594; Punchard MA, 2009, ANN BIOMED ENG, V37, P1322, DOI 10.1007/s10439-009-9701-6; Reneman RS, 2006, J VASC RES, V43, P251, DOI 10.1159/000091648; Schober A, 2008, J MOL MED, V86, P761, DOI 10.1007/s00109-008-0334-2; SHASBY DM, 1982, CIRC RES, V51, P657, DOI 10.1161/01.RES.51.5.657; Soulls JV, 2006, J BIOMECH, V39, P742, DOI 10.1016/j.jbiomech.2004.12.026; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Uboldi C, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-18; von Kampen O, 2010, J BIOL CHEM, V285, P19921, DOI 10.1074/jbc.M110.127480; Won M, 2010, CELL DEATH DIFFER, V17, P1830, DOI 10.1038/cdd.2010.47; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	32	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90213	10.1371/journal.pone.0090213	http://dx.doi.org/10.1371/journal.pone.0090213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587287	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000145
J	Tsugawa, Y; Kato, H; Fujita, T; Shimotohno, K; Hijikata, M				Tsugawa, Yoji; Kato, Hiroki; Fujita, Takashi; Shimotohno, Kunitada; Hijikata, Makoto			Critical Role of Interferon-alpha Constitutively Produced in Human Hepatocytes in Response to RNA Virus Infection	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; DOUBLE-STRANDED-RNA; IFN-A GENES; DENDRITIC CELLS; IN-VIVO; RIG-I; ANTIVIRAL RESPONSES; INNATE IMMUNITY; INDUCTION; BETA	Several viruses are known to infect human liver and cause the hepatitis, but the interferon (IFN) response, a first-line defense against viral infection, of virus-infected hepatocytes is not clearly defined yet. We investigated innate immune system against RNA viral infection in immortalized human hepatocytes (HuS-E/2 cells), as the cells showed similar early innate immune responses to primary human hepatocytes (PHH). The low-level constitutive expression of IFN-alpha 1 gene, but not IFN-beta and IFN-lambda, was observed in both PHH and HuS-E/2 cells in the absence of viral infection, suggesting a particular subtype(s) of IFN-alpha is constitutively produced in human hepatocytes. To examine the functional role of such IFN-alpha in the antiviral response, the expression profiles of innate immune-related genes were studied in the cells with the treatment of neutralization against type I IFN receptor 2 (IFNAR2) or IFN-alpha itself to inhibit the constitutive IFN-alpha signaling before and after virus infection. As the results, a clear reduction of basal level expression of IFN-inducible genes was observed in uninfected cells. When the effect of the inhibition on the cells infected with hepatitis C virus (HCV) was examined, the significant decrease of IFN stimulated gene expression and the enhancement of initial HCV replication were observed, suggesting that the steady-state production of IFN-alpha plays a role in amplification of antiviral responses to control the spread of RNA viral infection in human hepatocytes.	[Tsugawa, Yoji; Hijikata, Makoto] Kyoto Univ, Inst Virus Res, Lab Human Tumor Viruses, Kyoto 606, Japan; [Tsugawa, Yoji; Hijikata, Makoto] Kyoto Univ, Grad Sch Biostudies, Lab Viral Oncol, Kyoto, Japan; [Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Shimotohno, Kunitada] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan	Kyoto University; Kyoto University; Kyoto University; National Center for Global Health & Medicine - Japan	Hijikata, M (corresponding author), Kyoto Univ, Inst Virus Res, Lab Human Tumor Viruses, Kyoto 606, Japan.	mhijikat@virus.kyoto-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Aly HH, 2009, HEPATOLOGY, V50, P689, DOI 10.1002/hep.23034; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Braganca J, 1998, BIOCHIMIE, V80, P673, DOI 10.1016/S0300-9084(99)80021-2; Colantonio AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024252; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Genin P, 1995, NUCLEIC ACIDS RES, V23, P5055; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hata N, 2001, BIOCHEM BIOPH RES CO, V285, P518, DOI 10.1006/bbrc.2001.5159; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Hsu ACY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032947; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; KELLER AD, 1988, P NATL ACAD SCI USA, V85, P3309, DOI 10.1073/pnas.85.10.3309; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Kushima Y, 2010, J VIROL, V84, P9118, DOI 10.1128/JVI.00402-10; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; MAENO K, 1966, VIROLOGY, V29, P255, DOI 10.1016/0042-6822(66)90032-8; Matsumiya T, 2011, ARCH IMMUNOL THER EX, V59, P41, DOI 10.1007/s00005-010-0107-9; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; TOVEY MG, 1987, P NATL ACAD SCI USA, V84, P5038, DOI 10.1073/pnas.84.14.5038; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89869	10.1371/journal.pone.0089869	http://dx.doi.org/10.1371/journal.pone.0089869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587086	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000102
J	Krai, P; Dalal, S; Klemba, M				Krai, Priscilla; Dalal, Seema; Klemba, Michael			Evidence for a Golgi-to-Endosome Protein Sorting Pathway in Plasmodium falciparum	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BREFELDIN-A CAUSES; ENDOPLASMIC-RETICULUM; MALARIA PARASITES; GUANINE-NUCLEOTIDE; RETROMER COMPLEX; SECRETORY ORGANELLE; FLUORESCENT PROTEIN; MAMMALIAN RETROMER; RING STAGE	During the asexual intraerythrocytic stage, the malaria parasite Plasmodium falciparum must traffic newly-synthesized proteins to a broad array of destinations within and beyond the parasite's plasma membrane. In this study, we have localized two well-conserved protein components of eukaryotic endosomes, the retromer complex and the small GTPase Rab7, to define a previously-undescribed endosomal compartment in P. falciparum. Retromer and Rab7 co-localized to a small number of punctate structures within parasites. These structures, which we refer to as endosomes, lie in close proximity to the Golgi apparatus and, like the Golgi apparatus, are inherited by daughter merozoites. However, the endosome is clearly distinct from the Golgi apparatus as neither retromer nor Rab7 redistributed to the endoplasmic reticulum upon brefeldin A treatment. Nascent rhoptries (specialized secretory organelles required for invasion) developed adjacent to endosomes, an observation that suggests a role for the endosome in rhoptry biogenesis. A P. falciparum homolog of the sortilin family of protein sorting receptors (PfSortilin) was localized to the Golgi apparatus. Together, these results elaborate a putative Golgi-to-endosome protein sorting pathway in asexual blood stage parasites and suggest that one role of retromer is to mediate the retrograde transport of PfSortilin from the endosome to the Golgi apparatus.	[Krai, Priscilla; Dalal, Seema; Klemba, Michael] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Klemba, M (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	klemba@vt.edu			Department of Biochemistry at Virginia Tech; NSF S-STEM Graduate Scholarship	Department of Biochemistry at Virginia Tech; NSF S-STEM Graduate Scholarship	This work was supported by the Department of Biochemistry at Virginia Tech and an NSF S-STEM Graduate Scholarship to P. Krai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa A, 2007, INT J PARASITOL, V37, P1127, DOI 10.1016/j.ijpara.2007.02.009; Attar N, 2010, ADV ENZYME REGUL, V50, P216, DOI 10.1016/j.advenzreg.2009.10.002; Balderhaar HJK, 2010, J CELL SCI, V123, P4085, DOI 10.1242/jcs.071977; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Bannister LH, 2004, MICROSC MICROANAL, V10, P551, DOI 10.1017/S1431927604040917; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051; Boal F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009898; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; Denloye T, 2012, MOL BIOCHEM PARASIT, V186, P29, DOI 10.1016/j.molbiopara.2012.09.004; Deponte M, 2012, MOL BIOCHEM PARASIT, V186, P95, DOI 10.1016/j.molbiopara.2012.09.007; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Feng Y, 2001, METHOD ENZYMOL, V329, P175; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffin CT, 2005, P NATL ACAD SCI USA, V102, P15173, DOI 10.1073/pnas.0409558102; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Gubbels MJ, 2012, INT J PARASITOL, V42, P1071, DOI 10.1016/j.ijpara.2012.09.009; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Koumandou VL, 2011, J CELL SCI, V124, P1496, DOI 10.1242/jcs.081596; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; Langsley G, 2008, MICROBES INFECT, V10, P462, DOI 10.1016/j.micinf.2008.01.017; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee MCS, 2008, MOL MICROBIOL, V68, P1535, DOI 10.1111/j.1365-2958.2008.06250.x; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu TT, 2012, MOL BIOL CELL, V23, P2505, DOI 10.1091/mbc.E11-11-0915; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; MERESSE S, 1995, J CELL SCI, V108, P3349; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Quevillon E, 2003, GENE, V306, P13, DOI 10.1016/S0378-1119(03)00381-0; Reilly HB, 2007, INT J PARASITOL, V37, P1599, DOI 10.1016/j.ijpara.2007.05.003; ROA M, 1993, J CELL SCI, V106, P789; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; SCHOFIELD L, 1986, MOL BIOCHEM PARASIT, V18, P183, DOI 10.1016/0166-6851(86)90037-X; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Singh S, 2007, P NATL ACAD SCI USA, V104, P20043, DOI 10.1073/pnas.0709999104; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Spielmann T, 2000, MOL BIOCHEM PARASIT, V111, P453, DOI 10.1016/S0166-6851(00)00333-9; Struck NS, 2008, J CELL SCI, V121, P2123, DOI 10.1242/jcs.021154; Struck NS, 2008, MOL MICROBIOL, V67, P1320, DOI 10.1111/j.1365-2958.2008.06125.x; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tonkin CJ, 2006, MOL MICROBIOL, V61, P614, DOI 10.1111/j.1365-2958.2006.05244.x; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; VanWye J, 1996, MOL BIOCHEM PARASIT, V83, P107, DOI 10.1016/S0166-6851(96)02759-4; Vinke FP, 2011, BIOCHEM J, V433, P423, DOI 10.1042/BJ20101540; von Itzstein M, 2008, TRENDS PARASITOL, V24, P210, DOI 10.1016/j.pt.2008.02.007; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wellems TE, 2009, J CLIN INVEST, V119, P2496, DOI 10.1172/JCI38307; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Wunderlich Juliane, 2012, Front Biosci (Schol Ed), V4, P1424; Yang M, 2004, J CELL SCI, V117, P3831, DOI 10.1242/jcs.01237; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	90	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89771	10.1371/journal.pone.0089771	http://dx.doi.org/10.1371/journal.pone.0089771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587025	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900080
J	Kim, YR; Kim, HN; Ahn, SM; Choi, YH; Shin, HK; Choi, BT				Kim, Yu Ri; Kim, Ha Neui; Ahn, Sung Min; Choi, Yung Hyun; Shin, Hwa Kyoung; Choi, Byung Tae			Electroacupuncture Promotes Post-Stroke Functional Recovery via Enhancing Endogenous Neurogenesis in Mouse Focal Cerebral Ischemia	PLOS ONE			English	Article							NEURAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; NEUROTROPHIC FACTOR; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; STIMULATES NEUROGENESIS; PROGENITOR CELLS; IN-VITRO; BRAIN; STROKE	To investigate the question of whether electroacupuncture (EA) promotes functional recovery via enhancement of proliferation and differentiation of neuronal stem cells (NSCs) in ischemic stroke, EA stimulation with 2 Hz was applied at bilateral acupoints to Baihui (GV20) and Dazhui (GV14) in middle cerebral artery occlusion (MCAO) mice. EA stimulation improved neuromotor function and cognitive ability after ischemic stroke. EA stimulation resulted in an increase in the number of proliferated cells, especially in the subventricular zone (SVZ) of the ipsilateral hemisphere. Although a very limited number of NSCs survived and differentiated into neurons or astrocytes, EA treatment resulted in a significant increase in the number of proliferative cells and differentiated cells in the hippocampus and SVZ of the ipsilateral hemisphere compared to MCAO mice. EA stimulation resulted in significantly increased mRNA expression of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF). Protein levels of these factors were confirmed in the ipsilateral hippocampus and SVZ by immunohistochemical and Western blotting analyses. Expression of phosphorylated phosphatidylinositol-3-kinase, BDNF, and VEGF-mediated down-stream were enhanced by EA stimulation in newly formed neuroblasts. These results indicate that EA treatment after ischemic stroke may promote post-stroke functional recovery by enhancement of proliferation and differentiation of NSCs via the BDNF and VEGF signaling pathway.	[Kim, Yu Ri; Kim, Ha Neui; Choi, Byung Tae] Pusan Natl Univ, Dept Korean Med Sci, Sch Korean Med, Yangsan, South Korea; [Ahn, Sung Min; Shin, Hwa Kyoung; Choi, Byung Tae] Pusan Natl Univ, Div Meridian & Struct Med, Sch Korean Med, Yangsan, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Dept Biochem, Coll Oriental Med, Pusan, Yangjeong, South Korea	Pusan National University; Pusan National University; Dong-Eui University	Choi, BT (corresponding author), Pusan Natl Univ, Dept Korean Med Sci, Sch Korean Med, Yangsan, South Korea.	choibt@pusan.ac.kr		Kim, Haneui/0000-0002-5651-4727	Ministry of Education, Science and Technology [2013R1A1A2005824]; Basic Science Research Program through the National Research Foundation of Korea (NRF)	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2005824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2012, J CEREBR BLOOD F MET, V32, P1317, DOI 10.1038/jcbfm.2011.187; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; Cheng SM, 2009, NEUROL RES, V31, P753, DOI 10.1179/174313209X382557; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hong JC, 2013, INT J MOL MED, V31, P225, DOI 10.3892/ijmm.2012.1166; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Iwai M, 2003, J CEREBR BLOOD F MET, V23, P331, DOI 10.1097/01.WCB.0000050060.57184.E7; Iwai M, 2002, J CEREBR BLOOD F MET, V22, P411, DOI 10.1097/00004647-200204000-00005; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Lindvall O, 2011, STROKE, V42, P2369, DOI 10.1161/STROKEAHA.110.599654; Manni L, 2010, AUTON NEUROSCI-BASIC, V157, P9, DOI 10.1016/j.autneu.2010.03.020; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Quirie A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044218; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Wang K, 2012, J NEUROSCI RES, V90, P1464, DOI 10.1002/jnr.23028; Wu P, 2010, STROKE, V41, pE171, DOI 10.1161/STROKEAHA.109.573576; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang ZJ, 2005, ACUPUNCTURE ELECTRO, V30, P185, DOI 10.3727/036012905815901244; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yu JC, 2005, PHYSIOL BEHAV, V86, P434, DOI 10.1016/j.physbeh.2005.07.015; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004	40	68	78	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e90000	10.1371/journal.pone.0090000	http://dx.doi.org/10.1371/journal.pone.0090000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587178	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700124
J	Li, H; Guo, XJ; Ye, XF; Jiang, H; Du, WM; Xu, JF; Zhang, XJ; He, J				Li, Hui; Guo, Xiao-Jing; Ye, Xiao-Fei; Jiang, Hong; Du, Wen-Min; Xu, Jin-Fang; Zhang, Xin-Ji; He, Jia			Adverse Drug Reactions of Spontaneous Reports in Shanghai Pediatric Population	PLOS ONE			English	Article							RISK-FACTORS; INTERNAL-MEDICINE; CHILDREN; SURVEILLANCE; METAANALYSIS; ADMISSION; FREQUENCY; DATABASE; TRIALS	Background: Knowledge of drug safety in the pediatric population of China is limited. This study was designed to evaluate ADRs in children reported to the spontaneous reporting system (SRS) of Shanghai in 2009. Methodology and Principal Findings: Crude ADR reports submitted to Shanghai SRS in 2009 for individuals aged from birth to 17 years (including 17 years) were included. Data were analyzed with respect to age, gender, category of ADR (System Organ Class [SOC]), the severity of reports and type of reporter. Results: A male overrepresentation was observed regarding the total number of reports. The most frequently reported group of drugs were vaccines (42.15%). Skin rash and fever were the commonest symptoms reported in the total pediatric dataset. The proportion of children that suffered from a serious ADR was 2.16% and that for drug related deaths was 0.34%. And we found that the multiple drug exposure experienced a high proportion of serious ADRs compared with the single drug use (chi(2) = 15.99, P<0.0001). Sixty-five percent of ADRs were for children less than 6 years of age. And more than half of reports were from doctors. Conclusions: In our study, consumers were more likely to report new ADRs though they appear to contribute a relatively small percentage of total reports. We propose that patients would take an active role in reporting ADRs. More researches are needed in order to achieve better understanding the characteristics of ADRs in pediatric population of China.	[Li, Hui; Guo, Xiao-Jing; Ye, Xiao-Fei; Jiang, Hong; Xu, Jin-Fang; Zhang, Xin-Ji; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Jiang, Hong] Second Mil Med Univ, Dept Polit, Shanghai, Peoples R China; [Du, Wen-Min] Adverse Drug React Monitoring Ctr Shanghai, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	He, J (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yeah.net	guo, xiaojing/GYJ-0885-2022	ye, xiaofei/0000-0003-3692-1285; He, Jia/0000-0002-2338-9501	National Natural Science Foundation of China [81072388, 81202285, 81373105]; key discipline construction of evidence-based public health in Shanghai [12GWZX0602]; Natural Science Foundation of Shanghai [12ZR1453700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key discipline construction of evidence-based public health in Shanghai; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study was funded by three grants from the National Natural Science Foundation of China (No. 81072388, No. 81202285, No. 81373105), the key discipline construction of evidence-based public health in Shanghai (No. 12GWZX0602) and Natural Science Foundation of Shanghai (No. 12ZR1453700). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2010, DRUG SAFETY, V33, P327, DOI 10.2165/11319100-000000000-00000; Carleton BC, 2007, J POPUL THER CLIN PH, V14, pE45; Choonara I, 2002, DRUG SAFETY, V25, P1, DOI 10.2165/00002018-200225010-00001; Clavenna A, 2009, EUR J PEDIATR, V168, P173, DOI 10.1007/s00431-008-0725-y; Committee of Chinese Pharmacopoeia, 2005, CHINESE PHARMACOPOEI; Conroy S, 2000, BRIT J CLIN PHARMACO, V49, P93, DOI 10.1046/j.1365-2125.2000.00125.x; Easton KL, 2004, BRIT J CLIN PHARMACO, V57, P611, DOI 10.1111/j.1365-2125.2003.02052.x; Fattinger K, 2000, BRIT J CLIN PHARMACO, V49, P158, DOI 10.1046/j.1365-2125.2000.00132.x; Hawcutt DB, 2012, BRIT J CLIN PHARMACO, V73, P437, DOI 10.1111/j.1365-2125.2011.04113.x; Horen B, 2002, BRIT J CLIN PHARMACO, V54, P665, DOI 10.1046/j.1365-2125.2002.t01-3-01689.x; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Jain SS, 2008, INDIAN J PEDIATR, V75, P1133, DOI 10.1007/S12098-008-0188-1; KILEN, 2000, CONS REP MED CONS DO; Kimland E, 2005, PHARMACOEPIDEM DR S, V14, P493, DOI 10.1002/pds.1121; Koh N. Y., 2002, SMJ Singapore Medical Journal, V43, P279; Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037; Lacoste-Roussillon C, 2001, CLIN PHARMACOL THER, V69, P458, DOI 10.1067/mcp.2001.116145; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Le J, 2006, PEDIATRICS, V118, P555, DOI 10.1542/peds.2005-2429; Ministry of Health of The People's Republic of China, 2011, MEAS REP MON ADV DRU; Morales-Olivas FJ, 2000, J CLIN EPIDEMIOL, V53, P1076, DOI 10.1016/S0895-4356(00)00190-6; Noren GN, 2008, STAT MED, V27, P3057, DOI 10.1002/sim.3247; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rambhade Sujit, 2012, Toxicol Int, V19, P68, DOI 10.4103/0971-6580.94506; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P801, DOI 10.1007/s00228-011-1183-4; Sammons HM, 2005, EUR J CLIN PHARMACOL, V61, P165, DOI 10.1007/s00228-005-0894-9; Munoz-Torrero JFS, 2010, EUR J CLIN PHARMACOL, V66, P1257, DOI 10.1007/s00228-010-0866-6; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Star K, 2011, DRUG SAFETY, V34, P415, DOI 10.2165/11587540-000000000-00000; Sturkenboom MCJM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2245; Temple ME, 2004, DRUG SAFETY, V27, P819, DOI 10.2165/00002018-200427110-00005; Thakrar BT, 2007, BRIT J CLIN PHARMACO, V64, P489, DOI 10.1111/j.1365-2125.2007.02900.x; van Grootheest A C, 2005, Ned Tijdschr Geneeskd, V149, P529; van Grootheest K, 2003, DRUG SAFETY, V26, P211, DOI 10.2165/00002018-200326040-00001; van Puijenbroek EP, 1999, BRIT J CLIN PHARMACO, V47, P689, DOI 10.1046/j.1365-2125.1999.00957.x; Wallerstedt SM, 2011, DRUG SAFETY, V34, P669, DOI 10.2165/11591730-000000000-00000; Wiholm BE, 2000, PHARMACOEPIDEMIOLOGY, V3, P175, DOI [DOI 10.1002/0470842555.CH11, DOI 10.1002/0470842555.ch11]; Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363; Zopf Y, 2008, DRUG SAFETY, V31, P789, DOI 10.2165/00002018-200831090-00007	39	30	32	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89829	10.1371/journal.pone.0089829	http://dx.doi.org/10.1371/journal.pone.0089829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587066	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700101
J	Ji, J; Ling, XFB; Zhao, YZ; Hu, ZK; Zheng, XL; Xu, ZN; Wen, QJ; Kastenberg, ZJ; Li, P; Abdullah, F; Brandt, ML; Ehrenkranz, RA; Harris, MC; Lee, TC; Simpson, BJ; Bowers, C; Moss, RL; Sylvester, KG				Ji, Jun; Ling, Xuefeng B.; Zhao, Yingzhen; Hu, Zhongkai; Zheng, Xiaolin; Xu, Zhening; Wen, Qiaojun; Kastenberg, Zachary J.; Li, Ping; Abdullah, Fizan; Brandt, Mary L.; Ehrenkranz, Richard A.; Harris, Mary Catherine; Lee, Timothy C.; Simpson, B. Joyce; Bowers, Corinna; Moss, R. Lawrence; Sylvester, Karl G.			A Data-Driven Algorithm Integrating Clinical and Laboratory Features for the Diagnosis and Prognosis of Necrotizing Enterocolitis	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; ISOLATED INTESTINAL PERFORATION; NEONATAL-RESEARCH-NETWORK; OUTCOMES; COHORT	Background: Necrotizing enterocolitis (NEC) is a major source of neonatal morbidity and mortality. Since there is no specific diagnostic test or risk of progression model available for NEC, the diagnosis and outcome prediction of NEC is made on clinical grounds. The objective in this study was to develop and validate new NEC scoring systems for automated staging and prognostic forecasting. Study design: A six-center consortium of university based pediatric teaching hospitals prospectively collected data on infants under suspicion of having NEC over a 7-year period. A database comprised of 520 infants was utilized to develop the NEC diagnostic and prognostic models by dividing the entire dataset into training and testing cohorts of demographically matched subjects. Developed on the training cohort and validated on the blind testing cohort, our multivariate analyses led to NEC scoring metrics integrating clinical data. Results: Machine learning using clinical and laboratory results at the time of clinical presentation led to two NEC models: (1) an automated diagnostic classification scheme; (2) a dynamic prognostic method for risk-stratifying patients into low, intermediate and high NEC scores to determine the risk for disease progression. We submit that dynamic risk stratification of infants with NEC will assist clinicians in determining the need for additional diagnostic testing and guide potential therapies in a dynamic manner. Algorithm availability: http://translationalmedicine.stanford.edu/cgi-bin/NEC/index.pl and smartphone application upon request.	[Ji, Jun; Wen, Qiaojun; Li, Ping] Zhejiang Univ, Inst Ind Proc Control, State Key Lab Ind Control, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Yingzhen] Hangzhou Normal Univ, Sch Hlth Management, Hangzhou, Zhejiang, Peoples R China; [Ji, Jun; Ling, Xuefeng B.; Zhao, Yingzhen; Hu, Zhongkai; Zheng, Xiaolin; Xu, Zhening; Wen, Qiaojun; Kastenberg, Zachary J.; Sylvester, Karl G.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Hu, Zhongkai; Zheng, Xiaolin] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China; [Abdullah, Fizan] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Brandt, Mary L.; Lee, Timothy C.] Texas Childrens Hosp, Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Ehrenkranz, Richard A.; Simpson, B. Joyce] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Harris, Mary Catherine] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Bowers, Corinna; Moss, R. Lawrence] Nationwide Childrens Hosp, Div Pediat Surg, Columbus, OH USA; [Bowers, Corinna; Moss, R. Lawrence] Ohio State Coll Med, Dept Surg, Columbus, OH USA	Zhejiang University; Hangzhou Normal University; Stanford University; Zhejiang University; Johns Hopkins University; Baylor College of Medicine; Yale University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Sylvester, KG (corresponding author), Stanford Univ, Dept Surg, Stanford, CA 94305 USA.	Sylvester@stanford.edu		Sylvester, Karl G./0000-0002-8559-0155; Ling, Bruce/0000-0002-5386-3884	China Scholarship Council [2011632151]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	JJ is supported by China Scholarship Council grant (No. 2011632151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnama S, 1998, LINEAR DISPLACEMENT; BALLANCE WA, 1990, J PEDIATR-US, V117, pS6, DOI 10.1016/S0022-3476(05)81124-2; Bates D., 2008, LME4 PACKAGE; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bishop C, 2009, VARIATIONAL RELEVANC, P46; Blakely ML, 2006, PEDIATRICS, V117, pE680, DOI 10.1542/peds.2005-1273; Blakely ML, 2005, ANN SURG, V241, P984, DOI 10.1097/01.sla.0000164181.67862.7f; Chongsuvivatwong V., 2011, EPICALC EPIDEMIOLOGI; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Kamitsuka MD, 2000, PEDIATRICS, V105, P379, DOI 10.1542/peds.105.2.379; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Ling XB, 2009, BIOINFORMATICS, V25, P1461, DOI 10.1093/bioinformatics/btp176; MCCORMACK CJ, 1987, J PEDIATR SURG, V22, P488, DOI 10.1016/S0022-3468(87)80202-6; Moss RL, 2008, J PERINATOL, V28, P665, DOI 10.1038/jp.2008.119; Rabe-Hesketh S, 2008, LONGITUDINAL DATA AN, V79; Ripley B., 2002, MODERN APPL STAT S; Sutherland SM, 2013, CLIN J AM SOC NEPHRO, V8, P1661, DOI 10.2215/CJN.00270113; Sylvester KG, 2014, J PEDIAT; Sylvester KG, 2013, GUT; Zeileis A., 2004, ECONOMETRIC COMPUTIN; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; ZWEIG MH, 1993, CLIN CHEM, V39, P561	23	23	23	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89860	10.1371/journal.pone.0089860	http://dx.doi.org/10.1371/journal.pone.0089860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587080	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200089
J	Kesavaraju, B; Leisnham, PT; Keane, S; Delisi, N; Pozatti, R				Kesavaraju, Banugopan; Leisnham, Paul T.; Keane, Samantha; Delisi, Nicholas; Pozatti, Rachel			Interspecific Competition between Aedes albopictus and A. sierrensis: Potential for Competitive Displacement in the Western United States	PLOS ONE			English	Article							CONTAINER MOSQUITOS; PHOTOPERIODIC DIAPAUSE; TRISERIATUS DIPTERA; LAMBORNELLA-CLARKI; AE.-TRISERIATUS; DETRITUS TYPE; CULICIDAE; AEGYPTI; CALIFORNIA; POPULATIONS	The Asian tiger mosquito, Aedes albopictus, was first detected in North America twenty five years ago. It utilizes water-holding container habitats as immature development sites, and has rapidly spread throughout the eastern United States. Aedes albopictus has occasionally been detected in the western United States, but until recently no established populations of A. albopictus were reported. The western tree-hole mosquito, Aedes sierrensis, is the most common tree-hole mosquito throughout the western United States, and is expected to more frequently encounter A. albopictus. In this study, competition between A. albopictus from the eastern United States and A. sierrensis from the western United States was tested in order to better understand the potential for either competitive displacement of A. sierrensis by A. albopictus or competitive resistance of A. sierrensis to A. albopictus. Varying densities of each species were reared with limited resources in a response surface design. Consistent with a prior study, we found that A. albopictus was clearly a superior larval competitor than A. sierrensis. Aedes sierrensis lambda' (finite rate of increase) decreased with increasing A. albopictus density, but in contrast, A. albopictus lambda' actually increased with increasing A. sierrensis density; a result that was not reflected by individual fitness parameters. These results indicate that A. sierrensis will not be an effective barrier to A. albopictus invasion into tree-holes in the western United States.	[Kesavaraju, Banugopan; Delisi, Nicholas] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA; [Leisnham, Paul T.; Keane, Samantha; Pozatti, Rachel] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Kesavaraju, B (corresponding author), Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA.	banu@slcmad.org		Leisnham, Paul T./0000-0003-3527-8435	Global Human Scholars program at the University of Maryland; University of Maryland; Salt Lake City Mosquito Abatement District	Global Human Scholars program at the University of Maryland; University of Maryland; Salt Lake City Mosquito Abatement District	SK was supported by the Global Human Scholars program at the University of Maryland under the supervision of PTL. We thank funding by the University of Maryland. ND was supported by the internship program established by the Salt Lake City Mosquito Abatement District under the supervision of BK for University of Utah students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi Brianna W., 2002, Biological Invasions, V4, P283, DOI 10.1023/A:1020933705556; Alto BW, 2009, J ANIM ECOL, V78, P928, DOI 10.1111/j.1365-2656.2009.01558.x; Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110; Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403; Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x; BRADSHAW WE, 1983, OECOLOGIA, V57, P239, DOI 10.1007/BF00379586; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; BROADIE KS, 1991, ECOL ENTOMOL, V16, P145, DOI 10.1111/j.1365-2311.1991.tb00203.x; Byers JE, 2002, OIKOS, V97, P449, DOI 10.1034/j.1600-0706.2002.970316.x; Byers JE, 2000, ECOLOGY, V81, P1225, DOI 10.2307/177203; Cassell D. L., 2002, P 27 ANN SAS US GROU; Chase J.M., 2009, ECOLOGICAL NICHES LI; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Daugherty MP, 2000, J MED ENTOMOL, V37, P364, DOI 10.1603/0022-2585(2000)037[0364:ICAARF]2.0.CO;2; Dickson S, 2010, SALT LAKE CITY MOSQU; Duyck PF, 2006, ECOLOGY, V87, P1770, DOI 10.1890/0012-9658(2006)87[1770:IOCMIS]2.0.CO;2; DYE C, 1984, ECOL ENTOMOL, V9, P355, DOI 10.1111/j.1365-2311.1984.tb00859.x; Edgerly JS, 1999, J MED ENTOMOL, V36, P394, DOI 10.1093/jmedent/36.3.394; EGERTER DE, 1986, P NATL ACAD SCI USA, V83, P7335, DOI 10.1073/pnas.83.19.7335; GARCIA JJ, 1994, J AM MOSQUITO CONTR, V10, P413; Goldberg D, 1993, DESIGN ANAL ECOLOGIC, P77; GOLDBERG DE, 1987, J ECOL, V75, P1131, DOI 10.2307/2260318; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; JOSHI A, 1995, EVOLUTION, V49, P616, DOI 10.1111/j.1558-5646.1995.tb02298.x; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Kesavaraju B, 2008, OECOLOGIA, V155, P631, DOI 10.1007/s00442-007-0935-4; Kesavaraju B, 2007, ECOL ENTOMOL, V32, P262, DOI 10.1111/j.1365-2311.2006.00846.x; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; LAWTON JH, 1981, NATURE, V289, P793, DOI 10.1038/289793a0; Leisnham PT, 2011, ANN ENTOMOL SOC AM, V104, P1309, DOI 10.1603/AN11032; Leisnham PT, 2009, OECOLOGIA, V160, P343, DOI 10.1007/s00442-009-1305-1; Linthicum KJ, 2003, J AM MOSQUITO CONTR, V19, P301; LIVDAHL TP, 1984, J ANIM ECOL, V53, P573, DOI 10.2307/4535; LIVDAHL TP, 1991, SCIENCE, V253, P189, DOI 10.1126/science.1853204; Lounibos L.P., 1983, P223; Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Madon MB, 2002, J VECTOR ECOL, V27, P149; MOORE CG, 1969, ANN ENTOMOL SOC AM, V62, P1325, DOI 10.1093/aesa/62.6.1325; Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2; O'Donnell D, 2009, ANN ENTOMOL SOC AM, V102, P1135, DOI 10.1603/008.102.0623; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; PAINE RT, 1984, ECOLOGY, V65, P1339, DOI 10.2307/1939114; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Powers NR, 2006, J AM MOSQUITO CONTR, V22, P756, DOI 10.2987/8756-971X(2006)22[756:TRAPEO]2.0.CO;2; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Smith C, 2013, J MED ENTOMOL, V50, P521, DOI 10.1603/ME12149; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Tilman D., 1982, Monographs in Population Biology, pi; Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677; WASHBURN JO, 1986, J INVERTEBR PATHOL, V48, P296, DOI 10.1016/0022-2011(86)90058-3; WASHBURN JO, 1992, J MED ENTOMOL, V29, P995, DOI 10.1093/jmedent/29.6.995; Williamson M., 1996, BIOL INVASIONS; Yee DA, 2006, FRESHWATER BIOL, V51, P448, DOI 10.1111/j.1365-2427.2005.01504.x; Yee DA, 2007, J ANIM ECOL, V76, P1105, DOI 10.1111/j.1365-2656.2007.01297.x; Zhong Daibin, 2013, PLoS ONE, V8, P1	58	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89698	10.1371/journal.pone.0089698	http://dx.doi.org/10.1371/journal.pone.0089698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586969	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200073
J	Kringen, MK; Piehler, AP; Grimholt, RM; Opdal, MS; Haug, KBF; Urdal, P				Kringen, Marianne K.; Piehler, Armin P.; Grimholt, Runa M.; Opdal, Mimi S.; Haug, Kari Bente F.; Urdal, Petter			Serum Bilirubin Concentration in Healthy Adult North-Europeans Is Strictly Controlled by the UGT1A1 TA-Repeat Variants	PLOS ONE			English	Article							REFERENCE INTERVAL PROJECT-2000; GILBERTS-SYNDROME; LINKAGE DISEQUILIBRIUM; GENE; PROMOTER; VARIABILITY; POPULATION; METABOLISM; EXPRESSION; HAPLOTYPES	The major enzyme responsible for the glucuronidation of bilirubin is the uridine 5'-diphosphoglucose glucuronosyltransferase A1 (UGT1A1) enzyme, and genetic variation in the UGT1A1 gene is reported to influence the bilirubin concentration in the blood. In this study, we have investigated which gene-/haplotype variants may be useful for genetic testing of Gilbert's syndrome. Two groups of samples based on serum bilirubin concentrations were obtained from the Nordic Reference Interval Project Bio-bank and Database (NOBIDA): the 150 individuals with the highest bilirubin (>17.5 mu mol/L) and the 150 individuals with normal bilirubin concentrations (<17.5 mu mol/L). The individuals were examined for the TA(6)>TA(7) variant in the UGT1A1 promoter and 7 tag-SNPs in an extended promoter region of UGT1A1 (haplotype analysis) and in selected SNPs in candidate genes (SLCO1B3, ABCC2 and NUP153). We found significant odds ratios for high bilirubin level for all the selected UGT1A1 variants. However, in stepwise multivariate logistic regression analysis of all genetic variants together with age, sex, country of origin and fasting time, the repeat variants of UGT1A1 TA(6)>TA(7) and SLCO1B3 rs2117032 T>C were the only variants significantly associated with higher bilirubin concentrations. Most individuals with high bilirubin levels were homozygous for the TA(7)-repeat (74%) while only 3% were homozygous for the TA(7)-repeat in individuals with normal bilirubin levels. Among individuals heterozygous for the TA(7)-repeat, a low frequent UGT1A1-diplotype harboring the rs7564935 G-variant was associated with higher bilirubin levels. In conclusion, our results demonstrate that in testing for Gilbert's syndrome, analyzing for the homozygous TA(7)/TA(7)-genotype would be appropriate.	[Kringen, Marianne K.; Opdal, Mimi S.] Oslo Univ Hosp, Dept Pharmacol, Oslo, Norway; [Piehler, Armin P.] Furst Med Lab, Oslo, Norway; [Grimholt, Runa M.; Haug, Kari Bente F.; Urdal, Petter] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Urdal, Petter] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Kringen, MK (corresponding author), Oslo Univ Hosp, Dept Pharmacol, Oslo, Norway.	m.k.kringen@medisin.uio.no			South-Eastern Norway Regional Health Authority; Norsk Fond for Klinisk Kjemi	South-Eastern Norway Regional Health Authority; Norsk Fond for Klinisk Kjemi	This study has been financed with aid from the South-Eastern Norway Regional Health Authority and a grant from Norsk Fond for Klinisk Kjemi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Borucki K, 2009, CLIN BIOCHEM, V42, P1635, DOI 10.1016/j.clinbiochem.2009.08.011; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Choi JH, 2007, PHARMACOGENET GENOM, V17, P403, DOI 10.1097/01.fpc.0000236337.41799.b3; Court M., 2012, COURTS 2005 2008 ONL; Datta S, 2012, ANN HUM GENET, V76, P33, DOI 10.1111/j.1469-1809.2011.00688.x; Hall D, 1999, PHARMACOGENETICS, V9, P591, DOI 10.1097/01213011-199910000-00006; Jedlitschky G, 1997, BIOCHEM J, V327, P305, DOI 10.1042/bj3270305; Kahn KK, 2006, AM J HEALTH-SYST PH, V63, P2211, DOI 10.2146/ajhp060155; Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8; OWENS D, 1975, J MED GENET, V12, P152, DOI 10.1136/jmg.12.2.152; Rodrigues C, 2012, BLOOD CELL MOL DIS, V48, P166, DOI 10.1016/j.bcmd.2012.01.004; Rudenski AS, 1998, CLIN CHEM, V44, P1604; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P431, DOI 10.1080/00365510410006694; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P343, DOI 10.1080/00365510410006306; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; Sanna S, 2009, HUM MOL GENET, V18, P2711, DOI 10.1093/hmg/ddp203; SIEG A, 1987, DEUT MED WOCHENSCHR, V112, P1206, DOI 10.1055/s-2008-1068222; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strassburg CP, 2010, DRUG METAB REV, V42, P168, DOI 10.3109/03602530903209429; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581	25	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90248	10.1371/journal.pone.0090248	http://dx.doi.org/10.1371/journal.pone.0090248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587300	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200154
J	Lee, TF; Chao, PJ; Ting, HM; Chang, LY; Huang, YJ; Wu, JM; Wang, HY; Horng, MF; Chang, CM; Lan, JH; Huang, YY; Fang, FM; Leung, SW				Lee, Tsair-Fwu; Chao, Pei-Ju; Ting, Hui-Min; Chang, Liyun; Huang, Yu-Jie; Wu, Jia-Ming; Wang, Hung-Yu; Horng, Mong-Fong; Chang, Chun-Ming; Lan, Jen-Hong; Huang, Ya-Yu; Fang, Fu-Min; Leung, Stephen Wan			Using Multivariate Regression Model with Least Absolute Shrinkage and Selection Operator (LASSO) to Predict the Incidence of Xerostomia after Intensity-Modulated Radiotherapy for Head and Neck Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; COMPLICATION PROBABILITY-MODELS; PATIENT-RATED XEROSTOMIA; NASOPHARYNGEAL CARCINOMA; CLINICAL FACTORS; STICKY SALIVA; NTCP MODELS; CONVENTIONAL RADIOTHERAPY; GLAND FUNCTION	Purpose: The aim of this study was to develop a multivariate logistic regression model with least absolute shrinkage and selection operator (LASSO) to make valid predictions about the incidence of moderate-to-severe patient-rated xerostomia among head and neck cancer (HNC) patients treated with IMRT. Methods and Materials: Quality of life questionnaire datasets from 206 patients with HNC were analyzed. The European Organization for Research and Treatment of Cancer QLQ-H&N35 and QLQ-C30 questionnaires were used as the endpoint evaluation. The primary endpoint (grade 3(+) xerostomia) was defined as moderate-to-severe xerostomia at 3 (XER3m) and 12 months (XER12m) after the completion of IMRT. Normal tissue complication probability (NTCP) models were developed. The optimal and suboptimal numbers of prognostic factors for a multivariate logistic regression model were determined using the LASSO with bootstrapping technique. Statistical analysis was performed using the scaled Brier score, Nagelkerke R-2, chi-squared test, Omnibus, Hosmer-Lemeshow test, and the AUC. Results: Eight prognostic factors were selected by LASSO for the 3-month time point: Dmean-c, Dmean-i, age, financial status, T stage, AJCC stage, smoking, and education. Nine prognostic factors were selected for the 12-month time point: Dmean-i, education, Dmean-c, smoking, T stage, baseline xerostomia, alcohol abuse, family history, and node classification. In the selection of the suboptimal number of prognostic factors by LASSO, three suboptimal prognostic factors were fine-tuned by Hosmer-Lemeshow test and AUC, i.e., Dmean-c, Dmean-i, and age for the 3-month time point. Five suboptimal prognostic factors were also selected for the 12-month time point, i.e., Dmean-i, education, Dmean-c, smoking, and T stage. The overall performance for both time points of the NTCP model in terms of scaled Brier score, Omnibus, and Nagelkerke R-2 was satisfactory and corresponded well with the expected values. Conclusions: Multivariate NTCP models with LASSO can be used to predict patient-rated xerostomia after IMRT.	[Lee, Tsair-Fwu; Chang, Chun-Ming] Natl Kaohsiung Univ Appl Sci, Med Phys & Informat Lab Elect Engn, Kaohsiung 807, Taiwan; [Chao, Pei-Ju; Ting, Hui-Min; Huang, Yu-Jie; Lan, Jen-Hong; Huang, Ya-Yu; Fang, Fu-Min] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Chao, Pei-Ju; Ting, Hui-Min; Huang, Yu-Jie; Lan, Jen-Hong; Huang, Ya-Yu; Fang, Fu-Min] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Ting, Hui-Min; Wang, Hung-Yu; Horng, Mong-Fong; Lan, Jen-Hong] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Chang, Liyun] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Wu, Jia-Ming] E Da Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Leung, Stephen Wan] Kaohsiung Yuans Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; National Kaohsiung University of Science & Technology; I Shou University; E-Da Hospital	Fang, FM (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan.	fang2569@gmail.com; lwan@ms36.hinet.net	chao, P/GSD-8001-2022	Lee, Tsair-Fwu/0000-0002-3112-3594	National Science Council (NSC) of the Executive Yuan of the Republic of China [NSC-101-2221-E-151-007-MY3, NSC-102-2221-E-182A-002]	National Science Council (NSC) of the Executive Yuan of the Republic of China	This study was supported financially, in part, by grants from the National Science Council (NSC) of the Executive Yuan of the Republic of China, (NSC-101-2221-E-151-007-MY3, and NSC-102-2221-E-182A-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beetz I, 2013, ACTA ONCOL, P1; Beetz I, 2012, RADIOTHER ONCOL, V105, P101, DOI 10.1016/j.radonc.2012.03.004; Beetz I, 2012, RADIOTHER ONCOL, V105, P94, DOI 10.1016/j.radonc.2011.11.006; Beetz I, 2012, RADIOTHER ONCOL, V105, P86, DOI 10.1016/j.radonc.2011.05.010; Bjordal K, 1999, J CLIN ONCOL, V17, P1008, DOI 10.1200/JCO.1999.17.3.1008; Chen WC, 2009, ORAL ONCOL, V45, P505, DOI 10.1016/j.oraloncology.2008.07.002; Colombani C, 2013, J DAIRY SCI, V96, P575, DOI 10.3168/jds.2011-5225; Deasy JO, 2010, INT J RADIAT ONCOL, V76, pS58, DOI 10.1016/j.ijrobp.2009.06.090; Eisbruch A, 2001, INT J RADIAT ONCOL, V50, P695, DOI 10.1016/S0360-3016(01)01512-7; Eisbruch A, 1999, INT J RADIAT ONCOL, V45, P577, DOI 10.1016/S0360-3016(99)00247-3; El Naqa I, 2006, INT J RADIAT ONCOL, V64, P1275, DOI 10.1016/j.ijrobp.2005.11.022; Fang FM, 2010, RADIOTHER ONCOL, V97, P263, DOI 10.1016/j.radonc.2010.05.022; Fortin I, 2013, HEAD NECK J SCI SPEC; FRANZEN L, 1992, EUR J CANCER, V28A, P457, DOI 10.1016/S0959-8049(05)80076-0; Graff P, 2007, INT J RADIAT ONCOL, V67, P1309, DOI 10.1016/j.ijrobp.2006.11.012; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Henson BS, 2001, ORAL ONCOL, V37, P84, DOI 10.1016/S1368-8375(00)00063-4; Hsiung CY, 2006, INT J RADIAT ONCOL, V66, P454, DOI 10.1016/j.ijrobp.2006.04.033; Kaneko M, 1998, ORAL ONCOL, V34, P140, DOI 10.1016/S1368-8375(97)00087-0; Kwong DLW, 2004, CANCER, V101, P1584, DOI 10.1002/cncr.20552; Leal SC, 2010, GERODONTOLOGY, V27, P129, DOI 10.1111/j.1741-2358.2009.00293.x; Lee TF, 2012, CLIN ONCOL-UK, V24, P196, DOI 10.1016/j.clon.2011.06.006; Lee TF, 2013, RADIOTHER ONCOL, V106, P352, DOI 10.1016/j.radonc.2012.11.013; Leung SW, 2013, BMC CANCER, V5, p[9, 1]; Lim CH, 2012, STUD HEALTH TECHNOL, V176, P255, DOI 10.3233/978-1-61499-067-3-255; Moiseenko V, 2012, INT J RADIAT ONCOL, V82, P1108, DOI 10.1016/j.ijrobp.2011.04.020; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Ogutu Joseph O, 2012, BMC Proc, V6 Suppl 2, pS10, DOI 10.1186/1753-6561-6-S2-S10; Rad M, 2013, J ORAL HEALTH ORAL E, V2, P28; Rasmussen MA, 2012, TUTORIAL LASSO APPRO; Skwarchuk MW, 2000, INT J RADIAT ONCOL, V47, P103, DOI 10.1016/S0360-3016(99)00560-X; Sturgis EM, 2004, SEMIN ONCOL, V31, P726, DOI 10.1053/j.seminoncol.2004.09.013; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Teppola P, 2013, ANAL CHIM ACTA, V768, P57, DOI 10.1016/j.aca.2013.01.005; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tribius S, 2013, STRAHLENTHER ONKOL, V189, P216, DOI 10.1007/s00066-012-0257-2; van de Water TA, 2009, RADIOTHER ONCOL, V93, P545, DOI 10.1016/j.radonc.2009.09.008; van der Schaaf A, 2012, RADIOTHER ONCOL, V105, P115, DOI 10.1016/j.radonc.2011.12.006; Xu CJ, 2012, INT J RADIAT ONCOL, V84, pE123, DOI 10.1016/j.ijrobp.2012.02.022; Xu CJ, 2012, INT J RADIAT ONCOL, V82, pE677, DOI 10.1016/j.ijrobp.2011.09.036; Xu J, 2013, IET COMPUT VIS, V7, P48, DOI 10.1049/iet-cvi.2011.0193	42	58	61	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89700	10.1371/journal.pone.0089700	http://dx.doi.org/10.1371/journal.pone.0089700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586971	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200075
J	Colciaghi, F; Finardi, A; Nobili, P; Locatelli, D; Spigolon, G; Battaglia, GS				Colciaghi, Francesca; Finardi, Adele; Nobili, Paola; Locatelli, Denise; Spigolon, Giada; Battaglia, Giorgio Stefano			Progressive Brain Damage, Synaptic Reorganization and NMDA Activation in a Model of Epileptogenic Cortical Dysplasia	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PILOCARPINE-INDUCED SEIZURES; D-ASPARTATE RECEPTOR; SPONTANEOUS RECURRENT SEIZURES; GRANULE CELL DISPERSION; STATUS EPILEPTICUS; RAT MODEL; DENTATE GYRUS; TYROSINE PHOSPHORYLATION; HIPPOCAMPAL-NEURONS	Whether severe epilepsy could be a progressive disorder remains as yet unresolved. We previously demonstrated in a rat model of acquired focal cortical dysplasia, the methylazoxymethanol/pilocarpine - MAM/pilocarpine - rats, that the occurrence of status epilepticus (SE) and subsequent seizures fostered a pathologic process capable of modifying the morphology of cortical pyramidal neurons and NMDA receptor expression/localization. We have here extended our analysis by evaluating neocortical and hippocampal changes in MAM/pilocarpine rats at different epilepsy stages, from few days after onset up to six months of chronic epilepsy. Our findings indicate that the process triggered by SE and subsequent seizures in the malformed brain i) is steadily progressive, deeply altering neocortical and hippocampal morphology, with atrophy of neocortex and CA regions and progressive increase of granule cell layer dispersion; ii) changes dramatically the fine morphology of neurons in neocortex and hippocampus, by increasing cell size and decreasing both dendrite arborization and spine density; iii) induces reorganization of glutamatergic and GABAergic networks in both neocortex and hippocampus, favoring excitatory vs inhibitory input; iv) activates NMDA regulatory subunits. Taken together, our data indicate that, at least in experimental models of brain malformations, severe seizure activity, i. e., SE plus recurrent seizures, may lead to a widespread, steadily progressive architectural, neuronal and synaptic reorganization in the brain. They also suggest the mechanistic relevance of glutamate/NMDA hyper-activation in the seizure-related brain pathologic plasticity.	[Colciaghi, Francesca; Finardi, Adele; Nobili, Paola; Locatelli, Denise; Battaglia, Giorgio Stefano] IRCCS Neurol Inst C Besta, Mol Neuroanat & Pathogenesis Unit, Milan, Italy; [Spigolon, Giada] Univ Turin, NICO, Turin, Italy	University of Turin	Battaglia, GS (corresponding author), IRCCS Neurol Inst C Besta, Mol Neuroanat & Pathogenesis Unit, Milan, Italy.	giorgio.battaglia@istituto-besta.it	Colciaghi, Francesca/J-8772-2016; Finardi, Adele/K-3970-2016; Nobili, Paola/Z-2701-2019; Locatelli, Denise/J-8655-2016	Colciaghi, Francesca/0000-0002-6487-380X; Finardi, Adele/0000-0001-6156-975X; Nobili, Paola/0000-0003-2313-4223; Locatelli, Denise/0000-0001-9783-7111; Spigolon, Giada/0000-0002-1704-8372	Italian Ministry of Health; "Sovvenzione Globale Ingenio - Regione Lombardia" from the Social European Fund [A0000844]	Italian Ministry of Health(Ministry of Health, Italy); "Sovvenzione Globale Ingenio - Regione Lombardia" from the Social European Fund	This work was supported by the Italian Ministry of Health, and by the "Sovvenzione Globale Ingenio - Regione Lombardia" from the Social European Fund (Grant n. A0000844). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060.abs; Arias C, 2002, EXP NEUROL, V177, P284, DOI 10.1006/exnr.2002.7988; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bandyopadhyay S, 2006, EPILEPSY RES, V72, P127, DOI 10.1016/j.eplepsyres.2006.07.013; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bassanini S, 2007, NEUROBIOL DIS, V26, P481, DOI 10.1016/j.nbd.2007.02.008; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Bothwell S, 2001, J NEUROSCI, V21, P4789, DOI 10.1523/JNEUROSCI.21-13-04789.2001; Boulland JL, 2007, J COMP NEUROL, V503, P466, DOI 10.1002/cne.21384; Calcagnotto ME, 2005, J NEUROSCI, V25, P9649, DOI 10.1523/JNEUROSCI.2687-05.2005; Cepeda C, 2005, EPILEPSIA, V46, P82, DOI 10.1111/j.1528-1167.2005.01013.x; CLIFFORD DB, 1987, NEUROSCIENCE, V23, P953, DOI 10.1016/0306-4522(87)90171-0; Colacitti C, 1999, J NEUROPATH EXP NEUR, V58, P92, DOI 10.1097/00005072-199901000-00010; Colciaghi F, 2011, BRAIN, V134, P2828, DOI 10.1093/brain/awr045; Crino PB, 2001, NEUROLOGY, V56, P906, DOI 10.1212/WNL.56.7.906; da Silva AV, 2006, BRAIN RES, V1072, P200, DOI 10.1016/j.brainres.2005.10.088; Defazio RA, 2000, J NEUROPHYSIOL, V83, P315, DOI 10.1152/jn.2000.83.1.315; Dinocourt C, 2003, J COMP NEUROL, V459, P407, DOI 10.1002/cne.10622; Dykstra CM, 2009, J NEUROPATH EXP NEUR, V68, P823, DOI 10.1097/NEN.0b013e3181ac6b70; Fan QY, 2008, NEUROBIOL DIS, V32, P499, DOI 10.1016/j.nbd.2008.09.007; Fauser S, 2006, BRAIN, V129, P1907, DOI 10.1093/brain/awl133; Finardi A, 2006, J NEUROPATH EXP NEUR, V65, P883, DOI 10.1097/01.jnen.0000235117.67558.6d; Finardi A, 2013, ACTA NEUROPATHOL, V126, P219, DOI 10.1007/s00401-013-1143-4; Flores G, 2005, NEUROSCIENCE, V133, P463, DOI 10.1016/j.neuroscience.2005.02.021; Frasca A, 2011, NEUROBIOL DIS, V43, P507, DOI 10.1016/j.nbd.2011.04.024; Garbossa D, 2003, BRAIN RES BULL, V60, P329, DOI 10.1016/S0361-9230(03)00053-4; Gardoni F, 2003, J NEUROPATH EXP NEUR, V62, P662, DOI 10.1093/jnen/62.6.662; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Gibbs S, 2011, NEUROBIOL DIS, V43, P312, DOI 10.1016/j.nbd.2011.02.013; GLASER JR, 1990, COMPUT MED IMAG GRAP, V14, P307, DOI 10.1016/0895-6111(90)90105-K; Guo DJ, 2012, NEUROBIOL DIS, V45, P348, DOI 10.1016/j.nbd.2011.08.020; Haas CA, 2002, J NEUROSCI, V22, P5797; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Huo JZ, 2006, NEUROSCI LETT, V401, P266, DOI 10.1016/j.neulet.2006.03.033; ISOKAWA M, 1991, NEUROSCI LETT, V132, P212, DOI 10.1016/0304-3940(91)90304-C; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jiruska P, 2013, NEUROBIOL DIS, V54, P492, DOI 10.1016/j.nbd.2013.02.001; Kojima N, 1998, LEARN MEMORY, V5, P429; Kubova H, 2013, NEUROSCIENCE, V235, P232, DOI 10.1016/j.neuroscience.2012.12.055; Kurz JE, 2008, EPILEPSIA, V49, P1696, DOI 10.1111/j.1528-1167.2008.01616.x; Kuzniecky R, 2009, NAT REV NEUROL, V5, P356, DOI 10.1038/nrneurol.2009.82; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; MACHIN D, 1997, SAMPLE SIZE TABLES C, P24; Marchi N, 2006, NEUROBIOL DIS, V24, P429, DOI 10.1016/j.nbd.2006.07.019; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Mikuni N, 1999, EPILEPSIA, V40, P1683, DOI 10.1111/j.1528-1157.1999.tb01584.x; Moddel G, 2005, BRAIN RES, V1046, P10, DOI 10.1016/j.brainres.2005.03.042; Moussa RC, 2001, MOL BRAIN RES, V95, P36, DOI 10.1016/S0169-328X(01)00231-5; Nairismagi J, 2004, EPILEPSIA, V45, P1024, DOI 10.1111/j.0013-9580.2004.08904.x; Najm IM, 2000, EPILEPSIA, V41, P971, DOI 10.1111/j.1528-1157.2000.tb00281.x; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Niimura M, 2005, J NEUROCHEM, V92, P1377, DOI 10.1111/j.1471-4159.2005.02977.x; PALMINI A, 1995, ANN NEUROL, V37, P476, DOI 10.1002/ana.410370410; Parent JM, 1997, J NEUROSCI, V17, P3727; PINEL JPJ, 1978, EXP NEUROL, V58, P335, DOI 10.1016/0014-4886(78)90145-0; PINEL JPJ, 1978, EXP NEUROL, V58, P190, DOI 10.1016/0014-4886(78)90133-4; Pitkanen A, 2002, PROG BRAIN RES, V135, P67; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sancini G, 1998, NEUROSCI LETT, V246, P181, DOI 10.1016/S0304-3940(98)00258-4; SCHEIBEL ME, 1974, EPILEPSIA, V15, P55, DOI 10.1111/j.1528-1157.1974.tb03997.x; Schwartzkroin PA, 2012, EPILEPSIA, V53, P35, DOI 10.1111/j.1528-1167.2012.03473.x; SHOLL DA, 1953, J ANAT, V87, P387; Silva-Gomez AB, 2003, BRAIN RES, V983, P128, DOI 10.1016/S0006-8993(03)03042-7; Sloviter RS, 2007, EPILEPSIA, V48, P6, DOI 10.1111/j.1528-1167.2007.01335.x; Sloviter RS, 2008, EPILEPSIA, V49, P85, DOI 10.1111/j.1528-1167.2008.01931.x; Sloviter RS, 2006, J COMP NEUROL, V494, P944, DOI 10.1002/cne.20850; SLOVITER RS, 1992, NEUROSCI LETT, V137, P91, DOI 10.1016/0304-3940(92)90306-R; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Takase K, 2008, EPILEPSIA, V49, P997, DOI 10.1111/j.1528-1167.2008.01558.x; Tassi L, 2002, BRAIN, V125, P1719, DOI 10.1093/brain/awf175; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; Thom M, 2005, BRAIN, V128, P1344, DOI 10.1093/brain/awh475; van der Hel WS, 2009, EPILEPSIA, V50, P1717, DOI 10.1111/j.1528-1167.2009.02054.x; Walter C, 2007, J NEUROSCI, V27, P7541, DOI 10.1523/JNEUROSCI.0431-07.2007; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019; Wuarin JP, 1996, J NEUROSCI, V16, P4438; Ying Z, 1998, J NEUROPATH EXP NEUR, V57, P47; Ying Z, 2004, EPILEPSIA, V45, P314, DOI 10.1111/j.0013-9580.2004.37703.x; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhang W, 2012, J NEUROSCI, V32, P1183, DOI 10.1523/JNEUROSCI.5342-11.2012; Zhou FW, 2010, EPILEPSIA, V51, P1468, DOI 10.1111/j.1528-1167.2010.02583.x	86	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89898	10.1371/journal.pone.0089898	http://dx.doi.org/10.1371/journal.pone.0089898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587109	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800054
J	Famoso, NA; Davis, EB				Famoso, Nicholas A.; Davis, Edward Byrd			Occlusal Enamel Complexity in Middle Miocene to Holocene Equids (Equidae: Perissodactyla) of North America	PLOS ONE			English	Article							FOSSIL HORSES; R PACKAGE; EVOLUTION; MAMMALIA; DIVERSIFICATION; SYSTEMATICS; HYPSODONTY; WORLD; RATES	Four groups of equids, "Anchitheriinae,'' Merychippine-grade Equinae, Hipparionini, and Equini, coexisted in the middle Miocene, but only the Equini remains after 16 Myr of evolution and extinction. Each group is distinct in its occlusal enamel pattern. These patterns have been compared qualitatively but rarely quantitatively. The processes influencing the evolution of these occlusal patterns have not been thoroughly investigated with respect to phylogeny, tooth position, and climate through geologic time. We investigated Occlusal Enamel Index, a quantitative method for the analysis of the complexity of occlusal patterns. We used analyses of variance and an analysis of co-variance to test whether equid teeth increase resistive cutting area for food processing during mastication, as expressed in occlusal enamel complexity, in response to increased abrasion in their diet. Results suggest that occlusal enamel complexity was influenced by climate, phylogeny, and tooth position through time. Occlusal enamel complexity in middle Miocene to Modern horses increased as the animals experienced increased tooth abrasion and a cooling climate.	[Famoso, Nicholas A.] Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; Univ Oregon, Museum Nat & Cultural Hist, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Famoso, NA (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.	nfamoso2@uoregon.edu	Famoso, Nicholas/GRS-5929-2022	Famoso, Nicholas/0000-0002-1795-624X	University of Oregon Museum of Natural and Cultural History; Paleontological Society Richard K. Bambach Award; Geological Society of America Graduate Student Grant	University of Oregon Museum of Natural and Cultural History; Paleontological Society Richard K. Bambach Award; Geological Society of America Graduate Student Grant	Funding for this project was provided by the University of Oregon Museum of Natural and Cultural History, Paleontological Society Richard K. Bambach Award, and Geological Society of America Graduate Student Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzaroli Augusto, 1993, Palaeontographia Italica, V80, P175; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Becerra F, 2012, J MORPHOL, V273, P1150, DOI 10.1002/jmor.20051; CARRASCO MA, 2005, MIOCENE MAMMAL MAPPI; Cayuela L, 2012, METHODS ECOL EVOL, V3, P1078, DOI 10.1111/j.2041-210X.2012.00232.x; Damuth J, 2011, BIOL REV, V86, P733, DOI 10.1111/j.1469-185X.2011.00176.x; Eisenmann V., 1988, P1; Famoso NA, 2011, T NEBRASKA ACAD SCI, V32, P98; Famoso NA, 2013, PALAEOGEOGR PALAEOCL, V387, P211, DOI 10.1016/j.palaeo.2013.07.006; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Forsten A. M, 1975, TEXAS MEMORIAL MUSEU, V22, P1; Franzen JL., 2010, RISE HORSES 55 MILLI; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Heywood JJN, 2010, J ZOOL, V281, P1, DOI 10.1111/j.1469-7998.2009.00668.x; HULBERT R C JR, 1988, Bulletin of the Florida State Museum Biological Sciences, V33, P229; HULBERT R C JR, 1988, Bulletin of the Florida State Museum Biological Sciences, V32, P221; Hulbert R.C. Jr, 1991, American Museum Novitates, P1; Hulbert Richard C. Jr., 2006, Bulletin of the Florida Museum of Natural History, V46, P1; Jardine PE, 2012, PALAEOGEOGR PALAEOCL, V365, P1, DOI 10.1016/j.palaeo.2012.09.001; Kaiser TM, 2010, J ZOOL, V281, P12, DOI 10.1111/j.1469-7998.2009.00674.x; Kelly Thomas S., 1995, Contributions in Science (Los Angeles), V455, P1; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; Macdonald J.R., 1992, Dakoterra, V4, P1; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; MACFADDEN BJ, 1984, B AM MUS NAT HIST, V179, P1; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; MACFADDEN BJ, 1988, BIOL J LINN SOC, V35, P37, DOI 10.1111/j.1095-8312.1988.tb00457.x; MACFADDEN BJ, 1988, NATURE, V336, P466, DOI 10.1038/336466a0; Macfadden Bruce J., 1998, P537; Martins EP, 2002, EVOLUTION, V56, P1; Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; Osborn H. F., 1918, Mem Amer Mus Nat Hist New Ser, V2; Pagnac Darrin, 2006, Journal of Mammalian Evolution, V13, P37, DOI 10.1007/s10914-005-9002-2; Pfretzschner Hans Ulrich, 1993, Journal of Vertebrate Paleontology, V13, P342; Prado JL, 1996, PALAEONTOLOGY, V39, P663; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Quinn J. H., 1955, Publications University of Texas, VNo. 5516, P1; Renaud S, 2010, J ZOOL SYST EVOL RES, V48, P138, DOI 10.1111/j.1439-0469.2009.00527.x; RENSBERGER JM, 1984, PALEOBIOLOGY, V10, P439, DOI 10.1017/S0094837300008447; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; ROTH VL, 1989, PALEOBIOLOGY, V15, P165, DOI 10.1017/S0094837300009349; ROTH VL, 1992, PALEOBIOLOGY, V18, P184, DOI 10.1017/S0094837300013968; Roy T, 2011, J CLIMATE, V24, P2300, DOI 10.1175/2010JCLI3787.1; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SIMPSON G.G., 1951, HORSES STORY HORSE F; SKINNER MF, 1977, J PALEONTOL, V51, P912; Slater GJ, 2013, METHODS ECOL EVOL, V4, P699, DOI 10.1111/2041-210X.12091; Stack JC, 2011, METHODS ECOL EVOL, V2, P660, DOI 10.1111/j.2041-210X.2011.00112.x; Stirton R. A., 1940, University of California Publications in Geology, V25, P165; Stromberg CAE, 2006, PALEOBIOLOGY, V32, P236, DOI 10.1666/0094-8373(2006)32[236:EOHIET]2.0.CO;2; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Whistler DP, 1991, SAN BERNARDINO COUNT, V38, P108; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Woodburne MO, 2007, B AM MUS NAT HIST, P3; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zar J.H., 1996, BIOSTAT ANAL	60	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90184	10.1371/journal.pone.0090184	http://dx.doi.org/10.1371/journal.pone.0090184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587267	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800087
J	Menager, J; Ebstein, F; Oger, R; Hulin, P; Nedellec, S; Duverger, E; Lehmann, A; Kloetzel, PM; Jotereau, F; Guilloux, Y				Menager, Jeremie; Ebstein, Frederic; Oger, Romain; Hulin, Philippe; Nedellec, Steven; Duverger, Eric; Lehmann, Andrea; Kloetzel, Peter-Michael; Jotereau, Francine; Guilloux, Yannick			Cross-Presentation of Synthetic Long Peptides by Human Dendritic Cells: A Process Dependent on ERAD Component p97/VCP but Not sec61 and/or Derlin-1	PLOS ONE			English	Article							ANTIGEN PRESENTATION; ENDOPLASMIC-RETICULUM; CANCER-IMMUNOTHERAPY; PRESENTATION PATHWAY; EXOGENOUS ANTIGENS; T-LYMPHOCYTES; PROTEASOME; VACCINE; INDUCTION; IMMUNITY	Antitumor vaccination using synthetic long peptides (SLP) is an additional therapeutic strategy currently under development. It aims to activate tumor-specific CD8(+) CTL by professional APCs such as DCs. DCs can activate T lymphocytes by MHC class I presentation of exogenous antigens - a process referred to as "cross-presentation". Until recently, the intracellular mechanisms involved in cross-presentation of soluble antigens have been unclear. Here, we characterize the cross-presentation pathway of SLP Melan-A(16-40) containing the HLA-A2-restricted epitope(26-35) (A27L) in human DCs. Using confocal microscopy and specific inhibitors, we show that SLP16-40 is rapidly taken up by DC and follows a classical TAP-and proteasome-dependent cross-presentation pathway. Our data support a role for the ER-associated degradation machinery (ERAD)-related protein p97/VCP in the transport of SLP16-40 from early endosomes to the cytoplasm but formally exclude both sec61 and Derlin-1 as possible retro-translocation channels for cross-presentation. In addition, we show that generation of the Melan-A(26-35) peptide from the SLP16-40 was absolutely not influenced by the proteasome subunit composition in DC. Altogether, our findings propose a model for cross-presentation of SLP which tends to enlarge the repertoire of potential candidates for retro-translocation of exogenous antigens to the cytosol.	[Menager, Jeremie; Oger, Romain; Hulin, Philippe; Nedellec, Steven; Jotereau, Francine; Guilloux, Yannick] INSERM, U892, Nantes, France; [Menager, Jeremie; Oger, Romain; Jotereau, Francine; Guilloux, Yannick] Univ Nantes, Nantes, France; [Menager, Jeremie; Oger, Romain; Hulin, Philippe; Nedellec, Steven; Jotereau, Francine; Guilloux, Yannick] CNRS, UMR 6299, Nantes, France; [Ebstein, Frederic; Lehmann, Andrea; Kloetzel, Peter-Michael] Humboldt Univ, Inst Biochem, Charite Univ Hosp, Berlin, Germany; [Duverger, Eric] Univ Orleans, ICOA, Orleans, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Guilloux, Y (corresponding author), INSERM, U892, Nantes, France.	Yannick.guilloux@univ-nantes.fr	Jotereau, Francine/L-8668-2015; guilloux, yannick/L-4801-2015; Jotereau, Francine/AAU-1735-2020; OGER, Romain/K-7423-2015	Jotereau, Francine/0000-0002-2508-4875; OGER, Romain/0000-0001-5012-6099; Duverger, Eric/0000-0001-9129-1488; MENAGER, Jeremie/0000-0002-4032-5884	Ligue Nationale contre le Cancer and Comite 44; Institut National de la Sante et de la Recherche Medical; Institut National du Cancer [PL074]; European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Tumor Immunology Network [503306]; Ministere de l'Ensiegnement Superieur et de la Recherche	Ligue Nationale contre le Cancer and Comite 44; Institut National de la Sante et de la Recherche Medical; Institut National du Cancer(Institut National du Cancer (INCA) France); European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Tumor Immunology Network; Ministere de l'Ensiegnement Superieur et de la Recherche	This work was supported by grants from the Ligue Nationale contre le Cancer and Comite 44, Institut National de la Sante et de la Recherche Medical, Institut National du Cancer (PL074), and the European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Tumor Immunology Network (503306). JM was supported by a doctoral fellowship from the Ministere de l'Ensiegnement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Baxevanis CN, 2009, CRIT REV CL LAB SCI, V46, P167, DOI 10.1080/10408360902937809; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; CASTELLI C, 1995, J EXP MED, V181, P363, DOI 10.1084/jem.181.1.363; Chapatte L, 2006, CANCER RES, V66, P5461, DOI 10.1158/0008-5472.CAN-05-4310; Chauvin JM, 2012, J IMMUNOL, V188, P2102, DOI 10.4049/jimmunol.1101807; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Coley WB, 1928, ANN SURG, V88, P641, DOI 10.1097/00000658-192810000-00002; Coulais D, 2012, CYTOTHERAPY, V14, P887, DOI 10.3109/14653249.2012.689129; Crespo MI, 2013, J IMMUNOL, V190, P948, DOI 10.4049/jimmunol.1102725; Faure F, 2009, EUR J IMMUNOL, V39, P380, DOI 10.1002/eji.200838669; Fonteneau JF, 2003, BLOOD, V102, P4448, DOI 10.1182/blood-2003-06-1801; Giodini A, 2009, P NATL ACAD SCI USA, V106, P3324, DOI 10.1073/pnas.0813305106; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107; Hotta C, 2006, IMMUNOLOGY, V117, P97, DOI 10.1111/j.1365-2567.2005.02270.x; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Lattanzi L, 2011, IMMUNOBIOLOGY, V216, P537, DOI 10.1016/j.imbio.2010.10.003; Leffers N, 2009, INT J CANCER, V125, P2104, DOI 10.1002/ijc.24597; Liu YF, 2011, CELL RES, V21, P867, DOI 10.1038/cr.2011.75; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Needham PG, 2013, BIOCH BIOPHYSICA ACT; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Quakkelaar ED, 2012, ADV IMMUNOL, V114, P77, DOI 10.1016/B978-0-12-396548-6.00004-4; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosalia RA, 2013, EUR J IMMUNOL, V43, P2554, DOI 10.1002/eji.201343324; Segura E, 2011, TRAFFIC, V12, P1677, DOI 10.1111/j.1600-0854.2011.01254.x; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Valmori D, 1998, J IMMUNOL, V160, P1750; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; Vignard V, 2005, J IMMUNOL, V175, P4797, DOI 10.4049/jimmunol.175.7.4797; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Zehner M, 2011, P NATL ACAD SCI USA, V108, P9933, DOI 10.1073/pnas.1102397108	51	42	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89897	10.1371/journal.pone.0089897	http://dx.doi.org/10.1371/journal.pone.0089897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587108	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800053
J	Pripp, AH; Stanisic, M				Pripp, Are Hugo; Stanisic, Milo			The Correlation between Pro- and Anti-Inflammatory Cytokines in Chronic Subdural Hematoma Patients Assessed with Factor Analysis	PLOS ONE			English	Article							INFLAMMATORY CYTOKINES; RISK-FACTORS; RECURRENCE; SEVERITY; CLUSTERS	Chronic subdural hematoma (CSDH) is a relatively common disorder in neurosurgery on elderly patients, though the mechanism that causes the disease remains unclear. Studies have suggested that local anticoagulation and inflammatory changes may be important in its pathogenesis. Most studies have used a basic bivariate statistical analysis to assess complex immunological responses in patients with this disorder, hence a more sophisticated multivariate statistical approach might be warranted. Our objective was to assess the association and correlation between the pro-and anti-inflammatory responses in a cohort of patients with chronic subdural hematoma (n = 57) using an exploratory and confirmatory factor analysis. Thirteen assigned pro-inflammatory (TNF-alpha, IL-1 beta, IL-2, IL-2R, IL-6, IL-7, IL-12, IL-15, IL-17, CCL2, CXCL8, CXCL9 and CXCL10) and five assigned anti-inflammatory (IL-1RA, IL-4, IL-5, IL-10 and IL-13) cytokines from blood and hematoma fluid samples were examined. Exploratory factor analysis indicated two major underlying immunological processes expressed by the cytokines in both blood and hematoma fluid, but with a different pattern and particularly regarding the cytokines IL-13, IL-6, IL-4 and TNF-a. Scores from confirmatory factor analysis models exhibited a higher correlation between pro-and anti-inflammatory activities in blood (r = 0.98) than in hematoma fluid samples (r = 0.92). However, correlations of inflammatory processes between blood and hematoma fluid samples were lower and non-significant. A structural equation model showed a significant association between increased anti-inflammatory activity in hematoma fluid samples and a lower risk of recurrence, but this relationship was not statistically significant in venous blood samples. Moreover, these findings indicate that anti-inflammatory activities in the hematoma may play a role in the risk of a recurrence of CSDH.	[Pripp, Are Hugo] Oslo Univ Hosp, Dept Biostat Epidemiol & Hlth Econ, Oslo, Norway; [Stanisic, Milo] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway	University of Oslo; University of Oslo	Pripp, AH (corresponding author), Oslo Univ Hosp, Dept Biostat Epidemiol & Hlth Econ, Oslo, Norway.	apripp@ous-hf.no						Abouzari M, 2009, NEUROSURG REV, V32, P479, DOI 10.1007/s10143-009-0215-3; Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Fagerland MW, 2009, CONTEMP CLIN TRIALS, V30, P490, DOI 10.1016/j.cct.2009.06.007; Feng JF, 2008, MED HYPOTHESES, V70, P1147, DOI 10.1016/j.mehy.2007.11.014; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johansson P, 2011, AM HEART J, V161, P1053, DOI 10.1016/j.ahj.2011.03.011; Johnson RA., 2007, APPL MULTIVARIATE ST; Juntti H, 2009, J ALLERGY CLIN IMMUN, V124, P52, DOI 10.1016/j.jaci.2009.04.014; Kitazono M, 2012, NEUROL MED-CHIR, V52, P810, DOI 10.2176/nmc.52.810; Lim Dong-Jun, 1995, Journal of Korean Medical Science, V10, P373; Mommersteeg PMC, 2008, PSYCHONEUROENDOCRINO, V33, P1041, DOI 10.1016/j.psyneuen.2008.05.007; Moskala M, 2007, MICROSC MICROANAL, V13, P211, DOI 10.1017/S1431927607070286; Pont LMEB, 2012, EUR J NEUROL, V19, P1397, DOI 10.1111/j.1468-1331.2012.03768.x; Ross D., 2011, NEUROSCI MED, V2, P347, DOI DOI 10.4236/NM.2011.24045; Simhan HN, 2011, PAEDIATR PERINAT EP, V25, P277, DOI 10.1111/j.1365-3016.2010.01176.x; Stanisic M, 2012, INFLAMM RES, V61, P845, DOI 10.1007/s00011-012-0476-0; Stanisic M, 2012, ACTA NEUROCHIR, V154, P113, DOI 10.1007/s00701-011-1203-2; Stoodley M, 2000, NEUROSURG CLIN N AM, V11, P425, DOI 10.1016/S1042-3680(18)30104-9; STROOBANDT G, 1995, ACTA NEUROCHIR, V137, P6, DOI 10.1007/BF02188772; Sultani Masooma, 2012, Chemother Res Pract, V2012, P490804, DOI 10.1155/2012/490804; Suzuki M, 1998, ACTA NEUROCHIR, V140, P51, DOI 10.1007/s007010050057; Tang JY, 2011, ACTA NEUROCHIR SUPPL, V111, P25, DOI 10.1007/978-3-7091-0693-8_5; Thomson AW, 2003, CYTOKINE HDB; Tziakas DN, 2007, ATHEROSCLEROSIS, V193, P196, DOI 10.1016/j.atherosclerosis.2006.06.016; VANDEUREN M, 1995, J INFECT DIS, V172, P433, DOI 10.1093/infdis/172.2.433; Vaquero J, 2002, ACTA NEUROCHIR, V144, P343, DOI 10.1007/s007010200047; Wang J., 2020, STRUCTURAL EQUATION, DOI [DOI 10.1002/, DOI 10.1002/9781118356258]; Waters KA, 2007, J SLEEP RES, V16, P388, DOI 10.1111/j.1365-2869.2007.00614.x; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Weigel R, 2007, NEUROSURGERY, V61, P788, DOI 10.1227/01.NEU.0000298907.56012.E8; YAMASHIMA T, 1985, ACTA NEUROPATHOL, V67, P219, DOI 10.1007/BF00687804	34	41	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90149	10.1371/journal.pone.0090149	http://dx.doi.org/10.1371/journal.pone.0090149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587250	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800082
J	Forlani, M; Morri, M; Murri, MB; Bernabei, V; Moretti, F; Attili, T; Biondini, A; De Ronchi, D; Atti, AR				Forlani, Martina; Morri, Monica; Murri, Martino Belvederi; Bernabei, Virginia; Moretti, Francesca; Attili, Tobias; Biondini, Anna; De Ronchi, Diana; Atti, Anna Rita			Anxiety Symptoms in 74+Community-Dwelling Elderly: Associations with Physical Morbidity, Depression and Alcohol Consumption	PLOS ONE			English	Article							OLDER-ADULTS; MENTAL-HEALTH; LATER LIFE; STANDARDIZED INSTRUMENT; RISK-FACTORS; DISORDERS; COMORBIDITY; PREVALENCE; DIAGNOSIS; COOCCURRENCE	Objective: Anxiety among community-dwelling older adults has not been studied sufficiently. The aims of this cross-sectional population-based study were to estimate the point prevalence of clinically relevant anxiety symptoms and to describe their socio-demographic and clinical features, with particular focus on the association with somatic illnesses. Methods: Three-hundred-sixty-six non-demented older adults (mean age 83.7 +/- 6.2, range 74-99 years) from the Faenza Project (Northern Italy) were assessed using the Cambridge Mental Disorders of the Elderly Examination-Revised (CAMDE-XR) and the Geriatric Anxiety Inventory short form (GAI-sf). Multi-adjusted regression analyses were used to estimate Odds Ratio (OR) and 95% Confidence Intervals (95% CI). Results: Clinically relevant anxiety symptoms occurred in one out of five participants (point prevalence 21.0%) and were significantly associated with depression (OR 5.6 per rank; 95% CI: 3.1-10.1), physical morbidity (OR 3.5 per illness; 95% CI: 1.0-11.9) and female gender (OR 2.8; 95% CI: 1.4-5.5). Further, there were significant associations with a consumption of alcohol exceeding 1 alcoholic unit/day. Conclusions: Anxiety symptoms are very common in older subjects, especially when medically ill. Depression and alcohol consumption often co-occur with late-life anxiety symptoms, thus requiring special attention in daily clinical practice.	[Forlani, Martina; Morri, Monica; Bernabei, Virginia; Moretti, Francesca; Attili, Tobias; Biondini, Anna; De Ronchi, Diana; Atti, Anna Rita] Univ Bologna, Dept Biomed & NeuroMotor Sci Psychiat, Bologna, Italy; [Murri, Martino Belvederi] Univ Parma, Dept Neurosci, Div Psychiat, I-43100 Parma, Italy	University of Bologna; University of Parma	Atti, AR (corresponding author), Univ Bologna, Dept Biomed & NeuroMotor Sci Psychiat, Bologna, Italy.	annarita.atti@unibo.it	Atti, Anna Rita/AAP-7878-2020; Belvederi Murri, Martino/G-8781-2011; Murri, Martino Belvederi/AEP-7492-2022	Belvederi Murri, Martino/0000-0002-7262-3528; Murri, Martino Belvederi/0000-0002-7262-3528	Italian Ministry of University and Scientific Research and Technology	Italian Ministry of University and Scientific Research and Technology	The research described in this article was supported in part by grants from the Italian Ministry of University and Scientific Research and Technology awarded to Dr. De Ronchi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2002, DIAGN STAT MAN MENT, Vfifth; Beekman ATF, 1998, INT J GERIATR PSYCH, V13, P717, DOI 10.1002/(SICI)1099-1166(1998100)13:10<717::AID-GPS857>3.0.CO;2-M; Beekman ATF, 2000, AM J PSYCHIAT, V157, P89, DOI 10.1176/ajp.157.1.89; Blay SL, 2012, CURR OPIN PSYCHIATR, V25, P462, DOI 10.1097/YCO.0b013e3283578cdd; Bryant C, 2008, J AFFECT DISORDERS, V109, P233, DOI 10.1016/j.jad.2007.11.008; Byers AL, 2010, ARCH GEN PSYCHIAT, V67, P489, DOI 10.1001/archgenpsychiatry.2010.35; Byrne GJ, 2010, INT PSYCHOGERIATR, P1; Carriere I, 2013, ANXIETY MORTALITY RI; De Beurs E, 2001, BRIT J PSYCHIAT, V179, P426, DOI 10.1192/bjp.179.5.426; De Ronchi D, 2005, AM J GERIAT PSYCHIAT, V13, P672; De Ronchi D, 2005, DEMENT GERIATR COGN, V19, P97, DOI 10.1159/000082660; Doraiswamy PM, 2001, J CLIN PSYCHIAT, V62, P30; Flint AJ, 2005, DRUG AGING, V22, P101, DOI 10.2165/00002512-200522020-00002; FLINT AJ, 1994, AM J PSYCHIAT, V151, P640; Flint AJ, 1999, CAN FAM PHYSICIAN, V45, P2672; Flood M, 2009, J GERONTOL NURS, V35, P26, DOI 10.3928/00989134-20090201-03; Forlani C, 2014, AM J GERIAT PSYCHIAT, V22, P370, DOI 10.1016/j.jagp.2012.08.015; Goncalves DC, 2011, J AFFECT DISORDERS, V132, P223, DOI 10.1016/j.jad.2011.02.023; HENDRIE HC, 1988, J AM GERIATR SOC, V36, P402, DOI 10.1111/j.1532-5415.1988.tb02378.x; Kastenschmidt EK, 2011, MT SINAI J MED, V78, P527, DOI 10.1002/msj.20266; Kim JW, 2012, PSYCHIAT INVEST, V9, P8, DOI 10.4306/pi.2012.9.1.8; King-Kallimanis Bellinda, 2009, Am J Geriatr Psychiatry, V17, P782, DOI 10.1097/JGP.0b013e3181ad4d17; Lenze Eric J, 2003, Curr Psychiatry Rep, V5, P62, DOI 10.1007/s11920-003-0011-7; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mehta KM, 2003, J AM GERIATR SOC, V51, P499, DOI 10.1046/j.1532-5415.2003.51158.x; Pachana NA, 2007, INT PSYCHOGERIATR, V19, P103, DOI 10.1017/S1041610206003504; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Rozzini L, 2009, INT J GERIATR PSYCH, V24, P300, DOI 10.1002/gps.2106; Samuelsson G, 2005, AGING MENT HEALTH, V9, P571, DOI 10.1080/13607860500193591; Schoevers RA, 2003, INT J GERIATR PSYCH, V18, P994, DOI 10.1002/gps.1001; Schoevers RA, 2005, AM J GERIAT PSYCHIAT, V13, P31, DOI 10.1176/appi.ajgp.13.1.31; Vink D, 2008, J AFFECT DISORDERS, V106, P29, DOI 10.1016/j.jad.2007.06.005; Watts SC, 2002, INT J GERIATR PSYCH, V17, P427, DOI 10.1002/gps.632; Wetherell JL, 2010, AGING MENT HEALTH, V14, P764, DOI 10.1080/13607861003713240; World Health Organization, 1992, ICD 10 CLASSIFICATIO	35	35	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89859	10.1371/journal.pone.0089859	http://dx.doi.org/10.1371/journal.pone.0089859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24587079	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000100
J	Krutikov, K; Zheng, YZ; Chesney, A; Huang, XY; Vaags, AK; Evdokimova, V; Hough, MR; Chen, E				Krutikov, Konstantin; Zheng, Yanzhen; Chesney, Alden; Huang, Xiaoyong; Vaags, Andrea K.; Evdokimova, Valentina; Hough, Margaret R.; Chen, Edwin			Ectopic TLX1 Expression Accelerates Malignancies in Mice Deficient in DNA-PK	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL LYMPHOMAGENESIS; GENE-EXPRESSION; HOMEOBOX GENE; HOX11; ONCOGENE; CHECKPOINT; ANEUPLOIDY; LINEAGE; SPLEEN	The noncluster homeobox gene HOX11/TLX1 (TLX1) is detected at the breakpoint of the t(10;14)(q24;q11) chromosome translocation in patients with T cell acute lymphoblastic leukemia (T-ALL). This translocation results in the inappropriate expression of TLX1 in T cells. The oncogenic potential of TLX1 was demonstrated in IgH mu-TLX1(Tg) mice which develop mature B cell lymphoma after a long latency period, suggesting the requirement of additional mutations to initiate malignancy. To determine whether dysregulation of genes involved in the DNA damage response contributed to tumor progression, we crossed IgH mu-TLX1(Tg) mice with mice deficient in the DNA repair enzyme DNA-PK (Prkdc(Scid/Scid) mice). IgHm-TLX1(Tg) Prkdc(Scid/Scid) mice developed T-ALL and acute myeloid leukemia (AML) with reduced latency relative to control Prkdc(Scid/Scid) mice. Further analysis of thymi from premalignant mice revealed greater thymic cellularity concomitant with increased thymocyte proliferation and decreased apoptotic index. Moreover, premalignant and malignant thymocytes exhibited impaired spindle checkpoint function, in association with aneuploid karyotypes. Gene expression profiling of premalignant IgH mu-TLX1(Tg)Prkdc(Scid/Scid) thymocytes revealed dysregulated expression of cell cycle, apoptotic and mitotic spindle checkpoint genes in double negative 2 (DN2) and DN3 stage thymocytes. Collectively, these findings reveal a novel synergy between TLX1 and impaired DNA repair pathway in leukemogenesis.	[Krutikov, Konstantin; Vaags, Andrea K.; Hough, Margaret R.; Chen, Edwin] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Krutikov, Konstantin; Zheng, Yanzhen; Huang, Xiaoyong; Vaags, Andrea K.; Evdokimova, Valentina; Chen, Edwin] Sunnybrook Res Inst, Dept Mol & Cellular Biol, Toronto, ON, Canada; [Chesney, Alden] Sunnybrook Hlth Sci Ctr, Dept Clin Pathol, Toronto, ON M4N 3M5, Canada; [Chesney, Alden; Hough, Margaret R.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Chen, E (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	mhough@yorku.ca; echen8@partners.org	yang, zheng/HGC-7753-2022; Hough, Margaret/AAA-1026-2019	Hough, Margaret/0000-0001-8539-6398; Chen, Edwin/0000-0003-0742-9734	Canadian Institutes of Health Research (CIHR); doctoral completion award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); doctoral completion award	This study was funded by the Canadian Institutes of Health Research (CIHR) grant (to MRH) and the doctoral completion award (to KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SM, 2004, DNA REPAIR, V3, P349, DOI 10.1016/j.dnarep.2003.11.007; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; Chen E, 2006, ONCOGENE, V25, P5752, DOI 10.1038/sj.onc.1209573; Chen E, 2006, ONCOGENE, V25, P2575, DOI 10.1038/sj.onc.1209285; CUSTER RP, 1985, AM J PATHOL, V120, P464; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; DEAR TN, 1995, DEVELOPMENT, V121, P2909; DUBE ID, 1991, BLOOD, V78, P2996; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Gutierrez A, 2011, J EXP MED, V208, P1595, DOI 10.1084/jem.20101691; HARDY RR, 1989, CURR TOP MICROBIOL, V152, P19; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; Hough MR, 1998, P NATL ACAD SCI USA, V95, P13853, DOI 10.1073/pnas.95.23.13853; Huang PG, 2011, COMPARATIVE MED, V61, P227; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Imada K, 2003, INT J HEMATOL, V77, P336, DOI 10.1007/BF02982640; Kawabe T, 1997, NATURE, V385, P454, DOI 10.1038/385454a0; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; Lee KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.212969; Muehlbauer PA, 2005, MUTAT RES-GEN TOX EN, V585, P156, DOI 10.1016/j.mrgentox.2005.05.002; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Rakowski LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016761; Renn LAZ, 2010, GENE CHROMOSOME CANC, V49, P119, DOI 10.1002/gcc.20725; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; Riz I, 2005, ONCOGENE, V24, P5561, DOI 10.1038/sj.onc.1208727; ROBERTS CWM, 1994, NATURE, V368, P747, DOI 10.1038/368747a0; ROBERTS CWM, 1995, AM J PATHOL, V146, P1089; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; WASYLYK C, 1986, EMBO J, V5, P553, DOI 10.1002/j.1460-2075.1986.tb04246.x; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yang CY, 2012, DNA REPAIR, V11, P185, DOI 10.1016/j.dnarep.2011.10.018; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	35	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89649	10.1371/journal.pone.0089649	http://dx.doi.org/10.1371/journal.pone.0089649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586935	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000071
J	Mullensiefan, D; Gingras, B; Musil, J; Stewart, L				Muellensiefan, Daniel; Gingras, Bruno; Musil, Jason; Stewart, Lauren			The Musicality of Non-Musicians: An Index for Assessing Musical Sophistication in the General Population	PLOS ONE			English	Article							BRAIN ORGANIZATION; PERSONALITY; INTELLIGENCE; RECOGNITION; APTITUDE; ACHIEVEMENT; PERCEPTION; LESSONS; NUMBER; MEMORY	Musical skills and expertise vary greatly in Western societies. Individuals can differ in their repertoire of musical behaviours as well as in the level of skill they display for any single musical behaviour. The types of musical behaviours we refer to here are broad, ranging from performance on an instrument and listening expertise, to the ability to employ music in functional settings or to communicate about music. In this paper, we first describe the concept of 'musical sophistication' which can be used to describe the multi-faceted nature of musical expertise. Next, we develop a novel measurement instrument, the Goldsmiths Musical Sophistication Index (Gold-MSI) to assess self-reported musical skills and behaviours on multiple dimensions in the general population using a large Internet sample (n = 147,636). Thirdly, we report results from several lab studies, demonstrating that the Gold-MSI possesses good psychometric properties, and that self-reported musical sophistication is associated with performance on two listening tasks. Finally, we identify occupation, occupational status, age, gender, and wealth as the main socio-demographic factors associated with musical sophistication. Results are discussed in terms of theoretical accounts of implicit and statistical music learning and with regard to social conditions of sophisticated musical engagement.	[Muellensiefan, Daniel; Musil, Jason; Stewart, Lauren] Univ London, Goldsmiths, Dept Psychol, London, England; [Gingras, Bruno] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of London; Goldsmiths University London; University of Vienna	Mullensiefan, D (corresponding author), Univ London, Goldsmiths, Dept Psychol, London, England.	d.mullensiefen@gold.ac.uk	Stewart, Lauren/HHC-2911-2022; lee, yujun/P-6069-2014	lee, yujun/0000-0002-5821-7355; stewart, lauren/0000-0002-6221-6064	Goldsmiths Early Career Development grant	Goldsmiths Early Career Development grant	The research was supported by a Goldsmiths Early Career Development grant awarded to Daniel Mullensiefen in 2010. The technical implementation of the large internet survey was supported and carried by BBC Lab UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aheadi A, 2010, PSYCHOL MUSIC, V38, P107, DOI 10.1177/0305735609336057; [Anonymous], 2012, ANN SURV HOURS EARN; Augustin D., 2006, PSYCHOL SCI, V48, P135; Baker F.B., 2004, ITEM RESPONSE THEORY; BARTLETT JC, 1980, J EXP PSYCHOL HUMAN, V6, P501, DOI 10.1037/0096-1523.6.3.501; Bentley A., 1966, BENTLEY MEASURES MUS; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Blacking J, 1995, MUSIC CULTURE EXPERI; Blacking John, 1973, MUSICAL IS MAN; Boyle J. D., 1987, MEASUREMENT EVALUATI; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Builione R.S., 1983, PSYCHOMUSICOLOGY, V3, P36, DOI DOI 10.1037/H0094257; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chamorro-Premuzic T, 2004, J RES PERS, V38, P505, DOI 10.1016/j.jrp.2003.10.002; Chamorro-Premuzic T, 2007, BRIT J PSYCHOL, V98, P175, DOI 10.1348/000712606X111177; Chamorro-Premuzic T, 2009, PSYCHOL AESTHET CREA, V3, P149, DOI 10.1037/a0015342; Chamorro-Premuzic T, 2009, J INDIVID DIFFER, V30, P20, DOI 10.1027/1614-0001.30.1.20; CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; Chin TC, 2012, MUSIC PERCEPT, V29, P429, DOI 10.1525/MP.2012.29.4.429; Chin T, 2010, MUSIC PERCEPT, V27, P197, DOI 10.1525/MP.2010.27.3.197; Cuddy L.L., 1981, PSYCHOMUSICOLOGY, V1, P15, DOI [10.1037/h0094283, DOI 10.1037/H0094283]; Cuddy LL, 2005, ANN NY ACAD SCI, V1060, P311, DOI 10.1196/annals.1360.026; Dandurand F, 2008, BEHAV RES METHODS, V40, P428, DOI 10.3758/BRM.40.2.428; Davies JB, 1978, PSYCHOL MUSIC; Davies John, 2008, WELSH ACAD ENCY WALE; Dinno A, 2009, STATA J, V9, P291, DOI 10.1177/1536867X0900900207; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Droves TJ, 2008, B COUN RES MUSIC ED, P35; Campos JADB, 2011, COMPUT HUM BEHAV, V27, P1875, DOI 10.1016/j.chb.2011.04.011; Ericsson KA, 1991, GEN THEORY EXERCISE; EYSENCK MW, 1979, J RES PERS, V13, P363, DOI 10.1016/0092-6566(79)90001-1; Furnham A, 2004, PERS INDIV DIFFER, V36, P705, DOI 10.1016/S0191-8869(03)00128-4; Furnham A, 2002, ERGONOMICS, V45, P203, DOI 10.1080/00140130210121932; Furnham A, 2009, CURR PSYCHOL, V28, P225, DOI 10.1007/s12144-009-9064-z; Gaser C, 2003, J NEUROSCI, V23, P9240; Gembris H, 1999, PSYCHOMUSICOLOGY, V16, P17, DOI DOI 10.1037/H0094070; Glaser R, 1994, BLACKWELL DICT COGNI, P139; Gordon Edwin, 1989, ADV MEASURES MUSIC A; Gordon Edwin, 1990, PREDICTIVE VALIDITY; Gordon EE, 1975, RES PSYCHOL MUSIC, V10, P24; Gordon EE, 1991, ADV MEASURES MUSIC A, P1; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Granota RY, 2007, EVOL HUM BEHAV, V28, P313, DOI 10.1016/j.evolhumbehav.2007.05.003; GUTTMAN L., 1945, PSYCHOMETRIKA, V10, P255; Hallam S., 2003, RES STUD MUSIC EDUC, V20, P2, DOI [10.1177/1321103X030200010101, DOI 10.1177/1321103X030200010101]; Hallam S, 2010, PSYCHOL MUSIC, V38, P308, DOI 10.1177/0305735609351922; Halpern AR, 2010, SPRINGER HANDB AUDIT, V36, P233, DOI 10.1007/978-1-4419-6114-3_8; HALPERN AR, 1995, PSYCHOL AGING, V10, P325, DOI 10.1037/0882-7974.10.3.325; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hargreaves D, 2002, BRIT J EDUC PSYCHOL, V72, P139; HASSLER M, 1993, NEUROPSYCHOLOGIA, V31, P655, DOI 10.1016/0028-3932(93)90137-O; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Herdener M, 2010, J NEUROSCI, V30, P1377, DOI 10.1523/JNEUROSCI.4513-09.2010; HONECK RP, 1987, B PSYCHONOMIC SOC, V25, P431; Honing H, 2006, MUSIC PERCEPT, V23, P365, DOI 10.1525/mp.2006.23.5.365; Honing H, 2012, ANN NY ACAD SCI, V1252, P85, DOI 10.1111/j.1749-6632.2011.06402.x; Honing Henkjan., 2011, MUSICAL COGNITION SC; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hughson AL, 2002, FOOD QUAL PREFER, V13, P463, DOI 10.1016/S0950-3293(02)00051-4; Hughson AL, 2009, Q J EXP PSYCHOL, V62, P1, DOI 10.1080/17470210802214890; Hunter PG, 2011, PERS INDIV DIFFER, V50, P175, DOI 10.1016/j.paid.2010.09.021; Hyde KL, 2003, ANN NY ACAD SCI, V999, P173, DOI 10.1196/annals.1284.023; Iversen J.R., 2008, P 10 INT C MUSIC PER, P465, DOI DOI 10.1016/J.HEARES.2007.10.007; Jonaitis EM, 2009, COGNITIVE SCI, V33, P951, DOI 10.1111/j.1551-6709.2009.01036.x; Karma K., 2007, PSYCHOMUSICOLOGY, V19, P79, DOI [10.1037/h0094033, DOI 10.1037/H0094033]; Kemp A. E., 1981, PSYCHOL MUSIC, V9, P3, DOI [DOI 10.1177/03057356810090010201, 10.1177/03057356810090010201]; Kemp A.E., 1996, MUSICAL TEMPERAMENT; Kemp A.E., 1982, PSYCHOL MUSIC, V10, P3, DOI DOI 10.1177/0305735682102001; KEMP AE, 1981, B COUN RES MUSIC ED, P33; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Ladinig O, 2012, PSYCHOL AESTHET CREA, V6, P146, DOI 10.1037/a0024671; Law LNC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052508; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Levitin DJ, 2012, NEURON, V73, P633, DOI 10.1016/j.neuron.2012.01.017; LIPTON JP, 1987, J PSYCHOL, V121, P85, DOI 10.1080/00223980.1987.9712647; LITLE P, 1986, PERS INDIV DIFFER, V7, P575, DOI 10.1016/0191-8869(86)90136-4; McCrae RR, 2007, MOTIV EMOTION, V31, P5, DOI 10.1007/s11031-007-9053-1; McDonald, 1999, TEST THEORY UNIFIED, DOI DOI 10.4324/9781410601087; McDonald C, 2008, MUSIC PERCEPT, V25, P345, DOI 10.1525/MP.2008.25.4.345; McManus IC, 2006, BRIT J PSYCHOL, V97, P555, DOI 10.1348/000712606X101088; McPherson G, 2009, OXFORD HDB MUSIC PSY, P225; McPherson G. E, 2006, CHILD MUSICIAN HDB M, P239, DOI DOI 10.1093/ACPROF:OSO/9780198530329.003.0012; Merriam AlanP., 1964, ANTHR MUSIC; MONTANELLI RG, 1976, PSYCHOMETRIKA, V41, P341, DOI 10.1007/BF02293559; Mullensiefen D., 2011, GOLDSMITHS MUSICAL S; Murphy C., 1999, BRIT J MUSICAL ED, V16, P39, DOI DOI 10.1017/S0265051799000133; Musek J, 2007, J RES PERS, V41, P1213, DOI 10.1016/j.jrp.2007.02.003; Ollen J.E., 2006, THESIS OHIO STATE U; Paraskevopoulos E, 2012, NEUROPSYCHOLOGIA, V50, P341, DOI 10.1016/j.neuropsychologia.2011.12.007; Park H, 2012, J MED GENET, V49, P747, DOI 10.1136/jmedgenet-2012-101209; Paulhus DL, 1998, J PERS, V66, P525, DOI 10.1111/1467-6494.00023; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; R Core Team, 2021, R LANGUAGE ENV STAT; Reimers S, 2007, ARCH SEX BEHAV, V36, P147, DOI 10.1007/s10508-006-9143-2; Rentfrow PJ, 2006, PSYCHOL SCI, V17, P236, DOI 10.1111/j.1467-9280.2006.01691.x; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; Revelle W, 1979, Multivariate Behav Res, V14, P403, DOI 10.1207/s15327906mbr1404_2; Revelle W, 2013, J RES PERS, V47, P493, DOI 10.1016/j.jrp.2013.04.012; Rizopoulos D., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I05; Ruthsatz J, 2008, INTELLIGENCE, V36, P330, DOI 10.1016/j.intell.2007.08.003; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2000, COGNITION, V77, pB15, DOI 10.1016/S0010-0277(00)00095-0; Samejima F., 1969, ESTIMATION LATENT AB; Schellenberg EG, 2006, J EDUC PSYCHOL, V98, P457, DOI 10.1037/0022-0663.98.2.457; Schellenberg EG, 2011, MUSIC PERCEPT, V29, P185, DOI 10.1525/MP.2011.29.2.185; Schellenberg EG, 2011, MUSIC PERCEPT, V29, P129, DOI 10.1525/MP.2011.29.2.129; Schellenberg EG, 2011, BRIT J PSYCHOL, V102, P283, DOI 10.1111/j.2044-8295.2010.02000.x; Schleuter SL, 1978, CONTRIBUTIONS MUSIC, V6, P2; SCHMID J, 1957, PSYCHOMETRIKA, V22, P53, DOI 10.1007/BF02289209; Schmithorst VJ, 2002, NEUROSCI LETT, V321, P57, DOI 10.1016/S0304-3940(02)00054-X; Seashore C.E., 1938, PSYCHOL MUSIC; Seashore CE., 1960, SEASHORE MEASURES MU; Seppanen M, 2007, NEUROBIOL LEARN MEM, V87, P236, DOI 10.1016/j.nlm.2006.08.011; SMITH JD, 1994, COGNITION, V52, P23; Stewart L, 2006, BRAIN, V129, P2533, DOI 10.1093/brain/awl171; Stewart L, 2011, Q J EXP PSYCHOL, V64, P625, DOI 10.1080/17470218.2011.552730; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Tillmann B, 2004, J EXP PSYCHOL LEARN, V30, P1131, DOI 10.1037/0278-7393.30.5.1131; Tillmann B, 2000, PERSP NEURAL COMP, P175; Ukkola LT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005534; van der Linden W, 1997, HDB MODERN ITEM RESP; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Vuoskoski JK, 2011, MUSIC SCI, V15, P159, DOI 10.1177/1029864911403367; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; WEISER M, 1983, INT J MAN MACH STUD, V19, P391, DOI 10.1016/S0020-7373(83)80061-3; WERKER JF, 1988, DEV PSYCHOL, V24, P672, DOI 10.1037/0012-1649.24.5.672; WERKER JF, 1984, J ACOUST SOC AM, V75, P1866, DOI 10.1121/1.390988; Werner PD, 2006, J PSYCHOL, V140, P329, DOI 10.3200/JRLP.140.4.329-345; WESTFALL PH, 1993, BIOMETRICS, V49, P941, DOI 10.2307/2532216; WHITE BW, 1960, AM J PSYCHOL, V73, P100, DOI 10.2307/1419120; Wilson G. D., 2002, PSYCHOL PERFORMING A; WING HD, 1962, J RES MUSIC EDUC, V10, P39, DOI 10.2307/3343909; Wing HD, 1962, WING STANDARDIZED TE; Woody RH, 1999, CREATIVITY RES J, V12, P241, DOI 10.1207/s15326934crj1204_2; Yau H, 1999, CONSTRUCTION CRITERI; YOUNG WT, 1976, J RES MUSIC EDUC, V24, P97, DOI 10.2307/3345153; YOUNG WT, 1971, J RES MUSIC EDUC, V19, P385, DOI 10.2307/3344291; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7	143	347	349	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89642	10.1371/journal.pone.0089642	http://dx.doi.org/10.1371/journal.pone.0089642			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24586929	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332389000070
J	Wang, HJ; Zhao, Y; Zhang, CB; Li, MY; Jiang, CL; Li, YL				Wang, Hongjun; Zhao, Yan; Zhang, Chuanbao; Li, Mingyang; Jiang, Chuanlu; Li, Yongli			Rab27a Was Identified as a Prognostic Biomaker by mRNA Profiling, Correlated with Malignant Progression and Subtype Preference in Gliomas	PLOS ONE			English	Article							TUMOR PROGRESSION; EXPRESSION; CANCER; CELLS; GLIOBLASTOMA; GENE; INHIBITION; CARCINOMA; PROTEIN; GTPASES	Purpose: Rab27a belongs to the Rab small GTPase superfamily. The protein is membrane-bound and may be involved in protein transport and small GTPase-mediated signal transduction. Mutations in this gene are associated with Griscelli syndrome type 2. However, the prognostic and molecular features of gliomas with Rab27a expression are still unclear. Experimental Design: We used a whole-genome mRNA expression microarray dataset of 220 glioma samples from the Chinese Glioma Genome Atlas (CGGA) database (http://www.cgga.org.cn) as a discovery set. In this set, 220 gliomas, consisting of 97 WHO Grade II gliomas, 34 WHO Grade III gliomas, and 89 WHO Grade IV gliomas, were analyzed using the Kaplan-Meier method. To validate the protein expression of Rab27a, we assayed another 162 glioma samples by immunohistochemistry. Three additional datasets were obtained as validation sets. Gene ontology (GO) analysis and gene set variation analysis (GSVA) were used for the functional annotation of Rab27a in 89 WHO Grade IV gliomas. Results: Rab27a was significantly associated with grade progression and high mortality in all grades of glioma in the discovery set. Rab27a also showed a mesenchymal subtype, G3 subtype and isocitrate dehydrogenase 1 (IDH1) wild-type preference and association with migration. The 3 validation datasets revealed similar findings. Rab27a was more highly expressed in gliomas than in normal brain tissues, and its expression increased with glioma grade progression. Conclusions: Rab27a expression was significantly associated with grade progression and worse prognosis in all grades of gliomas, suggesting Rab27a as a novel biomarker with potentially important therapeutic implications.	[Wang, Hongjun; Zhao, Yan; Jiang, Chuanlu; Li, Yongli] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China; [Zhang, Chuanbao; Li, Mingyang] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China	Harbin Medical University; Capital Medical University	Li, YL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China.	jcl6688jcl@163.com	Li, Mingyang/C-2324-2018	Li, Mingyang/0000-0003-1766-7867	National High Technology Research and Development Program [2012AA02A508]; International Science and Technology Cooperation Program [2012DFA30470]; National 973 program [2011CB7 07804]; National Natural Science Foundation of China [81201993]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); International Science and Technology Cooperation Program; National 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from National High Technology Research and Development Program (No. 2012AA02A508), International Science and Technology Cooperation Program (No. 2012DFA30470), National 973 program (No. 2011CB7 07804) and National Natural Science Foundation of China (No. 81201993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, COR TEAM LANG ENV ST; Bao ZS, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-100; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Catz SD, 2008, METHOD ENZYMOL, V438, P25, DOI 10.1016/S0076-6879(07)38003-8; CULINE S, 1994, EUR J CANCER, V30A, P670, DOI 10.1016/0959-8049(94)90542-8; Dong WW, 2012, WORLD J GASTROENTERO, V18, P1806, DOI 10.3748/wjg.v18.i15.1806; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045910; Overmeyer JH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-69; Recchi C, 2012, BIOCHEM SOC T, V40, P1398, DOI 10.1042/BST20120199; Senft C, 2011, J NEURO-ONCOL, V101, P393, DOI 10.1007/s11060-010-0273-y; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Uchino K, 2013, MOL THER, V21, P610, DOI 10.1038/mt.2012.269; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang HJ, 2013, INT J ONCOL, V42, P1716, DOI 10.3892/ijo.2013.1847; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Wang YZ, 2011, ONCOL REP, V26, P1173, DOI 10.3892/or.2011.1396; Wu X, 2013, TUMOUR BIOL; Yan W, 2012, NEURO-ONCOLOGY, V14, P1432, DOI 10.1093/neuonc/nos263; Yao RS, 2002, ONCOGENE, V21, P5814, DOI 10.1038/sj.onc.1205422	23	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89782	10.1371/journal.pone.0089782	http://dx.doi.org/10.1371/journal.pone.0089782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587032	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000093
J	Guo, XQ; Jiang, XW; Xiao, Y; Zhou, TT; Guo, YL; Wang, RX; Zhao, Z; Xiao, H; Hou, CM; Ma, LY; Lin, YH; Lang, XL; Feng, JN; Chen, GJ; Shen, BF; Han, GC; Li, Y				Guo, Xiaoqin; Jiang, Xingwei; Xiao, Yan; Zhou, Tingting; Guo, Yueling; Wang, Renxi; Zhao, Zhi; Xiao, He; Hou, Chunmei; Ma, Lingyun; Lin, Yanhua; Lang, Xiaoling; Feng, Jiannan; Chen, Guojiang; Shen, Beifen; Han, Gencheng; Li, Yan			IL-17A Signaling in Colonic Epithelial Cells Inhibits Pro-Inflammatory Cytokine Production by Enhancing the Activity of ERK and PI3K	PLOS ONE			English	Article							DSS-INDUCED COLITIS; BOWEL-DISEASE; TNF-ALPHA; T-CELLS; EXPRESSION; INTERLEUKIN-17; ACTIVATION; BINDING; CHEMOKINE; GAMMA	Our previous data suggested that IL-17A contributes to the inhibition of Th1 cell function in the gut. However, the underlying mechanisms remain unclear. Here we demonstrate that IL-17A signaling in colonic epithelial cells (CECs) increases TNF-alpha-induced PI3K-AKT and ERK phosphorylation and inhibits TNF-alpha induced expression of IL-12P35 and of a Th1 cell chemokine, CXCL11 at mRNA level. In a co-culture system using HT-29 cells and PBMCs, IL-17A inhibited TNF-(a) over tilde induced IL-12P35 expression by HT-29 cells and led to decreased expression of IFN-gamma and T-bet by PBMCs. Finally, adoptive transfer of CECs from mice with Crohn's Disease (CD) led to an enhanced Th1 cell response and exacerbated colitis in CD mouse recipients. The pathogenic effect of CECs derived from CD mice was reversed by co-administration of recombinant IL-17A. Our data demonstrate a new IL-17A-mediated regulatory mechanism in CD. A better understanding of this pathway might shed new light on the pathogenesis of CD.	[Guo, Xiaoqin; Jiang, Xingwei; Zhou, Tingting; Wang, Renxi; Zhao, Zhi; Xiao, He; Hou, Chunmei; Lin, Yanhua; Lang, Xiaoling; Feng, Jiannan; Chen, Guojiang; Shen, Beifen; Han, Gencheng; Li, Yan] Beijing Inst Basic Med Sci, Dept Mol Immunol, Beijing, Peoples R China; [Guo, Xiaoqin] Chinese Peoples Armed Police Forces, Dept Immunol, Logist Coll, Tianjin, Peoples R China; [Xiao, Yan; Ma, Lingyun] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Affiliated Hosp 1, Beijing, Peoples R China; [Guo, Yueling] Beijing PLA, Dept Med Engn, Mil Gen Hosp, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital	Chen, GJ (corresponding author), Beijing Inst Basic Med Sci, Dept Mol Immunol, Beijing, Peoples R China.	guogangch@yahoo.com; genchenghan@163.com	Wang, Renxi/AAM-1326-2020	Wang, Renxi/0000-0003-4130-3334	National "973" Fund [2013CB530506]; National Natural Sciences Foundation of China [81072475, 81172800, 31100961]	National "973" Fund(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a National "973" Fund (grant number 2013CB530506), and the National Natural Sciences Foundation of China (grants 81072475, 81172800, and 31100961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awane M, 1999, J IMMUNOL, V162, P5337; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; BRANDTZAEG P, 1992, ANN NY ACAD SCI, V664, P157, DOI 10.1111/j.1749-6632.1992.tb39758.x; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; FUNAKOSHI K, 1995, J GASTROENTEROL, V30, P61; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hansen JJ, 2009, INFLAMM BOWEL DIS, V15, P890, DOI 10.1002/ibd.20850; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kollet J, 2001, J IMMUNOL, V167, P5653, DOI 10.4049/jimmunol.167.10.5653; Lee JW, 2008, J IMMUNOL, V181, P6536, DOI 10.4049/jimmunol.181.9.6536; Lefrancois L., 2001, CURR PROTOC IMMUNOL; Li X, 2010, CLIN IMMUNOL, V134, P169, DOI 10.1016/j.clim.2009.09.012; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lytle C, 2005, INFLAMM BOWEL DIS, V11, P231, DOI 10.1097/01.MIB.0000160805.46235.eb; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; PALLONE F, 1988, CLIN EXP IMMUNOL, V74, P75; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rahimi R, 2007, BIOMED PHARMACOTHER, V61, P75, DOI 10.1016/j.biopha.2006.06.022; Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Schreiber S, 2005, GASTROENTEROLOGY, V129, P807, DOI 10.1053/j.gastro.2005.06.064; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Shi FM, 2012, CLIN IMMUNOL, V145, P230, DOI 10.1016/j.clim.2012.09.001; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; van Dop WA, 2010, IMMUNOL LETT, V131, P33, DOI 10.1016/j.imlet.2010.03.008; Wang QD, 2000, BIOCHEM BIOPH RES CO, V273, P853, DOI 10.1006/bbrc.2000.3034; Yamada S, 2011, J GASTROEN HEPATOL, V26, P398, DOI 10.1111/j.1440-1746.2010.06496.x; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978	42	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89714	10.1371/journal.pone.0089714	http://dx.doi.org/10.1371/journal.pone.0089714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586980	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900069
J	Tanimura, A; Horiguchi, T; Miyoshi, K; Hagita, H; Noma, T				Tanimura, Ayako; Horiguchi, Taigo; Miyoshi, Keiko; Hagita, Hiroko; Noma, Takafumi			Differential Expression of Adenine Nucleotide Converting Enzymes in Mitochondrial Intermembrane Space: A Potential Role of Adenylate Kinase Isozyme 2 in Neutrophil Differentiation	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; DIPHOSPHATE-KINASE; ENERGY-METABOLISM; CREATINE-KINASE; INDUCTION; MUSCLE; OXYGEN; COMPARTMENTATION; RESPIRATION; TRANSLOCASE	Adenine nucleotide dynamics in the mitochondrial intermembrane space (IMS) play a key role in oxidative phosphorylation. In a previous study, Drosophila adenylate kinase isozyme 2 (Dak2) knockout was reported to cause developmental lethality at the larval stage in Drosophila melanogaster. In addition, two other studies reported that AK2 is a responsible gene for reticular dysgenesis (RD), a human disease that is characterized by severe combined immunodeficiency and deafness. Therefore, mitochondrial AK2 may play an important role in hematopoietic differentiation and ontogenesis. Three additional adenine nucleotide metabolizing enzymes, including mitochondrial creatine kinases (CKMT1 and CKMT2) and nucleoside diphosphate kinase isoform D (NDPK-D), have been found in IMS. Although these kinases generate ADP for ATP synthesis, their involvement in RD remains unclear and still an open question. In this study, mRNA and protein expressions of these mitochondrial kinases were firstly examined in mouse ES cells, day 8 embryos, and 7-week-old adult mice. It was found that their expressions are spatiotemporally regulated, and Ak2 is exclusively expressed in bone marrow, which is a major hematopoietic tissue in adults. In subsequent experiments, we identified increased expression of both AK2 and CKMT1 during macrophage differentiation and exclusive production of AK2 during neutrophil differentiation using HL-60 cells as an in vitro model of hematopoietic differentiation. Furthermore, AK2 knockdown specifically inhibited neutrophil differentiation without affecting macrophage differentiation. These data suggest that AK2 is indispensable for neutrophil differentiation and indicate a possible causative link between AK2 deficiency and neutropenia in RD.	[Tanimura, Ayako; Horiguchi, Taigo; Miyoshi, Keiko; Hagita, Hiroko; Noma, Takafumi] Univ Tokushima, Grad Sch, Dept Mol Biol, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University	Noma, T (corresponding author), Univ Tokushima, Grad Sch, Dept Mol Biol, Inst Hlth Biosci, Tokushima 770, Japan.	ntaka@tokushima-u.ac.jp	Horiguchi, Taigo/AGO-4389-2022; Miyoshi, Keiko/AAZ-4205-2020	Miyoshi, Keiko/0000-0001-6910-4172	Ministry of Education, Science, Sports and Culture [13278393]; Ministry of Education, Culture, Sports, Science, and Technology; Kojinkai Foundation; University of Tokushima	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kojinkai Foundation; University of Tokushima	This work was partly supported by a Grant-in-Aid for Young Scientists (B) 13278393) from the Ministry of Education, Science, Sports and Culture, a grant for the special scientific research program aimed at the improvement of QOL (Quality of Life) via oral function in collaboration with universities from the Ministry of Education, Culture, Sports, Science, and Technology, and a research grant supported by Kojinkai Foundation, and the President discretion research budget of the University of Tokushima. No additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathocleous M, 2013, TRENDS CELL IN PRESS, DOI [10.1016/j.tcb.2013.05.004, DOI 10.1016/J.TCB.2013.05.004.IN]; Aliev M, 2011, INT J MOL SCI, V12, P9296, DOI 10.3390/ijms12129296; Amiri M, 2013, INT J BIOCHEM CELL B, V45, P925, DOI 10.1016/j.biocel.2013.02.004; BANDLOW W, 1988, EUR J BIOCHEM, V178, P451, DOI 10.1111/j.1432-1033.1988.tb14469.x; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Burkart A, 2011, J BIOL CHEM, V286, P4081, DOI 10.1074/jbc.M110.134106; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen RP, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-31; COHEN MS, 1981, J IMMUNOL, V127, P1007; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; Conner J, 1983, BIOCHEM BIOPH RES CO, V31, P348; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Dzeja PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019300; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Fujisawa K, 2009, COMP BIOCHEM PHYS B, V153, P29, DOI 10.1016/j.cbpb.2009.01.006; Guerrero K, 2005, AM J PHYSIOL-REG I, V289, pR1144, DOI 10.1152/ajpregu.00229.2005; Guzun R, 2012, BBA-BIOMEMBRANES, V1818, P1545, DOI 10.1016/j.bbamem.2011.12.034; Horiguchi T, 2014, J MED INVES IN PRESS; Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Klimmeck D, 2012, MOL CELL PROTEOMICS, V11, P286, DOI 10.1074/mcp.M111.016790; Kohler C, 1999, FEBS LETT, V447, P10, DOI 10.1016/S0014-5793(99)00251-3; Korshunov S., 1997, FEBS LETT, V41, P15; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; Lee HJ, 2007, NAT CELL BIOL, V9, P1303, DOI 10.1038/ncb1650; Lee Y, 1998, J BIOCHEM-TOKYO, V123, P47; McKee T, 2008, BIOCH MOL BASIS LIFE, P325; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Miyoshi K, 2009, ACTA HISTOCHEM CYTOC, V42, P55, DOI 10.1267/ahc.08012; Nobumoto M, 1998, J BIOCHEM, V123, P128; Noma T, 1998, BBA-GENE STRUCT EXPR, V1395, P34, DOI 10.1016/S0167-4781(97)00193-0; Noma T, 2001, BIOCHEM J, V358, P225, DOI 10.1042/0264-6021:3580225; Noma T, 2005, J MED INVESTIG, V52, P127, DOI 10.2152/jmi.52.127; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Panayiotou C, 2011, BIOCHEM J, V433, P527, DOI 10.1042/BJ20101443; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Ruspita I, 2008, J MED INVESTIG, V55, P87, DOI 10.2152/jmi.55.87; Saks V, 2007, MOL SYSTEM BIOENERGE, P59; TANABE T, 1993, J BIOCHEM-TOKYO, V113, P200, DOI 10.1093/oxfordjournals.jbchem.a124026; Tanimoto Y, 2008, COMPARATIVE MED, V58, P347; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; Urao N, 2013, FREE RADICAL BIO MED, V54, P26, DOI 10.1016/j.freeradbiomed.2012.10.532; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Wallimann T, 2007, MOL SYSTEM BIOENERGE, P195, DOI [10.1002/9783527621095.ch7, DOI 10.1002/9783527621095.CH7, DOI 10.1002/9783527621095]; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Ward MS, 2013, CURR OPIN PHARMACOL, V13, P654, DOI 10.1016/j.coph.2013.06.009	49	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89916	10.1371/journal.pone.0089916	http://dx.doi.org/10.1371/journal.pone.0089916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587121	gold, Green Published			2022-12-27	WOS:000332385900095
J	Vida, M; Rivera, P; Gavito, AL; Suarez, J; Pavon, FJ; Arrabal, S; Romero-Cuevas, M; Bautista, D; Martinez, A; de Fonseca, FR; Serrano, A; Baixeras, E				Vida, Margarita; Rivera, Patricia; Luisa Gavito, Ana; Suarez, Juan; Javier Pavon, Francisco; Arrabal, Sergio; Romero-Cuevas, Miguel; Bautista, Dolores; Martinez, Ana; Rodriguez de Fonseca, Fernando; Serrano, Antonia; Baixeras, Elena			CB1 Blockade Potentiates Down-Regulation of Lipogenic Gene Expression in Perirenal Adipose Tissue in High Carbohydrate Diet-Induced Obesity	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; LIVER-X-RECEPTOR; ENDOCANNABINOID SYSTEM; HEPATIC LIPOGENESIS; KINASE; ACTIVATION; DYSREGULATION; DYSLIPIDEMIA; STIMULATION; METABOLISM	De novo lipogenesis and hypercaloric diets are thought to contribute to increased fat mass, particularly in abdominal fat depots. CB1 is highly expressed in adipose tissue, and CB1-mediated signalling is associated with stimulation of lipogenesis and diet-induced obesity, though its contribution to increasing fat deposition in adipose tissue is controversial. Lipogenesis is regulated by transcription factors such as liver X receptor (LXR), sterol-response element binding protein (SREBP) and carbohydrate-responsive-element-binding protein (ChREBP). We evaluated the role of CB1 in the gene expression of these factors and their target genes in relation to lipogenesis in the perirenal adipose tissue (PrAT) of rats fed a high-carbohydrate diet (HCHD) or a high-fat diet (HFD). Both obesity models showed an up-regulated gene expression of CB1 and Lxr alpha in this adipose pad. The Srebf-1 and ChREBP gene expressions were down-regulated in HFD but not in HCHD. The expression of their target genes encoding for lipogenic enzymes showed a decrease in diet-induced obesity and was particularly dramatic in HFD. In HCHD, CB1 blockade by AM251 reduced the Srebf-1 and ChREBP expression and totally abrogated the remnant gene expression of their target lipogenic enzymes. The phosphorylated form of the extracellular signal-regulated kinase (ERK-p), which participates in the CB1-mediated signalling pathway, was markedly present in the PrAT of obese rats. ERK-p was drastically repressed by AM251 indicating that CB1 is actually functional in PrAT of obese animals, though its activation loses the ability to stimulate lipogenesis in PrAT of obese rats. Even so, the remnant expression levels of lipogenic transcription factors found in HCHD-fed rats are still dependent on CB1 activity. Hence, in HCHD-induced obesity, CB1 blockade may help to further potentiate the reduction of lipogenesis in PrAT by means of inducing down-regulation of the ChREBP and Srebf-1 gene expression, and consequently in the expression of lipogenic enzymes.	[Vida, Margarita; Rivera, Patricia; Luisa Gavito, Ana; Suarez, Juan; Javier Pavon, Francisco; Arrabal, Sergio; Romero-Cuevas, Miguel; Rodriguez de Fonseca, Fernando; Serrano, Antonia] Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, E-29071 Malaga, Spain; [Baixeras, Elena] Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Med Interna, E-29071 Malaga, Spain; [Bautista, Dolores] Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Anat Patol, E-29071 Malaga, Spain; [Vida, Margarita; Rivera, Patricia; Luisa Gavito, Ana; Suarez, Juan; Javier Pavon, Francisco; Arrabal, Sergio; Romero-Cuevas, Miguel; Bautista, Dolores; Rodriguez de Fonseca, Fernando; Serrano, Antonia; Baixeras, Elena] Univ Malaga, Hosp Reg Univ Malaga, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain; [Martinez, Ana] CSIC, Inst Quim Med Lora Tamayo, Madrid, Spain; [Vida, Margarita; Rivera, Patricia; Luisa Gavito, Ana; Suarez, Juan; Javier Pavon, Francisco; Arrabal, Sergio; Romero-Cuevas, Miguel; Rodriguez de Fonseca, Fernando; Serrano, Antonia; Baixeras, Elena] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Santiago De Compostela, Spain	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Serrano, A (corresponding author), Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, E-29071 Malaga, Spain.	antonia.serrano@fundacionimabis.org; elena.baixeras@ibima.eu	Martinez, Ana/L-6414-2014; Pavón Morón, Francisco Javier/AAG-9721-2020; Romero-Cuevas, Miguel/M-3461-2016; Suarez, Juan/I-5188-2015	Martinez, Ana/0000-0002-2707-8110; Pavón Morón, Francisco Javier/0000-0002-5256-8904; Romero-Cuevas, Miguel/0000-0002-8323-0893; Suarez, Juan/0000-0001-5254-9802; Serrano, Antonia/0000-0002-8017-9754; BAIXERAS, ELENA/0000-0001-6955-2434; Gavito, Ana Luisa/0000-0002-2782-5999; Arrabal Nunez, Sergio/0000-0002-0600-9634; Rivera, Patricia/0000-0002-0478-6667; Bautista, Dolores/0000-0002-1384-3352	Spanish Institute of Health Carlos III [PI061109, CP12/03109, CIBERobn EU-ERDF-CB06/03/1008]; Andalusian Ministry of Health [PI0552]; Andalusian Ministry of Economy, Innovation, Science and Employment EU-ERDF [CTS-8221, CTS-433]; Spanish Ministry of Science and Innovation [SAF2010-20521]; European Union (REPROBESITY) [Health-F2-2008-223713]; I3SNS Program of the Spanish National Health System of Spanish Ministry of Science and Innovation	Spanish Institute of Health Carlos III(Instituto de Salud Carlos III); Andalusian Ministry of Health; Andalusian Ministry of Economy, Innovation, Science and Employment EU-ERDF; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union (REPROBESITY); I3SNS Program of the Spanish National Health System of Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN))	This work was supported by Grants: from the Spanish Institute of Health Carlos III (PI061109; CP12/03109; CIBERobn EU-ERDF-CB06/03/1008); from the Andalusian Ministry of Health (PI0552); from Andalusian Ministry of Economy, Innovation, Science and Employment EU-ERDF (CTS-8221 and CTS-433); from Spanish Ministry of Science and Innovation (SAF2010-20521); from European Union's 7th Framework Programme (Health-F2-2008-223713, REPROBESITY). Elena Baixeras is a tenured investigator through the I3SNS Program of the Spanish National Health System of Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Britton KA, 2011, CLIN LIPIDOL, V6, P79, DOI 10.2217/CLP.10.89; Carr MC, 2004, J CLIN ENDOCR METAB, V89, P2601, DOI 10.1210/jc.2004-0432; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chambers AP, 2004, PHYSIOL BEHAV, V82, P863, DOI [10.1016/S0031-9384(04)00302-6, 10.1016/j.physbeh.2004.07.004]; CHASCIONE C, 1987, AM J PHYSIOL, V253, pE664, DOI 10.1152/ajpendo.1987.253.6.E664; Cinti S, 1999, ADIPOSE ORGAN; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Crespillo A, 2011, BIOCHEM J, V433, P175, DOI 10.1042/BJ20100751; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; Diraison F, 2002, AM J PHYSIOL-ENDOC M, V282, pE46, DOI 10.1152/ajpendo.2002.282.1.E46; Engeli S, 2008, OBESITY FACTS, V1, P8, DOI 10.1159/000114255; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Hwahng SH, 2009, HEPATOLOGY, V49, P1913, DOI 10.1002/hep.22887; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kirkham TC, 2005, BEHAV PHARMACOL, V16, P297, DOI 10.1097/00008877-200509000-00004; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Kotzka J, 2000, J LIPID RES, V41, P99; Kotzka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032609; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; Minehira K, 2004, INT J OBESITY, V28, P1291, DOI 10.1038/sj.ijo.0802760; Miyashita Y, 2004, DIABETES RES CLIN PR, V65, P235, DOI 10.1016/j.diabres.2004.01.008; Morgan K, 2008, EUR J GASTROEN HEPAT, V20, P843, DOI 10.1097/MEG.0b013e3282f9b203; Muniyappa R, 2013, DIABETES CARE, V36, P2415, DOI 10.2337/dc12-2303; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nicklas BJ, 2004, AM J EPIDEMIOL, V160, P741, DOI 10.1093/aje/kwh281; Ortega FJ, 2010, OBESITY, V18, P13, DOI 10.1038/oby.2009.202; Osei-Hyiaman D, 2006, INT J OBESITY, V30, pS33, DOI 10.1038/sj.ijo.0803276; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pagano C, 2008, J NEUROENDOCRINOL, V20, P124, DOI 10.1111/j.1365-2826.2008.01690.x; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Piche ME, 2005, DIABETES, V54, P770, DOI 10.2337/diabetes.54.3.770; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Sasakabe T, 2011, DIABET METAB SYND OB, V4, P167, DOI 10.2147/DMSO.S19635; Sipe JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008792; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Williams CM, 1999, PSYCHOPHARMACOLOGY, V143, P315, DOI 10.1007/s002130050953; Wu HM, 2011, MOL PHARMACOL, V80, P859, DOI 10.1124/mol.111.072769; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; Yap F, 2011, INT J BIOL SCI, V7, P645, DOI 10.7150/ijbs.7.645; Yu RN, 2006, OBESITY, V14, P1353, DOI 10.1038/oby.2006.153; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	54	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e90016	10.1371/journal.pone.0090016	http://dx.doi.org/10.1371/journal.pone.0090016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587189	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900108
J	Wang, TJ; Chen, JR; Wang, WJ; Wang, YJ; Tseng, GF				Wang, Tsyr-Jiuan; Chen, Jeng-Rung; Wang, Wen-Jay; Wang, Yueh-Jan; Tseng, Guo-Fang			Genistein Partly Eases Aging and Estropause-Induced Primary Cortical Neuronal Changes in Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DENDRITIC SPINE DENSITY; BETA MESSENGER-RNA; MIDDLE-AGED RATS; COGNITIVE FUNCTION; PREFRONTAL CORTEX; PYRAMIDAL NEURONS; ESTRADIOL REPLACEMENT; SPATIAL MEMORY; ER-BETA	Gonadal hormones can modulate brain morphology and behavior. Recent studies have shown that hypogonadism could result in cortical function deficits. To this end, hormone therapy has been used to ease associated symptoms but the risk may outweigh the benefits. Here we explored whether genistein, a phytoestrogen, is effective in restoring the cognitive and central neuronal changes in late middle age and surgically estropause female rats. Both animal groups showed poorer spatial learning than young adults. The dendritic arbors and spines of the somatosensory cortical and CA1 hippocampal pyramidal neurons were revealed with intracellular dye injection and analyzed. The results showed that dendritic spines on these neurons were significantly decreased. Remarkably, genistein treatment rescued spatial learning deficits and restored the spine density on all neurons in the surgically estropause young females. In late middle age females, genistein was as effective as estradiol in restoring spines; however, the recovery was less thorough than on young OHE rats. Neither genistein nor estradiol rectified the shortened dendritic arbors of the aging cortical pyramidal neurons suggesting that dendritic arbors and spines are differently modulated. Thus, genistein could work at central level to restore excitatory connectivity and appears to be potent alternative to estradiol for easing aging and menopausal syndromes.	[Wang, Tsyr-Jiuan] Natl Taichung Univ Sci & Technol, Dept Nursing, Taichung, Taiwan; [Chen, Jeng-Rung; Wang, Wen-Jay] Natl Chung Hsing Univ, Coll Vet Med, Dept Vet Med, Taichung 40227, Taiwan; [Wang, Yueh-Jan; Tseng, Guo-Fang] Tzu Chi Univ, Coll Med, Dept Anat, Hualien, Taiwan	National Taichung University of Science & Technology; National Chung Hsing University; Tzu Chi University	Wang, TJ (corresponding author), Natl Taichung Univ Sci & Technol, Dept Nursing, Taichung, Taiwan.	wtj@nutc.edu.tw; guofang@mail.tcu.edu.tw		Chen, Jeng-Rung/0000-0002-4429-283X	National Science Council of Taiwan [NSC102-2320-B-005-001-MY3, NSC100-2320-B-320-002, NSC100-2320-B-320-001]; NUTC [99T23308]; Tzu-Chi University [TCIRP98006]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NUTC; Tzu-Chi University	This work was supported by research grants from the National Science Council of Taiwan to Chen, J-R (NSC102-2320-B-005-001-MY3); Wang, Y-J (NSC100-2320-B-320-002); and Tseng, G-F (NSC100-2320-B-320-001). This work was also supported by grants from the NUTC to Wang, T-J (99T23308) and Tzu-Chi University to Wang, Y-J and Tseng, G-F (TCIRP98006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2001, IEEE COMMUN MAG, V39, P98, DOI 10.1109/35.925676; Adams MM, 2002, J NEUROSCI, V22, P3608; Adams MM, 2003, CEREB CORTEX, V13, P1271, DOI 10.1093/cercor/bhg078; Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Akama KT, 2003, J NEUROSCI, V23, P2333; ANDREWS TJ, 1994, J NEUROSCI, V14, P3048; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Beeri R, 1997, J NEUROCHEM, V69, P2441; Bimonte-Nelson HA, 2006, EUR J NEUROSCI, V24, P229, DOI 10.1111/j.1460-9568.2006.04867.x; Bohacek J, 2009, J NEUROENDOCRINOL, V21, P640, DOI 10.1111/j.1365-2826.2009.01882.x; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Cassidy A, 1999, CURR OPIN LIPIDOL, V10, P47, DOI 10.1097/00041433-199902000-00009; Chen JR, 2010, NEUROSCIENCE, V167, P414, DOI 10.1016/j.neuroscience.2010.02.028; Chen JR, 2009, NEUROSCIENCE, V161, P1104, DOI 10.1016/j.neuroscience.2009.04.022; Chen JR, 2013, BRAIN STRUCT FUNCT, V218, P1407, DOI 10.1007/s00429-012-0465-7; Chen JR, 2009, CEREB CORTEX, V19, P2719, DOI 10.1093/cercor/bhp048; Chen JR, 2004, J NEUROTRAUM, V21, P1640, DOI 10.1089/0897715042441729; Chen JR, 2003, J NEUROTRAUM, V20, P767, DOI 10.1089/089771503767869999; Choi JM, 2003, ENDOCRINOLOGY, V144, P4734, DOI 10.1210/en.2003-0216; Daniel JM, 2006, ENDOCRINOLOGY, V147, P607, DOI 10.1210/en.2005-0998; del Valle J, 2012, J ALZHEIMERS DIS, V32, P233, DOI 10.3233/JAD-2012-120718; Dickstein DL, 2012, NEUROSCIENCE, DOI [10.1016/j.neuroscience.2012.09.077, DOI 10.1016/J.NEUR0SCI-ENCE.2012.09.077]; Doumouchtsis KK, 2009, ENDOCR RES, V34, P90, DOI 10.1080/07435800903127598; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Foster TC, 2005, FRONT NEUROENDOCRIN, V26, P51, DOI 10.1016/j.yfrne.2005.04.004; Foster TC, 2003, NEUROBIOL AGING, V24, P839, DOI 10.1016/S0197-4580(03)00014-9; Foster TC, 2012, HIPPOCAMPUS, V22, P656, DOI 10.1002/hipo.20935; Fowler CD, 2003, J NEUROBIOL, V57, P257, DOI 10.1002/neu.10273; FRANKFURT M, 1990, NEUROENDOCRINOLOGY, V51, P530, DOI 10.1159/000125387; GARCIASEGURA LM, 1986, BRAIN RES, V366, P131, DOI 10.1016/0006-8993(86)91287-4; Gibbs RB, 2010, ENDOCR REV, V31, P224, DOI 10.1210/er.2009-0036; GOULD E, 1990, J NEUROSCI, V10, P1286; Hao JD, 2006, J NEUROSCI, V26, P2571, DOI 10.1523/JNEUROSCI.3440-05.2006; Hart SA, 2001, J COMP NEUROL, V440, P144, DOI 10.1002/cne.1376; HORNER CH, 1993, PROG NEUROBIOL, V41, P281, DOI 10.1016/0301-0082(93)90002-A; Jelks KB, 2007, J NEUROSCI, V27, P6903, DOI 10.1523/JNEUROSCI.0909-07.2007; Kalita K, 2005, HIPPOCAMPUS, V15, P404, DOI 10.1002/hipo.20066; Knight DC, 1996, OBSTET GYNECOL, V87, P897; Kritzer MF, 2006, CEREB CORTEX, V16, P1181, DOI 10.1093/cercor/bhj059; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lee YB, 2005, J NUTR BIOCHEM, V16, P641, DOI 10.1016/j.jnutbio.2005.06.010; Lephart ED, 2002, NEUROTOXICOL TERATOL, V24, P5, DOI 10.1016/S0892-0362(01)00197-0; Lephart ED, 2005, BRAIN RES BULL, V65, P193, DOI 10.1016/j.brainresbull.2004.11.022; Lethaby A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003122.pub2; Luine V, 2006, BRAIN RES, V1126, P183, DOI 10.1016/j.brainres.2006.07.016; Luine V.N., 2011, CURR GERONTOL GERIAT, V2011, DOI DOI 10.1155/2011/316386; Ma CHE, 2010, CELL TISSUE RES, V339, P297, DOI 10.1007/s00441-009-0897-4; Markham JA, 2002, HORM BEHAV, V42, P284, DOI 10.1006/hbeh.2002.1819; Markowska AL, 2002, J NEUROSCI, V22, P10985; Mehra RD, 2005, BRAIN RES, V1056, P22, DOI 10.1016/j.brainres.2005.06.073; Milner TA, 2005, J COMP NEUROL, V491, P81, DOI 10.1002/cne.20724; Milner TA, 2001, J COMP NEUROL, V429, P355; Miranda P, 1999, J NEUROSCI, V19, P3316; MIYAKAWA M, 1987, BRAIN RES, V436, P184, DOI 10.1016/0006-8993(87)91574-5; Morissette M, 2008, J NEUROENDOCRINOL, V20, P1006, DOI 10.1111/j.1365-2826.2008.01754.x; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; PEGGS JF, 1992, AM FAM PHYSICIAN, V46, P1763; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; Rapp PR, 2003, J NEUROSCI, V23, P5708; Rodgers SP, 2010, ENDOCRINOLOGY, V151, P1194, DOI 10.1210/en.2009-1245; Ryan J, 2008, INT PSYCHOGERIATR, V20, P47, DOI 10.1017/S1041610207006485; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Shughrue PJ, 2000, NEUROSCIENCE, V96, P41, DOI 10.1016/S0306-4522(99)00520-5; Smith Caroline C, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS130, DOI 10.1016/j.psyneuen.2009.06.003; Talboom JS, 2008, NEUROBIOL LEARN MEM, V90, P155, DOI 10.1016/j.nlm.2008.04.002; Towart LA, 2003, J COMP NEUROL, V463, P390, DOI 10.1002/cne.10753; Tseng GF, 1996, J NEUROPHYSIOL, V75, P248, DOI 10.1152/jn.1996.75.1.248; Tseng GF, 1996, ACTA ANAT, V155, P184; Wallace M, 2006, BRAIN RES, V1126, P176, DOI 10.1016/j.brainres.2006.07.064; Wallace M, 2007, ANN NY ACAD SCI, V1097, P54, DOI 10.1196/annals.1379.026; Wang TJ, 2009, NEUROSCIENCE, V158, P776, DOI 10.1016/j.neuroscience.2008.10.025; Wang VC, 2011, NEUROTOXICOL TERATOL, V33, P405, DOI 10.1016/j.ntt.2011.01.003; Waters EM, 2011, BRAIN RES, V1379, P86, DOI 10.1016/j.brainres.2010.09.069; Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665; Witty CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051385; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; Woolley CS, 1998, EPILEPSIA, V39, pS2, DOI 10.1111/j.1528-1157.1998.tb02601.x; Wu WW, 2011, J NEUROSCI, V31, P2638, DOI 10.1523/JNEUROSCI.6081-10.2011; Xu J, 2007, J MOL NEUROSCI, V31, P101, DOI 10.1007/s12031-007-0010-y; Xu XH, 2007, PLANTA MED, V73, P1047, DOI 10.1055/s-2007-981564; Yamaguchi N, 2014, BRAIN RES, V1543, P49, DOI 10.1016/j.brainres.2013.11.010; Yamaguchi-Shima N, 2007, BRAIN RES, V1155, P34, DOI 10.1016/j.brainres.2007.04.016; Yamamoto H, 2007, J STEROID BIOCHEM, V107, P70, DOI 10.1016/j.jsbmb.2007.03.035; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yildirim M, 2008, NEUROSCIENCE, V152, P360, DOI 10.1016/j.neuroscience.2008.01.004; Yuen GS, 2011, BRAIN RES, V1379, P44, DOI 10.1016/j.brainres.2010.07.067	89	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89819	10.1371/journal.pone.0089819	http://dx.doi.org/10.1371/journal.pone.0089819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587060	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900088
J	Ishii, K; Hamamoto, H; Sekimizu, K				Ishii, Kenichi; Hamamoto, Hiroshi; Sekimizu, Kazuhisa			Establishment of a Bacterial Infection Model Using the European Honeybee, Apis mellifera L.	PLOS ONE			English	Article							SILKWORM BOMBYX-MORI; STAPHYLOCOCCUS-AUREUS; INNATE IMMUNITY; PAENIBACILLUS-LARVAE; VIRULENCE GENES; ANIMAL-MODEL; CYTOKINE; IDENTIFICATION; EXPRESSION; SYSTEM	Injection of human pathogenic bacteria (Pseudomonas aeruginosa, Serratia marcescens, Salmonella enterica, Staphylococcus aureus, and Listeria monocytogenes) into the hemocoel of honeybee (Apis mellifera L.) workers kills the infected bees. The bee-killing effects of the pathogens were affected by temperature, and the LD50 values at 37 degrees C were more than 100-fold lower than those at 15 degrees C. Gene-disrupted S. aureus mutants of virulence genes such as agrA, saeS, arlR, srtA, hla, and hlb had attenuated bee-killing ability. Nurse bees were less susceptible than foragers and drones to S. aureus infection. Injection of antibiotics clinically used for humans had therapeutic effects against S. aureus infections of bees, and the ED50 values of these antibiotics were comparable with those determined in mammalian models. Moreover, the effectiveness of orally administered antibiotics was consistent between honeybees and mammals. These findings suggest that the honeybee could be a useful model for assessing the pathogenesis of human-infecting bacteria and the effectiveness of antibiotics.	[Ishii, Kenichi; Hamamoto, Hiroshi; Sekimizu, Kazuhisa] Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Sekimizu, K (corresponding author), Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Hamamoto, Hiroshi/G-6397-2019; Ishii, Kenichi/H-5469-2019	Hamamoto, Hiroshi/0000-0001-9315-7442; 	JSPS KAKENHI [24-11042, 24689008]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant number 24-11042 (Grant-in-Aid for JSPS Fellows to KI) and 24689008 (Grant-in-Aid for Young Scientists (A) to HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2011, INSECT BIOCHEM MOLEC, V41, P968, DOI 10.1016/j.ibmb.2011.09.006; Aliferis KA, 2012, J INSECT PHYSIOL, V58, P1349, DOI 10.1016/j.jinsphys.2012.07.010; Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Baumans V, 2004, GENE THER, V11, pS64, DOI 10.1038/sj.gt.3302371; Behrens D, 2010, ENVIRON MICROBIOL, V12, P2838, DOI 10.1111/j.1462-2920.2010.02257.x; Benton BM, 2004, J BACTERIOL, V186, P8478, DOI 10.1128/JB.186.24.8478-8489.2004; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Dantzer R, 2001, BRAIN BEHAV IMMUN, V15, P7, DOI 10.1006/brbi.2000.0613; Doums C, 2002, ECOL ENTOMOL, V27, P138, DOI 10.1046/j.1365-2311.2002.00388.x; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2005, RES ADV ANTIMICROB A, V5, P1; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Heyer G, 2002, INFECT IMMUN, V70, P127, DOI 10.1128/IAI.70.1.127-133.2002; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Ishii K, 2014, J BIOL CHEM IN PRESS; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Ishii K, 2013, DEV COMP IMMUNOL, V39, P147, DOI 10.1016/j.dci.2012.10.014; Ishii K, 2012, J BIOL CHEM, V287, P36582, DOI 10.1074/jbc.M112.399667; Ishii K, 2010, J BIOL CHEM, V285, P33338, DOI 10.1074/jbc.M110.112987; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; James RR, 2012, J INVERTEBR PATHOL, V109, P175, DOI 10.1016/j.jip.2011.12.005; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2011, DRUG DISCOV THER, V5, P66, DOI 10.5582/ddt.2011.v5.2.66; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Linder JE, 2008, J INSECT PHYSIOL, V54, P297, DOI 10.1016/j.jinsphys.2007.10.001; Master RN, 2013, ANN NY ACAD SCI, V1277, P1, DOI 10.1111/nyas.12022; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; Richard FJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-50; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Uno Y, 2007, FEBS LETT, V581, P97, DOI 10.1016/j.febslet.2006.12.004; Weiss WJ, 2004, J ANTIMICROB CHEMOTH, V53, P480, DOI 10.1093/jac/dkh078; Wilson-Rich N, 2012, J INSECT PHYSIOL, V58, P402, DOI 10.1016/j.jinsphys.2011.12.020; Winston M.L., 1991, BIOL HONEY BEE	42	10	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89917	10.1371/journal.pone.0089917	http://dx.doi.org/10.1371/journal.pone.0089917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587122	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700114
J	Laskowski, M; Greer, AL; Moghadas, SM				Laskowski, Marek; Greer, Amy L.; Moghadas, Seyed M.			Antiviral Strategies for Emerging Influenza Viruses in Remote Communities	PLOS ONE			English	Article							PANDEMIC H1N1 2009; TRANSMISSION	Background: Due to the lack of timely access to resources for critical care, strategic use of antiviral drugs is crucial for mitigating the impact of novel influenza viruses with pandemic potential in remote and isolated communities. We sought to evaluate the effect of antiviral treatment and prophylaxis of close contacts in a Canadian remote northern community. Methods: We used an agent-based, discrete-time simulation model for disease spread in a remote community, which was developed as an in-silico population using population census data. Relative and cumulative age-specific attack rates, and the total number of infections in simulated model scenarios were obtained. Results: We found that early initiation of antiviral treatment is more critical for lowering attack rates in a remote setting with a low population-average age compared to an urban population. Our results show that a significant reduction in the relative, age-specific attack rates due to increasing treatment coverage does not necessarily translate to a significant reduction in the overall arrack rate. When treatment coverage varies from low to moderate, targeted prophylaxis has a very limited impact in reducing attack rates and should be offered at a low level (below 10%) to avoid excessive waste of drugs. Conclusions: In contrast to previous work, for conservative treatment coverages, our results do not provide any convincing evidence for the implementation of targeted prophylaxis. The findings suggest that public health strategies in remote communities should focus on the wider availability (higher coverage) and timely distribution of antiviral drugs for treatment of clinically ill individuals.	[Laskowski, Marek] UCL, Bartlett Sch Grad Studies, London, England; [Greer, Amy L.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada; [Laskowski, Marek; Moghadas, Seyed M.] York Univ, Agent Based Modelling Lab, Toronto, ON M3J 2R7, Canada	University of London; University College London; University of Guelph; York University - Canada	Moghadas, SM (corresponding author), York Univ, Agent Based Modelling Lab, Toronto, ON M3J 2R7, Canada.	moghadas@yorku.ca			Canadian Institutes of Health Research [114932]; National Collaborating Centre for Infectious Diseases; Public Health Agency of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Collaborating Centre for Infectious Diseases; Public Health Agency of Canada	This work was supported by the Canadian Institutes of Health Research (Grant no. 114932), National Collaborating Centre for Infectious Diseases, and Public Health Agency of Canada. The authors would also like to acknowledge the Sharcnet system and Compute Canada for providing computational resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz-Baumgartner E, 2012, EMERG INFECT DIS, V18, P146, DOI 10.3201/eid1801.101996; Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Centers for Disease Control and Prevention, INFL ANT MED SUMM CL; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glezen WP, 2011, LANCET, V377, P698, DOI 10.1016/S0140-6736(11)60174-8; Greer AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067253; Gu Y, 2011, EMERG INFECT DIS, V17, P1737, DOI 10.3201/eid1709.101411; Hahne S, 2009, EUROSURVEILLANCE, V14, P2; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Kondro W, 2009, CAN MED ASSOC J, V181, pE199, DOI 10.1503/cmaj.109-3055; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Laskowski M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00105; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Masecar D., 2009, SUICIDE CLUSTERS DIS; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Moghadas SM, 2011, INFLUENZA OTHER RESP, V5, P83, DOI 10.1111/j.1750-2659.2010.00184.x; Moghadas SM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-73; Mostaco-Guidolin LC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001614; Mostaco-Guidolin Luiz C, 2013, Am J Public Health, V103, pe39, DOI 10.2105/AJPH.2012.300820; Mostaco-Guidolin Luiz C, 2011, BMC Res Notes, V4, P537, DOI 10.1186/1756-0500-4-537; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nishiura H, 2010, MATH BIOSCI ENG, V7, P851, DOI 10.3934/mbe.2010.7.851; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Rodriguez-Noriega E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010658; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Statistics Canada, 2007, MAN CODE4622048 TABL; Tomba GS, 2010, MATH BIOSCI, V223, P24, DOI 10.1016/j.mbs.2009.10.004; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	34	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89651	10.1371/journal.pone.0089651	http://dx.doi.org/10.1371/journal.pone.0089651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586937	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900137
J	Buchhaupt, M; Sharma, S; Kellner, S; Oswald, S; Paetzold, M; Peifer, C; Watzinger, P; Schrader, J; Helm, M; Entian, KD				Buchhaupt, Markus; Sharma, Sunny; Kellner, Stefanie; Oswald, Stefanie; Paetzold, Melanie; Peifer, Christian; Watzinger, Peter; Schrader, Jens; Helm, Mark; Entian, Karl-Dieter			Partial Methylation at Am100 in 18S rRNA of Baker's Yeast Reveals Ribosome Heterogeneity on the Level of Eukaryotic rRNA Modification	PLOS ONE			English	Article							LINKED DYSKERATOSIS-CONGENITA; HUMAN BREAST-CANCER; SACCHAROMYCES-CEREVISIAE; GEL-ELECTROPHORESIS; SNORNA U50; GENE; CELLS; EFFICIENCY; MUTATIONS; PROTEINS	Ribosome heterogeneity is of increasing biological significance and several examples have been described for multicellular and single cells organisms. In here we show for the first time a variation in ribose methylation within the 18S rRNA of Saccharomyces cerevisiae. Using RNA-cleaving DNAzymes, we could specifically demonstrate that a significant amount of S. cerevisiae ribosomes are not methylated at 2'-O-ribose of A100 residue in the 18S rRNA. Furthermore, using LC-UV-MS/ MS of a respective 18S rRNA fragment, we could not only corroborate the partial methylation at A100, but could also quantify the methylated versus non-methylated A100 residue. Here, we exhibit that only 68% of A100 in the 18S rRNA of S. cerevisiae are methylated at 2'-O ribose sugar. Polysomes also contain a similar heterogeneity for methylated Am100, which shows that 40S ribosome subunits with and without Am100 participate in translation. Introduction of a multicopy plasmid containing the corresponding methylation guide snoRNA gene SNR51 led to an increased A100 methylation, suggesting the cellular snR51 level to limit the extent of this modification. Partial rRNA modification demonstrates a new level of ribosome heterogeneity in eukaryotic cells that might have substantial impact on regulation and fine-tuning of the translation process.	[Buchhaupt, Markus; Paetzold, Melanie; Schrader, Jens] DECHEMA Res Inst, Frankfurt, Germany; [Sharma, Sunny; Oswald, Stefanie; Peifer, Christian; Watzinger, Peter; Entian, Karl-Dieter] Goethe Univ Frankfurt, Inst Mol Biosci, D-60054 Frankfurt, Germany; [Kellner, Stefanie; Helm, Mark] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany	Goethe University Frankfurt; Johannes Gutenberg University of Mainz	Buchhaupt, M (corresponding author), DECHEMA Res Inst, Frankfurt, Germany.	buchhaupt@dechema.de; entian@bio.uni-frankfurt.de	Helm, Mark/AAD-5433-2022; Sharma, Sunny/N-2341-2019	Sharma, Sunny/0000-0001-8896-9016; /0000-0003-3224-7502; Buchhaupt, Markus/0000-0003-2720-5973; Helm, Mark/0000-0002-0154-0928				Andersen TE, 2004, RNA, V10, P907, DOI 10.1261/rna.5259404; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; Buchhaupt M, 2007, ANAL BIOCHEM, V361, P102, DOI 10.1016/j.ab.2006.11.001; Castle JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011779; DELAUNAY J, 1972, EUR J BIOCHEM, V31, P561, DOI 10.1111/j.1432-1033.1972.tb02565.x; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Esguerra J, 2008, THESIS U GOTHENBURG; Esguerra J, 2008, RNA, V14, P649, DOI 10.1261/rna.845808; Gilbert WV, 2011, TRENDS BIOCHEM SCI, V36, P127, DOI 10.1016/j.tibs.2010.12.002; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; Hansen MA, 2002, RNA, V8, P202, DOI 10.1017/S1355838202013365; Hatin I, 2007, GENETICS, V177, P1527, DOI 10.1534/genetics.107.070771; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Higa-Nakamine S, 2012, NUCLEIC ACIDS RES, V40, P391, DOI 10.1093/nar/gkr700; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; Kellner S, 2011, NUCLEIC ACIDS RES, V39, P7348, DOI 10.1093/nar/gkr449; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; LAMBERTSSON AG, 1975, MOL GEN GENET, V139, P133; Liao JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-198; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4; MCENTEE CM, 1989, ANAL BIOCHEM, V176, P303, DOI 10.1016/0003-2697(89)90313-8; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; RAMAGOPAL S, 1992, BIOCHEM CELL BIOL, V70, P269, DOI 10.1139/o92-042; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schoemaker RJW, 2006, NUCLEIC ACIDS RES, V34, P2015, DOI 10.1093/nar/gkl154; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P5428, DOI 10.1093/nar/gkt195; SIKORSKI RS, 1989, GENETICS, V122, P19; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yu YT, 1997, RNA, V3, P324	38	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89640	10.1371/journal.pone.0089640	http://dx.doi.org/10.1371/journal.pone.0089640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586927	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200066
J	Cong, L; Zhan, JQ; Yang, L; Zhang, W; Li, SG; Chen, C; Zhang, HY; Ma, ZP; Hao, XL; Simayi, D; Tao, L; Zhao, J; Amanguli, A; Mohemaiti, M; Jing, MX; Wang, W; Saimaiti, A; Zou, XG; Gu, Y; Li, L; Wang, YH; Li, F; Zhang, WJ				Cong, Li; Zhan, Jin Qiong; Yang, Lan; Zhang, Wei; Li, Shu Gang; Chen, Cheng; Zhang, Hong Yan; Ma, Zhi Ping; Hao, Xiao Ling; Simayi, Dilixia; Tao, Lin; Zhao, Jin; Amanguli, A.; Mohemaiti, Meiliguli; Jing, Ming Xia; Wang, Wei; Saimaiti, Abudukeyoumu; Zou, Xiao Guang; Gu, Yan; Li, Li; Wang, Ying Hong; Li, Feng; Zhang, Wen Jie			Overweight and Obesity among Low-Income Muslim Uyghur Women in Far Western China: Correlations of Body Mass Index with Blood Lipids and Implications in Preventive Public Health	PLOS ONE			English	Article							OPTIMAL CUTOFF POINTS; RISK-FACTORS; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; PREDICTIVE VALUES; ADULTS; DISEASE; MORTALITY; JAPAN; BMI	Background: The pandemic of obesity is a global public health concern. Most studies on obesity are skewed toward high-income and urban settings and few covers low-income populations. This study focused on the prevalence of overweight and obesity and their correlations with blood lipids/metabolites/enzymes (bio-indicators) in a rural community typical of low-income in remote western China. Methods: This study was performed in a Muslim ethnic Uyghur rural community in Kashi Prefecture of Xinjiang, about 4,407 km (2,739 miles) away from Beijing. Body mass index (BMI) and major blood bio-indicators (25 total items) were measured and demographic information was collected from 1,733 eligible healthy women aged 21 to 71 yrs, of whom 1,452 had complete data for analysis. More than 92% of the women lived on US$1.00/day or less. According to the Chinese criteria, overweight and obesity were defined as BMI at 24 to <28 kg/m(2) and at >= 28 kg/m(2), respectively. Results: The average BMI among these low-income women was 24.0 +/- 4.0 (95% CI, 17.5-33.7) kg/m(2). The prevalence of obesity and overweight was high at 15.1% and 28.9%, respectively. Among 25 bio-indicators, BMI correlated positively with the levels of 11 bio-indicators including triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TCHOL), glucose (GLU), and uric acid (UA); but negatively with the levels of 5 bio-indicators including high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A/B (APO A/B). Conclusions: This is the first investigation reporting overweight and obesity being common in low-income Muslim Uyghur women, whose BMI correlates with several important blood bio-indicators which are risk factors for diabetes and cardiovascular diseases. These findings may help make preventive public health policies in Uyghur communities. To prevent diabetes and cardiovascular diseases in low-income settings, we therefore propose a cost-effective, two-step strategy first to screen for obesity and then to screen persons with obesity for diabetes and cardiovascular diseases.	[Cong, Li; Yang, Lan; Zhang, Wei; Chen, Cheng; Ma, Zhi Ping; Hao, Xiao Ling; Simayi, Dilixia; Tao, Lin; Zhao, Jin; Li, Feng; Zhang, Wen Jie] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Cong, Li; Yang, Lan; Zhang, Wei; Chen, Cheng; Wang, Ying Hong; Li, Feng; Zhang, Wen Jie] Shihezi Univ, Key Labs Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Amanguli, A.; Mohemaiti, Meiliguli; Wang, Ying Hong] Shihezi Univ, Sch Med, Affiliated Univ Hosp 1, Dept Obstet & Gynecol, Shihezi, Xinjiang, Peoples R China; [Li, Shu Gang; Jing, Ming Xia] Shihezi Univ, Sch Med, Fac Prevent Med, Shihezi, Xinjiang, Peoples R China; [Wang, Wei] Shihezi Univ, Sch Med, Inst Humanities, Shihezi, Xinjiang, Peoples R China; [Cong, Li] First Peoples Hosp Suqian, Dept Oncol, Suqian, Jiangsu, Peoples R China; [Zhan, Jin Qiong] JiangXi Mental Hlth Ctr, Dept Lab Med, Nanchang, Jiangxi, Peoples R China; [Zhang, Hong Yan] Xian Ctr Dis Control & Prevent, Dept Immunizat, Xian, Shanxi, Peoples R China; [Saimaiti, Abudukeyoumu; Zou, Xiao Guang] Kashi Prefecture Hlth Bur, Kashi Prefecture Peoples Hosp 1, Kashi, Xinjiang, Peoples R China; [Gu, Yan; Li, Li] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Obstet & Gynecol, Chongqing, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Shihezi University; Shihezi University; Army Medical University	Zhang, WJ (corresponding author), Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China.	zhangwj82@yahoo.com			Chinese Ministry of Science and Technology [2010DFB34100, 2009BAI82B02]; Oasis Scholar Fund from Shihezi University [LZXZ201023]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Oasis Scholar Fund from Shihezi University	This work was supported by grants from the Chinese Ministry of Science and Technology (Nos. 2010DFB34100, 2009BAI82B02) and the Oasis Scholar Fund from Shihezi University (No. LZXZ201023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Zinah Abd Ulelah Abd, 2011, Oman Med J, V26, P263, DOI 10.5001/omj.2011.63; Allison DB, 2008, OBESITY, V16, P1161, DOI 10.1038/oby.2008.231; [Anonymous], 2013, OB OV; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bell AC, 2002, OBES RES, V10, P277, DOI 10.1038/oby.2002.38; Calcaterra V, 2008, CLIN ENDOCRINOL, V68, P868, DOI 10.1111/j.1365-2265.2007.03115.x; CHEN JF, 2011, J 3 MIL MED U, V33, P1262; Chen XX, 2009, J XINJIANG MED U, V32, P15; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Field AE, 2013, JAMA-J AM MED ASSOC, V310, P2147, DOI 10.1001/jama.2013.281501; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gele Abdi A, 2013, BMC Res Notes, V6, P119, DOI 10.1186/1756-0500-6-119; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Gu W., 2012, FRONTIERS BIOSCIENCE, V5, P109; Iseri A, 2009, EUR J PUBLIC HEALTH, V19, P91, DOI 10.1093/eurpub/ckn107; Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Katzmarzyk PT, 2005, DIABETES CARE, V28, P391, DOI 10.2337/diacare.28.2.391; Kuriyama S, 2004, J EPIDEMIOL, V14, pS33, DOI 10.2188/jea.14.S33; Levine JA, 2008, CHINESE MED J-PEKING, V121, P1043, DOI 10.1097/00029330-200806010-00015; [罗仁 LUO Ren], 2010, [中国糖尿病杂志, Chinese Journal of Diabetes], V18, P270; *NAT BUR STAT CHIN, 2010, 6 NAT BUR STAT CHIN; Ogden CL, 2010, PREVALENCE OVERWEIGH; *PEOPL REP CHIN NA, 2004, CHIN J CARDIOVASC RE, V12, P919; Pihl E, 2001, INT J OBESITY, V25, P1057, DOI 10.1038/sj.ijo.0801642; Pollack A., 2013, NY TIMES; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; POPKIN BM, 1995, OBES RES, V3, pS135, DOI 10.1002/j.1550-8528.1995.tb00456.x; Sandhu Hardev Singh, 2008, Journal of Human Ecology, V24, P227; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Taylor JY, 2013, BIOL RES NURS, V15, P105, DOI 10.1177/1099800411419026; TONG J, 2013, SOC PSYCHIAT PSYCHIA; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; Wang Zhihong, 2008, Wei Sheng Yan Jiu, V37, P62; World Health Organization, 2012, GLOB HLTH OBS DAT RE; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Zhang WJ, 2013, NAT BIOTECHNOL, V31, P590, DOI 10.1038/nbt.2631; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	40	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90262	10.1371/journal.pone.0090262	http://dx.doi.org/10.1371/journal.pone.0090262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587304	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200156
J	Spans, L; Helsen, C; Clinckemalie, L; Van den Broeck, T; Prekovic, S; Joniau, S; Lerut, E; Claessens, F				Spans, Lien; Helsen, Christine; Clinckemalie, Liesbeth; Van den Broeck, Thomas; Prekovic, Stefan; Joniau, Steven; Lerut, Evelyne; Claessens, Frank			Comparative Genomic and Transcriptomic Analyses of LNCaP and C4-2B Prostate Cancer Cell Lines	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; GENE-EXPRESSION; MISMATCH REPAIR; MUTATION-RATES; IN-VITRO; PROGRESSION; METASTASIS; LANDSCAPE; RNA; IDENTIFICATION	The LNCaP and C4-2B cell lines form an excellent preclinical model to study the development of metastatic castration-resistant prostate cancer, since C4-2B cells were derived from a bone metastasis that grew in nude mice after inoculation with the LNCaP-derived, castration-resistant C4-2 cells. Exome sequencing detected 2188 and 3840 mutations in LNCaP and C4-2B cells, respectively, of which 1784 were found in both cell lines. Surprisingly, the parental LNCaP cells have over 400 mutations that were not found in the C4-2B genome. More than half of the mutations found in the exomes were confirmed by analyzing the RNA-seq data, and we observed that the expressed genes are more prone to mutations than non-expressed genes. The transcriptomes also revealed that 457 genes show increased expression and 246 genes show decreased expression in C4-2B compared to LNCaP cells. By combining the list of C4-2B-specific mutations with the list of differentially expressed genes, we detected important changes in the focal adhesion and ECM-receptor interaction pathways. Integration of these pathways converges on the myosin light chain kinase gene (MLCK) which might contribute to the metastatic potential of C4-2B cells. In conclusion, we provide extensive databases for mutated genes and differentially expressed genes in the LNCaP and C4-2B prostate cancer cell lines. These can be useful for other researchers using these cell models.	[Spans, Lien; Helsen, Christine; Clinckemalie, Liesbeth; Van den Broeck, Thomas; Prekovic, Stefan; Claessens, Frank] Katholieke Univ Leuven, Dept Cellular & Mol Med, Mol Endocrinol Lab, Louvain, Belgium; [Joniau, Steven] Katholieke Univ Leuven Hosp, Dept Dev & Regenerat, Louvain, Belgium; [Lerut, Evelyne] Katholieke Univ Leuven Hosp, Dept Imaging & Pathol, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Claessens, F (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Mol Endocrinol Lab, Campus Gasthuisberg, Louvain, Belgium.	frank.claessens@med.kuleuven.be	Joniau, Steven/K-7655-2013; Claessens, Frank/M-8565-2016; Prekovic, Stefan/AAE-6247-2021	Joniau, Steven/0000-0003-3195-9890; Claessens, Frank/0000-0002-8676-7709; Prekovic, Stefan/0000-0002-7051-9321; Van den Broeck, Thomas/0000-0002-7237-7160; Helsen, Christine/0000-0003-1048-2798	FWO-Vlaanderen [G.0684.12N]; Belgian federal government [KPC_29_023]; KU Leuven [OT/11/081]	FWO-Vlaanderen(FWO); Belgian federal government; KU Leuven(KU Leuven)	This work was possible thanks to research grants from the FWO-Vlaanderen (G.0684.12N), from the Belgian federal government (National Cancer Plan KPC_29_023) and from the KU Leuven (OT/11/081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bisoffi M, 2004, J UROLOGY, V172, P1145, DOI 10.1097/01.ju.0000135117.40086.fa; Chen Y, 2001, CANCER RES, V61, P4112; Cui WJ, 2010, ACTA PHARMACOL SIN, V31, P725, DOI 10.1038/aps.2010.56; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fu Z, 2002, PROSTATE, V51, P10, DOI 10.1002/pros.10056; Fujita A, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-106; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Haffner MC, 2013, J CLIN INVEST, V123, P4918, DOI 10.1172/JCI70354; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Ianculescu I, 2012, J BIOL CHEM, V287, P4000, DOI 10.1074/jbc.M111.300194; Kaneko K, 2002, PANCREAS, V24, P34, DOI 10.1097/00006676-200201000-00005; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lang GI, 2013, G3-GENES GENOM GENET, V3, P1453, DOI 10.1534/g3.113.006429; Leach FS, 2000, J UROLOGY, V164, P1830, DOI 10.1016/S0022-5347(05)67115-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Liu AY, 2004, PROSTATE, V60, P98, DOI 10.1002/pros.20031; Liu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075619; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; Niggli V, 2006, BIOCHEM BIOPH RES CO, V343, P602, DOI 10.1016/j.bbrc.2006.03.022; Oudes AJ, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-86; Pan Y, 1999, CYTOGENET CELL GENET, V87, P225, DOI 10.1159/000015432; Rider JR, 2013, EUR UROL, V63, P88, DOI 10.1016/j.eururo.2012.08.001; Sampson N, 2013, ENDOCR-RELAT CANCER, V20, pR49, DOI 10.1530/ERC-12-0401; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spans L, 2013, INT J MOL SCI, V14, P10822, DOI 10.3390/ijms140610822; Spans L, 2012, PROSTATE, V72, P1317, DOI 10.1002/pros.22480; THALMANN GN, 1994, CANCER RES, V54, P2577; Tohtong R, 2003, PROSTATE CANCER P D, V6, P212, DOI 10.1038/sj.pcan.4500663; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trojan L, 2005, ANTICANCER RES, V25, P183; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Xie BX, 2011, J ANDROL, V32, P170, DOI 10.2164/jandrol.109.008748	43	26	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90002	10.1371/journal.pone.0090002	http://dx.doi.org/10.1371/journal.pone.0090002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587179	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200108
J	Yin, J; Zhang, YA; Liu, TT; Zhu, JM; Shen, XZ				Yin, Jie; Zhang, Yi-An; Liu, Tao-Tao; Zhu, Ji-Min; Shen, Xi-Zhong			DNA Damage Induces Down-Regulation of Prp19 via Impairing Prp19 Stability in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HUMAN PSO4; LIFE-SPAN; APOPTOSIS; PROTEIN; ASSOCIATION; INTERACTS; REPAIR	Pre-mRNA processing factor 19 (Prp19) activates pre-mRNA spliceosome and also mediates DNA damage response. Prp19 overexpression in cells with functional p53 leads to decreased apoptosis and increases cell survival after DNA damage. Here we showed that in hepatocellular carcinoma (HCC) cells with inactive p53 or functional p53, Prp19 was down-regulated due to the impaired stability under chemotherapeutic drug treatment. Silencing Prp19 expression enhanced apoptosis of HCC cells with or without chemotherapeutic drug treatment. Furthermore high level of Prp19 may inhibit chemotherapeutic drugs induced apoptosis in hepatocellular carcinoma cells through modulating myeloid leukemia cell differentiation 1 expression. These results indicated that targeting Prp19 may potentiate pro-apoptotic effect of chemotherapeutic agents on HCC.	[Yin, Jie; Zhang, Yi-An; Liu, Tao-Tao; Zhu, Ji-Min; Shen, Xi-Zhong] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China	Fudan University	Zhu, JM (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	jiminzhu@gmail.com; shen.xizhong@zs-hospital.sh.cn	liu, taotao/GSI-7460-2022; zhu, jimin/HDN-1451-2022	Zhu, Ji-Min/0000-0002-2150-473X	Independent Study of Fudan University [20520133387]; Shanghai Science and Technology Commission [10410709400, 10411950100]; China Postdoctoral Science Foundation; National Nature Science Foundation of China [81000968, 81101540, 81101637, 81172273]; National Clinical Key Special Subject of China	Independent Study of Fudan University; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Clinical Key Special Subject of China	This study was partially supported by grants from Independent Study of Fudan University (NO. 20520133387, web: http://www.fudan.edu.cn/), Shanghai Science and Technology Commission (No. 10410709400 and 10411950100, web: http://www.stcsm.gov.cn/), China Postdoctoral Science Foundation (web: http://res.chinapostdoctor.org.cn/Program/Main.html) and National Nature Science Foundation of China (No. 81000968, No. 81101540, No. 81101637, and No. 81172273, web: http://www.nsfc.gov.cn/nsfc/cen/00/download.html), National Clinical Key Special Subject of China (web: http://www.moh.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; Dellago H, 2012, AGING-US, V4, P290, DOI 10.18632/aging.100452; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gish RG, 2007, J CLIN ONCOL, V25, P3069, DOI 10.1200/JCO.2006.08.4046; Kuo PC, 2009, CANCER RES, V69, P8877, DOI 10.1158/0008-5472.CAN-09-2023; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Oliveri RS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004787.pub2; Sato M, 2010, EXP CELL RES, V316, P2871, DOI 10.1016/j.yexcr.2010.06.018; Sorrells S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002922; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Sun L, 2008, J INT MED RES, V36, P1015, DOI 10.1177/147323000803600519; van den Bergh RCN, 2009, CANCER-AM CANCER SOC, V115, P3868, DOI 10.1002/cncr.24446; Voglauer R, 2006, EXP CELL RES, V312, P746, DOI 10.1016/j.yexcr.2005.11.025; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yin J, 2012, BIOL CELL, V104, P695, DOI 10.1111/boc.201200011; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200	23	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89976	10.1371/journal.pone.0089976	http://dx.doi.org/10.1371/journal.pone.0089976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587161	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200101
J	Carlucci, MTO; Braz, JRC; do Nascimento, P; de Carvalho, LR; Castiglia, YMM; Braz, LG				Carlucci, Marcelo T. O.; Braz, Jose R. C.; do Nascimento, Paulo, Jr.; de Carvalho, Lidia R.; Castiglia, Yara M. M.; Braz, Leandro G.			Intraoperative Cardiac Arrest and Mortality in Trauma Patients. A 14-Yr Survey from a Brazilian Tertiary Teaching Hospital	PLOS ONE			English	Article							RESUSCITATION; ANESTHETICS; INJURIES	Background: Little information on the factors influencing intraoperative cardiac arrest and its outcomes in trauma patients is available. This survey evaluated the associated factors and outcomes of intraoperative cardiac arrest in trauma patients in a Brazilian teaching hospital between 1996 and 2009. Methods: Cardiac arrest during anesthesia in trauma patients was identified from an anesthesia database. The data collected included patient demographics, ASA physical status classification, anesthesia provider information, type of surgery, surgical areas and outcome. All intraoperative cardiac arrests and deaths in trauma patients were reviewed and grouped by associated factors and also analyzed as totally anesthesia-related, partially anesthesia-related, totally surgery-related or totally trauma patient condition-related. Findings: Fifty-one cardiac arrests and 42 deaths occurred during anesthesia in trauma patients. They were associated with male patients (P<0.001) and young adults (18-35 years) (P = 0.04) with ASA physical status IV or V (P<0.001) undergoing gastroenterological or multiclinical surgeries (P<0.001). Motor vehicle crashes and violence were the main causes of trauma (P<0.001). Uncontrolled hemorrhage or head injury were the most significant associated factors of intraoperative cardiac arrest and mortality (P<0.001). All cardiac arrests and deaths reported were totally related to trauma patient condition. Conclusions: Intraoperative cardiac arrest and mortality incidence was highest in male trauma patients at a younger age with poor clinical condition, mainly related to uncontrolled hemorrhage and head injury, resulted from motor vehicle accidents and violence.	[Carlucci, Marcelo T. O.; Braz, Jose R. C.; do Nascimento, Paulo, Jr.; Castiglia, Yara M. M.; Braz, Leandro G.] UNESP Univ Estadual Paulista, Botucatu Med Sch, Dept Anesthesiol, Botucatu, SP, Brazil; [de Carvalho, Lidia R.] UNESP Univ Estadual Paulista, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Braz, LG (corresponding author), UNESP Univ Estadual Paulista, Botucatu Med Sch, Dept Anesthesiol, Botucatu, SP, Brazil.	lbraz@fmb.unesp.br	Carvalho, L.R./C-2973-2013; Braz, Leandro Gobbo/W-4445-2019; Braz, Leandro/AAK-8378-2021; Junior, Paulo do Nascimento/C-6966-2010	Carvalho, L.R./0000-0003-0575-2263; Braz, Leandro Gobbo/0000-0002-1927-8729; Junior, Paulo do Nascimento/0000-0002-2323-9159				An JX, 2011, CHINESE MED J-PEKING, V124, P227, DOI 10.3760/cma.j.issn.0366-6999.2011.02.014; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Braz LG, 2009, CLINICS, V64, P999, DOI 10.1590/S1807-59322009001000011; Braz LG, 2006, BRIT J ANAESTH, V96, P569, DOI 10.1093/bja/ael065; Cothren CC, 2007, WORLD J SURG, V31, P1507, DOI 10.1007/s00268-007-9087-2; Davis PJ, 2007, ANESTH ANALG, V105, P301, DOI 10.1213/01.ane.0000268711.86620.76; Holcomb JB, 2004, CRIT CARE, V8, pS57, DOI 10.1186/cc2407; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; IBGE Instituto Brasileiro de Geografia e Estatistica, 2009, QUAL REC INF MORT BR; IBGE Instituto Brasileiro de Geografia e Estatistica, 2010, LIF EXP; Lockey D, 2006, ANN EMERG MED, V48, P240, DOI 10.1016/j.annemergmed.2006.03.015; Luciano BA, 2010, WORLD J EMERG SURG, V5, DOI 10.1186/1749-7922-5-25; Lundy DJ, 2011, J TRAUMA, V71, pE12, DOI 10.1097/TA.0b013e3181fc5c70; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Morray JP, 2011, PEDIATR ANESTH, V21, P722, DOI 10.1111/j.1460-9592.2010.03440.x; Newland MC, 2002, ANESTHESIOLOGY, V97, P108, DOI 10.1097/00000542-200207000-00016; Osinowo A, 2011, EXTERNAL CAUSES DEAT; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Peden M, 2002, INJURY CHART BOOK GR; Pickens JJ, 2005, J TRAUMA, V58, P951, DOI 10.1097/01.TA.0000162174.06448.5A; Rebholz CM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-56; Sleet DA, 2010, ANNU REV PUBL HEALTH, V31, P195, DOI 10.1146/annurev.publhealth.012809.103616; Tobin JM, 2012, ANESTH ANALG, V115, P1326, DOI 10.1213/ANE.0b013e3182639f20; Toledo FO, 2013, RESUSCITATION, V84, P635, DOI 10.1016/j.resuscitation.2012.09.019; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Waiselfizs JJ, 2011, MAP VIOLENCE 2011 YO; Zar JH, 1999, BIOSTATISTICAL ANAL	27	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90125	10.1371/journal.pone.0090125	http://dx.doi.org/10.1371/journal.pone.0090125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587237	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800080
J	Endo, F; Nishizuka, SS; Kume, K; Ishida, K; Katagiri, H; Ishida, K; Sato, K; Iwaya, T; Koeda, K; Wakabayashi, G				Endo, Fumitaka; Nishizuka, Satoshi S.; Kume, Kohei; Ishida, Kazushige; Katagiri, Hirokatsu; Ishida, Kaoru; Sato, Kei; Iwaya, Takeshi; Koeda, Keisuke; Wakabayashi, Go			A Compensatory Role of NF-kappa B to p53 in Response to 5-FU-Based Chemotherapy for Gastric Cancer Cell Lines	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; CODON-72 POLYMORPHISM; TP53; GENE; 5-FLUOROURACIL; EXPRESSION; ACTIVATION; APOPTOSIS; IDENTIFICATION; INFLAMMATION	Despite of remarkable improvement of postoperative 5-FU-based adjuvant chemotherapy, the relapse rate of gastric cancer patients who undergo curative resection followed by the adjuvant chemotherapy remains substantial. Therefore, it is important to identify prediction markers for the chemotherapeutic efficacy of 5-FU. We recently identified NF-kappa B as a candidate relapse prediction biomarker in gastric cancer. To evaluate the biological significance of NF-kappa B in the context of 5-FU-based chemotherapy, we analyzed the NF-kappa B-dependent biological response upon 5-FU treatment in gastric cancer cell lines. Seven genes induced by 5-FU treatment in an NF-kappa B-dependent manner were identified, five of which are known p53 targets. Knockdown of RELA, which encodes the p65 subunit of NF-kappa B, decreased both p53 and p53 target protein levels. In contrast, NF-kappa B was not affected by TP53 knockdown. We also demonstrated that cell lines bearing Pro/Pro homozygosity in codon72 of p53 exon4, which is important for NF-kappa B binding to p53, are more resistant to 5-FU than those with Arg/Arg homozygosity. We conclude that NF-kappa B plays an important role in the response to 5-FU treatment in gastric cancer cell lines, with a possible compensatory function of p53. These results suggest that NF-kappa B is a potential 5-FU-chemosensitivity prediction marker that may reflect 5-FU-induced stress-response pathways, including p53.	[Endo, Fumitaka; Nishizuka, Satoshi S.; Kume, Kohei; Ishida, Kazushige; Katagiri, Hirokatsu; Ishida, Kaoru; Sato, Kei; Iwaya, Takeshi] Iwate Med Univ, Sch Med, Mol Therapeut Lab, Morioka, Iwate 020, Japan; [Endo, Fumitaka; Nishizuka, Satoshi S.; Kume, Kohei; Ishida, Kazushige; Katagiri, Hirokatsu; Ishida, Kaoru; Sato, Kei; Iwaya, Takeshi; Koeda, Keisuke; Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan; [Nishizuka, Satoshi S.; Kume, Kohei] Iwate Med Univ, MIAST Med Innovat Adv Sci & Technol Project, Morioka, Iwate 020, Japan; [Nishizuka, Satoshi S.; Kume, Kohei] Iwate Med Univ, Inst Biomed Sci, Yahaba, Iwate, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University	Nishizuka, SS (corresponding author), Iwate Med Univ, Sch Med, Mol Therapeut Lab, Morioka, Iwate 020, Japan.	snishizu@iwate-med.ac.jp			Ministry of Education, Culture, Science and Technology of Japan;  [11863286];  [12877914]	Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	This work was supported by MIAST (Medical Innovation by Advanced Science and Technology) project of Grant-in-Aid for Strategic Medical Science Research Center from the Ministry of Education, Culture, Science and Technology of Japan, 2010-2014 (S.S.N., K.Ku., G. W.); and Grant-in-Aid for Scientific Research (C) (11863286) (S.S.N.), and (12877914) (K.Ko.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Barre B, 2010, MOL CELL, V38, P524, DOI 10.1016/j.molcel.2010.03.018; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Cattelani S, 2012, NEOPLASIA, V14, P634, DOI 10.1593/neo.12594; Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fenoglio-Preiser CM, 2003, HUM MUTAT, V21, P258, DOI 10.1002/humu.10180; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Francisco G, 2011, INT J CANCER, V129, P920, DOI 10.1002/ijc.25710; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Godai T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-420; Goetz CA, 2008, IMMUNOL RES, V41, P233, DOI 10.1007/s12026-008-8033-1; Huang ZH, 2008, J CANCER RES CLIN, V134, P1129, DOI 10.1007/s00432-008-0380-8; Ishida K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043236; Ju J, 2007, CLIN CANCER RES, V13, P4245, DOI 10.1158/1078-0432.CCR-06-2890; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kimura Y, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013268; Kuroda Y, 2007, ORAL ONCOL, V43, P1043, DOI 10.1016/j.oraloncology.2006.12.001; Kusser W C, 1993, PCR Methods Appl, V2, P250; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Matsuo T, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-11; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Nishizuka S, 2003, CANCER RES, V63, P5243; Nishizuka S, 2001, CANCER LETT, V165, P201, DOI 10.1016/S0304-3835(01)00437-2; Nishizuka S, 2008, J PROTEOME RES, V7, P803, DOI 10.1021/pr0702971; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Proestling K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047325; Rouault JP, 1998, J BIOL CHEM, V273, P22563, DOI 10.1074/jbc.273.35.22563; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Santos AM, 2006, BIOCHEM BIOPH RES CO, V340, P256, DOI 10.1016/j.bbrc.2005.11.176; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schneider G, 2011, BBA-REV CANCER, V1815, P90, DOI 10.1016/j.bbcan.2010.10.003; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Uetsuka H, 2003, EXP CELL RES, V289, P27, DOI 10.1016/S0014-4827(03)00223-4; Vilgelm AE, 2010, MOL CANCER THER, V9, P693, DOI 10.1158/1535-7163.MCT-09-0912; Wang WG, 2004, CANCER RES, V64, P8167, DOI 10.1158/0008-5472.CAN-04-0970; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; WU HY, 1994, J BIOL CHEM, V269, P20067; Xu Y, 2005, CLIN CANCER RES, V11, P7328, DOI 10.1158/1078-0432.CCR-05-0507; YAMADA Y, 1991, CANCER RES, V51, P5800; Zhang YH, 2009, CANCER RES, V69, P6049, DOI 10.1158/0008-5472.CAN-09-0621; Zhou Y, 2007, INT J CANCER, V121, P1481, DOI 10.1002/ijc.22833	56	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90155	10.1371/journal.pone.0090155	http://dx.doi.org/10.1371/journal.pone.0090155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587255	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800083
J	Li, W; Tang, XQ; Xing, J; Sheng, XZ; Zhan, WB				Li, Wei; Tang, Xiaoqian; Xing, Jing; Sheng, Xiuzhen; Zhan, Wenbin			Proteomic Analysis of Differentially Expressed Proteins in Fenneropenaeus chinensis Hemocytes upon White Spot Syndrome Virus Infection	PLOS ONE			English	Article							SHRIMP LITOPENAEUS-VANNAMEI; PENAEUS-MONODON; CHINESE SHRIMP; IDENTIFICATION; BINDING; WSSV; REPLICATION; ASSOCIATION; HEMOLYMPH; MEMBRANE	To elucidate molecular responses of shrimp hemocytes to white spot syndrome virus (WSSV) infection, two-dimensional gel electrophoresis was applied to investigate differentially expressed proteins in hemocytes of Chinese shrimp (Fenneropenaeus chinensis) at 24 h post infection (hpi). Approximately 580 protein spots were detected in hemocytes of healthy and WSSV-infected shrimps. Quantitative intensity analysis revealed 26 protein spots were significantly up-regulated, and 19 spots were significantly down-regulated. By mass spectrometry, small ubiquitin-like modifier (SUMO) 1, cytosolic MnSOD, triosephosphate isomerase, tubulin alpha-1 chain, microtubule-actin cross-linking factor 1, nuclear receptor E75 protein, vacuolar ATP synthase subunit B L form, inositol 1,4,5-trisphosphate receptor, arginine kinase, etc., amounting to 33 differentially modulated proteins were identified successfully. According to Gene Ontology annotation, the identified proteins were classified into nine categories, consisting of immune related proteins, stimulus response proteins, proteins involved in glucose metabolic process, cytoskeleton proteins, DNA or protein binding proteins, proteins involved in steroid hormone mediated signal pathway, ATP synthases, proteins involved in transmembrane transport and ungrouped proteins. Meanwhile, the expression profiles of three up-regulated proteins (SUMO, heat shock protein 70, and arginine kinase) and one down-regulated protein (prophenoloxidase) were further analyzed by real-time RT-PCR at the transcription level after WSSV infection. The results showed that SUMO and heat shock protein 70 were significantly up-regulated at each sampling time point, while arginine kinase was significantly up-regulated at 12 and 24 hpi. In contrast, prophenoloxidase was significantly down-regulated at each sampling time point. The results of this work provided preliminary data on proteins in shrimp hemocytes involved in WSSV infection.	[Li, Wei; Tang, Xiaoqian; Xing, Jing; Sheng, Xiuzhen; Zhan, Wenbin] Ocean Univ China, Lab Pathol & Immunol Aquat Anim, Qingdao, Shandong, Peoples R China	Ocean University of China	Zhan, WB (corresponding author), Ocean Univ China, Lab Pathol & Immunol Aquat Anim, Qingdao, Shandong, Peoples R China.	wbzhan@ouc.edu.cn			NBRPC [2012CB114405]; Key Technology R&D Program of China [2012BAD17B01]; Special Fund for Agro-scientific Research in the Public Interest [201103034]	NBRPC(National Basic Research Program of China); Key Technology R&D Program of China(National Key Technology R&D Program); Special Fund for Agro-scientific Research in the Public Interest	NBRPC (grant 2012CB114405); Key Technology R&D Program of China (grant 2012BAD17B01); Special Fund for Agro-scientific Research in the Public Interest (grant 201103034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourchookarn A, 2008, BBA-PROTEINS PROTEOM, V1784, P504, DOI 10.1016/j.bbapap.2007.12.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bu Q, 2012, J PROTEOMICS, V75, P1330, DOI 10.1016/j.jprot.2011.11.008; Chai YM, 2010, FISH SHELLFISH IMMUN, V29, P480, DOI 10.1016/j.fsi.2010.05.009; Chang PS, 1996, DIS AQUAT ORGAN, V27, P131, DOI 10.3354/dao027131; Chen AJ, 2013, J VIROL, V87, P636, DOI 10.1128/JVI.01671-12; Chen XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073218; Chen YH, 2011, MOL IMMUNOL, V48, P793, DOI 10.1016/j.molimm.2010.11.020; Chevalier F, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-23; Chongsatja PO, 2007, PROTEOMICS, V7, P3592, DOI 10.1002/pmic.200700281; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Holley AK, 2010, MITOCHONDRION, V10, P649, DOI 10.1016/j.mito.2010.06.003; Jiang H, 2014, MAR BIOTECHNOL, V16, P111, DOI 10.1007/s10126-013-9538-8; Jiang YS, 2007, AQUACULTURE, V272, P216, DOI 10.1016/j.aquaculture.2007.07.229; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; Kaukinen P, 2003, VIRUS RES, V92, P37, DOI 10.1016/S0168-1702(02)00312-X; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Liu BL, 2011, AQUACULTURE, V314, P13, DOI 10.1016/j.aquaculture.2011.01.023; Liu W, 2011, AQUACULTURE, V314, P53, DOI 10.1016/j.aquaculture.2011.02.021; Lu LQ, 2004, FEBS LETT, V577, P141, DOI 10.1016/j.febslet.2004.08.087; Merino-Gracia J, 2011, FEBS J, V278, P2997, DOI 10.1111/j.1742-4658.2011.08252.x; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Paul AL, 1997, ANN BOT-LONDON, V79, P33, DOI 10.1093/oxfordjournals.aob.a010304; Pongsomboon S, 2011, FISH SHELLFISH IMMUN, V30, P439, DOI 10.1016/j.fsi.2010.10.015; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Robalino J, 2009, VET IMMUNOL IMMUNOP, V128, P110, DOI 10.1016/j.vetimm.2008.10.329; Rogan S, 2000, VIRUS GENES, V21, P193, DOI 10.1023/A:1008139514123; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sanchez-Martinez JG, 2007, AQUAC RES, V38, P1339, DOI 10.1111/j.1365-2109.2007.01827.x; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Sangsuriya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025420; Sritunyalucksana K, 2012, FISH SHELLFISH IMMUN, V33, P1269, DOI 10.1016/j.fsi.2012.09.017; Steel LF, 2005, J CHROMATOGR B, V815, P275, DOI 10.1016/j.jchromb.2004.10.072; Tassanakajon A, 2013, FISH SHELLFISH IMMUN, V34, P954, DOI 10.1016/j.fsi.2012.09.021; Tastet L, 2006, ANAL BIOANAL CHEM, V385, P948, DOI 10.1007/s00216-006-0482-6; Thio CLP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061444; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yao CL, 2005, FISH SHELLFISH IMMUN, V19, P317, DOI 10.1016/j.fsi.2005.01.006; Zhan WB, 2013, FISH SHELLFISH IMMUN, V34, P228, DOI 10.1016/j.fsi.2012.10.019; Zhang XB, 2004, PROTEINS, V55, P229, DOI 10.1002/prot.10640; Zhong RJ, 2013, FISH SHELLFISH IMMUN, V35, P539, DOI 10.1016/j.fsi.2013.05.004	44	40	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89962	10.1371/journal.pone.0089962	http://dx.doi.org/10.1371/journal.pone.0089962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587154	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800060
J	Paynter, S; Yakob, L; Simoes, EAF; Lucero, MG; Tallo, V; Nohynek, H; Ware, RS; Weinstein, P; Williams, G; Sly, PD				Paynter, Stuart; Yakob, Laith; Simoes, Eric A. F.; Lucero, Marilla G.; Tallo, Veronica; Nohynek, Hanna; Ware, Robert S.; Weinstein, Philip; Williams, Gail; Sly, Peter D.			Using Mathematical Transmission Modelling to Investigate Drivers of Respiratory Syncytial Virus Seasonality in Children in the Philippines	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; INFLUENZA SEASONALITY; HUMAN METAPNEUMOVIRUS; TIME-SERIES; INFECTION; PNEUMONIA; INFANTS; SEROPREVALENCE; REINFECTION; DYNAMICS	We used a mathematical transmission model to estimate when ecological drivers of respiratory syncytial virus (RSV) transmissibility would need to act in order to produce the observed seasonality of RSV in the Philippines. We estimated that a seasonal peak in transmissibility would need to occur approximately 51 days prior to the observed peak in RSV cases (range 49 to 67 days). We then compared this estimated seasonal pattern of transmissibility to the seasonal patterns of possible ecological drivers of transmissibility: rainfall, humidity and temperature patterns, nutritional status, and school holidays. The timing of the seasonal patterns of nutritional status and rainfall were both consistent with the estimated seasonal pattern of transmissibility and these are both plausible drivers of the seasonality of RSV in this setting.	[Paynter, Stuart; Yakob, Laith; Ware, Robert S.; Williams, Gail] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Simoes, Eric A. F.] Univ Colorado, Sch Med, Aurora, CO USA; [Lucero, Marilla G.; Tallo, Veronica] Res Inst Trop Med, Dept Hlth, Muntinlupa, Metro Manila, Philippines; [Nohynek, Hanna] Natl Inst Hlth & Welf, Dept Vaccines & Immune Protect, Helsinki, Finland; [Weinstein, Philip] Univ S Australia, Barbara Hardy Inst, Adelaide, SA 5001, Australia; [Ware, Robert S.; Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Simoes, Eric A. F.] Univ Colorado, Colorado Sch Publ Hlth, Aurora, CO USA	University of Queensland; University of Colorado System; University of Colorado Anschutz Medical Campus; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Finland National Institute for Health & Welfare; University of South Australia; University of Queensland; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Paynter, S (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	s.paynter@uq.edu.au	Ware, Robert S./B-2024-2014; Williams, Gail/S-8833-2019; Yakob, Laith/AAD-4521-2019; Yakob, Laith/B-1059-2012; Sly, Peter D/F-1486-2010	Ware, Robert S./0000-0002-6129-6736; Williams, Gail/0000-0002-4822-5263; Yakob, Laith/0000-0001-8639-4511; Sly, Peter D/0000-0001-6305-2201; Weinstein, Philip/0000-0001-9860-7166	European Commission DG Research INCO program [IC18-CY97-2019, ICA4-CT-1999-10008, ICA4-CT-2002-10062]; Academy of Finland [206283, 106974, 108873, 108878]; Finnish Ministry of Foreign Affairs [75502901, 327/412/2000]; Finnish Physicians for Social Responsibility; GAVI ADIP Pneumo; Sanofi Pasteur; Research Institute for Tropical Medicine of the Philippines; National Public Health Institute Finland; University of Queensland; University of Colorado; National Health and Medical Research Council of Australia; Programme for Appropriate Technology in Health (PATH)	European Commission DG Research INCO program; Academy of Finland(Academy of Finland); Finnish Ministry of Foreign Affairs; Finnish Physicians for Social Responsibility; GAVI ADIP Pneumo; Sanofi Pasteur; Research Institute for Tropical Medicine of the Philippines; National Public Health Institute Finland; University of Queensland(University of Queensland); University of Colorado; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Programme for Appropriate Technology in Health (PATH)	The RSV admissions data and weight for age data were collected as part of the ARIVAC project, which was supported by the European Commission DG Research INCO program (contracts IC18-CY97-2019, ICA4-CT-1999-10008, ICA4-CT-2002-10062); Academy of Finland (contracts: 206283, 106974, 108873, and 108878); Finnish Ministry of Foreign Affairs (bilateral contracts 75502901 and 327/412/2000); Finnish Physicians for Social Responsibility; GAVI ADIP Pneumo; Sanofi Pasteur; Research Institute for Tropical Medicine of the Philippines; National Public Health Institute Finland; University of Queensland; University of Colorado; National Health and Medical Research Council of Australia; and Programme for Appropriate Technology in Health (PATH). The views expressed by the authors do not necessarily reflect the views of PATH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; Belderbos ME, 2011, PEDIATRICS, V127, pE1513, DOI 10.1542/peds.2010-3054; Bhattarakosol P, 2003, ASIAN PAC J ALLERGY, V21, P269; CASTILLODURAN C, 1987, AM J CLIN NUTR, V45, P602, DOI 10.1093/ajcn/45.3.602; Chevalier P, 1998, J TROP PEDIATRICS, V44, P304, DOI 10.1093/tropej/44.5.304; Cilla G, 2006, EPIDEMIOL INFECT, V134, P506, DOI 10.1017/S0950268805005571; Cox MJ, 1998, J MED VIROL, V55, P234, DOI 10.1002/(SICI)1096-9071(199807)55:3&lt;234::AID-JMV9&gt;3.0.CO;2-2; Crowcroft NS, 2008, EUR J PEDIATR, V167, P395, DOI 10.1007/s00431-007-0509-9; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Dietz K, 1976, MATH MODELS MED, P1; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; HALL CB, 1976, J PEDIATR-US, V89, P11, DOI 10.1016/S0022-3476(76)80918-3; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Hawker J, 2005, COMMUNICABLE DIS CON; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; HORT KP, 1987, ANN TROP PAEDIATR, V7, P66, DOI 10.1080/02724936.1987.11748476; KAPIKIAN AZ, 1961, AM J HYG, V74, P234, DOI 10.1093/oxfordjournals.aje.a120216; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; KRAVETZ HM, 1961, JAMA-J AM MED ASSOC, V176, P657; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu GL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-62; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; MILLS J, 1971, J IMMUNOL, V107, P123; MUFSON MA, 1987, J CLIN MICROBIOL, V25, P1535, DOI 10.1128/JCM.25.8.1535-1539.1987; Murray EL, 2012, EPIDEMIOL INFECT, V140, P78, DOI 10.1017/S0950268811000252; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nassar M. F., 2007, Eastern Mediterranean Health Journal, V13, P1031; O'Grady KAF, 2010, MED J AUSTRALIA, V192, P586, DOI 10.5694/j.1326-5377.2010.tb03643.x; Ohuma EO, 2012, AM J EPIDEMIOL, V176, P794, DOI 10.1093/aje/kws257; Okiro EA, 2008, TROP MED INT HEALTH, V13, P914, DOI 10.1111/j.1365-3156.2008.02092.x; Okiro EA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-15; Paynter S, 2013, EPIDEMIOL INFECT, V141, P1328, DOI 10.1017/S0950268812001379; Paynter S, 2014, PEDIAT INFE IN PRESS; Paynter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067528; Rajakumar K, 2011, J CLIN ENDOCR METAB, V96, P1560, DOI 10.1210/jc.2010-2388; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Simoes EAF, 2013, J CLIN MICROBIOL, V51, P945, DOI 10.1128/JCM.02317-12; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; WARIS M, 1992, J MED VIROL, V38, P111, DOI 10.1002/jmv.1890380208; WATT PJ, 1990, VACCINE, V8, P231, DOI 10.1016/0264-410X(90)90051-M; Weber A, 2001, MATH BIOSCI, V172, P95, DOI 10.1016/S0025-5564(01)00066-9; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; White LJ, 2007, MATH BIOSCI, V209, P222, DOI 10.1016/j.mbs.2006.08.018; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X; ZELAYA EAC, 1994, AM J TROP MED HYG, V51, P577, DOI 10.4269/ajtmh.1994.51.577; Zhang Q, 2008, CHINESE MED J-PEKING, V121, P2162, DOI 10.1097/00029330-200811010-00011; Zhu ZW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-126	56	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90094	10.1371/journal.pone.0090094	http://dx.doi.org/10.1371/journal.pone.0090094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587222	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000332390800076
J	Wang, L; Xia, JH; Liu, XJ; Liu, P; Wan, ZY; Yue, GH				Wang, Le; Xia, Jun Hong; Liu, Xiao Jun; Liu, Peng; Wan, Zi Yi; Yue, Gen Hua			Molecular Characterization and Mapping of Fgf21 Gene in a Foodfish Species Asian Seabass	PLOS ONE			English	Article							PPAR-ALPHA; METABOLIC SYNDROME; GROWTH; LEPTIN; ASSOCIATION; OBESITY; MODEL; FIBROBLAST-GROWTH-FACTOR-21; POLYMORPHISMS; ACTIVATION	Fgf21 is a newly discovered fibroblast growth factor. It is typically induced by fasting and plays important roles in the regulation of glucose and lipid metabolisms and energy balance in mammals, whereas potential functions of this gene in teleosts are still unknown. We identified the Fgf21 gene and studied its functions in Asian seabass (Lates calcarifer). The cDNA of the Fgf21 encoded a protein with 206 amino acids. Analysis of DNA and amino acid sequences of Fgf21 genes revealed that the sequences and structure of the Fgf21 genes were highly conserved in vertebrates. Real-time PCR revealed that Fgf21 was exclusively expressed in the intestine and kidney, which was different from the expression profiles of mammals. Fgf21 was down-regulated under fasting, whereas it was significantly increased during the LPS challenge. Exogenous recombinant FGF21 significantly suppressed the appetite of Asian seabass. Our data suggest that Fgf21 plays a role in energy regulation and acute phase response in Asian seabass, and may have different functions in fish and mammals. In addition, we identified one SNP in Fgf21. By using this SNP, the gene was mapped on the linkage group 23, where a suggestive QTL for growth was mapped previously. Association mapping identified significant associations between Fgf21 genotypes at the SNP and growth traits. These results not only provide important information of the functions of Fgf21, but also suggest that the SNP in this gene can be used as a marker in selecting fast-growing individuals of Asian seabass.	[Wang, Le; Xia, Jun Hong; Liu, Xiao Jun; Liu, Peng; Wan, Zi Yi; Yue, Gen Hua] Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore; [Yue, Gen Hua] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248; Liu, Xiaojun/0000-0002-0332-2940	National Research Foundation Singapore under its Competitive Research Program (CRP Award) [NRF-CRP002-001]	National Research Foundation Singapore under its Competitive Research Program (CRP Award)(National Research Foundation, Singapore)	This research is supported by the National Research Foundation Singapore under its Competitive Research Program (CRP Award No. NRF-CRP002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chu AY, 2013, HUM MOL GENET, V22, P1895, DOI 10.1093/hmg/ddt032; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; de Pedro N, 2006, J ENDOCRINOL, V188, P513, DOI 10.1677/joe.1.06349; Feingold KR, 2012, ENDOCRINOLOGY, V153, P2689, DOI 10.1210/en.2011-1496; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; He XP, 2012, ANIM GENET, V43, P233, DOI 10.1111/j.1365-2052.2011.02230.x; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Kaess BM, 2010, EUR J HUM GENET, V18, P1344, DOI 10.1038/ejhg.2010.130; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Lee P, 2013, J CLIN ENDOCR METAB, V98, pE98, DOI 10.1210/jc.2012-3107; Li XF, 2009, FEBS LETT, V583, P3230, DOI 10.1016/j.febslet.2009.09.012; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Murata Y, 2011, J NUTR METABOLISM, V2011, P1; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Oishi K, 2010, NEUROENDOCRINOL LETT, V31, P198; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Thissen JP, 1999, NUTR REV, V57, P167, DOI 10.1111/j.1753-4887.1999.tb06939.x; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tipsmark CK, 2008, J ENDOCRINOL, V196, P275, DOI 10.1677/JOE-07-0540; Uebanso T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022976; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; Wang CM, 2011, MAR BIOTECHNOL, V13, P74, DOI 10.1007/s10126-010-9271-5; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Won ET, 2012, GEN COMP ENDOCR, V178, P98, DOI 10.1016/j.ygcen.2012.04.019; Xia JH, 2013, MARINE BIOT IN PRESS, DOI 101007/s10126-013-9524-1; Xia JH, 2013, DNA RES, V20, P449, DOI 10.1093/dnares/dst022; Xia JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-295; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yamauchi H, 2006, EMBO REP, V7, P649, DOI 10.1038/sj.embor.7400685; Yang CF, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-67; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Zhang M, 2012, DNA CELL BIOL, V31, P547, DOI 10.1089/dna.2011.1302; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	48	16	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90172	10.1371/journal.pone.0090172	http://dx.doi.org/10.1371/journal.pone.0090172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587261	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800085
J	Lee, SA; Erath, J; Zheng, GA; Ou, XZ; Willems, P; Eichinger, D; Rodriguez, A; Yang, CH				Lee, Seung Ah; Erath, Jessey; Zheng, Guoan; Ou, Xiaoze; Willems, Phil; Eichinger, Daniel; Rodriguez, Ana; Yang, Changhuei			Imaging and Identification of Waterborne Parasites Using a Chip-Scale Microscope	PLOS ONE			English	Article							PROTOZOAN PARASITES; GIARDIA; CRYPTOSPORIDIUM; TRANSMISSION; ENCYSTATION; OUTBREAKS	We demonstrate a compact portable imaging system for the detection of waterborne parasites in resource-limited settings. The previously demonstrated sub-pixel sweeping microscopy (SPSM) technique is a lens-less imaging scheme that can achieve high-resolution (<1 mu m) bright-field imaging over a large field-of-view (5.7 mmx4.3 mm). A chip-scale microscope system, based on the SPSM technique, can be used for automated and high-throughput imaging of protozoan parasite cysts for the effective diagnosis of waterborne enteric parasite infection. We successfully imaged and identified three major types of enteric parasite cysts, Giardia, Cryptosporidium, and Entamoeba, which can be found in fecal samples from infected patients. We believe that this compact imaging system can serve well as a diagnostic device in challenging environments, such as rural settings or emergency outbreaks.	[Lee, Seung Ah; Zheng, Guoan; Ou, Xiaoze; Yang, Changhuei] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; [Erath, Jessey; Eichinger, Daniel; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA; [Zheng, Guoan; Willems, Phil; Yang, Changhuei] ePetri Inc, Pasadena, CA USA; [Yang, Changhuei] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; New York University; California Institute of Technology	Lee, SA (corresponding author), CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA.	salee30@caltech.edu	Rodríguez, Ana/GQR-0554-2022	Zheng, Guoan/0000-0002-4268-2690; Erath, Jessey/0000-0001-8802-635X; Rodriguez, Ana/0000-0002-0060-3405	NIH [1R01AI096226-01]; Whittier Foundations agency [9900040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096226] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whittier Foundations agency; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant 1R01AI096226-01 (http://grants.nih.gov/grants/funding/r01.htm); Whittier Foundations agency award 9900040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Eichinger D, 1997, BIOESSAYS, V19, P633, DOI 10.1002/bies.950190714; Haque R, 2007, AM J TROP MED HYG, V76, P713, DOI 10.4269/ajtmh.2007.76.713; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Lee SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026127; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Minak J, 2012, J CLIN MICROBIOL, V50, P154, DOI 10.1128/JCM.01194-11; Mudanyali O, 2010, LAB CHIP, V10, P2419, DOI 10.1039/c004829a; SANCHEZ L, 1994, MOL BIOCHEM PARASIT, V67, P125, DOI 10.1016/0166-6851(94)90102-3; Xu WB, 2001, P NATL ACAD SCI USA, V98, P11301, DOI 10.1073/pnas.191361398; Zheng GA, 2011, OPT LETT, V36, P3987, DOI 10.1364/OL.36.003987; Zheng GA, 2011, P NATL ACAD SCI USA, V108, P16889, DOI 10.1073/pnas.1110681108; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	13	20	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89712	10.1371/journal.pone.0089712	http://dx.doi.org/10.1371/journal.pone.0089712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586978	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000332389000085
J	Rose, J; Chang, DC; Weiser, TG; Kassebaum, NJ; Bickler, SW				Rose, John; Chang, David C.; Weiser, Thomas G.; Kassebaum, Nicholas J.; Bickler, Stephen W.			The Role of Surgery in Global Health: Analysis of United States Inpatient Procedure Frequency by Condition Using the Global Burden of Disease 2010 Framework	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; LOW-INCOME; SURGICAL CONDITIONS; SYSTEMATIC ANALYSIS; SIERRA-LEONE; CARE; EMERGENCY; RATES; OPPORTUNITIES; PERFORMANCE	Background: The role of surgical care in promoting global health is the subject of much debate. The Global Burden of Disease 2010 study (GBD 2010) offers a new opportunity to consider where surgery fits amongst global health priorities. The GBD 2010 reinforces the DALY as the preferred methodology for determining the relative contribution of disease categories to overall global burden of disease without reference to the likelihood of each category requiring surgery. As such, we hypothesize that the GBD framework underestimates the role of surgery in addressing the global burden of disease. Methods and Findings: We compiled International Classification of Diseases, Version 9, codes from the United States Nationwide Inpatient Sample from 2010. Using the primary diagnosis code for each hospital admission, we aggregated admissions into GBD 2010 disease sub-categories. We queried each hospitalization for a major operation to determine the frequency of admitted patients whose care required surgery. Major operation was defined according to the Agency for Healthcare Research and Quality (AHRQ). In 2010, 10 million major inpatient operations were performed in the United States, associated with 28.6% of all admissions. Major operations were performed in every GBD disease subcategory (range 0.2%-84.0%). The highest frequencies of operation were in the subcategories of Musculoskeletal (84.0%), Neoplasm (61.4%), and Transport Injuries (43.2%). There was no disease subcategory that always required an operation; nor was there any disease subcategory that never required an operation. Conclusions: Surgical care cuts across the entire spectrum of GBD disease categories, challenging dichotomous traditional classifications of 'surgical' versus 'nonsurgical' diseases. Current methods of measuring global burden of disease do not reflect the fundamental role operative intervention plays in the delivery of healthcare services. Novel methodologies should be aimed at understanding the integration of surgical services into health systems to address the global burden of disease.	[Rose, John; Chang, David C.; Bickler, Stephen W.] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Rose, John] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Weiser, Thomas G.] Stanford Univ, Dept Surg, Palo Alto, CA 94304 USA; [Kassebaum, Nicholas J.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Kassebaum, Nicholas J.] Univ Washington, Dept Anesthesiol Pain Med, Seattle, WA 98195 USA; [Bickler, Stephen W.] Rady Childrens Hosp, Div Pediat Surg, San Diego, CA USA	University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Stanford University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rady Childrens Hospital San Diego	Rose, J (corresponding author), Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA.	jorose@ucsd.edu	Weiser, Thomas G/AAC-4609-2022	Weiser, Thomas G/0000-0002-3118-3888	NIH [R24TW008910]; Universidade Eduardo Mondlane; Department of Surgery at UC San Diego School of Medicine; NIH through the Fogarty International Center [R25TW009343]; NIH through Office of Behavioral and Social Sciences Research; NIH through Office of Research on Women's Health; NIH through Office of AIDS Research; NIH through National Institute of Mental Health; NIH through National Institute on Drug Abuse; NIH through University of California Global Health Institute; NIH through Agency for Healthcare Research and Quality [1F32HS022398]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS022398] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R24TW008908, R25TW009343, R24TW008910] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidade Eduardo Mondlane; Department of Surgery at UC San Diego School of Medicine; NIH through the Fogarty International Center; NIH through Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH through Office of Research on Women's Health; NIH through Office of AIDS Research; NIH through National Institute of Mental Health; NIH through National Institute on Drug Abuse; NIH through University of California Global Health Institute; NIH through Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by multiple grants through the NIH including; (1) a MEPI Linked Award (R24TW008910) with a partnership between Universidade Eduardo Mondlane and the Department of Surgery at UC San Diego School of Medicine; (2) a Research Training Grant (R25TW009343) through the Fogarty International Center, Office of Behavioral and Social Sciences Research, Office of Research on Women's Health, Office of AIDS Research, National Institute of Mental Health, and National Institute on Drug Abuse, and the University of California Global Health Institute; and (3) a National Service Research Award through the Agency for Healthcare Research and Quality (1F32HS022398). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the University of California Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CURR OPIN OPHTHALMOL, V22, P15, DOI 10.1097/ICU.0b013e3283414f64; Agency for Healthcare Research and Quality and Healthcare Cost and Utilization Project (HCUP), 2007, CLIN CLASS SOFTW CCS; [Anonymous], 2003, SURG CAR DISTR HOSP; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Barbour V, 2008, PLOS MED, V5, P1165, DOI 10.1371/journal.pmed.0050182; Bian John, 2011, Chin J Cancer, V30, P197; Bickler S, 2010, WORLD J SURG, V34, P374, DOI 10.1007/s00268-009-0261-6; Bickler SW, 2008, LANCET, V372, P90, DOI 10.1016/S0140-6736(08)60924-1; Bickler SW, 2010, WORLD J SURG, V34, P386, DOI 10.1007/s00268-009-0273-2; Birkmeyer JD, 2000, ANN SURG, V232, P724, DOI 10.1097/00000658-200011000-00023; Birkmeyer NJO, 2001, CURR OPIN CARDIOL, V16, P152, DOI 10.1097/00001573-200103000-00013; Brundtland GH, 2003, LANCET, V361, P2155, DOI 10.1016/S0140-6736(03)13702-6; Carlson LC, 2012, VALUE HEALTH, V15, P887, DOI 10.1016/j.jval.2012.06.004; CORTAZZO JM, 1993, AM J EMERG MED, V11, P456, DOI 10.1016/0735-6757(93)90082-M; Cubitt JJ, 2013, CLEF PALATE IN PRESS; Debas HT, 2006, DIS CONTROL PRIORITI; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Caballero MG, 2012, NUTR HOSP, V27, P1373, DOI 10.3305/nh.2012.27.5.5993; GBD 2001 Country Collaboration, 2013, LANCET, V381, P965, DOI 10.1016/S0140-6736(13)60283-4; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; Gosselin R, 2013, WORLD J SURG, V37, P2507, DOI 10.1007/s00268-013-2182-7; Groen RS, 2012, LANCET, V380, P1082, DOI 10.1016/S0140-6736(12)61081-2; Guterman S, 2006, HEALTH AFFAIR, V25, P95, DOI 10.1377/hlthaff.25.1.95; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Healthcare Cost and Utilization Project, 2013, OV NAT INP SAMPL NIS; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hollier LH, 2010, J CRANIOFAC SURG, V21, P1488, DOI 10.1097/SCS.0b013e3181edc593; Institute for Health Metrics and Evaluation, VIS; Kamath A, 2010, JAMA-J AM MED ASSOC, V304, P2176, DOI 10.1001/jama.2010.1675; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Kushner AL, 2010, ARCH SURG-CHICAGO, V145, P154, DOI 10.1001/archsurg.2009.263; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacGowan W A, 1987, Bull Am Coll Surg, V72, P5; Martin BI, 2007, SPINE, V32, P2119, DOI 10.1097/BRS.0b013e318145a56a; Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46; Martin BI, 2009, SPINE, V34, P2077, DOI 10.1097/BRS.0b013e3181b1fad1; McPake B, 2000, B WORLD HEALTH ORGAN, V78, P811; McQueen K A Kelly, 2010, Health Hum Rights, V12, P137; MedPAC, 2013, US SURG PROC VOL; Mills A, 2008, LANCET, V372, P1527, DOI 10.1016/S0140-6736(08)61633-5; Mock C, 2013, WORLD J SURG, V37, P1457, DOI 10.1007/s00268-013-2102-x; Mock C, 2010, WORLD J SURG, V34, P381, DOI 10.1007/s00268-009-0263-4; Moon W, 2012, WORLD J SURG, V36, P2819, DOI 10.1007/s00268-012-1761-3; Murray C, 2001, LANCET, V357, P1698, DOI 10.1016/S0140-6736(00)04826-1; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; Murray CJL, 2013, LANCET, V382, P9, DOI 10.1016/S0140-6736(13)60225-1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2010, NEW ENGL J MED, V362, P98, DOI 10.1056/NEJMp0910064; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Nallamothu BK, 2011, JAMA-J AM MED ASSOC, V306, P1338, DOI 10.1001/jama.2011.1357; Ozgediz D, 2008, PLOS MED, V5, P850, DOI 10.1371/journal.pmed.0050121; Ozgediz D, 2008, B WORLD HEALTH ORGAN, V86, P646, DOI 10.2471/BLT.07.050435; PAINTER NS, 1971, BMJ-BRIT MED J, V2, P450, DOI 10.1136/bmj.2.5759.450; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Petroze RT, 2012, BRIT J SURG, V99, P436, DOI 10.1002/bjs.7816; Petroze RT, 2013, WORLD J SURG, V37, P1500, DOI 10.1007/s00268-012-1769-8; Petroze RT, 2013, SURGERY, V153, P457, DOI 10.1016/j.surg.2012.10.001; Rao GN, 2011, CURR OPIN OPHTHALMOL, V22, P4, DOI 10.1097/ICU.0b013e3283414fc8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Semel ME, 2012, SURGERY, V151, P171, DOI 10.1016/j.surg.2011.07.021; Shah SP, 2011, B WORLD HEALTH ORGAN, V89, P749, DOI 10.2471/BLT.10.080366; Shillcutt SD, 2010, ARCH SURG-CHICAGO, V145, P954, DOI 10.1001/archsurg.2010.208; Spiegel DA, 2007, LANCET, V370, P1013, DOI 10.1016/S0140-6736(07)61457-3; Spiegel DA, 2013, WORLD J SURG, V37, P1462, DOI 10.1007/s00268-012-1831-6; Taira B, 2009, WORLD J SURG, V33, P893, DOI 10.1007/s00268-009-9981-x; von Conrady D, 2010, ANZ J SURG, V80, P933, DOI 10.1111/j.1445-2197.2010.05490.x; Vos T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000149; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Weiser TG, 2011, WORLD J SURG, V35, P1950, DOI 10.1007/s00268-011-1169-5; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2010, ESS SURG CAR MAK DIF; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, GLOB IN EM ESS SURG; World Health Organization, SAF SURG SAV LIV; World Health Organization, 2009, VEN CONCL S IN PRESS	84	53	53	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89693	10.1371/journal.pone.0089693	http://dx.doi.org/10.1371/journal.pone.0089693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586967	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000078
J	Cook, M; Bolkan, BJ; Kretzschmar, D				Cook, Mandy; Bolkan, Bonnie J.; Kretzschmar, Doris			Increased Actin Polymerization and Stabilization Interferes with Neuronal Function and Survival in the AMPK gamma Mutant Loechrig	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ALZHEIMERS-DISEASE; LIM-KINASE; PROGRESSIVE NEURODEGENERATION; COFILIN PHOSPHORYLATION; SLINGSHOT PHOSPHATASE; NEURITE OUTGROWTH; AXONAL-TRANSPORT; DROSOPHILA; GROWTH	loechrig (loe) mutant flies are characterized by progressive neuronal degeneration, behavioral deficits, and early death. The mutation is due to a P-element insertion in the gene for the gamma-subunit of the trimeric AMP-activated protein kinase (AMPK) complex, whereby the insertion affects only one of several alternative transcripts encoding a unique neuronal isoform. AMPK is a cellular energy sensor that regulates a plethora of signaling pathways, including cholesterol and isoprenoid synthesis via its downstream target hydroxy-methylglutaryl (HMG)-CoA reductase. We recently showed that loe interferes with isoprenoid synthesis and increases the prenylation and thereby activation of RhoA. During development, RhoA plays an important role in neuronal outgrowth by activating a signaling cascade that regulates actin dynamics. Here we show that the effect of loe/AMPK gamma on RhoA prenylation leads to a hyperactivation of this signaling pathway, causing increased phosphorylation of the actin depolymerizating factor cofilin and accumulation of filamentous actin. Furthermore, our results show that the resulting cytoskeletal changes in loe interfere with neuronal growth and disrupt axonal integrity. Surprisingly, these phenotypes were enhanced by expressing the Slingshot (SSH) phosphatase, which during development promotes actin depolymerization by dephosphorylating cofilin. However, our studies suggest that in the adult SSH promotes actin polymerization, supporting in vitro studies using human SSH1 that suggested that SSH can also stabilize and bundle filamentous actin. Together with the observed increase in SSH levels in the loe mutant, our experiments suggest that in mature neurons SSH may function as a stabilization factor for filamentous actin instead of promoting actin depolymerization.	[Cook, Mandy; Bolkan, Bonnie J.; Kretzschmar, Doris] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA	Oregon Health & Science University	Kretzschmar, D (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA.	kretzsch@ohsu.edu		kretzschmar, doris/0000-0002-0519-2377	Alzheimer Forschung Initiative e. V.; Medical Research Foundation of Oregon; Oregon Tax Check-off program	Alzheimer Forschung Initiative e. V.; Medical Research Foundation of Oregon; Oregon Tax Check-off program	This work was supported by a grant from the Alzheimer Forschung Initiative e. V., the Medical Research Foundation of Oregon, and the Oregon Tax Check-off program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo K, 2007, EXP CELL RES, V313, P4091, DOI 10.1016/j.yexcr.2007.08.012; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Cook M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044440; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Fischbach Jaeger, 1989, DROSOPHILA LAB MANUA, P254; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jovceva E, 2007, J CELL SCI, V120, P1888, DOI 10.1242/jcs.004366; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kraft R, 1998, J NEUROSCI, V18, P8886; Kurita S, 2007, GENES CELLS, V12, P663, DOI 10.1111/j.1365-2443.2007.01078.x; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Ma QL, 2008, J BIOL CHEM, V283, P14132, DOI 10.1074/jbc.M708034200; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Salminen A, 2008, BIOCHEM BIOPH RES CO, V371, P587, DOI 10.1016/j.bbrc.2008.04.148; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Siudeja K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043145; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Spasic MR, 2009, NEUROSCIENTIST, V15, P309, DOI 10.1177/1073858408327805; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Tschape JA, 2003, J NEURAL TRANSM-SUPP, P51; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	45	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89847	10.1371/journal.pone.0089847	http://dx.doi.org/10.1371/journal.pone.0089847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24587072	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900090
J	Neunzig, J; Bernhardt, R				Neunzig, Jens; Bernhardt, Rita			Dehydroepiandrosterone Sulfate (DHEAS) Stimulates the First Step in the Biosynthesis of Steroid Hormones	PLOS ONE			English	Article							SIDE-CHAIN CLEAVAGE; HEME IRON PROTEINS; ESCHERICHIA-COLI; CHOLESTEROL SULFATE; LIVER MICROSOMES; MOLECULAR-LEVEL; E.-COLI; EXPRESSION; PURIFICATION; MITOCHONDRIA	Dehydroepiandrosterone sulfate (DHEAS) is the most abundant circulating steroid in human, with the highest concentrations between age 20 and 30, but displaying a significant decrease with age. Many beneficial functions are ascribed to DHEAS. Nevertheless, long-term studies are very scarce concerning the intake of DHEAS over several years, and molecular investigations on DHEAS action are missing so far. In this study, the role of DHEAS on the first and rate-limiting step of steroid hormone biosynthesis was analyzed in a reconstituted in vitro system, consisting of purified CYP11A1, adrenodoxin and adrenodoxin reductase. DHEAS enhances the conversion of cholesterol by 26%. Detailed analyses of the mechanism of DHEAS action revealed increased binding affinity of cholesterol to CYP11A1 and enforced interaction with the electron transfer partner, adrenodoxin. Difference spectroscopy showed K-d-values of 40 +/- 2.7 mu M and 24.8 +/- 0.5 mu M for CYP11A1 and cholesterol without and with addition of DHEAS, respectively. To determine the K-d-value for CYP11A1 and adrenodoxin, surface plasmon resonance measurements were performed, demonstrating a K-d-value of 3.0 +/- 0.35 nM (with cholesterol) and of 2.4 +/- 0.05 nM when cholesterol and DHEAS were added. Kinetic experiments showed a lower K-m and a higher k(cat) value for CYP11A1 in the presence of DHEAS leading to an increase of the catalytic efficiency by 75%. These findings indicate that DHEAS affects steroid hormone biosynthesis on a molecular level resulting in an increased formation of pregnenolone.	[Neunzig, Jens; Bernhardt, Rita] Univ Saarland, Dept Biochem, Fac Tech & Nat Sci 3, D-66123 Saarbrucken, Germany	Saarland University	Bernhardt, R (corresponding author), Univ Saarland, Dept Biochem, Fac Tech & Nat Sci 3, D-66123 Saarbrucken, Germany.	ritabern@mx.uni-saarland.de			Deutsche Forschungsgemeinschaft [DFG-FOR1369]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is funded by the "Deutsche Forschungsgemeinschaft DFG-FOR1369" (URL:http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; Baulieu EE, 1996, J CLIN ENDOCR METAB, V81, P3147, DOI 10.1210/jc.81.9.3147; Bernhardt R., 2007, CYTOCHROME P450 STER, P361; Berwanger A, 2010, J INORG BIOCHEM, V104, P118, DOI 10.1016/j.jinorgbio.2009.10.007; CLAUS R, 1980, ACTA ENDOCRINOL-COP, V94, P404, DOI 10.1530/acta.0.0940404; Geyer J, 2004, BIOCHEM BIOPH RES CO, V316, P300, DOI 10.1016/j.bbrc.2004.02.048; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Harnastai IN, 2006, PROTEIN EXPRES PURIF, V46, P47, DOI 10.1016/j.pep.2005.07.006; HIWATASHI A, 1976, BIOCHEMISTRY-US, V15, P3082, DOI 10.1021/bi00659a023; Hobler A, 2012, J STEROID BIOCHEM, V132, P57, DOI 10.1016/j.jsbmb.2012.03.002; Hoffmann B, 1999, ANIM REPROD SCI, V57, P89, DOI 10.1016/S0378-4320(99)00050-0; Janocha S, 2011, BBA-PROTEINS PROTEOM, V1814, P126, DOI 10.1016/j.bbapap.2010.06.002; Janowski T, 1999, TIERARZTL PRAX G N, V27, P107; Kagawa N, 2011, METHODS MOL BIOL, V705, P109, DOI 10.1007/978-1-61737-967-3_7; KIMURA T, 1968, J BIOCHEM-TOKYO, V63, P716, DOI 10.1093/oxfordjournals.jbchem.a128836; KORTE K, 1982, J CLIN ENDOCR METAB, V55, P671, DOI 10.1210/jcem-55-4-671; Kroboth PD, 1999, J CLIN PHARMACOL, V39, P327, DOI 10.1177/00912709922007903; LAMBETH JD, 1987, J BIOL CHEM, V262, P9181; Leowattana W, 2004, CLIN CHIM ACTA, V341, P1, DOI 10.1016/j.cccn.2003.10.031; Lisurek M, 2004, MOL CELL ENDOCRINOL, V215, P149, DOI 10.1016/j.mce.2003.11.008; MONTANINI V, 1988, HORM RES, V29, P1, DOI 10.1159/000180956; Nawata H, 2002, MECH AGEING DEV, V123, P1101, DOI 10.1016/S0047-6374(01)00393-1; NIESCHLAG E, 1973, J ENDOCRINOL, V57, P123, DOI 10.1677/joe.0.0570123; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; OMURA T, 1964, J BIOL CHEM, V239, P2379; Pasqualini JR, 2005, J STEROID BIOCHEM, V93, P221, DOI 10.1016/j.jsbmb.2005.02.007; SAGARA Y, 1993, ARCH BIOCHEM BIOPHYS, V304, P272, DOI 10.1006/abbi.1993.1349; SCHENKMAN JB, 1970, BIOCHEMISTRY-US, V9, P2081, DOI 10.1021/bi00812a009; Schuler G, 2008, EXP CLIN ENDOCR DIAB, V116, P429, DOI 10.1055/s-2008-1042408; SEKIHARA H, 1972, STEROIDS, V20, P813; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Strott CA, 1996, ENDOCR REV, V17, P670, DOI 10.1210/er.17.6.670; Tsutsumi R, 2008, ENDOCR J, V55, P575, DOI 10.1507/endocrj.K07-097; TUCKEY RC, 1990, J STEROID BIOCHEM, V37, P121, DOI 10.1016/0960-0760(90)90380-4; UHLMANN H, 1992, BIOCHEM BIOPH RES CO, V188, P1131, DOI 10.1016/0006-291X(92)91349-U; Vacheron-Trystram MN, 2002, ENCEPHALE, V28, P563; WADA A, 1991, ARCH BIOCHEM BIOPHYS, V290, P376, DOI 10.1016/0003-9861(91)90554-V; XU XX, 1989, J BIOL CHEM, V264, P7222; Yamato S, 2010, J CHROMATOGR B, V878, P3358, DOI 10.1016/j.jchromb.2010.10.020; Zollner A, 2008, FEBS J, V275, P799, DOI 10.1111/j.1742-4658.2008.06253.x	40	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89727	10.1371/journal.pone.0089727	http://dx.doi.org/10.1371/journal.pone.0089727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586990	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900145
J	Henningsson, P; Hedenstrom, A; Bomphrey, RJ				Henningsson, Per; Hedenstrom, Anders; Bomphrey, Richard J.			Efficiency of Lift Production in Flapping and Gliding Flight of Swifts	PLOS ONE			English	Article							PARTICLE IMAGE VELOCIMETRY; DESERT LOCUST; VORTEX WAKE; AERODYNAMICS; PERFORMANCE; KINEMATICS; BIRDS	Many flying animals use both flapping and gliding flight as part of their routine behaviour. These two kinematic patterns impose conflicting requirements on wing design for aerodynamic efficiency and, in the absence of extreme morphing, wings cannot be optimised for both flight modes. In gliding flight, the wing experiences uniform incident flow and the optimal shape is a high aspect ratio wing with an elliptical planform. In flapping flight, on the other hand, the wing tip travels faster than the root, creating a spanwise velocity gradient. To compensate, the optimal wing shape should taper towards the tip (reducing the local chord) and/or twist from root to tip (reducing local angle of attack). We hypothesised that, if a bird is limited in its ability to morph its wings and adapt its wing shape to suit both flight modes, then a preference towards flapping flight optimization will be expected since this is the most energetically demanding flight mode. We tested this by studying a well-known flap-gliding species, the common swift, by measuring the wakes generated by two birds, one in gliding and one in flapping flight in a wind tunnel. We calculated span efficiency, the efficiency of lift production, and found that the flapping swift had consistently higher span efficiency than the gliding swift. This supports our hypothesis and suggests that even though swifts have been shown previously to increase their lift-to-drag ratio substantially when gliding, the wing morphology is tuned to be more aerodynamically efficient in generating lift during flapping. Since body drag can be assumed to be similar for both flapping and gliding, it follows that the higher total drag in flapping flight compared with gliding flight is primarily a consequence of an increase in wing profile drag due to the flapping motion, exceeding the reduction in induced drag.	[Henningsson, Per; Hedenstrom, Anders] Lund Univ, Dept Biol, Lund, Sweden; [Bomphrey, Richard J.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England	Lund University; University of London; University of London Royal Veterinary College	Henningsson, P (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	per.henningsson@biol.lu.se	Bomphrey, Richard/I-6272-2013; Hedenström, Anders/F-5377-2010	Bomphrey, Richard/0000-0002-4748-0510; Hedenström, Anders/0000-0002-1757-0945	Swedish Research Council; Knut and Alice Wallenberg Foundation; Centre for Animal Movement Research (CAnMove); Swedish Research Council [349-2007-8690]; Lund University; EPSRC [EP/H004025/1]; BBSRC [BB/J001244/1]; EPSRC; Biotechnology and Biological Sciences Research Council [BB/J001244/1, BB/J001244/2, BB/J000523/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H004025/2, EP/H004025/1] Funding Source: researchfish; BBSRC [BB/J001244/2, BB/J000523/1] Funding Source: UKRI; EPSRC [EP/H004025/2] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Centre for Animal Movement Research (CAnMove); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was supported financially by grants from the Swedish Research Council and the Knut and Alice Wallenberg Foundation. It also received support from the Centre for Animal Movement Research (CAnMove) financed by a Linnaeus grant (349-2007-8690) from the Swedish Research Council and Lund University, the EPSRC (EP/H004025/1) and BBSRC (BB/J001244/1). RJB holds an EPSRC Career Acceleration Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bomphrey RJ, 2012, J R SOC INTERFACE, V9, P3378, DOI 10.1098/rsif.2012.0418; Bomphrey RJ, 2006, J R SOC INTERFACE, V3, P311, DOI 10.1098/rsif.2005.0090; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P17, DOI 10.1098/rstb.1984.0050; Henningsson P, 2008, J EXP BIOL, V211, P717, DOI 10.1242/jeb.012146; Henningsson P, 2011, J R SOC INTERFACE, V8, P807, DOI 10.1098/rsif.2010.0533; Henningsson P, 2011, J EXP BIOL, V214, P382, DOI 10.1242/jeb.050609; Henningsson P, 2009, P ROY SOC B-BIOL SCI, V276, P2395, DOI 10.1098/rspb.2009.0195; Henningsson P, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0099; Henningsson P, 2012, J R SOC INTERFACE, V9, P1177, DOI 10.1098/rsif.2011.0749; Johansson LC, 2012, J R SOC INTERFACE, V9, P2745, DOI 10.1098/rsif.2012.0053; Lack D., 1956, SWIFTS TOWER; Lentink D, 2007, NATURE, V446, P1082, DOI 10.1038/nature05733; Muijres FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037335; Muijres FT, 2012, J THEOR BIOL, V306, P120, DOI 10.1016/j.jtbi.2012.04.014; Muijres FT, 2012, J R SOC INTERFACE, V9, P292, DOI 10.1098/rsif.2011.0238; Muijres FT, 2011, EXP FLUIDS, V51, P511, DOI 10.1007/s00348-011-1067-5; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; Sakamoto KQ, 2013, J EXP BIOL, V216, P3175, DOI 10.1242/jeb.079905; Stepniewski W. Z., 1984, ROTARY WING AERODYNA; THOMAS ALR, 1993, PHILOS T ROY SOC B, V340, P361, DOI 10.1098/rstb.1993.0079; Videler JJ, 2004, SCIENCE, V306, P1960, DOI 10.1126/science.1104682; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; WEISFOGH T, 1973, J EXP BIOL, V59, P169	23	28	29	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90170	10.1371/journal.pone.0090170	http://dx.doi.org/10.1371/journal.pone.0090170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587260	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200141
J	Kanagavelu, S; Termini, JM; Gupta, S; Raffa, FN; Fuller, KA; Rivas, Y; Philip, S; Kornbluth, RS; Stone, GW				Kanagavelu, Saravana; Termini, James M.; Gupta, Sachin; Raffa, Francesca N.; Fuller, Katherine A.; Rivas, Yaelis; Philip, Sakhi; Kornbluth, Richard S.; Stone, Geoffrey W.			HIV-1 Adenoviral Vector Vaccines Expressing Multi-Trimeric BAFF and 4-1BBL Enhance T Cell Mediated Anti-Viral Immunity	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; SOLUBLE CD40 LIGAND; RHESUS-MONKEYS; MEMORY RESPONSES; B-CELL; GAG/POL/NEF VACCINE; DENDRITIC CELLS; SIV CHALLENGE; AIDS VACCINE; DNA VACCINES	Adenoviral vectored vaccines have shown considerable promise but could be improved by molecular adjuvants. Ligands in the TNF superfamily (TNFSF) are potential adjuvants for adenoviral vector (Ad5) vaccines based on their central role in adaptive immunity. Many TNFSF ligands require aggregation beyond the trimeric state (multi-trimerization) for optimal biological function. Here we describe Ad5 vaccines for HIV-1 Gag antigen (Ad5-Gag) adjuvanted with the TNFSF ligands 4-1BBL, BAFF, GITRL and CD27L constructed as soluble multi-trimeric proteins via fusion to Surfactant Protein D (SP-D) as a multimerization scaffold. Mice were vaccinated with Ad5-Gag combined with Ad5 expressing one of the SP-D-TNFSF constructs or single-chain IL-12p70 as adjuvant. To evaluate vaccine-induced protection, mice were challenged with vaccinia virus expressing Gag (vaccinia-Gag) which is known to target the female genital tract, a major route of sexually acquired HIV-1 infection. In this system, SP-D-4-1BBL or SP-D-BAFF led to significantly reduced vaccinia-Gag replication when compared to Ad5-Gag alone. In contrast, IL-12p70, SP-D-CD27L and SP-D-GITRL were not protective. Histological examination following vaccinia-Gag challenge showed a dramatic lymphocytic infiltration into the uterus and ovaries of SP-D-4-1BBL and SP-D-BAFF-treated animals. By day 5 post challenge, proinflammatory cytokines in the tissue were reduced, consistent with the enhanced control over viral replication. Splenocytes had no specific immune markers that correlated with protection induced by SP-D-4-1BBL and SP-D-BAFF versus other groups. IL-12p70, despite lack of anti-viral efficacy, increased the total numbers of splenic dextramer positive CD8+ T cells, effector memory T cells, and effector Gag-specific CD8+ T cells, suggesting that these markers are poor predictors of anti-viral immunity in this model. In conclusion, soluble multi-trimeric 4-1BBL and BAFF adjuvants led to strong protection from vaccinia-Gag challenge, but the protection was independent of standard immune markers. Soluble multi-trimeric SP-D-4-1BBL and SP-D-BAFF provide a novel technology to enhance adenoviral vector vaccines against HIV-1.	[Kanagavelu, Saravana; Termini, James M.; Gupta, Sachin; Raffa, Francesca N.; Fuller, Katherine A.; Rivas, Yaelis; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA; [Kanagavelu, Saravana; Termini, James M.; Gupta, Sachin; Raffa, Francesca N.; Fuller, Katherine A.; Rivas, Yaelis; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Kornbluth, Richard S.] Multimer Biotherapeut Inc, La Jolla, CA USA; [Philip, Sakhi] Univ Miami, Miller Sch Med, Dept Radiat Oncol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA.	gstone@med.miami.edu		Kornbluth, Richard/0000-0002-0218-2026	NIH [NIAID K22 AI-068489-01, NIAID 1P30AI073961]; University of Miami; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961, K22AI068489] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funders include: (1) NIH, NIAID K22 AI-068489-01, www.niaid.nih.gov; (2) University of Miami (Startup funds), www.miami.edu; and (3) NIH, NIAID 1P30AI073961 to the Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine (PI: Dr. Savita Pahwa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejo DM, 2013, VACCINE, V31, P2302, DOI 10.1016/j.vaccine.2013.02.060; Baliga CS, 2006, MOL THER, V14, P432, DOI 10.1016/j.ymthe.2006.02.021; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barratt-Boyes SM, 2006, J GEN VIROL, V87, P139, DOI 10.1099/vir.0.81445-0; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Bukczynski J, 2004, P NATL ACAD SCI USA, V101, P1291, DOI 10.1073/pnas.0306567101; Chacon JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060031; Cheng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033969; Cox KS, 2008, J VIROL, V82, P8161, DOI 10.1128/JVI.00620-08; Croft M, 2003, CYTOKINE GROWTH F R, V14, P265, DOI 10.1016/S1359-6101(03)00025-X; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch EC, 1998, BBA-MOL BASIS DIS, V1408, P278, DOI 10.1016/S0925-4439(98)00073-8; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Curran MA, 2013, J EXP MED, V210, P743, DOI 10.1084/jem.20121190; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Dolfi DV, 2008, J IMMUNOL, V180, P2912, DOI 10.4049/jimmunol.180.5.2912; Du XG, 2007, J GENE MED, V9, P136, DOI 10.1002/jgm.1004; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Ganguly S, 2010, VACCINE, V28, P1300, DOI 10.1016/j.vaccine.2009.11.020; Gri G, 2003, J IMMUNOL, V170, P99, DOI 10.4049/jimmunol.170.1.99; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Kanagavelu SK, 2012, VACCINE, V30, P691, DOI 10.1016/j.vaccine.2011.11.088; Kaufman DR, 2012, VACCINE, V30, P506, DOI 10.1016/j.vaccine.2011.11.079; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Kutzler MA, 2004, J CLIN INVEST, V114, P1241, DOI 10.1172/JCI200423467; Lee CT, 1997, HUM GENE THER, V8, P187, DOI 10.1089/hum.1997.8.2-187; Letvin NL, 2004, J VIROL, V78, P7490, DOI 10.1128/JVI.78.14.7490-7497.2004; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Liu J, 2008, VACCINE, V26, P4062, DOI 10.1016/j.vaccine.2008.05.018; Liu J, 2010, HUM VACCINES, V6, P355, DOI 10.4161/hv.6.4.10867; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; Massie B, 1998, CYTOTECHNOLOGY, V28, P53, DOI 10.1023/A:1008013211222; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McEnery Regina, 2011, IAVI Rep, V15, P17; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Melchers M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-48; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; MIMS CA, 1968, BRIT J EXP PATHOL, V49, P24; Moraes TJ, 2011, VACCINE, V29, P6301, DOI 10.1016/j.vaccine.2011.06.022; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Palazon A, 2011, CANCER RES, V71, P801, DOI 10.1158/0008-5472.CAN-10-1733; Penaloza-MacMaster P, 2013, J VIROL, V87, P1373, DOI 10.1128/JVI.02058-12; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Ratto-Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045840; Reynolds MR, 2012, VACCINE, V30, P4465, DOI 10.1016/j.vaccine.2012.04.082; Rowley TF, 2004, J IMMUNOL, V172, P6039, DOI 10.4049/jimmunol.172.10.6039; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shacklett BL, 2011, CURR OPIN HIV AIDS, V6, P202, DOI 10.1097/COH.0b013e3283453e2b; Shedlock DJ, 2011, VACCINE, V29, P6755, DOI 10.1016/j.vaccine.2010.12.064; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stone GW, 2006, CLIN VACCINE IMMUNOL, V13, P1223, DOI 10.1128/CVI.00198-06; Stone GW, 2006, J VIROL, V80, P1762, DOI 10.1128/JVI.80.4.1762-1772.2006; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Terabe M, 2008, J IMMUNOL, V180, P7276, DOI 10.4049/jimmunol.180.11.7276; van Olffen RW, 2009, J IMMUNOL, V182, P7490, DOI 10.4049/jimmunol.0802751; Vojnov L, 2011, VACCINE, V29, P7483, DOI 10.1016/j.vaccine.2011.07.048; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Xin KQ, 2005, GENE THER, V12, P1769, DOI 10.1038/sj.gt.3302590; Ye OR, 2004, EUR J IMMUNOL, V34, P2750, DOI 10.1002/eji.200425198; Yu H, 2011, J LEUKOC BIOL; Zhang SN, 2011, MOL THER, V19, P1558, DOI 10.1038/mt.2011.29; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	75	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90100	10.1371/journal.pone.0090100	http://dx.doi.org/10.1371/journal.pone.0090100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587225	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200125
J	McClellan, CM; Brereton, T; Dell'Amico, F; Johns, DG; Cucknell, AC; Patrick, SC; Penrose, R; Ridoux, V; Solandt, JL; Stephan, E; Votier, SC; Williams, R; Godley, BJ				McClellan, Catherine M.; Brereton, Tom; Dell'Amico, Florence; Johns, David G.; Cucknell, Anna-C.; Patrick, Samantha C.; Penrose, Rod; Ridoux, Vincent; Solandt, Jean-Luc; Stephan, Eric; Votier, Stephen C.; Williams, Ruth; Godley, Brendan J.			Understanding the Distribution of Marine Megafauna in the English Channel Region: Identifying Key Habitats for Conservation within the Busiest Seaway on Earth	PLOS ONE			English	Article							PORPOISES PHOCOENA-PHOCOENA; BOTTLE-NOSED DOLPHINS; ECOSYSTEM-BASED MANAGEMENT; HARBOR PORPOISES; COMMON DOLPHINS; BASKING SHARKS; SATELLITE TELEMETRY; DISTRIBUTION MODELS; HALICHOERUS-GRYPUS; NORTHERN GANNETS	The temperate waters of the North-Eastern Atlantic have a long history of maritime resource richness and, as a result, the European Union is endeavouring to maintain regional productivity and biodiversity. At the intersection of these aims lies potential conflict, signalling the need for integrated, cross-border management approaches. This paper focuses on the marine megafauna of the region. This guild of consumers was formerly abundant, but is now depleted and protected under various national and international legislative structures. We present a meta-analysis of available megafauna datasets using presence-only distribution models to characterise suitable habitat and identify spatially-important regions within the English Channel and southern bight of the North Sea. The integration of studies from dedicated and opportunistic observer programmes in the United Kingdom and France provide a valuable perspective on the spatial and seasonal distribution of various taxonomic groups, including large pelagic fishes and sharks, marine mammals, seabirds and marine turtles. The Western English Channel emerged as a hotspot of biodiversity for megafauna, while species richness was low in the Eastern English Channel. Spatial conservation planning is complicated by the highly mobile nature of marine megafauna, however they are important components of the marine environment and understanding their distribution is a first crucial step toward their inclusion into marine ecosystem management.	[McClellan, Catherine M.; Godley, Brendan J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Brereton, Tom] Marinelife, Bridport, Dorset, England; [Dell'Amico, Florence] Aquarium La Rochelle, Ctr Etud & Soins Tortues Marines, La Rochelle, France; [Johns, David G.] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [Cucknell, Anna-C.] Int Fund Anim Welf, Kelvedon, Essex, England; [Cucknell, Anna-C.] Marine Conservat Res Int, Kelvedon, Essex, England; [Patrick, Samantha C.] Univ Gloucestershire, Cheltenham, Glos, England; [Penrose, Rod] Marine Environm Monitoring, Llechryd, Ceredigion, Wales; [Ridoux, Vincent] Univ La Rochelle, CNRS, Observ PELAGIS, La Rochelle, France; [Solandt, Jean-Luc] Marine Conservat Soc, Ross On Wye, Hereford, England; [Stephan, Eric] Assoc Etud & Conservat Selaciens, Brest, France; [Votier, Stephen C.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Williams, Ruth] Cornwall Wildlife Trust, Truro, Cornwall, England	University of Exeter; University of Gloucestershire; Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; University of Exeter	McClellan, CM (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England.	c.mcclellan@exeter.ac.uk	godley, brendan/O-1959-2019; Votier, Stephen C/G-2348-2014; godley, brendan j/A-6139-2009	godley, brendan/0000-0003-3845-0034; Votier, Stephen C/0000-0002-0976-0167; godley, brendan j/0000-0003-3845-0034; Ridoux, Vincent/0000-0002-9779-9319; Johns, David/0000-0003-3270-6764	European Regional Development Fund as part of the CHannel integrated Approach for marine Resource Management (CHARM) Phase III project through EU; UK Department for Environment, Food and Rural Affairs (Defra); Department of Energy and Climate Change; EU LIFE Nature projects [LIFE 92-2/UK/027, LIFE04NAT/GB/000245]; devolved government in Scotland; devolved government in Wales; Division Of Ocean Sciences [1154661] Funding Source: National Science Foundation	European Regional Development Fund as part of the CHannel integrated Approach for marine Resource Management (CHARM) Phase III project through EU; UK Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Department of Energy and Climate Change; EU LIFE Nature projects; devolved government in Scotland; devolved government in Wales; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The INTERREG IV A France (Channel) - England cross-border European cooperation programme, co-financed by the European Regional Development Fund as part of the CHannel integrated Approach for marine Resource Management (CHARM) Phase III project provided funding for the meta-analysis presented in this manuscript through EU postdoctoral fellowships to C. McClellan and S. Patrick. R. Deaville provided the UK cetacean strandings data, which together with the marine turtle data was co-funded by the UK Department for Environment, Food and Rural Affairs (Defra) and by the devolved governments in Scotland and Wales. G. Bradbury and J. Darke provided data from the UK's Wildfowl and Wetlands Trust, which was funded by the Department of Energy and Climate Change. T. Dunn provided the Joint Cetacean Database and the European Seabirds at Sea data. P. S. Hammond provided the SCANS and SCANS-II data funded by EU LIFE Nature projects LIFE 92-2/UK/027 and LIFE04NAT/GB/000245, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Baumgartner MF, 1997, MAR MAMMAL SCI, V13, P614, DOI 10.1111/j.1748-7692.1997.tb00087.x; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Buleon P, 2008, CHANNEL SPACES WORLD; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Camphuysen Kees C. J., 2004, Lutra, V47, P113; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Cheney B, 2013, MAMMAL REV, V43, P71, DOI 10.1111/j.1365-2907.2011.00208.x; Chesworth J.C., 2010, SOLENT SEAL TAGGING; Alves MDD, 2013, BIOL CONSERV, V161, P91, DOI 10.1016/j.biocon.2013.02.015; De Smet W.M.A., 1981, FAO FISHERIES SERIES, V5, P301; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; DUGUY R, 1982, Annales de la Societe des Sciences Naturelles de la Charente-Maritime, V6, P1029; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Embling CB, 2010, BIOL CONSERV, V143, P267, DOI 10.1016/j.biocon.2009.09.005; ESRI, 2009, ARCGIS; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; European Commission, 2008, OFFICIAL J EUROPEAN, VL164, P19, DOI DOI 10.1016/J.MARENVRES.2012.03.003; EVANS PGH, 1980, MAMMAL REV, V10, P1, DOI 10.1111/j.1365-2907.1980.tb00232.x; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Game ET, 2009, ECOL LETT, V12, P1336, DOI 10.1111/j.1461-0248.2009.01384.x; Garthe S, 2004, J APPL ECOL, V41, P724, DOI 10.1111/j.0021-8901.2004.00918.x; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Grecian WJ, 2012, BIOL CONSERV, V156, P43, DOI 10.1016/j.biocon.2011.12.010; Gremillet D, 2006, MAR ECOL PROG SER, V319, P15, DOI 10.3354/meps319015; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamazaki T, 2002, MAR MAMMAL SCI, V18, P920, DOI 10.1111/j.1748-7692.2002.tb01082.x; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; Hammond PS, 2002, J APPL ECOL, V39, P361, DOI 10.1046/j.1365-2664.2002.00713.x; Hardisty J, 1990, BRIT SEAS INTRO OCEA, V34; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; HOSMER DW, 1989, APPL LOGISTIC REGRES; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Hsu RCC, 2012, DIVERS DISTRIB, V18, P334, DOI 10.1111/j.1472-4642.2011.00819.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Jewell R, 2012, MAR ECOL PROG SER, V453, P227, DOI 10.3354/meps09636; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Jung JL, 2009, J MAR BIOL ASSOC UK, V89, P1045, DOI 10.1017/S0025315409000307; Kiszka Jeremy, 2004, Lutra, V47, P33; Kiszka J, 2007, ICES J MAR SCI, V64, P1033, DOI 10.1093/icesjms/fsm067; Kober K, 2010, 431 JOINT NAT CONS C; Leeney RH, 2012, J MAR BIOL ASSOC UK, V92, P1823, DOI 10.1017/S002531541100155X; Leeney RH, 2010, J MAR BIOL ASSOC UK, V90, P1033, DOI 10.1017/S0025315409991512; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lubchenco J, 2003, ECOL APPL, V13, pS3; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Macleod CD, 2008, J MAR BIOL ASSOC UK, V88, P1193, DOI 10.1017/S002531540800074X; Macleod CD, 2009, J MAR BIOL ASSOC UK, V89, P1059, DOI 10.1017/S0025315408002828; Arcos JM, 2012, BIOL CONSERV, V156, P30, DOI 10.1016/j.biocon.2011.12.011; Marks KM, 2006, MAR GEOPHYS RES, V27, P19, DOI 10.1007/s11001-005-2095-4; Marubini F, 2009, MAR ECOL PROG SER, V381, P297, DOI 10.3354/meps07893; Matthiopoulos J, 2004, J APPL ECOL, V41, P476, DOI 10.1111/j.0021-8901.2004.00911.x; McClellan Catherine M., 2010, Endangered Species Research, V10, P165, DOI 10.3354/esr00199; McClellan CM, 2009, ECOL APPL, V19, P1660, DOI 10.1890/08-1091.1; McMahon CR, 2009, OECOLOGIA, V159, P69, DOI 10.1007/s00442-008-1205-9; Mitchell PI, 2004, SEABIRD POPULATIONS; Musick J. A., 1999, AM FISHERIES SOC S; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Norse Elliott A., 2005, P302; Norse EA, 2010, B MAR SCI, V86, P179; OBrien J., 2009, J CETACEAN RES MANAG, V11, P71; Pais MP, 2012, OCEAN COAST MANAGE, V69, P173, DOI 10.1016/j.ocecoaman.2012.06.009; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pikesley SK, 2012, J MAR BIOL ASSOC UK, V92, P1809, DOI 10.1017/S0025315411000464; Pingree R.D., 1980, Elsevier Oceanography Series, V24B, P415; PINGREE RD, 1978, J GEOPHYS RES-OCEANS, V83, P4615, DOI 10.1029/JC083iC09p04615; PINGREE RD, 1974, J MAR BIOL ASSOC UK, V54, P469, DOI 10.1017/S0025315400058653; PINGREE RD, 1987, J MAR BIOL ASSOC UK, V67, P691, DOI 10.1017/S0025315400056976; PINGREE RD, 1986, ESTUAR COAST SHELF S, V23, P581, DOI 10.1016/0272-7714(86)90100-9; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Read AJ, 1997, MAR BIOL, V130, P315, DOI 10.1007/s002270050251; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Reid J.B., 2003, ATLAS CETACEAN DISTR; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Ryan C, 2011, IRISH NAT J, V31, P1; SELZER LA, 1988, MAR MAMMAL SCI, V4, P141, DOI 10.1111/j.1748-7692.1988.tb00194.x; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2002, J MAR BIOL ASSOC UK, V82, P927, DOI 10.1017/S0025315402006409; Skov H, 2008, ECOL MODEL, V212, P504, DOI 10.1016/j.ecolmodel.2007.11.006; Southhall EJ, 2005, J MAR BIOL ASSOC UK, V85, P1083, DOI 10.1017/S0025315405012129; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Srokosz M, 2012, B AM METEOROL SOC, V93, P1663, DOI 10.1175/BAMS-D-11-00151.1; Stone C.J., 1995, ATLAS SEABIRD DISTRI; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; Tetley MJ, 2008, REMOTE SENS ENVIRON, V112, P3449, DOI 10.1016/j.rse.2007.10.015; Thorne LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043167; Vincent C, 2005, BIOL CONSERV, V126, P62, DOI 10.1016/j.biocon.2005.04.022; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; Witt MJ, 2007, MAR ECOL PROG SER, V337, P231, DOI 10.3354/meps337231; Witt MJ, 2012, MAR ECOL PROG SER, V459, P121, DOI 10.3354/meps09737; Wolff WJ, 2000, BIOL CONSERV, V95, P209, DOI 10.1016/S0006-3207(00)00035-5; Wood CJ, 1998, J ZOOL, V246, P155, DOI 10.1017/S0952836998010048; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X; Wynn RB, 2007, BIOL LETTERS, V3, P529, DOI 10.1098/rsbl.2007.0162; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.09.015; Zacharias MA, 2000, CONSERV BIOL, V14, P1327, DOI 10.1046/j.1523-1739.2000.99191.x	126	45	47	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89720	10.1371/journal.pone.0089720	http://dx.doi.org/10.1371/journal.pone.0089720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586985	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000332396200076
J	Zhang, ZH; Liu, ZH; Hu, YM; Li, WH; Fu, ZY; Ding, D; Li, HC; Qiao, MM; Tang, JH				Zhang, Zhanhui; Liu, Zonghua; Hu, Yanmin; Li, Weihua; Fu, Zhiyuan; Ding, Dong; Li, Haochuan; Qiao, Mengmeng; Tang, Jihua			QTL Analysis of Kernel-Related Traits in Maize Using an Immortalized F-2 Population	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; GRAIN-YIELD; GENETIC ARCHITECTURE; ENZYME-ACTIVITIES; WATER-DEFICIT; SINK CAPACITY; COMPONENTS; ENDOSPERM; WEIGHT; LOCI	Kernel size and weight are important determinants of grain yield in maize. In this study, multivariate conditional and unconditional quantitative trait loci (QTL), and digenic epistatic analyses were utilized in order to elucidate the genetic basis for these kernel-related traits. Five kernel-related traits, including kernel weight (KW), volume (KV), length (KL), thickness (KT), and width (KWI), were collected from an immortalized F-2 (IF2) maize population comprising of 243 crosses performed at two separate locations over a span of two years. A total of 54 unconditional main QTL for these five kernel-related traits were identified, many of which were clustered in chromosomal bins 6.04-6.06, 7.02-7.03, and 10.06-10.07. In addition, qKL3, qKWI6, qKV10a, qKV10b, qKW10a, and qKW7a were detected across multiple environments. Sixteen main QTL were identified for KW conditioned on the other four kernel traits (KL, KWI, KT, and KV). Thirteen main QTL were identified for KV conditioned on three kernel-shape traits. Conditional mapping analysis revealed that KWI and KV had the strongest influence on KW at the individual QTL level, followed by KT, and then KL; KV was mostly strongly influenced by KT, followed by KWI, and was least impacted by KL. Digenic epistatic analysis identified 18 digenic interactions involving 34 loci over the entire genome. However, only a small proportion of them were identical to the main QTL we detected. Additionally, conditional digenic epistatic analysis revealed that the digenic epistasis for KW and KV were entirely determined by their constituent traits. The main QTL identified in this study for determining kernel-related traits with high broad-sense heritability may play important roles during kernel development. Furthermore, digenic interactions were shown to exert relatively large effects on KL (the highest AA and DD effects were 4.6% and 6.7%, respectively) and KT (the highest AA effects were 4.3%).	[Zhang, Zhanhui; Liu, Zonghua; Hu, Yanmin; Li, Weihua; Fu, Zhiyuan; Ding, Dong; Li, Haochuan; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China; [Qiao, Mengmeng] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Henan Agricultural University; Michigan Technological University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	tangjihua1@163.com	Zhang, Zhanhui/AAX-9545-2021	fu, zhiyuan/0000-0002-9078-5133	National Project 973 of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]	National Project 973 of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was funded by grant support from the National Project 973 of China (2012CB723001) and the National High Technology Research and Development Program of China (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2009, CROP SCI, V49, P999, DOI 10.2135/cropsci2008.08.0475; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Carlson SJ, 1999, PLANT PHYSIOL, V121, P1025, DOI 10.1104/pp.121.3.1025; COCKERHAM CC, 1954, GENETICS, V39, P859; Cui F, 2013, MOL BREEDING, V31, P265, DOI 10.1007/s11032-012-9786-8; Cui F, 2011, J GENET, V90, P409, DOI 10.1007/s12041-011-0103-9; Cui F, 2011, THEOR APPL GENET, V122, P1517, DOI 10.1007/s00122-011-1551-6; GOLDMAN IL, 1993, THEOR APPL GENET, V87, P217, DOI 10.1007/BF00223767; Guo JF, 2008, AFR J BIOTECHNOL, V7, P1829; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hua JP, 2002, GENETICS, V162, P1885; Jones RJ, 1996, CROP SCI, V36, P301, DOI 10.2135/cropsci1996.0011183X003600020015x; Li M, 2010, PLANT SCI, V178, P454, DOI 10.1016/j.plantsci.2010.02.019; Li YongXiang, 2009, Scientia Agricultura Sinica, V42, P408; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZongHua, 2007, Scientia Agricultura Sinica, V40, P2409; Ma XQ, 2007, MOL BREEDING, V20, P41, DOI 10.1007/s11032-006-9071-9; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; OBER ES, 1991, PLANT PHYSIOL, V97, P154, DOI 10.1104/pp.97.1.154; Peng B, 2011, THEOR APPL GENET, V122, P1305, DOI 10.1007/s00122-011-1532-9; SAS S., 2009, STAT US GUID VERS 9; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Tang JiHua, 2007, Acta Agronomica Sinica, V33, P1299; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; Vilhar B, 2002, PLANT PHYSIOL, V129, P23, DOI 10.1104/pp.001826; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Yan JB, 2006, EUPHYTICA, V149, P121, DOI 10.1007/s10681-005-9060-9; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Young TE, 2000, PLANT MOL BIOL, V44, P283, DOI 10.1023/A:1026588408152; Young TE, 2000, PLANT MOL BIOL, V42, P397, DOI 10.1023/A:1006333103342; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang Z, 2013, PLOS ONE, V8; Zhao JY, 2006, THEOR APPL GENET, V113, P33, DOI 10.1007/s00122-006-0267-5; ZHU J, 1995, GENETICS, V141, P1633	41	48	56	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89645	10.1371/journal.pone.0089645	http://dx.doi.org/10.1371/journal.pone.0089645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586932	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200067
J	Bachmaier, K; Toya, S; Malik, AB				Bachmaier, Kurt; Toya, Sophie; Malik, Asrar B.			Therapeutic Administration of the Chemokine CXCL1/KC Abrogates Autoimmune Inflammatory Heart Disease	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; INNATE IMMUNITY; FOXP3-EXPRESSING CD25(+); DILATED CARDIOMYOPATHY; DENDRITIC CELLS; MYOCARDITIS; MICE; TOLL-LIKE-RECEPTOR-4; LIPOPOLYSACCHARIDE	Myocarditis, often due to an aberrant immune response to infection, is a major cause of dilated cardiomyopathy. Microbial pattern recognition receptors, such as TLRs, orchestrate the cytokine and chemokine responses that augment or limit the severity of myocarditis. Using the mouse model of experimental autoimmune myocarditis (EAM), in which disease is induced by immunization with a heart-specific self peptide and the agonist to multiple TLRs, complete Freund's adjuvant, we found that increased serum concentrations of the chemokine CXCL1/KC correlated directly with decreased severity of myocarditis. To directly test whether CXCL1/KC caused the amelioration of myocarditis, we treated mice, after challenge with heart-specific self peptide, with exogenous recombinant CXCL1/KC. We found that the administration of recombinant mouse CXCL1/KC completely abrogated heart inflammatory infiltration and cardiomyocyte damage. Moreover, we show that TLR4 signaling is required to increase serum protein concentrations of CXCL1/KC in EAM, and we demonstrate that the administration of the TLR4 agonist LPS significantly decreased severity and prevalence of EAM and reduced the number of heart-specific self peptide reactive effector T cells. These findings reveal a novel function of CXCL1/KC in the context of organ-specific autoimmune disease that may prove useful for the treatment of inflammatory conditions that underlie human heart disease.	[Bachmaier, Kurt; Toya, Sophie; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bachmaier, K (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60680 USA.	kbachmai@uic.edu	Bachmaier, Kurt/AHC-5491-2022; Bachmaier, Kurt/B-6331-2014	Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; Malik, Asrar/0000-0002-8205-7128	US National Institutes of Health [P01 HL77806, PO1 HL60678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, P01HL077806, R01HL090152] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by US National Institutes of Health grants P01 HL77806 and PO1 HL60678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva M, 2001, CIRCULATION, V104, P3145, DOI 10.1161/hc5001.100629; Afanasyeva M, 2001, AM J PATHOL, V159, P193, DOI 10.1016/S0002-9440(10)61685-9; Bachmaier K, 1997, CIRCULATION, V96, P585; Bachmaier K, 1997, CIRCULATION, V95, P655, DOI 10.1161/01.CIR.95.3.655; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bachmaier K, 1999, SCIENCE, V283, P1335, DOI 10.1126/science.283.5406.1335; BACHMAIER K, 1995, CIRCULATION, V92, P1927, DOI 10.1161/01.CIR.92.7.1927; Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Baughman KL, 2006, CIRCULATION, V113, P593, DOI 10.1161/CIRCULATIONAHA.105.589663; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Coats SR, 2003, INFECT IMMUN, V71, P6799, DOI 10.1128/IAI.71.12.6799-6807.2003; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Correale J, 2011, MULT SCLER J, V17, P1162, DOI 10.1177/1352458511418027; Cunningham MW, 2009, CIRC RES, V105, P403, DOI 10.1161/CIRCRESAHA.109.205195; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; DONERMEYER DL, 1995, J EXP MED, V182, P1291, DOI 10.1084/jem.182.5.1291; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Eriksson U, 2001, J IMMUNOL, V167, P5464, DOI 10.4049/jimmunol.167.9.5464; Fairweather D, 2003, J IMMUNOL, V170, P4731, DOI 10.4049/jimmunol.170.9.4731; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; GROGAN M, 1995, J AM COLL CARDIOL, V26, P80, DOI 10.1016/0735-1097(95)00148-S; Hizo-Abes P, 2012, CANADIAN MED ASS J; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Magnani JW, 2006, CIRCULATION, V113, P876, DOI 10.1161/CIRCULATIONAHA.105.584532; Marty RR, 2006, CIRCULATION, V113, P258, DOI 10.1161/CIRCULATIONAHA.105.564294; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nishikubo K, 2007, J AUTOIMMUN, V29, P146, DOI 10.1016/j.jaut.2007.07.001; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Riad A, 2012, J BIOL CHEM, V287, P27236, DOI 10.1074/jbc.M112.369728; Roberts BJ, 2013, EXP MOL PATHOL, V94, P58, DOI 10.1016/j.yexmp.2012.06.005; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Tarabishy AB, 2008, J IMMUNOL, V181, P593, DOI 10.4049/jimmunol.181.1.593; Valaperti A, 2008, J IMMUNOL, V180, P2686, DOI 10.4049/jimmunol.180.4.2686; VOGEL SN, 1994, INFECT IMMUN, V62, P4454, DOI 10.1128/IAI.62.10.4454-4459.1994; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Yamashita T, 2011, CARDIOVASC RES, V91, P640, DOI 10.1093/cvr/cvr148	51	13	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89647	10.1371/journal.pone.0089647	http://dx.doi.org/10.1371/journal.pone.0089647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586934	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800032
J	Cingolani, A; Cozzi-Lepri, A; Ammassari, A; Mussini, C; Ursitti, MA; Caramello, P; Angarano, G; Bonfanti, P; De Luca, A; Mura, MS; Girardi, E; Antinori, A; Monforte, AD				Cingolani, Antonella; Cozzi-Lepri, Alessandro; Ammassari, Adriana; Mussini, Cristina; Ursitti, Maria Alessandra; Caramello, Pietro; Angarano, Gioacchino; Bonfanti, Paolo; De Luca, Andrea; Mura, Maria Stella; Girardi, Enrico; Antinori, Andrea; Monforte, Antonela D'Arminio		Icona Foundation Study GrP	Timing of Antiretroviral Therapy Initiation after a First AIDS-Defining Event: Temporal Changes in Clinical Attitudes in the ICONA Cohort	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ADULTS; TIME	Background: Time of starting antiretroviral therapy (ART) after diagnosis of specific AIDS-defining event (ADE) is a crucial aspect. Objectives of this study were to evaluate if in patients diagnosed with ADE the time to ART initiation may vary according to year of diagnosis and type of ADE. Methods: All HIV+ persons diagnosed with an ADE over the 6 months prior to or after enrolment in the Icona Foundation study cohort and while ART-naive were grouped according to type of diagnosis: Those with ADE requiring medications interacting with ART [group A], those with ADE treatable only with ART [B] and other ADE [C]. Survival analysis by Kaplan-Meier was used to estimate the percentage of people starting ART, overall and after stratification for calendar period and ADE group. Multivariable Cox regression model was used to investigate association between calendar year of specific ADE and time to ART initiation. Results: 720 persons with first ADE were observed over 1996-2013 (group A, n = 171; B, n = 115; C, n = 434). By 30 days from diagnosis, 27% (95% CI: 22-32) of those diagnosed in 1996-2000 had started ART vs. 32% (95% CI: 24-40) in 2001-2008 and 43% (95% CI: 33-47) after 2008 (log-rank p = 0.001). The proportion of patients starting ART by 30 days was 13% (95% CI 7-19), 40% (95% CI: 30-50) and 38% (95% CI 33-43) in ADE groups A, B and C (log-rank p = 0.0001). After adjustment for potential confounders, people diagnosed after 2008 remained at increased probability of starting ART more promptly than those diagnosed in 1996-1999 (AHR 1.72 (95% CI 1.16-2.56). Conclusions: In our "real-life" setting, the time from ADE to ART initiation was significantly shorter in people diagnosed in more recent years, although perhaps less prompt than expected.	[Cingolani, Antonella] Cathol Univ, Inst Infect Dis, Dept Publ Hlth, Rome, Italy; [Cozzi-Lepri, Alessandro] UCL, Res Dept Infect Populat Hlth, London, England; [Ammassari, Adriana] Natl Inst Infect Dis L Spallanzani, Clin Dept, Rome, Italy; [Mussini, Cristina] Univ Modena & Reggio Emilia, Inst Infect Dis, Modena, Italy; [Ursitti, Maria Alessandra] S Maria Nuova IRCCS Hosp, Dept Infect Dis, Reggio Emilia, Italy; [Caramello, Pietro] Amedeo Savoia Hosp, Dept Infect Dis, Infect & Trop Dis Unit, Turin, Italy; [Angarano, Gioacchino] Univ Bari, Dept Infect Dis, Bari, Italy; [Bonfanti, Paolo] A Manzoni Hosp, Infect Dis Unit, Lecce, Italy; [De Luca, Andrea] Azienda Osped Univ Senese, Univ Infect Dis Unit, Dept Internal & Specialty Med, Siena, Italy; [Mura, Maria Stella] Univ Sassari, Dept Infect Dis, Sassari, Italy; [Girardi, Enrico] Natl Inst Infect Dis L Spallanzani, Dept Epidemiol, Rome, Italy; [Monforte, Antonela D'Arminio] Surg & Dent Univ Milan, Clin Infect Dis, San Paolo Hosp, Dept Med, Milan, Italy	Catholic University of the Sacred Heart; University of London; University College London; IRCCS Lazzaro Spallanzani; Universita di Modena e Reggio Emilia; Universita degli Studi di Bari Aldo Moro; University of Siena; University Hospital of Siena; University of Sassari; IRCCS Lazzaro Spallanzani; San Paolo-Polo Universitaria Hospital	Cingolani, A (corresponding author), Cathol Univ, Inst Infect Dis, Dept Publ Hlth, Rome, Italy.	a.cingolani@rm.unicatt.it	Mussini, Cristina/K-8672-2016; De Luca, Andrea/G-8810-2011; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; Cingolani, antonella/J-8921-2018; Antinori, Andrea/K-7125-2016; Bonfanti, Paolo/AAK-9800-2020	Mussini, Cristina/0000-0002-6615-4198; De Luca, Andrea/0000-0002-9561-9193; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; Cingolani, antonella/0000-0002-3793-2755; Antinori, Andrea/0000-0003-2121-4684; Bonfanti, Paolo/0000-0001-7289-8823; d'Arminio Monforte, Antonella/0000-0003-0073-1789; Ammassari, Adriana/0000-0002-0284-0340; ANGARANO, Gioacchino/0000-0003-3207-7523; Girardi, Enrico/0000-0001-8182-5896	Abbott; Bristol-Myers Squibb; Gilead; JANNSEN; ViiV	Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); JANNSEN; ViiV	The Icona Foundation Study is supported by unrestricted educational grants of Abbott, Bristol-Myers Squibb, Gilead, JANNSEN, ViiV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GUID PREV TREATM OPP; [Anonymous], 2009, CLIN MAN TREATM HIV; [Anonymous], 1993, MMWR RECOMM REP, V41, P1; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Antinori A, 2012, NEW MICROBIOL, V35, P113; Bisson GP, 2013, CLIN INFECT DIS, V56, P1165, DOI 10.1093/cid/cit019; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulanger C, 2009, CLIN INFECT DIS, V49, P1305, DOI 10.1086/606056; Boulware D, 2013, 20 C RETR OPP INF 3; Centers for Disease Control and Prevention, MAN DRUG INT TREATM; Cingolani A, 2010, AIDS, V24, P2408, DOI 10.1097/QAD.0b013e32833db989; Daniel RM, 2013, STAT MED, V32, P1584, DOI 10.1002/sim.5686; Geng EH, 2011, CLIN INFECT DIS, V53, P1008, DOI 10.1093/cid/cir608; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Khachi H, 2009, J ANTIMICROB CHEMOTH, V64, P871, DOI 10.1093/jac/dkp263; Miro JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026009; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Monforte AD, 2011, ANTIVIR THER, V16, P1103, DOI 10.3851/IMP1883; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Sax PE, 2010, HIV CLIN TRIALS, V11, P248, DOI 10.1310/hct1105-248; Zolopa A, 2008, 15 CROI BOST MA; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89861	10.1371/journal.pone.0089861	http://dx.doi.org/10.1371/journal.pone.0089861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587081	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800049
J	Jia, YN; Usagawa, T; Fu, H				Jia, Yingnan; Usagawa, Tricia; Fu, Hua			The Association between Walking and Perceived Environment in Chinese Community Residents: A Cross-Sectional Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; NEIGHBORHOOD ENVIRONMENT; BUILT ENVIRONMENT; ADULTS; HEALTH; RECOMMENDATIONS; ATTRIBUTES; NUTRITION	Background: The neighborhood environment, as a determinant of walking, has been assessed in several developed countries. However, few studies have investigated these associations in Chinese populations. Objective: To examine the association between the perceived neighborhood environment and walking for recreation or transportation purposes among Chinese community residents. Methods: We used a multi-stage stratified random sampling design to conduct a cross-sectional study of 1528 Chinese adults in Shanghai. Environmental and walking variables were assessed using a revised Abbreviated Neighborhood Environment Walkability Scale for Chinese subjects and a long version of International Physical Activity Questionnaire. Self-reported demographic variables including gender, age, employment status, and location of community were also collected. Multiple logistic regression analysis was applied to examine the association between the neighborhood environment and walking. Results: Based on the results of IPAQ, 13.7% of the overall subjects were physical inactive, which was considered to be lowly active. For all participants, accessibility to services was significantly associated with walking for both recreation and transportation (odds ratio = 1.062, 95% confidence interval: 1.016, 1.110; odds ratio = 1.053; 95% confidence interval: 1.008, 1.100, respectively). In males, accessibility to services was significantly associated both with walking for recreation and walking for transportation. However, a significantly negative association was found between the neighborhood surroundings and walking for recreation. In contrast, females who perceived good traffic safety tended to walk for recreation. Data also revealed a difference between working and retired individuals. Among working participants, perceived environmental variables were not significantly associated with walking for recreation and transportation. Conclusions: The association between neighborhood environment and walking varied depending on the reason for walking and the characteristics of the participants. Our findings suggest that interventions to promote walking in community residents should include improving the neighborhood environment, particularly accessibility to services such as building more stores, parks, and public transit facilities.	[Jia, Yingnan; Fu, Hua] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Jia, Yingnan; Fu, Hua] Fudan Univ, Hlth Commun Inst, Shanghai 200433, Peoples R China; [Usagawa, Tricia] Univ Hawaii, Off Publ Hlth Studies, Honolulu, HI 96822 USA	Fudan University; Fudan University; University of Hawaii System	Fu, H (corresponding author), Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Sch Publ Hlth, Shanghai 200433, Peoples R China.	hfu@fudan.edu.cn			World Health Organization	World Health Organization(World Health Organization)	The study was supported by the World Health Organization. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-34; Bamana A, 2008, J PUBLIC HEALTH-UK, V30, P274, DOI 10.1093/pubmed/fdn041; Cerin E, 2012, J URBAN HLTH; Cerin E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-851; Chen TA, 2013, ENV HLTH PREV MED; Chen Xiao-rong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P399; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Duncan Mitch J, 2005, Int J Behav Nutr Phys Act, V2, P11, DOI 10.1186/1479-5868-2-11; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS213, DOI 10.1123/jpah.7.s2.s213; Herazo-Beltrán Yaneth, 2010, Rev. salud pública, V12, P744; Hill JO, 2004, AM J PREV MED, V27, P111, DOI 10.1016/j.amepre.2004.06.010; Huang SJ, 2010, HEALTH PLACE, V16, P470, DOI 10.1016/j.healthplace.2009.12.004; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Inoue S, 2011, J EPIDEMIOL, V21, P481, DOI 10.2188/jea.JE20110044; Inoue S, 2010, J EPIDEMIOL, V20, P277, DOI 10.2188/jea.JE20090120; Jia Yu-jian, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1078; Kirby AM, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-63; Li Chao, 2011, Occupation and Health, V27, P1321; Lv TJ, 2010, CHINESE PRIMARY HLTH, V24, P42; MACFARLANE D, 2010, PUBLIC HEALTH NUTR, P1; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Oyeyemi AL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-294; Qin L, 2010, DIABETES CARE, V33, P2342, DOI 10.2337/dc10-0369; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Salanave B, 2012, PUBLIC HEALTH NUTR, V15, P2054, DOI 10.1017/S1368980012003278; Stronegger WJ, 2010, HEALTH PLACE, V16, P736, DOI 10.1016/j.healthplace.2010.03.005; Taylor VM, 2012, J COMMUN HEALTH, V37, P1040, DOI 10.1007/s10900-011-9528-6; Troped PJ, 2011, AM J PREV MED, V41, P473, DOI 10.1016/j.amepre.2011.07.023; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Van Cauwenberg J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-85; Van Dyck D, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-70; Vanhees L, 2012, EUR J PREV CARDIOL, V19, P670, DOI 10.1177/2047487312437059; Wallmann B, 2012, EUR J PUBLIC HEALTH, V22, P502, DOI 10.1093/eurpub/ckr069; Wang Shu-mei, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1033; Weber CM, 2012, J ENV PUBLIC HLTH, V2012; Yao LY, 2006, P 6 INT C TRANSP PRO; Zhou R, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/239595; [周热娜 ZHOU Rena], 2011, [中国公共卫生, China Public Health], V27, P841	43	25	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90078	10.1371/journal.pone.0090078	http://dx.doi.org/10.1371/journal.pone.0090078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587214	Green Published, gold			2022-12-27	WOS:000332390800072
J	Schafer, K; Di Pietro, A; Gow, NAR; MacCallum, D				Schaefer, Katja; Di Pietro, Antonio; Gow, Neil A. R.; MacCallum, Donna			Murine Model for Fusarium oxysporum Invasive Fusariosis Reveals Organ-Specific Structures for Dissemination and Long-Term Persistence	PLOS ONE			English	Article							ENZYME-IMMUNOASSAY; FUNGAL BURDEN; INFECTION; VIRULENCE; ASPERGILLOSIS; DIAGNOSIS; PATHOGEN; SKIN; CHLAMYDOSPORES; KERATITIS	The soil-borne plant pathogen Fusarium oxysporum causes life-threatening invasive fusariosis in immunocompromised individuals. The mechanism of infection in mammalian hosts is largely unknown. In the present study we show that the symptoms of disseminated fusariosis caused by F. oxysporum in immunosuppressed mice are remarkably similar to those reported in humans. Distinct fungal structures were observed inside the host, depending on the infected organ. Invasive hyphae developed in the heart and kidney, causing massive colonization of the organs. By contrast, chlamydospore-like survival structures were found in lung, spleen and liver. Systemically infected mice also developed skin and eye infections, as well as thrombosis and necrosis in the tail. We further show that F. oxysporum can disseminate and persist in the organs of immunocompetent animals, and that these latent infections can lead to lethal systemic fusariosis if the host is later subjected to immunosuppressive treatment.	[Schaefer, Katja; Di Pietro, Antonio] Univ Cordoba, Dept Genet, Cordoba, Spain; [Gow, Neil A. R.; MacCallum, Donna] Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland	Universidad de Cordoba; University of Aberdeen	Schafer, K (corresponding author), Univ Cordoba, Dept Genet, Cordoba, Spain.	k_scha11@hotmail.de	Schäfer, Katrin/P-4728-2015; Di Pietro, Antonio/K-9220-2014; MacCallum, Donna M./D-7897-2011; GOW, Neil/AAS-5323-2021	Di Pietro, Antonio/0000-0001-5930-5763; MacCallum, Donna M./0000-0003-4833-0378; GOW, Neil/0000-0002-2776-5850	Marie Curie Initial Training Netwok ARIADNE [FP7-PEOPLE-ITN-237936]; Spanish Ministerio de Economia y Competitividad (MINECO) [BIO2010-15505]; Wellcome Trust [080088, 086827, 075470, 099215, 097377, HEALTH-F2-2010-260338-ALLFUN]	Marie Curie Initial Training Netwok ARIADNE; Spanish Ministerio de Economia y Competitividad (MINECO); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the following grants: Marie Curie Initial Training Netwok ARIADNE (FP7-PEOPLE-ITN-237936) to NARG and ADP; BIO2010-15505 from the Spanish Ministerio de Economia y Competitividad (MINECO) to ADP; Wellcome Trust (080088, 086827, 075470 and 099215) including a Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology 097377 and FP7-2007-2013 grant agreement HEALTH-F2-2010-260338-ALLFUN to NARG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAISSIE E, 1991, EUR J CLIN MICROBIOL, V10, P665, DOI 10.1007/BF01975823; [Anonymous], 1987, NATURE WILT DIS PLAN; Bharathi M. Jayahar, 2003, Indian Journal of Ophthalmology, V51, P315; Bodey GP, 2002, J AM ACAD DERMATOL, V47, P659, DOI 10.1067/mjd.2002.123489; Boutati EI, 1997, BLOOD, V90, P999, DOI 10.1182/blood.V90.3.999.999_999_1008; COUTEAUDIER Y, 1990, CAN J MICROBIOL, V36, P551, DOI 10.1139/m90-096; de Pauw BE, 1999, CHEMOTHERAPY, V45, P1, DOI 10.1159/000048465; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Dignani MC, 2004, CLIN MICROBIOL INFEC, V10, P67, DOI 10.1111/j.1470-9465.2004.00845.x; Fan Y, 2010, CASE REP DERMATOL, V2, P76, DOI 10.1159/000313934; FOSTER CS, 1992, INFECT DIS CLIN N AM, V6, P851; Gonzalez GM, 2013, MYCOPATHOLOGIA, V176, P219, DOI 10.1007/s11046-013-9687-3; GUARRO J, 1995, EUR J CLIN MICROBIOL, V14, P741, DOI 10.1007/BF01690988; GUGNANI HC, 1976, BRIT J OPHTHALMOL, V60, P607, DOI 10.1136/bjo.60.9.607; Ishibashi Y, 1982, Nippon Ganka Gakkai Zasshi, V86, P651; Jones D B, 1970, Trans Ophthalmol Soc U K, V89, P781; KONO Y, 1995, BBA-MOL CELL RES, V1268, P35, DOI 10.1016/0167-4889(95)00069-5; LIESEGANG TJ, 1980, AM J OPHTHALMOL, V90, P38, DOI 10.1016/S0002-9394(14)75075-5; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Low Chian-Yong, 2011, F1000 Med Rep, V3, P14, DOI 10.3410/M3-14; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; Martinez-Rocha AL, 2008, CELL MICROBIOL, V10, P1339, DOI 10.1111/j.1462-5822.2008.01130.x; Mayayo E, 1999, J MED MICROBIOL, V48, P363, DOI 10.1099/00222615-48-4-363; Musher B, 2004, J CLIN MICROBIOL, V42, P5517, DOI 10.1128/JCM.42.12.5517-5522.2004; Naggie S, 2009, CLIN CHEST MED, V30, P337, DOI 10.1016/j.ccm.2009.02.009; Nelson P.E., 1981, FUNGAL WILT DIS PLAN, P51, DOI [10.1016/B978-0-12-464450-2.50008-5, DOI 10.1016/B978-0-12-464450-2.50008-5]; NELSON PE, 1994, CLIN MICROBIOL REV, V7, P479, DOI 10.1128/CMR.7.4.479-504.1994; Nucci M, 2002, CLIN INFECT DIS, V35, P909, DOI 10.1086/342328; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Nucci M, 2006, INFECT DIS CLIN N AM, V20, P563, DOI 10.1016/j.idc.2006.06.002; Odds FC, 1998, ANTIMICROB AGENTS CH, V42, P282; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Patterson TF, 2009, NEW ENGL J MED, V361, P287, DOI 10.1056/NEJMcpc0809065; POLACK FM, 1971, ARCH OPHTHALMOL-CHIC, V85, P410, DOI 10.1001/archopht.1971.00990050412003; Prados-Rosales RC, 2012, J BIOL CHEM, V287, P21970, DOI 10.1074/jbc.M112.364034; REUBEN A, 1989, ANTIMICROB AGENTS CH, V33, P1647, DOI 10.1128/AAC.33.9.1647; ROTOWA NA, 1990, MYCOSES, V33, P203, DOI 10.1111/myc.1990.33.4.203; Schippers B., 1981, FUSARIUM DIS BIOL TA, P250; Sheppard DC, 2006, CLIN MICROBIOL INFEC, V12, P376, DOI 10.1111/j.1469-0691.2005.01349.x; Silveira FP, 2007, MED MYCOL, V45, P305, DOI 10.1080/13693780701200372; STEVENSON IL, 1972, CAN J MICROBIOL, V18, P997, DOI 10.1139/m72-155; Walsh TJ, 1996, INFECT DIS CLIN N AM, V10, P365, DOI 10.1016/S0891-5520(05)70303-2; Zhao YA, 2010, J CLIN MICROBIOL, V48, P1378, DOI 10.1128/JCM.02214-09	44	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89920	10.1371/journal.pone.0089920	http://dx.doi.org/10.1371/journal.pone.0089920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587124	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800057
J	Huang, CL; Wu, IH; Wu, YW; Hwang, JJ; Wang, SS; Chen, WJ; Lee, WJ; Yang, WS				Huang, Chi-Lun; Wu, I-Hui; Wu, Yen-Wen; Hwang, Juey-Jen; Wang, Shoei-Shen; Chen, Wen-Jone; Lee, Wen-Jeng; Yang, Wei-Shiung			Association of Lower Extremity Arterial Calcification with Amputation and Mortality in Patients with Symptomatic Peripheral Artery Disease	PLOS ONE			English	Article							VASCULAR CALCIFICATION; CARDIOVASCULAR RISK; CORONARY ATHEROSCLEROSIS; COMPUTED-TOMOGRAPHY; PROGRESSION; PATHOPHYSIOLOGY; PREVALENCE	Objective: The clinical implication of the coronary artery calcium score (CS) is well demonstrated. However, little is known about the association between lower extremity arterial calcification and clinical outcomes. Methods and Results: Eighty-two patients with symptomatic peripheral artery disease (age 61.0+/-12.4 years) were followed for 21+/-11 months. CSs, ranging from the common iliac artery bifurcation to the ankle area, were analyzed through noncontrast multidetector computed tomography images retrospectively. The primary endpoints of this study were amputation and mortality. Old age, diabetes, hyperlipidemia, and end-stage renal disease were associated with higher CSs. Patients with more advanced Fontaine stages also tended to have significantly higher CSs (p = 0.03). During the follow-up period (21+/-11 months), 29 (35%) patients underwent amputation, and 24 (29%) patients died. Among the patients who underwent amputation, there were no significant differences in CSs between the amputated legs and the non-amputated legs. In the Cox proportional hazard model with CS divided into quartiles, patients with CS in the highest quartile had a 2.88-fold (95% confidence interval [CI] 1.18-12.72, p = 0.03) and a 5.16-fold (95% CI 1.13-21.61, p = 0.04) higher risk for amputation and all-cause mortality, respectively, than those with CS in the lowest quartile. These predictive effects remained after conventional risk factor adjustment. Conclusion: Lower extremity arterial CSs are associated with disease severity and outcomes, including amputation and all-cause mortality, in patients with symptomatic peripheral artery disease. However, the independent predictive value needs further investigation in large scale, prospective studies.	[Huang, Chi-Lun] Taoyuan Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Huang, Chi-Lun; Wu, Yen-Wen; Hwang, Juey-Jen; Chen, Wen-Jone; Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Chi-Lun; Wu, I-Hui; Yang, Wei-Shiung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wu, I-Hui; Wang, Shoei-Shen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Wen-Jone] Lotung Poh Al Hosp, Dept Emergency Med, Luodong Township, Yilan County, Taiwan; [Lee, Wen-Jeng] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Lee, WJ (corresponding author), Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan.	wenjeng@gmail.com; wsyang@ntu.edu.tw		Wang, Shoei-Shen/0000-0003-3201-4143; Wu, I-Hui/0000-0003-4367-9108; LEE, WEN-JENG/0000-0003-3267-4811; CHEN, WEN-JONE/0000-0002-2098-5922; WU, YEN-WEN/0000-0003-1520-1166; YANG, WEI-SHIUNG/0000-0001-5087-373X; Hwang, Juey-Jen/0000-0001-6437-0455				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Chen NX, 2012, CURR HYPERTENS REP, V14, P228, DOI 10.1007/s11906-012-0265-8; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Goncalves FB, 2012, HEART, V98, P988, DOI 10.1136/heartjnl-2011-301464; Guzman RJ, 2008, J AM COLL CARDIOL, V51, P1967, DOI 10.1016/j.jacc.2007.12.058; Jeon GH, 2010, MENOPAUSE, V17, P902, DOI 10.1097/gme.0b013e3181d76768; Kalsch H, 2013, INT J CARDIOVAS IMAG, V29, P207, DOI 10.1007/s10554-012-0051-3; Karwowski W, 2012, MED SCI MONITOR, V18, pRA1, DOI 10.12659/MSM.882181; London GM, 2011, NEFROLOGIA, V31, P644, DOI 10.3265/Nefrologia.pre2011.Oct.11175; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Nicholls SJ, 2007, J AM COLL CARDIOL, V49, P263, DOI 10.1016/j.jacc.2006.10.038; Ohtake T, 2011, J VASC SURG, V53, P676, DOI 10.1016/j.jvs.2010.09.070; Pohle K, 2001, CIRCULATION, V104, P1927, DOI 10.1161/hc4101.097527; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Rifkin DE, 2012, J AM COLL CARDIOL, V60, P1079, DOI 10.1016/j.jacc.2012.06.015; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Schmermund A, 2006, CIRCULATION, V113, P427, DOI 10.1161/CIRCULATIONAHA.105.568147; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Singh DK, 2012, DIABETES RES CLIN PR, V97, P158, DOI 10.1016/j.diabres.2012.01.038; Smith CD, 2008, FOOT ANKLE INT, V29, P185, DOI 10.3113/FAI.2008.0185; van Gils MJ, 2013, ATHEROSCLEROSIS, V227, P95, DOI 10.1016/j.atherosclerosis.2012.12.017; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175	26	38	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90201	10.1371/journal.pone.0090201	http://dx.doi.org/10.1371/journal.pone.0090201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587279	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000143
J	Li, Y; Lawrence, GW; Lu, SE; Balbalian, C; Klink, VP				Li, Yan; Lawrence, Gary W.; Lu, Shien; Balbalian, Clarissa; Klink, Vincent P.			Quantitative Field Testing Heterodera glycines from Metagenomic DNA Samples Isolated Directly from Soil under Agronomic Production	PLOS ONE			English	Article							UNITED-STATES; CAENORHABDITIS-ELEGANS; MAJOR MELOIDOGYNE; IDENTIFICATION; NEMATODES; QUANTIFICATION; EXPRESSION; JUVENILES; SOLANI; SCHEME	A quantitative PCR procedure targeting the Heterodera glycines ortholog of the Caenorhabditis elegans uncoordinated-78 gene was developed. The procedure estimated the quantity of H. glycines from metagenomic DNA samples isolated directly from field soil under agronomic production. The estimation of H. glycines quantity was determined in soil samples having other soil dwelling plant parasitic nematodes including Hoplolaimus, predatory nematodes including Mononchus, free-living nematodes and biomass. The methodology provides a framework for molecular diagnostics of nematodes from metagenomic DNA isolated directly from field soil.	[Li, Yan; Lawrence, Gary W.; Lu, Shien; Balbalian, Clarissa] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Klink, Vincent P.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Klink, VP (corresponding author), Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA.	vklink@biology.msstate.edu			Mississippi Soybean Promotion Board	Mississippi Soybean Promotion Board	The work was supported by the Mississippi Soybean Promotion Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo P, 2005, J NEMATOL, V37, P105; Alkharouf NW, 2007, EXP PARASITOL, V115, P247, DOI 10.1016/j.exppara.2006.09.009; Atallah ZK, 2006, PHYTOPATHOLOGY, V96, P1037, DOI 10.1094/PHYTO-96-1037; Bastian H. C., 1865, Transactions of the Linnean Society, Vvol. xxv, P73; Berry SD, 2008, MOL CELL PROBE, V22, P168, DOI 10.1016/j.mcp.2008.01.003; Blok VC, 2005, CAN J PLANT PATHOL, V27, P176; CENIS JL, 1993, PHYTOPATHOLOGY, V83, P76, DOI 10.1094/Phyto-83-76; CHITWOOD BG, 1949, P HELM SOC WASH, V16, P90; Cobb NA, 1918, AGR TECH CIRC BUR PL, V1, P1; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Daday EV., 1905, ZOOLOGICA STUTTGART, V44, P1; Davis E.L., 2000, PLANT HEAL INSTR, P1, DOI [10.1094/phi-i-2000-0725-01, DOI 10.1094/PHI-I-2000-0725-01]; EPPS JAMES M., 1958, PLANT DIS REPORTER, V42, P194; EPPS JM, 1972, J NEMATOL, V4, P222; Finetti-Sialer MM, 2005, PHYTOPATHOLOGY, V95, P262, DOI 10.1094/PHYTO-95-0262; Gao X, 2004, PLANT DIS, V88, P1372, DOI 10.1094/PDIS.2004.88.12.1372; Gasser RB, 1997, MOL CELL PROBE, V11, P201, DOI 10.1006/mcpr.1997.0106; GOLDEN A. M., 1970, Plant Disease Reporter, V54, P544; HARRIS TS, 1990, J NEMATOL, V22, P518; Ichinohe M., 1952, MAGAZINE APPL ZOOLOG, V17, P1; Inagaki H., 1971, APPL ENTOMOL ZOOL JP, V8, P53; JONES MGK, 1972, J CELL SCI, V10, P789; Klink VP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-35; Kofoid CA, 1919, J AMER MED ASSOC, V72, P567, DOI 10.1001/jama.1919.02610080033010; LAURITIS JA, 1983, J NEMATOL, V15, P272; Lawton K, 2010, PROGR FARMER, P28; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUEDDERS VD, 1989, J NEMATOL, V21, P264; Matsye PD, 2012, PLANT MOL BIOL, V80, P131, DOI 10.1007/s11103-012-9932-z; Niblack TL, 2005, PLANT DIS, V89, P1020, DOI 10.1094/PD-89-1020; Niblack TL, 2002, J NEMATOL, V34, P279; Okubara PA, 2008, PHYTOPATHOLOGY, V98, P837, DOI 10.1094/PHYTO-98-7-0837; POWERS TO, 1993, J NEMATOL, V25, P1; RIGGS R. D., 1966, PLANT DIS REPORTER, V50, P15; RIGGS RD, 1991, J NEMATOL, V23, P149; RIGGS RD, 1988, J NEMATOL, V20, P392; Riggs RD, 1962, ARKANSAS AGR EXPT ST, V110; Riggs RD, 1966, ARKANSAS AGR EXPT ST, V718; Ritter ME, 2009, PHYS ENV INTRO PHYS; ROOSIEN J, 1993, PARASITOLOGY, V107, P567, DOI 10.1017/S0031182000068153; ROSS J. P., 1958, PHYTOPATH, V48, P578; ROSS J. P., 1957, PLANT DIS REPORTER, V41, P923; Rupe J.C., 1999, COMPENDIUM SOYBEAN D, V4th ed., P52; Semblat JP, 1998, MOL ECOL, V7, P119, DOI 10.1046/j.1365-294x.1998.00326.x; Shannon J.G., 2004, BIOL MANAGEMENT SOYB, P155; Showmaker K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028954; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Wang J, 2003, PLANT DIS, V87, P623, DOI 10.1094/PDIS.2003.87.6.623; WINSTEAD N. N., 1955, PLANT DIS REPORTER, V39, P9; Wrather JA, 2006, J NEMATOL, V38, P173; WRATHER JA, 1995, PLANT DIS, V79, P1076; Wrather JA, 2001, CAN J PLANT PATHOL, V23, P115; Wrather JA, 2001, CAN J PLANT PATHOL, V23, P122, DOI 10.1080/07060660109506919; Wrather JA, 2003, PLANT HLTH PROGR, DOI [10.1094/PHP-2003-0325-01-RV, DOI 10.1094/PHP-2003-0325-01-RV]; YIK CP, 1982, PLANT DIS, V66, P707, DOI 10.1094/PD-66-707; ZENGEL JM, 1980, CELL MOTIL CYTOSKEL, V1, P73, DOI 10.1002/cm.970010107	56	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89887	10.1371/journal.pone.0089887	http://dx.doi.org/10.1371/journal.pone.0089887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587100	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700110
J	Magain, N; Serusiaux, E				Magain, Nicolas; Serusiaux, Emmanuel			Do Photobiont Switch and Cephalodia Emancipation Act as Evolutionary Drivers in the Lichen Symbiosis? A Case Study in the Pannariaceae (Peltigerales)	PLOS ONE			English	Article							RIBOSOMAL-RNA SMALL; FAMILY PANNARIACEAE; PHYLOGENETIC ANALYSES; NOSTOC COMMUNE; BOREAL FOREST; FUNGAL LECTIN; GENUS; CYANOBACTERIA; ASCOMYCOTA; DNA	Lichen symbioses in the Pannariaceae associate an ascomycete and either cyanobacteria alone (usually Nostoc; bipartite thalli) or green algae and cyanobacteria (cyanobacteria being located in dedicated structures called cephalodia; tripartite thalli) as photosynthetic partners (photobionts). In bipartite thalli, cyanobacteria can either be restricted to a well-delimited layer within the thallus ('pannarioid' thalli) or spread over the thallus that becomes gelatinous when wet ('ollematoid' thalli). We studied the collematoid genera Kroswia and Physma and an undescribed tripartite species along with representatives of the pannarioid genera Fuscopannaria, Pannaria and Parmeliella. Molecular inferences from 4 loci for the fungus and 1 locus for the photobiont and statistical analyses within a phylogenetic framework support the following: (a) several switches from pannarioid to collematoid thalli occured and are correlated with photobiont switches; the collematoid genus Kroswia is nested within the pannarioid genus Fuscopannaria and the collematoid genus Physma is sister to the pannarioid Parmeliella mariana group; (b) Nostoc associated with collematoid thalli in the Pannariaceae are related to that of the Collemataceae (which contains only collematoid thalli), and never associated with pannarioid thalli; Nostoc associated with pannarioid thalli also associate in other families with similar morphology; (c) ancestors of several lineages in the Pannariaceae developed tripartite thalli, bipartite thalli probably resulting from cephalodia emancipation from tripartite thalli which eventually evolved and diverged, as suggested by the same Nostoc present in the collematoid genus Physma and in the cephalodia of a closely related tripartite species; Photobiont switches and cephalodia emancipation followed by divergence are thus suspected to act as evolutionary drivers in the family Pannariaceae.	[Magain, Nicolas; Serusiaux, Emmanuel] Univ Liege, Evolut & Conservat Biol Unit, Liege, Belgium	University of Liege	Magain, N (corresponding author), Univ Liege, Evolut & Conservat Biol Unit, Liege, Belgium.	Nicolas.Magain@ulg.ac.be	Sérusiaux, Emmanuël/L-1568-2019	Magain, Nicolas/0000-0001-5409-9518	University of Liege; FRIA, an organ of the Belgian Scientific Research Foundation	University of Liege(University of Liege); FRIA, an organ of the Belgian Scientific Research Foundation(Fonds de la Recherche Scientifique - FNRS)	Nicolas Magain is a Ph. D. Student at the University of Liege and acknowledges the financial support by FRIA, an organ of the Belgian Scientific Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2009, INFECT GENET EVOL, V9, P656, DOI 10.1016/j.meegid.2009.03.010; [Anonymous], 2006, STOCHCHAR PACKAGE ME; Arima H, 2012, FEMS MICROBIOL ECOL, V79, P34, DOI 10.1111/j.1574-6941.2011.01195.x; Backor M, 2010, ECOTOX ENVIRON SAFE, V73, P603, DOI 10.1016/j.ecoenv.2009.11.002; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Carlsen T, 2012, LICHENOLOGIST, V44, P565, DOI 10.1017/S0024282912000199; Casano LM, 2011, ENVIRON MICROBIOL, V13, P806, DOI 10.1111/j.1462-2920.2010.02386.x; Cornejo C, 2013, LICHENOLOGIST, V45, P77, DOI 10.1017/S0024282912000631; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Cuzman OA, 2010, MICROB ECOL, V60, P81, DOI 10.1007/s00248-010-9672-z; del Campo EM, 2013, FEMS MICROBIOL ECOL, V83, P310, DOI 10.1111/j.1574-6941.2012.01474.x; Drummond A.J., 2007, TRACER VERSION 15; Ekman S, 2002, CAN J BOT, V80, P625, DOI 10.1139/B02-043; Elvebakk A, 2007, CRYPTOGAMIE MYCOL, V28, P225; Elvebakk A, 2005, LICHENOLOGIST, V37, P47, DOI 10.1017/S0024282904014525; Elvebakk A, 2003, NZ AUSTRALASIAN LICH, V53, P4; Elvebakk A, 2008, J PHYCOL, V44, P1049, DOI 10.1111/j.1529-8817.2008.00556.x; Elvebakk A, 2013, LICHENOLOGIST, V45, P9, DOI 10.1017/S0024282912000679; Elvebakk A, 2012, LICHENOLOGIST, V44, P457, DOI 10.1017/S0024282912000047; Elvebakk A, 2012, NOVA HEDWIGIA, V94, P505, DOI 10.1127/0029-5035/2012/0011; Elvebakk A, 2010, LICHENOLOGIST, V42, P563, DOI 10.1017/S0024282910000083; Fedrowitz K, 2011, BRYOLOGIST, V114, P220, DOI 10.1639/0007-2745-114.1.220; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; Fewer D, 2002, MOL PHYLOGENET EVOL, V23, P82, DOI 10.1006/mpev.2001.1075; Flechtner VR, 2002, NOVA HEDWIGIA, V74, P1, DOI 10.1127/0029-5035/2002/0074-0001; Galun M., 1995, Cryptogamic Botany, V5, P144; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Guzow-Krzeminska B, 2006, LICHENOLOGIST, V38, P469, DOI 10.1017/S0024282906005068; Hayes ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-150; Henskens FL, 2012, ANN BOT-LONDON, V110, P555, DOI 10.1093/aob/mcs108; Henssen A, 1999, NOVA HEDWIGIA, V68, P117; HENSSEN A, 1979, BOT NOTISER, V132, P257; Henssen A., 1965, LICHENOLOGIST, V3, P29; Henssen A, 1974, LICHENES EINFUHRUNG; Henssen Aino, 2007, V96, P129; HILL DR, 1994, PROTOPLASMA, V182, P126, DOI 10.1007/BF01403474; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iguchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020140; Ishida T, 2001, FEMS MICROBIOL LETT, V201, P79, DOI 10.1111/j.1574-6968.2001.tb10736.x; James P. W, 1976, LICHENOLOGY PROGR PR, P27; Jorgensen P. M., 2004, BIBLIOTHECA LICHENOL, V88, P229; Jorgensen P. M., 1994, J HATTORI BOT LAB, V76, P197; JORGENSEN P. M., 2007, NORDIC LICHEN FLORA, P96; Jorgensen PM, 2008, LICHENOLOGIST, V40, P221, DOI 10.1017/S0024282908007780; Jorgensen PM, 2007, LICHENOLOGIST, V39, P305, DOI 10.1017/S0024282907006767; Jorgensen PM, 2007, LICHENOLOGIST, V39, P235, DOI 10.1017/S0024282907006858; Jorgensen PM, 2013, TAXON, V62, P629, DOI 10.12705/623.20; Jorgensen PM, 2010, LICHENOLOGIST, V42, P697, DOI 10.1017/S0024282910000484; Jorgensen PM, 2009, LICHENOLOGIST, V41, P257, DOI 10.1017/S0024282909008652; Jorgensen PM, 1999, LICHENOLOGIST, V31, P341, DOI 10.1017/S0024282999000456; Jorgensen PM, 2003, LICHENOLOGIST, V35, P11, DOI 10.1006/lich.2002.0424; Jorgensen PM, 2002, LICHENOLOGIST, V34, P297, DOI 10.1006/lich.2002.0401; Jorgensen PM, 2000, BRYOLOGIST, V103, P670, DOI 10.1639/0007-2745(2000)103[0670:SOTLFP]2.0.CO;2; Jorgensen PM, 1999, BRYOLOGIST, V102, P22, DOI 10.2307/3244454; Jorgensen PM, 2001, BIBLIOTHECA LICHENOL, V78, P109; Jorgensen PM, 2003, CONSPECTUS FAMILIAE; Kaasalainen U, 2012, P NATL ACAD SCI USA, V109, P5886, DOI 10.1073/pnas.1200279109; Kaasalainen U, 2009, MOL PLANT MICROBE IN, V22, P695, DOI 10.1094/MPMI-22-6-0695; Kauff F, 2002, MOL PHYLOGENET EVOL, V25, P138, DOI 10.1016/S1055-7903(02)00214-2; Keuck G, 1977, ONTOGENETISCH SYSTEM; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Krog H, 2000, CORTICOLOUS MACROLIC; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Legaz ME, 2004, EUR J CELL BIOL, V83, P435, DOI 10.1078/0171-9335-00384; Lehr H, 2000, SYMBIOSIS, V29, P357; Lendemer JC., 2011, OPUSCULA PHILOLICHEN, V9, P99; LOCKHART CM, 1978, FEMS MICROBIOL LETT, V3, P127; Lohtander K, 2003, LICHENOLOGIST, V35, P325, DOI 10.1016/S0024-2829(03)00051-3; Lucking R, 2009, AM J BOT, V96, P1409, DOI 10.3732/ajb.0800258; Lumbsch HT, 2007, MYCOL RES, V111, P257, DOI 10.1016/j.mycres.2007.01.006; Lumbsch HT, 2011, MYCONET; Maddison DR, 2005, MACCLADE V 4 08; Maddison WP, 2009, MESQUITE MODULAR SYS; Magain N, 2012, BRYOLOGIST, V115, P243, DOI 10.1639/0007-2745-115.2.243; Manoharan Sheeba S, 2012, Symbiosis, V58, P91; Diaz EM, 2011, PLANT SIGNAL BEHAV, V6, P1525, DOI 10.4161/psb.6.10.16687; Mateo P, 2011, FEMS MICROBIOL ECOL, V76, P185, DOI 10.1111/j.1574-6941.2010.01040.x; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miadlikowska J, 2004, AM J BOT, V91, P449, DOI 10.3732/ajb.91.3.449; Miadlikowska J, 2000, INT J PLANT SCI, V161, P925, DOI 10.1086/317568; Miadlikowska J, 2006, MYCOLOGIA, V98, P1088, DOI 10.3852/mycologia.98.6.1088; Miao VPW, 2012, SYMBIOSIS, V57, P23, DOI 10.1007/s13199-012-0175-1; Miller M.A., 2010, P GAT COMP ENV WORKS; Moncada B, 2014, FUNGAL DIVERS, V64, P205, DOI 10.1007/s13225-013-0230-0; Moncada B, 2013, BRYOLOGIST, V116, P169, DOI 10.1639/0007-2745-116.2.169; Muggia L, 2011, AM J BOT, V98, P1647, DOI 10.3732/ajb.1100046; Myllys L, 2007, NEW PHYTOL, V173, P621, DOI 10.1111/j.1469-8137.2006.01944.x; Nelsen MP, 2008, NEW PHYTOL, V177, P264, DOI 10.1111/j.1469-8137.2007.02241.x; Nelson PR, 2013, LICHENOLOGIST, V45, P694, DOI 10.1017/S002428291300039X; Nylander J. A. A., 2008, MRMODELTEST 2 3; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; O'Brien HE, 2005, EUR J PHYCOL, V40, P363, DOI 10.1080/09670260500342647; O'Brien HE, 2013, NEW PHYTOL; Olsson S, 2012, CURR GENET, V58, P49, DOI 10.1007/s00294-011-0364-0; Otalora MAG, 2013, LICHENOLOGIST, V45, P295, DOI 10.1017/S0024282912000849; Otalora MAG, 2010, MOL PHYLOGENET EVOL, V56, P1089, DOI 10.1016/j.ympev.2010.05.013; Otalora MAG, 2010, MYCOLOGIA, V102, P279, DOI 10.3852/09-114; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Palinska KA, 2006, INT J SYST EVOL MICR, V56, P2253, DOI 10.1099/ijs.0.64417-0; Papaefthimiou D, 2008, INT J SYST EVOL MICR, V58, P553, DOI 10.1099/ijs.0.65312-0; Passo A, 2006, LICHENOLOGIST, V38, P549, DOI 10.1017/S0024282906005688; Passo A, 2008, MYCOL RES, V112, P1465, DOI 10.1016/j.mycres.2008.06.025; Paulsrud P, 2001, NEW PHYTOL, V152, P117, DOI 10.1046/j.0028-646x.2001.00234.x; PETIT P, 1983, NEW PHYTOL, V94, P103, DOI 10.1111/j.1469-8137.1983.tb02726.x; Piercey-Normore MD, 2006, NEW PHYTOL, V169, P331, DOI 10.1111/j.1469-8137.2005.01576.x; Rajaniemi P, 2005, INT J SYST EVOL MICR, V55, P11, DOI 10.1099/ijs.0.63276-0; Rikkinen J, 2003, SYMBIOSIS, V34, P99; Rikkinen J, 2002, SCIENCE, V297, P357, DOI 10.1126/science.1072961; Rikkinen J, 2013, MYCOKEYS, P3, DOI 10.3897/mycokeys.6.3869; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schmidt HA, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P381; Schmull M, 2011, MYCOLOGIA, V103, P983, DOI 10.3852/10-234; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith FMJ, 2012, PHYCOLOGIA, V51, P542, DOI 10.2216/11-84.1; Spribille T, 2013, FUNGAL DIVERS, V58, P171, DOI 10.1007/s13225-012-0206-5; Spribille T, 2010, BRYOLOGIST, V113, P439, DOI 10.1639/0007-2745-113.3.439; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenroos S, 2006, CLADISTICS, V22, P230, DOI 10.1111/j.1096-0031.2006.00101.x; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Svenning MM, 2005, ARCH MICROBIOL, V183, P19, DOI 10.1007/s00203-004-0740-y; SWINSCOW TDV, 1986, LICHENOLOGIST, V18, P309, DOI 10.1017/S002428298600049X; Swinscow TDV, 1988, MACROLICHENS E AFRIC; Thompson J. N., 2005, INTERSPEC INTERACT; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Upreti DK, 2005, NOVA HEDWIGIA, V81, P97, DOI 10.1127/0029-5035/2005/0081-0097; Verdon D, 1995, ACTA BOT FENN, V150, P209; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vivas M, 2010, PLANT BIOLOGY, V12, P615, DOI 10.1111/j.1438-8677.2009.00250.x; Wedin M, 2007, LICHENOLOGIST, V39, P61, DOI 10.1017/S002428290700655X; Wedin M, 2010, LICHENOLOGIST, V43, P67, DOI 10.1017/S0024282910000642; Wedin M, 2009, MOL PHYLOGENET EVOL, V53, P862, DOI 10.1016/j.ympev.2009.08.013; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whitton B.A., 2000, ECOLOGY CYANOBACTERI; Yahr R, 2006, NEW PHYTOL, V171, P847, DOI 10.1111/j.1469-8137.2006.01792.x; Zoller S, 1999, LICHENOLOGIST, V31, P511	140	34	37	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89876	10.1371/journal.pone.0089876	http://dx.doi.org/10.1371/journal.pone.0089876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587091	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700107
J	Meque, I; Dube, K; Feldblum, PJ; Clements, ACA; Zango, A; Cumbe, F; Chen, PL; Ferro, JJ; van de Wijgert, JH				Meque, Ivete; Dube, Karine; Feldblum, Paul J.; Clements, Archie C. A.; Zango, Arlinda; Cumbe, Fidelina; Chen, Pai Lien; Ferro, Josefo J.; van de Wijgert, Janneke H.			Prevalence, Incidence and Determinants of Herpes Simplex Virus Type 2 Infection among HIV-Seronegative Women at High-Risk of HIV Infection: A Prospective Study in Beira, Mozambique	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HOTEL WORKERS; ANTIBODIES; BAR; EPIDEMIOLOGY; ASSOCIATION; ACQUISITION; TANZANIA; DISEASE; MEN	Objectives: To estimate the prevalence, incidence and determinants of herpes simplex type 2 (HSV-2) infection, and associations between HSV-2 and incident HIV infection, among women at higher risk for HIV infection in Beira, Mozambique. Methods: Between 2009 and 2012, 411 women aged 18-35 years at higher risk of HIV acquisition (defined as having had two or more sexual partners in the month prior to study enrollment) were enrolled and followed monthly for one year. At each study visit, they were counseled, interviewed, and tested for HSV-2 and HIV antibodies. Results: The HSV-2 prevalence at baseline was 60.6% (95% CI: 55.7%-65.4%). Increasing age (aOR = 2.94, 95% CI: 1.74-4.97, P<0.001 and aOR = 3.39, 95% CI: 1.58-7.29, P = 0.002 for age groups of 21-24 and 25-35 years old respectively), lower educational level (aOR = 1.81, 95% CI: 1.09-3.02, P = 0.022), working full time (aOR = 8.56, 95% CI: 1.01-72.53, P = 0.049) and having practiced oral sex (aOR = 3.02, 95% CI: 1.16-7.89, P = 0.024) were strongly associated with prevalent HSV-2 infection. Thirty one participants seroconverted for HSV-2 (20.5%; 95% CI: 14.4% -27.9%) and 22 for HIV during the study period. The frequency of vaginal sex with a casual partner using a condom in the last 7 days was independently associated with incident HSV-2 infection (aOR = 1.91, 95% CI: 1.05-3.47, P = 0.034). Positive HSV-2 serology at baseline was not significantly associated with risk of subsequent HIV seroconversion. Conclusions: Young women engaging in risky sexual behaviors in Beira had high prevalence and incidence of HSV-2 infection. Improved primary HSV-2 control strategies are urgently needed in Beira.	[Meque, Ivete; Zango, Arlinda; Cumbe, Fidelina; Ferro, Josefo J.] UCM, CIDI, Beira, Mozambique; [Dube, Karine; Feldblum, Paul J.; Chen, Pai Lien] FHI 360, Clin Sci Unit, Durham, NC USA; [Dube, Karine] US Mil HIV Res Program MHRP, Henry M Jackson Fdn Adv Mil Med Inc HJF, Bethesda, MD USA; [Clements, Archie C. A.] Univ Queensland, Sch Populat Hlth, Infect Dis Epidemiol Unit, Brisbane, Qld, Australia; [van de Wijgert, Janneke H.] AIGHD, Amsterdam, Netherlands; [van de Wijgert, Janneke H.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke H.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	FHI 360; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); University of Queensland; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool	Meque, I (corresponding author), UCM, CIDI, Beira, Mozambique.	ive.meque@yahoo.com.br	Clements, Archie/ABD-1615-2020	van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	U.S. Agency for International Development (USAID) [GPO-A-00-05-00022-00]; Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program; Preventive Technologies Agreement (PTA); European and Developing Countries Clinical Trials Partnership (EDCTP); Australian Government (AUSAID); NHMRC Career Development Award [631619];  [GHO-A-00-09-00016-00]; FOGARTY INTERNATIONAL CENTER [D43TW009753] Funding Source: NIH RePORTER	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program; Preventive Technologies Agreement (PTA); European and Developing Countries Clinical Trials Partnership (EDCTP); Australian Government (AUSAID)(Australian Aid (AusAID)); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was partly funded by the U.S. Agency for International Development (USAID), under Cooperative Agreement No. GPO-A-00-05-00022-00, the Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program, and Cooperative Agreement No. GHO-A-00-09-00016-00, the Preventive Technologies Agreement (PTA). The study also received funding from the European and Developing Countries Clinical Trials Partnership (EDCTP) through the AfrEVacc project. IM was partially supported by the Australian Government (AUSAID) through Australian Development Scholarship (ADS) program. ACAC is funded by a NHMRC Career Development Award (#631619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the authors and should not be construed to represent the positions of the funders. The views expressed in this paper are those of the authors and should not be construed to represent the positions of EDCTP, USAID, the U.S. Army or the U.S. Department of Defense.	Arama V, 2010, INT J INFECT DIS, V14, pE25, DOI 10.1016/j.ijid.2009.07.026; Asgari S, 2011, IRAN RED CRESCENT ME, V13, P818; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; Chohan V, 2009, SEX TRANSM INFECT, V85, P489, DOI 10.1136/sti.2009.036103; Delany-Moretlwe S, 2010, SEX TRANSM INFECT, V86, P46, DOI 10.1136/sti.2009.036541; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gottlieb SL, 2004, J INFECT DIS, V190, P1059, DOI 10.1086/423323; Heffron R, 2011, SEX TRANSM INFECT, V87, P283, DOI 10.1136/sti.2010.045617; Hogrefe W, 2002, J CLIN MICROBIOL, V40, P3635, DOI 10.1128/JCM.40.10.3635-3640.2002; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) and ICF Macro, 2010, NAT SURV PREV BEH RI; Kapiga SH, 2003, SEX TRANSM DIS, V30, P187, DOI 10.1097/00007435-200303000-00001; Makasa M, 2012, SEX TRANSM DIS, V39, P787, DOI 10.1097/OLQ.0b013e31826ae97d; Mbizvo EM, 2002, INT J STD AIDS, V13, P343, DOI 10.1258/0956462021925171; McFarland W, 1999, J INFECT DIS, V180, P1459, DOI 10.1086/315076; Mgalla Z, 1997, AIDS CARE, V9, P407, DOI 10.1080/713613167; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; Munjoma MW, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-2; Okuku HS, 2011, SEX TRANSM DIS, V38, P837, DOI 10.1097/OLQ.0b013e31821a6225; Paz-Bailey G, 2007, SEX TRANSM INFECT, V83, P16, DOI 10.1136/sti.2006.020966; Ramjee G, 2005, JAIDS-J ACQ IMM DEF, V39, P333, DOI 10.1097/01.qai.0000144445.44518.ea; Republica de Moc ambique Ministerio de Saude Conselho Nacional de Combate ao HIV/SIDA, 2009, PLAN ESTR NAC RESP A; Republica de Moc ambique Ministerio de Saude Programa Nacional de Controle as ITS/HIV/SIDA, 2006, GUIA TRAT CONTR INF; Rodriguez MDM, 2002, AIDS, V16, P451; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Tassiopoulos KK, 2007, J INFECT DIS, V195, P493, DOI 10.1086/510537; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Vandepitte J, 2011, SEX TRANSM DIS, V38, P316, DOI 10.1097/OLQ.0b013e3182099545; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Webb P, 2011, ESSENTIAL EPIDEMIOLO, P435; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; World Health Organization, 2001, HERP SIMPL VIR TYP 2; Zango A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063427	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89705	10.1371/journal.pone.0089705	http://dx.doi.org/10.1371/journal.pone.0089705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586973	gold, Green Published			2022-12-27	WOS:000331880700075
J	Rylander, C; Sandanger, TM; Engeset, D; Lund, E				Rylander, Charlotta; Sandanger, Torkjel M.; Engeset, Dagrun; Lund, Eiliv			Consumption of Lean Fish Reduces the Risk of Type 2 Diabetes Mellitus: A Prospective Population Based Cohort Study of Norwegian Women	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; FATTY-ACID; INSULIN SENSITIVITY; DIETARY PATTERNS; OIL SUPPLEMENT; CANCER; METAANALYSIS; NOWAC; OMEGA-3-FATTY-ACIDS; HEALTH	Background: The effects of fish consumption and n-3 fatty acids on type 2 diabetes mellitus (T2DM) have recently been debated. Objective: We explored the risk of T2DM in relation to consumption of lean fish, fatty fish, fish products and total fish as well as cod liver oil supplements in a representative sample of Norwegian women. Design: This was a prospective population based cohort study in 33740 women free of T2DM, stroke, angina or heart attack and with detailed information on important co-variates and dietary intake at baseline. Risk ratios and corresponding 95% CI were estimated using Poisson regression with log-person time as offset. Results: Lean fish consumption was inversely associated with T2DM compared to zero intake. Risk ratios and 95% CI for intake of 75 and 100 g lean fish per day were 0.71 (0.51, 0.98) and 0.67 (0.46, 0.98), respectively. There was no effect of intake of fatty fish, fish products, total fish or use of cod liver oil supplements on the risk of T2DM. Conclusion: Lean fish consumption of 75-100 g/d had a beneficial effect on T2DM. It remains unclear whether lean fish in itself has a protective effect on T2DM or that lean fish consumers have a protective life-style that we were not able to take into account in this study. Unfavorable effects of fatty fish consumption or use of cod liver oil supplements on T2DM were not observed.	[Rylander, Charlotta; Sandanger, Torkjel M.; Engeset, Dagrun; Lund, Eiliv] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Sandanger, Torkjel M.] Fram High North Res Ctr Climate & Environm, NILU, Tromso, Norway	UiT The Arctic University of Tromso; Norwegian Institute for Air Research	Rylander, C (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.	charlotta.rylander@uit.no	Rylander, Charlotta/AAE-2033-2022	Lund, Eiliv/0000-0002-8071-8711	Norwegian Research council [204360/H10]	Norwegian Research council(Research Council of NorwayEuropean Commission)	This study was funded by the Environmental exposures and health outcome program, project number 204360/H10, in the Norwegian Research council: http://www.forskningsradet.no/prognett-milgenhel/Forside/1228296301707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; Brustad M, 2004, EUR J CLIN NUTR, V58, P128, DOI 10.1038/sj.ejcn.1601759; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; Dumeaux V, 2008, BREAST CANCER RES, V10, P9; Eiliv L, 2003, CANCER CAUSE CONTROL, V14, P1001, DOI 10.1023/B:CACO.0000007982.18311.2e; Engeset D, 2005, EUR J CLIN NUTR, V59, P675, DOI 10.1038/sj.ejcn.1602129; Gormley TR, 2007, EUR FOOD RES TECHNOL, V225, P837, DOI 10.1007/s00217-006-0489-4; He K, 2009, PROG CARDIOVASC DIS, V52, P95, DOI 10.1016/j.pcad.2009.06.003; Hjartaker A, 1997, EUR J CLIN NUTR, V51, P736, DOI 10.1038/sj.ejcn.1600475; Hjartaker A, 2007, PUBLIC HEALTH NUTR, V10, P1094, DOI 10.1017/S1368980007702872; Imae M, 2012, AMINO ACIDS IN PRESS; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Lund E, 2008, INT J EPIDEMIOL, V37, P36, DOI 10.1093/ije/dym137; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Nanri A, 2011, AM J CLIN NUTR, V94, P884, DOI 10.3945/ajcn.111.012252; Parr CL, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-4; Patel PS, 2012, AM J CLIN NUTR, V95, P1445, DOI 10.3945/ajcn.111.029314; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Rylander C, 2012, ENVIRON INT, V43, P13, DOI 10.1016/j.envint.2012.02.008; Rylander C, 2010, ENVIRON SCI TECHNOL, V44, P5225, DOI 10.1021/es100224q; Stene Lars Christian, 2004, Tidsskr Nor Laegeforen, V124, P1511; van Woudenbergh GJ, 2009, DIABETES CARE, V32, P2021, DOI 10.2337/dc09-1042; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Welch AA, 2002, PUBLIC HEALTH NUTR, V5, P1273, DOI 10.1079/PHN2002404; Wu JHY, 2012, BRIT J NUTR, V107, pS214, DOI 10.1017/S0007114512001602; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S21	34	43	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89845	10.1371/journal.pone.0089845	http://dx.doi.org/10.1371/journal.pone.0089845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587071	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700102
J	Seifert, L; Wattebled, L; Herault, R; Poizat, G; Ade, D; Gal-Petitfaux, N; Davids, K				Seifert, Ludovic; Wattebled, Leo; Herault, Romain; Poizat, Germain; Ade, David; Gal-Petitfaux, Nathalie; Davids, Keith			Neurobiological Degeneracy and Affordance Perception Support Functional Intra-Individual Variability of Inter-Limb Coordination during Ice Climbing	PLOS ONE			English	Article							MOVEMENT SYSTEMS; RETROSPECTIVE INTERVIEWS; SITUATED ANALYSIS; TABLE-TENNIS; DYNAMICS; PERFORMANCE; BEHAVIOR; EXPERT; SPORT; CONSTRAINTS	This study investigated the functional intra-individual movement variability of ice climbers differing in skill level to understand how icefall properties were used by participants as affordances to adapt inter-limb coordination patterns during performance. Seven expert climbers and seven beginners were observed as they climbed a 30 m icefall. Movement and positioning of the left and right hand ice tools, crampons and the climber's pelvis over the first 20 m of the climb were recorded and digitized using video footage from a camera (25 Hz) located perpendicular to the plane of the icefall. Inter-limb coordination, frequency and types of action and vertical axis pelvis displacement exhibited by each climber were analysed for the first five minutes of ascent. Participant perception of climbing affordances was assessed through: (i) calculating the ratio between exploratory movements and performed actions, and (ii), identifying, by self-confrontation interviews, the perceptual variables of environmental properties, which were significant to climbers for their actions. Data revealed that experts used a wider range of upper and lower limb coordination patterns, resulting in the emergence of different types of action and fewer exploratory movements, suggesting that effective holes in the icefall provided affordances to regulate performance. In contrast, beginners displayed lower levels of functional intra-individual variability of motor organization, due to repetitive swinging of ice tools and kicking of crampons to achieve and maintain a deep anchorage, suggesting lack of perceptual attunement and calibration to environmental properties to support climbing performance.	[Seifert, Ludovic; Wattebled, Leo; Ade, David] Univ Rouen, CETAPS Lab EA 3832, Fac Sports Sci, Rouen, France; [Herault, Romain] INSA Rouen, LITIS Lab EA 4108, Rouen, France; [Poizat, Germain] Univ Geneva, Fac Psychol & Educ Sci, Dept Adult Educ, Geneva, Switzerland; [Gal-Petitfaux, Nathalie] Univ Clermont Ferrand, ACTE Lab EA 4281, Fac Sports Sci, Clermont Ferrand, France; [Davids, Keith] Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield S1 1WB, S Yorkshire, England	Universite de Rouen Normandie; University of Geneva; Sheffield Hallam University	Seifert, L (corresponding author), Univ Rouen, CETAPS Lab EA 3832, Fac Sports Sci, Rouen, France.	ludovic.seifert@univ-rouen.fr	SEIFERT, Ludovic/AAI-7486-2020	SEIFERT, Ludovic/0000-0003-1712-5013; Davids, Keith/0000-0003-1398-6123	CPER/GRR1880 Logistic Transport and Information Treatment; French National School of Skiing and Alpinism (ENSA); Petzl	CPER/GRR1880 Logistic Transport and Information Treatment; French National School of Skiing and Alpinism (ENSA); Petzl	This project received the funding of the CPER/GRR1880 Logistic Transport and Information Treatment 2007-2013 and the support of the French National School of Skiing and Alpinism (ENSA) and Petzl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramaniam R, 2004, BIOL CYBERN, V90, P176, DOI 10.1007/s00422-003-0460-4; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Batoux P., 2007, ICE CLIMBING DRY TOO; Beek P. J., 2003, EXPERT PERFORMANCE S, P321; BILLAT V, 1995, J SPORT MED PHYS FIT, V35, P20; Blanc-Gras J., 2012, ART ICE CLIMBING; Boschker MSJ, 2002, J MOTOR BEHAV, V34, P25, DOI 10.1080/00222890209601928; Bourdin C, 1998, EXP BRAIN RES, V122, P253, DOI 10.1007/s002210050513; Cordier P, 1996, HUM MOVEMENT SCI, V15, P789, DOI 10.1016/S0167-9457(96)00023-1; CORDIER P, 1994, HUM MOVEMENT SCI, V13, P745, DOI 10.1016/0167-9457(94)90016-7; Cote JN, 2008, MOTOR CONTROL, V12, P79, DOI 10.1123/mcj.12.2.79; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Davids K, 2008, DYNAMICS SKILL ACQUI; Davids K, 2010, EXERC SPORT SCI REV, V38, P86, DOI 10.1097/JES.0b013e3181d4968b; Durand M, DIALOGUE ENTRE CONCE; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Eden S, 2010, AREA, V42, P487, DOI 10.1111/j.1475-4762.2010.00943.x; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Gal-Petitfaux N, 2013, TRAV HUMAIN, V76, P257, DOI 10.3917/th.763.0257; Gibson J.J., 1986, ECOLOGICAL APPROACH; Glazier P.S., 2006, MOVEMENT SYSTEM VARI, P49; Hauw D, 2004, PERCEPT MOTOR SKILL, V98, P1139, DOI 10.2466/pms.98.3c.1139-1152; Hauw D, 2008, J SPORT SCI MED, V7, P8; Hauw D, 2007, J SPORT SCI, V25, P173, DOI 10.1080/02640410600624269; Havelange V., 2010, ENACTION NEW PARADIG, P335; Hristovski R, 2006, J SPORT SCI MED, V5, P60; Hristovski R., 2009, PERSPECTIVES COGNITI, P1; Jacobs DM, 2007, ECOL PSYCHOL, V19, P321, DOI 10.1080/10407410701432337; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Kelso JAS, 2008, ECOL PSYCHOL, V20, P180, DOI 10.1080/10407410801949297; Kelso JAS, 2012, PHILOS T R SOC B, V367, P906, DOI 10.1098/rstb.2011.0351; Kelso S., 1995, DYNAMIC PATTERNS SEL; Lefevre B, 2008, MEDIATIQUES RECIT SO, V42, P24; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Mason Paul H., 2010, Biology Theory, V5, P277; Michaels CF, 2003, ECOL PSYCHOL, V15, P135, DOI 10.1207/S15326969ECO1502_3; Newell K., 1985, DIFFERING PERSPECTIV, P295, DOI [https://doi.org/10.1016/S0166-4115(08)62541-8, DOI 10.1016/S0166-4115(08)62541-8, 10.1016/S0166-4115(08)62541-8]; Newell K.M, 1993, VARIABILITY MOTOR CO; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Palut Y, 2005, J SPORT SCI, V23, P1021, DOI 10.1080/02640410400021682; Pijpers JR, 2006, ECOL PSYCHOL, V18, P131, DOI 10.1207/s15326969eco1803_1; Poizat G., 2013, ROUTLEDGE HDB SPORTS, P309; Poizat G, 2012, PSYCHOL SPORT EXERC, V13, P630, DOI 10.1016/j.psychsport.2012.03.008; Post AA, 2000, BIOL CYBERN, V83, P443, DOI 10.1007/s004220000177; Rosenblum M., 1998, NONLINEAR ANAL PHYSL, P91, DOI 10.1007/978-3-642-71949-3_6; Sanchez X, 2010, SCAND J MED SCI SPOR, V20, P356, DOI 10.1111/j.1600-0838.2009.00904.x; Seifert L, 2013, SPORTS MED, V43, P167, DOI 10.1007/s40279-012-0011-z; Seve C, 2003, RES Q EXERCISE SPORT, V74, P71, DOI 10.1080/02701367.2003.10609066; Seve C, 2011, SCAN J MED SCI SPORT; Shaw R, 2001, ECOL PSYCHOL, V13, P275, DOI 10.1207/S15326969ECO1304_02; Sibella F, 2007, HUM MOVEMENT SCI, V26, P841, DOI 10.1016/j.humov.2007.05.008; Stoffregen TA, 2003, ECOL PSYCHOL, V15, P115, DOI 10.1207/S15326969ECO1502_2; Theureau J, 2003, HUM FAC ER, P55; Theureau J., 2004, COURS ACTION METHODE; Theureau J, 2006, COURS ACTION METHODE; Turvey M. T., 1992, Ecological Psychology, V4, P173, DOI 10.1207/s15326969eco0403_3; Usaj A, 2007, EUR J APPL PHYSIOL, V100, P685, DOI 10.1007/s00421-007-0461-4; Van Emmerik REA, 2004, J APPL BIOMECH, V20, P396, DOI 10.1123/jab.20.4.396; van Emmerik REA, 2000, J APPL BIOMECH, V16, P394, DOI 10.1123/jab.16.4.394; von Cranach M., 1982, ANAL ACTION RECENT T, P35; Withagen R, 2012, NEW IDEAS PSYCHOL, V30, P250, DOI 10.1016/j.newideapsych.2011.12.003	62	68	68	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89865	10.1371/journal.pone.0089865	http://dx.doi.org/10.1371/journal.pone.0089865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB6EP	24587084	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000331880700104
J	Tikh, IB; Quin, MB; Schmidt-Dannert, C				Tikh, Ilya B.; Quin, Maureen B.; Schmidt-Dannert, Claudia			A Tale of Two Reductases: Extending the Bacteriochlorophyll Biosynthetic Pathway in E. coli	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; RHODOBACTER-CAPSULATUS; MAGNESIUM CHELATASE; CHLOROPHYLL BIOSYNTHESIS; CHLOROPLAST BIOGENESIS; 4-VINYL CHLOROPHYLLIDE; DIVINYL REDUCTASE; 8-VINYL REDUCTASE; IDENTIFICATION	The creation of a synthetic microbe that can harvest energy from sunlight to drive its metabolic processes is an attractive approach to the economically viable biosynthetic production of target compounds. Our aim is to design and engineer a genetically tractable non-photosynthetic microbe to produce light-harvesting molecules. Previously we created a modular, multienzyme system for the heterologous production of intermediates of the bacteriochlorophyll (BChl) pathway in E. coli. In this report we extend this pathway to include a substrate promiscuous 8-vinyl reductase that can accept multiple intermediates of BChl biosynthesis. We present an informative comparative analysis of homologues of 8-vinyl reductase from the model photosynthetic organisms Rhodobacter sphaeroides and Chlorobaculum tepidum. The first purification of the enzymes leads to their detailed biochemical and biophysical characterization. The data obtained reveal that the two 8-vinyl reductases are substrate promiscuous, capable of reducing the C8-vinyl group of Mg protoporphyrin IX, Mg protoporphyrin IX methylester, and divinyl protochlorophyllide. However, activity is dependent upon the presence of chelated Mg2+ in the porphyrin ring, with no activity against non-Mg2+ chelated intermediates observed. Additionally, CD analyses reveal that the two 8-vinyl reductases appear to bind the same substrate in a different fashion. Furthermore, we discover that the different rates of reaction of the two 8-vinyl reductases both in vitro, and in vivo as part of our engineered system, results in the suitability of only one of the homologues for our BChl pathway in E. coli. Our results offer the first insights into the different functionalities of homologous 8-vinyl reductases. This study also takes us one step closer to the creation of a nonphotosynthetic microbe that is capable of harvesting energy from sunlight for the biosynthesis of molecules of choice.	[Tikh, Ilya B.; Quin, Maureen B.; Schmidt-Dannert, Claudia] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Schmidt-Dannert, C (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA.	schmi232@umn.edu		Quin, Maureen/0000-0001-7193-639X	Institute on the Environment (University of Minnesota); National Science Foundation [CBET-0756296]; National Institute of Health [GM008347]	Institute on the Environment (University of Minnesota)(University of Minnesota System); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Institute on the Environment (University of Minnesota) and National Science Foundation Grant CBET-0756296. IBT was supported by a predoctoral National Institute of Health traineeship (GM008347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BATTERSBY AR, 1980, NATURE, V285, P17, DOI 10.1038/285017a0; Boldareva-Nuianzina EN, 2013, APPL ENVIRON MICROB, V79, P2596, DOI 10.1128/AEM.00104-13; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; BOLLIVAR DW, 1994, J BACTERIOL, V176, P5290, DOI 10.1128/JB.176.17.5290-5296.1994; Broecker MJ, 2010, J BIOL CHEM, V285, P27336, DOI 10.1074/jbc.M110.126698; Canniffe DP, 2013, BIOCHEM J, V450, P397, DOI 10.1042/BJ20121723; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; FELSENSTEIN J, 1992, GENET RES, V60, P209, DOI 10.1017/S0016672300030962; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRIFFITHS WT, 1980, BIOCHEM J, V186, P267, DOI 10.1042/bj1860267; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; Huang XF, 2000, CHIRALITY, V12, P237, DOI 10.1002/(SICI)1520-636X(2000)12:4<237::AID-CHIR10>3.0.CO;2-6; Johnson ET, 2008, J BIOL CHEM, V283, P27776, DOI 10.1074/jbc.M804486200; Johnson ET, 2010, APPL ENVIRON MICROB, V76, P4123, DOI 10.1128/AEM.02425-09; Johnson ET, 2008, TRENDS BIOTECHNOL, V26, P682, DOI 10.1016/j.tibtech.2008.09.002; Kim MH, 2008, J BIOL CHEM, V283, P31981, DOI 10.1074/jbc.M804092200; Kolossov VL, 2001, ANAL BIOCHEM, V295, P214, DOI 10.1006/abio.2001.5195; Kwon SJ, 2003, APPL ENVIRON MICROB, V69, P4875, DOI 10.1128/AEM.69.8.4875-4883.2003; Liu ZF, 2011, J BACTERIOL, V193, P4996, DOI 10.1128/JB.05520-11; Lopez-Gallego F, 2010, CURR OPIN CHEM BIOL, V14, P174, DOI 10.1016/j.cbpa.2009.11.023; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Mackenzie C, 2007, ANNU REV MICROBIOL, V61, P283, DOI 10.1146/annurev.micro.61.080706.093402; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Maurino VG, 2013, J EXP BOT, V64, P743, DOI 10.1093/jxb/ers263; Mijts BN, 2005, CHEM BIOL, V12, P453, DOI 10.1016/j.chembiol.2005.02.010; Mijts BN, 2004, METHOD ENZYMOL, V388, P315; Mijts BN, 2003, CURR OPIN BIOTECH, V14, P597, DOI 10.1016/j.copbio.2003.09.009; Mizoguchi T, 2012, BIOORGAN MED CHEM, V20, P6803, DOI 10.1016/j.bmc.2012.09.054; Moser J, 2013, P NATL ACAD SCI USA, V110, P2094, DOI 10.1073/pnas.1218303110; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nagata N, 2007, PLANT CELL PHYSIOL, V48, P1803, DOI 10.1093/pcp/pcm153; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Paddock T, 2012, PLANT MOL BIOL, V78, P447, DOI 10.1007/s11103-012-9873-6; PARHAM R, 1992, BIOCHEMISTRY-US, V31, P8460, DOI 10.1021/bi00151a011; PARHAM R, 1995, ANAL BIOCHEM, V231, P164, DOI 10.1006/abio.1995.1516; Pereira PJB, 2001, NAT STRUCT BIOL, V8, P215, DOI 10.1038/84948; RESCIGNO M, 1994, BIOCHEMISTRY-US, V33, P5721, DOI 10.1021/bi00185a008; Rosgaard L, 2012, J BIOTECHNOL, V162, P134, DOI 10.1016/j.jbiotec.2012.05.006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunders AH, 2013, BIOCHEMISTRY; Sawicki A, 2010, FEBS J, V277, P4709, DOI 10.1111/j.1742-4658.2010.07877.x; SCHULZ R, 1989, MOL GEN GENET, V217, P355, DOI 10.1007/BF02464904; Senge MO, 2011, CHEM COMMUN, V47, P1943, DOI 10.1039/c0cc03984e; Shen F, 2008, THESIS; Shisler KA, 2012, CURR OPIN STRUC BIOL, V22, P701, DOI 10.1016/j.sbi.2012.10.005; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SUZUKI JY, 1995, J BIOL CHEM, V270, P3732, DOI 10.1074/jbc.270.8.3732; Sytina OA, 2009, BIOCHEM SOC T, V37, P387, DOI 10.1042/BST0370387; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang KH, 2009, J BACTERIOL, V191, P3580, DOI 10.1128/JB.00110-09; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tikh I, 2013, SYNTHETIC BIOLOGY: TOOLS AND APPLICATIONS, P303, DOI 10.1016/B978-0-12-394430-6.00016-9; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; Vick JE, 2011, APPL MICROBIOL BIOT, V92, P1275, DOI 10.1007/s00253-011-3633-4; Wang PR, 2013, PLANT PHYSIOL, V161, P521, DOI 10.1104/pp.112.208421; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weeks AM, 2011, BIOCHEMISTRY-US, V50, P5404, DOI 10.1021/bi200416g; Willows RD, 1996, EUR J BIOCHEM, V235, P438, DOI 10.1111/j.1432-1033.1996.00438.x; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n; Work VH, 2012, CURR OPIN BIOTECH, V23, P290, DOI 10.1016/j.copbio.2011.11.022	65	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89734	10.1371/journal.pone.0089734	http://dx.doi.org/10.1371/journal.pone.0089734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586995	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900147
J	Zhang, RN; Bloch, N; Nguyen, LA; Kim, B; Landau, NR				Zhang, Ruonan; Bloch, Nicolin; Nguyen, Laura A.; Kim, Baek; Landau, Nathaniel R.			SAMHD1 Restricts HIV-1 Replication and Regulates Interferon Production in Mouse Myeloid Cells	PLOS ONE			English	Article							AICARDI-GOUTIERES-SYNDROME; IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELLS; VPX; MACROPHAGES; EXPRESSION; MUTATIONS; TREX1; INFECTION; GENE	SAMHD1 restricts the replication of HIV-1 and other retroviruses in human myeloid and resting CD4(+) T cells and that is counteracted in SIV and HIV-2 by the Vpx accessory protein. The protein is a phosphohydrolase that lowers the concentration of deoxynucleoside triphosphates (dNTP), blocking reverse transcription of the viral RNA genome. Polymorphisms in the gene encoding SAMHD1 are associated with Aicardi-Goutieres Syndrome, a neurological disorder characterized by increased type-I interferon production. SAMHD1 is conserved in mammals but its role in restricting virus replication and controlling interferon production in non-primate species is not well understood. We show that SAMHD1 is catalytically active and expressed at high levels in mouse spleen, lymph nodes, thymus and lung. siRNA knock-down of SAMHD1 in bone marrow-derived macrophages increased their susceptibility to HIV-1 infection. shRNA knock-down of SAMHD1 in the murine monocytic cell-line RAW264.7 increased its susceptibility to HIV-1 and murine leukemia virus and increased the levels of the dNTP pool. In addition, SAMHD1 knock-down in RAW264.7 cells induced the production of type-I interferon and several interferon-stimulated genes, modeling the situation in Aicardi-Goutieres Syndrome. Our findings suggest that the role of SAMHD1 in restricting viruses is conserved in the mouse. The RAW264.7 cell-line serves as a useful tool to study the antiviral and innate immune response functions of SAMHD1.	[Zhang, Ruonan; Bloch, Nicolin; Landau, Nathaniel R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Nguyen, Laura A.] Univ Rochester, Dept Pathol, Rochester, NY 14627 USA; [Kim, Baek] Emory Sch Med, Dept Pediat, Ctr Drug Discovery, Atlanta, GA USA	New York University; University of Rochester; Emory University	Landau, NR (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Nathaniel.Landau@med.nyu.edu			National Institutes of Health [5R01 AI067059, 5R01 AI058864]; Public Health Service Institutional Research Training Award [AI07647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R01AI067059, R01AI058864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service Institutional Research Training Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by the National Institutes of Health (grant 5R01 AI067059 and grant 5R01 AI058864 to N.R.L) and supported in part by a Public Health Service Institutional Research Training Award AI07647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Bloch N., 2013, AIDS RES HUM RETROVI; Bobadilla S, 2012, GENE THER; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Dragin L, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-30; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; LAFUSE WP, 1995, J LEUKOCYTE BIOL, V57, P477, DOI 10.1002/jlb.57.3.477; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Li ZQ, 2012, J VIROL, V86, P3787, DOI 10.1128/JVI.06307-11; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Onishi M, 1996, EXP HEMATOL, V24, P324; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rehwinkel J, 2013, EMBO J; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Vandegraaff N, 2001, J VIROL, V75, P11253, DOI 10.1128/JVI.75.22.11253-11260.2001; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991	47	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89558	10.1371/journal.pone.0089558	http://dx.doi.org/10.1371/journal.pone.0089558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586870	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900152
J	Muthukumar, R; Alexandar, V; Thangam, B; Ahmed, SSSJ				Muthukumar, R.; Alexandar, V; Thangam, Berla; Ahmed, Shiek S. S. J.			A Systems Biological Approach Reveals Multiple Crosstalk Mechanism between Gram-Positive and Negative Bacterial Infections: An Insight into Core Mechanism and Unique Molecular Signatures	PLOS ONE			English	Article							GENE-EXPRESSION; TLR4; NETWORK; IDENTIFICATION; ACTIVATION; PREDICTION; SEPSIS; ROLES; TOOL	Background: Bacterial infections remain a major threat and a leading cause of death worldwide. Most of the bacterial infections are caused by gram-positive and negative bacteria, which are recognized by Toll-like receptor (TLR) 2 and 4, respectively. Activation of these TLRs initiates multiple pathways that subsequently lead to effective immune response. Although, both the TLRs share common signaling mechanism yet they may exhibit specificity as well, resulting in the release of diverse range of inflammatory mediators which could be used as candidate biomolecules for bacterial infections. Results: We adopted systems biological approach to identify signaling pathways mediated by TLRs to determine candidate molecules associated with bacterial infections. We used bioinformatics concepts, including literature mining to construct protein-protein interaction network, prioritization of TLRs specific nodes using microarray data and pathway analysis. Our constructed PPI network for TLR 2 (nodes: 4091 and edges: 66068) and TLR 4 (node: 4076 and edges: 67898) showed 3207 common nodes, indicating that both the TLRs might share similar signaling events that are attributed to cell migration, MAPK pathway and several inflammatory cascades. Our results propose the potential collaboration between the shared signaling pathways of both the receptors may enhance the immune response against invading pathogens. Further, to identify candidate molecules, the TLRs specific nodes were prioritized using microarray differential expressed genes. Of the top prioritized TLR 2 molecules, 70% were co-expressed. A similar trend was also observed within TLR 4 nodes. Further, most of these molecules were preferentially found in blood plasma for feasible diagnosis. Conclusions: The analysis reveals the common and unique mechanism regulated by both the TLRs that provide a broad perspective of signaling events in bacterial infections. Further, the identified candidate biomolecules could potentially aid future research efforts concerning the possibility in differential diagnosis of gram-positive and negative bacterial infections.	[Muthukumar, R.; Thangam, Berla] SRM Univ, Sch Bioengn, Dept Biotechnol, Potheri, Tamil Nadu, India; [Alexandar, V] Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Chettinad, Tamil Nadu, India; [Ahmed, Shiek S. S. J.] Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Dept Computat Biol, Chettinad, Tamil Nadu, India	SRM Institute of Science & Technology Chennai	Ahmed, SSSJ (corresponding author), Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Dept Computat Biol, Chettinad, Tamil Nadu, India.	shiekssjahmed@gmail.com	Raghunatan, Muthukumar/ABE-7757-2021	Raghunatan, Muthukumar/0000-0003-0947-8513	CARE	CARE	We thank Profs. R. Murugesan, R. M Pitchappan, M. Vairamani and S. Thyagarajan for their intellectual input. Authors thank Chettinad Academy of Research and Education (CARE), and SRM University for the infrastructure support and encouragement. AV specially thanks CARE for the research fellowship.	Aderem A, 2011, MBIO, V2, DOI 10.1128/mBio.00325-10; Ahmed SSSJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-6; Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Andaluz-Ojeda D, 2012, CYTOKINE, V57, P332, DOI 10.1016/j.cyto.2011.12.002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Barbosa-Silva A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-70; Bauer-Mehren A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.47; Bromberg Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002902; Cahill Catherine M, 2012, J Signal Transduct, V2012, P358476, DOI 10.1155/2012/358476; Chang JH, 2006, IMMUNOLOGY, V118, P164, DOI 10.1111/j.1365-2567.2006.02347.x; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Diaz-Beltran L, 2013, BEHAV SCI-BASEL, V3, P253, DOI 10.3390/bs3020253; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Estrada E, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066102; Fontaine JF, 2009, NUCLEIC ACIDS RES, V37, pW141, DOI 10.1093/nar/gkp353; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Huang QY, 2008, J HUM GENET, V53, P644, DOI 10.1007/s10038-008-0295-x; Jegga AG, 2011, AUTOPHAGY, V7, P477, DOI 10.4161/auto.7.5.14811; Jia P, 2011, BMC SYST BIOL, V23, P5; Krishnan Jayalakshmi, 2012, Genomics & Informatics, V10, P153, DOI 10.5808/GI.2012.10.3.153; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Patil S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-137; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schrag B, 2012, INT J LEGAL MED, V126, P505, DOI 10.1007/s00414-011-0596-z; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sookoian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058895; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Tu CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055230; van Dam S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-535; Vandenbon A, 2012, WIRES SYST BIOL MED, V4, P497, DOI 10.1002/wsbm.1178; Vasselon T, 2002, J LEUKOCYTE BIOL, V71, P503; Verboon-Maciolek MA, 2006, PEDIATR RES, V59, P457, DOI 10.1203/01.pdr.0000200808.35368.57; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; Xue MZ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/256782; Zhang BH, 2013, EUR REV MED PHARMACO, V17, P758	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89993	10.1371/journal.pone.0089993	http://dx.doi.org/10.1371/journal.pone.0089993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587173	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200103
J	Williams, SK; Maier, O; Fischer, R; Fairless, R; Hochmeister, S; Stojic, A; Pick, L; Haar, D; Musiol, S; Storch, MK; Pfizenmaier, K; Diem, R				Williams, Sarah K.; Maier, Olaf; Fischer, Roman; Fairless, Richard; Hochmeister, Sonja; Stojic, Aleksandar; Pick, Lara; Haar, Doreen; Musiol, Sylvia; Storch, Maria K.; Pfizenmaier, Klaus; Diem, Ricarda			Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; FACTOR-ALPHA; MONOCLONAL-ANTIBODIES; FACTOR RECEPTORS; KAPPA-B; MICE; DEMYELINATION	Tumour necrosis factor (TNF) is a proinflammatory cytokine that is known to regulate inflammation in a number of autoimmune diseases, including multiple sclerosis (MS). Although targeting of TNF in models of MS has been successful, the pathological role of TNF in MS remains unclear due to clinical trials where the non-selective inhibition of TNF resulted in exacerbated disease. Subsequent experiments have indicated that this may have resulted from the divergent effects of the two TNF receptors, TNFR1 and TNFR2. Here we show that the selective targeting of TNFR1 with an antagonistic antibody ameliorates symptoms of the most common animal model of MS, experimental autoimmune encephalomyelitis (EAE), when given following both a prophylactic and therapeutic treatment regime. Our results demonstrate that antagonistic TNFR1-specific antibodies may represent a therapeutic approach for the treatment of MS in the future.	[Williams, Sarah K.; Fairless, Richard; Stojic, Aleksandar; Diem, Ricarda] Univ Clin Heidelberg, Dept Neurooncol, Heidelberg, Germany; [Maier, Olaf; Fischer, Roman; Pfizenmaier, Klaus] Univ Stuttgart, Inst Cell Biol & Immunol, D-70174 Stuttgart, Germany; [Hochmeister, Sonja; Storch, Maria K.] Med Univ Graz, Dept Neurol, Graz, Austria; [Pick, Lara; Haar, Doreen; Musiol, Sylvia] Univ Saarland, Dept Neurol, Homburg, Germany	Ruprecht Karls University Heidelberg; University of Stuttgart; Medical University of Graz; Saarland University	Williams, SK (corresponding author), Univ Clin Heidelberg, Dept Neurooncol, Heidelberg, Germany.	s.williams@dkfz-heidelberg.de	Fischer, Roman/M-8045-2017; Fischer, Roman/AAA-9695-2021	Fischer, Roman/0000-0001-7927-604X; Fischer, Roman/0000-0001-7927-604X	EC FP6, Project NeuroproMiSe [LSHM-CT-2005-018637]; Hertie Foundation [1.01.1/12/008]	EC FP6, Project NeuroproMiSe; Hertie Foundation	This work was supported by grants from the EC FP6, Project NeuroproMiSe (LSHM-CT-2005-018637) and the Hertie Foundation (1.01.1/12/008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation on the manuscript.	Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; BAKER D, 1994, EUR J IMMUNOL, V24, P2040, DOI 10.1002/eji.1830240916; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; Caminero A, 2011, J NEUROIMMUNOL, V234, P1, DOI 10.1016/j.jneuroim.2011.03.004; Canella B, 1995, ANN NEUROL, V27, P424; Davie CA, 1995, BRAIN, V118, P1583, DOI 10.1093/brain/118.6.1583; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dolga AM, 2008, J ALZHEIMERS DIS, V13, P111; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.3.CO;2-1; Fairless R, 2012, J NEUROSCI, V32, P5585, DOI 10.1523/JNEUROSCI.5705-11.2012; Fischer R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027621; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Gimenez MAT, 2004, J NEUROIMMUNOL, V151, P116, DOI 10.1016/j.jneuroim.2004.02.012; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; HAUSER SL, 1990, NEUROLOGY, V40, P1735, DOI 10.1212/WNL.40.11.1735; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kitagaki M, 2012, J ATHEROSCLER THROMB, V19, P36, DOI 10.5551/jat.9746; Kontermann RE, 2009, EXPERT OPIN DRUG DIS, V4, P279, DOI 10.1517/17460440902785167; KORNER H, 1995, P NATL ACAD SCI USA, V92, P11066, DOI 10.1073/pnas.92.24.11066; Korner H, 1997, EUR J IMMUNOL, V27, P1973, DOI 10.1002/eji.1830270822; Losseff NA, 1996, BRAIN, V119, P2009, DOI 10.1093/brain/119.6.2009; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Nomura T, 2011, J CONTROL RELEASE, V149, P8, DOI 10.1016/j.jconrel.2009.12.015; Patel JR, 2012, ACTA NEUROPATHOL, V124, P847, DOI 10.1007/s00401-012-1034-0; Richez C, 2005, NEUROLOGY, V64, P1468, DOI 10.1212/01.WNL.0000158681.29117.8B; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; Steed PM, 2003, SCIENCE, V301, P1895, DOI 10.1126/science.1081297; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Taoufik E, 2011, BRAIN, V134, P2722, DOI 10.1093/brain/awr203; Teuscher C, 2004, AM J PATHOL, V165, P1593, DOI 10.1016/S0002-9440(10)63416-5; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Van Hauwermeiren F, 2011, CYTOKINE GROWTH F R, V22, P311, DOI 10.1016/j.cytogfr.2011.09.004; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Veroni C, 2010, MOL CELL NEUROSCI, V45, P234, DOI 10.1016/j.mcn.2010.06.014; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang YL, 2011, J AUTOIMMUN, V37, P160, DOI 10.1016/j.jaut.2011.05.013	48	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90117	10.1371/journal.pone.0090117	http://dx.doi.org/10.1371/journal.pone.0090117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587232	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200131
J	Durschmid, S; Quandt, F; Kramer, UM; Hinrichs, H; Heinze, HJ; Schulz, R; Pannek, H; Chang, EF; Knight, RT				Duerschmid, Stefan; Quandt, Fanny; Kraemer, Ulrike M.; Hinrichs, Hermann; Heinze, Hans-Jochen; Schulz, Reinhard; Pannek, Heinz; Chang, Edward F.; Knight, Robert T.			Oscillatory Dynamics Track Motor Performance Improvement in Human Cortex	PLOS ONE			English	Article							SENSORIMOTOR CORTEX; THETA-OSCILLATIONS; GAMMA-OSCILLATIONS; HUMAN HIPPOCAMPUS; FREQUENCY; ATTENTION; MEMORY; CONSOLIDATION; ANATOMY; ALPHA	Improving performance in motor skill acquisition is proposed to be supported by tuning of neural networks. To address this issue we investigated changes of phase-amplitude cross-frequency coupling (paCFC) in neuronal networks during motor performance improvement. We recorded intracranially from subdural electrodes (electrocorticogram; ECoG) from 6 patients who learned 3 distinct motor tasks requiring coordination of finger movements with an external cue (serial response task, auditory motor coordination task, go/no-go). Performance improved in all subjects and all tasks during the first block and plateaued in subsequent blocks. Performance improvement was paralled by increasing neural changes in the trial-to-trial paCFC between theta (theta; 4-8 Hz) phase and high gamma (HG; 80-180 Hz) amplitude. Electrodes showing this covariation pattern (Pearson's r ranging up to .45) were located contralateral to the limb performing the task and were observed predominantly in motor brain regions. We observed stable paCFC when task performance asymptoted. Our results indicate that motor performance improvement is accompanied by adjustments in the dynamics and topology of neuronal network interactions in the theta and HG range. The location of the involved electrodes suggests that oscillatory dynamics in motor cortices support performance improvement with practice.	[Duerschmid, Stefan; Hinrichs, Hermann; Heinze, Hans-Jochen] Otto Guericke Univ, Dept Neurol, Magdeburg, Germany; [Duerschmid, Stefan; Quandt, Fanny; Hinrichs, Hermann; Heinze, Hans-Jochen] LIN, Magdeburg, Germany; [Kraemer, Ulrike M.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Hinrichs, Hermann; Heinze, Hans-Jochen] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Pannek, Heinz] Epilepsiezentrum Bethel, Bielefeld, Germany; [Chang, Edward F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); University of Lubeck; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Durschmid, S (corresponding author), Otto Guericke Univ, Dept Neurol, Magdeburg, Germany.	stefan.duerschmid@med.ovgu.de	Krämer, Ulrike/AAF-2966-2020; Krämer, Ulrike M./A-8871-2019	Krämer, Ulrike M./0000-0002-3841-1812	Land-Sachsen-Anhalt Grant [MK48-2009/003]; ECHORD [231143]; NINDS [NS21135]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021135, R01NS021135, R56NS021135] Funding Source: NIH RePORTER	Land-Sachsen-Anhalt Grant; ECHORD; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by the following funding source: Land-Sachsen-Anhalt Grant MK48-2009/003, ECHORD 231143, NINDS Grant NS21135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00059; Aron AR, 2010, BIOL PSYCHIAT; Axmacher N, 2010, NEURON, V65, P541, DOI 10.1016/j.neuron.2010.02.006; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brovelli A, 2005, NEUROIMAGE, V28, P154, DOI 10.1016/j.neuroimage.2005.05.045; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Cantero JL, 2003, J NEUROSCI, V23, P10897; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cheyne D, 2008, NEUROIMAGE, V42, P332, DOI 10.1016/j.neuroimage.2008.04.178; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crowell AL, 2012, BRAIN, V135, P615, DOI 10.1093/brain/awr332; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Grafton S T, 1994, Hum Brain Mapp, V1, P221, DOI 10.1002/hbm.460010307; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Miller KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002655; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Scheffer-Teixeira R, 2013, J NEUROSCI, V33, P1535, DOI 10.1523/JNEUROSCI.4217-12.2013; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Yanagisawa T, 2012, J NEUROSCI, V32, P15467, DOI 10.1523/JNEUROSCI.2929-12.2012	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89576	10.1371/journal.pone.0089576	http://dx.doi.org/10.1371/journal.pone.0089576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586885	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800028
J	Taguchi, A; Kawana, K; Tomio, K; Yamashita, A; Isobe, Y; Nagasaka, K; Koga, K; Inoue, T; Nishida, H; Kojima, S; Adachi, K; Matsumoto, Y; Arimoto, T; Wada-Hiraike, O; Oda, K; Kang, JX; Arai, H; Arita, M; Osuga, Y; Fujii, T				Taguchi, Ayumi; Kawana, Kei; Tomio, Kensuke; Yamashita, Aki; Isobe, Yosuke; Nagasaka, Kazunori; Koga, Kaori; Inoue, Tomoko; Nishida, Haruka; Kojima, Satoko; Adachi, Katsuyuki; Matsumoto, Yoko; Arimoto, Takahide; Wada-Hiraike, Osamu; Oda, Katsutoshi; Kang, Jing X.; Arai, Hiroyuki; Arita, Makoto; Osuga, Yutaka; Fujii, Tomoyuki			Matrix Metalloproteinase (MMP)-9 in Cancer-Associated Fibroblasts (CAFs) Is Suppressed by Omega-3 Polyunsaturated Fatty Acids In Vitro and In Vivo	PLOS ONE			English	Article							KAPPA-B ACTIVATION; FAT-1 TRANSGENIC MICE; TNF-ALPHA; STROMAL FIBROBLASTS; TUMOR MICROENVIRONMENT; DOCOSAHEXAENOIC ACID; ENDOTHELIAL-CELLS; LINOLEIC-ACID; COLON-CANCER; EXPRESSION	Cancer associated fibroblasts (CAFs) are responsible for tumor growth, angiogenesis, invasion, and metastasis. Matrix metalloproteinase (MMP)-9 secreted from cancer stroma populated by CAFs is a prerequisite for cancer angiogenesis and metastasis. Omega-3 polyunsaturated fatty acids (omega-3 PUFA) have been reported to have anti-tumor effects on diverse types of malignancies. Fat-1 mice, which can convert omega-6 to omega-3 PUFA independent of diet, are useful to investigate the functions of endogenous omega-3 PUFA. To examine the effect of omega-3 PUFA on tumorigenesis, TC-1 cells, a murine epithelial cell line immortalized by human papillomavirus (HPV) oncogenes, were injected subcutaneously into fat-1 or wild type mice. Tumor growth and angiogenesis of the TC-1 tumor were significantly suppressed in fat-1 compared to wild type mice. cDNA microarray of the tumors derived from fat-1 and wild type mice revealed that MMP-9 is downregulated in fat-1 mice. Immunohistochemical study demonstrated immunoreactivity for MMP-9 in the tumor stromal fibroblasts was diffusely positive in wild type whereas focal in fat-1 mice. MMP-9 was expressed in primary cultured fibroblasts isolated from fat-1 and wild type mice but was not expressed in TC-1 cells. Co-culture of fibroblasts with TC-1 cells enhanced the expression and the proteinase activity of MMP-9, although the protease activity of MMP-9 in fat-1-derived fibroblasts was lower than that in wild type fibroblasts. Our data suggests that omega-3 PUFAs suppress MMP-9 induction and tumor angiogenesis. These findings may provide insight into mechanisms by which omega-3 PUFAs exert anti-tumor effects by modulating tumor microenvironment.	[Taguchi, Ayumi; Kawana, Kei; Tomio, Kensuke; Yamashita, Aki; Nagasaka, Kazunori; Koga, Kaori; Inoue, Tomoko; Nishida, Haruka; Kojima, Satoko; Adachi, Katsuyuki; Matsumoto, Yoko; Arimoto, Takahide; Wada-Hiraike, Osamu; Oda, Katsutoshi; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Isobe, Yosuke; Arai, Hiroyuki; Arita, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan; [Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Charlestown, MA USA; [Kang, Jing X.] Harvard Univ, Sch Med, Charlestown, MA USA	University of Tokyo; University of Tokyo; Harvard University; Massachusetts General Hospital; Harvard University	Kawana, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	kkawana-tky@umin.org; marita@mol.f.u-tokyo.ac.jp	Koga, Kaori/ABA-5601-2020; Nagasaka, Kazunori/AAM-4311-2020	Koga, Kaori/0000-0002-5057-4120; Nagasaka, Kazunori/0000-0002-0696-5175; Wada-Hiraike, Osamu/0000-0002-3458-6711; Arita, Makoto/0000-0001-9902-0463	Tokyo IGAKUKAI; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [26293357] Funding Source: KAKEN	Tokyo IGAKUKAI; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by Tokyo IGAKUKAI (K.K.), the Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO) (M.A.), the Ministry of Education, Culture, Sports, Science, and Technology of Japan (M.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Calviello G, 2004, CARCINOGENESIS, V25, P2303, DOI 10.1093/carcin/bgh265; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Dichtl W, 2002, METABOLISM, V51, P327, DOI 10.1053/meta.2002.29963; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Field CJ, 2004, AM J CLIN NUTR, V79, p1190S, DOI 10.1093/ajcn/79.6.1190S; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Genersch E, 2000, J CELL SCI, V113, P4319; Habermann N, 2010, APOPTOSIS, V15, P621, DOI 10.1007/s10495-010-0459-y; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hardman WE, 2002, J NUTR, V132, p3508S, DOI 10.1093/jn/132.11.3508S; Heissig B, 2003, CURR OPIN HEMATOL, V10, P136, DOI 10.1097/00062752-200303000-00007; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kim HH, 2008, BIOCHEM BIOPH RES CO, V368, P343, DOI 10.1016/j.bbrc.2008.01.062; Kupferman ME, 2000, AM J PATHOL, V157, P1777, DOI 10.1016/S0002-9440(10)64815-8; Lee CYK, 2010, INT J ONCOL, V36, P991, DOI 10.3892/ijo_00000579; Lin KY, 1996, CANCER RES, V56, P21; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Mishra A, 2004, ARTERIOSCL THROM VAS, V24, P1621, DOI 10.1161/01.ATV.0000137191.02577.86; Mukutmoni-Norris M, 2000, CANCER LETT, V150, P101, DOI 10.1016/S0304-3835(99)00380-8; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Nowak J, 2007, CARCINOGENESIS, V28, P1991, DOI 10.1093/carcin/bgm166; Robinson LE, 2002, BREAST CANCER RES TR, V73, P145, DOI 10.1023/A:1015261111605; Roomi MW, 2009, ONCOL REP, V22, P1283, DOI 10.3892/or_00000566; Rose DP, 1999, INT J ONCOL, V15, P1011; Ross JA, 2003, INT J ONCOL, V23, P1733; Rowe RG, 2011, AM J PHYSIOL-LUNG C, V301, pL683, DOI 10.1152/ajplung.00187.2011; Schauer IG, 2013, NEOPLASIA, V15, P409, DOI 10.1593/neo.121228; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serini S, 2009, APOPTOSIS, V14, P135, DOI 10.1007/s10495-008-0298-2; Simon C, 2001, EXP CELL RES, V271, P344, DOI 10.1006/excr.2001.5374; Spencer L, 2009, EUR J CANCER, V45, P2077, DOI 10.1016/j.ejca.2009.04.026; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stuelten CH, 2005, J CELL SCI, V118, P2143, DOI 10.1242/jcs.02334; Tevar R, 2002, JPEN-PARENTER ENTER, V26, P285, DOI 10.1177/0148607102026005285; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Weylandt KH, 2011, CARCINOGENESIS, V32, P897, DOI 10.1093/carcin/bgr049; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Zhao Y, 2004, J AM COLL NUTR, V23, P71, DOI 10.1080/07315724.2004.10719345; Zhu YT, 2012, EXP CELL RES, V318, P2520, DOI 10.1016/j.yexcr.2012.07.021; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	48	48	50	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89605	10.1371/journal.pone.0089605	http://dx.doi.org/10.1371/journal.pone.0089605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586907	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800030
J	Arichika, S; Uji, A; Ooto, S; Miyamoto, K; Yoshimura, N				Arichika, Shigeta; Uji, Akihito; Ooto, Sotaro; Miyamoto, Kazuaki; Yoshimura, Nagahisa			Adaptive Optics-Assisted Identification of Preferential Erythrocyte Aggregate Pathways in the Human Retinal Microvasculature	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPE; BLOOD-FLOW-VELOCITY; PARAFOVEAL CAPILLARIES; DIABETES-MELLITUS; LEUKOCYTE DYNAMICS; IN-VIVO; MICROCIRCULATION; RATS; VISUALIZATION; HYPERTENSION	Purpose: To characterize human parafoveal blood flow using adaptive optics scanning laser ophthalmoscopy (AO-SLO). Methods: In 5 normal subjects, erythrocyte aggregate distributions were analyzed on 3 different days. Erythrocyte aggregates were described as a "dark tail'' in AO-SLO. The characteristics of the pathways with dark tail flow in the parafovea were measured. Additionally, the tendency for dark tail flow before and after bifurcations was analyzed to study the blood flow in detail. Results: Average velocity in parent vessels with dark tail flow was 1.30 +/- 0.27 mm/s. Average velocity in daughter vessels with dark tail flow was 1.12 +/- 0.25 mm/s, and the average velocity of plasma gaps in daughter vessels without dark tail flow was 0.64 +/- 0.11 mm/s. Downstream from the bifurcations, the velocity in vessels with dark tail flow was higher than that in those without it (p < 0.001), and the branching angles of vessels with dark tail flow were smaller than those of vessels without it (p < 0.001). Conclusions: Images from the AO-SLO noninvasively revealed pathways with and without dark tail flow in the human parafovea. Pathways with dark tail flow in the daughter vessels generally had faster flow and smaller bifurcation angles than daughter vessels without dark tail flow. Thus, AO-SLO is an instructive tool for analyzing retinal microcirculatory hemodynamics.	[Arichika, Shigeta; Uji, Akihito; Ooto, Sotaro; Miyamoto, Kazuaki; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kyoto University	Uji, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	akihito1@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Innovative Techno-Hub for Integrated Medical Bioimaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arichika S, 2013, INVEST OPHTH VIS SCI, V54, P4394, DOI 10.1167/iovs.12-11138; Babu N, 2005, CLIN HEMORHEOL MICRO, V32, P269; Bedggood Phillip, 2012, Biomed Opt Express, V3, P3264, DOI 10.1364/BOE.3.003264; Burgansky-Eliash Z, 2012, RETINA-J RET VIT DIS, V32, P112, DOI 10.1097/IAE.0b013e31821ba2c4; Burgansky-Eliash Z, 2010, RETINA-J RET VIT DIS, V30, P765, DOI 10.1097/IAE.0b013e3181c596c6; Cheung CYL, 2012, HYPERTENSION, V60, P1094, DOI 10.1161/HYPERTENSIONAHA.111.189142; Cho Young I, 2008, J Diabetes Sci Technol, V2, P1130; Chui TYP, 2012, BIOMED OPT EXPRESS, V3, P2537, DOI 10.1364/BOE.3.002537; Cooper RF, 2011, BIOMED OPT EXPRESS, V2, P2577, DOI 10.1364/BOE.2.002577; Demiroglu H, 1997, BLOOD, V89, P4236, DOI 10.1182/blood.V89.11.4236; KEITH NM, 1974, AM J MED SCI, V268, P336, DOI 10.1097/00000441-197412000-00004; KIMURA H, 1995, CURR EYE RES, V14, P223, DOI 10.3109/02713689509033518; Le Devehat C, 2001, CLIN HEMORHEOL MICRO, V25, P43; Martin JA, 2005, OPHTHALMOLOGY, V112, P2219, DOI 10.1016/j.ophtha.2005.06.033; Martin JA, 2009, EXP EYE RES, V88, P356, DOI 10.1016/j.exer.2008.07.008; Merino D, 2011, BIOMED OPT EXPRESS, V2, P2189, DOI 10.1364/BOE.2.002189; Miyamoto K, 1998, INVEST OPHTH VIS SCI, V39, P2190; NISHIWAKI H, 1995, INVEST OPHTH VIS SCI, V36, P123; Nishiwaki H, 1996, INVEST OPHTH VIS SCI, V37, P1341; Ott C, 2013, HYPERTENSION, V61, P1340, DOI 10.1161/HYPERTENSIONAHA.111.00617; PUNIYANI RR, 1991, J BIOMED ENG, V13, P441, DOI 10.1016/0141-5425(91)90029-7; Ritt M, 2009, HYPERTENSION, V54, P384, DOI 10.1161/HYPERTENSIONAHA.109.133025; RIVA CE, 1985, INVEST OPHTH VIS SCI, V26, P1124; SCHEIE HG, 1953, AMA ARCH OPHTHALMOL, V49, P117; Singh M, 2009, INDIAN J EXP BIOL, V47, P7; Spengler MI, 2011, CLIN HEMORHEOL MICRO, V47, P279, DOI 10.3233/CH-2011-1409; Srinivasan VJ, 2012, BIOMED OPT EXPRESS, V3, P612, DOI 10.1364/BOE.3.000612; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Takayama K, 2013, AM J OPHTHALMOL, V155, P870, DOI 10.1016/j.ajo.2012.11.016; Tam J, 2011, INVEST OPHTH VIS SCI, V52, P9257, DOI 10.1167/iovs.11-8481; Tam J, 2011, BIOMED OPT EXPRESS, V2, P781, DOI 10.1364/BOE.2.000781; Tam J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548880; Tam J, 2010, INVEST OPHTH VIS SCI, V51, P1691, DOI 10.1167/iovs.09-4483; Uji A, 2012, INVEST OPHTH VIS SCI, V53, P171, DOI 10.1167/iovs.11-8192; Zhong ZY, 2011, INVEST OPHTH VIS SCI, V52, P4151, DOI 10.1167/iovs.10-6940	35	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89679	10.1371/journal.pone.0089679	http://dx.doi.org/10.1371/journal.pone.0089679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586959	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000076
J	Boutilier, MSH; Lee, JH; Chambers, V; Venkatesh, V; Karnik, R				Boutilier, Michael S. H.; Lee, Jongho; Chambers, Valerie; Venkatesh, Varsha; Karnik, Rohit			Water Filtration Using Plant Xylem	PLOS ONE			English	Article							DRINKING-WATER; BORDERED PITS; TECHNOLOGY; COUNTRIES; ACCESS; WORLD; POINT	Effective point-of-use devices for providing safe drinking water are urgently needed to reduce the global burden of waterborne disease. Here we show that plant xylem from the sapwood of coniferous trees - a readily available, inexpensive, biodegradable, and disposable material - can remove bacteria from water by simple pressure-driven filtration. Approximately 3 cm 3 of sapwood can filter water at the rate of several liters per day, sufficient to meet the clean drinking water needs of one person. The results demonstrate the potential of plant xylem to address the need for pathogen-free drinking water in developing countries and resource-limited settings.	[Boutilier, Michael S. H.; Lee, Jongho; Chambers, Valerie; Venkatesh, Varsha; Karnik, Rohit] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Karnik, R (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	karnik@mit.edu		Boutilier, Michael/0000-0001-6309-2318	James H. Ferry, Jr. Fund for Innovation in Research Education award; National Science Foundation under NSF [ECS-0335765]	James H. Ferry, Jr. Fund for Innovation in Research Education award; National Science Foundation under NSF(National Science Foundation (NSF))	This work was supported by the James H. Ferry, Jr. Fund for Innovation in Research Education award to R. K. administered by the Massachusetts Institute of Technology. SEM imaging was performed at the Harvard Center for Nanoscale Systems, a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal JMA, 2001, DESALINATION, V137, P63, DOI 10.1016/S0011-9164(01)00205-3; Choat B, 2003, PLANT PHYSIOL, V131, P41, DOI 10.1104/pp.014100; Choat B, 2008, NEW PHYTOL, V177, P608, DOI 10.1111/j.1469-8137.2007.02317.x; DUNNICK JK, 1993, J NATL CANCER I, V85, P817, DOI 10.1093/jnci/85.10.817; Espino S, 2011, J EXP BOT, V62, P1119, DOI 10.1093/jxb/erq338; Gadgil A, 1998, ANNU REV ENERG ENV, V23, P253, DOI 10.1146/annurev.energy.23.1.253; Jansen S, 2009, AM J BOT, V96, P409, DOI 10.3732/ajb.0800248; Lantagne D. S., 2006, NAVIGATION-US, V99, P17; Loo SL, 2012, WATER RES, V46, P3125, DOI 10.1016/j.watres.2012.03.030; Madaeni SS, 1999, WATER RES, V33, P301, DOI 10.1016/S0043-1354(98)00212-7; Mintz E, 2001, AM J PUBLIC HEALTH, V91, P1565, DOI 10.2105/AJPH.91.10.1565; Peter-Varbanets M, 2009, WATER RES, V43, P245, DOI 10.1016/j.watres.2008.10.030; PETTY JA, 1972, PROC R SOC SER B-BIO, V181, P395, DOI 10.1098/rspb.1972.0057; Reed B., 2011, MUCH WATER IS NEEDED; Sens ML, 2013, DESALINATION WATER T; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n; Sperry JS, 2003, INT J PLANT SCI, V164, pS115, DOI 10.1086/368398; van Ieperen W, 2000, J EXP BOT, V51, P769, DOI 10.1093/jexbot/51.345.769	19	50	54	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89934	10.1371/journal.pone.0089934	http://dx.doi.org/10.1371/journal.pone.0089934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587134	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000113
J	Dabernat, H; Theves, C; Bouakaze, C; Nikolaeva, D; Keyser, C; Mokrousov, I; Geraut, A; Duchesne, S; Gerard, P; Alexeev, AN; Crubezy, E; Ludes, B				Dabernat, Henri; Theves, Catherine; Bouakaze, Caroline; Nikolaeva, Dariya; Keyser, Christine; Mokrousov, Igor; Geraut, Annie; Duchesne, Sylvie; Gerard, Patrice; Alexeev, Anatoly N.; Crubezy, Eric; Ludes, Bertrand			Tuberculosis Epidemiology and Selection in an Autochthonous Siberian Population from the 16th-19th Century	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BEIJING GENOTYPE; MOLECULAR EPIDEMIOLOGY; RUSSIAN-FEDERATION; GLOBAL PHYLOGENY; ANCIENT DNA; CHILDREN; POLYMORPHISM; HISTORY; DIVERSITY	Tuberculosis is one of most ancient diseases affecting human populations. Although numerous studies have tried to detect pathogenic DNA in ancient skeletons, the successful identification of ancient tuberculosis strains remains rare. Here, we describe a study of 140 ancient subjects inhumed in Yakutia (Eastern Siberia) during a tuberculosis outbreak, dating from the 16th-19th century. For a long time, Yakut populations had remained isolated from European populations, and it was not until the beginning of the 17th century that first contacts were made with European settlers. Subsequently, tuberculosis spread throughout Yakutia, and the evolution of tuberculosis frequencies can be tracked until the 19th century. This study took a multidisciplinary approach, examining historical and paleo-epidemiological data to understand the impact of tuberculosis on ancient Yakut population. In addition, molecular identification of the ancient tuberculosis strain was realized to elucidate the natural history and host-pathogen co-evolution of human tuberculosis that was present in this population. This was achieved by the molecular detection of the IS6110 sequence and SNP genotyping by the SNaPshot technique. Results demonstrated that the strain belongs to cluster PGG2-SCG-5, evocating a European origin. Our study suggests that the Yakut population may have been shaped by selection pressures, exerted by several illnesses, including tuberculosis, over several centuries. This confirms the validity and necessity of using a multidisciplinary approach to understand the natural history of Mycobacterium tuberculosis infection and disease.	[Dabernat, Henri; Theves, Catherine; Bouakaze, Caroline; Keyser, Christine; Geraut, Annie; Duchesne, Sylvie; Gerard, Patrice; Crubezy, Eric; Ludes, Bertrand] Univ Strasbourg, Univ Toulouse Paul Sabatier 3, CNRS, Mol Anthropol & Image Synth AMIS Lab,UMR 5288, Toulouse, France; [Nikolaeva, Dariya] Univ Versailles St Quentin En Yvelines, Cultural Hist Ctr Contemporary Societies CHCSC, Versailles, France; [Mokrousov, Igor] St Petersburg Pasteur Inst, Mol Microbiol Lab, St Petersburg, Russia; [Ludes, Bertrand] Univ Paris 05, Inst Legal Med, Paris, France; [Alexeev, Anatoly N.] Russian Acad Sci, Inst Humanities & Indigenous Peoples North, Siberian Branch, Yakutsk, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universite Paris Saclay; Saint-Petersburg Pasteur Institute; UDICE-French Research Universities; Universite Paris Cite; Institute for Humanities Research & Indigenous Studies of the North; Russian Academy of Sciences	Crubezy, E (corresponding author), Univ Strasbourg, Univ Toulouse Paul Sabatier 3, CNRS, Mol Anthropol & Image Synth AMIS Lab,UMR 5288, Toulouse, France.	crubezy.eric@free.fr	Alekseev, Anatoliy Nickolaevich/O-1096-2015; LUDES, Bertrand/AAB-6309-2022; Crubézy, Eric/AAB-5165-2022; Mokrousov, Igor/J-3640-2014; Duchesne, Sylvie/AAA-7467-2022; Mokrousov, Igor/Q-5941-2019	Alekseev, Anatoliy Nickolaevich/0000-0002-9488-573X; Crubézy, Eric/0000-0001-9417-9053; Mokrousov, Igor/0000-0001-5924-0576; Duchesne, Sylvie/0000-0003-0138-8409; Mokrousov, Igor/0000-0001-5924-0576; /0000-0002-3854-4420; Gerard, Patrice/0000-0002-6018-6092	French archaeological Mission in Oriental Siberia (Ministere des Affaires Etrangeres et Europeennes, France); North-Eastern Federal University (Yakutsk, Sakha Republic); program HUMAD from IPEV (Institut Polaire franAcais Paul Emile Victor)	French archaeological Mission in Oriental Siberia (Ministere des Affaires Etrangeres et Europeennes, France); North-Eastern Federal University (Yakutsk, Sakha Republic); program HUMAD from IPEV (Institut Polaire franAcais Paul Emile Victor)	This project was funded by the French archaeological Mission in Oriental Siberia (Ministere des Affaires Etrangeres et Europeennes, France), the North-Eastern Federal University (Yakutsk, Sakha Republic), the program HUMAD from IPEV (Institut Polaire franA ais Paul Emile Victor). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Andreiev EN, 1953, TUBERCULOSE BORBA NI; [Anonymous], 2006, TUBERCULOSIS MANUAL; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; BATES JH, 1993, MED CLIN N AM, V77, P1205, DOI 10.1016/S0025-7125(16)30188-2; Biagini P, 2012, NEW ENGL J MED, V367, P2057, DOI 10.1056/NEJMc1208124; Bouakaze C, 2010, J CLIN MICROBIOL, V48, P1758, DOI 10.1128/JCM.02255-09; Boushkov PM, 1928, MAT IZYSHENIYU TUBER; Broca A, 1925, TUBERCULOSE CHIRURG; Chan JZM, 2013, NEW ENGL J MED, V369, P289, DOI 10.1056/NEJMc1302295; Comas I, 2011, TRENDS MICROBIOL, V19, P492, DOI 10.1016/j.tim.2011.07.002; Cook N.D., 1992, SECRET JUDGMENTS GOD; COOK ND, 1998, BORN DIE DIS NEW WOR, P1492; Crubezy E, 2012, WORLD ANCIENT YAKOUT; Crubezy E, 2007, CHAMANE KYYS JEUNE F; Crubezy E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-25; Dabernat H, 2013, ARCHEOLOGIY IN PRESS; De Vuyst D, 2003, EUR RADIOL, V13, P1809, DOI 10.1007/s00330-002-1609-6; Dedouit F, 2010, FORENSIC SCI INT, V200, DOI 10.1016/j.forsciint.2010.03.028; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dymova M, 2011, ANAL GENETIC DIVERSI; Dymova MA, 2011, J MED MICROBIOL, V60, P1003, DOI 10.1099/jmm.0.027995-0; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fletcher HA, 2003, MICROBIOL-SGM, V149, P143, DOI 10.1099/mic.0.25961-0; Forsyth James, 1992, HIST PEOPLES SIBERIA; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huang CH, 1996, INT ORTHOP, V20, P169, DOI 10.1007/s002640050056; Kaganovitch RB, 1952, IZ ISTORII BORBY TYB; Keyser-Tracqui Christine, 2005, V297, P253; Kiple KE, 1999, CAMBRIDGE WORLD HIST; Kon FA, 1889, FISIOLOGISHESKIE BIO; Lewis M. E., 2006, BIOARCHAEOLOGY CHILD; Matrakshin A G, 2004, Probl Tuberk Bolezn Legk, P37; Mendisco F, 2011, ELECTROPHORESIS, V32, P386, DOI 10.1002/elps.201000483; Mizkevitsj SM, 1969, ZAPISKI VRASHA OBSHE; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2012, CAUSES CONSEQUENCES, P317; Myglan VS, 2005, ARCHAEOLOGY ETHNOGRA, V4, P136; Nathanson L., 1941, RADIOLOGY, V36, P550; Naumov I.V., 2006, HIST SIBERIA; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Aparicio JP, 2009, MATH BIOSCI ENG, V6, P209, DOI 10.3934/mbe.2009.6.209; Popov NA, 2009, PROSHLOE JAKUTII PAS, P219; RASOOL MN, 1994, J BONE JOINT SURG BR, V76B, P113, DOI 10.1302/0301-620X.76B1.8300652; Shabbeer A, 2012, INFECT GENET EVOL, V12, P767, DOI 10.1016/j.meegid.2011.08.019; Shreiber SE, 1929, PREDVARITELNY OTCHET; Sinkov VV, 2011, MOL GENET MICROBIOL+, V26, P120, DOI 10.3103/S0891416811030050; Sorrel E., 1932, TUBERCULOSE OSSEUSE; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Suzuki T, 2007, INT J OSTEOARCHAEOL, V17, P392, DOI 10.1002/oa.871; Taylor GM, 1996, J ARCHAEOL SCI, V23, P789; Teo HEL, 2004, PEDIATR RADIOL, V34, P853, DOI 10.1007/s00247-004-1223-7; Theves C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021733; Thorne N, 2011, INFECT GENET EVOL, V11, P132, DOI 10.1016/j.meegid.2010.09.011; Tyrylgin MA, 2010, OTSHERKI ISTORII ORG; Ussery XT, 1996, PEDIATR INFECT DIS J, V15, P697, DOI 10.1097/00006454-199608000-00013; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Waldron T., 2007, PALAEOEPIDEMIOLOGY M; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Zhdanova S, 2013, EMERG INFECT DIS, V19, P1649, DOI 10.3201/eid1910.121108	67	18	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89877	10.1371/journal.pone.0089877	http://dx.doi.org/10.1371/journal.pone.0089877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587092	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000104
J	Dai, WT; Song, TR; Wang, X; Jin, XY; Deng, LZ; Wu, AP; Jiang, TJ				Dai, Wentao; Song, Tingrui; Wang, Xuan; Jin, Xiaoyang; Deng, Lizong; Wu, Aiping; Jiang, Taijiao			Improvement in Low-Homology Template-Based Modeling by Employing a Model Evaluation Method with Focus on Topology	PLOS ONE			English	Article							PROTEIN FOLD RECOGNITION; SECONDARY STRUCTURE; SEQUENCE-PROFILE; PREDICTION; QUALITY	Many template-based modeling (TBM) methods have been developed over the recent years that allow for protein structure prediction and for the study of structure-function relationships for proteins. One major problem all TBM algorithms face, however, is their unsatisfactory performance when proteins under consideration are low-homology. To improve the performance of TBM methods for such targets, a novel model evaluation method was developed here, and named MEFTop. Our novel method focuses on evaluating the topology by using two novel groups of features. These novel features included secondary structure element (SSE) contact information and 3-dimensional topology information. By combining MEFTop algorithm with FR-t5, a threading program developed by our group, we found that this modified TBM program, which was named FR-t5-M, exhibited significant improvements in predictive abilities for low-homology protein targets. We further showed that the MEFTop could be a generalized method to improve threading programs for low-homology protein targets. The softwares (FR-t5-M and MEFTop) are available to non-commercial users at our website: http://jianglab.ibp.ac.cn/lims/FRt5M/FRt5M.html.	[Dai, Wentao; Song, Tingrui; Wang, Xuan; Jin, Xiaoyang; Deng, Lizong; Wu, Aiping; Jiang, Taijiao] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Key Lab Prot & Peptide Pharmaceut, Beijing 100080, Peoples R China; [Dai, Wentao; Song, Tingrui; Wang, Xuan; Jin, Xiaoyang; Deng, Lizong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, AP (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Key Lab Prot & Peptide Pharmaceut, Beijing 100080, Peoples R China.	wuaiping@moon.ibp.ac.cn; taijiao@moon.ibp.ac.cn		Wu, Aiping/0000-0002-5869-651X	Project 973 [2009CB918503]; National Natural Science Foundation of China [31371338, 31100950]; Major National earmark Project for Infectious Diseases [2013ZX10004611-002]	Project 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National earmark Project for Infectious Diseases	This study was supported by Project 973 (2009CB918503), National Natural Science Foundation of China (31371338), Major National earmark Project for Infectious Diseases (2013ZX10004611-002) to TJ and National Natural Science Foundation of China (31100950) to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Drucker H, 1997, ADV NEUR IN, V9, P155; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017215; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Ma JZ, 2013, BIOINFORMATICS, V29, P257, DOI 10.1093/bioinformatics/btt210; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Qiu J, 2008, PROTEINS, V71, P1175, DOI 10.1002/prot.21809; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rice DW, 1997, J MOL BIOL, V267, P1026, DOI 10.1006/jmbi.1997.0924; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Tian LQ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-208; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang Z, 2009, PROTEINS, V75, P638, DOI 10.1002/prot.22275; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Xu Jinbo, 2003, J Bioinform Comput Biol, V1, P95, DOI 10.1142/S0219720003000186; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Xu X, 2013, CURR BIOL, V23, P1031, DOI 10.1016/j.cub.2013.04.054; Yang YD, 2008, PROTEINS, V72, P793, DOI 10.1002/prot.21968; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhao F, 2012, STRUCTURE, V20, P1118, DOI 10.1016/j.str.2012.04.003; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012; Zhou HY, 2004, PROTEINS, V55, P1005, DOI 10.1002/prot.20007; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	34	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89935	10.1371/journal.pone.0089935	http://dx.doi.org/10.1371/journal.pone.0089935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587135	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000114
J	Qu, JG; Rizak, JD; Zhao, L; Li, MH; Ma, YY				Qu, Jiagui; Rizak, Joshua D.; Zhao, Lun; Li, Minghong; Ma, Yuanye			Effects of Visual Working Memory on Brain Information Processing of Irrelevant Auditory Stimuli	PLOS ONE			English	Article							LOCALIZATION; ATTENTION; OBJECT	Selective attention has traditionally been viewed as a sensory processing modulator that promotes cognitive processing efficiency by favoring relevant stimuli while inhibiting irrelevant stimuli. However, the cross-modal processing of irrelevant information during working memory (WM) has been rarely investigated. In this study, the modulation of irrelevant auditory information by the brain during a visual WM task was investigated. The N100 auditory evoked potential (N100-AEP) following an auditory click was used to evaluate the selective attention to auditory stimulus during WM processing and at rest. N100-AEP amplitudes were found to be significantly affected in the left-prefrontal, mid-prefrontal, right-prefrontal, left-frontal, and mid-frontal regions while performing a high WM load task. In contrast, no significant differences were found between N100-AEP amplitudes in WM states and rest states under a low WM load task in all recorded brain regions. Furthermore, no differences were found between the time latencies of N100-AEP troughs in WM states and rest states while performing either the high or low WM load task. These findings suggested that the prefrontal cortex (PFC) may integrate information from different sensory channels to protect perceptual integrity during cognitive processing.	[Qu, Jiagui] Univ Sci & Technol China, Hefei, Anhui, Peoples R China; [Qu, Jiagui; Rizak, Joshua D.; Li, Minghong; Ma, Yuanye] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Brain & Cognit Sci, Kunming, Yunnan, Peoples R China; [Rizak, Joshua D.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Lun] Beijing Yiran Sunny Technol Co Lt, Psychol Res Ctr, Beijing, Peoples R China; [Ma, Yuanye] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Li, MH (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Brain & Cognit Sci, Kunming, Yunnan, Peoples R China.	liminghong_jacky@sina.com; yuanma0716@vip.sina.com			973 program [2012CB825500, 2011CB707800]; NSFC [31271168, 91132307/H09, 31070965]; NSFC Finnish-Chinese joint project [813111172]	973 program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NSFC Finnish-Chinese joint project	This study was supported by 973 program (2012CB825500, 2011CB707800), NSFC (31271168, 91132307/H09, 31070965) and NSFC Finnish-Chinese joint project 813111172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JT, 1999, BRAIN COGNITION, V41, P27, DOI 10.1006/brcg.1999.1094; BROADBENT DE, 1954, J EXP PSYCHOL, V47, P191, DOI 10.1037/h0054182; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Dalton P, 2009, Q J EXP PSYCHOL, V62, P2126, DOI 10.1080/17470210903023646; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Elston GN, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-18-j0002.2000; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Jha AP, 2002, COGNITIVE BRAIN RES, V15, P61, DOI 10.1016/S0926-6410(02)00216-1; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; Muller-Gass A, 2007, BRAIN RES, V1136, P169, DOI 10.1016/j.brainres.2006.12.020; Muri RM, 1999, NEUROPSYCHOLOGIA, V37, P199; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R., 1992, ATTENTION BRAIN FUNC, P113; Olivers CNL, 2008, FRONT BIOSCI-LANDMRK, V13, P1182, DOI 10.2741/2754; PAPANICOLAOU AC, 1987, ELECTROEN CLIN NEURO, V66, P515, DOI 10.1016/0013-4694(87)90098-8; PAPANICOLAOU AC, 1984, INT J NEUROSCI, V24, P107, DOI 10.3109/00207458409089800; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; Rypma B, 2006, NEUROSCIENCE, V139, P223, DOI 10.1016/j.neuroscience.2005.07.062; Schiffer F, 1995, J NEUROPSYCHIATRY CL; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; SMITH EE, 1995, J COGNITIVE NEUROSCI, V7, P337, DOI 10.1162/jocn.1995.7.3.337; Sreenivasan KK, 2007, J COGNITIVE NEUROSCI, V19, P32, DOI 10.1162/jocn.2007.19.1.32; Wickelgren I, 1997, SCIENCE, V275, P1580, DOI 10.1126/science.275.5306.1580; Zhao L, 2004, GUIDELINES ERP EXPT	25	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89989	10.1371/journal.pone.0089989	http://dx.doi.org/10.1371/journal.pone.0089989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24587170	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000126
J	Sereda, SV; Wilke, T; Schultheiss, R				Sereda, Sergej Vital'evic; Wilke, Thomas; Schultheiss, Roland			Changes in Selection Regime Cause Loss of Phenotypic Plasticity in Planktonic Freshwater Copepods	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; ULTRAVIOLET-RADIATION; GENETIC ASSIMILATION; HABITAT DISTRIBUTION; UV; ZOOPLANKTON; BEHAVIOR; PIGMENTATION; PREDATION; THREATS	Rapid phenotypic adaptation is critical for populations facing environmental changes and can be facilitated by phenotypic plasticity in the selected traits. Whereas recurrent environmental fluctuations can favour the maintenance or de novo evolution of plasticity, strong selection is hypothesized to decrease plasticity or even fix the trait (genetic assimilation). Despite advances in the theoretical understanding of the impact of plasticity on diversification processes, comparatively little empirical data of populations undergoing diversification mediated by plasticity are available. Here we use the planktonic freshwater copepod Acanthodiaptomus denticornis from two lakes as model system to study UV stress responses of two phenotypically different populations under laboratory conditions. Our study reveals heritable lake-and sex-specific differences of behaviour, physiological plasticity, and mortality. We discuss specific selective scenarios causing these differences and argue that phenotypic plasticity will be higher when selection pressure is moderate, but will decrease or even be lost under stronger pressure.	[Sereda, Sergej Vital'evic; Wilke, Thomas; Schultheiss, Roland] Univ Giessen, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany; [Schultheiss, Roland] Univ Turku, Dept Biol, SF-20500 Turku, Finland	Justus Liebig University Giessen; University of Turku	Schultheiss, R (corresponding author), Univ Giessen, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany.	rolsch@utu.fi	Wilke, Thomas/G-1517-2012	Wilke, Thomas/0000-0001-8263-7758; Sereda, Sergej/0000-0003-3212-8722	German Research Foundation [SCHU 2689/1-1]	German Research Foundation(German Research Foundation (DFG))	This study was funded by a grant of the German Research Foundation to Roland Schultheiss, grant number SCHU 2689/1-1 (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AK, 2009, J PLANKTON RES, V31, P389, DOI 10.1093/plankt/fbn130; Chapron E, 2012, ADV NAT TECH HAZ RES, V31, P255, DOI 10.1007/978-94-007-2162-3_23; COX DR, 1972, J R STAT SOC B, V34, P187; DeWitt T. J, 2003, PHENOTYPIC PLASTICIT; Einsle U, 1993, CRUSTACEA COPEPODA C, P208; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gusmao LFM, 2009, J PLANKTON RES, V31, P1101, DOI 10.1093/plankt/fbp059; HAIRSTON NG, 1976, P NATL ACAD SCI USA, V73, P971, DOI 10.1073/pnas.73.3.971; HAIRSTON NG, 1981, HYDROBIOLOGIA, V81-2, P151, DOI 10.1007/BF00048712; Hansson LA, 2000, P ROY SOC B-BIOL SCI, V267, P2327, DOI 10.1098/rspb.2000.1287; Hansson LA, 2004, ECOLOGY, V85, P1005, DOI 10.1890/02-0525; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; Hays GC, 2001, LIMNOL OCEANOGR, V46, P2050, DOI 10.4319/lo.2001.46.8.2050; Hylander S, 2009, LIMNOL OCEANOGR, V54, P483, DOI 10.4319/lo.2009.54.2.0483; JACOBY CA, 1983, MAR BIOL, V76, P77, DOI 10.1007/BF00393058; Jersabek CD, 1996, J PLANKTON RES, V18, P2027, DOI 10.1093/plankt/18.11.2027; JERSABEK CD, 1995, J PLANKTON RES, V17, P2049, DOI 10.1093/plankt/17.11.2049; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawabata K, 1998, FRESHWATER BIOL, V39, P199, DOI 10.1046/j.1365-2427.1998.00267.x; Kruschke J. K., 2011, DOING BAYESIAN DATA; Lagergren R, 2008, LIMNOL OCEANOGR, V53, P1083, DOI 10.4319/lo.2008.53.3.1083; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Maier G, 2000, J PLANKTON RES, V22, P1977, DOI 10.1093/plankt/22.10.1977; Makino W, 2009, MOL ECOL, V18, P3699, DOI 10.1111/j.1365-294X.2009.04307.x; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; NEILL WE, 1990, NATURE, V345, P524, DOI 10.1038/345524a0; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; Persaud AD, 2007, FRESHWATER BIOL, V52, P2121, DOI 10.1111/j.1365-2427.2007.01833.x; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pierson JJ, 2013, MAR ECOL PROG SER, V475, P49, DOI 10.3354/meps10116; Pigliucci M, 2003, EVOLUTION, V57, P1455; Pigliucci M., 2001, SYN ECO EVO; Plummer M., 2003, P 3 INT WORKSH DISTR; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; R Core Team, 2021, R LANGUAGE ENV STAT; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; RINGELBERG J, 1984, HYDROBIOLOGIA, V112, P217, DOI 10.1007/BF00008087; RINGELBERG J, 1976, HYDROBIOLOGIA, V51, P113, DOI 10.1007/BF00009826; Ringelberg J, 2009, DIEL VERTICAL NIGRAT; Rocco VE, 2002, LIMNOL OCEANOGR, V47, P829, DOI 10.4319/lo.2002.47.3.0829; Rose KC, 2009, PHOTOCH PHOTOBIO SCI, V8, P1244, DOI 10.1039/b905616e; Schabetsberger R, 2004, ECOGRAPHY, V27, P506, DOI 10.1111/j.0906-7590.2004.03776.x; Schettler G, 2007, CHEM GEOL, V240, P11, DOI 10.1016/j.chemgeo.2007.01.003; Schneider T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043063; Schultheiss R, 2008, HYDROBIOLOGIA, V615, P141, DOI 10.1007/s10750-008-9553-3; Scoville AG, 2010, P NATL ACAD SCI USA, V107, P4260, DOI 10.1073/pnas.0912748107; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; SIEBECK OTTO, 1960, INTERNATL REV GES HYDROBIOL, V45, P125, DOI 10.1002/iroh.19600450107; Sommaruga R, 2001, J PHOTOCH PHOTOBIO B, V62, P35, DOI 10.1016/S1011-1344(01)00154-3; Svensson JE, 1997, ECOGRAPHY, V20, P407, DOI 10.1111/j.1600-0587.1997.tb00386.x; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Thibert-Plante X, 2011, J EVOLUTION BIOL, V24, P326, DOI 10.1111/j.1420-9101.2010.02169.x; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; WADDINGTON CH, 1956, EVOLUTION, V10, P1, DOI 10.2307/2406091; West-Eberhard Mary Jane, 2003, pi; Wilke T, 2000, BIOL J LINN SOC, V70, P89, DOI 10.1111/j.1095-8312.2000.tb00202.x; Wold A, 2004, POLAR RES, V23, P27, DOI 10.1111/j.1751-8369.2004.tb00126.x; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966; Zagarese HE, 1997, J PLANKTON RES, V19, P357, DOI 10.1093/plankt/19.3.357; Zengling MA, 2010, J PHOTOCH PHOTOBIO B, V101, P233, DOI 10.1016/j.jphotobiol.2010.07.008	61	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90010	10.1371/journal.pone.0090010	http://dx.doi.org/10.1371/journal.pone.0090010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587186	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000128
J	Zhang, HB; Chen, Q; Jiao, T; Cui, AF; Sun, XJ; Fang, WJ; Xie, LW; Liu, Y; Fang, FD; Chang, YS				Zhang, Huabing; Chen, Qi; Jiao, Tao; Cui, Anfang; Sun, Xiujing; Fang, Weijun; Xie, Liwei; Liu, Yang; Fang, Fude; Chang, Yongsheng			Involvement of KLF11 in Hepatic Glucose Metabolism in Mice via Suppressing of PEPCK-C Expression	PLOS ONE			English	Article							KRUPPEL-LIKE FACTORS; BETA-CELL FUNCTION; TRANSCRIPTION FACTORS; INSULIN-BIOSYNTHESIS; COACTIVATOR PGC-1; GLUCONEOGENESIS; GENE; VARIANTS; BINDING; MSIN3A	Background: Abnormal hepatic gluconeogenesis is related to hyperglycemia in mammals with insulin resistance. Despite the strong evidences linking Kruppel-like factor 11 (KLF11) gene mutations to development of Type 2 diabetes, the precise physiological functions of KLF11 in vivo remain largely unknown. Results: In current investigation, we showed that KLF11 is involved in modulating hepatic glucose metabolism in mice. Overexpression of KLF11 in primary mouse hepatocytes could inhibit the expression of gluconeogenic genes, including phosphoenolpyruvate carboxykinase (cytosolic isoform, PEPCK-C) and peroxisome proliferator-activated receptor c coactivator-1 alpha (PGC-1 alpha), subsequently decreasing the cellular glucose output. Diabetic mice with overexpression of KLF11 gene in livers significantly ameliorated hyperglycemia and glucose intolerance; in contrast, the knockdown of KLF11 expression in db/m and C57BL/6J mice livers impaired glucose tolerance. Conclusions: Our data strongly indicated the involvement of KLF11 in hepatic glucose homeostasis via modulating the expression of PEPCK-C.	[Zhang, Huabing] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei, Peoples R China; [Zhang, Huabing; Chen, Qi; Jiao, Tao; Fang, Fude; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Zhang, Huabing; Chen, Qi; Jiao, Tao; Fang, Fude; Chang, Yongsheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Cui, Anfang] Jining Med Univ, Dept Biochem, Jining, Peoples R China; [Sun, Xiujing] Capital Med Univ, Beijing Friendship Hosp, Beijing Digest Dis Ctr, Beijing Key Lab Precancerous Les Digest Dis, Beijing, Peoples R China; [Fang, Weijun] Anhui Med Univ, Sch Basic Med, Dept Chem, Hefei, Peoples R China; [Xie, Liwei] Univ Michigan, Ann Arbor, MI 48109 USA; [Liu, Yang] Liaoning Univ Tradit Chinese Med, Hosp Affiliated, Dept Endocrinol, Shenyang, Peoples R China	Anhui Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jining Medical University; Capital Medical University; Anhui Medical University; University of Michigan System; University of Michigan; Liaoning University of Traditional Chinese Medicine	Liu, Y (corresponding author), Liaoning Univ Tradit Chinese Med, Hosp Affiliated, Dept Endocrinol, Shenyang, Peoples R China.	liuyanglinda@gmail.com; changy@ibms.pumc.edu.cn		zhang, huabing/0000-0001-8402-7830	Peking Union Medical College (PUMC); Fundamental Research Funds for the Central Universities [3332013108]; National Natural Science Foundation of China [31371193, 30872992]; Scientific Research of BSKY [XJ201301]; Anhui Medical University [2013xkj004]	Peking Union Medical College (PUMC); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research of BSKY; Anhui Medical University	This work was supported by Peking Union Medical College (PUMC) Youth Fund and the Fundamental Research Funds for the Central Universities (3332013108), the National Natural Science Foundation of China (31371193 and 30872992), and the Scientific Research of BSKY (XJ201301) and the University's Research Fund (2013xkj004) of Anhui Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Gutierrez-Aguilar R, 2008, J CLIN ENDOCR METAB, V93, P3128, DOI 10.1210/jc.2007-2504; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Radziuk J, 2001, DIABETES-METAB RES, V17, P250, DOI 10.1002/dmrr.217; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Yamamoto K, 2010, BIOCHEM BIOPH RES CO, V400, P175, DOI 10.1016/j.bbrc.2010.08.039; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang HB, 2013, J HEPATOL, V58, P763, DOI 10.1016/j.jhep.2012.11.024; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	26	11	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89552	10.1371/journal.pone.0089552	http://dx.doi.org/10.1371/journal.pone.0089552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586865	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000059
J	Hirst, RA; Jackson, CL; Coles, JL; Williams, G; Rutman, A; Goggin, PM; Adam, EC; Page, A; Evans, HJ; Lackie, PM; O'Callaghan, C; Lucas, JS				Hirst, Robert A.; Jackson, Claire L.; Coles, Janice L.; Williams, Gwyneth; Rutman, Andrew; Goggin, Patricia M.; Adam, Elizabeth C.; Page, Anthony; Evans, Hazel J.; Lackie, Peter M.; O'Callaghan, Christopher; Lucas, Jane S.			Culture of Primary Ciliary Dyskinesia Epithelial Cells at Air-Liquid Interface Can Alter Ciliary Phenotype but Remains a Robust and Informative Diagnostic Aid	PLOS ONE			English	Article							BEAT PATTERN; MUTATIONS; CILIOGENESIS; CHILDREN; MODEL	Background: The diagnosis of primary ciliary dyskinesia (PCD) requires the analysis of ciliary function and ultrastructure. Diagnosis can be complicated by secondary effects on cilia such as damage during sampling, local inflammation or recent infection. To differentiate primary from secondary abnormalities, re-analysis of cilia following culture and re-differentiation of epithelial cells at an air-liquid interface (ALI) aids the diagnosis of PCD. However changes in ciliary beat pattern of cilia following epithelial cell culture has previously been described, which has brought the robustness of this method into question. This is the first systematic study to evaluate ALI culture as an aid to diagnosis of PCD in the light of these concerns. Methods: We retrospectively studied changes associated with ALI-culture in 158 subjects referred for diagnostic testing at two PCD centres. Ciliated nasal epithelium (PCD n = 54; non-PCD n = 111) was analysed by high-speed digital video microscopy and transmission electron microscopy before and after culture. Results: Ciliary function was abnormal before and after culture in all subjects with PCD; 21 PCD subjects had a combination of static and uncoordinated twitching cilia, which became completely static following culture, a further 9 demonstrated a decreased ciliary beat frequency after culture. In subjects without PCD, secondary ciliary dyskinesia was reduced. Conclusions: The change to ciliary phenotype in PCD samples following cell culture does not affect the diagnosis, and in certain cases can assist the ability to identify PCD cilia.	[Hirst, Robert A.; Williams, Gwyneth; Rutman, Andrew; O'Callaghan, Christopher] Univ Leicester, Primary Ciliary Dyskinesia Ctr, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Jackson, Claire L.; Coles, Janice L.; Goggin, Patricia M.; Adam, Elizabeth C.; Page, Anthony; Evans, Hazel J.; Lucas, Jane S.] Southampton Univ Hosp, Primary Ciliary Dyskinesia Ctr, Southampton, Hants, England; [Jackson, Claire L.; Coles, Janice L.; Goggin, Patricia M.; Adam, Elizabeth C.; Page, Anthony; Lackie, Peter M.; Lucas, Jane S.] Univ Southampton, Southampton Natl Inst Hlth Res, Resp Biomed Res Unit, Southampton, Hants, England; [O'Callaghan, Christopher] UCL, Dept Resp Med, Inst Child Hlth, London, England; [O'Callaghan, Christopher] Great Ormond St Childrens Hosp, London, England	University of Leicester; University of Southampton; University of Southampton; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Lucas, JS (corresponding author), Southampton Univ Hosp, Primary Ciliary Dyskinesia Ctr, Southampton, Hants, England.	jlucas1@soton.ac.uk	Hirst, Robert/AAD-1649-2022; jackson, claire/AAI-1677-2021	Lucas, Jane/0000-0001-8701-9975; Jackson, Claire/0000-0002-1200-0935	NHS National Specialised Commissioning Team, UK	NHS National Specialised Commissioning Team, UK	The national diagnostic PCD service in Southampton and Leicester is funded by NHS National Specialised Commissioning Team, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Chhin B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000422; Chilvers MA, 2000, THORAX, V55, P314, DOI 10.1136/thorax.55.4.314; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; DEJONG PM, 1994, AM J RESP CELL MOL, V10, P271, DOI 10.1165/ajrcmb.10.3.8117445; Hirst RA, 2010, CHEST, V138, P1441, DOI 10.1378/chest.10-0175; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072299; Jorissen M, 2000, Acta Otorhinolaryngol Belg, V54, P343; Jorissen M, 2000, ACTA OTO-LARYNGOL, V120, P291; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; Leigh MW, 2009, CURR OPIN PEDIATR, V21, P320, DOI 10.1097/MOP.0b013e328329cddb; Lucas JSA, 2011, EUR RESPIR MONOGR, P201, DOI 10.1183/1025448x.10008310; Lucas JS, 2012, HUM MUTAT, V33, P495, DOI 10.1002/humu.22001; Marthin JK, 2007, CHEST, V132, P966, DOI 10.1378/chest.06-2951; O'Callaghan C, 2010, ARCH DIS CHILD, V95, P51, DOI 10.1136/adc.2009.158493; O'Callaghan C, 2007, THORAX, V62, P656, DOI 10.1136/thx.2007.083147; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2009, METHOD CELL BIOL, V91, P123, DOI 10.1016/S0091-679X(08)91007-4; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Stannard WA, 2010, AM J RESP CRIT CARE, V181, P307, DOI 10.1164/rccm.200903-0459OC; Stennert E, 2008, EUR ARCH OTO-RHINO-L, V265, P1075, DOI 10.1007/s00405-008-0661-5; Thomas B, 2010, J ALLERGY CLIN IMMUN, V126, P722, DOI 10.1016/j.jaci.2010.05.046	24	75	76	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89675	10.1371/journal.pone.0089675	http://dx.doi.org/10.1371/journal.pone.0089675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586956	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900065
J	Arvanitis, C; Khuon, S; Spann, R; Ridge, KM; Chew, TL				Arvanitis, Constadina; Khuon, Satya; Spann, Rachel; Ridge, Karen M.; Chew, Teng-Leong			Structure and Biomechanics of the Endothelial Transcellular Circumferential Invasion Array in Tumor Invasion	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; CANCER-CELLS; TRANSENDOTHELIAL MIGRATION; CULTURED-CELLS; STRESS FIBERS; MYOSIN-II; IN-VIVO; CYTOSKELETON; DIAPEDESIS; INTRAVASATION	Cancer cells breach the endothelium not only through cell-cell junctions but also via individual endothelial cells (ECs), or transcellular invasion. The underlying EC forms a circular structure around the transcellular invasion pore that is dependent on myosin light chain kinase (MLCK) and myosin II regulatory light chain (RLC) phosphorylation. Here we offer mechanistic insights into transcellular invasive array formation amid persistent tensile force from activated EC myosin. Fluorescence recovery after photobleaching (FRAP) experiments, sarcomeric distance measurements using super-resolution microscopy and electron microscopy provide details about the nature of the myosin II invasion array. To probe the relationship between biomechanical forces and the tension required to maintain the curvature of contractile filaments, we targeted individual actin-myosin fibers at the invasion site for photoablation. We showed that adjacent filaments rapidly replace the ablat11ed structures. We propose that the transcellular circumferential invasion array (TCIA) provides the necessary constraint within the EC to blunt the radial compression from the invading cancer cell.	[Arvanitis, Constadina; Khuon, Satya; Spann, Rachel; Ridge, Karen M.; Chew, Teng-Leong] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Khuon, Satya; Chew, Teng-Leong] Northwestern Univ, Feinberg Sch Med, Ctr Adv Microscopy, Chicago, IL 60611 USA; [Ridge, Karen M.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Chew, TL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	t-chew@northwestern.edu		Arvanitis, Constadina/0000-0002-6311-0974	St. Baldrick's Postdoctoral Fellowship; National Institutes of Health [NL07190, P30 CA060553, S10 OD016342-01, S10 RR031680-01]; Veterans Affairs Merit Award; Rosenberg Foundation;  [ACS-IRG 93-037-15]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031680] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079190] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016342] Funding Source: NIH RePORTER	St. Baldrick's Postdoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); Rosenberg Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by St. Baldrick's Postdoctoral Fellowship (C.A.), National Institutes of Health (NL07190) and Veterans Affairs Merit Award (K.M.R.), (ACS-IRG 93-037-15) and Rosenberg Foundation (T.L.C.). Microscopy work was performed at Northwestern University Cell Imaging Facility-Nikon Imaging Center supported by National Institutes of Health (P30 CA060553, S10 OD016342-01 and S10 RR031680-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2009, J CELL SCI, V122, P3025, DOI 10.1242/jcs.047522; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; DEBRUYN PPH, 1982, J ULTRA MOL STRUCT R, V81, P189, DOI 10.1016/S0022-5320(82)90075-2; Foucard L, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3673551; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Howlader NNA, 2010, SEER CANC STAT REV 1; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kolega J, 1999, CELL MOTIL CYTOSKEL, V43, P255, DOI 10.1002/(SICI)1097-0169(1999)43:3<255::AID-CM8>3.0.CO;2-T; LANGANGER G, 1986, J CELL BIOL, V102, P200, DOI 10.1083/jcb.102.1.200; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Mamdouh Z, 2008, J EXP MED, V205, P951, DOI 10.1084/jem.20072328; Mamdouh Z, 2009, J EXP MED, V206, P2795, DOI 10.1084/jem.20082745; Martinelli R, 2013, J CELL BIOL, V201, P449, DOI 10.1083/jcb.201209077; Mierke CT, 2013, EUR J CELL BIOL, V92, P89, DOI 10.1016/j.ejcb.2012.12.002; Mierke CT, 2012, MOL BIOSYST, V8, P1639, DOI 10.1039/c2mb25024a; Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Parsons SA, 2012, EUR J IMMUNOL, V42, P436, DOI 10.1002/eji.201041303; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Simoneau B, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-18; Stroka KM, 2010, FEBS J, V277, P1145, DOI 10.1111/j.1742-4658.2009.07545.x; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; SVITKINA TM, 1989, CELL MOTIL CYTOSKEL, V12, P150, DOI 10.1002/cm.970120304; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Syverud K, 2007, APPITA J, V60, P286; Tanner K, 2010, BIOPHYS J, V99, P2775, DOI 10.1016/j.bpj.2010.08.071; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; VERKHOVSKY AB, 1993, J CELL BIOL, V123, P637, DOI 10.1083/jcb.123.3.637; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Wokosin DL, 2005, CHARACTERISATION EXC; Wyckoff JB, 2000, CANCER RES, V60, P2504	40	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89758	10.1371/journal.pone.0089758	http://dx.doi.org/10.1371/journal.pone.0089758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587014	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700087
J	Kamijho, Y; Shiozaki, Y; Sakurai, E; Hanaoka, K; Watanabe, D				Kamijho, Yuki; Shiozaki, Yayoi; Sakurai, Eiki; Hanaoka, Kazunori; Watanabe, Daisuke			Multiple Renal Cyst Development but Not Situs Abnormalities in Transgenic RNAi Mice against Inv::GFP Rescue Gene	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; SMALL INTERFERING RNA; KNOCK-DOWN; STEM-CELLS; EXPRESSION; INVERSIN; SYSTEM; TECHNOLOGY; GENERATION; CALMEGIN	In this study we generated RNA interference (RNAi)-mediated gene knockdown transgenic mice (transgenic RNAi mice) against the functional Inv gene. Inv mutant mice show consistently reversed internal organs (situs inversus), multiple renal cysts and neonatal lethality. The Inv::GFP-rescue mice, which introduced the Inv::GFP fusion gene, can rescue inv mutant mice phenotypes. This indicates that the Inv::GFP gene is functional in vivo. To analyze the physiological functions of the Inv gene, and to demonstrate the availability of transgenic RNAi mice, we introduced a short hairpin RNA expression vector against GFP mRNA into Inv::GFP-rescue mice and analyzed the gene silencing effects and Inv functions by examining phenotypes. Transgenic RNAi mice with the Inv::GFP-rescue gene (Inv-KD mice) down-regulated Inv::GFP fusion protein and showed hypomorphic phenotypes of inv mutant mice, such as renal cyst development, but not situs abnormalities or postnatal lethality. This indicates that shRNAi-mediated gene silencing systems that target the tag sequence of the fusion gene work properly in vivo, and suggests that a relatively high level of Inv protein is required for kidney development in contrast to left/right axis determination. Inv:: GFP protein was significantly down-regulated in the germ cells of Inv-KD mice testis compared with somatic cells, suggesting the existence of a testicular germ cell-specific enhanced RNAi system that regulates germ cell development. The Inv-KD mouse is useful for studying Inv gene functions in adult tissue that are unable to be analyzed in inv mutant mice showing postnatal lethality. In addition, the shRNA-based gene silencing system against the tag sequence of the fusion gene can be utilized as a new technique to regulate gene expression in either in vitro or in vivo experiments.	[Kamijho, Yuki; Shiozaki, Yayoi; Sakurai, Eiki; Hanaoka, Kazunori; Watanabe, Daisuke] Kitasato Univ, Sch Sci, Dept Biosci, Mol Embryol Lab, Sagamihara, Kanagawa 228, Japan	Kitasato University	Watanabe, D (corresponding author), Kitasato Univ, Sch Sci, Dept Biosci, Mol Embryol Lab, Sagamihara, Kanagawa 228, Japan.	watanada@kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish.	Bjork BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014375; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carmell MA, 2003, NAT STRUCT BIOL, V10, P91, DOI 10.1038/nsb896; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Gao X, 2007, PHYSIOLOGY, V22, P161, DOI 10.1152/physiol.00002.2007; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hasuwa H, 2002, FEBS LETT, V532, P227, DOI 10.1016/S0014-5793(02)03680-3; Hasuwa Hidetoshi, 2004, Methods Mol Biol, V252, P501; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Ito H, 2009, HUM MOL GENET, V18, P4239, DOI 10.1093/hmg/ddp378; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Paul CP, 2005, METHOD ENZYMOL, V392, P125, DOI 10.1016/S0076-6879(04)92008-3; Peng SH, 2006, P NATL ACAD SCI USA, V103, P2252, DOI 10.1073/pnas.0511034103; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Prawitt D, 2004, CYTOGENET GENOME RES, V105, P412, DOI 10.1159/000078214; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Shiba D, 2010, CYTOSKELETON, V67, P112, DOI 10.1002/cm.20428; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Shinagawa T, 2003, GENE DEV, V17, P1340, DOI 10.1101/gad.1073003; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; WATANABE D, 1994, J BIOL CHEM, V269, P7744; WATANABE D, 1992, MOL REPROD DEV, V33, P307, DOI 10.1002/mrd.1080330312; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89652	10.1371/journal.pone.0089652	http://dx.doi.org/10.1371/journal.pone.0089652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586938	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700069
J	Oncescu, V; Lee, S; Gumus, A; Karlsson, K; Erickson, D				Oncescu, Vlad; Lee, Seoho; Gumus, Abdurrahman; Karlsson, Kolbeinn; Erickson, David			Autonomous Device for Application in Late-Phase Hemorrhagic Shock Prevention	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; FUEL-CELL; DRUG; DELIVERY	Hemorrhagic shock (HS) is the leading cause of death for people with traumatic injuries. The onset of HS is correlated with marked changes in the plasma vasopressin levels and some studies indicate that administrating vasopressin in the bloodstream can help stabilize the situation. This situation calls naturally for the use of implantable devices for both the monitoring and treatment of HS. In this work, we present a self-powered hemorrhagic-shock autonomous integrated device (hemoAID) that continuously monitors vasopressin levels and releases vasopressin automatically when levels drop below a certain threshold. We demonstrate that the device can operate at physiological concentrations of vasopressin, in sheep serum, thus paving the way towards the development of an autonomous implantable device for HS prevention.	[Oncescu, Vlad; Lee, Seoho; Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Gumus, Abdurrahman; Karlsson, Kolbeinn] Cornell Univ, Ithaca, NY USA	Cornell University; Cornell University	Erickson, D (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	de54@cornell.edu	Erickson, David/A-3319-2009	Erickson, David/0000-0002-1624-9711	Office of Naval Research (ONR) [N000141010115]; Canadian institution NSERC; NSF [1014891]	Office of Naval Research (ONR)(Office of Naval Research); Canadian institution NSERC; NSF(National Science Foundation (NSF))	The authors wish to acknowledge the support of the Office of Naval Research (ONR) under award number N000141010115 "Autonomous Microfluidic Devices for Battlefield Health Assessment and Treatment''. In addition, V.O. wishes to acknowledge the support of the Canadian institution NSERC through a fellowship. Some elements of the integration were also carried out with the support of NSF grant #1014891. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2013, CIRCULATION, V127, P854, DOI 10.1161/CIRCULATIONAHA.112.146530; Anand T, 2012, J SURG RES, V178, P321, DOI 10.1016/j.jss.2012.02.062; Arriagada AJ, 2011, PHYSIOL MEAS, V32, P1103, DOI 10.1088/0967-3334/32/8/007; Bazaka K, 2013, ELECTRONICS-SWITZ, V2, P1, DOI 10.3390/electronics2010001; Cebotari S, 2010, HERZ, V35, P334, DOI 10.1007/s00059-010-3355-x; Chung AJ, 2012, MICROFLUID NANOFLUID, V13, P345, DOI 10.1007/s10404-012-0957-z; Chung AJ, 2009, BIOMED MICRODEVICES, V11, P861, DOI 10.1007/s10544-009-9303-y; Chung AJ, 2009, LAB CHIP, V9, P669, DOI 10.1039/b814911a; Cordovez B, 2011, MICROFLUID NANOFLUID, V10, P785, DOI 10.1007/s10404-010-0709-x; Dawson RMC, 1986, DATA BIOCH RES, V3, P31; Elman NM, 2009, BIOMED MICRODEVICES, V11, P625, DOI 10.1007/s10544-008-9272-6; Esquivel JP, 2012, LAB CHIP, V12, P4232, DOI 10.1039/c2lc40946a; Farra R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003276; Fojtik M, 2013, IEEE J SOLID-ST CIRC, V48, P801, DOI 10.1109/JSSC.2012.2233352; Gumus A, 2013, ANALYST IN PRESS; He P, 2013, ANAL CHIM ACTA, V759, P74, DOI 10.1016/j.aca.2012.10.038; Ho Duc HL, 2009, EMERGENCY DELIVERY V; Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830; Kerzenmacher S, 2008, J POWER SOURCES, V182, P1, DOI 10.1016/j.jpowsour.2008.03.031; Krabatsch T, 2011, HERZ, V36, P622, DOI 10.1007/s00059-011-3509-5; Krismer AC, 2005, ANAESTHESIST, V54, P220, DOI 10.1007/s00101-004-0793-y; Li H, 2012, C P IEEE ENG MED BIO; Liu SS, 2013, AM J MED, V126, P6, DOI 10.1016/j.amjmed.2012.04.033; Maehashi K, 2009, ELECTROANAL, V21, P1285, DOI 10.1002/elan.200804552; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; Oncescu V, 2013, HIGH VOLUMETRIC POWE, V3; Oncescu V, 2011, J POWER SOURCES, V196, P9169, DOI 10.1016/j.jpowsour.2011.06.100; Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003; Receveur RAM, 2007, J MICROMECH MICROENG, V17, pR50, DOI 10.1088/0960-1317/17/5/R02; Ricotti L, 2013, J ARTIF ORGANS, V16, P9, DOI 10.1007/s10047-012-0660-6; Vincent CA, 2000, SOLID STATE IONICS, V134, P159, DOI 10.1016/S0167-2738(00)00723-2; Voelckel WG, 2010, J TRAUMA, V69, pS69, DOI 10.1097/TA.0b013e3181e44937; Wenzel V, 2008, BEST PRACT RES-CLIN, V22, P299, DOI 10.1016/j.bpa.2008.02.003	33	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89903	10.1371/journal.pone.0089903	http://dx.doi.org/10.1371/journal.pone.0089903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24587112	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700112
J	Tran, QK; VerMeer, M				Quang-Kim Tran; VerMeer, Mark			Biosensor-Based Approach Identifies Four Distinct Calmodulin-Binding Domains in the G Protein-Coupled Estrogen Receptor 1	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE SYNTHASE; G-PROTEIN-COUPLED-RECEPTOR-30 GPR30; INDUCED ACTIVATION; PLASMA-MEMBRANE; GROWTH-RESPONSE; 17-BETA-ESTRADIOL; CA2+; PHOSPHORYLATION; CALCIUM	The G protein-coupled estrogen receptor 1 (GPER) has been demonstrated to participate in many cellular functions, but its regulatory inputs are not clearly understood. Here we describe a new approach that identifies GPER as a calmodulin-binding protein, locates interaction sites, and characterizes their binding properties. GPER coimmunoprecipitates with calmodulin in primary vascular smooth muscle cells under resting conditions, which is enhanced upon acute treatment with either specific ligands or a Ca2+-elevating agent. To confirm direct interaction and locate the calmodulin-binding domain(s), we designed a series of FRET biosensors that consist of enhanced cyan and yellow fluorescent proteins flanking each of GPER's submembrane domains (SMDs). Responses of these biosensors showed that all four submembrane domains directly bind calmodulin. Modifications of biosensor linker identified domains that display the strongest calmodulin-binding affinities and largest biosensor dynamics, including a. a. 83-93, 150-175, 242-259, 330-351, corresponding respectively to SMDs 1, 2, 3, and the juxta-membranous section of SMD4. These biosensors bind calmodulin in a strictly Ca2+-dependent fashion and with disparate affinities in the order SMD2>SMD4>SMD3>SMD1, apparent K-d values being 0.44 +/- 0.03, 1.40 +/- 0.16, 8.01 +/- 0.29, and 136.62 +/- 6.56 mu M, respectively. Interestingly, simultaneous determinations of biosensor responses and suitable Ca2+ indicators identified separate Ca2+ sensitivities for their interactions with calmodulin. SMD1-CaM complexes display a biphasic Ca2+ response, representing two distinct species (SMD1 sp1 and SMD1 sp2) with drastically different Ca2+ sensitivities. The Ca2+ sensitivities of CaM-SMDs interactions follow the order SMD1sp1>SMD4>SMD2>SMD1sp2>SMD3, EC50(Ca2+) values being 0.13 +/- 0.02, 0.75 +/- 0.05, 2.38 +/- 0.13, 3.71 +/- 0.13, and 5.15 +/- 0.25 mu M, respectively. These data indicate that calmodulin may regulate GPER-dependent signaling at the receptor level through multiple interaction sites. FRET biosensors represent a simple method to identify unknown calmodulin-binding domains in G protein-coupled receptors and to quantitatively assess binding properties.	[Quang-Kim Tran; VerMeer, Mark] Des Moines Univ Osteopath Med Ctr, Dept Physiol & Pharmacol, Des Moines, IA 50312 USA		Tran, QK (corresponding author), Des Moines Univ Osteopath Med Ctr, Dept Physiol & Pharmacol, Des Moines, IA 50312 USA.	kim.tran@dmu.edu		Tran, Kim/0000-0003-1881-1357	National Institutes of Health [HL112184]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL112184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL112184 to Q-K Tran. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; BOLZON BJ, 1989, HYPERTENSION, V14, P137, DOI 10.1161/01.HYP.14.2.137; BOUHOUTE A, 1995, BIOCHEM BIOPH RES CO, V208, P748, DOI 10.1006/bbrc.1995.1401; BOUHOUTE A, 1992, BIOCHEM BIOPH RES CO, V184, P1432, DOI 10.1016/S0006-291X(05)80043-9; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Cheng S.-B., 2011, J BIOL CHEM; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Improta-Brears T, 1999, P NATL ACAD SCI USA, V96, P4686, DOI 10.1073/pnas.96.8.4686; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; Kim SA, 2004, P NATL ACAD SCI USA, V101, P105, DOI 10.1073/pnas.2436461100; Kvingedal AM, 1997, FEBS LETT, V407, P59, DOI 10.1016/S0014-5793(97)00278-0; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Leik CE, 2004, HYPERTENSION, V43, P837, DOI 10.1161/01.HYP.0000119191.33112.9c; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; LU KP, 1993, ENDOCR REV, V14, P40, DOI 10.1210/er.14.1.40; LUBYPHELPS K, 1995, J BIOL CHEM, V270, P21532, DOI 10.1074/jbc.270.37.21532; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Mahon MJ, 2005, FEBS LETT, V579, P803, DOI 10.1016/j.febslet.2004.12.056; Maier LS, 2006, J MOL CELL CARDIOL, V41, P451, DOI 10.1016/j.yjmcc.2006.04.020; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Mendelsohn ME, 2010, J CLIN INVEST, V120, P2277, DOI 10.1172/JCI43756; Minakami R, 1997, J BIOL CHEM, V272, P20291, DOI 10.1074/jbc.272.32.20291; Murphy E, 2011, PEDIAT CARDIOL; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; O'Dowd BF, 1998, GENOMICS, V47, P310, DOI 10.1006/geno.1998.5095; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Owman C, 1996, BIOCHEM BIOPH RES CO, V228, P285, DOI 10.1006/bbrc.1996.1654; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Persechini Anthony, 2002, Methods Mol Biol, V173, P365; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Pizzo P, 2011, CELL CALCIUM, V50, P184, DOI 10.1016/j.ceca.2011.01.006; Prossnitz ER, 2009, PROSTAG OTH LIPID M, V89, P89, DOI 10.1016/j.prostaglandins.2009.05.001; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Sanden C, 2010, MOL PHARM; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Sheng JZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1531, DOI 10.1152/ajpcell.00561.2007; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; Takada Y, 1997, BIOCHEM BIOPH RES CO, V240, P737, DOI 10.1006/bbrc.1997.7734; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Thomas WG, 1999, FEBS LETT, V455, P367, DOI 10.1016/S0014-5793(99)00904-7; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Tran QK, 2008, BIOCHEMISTRY-US, V47, P7557, DOI 10.1021/bi8003186; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Ulrich-Merzenich G, 2002, IN VITRO CELL DEV-AN, V38, P265; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wang DX, 1999, J BIOL CHEM, V274, P22081, DOI 10.1074/jbc.274.31.22081; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; YAZAWA M, 1992, BIOCHEMISTRY-US, V31, P3171, DOI 10.1021/bi00127a018; Zhang RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065266; Zhang YH, 2012, J BIOL CHEM, V287, P9336, DOI 10.1074/jbc.M111.334797	69	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89669	10.1371/journal.pone.0089669	http://dx.doi.org/10.1371/journal.pone.0089669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586950	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900140
J	Le Gal, JP; Juvin, L; Cardoit, L; Thoby-Brisson, M; Morin, D				Le Gal, Jean-Patrick; Juvin, Laurent; Cardoit, Laura; Thoby-Brisson, Muriel; Morin, Didier			Remote Control of Respiratory Neural Network by Spinal Locomotor Generators	PLOS ONE			English	Article							SOMATIC AFFERENT STIMULATION; PRE-BOTZINGER COMPLEX; MAMMALIAN QUADRUPEDAL LOCOMOTION; RETROTRAPEZOID NUCLEUS NEURONS; VENTRAL SPINOCEREBELLAR TRACT; IN-VITRO; NEWBORN RAT; PREBOTZINGER COMPLEX; NEONATAL-RAT; RETICULOSPINAL NEURONS	During exercise and locomotion, breathing rate rapidly increases to meet the suddenly enhanced oxygen demand. The extent to which direct central interactions between the spinal networks controlling locomotion and the brainstem networks controlling breathing are involved in this rhythm modulation remains unknown. Here, we show that in isolated neonatal rat brainstem-spinal cord preparations, the increase in respiratory rate observed during fictive locomotion is associated with an increase in the excitability of pre-inspiratory neurons of the parafacial respiratory group (pFRG/Pre-I). In addition, this locomotion-induced respiratory rhythm modulation is prevented both by bilateral lesion of the pFRG region and by blockade of neurokinin 1 receptors in the brainstem. Thus, our results assign pFRG/Pre-I neurons a new role as elements of a previously undescribed pathway involved in the functional interaction between respiratory and locomotor networks, an interaction that also involves a substance P-dependent modulating mechanism requiring the activation of neurokinin 1 receptors. This neurogenic mechanism may take an active part in the increased respiratory rhythmicity produced at the onset and during episodes of locomotion in mammals.	[Le Gal, Jean-Patrick; Juvin, Laurent; Cardoit, Laura; Thoby-Brisson, Muriel; Morin, Didier] Univ Bordeaux, CNRS, Inst Neurosci Cognit & Integrat Aquitaine, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Morin, D (corresponding author), Univ Bordeaux, CNRS, Inst Neurosci Cognit & Integrat Aquitaine, Bordeaux, France.	didier.morin@u-bordeaux.fr	Morin, Didier/C-6651-2014; Juvin, Laurent/K-8532-2016; Thoby-Brisson, Muriel/E-1167-2014	Juvin, Laurent/0000-0001-8847-1891; Morin, Didier/0000-0001-8695-3184; Thoby-Brisson, Muriel/0000-0003-3214-1724	Conseil Regional d'Aquitaine; French Ministere de l'Enseignement Superieur et de la Recherche	Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); French Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by grants from the Conseil Regional d'Aquitaine. JPLG was supported by doctoral grant from the French Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antri M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020529; Antri M, 2009, J NEUROSCI, V29, P1140, DOI 10.1523/JNEUROSCI.3073-08.2009; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; ARSHAVSKY YI, 1972, BRAIN RES, V43, P276, DOI 10.1016/0006-8993(72)90296-X; Ballanyi K, 2009, PFLUG ARCH EUR J PHY, V458, P571, DOI 10.1007/s00424-009-0645-3; Bell HJ, 2006, RESP PHYSIOL NEUROBI, V152, P1, DOI 10.1016/j.resp.2006.02.005; Ben-Mabrouk F, 2010, EUR J NEUROSCI, V31, P1219, DOI 10.1111/j.1460-9568.2010.07156.x; Beyeler A, 2008, J NEUROPHYSIOL, V100, P1372, DOI 10.1152/jn.00023.2008; Bochorishvili G, 2012, J COMP NEUROL, V520, P1047, DOI 10.1002/cne.22769; Boggs DF, 2002, COMP BIOCHEM PHYS A, V133, P269, DOI 10.1016/S1095-6433(02)00160-5; Buchanan JT, 2008, BRAIN RES REV, V57, P37, DOI 10.1016/j.brainresrev.2007.07.010; Buchanan JT, 2011, J NEUROPHYSIOL, V106, P2346, DOI 10.1152/jn.01100.2010; BUSSIERES N, 1992, BRAIN RES, V575, P174, DOI 10.1016/0006-8993(92)90441-B; Combes D, 2008, CURR BIOL, V18, pR241, DOI 10.1016/j.cub.2008.02.018; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; DUBUC R, 1989, BRAIN RES, V483, P196, DOI 10.1016/0006-8993(89)90055-3; Duysens J, 2000, PHYSIOL REV, V80, P83, DOI 10.1152/physrev.2000.80.1.83; ELDRIDGE FL, 1981, SCIENCE, V211, P844, DOI 10.1126/science.7466362; Etlin A, 2013, J NEUROSCI, V33, P734, DOI 10.1523/JNEUROSCI.4390-12.2013; Falgairolle M, 2007, J PHYSIOL-LONDON, V580, P87, DOI 10.1113/jphysiol.2006.115709; Fedirchuk B, 2013, J NEUROPHYSIOL, V109, P375, DOI 10.1152/jn.00649.2012; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; FUNK GD, 1992, J APPL PHYSIOL, V73, P1014, DOI 10.1152/jappl.1992.73.3.1014; Gariepy JF, 2012, P NATL ACAD SCI USA, V109, pE84, DOI 10.1073/pnas.1113002109; Gariepy JF, 2010, PROG BRAIN RES, V187, P173, DOI [10.1016/S0079-6123(10)87012-8, 10.1016/B978-0-444-53613-6.00012-5]; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Giraudin A, 2008, J NEUROPHYSIOL, V99, P2626, DOI 10.1152/jn.01298.2007; Giraudin A, 2012, J NEUROSCI, V32, P11841, DOI 10.1523/JNEUROSCI.0360-12.2012; Gravel J, 2007, NEUROSCIENCE, V144, P1120, DOI 10.1016/j.neuroscience.2006.10.019; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guyenet PG, 2010, RESP PHYSIOL NEUROBI, V173, P244, DOI 10.1016/j.resp.2010.02.005; Guyenet PG, 2005, J NEUROSCI, V25, P8938, DOI 10.1523/JNEUROSCI.2415-05.2005; Guyenet PG, 2001, J NEUROPHYSIOL, V86, P438, DOI 10.1152/jn.2001.86.1.438; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Haouzi P, 1997, RESP PHYSIOL, V107, P181, DOI 10.1016/S0034-5687(96)02508-X; Hayes HB, 2009, J NEUROPHYSIOL, V101, P1114, DOI 10.1152/jn.90523.2008; Hayes JA, 2007, J NEUROPHYSIOL, V97, P4215, DOI 10.1152/jn.00228.2007; ISCOE S, 1976, J APPL PHYSIOL, V40, P138, DOI 10.1152/jappl.1976.40.2.138; Janczewski WA, 2002, J PHYSIOL-LONDON, V545, P1017, DOI 10.1113/jphysiol.2002.023408; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Johnson SM, 1996, J APPL PHYSIOL, V80, P2120, DOI 10.1152/jappl.1996.80.6.2120; Jordan LM, 1998, ANN NY ACAD SCI, V860, P83, DOI 10.1111/j.1749-6632.1998.tb09040.x; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Juvin L, 2012, J NEUROSCI, V32, P953, DOI 10.1523/JNEUROSCI.4640-11.2012; KAWAHARA K, 1988, BIOL CYBERN, V58, P235, DOI 10.1007/BF00364129; Lambert FM, 2012, CURR BIOL, V22, P1649, DOI 10.1016/j.cub.2012.07.019; Lev-Tov A, 2000, J NEUROPHYSIOL, V83, P888, DOI 10.1152/jn.2000.83.2.888; MATEIKA JH, 1995, EUR J APPL PHYSIOL, V71, P1, DOI 10.1007/BF00511228; Matsuyama K, 2000, J NEUROPHYSIOL, V84, P2237, DOI 10.1152/jn.2000.84.5.2237; Mellen NM, 2012, CURR OPIN NEUROBIOL, V22, P676, DOI 10.1016/j.conb.2012.01.001; Morin D, 2002, J NEUROSCI, V22, P4756, DOI 10.1523/JNEUROSCI.22-11-04756.2002; Mulkey DK, 2007, J NEUROSCI, V27, P14128, DOI 10.1523/JNEUROSCI.4167-07.2007; ONIMARU H, 1992, PFLUG ARCH EUR J PHY, V420, P399, DOI 10.1007/BF00374476; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2012, J PHYSIOL-LONDON, V590, P1615, DOI 10.1113/jphysiol.2011.222687; Onimaru H, 2009, RESP PHYSIOL NEUROBI, V168, P13, DOI 10.1016/j.resp.2009.03.007; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; Panaitescu B, 2010, ADV EXP MED BIOL, V669, P91, DOI 10.1007/978-1-4419-5692-7_19; Pearson K, 2000, CURR OPIN NEUROBIOL, V10, P649, DOI 10.1016/S0959-4388(00)00130-6; Potts JT, 2005, J NEUROSCI, V25, P1965, DOI 10.1523/JNEUROSCI.3881-04.2005; RICHARDS CD, 1970, J PHYSIOL-LONDON, V211, P571, DOI 10.1113/jphysiol.1970.sp009294; ROMANIUK JR, 1994, ACTA NEUROBIOL EXP, V54, P11; Ruangkittisakul A, 2007, J PHYSIOL-LONDON, V584, P489, DOI 10.1113/jphysiol.2007.142760; Rudzinski E, 2010, PEDIATR DEVEL PATHOL, V13, P291, DOI 10.2350/09-07-0682-OA.1; Shvarev YN, 2002, ACTA PHYSIOL SCAND, V174, P67, DOI 10.1046/j.1365-201x.2002.00926.x; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Tan WB, 2010, J COMP NEUROL, V518, P1862, DOI 10.1002/cne.22308; Telgkamp P, 2002, J NEUROPHYSIOL, V88, P206, DOI 10.1152/jn.2002.88.1.206; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; TOBIN MJ, 1986, J APPL PHYSIOL, V60, P1306, DOI 10.1152/jappl.1986.60.4.1306; Voituron N, 2006, J PHYSIOL-LONDON, V577, P55, DOI 10.1113/jphysiol.2006.111765; Voituron N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013644; von Uckermann G, 2013, J NEUROSCI, V33, P4253, DOI 10.1523/JNEUROSCI.4521-12.2013; Waldrop TG, 2006, J APPL PHYSIOL, V100, P1077, DOI 10.1152/japplphysiol.01528.2005; Wang S, 2013, J NEUROSCI; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Wittmeier S, 2008, P NATL ACAD SCI USA, V105, P18000, DOI 10.1073/pnas.0809377105	81	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89670	10.1371/journal.pone.0089670	http://dx.doi.org/10.1371/journal.pone.0089670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586951	gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700134
J	Chen, YY; Liu, JB; Huang, XB; Cai, SX; Su, ZM; Zhong, R; Zou, L; Miao, XP				Chen, Yan-Yan; Liu, Jian-Bing; Huang, Xi-Bao; Cai, Shun-Xiang; Su, Zheng-Ming; Zhong, Rong; Zou, Li; Miao, Xiao-Ping			New Integrated Strategy Emphasizing Infection Source Control to Curb Schistosomiasis japonica in a Marshland Area of Hubei Province, China: Findings from an Eight-Year Longitudinal Survey	PLOS ONE			English	Article							DONGTING LAKE REGION; REPUBLIC-OF-CHINA; ONCOMELANIA-HUPENSIS; CONTROL TRANSMISSION; GORGES DAM; IMPACT; PRAZIQUANTEL; METAANALYSIS; DOWNSTREAM; MORBIDITY	Background: Schistosomiasis remains a major public health problem in China. The major endemic foci are the lake and marshland regions of southern China, particularly the regions along the middle and lower reach of the Yangtze River in four provinces (Hubei, Hunan, Jiangxi, and Anhui). The purpose of our study is to assess the effect of a new integrated strategy emphasizing infection source control to curb schistosomiasis in marshland regions. Methods: In a longitudinal study, we implemented an integrated control strategy emphasizing infection source control in 16 villages from 2005 through 2012 in marshland regions of Hubei province. The interventions included removing cattle from snail-infested grasslands, providing farmers with mechanized farm equipment, improving sanitation by supplying tap water, building lavatories and latrines, praziquantel chemotherapy, controlling snails, and environmental modification. Results: Following the integrated control strategy designed to reduce the role of bovines and humans as sources of Schistosoma japonicum infection, the prevalence of human S. japonicum infection declined from 1.7% in 2005 to 0.4% in 2012 (P<0.001). Reductions were also observed in both sexes, across all age groups, and among high risk occupations. Moreover, the prevalence of bovine S. japonicum infection decreased from 11.7% in 2005 to 0.6% in 2012 (P<0.001). In addition, all the 16 villages achieved the national criteria of infection control in 2008. Conclusion: Our findings indicate that the integrated strategy was likely effective in controlling the transmission of S. japonicum in marshland regions in China.	[Chen, Yan-Yan; Zhong, Rong; Zou, Li; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth,Dept Epidemio, Wuhan 430074, Peoples R China; [Chen, Yan-Yan; Liu, Jian-Bing; Huang, Xi-Bao; Cai, Shun-Xiang; Su, Zheng-Ming] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China	Huazhong University of Science & Technology	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth,Dept Epidemio, Wuhan 430074, Peoples R China.	hbcdcxf@126.com; miaoxp@gmail.com	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Calu, Donna/0000-0003-2377-9494	National Science and Technology Support Program in China [2009BAI78B07]; Provincial Research of Schistosomiasis Prevention of Health Department of Hubei, China [XF2010-5, XF2010-30, XF2012-24, XF2012-26]	National Science and Technology Support Program in China; Provincial Research of Schistosomiasis Prevention of Health Department of Hubei, China	This study was funded by the National Science and Technology Support Program in China (2009BAI78B07), and the Provincial Research of Schistosomiasis Prevention of Health Department of Hubei, China (XF2010-5, XF2010-30, XF2012-24, XF2012-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, EP STAT SCHIST CHIN; [Anonymous], 1992, WORLD BANK LOAN PROG; Balen J, 2007, B WORLD HEALTH ORGAN, V85, P519, DOI 10.2471/BLT.06.034033; Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Chen XY, 2005, B WORLD HEALTH ORGAN, V83, P43; Chen YanYan, 2010, Chinese Journal of Schistosomiasis Control, V22, P411; Gray DJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001588; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Gray DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005900; Guo JG, 2006, AM J TROP MED HYG, V74, P335, DOI 10.4269/ajtmh.2006.74.335; HALL SC, 1970, CALIF MED, V113, P75; He Hui, 2010, Redai Yixue Zazhi, V10, P1243; Hong XC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002122; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Jiang MingSen, 2010, Chinese Journal of Schistosomiasis Control, V22, P201; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Kumagai T, 2010, AM J TROP MED HYG, V83, P542, DOI 10.4269/ajtmh.2010.10-0016; Li SZ, 2009, CHINESE MED J-PEKING, V122, P1009, DOI 10.3760/cma.j.issn.0366-6999.2009.09.002; Li YS, 2007, EMERG INFECT DIS, V13, P973, DOI 10.3201/eid1307.060848; Liao SiQi, 2009, Journal of Tropical Medicine (Guangzhou), V9, P1288; Liu R, 2013, PARASITOL RES, V112, P1483, DOI 10.1007/s00436-013-3295-5; Liu R, 2012, PARASITOL RES, V110, P2081, DOI 10.1007/s00436-011-2721-9; Liu Wei, 2013, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V31, P206; MAO SB, 1986, CHINESE MED J-PEKING, V99, P439; McManus DP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001053; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Ross Allen G.P., 2001, Biologist (London), V48, P121; Seto EYW, 2008, ECOHEALTH, V5, P149, DOI 10.1007/s10393-008-0169-x; SHOUPAI M, 1982, AM J TROP MED HYG, V31, P92, DOI 10.4269/ajtmh.1982.31.92; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stone R, 2008, SCIENCE, V321, P628, DOI 10.1126/science.321.5889.628; Sun CS, 2002, ACTA TROP, V82, P169, DOI 10.1016/S0001-706X(02)00008-6; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; WHO, 2006, WHO PREV CHEM HUM HE; X-hW Yang Hao, 2006, CHIN J SCHISTO CONTR, V18, P321; Zhao GM, 2005, ACTA TROP, V96, P288, DOI 10.1016/j.actatropica.2005.07.023; Zheng J, 2002, ACTA TROP, V82, P147, DOI 10.1016/S0001-706X(02)00046-3; Zhongdao Wu, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P163; Zhou D, 1994, World Health Forum, V15, P387; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhou YB, 2007, ANN TROP MED PARASIT, V101, P695, DOI 10.1179/136485907X241488; Zhou YB, 2011, AM J TROP MED HYG, V85, P83, DOI 10.4269/ajtmh.2011.10-0574; Zhu Hong, 2011, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V6, P908; Zhu Hong, 2010, Journal of Tropical Medicine (Guangzhou), V10, P982; Zhu HM, 2008, ECOHEALTH, V5, P137, DOI 10.1007/s10393-008-0168-y; Zhu HuiGuo, 2008, Chinese Journal of Schistosomiasis Control, V20, P251; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007	53	30	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89779	10.1371/journal.pone.0089779	http://dx.doi.org/10.1371/journal.pone.0089779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	25025329	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200081
J	Wei, XW; Ma, XW; Lu, R; Bai, G; Zhang, JW; Deng, RF; Gu, N; Feng, N; Guo, XH				Wei, Xiaowei; Ma, Xiaowei; Lu, Ran; Bai, Ge; Zhang, Jianwei; Deng, Ruifen; Gu, Nan; Feng, Nan; Guo, Xiaohui			Genetic Variants in PCSK1 Gene Are Associated with the Risk of Coronary Artery Disease in Type 2 Diabetes in a Chinese Han Population: A Case Control Study	PLOS ONE			English	Article							INSULIN SENSITIVITY; HEART-DISEASE; OBESITY; PROINSULIN; MELLITUS	Background: Insulin and glucagon-like peptide 1 (GLP-1), converted by proprotein convertase 1 (PC1/3) from proinsulin and proglucagon, are associated with type 2 diabetes (T2DM) and coronary artery disease (CAD). The aim of this study is to investigate the association of PCSK1 gene, which encodes PC1/3, with the risk of CAD in Chinese patients with T2DM. Methods: We selected and genotyped 5 haplotype-tagging single nucleotide polymorphisms (SNPs) at PCSK1 gene (across 39873bp locus) in a case-control study of Chinese Han population involving 425 diabetic patients (62.1% male, mean age 63.2 years) with CAD as positive cases and 258 diabetic patients (44.2% male, mean age 62.0 years) without CAD as controls. Results: The allele frequencies at rs3811951 were significantly different between cases and controls (30.7% vs. 37.2%), with the allele G associated with decreased risk for CAD (OR = 0.75, 95% CI = 0.59-0.94, p = 0.013). In recessive inheritance mode, the carriers of GG had a lower risk (OR = 0.50, 95% CI = 0.31-0.82, p = 0.005), even after adjusted for gender, age, BMI and smoking (OR = 0.43, 95% CI = 0.24-0.77, p = 0.004). The carriers of the minor allele A at rs156019 had a higher risk (OR = 1.66, 95% CI = 1.10-2.50, p = 0.016 after adjustment) in dominant inheritance mode. The SNP rs6234 was also significantly associated with CAD risk in women, with the carriers of the minor allele G at rs6234 associated with a reduced CAD risk in recessive inheritance mode (OR = 0.42, 95% CI = 0.18-0.95, p = 0.036 after adjustment). Conclusions: Our results found that common genetic variants in PCSK1 were associated with CAD in Chinese patients with T2DM.	[Wei, Xiaowei; Ma, Xiaowei; Lu, Ran; Bai, Ge; Zhang, Jianwei; Deng, Ruifen; Gu, Nan; Feng, Nan; Guo, Xiaohui] Peking Univ, Dept Endocrinol, Hosp 1, Beijing 100871, Peoples R China	Peking University	Ma, XW (corresponding author), Peking Univ, Dept Endocrinol, Hosp 1, Beijing 100871, Peoples R China.	mxiaowei@yahoo.com	FENG, NAN/HGD-3255-2022; lu, ran/HHC-8613-2022; Blanco, Juan A./A-4554-2009	Blanco, Juan A./0000-0002-6524-4335; Wei, Xiaohua (Adam)/0000-0003-2711-5636; Gu, Nan/0000-0001-9852-0060	National 973 project in China [2006CB503903, 2006CB503908]	National 973 project in China(National Basic Research Program of China)	The study was granted by National 973 project (2006CB503903, 2006CB503908) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostis P, 2011, DIABETES OBES METAB, V13, P302, DOI 10.1111/j.1463-1326.2010.01345.x; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Gjesing AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023907; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-4; Heni M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-86; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Kaplan M, 2012, PHARMACOL THERAPEUT, V136, P175, DOI 10.1016/j.pharmthera.2012.08.002; Mbikay M, 2011, MOL GENET METAB, V104, P682, DOI 10.1016/j.ymgme.2011.09.027; Qi Q, 2010, PLOS ONE, V5; Schneider Hans, 2003, Clin Biochem Rev, V24, P77; Sirois F, 2012, J COMMUN GENET, V3, P319, DOI 10.1007/s12687-012-0081-5; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563; Yu QJ, 2011, CARDIOVASC RES, V89, P516, DOI 10.1093/cvr/cvq349; Zethelius B, 2005, DIABETOLOGIA, V48, P862, DOI 10.1007/s00125-005-1711-9; Zethelius B, 2002, CIRCULATION, V105, P2153, DOI 10.1161/01.CIR.0000015855.04844.E7	19	36	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87168	10.1371/journal.pone.0087168	http://dx.doi.org/10.1371/journal.pone.0087168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24586964	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000113
J	Li, JF; Luo, C; Peng, YH; Xie, QK; Gong, JN; Dong, L; Lai, YX; Li, H; Yao, DZ				Li, Jianfu; Luo, Cheng; Peng, Yueheng; Xie, Qiankun; Gong, Jinnan; Dong, Li; Lai, Yongxiu; Li, Hong; Yao, Dezhong			Probabilistic Diffusion Tractography Reveals Improvement of Structural Network in Musicians	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; SUPPLEMENTARY MOTOR AREA; WHITE-MATTER PLASTICITY; SMALL-WORLD; GRAY-MATTER; HUMAN BRAIN; CORTICAL REPRESENTATION; PREMOTOR CORTEX; ABSOLUTE PITCH; PIANO PLAYERS	Purpose: Musicians experience a large amount of information transfer and integration of complex sensory, motor, and auditory processes when training and playing musical instruments. Therefore, musicians are a useful model in which to investigate neural adaptations in the brain. Methods: Here, based on diffusion-weighted imaging, probabilistic tractography was used to determine the architecture of white matter anatomical networks in musicians and non-musicians. Furthermore, the features of the white matter networks were analyzed using graph theory. Results: Small-world properties of the white matter network were observed in both groups. Compared with non-musicians, the musicians exhibited significantly increased connectivity strength in the left and right supplementary motor areas, the left calcarine fissure and surrounding cortex and the right caudate nucleus, as well as a significantly larger weighted clustering coefficient in the right olfactory cortex, the left medial superior frontal gyrus, the right gyrus rectus, the left lingual gyrus, the left supramarginal gyrus, and the right pallidum. Furthermore, there were differences in the node betweenness centrality in several regions. However, no significant differences in topological properties were observed at a global level. Conclusions: We illustrated preliminary findings to extend the network level understanding of white matter plasticity in musicians who have had long-term musical training. These structural, network-based findings may indicate that musicians have enhanced information transmission efficiencies in local white matter networks that are related to musical training.	[Li, Jianfu; Luo, Cheng; Peng, Yueheng; Xie, Qiankun; Gong, Jinnan; Dong, Li; Lai, Yongxiu; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Li, Hong] Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China	University of Electronic Science & Technology of China; Southwest University - China	Luo, C (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China.	chengluo@uestc.edu.cn; dyao@uestc.edu.cn	Luo, Cheng/A-4647-2015; zhang, ke/AAH-8217-2019	Luo, Cheng/0000-0003-0524-5886; Yao, Dezhong/0000-0002-8042-879X; Gong, Jinnan/0000-0002-9908-3517	973 project [2011CB707803]; National Nature Science Foundation of China [81271547, 81201159, 91232725]; Chinese Fundamental Research Funding for Central Universities [ZYGX 2011J097, ZYGX2012J110]	973 project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Fundamental Research Funding for Central Universities	This work was supported by grants from the 973 project 2011CB707803, the National Nature Science Foundation of China (grant number: 81271547, 81201159, and 91232725) and the Chinese Fundamental Research Funding for Central Universities (grant number: ZYGX 2011J097, ZYGX2012J110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Kareem IA, 2011, CEREBELLUM, V10, P611, DOI 10.1007/s12311-011-0274-1; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; [Anonymous], [No title captured]; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Barrett KE, 2012, GANONGS REV MED PHYS, P239; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Baumann S, 2008, J COGNITIVE NEUROSCI, V20, P2238, DOI 10.1162/jocn.2008.20157; Baumann S, 2007, BRAIN RES, V1161, P65, DOI 10.1016/j.brainres.2007.05.045; Bengtsson SL, 2006, NEUROIMAGE, V30, P272, DOI 10.1016/j.neuroimage.2005.09.019; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bermudez P, 2005, ANN NY ACAD SCI, V1060, P395, DOI 10.1196/annals.1360.057; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carretie L, 2009, NEUROSCIENCE, V164, P1615, DOI 10.1016/j.neuroscience.2009.09.031; Chen JL, 2012, NEUROIMAGE, V59, P1200, DOI 10.1016/j.neuroimage.2011.08.012; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Foundas AL, 1999, NEUROPSY NEUROPSY BE, V12, P1; Gaser C, 2003, ANN NY ACAD SCI, V999, P514, DOI 10.1196/annals.1284.062; Gaser C, 2003, J NEUROSCI, V23, P9240; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Groussard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013225; Habermeyer B, 2009, HUM BRAIN MAPP, V30, P3736, DOI 10.1002/hbm.20802; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hirata Y, 1999, NEUROREPORT, V10, P999, DOI 10.1097/00001756-199904060-00019; Hoenig K, 2011, NEUROIMAGE, V56, P1714, DOI 10.1016/j.neuroimage.2011.02.065; Huang Z, 2010, NEUROSCIENCE, V168, P179, DOI 10.1016/j.neuroscience.2010.03.027; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Iturria-Medina Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019071; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kansaku K, 2000, CEREB CORTEX, V10, P866, DOI 10.1093/cercor/10.9.866; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Li SY, 2010, CEREB CORTEX, V20, P25, DOI 10.1093/cercor/bhp074; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Luo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036568; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meister I, 2005, HUM BRAIN MAPP, V25, P345, DOI 10.1002/hbm.20112; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Penhune VB, 2011, CORTEX, V47, P1126, DOI 10.1016/j.cortex.2011.05.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Russeler J, 2001, NEUROSCI LETT, V308, P33, DOI 10.1016/S0304-3940(01)01977-2; Salimpoor VN, 2013, PSYCHOL AESTHET CREA, V7, P62, DOI 10.1037/a0031819; Schlaug G, 2005, ANN NY ACAD SCI, V1060, P219, DOI 10.1196/annals.1360.015; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schmithorst VJ, 2002, NEUROSCI LETT, V321, P57, DOI 10.1016/S0304-3940(02)00054-X; Schneider P, 2005, ANN NY ACAD SCI, V1060, P387, DOI 10.1196/annals.1360.033; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Shahin A, 2003, J NEUROSCI, V23, P5545; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; THALER D, 1995, EXP BRAIN RES, V102, P445; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xue KQ, 2014, EPILEPSY RES, V108, P125, DOI 10.1016/j.eplepsyres.2013.10.002	84	416	423	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105508	10.1371/journal.pone.0105508	http://dx.doi.org/10.1371/journal.pone.0105508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	24587291	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200034
J	Li, J; Zhang, KQ				Li, Juan; Zhang, Ke-Qin			Independent Expansion of Zincin Metalloproteinases in Onygenales Fungi May Be Associated with Their Pathogenicity	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; AMINO-ACID SITES; GENE FAMILY; PHYLOGENETIC ANALYSIS; LIKELIHOOD METHOD; SEQUENCE; MODEL; DISEASE; RATIO; COCCIDIOIDOMYCOSIS	To get a comprehensive view of fungal M35 family (deuterolysin) and M36 family (fungalysin) genes, we conducted genome-wide investigations and phylogenetic analyses of genes in these two families from 50 sequenced Ascomycota fungi with different life styles. Large variations in the number of M35 family and M36 family genes were found among different fungal genomes, indicating that these two gene families have been highly dynamic through fungal evolution. Moreover, we found obvious expansions of Meps in two families of Onygenales: Onygenaceae and Arthodermataceae, whereas species in family Ajellomycetace did not show expansion of these genes. The strikingly different gene duplication and loss patterns in Onygenales may be associated with the different pathogenicity of these species. Interestingly, likelihood ratio tests (LRT) of both M35 family and M36 family genes suggested that several branches leading to the duplicated genes in dermatophytic and Coccidioides fungi had signatures of positive selection, indicating that the duplicated Mep genes have likely diverged functionally to play important roles during the evolution of pathogenicity of dermatophytic and Coccidioides fungi. The potentially positively selected residues discovered by our analysis may have contributed to the development of new physiological functions of the duplicated Mep genes in dermatophytic fungi and Coccidioides species. Our study adds to the current knowledge of the evolution of Meps in fungi and also establishes a theoretical foundation for future experimental investigations.	[Zhang, Ke-Qin] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Peoples R China	Yunnan University; Yunnan University	Zhang, KQ (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China.	kqzhang1@ynu.edu.cn	Luo, Cheng/A-4647-2015; zhang, ke/AAH-8217-2019	Luo, Cheng/0000-0003-0524-5886; Yao, Dezhong/0000-0002-8042-879X; Gong, Jinnan/0000-0002-9908-3517	National Basic Research Program of China [2013CB127500]; National Natural Science Foundation of China [31100894]; 1/4 CE Youth Foundation of the Applied Basic Research Programs of Yunnan Province [2012FD006]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 1/4 CE Youth Foundation of the Applied Basic Research Programs of Yunnan Province	This work is jointly funded by National Basic Research Program of China (approved no. 2013CB127500), the National Natural Science Foundation of China (approved nos. 31100894) 1/4 CE Youth Foundation of the Applied Basic Research Programs of Yunnan Province (approved nos. 2012FD006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Brouta F, 2002, INFECT IMMUN, V70, P5676, DOI 10.1128/IAI.70.10.5676-5683.2002; Burmester A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r7; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Durkin M, 2001, J INFECT DIS, V183, P1822, DOI 10.1086/320720; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galgiani JN, 1999, ANN INTERN MED, V130, P293, DOI 10.7326/0003-4819-130-4-199902160-00015; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Gillespie JP, 2000, ARCH INSECT BIOCHEM, V44, P49, DOI 10.1002/1520-6327(200006)44:2&lt;49::AID-ARCH1&gt;3.0.CO;2-F; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haydon DT, 2001, GENETICS, V157, P7; Hector RF, 2005, PLOS MED, V2, P15, DOI 10.1371/journal.pmed.0020002; Hori T, 2001, ACTA CRYSTALLOGR D, V57, P361, DOI 10.1107/S0907444900019740; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031536; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Marcet-Houben M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004357; MARKARYAN A, 1994, INFECT IMMUN, V62, P2149, DOI 10.1128/IAI.62.6.2149-2157.1994; Mathy A, 2010, VET MICROBIOL, V146, P179, DOI 10.1016/j.vetmic.2010.04.019; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Nielsen R, 1998, GENETICS, V148, P929; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sainudiin R, 2005, J MOL EVOL, V60, P315, DOI 10.1007/s00239-004-0153-1; Segurado M, 1999, INFECT IMMUN, V67, P2377, DOI 10.1128/IAI.67.5.2377-2382.1999; Sentandreu M, 1998, J BACTERIOL, V180, P282, DOI 10.1128/JB.180.2.282-289.1998; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Staib P, 2010, MICROBIOL-SGM, V156, P884, DOI 10.1099/mic.0.033464-0; STLEGER RJ, 1994, ARCH BIOCHEM BIOPHYS, V313, P1, DOI 10.1006/abbi.1994.1350; Suzuki Y, 2001, MOL BIOL EVOL, V18, P2179, DOI 10.1093/oxfordjournals.molbev.a003764; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Untereiner WA, 2004, MYCOLOGIA, V96, P812, DOI 10.2307/3762114; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	55	416	423	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90225	10.1371/journal.pone.0090225	http://dx.doi.org/10.1371/journal.pone.0090225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587291	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200149
J	Wei, XH; Blanco, JA				Wei, Xiaohua; Blanco, Juan A.			Significant Increase in Ecosystem C Can Be Achieved with Sustainable Forest Management in Subtropical Plantation Forests	PLOS ONE			English	Article							CHINESE-FIR PLANTATIONS; CARBON SEQUESTRATION; CUNNINGHAMIA-LANCEOLATA; NITROGEN DEPOSITION; BIOMASS PRODUCTION; SIMULATION-MODEL; PHOEBE-BOURNEI; DOUGLAS-FIR; PRODUCTIVITY; IMPACTS	Subtropical planted forests are rapidly expanding. They are traditionally managed for intensive, short-term goals that often lead to long-term yield decline and reduced carbon sequestration capacity. Here we show how it is possible to increase and sustain carbon stored in subtropical forest plantations if management is switched towards more sustainable forestry. We first conducted a literature review to explore possible management factors that contribute to the potentials in ecosystem C in tropical and subtropical plantations. We found that broadleaves plantations have significantly higher ecosystem C than conifer plantations. In addition, ecosystem C increases with plantation age, and reaches a peak with intermediate stand densities of 1500-2500 trees ha(-1). We then used the FORECAST model to simulate the regional implications of switching from traditional to sustainable management regimes, using Chinese fir (Cunninghamia lanceolata) plantations in subtropical China as a study case. We randomly simulated 200 traditional short-rotation pure stands and 200 sustainably-managed mixed Chinese fir - Phoebe bournei plantations, for 120 years. Our results showed that mixed, sustainably-managed plantations have on average 67.5% more ecosystem C than traditional pure conifer plantations. If all pure plantations were gradually transformed into mixed plantations during the next 10 years, carbon stocks could rise in 2050 by 260.22 TgC in east-central China. Assuming similar differences for temperate and boreal plantations, if sustainable forestry practices were applied to all new forest plantation types in China, stored carbon could increase by 1,482.80 TgC in 2050. Such an increase would be equivalent to a yearly sequestration rate of 40.08 TgC yr(-1), offsetting 1.9% of China's annual emissions in 2010. More importantly, this C increase can be sustained in the long term through the maintenance of higher amounts of soil organic carbon and the production of timber products with longer life spans.	[Wei, Xiaohua] Univ British Columbia, Dept Earth & Environm Sci, Kelowna, BC, Canada; [Blanco, Juan A.] Univ Publ Navarra, Dept Ciencias Medio Nat, Navarra, Spain	University of British Columbia; Universidad Publica de Navarra	Blanco, JA (corresponding author), Univ Publ Navarra, Dept Ciencias Medio Nat, Navarra, Spain.	juan.blanco@unavarra.es	FENG, NAN/HGD-3255-2022; lu, ran/HHC-8613-2022; Blanco, Juan A./A-4554-2009	Blanco, Juan A./0000-0002-6524-4335; Wei, Xiaohua (Adam)/0000-0003-2711-5636; Gu, Nan/0000-0001-9852-0060	Forest Carbon Counting Method Project of the Chinese Academy of Science Strategic and Flagship Program on the Chinese Ecological and Engineering Projects and their Contributions to Carbon [XDA05060101]; BC-China Innovation and Commercialization Strategic Development Program [ICSD-2007-Wei-Kimmins]	Forest Carbon Counting Method Project of the Chinese Academy of Science Strategic and Flagship Program on the Chinese Ecological and Engineering Projects and their Contributions to Carbon; BC-China Innovation and Commercialization Strategic Development Program	Funding for this research was provided by: 1) Forest Carbon Counting Method Project (XDA05060101) of the Chinese Academy of Science Strategic and Flagship Program on the Chinese Ecological and Engineering Projects and their Contributions to Carbon; and 2) BC-China Innovation and Commercialization Strategic Development Program (ICSD-2007-Wei-Kimmins). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso MM, 2006, CAN J FOREST RES, V36, P1484, DOI 10.1139/X06-042; Bauhus J, 2000, CAN J FOREST RES, V30, P1886, DOI 10.1139/cjfr-30-12-1886; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Bi J, 2007, CAN J FOREST RES, V37, P1615, DOI 10.1139/X07-018; Blanco JA, 2010, J TROP FOR SCI, V22, P139; Blanco JA, 2005, FOREST ECOL MANAG, V213, P209, DOI 10.1016/j.foreco.2005.03.042; Blanco JA, 2007, CAN J FOREST RES, V37, P1808, DOI 10.1139/X07-041; Blanco JA, 2012, SCI TOTAL ENVIRON, V437, P91, DOI 10.1016/j.scitotenv.2012.07.082; Blanco JA, 2012, CAN J FOREST RES, V42, P437, DOI [10.1139/X2012-004, 10.1139/x2012-004]; Cannell MGR, 2003, BIOMASS BIOENERG, V24, P97, DOI 10.1016/S0961-9534(02)00103-4; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; [陈淑容 CHEN Shu-rong], 2010, [福建林学院学报, Journal of Fujian College of Forestry], V30, P157; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; CHEN XY, 2009, JIANGXI FOREST SCI T, V1, P14, DOI DOI 10.3724/SP.J.1227.00001; Cheng Y, 2003, THESIS FUJIAN AGR FO; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Ding Y. X., 1995, Pedosphere, V5, P57; Ding YX, 1999, FOREST STUD CHINA, V1, P34; Du Juan, 2010, Journal of Zhejiang Forestry Science and Technology, V30, P37; Du Juan, 2009, Journal of Zhejiang Forestry Science and Technology, V29, P9; Duan W, 2008, SICHUAN ENV, V27, P57; Eriksson E, 2007, CAN J FOREST RES, V37, P671, DOI 10.1139/X06-257; Erskine PD, 2006, FOREST ECOL MANAG, V233, P205, DOI 10.1016/j.foreco.2006.05.013; Evans J., 2001, 2 FAO FOR RES DEV SE; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; Fan X, 2001, FOR RES, V14, P11; FAO, 2012, STAT WORLDS FOR 2012; FAO, 2006, 38 FAO; Forrester DI, 2006, FOREST ECOL MANAG, V233, P211, DOI 10.1016/j.foreco.2006.05.012; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Guan BT, 2012, FOREST ECOL MANAG, V267, P50, DOI 10.1016/j.foreco.2011.11.028; Guan DB, 2012, NAT CLIM CHANGE, V2, P672, DOI [10.1038/NCLIMATE1560, 10.1038/nclimate1560]; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; [郭玉硕 GUO Yushuo], 2007, [福建林学院学报, Journal of Fujian College of Forestry], V27, P199; Hu JingNan, 2010, Journal of Anhui Agricultural University, V37, P541; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jie C, 2011, P 2011 19 INT C GEOI, DOI [10.1109/GeoInformatics.2011.5981581, DOI 10.1109/GE0INF0RMATICS.2011.5981581]; Keith H, 2010, GLOBAL CHANGE BIOL, V16, P2971, DOI 10.1111/j.1365-2486.2009.02146.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; KELTY MJ, 1992, FOR SCI, V40, P125; Kimmins J.P., 2010, FORECASTING FOREST F; Kimmins JP, 2008, FOREST ECOL MANAG, V256, P1646, DOI [10.1016/j.foreco.2008.03.011, 10.1016/j.foreco.2008.02.057]; Kimmins JP, 1999, ECOL MODEL, V122, P195, DOI 10.1016/S0304-3800(99)00138-6; Kirilenko AP, 2007, P NATL ACAD SCI USA, V104, P19697, DOI 10.1073/pnas.0701424104; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Li MH, 1999, NEW FOREST, V18, P131, DOI 10.1023/A:1006558900234; Liao CZ, 2012, GLOBAL ECOL BIOGEOGR, V21, P318, DOI 10.1111/j.1466-8238.2011.00690.x; Liao H, 1989, J FUJIAN COLL FOREST, V9, P80; Liao L., 2000, ACTA PHYTOECCOL SIN, V24, P27; Lin Kai-min, 2010, Journal of Plant Resources and Environment, V19, P34; [林开敏 LIN KaiMin], 2006, [生态学报, Acta Ecologica Sinica], V26, P2732; Lin KM, 2001, SCI SILVAE SINICAE, V37, P94, DOI DOI 10.11707/J.1001-7488.2001S117; Lin T, 2011, JIANGXI FORESTRY SCI, V3, P16; Lippke B, 2011, CARBON MANAG, V2, P303, DOI 10.4155/CMT.11.24; Liu F, 1991, J NANJING FOR U, P7; Liu P, 2012, FORESTS, V3, P417, DOI 10.3390/f3020417; Liu Q, 2009, J JIANXI FORESTRY SC, V1, P31; Lo YH, 2012, FOREST ECOSYSTEMS MO, P339; Lu M, 2006, THESIS FUJIAN AGR FO; Lu Zhao-hua, 2002, Journal of Forestry Research (Harbin), V13, P319, DOI 10.1007/BF02860099; Ma MingDong, 2008, Scientia Silvae Sinicae, V44, P34; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; Masera OR, 2003, ECOL MODEL, V164, P177, DOI 10.1016/S0304-3800(02)00419-2; McKinley DC, 2011, ECOL APPL, V21, P1902, DOI 10.1890/10-0697.1; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nabuurs GJ, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P541; Niu XZ, 2006, FOREST ECOL MANAG, V223, P415, DOI 10.1016/j.foreco.2005.12.044; Pan WC, 1983, J CENTRAL S FORESTRY, V3, P1; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Peng L, 2008, J FUJIAN FORESTRY SC, V35, P10; Peng L, 2008, J FUJIAN FOR SIC TEC, V35, P15; Peng LongFu, 2003, Journal of Fujian College of Forestry, V23, P128; Perez-Garcia J, 2005, WOOD FIBER SCI, V37, P140; Pretzsch H, 2013, EUR J FOREST RES, V132, P263, DOI 10.1007/s10342-012-0673-y; Primicia I, 2013, EUR J FOREST RES, V132, P121, DOI 10.1007/s10342-012-0662-1; Qi G, 2011, THESIS CHINESE ACAD; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ren CH, 1990, J FUJIAN COLL FOREST, V10, P67; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Seely B, 2002, FOREST ECOL MANAG, V169, P123, DOI 10.1016/S0378-1127(02)00303-1; Seely B, 2010, ECOL INDIC, V10, P999, DOI 10.1016/j.ecolind.2010.02.008; Shao L, 1992, RES SITE DEGRADATION, P87; State Forestry Administration People's Republic of China, 2009, APFSOS2WP200911 FAO; Tian DL, 2011, FORESTRY, V84, P411, DOI 10.1093/forestry/cpr029; Tian DL, 1994, STUDIES FOREST ECOSY, P136; Tian DL, 1989, J CENT S FOR U, V9, P38; Tian DL, 1989, J CENTRAL S FOR COLL, V9, P45; Tummer B, 2006, DATATHEIF 3 V1 6; [吴载璋 Tun Zaizhang], 2004, [福建林学院学报, Journal of Fujian College of Forestry], V24, P371; van Minnen Jelle G, 2008, Carbon Balance Manag, V3, P3, DOI 10.1186/1750-0680-3-3; Wang WF, 2013, FOREST ECOL MANAG, V300, P21, DOI 10.1016/j.foreco.2012.06.044; Wei XH, 2012, SCI TOTAL ENVIRON, V416, P351, DOI 10.1016/j.scitotenv.2011.11.087; Wu W. M., 2009, CHINA FOR SCI TECHNO, V23, P75; Wu ZaiZhang, 2005, Journal of Fujian College of Forestry, V25, P142; Wu ZL, 1984, CHINESE FIR CHINA FO; [项文化 Xiang Wenhua], 2003, [生态学报, Acta Ecologica Sinica], V23, P695; Xiao W, 1999, FOR RES, V3, P253; Yan W, 2003, FOR RES, V16, P82; Yang YuSheng, 2000, Journal of Nanjing Forestry University, V24, P25; Yang YuSheng, 1999, Scientia Silvae Sinicae, V35, P32; Yu X., 1997, SILVICULTURE CHINESE; Yu XT, 1999, CHINESE FORESTS, P1; Zhang G, 2009, ANHUI AGR SCI B, V15, P131; Zhang XQ, 2004, FOREST ECOL MANAG, V202, P131, DOI 10.1016/j.foreco.2004.07.032; ZHONG AL, 1993, FOREST ECOL MANAG, V62, P245, DOI 10.1016/0378-1127(93)90053-P; Zhou H, 1999, J FUJIAN COLL FOR, V2, P165; Zhou X, 1991, J NANJING FOR U, V3, P47; Zhou X. F, 1994, LONG TERM RES CHINAS	110	36	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89688	10.1371/journal.pone.0089688	http://dx.doi.org/10.1371/journal.pone.0089688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586964	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700073
J	Chen, YW; Fiscella, KA; Bacharach, SZ; Calu, DJ				Chen, Yu-Wei; Fiscella, Kimberly A.; Bacharach, Samuel Z.; Calu, Donna J.			Effect of Cafeteria Diet History on Cue-, Pellet-Priming-, and Stress-Induced Reinstatement of Food Seeking in Female Rats	PLOS ONE			English	Article							SUCCESSIVE NEGATIVE CONTRAST; DOPAMINE D2 RECEPTORS; COCAINE-SEEKING; DRUG-SEEKING; HEROIN-SEEKING; WEIGHT-LOSS; DARK SIDE; RELAPSE; BEHAVIOR; REWARD	Background: Relapse to unhealthy eating habits is a major problem in human dietary treatment. The individuals most commonly seeking dietary treatment are overweight or obese women, yet the commonly used rat reinstatement model to study relapse to palatable food seeking during dieting primarily uses normal-weight male rats. To increase the clinical relevance of the relapse to palatable food seeking model, here we pre-expose female rats to a calorically-dense cafeteria diet in the home-cage to make them overweight prior to examining the effect of this diet history on cue-, pellet-priming-and footshock-induced reinstatement of food seeking. Methods: Post-natal day 32 female Long-Evans rats had seven weeks of home-cage access to either chow only or daily or intermittent cafeteria diet alongside chow. Next, they were trained to self-administer normally preferred 45 mg food pellets accompanied by a tone-light cue. After extinction, all rats were tested for reinstatement induced by discrete cue, pellet-priming, and intermittent footshock under extinction conditions. Results: Access to daily cafeteria diet and to a lesser degree access to intermittent cafeteria diet decreased food pellet self-administration compared to chow-only. Prior history of these cafeteria diets also reduced extinction responding, cue-and pellet-priming-induced reinstatement. In contrast, modest stress-induced reinstatement was only observed in rats with a history of daily cafeteria diet. Conclusion: A history of cafeteria diet does not increase the propensity for cue-and pellet-priming-induced relapse in the rat reinstatement model but does appear to make rats more susceptible to footshock stress-induced reinstatement.	[Chen, Yu-Wei; Fiscella, Kimberly A.; Bacharach, Samuel Z.; Calu, Donna J.] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Calu, DJ (corresponding author), NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	donna.calu@nih.gov	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Calu, Donna/0000-0003-2377-9494	Intramural Research Program of the National Institute on Drug Abuse	Intramural Research Program of the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	The work was supported by the Intramural Research Program of the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 1997, PSYCHOPHARMACOLOGY, V132, P289, DOI 10.1007/s002130050347; Anker JJ, 2011, CURR TOP BEHAV NEURO, V8, P73, DOI 10.1007/7854_2010_93; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bossert JM, 2013, PSYCHOPHARMACOLOGY, V229, P453, DOI 10.1007/s00213-013-3120-y; Buczek Y, 1999, PSYCHOPHARMACOLOGY, V144, P183, DOI 10.1007/s002130050992; Calu DJ, 2014, NEUROPHARMACOLOGY, V76, P395, DOI 10.1016/j.neuropharm.2013.04.030; Cifani C, 2012, J NEUROSCI, V32, P8480, DOI 10.1523/JNEUROSCI.5895-11.2012; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; Crespi LP, 1942, AM J PSYCHOL, V55, P467, DOI 10.2307/1417120; Davy SR, 2006, J AM DIET ASSOC, V106, P1673, DOI 10.1016/j.jada.2006.07.017; De Vries TJ, 2002, NEUROPSYCHOPHARMACOL, V26, P18, DOI 10.1016/S0893-133X(01)00293-7; Deroche V, 1999, EUR J NEUROSCI, V11, P2731, DOI 10.1046/j.1460-9568.1999.00696.x; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Donahue RJ, 2014, BIOL PSYCHIAT, V76, P550, DOI 10.1016/j.biopsych.2013.12.014; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Feltenstein MW, 2011, PSYCHOPHARMACOLOGY, V216, P53, DOI 10.1007/s00213-011-2187-6; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Fuchs RA, 2005, PSYCHOPHARMACOLOGY, V179, P662, DOI 10.1007/s00213-004-2080-7; Funk D, 2005, PSYCHOPHARMACOLOGY, V183, P341, DOI 10.1007/s00213-005-0194-1; Ghitza UE, 2007, J NEUROSCI, V27, P11522, DOI 10.1523/JNEUROSCI.5405-06.2007; Ghitza UE, 2006, NEUROPSYCHOPHARMACOL, V31, P2188, DOI 10.1038/sj.npp.1300964; GREENO CG, 1994, PSYCHOL BULL, V115, P444, DOI 10.1037/0033-2909.115.3.444; GRILO CM, 1989, J CONSULT CLIN PSYCH, V57, P488, DOI 10.1037/0022-006X.57.4.488; Grimm JW, 2000, NEUROPSYCHOPHARMACOL, V22, P473, DOI 10.1016/S0893-133X(99)00157-8; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P138, DOI 10.1037/0022-3514.60.1.138; Iemolo A, 2012, BEHAV PHARMACOL, V23, P593, DOI 10.1097/FBP.0b013e328357697f; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; KAYMAN S, 1990, AM J CLIN NUTR, V52, P800, DOI 10.1093/ajcn/52.5.800; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; KRAMER FM, 1989, INT J OBESITY, V13, P123; Lu L, 2004, PSYCHOPHARMACOLOGY, V176, P101, DOI 10.1007/s00213-004-1860-4; Martire SI, 2014, BEHAV BRAIN RES, V265, P132, DOI 10.1016/j.bbr.2014.02.027; McGuire MT, 1999, J CONSULT CLIN PSYCH, V67, P177, DOI 10.1037/0022-006X.67.2.177; Mitchell EN, 2012, BEHAV BRAIN RES, V234, P155, DOI 10.1016/j.bbr.2012.06.016; Nair SG, 2006, PHYSIOL BEHAV, V88, P559, DOI 10.1016/j.physbeh.2006.05.014; Nair SG, 2011, NEUROPSYCHOPHARMACOL, V36, P497, DOI 10.1038/npp.2010.181; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Nair SG, 2009, PSYCHOPHARMACOLOGY, V205, P129, DOI 10.1007/s00213-009-1523-6; Pankevich DE, 2010, J NEUROSCI, V30, P16399, DOI 10.1523/JNEUROSCI.1955-10.2010; Parylak SL, 2011, PHYSIOL BEHAV, V104, P149, DOI 10.1016/j.physbeh.2011.04.063; Peterson CB, 1999, J CLIN PSYCHOL, V55, P685, DOI 10.1002/(SICI)1097-4679(199906)55:6<685::AID-JCLP3>3.0.CO;2-Y; Pickens CL, 2012, PSYCHOPHARMACOLOGY, V221, P341, DOI 10.1007/s00213-011-2585-9; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136; Polivy J, 1999, INT J EAT DISORDER, V26, P153, DOI 10.1002/(SICI)1098-108X(199909)26:2&lt;153::AID-EAT4&gt;3.0.CO;2-R; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Sastre A, 2006, BEHAV BRAIN RES, V170, P34, DOI 10.1016/j.bbr.2006.01.026; See RE, 1999, DRUG ALCOHOL DEPEN, V57, P41, DOI 10.1016/S0376-8716(99)00043-5; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; Self DW, 1998, DRUG ALCOHOL DEPEN, V51, P49, DOI 10.1016/S0376-8716(98)00065-9; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shaham Y, 1996, J NEUROSCI, V16, P1957; SHAHAM Y, 1995, PSYCHOPHARMACOLOGY, V119, P334, DOI 10.1007/BF02246300; Shalev U, 2001, PSYCHOPHARMACOLOGY, V156, P98, DOI 10.1007/s002130100748; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Skender ML, 1996, J AM DIET ASSOC, V96, P342, DOI 10.1016/S0002-8223(96)00096-X; South T, 2012, PHYSIOL BEHAV, V105, P1052, DOI 10.1016/j.physbeh.2011.11.019; Spealman RD, 1999, PHARMACOL BIOCHEM BE, V64, P327, DOI 10.1016/S0091-3057(99)00049-0; STEWART J, 1992, PSYCHOPHARMACOLOGY, V108, P79, DOI 10.1007/BF02245289; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; Tannenbaum BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE1168, DOI 10.1152/ajpendo.1997.273.6.E1168; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Vendruscolo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009296; Weiss F, 2001, NEUROPSYCHOPHARMACOL, V25, P361, DOI 10.1016/S0893-133X(01)00238-X; WEST TEG, 1988, BRAIN RES, V462, P126, DOI 10.1016/0006-8993(88)90594-X; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004	73	30	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102213	10.1371/journal.pone.0102213	http://dx.doi.org/10.1371/journal.pone.0102213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025329	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992400051
J	Li, X; Wu, LH; Liu, W; Jin, YC; Chen, Q; Wang, LL; Fan, XH; Li, Z; Cheng, YY				Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Li, Zheng; Cheng, Yiyu			A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action	PLOS ONE			English	Article							PPAR-GAMMA AGONISTS; SIGNALING PATHWAYS; HEME OXYGENASE-1; RAW264.7; EXPRESSION; MECHANISMS; PROTEIN; LIPOPOLYSACCHARIDE; INFLAMMATION; THERAPEUTICS	Chinese medicine is a complex system guided by traditional Chinese medicine (TCM) theories, which has proven to be especially effective in treating chronic and complex diseases. However, the underlying modes of action (MOA) are not always systematically investigated. Herein, a systematic study was designed to elucidate the multi-compound, multi-target and multi-pathway MOA of a Chinese medicine, QiShenYiQi (QSYQ), on myocardial infarction. QSYQ is composed of Astragalus membranaceus (Huangqi), Salvia miltiorrhiza (Danshen), Panax notoginseng (Sanqi), and Dalbergia odorifera (Jiangxiang). Male Sprague Dawley rat model of myocardial infarction were administered QSYQ intragastrically for 7 days while the control group was not treated. The differentially expressed genes (DEGs) were identified from myocardial infarction rat model treated with QSYQ, followed by constructing a cardiovascular disease (CVD)-related multilevel compound-target-pathway network connecting main compounds to those DEGs supported by literature evidences and the pathways that are functionally enriched in ArrayTrack. 55 potential targets of QSYQ were identified, of which 14 were confirmed in CVD-related literatures with experimental supporting evidences. Furthermore, three sesquiterpene components of QSYQ, Trans-nerolidol, (3S, 6S, 7R)-3,7,11-trimethyl-3,6-epoxy-1,10-dodecadien-7-ol and (3S, 6R, 7R)-3,7,11-trimethyl- 3,6-epoxy-1,10-dodecadien-7-ol from Dalbergia odorifera T. Chen, were validated experimentally in this study. Their anti-inflammatory effects and potential targets including extracellular signal-regulated kinase-1/2, peroxisome proliferator-activated receptor-gamma and heme oxygenase-1 were identified. Finally, through a three-level compound-target-pathway network with experimental analysis, our study depicts a complex MOA of QSYQ on myocardial infarction.	[Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Cheng, Yiyu] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zheng] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Zhejiang University; Tianjin University of Traditional Chinese Medicine	Fan, XH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn; lizheng1@gmail.com	Wu, Leihong/AAM-9483-2020; FAN, Xiaohui/F-6458-2010; Bligh, S W Annie/AAI-9786-2020	Wu, Leihong/0000-0002-4093-3708; FAN, Xiaohui/0000-0002-6336-3007; Bligh, S W Annie/0000-0002-4757-2159; LI, Xiaojun/0000-0003-0336-8081	National Basic Research Program of China [2012CB518405]; National Natural Science Foundation of China [81373893]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (no. 2012CB518405) and the National Natural Science Foundation of China (no. 81373893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Microarray test was performed by National Engineering Center for Biochip at Shanghai by Dr. Huasheng Xiao's team.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Campbell IW, 2005, CURR MOL MED, V5, P349, DOI 10.2174/1566524053766068; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen T, 2011, JIANGXI MED J, V46, P3; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hirota SA, 2009, RECENT PATENTS INFLA, V3, P1, DOI 10.2174/187221309787158434; Hong SeChul, 2012, Journal of Medicinal Plants Research, V6, P4494; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Jeong JB, 2013, FOOD CHEM TOXICOL, V55, P229, DOI 10.1016/j.fct.2012.12.062; Ji HY, 2010, INFLAMM RES, V59, P921, DOI 10.1007/s00011-010-0203-7; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim BC, 2006, J ETHNOPHARMACOL, V106, P364, DOI 10.1016/j.jep.2006.01.009; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee M, 2012, STRAD, V123, P7; Li YF, 2008, J PHARMACEUT BIOMED, V47, P407, DOI 10.1016/j.jpba.2007.12.037; Li YF, 2008, CHROMATOGRAPHIA, V67, P293, DOI 10.1365/s10337-007-0479-0; Lin HY, 2003, BIOCHEM PHARMACOL, V66, P1821, DOI 10.1016/S0006-2952(03)00422-2; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Martin H, 2009, MUTAT RES-FUND MOL M, V669, P1, DOI 10.1016/j.mrfmmm.2009.06.009; Miksa M, 2007, J IMMUNOL, V179, P6263, DOI 10.4049/jimmunol.179.9.6263; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Robinson ES, 2010, SEMIN NEPHROL, V30, P591, DOI 10.1016/j.semnephrol.2010.09.007; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Suefuji H, 1997, AM HEART J, V134, P253, DOI 10.1016/S0002-8703(97)70132-7; Suh SJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P136, DOI 10.1016/j.abb.2006.01.016; Tang S, 2011, INFLAMMATION, V34, P111, DOI 10.1007/s10753-010-9214-3; Tao Y, 2010, FITOTERAPIA, V81, P393, DOI 10.1016/j.fitote.2009.11.012; Terzic A, 2011, CTS-CLIN TRANSL SCI, V4, P225, DOI 10.1111/j.1752-8062.2011.00295.x; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; von Knethen A, 2011, FREE RADICAL BIO MED, V51, P396, DOI 10.1016/j.freeradbiomed.2011.04.033; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Waldman SA, 2011, CLIN PHARMACOL THER, V90, P483, DOI 10.1038/clpt.2011.213; Wang Linli, 2013, Evid Based Complement Alternat Med, V2013, P652373, DOI 10.1155/2013/652373; [魏万林 WEI Wan-lin], 2009, [中国循环杂志, Chinese Circulation Journal], V24, P182; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu Leihong, 2013, Database (Oxford), V2013, pbat047, DOI 10.1093/database/bat047; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Yamaguchi F, 1997, J MOL CELL CARDIOL, V29, P753, DOI 10.1006/jmcc.1996.0319; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan F. F., 2007, SHANGHAI J TRADITION, V41, P59; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1; Zaytseva YY, 2011, ANTICANCER RES, V31, P813; Zhang L, 2010, INT J CARDIOL, V143, P105, DOI 10.1016/j.ijcard.2008.11.210; Zhang YF, 2012, CURR DRUG METAB, V13, P510, DOI 10.2174/1389200211209050510; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520; Zheng XH, 2007, AM J CHINESE MED, V35, P831, DOI 10.1142/S0192415X07005302; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; 朱明丹, 2013, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V24, P22; 刘梅, 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P829	80	220	235	12	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95004	10.1371/journal.pone.0095004	http://dx.doi.org/10.1371/journal.pone.0095004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24587076	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000010
